PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gong, C; Bauvy, C; Tonelli, G; Yue, W; Delomenie, C; Nicolas, V; Zhu, Y; Domergue, V; Marin-Esteban, V; Tharinger, H; Delbos, L; Gary-Gouy, H; Morel, AP; Ghavami, S; Song, E; Codogno, P; Mehrpour, M				Gong, C.; Bauvy, C.; Tonelli, G.; Yue, W.; Delomenie, C.; Nicolas, V.; Zhu, Y.; Domergue, V.; Marin-Esteban, V.; Tharinger, H.; Delbos, L.; Gary-Gouy, H.; Morel, A-P; Ghavami, S.; Song, E.; Codogno, P.; Mehrpour, M.			Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells	ONCOGENE			English	Article						breast cancer; autophagy; cancer stem-like/progenitor cell; Beclin 1	EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO PROPAGATION; SELF-RENEWAL; IDENTIFICATION; INHIBITION; MODULATION; ACTIVATION; INDUCTION; SURVIVAL; GROWTH	Malignant breast tissue contains a rare population of multi-potent cells with the capacity to self-renew; these cells are known as cancer stem-like cells (CSCs) or tumor-initiating cells. Primitive mammary CSCs/progenitor cells can be propagated in culture as floating spherical colonies termed 'mammospheres'. We show here that the expression of the autophagy protein Beclin 1 is higher in mammospheres established from human breast cancers or breast cancer cell lines (MCF-7 and BT474) than in the parental adherent cells. As a result, autophagic flux is more robust in mammospheres. We observed that basal and starvation-induced autophagy flux is also higher in aldehyde dehydrogenase 1-positive (ALDH1(+)) population derived from mammospheres than in the bulk population. Beclin 1 is critical for CSC maintenance and tumor development in nude mice, whereas its expression limits the development of tumors not enriched with breast CSCs/progenitor cells. We found that decreased survival in autophagy-deficient cells (MCF-7 Atg7 knockdown cells) during detachment does not contribute to an ultimate deficiency in mammosphere formation. This study demonstrates that a prosurvival autophagic pathway is critical for CSC maintenance, and that Beclin 1 plays a dual role in tumor development.	[Gong, C.; Bauvy, C.; Tonelli, G.; Yue, W.; Codogno, P.; Mehrpour, M.] INSERM, Fac Pharm, U984, Chatenay Malabry, France; [Gong, C.; Zhu, Y.; Song, E.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China; [Bauvy, C.; Tonelli, G.; Yue, W.; Delomenie, C.; Nicolas, V.; Domergue, V.; Marin-Esteban, V.; Tharinger, H.; Delbos, L.; Gary-Gouy, H.; Codogno, P.; Mehrpour, M.] Univ Paris 11, Fac Pharm, UMRS 996, F-92296 Chatenay Malabry, France; [Delomenie, C.; Nicolas, V.; Domergue, V.; Tharinger, H.; Delbos, L.; Gary-Gouy, H.] IFR 141 IPSIT, Fac Pharm, UMRS 996, Chatenay Malabry, France; [Marin-Esteban, V.] INSERM, Fac Pharm, UMRS 996, Chatenay Malabry, France; [Morel, A-P] INSERM, U520, F-69008 Lyon, France; [Ghavami, S.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Sun Yat Sen University; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Manitoba	Song, E (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	songerwei02@yahoo.com.cn; patrice.codogno@u-psud.fr; mehrpourmaryam@yahoo.fr	Marin-Esteban, Viviana/A-8856-2014; MOREL, Anne-Pierre/AAN-7072-2021; Mehrpour, Maryam/D-8640-2017; Ghavami, Saeid/Q-8918-2016; Ghavami, Saeid/GLT-0606-2022; Codogno, Patrice/G-1384-2013	Ghavami, Saeid/0000-0001-5948-508X; Codogno, Patrice/0000-0002-5492-3180; Delomenie, Claudine/0000-0002-6326-966X	INSERM; Universite Paris-Sud 11; PHC-PFCC programme francais de cooperation avec la Chine; INCa; ANR; National Natural Science Foundation of China [30830110, 30921140312, 30801376, 30972785, 81172524]; 973 Projects from Ministry of Science and Technology of China [2010CB912800, 2011CB504203, 2009CB521706]; Development of Important New Drugs from Ministry of Health of China [2011ZX09102-010-02]; Clinical Key Project of Public Health Administration of China; Sun Yat-sen University Training Project [11ykpy28, 11ykzd12]; Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University [KLB09001]; Parker B Francis Fellowship in Respiratory Disease	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Sud 11; PHC-PFCC programme francais de cooperation avec la Chine; INCa(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Projects from Ministry of Science and Technology of China; Development of Important New Drugs from Ministry of Health of China; Clinical Key Project of Public Health Administration of China; Sun Yat-sen University Training Project; Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University; Parker B Francis Fellowship in Respiratory Disease	We thank B Levine for providing us with the MCF-7.beclin 1 cell line, M Jaattela and N Brady for providing the MCF-7 GFP-LC3 and the mCherry-GFP-LC3 cell lines, respectively. We thank A Hamai for his careful reading of our manuscript. We thank N Modjtahedi for helpful discussions. This work was supported by grants from INSERM, Universite Paris-Sud 11, PHC-PFCC programme francais de cooperation avec la Chine, INCa, ANR, the National Natural Science Foundation of China (30830110, 30921140312, 30801376, 30972785, 81172524), 973 Projects from Ministry of Science and Technology of China (2010CB912800, 2011CB504203, 2009CB521706), Development of Important New Drugs from Ministry of Health of China (2011ZX09102-010-02), Clinical Key Project of Public Health Administration of China, Sun Yat-sen University Training Project (11ykpy28,11ykzd12) and Key Laboratory of malignant tumor gene regulation and target therapy of Guangdong Higher Education Institutes, Sun Yat-sen University (KLB09001). SG was supported with Parker B Francis Fellowship in Respiratory Disease.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gangemi R, 2009, CURR MED CHEM, V16, P1688, DOI 10.2174/092986709788186147; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Ghavami S, 2012, AM J PHYSIOL-LUNG C, V302, pL420, DOI 10.1152/ajplung.00312.2011; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2011, COLD SPRING HARB SYM, VLXXVI, P3; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Singh SK, 2003, CANCER RES, V63, P5821; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	50	246	255	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2013	32	18					2261	2272		10.1038/onc.2012.252	http://dx.doi.org/10.1038/onc.2012.252			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22733132	Green Published			2022-12-25	WOS:000318683600003
J	Nie, MH; Aslanian, A; Prudden, J; Heideker, J; Vashisht, AA; Wohlschlegel, JA; Yates, JR; Boddy, MN				Nie, Minghua; Aslanian, Aaron; Prudden, John; Heideker, Johanna; Vashisht, Ajay A.; Wohlschlegel, James A.; Yates, John R., III; Boddy, Michael N.			Dual Recruitment of Cdc48 (p97)-Ufd1-Npl4 Ubiquitin-selective Segregase by Small Ubiquitin-like Modifier Protein (SUMO) and Ubiquitin in SUMO-targeted Ubiquitin Ligase-mediated Genome Stability Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; AAA-ATPASE; AURORA-B; FISSION YEAST; REPLICATION; DEGRADATION; REPAIR; SUMOYLATION; CHECKPOINT	Protein modification by SUMO and ubiquitin critically impacts genome stability via effectors that "read" their signals using SUMO interaction motifs or ubiquitin binding domains, respectively. A novel mixed SUMO and ubiquitin signal is generated by the SUMO-targeted ubiquitin ligase (STUbL), which ubiquitylates SUMO conjugates. Herein, we determine that the "ubiquitin-selective" segregase Cdc48-Ufd1-Npl4 also binds SUMO via aSUMOinteraction motif in Ufd1 and can thus act as a selective receptor for STUbL targets. Indeed, we define key cooperative DNA repair functions for Cdc48-Ufd1-Npl4 and STUbL, thereby revealing a new signaling mechanism involving dual recruitment by SUMO and ubiquitin for Cdc48-Ufd1-Npl4 functions in maintaining genome stability.	[Nie, Minghua; Prudden, John; Heideker, Johanna; Boddy, Michael N.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Aslanian, Aaron] Salk Inst Biol Sci, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Salk Institute	Boddy, MN (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nboddy@scripps.edu			National Institutes of Health [GM068608, GM081840, GM093600, P41 RR011823]; Leukemia and Lymphoma Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081840, R01GM089778, R01GM068608, F32GM093600, P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM068608, GM081840 (to M. N. B.), GM093600 (to M. N.), and P41 RR011823 (to J. R. Y., III).; Supported by a Scholar Award from the Leukemia and Lymphoma Society.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heideker J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001320; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meyer H, 2010, BIOCHEM CELL BIOL, V88, P23, DOI [10.1139/o09-119, 10.1139/O09-119]; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morris JR, 2010, BIOCHEM SOC T, V38, P92, DOI 10.1042/BST0380092; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nakamura TM, 2005, MOL CELL BIOL, V25, P10721, DOI 10.1128/MCB.25.24.10721-10730.2005; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Parnas O, 2011, CELL CYCLE, V10, P2894, DOI 10.4161/cc.10.17.16778; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Ramanathan HN, 2011, MOL CELL, V44, P3, DOI 10.1016/j.molcel.2011.09.006; Rhind N, 1998, CURR OPIN CELL BIOL, V10, P749, DOI 10.1016/S0955-0674(98)80118-X; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Xie Y, 2010, GENE DEV, V24, P893, DOI 10.1101/gad.1906510; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003	50	63	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29610	29619		10.1074/jbc.M112.379768	http://dx.doi.org/10.1074/jbc.M112.379768			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22730331	Green Published, hybrid			2022-12-25	WOS:000308286900036
J	Bishop, DF; Tchaikovskii, V; Hoffbrand, AV; Fraser, ME; Margolis, S				Bishop, David F.; Tchaikovskii, Vassili; Hoffbrand, A. Victor; Fraser, Marie E.; Margolis, Steven			X-linked Sideroblastic Anemia Due to Carboxyl-terminal ALAS2 Mutations That Cause Loss of Binding to the beta-Subunit of Succinyl-CoA Synthetase (SUCLA2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; NUCLEOSIDE-DIPHOSPHATE KINASE; 5-AMINOLEVULINATE SYNTHASE; IRON OVERLOAD; PYRIDOXINE RESPONSIVENESS; HEME-BIOSYNTHESIS; GENE; ENCEPHALOMYOPATHY; ENZYME; SUBSTITUTION	Mutations in the erythroid-specific aminolevulinic acid synthase gene (ALAS2) cause X-linked sideroblastic anemia (XLSA) by reducing mitochondrial enzymatic activity. Surprisingly, a patient with the classic XLSA phenotype had a novel exon 11 mutation encoding a recombinant enzyme (p.Met567Val) with normal activity, kinetics, and stability. Similarly, both an expressed adjacent XLSA mutation, p.Ser568Gly, and a mutation (p.Phe557Ter) lacking the 31 carboxyl-terminal residues also had normal or enhanced activity, kinetics, and stability. Because ALAS2 binds to the beta subunit of succinyl-CoA synthetase (SUCLA2), the mutant proteins were tested for their ability to bind to this protein. Wild type ALAS2 bound strongly to a SUCLA2 affinity column, but the adjacent XLSA mutant enzymes and the truncated mutant did not bind. In contrast, vitamin B6-responsive XLSA mutations p. Arg452Cys and p.Arg452His, with normal in vitro enzyme activity and stability, did not interfere with binding to SUCLA2 but instead had loss of positive cooperativity for succinyl-CoA binding, an increased Km for succinyl-CoA, and reduced vitamin B6 affinity. Consistent with the association of SUCLA2 binding with in vivo ALAS2 activity, the p. Met567GlufsX2 mutant protein that causes X-linked protoporphyria bound strongly to SUCLA2, highlighting the probable role of an ALAS2-succinyl-CoA synthetase complex in the regulation of erythroid heme biosynthesis.	[Bishop, David F.; Tchaikovskii, Vassili; Margolis, Steven] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Hoffbrand, A. Victor] Royal Free Hosp, Dept Haematol, London NW3 2QG, England; [Fraser, Marie E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Icahn School of Medicine at Mount Sinai; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Calgary	Bishop, DF (corresponding author), 1425 Madison Ave, New York, NY 10029 USA.	david.bishop@mssm.edu	Bishop, David F./X-4102-2019	Bishop, David/0000-0003-1958-8601; Fraser, Marie/0000-0001-8501-1494	National Institutes of Health [R01DK40895]; New York State Department of Health [C024404]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK40895. This work was also supported by New York State Department of Health Research Grant C024404 and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada.	Anderson K. E., 2001, METABOLIC MOL BASES, P2991; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bertoldi M, 2005, BIOCHEM J, V389, P885, DOI 10.1042/BJ20050279; BISHOP DF, 1978, BIOCHIM BIOPHYS ACTA, V524, P109, DOI 10.1016/0005-2744(78)90109-2; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BOTTOMLEY SS, 1995, J BIOENERG BIOMEMBR, V27, P161, DOI 10.1007/BF02110031; Bottomley SS, 2009, WINTROBES CLIN HEMAT, P835; Camaschella C, 2008, BRIT J HAEMATOL, V143, P27, DOI 10.1111/j.1365-2141.2008.07290.x; Carrozzo R, 2007, BRAIN, V130, P862, DOI 10.1093/brain/awl389; Cazzola M, 2002, BLOOD, V100, P4236, DOI 10.1182/blood-2002-03-0685; Collins TS, 2004, AM J MED, V116, P501, DOI 10.1016/j.amjmed.2003.10.032; Cotter PD, 1999, BLOOD, V93, P1757, DOI 10.1182/blood.V93.5.1757.405a12_1757_1769; COTTER PD, 1992, P NATL ACAD SCI USA, V89, P4028, DOI 10.1073/pnas.89.9.4028; COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915; COTTER PD, 1995, J CLIN INVEST, V96, P2090, DOI 10.1172/JCI118258; Cox TC, 2004, INT J BIOCHEM CELL B, V36, P281, DOI 10.1016/S1357-2725(03)00246-2; COX TC, 1994, NEW ENGL J MED, V330, P675, DOI 10.1056/NEJM199403103301004; Dzikaite V, 2000, BLOOD, V96, P740; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1995, PROTEIN SCI, V4, P1001; Furuyama K, 2006, EUR J HAEMATOL, V76, P33, DOI 10.1111/j.1600-0609.2005.00541.x; Furuyama K, 2000, J CLIN INVEST, V105, P757, DOI 10.1172/JCI6816; Harigae H, 1999, BRIT J HAEMATOL, V106, P175, DOI 10.1046/j.1365-2141.1999.01479.x; Harigae H, 2010, INT J HEMATOL, V92, P425, DOI 10.1007/s12185-010-0688-4; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Kadirvel S, 2012, EXP HEMATOL, V40, P477, DOI 10.1016/j.exphem.2012.01.013; KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S; KAVANAUGHBLACK A, 1994, P NATL ACAD SCI USA, V91, P5883, DOI 10.1073/pnas.91.13.5883; Koc S, 1997, BLOOD, V90, P2756; Lee PL, 2006, BLOOD CELL MOL DIS, V36, P292, DOI 10.1016/j.bcmd.2005.12.004; Lendrihas T, 2010, J BIOL CHEM, V285, P13704, DOI 10.1074/jbc.M109.074237; MAUZERALL D, 1956, J BIOL CHEM, V219, P435; May A, 1998, HAEMATOLOGICA, V83, P56; Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383; Pereira J. C., 2004, HUM GENET, V115, P533; Segel I. H., 1975, ENZYME KINETICS, P360; URATA G, 1963, J BIOL CHEM, V238, P811; Valayannopoulos V, 2010, MITOCHONDRION, V10, P335, DOI 10.1016/j.mito.2010.02.006; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003	41	38	42	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28943	28955		10.1074/jbc.M111.306423	http://dx.doi.org/10.1074/jbc.M111.306423			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740690	hybrid, Green Published			2022-12-25	WOS:000308074600063
J	Jalak, J; Kurasin, M; Teugjas, H; Valjamae, P				Jalak, Juergen; Kurasin, Mihhail; Teugjas, Hele; Vaeljamaee, Priit			Endo-exo Synergism in Cellulose Hydrolysis Revisited	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; TRICHODERMA-REESEI CELLOBIOHYDROLASE; PHANEROCHAETE-CHRYSOSPORIUM CEL7D; CRYSTALLINE CELLULOSE; MICROCRYSTALLINE CELLULOSE; ENZYMATIC DECONSTRUCTION; LIGNOCELLULOSIC BIOMASS; INSOLUBLE CELLULOSE; ENDOGLUCANASE-I; CELLULASES	Synergistic cooperation of different enzymes is a prerequisite for efficient degradation of cellulose. The conventional mechanistic interpretation of the synergism between randomly acting endoglucanases (EGs) and chain end-specific processive cellobiohydrolases (CBHs) is that EG-generated new chain ends on cellulose surface serve as starting points for CBHs. Here we studied the hydrolysis of bacterial cellulose (BC) by CBH TrCel7A and EG TrCel5A from Trichoderma reesei under both single-turnover and "steady state" conditions. Unaccountable by conventional interpretation, the presence of EG increased the rate constant of TrCel7A-catalyzed hydrolysis of BC in steady state. At optimal enzyme/substrate ratios, the "steady state" rate of synergistic hydrolysis became limited by the velocity of processive movement of TrCel7A on BC. A processivity value of 66 +/- 7 cellobiose units measured for TrCel7A on C-14-labeled BC was close to the leveling off degree of polymerization of BC, suggesting that TrCel7A cannot pass through the amorphous regions on BC and stalls. We propose a mechanism of endo-exo synergism whereby the degradation of amorphous regions by EG avoids the stalling of TrCel7A and leads to its accelerated recruitment. Hydrolysis of pretreated wheat straw suggested that this mechanism of synergism is operative also in the degradation of lignocellulose. Although both mechanisms of synergism are used in parallel, the contribution of conventional mechanism is significant only at high enzyme/substrate ratios.	[Jalak, Juergen; Kurasin, Mihhail; Teugjas, Hele; Vaeljamaee, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51014 Tartu, Estonia	University of Tartu	Valjamae, P (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Vanemuise 46-138, EE-51014 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	European Union Commission [213139]; Estonian Science Foundation [9227]	European Union Commission(European Commission); Estonian Science Foundation	This work was supported by the European Union Commission (FP7/2007-2013, Grant 213139) and Estonian Science Foundation (Grant 9227).	Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; Boisset C, 2001, BIOTECHNOL BIOENG, V72, P339, DOI 10.1002/1097-0290(20010205)72:3<339::AID-BIT11>3.0.CO;2-#; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Chanzy H, 2011, CELLULOSE, V18, P853, DOI 10.1007/s10570-011-9547-6; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; FAGERSTAM LG, 1980, FEBS LETT, V119, P97, DOI 10.1016/0014-5793(80)81006-4; Fenske JJ, 1999, J THEOR BIOL, V199, P113, DOI 10.1006/jtbi.1999.0938; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao L, 2012, J BIOL CHEM, V287, P15906, DOI 10.1074/jbc.M111.332890; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Hoshino E, 1997, J FERMENT BIOENG, V84, P300, DOI 10.1016/S0922-338X(97)89248-3; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Kostylev M, 2012, BIOFUELS-UK, V3, P61, DOI 10.4155/BFS.11.150; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; MEDVE J, 1994, BIOTECHNOL BIOENG, V44, P1064, DOI 10.1002/bit.260440907; Mulakala C, 2005, PROTEINS, V60, P598, DOI 10.1002/prot.20547; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; Nishiyama Y, 2003, BIOMACROMOLECULES, V4, P1013, DOI 10.1021/bm025772x; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Riedel K, 1998, MOL MICROBIOL, V28, P767, DOI 10.1046/j.1365-2958.1998.00834.x; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Samejima M, 1997, CARBOHYD RES, V305, P281, DOI 10.1016/S0008-6215(97)10034-9; SELBY K, 1967, BIOCHEM J, V104, P716, DOI 10.1042/bj1040716; Sipos B, 2010, APPL BIOCHEM BIOTECH, V161, P347, DOI 10.1007/s12010-009-8824-4; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; STORVICK WO, 1960, J BIOL CHEM, V235, P303; Thomsen MH, 2006, APPL BIOCHEM BIOTECH, V130, P448; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Ubhayasekera W, 2005, FEBS J, V272, P1952, DOI 10.1111/j.1742-4658.2005.04625.x; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Valjamae P, 2001, EUR J BIOCHEM, V268, P4520, DOI 10.1046/j.1432-1327.2001.02377.x; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wilson DB, 2012, APPL MICROBIOL BIOT, V93, P497, DOI 10.1007/s00253-011-3701-9; WOOD TM, 1972, BIOCHEM J, V128, P1183, DOI 10.1042/bj1281183; WOODWARD J, 1988, BIO-TECHNOL, V6, P301, DOI 10.1038/nbt0388-301; WOODWARD J, 1991, BIORESOURCE TECHNOL, V36, P67, DOI 10.1016/0960-8524(91)90100-X; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	69	159	161	2	90	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28802	28815		10.1074/jbc.M112.381624	http://dx.doi.org/10.1074/jbc.M112.381624			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733813	Green Published, hybrid			2022-12-25	WOS:000308074600053
J	Bond, D; Foley, E				Bond, David; Foley, Edan			Autocrine Platelet-derived Growth Factor-Vascular Endothelial Growth Factor Receptor-related (Pvr) Pathway Activity Controls Intestinal Stem Cell Proliferation in the Adult Drosophila Midgut	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-INFECTION; TISSUE HOMEOSTASIS; PDGF/VEGF RECEPTOR; MULTIPLE PATHWAYS; MESSENGER-RNA; HOST-DEFENSE; MIGRATION; EGFR; REGENERATION; CANCER	A dynamic pool of undifferentiated somatic stem cells proliferate and differentiate to replace dead or dying mature cell types and maintain the integrity and function of adult tissues. Intestinal stem cells (ISCs) in the Drosophila posterior midgut are a well established model to study the complex genetic circuitry that governs stem cell homeostasis. Exposure of the intestinal epithelium to environmental toxins results in the expression of cytokines and growth factors that drive the rapid proliferation and differentiation of ISCs. In the absence of stress signals, ISC homeostasis is maintained through intrinsic pathways. In this study, we uncovered the PDGF- and VEGF-receptor related (Pvr) pathway as an essential regulator of ISC homeostasis under unstressed conditions in the posterior midgut. We found that Pvr is coexpressed with its ligand Pvf2 in ISCs and that hyperactivation of the Pvr pathway distorts the ISC developmental program and drives intestinal dysplasia. In contrast, we show that mutant ISCs in the Pvf/Pvr pathway are defective in homeostatic proliferation and differentiation, resulting in a failure to generate mature cell types. Additionally, we determined that extrinsic stress signals generated by enteropathogenic infection are epistatic to the hypoplasia generated in Pvf/Pvr mutants, making the Pvr pathway unique among all previously studied intrinsic pathways. Our findings illuminate an evolutionarily conserved signal transduction pathway with essential roles in metazoan embryonic development and direct involvement in numerous disease states.	[Bond, David; Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Foley, E (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	efoley@ualberta.ca			Canadian Institute for Heath Research Grant [MOP 77746]; Alberta Innovates Heath Solutions grant	Canadian Institute for Heath Research Grant; Alberta Innovates Heath Solutions grant	This work was supported by Canadian Institute for Heath Research Grant MOP 77746 and a Alberta Innovates Heath Solutions grant.	Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Choi NH, 2011, P NATL ACAD SCI USA, V108, P18702, DOI 10.1073/pnas.1109348108; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Liu W, 2010, J CELL BIOCHEM, V109, P992, DOI 10.1002/jcb.22482; Macias A, 2004, INT J DEV BIOL, V48, P1087, DOI 10.1387/ijdb.041859am; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Poernbacher I, 2012, CURR BIOL, V22, P389, DOI 10.1016/j.cub.2012.01.019; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sears HC, 2003, DEVELOPMENT, V130, P3557, DOI 10.1242/dev.00586; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sims D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r20; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Takashima S, 2011, DEV BIOL, V353, P161, DOI 10.1016/j.ydbio.2011.01.039; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Weber U, 2000, DEVELOPMENT, V127, P3619; Wu YJ, 2009, CURR BIOL, V19, P1473, DOI 10.1016/j.cub.2009.07.019; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Zeng XK, 2010, GENESIS, V48, P607, DOI 10.1002/dvg.20661	65	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27359	27370		10.1074/jbc.M112.378018	http://dx.doi.org/10.1074/jbc.M112.378018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722927	Green Published, hybrid			2022-12-25	WOS:000307840700008
J	Culham, DE; Meinecke, M; Wood, JM				Culham, Doreen E.; Meinecke, Michael; Wood, Janet M.			Impacts of the Osmolality and the Lumenal Ionic Strength on Osmosensory Transporter ProP in Proteoliposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETAINE CARRIER BETP; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; OSMOTIC ACTIVATION; COILED-COIL; WATER; ROLES; SOLUTES; PROTEIN; K+	H+ symporter ProP serves as a paradigm for the study of osmosensing. ProP attains the same activity at the same osmolality when the medium outside cells or proteoliposomes is supplemented with diverse, membrane-impermeant solutes. The osmosensory mechanism of ProP has been probed by varying the solvent within membrane vesicles and proteoliposomes. ProP activation was not ion specific, did not require K+, and could be elicited by large, uncharged solutes polyethylene glycols (PEGS). We hypothesized that ProP is an ionic strength sensor and lumenal macromolecules activate ProP by altering ion activities. The attainable range of lumenal ionic strength was expanded by lowering the phosphate concentration within proteoliposomes. ProP activity at high osmolality, but not the osmolality, yielding half-maximal activity (Pi(1/2)/RT), decreased with the lumenal phosphate concentration. This was attributed to acidification of the proteoliposome lumen due to H+-proline symport. The ionic strength yielding half-maximal ProP activity was more anion-dependent than Pi(1/2)/RT for proteoliposomes loaded with citrate, sulfate, phosphate, chloride, or iodide. The anion effects followed the Hofmeister series. Lumenal bovine serum albumin (BSA) lowered the lumenal ionic strength at which ProP became active. Osmolality measurements documented the non-idealities of solutions including potassium phosphate and other solutes. The impacts of PEGS and BSA on ion activities did not account for their impacts on ProP activity. The effects of the tested solutes on ProP appear to be non-coulombic in nature. They may arise from effects of preferential interactions and macromolecular crowding on the membrane or on ProP.	[Culham, Doreen E.; Meinecke, Michael; Wood, Janet M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Wood, JM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jwood@uoguelph.ca	Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951	Canadian Institutes for Health Research Operating [MOP-89990]	Canadian Institutes for Health Research Operating(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Operating Grant MOP-89990 (to J. M. W.) and by a travel award by the Muhlenhoff Stiftung (to M. M.).	[Anonymous], 1888, ARCH EXP PATHOL PHAR, DOI DOI 10.1007/BF01918191; BENGA G, 1984, PROG BIOPHYS MOL BIO, V43, P195, DOI 10.1016/0079-6107(84)90014-2; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; Culham DE, 2000, J MOL RECOGNIT, V13, P309, DOI 10.1002/1099-1352(200009/10)13:5<309::AID-JMR505>3.3.CO;2-I; CULHAM DE, 1993, J MOL BIOL, V229, P268, DOI 10.1006/jmbi.1993.1030; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Culham DE, 2008, BIOCHEMISTRY-US, V47, P13584, DOI 10.1021/bi801576x; ERTEL A, 1993, BIOPHYS J, V64, P426, DOI 10.1016/S0006-3495(93)81383-3; Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haussinger D, 2007, METHOD ENZYMOL, V428, P1; Karasawa A, 2011, J BIOL CHEM, V286, P37280, DOI 10.1074/jbc.M111.284059; Keates RAB, 2010, BIOCHEMISTRY-US, V49, P8847, DOI 10.1021/bi101281f; Konopka MC, 2007, METHOD ENZYMOL, V428, P487, DOI 10.1016/S0076-6879(07)28027-9; Koynova R, 1997, EUR BIOPHYS J BIOPHY, V25, P261, DOI 10.1007/s002490050038; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Parsegian VA, 2002, INT REV CYTOL, V215, P1; Pegram LM, 2007, J PHYS CHEM B, V111, P5411, DOI 10.1021/jp070245z; Pegram Laurel M., 2009, V490, P179, DOI 10.1007/978-1-59745-367-7_8; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Poolman B, 2002, MOL MICROBIOL, V44, P889, DOI 10.1046/j.1365-2958.2002.02894.x; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; ROBINSON DR, 1965, J AM CHEM SOC, V87, P2470, DOI 10.1021/ja01089a029; Romantsov T, 2008, J BIOL CHEM, V283, P12314, DOI 10.1074/jbc.M709871200; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Rubenhagen R, 2000, J BIOL CHEM, V275, P735, DOI 10.1074/jbc.275.2.735; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SANDERSON PW, 1991, BIOCHIM BIOPHYS ACTA, V1067, P43, DOI 10.1016/0005-2736(91)90024-3; Schiller D, 2006, J BIOL CHEM, V281, P7737, DOI 10.1074/jbc.M513052200; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; SEIGNEURET M, 1985, FEBS LETT, V188, P101, DOI 10.1016/0014-5793(85)80883-8; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Von Hippel P. H., 1969, STRUCTURE STABILITY, P417; Waggoner A S, 1979, Methods Enzymol, V55, P689; White GF, 2000, BBA-BIOMEMBRANES, V1468, P175, DOI 10.1016/S0005-2736(00)00255-8; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zhang WT, 1996, BIOCHEMISTRY-US, V35, P10506, DOI 10.1021/bi960795f; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	49	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27813	27822		10.1074/jbc.M112.387936	http://dx.doi.org/10.1074/jbc.M112.387936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740696	Green Published, hybrid			2022-12-25	WOS:000307840700055
J	Paleskava, A; Konevega, AL; Rodnina, MV				Paleskava, Alena; Konevega, Andrey L.; Rodnina, Marina V.			Thermodynamics of the GTP-GDP-operated Conformational Switch of Selenocysteine-specific Translation Factor SelB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR SELB; ISOTHERMAL TITRATION CALORIMETRY; CRYSTAL-STRUCTURE; FACTOR TU; TRANSFER-RNA; RECOGNITION; PROTEINS; BINDING; NUCLEOTIDES; RIBOSOME	SelB is a specialized translation factor that binds GTP and GDP and delivers selenocysteyl-tRNA (Sec-tRNA(Sec)) to the ribosome. By analogy to elongation factor Tu (EF-Tu), SelB is expected to control the delivery and release of Sec-tRNA(Sec) to the ribosome by the structural switch between GTP- and GDP-bound conformations. However, crystal structures of SelB suggested a similar domain arrangement in the apo form and GDP- and GTP-bound forms of the factor, raising the question of how SelB can fulfill its delivery function. Here, we studied the thermodynamics of guanine nucleotide binding to SelB by isothermal titration calorimetry in the temperature range between 10 and 25 degrees C using GTP, GDP, and two nonhydrolyzable GTP analogs, guanosine 5'-O-(gamma-thio) triphosphate (GTP gamma S) and guanosine 5'-(beta,gamma-imido)-triphosphate (GDPNP). The binding of SelB to either guanine nucleotide is characterized by a large heat capacity change (-621, -467, -235, and -275 cal x mol(-1) x K-1, with GTP, GTP gamma S, GDPNP, and GDP, respectively), associated with compensatory changes in binding entropy and enthalpy. Changes in heat capacity indicate a large decrease of the solvent-accessible surface area in SelB, amounting to 43 or 32 amino acids buried upon binding of GTP or GTP gamma S, respectively, and 15-19 amino acids upon bindingGDP or GDPNP. The similarity of the GTP and GDP forms in the crystal structures can be attributed to the use of GDPNP, which appears to induce a structure of SelB that is more similar to the GDP than to the GTP-bound form.	[Paleskava, Alena; Konevega, Andrey L.; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, Fassberg 11, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Paleskava, Alena/AAO-7332-2020; Rodnina, Marina V./AAD-4667-2019; Konevega, Andrey L./B-7887-2008	Rodnina, Marina V./0000-0003-0105-3879; Konevega, Andrey L./0000-0003-0125-7150; Paleskava, Alena/0000-0001-8623-8404	Deutsche Forschungsgemeinschaft; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and by the funding of the Max Planck Society.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Allmang C, 2006, BIOCHIMIE, V88, P1561, DOI 10.1016/j.biochi.2006.04.015; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Doyle M, 1999, CURRENT PROTOCOLS PR, P2041; Fischer N, 2007, BIOL CHEM, V388, P1061, DOI 10.1515/BC.2007.108; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hauryliuk V, 2008, P NATL ACAD SCI USA, V105, P15678, DOI 10.1073/pnas.0807912105; Hauryliuk V, 2009, J MOL BIOL, V394, P621, DOI 10.1016/j.jmb.2009.10.015; Hilgenfeld R, 1996, BIOCHIMIE, V78, P971, DOI 10.1016/S0300-9084(97)86719-3; Hilgenfeld R, 1995, CURR OPIN STRUC BIOL, V5, P810, DOI 10.1016/0959-440X(95)80015-8; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Keeling PJ, 1998, J MOL EVOL, V47, P649, DOI 10.1007/PL00006422; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; MURPHY KP, 1992, J MOL BIOL, V227, P293, DOI 10.1016/0022-2836(92)90699-K; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Paleskava A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.081380; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Samanta U, 2002, PROTEIN ENG, V15, P659, DOI 10.1093/protein/15.8.659; Schrader JM, 2011, P NATL ACAD SCI USA, V108, P5215, DOI 10.1073/pnas.1102128108; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; Thanbichler M, 2003, PROTEIN EXPRES PURIF, V31, P265, DOI 10.1016/S1046-5928(03)00167-0; Yoshizawa S, 2005, NAT STRUCT MOL BIOL, V12, P198, DOI 10.1038/nsmb890; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010	36	19	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27906	27912		10.1074/jbc.M112.366120	http://dx.doi.org/10.1074/jbc.M112.366120			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740700	Green Published, hybrid			2022-12-25	WOS:000307840700064
J	Wilhelms, M; Fulton, KM; Twine, SM; Tomas, JM; Merino, S				Wilhelms, Markus; Fulton, Kelly M.; Twine, Susan M.; Tomas, Juan M.; Merino, Susana			Differential Glycosylation of Polar and Lateral Flagellins in Aeromonas hydrophila AH-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN GLYCOSYLATION; BIOSYNTHESIS; MOTILITY; PATHWAY; ISLAND	Polar and lateral flagellin proteins from Aeromonas hydrophila strain AH-3 (serotype O34) were found to be glycosylated with different carbohydrate moieties. The lateral flagellin was modified at three sites in O-linkage, with a single monosaccharide of 376 Da, which we show to be a pseudaminic acid derivative. The polar flagellin was modified with a heterogeneous glycan, comprised of a heptasaccharide, linked through the same 376-Da sugar to the protein backbone, also in O-linkage. In-frame deletion mutants of pseudaminic acid biosynthetic genes pseB and pseF homologues resulted in abolition of polar and lateral flagellar formation by posttranscriptional regulation of the flagellins, which was restored by complementation with wild type pseB or F homologues or Campylobacter pseB and F.	[Wilhelms, Markus; Tomas, Juan M.; Merino, Susana] Univ Barcelona, Fac Biol, Dept Microbiol, E-08071 Barcelona, Spain; [Fulton, Kelly M.; Twine, Susan M.] CNR, Ottawa, ON K1A 0R1, Canada	University of Barcelona; National Research Council Canada	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Diagonal 643, E-08071 Barcelona, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia); National Research Council Canada	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya); National Research Council Canada	This work was supported by Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain), Generalitat de Catalunya (Centre de Referencia en Biotecnologia), and the National Research Council Canada.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arora SK, 2004, J BACTERIOL, V186, P2115, DOI 10.1128/JB.186.7.2115-2122.2004; Canals R, 2006, J BACTERIOL, V188, P852, DOI 10.1128/JB.188.3.852-862.2006; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Canals R, 2007, MICROBIOL-SGM, V153, P1165, DOI 10.1099/mic.0.2006/000687-0; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; Gavin R, 2002, MOL MICROBIOL, V43, P383, DOI 10.1046/j.1365-2958.2002.02750.x; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jimenez N, 2009, J BACTERIOL, V191, P2228, DOI 10.1128/JB.01395-08; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Kirov SM, 2002, J BACTERIOL, V184, P547, DOI 10.1128/JB.184.2.547-555.2002; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nogueras MM, 2000, INFECT IMMUN, V68, P1849, DOI 10.1128/IAI.68.4.1849-1854.2000; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; SHIMADA T, 1985, JPN J MED SCI BIOL, V38, P141, DOI 10.7883/yoken1952.38.141; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Tabei SMB, 2009, J BACTERIOL, V191, P2851, DOI 10.1128/JB.01406-08; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Twine SM, 2012, BACTERIAL GLYCOMICS: CURRENT RESEARCH, TECHNOLOGY AND APPLICATIONS, P69; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wilhelms M, 2011, J BACTERIOL, V193, P5179, DOI 10.1128/JB.05355-11	37	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27851	27862		10.1074/jbc.M112.376525	http://dx.doi.org/10.1074/jbc.M112.376525			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733809	Green Published, hybrid			2022-12-25	WOS:000307840700059
J	Zhong, YW; Fang, SY				Zhong, Yongwang; Fang, Shengyun			Live Cell Imaging of Protein Dislocation from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN-PROTEASOME PATHWAY; QUALITY-CONTROL; MUTANT ALPHA-1-ANTITRYPSIN; MISFOLDED GLYCOPROTEINS; RETRO-TRANSLOCATION; LIGASE COMPLEX; IMPORTIN-BETA; EGF RECEPTOR; AAA-ATPASE	Misfolded proteins in the endoplasmic reticulum (ER) are dislocated to the cytosol to be degraded by the proteasomes. Various plant and bacterial toxins and certain viruses hijack this dislocation pathway to exert their toxicity or to infect cells. In this study, we report a dislocation-dependent reconstituted GFP (drGFP) assay that allows, for the first time, imaging proteins dislocated from the ER lumen to the cytosol in living cells. Our results indicate that both luminal and membrane-spanning ER proteins can be fully dislocated from the ER to the cytosol. By combining the drGFP assay with RNAi or chemical inhibitors of proteins in the Hrd1 ubiquitin ligase complex, we demonstrate that the Sel1L, Hrd1, p97/VCP, and importin beta proteins are required for the dislocation of misfolded luminal alpha-1 antitrypsin. The strategy described in this work is broadly applicable to the study of other types of transmembrane transport of proteins and likely also of viruses and toxins in living cells.	[Fang, Shengyun] Univ Maryland, Sch Med, Dept Physiol, Ctr Biomed Engn & Technol,BioMET, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Fang, SY (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Ctr Biomed Engn & Technol,BioMET, 725 W Lombard St, Baltimore, MD 21201 USA.	sfang@umaryland.edu	Fang, Shengyun/H-3802-2011; Zhong, Yongwang/A-2527-2012	Fang, Shengyun/0000-0001-7280-5463	NSF [1120833]	NSF(National Science Foundation (NSF))	This work was supported by NSF Grant 1120833 (to S.F.).	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200; Zhong YW, 2011, J BIOL CHEM, V286, P33921, DOI 10.1074/jbc.M111.272906	63	23	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28057	28066		10.1074/jbc.M112.381798	http://dx.doi.org/10.1074/jbc.M112.381798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722934	Green Published, hybrid			2022-12-25	WOS:000307840700079
J	Kim, BM; Thier, MC; Oh, S; Sherwood, R; Kanellopoulou, C; Edenhofer, F; Choi, MY				Kim, Byeong-Moo; Thier, Marc-Christian; Oh, Sangnam; Sherwood, Richard; Kanellopoulou, Chryssa; Edenhofer, Frank; Choi, Michael Y.			MicroRNAs Are Indispensable for Reprogramming Mouse Embryonic Fibroblasts into Induced Stem Cell-Like Cells	PLOS ONE			English	Article							MICROPROCESSOR COMPLEX; RNA INTERFERENCE; NUCLEAR EXPORT; ENZYME DICER; BIOGENESIS; PLURIPOTENCY; EXPRESSION; GENERATION; DIFFERENTIATION; MIR-302	MicroRNAs play a pivotal role in cellular maintenance, proliferation, and differentiation. They have also been implicated to play a key role in disease pathogenesis, and more recently, cellular reprogramming. Certain microRNA clusters can enhance or even directly induce reprogramming, while repressing key proteins involved in microRNA processing decreases reprogramming efficiency. Although microRNAs clearly play important roles in cellular reprogramming, it remains unknown whether microRNAs are absolutely necessary. We endeavored to answer this fundamental question by attempting to reprogram Dicer-null mouse embryonic fibroblasts (MEFs) that lack almost all functional microRNAs using a defined set of transcription factors. Transduction of reprogramming factors using either lentiviral or piggyBac transposon vector into two, independently derived lines of Dicer-null MEFs failed to produce cells resembling embryonic stem cells (ESCs). However, expression of human Dicer in the Dicer-null MEFs restored their reprogramming potential. Our study demonstrates for the first time that microRNAs are indispensable for dedifferentiation reprogramming.	[Kim, Byeong-Moo; Oh, Sangnam; Choi, Michael Y.] Massachusetts Gen Hosp, Dept Med, GI Unit, Boston, MA 02114 USA; [Kim, Byeong-Moo; Oh, Sangnam; Sherwood, Richard; Choi, Michael Y.] Harvard Univ, Sch Med, Boston, MA USA; [Thier, Marc-Christian; Edenhofer, Frank] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, Bonn, Germany; [Sherwood, Richard] Brigham & Womens Hosp, Boston, MA 02115 USA; [Kanellopoulou, Chryssa] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bonn; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kim, BM (corresponding author), Massachusetts Gen Hosp, Dept Med, GI Unit, Boston, MA 02114 USA.	mchoi@partners.org	Edenhofer, Frank/ABG-9458-2020	Edenhofer, Frank/0000-0002-6489-714X	NIH [K08 DK078641]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K08DK078641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by NIH grants to M.Y.C. (K08 DK078641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Havens MA, 2012, NUCL ACIDS RES; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]	39	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39239	10.1371/journal.pone.0039239	http://dx.doi.org/10.1371/journal.pone.0039239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737231	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100029
J	Nishida, N; Sawai, H; Matsuura, K; Sugiyama, M; Ahn, SH; Park, JY; Hige, S; Kang, JH; Suzuki, K; Kurosaki, M; Asahina, Y; Mochida, S; Watanabe, M; Tanaka, E; Honda, M; Kaneko, S; Orito, E; Itoh, Y; Mita, E; Tamori, A; Murawaki, Y; Hiasa, Y; Sakaida, I; Korenaga, M; Hino, K; Ide, T; Kawashima, M; Mawatari, Y; Sageshima, M; Ogasawara, Y; Koike, A; Izumi, N; Han, KH; Tanaka, Y; Tokunaga, K; Mizokami, M				Nishida, Nao; Sawai, Hiromi; Matsuura, Kentaro; Sugiyama, Masaya; Ahn, Sang Hoon; Park, Jun Yong; Hige, Shuhei; Kang, Jong-Hon; Suzuki, Kazuyuki; Kurosaki, Masayuki; Asahina, Yasuhiro; Mochida, Satoshi; Watanabe, Masaaki; Tanaka, Eiji; Honda, Masao; Kaneko, Shuichi; Orito, Etsuro; Itoh, Yoshito; Mita, Eiji; Tamori, Akihiro; Murawaki, Yoshikazu; Hiasa, Yoichi; Sakaida, Isao; Korenaga, Masaaki; Hino, Keisuke; Ide, Tatsuya; Kawashima, Minae; Mawatari, Yoriko; Sageshima, Megumi; Ogasawara, Yuko; Koike, Asako; Izumi, Namiki; Han, Kwang-Hyub; Tanaka, Yasuhito; Tokunaga, Katsushi; Mizokami, Masashi			Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean	PLOS ONE			English	Article							VIRUS CLEARANCE; MANAGEMENT; LOCUS	Hepatitis B virus (HBV) infection can lead to serious liver diseases, including liver cirrhosis (LC) and hepatocellular carcinoma (HCC); however, about 85-90% of infected individuals become inactive carriers with sustained biochemical remission and very low risk of LC or HCC. To identify host genetic factors contributing to HBV clearance, we conducted genome-wide association studies (GWAS) and replication analysis using samples from HBV carriers and spontaneously HBV-resolved Japanese and Korean individuals. Association analysis in the Japanese and Korean data identified the HLA-DPA1 and HLA-DPB1 genes with P-meta = 1.89 x 10(-12) for rs3077 and P-meta = 9.69 x 10(-10) for rs9277542. We also found that the HLA-DPA1 and HLA-DPB1 genes were significantly associated with protective effects against chronic hepatitis B (CHB) in Japanese, Korean and other Asian populations, including Chinese and Thai individuals (P-meta = 4.40 x 10(-19) for rs3077 and P-meta = 1.28 x 10(-15) for rs9277542). These results suggest that the associations between the HLA-DP locus and the protective effects against persistent HBV infection and with clearance of HBV were replicated widely in East Asian populations; however, there are no reports of GWAS in Caucasian or African populations. Based on the GWAS in this study, there were no significant SNPs associated with HCC development. To clarify the pathogenesis of CHB and the mechanisms of HBV clearance, further studies are necessary, including functional analyses of the HLA-DP molecule.	[Nishida, Nao; Sugiyama, Masaya; Mawatari, Yoriko; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan; [Nishida, Nao; Sawai, Hiromi; Kawashima, Minae; Mawatari, Yoriko; Sageshima, Megumi; Ogasawara, Yuko; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Bunkyo Ku, Tokyo, Japan; [Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Ahn, Sang Hoon; Park, Jun Yong; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Hige, Shuhei] Hokkaido Univ, Dept Internal Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Kang, Jong-Hon] Teine Keijinkai Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan; [Suzuki, Kazuyuki] Iwate Med Univ, Dept Gastroenterol & Hepatol, Morioka, Iwate 020, Japan; [Kurosaki, Masayuki; Asahina, Yasuhiro; Izumi, Namiki] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Tokyo, Japan; [Mochida, Satoshi] Saitama Med Univ, Div Gastroenterol & Hepatol, Saitama, Japan; [Watanabe, Masaaki] Kitasato Univ, Sch Med, Dept Gastroenterol, Sagamihara, Kanagawa 228, Japan; [Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 390, Japan; [Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Dept Gastroenterol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Orito, Etsuro] Nagoya Daini Red Cross Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Itoh, Yoshito] Kyoto Prefectural Univ Med, Kyoto, Japan; [Mita, Eiji] Osaka Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Osaka, Japan; [Tamori, Akihiro] Osaka City Univ, Dept Hepatol, Grad Sch Med, Osaka 558, Japan; [Murawaki, Yoshikazu] Tottori Univ, Fac Med, Dept Internal Med 2, Yonago, Tottori 683, Japan; [Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan; [Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Korenaga, Masaaki; Hino, Keisuke] Kawasaki Med Coll, Div Hepatol & Pancreatol, Kurashiki, Okayama, Japan; [Ide, Tatsuya] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Fukuoka, Japan; [Koike, Asako] Hitachi Ltd, Cent Res Lab, Kokubunji, Tokyo 185, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; Nagoya City University; Nagoya City University; Yonsei University; Yonsei University Health System; Hokkaido University; Teine Keijinkai Hospital; Iwate Medical University; Saitama Medical University; Kitasato University; Shinshu University; Kanazawa University; Japanese Red Cross Nagoya Daini Hospital; Kyoto Prefectural University of Medicine; Osaka National Hospital; Osaka Metropolitan University; Tottori University; Ehime University; Yamaguchi University; Kawasaki Medical School; Kurume University; Hitachi Limited	Nishida, N (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba, Japan.	nishida-75@umin.ac.jp	Hiasa, Yoichi/ABD-2759-2021; Park, Jun Yong/H-7127-2019; Korenaga, Masaaki/AAE-7479-2020	Hiasa, Yoichi/0000-0003-4117-339X; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Jun Yong/0000-0001-6324-2224; Tanaka, Yasuhito/0000-0002-2473-6966; Ahn, Sang Hoon/0000-0002-3629-4624	Ministry of Health, Labour, and Welfare of Japan [H22-kanen-005, H23-kanen-005]; Japan Science and Technology Agency [09038024]; Miyakawa Memorial Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology [22710191]; Grants-in-Aid for Scientific Research [22133008, 23590985, 24790728, 24590960] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Miyakawa Memorial Research Foundation; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Health, Labour, and Welfare of Japan (H22-kanen-005, H23-kanen-005), the Japan Science and Technology Agency (09038024), and the Miyakawa Memorial Research Foundation. Partial support by Grant-in-Aid for Young Scientists (B) (22710191) from the Ministry of Education, Culture, Sports, Science, and Technology is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2011, J INFECT DIS, V203, P943, DOI 10.1093/infdis/jiq154; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Godkin A, 2005, HEPATOLOGY, V41, P1383, DOI 10.1002/hep.20716; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hu L, 2011, HEPATOLOGY IN PRESS; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kobayashi M, 2008, J MED VIROL, V80, P1880, DOI 10.1002/jmv.21309; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024221; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Miyagawa T, 2008, J HUM GENET, V53, P886, DOI 10.1007/s10038-008-0322-y; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Nishida N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029967; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; STEVENS CE, 1992, PEDIATRICS, V90, P170; SZMUNESS W, 1979, J MED VIROL, V4, P327, DOI 10.1002/jmv.1890040411; Tada Hiroshi, 1992, Acta Paediatrica Japonica, V34, P656; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Yano K, 2010, INTERVIROLOGY, V53, P70, DOI 10.1159/000252788; Yokosuka O, 2011, HEPATOL RES, V41, P1, DOI 10.1111/j.1872-034X.2010.00739.x	22	114	122	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39175	10.1371/journal.pone.0039175	http://dx.doi.org/10.1371/journal.pone.0039175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737229	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100027
J	Artmann, S; Jung, K; Bleckmann, A; Beissbarth, T				Artmann, Stephan; Jung, Klaus; Bleckmann, Annalen; Beissbarth, Tim			Detection of Simultaneous Group Effects in MicroRNA Expression and Related Target Gene Sets	PLOS ONE			English	Article							GLOBAL TEST; PROFILES; VARIANCE	Expression levels of mRNAs are among other factors regulated by microRNAs. A particular microRNA can bind specifically to several target mRNAs and lead to their degradation. Expression levels of both, mRNAs and microRNAs, can be obtained by microarray experiments. In order to increase the power of detecting microRNAs that are differentially expressed between two different groups of samples, we incorporate expression levels of their related target gene sets. Group effects are determined individually for each microRNA, and by enrichment tests and global tests for target gene sets. The resulting lists of p-values from individual and set-wise testing are combined by means of meta analysis. We propose a new approach to connect microRNA-wise and gene set-wise information by means of p-value combination as often used in meta-analysis. In this context, we evaluate the usefulness of different approaches of gene set tests. In a simulation study we reveal that our combination approach is more powerful than microRNA-wise testing alone. Furthermore, we show that combining microRNA-wise results with 'competitive' gene set tests maintains a pre-specified false discovery rate. In contrast, a combination with 'self-contained' gene set tests can harm the false discovery rate, particularly when gene sets are not disjunct.	[Artmann, Stephan; Jung, Klaus; Bleckmann, Annalen; Beissbarth, Tim] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Bleckmann, Annalen] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany	University of Gottingen; University of Gottingen	Artmann, S (corresponding author), Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany.	tim.beissbarth@med.uni-goettingen.de	Beissbarth, Tim/B-3129-2013	Beissbarth, Tim/0000-0001-6509-2143; Jung, Klaus/0000-0001-9955-748X	Deutsche Forschungsgemeinschaft (clinical research group KFO 179); German Ministry of Education and Research (BMBF) grant BreastSys from the platform MedSys; Deutsche Forschungsgemeinschaft, research group FOR 942	Deutsche Forschungsgemeinschaft (clinical research group KFO 179)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF) grant BreastSys from the platform MedSys(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft, research group FOR 942(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) (clinical research group KFO 179), research group FOR 942 as well as from the German Ministry of Education and Research (BMBF) (http://www.bmbf.de/) grant BreastSys from the platform MedSys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley AN, 2011, CLIN CANCER RES, V17, P7283, DOI 10.1158/1078-0432.CCR-11-1452; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Brunner E., 2009, P 6 ST PET WORKSH SI, P605; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Fisher R., 1970, STAT METHODS RES WOR; Genovesi LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023935; Goeman JJ, 2008, BIOINFORMATICS, V24, P537, DOI 10.1093/bioinformatics/btm628; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hummel M, 2008, BIOINFORMATICS, V24, P78, DOI 10.1093/bioinformatics/btm531; Jung K, 2011, BIOINFORMATICS, V27, P1377, DOI 10.1093/bioinformatics/btr152; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Langsrud O, 2005, STAT COMPUT, V15, P53, DOI 10.1007/s11222-005-4789-5; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Manakov SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-419; Mansmann U, 2005, METHOD INFORM MED, V44, P449; Marot G, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1368; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stouffer S. A., 1949, AM SOLDIER, V1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401	38	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38365	10.1371/journal.pone.0038365	http://dx.doi.org/10.1371/journal.pone.0038365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723856	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700014
J	Cai, XL; Han, XY; Luo, YY; Ji, LN				Cai, Xiaoling; Han, Xueyao; Luo, Yingying; Ji, Linong			Analysis of Insulin Doses of Chinese Type 2 Diabetic Patients with Intensive Insulin Treatment	PLOS ONE			English	Article							BASAL-BOLUS REGIMEN; BEDTIME NPH INSULIN; CONSENSUS ALGORITHM; GLYCEMIC CONTROL; THERAPY; GLARGINE; MANAGEMENT; DETEMIR; HYPERGLYCEMIA; HYPOGLYCEMIA	Background: To investigate the daily insulin doses and the ratio of basal insulin to total daily insulin in Chinese type 2 diabetic patients who received basal bolus insulin therapy. Methodology/Principal Findings: Totally 2480 patients prescribed with pre-meal bolus insulin and bedtime basal insulin were included. The mean daily insulin doses was 38.22 +/- 14.92 IU/day, the mean daily insulin doses per weight was 0.58 +/- 0.22 IU/kg, the mean bolus insulin dose was 0.44 +/- 0.17 IU/kg and the mean basal insulin dose was 0.13 +/- 0.08 IU/kg. The mean basal/total daily insulin ratio (BD/TDD) was 0.23 +/- 0.08. In most patients (47.94%), the BD/TDD was between 0.20 and 0.30. Diabetic duration, BMI, HbA1c, fasting and postprandial blood glucose level were positively associated with daily insulin dose, while age was negatively associated with daily insulin dose. Diabetic duration, BMI, HbA1c, fasting blood glucose level, and using metformin were positively associated with BD/TDD ratio, while age, postprandial C peptide, postprandial blood glucose level and CRE level were negatively associated with BD/TDD ratio. Conclusions/Significance: The daily insulin doses of intensive treatment in Chinese type 2 diabetic patients was 38.22 IU/day, the mean daily insulin doses per weight was 0.58 IU/kg, mean BD/TDD ratio was 0.23.	[Cai, Xiaoling; Han, Xueyao; Luo, Yingying; Ji, Linong] Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing 100871, Peoples R China	Peking University	Cai, XL (corresponding author), Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Beijing 100871, Peoples R China.	prof_jilinong@yahoo.cn	Linong, Ji/AAB-6543-2020	Cai, Xiaoling/0000-0002-7881-0543				Fonseca V, 2004, AM J MED SCI, V328, P274, DOI 10.1097/00000441-200411000-00007; Goudswaard AN, 2004, COCHRANE DATABASE SY; Hirsch I, 2005, CLIN DIABETES, V23, P78, DOI DOI 10.2337/DIACLIN.23.2.78]; Hollander P, 2008, CLIN THER, V30, P1976, DOI 10.1016/j.clinthera.2008.11.001; Masuda H, 2008, DIABETES OBES METAB, V10, P1261, DOI 10.1111/j.1463-1326.2008.00897.x; Miyashita Y, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-16; Nathan DM, 2006, DIABETOLOGIA, V49, P1711, DOI 10.1007/s00125-006-0316-2; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Raskin P, 2009, DIABETES-METAB RES, V25, P542, DOI 10.1002/dmrr.989; Rosenstock J, 2004, AM J MED, V116, P10, DOI 10.1016/j.amjmed.2003.12.004; Rosenstock J, 2008, DIABETES CARE, V31, P20, DOI 10.2337/dc07-1122; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamaki M, 2008, DIABETES RES CLIN PR, V81, P296, DOI 10.1016/j.diabres.2008.03.021; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierrez GE, 2008, J CLIN ENDOCR METAB, P1441; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295; Vague P, 2003, DIABETES CARE, V26, P590, DOI 10.2337/diacare.26.3.590; Yki-Jarvinen H, 2000, DIABETES CARE, V23, P1130, DOI 10.2337/diacare.23.8.1130; Yokoyama H, 2006, DIABETES RES CLIN PR, V73, P35, DOI 10.1016/j.diabres.2005.12.009	19	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38962	10.1371/journal.pone.0038962	http://dx.doi.org/10.1371/journal.pone.0038962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22720003	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300071
J	Cheng, XY; Huang, WJ; Hu, SC; Zhang, HL; Wang, H; Zhang, JX; Lin, HH; Chen, YZ; Zou, Q; Ji, ZL				Cheng, Xian-Ying; Huang, Wei-Juan; Hu, Shi-Chang; Zhang, Hai-Lei; Wang, Hao; Zhang, Jing-Xian; Lin, Hong-Huang; Chen, Yu-Zong; Zou, Quan; Ji, Zhi-Liang			A Global Characterization and Identification of Multifunctional Enzymes	PLOS ONE			English	Article							MITOCHONDRIAL C-1-TETRAHYDROFOLATE SYNTHASE; MOONLIGHTING PROTEINS; BIOSYNTHESIS; EVOLUTION; DATABASE; PATHWAY; CLASSIFICATION; PROMISCUITY	Multi-functional enzymes are enzymes that perform multiple physiological functions. Characterization and identification of multi-functional enzymes are critical for communication and cooperation between different functions and pathways within a complex cellular system or between cells. In present study, we collected literature-reported 6,799 multi-functional enzymes and systematically characterized them in structural, functional, and evolutionary aspects. It was found that four physiochemical properties, that is, charge, polarizability, hydrophobicity, and solvent accessibility, are important for characterization of multi-functional enzymes. Accordingly, a combinational model of support vector machine and random forest model was constructed, based on which 6,956 potential novel multi-functional enzymes were successfully identified from the ENZYME database. Moreover, it was observed that multi-functional enzymes are non-evenly distributed in species, and that Bacteria have relatively more multi-functional enzymes than Archaebacteria and Eukaryota. Comparative analysis indicated that the multi-functional enzymes experienced a fluctuation of gene gain and loss during the evolution from S. cerevisiae to H. sapiens. Further pathway analyses indicated that a majority of multi-functional enzymes were well preserved in catalyzing several essential cellular processes, for example, metabolisms of carbohydrates, nucleotides, and amino acids. What's more, a database of known multi-functional enzymes and a server for novel multi-functional enzyme prediction were also constructed for free access at http://bioinf.xmu.edu.cn/databases/MFEs/index.htm.	[Cheng, Xian-Ying; Huang, Wei-Juan; Wang, Hao; Ji, Zhi-Liang] Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China; [Hu, Shi-Chang; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China; [Zhang, Hai-Lei; Zhang, Jing-Xian; Lin, Hong-Huang; Chen, Yu-Zong] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Ji, Zhi-Liang] Xiamen Univ, Key Lab Chem Biol Fujian Prov, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; National University of Singapore; Xiamen University	Cheng, XY (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China.	zouquan@xmu.edu.cn; appo@xmu.edu.cn	Zou, Quan/A-7801-2015; Lin, Honghuang/A-3269-2019; Zhang, Jing/GWZ-7332-2022	Lin, Honghuang/0000-0003-3043-3942; Chen, Yu Zong/0000-0002-5473-8022	Natural Science Foundation of China (NSFC) [30873159]; Fundamental Research Funds for the Central Universities [2010121084]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Financial support from the Natural Science Foundation of China (NSFC#30873159) and the Fundamental Research Funds for the Central Universities (#2010121084) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Breitling R, 2001, MOL CELL ENDOCRINOL, V171, P205, DOI 10.1016/S0303-7207(00)00415-9; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Canada KA, 2002, J BACTERIOL, V184, P344, DOI 10.1128/JB.184.2.344-349.2002; Carbonell P, 2011, J BIOL CHEM, V286, P43994, DOI 10.1074/jbc.M111.274050; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Elkins JM, 2005, BIOCHEM J, V385, P565, DOI 10.1042/BJ20040814; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Genschel U, 2004, MOL BIOL EVOL, V21, P1242, DOI 10.1093/molbev/msh119; Gomez A, 2003, BIOINFORMATICS, V19, P895, DOI 10.1093/bioinformatics/btg111; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jeffery CJ, 2003, ANN MED, V35, P28, DOI 10.1080/07853890310004101; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Lee HC, 1997, ADV EXP MED BIOL, V419, P411; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchot P, 2012, PROTEIN PEPTIDE LETT, V19, P132, DOI 10.2174/092986612799080284; Mohammad TAS, 2011, J BIOINF COMPUT BIOL, V9, P489, DOI 10.1142/S0219720011005422; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Peregrin-Alvarez JM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r63; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; SAKANYAN V, 1993, J GEN MICROBIOL, V139, P393, DOI 10.1099/00221287-139-3-393; Schmidt S, 2003, TRENDS BIOCHEM SCI, V28, P336, DOI 10.1016/S0968-0004(03)00114-2; Timofeyeva NA, 2009, J BIOMOL STRUCT DYN, V26, P637, DOI 10.1080/07391102.2009.10507278; Tochio H, 1998, NAT STRUCT BIOL, V5, P965, DOI 10.1038/2940; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; WHITEHEAD TR, 1988, J BACTERIOL, V170, P995, DOI 10.1128/jb.170.2.995-997.1988; Zheng WP, 2001, CHEM BIOL, V8, P379, DOI 10.1016/S1074-5521(01)00020-5; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	41	46	47	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38979	10.1371/journal.pone.0038979	http://dx.doi.org/10.1371/journal.pone.0038979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723914	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300076
J	Hu, MG; Li, ZJ; Wang, JF; Jia, L; Liao, YL; Lai, SJ; Guo, YS; Zhao, D; Yang, WZ				Hu, Maogui; Li, Zhongjie; Wang, Jinfeng; Jia, Lin; Liao, Yilan; Lai, Shengjie; Guo, Yansha; Zhao, Dan; Yang, Weizhong			Determinants of the Incidence of Hand, Foot and Mouth Disease in China Using Geographically Weighted Regression Models	PLOS ONE			English	Article							EPIDEMIOLOGY	Background: Over the past two decades, major epidemics of hand, foot, and mouth disease (HFMD) have occurred throughout most of the West-Pacific Region countries, causing thousands of deaths among children. However, few studies have examined potential determinants of the incidence of HFMD. Methods: Reported HFMD cases from 2912 counties in China were obtained for May 2008. The monthly HFMD cumulative incidence was calculated for children aged 9 years and younger. Child population density (CPD) and six climate factors (average-temperature [AT], average-minimum-temperature [AT(min)], average-maximum-temperature [AT(max)], average-temperature-difference [AT(diff)], average-relative-humidity [ARH], and monthly precipitation [MP]) were selected as potential explanatory variables for the study. Geographically weighted regression (GWR) models were used to explore the associations between the selected factors and HFMD incidence at county level. Results: There were 176,111 HFMD cases reported in the studied counties. The adjusted monthly cumulative incidence by county ranged from 0.26 cases per 100,000 children to 2549.00 per 100,000 children. For local univariate GWR models, the percentage of counties with statistical significance (p < 0.05) between HFMD incidence and each of the seven factors were: CPD 84.3%, AT(max) 54.9%, AT 57.8%, AT(min) 61.2%, ARH 54.4%, MP 50.3%, and AT(diff) 51.6%. The R-2 for the seven factors' univariate GWR models are CPD 0.56, AT(max) 0.53, AT 0.52, MP 0.51, AT(min) 0.52, ARH 0.51, and AT(diff) 0.51, respectively. CPD, MP, AT, ARH and AT(diff) were further included in the multivariate GWR model, with R-2 0.62, and all counties show statistically significant relationship. Conclusion: Child population density and climate factors are potential determinants of the HFMD incidence in most areas in China. The strength and direction of association between these factors and the incidence of HFDM is spatially heterogeneous at the local geographic level, and child population density has a greater influence on the incidence of HFMD than the climate factors.	[Hu, Maogui; Wang, Jinfeng] Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Li, Zhongjie; Lai, Shengjie; Zhao, Dan; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Key Lab Infect Dis Surveillance & Early Warning, Beijing, Peoples R China; [Jia, Lin] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Liao, Yilan] Peking Univ, Inst Populat Res, Beijing 100871, Peoples R China; [Guo, Yansha] Chinese Acad Sci, Inst Comp Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Center for Disease Control & Prevention; Chinese Research Academy of Environmental Sciences; Peking University; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Hu, MG (corresponding author), Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	humg@lreis.ac.cn; yangwz@chinacdc.cn	Hu, Maogui/N-7105-2013	Hu, Maogui/0000-0002-7671-7863; Lai, Shengjie/0000-0001-9781-8148; Wang, Jinfeng/0000-0002-6687-9420	MOST (Ministry of Science and Technology of the People's Republic of China) [2012CB955500, 2011AA120305, 2009ZX10004-201, 200802025]; NSFC (The National Natural Science Foundation of China) [41023010]; CAS (Chinese Academy of Sciences) [XDA05090102]; LREIS (Laboratory of Resources and Environment Information System) [08R8B650KA]	MOST (Ministry of Science and Technology of the People's Republic of China)(Ministry of Science and Technology, China); NSFC (The National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); CAS (Chinese Academy of Sciences)(Chinese Academy of Sciences); LREIS (Laboratory of Resources and Environment Information System)	This study was supported by the following grants: MOST (Ministry of Science and Technology of the People's Republic of China) (2012CB955500, 2011AA120305, 2009ZX10004-201, 200802025), NSFC (The National Natural Science Foundation of China) (41023010), CAS (Chinese Academy of Sciences) (XDA05090102), and LREIS (Laboratory of Resources and Environment Information System) (08R8B650KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Belanger M, 2009, ANN EPIDEMIOL, V19, P180, DOI 10.1016/j.annepidem.2008.12.008; BOER EPJ, 2001, INT J APPL EARTH OBS, V3, P146, DOI DOI 10.1016/S0303-2434(01)85006-6; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gilbert A, 2011, SOC SCI RES, V40, P273, DOI 10.1016/j.ssresearch.2010.08.006; Haining R., 2003, SPATIAL DATA ANAL TH; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hong Y, 2005, INT J CLIMATOL, V25, P1369, DOI 10.1002/joc.1187; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; Lawson A. B., 2003, DIS MAPPING WINBUGS; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Porta M, 2008, DICT EPIDEMIOLOGY; Suminski RR, 2008, INT J BIOMETEOROL, V52, P189, DOI 10.1007/s00484-007-0110-y; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tong CYW, 2009, FUTURE VIROL, V4, P501, DOI 10.2217/FVL.09.25; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-52; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; World Health Organization, 2009, HAND FOOT MOUTH DIS; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; [郑景云 ZHENG Jingyun], 2010, [地理学报, Acta Geographica Sinica], V65, P3	27	101	110	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38978	10.1371/journal.pone.0038978	http://dx.doi.org/10.1371/journal.pone.0038978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723913	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300075
J	Zhou, YJ; Meng, X; Zhang, SF; Lee, EYC; Lee, MYWT				Zhou, Yajing; Meng, Xiao; Zhang, Sufang; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.			Characterization of Human DNA Polymerase Delta and Its Subassemblies Reconstituted by Expression in the Multibac System	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; P12 SUBUNIT; CALF THYMUS; CATALYTIC SUBUNIT; DAMAGE RESPONSE; 3RD SUBUNIT; REPLICATION; PCNA; IDENTIFICATION; CHROMATOGRAPHY	Mammalian DNA polymerase delta (Pol delta), a four-subunit enzyme, plays a crucial and versatile role in DNA replication and DNA repair processes. We have reconstituted human Pol delta complexes in insect cells infected with a single baculovirus into which one or more subunits were assembled. This system allowed for the efficient expression of the tetrameric Pol delta holoenzyme, the p125/p50 core dimer, the core+p68 trimer and the core+p12 trimer, as well as the p125 catalytic subunit. These were isolated in milligram amounts with reproducible purity and specific activities by a highly standardized protocol. We have systematically compared their activities in order to gain insights into the roles of the p12 and p68 subunits, as well as their responses to PCNA. The relative specific activities (apparent k(cat)) of the Pol delta holoenzyme, core+p68, core+p12 and p125/p50 core were 100, 109, 40, and 29. The corresponding apparent K-d's for PCNA were 7.1, 8.7, 9.3 and 73 nM. Our results support the hypothesis that Pol delta interacts with PCNA through multiple interactions, and that there may be a redundancy in binding interactions that may permit Pol delta to adopt flexible configurations with PCNA. The abilities of the Pol delta complexes to fully extend singly primed M13 DNA were examined. All the subassemblies except the core+p68 were defective in their abilities to completely extend the primer, showing that the p68 subunit has an important function in synthesis of long stretches of DNA in this assay. The core+p68 trimer could be reconstituted by addition of p12.	[Zhou, Yajing] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Meng, Xiao; Zhang, Sufang; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	Jiangsu University; New York Medical College	Zhou, YJ (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	Marietta_Lee@NYMC.edu		Zhang, Sufang/0000-0003-3883-023X	United States Public Health Service [GM31973, ES14737]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the United States Public Health Service, GM31973 and ES14737 to MYWTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Ducoux M, 2001, J BIOL CHEM, V276, P49258, DOI 10.1074/jbc.M106990200; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Henry RA, 2010, J BIOL CHEM, V285, P28496, DOI 10.1074/jbc.M110.131870; Huang QM, 2010, CANCER RES, V70, P8407, DOI 10.1158/0008-5472.CAN-10-0784; Huang QM, 2010, BIOCHEM BIOPH RES CO, V391, P542, DOI 10.1016/j.bbrc.2009.11.094; Hughes P, 1999, NUCLEIC ACIDS RES, V27, P2108, DOI 10.1093/nar/27.10.2108; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; JIANG YQ, 1995, ARCH BIOCHEM BIOPHYS, V320, P297, DOI 10.1016/0003-9861(95)90013-6; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lee M Y, 1981, Prog Nucleic Acid Res Mol Biol, V26, P83; LEE MYWT, 1991, J BIOL CHEM, V266, P2423; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1980, BIOCHEMISTRY-US, V19, P2096, DOI 10.1021/bi00551a015; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; Liu W, 2000, NUCLEIC ACIDS RES, V28, P4180, DOI 10.1093/nar/28.21.4180; Lu XQ, 2002, J BIOL CHEM, V277, P24340, DOI 10.1074/jbc.M200065200; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mo JY, 2000, BIOCHEMISTRY-US, V39, P7245, DOI 10.1021/bi0000871; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Rahmeh AA, 2012, BIOCHEMISTRY-US, V51, P416, DOI 10.1021/bi201638e; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Vijayachandran LS, 2011, J STRUCT BIOL, V175, P198, DOI 10.1016/j.jsb.2011.03.007; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002; Zhang P, 1999, J BIOL CHEM, V274, P26647, DOI 10.1074/jbc.274.38.26647; ZHANG SJ, 1995, J BIOL CHEM, V270, P7988, DOI 10.1074/jbc.270.14.7988; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	51	105	107	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39156	10.1371/journal.pone.0039156	http://dx.doi.org/10.1371/journal.pone.0039156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723953	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300107
J	de Llera, AH; Martin-Hidalgo, D; Gil, MC; Garcia-Marin, LJ; Bragado, MJ				Hurtado de Llera, Ana; Martin-Hidalgo, David; Gil, Maria C.; Garcia-Marin, Luis J.; Bragado, Maria J.			AMP-Activated Kinase AMPK Is Expressed in Boar Spermatozoa and Regulates Motility	PLOS ONE			English	Article							CAUSES MALE-INFERTILITY; HUMAN SPERM MOTILITY; PROTEIN-KINASE; CELL-MIGRATION; PHOSPHORYLATION; PATHWAY; INHIBITION; GLYCOLYSIS; HYPOXIA; CALCIUM	The main functions of spermatozoa required for fertilization are dependent on the energy status and metabolism. AMP-activated kinase, AMPK, acts a sensor and regulator of cell metabolism. As AMPK studies have been focused on somatic cells, our aim was to investigate the expression of AMPK protein in spermatozoa and its possible role in regulating motility. Spermatozoa from boar ejaculates were isolated and incubated under different conditions (38,5 degrees C or 17 degrees C, basal medium TBM or medium with Ca2+ and bicarbonate TCM, time from 1-24 hours) in presence or absence of AMPK inhibitor, compound C (CC, 30 mu M). Western blotting reveals that AMPK is expressed in boar spermatozoa at relatively higher levels than in somatic cells. AMPK phosphorylation (activation) in spermatozoa is temperature-dependent, as it is undetectable at semen preservation temperature (17 degrees C) and increases at 38,5 degrees C in a time-dependent manner. AMPK phosphorylation is independent of the presence of Ca2+ and/or bicarbonate in the medium. We confirm that CC effectively blocks AMPK phosphorylation in boar spermatozoa. Analysis of spermatozoa motility by CASA shows that CC treatment either in TBM or in TCM causes a significant reduction of any spermatozoa motility parameter in a time-dependent manner. Thus, AMPK inhibition significantly decreases the percentages of motile and rapid spermatozoa, significantly reduces spermatozoa velocities VAP, VCL and affects other motility parameters and coefficients. CC treatment does not cause additional side effects in spermatozoa that might lead to a lower viability even at 24 h incubation. Our results show that AMPK is expressed in spermatozoa at high levels and is phosphorylated under physiological conditions. Moreover, our study suggests that AMPK regulates a relevant function of spermatozoa, motility, which is essential for their ultimate role of fertilization.	[Hurtado de Llera, Ana; Martin-Hidalgo, David; Gil, Maria C.; Garcia-Marin, Luis J.; Bragado, Maria J.] Univ Extremadura, Sch Vet, Res Grp Intracellular Signalling & Technol Reprod, Caceres, Spain	Universidad de Extremadura	de Llera, AH (corresponding author), Univ Extremadura, Sch Vet, Res Grp Intracellular Signalling & Technol Reprod, Caceres, Spain.	ljgarcia@unex.es; jbragado@unex.es	Hidalgo, David Martín/N-4005-2019; Bragado, M Julia/L-6988-2014; Garcia-Marin, Luis J/L-4680-2014; Hidalgo, David Martín/I-2840-2015; Anaya, Maria Cruz Gil/M-3308-2014	Hidalgo, David Martín/0000-0002-6787-0006; Bragado, M Julia/0000-0001-7770-0775; Garcia-Marin, Luis J/0000-0002-1795-7381; Hidalgo, David Martín/0000-0002-6787-0006; Anaya, Maria Cruz Gil/0000-0001-7041-9673; HURTADO DE LLERA, ANA/0000-0002-6782-9783	National Grant from the Spanish Ministry of Education and Science [AGL2010-15188]; regional Grant from Junta de Extremadura, Spain [PRI09A077, GR10156]; Junta de Extremadura, Spain	National Grant from the Spanish Ministry of Education and Science(German Research Foundation (DFG)); regional Grant from Junta de Extremadura, Spain; Junta de Extremadura, Spain	This work was supported by National Grant AGL2010-15188 (from the Spanish Ministry of Education and Science) and regional Grant PRI09A077 and GR10156 (from Junta de Extremadura, Spain). D. Martin-Hidalgo received a Ph D fellowship award from the Junta de Extremadura, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD K, 1995, ARCH ANDROLOGY, V35, P187, DOI 10.3109/01485019508987871; Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Aparicio IM, 2005, REPRODUCTION, V129, P283, DOI 10.1530/rep.1.00447; Aparicio IM, 2003, BBA-MOL CELL RES, V1643, P37, DOI 10.1016/j.bbamcr.2003.08.007; Bajpai M, 2003, REPRODUCTION, V126, P183, DOI 10.1530/rep.0.1260183; Baron SJ, 2005, CIRC RES, V96, P337, DOI 10.1161/01.RES.0000155723.53868.d2; Bragado MJ, 2010, J CELL BIOCHEM, V109, P65, DOI 10.1002/jcb.22393; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chen JH, 2011, J CELL BIOCHEM, V112, P2931, DOI 10.1002/jcb.23209; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Espinal J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022619; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Khan M, 2005, J NEUROSCI RES, V80, P845, DOI 10.1002/jnr.20529; Kim EK, 2011, J BIOL CHEM, V286, P24036, DOI 10.1074/jbc.M110.209908; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Rodriguez-Gil JE, 2006, REPROD DOMEST ANIM, V41, P11, DOI 10.1111/j.1439-0531.2006.00765.x; Rubin LJ, 2005, J APPL PHYSIOL, V98, P296, DOI 10.1152/japplphysiol.00075.2004; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vetterli L, 2011, J BIOL CHEM, V286, P6049, DOI 10.1074/jbc.M110.176842; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Williams AC, 2001, J ANDROL, V22, P680; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Xu B, 2007, Soc Reprod Fertil Suppl, V63, P87; Xu BF, 2008, DEV BIOL, V319, P211, DOI 10.1016/j.ydbio.2008.03.047; Zhang LL, 2000, J NEUROSCI RES, V62, P389, DOI 10.1002/1097-4547(20001101)62:3<389::AID-JNR9>3.0.CO;2-M; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254	38	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38840	10.1371/journal.pone.0038840	http://dx.doi.org/10.1371/journal.pone.0038840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719961	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800022
J	Ward, DV; Gevers, D; Giannoukos, G; Earl, AM; Methe, BA; Sodergren, E; Feldgarden, M; Ciulla, DM; Tabbaa, D; Arze, C; Appelbaum, E; Aird, L; Anderson, S; Ayvaz, T; Belter, E; Bihan, M; Bloom, T; Crabtree, J; Courtney, L; Carmichael, L; Dooling, D; Erlich, RL; Farmer, C; Fulton, L; Fulton, R; Gao, HY; Gill, JA; Haas, BJ; Hemphill, L; Hall, O; Hamilton, SG; Hepburn, TA; Lennon, NJ; Joshi, V; Kells, C; Kovar, CL; Kalra, D; Li, K; Lewis, L; Leonard, S; Muzny, DM; Mardis, E; Mihindukulasuriya, K; Magrini, V; O'Laughlin, M; Pohl, C; Qin, X; Ross, K; Ross, MC; Rogers, YHA; Singh, N; Shang, Y; Wilczek-Boney, K; Wortman, JR; Worley, KC; Youmans, BP; Yooseph, S; Zhou, Y; Schloss, PD; Wilson, R; Gibbs, RA; Nelson, KE; Weinstock, G; DeSantis, TZ; Petrosino, JF; Highlander, SK; Birren, BW				Ward, Doyle V.; Gevers, Dirk; Giannoukos, Georgia; Earl, Ashlee M.; Methe, Barbara A.; Sodergren, Erica; Feldgarden, Michael; Ciulla, Dawn M.; Tabbaa, Diana; Arze, Cesar; Appelbaum, Elizabeth; Aird, Leigh; Anderson, Scott; Ayvaz, Tulin; Belter, Edward; Bihan, Monika; Bloom, Toby; Crabtree, Jonathan; Courtney, Laura; Carmichael, Lynn; Dooling, David; Erlich, Rachel L.; Farmer, Candace; Fulton, Lucinda; Fulton, Robert; Gao, Hongyu; Gill, John A.; Haas, Brian J.; Hemphill, Lisa; Hall, Otis; Hamilton, Susanna G.; Hepburn, Theresa A.; Lennon, Niall J.; Joshi, Vandita; Kells, Cristyn; Kovar, Christie L.; Kalra, Divya; Li, Kelvin; Lewis, Lora; Leonard, Shawn; Muzny, Donna M.; Mardis, Elaine; Mihindukulasuriya, Kathie; Magrini, Vincent; O'Laughlin, Michelle; Pohl, Craig; Qin, Xiang; Ross, Keenan; Ross, Matthew C.; Rogers, Yu-Hui A.; Singh, Navjeet; Shang, Yue; Wilczek-Boney, Katarzyna; Wortman, Jennifer R.; Worley, Kim C.; Youmans, Bonnie P.; Yooseph, Shibu; Zhou, Yanjiao; Schloss, Patrick D.; Wilson, Richard; Gibbs, Richard A.; Nelson, Karen E.; Weinstock, George; DeSantis, Todd Z.; Petrosino, Joseph F.; Highlander, Sarah K.; Birren, Bruce W.		Jumpstart Consortium Human Microbi	Evaluation of 16S rDNA-Based Community Profiling for Human Microbiome Research	PLOS ONE			English	Article							DIVERSITY; SEQUENCES; ABUNDANCE	The Human Microbiome Project will establish a reference data set for analysis of the microbiome of healthy adults by surveying multiple body sites from 300 people and generating data from over 12,000 samples. To characterize these samples, the participating sequencing centers evaluated and adopted 16S rDNA community profiling protocols for ABI 3730 and 454 FLX Titanium sequencing. In the course of establishing protocols, we examined the performance and error characteristics of each technology, and the relationship of sequence error to the utility of 16S rDNA regions for classification-and OTU-based analysis of community structure. The data production protocols used for this work are those used by the participating centers to produce 16S rDNA sequence for the Human Microbiome Project. Thus, these results can be informative for interpreting the large body of clinical 16S rDNA data produced for this project.	[Ward, Doyle V.; Gevers, Dirk; Giannoukos, Georgia; Earl, Ashlee M.; Feldgarden, Michael; Ciulla, Dawn M.; Tabbaa, Diana; Anderson, Scott; Bloom, Toby; Erlich, Rachel L.; Haas, Brian J.; Hemphill, Lisa; Hamilton, Susanna G.; Hepburn, Theresa A.; Lennon, Niall J.; Kells, Cristyn; Ross, Keenan; Birren, Bruce W.] Broad Inst, Cambridge, MA USA; [Sodergren, Erica; Appelbaum, Elizabeth; Belter, Edward; Courtney, Laura; Carmichael, Lynn; Dooling, David; Farmer, Candace; Fulton, Lucinda; Fulton, Robert; Gao, Hongyu; Hall, Otis; Leonard, Shawn; Mardis, Elaine; Mihindukulasuriya, Kathie; Magrini, Vincent; O'Laughlin, Michelle; Pohl, Craig; Wilson, Richard; Weinstock, George] Washington Univ Sch Med, Genome Inst, St Louis, MO USA; [Ross, Matthew C.; Youmans, Bonnie P.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Joshi, Vandita; Kovar, Christie L.; Kalra, Divya; Lewis, Lora; Muzny, Donna M.; Qin, Xiang; Shang, Yue; Wilczek-Boney, Katarzyna; Gibbs, Richard A.; Petrosino, Joseph F.; Highlander, Sarah K.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bihan, Monika; Li, Kelvin] J Craig Venter Inst, Rockville, MD USA; [Methe, Barbara A.; Nelson, Karen E.] J Craig Venter Inst, Human Genom Med, Rockville, MD USA; [Yooseph, Shibu] J Craig Venter Inst, San Diego, CA USA; [Gill, John A.; Rogers, Yu-Hui A.] J Craig Venter Inst, Sequencing, Rockville, MD USA; [Singh, Navjeet; DeSantis, Todd Z.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Berkeley, CA 94720 USA; [Arze, Cesar; Crabtree, Jonathan; Wortman, Jennifer R.] Univ Maryland Sch Med, Inst Genome Sci, Baltimore, MD USA; [Schloss, Patrick D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; J. Craig Venter Institute; J. Craig Venter Institute; J. Craig Venter Institute; J. Craig Venter Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University System of Maryland; University of Maryland Baltimore; University of Michigan System; University of Michigan	Ward, DV (corresponding author), Broad Inst, Cambridge, MA USA.		Gevers, Dirk/C-1451-2009; Wilson, Richard K./AAF-4139-2019; Kalra, Divya/N-5453-2014; Petrosino, Joseph F./AAF-1621-2019; Mardis, Elaine/W-2202-2019; Bihan, Monika/C-7469-2014; Magrini, Vincent/AAT-5830-2020; Weinstock, George M/C-6314-2013; Kalra, D/H-6661-2019	Wilson, Richard K./0000-0002-1992-1358; Magrini, Vincent/0000-0002-2019-4872; Weinstock, George M/0000-0002-2997-4592; Kalra, D/0000-0001-5254-4067; ross, matthew/0000-0002-7621-8829; Arze, Cesar/0000-0002-3606-4183; Earl, Ashlee/0000-0001-7857-9145; Worley, Kim/0000-0002-0282-1000; Schloss, Patrick/0000-0002-6935-4275; Wortman, Jennifer/0000-0002-8713-1227; Yooseph, Shibu/0000-0001-5581-5002	National Institutes of Health [U54HG004973]; Broad Insitute [HHSN2722009000018C, U54HG004969]; J. Craig Venter Institute [U54AI084844]; University of Maryland, Baltimore [1U01HG004866]; Washington University [U54HG003079, U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U01HG004866, U54HG004973, U54HG004968, U54HG004969, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Insitute; J. Craig Venter Institute; University of Maryland, Baltimore; Washington University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge National Institutes of Health funding of this work with grants to Baylor College of Medicine (U54HG004973), the Broad Insitute (HHSN2722009000018C and U54HG004969), the J. Craig Venter Institute (U54AI084844), the University of Maryland, Baltimore (1U01HG004866), and Washington University (U54HG003079 and U54HG004968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Coolen MJL, 2005, APPL ENVIRON MICROB, V71, P8729, DOI 10.1128/AEM.71.12.8729-8737.2005; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Garrity G. M., 2007, TAXONOMIC OUTLINE BA, DOI [10.1601/TOBA7.7, DOI 10.1601/TOBA7.7]; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haas BJ, 2011, GENOME RES; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Huffnagle GB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000549; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kunin V, 2009, ENV MICROBIOLOGY, V9999; Larkin M, 2005, MOL TOOLBOX MICROBIA; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Kelvin, 2010, BMC Res Notes, V3, P199, DOI 10.1186/1756-0500-3-199; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; RAVEL J, 2010, P NATL ACAD SCI US; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x	39	169	172	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39315	10.1371/journal.pone.0039315	http://dx.doi.org/10.1371/journal.pone.0039315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720093	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900095
J	Ribeiro, JD; Morey, L; Mas, A; Gutierrez, A; Luis, NM; Mejetta, S; Richly, H; Benitah, SA; Keyes, WM; Di Croce, L				Ribeiro, J. D.; Morey, L.; Mas, A.; Gutierrez, A.; Luis, N. M.; Mejetta, S.; Richly, H.; Benitah, S. A.; Keyes, W. M.; Di Croce, L.			ZRF1 controls oncogene-induced senescence through the INK4-ARF locus	ONCOGENE			English	Article						chromatin; Polycomb; senescence; ZRF1	DEMETHYLASE JMJD3 CONTRIBUTES; DEPENDENT KINASE INHIBITORS; HUMAN EMBRYONAL CARCINOMA; TUMOR-SUPPRESSOR LOCUS; NEURONAL DIFFERENTIATION; INK4A-ARF LOCUS; TRANSCRIPTIONAL ACTIVATION; CELLULAR SENESCENCE; CELLS; RAS	The reactivation of the INK4-ARF locus, which is epigenetically repressed by Polycomb proteins in healthy cells, is a hallmark of senescence. One mechanism of reactivating Polycomb-silenced genes is mediated by the epigenetic factor ZRF1, which associates with ubiquitinated histone H2A. We show that cells undergoing senescence following oncogenic Ras expression have increased ZRF1 levels, and that this binds to the p15INK4b, ARF and p16INK4a promoters. Furthermore, ZRF1 depletion in oncogenic Ras-expressing cells restores proliferation by preventing Arf and p16Ink4a expression, consequently bypassing senescence. Thus, ZRF1 regulates the INK4-ARF locus during cellular proliferation and senescence, and alterations in ZRF1 may contribute to tumorigenesis. Oncogene (2013) 32, 2161-2168; doi:10.1038/onc.2012.241; published online 25 June 2012	[Ribeiro, J. D.; Morey, L.; Mas, A.; Gutierrez, A.; Luis, N. M.; Mejetta, S.; Richly, H.; Benitah, S. A.; Keyes, W. M.; Di Croce, L.] CRG, Dept Differentiat & Canc, Barcelona 08003, Spain; [Ribeiro, J. D.; Morey, L.; Mas, A.; Gutierrez, A.; Luis, N. M.; Mejetta, S.; Richly, H.; Benitah, S. A.; Keyes, W. M.; Di Croce, L.] UPF, Barcelona 08003, Spain; [Benitah, S. A.; Di Croce, L.] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Di Croce, L (corresponding author), CRG, Dept Differentiat & Canc, Barcelona 08003, Spain.	luciano.dicroce@crg.es	Luis, Nuno/F-2405-2012; Ribeiro, Jose Dirceu D/I-7308-2012; Di Croce, Luciano/E-7759-2015; Aznar-Benitah, Salvador/F-4761-2016; Gutierrez, Arantxa/K-8213-2015; Luis, Nuno Miguel/ABD-9784-2020; Ribeiro, Joana/K-3357-2014	Luis, Nuno/0000-0001-5438-9638; Ribeiro, Jose Dirceu D/0000-0002-3387-5642; Di Croce, Luciano/0000-0003-3488-6228; Aznar-Benitah, Salvador/0000-0002-9059-5049; Gutierrez, Arantxa/0000-0001-9033-3834; Luis, Nuno Miguel/0000-0001-5438-9638; Ribeiro, Joana/0000-0003-2221-4002; Morey, Lluis/0000-0001-9851-4066; Keyes, William M./0000-0002-8917-2268	Spanish 'Ministerio de Educacion y Ciencia' (CONSOLIDER) [BFU2010-18692]; European Commission FP7 project 4DCellFate [277899]; AICR [10-0177]; Foundation for Science and Technology (FCT) Portugal [SFRH/BD/15908/2005]; CRG-Novartis fellowship; ICREA Funding Source: Custom; Worldwide Cancer Research [10-0177] Funding Source: researchfish	Spanish 'Ministerio de Educacion y Ciencia' (CONSOLIDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission FP7 project 4DCellFate; AICR; Foundation for Science and Technology (FCT) Portugal(Portuguese Foundation for Science and Technology); CRG-Novartis fellowship; ICREA(ICREA); Worldwide Cancer Research	We thank VA Raker for help in preparing the manuscript, and to the CRG Genomic Unit. This work was supported by grants from the Spanish 'Ministerio de Educacion y Ciencia' (CONSOLIDER and BFU2010-18692), from the European Commission FP7 project 4DCellFate (277899), and from AICR (10-0177) to LDC. JDR was supported by grant SFRH/BD/15908/2005 from Foundation for Science and Technology (FCT) Portugal and is a fellow of the Graduate Program in Areas of Basic and Applied Biology (GABBA), University of Oporto, Portugal; LM was supported by a post-doctoral CRG-Novartis fellowship.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cruickshanks HA, 2011, CURR OPIN GENET DEV, V21, P100, DOI 10.1016/j.gde.2010.10.007; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj.onc.1205408; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; LOIS AF, 1995, CANCER RES, V55, P4010; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455, DOI 10.1091/mbc.7.9.1455; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Resto VA, 2000, CANCER RES, V60, P5529; Richly H, 2011, CELL CYCLE, V10, P745, DOI 10.4161/cc.10.5.14795; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHOJI W, 1995, J BIOL CHEM, V270, P24818, DOI 10.1074/jbc.270.42.24818; Simboeck E, 2011, BIOCHEM PHARMACOL, V82, P1361, DOI 10.1016/j.bcp.2011.07.084; Smith JC, 2007, J PROTEOME RES, V6, P3174, DOI 10.1021/pr070122r; Thullberg M, 2000, FEBS LETT, V470, P161, DOI 10.1016/S0014-5793(00)01307-7; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	40	22	24	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 25	2013	32	17					2161	2168		10.1038/onc.2012.241	http://dx.doi.org/10.1038/onc.2012.241			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22733129				2022-12-25	WOS:000318062800005
J	DiCostanzo, AC; Thompson, JR; Peterson, FC; Volkman, BF; Ramirez-Alvarado, M				DiCostanzo, Ara Celi; Thompson, James R.; Peterson, Francis C.; Volkman, Brian F.; Ramirez-Alvarado, Marina			Tyrosine Residues Mediate Fibril Formation in a Dynamic Light Chain Dimer Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOIDOSIS; STABILITY; PROTEIN; AMYLOIDOGENICITY; AGGREGATION	Light chain amyloidosis is an incurable protein misfolding disease where monoclonal immunoglobulin light chains misfold and deposit as amyloid fibrils, causing organ failure and death. Previously, we determined that amyloidogenic light chains AL-09 and AL-103 do not form fibrils at pH 10 (tyrosine pK(a)). There are three tyrosine residues (32, 91, and 96) clustered in the dimer interface, interacting differently in the two light chain proteins due to their two different dimer conformations. These tyrosines may be ionized at pH 10, causing repulsion and inhibiting fibril formation. Here, we characterize single and double Tyr-to-Phe mutations in AL-09 and AL-103. All AL-09 Tyr-to-Phe mutants form fibrils at pH 10, whereas none of the AL-103 mutants form fibrils at pH 10. NMR studies suggest that although both AL-09 and AL-103 present conformational heterogeneity, only AL-09 favors dimer conformations where tyrosine residues mediate crucial interactions for amyloid formation.	[DiCostanzo, Ara Celi; Ramirez-Alvarado, Marina] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Peterson, Francis C.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Mayo Clinic; Mayo Clinic; Medical College of Wisconsin	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu	Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Ramirez-Alvarado, Marina/0000-0003-2325-6773	NIAID NIH HHS [R56 AI063325, R01 AI063325] Funding Source: Medline; NIGMS NIH HHS [R01 GM071514] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063325, R56AI063325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBINSSON B, 1992, J PHYS CHEM-US, V96, P6204, DOI 10.1021/j100194a023; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Brenner DA, 2004, CIRC RES, V94, P1008, DOI 10.1161/01.RES.0000126569.75419.74; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; HALSALL HB, 1982, J CHEM EDUC, V59, P1076; Hu DM, 2008, BIOCHEMISTRY-US, V47, P8665, DOI 10.1021/bi800806d; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kossiakoff AA, 2008, CURR OPIN STRUC BIOL, V18, P499, DOI 10.1016/j.sbi.2008.06.004; Kumar SK, 2011, MAYO CLIN PROC, V86, P12, DOI 10.4065/mcp.2010.0480; Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Martin DJ, 2010, CONTEMP HEMATOL, P1, DOI 10.1007/978-1-60761-631-3_1; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Meng XY, 2008, J MOL BIOL, V381, P989, DOI 10.1016/j.jmb.2008.06.062; Peterson FC, 2010, STRUCTURE, V18, P563, DOI 10.1016/j.str.2010.02.012; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Randles EG, 2009, J MOL BIOL, V389, P199, DOI 10.1016/j.jmb.2009.04.010; SANTORO J, 1992, J MAGN RESON, V97, P202, DOI 10.1016/0022-2364(92)90250-B; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; Sikkink LA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.75; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Torchia DA, 2011, J MAGN RESON, V212, P1, DOI 10.1016/j.jmr.2011.07.010; UEDAIRA H, 1970, J PHYS CHEM-US, V74, P2211, DOI 10.1021/j100909a030; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wechalekar AD, 2008, BRIT J HAEMATOL, V140, P365, DOI 10.1111/j.1365-2141.2007.06936.x	33	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27997	28006		10.1074/jbc.M112.362921	http://dx.doi.org/10.1074/jbc.M112.362921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740699	Green Published, hybrid			2022-12-25	WOS:000307840700073
J	Skovstrup, S; David, L; Taboureau, O; Jorgensen, FS				Skovstrup, Soren; David, Laurent; Taboureau, Olivier; Jorgensen, Flemming Steen			A Steered Molecular Dynamics Study of Binding and Translocation Processes in the GABA Transporter	PLOS ONE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; TRANSMEMBRANE DOMAIN-I; FREE-ENERGY DIFFERENCES; NEUROTRANSMITTER TRANSPORTERS; BACTERIAL HOMOLOG; HIGH-AFFINITY; RAT-BRAIN; SUBSTRATE-BINDING; DRUG TARGETS; ION-BINDING	The entire substrate translocation pathway in the human GABA transporter (GAT-1) was explored for the endogenous substrate GABA and the anti-convulsive drug tiagabine. Following a steered molecular dynamics (SMD) approach, in which a harmonic restraining potential is applied to the ligand, dissociation and re-association of ligands were simulated revealing events leading to substrate (GABA) translocation and inhibitor (tiagabine) mechanism of action. We succeeded in turning the transporter from the outward facing occluded to the open-to-out conformation, and also to reorient the transporter to the open-to-in conformation. The simulations are validated by literature data and provide a substrate pathway fingerprint in terms of which, how, and in which sequence specific residues are interacted with. They reveal the essential functional roles of specific residues, e.g. the role of charged residues in the extracellular vestibule including two lysines (K76 (TM1) and K448 (TM10)) and a TM6-triad (D281, E283, and D287) in attracting and relocating substrates towards the secondary/interim substrate-binding site (S2). Likewise, E101 is highlighted as essential for the relocation of the substrate from the primary substrate-binding site (S1) towards the cytoplasm.	[Skovstrup, Soren; Jorgensen, Flemming Steen] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Skovstrup, Soren; David, Laurent] H Lundbeck & Co AS, Dept Computat Chem, Valby, Denmark; [Taboureau, Olivier] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	University of Copenhagen; Lundbeck Corporation; Technical University of Denmark	Skovstrup, S (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark.	fsj@farma.ku.dk		Jorgensen, Flemming Steen/0000-0001-8040-2998	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	The work was supported by a grant to Soren Skovstrup from the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2007, BIOCHEMISTRY-US, V46, P2156, DOI 10.1021/bi061708e; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; BENDAHAN A, 1993, FEBS LETT, V318, P41, DOI 10.1016/0014-5793(93)81323-R; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Mai BK, 2010, J CHEM INF MODEL, V50, P2236, DOI 10.1021/ci100346s; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Bowers KJ, 2006, SC06, P4343; BRAESTRUP C, 1990, J NEUROCHEM, V54, P639, DOI 10.1111/j.1471-4159.1990.tb01919.x; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Cherubino F, 2009, CELL MOL LIFE SCI, V66, P3797, DOI 10.1007/s00018-009-0153-9; Clausen RP, 2006, ADV PHARMACOL, V54, P265, DOI 10.1016/S1054-3589(06)54011-6; Clausen RP, 2006, NEUROCHEM INT, V48, P637, DOI 10.1016/j.neuint.2005.12.031; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; *DE SHAW RES, 2009, DESM MOL DYN SYST VE; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Forlani G, 2001, J PHYSIOL-LONDON, V536, P479, DOI 10.1111/j.1469-7793.2001.0479c.xd; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Genchev GZ, 2009, CELL BIOCHEM BIOPHYS, V55, P141, DOI 10.1007/s12013-009-9064-5; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Hansra N, 2004, J NEUROSCI, V24, P4082, DOI 10.1523/JNEUROSCI.0664-04.2004; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Jensen MO, 2007, BIOPHYS J, V93, P92, DOI 10.1529/biophysj.107.103994; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KESHET GI, 1995, FEBS LETT, V371, P39, DOI 10.1016/0014-5793(95)00859-8; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; MacAulay N, 2003, J BIOL CHEM, V278, P28771, DOI 10.1074/jbc.M213023200; Madsen KK, 2010, PHARMACOL THERAPEUT, V125, P394, DOI 10.1016/j.pharmthera.2009.11.007; Madsen KK, 2009, J NEUROCHEM, V109, P139, DOI 10.1111/j.1471-4159.2009.05982.x; Maestro, 2009, MAESTR VERS 9 0; Mager S, 1996, J NEUROSCI, V16, P5405; Meinild AK, 2009, J BIOL CHEM, V284, P16226, DOI 10.1074/jbc.M109.003137; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Schousboe A, 2004, BIOCHEM PHARMACOL, V68, P1557, DOI 10.1016/j.bcp.2004.06.041; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Skovstrup S, 2010, CHEMMEDCHEM, V5, P986, DOI 10.1002/cmdc.201000100; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; TAMURA S, 1995, J BIOL CHEM, V270, P28712, DOI 10.1074/jbc.270.48.28712; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu N, 1998, FEBS LETT, V426, P174, DOI 10.1016/S0014-5793(98)00333-0; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	58	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39360	10.1371/journal.pone.0039360	http://dx.doi.org/10.1371/journal.pone.0039360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737235	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100033
J	Traian, MMD; Cattoni, DI; Levi, V; Flecha, FLG				Dodes Traian, Martin M.; Cattoni, Diego I.; Levi, Valeria; Gonzalez Flecha, F. Luis			A Two-Stage Model for Lipid Modulation of the Activity of Integral Membrane Proteins	PLOS ONE			English	Article							CELL CALCIUM-PUMP; THERMAL-STABILITY; QUANTITATIVE-ANALYSIS; BIOLOGICAL-MEMBRANES; ACIDIC PHOSPHOLIPIDS; CA2+-ATPASE; CA2+-ATPASE; OLIGOMERIZATION; AGGREGATION; TRYPTOPHAN	Lipid-protein interactions play an essential role in the regulation of biological function of integral membrane proteins; however, the underlying molecular mechanisms are not fully understood. Here we explore the modulation by phospholipids of the enzymatic activity of the plasma membrane calcium pump reconstituted in detergent-phospholipid mixed micelles of variable composition. The presence of increasing quantities of phospholipids in the micelles produced a cooperative increase in the ATPase activity of the enzyme. This activation effect was reversible and depended on the phospholipid/detergent ratio and not on the total lipid concentration. Enzyme activation was accompanied by a small structural change at the transmembrane domain reported by 1-aniline-8-naphtalenesulfonate fluorescence. In addition, the composition of the amphipilic environment sensed by the protein was evaluated by measuring the relative affinity of the assayed phospholipid for the transmembrane surface of the protein. The obtained results allow us to postulate a two-stage mechanistic model explaining the modulation of protein activity based on the exchange among non-structural amphiphiles at the hydrophobic transmembrane surface, and a lipid-induced conformational change. The model allowed to obtain a cooperativity coefficient reporting on the efficiency of the transduction step between lipid adsorption and catalytic site activation. This model can be easily applied to other phospholipid/detergent mixtures as well to other membrane proteins. The systematic quantitative evaluation of these systems could contribute to gain insight into the structure-activity relationships between proteins and lipids in biological membranes.	[Dodes Traian, Martin M.; Cattoni, Diego I.; Gonzalez Flecha, F. Luis] Univ Buenos Aires, Lab Biofis Mol, Inst Quim & Fis Quim Biol, CONICET, Buenos Aires, DF, Argentina; [Dodes Traian, Martin M.; Levi, Valeria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Dinam Intracelular, Dept Quim Biol, Buenos Aires, DF, Argentina; [Cattoni, Diego I.] Univ Montpellier 1 & 2, Ctr Biochim Struct, INSERM, U554,CNRS,UMR 5048, Montpellier, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Traian, MMD (corresponding author), Univ Buenos Aires, Lab Biofis Mol, Inst Quim & Fis Quim Biol, CONICET, Buenos Aires, DF, Argentina.	lgf@qb.ffyb.uba.ar	González Flecha, F Luis/J-7060-2014	González Flecha, F Luis/0000-0003-2828-7907; Levi, Valeria/0000-0002-1666-4675; Cattoni, Diego I./0000-0002-0048-8531	Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCyT [PICT 2010-1876, PICT 2008-1104]; Universidad de Buenos Aires, UBACyT [20020090200201, 20020100100048]	Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCyT(ANPCyT); Universidad de Buenos Aires, UBACyT(University of Buenos Aires)	This work was partially supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCyT (PICT 2010-1876, PICT 2008-1104), and Universidad de Buenos Aires, UBACyT (20020090200201 and 20020100100048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Atkins P., 2006, PHYS CHEM; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CASTELLO PR, 1994, BIOCHEM BIOPH RES CO, V201, P194, DOI 10.1006/bbrc.1994.1688; Castello PR, 1997, PROTEIN SCI, V6, P1708, DOI 10.1002/pro.5560060811; Cattoni DI, 2008, ARCH BIOCHEM BIOPHYS, V471, P198, DOI 10.1016/j.abb.2007.12.013; Cattoni DI, 2009, BBA-PROTEINS PROTEOM, V1794, P1700, DOI 10.1016/j.bbapap.2009.08.007; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; EA Roman, 2012, CIRCULAR DICHROISM T, P217; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Flecha FLG, 1999, J MEMBRANE BIOL, V171, P25, DOI 10.1007/s002329900555; Cohen IPG, 2010, BBA-BIOMEMBRANES, V1798, P2040, DOI 10.1016/j.bbamem.2010.07.035; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Jost P C, 1980, Ann N Y Acad Sci, V348, P391, DOI 10.1111/j.1749-6632.1980.tb21315.x; JOST PC, 1973, P NATL ACAD SCI USA, V70, P480, DOI 10.1073/pnas.70.2.480; KOSKKOSICKA D, 1990, MOL CELL BIOCHEM, V99, P75; Kozachkov L, 2011, P NATL ACAD SCI USA, V108, P15769, DOI 10.1073/pnas.1109256108; Ladokhin AS, 2010, J MEMBRANE BIOL, V236, P247, DOI 10.1007/s00232-010-9291-0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Levi V, 2000, J MEMBRANE BIOL, V173, P215, DOI 10.1007/s002320001021; Levi V, 2000, FEBS LETT, V483, P99, DOI 10.1016/S0014-5793(00)02093-7; Levi V, 2003, ANAL BIOCHEM, V317, P171, DOI 10.1016/S0003-2697(03)00132-5; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Levi V, 2008, BIOCHEM J, V416, P145, DOI 10.1042/BJ20080618; Loura LMS, 2010, EUR BIOPHYS J BIOPHY, V39, P565, DOI [10.1007/s00249-009-0532-z, 10.1007/s00249-010-0580-4]; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Marsh D, 2008, METHODS, V46, P83, DOI 10.1016/j.ymeth.2008.07.001; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; O'Keeffe AH, 2000, BIOPHYS J, V79, P2066, DOI 10.1016/S0006-3495(00)76454-X; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; REED LJ, 1928, J PHYS CHEM, V33, P760, DOI DOI 10.1021/J150299A014; Roman EA, 2010, J MOL BIOL, V397, P550, DOI 10.1016/j.jmb.2010.01.045; RONNER P, 1977, ARCH BIOCHEM BIOPHYS, V179, P578, DOI 10.1016/0003-9861(77)90146-1; Sanders CR, 2011, BIOCHEMISTRY-US, V50, P7858, DOI 10.1021/bi2011527; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seber G., 1989, NONLINEAR REGRESSION; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; TANFORD C, 1980, HYDROPHOBIC EFFECT; Tang DX, 2006, CELL CALCIUM, V39, P209, DOI 10.1016/j.ceca.2005.10.010; TUMMINO PJ, 1993, BIOPHYS J, V64, P1580, DOI 10.1016/S0006-3495(93)81528-5; WALSH JP, 1986, J BIOL CHEM, V261, P5062; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	47	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39255	10.1371/journal.pone.0039255	http://dx.doi.org/10.1371/journal.pone.0039255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723977	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700059
J	van der Ham, IJM; Duijndam, MJA; Raemaekers, M; van Wezel, RJA; Oleksiak, A; Postma, A				van der Ham, Ineke J. M.; Duijndam, Maarten J. A.; Raemaekers, Mathijs; van Wezel, Richard J. A.; Oleksiak, Anna; Postma, Albert			Retinotopic Mapping of Categorical and Coordinate Spatial Relation Processing in Early Visual Cortex	PLOS ONE			English	Article							RECEPTIVE-FIELD SIZE; HEMISPHERIC-SPECIALIZATION; CEREBRAL HEMISPHERES; WORKING-MEMORY; ATTENTION; FMRI; REPRESENTATIONS; LATERALIZATION; REHEARSAL; BRAIN	Spatial relations are commonly divided in two global classes. Categorical relations concern abstract relations which define areas of spatial equivalence, whereas coordinate relations are metric and concern exact distances. Categorical and coordinate relation processing are thought to rely on at least partially separate neurocognitive mechanisms, as reflected by differential lateralization patterns, in particular in the parietal cortex. In this study we address this textbook principle from a new angle. We studied retinotopic activation in early visual cortex, as a reflection of attentional distribution, in a spatial working memory task with either a categorical or a coordinate instruction. Participants were asked to memorize a dot position, with regard to a central cross, and to indicate whether a subsequent dot position matched the first dot position, either categorically (opposite quadrant of the cross) or coordinately (same distance to the centre of the cross). BOLD responses across the retinotopic maps of V1, V2, and V3 indicate that the spatial distribution of cortical activity was different for categorical and coordinate instructions throughout the retention interval; a more local focus was found during categorical processing, whereas focus was more global for coordinate processing. This effect was strongest for V3, approached significance in V2 and was absent in V1. Furthermore, during stimulus presentation the two instructions led to different levels of activation in V3 during stimulus encoding; a stronger increase in activity was found for categorical processing. Together this is the first demonstration that instructions for specific types of spatial relations may yield distinct attentional patterns which are already reflected in activity early in the visual cortex.	[van der Ham, Ineke J. M.; Duijndam, Maarten J. A.; van Wezel, Richard J. A.; Oleksiak, Anna; Postma, Albert] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Raemaekers, Mathijs] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands; [van Wezel, Richard J. A.; Oleksiak, Anna] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [van Wezel, Richard J. A.] Univ Twente, Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Wezel, Richard J. A.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Postma, Albert] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; University of Twente; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	van der Ham, IJM (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	c.j.m.vanderham@uu.nl	van Wezel, Richard R J/G-4455-2011	van Wezel, Richard R J/0000-0001-5753-7069; van der Ham, Ineke/0000-0003-2520-7422	Netherlands Organisation for Scientific Research (NWO) [051-14-027]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was made possible by a grant of the Netherlands Organisation for Scientific Research (NWO) (Evolution and Behaviour: 051-14-027) (website: www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Awh E, 1995, ANN NY ACAD SCI, V769, P97, DOI 10.1111/j.1749-6632.1995.tb38134.x; Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; Awh E, 1998, ATTENTIVE BRAIN, P353; Baciu M, 1999, NEUROREPORT, V10, P1373, DOI 10.1097/00001756-199904260-00040; Banich MT, 1999, J COGNITIVE NEUROSCI, V11, P153, DOI 10.1162/089892999563292; Borst G, 2010, NEUROPSYCHOLOGIA, V48, P2769, DOI 10.1016/j.neuropsychologia.2010.04.027; Bruyer R, 1997, BRAIN COGNITION, V33, P245, DOI 10.1006/brcg.1997.0867; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; HELLIGE JB, 1989, MEM COGNITION, V17, P770, DOI 10.3758/BF03202638; Ivry RB, 1997, 2 SIDES PERCEPTION; JACOBS RA, 1994, COGNITIVE SCI, V18, P361, DOI 10.1207/s15516709cog1803_1; Jager G, 2003, NEUROPSYCHOLOGIA, V41, P504, DOI 10.1016/S0028-3932(02)00086-6; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; KOSSLYN SM, 1992, J EXP PSYCHOL HUMAN, V18, P562, DOI 10.1037/0096-1523.18.2.562; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; Laeng B, 2003, ASYMMETRICAL BRAIN, P303; LAENG B, 1995, NEUROPSYCHOLOGIA, V33, P421, DOI 10.1016/0028-3932(94)00126-A; Laeng B, 2011, COGNITIVE SCI, V35, P297, DOI 10.1111/j.1551-6709.2010.01139.x; Martin R, 2008, NEUROPSYCHOLOGIA, V46, P576, DOI 10.1016/j.neuropsychologia.2007.10.010; Munneke J, 2010, BRAIN COGNITION, V72, P368, DOI 10.1016/j.bandc.2009.11.001; Okubo M, 2010, ACTA PSYCHOL, V135, P1, DOI 10.1016/j.actpsy.2010.04.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ramsey NF, 1998, NEUROIMAGE, V8, P240, DOI 10.1006/nimg.1998.0358; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Slotnick SD, 2001, J COGNITIVE NEUROSCI, V13, P1088, DOI 10.1162/089892901753294383; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Trojano L, 2006, NEUROPSYCHOLOGIA, V44, P1569, DOI 10.1016/j.neuropsychologia.2006.01.017; Van der Ham IJM, 2011, BRAIN COGNITION; van der Ham IJM, 2007, NEUROPSYCHOLOGIA, V45, P2492, DOI 10.1016/j.neuropsychologia.2007.03.021; van der Ham IJM, 2010, MEM COGNITION, V38, P582, DOI 10.3758/MC.38.5.582; van der Ham IJM, 2009, BRAIN RES, V1297, P70, DOI 10.1016/j.brainres.2009.07.088; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; VANGELDEREN P, 1995, P NATL ACAD SCI USA, V92, P6906, DOI 10.1073/pnas.92.15.6906; VANKLEECK MH, 1989, NEUROPSYCHOLOGIA, V27, P1165, DOI 10.1016/0028-3932(89)90099-7	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38644	10.1371/journal.pone.0038644	http://dx.doi.org/10.1371/journal.pone.0038644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723872	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700018
J	Zhang, Y; Endam, LM; Filali-Mouhim, A; Zhao, LP; Desrosiers, M; Han, DM; Zhang, L				Zhang, Yuan; Endam, Leandra Mfuna; Filali-Mouhim, Abdelali; Zhao, Liping; Desrosiers, Martin; Han, Demin; Zhang, Luo			Polymorphisms in RYBP and AOAH Genes Are Associated with Chronic Rhinosinusitis in a Chinese Population: A Replication Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INNATE	Background: The development of CRS is believed to be the result of combined interactions between the genetic background of the affected subject and environmental factors. Objectives: To replicate and extend our recent findings from genetic association studies in chronic rhinosinusitis (CRS) performed in a Canadian Caucasian population in a Chinese population. Methods: In a case-control replication study, DNA samples were obtained from CRS with (n = 306; CRSwNP) and without (n = 332; CRSsNP) nasal polyps, and controls (n = 315) in a Chinese population. A total of forty-nine single nucleotide polymorphisms (SNPs) selected from previous identified SNPs associated with CRS in Canadian population, and SNPs from the CHB HapMap dataset were individually genotyped. Results: We identified two SNPs respectively in RYBP (rs4532099, p = 2.15E-06, OR = 2.59) and AOAH (rs4504543, p = 0.0001152, OR = 0.58) significantly associated with whole CRS cohort. Subgroup analysis for the presence of nasal polyps (CRSwNP and CRSsNP) displayed significant association in CRSwNP cohorts regarding to one SNP in RYBP (P = 3.24(E)-006, OR = 2.76). Evidence of association in the CRSsNP groups in terms of 2 SNPs (AOAH_rs4504543 and RYBP_rs4532099) was detected as well. Stratifying analysis by gender demonstrated that none of the selected SNPs were associated with CRSwNP as well as CRSsNP. Meanwhile 3 SNPs (IL1A_rs17561, P = 0.005778; IL1A_rs1800587, P = 0.009561; IRAK4_rs4251513, P = 0.03837) were associated with serum total IgE level. Conclusions: These genes are biologically plausible, with roles in regulation of transcription (RYBP) and inflammatory response (AOAH). The present data suggests the potential common genetic basis in the development of CRS in Chinese and Caucasian population.	[Zhang, Yuan; Han, Demin; Zhang, Luo] Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing TongRen Hosp, Beijing, Peoples R China; [Zhang, Yuan; Zhao, Liping; Han, Demin; Zhang, Luo] Beijing Inst Otolaryngol, Key Lab Otolaryngol Head & Neck Surg, Minist Educ China, Beijing, Peoples R China; [Endam, Leandra Mfuna; Filali-Mouhim, Abdelali; Desrosiers, Martin] CRCHUM, Dept Otolaryngol, Montreal, PQ, Canada; [Desrosiers, Martin] McGill Univ, Montreal Gen Hosp, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H3G 1A4, Canada	Capital Medical University; Ministry of Education, China; Universite de Montreal; McGill University	Zhang, Y (corresponding author), Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing TongRen Hosp, Beijing, Peoples R China.	desrosiers_martin@hotmail.com; handm@trhos.com; dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	National Science Fund for Distinguished Young Scholars [81025007]; National Natural Science Foundation of China [30973282, 81100706]; Beijing Natural Science Foundation [7102030]; Special Fund of Sanitation Elite Reconstruction of Beijing [2009-2-007]; Beijing Nova Program [2010B022]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Special Fund of Sanitation Elite Reconstruction of Beijing; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (81025007), the National Natural Science Foundation of China (30973282 and 81100706), the Beijing Natural Science Foundation (7102030), the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007), and Beijing Nova Program (2010B022) to LZ and YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barnes KC, 2006, J ALLERGY CLIN IMMUN, V118, P70, DOI 10.1016/j.jaci.2006.03.036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Castano R, 2010, OTOLARYNG HEAD NECK, V142, P665, DOI 10.1016/j.otohns.2010.01.004; Castano R, 2009, AMJ RHINOL ALLERGY, V23, P377, DOI 10.2500/ajra.2009.23.3303; Cormier C, 2009, J OTOLARYNGOL-HEAD N, V38, P133, DOI 10.2310/7070.2008.OA0220; Divoy C, 2011, J ALLERGY CLIN IMMUN, V127, pAB2, DOI 10.1016/j.jaci.2011.01.009; Endam LM, 2010, ARCH OTOLARYNGOL, V136, P187, DOI 10.1001/archoto.2009.219; Endam LM, 2009, OTOLARYNG HEAD NECK, V140, P741, DOI 10.1016/j.otohns.2008.12.058; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Kilty SJ, 2010, AM J RHINOL ALLERGY, V24, pE4, DOI 10.2500/ajra.2010.24.3429; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Lee L, 2008, MOL CELL BIOL, V28, P949, DOI 10.1128/MCB.00354-07; Lu MF, 2008, CELL HOST MICROBE, V4, P293, DOI 10.1016/j.chom.2008.06.009; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mfuna-Endam L, 2011, CURR ALLERGY ASTHM R, V11, P236, DOI 10.1007/s11882-011-0189-4; Nader ME, 2010, J OTOLARYNGOL-HEAD N, V39, P69, DOI 10.2310/7070.2009.080223; Ojogun N, 2009, J INFECT DIS, V200, P1685, DOI 10.1086/646616; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; Suzuki N, 2006, TRENDS IMMUNOL, V27, P566, DOI 10.1016/j.it.2006.10.003; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tewfik MA, 2009, ALLERGY, V64, P746, DOI 10.1111/j.1398-9995.2008.01889.x; Tewfik MA, 2010, J OTOLARYNGOL-HEAD N, V39, P62, DOI 10.2310/7070.2009.090009; Tournas A, 2010, J OTOLARYNGOL-HEAD N, V39, P188, DOI 10.2310/7070.2009.090080; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021769; Zhang Y, 2011, AM J RHINOL ALLERGY, V25, pE49, DOI 10.2500/ajra.2011.25.3588	29	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39247	10.1371/journal.pone.0039247	http://dx.doi.org/10.1371/journal.pone.0039247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723975	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700058
J	Caut, S; Angulo, E; Pisanu, B; Ruffino, L; Faulquier, L; Lorvelec, O; Chapuis, JL; Pascal, M; Vidal, E; Courchamp, F				Caut, Stephane; Angulo, Elena; Pisanu, Benoit; Ruffino, Lise; Faulquier, Lucie; Lorvelec, Olivier; Chapuis, Jean-Louis; Pascal, Michel; Vidal, Eric; Courchamp, Franck			Seabird Modulations of Isotopic Nitrogen on Islands	PLOS ONE			English	Article							FOOD WEBS; TERRESTRIAL ECOSYSTEMS; MEDITERRANEAN ISLANDS; INTRODUCED PREDATORS; ALLOCHTHONOUS INPUT; SPECIES RICHNESS; MARINE SUBSIDIES; STABLE-ISOTOPES; PENGUIN ROOKERY; SEA-TURTLES	The transport of nutrients by migratory animals across ecosystem boundaries can significantly enrich recipient food webs, thereby shaping the ecosystems' structure and function. To illustrate the potential role of islands in enabling the transfer of matter across ecosystem boundaries to be gauged, we investigated the influence of seabirds on nitrogen input on islands. Basing our study on four widely differing islands in terms of their biogeography and ecological characteristics, sampled at different spatial and temporal intervals, we analyzed the nitrogen isotopic values of the main terrestrial ecosystem compartments (vascular plants, arthropods, lizards and rodents) and their relationship to seabird values. For each island, the isotopic values of the ecosystem were driven by those of seabirds, which ultimately corresponded to changes in their marine prey. First, terrestrial compartments sampled within seabird colonies were the most enriched in delta N-15 compared with those collected at various distances outside colonies. Second, isotopic values of the whole terrestrial ecosystems changed over time, reflecting the values of seabirds and their prey, showing a fast turnover throughout the ecosystems. Our results demonstrate that seabird-derived nutrients not only spread across the terrestrial ecosystems and trophic webs, but also modulate their isotopic values locally and temporally on these islands. The wealth of experimental possibilities in insular ecosystems justifies greater use of these model systems to further our understanding of the modalities of trans-boundary nutrient transfers.	[Caut, Stephane; Angulo, Elena] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Pisanu, Benoit; Chapuis, Jean-Louis] Museum Natl Hist Nat, Dept EGB, F-75231 Paris, France; [Ruffino, Lise] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Faulquier, Lucie] Soc Ornithol Polynesie, Tahiti, Polynesie, France; [Lorvelec, Olivier; Pascal, Michel] INRA, Batiment, France; [Lorvelec, Olivier; Pascal, Michel] Agrocampus Ouest Ecol & Sante Ecosyst, Batiment, France; [Vidal, Eric] Aix Marseille Univ, IMBE, Ctr IRD Noumea, Noumea, New Caledonia; [Courchamp, Franck] Univ Paris, Lab ESE, F-75252 Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Museum National d'Histoire Naturelle (MNHN); University of Turku; INRAE; Institut Agro; Agrocampus Ouest; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; AgroParisTech; UDICE-French Research Universities; Universite Paris Cite	Caut, S (corresponding author), CSIC, Estn Biol Donana, Avda Americo Vespucio, E-41080 Seville, Spain.	stephanecaut@gmail.com	Angulo, Elena/A-8107-2013; Courchamp, Franck/ABE-7204-2020	Angulo, Elena/0000-0001-5545-4032; Courchamp, Franck/0000-0001-7605-4548	French Navy in New Caledonia; OPT Noumea; IFB; INSU (ACI ECCO-PNBC); Agence Nationale de la Recherche (ALIENS); Government of New Caledonia; Te manu Association; Hua Uka Town Hall; Conseil Regional PACA; The French Polar Institute (IPEV, program 136); Spanish Ministry of Science and Innovation; Consejo Superior de Investigaciones Cientificas	French Navy in New Caledonia; OPT Noumea; IFB; INSU (ACI ECCO-PNBC); Agence Nationale de la Recherche (ALIENS)(French National Research Agency (ANR)); Government of New Caledonia; Te manu Association; Hua Uka Town Hall; Conseil Regional PACA(Region Provence-Alpes-Cote d'Azur); The French Polar Institute (IPEV, program 136); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas	This study was made possible thanks to logistical support from the French Navy in New Caledonia and from OPT Noumea, authorities from Port-Cros National Park and to financial support from IFB, INSU (ACI ECCO-PNBC), Agence Nationale de la Recherche (ALIENS), the Government of New Caledonia, Te manu Association, Hua Uka Town Hall, Conseil Regional PACA, The French Polar Institute (IPEV, program 136), the Spanish Ministry of Science and Innovation (Juan de la Cierva contract to EA) and Consejo Superior de Investigaciones Cientificas (JAE postdoctoral contract to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; Anderson WB, 2008, ECOLOGY, V89, P660, DOI 10.1890/07-0234.1; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Beerling DJ, 1999, P ROY SOC B-BIOL SCI, V266, P1821, DOI 10.1098/rspb.1999.0852; Blais JM, 2007, ENVIRON SCI TECHNOL, V41, P1075, DOI 10.1021/es061314a; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; Brooks ML, 2003, J APPL ECOL, V40, P344, DOI 10.1046/j.1365-2664.2003.00789.x; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Caut S, 2009, BIOL INVASIONS, V11, P1689, DOI 10.1007/s10530-008-9397-9; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Ellis JC, 2006, J ANIM ECOL, V75, P565, DOI 10.1111/j.1365-2656.2006.01077.x; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; Farina JM, 2003, J ANIM ECOL, V72, P873, DOI 10.1046/j.1365-2656.2003.00760.x; Finney SK, 2003, J APPL ECOL, V40, P545, DOI 10.1046/j.1365-2664.2003.00810.x; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Hannan LB, 2007, ECOLOGY, V88, P1053, DOI 10.1890/06-0629; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kolb A, 2002, J ECOL, V90, P871, DOI 10.1046/j.1365-2745.2002.00719.x; Kolb GS, 2011, SEABIRD ISLANDS ECOL; LINDEBOOM HJ, 1984, ECOLOGY, V65, P269, DOI 10.2307/1939479; Markwell TJ, 2002, ECOSCIENCE, V9, P293, DOI 10.1080/11956860.2002.11682715; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; Michelutti N, 2009, P ROY SOC B-BIOL SCI, V276, P591, DOI 10.1098/rspb.2008.1103; MIZUTANI H, 1988, ECOLOGY, V69, P340, DOI 10.2307/1940432; MIZUTANI H, 1985, GEOCHEM J, V19, P323, DOI 10.2343/geochemj.19.323; Mulder CPH, 2009, BIOL INVASIONS, V11, P1671, DOI 10.1007/s10530-008-9396-x; Mulder CPH, 2011, SEABIRD ISLANDS ECOL; Orgeas J, 2003, ECOSCIENCE, V10, P38; Pascal M, 2009, TE MANU, V65, P6; Pisanu B, 2011, POLAR BIOL, V34, P169, DOI 10.1007/s00300-010-0867-z; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; POWELL GVN, 1991, ESTUAR COAST SHELF S, V32, P567, DOI 10.1016/0272-7714(91)90075-M; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Ruffino L, 2011, POPUL ECOL, V53, P535, DOI 10.1007/s10144-011-0265-6; Sanchez-Pinero F, 2000, ECOLOGY, V81, P3117, DOI 10.1890/0012-9658(2000)081[3117:BUDOAI]2.0.CO;2; SAS Institute Inc, 2004, SAS 9 1 3 HELP DOC; Schmidt S, 2004, FUNCT PLANT BIOL, V31, P517, DOI 10.1071/FP04024; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Stapp P, 2003, OIKOS, V102, P111, DOI 10.1034/j.1600-0706.2003.12445.x; Sun LG, 2000, NATURE, V407, P858, DOI 10.1038/35038163; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Vidal E, 1998, BIOL CONSERV, V84, P235, DOI 10.1016/S0006-3207(97)00130-4; Vidal E, 2000, OECOLOGIA, V122, P427, DOI 10.1007/s004420050049; Wainright SC, 1998, MAR BIOL, V131, P63, DOI 10.1007/s002270050297; Wait DA, 2005, J ARID ENVIRON, V60, P681, DOI 10.1016/j.jaridenv.2004.07.001; Wardle DA, 2007, BIOL LETTERS, V3, P479, DOI 10.1098/rsbl.2007.0163; WHITTAKER R, 1961, ECOL MONOGR, V31, P157, DOI 10.2307/1950753; WOOTTON JT, 1991, J EXP MAR BIOL ECOL, V151, P139, DOI 10.1016/0022-0981(91)90121-C	52	41	41	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39125	10.1371/journal.pone.0039125	http://dx.doi.org/10.1371/journal.pone.0039125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723945	Green Published, gold			2022-12-25	WOS:000305583300098
J	Choorapoikayil, S; Willems, B; Strohle, P; Gajewski, M				Choorapoikayil, Suma; Willems, Bernd; Stroehle, Peter; Gajewski, Martin			Analysis of her1 and her7 Mutants Reveals a Spatio Temporal Separation of the Somite Clock Module	PLOS ONE			English	Article							PRESOMITIC MESODERM; ZEBRAFISH SOMITOGENESIS; SEGMENTATION CLOCK; GENE-EXPRESSION; ANTERIOR; OSCILLATOR; BOUNDARIES; DIFFERENTIATION; HAIRY/ENHANCER; REPRESSION	Somitogenesis is controlled by a genetic network consisting of an oscillator (clock) and a gradient (wavefront). The "hairy and Enhancer of Split''- related (her) genes act downstream of the Delta/Notch (D/N) signaling pathway, and are crucial components of the segmentation clock. Due to genome duplication events, the zebrafish genome, possesses two gene copies of the mouse Hes7 homologue: her1 and her7. To better understand the functional consequences of this gene duplication, and to determine possible independent roles for these two genes during segmentation, two zebrafish mutants her1(hu2124) and her7(hu2526) were analyzed. In the course of embryonic development, her1(hu2124) mutants exhibit disruption of the three anterior-most somite borders, whereas her7(hu2526) mutants display somite border defects restricted to somites 8 (+/-3) to 17 (+/-3) along the anterior-posterior axis. Analysis of the molecular defects in her1(hu2124) mutants reveals a her1 auto regulatory feedback loop during early somitogenesis that is crucial for correct patterning and independent of her7 oscillation. This feedback loop appears to be restricted to early segmentation, as cyclic her1 expression is restored in her1(hu2124) embryos at later stages of development. Moreover, only the anterior deltaC expression pattern is disrupted in the presomitic mesoderm of her1(hu2124) mutants, while the posterior expression pattern of deltaC remains unaltered. Together, this data indicates the existence of an independent and genetically separable anterior and posterior deltaC clock modules in the presomitic mesdorm (PSM).	[Choorapoikayil, Suma; Stroehle, Peter; Gajewski, Martin] Univ Cologne, Inst Genet, Cologne, Germany; [Willems, Bernd] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Willems, Bernd] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117548, Singapore	University of Cologne; National University of Singapore; National University of Singapore	Choorapoikayil, S (corresponding author), Hubrecht Inst, Utrecht, Netherlands.	S.Choorapoikayil@hubrecht.eu			Deutsche Forschungsgemeinschaft Sonderforschungsbereich [572]	Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma T, 2007, EMBO REP, V8, P858, DOI 10.1038/sj.embor.7401045; AOYAMA H, 1988, DEVELOPMENT, V104, P15; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Gajewski M, 2003, DEVELOPMENT, V130, P4269, DOI 10.1242/dev.00627; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kawamura A, 2005, DEV CELL, V9, P735, DOI 10.1016/j.devcel.2005.09.021; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leve C, 2001, DEV GENES EVOL, V211, P493, DOI 10.1007/s00427-001-0181-4; Maul RS, 2001, GENE, V262, P155, DOI 10.1016/S0378-1119(00)00540-0; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sieger D, 2003, MECH DEVELOP, V120, P1083, DOI 10.1016/S0925-4773(03)00154-0; STERN CD, 1987, DEVELOPMENT, V99, P261; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Takke C, 1999, DEVELOPMENT, V126, P3005; Weinberg ES, 1996, DEVELOPMENT, V122, P271	28	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39073	10.1371/journal.pone.0039073	http://dx.doi.org/10.1371/journal.pone.0039073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723933	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300091
J	Larssen, BC; Ong, NT; Hodges, NJ				Larssen, Beverley C.; Ong, Nicole T.; Hodges, Nicola J.			Watch and Learn: Seeing Is Better than Doing when Acquiring Consecutive Motor Tasks	PLOS ONE			English	Article							VISUOMOTOR ADAPTATION; INTERNAL-MODEL; SPATIAL ALIGNMENT; PHYSICAL PRACTICE; WORKING-MEMORY; ABSENCE; INTERFERENCE; COORDINATION; IMAGERY; CORTEX	During motor adaptation learning, consecutive physical practice of two different tasks compromises the retention of the first. However, there is evidence that observational practice, while still effectively aiding acquisition, will not lead to interference and hence prove to be a better practice method. Observers and Actors practised in a clockwise (Task A) followed by a counterclockwise (Task B) visually rotated environment, and retention was immediately assessed. An Observe-all and Act-all group were compared to two groups who both physically practised Task A, but then only observed (ObsB) or did not see or practice Task B (NoB). The two observer groups and the NoB control group better retained Task A than Actors, although importantly only the observer groups learnt Task B. RT data and explicit awareness of the rotation suggested that the observers had acquired their respective tasks in a more strategic manner than Actor and Control groups. We conclude that observational practice benefits learning of multiple tasks more than physical practice due to the lack of updating of implicit, internal models for aiming in the former.	[Larssen, Beverley C.; Ong, Nicole T.; Hodges, Nicola J.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Larssen, BC (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada.	nicola.hodges@ubc.ca	Hodges, Nicola/AAA-8288-2022; Larssen, Beverley/AAW-8001-2021	Larssen, Beverley/0000-0002-2030-8198	Natural Sciences and Engineering Research Council of Canada (NSERC) [15R82559]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Discovery grant operating funds awarded to the corresponding author (Hodges) from The Natural Sciences and Engineering Research Council of Canada (NSERC, # 15R82559; http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bays PM, 2005, CURR BIOL, V15, P1125, DOI 10.1016/j.cub.2005.05.023; Bernier PM, 2006, NEUROREPORT, V17, P1421, DOI 10.1097/01.wnr.0000233096.13032.34; Bird G, 2005, J EXP PSYCHOL HUMAN, V31, P262, DOI 10.1037/0096-1523.31.2.262; Brown LE, 2009, J COGNITIVE NEUROSCI, V21, P1013, DOI 10.1162/jocn.2009.21079; Buchanan JJ, 2008, EXP BRAIN RES, V191, P157, DOI 10.1007/s00221-008-1512-8; Cross ES, 2011, CEREB CORTEX, V19, P315; Fernandez-Ruiz J, 2011, BEHAV BRAIN RES, V219, P8, DOI 10.1016/j.bbr.2010.11.060; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Gruetzmacher N, 2011, Q J EXP PSYCHOL, V64, P1111, DOI 10.1080/17470218.2010.543286; Hinder MR, 2007, EXP BRAIN RES, V180, P629, DOI 10.1007/s00221-007-0888-1; Hinder MR, 2010, EXP BRAIN RES, V201, P191, DOI 10.1007/s00221-009-2025-9; Hodges NJ, 2007, J SPORT SCI, V25, P531, DOI 10.1080/02640410600946860; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Maslovat D., 2010, VISION GOAL DIRECTED, P315, DOI DOI 10.5040/9781492597322.CH-017; Maslovat D, 2010, EXP BRAIN RES, V204, P119, DOI 10.1007/s00221-010-2302-7; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McCullagh P., 2001, HDB SPORT PSYCHOL, V2nd ed., P205; Melendez-Calderon A, 2011, IEEE T NEUR SYS REH, V19, P298, DOI 10.1109/TNSRE.2011.2125990; Ong NT, 2012, EXP BRAIN RES, V218, P9, DOI 10.1007/s00221-011-2996-1; Ong NT, 2010, EXP BRAIN RES, V205, P325, DOI 10.1007/s00221-010-2366-4; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; REDDING GM, 1993, J MOTOR BEHAV, V25, P75, DOI 10.1080/00222895.1993.9941642; Redding GM, 2002, J MOTOR BEHAV, V34, P126, DOI 10.1080/00222890209601935; Rizzolatti G, 2005, ANAT EMBRYOL, V210, P419, DOI 10.1007/s00429-005-0039-z; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Trempe M, 2011, EXP BRAIN RES, V209, P181, DOI 10.1007/s00221-011-2540-3; Wang JS, 2011, J NEUROPHYSIOL, V106, P259, DOI 10.1152/jn.00254.2011; Weeks DL, 2000, ACTA PSYCHOL, V104, P259, DOI 10.1016/S0001-6918(00)00039-1; Wigmore V, 2002, J EXP PSYCHOL HUMAN, V28, P447, DOI 10.1037//0096-1523.28.2.447; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	40	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38938	10.1371/journal.pone.0038938	http://dx.doi.org/10.1371/journal.pone.0038938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22723909	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300069
J	Miller, MA; Feng, XJ; Li, GY; Rabitz, HA				Miller, Miles A.; Feng, Xiao-Jiang; Li, Genyuan; Rabitz, Herschel A.			Identifying Biological Network Structure, Predicting Network Behavior, and Classifying Network State With High Dimensional Model Representation (HDMR)	PLOS ONE			English	Article							PROTEIN-SIGNALING NETWORKS; KINASE-B; BETA-GAMMA; RS-HDMR; ACTIVATION; EXPRESSION; PHOSPHORYLATION; RECEPTOR; INFERENCE; DYNAMICS	This work presents an adapted Random Sampling - High Dimensional Model Representation (RS-HDMR) algorithm for synergistically addressing three key problems in network biology: (1) identifying the structure of biological networks from multivariate data, (2) predicting network response under previously unsampled conditions, and (3) inferring experimental perturbations based on the observed network state. RS-HDMR is a multivariate regression method that decomposes network interactions into a hierarchy of non-linear component functions. Sensitivity analysis based on these functions provides a clear physical and statistical interpretation of the underlying network structure. The advantages of RS-HDMR include efficient extraction of nonlinear and cooperative network relationships without resorting to discretization, prediction of network behavior without mechanistic modeling, robustness to data noise, and favorable scalability of the sampling requirement with respect to network size. As a proof-of-principle study, RS-HDMR was applied to experimental data measuring the single-cell response of a protein-protein signaling network to various experimental perturbations. A comparison to network structure identified in the literature and through other inference methods, including Bayesian and mutual-information based algorithms, suggests that RS-HDMR can successfully reveal a network structure with a low false positive rate while still capturing non-linear and cooperative interactions. RS-HDMR identified several higher-order network interactions that correspond to known feedback regulations among multiple network species and that were unidentified by other network inference methods. Furthermore, RS-HDMR has a better ability to predict network response under unsampled conditions in this application than the best statistical inference algorithm presented in the recent DREAM3 signaling-prediction competition. RS-HDMR can discern and predict differences in network state that arise from sources ranging from intrinsic cell-cell variability to altered experimental conditions, such as when drug perturbations are introduced. This ability ultimately allows RS-HDMR to accurately classify the experimental conditions of a given sample based on its observed network state.	[Miller, Miles A.; Feng, Xiao-Jiang; Li, Genyuan; Rabitz, Herschel A.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Miller, Miles A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Princeton University; Massachusetts Institute of Technology (MIT)	Miller, MA (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	hrabitz@princeton.edu		Miller, Miles/0000-0001-7638-8898	NSF (National Science Foundation); AFOSR (Air Force Office of Scientific Research); EPA-ebCTC (Environmental Protection Agency - environmental bioinformatics and Computational Toxicology Center)	NSF (National Science Foundation)(National Science Foundation (NSF)); AFOSR (Air Force Office of Scientific Research)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); EPA-ebCTC (Environmental Protection Agency - environmental bioinformatics and Computational Toxicology Center)	The authors acknowledge the NSF (National Science Foundation), the AFOSR (Air Force Office of Scientific Research), and the EPA-ebCTC (Environmental Protection Agency - environmental bioinformatics and Computational Toxicology Center) for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; Alis OF, 2001, J MATH CHEM, V29, P127, DOI 10.1023/A:1010979129659; Ambrosini A, 2000, MOL BRAIN RES, V75, P54, DOI 10.1016/S0169-328X(99)00294-6; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bogdan M, 2004, GENETICS, V167, P989, DOI 10.1534/genetics.103.021683; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; BROWN KD, 1984, BIOCHEM BIOPH RES CO, V123, P377, DOI 10.1016/0006-291X(84)90424-8; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; Chatterjee S, 1977, REGRESSION ANAL EXAM; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; D'haeseleer P, 1999, Pac Symp Biocomput, P41; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Deutsch F., 2001, BEST APPROXIMATION I; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fortino V, 2002, CELL MOL LIFE SCI, V59, P2165, DOI 10.1007/s000180200015; Frenkel-Morgenstern M, 2010, NUCLEIC ACIDS RES, V38, pD508, DOI 10.1093/nar/gkp808; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1998, P UAI; Fukuda R, 2003, CANCER RES, V63, P2330; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Greco S, 2006, J ENDOCRINOL, V188, P79, DOI 10.1677/joe.1.06433; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Gringhuis SI, 1997, J BIOL CHEM, V272, P31809, DOI 10.1074/jbc.272.50.31809; Guex N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008012; Honaker J, 2011, J STAT SOFTWARE; Imoto S, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P219, DOI 10.1109/CSB.2002.1039344; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Li G, 2010, J POLYM RES     1022, P1; Li G.Q., 2011, J MATH CHEM, P1; Li GY, 2010, J PHYS CHEM A, V114, P6022, DOI 10.1021/jp9096919; Li GY, 2006, J PHYS CHEM A, V110, P2474, DOI 10.1021/jp054148m; Li GY, 2003, J COMPUT CHEM, V24, P647, DOI 10.1002/jcc.10232; Li GY, 2003, J COMPUT CHEM, V24, P277, DOI 10.1002/jcc.10172; Li GY, 2001, J PHYS CHEM A, V105, P7765, DOI 10.1021/jp010450t; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller MA, 2011, INTEGR BIOL-UK, V3, P422, DOI 10.1039/c0ib00083c; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Neapolitan R.E., 2003, LEARNING BAYESIAN NE; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rabitz H, 1999, COMPUT PHYS COMMUN, V117, P11, DOI 10.1016/S0010-4655(98)00152-0; RANA RS, 1990, PHYSIOL REV, V70, P115, DOI 10.1152/physrev.1990.70.1.115; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shim K, 1998, PHYS REV B, V58, P1940, DOI 10.1103/PhysRevB.58.1940; Shorter JA, 1999, J PHYS CHEM A, V103, P7192, DOI 10.1021/jp9843398; Srividhya J, 2007, PROTEOMICS, V7, P828, DOI 10.1002/pmic.200600428; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; van Someren EP, 2006, BIOINFORMATICS, V22, P477, DOI 10.1093/bioinformatics/bti816; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Wang K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P264; Wang SW, 2003, J PHYS CHEM A, V107, P4707, DOI 10.1021/jp022500f; Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zheng M, 2000, J BIOL CHEM, V275, P40635, DOI 10.1074/jbc.M006325200	77	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37664	10.1371/journal.pone.0037664	http://dx.doi.org/10.1371/journal.pone.0037664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723838	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300010
J	Violante, IR; Ribeiro, MJ; Cunha, G; Bernardino, I; Duarte, JV; Ramos, F; Saraiva, J; Silva, E; Castelo-Branco, M				Violante, Ines R.; Ribeiro, Maria J.; Cunha, Gil; Bernardino, Ines; Duarte, Joao V.; Ramos, Fabiana; Saraiva, Jorge; Silva, Eduardo; Castelo-Branco, Miguel			Abnormal Brain Activation in Neurofibromatosis Type 1: A Link between Visual Processing and the Default Mode Network	PLOS ONE			English	Article							PREFRONTAL CORTEX; FMR1 GENE; PATHWAY; SCHIZOPHRENIA; MATURATION; DEACTIVATE; ADVANTAGE; MECHANISM; RESPONSES; CHILDREN	Neurofibromatosis type 1 (NF1) is one of the most common single gene disorders affecting the human nervous system with a high incidence of cognitive deficits, particularly visuospatial. Nevertheless, neurophysiological alterations in low-level visual processing that could be relevant to explain the cognitive phenotype are poorly understood. Here we used functional magnetic resonance imaging (fMRI) to study early cortical visual pathways in children and adults with NF1. We employed two distinct stimulus types differing in contrast and spatial and temporal frequencies to evoke relatively different activation of the magnocellular (M) and parvocellular (P) pathways. Hemodynamic responses were investigated in retinotopically-defined regions V1, V2 and V3 and then over the acquired cortical volume. Relative to matched control subjects, patients with NF1 showed deficient activation of the low-level visual cortex to both stimulus types. Importantly, this finding was observed for children and adults with NF1, indicating that low-level visual processing deficits do not ameliorate with age. Moreover, only during M-biased stimulation patients with NF1 failed to deactivate or even activated anterior and posterior midline regions of the default mode network. The observation that the magnocellular visual pathway is impaired in NF1 in early visual processing and is specifically associated with a deficient deactivation of the default mode network may provide a neural explanation for high-order cognitive deficits present in NF1, particularly visuospatial and attentional. A link between magnocellular and default mode network processing may generalize to neuropsychiatric disorders where such deficits have been separately identified.	[Violante, Ines R.; Ribeiro, Maria J.; Cunha, Gil; Bernardino, Ines; Duarte, Joao V.; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, Inst Biomed Res Light & Image, Visual Neurosci Lab, Coimbra, Portugal; [Ramos, Fabiana; Saraiva, Jorge] Pediat Hosp Coimbra, Dept Med Genet, Coimbra, Portugal; [Silva, Eduardo] Univ Hosp Coimbra, Ctr Hereditary Eye Dis, Dept Ophthalmol, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)	Violante, IR (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Res Light & Image, Visual Neurosci Lab, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Duarte, João Valente/B-3788-2018; Castelo-Branco, Miguel/F-3866-2019; Bernardino, Inês/D-4487-2018; Castelo-Branco, Miguel/E-5689-2010; Bernardino, Inês/AAF-6741-2020; Ribeiro, Maria J/J-4618-2013	Duarte, João Valente/0000-0001-8586-9554; Castelo-Branco, Miguel/0000-0003-4364-6373; Bernardino, Inês/0000-0003-3123-008X; Bernardino, Inês/0000-0003-3123-008X; Ribeiro, Maria J/0000-0001-6422-3279; Ramos, Fabiana/0000-0001-7780-9762; Violante, Ines/0000-0002-4787-2901; Saraiva, Jorge Manuel/0000-0002-7232-3509; Silva, Eduardo/0000-0002-2739-9854	University of Coimbra [III/14/2008]; Portuguese Foundation for Science and Technology [PIC/IC/83155/2007, PTDC_SAU-ORG_118380, PIC/IC/82986/2007, SFRH/BD/41348/2007, SFRH/BPD/34392/2006, SFRH/BD/41401/2007]	University of Coimbra; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the University of Coimbra [Grant number III/14/2008] and the Portuguese Foundation for Science and Technology [Grant numbers PIC/IC/83155/2007, PTDC_SAU-ORG_118380, PIC/IC/82986/2007, SFRH/BD/41348/2007 to I.R.V., SFRH/BPD/34392/2006 to M.J.R, and SFRH/BD/41401/2007 to I.B.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Billingsley RL, 2003, J CHILD NEUROL, V18, P731, DOI 10.1177/08830738030180110701; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bucher K, 2006, NEUROIMAGE, V31, P1625, DOI 10.1016/j.neuroimage.2006.02.032; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Bullier J, 2001, PROG BRAIN RES, V134, P193; Clements-Stephens AM, 2008, NEUROPSYCHOLOGIA, V46, P690, DOI 10.1016/j.neuropsychologia.2007.09.013; Coleman MJ, 2009, SCHIZOPHRENIA BULL, V35, P1108, DOI 10.1093/schbul/sbp090; Eickhoff SB, 2008, CEREB CORTEX, V18, P2637, DOI 10.1093/cercor/bhn024; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Formisano E, 2004, MAGN RESON IMAGING, V22, P1493, DOI 10.1016/j.mri.2004.10.020; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRIEDMAN JM, 1993, AM J MED GENET, V45, P88, DOI 10.1002/ajmg.1320450121; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; Huijbregts S, 2010, DEV NEUROPSYCHOL, V35, P737, DOI 10.1080/87565641.2010.508670; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Jo HJ, 2007, NEUROIMAGE, V34, P550, DOI 10.1016/j.neuroimage.2006.09.047; Kayl AE, 2000, MENT RETARD DEV D R, V6, P117, DOI 10.1002/1098-2779(2000)6:2<117::AID-MRDD5>3.0.CO;2-X; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kesler SR, 2004, CEREB CORTEX, V14, P174, DOI 10.1093/cercor/bhg116; Klaver P, 2008, NEUROIMAGE, V39, P1815, DOI 10.1016/j.neuroimage.2007.11.009; Kogan CS, 2004, BRAIN, V127, P591, DOI 10.1093/brain/awh069; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Laycock R, 2008, NEUROSCI BIOBEHAV R, V32, P1409, DOI 10.1016/j.neubiorev.2008.04.008; Laycock R, 2007, NEUROSCI BIOBEHAV R, V31, P363, DOI 10.1016/j.neubiorev.2006.10.003; Leventhal A G, 1991, VISION VISUAL DYSFUN, V4; Levine Terry M, 2006, Semin Pediatr Neurol, V13, P8, DOI 10.1016/j.spen.2006.01.006; Liu CSJ, 2006, AM J NEURORADIOL, V27, P1628; Liu TH, 2006, J VISION, V6, P1294, DOI 10.1167/6.11.12; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Loenneker T, HUM BRAIN MAPP, V935- 946; Martinez A, 2008, J NEUROSCI, V28, P7492, DOI 10.1523/JNEUROSCI.1852-08.2008; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mendola JD, 2006, J COGNITIVE NEUROSCI, V18, P363, DOI 10.1162/089892906775990624; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Payne JM, 2010, J NEUROL NEUROSUR PS, V81, P304, DOI 10.1136/jnnp.2009.179630; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Penny W., 2003, HUMAN BRAIN FUNCTION; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raven J. C, 1993, MANUAL RAVENS PROGRE; Ribeiro MJ, 2012, INVEST OPHTH VIS SCI, V53, P287, DOI 10.1167/iovs.11-8225; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Rowbotham I, 2009, NEUROPSYCHOLOGY, V23, P50, DOI 10.1037/a0013927; Salgado-Pineda P, 2011, SCHIZOPHR RES, V125, P101, DOI 10.1016/j.schres.2010.10.027; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shilyansky C, 2010, P NATL ACAD SCI USA, V107, P13141, DOI 10.1073/pnas.1004829107; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Talairach J., 1988, COPLANAR STEREOTAXIC; Tranel D, 2009, J CLIN EXP NEUROPSYC, V31, P219, DOI 10.1080/13803390802317542; Wechsler D., 2003, ESCALA INTELIGENCIA	60	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38785	10.1371/journal.pone.0038785	http://dx.doi.org/10.1371/journal.pone.0038785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723888	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300049
J	Wu, J; Cui, N; Wang, R; Li, JW; Wong, JM				Wu, Jing; Cui, Nan; Wang, Rui; Li, Jiwen; Wong, Jiemin			A Role for CARM1-Mediated Histone H3 Arginine Methylation in Protecting Histone Acetylation by Releasing Corepressors from Chromatin	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; RNA-POLYMERASE-II; GENE-EXPRESSION; HETEROCHROMATIN FORMATION; LYSINE-4 METHYLATION; PROTEIN METHYLATION; TRANSCRIPTION; BINDING; COMPLEX; METHYLTRANSFERASE	Arginine methylation broadly occurs in histones and has been linked to transcriptional regulation, cell cycle regulation and DNA repair. While numerous proteins (histone code effectors) that specifically recognize or read the methylated lysine residues in core histones have been identified, little is known for effectors specific for methylated arginines in histones. In this study, we attempted to identify effector(s) recognizing asymmetrically methylated R17 and R26 in H3, which are catalyzed by CARM1/PRMT4, through an unbiased biochemical approach. Although we have yet to identify such effector using this approach, we find that these modifications function cooperatively with histone acetylation to inhibit the binding of the nucleosome remodeling and deacetylase complex (NuRD) and TIF1 family corepressors to H3 tail in vitro. In support of this finding, we show that overexpression of CARM1 in 293 T cells leads to reduced association of NuRD with chromatin, whereas knockdown of CARM1 in HeLa cells leads to increased association of NuRD with chromatin and decreased level of histone acetylation. Furthermore, in the Carm1-/- MEF cells there is an increased association of NuRD and TIF1 beta with chromatin and a global decrease in histone acetylation. By chromatin immunoprecipitation assay, we show that overexpression of CARM1 results in reduced association of NuRD complex and TIF1 beta with an episomal reporter and that CARM1 is required in MEF cells for LPS-induced dissociation of NuRD from a NF-kappa b target gene. Taking together, our study provides evidence for a role of CARM1-mediated arginine methylation in regulation of histone acetylation and transcription: facilitating transcription by discharging corepressors from chromatin.	[Wu, Jing] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Wu, J (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China.	jmweng@bio.ecnu.edu.cn		Wong, Jiemin/0000-0002-5311-842X	National Natural Science Foundation of China [90919025, 30871381]; Ministry of Science and Technology of China [2009CB918402, 2009CB825601, 2010CB944903]; Science and Technology Commission of Shanghai Municipality [09DJ1400400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was partially supported by grants from the National Natural Science Foundation of China (90919025 and 30871381), the Ministry of Science and Technology of China (2009CB918402, 2009CB825601, 2010CB944903), the Science and Technology Commission of Shanghai Municipality (09DJ1400400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kustatscher G, 2007, CURR OPIN CHEM BIOL, V11, P628, DOI 10.1016/j.cbpa.2007.09.011; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schneider R, 2004, J BIOL CHEM, V279, P23859, DOI 10.1074/jbc.C400151200; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	48	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e34692	10.1371/journal.pone.0034692	http://dx.doi.org/10.1371/journal.pone.0034692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723830	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300001
J	Morris, LM; DeGagne, JM; Kempton, JB; Hausman, F; Trune, DR				Morris, Lisa M.; DeGagne, Jacqueline M.; Kempton, J. Beth; Hausman, Frances; Trune, Dennis R.			Mouse Middle Ear Ion Homeostasis Channels and Intercellular Junctions	PLOS ONE			English	Article							INNER-EAR; OTITIS-MEDIA; EXPRESSION PATTERNS; EPITHELIAL-CELLS; SECRETORY OTITIS; EUSTACHIAN-TUBE; AQUAPORIN-4; CLEARANCE; TRANSPORT; EPIDEMIOLOGY	Hypothesis: The middle ear contains homeostatic mechanisms that control the movement of ions and fluids similar to those present in the inner ear, and are altered during inflammation. Background: The normal middle ear cavity is fluidfree and airfilled to allow for effective sound transmission. Within the inner ear, the regulation of fluid and ion movement is essential for normal auditory and vestibular function. The same ion and fluid channels active in the inner ear may have similar roles with fluid regulation in the middle ear. Methods: Middle and inner ears from BALB/c mice were processed for immunohistochemistry of 10 specific ion homeostasis factors to determine if similar transport and barrier mechanisms are present in the tympanic cavity. Examination also was made of BALB/c mice middle ears after transtympanic injection with heatkilled Haemophilus influenza to determine if these channels are impacted by inflammation. Results: The most prominent ion channels in the middle ear included aquaporins 1, 4 and 5, claudin 3, ENaC and Na+, K+-ATPase. Moderate staining was found for GJB2, KCNJ10 and KCNQ1. The inflamed middle ear epithelium showed increased staining due to expected cellular hypertrophy. Localization of ion channels was preserved within the inflamed middle ear epithelium. Conclusions: The middle ear epithelium is a dynamic environment with intrinsic mechanisms for the control of ion and water transport to keep the middle ear clear of fluids. Compromise of these processes during middle ear disease may underlie the accumulation of effusions and suggests they may be a therapeutic target for effusion control.	[Morris, Lisa M.; DeGagne, Jacqueline M.; Kempton, J. Beth; Hausman, Frances; Trune, Dennis R.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University	Morris, LM (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	truned@ohsu.edu			National Institutes of Health-National Institute on Deafness and Other Communication Disorders [R01 DC009455 and DC005593]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005593, P30DC005983, R01DC009455] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health-National Institute on Deafness and Other Communication Disorders R01 DC009455 and DC005593 (DRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beitz E, 2003, CELL MOL NEUROBIOL, V23, P315, DOI 10.1023/A:1023636620721; Choi JY, 2007, EUR J PHARMACOL, V567, P19, DOI 10.1016/j.ejphar.2007.04.026; Choi JY, 2006, HEARING RES, V211, P26, DOI 10.1016/j.heares.2005.08.007; Couloigner V, 2006, PFLUG ARCH EUR J PHY, V453, P11, DOI 10.1007/s00424-006-0103-4; Dinh EH, 2009, BRAIN RES, V1277, P52, DOI 10.1016/j.brainres.2009.02.008; Florian P, 2003, BIOCHEM BIOPH RES CO, V304, P5, DOI 10.1016/S0006-291X(03)00498-4; HERMAN P, 1992, AM J PHYSIOL, V262, pF373, DOI 10.1152/ajprenal.1992.262.3.F373; Herman P, 1998, KIDNEY INT, pS94; HONJO I, 1985, AM J OTOLARYNG, V6, P241, DOI 10.1016/S0196-0709(85)80095-8; Huang DL, 2002, HEARING RES, V165, P85, DOI 10.1016/S0378-5955(02)00288-5; INAGAKI M, 1988, ANN OTO RHINOL LARYN, V97, P313, DOI 10.1177/000348948809700321; Kang SH, 2007, ACTA OTO-LARYNGOL, V127, P687, DOI 10.1080/00016480500452574; Kitajiri S, 2004, HEARING RES, V187, P25, DOI 10.1016/S0378-5955(03)00338-1; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Li JP, 2005, HEARING RES, V210, P1, DOI 10.1016/j.heares.2005.04.011; MacArthur CJ, 2006, HEARING RES, V219, P12, DOI 10.1016/j.heares.2006.05.012; MacArthur CJ, 2011, OTOL NEUROTOL, V32, P508, DOI 10.1097/MAO.0b013e31820e6de4; Minami S, 2001, HEARING RES, V158, P51, DOI 10.1016/S0378-5955(01)00284-2; Miyabe Y, 2002, TOHOKU J EXP MED, V196, P247, DOI 10.1620/tjem.196.247; SADE J, 1975, ACTA OTO-LARYNGOL, V79, P277, DOI 10.3109/00016487509124685; Smith DJ, 2008, RESP PHYSIOL NEUROBI, V163, P178, DOI 10.1016/j.resp.2008.03.006; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; TOS M, 1984, AM J OTOL, V5, P459; Trune DR, 2010, CURR OPIN OTOLARYNGO; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009; Zhang Q, 2009, ORL-J OTO-RHIN-LARYN, V71, P70, DOI 10.1159/000182419	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39004	10.1371/journal.pone.0039004	http://dx.doi.org/10.1371/journal.pone.0039004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720014	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000033
J	Nugteren, JJ; Snijder, CA; Hofman, A; Jaddoe, VWV; Steegers, EAP; Burdorf, A				Nugteren, Jaap Jan; Snijder, Claudia A.; Hofman, Albert; Jaddoe, Vincent W. V.; Steegers, Eric A. P.; Burdorf, Alex			Work-Related Maternal Risk Factors and the Risk of Pregnancy Induced Hypertension and Preeclampsia during Pregnancy. The Generation R Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; LOW-BIRTH-WEIGHT; GESTATIONAL HYPERTENSION; OCCUPATIONAL-EXPOSURE; FETAL DEVELOPMENT; BLOOD-PRESSURE; JOB STRAIN; STRESS; CATECHOLAMINES; PATHOGENESIS	Objective: To study the associations between physically demanding work and occupational exposure to chemicals and hypertensive disorders during pregnancy within a large birth cohort study, the Generation R Study. Methods: Associations between occupational characteristics and hypertensive disorders during pregnancy were studied in 4465 pregnant woman participating in a population-based prospective cohort study from early pregnancy onwards in the Netherlands (2002-2006). Mothers who filled out a questionnaire during mid-pregnancy (response 77% of enrolment), were included if they conducted paid employment, had a spontaneously conceived singleton live born pregnancy, and did not suffer from pre-existing hypertension (n = 4465). Questions on physical demanding work were obtained from the Dutch Musculoskeletal Questionnaire and concerned questions on manually handling loads of 25 kg or more, long periods of standing or walking, night shifts, and working hours. To assess occupational exposure to chemicals, job titles and task descriptions were linked to a job-exposure-matrix (JEM), an expert judgment on exposure to chemicals at the workplace. Information on hypertensive disorders during pregnancy was obtained from medical records. Results: We observed no consistent associations between any of the work related risk factors, such as long periods of standing or walking, heavy lifting, night shifts, and working hours, nor exposure to chemicals with hypertensive disorders during pregnancy. Conclusion: This prospective birth cohort study suggests that there is no association of hypertensive disorders during pregnancy with physically demanding work or exposure to chemicals. However, the low prevalence of PIH and PE, combined with the low prevalence of occupational risk factors limit the power for inference and larger studies are needed to corroborate or refute these findings.	[Nugteren, Jaap Jan; Snijder, Claudia A.; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Nugteren, Jaap Jan; Snijder, Claudia A.; Burdorf, Alex] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Paediat, Rotterdam, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Nugteren, JJ (corresponding author), Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands.	a.burdorf@erasmusmc.nl	Burdorf, Alex/A-2226-2008	Burdorf, Alex/0000-0003-3129-2862	Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); European Union [212502]	Erasmus Medical Centre, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union(European Commission)	The first phase of the Generation R Study is made possible by financial support from: Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw). The present study was conducted in commission of the European project CONTAMED with funding from the European Union's Seventh Framework Programme (FP7) for Research and Technology Development. EU grant agreement no. 212502. There are no commercial associations that may pose any conflict of interest. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bakker R, 2010, J HYPERTENS, V28, P2210, DOI 10.1097/HJH.0b013e32833e2a3d; Bonzini M, 2007, OCCUP ENVIRON MED, V64, P228, DOI 10.1136/oem.2006.026872; Brouwers MM, 2009, OCCUP ENVIRON MED, V66, P607, DOI 10.1136/oem.2008.042184; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Burdorf A, 2011, OCCUP ENVIRON MED, V68, P197, DOI 10.1136/oem.2009.046516; Coolman M, 2010, J CLIN EPIDEMIOL, V63, P932, DOI 10.1016/j.jclinepi.2009.10.010; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; ESKENAZI B, 1988, AM J IND MED, V14, P177, DOI 10.1002/ajim.4700140208; Fujiwara K, 2004, SCAND J WORK ENV HEA, V30, P129, DOI 10.5271/sjweh.770; Gaillard R, 2011, J HYPERTENS, V29, P937, DOI 10.1097/HJH.0b013e328345500c; Haelterman E, 2007, SCAND J WORK ENV HEA, V33, P304, DOI 10.5271/sjweh.1147; Hernandez-Diaz Sonia, 2009, BMJ, V338, pb2255, DOI 10.1136/bmj.b2255; Hildebrandt VH, 2001, ERGONOMICS, V44, P1038, DOI 10.1080/00140130110087437; IRWIN DE, 1994, AM J IND MED, V25, P349, DOI 10.1002/ajim.4700250305; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Jansen PW, 2010, OCCUP ENVIRON MED, V67, P387, DOI 10.1136/oem.2009.046300; Kaaja R, 2008, Minerva Ginecol, V60, P421; KATZ VL, 1991, OBSTET GYNECOL, V77, P338; Khatun S, 1997, EUR J OBSTET GYN R B, V74, P103, DOI 10.1016/S0301-2115(97)00112-7; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Landsbergis PA, 1996, EPIDEMIOLOGY, V7, P346, DOI 10.1097/00001648-199607000-00002; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Marcoux S, 1999, EPIDEMIOLOGY, V10, P376, DOI 10.1097/00001648-199907000-00007; Mozurkewich EL, 2000, OBSTET GYNECOL, V95, P623, DOI 10.1016/S0029-7844(99)00598-0; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; NURMINEN T, 1989, SCAND J WORK ENV HEA, V15, P404, DOI 10.5271/sjweh.1832; NURMINEN T, 1989, SCAND J WORK ENV HEA, V15, P395, DOI 10.5271/sjweh.1833; Pierik FH, 2004, ENVIRON HEALTH PERSP, V112, P1570, DOI 10.1289/ehp.7243; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Saftlas AF, 2004, AM J EPIDEMIOL, V160, P758, DOI 10.1093/aje/kwh277; Saldana TM, 2009, ENVIRON HEALTH PERSP, V117, P1393, DOI 10.1289/ehp.0900672; Schobel HP, 1996, NEW ENGL J MED, V335, P1480, DOI 10.1056/NEJM199611143352002; Snijder CA, 2011, FERTIL STERIL, V95, P2067, DOI 10.1016/j.fertnstert.2011.02.017; Statistics Netherlands, 1992, DUTCH CLASS OCC SBC; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; VANDERBEEK AJ, 1995, OCCUP ENVIRON MED, V52, P464, DOI 10.1136/oem.52.7.464; Vrijheid M, 2003, OCCUP ENVIRON MED, V60, P543, DOI 10.1136/oem.60.8.543; Wigle DT, 2008, J TOXICOL ENV HEAL B, V11, P373, DOI 10.1080/10937400801921320; Young KB, 1998, WILLIAMS TXB ENDOCRI, P665; Zhang J, 1997, EPIDEMIOL REV, V19, P218, DOI 10.1093/oxfordjournals.epirev.a017954	45	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39263	10.1371/journal.pone.0039263	http://dx.doi.org/10.1371/journal.pone.0039263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720087	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350000055
J	Wada, S; Kawano-Yamashita, E; Koyanagi, M; Terakita, A				Wada, Seiji; Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Terakita, Akihisa			Expression of UV-Sensitive Parapinopsin in the Iguana Parietal Eyes and Its Implication in UV-Sensitivity in Vertebrate Pineal-Related Organs	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; GREEN IGUANA; G-PROTEIN; PIGMENT; OPSIN; PHOTORECEPTORS; MECHANISM; FAMILY	The pineal-related organs of lower vertebrates have the ability to discriminate different wavelengths of light. This wavelength discrimination is achieved through antagonistic light responses to UV or blue and visible light. Previously, we demonstrated that parapinopsin underlies the UV reception in the lamprey pineal organ and identified parapinopsin genes in teleosts and frogs of which the pineal-related organs were reported to discriminate light. In this study, we report the first identification of parapinopsin in the reptile lineage and show its expression in the parietal eye of the green iguana. Spectroscopic analysis revealed that iguana parapinopsin is a UV-sensitive pigment, similar to lamprey parapinopsin. Interestingly, immunohistochemical analyses using antibodies specific to parapinopsin and parietopsin, a parietal eye green-sensitive pigment, revealed that parapinopsin and parietopsin are colocalized in the outer segments of the parietal eye photoreceptor cells in iguanas. These results strongly suggest that parapinopsin underlies the wavelength discrimination involving UV reception in the iguana parietal eye. The current findings support the idea that parapinopsin is a common photopigment underlying the UV-sensitivity in wavelength discrimination of the pineal-related organs found from lampreys to reptiles.	[Wada, Seiji; Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 558, Japan	Osaka Metropolitan University	Wada, S (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 558, Japan.	terakita@sci.osaka-cu.ac.jp	WADA, SEIJI/GZL-0272-2022	Koyanagi, Mitsumasa/0000-0002-7741-918X; Terakita, Akihisa/0000-0002-8379-8913	Japanese Ministry of Education, Science, Sports, and Culture; Naito Foundation; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22687005] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (to A. T. and M. K.) and the Naito Foundation (to A. T.). E.K-Y. is supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshaw S, 1997, J NEUROSCI, V17, P8083; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; DODT E, 1962, J NEUROPHYSIOL, V25, P405, DOI 10.1152/jn.1962.25.3.405; ELDRED WD, 1978, VISION RES, V18, P29, DOI 10.1016/0042-6989(78)90073-1; FALCON J, 1981, J COMP PHYSIOL, V144, P127, DOI 10.1007/BF00612806; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HAMASAKI DI, 1968, VISION RES, V8, P591, DOI 10.1016/0042-6989(68)90100-4; HAMASAKI DI, 1969, VISION RES, V9, P515, DOI 10.1016/0042-6989(69)90139-4; JENISON G, 1980, BRAIN RES, V194, P506, DOI 10.1016/0006-8993(80)91232-9; KAPPERS J A, 1965, Prog Brain Res, V10, P87; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawano-Yamashita E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016402; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MORITA Y, 1966, PFLUG ARCH GES PHYS, V289, P155, DOI 10.1007/BF00412906; Morita Y, 1973, NOVA ACTA LEOPOLDINA, V38, P331; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; OKSCHE A, 1965, Prog Brain Res, V10, P3; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; UCHIDA K, 1994, PFLUG ARCH EUR J PHY, V427, P373, DOI 10.1007/BF00374547; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107	27	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39003	10.1371/journal.pone.0039003	http://dx.doi.org/10.1371/journal.pone.0039003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720013	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347800035
J	Huttemann, M; Lee, I; Gao, XF; Pecina, P; Pecinova, A; Liu, J; Aras, S; Sommer, N; Sanderson, TH; Tost, M; Neff, F; Aguilar-Pimentel, JA; Becker, L; Naton, B; Rathkolb, B; Rozman, J; Favor, J; Hans, W; Prehn, C; Puk, O; Schrewe, A; Sun, MX; Hofler, H; Adamski, J; Bekeredjian, R; Graw, J; Adler, T; Busch, DH; Klingenspor, M; Klopstock, T; Ollert, M; Wolf, E; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Weissmann, N; Doan, JW; Bassett, DJP; Grossman, LI				Huettemann, Maik; Lee, Icksoo; Gao, Xiufeng; Pecina, Petr; Pecinova, Alena; Liu, Jenney; Aras, Siddhesh; Sommer, Natascha; Sanderson, Thomas H.; Tost, Monica; Neff, Frauke; Aguilar-Pimentel, Juan Antonio; Becker, Lore; Naton, Beatrix; Rathkolb, Birgit; Rozman, Jan; Favor, Jack; Hans, Wolfgang; Prehn, Cornelia; Puk, Oliver; Schrewe, Anja; Sun, Minxuan; Hoefler, Heinz; Adamski, Jerzy; Bekeredjian, Raffi; Graw, Jochen; Adler, Thure; Busch, Dirk H.; Klingenspor, Martin; Klopstock, Thomas; Ollert, Markus; Wolf, Eckhard; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Weissmann, Norbert; Doan, Jeffrey W.; Bassett, David J. P.; Grossman, Lawrence I.			Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology	FASEB JOURNAL			English	Article						asthma; CCO4-2; COX4-2; COX4i2; inflammation; oxidative phosphorylation	HYPOXIC PULMONARY VASOCONSTRICTION; INFLAMMATORY CELL CHANGES; OXIDATIVE-PHOSPHORYLATION; MURINE MODEL; IN-VIVO; RESPIRATION; OXYGEN; SEX; ATP; MITOCHONDRIA	Cytochrome c oxidase (COX) is the terminal enzyme of the mitochondrial electron transport chain. The purpose of this study was to analyze the function of lung-specific cytochrome c oxidase subunit 4 isoform 2 (COX4i2) in vitro and in COX4i2-knockout mice in vivo. COX was isolated from cow lung and liver as control and functionally analyzed. COX4i2-knockout mice were generated and the effect of the gene knockout was determined, including COX activity, tissue energy levels, noninvasive and invasive lung function, and lung pathology. These studies were complemented by a comprehensive functional screen performed at the German Mouse Clinic (Neuherberg, Germany). We show that isolated cow lung COX containing COX4i2 is about twice as active (88 and 102% increased activity in the presence of allosteric activator ADP and inhibitor ATP, respectively) as liver COX, which lacks COX4i2. In COX4i2-knockout mice, lung COX activity and cellular ATP levels were significantly reduced (-50 and -29%, respectively). Knockout mice showed decreased airway responsiveness (60% reduced P-enh and 58% reduced airway resistance upon challenge with 25 and 100 mg methacholine, respectively), and they developed a lung pathology deteriorating with age that included the appearance of Charcot-Leyden crystals. In addition, there was an interesting sex-specific phenotype, in which the knockout females showed reduced lean mass (-12%), reduced total oxygen consumption rate (-8%), improved glucose tolerance, and reduced grip force (-14%) compared to wild-type females. Our data suggest that high activity lung COX is a central determinant of airway function and is required for maximal airway responsiveness and healthy lung function. Since airway constriction requires energy, we propose a model in which reduced tissue ATP levels explain protection from airway hyperresponsiveness, i.e., absence of COX4i2 leads to reduced lung COX activity and ATP levels, which results in impaired airway constriction and thus reduced airway responsiveness; long-term lung pathology develops in the knockout mice due to impairment of energy-costly lung maintenance processes; and therefore, we propose mitochondrial oxidative phosphorylation as a novel target for the treatment of respiratory diseases, such as asthma.-Huttemann, M., Lee, I., Gao, X., Pecina, P., Pecinova, A., Liu, J., Aras, S., Sommer, N., Sanderson, T. H., Tost, M., Neff, F., Aguilar-Pimentel, J. A., Becker, L., Naton, B., Rathkolb, B., Rozman, J., Favor, J., Hans, W., Prehn, C., Puk, O., Schrewe, A., Sun, M., Hofler, H., Adamski, J., Bekeredjian, R., Graw, J., Adler, T., Busch, D. H., Klingenspor, M., Klopstock, T., Ollert, M., Wolf, E., Fuchs, H., Gailus-Durner, V., Hrabe. de Angelis, M., Weissmann, N., Doan, J. W., Bassett, D. J. P., Grossman, L. I. Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology. FASEB J. 26, 3916-3930 (2012). www.fasebj.org	[Huettemann, Maik; Lee, Icksoo; Pecina, Petr; Pecinova, Alena; Liu, Jenney; Aras, Siddhesh; Doan, Jeffrey W.; Bassett, David J. P.; Grossman, Lawrence I.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Gao, Xiufeng; Bassett, David J. P.] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI 48201 USA; [Sanderson, Thomas H.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI 48201 USA; [Sommer, Natascha; Weissmann, Norbert] Univ Giessen, Dept Internal Med 2, Univ Giessen Lung Ctr, D-35390 Giessen, Germany; [Tost, Monica; Neff, Frauke; Hoefler, Heinz] German Res Ctr Environm Hlth, Inst Pathol, Neuherberg, Germany; [Becker, Lore; Naton, Beatrix; Rathkolb, Birgit; Rozman, Jan; Hans, Wolfgang; Prehn, Cornelia; Schrewe, Anja; Adamski, Jerzy; Adler, Thure; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Favor, Jack] German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Puk, Oliver; Sun, Minxuan; Graw, Jochen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Aguilar-Pimentel, Juan Antonio; Ollert, Markus] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Aguilar-Pimentel, Juan Antonio; Ollert, Markus] Tech Univ Munich, Clin Res Div Mol & Clin Allergotoxicol, Munich, Germany; [Hoefler, Heinz] Tech Univ Munich, Inst Allgemeine Pathol & Pathol Anat, Klinikum Rechts Isar, Munich, Germany; [Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Aguilar-Pimentel, Juan Antonio; Ollert, Markus] Tech Univ Munich, Div Environm Dermatol & Allergy, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Gene Ctr, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Gene Ctr, Dept Mol Anim Breeding & Biotechnol, Munich, Germany; [Rozman, Jan; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, Dept Mol Nutr Med, Freising Weihenstephan, Germany; [Adamski, Jerzy; de Angelis, Martin Hrabe] Tech Univ Munich, Dept Expt Genet, Freising Weihenstephan, Germany; [Bekeredjian, Raffi] Heidelberg Univ, Otto Meyerhof Zentrum, Dept Med 3, Div Cardiol, Heidelberg, Germany	Wayne State University; Wayne State University; Wayne State University; Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; Ruprecht Karls University Heidelberg	Huttemann, M (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu	de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014; Gailus-Durner, Valerie/M-7337-2014; Becker, Lore/E-3717-2010; Becker, Lore/AAJ-1203-2020; Klingenspor, Martin/K-5033-2019; Pecinová, Alena/A-8695-2010; Puk, Oliver/E-1443-2013; Naton, Beatrix/B-5392-2013; Pecina, Petr/A-9396-2010; Sommer, Natascha/AAD-5406-2020; Rathkolb, Birgit/F-7041-2013; Rozman, Jan/A-2540-2010; Klingenspor, Martin/D-6930-2011; Graw, Jochen/D-9336-2013; Sanderson, Thomas H/K-6656-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; Becker, Lore/0000-0002-6890-4984; Pecinová, Alena/0000-0002-0204-7502; Naton, Beatrix/0000-0002-9453-8877; Pecina, Petr/0000-0003-0641-2834; Rozman, Jan/0000-0002-8035-8904; Klingenspor, Martin/0000-0002-4502-6664; Sanderson, Thomas H/0000-0003-0112-8164; Graw, Jochen/0000-0003-0298-9660; Huttemann, Maik/0000-0001-6310-7081; Adamski, Jerzy/0000-0001-9259-0199; Ollert, Markus W./0000-0002-8055-0103; Wolf, Eckhard/0000-0002-0430-9510; Sommer, Natascha/0000-0002-8915-7762; Weissmann, Norbert/0000-0003-2675-3871; Prehn, Cornelia/0000-0002-1274-4715	Philip Morris USA Inc.; Philip Morris International; U.S. National Institutes of Health (NIH) [GM089900]; NIH [GM48517]; German Federal Ministry of Education and Research (BMBF) [01GS0850, 01GS0851, 01GS0868, 01GS0869, 01GS0854]; EU grant (EU-MODIC) [LSHG-2006-037188]; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048517, R01GM089900] Funding Source: NIH RePORTER	Philip Morris USA Inc.; Philip Morris International; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU grant (EU-MODIC); Center for Molecular Medicine and Genetics, Wayne State University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank R. Seeliger, S. Bothur, R. Fischer, M. Grandl, E. Holupirek, M. Kugler, A. Langer, K. Laube, J. Muller, E. Samson, F. Schleicher, D. Schmidt, W. Schneider, A. E. Schwarz, W. Stettinger, L. Thumann, S. Wittich, and Anja Wohlbier, as well as the German Mouse Clinic (GMC; Neuherberg, Germany) animal caretaker team, M. Huber, B. Schon, H. Marr, A. Miedl, T. Reichelt, M. Gerstlauer, R. Huber, and H. Wenig, for expert technical help. The authors thank Christopher Sinkler (Wayne State University) for conducting quantitative real-time PCR experiments. Research described in this article was supported by Philip Morris USA Inc. and Philip Morris International (M. H.), the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine (M. H.), grant GM089900 from the U.S. National Institutes of Health (NIH; M. H.), and a grant supplement from the NIH (GM48517; L. I. G.). Work performed at the GMC was funded by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD eV) and to the GMC (NGFN-Plus grants 01GS0850, 01GS0851, 01GS0868, 01GS0869, and 01GS0854) as well as by an EU grant (EU-MODIC, LSHG-2006-037188, GMC).	Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; Alphonse MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001921; Arnold S, 1999, FEBS LETT, V443, P105, DOI 10.1016/S0014-5793(98)01694-9; Bassett D, 2010, J TOXICOL ENV HEAL A, V73, P711, DOI 10.1080/15287391003614018; BASSETT DJP, 1992, AM J PHYSIOL, V263, pL439, DOI 10.1152/ajplung.1992.263.4.L439; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Birrell MA, 2003, RESPIR RES, V4, DOI 10.1186/rr197; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Corteling Randolph, 2004, BMC Pharmacology, V4, P4, DOI 10.1186/1471-2210-4-4; Dalmonte ME, 2009, J BIOL CHEM, V284, P32331, DOI 10.1074/jbc.M109.050146; DeLorme MP, 2002, J PHARMACOL TOXICOL, V47, P1, DOI 10.1016/S1056-8719(02)00191-0; DeLorme MP, 2002, J TOXICOL ENV HEAL A, V65, P1453, DOI 10.1080/00984100290071432; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; Dudley R, 1998, J EXP BIOL, V201, P1043; FISHER AB, 1973, BIOCHEMISTRY-US, V12, P1438, DOI 10.1021/bi00731a026; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Grossman LI, 1997, BBA-GENE STRUCT EXPR, V1352, P174, DOI 10.1016/S0167-4781(97)00025-0; Hahn YS, 2003, J IMMUNOL, V171, P3170, DOI 10.4049/jimmunol.171.6.3170; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Holgate ST, 2005, AM J RESP CRIT CARE, V172, P941, DOI 10.1164/rccm.2507007; HOLT PG, 1985, IMMUNOLOGY, V54, P139; Huttemann M, 2007, FEBS J, V274, P5737, DOI 10.1111/j.1742-4658.2007.06093.x; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Huttemann M, 2003, GENE, V312, P95, DOI 10.1016/S0378-1119(03)00604-8; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Kiernan MC, 2004, NEUROMUSCULAR DISORD, V14, P375, DOI 10.1016/j.nmd.2004.02.014; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005; Lee I, 2009, METHOD ENZYMOL, V457, P193, DOI 10.1016/S0076-6879(09)05011-3; LI CY, 1973, J HISTOCHEM CYTOCHEM, V21, P1; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Marin DP, 2010, CELL BIOCHEM FUNCT, V28, P394, DOI 10.1002/cbf.1669; Mason CE, 2010, NUCLEIC ACIDS RES, V38, P2355, DOI 10.1093/nar/gkp1188; Molloy EJ, 2003, BLOOD, V102, P2653, DOI 10.1182/blood-2003-02-0649; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; Okuyama K, 2008, CLIN EXP ALLERGY, V38, P1212, DOI 10.1111/j.1365-2222.2008.03015.x; Pacelli C, 2011, MITOCHONDRION, V11, P334, DOI 10.1016/j.mito.2010.12.004; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Roemgens A, 2011, NEUROTOX RES, V20, P1, DOI 10.1007/s12640-010-9213-z; Rosai J., 2004, ROSAI ACKERMANS SURG; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; SCHULTHEIS AH, 1994, LUNG, V172, P169; SHANSKE AL, 1993, NEUROMUSCULAR DISORD, V3, P191, DOI 10.1016/0960-8966(93)90058-R; Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vijayasarathy C, 1998, BBA-BIOMEMBRANES, V1371, P71, DOI 10.1016/S0005-2736(97)00278-2; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Weissmann N, 2004, RESP PHYSIOL NEUROBI, V139, P191, DOI 10.1016/j.resp.2003.10.003; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; WELLER PF, 1984, J BIOL CHEM, V259, P5100; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Yamano K, 2005, BIOCHEM PHARMACOL, V70, P1487, DOI 10.1016/j.bcp.2005.08.003	67	53	54	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2012	26	9					3916	3930		10.1096/fj.11-203273	http://dx.doi.org/10.1096/fj.11-203273			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	000MY	22730437	Green Published			2022-12-25	WOS:000308391600031
J	Kumar, A; Bhandari, A; Sinha, R; Sardar, P; Sushma; Goyal, P; Goswami, C; Grapputo, A				Kumar, Abhishek; Bhandari, Anita; Sinha, Rahul; Sardar, Puspendu; Miss Sushma; Goyal, Pankaj; Goswami, Chandan; Grapputo, Alessandro			Molecular Phylogeny of OVOL Genes Illustrates a Conserved C2H2 Zinc Finger Domain Coupled by Hypervariable Unstructured Regions	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NATIVELY UNFOLDED PROTEINS; INTRINSIC DISORDER; DROSOPHILA-OVO; GENOME SEQUENCE; TRANSCRIPTION; DUPLICATION; PREDICTION; DATABASE; REVEALS	OVO-like proteins (OVOL) are members of the zinc finger protein family and serve as transcription factors to regulate gene expression in various differentiation processes. Recent studies have shown that OVOL genes are involved in epithelial development and differentiation in a wide variety of organisms; yet there is a lack of comprehensive studies that describe OVOL proteins from an evolutionary perspective. Using comparative genomic analysis, we traced three different OVOL genes (OVOL1-3) in vertebrates. One gene, OVOL3, was duplicated during a whole-genome-duplication event in fish, but only the copy (OVOL3b) was retained. From early-branching metazoa to humans, we found that a core domain, comprising a tetrad of C2H2 zinc fingers, is conserved. By domain comparison of the OVOL proteins, we found that they evolved in different metazoan lineages by attaching intrinsically-disordered (ID) segments of N/C-terminal extensions of 100 to 1000 amino acids to this conserved core. These ID regions originated independently across different animal lineages giving rise to different types of OVOL genes over the course of metazoan evolution. We illustrated the molecular evolution of metazoan OVOL genes over a period of 700 million years (MY). This study both extends our current understanding of the structure/function relationship of metazoan OVOL genes, and assembles a good platform for further characterization of OVOL genes from diverged organisms.	[Kumar, Abhishek; Grapputo, Alessandro] Univ Padua, Dept Biol, Padua, Italy; [Kumar, Abhishek] Univ Kiel, Abt Bot Genet & Mol Biol, Bot Inst & Bot Garten, Kiel, Germany; [Bhandari, Anita] Univ Kiel, Lehrstuhl Mol Phytopathol, Kiel, Germany; [Sinha, Rahul] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sardar, Puspendu; Goswami, Chandan] Natl Inst Sci Educ & Res, Inst Phys Campus, Bhubaneswar, Orissa, India; [Miss Sushma] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Goyal, Pankaj] Univ Greifswald, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Univ Klinikum, Greifswald, Germany	University of Padua; University of Kiel; University of Kiel; Cold Spring Harbor Laboratory; Institute of Physics Bhubaneswar (IOPB); National Institute of Science Education & Research (NISER); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kumar, A (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	abhishek.abhishekkumar@gmail.com	Sardar, Puspendu/W-6727-2019; Kumar, Abhishek/A-8727-2012; Grapputo, Alessandro/AAR-1252-2020	Sardar, Puspendu/0000-0001-8011-2915; Kumar, Abhishek/0000-0003-4172-4059; Grapputo, Alessandro/0000-0001-9255-4294				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews J, 1998, DEV GENES EVOL, V207, P482, DOI 10.1007/s004270050139; Andrews J, 2000, DEVELOPMENT, V127, P881; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Guerzoni D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002381; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Johnson AD, 2001, DEVELOPMENT, V128, P2857; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li BA, 2005, DEVELOPMENT, V132, P1463, DOI 10.1242/dev.01658; Li BA, 2002, P NATL ACAD SCI USA, V99, P6064, DOI 10.1073/pnas.092137099; Lu JN, 1998, DEV GENES EVOL, V208, P213, DOI 10.1007/s004270050175; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; MEVELNINIO M, 1995, MECH DEVELOP, V49, P83, DOI 10.1016/0925-4773(94)00305-7; MevelNinio M, 1996, DEVELOPMENT, V122, P4131; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nair M, 2006, J CELL BIOL, V173, P253, DOI 10.1083/jcb.200508196; Nair M, 2007, NUCLEIC ACIDS RES, V35, P1687, DOI 10.1093/nar/gkl1141; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Ohno S., 1970, P1; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Sardar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031448; Schwarz R, 1979, ATLAS PROTEIN SEQUEN, P353, DOI DOI 10.2307/2408678; Siltberg-Liberles J, 2011, MOL BIOL EVOL, V28, P59, DOI 10.1093/molbev/msq291; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Szilagyi A, 2008, BIOPHYS J, V95, P1612, DOI 10.1529/biophysj.108.131151; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Team RDC, 2011, R STAT PACK; Teng A, 2007, BBA-MOL BASIS DIS, V1772, P89, DOI 10.1016/j.bbadis.2006.08.012; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Williams R M, 2001, Pac Symp Biocomput, P89; Wolfsberg Tyra G, 2010, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0105s29	82	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39399	10.1371/journal.pone.0039399	http://dx.doi.org/10.1371/journal.pone.0039399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737237	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000305695100036
J	Siu, E; Campitelli, MA; Kwong, JC				Siu, Eric; Campitelli, Michael A.; Kwong, Jeffrey C.			Physical Activity and Influenza-Coded Outpatient Visits, a Population-Based Cohort Study	PLOS ONE			English	Article							METABOLIC EQUIVALENT; ANTIBODY-RESPONSES; IMMUNE FUNCTION; EXERCISE; RISK; RELIABILITY; VIRUS; SERUM; DIAGNOSES; COMMUNITY	Background: Although the benefits of physical activity in preventing chronic medical conditions are well established, its impacts on infectious diseases, and seasonal influenza in particular, are less clearly defined. We examined the association between physical activity and influenza-coded outpatient visits, as a proxy for influenza infection. Methodology/Principal Findings: We conducted a cohort study of Ontario respondents to Statistics Canada's population health surveys over 12 influenza seasons. We assessed physical activity levels through survey responses, and influenza-coded physician office and emergency department visits through physician billing claims. We used logistic regression to estimate the risk of influenza-coded outpatient visits during influenza seasons. The cohort comprised 114,364 survey respondents who contributed 357,466 person-influenza seasons of observation. Compared to inactive individuals, moderately active (OR 0.83; 95% CI 0.74-0.94) and active (OR 0.87; 95% CI 0.77-0.98) individuals were less likely to experience an influenza-coded visit. Stratifying by age, the protective effect of physical activity remained significant for individuals <65 years (active OR 0.86; 95% CI 0.75-0.98, moderately active: OR 0.85; 95% CI 0.74-0.97) but not for individuals >= 65 years. The main limitations of this study were the use of influenza-coded outpatient visits rather than laboratory-confirmed influenza as the outcome measure, the reliance on self-report for assessing physical activity and various covariates, and the observational study design. Conclusion/Significance: Moderate to high amounts of physical activity may be associated with reduced risk of influenza for individuals <65 years. Future research should use laboratory-confirmed influenza outcomes to confirm the association between physical activity and influenza.	[Siu, Eric; Campitelli, Michael A.; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Siu, E (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	jeff.kwong@utoronto.ca			Canadian Institutes of Health Research [XIN 82408]; University of Toronto Department of Family and Community Medicine; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Department of Family and Community Medicine; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by an operating grant from the Canadian Institutes of Health Research (XIN 82408). JCK was supported by a Clinician Scientist Award from the University of Toronto Department of Family and Community Medicine. JCK and MAC receive salary support from the Institute for Clinical Evaluative Sciences (ICES). This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHTARDANESH N, 2008, OPEN MED, V2, P14; Beland Yves, 2002, Health Rep, V13, P9; Ben-Yehuda A, 1992, Clin Geriatr Med, V8, P701; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Chan B, 1999, Hosp Q, V3, P17; Chen Y, 2006, PREV MED, V42, P261, DOI 10.1016/j.ypmed.2006.01.006; Craig CL, 2002, MED SCI SPORT EXER, V34, P1462, DOI 10.1097/00005768-200209000-00010; deJong A, 2010, ACSMS HEALTH FIT J, V14, P43, DOI 10.1249/FIT.0b013e3181e438f9; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; FOLSOM AR, 1986, J CHRON DIS, V39, P505, DOI 10.1016/0021-9681(86)90195-5; Fondell E, 2011, MED SCI SPORT EXER, V43, P272, DOI 10.1249/MSS.0b013e3181edf108; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; HEATH GW, 1991, MED SCI SPORT EXER, V23, P152; Hemila H, 2003, MED SCI SPORT EXER, V35, P1815, DOI 10.1249/01.MSS.0000093616.60899.92; HOFFMANGOETZ L, 1994, IMMUNOL TODAY, V15, P382, DOI 10.1016/0167-5699(94)90177-5; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Iron K, 2008, LIVING DYING ONTARIO; Kwan M, 2004, INT J FOOD SCI NUTR, V55, P179, DOI 10.1080/09637480410001725201; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; MACNEIL B, 1991, J APPL PHYSIOL, V70, P179, DOI 10.1152/jappl.1991.70.1.179; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; Merchant AT, 2007, CAN J PUBLIC HEALTH, V98, P203, DOI 10.1007/BF03403713; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Naylor CD, 1999, CARDIOVASCULAR HLTH; Nieman David C, 2003, Curr Sports Med Rep, V2, P239; Nieman DC, 2000, IMMUNOL CELL BIOL, V78, P496, DOI 10.1046/j.1440-1711.2000.00950.x; NIEMAN DC, 1990, J SPORT MED PHYS FIT, V30, P316; NIEMAN DC, 1990, INT J SPORTS MED, V11, P467, DOI 10.1055/s-2007-1024839; NIEMAN DC, 1993, MED SCI SPORT EXER, V25, P823, DOI 10.1249/00005768-199307000-00011; NIEMAN DC, 1994, SEMIN HEMATOL, V31, P166; NIEMAN DC, 1994, INT J SPORTS MED, V15, pS131, DOI 10.1055/s-2007-1021128; NIEMAN DC, 1991, SPORTS MED, V11, P183, DOI 10.2165/00007256-199111030-00003; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; PEDERSEN BK, 1995, SPORTS MED, V19, P393, DOI 10.2165/00007256-199519060-00003; POWERS DC, 1994, J MED VIROL, V43, P57, DOI 10.1002/jmv.1890430111; POWERS DC, 1993, J INFECT DIS, V167, P584, DOI 10.1093/infdis/167.3.584; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; SISCOVICK DS, 1982, JAMA-J AM MED ASSOC, V248, P3113, DOI 10.1001/jama.248.23.3113; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Tambay J L, 1995, Health Rep, V7, P29; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; Wilkins R., 2004, AUTOMATED GEOGRAPHIC; Wong CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002108; Yung RL, 2000, RHEUM DIS CLIN N AM, V26, P455, DOI 10.1016/S0889-857X(05)70151-4; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250	50	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39518	10.1371/journal.pone.0039518	http://dx.doi.org/10.1371/journal.pone.0039518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KY	22737242	gold, Green Published, Green Submitted			2022-12-25	WOS:000305695100041
J	Gandhi, MP; Kumar, AMV; Toshniwal, MN; Reddy, RHR; Oeltmann, JE; Nair, SA; Satyanarayana, S; Dewan, PK; Mannan, S				Gandhi, Mohit Padamchand; Kumar, Ajay M. V.; Toshniwal, Manoj Nandkishor; Reddy, Raveendra H. R.; Oeltmann, John E.; Nair, Sreenivas Achuthan; Satyanarayana, Srinath; Dewan, Puneet Kumar; Mannan, Shamim			Sputum Smear Microscopy at Two Months into Continuation-Phase: Should It Be Done in All Patients with Sputum Smear-Positive Tuberculosis?	PLOS ONE			English	Article								Background: The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up sputum smear examination at two months into the continuation phase of treatment. The main intent of this (mid-CP) follow-up is to detect patients not responding to treatment around two-three months earlier than at the end of the treatment. However, the utility of mid-CP follow-up under programmatic conditions has been questioned. We undertook a multi-district study to determine if mid-CP follow-up is able to detect cases of treatment failures early among all types of patients with sputum smear-positive TB. Methodology: We reviewed existing records of patients with sputum smear-positive TB registered under the RNTCP in 43 districts across three states of India during a three month period in 2009. We estimated proportions of patients that could be detected as a case of treatment failure early, and assessed the impact of various policy options on laboratory workload and number needed to test to detect one case of treatment failure early. Results: Of 10055 cases, mid-CP follow-up was done in 6944 (69%) cases. Mid-CP follow-up could benefit 117/8015 (1.5%) new and 206/2040 (10%) previously-treated sputum smear-positive cases by detecting their treatment failure early. Under the current policy, 31 patients had to be tested to detect one case of treatment failure early. All cases of treatment failure would still be detected early if mid-CP follow-up were discontinued for new sputum smear-positive cases who become sputum smear-negative after the intensive-phase of treatment. This would reduce the related laboratory workload by 69% and only 10 patients would need to be tested to detect one case of treatment failure early. Conclusion: Discontinuation of mid-CP follow-up among new sputum smear-positive cases who become sputum smear-negative after completing the intensive-phase of treatment will reduce the laboratory workload without impacting overall early detection of cases of treatment failure.	[Gandhi, Mohit Padamchand; Toshniwal, Manoj Nandkishor; Nair, Sreenivas Achuthan; Dewan, Puneet Kumar; Mannan, Shamim] Off World Hlth Org Representat India, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath] Int Union TB & Lung Dis, SE Asia Reg Off, New Delhi, India; [Reddy, Raveendra H. R.] Program Appropriate Technol Hlth, Hyderabad, Andhra Pradesh, India; [Oeltmann, John E.] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Kumar, Ajay M. V.] Minist Hlth & Family Welf, Cent TB Div, Directorate Gen Hlth Serv, New Delhi, India	World Health Organization; Centers for Disease Control & Prevention - USA	Gandhi, MP (corresponding author), Off World Hlth Org Representat India, New Delhi, India.	gandhim@tbcindia.nic.in	Gandhi, Mohit P./AAB-7637-2022	Gandhi, Mohit P./0000-0001-8660-8436; Toshniwal, Manoj/0000-0002-3538-5225; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Satyanarayana, Srinath/0000-0002-5420-2551; Nair, Sreenivas/0000-0002-2586-6797	Union from Global Fund Round 9 India TB Project funds; WHO-India from United States Agency for International Development funds	Union from Global Fund Round 9 India TB Project funds; WHO-India from United States Agency for International Development funds(United States Agency for International Development (USAID)World Health Organization)	The study was conducted as a part of the 'TB Operations Research Training Project' aimed to build operational research capacity within the Government of India's Revised National Tuberculosis Control Progra. This training project was conceived and implemented jointly by Central TB Division (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India), The National TB Institute (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India Bangalore, India), World Health Organization (WHO)(India Country Office), The International Union Against Tuberculosis and Lung Diseases (The Union, South-East Asia Regional Office, New Delhi, India) and United States Centers for Disease Control and Prevention (Division of TB Elimination, Atlanta, United States of America). Funding support was provided in part by The Union from Global Fund Round 9 India TB Project funds and by WHO-India from United States Agency for International Development funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Tuberculosis Division, 2011, TRAIN COURS PROGR MA; Central Tuberculosis Division, 2011, TB IND 2011; Thomas A., 2006, Indian Journal of Tuberculosis, V53, P37; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	4	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39296	10.1371/journal.pone.0039296	http://dx.doi.org/10.1371/journal.pone.0039296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723991	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700064
J	Griffiths, CJ; Zuel, N; Tatayah, V; Jones, CG; Griffiths, O; Harris, S				Griffiths, Christine J.; Zuel, Nicolas; Tatayah, Vikash; Jones, Carl G.; Griffiths, Owen; Harris, Stephen			The Welfare Implications of Using Exotic Tortoises as Ecological Replacements	PLOS ONE			English	Article							WILDING NORTH-AMERICA; GIANT TORTOISES; ALDABRA-ATOLL; ASSISTED COLONIZATION; GEOCHELONE-RADIATA; REINTRODUCTION PROGRAMS; NATURAL REGULATION; CONSERVATION TOOL; PLEISTOCENE PARK; GOPHER TORTOISES	Background: Ecological replacement involves the introduction of non-native species to habitats beyond their historical range, a factor identified as increasing the risk of failure for translocations. Yet the effectiveness and success of ecological replacement rely in part on the ability of translocatees to adapt, survive and potentially reproduce in a novel environment. We discuss the welfare aspects of translocating captive-reared non-native tortoises, Aldabrachelys gigantea and Astrochelys radiata, to two offshore Mauritian islands, and the costs and success of the projects to date. Methodology/Principal Findings: Because tortoises are long-lived, late-maturing reptiles, we assessed the progress of the translocation by monitoring the survival, health, growth, and breeding by the founders. Between 2000 and 2011, a total of 26 A. gigantea were introduced to Ile aux Aigrettes, and in 2007 twelve sexually immature A. gigantea and twelve male A. radiata were introduced to Round Island, Mauritius. Annual mortality rates were low, with most animals either maintaining or gaining weight. A minimum of 529 hatchlings were produced on Ile aux Aigrettes in 11 years; there was no potential for breeding on Round Island. Project costs were low. We attribute the success of these introductions to the tortoises' generalist diet, habitat requirements, and innate behaviour. Conclusions/Significance: Feasibility analyses for ecological replacement and assisted colonisation projects should consider the candidate species' welfare during translocation and in its recipient environment. Our study provides a useful model for how this should be done. In addition to serving as ecological replacements for extinct Mauritian tortoises, we found that releasing small numbers of captive-reared A. gigantea and A. radiata is cost-effective and successful in the short term. The ability to release small numbers of animals is a particularly important attribute for ecological replacement projects since it reduces the potential risk and controversy associated with introducing non-native species.	[Griffiths, Christine J.; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Griffiths, Christine J.; Zuel, Nicolas; Tatayah, Vikash; Jones, Carl G.] Mauritian Wildlife Fdn, Vacoas, Mauritius; [Griffiths, Christine J.; Zuel, Nicolas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Jones, Carl G.] Durrell Wildlife Conservat Trust, Trinity, Jersey, England; [Griffiths, Owen] Bioculture Ltd, Senneville, Riviere Des Ang, Mauritius	University of Bristol; University of Zurich	Griffiths, CJ (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	christine.griffiths@bristol.ac.uk			Dulverton Trust; Faculty of Mathematics and Natural Sciences of the University of Zurich; La Vanille Reserve des Mascareignes; Mauritian Wildlife Foundation; National Parks and Conservation Service of Mauritius; Swiss National Science Foundation [631-065950]	Dulverton Trust; Faculty of Mathematics and Natural Sciences of the University of Zurich; La Vanille Reserve des Mascareignes; Mauritian Wildlife Foundation; National Parks and Conservation Service of Mauritius; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided by the Dulverton Trust, the Faculty of Mathematics and Natural Sciences of the University of Zurich, La Vanille Reserve des Mascareignes, Mauritian Wildlife Foundation, National Parks and Conservation Service of Mauritius, and the Swiss National Science Foundation (grant 631-065950 to Christine Muller). The study was a collaborative project and while three of the authors (VT, CGJ, and OG) worked for funding bodies at the time, they had no disproportionate influence on the study design, data collection, and analysis.	[Anonymous], 1998, IUCN GUIDELINES REIN; [Anonymous], 1987, IUCN POSITION STATEM; ARNOLD EN, 1979, PHILOS T ROY SOC B, V286, P127, DOI 10.1098/rstb.1979.0022; Balmer O, 2011, J HERED, V102, P29, DOI 10.1093/jhered/esq096; Bertolero A, 2007, ANIM CONSERV, V10, P360, DOI 10.1111/j.1469-1795.2007.00121.x; BOURN D, 1978, PHILOS T ROY SOC B, V282, P139, DOI 10.1098/rstb.1978.0011; BRATTSTROM BH, 1974, AM ZOOL, V14, P35; Burbidge Andrew A., 2011, Pacific Conservation Biology, V17, P259; Cayford J, 1992, NEW SCI, V1807, P29; Cheke A., 2008, LOST LAND DODO ECOLO; COE MJ, 1979, PHILOS T R SOC B, V286, P163, DOI 10.1098/rstb.1979.0024; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Dinerstein E, 2005, NATURE, V437, P476, DOI 10.1038/437476a; DODD CK, 1991, HERPETOLOGICA, V47, P336; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Field KJ, 2007, BIOL CONSERV, V136, P232, DOI 10.1016/j.biocon.2006.11.022; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Galetti M., 2004, NAT CONSERV, V2, P93; GIBBONS JW, 1987, BIOSCIENCE, V37, P262, DOI 10.2307/1310589; GIBSON CWD, 1984, OECOLOGIA, V61, P230, DOI 10.1007/BF00396766; GIBSON CWD, 1983, OECOLOGIA, V56, P84, DOI 10.1007/BF00378221; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; Griffiths CJ, 2010, RESTOR ECOL, V18, P1, DOI 10.1111/j.1526-100X.2009.00612.x; GRUBB P, 1971, PHILOS T ROY SOC B, V260, P327, DOI 10.1098/rstb.1971.0018; HAMBLER C, 1994, BIOL CONSERV, V69, P293, DOI 10.1016/0006-3207(94)90429-4; Hansen Dennis M., 2010, P111; Hansen DM, 2010, ECOGRAPHY, V33, P272, DOI 10.1111/j.1600-0587.2010.06305.x; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; IUCN, IUCN SSC GUID UNPUB; JACKSON OF, 1980, J SMALL ANIM PRACT, V21, P409, DOI 10.1111/j.1748-5827.1980.tb01269.x; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Leuteritz T, 2008, ASTROCHELYS RADIATA; Leuteritz TEJ, 2005, AFR ZOOL, V40, P233; Leuteritz TEJ, 2005, BIOL CONSERV, V124, P451, DOI 10.1016/j.biocon.2005.02.003; Leuteritz Thomas E. J., 2003, African Journal of Herpetology, V52, P127; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lingard M., 2003, CONSERV SOC, V1, P223; MACFARLAND C G, 1974, Biological Conservation, V6, P118, DOI 10.1016/0006-3207(74)90024-X; MERTON L F H, 1976, Biological Conservation, V9, P293, DOI 10.1016/0006-3207(76)90051-3; O'Brien S, 2003, ORYX, V37, P338, DOI 10.1017/S0030605303000590; Oliveira-Santos LGR, 2010, CONSERV BIOL, V24, P4, DOI 10.1111/j.1523-1739.2009.01379.x; Parker KA, 2010, RESTOR ECOL, V18, P269, DOI 10.1111/j.1526-100X.2010.00676.x; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Pedrono M, 2000, BIOL CONSERV, V95, P333, DOI 10.1016/S0006-3207(00)00023-9; Pedrono M., 2008, TORTOISES TURTLES MA; Pemberton JW, 2009, CHELONIAN CONSERV BI, V8, P57, DOI 10.2744/CCB-0728.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RANDRIAMAHAZO H., 2007, POPULATION HABITAT V; REINERT HK, 1991, HERPETOLOGICA, V47, P357; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Rubenstein DR, 2006, BIOL CONSERV, V132, P232, DOI 10.1016/j.biocon.2006.04.003; SAMOUR HJ, 1987, BIOL CONSERV, V41, P147, DOI 10.1016/0006-3207(87)90117-0; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Schlaepfer MA, 2005, NATURE, V437, P951, DOI 10.1038/437951a; Schlaepfer MA, 2009, TRENDS ECOL EVOL, V24, P471, DOI 10.1016/j.tree.2009.05.008; Seddon PJ, 1999, TRENDS ECOL EVOL, V14, P503, DOI 10.1016/S0169-5347(99)01720-6; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; Soorae P. S., 2008, GLOBAL REINTRODUCTIO; STODDART DR, 1982, BIOL CONSERV, V24, P67, DOI 10.1016/0006-3207(82)90047-7; SWINGLAND IR, 1979, PHILOS T ROY SOC B, V286, P177, DOI 10.1098/rstb.1979.0025; SWINGLAND IR, 1979, J ANIM ECOL, V48, P639, DOI 10.2307/4184; TAYLOR JD, 1979, PHILOS T ROY SOC B, V286, P47, DOI 10.1098/rstb.1979.0015; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Tuberville TD, 2005, ANIM CONSERV, V8, P349, DOI 10.1017/S1367943005002398; Tuberville TD, 2008, BIOL CONSERV, V141, P2690, DOI 10.1016/j.biocon.2008.08.004; Tuberville TD, 2011, BIOL CONSERV, V144, P175, DOI 10.1016/j.biocon.2010.08.012; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442	70	10	10	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39395	10.1371/journal.pone.0039395	http://dx.doi.org/10.1371/journal.pone.0039395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724012	Green Submitted, Green Published, gold			2022-12-25	WOS:000305652700077
J	Johnston, NE; Atlas, LY; Wager, TD				Johnston, Natalie E.; Atlas, Lauren Y.; Wager, Tor D.			Opposing Effects of Expectancy and Somatic Focus on Pain	PLOS ONE			English	Article							BRAIN MEDIATORS; CARDIOVASCULAR-RESPONSES; SOCIAL THREAT; ATTENTION; INTENSITY; ANTICIPATION; EXPECTATIONS; CORTEX; DISTRACTION; INFORMATION	High-pain expectancy increases pain and pain-related brain activity, creating a cycle of psychologically maintained pain. Though these effects are robust, little is known about how expectancy works and what psychological processes either support or mitigate its effects. To address this, we independently manipulated pain expectancy and "top-down" attention to the body, and examined their effects on both a performance-based measure of body-focus and heat-induced pain. Multilevel mediation analyses showed that high-pain expectancy substantially increased pain, replicating previous work. However, attention to the body reduced pain, partially suppressing the effects of expectancy. Furthermore, increased bodyfocus had larger pain-reducing effects when pain expectancy was high, suggesting that attempts to focus on external distractors are counterproductive in this situation. Overall, the results show that attention to the body cannot explain pain-enhancing expectancy effects, and that focusing on sensory/discriminative aspects of pain might be a useful pain-regulation strategy when severe pain is expected.	[Johnston, Natalie E.] Weill Cornell Med Coll, Dept Neurosci, New York, NY USA; [Atlas, Lauren Y.] NYU, Dept Psychol, New York, NY 10003 USA; [Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Cornell University; New York University; University of Colorado System; University of Colorado Boulder	Johnston, NE (corresponding author), Weill Cornell Med Coll, Dept Neurosci, New York, NY USA.	tor.wager@colorado.edu	Atlas, Lauren/W-9619-2019; Atlas, Lauren Yvette/GXV-6811-2022	Atlas, Lauren/0000-0001-5693-4169	National Institutes of Health [NIH MH076136, NIH RC1DA028608, NIH R01DA027794]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028608, R01DA027794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was made possible with the support of the following National Institutes of Health grants awarded to Tor D. Wager: NIH MH076136; NIH RC1DA028608; and NIH R01DA027794. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 1996, J AM STAT ASSOC, V91, P468, DOI 10.2307/2291634; ARNTZ A, 1991, BEHAV RES THER, V29, P41, DOI 10.1016/S0005-7967(09)80006-5; Atlas LY, 2010, J NEUROSCI, V30, P12964, DOI 10.1523/JNEUROSCI.0057-10.2010; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown CA, 2008, CLIN NEUROPHYSIOL, V119, P2370, DOI 10.1016/j.clinph.2008.06.014; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Buhle JT, 2012, PSYCHOL SCI; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Crombez G, 2004, CLIN J PAIN, V20, P98, DOI 10.1097/00002508-200403000-00006; Crombez G, 2005, PAIN RES MANAG, V7, P31; ECCLESTON C, 1995, PAIN, V63, P3, DOI 10.1016/0304-3959(95)00093-8; Efron B., 1994, INTRO BOOTSTRAP; Geers AL, 1999, J EXP SOC PSYCHOL, V35, P394, DOI 10.1006/jesp.1999.1377; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kenny DA, 2003, PSYCHOL METHODS, V8, P115, DOI 10.1037/1082-989X.8.2.115; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; LEVENTHAL H, 1979, J PERS SOC PSYCHOL, V37, P688, DOI 10.1037/0022-3514.37.5.688; Lorenz R, 2005, BRAIN BEHAV IMMUN, V19, P283, DOI 10.1016/j.bbi.2005.03.010; LYON DR, 1990, ACTA PSYCHOL, V73, P69, DOI 10.1016/0001-6918(90)90059-O; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MCCAUL KD, 1982, J PERS SOC PSYCHOL, V43, P154, DOI 10.1037/0022-3514.43.1.154; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; MIRON D, 1989, PAIN, V39, P345, DOI 10.1016/0304-3959(89)90048-1; Petrovic P, 2000, PAIN, V85, P19, DOI 10.1016/S0304-3959(99)00232-8; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Plaghki L, 1998, J NEUROPHYSIOL, V79, P2557, DOI 10.1152/jn.1998.79.5.2557; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Shih SI, 2002, PSYCHOL REV, V109, P260, DOI 10.1037//0033-295X.109.2.260; SULS J, 1985, HEALTH PSYCHOL, V4, P249, DOI 10.1037/0278-6133.4.3.249; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wager TD, 2009, NEUROIMAGE, V47, P836, DOI 10.1016/j.neuroimage.2009.05.044; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; Willer JC, 1999, NEUROPHYSIOL CLIN, V29, P379, DOI 10.1016/S0987-7053(00)87263-9; Wilson TD, 1989, J PERS SOC	45	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38854	10.1371/journal.pone.0038854	http://dx.doi.org/10.1371/journal.pone.0038854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723896	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700034
J	Novoseltsev, VN; Michalski, AI; Novoseltseva, JA; Yashin, AI; Carey, JR; Ellis, AM				Novoseltsev, Vasiliy N.; Michalski, Anatoli I.; Novoseltseva, Janna A.; Yashin, Anatoliy I.; Carey, James R.; Ellis, Alicia M.			An Age-Structured Extension to the Vectorial Capacity Model	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; ANOPHELES-GAMBIAE; MALARIA TRANSMISSION; RELEASE-RECAPTURE; MORTALITY; SURVIVAL; CULICIDAE; POPULATIONS; MOSQUITOS; RATES	Background: Vectorial capacity and the basic reproductive number (R-0) have been instrumental in structuring thinking about vector-borne pathogen transmission and how best to prevent the diseases they cause. One of the more important simplifying assumptions of these models is age-independent vector mortality. A growing body of evidence indicates that insect vectors exhibit age-dependent mortality, which can have strong and varied affects on pathogen transmission dynamics and strategies for disease prevention. Methodology/Principal Findings: Based on survival analysis we derived new equations for vectorial capacity and R-0 that are valid for any pattern of age-dependent (or age-independent) vector mortality and explore the behavior of the models across various mortality patterns. The framework we present (1) lays the groundwork for an extension and refinement of the vectorial capacity paradigm by introducing an age-structured extension to the model, (2) encourages further research on the actuarial dynamics of vectors in particular and the relationship of vector mortality to pathogen transmission in general, and (3) provides a detailed quantitative basis for understanding the relative impact of reductions in vector longevity compared to other vector-borne disease prevention strategies. Conclusions/Significance: Accounting for age-dependent vector mortality in estimates of vectorial capacity and R-0 was most important when (1) vector densities are relatively low and the pattern of mortality can determine whether pathogen transmission will persist; i.e., determines whether R-0 is above or below 1, (2) vector population growth rate is relatively low and there are complex interactions between birth and death that differ fundamentally from birth-death relationships with age-independent mortality, and (3) the vector exhibits complex patterns of age-dependent mortality and R-0 similar to 1. A limiting factor in the construction and evaluation of new age-dependent mortality models is the paucity of data characterizing vector mortality patterns, particularly for free ranging vectors in the field.	[Novoseltsev, Vasiliy N.; Michalski, Anatoli I.; Novoseltseva, Janna A.] Inst Control Sci, Moscow, Russia; [Yashin, Anatoliy I.] Duke Univ, Durham, NC USA; [Carey, James R.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Ellis, Alicia M.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	V.A. Trapeznikov Institute of Control Sciences, Russian Academy of Sciences; Duke University; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Novoseltsev, VN (corresponding author), Inst Control Sci, Moscow, Russia.	mpoctok@yandex.ru	Novoseltseva, Janna/B-9482-2017; Michalski, Anatoli/B-3959-2017	Michalski, Anatoli/0000-0003-1998-1315	California Department of Agriculture and Natural Resources; National Institute of Aging/National Institute of Health [P01 AG022500-01, P01 AG08761-10]; NATIONAL INSTITUTE ON AGING [P01AG008761, P01AG022500] Funding Source: NIH RePORTER	California Department of Agriculture and Natural Resources; National Institute of Aging/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research was supported by the California Department of Agriculture and Natural Resources, National Institute of Aging/National Institute of Health grants P01 AG022500-01 and P01 AG08761-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; ANDERSON R M, 1991; Basanez MG, 1996, PARASITOLOGY, V113, P331, DOI 10.1017/S003118200006649X; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Chaves LF, 2004, ACTA TROP, V92, P119, DOI 10.1016/j.actatropica.2004.06.005; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Cohen JM, 2010, MALARIA J, P22; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531; GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339; GOLDMAN N, 1986, DEMOGRAPHY, V23, P275, DOI 10.2307/2061621; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; Hugo LE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000608; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lord CC, 2007, J AM MOSQUITO CONTR, V23, P252, DOI 10.2987/8756-971X(2007)23[252:MABCOM]2.0.CO;2; Luz PM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000761; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Ross R., 1910, PREVENTION MALARIA; SCOTT T. W., 2008, VECTOR BORNE DIS UND, P132; Sierra F, 2007, ENCY GERONTOLOGY, P10; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216	35	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39479	10.1371/journal.pone.0039479	http://dx.doi.org/10.1371/journal.pone.0039479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724022	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700085
J	Stoyanova, E; Trudel, M; Felfly, H; Lemsaddek, W; Garcia, D; Cloutier, G				Stoyanova, Ekatherina; Trudel, Marie; Felfly, Hady; Lemsaddek, Wafaa; Garcia, Damien; Cloutier, Guy			Vascular Endothelial Dysfunction in beta-Thalassemia Occurs Despite Increased eNOS Expression and Preserved Vascular Smooth Muscle Cell Reactivity to NO	PLOS ONE			English	Article							NITRIC-OXIDE; PULMONARY-HYPERTENSION; OXIDATIVE STRESS; MAJOR PATIENTS; HEMOLYSIS; DISEASE; HEMOGLOBIN; STIFFNESS; BLOOD; MODEL	Aims: The hereditary beta-thalassemia major condition requires regular lifelong blood transfusions. Transfusion-related iron overloading has been associated with the onset of cardiovascular complications, including cardiac dysfunction and vascular anomalies. By using an untransfused murine model of beta-thalassemia major, we tested the hypothesis that vascular endothelial dysfunction, alterations of arterial structure and of its mechanical properties would occur despite the absence of treatments. Methods and Results: Vascular function and structure were evaluated ex vivo. Compared to the controls, endothelium-dependent vasodilation with acetylcholine was blunted in mesenteric resistance arteries of beta-thalassemic mice while the endothelium-independent vasodilator (sodium nitroprusside) produced comparable vessel dilation, indicating endothelial cell impairment with preserved smooth muscle cell reactivity to nitric oxide (NO). While these findings suggest a decrease in NO bioavailability, Western blotting showed heightened expression of aortic endothelial NO synthase (eNOS) in beta-thalassemia. Vascular remodeling of the common carotid arteries revealed increased medial elastin content. Under isobaric conditions, the carotid arteries of beta-thalassemic mice exhibited decreased wall stress and softening due to structural changes of the vessel wall. Conclusions: A complex vasculopathy was identified in untransfused beta-thalassemic mice characterized by altered carotid artery structure and endothelial dysfunction of resistance arterioles, likely attributable to reduced NO bioavailability despite enhanced vascular eNOS expression.	[Stoyanova, Ekatherina; Garcia, Damien; Cloutier, Guy] Univ Montreal Hosp Res Ctr, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Stoyanova, Ekatherina; Trudel, Marie; Felfly, Hady; Lemsaddek, Wafaa] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; [Cloutier, Guy] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal	Stoyanova, E (corresponding author), Univ Montreal Hosp Res Ctr, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada.	guy.cloutier@umontreal.ca	Garcia, Damien/E-2206-2011	Garcia, Damien/0000-0002-8552-1475; Trudel, Marie/0000-0003-0057-2669	Canadian Institutes of Health Research [CIHR CMI-72323]; Heart and Stroke Foundation of Canada [PG-05-0313]; National Institutes of Health of United States of America [RO1HL078655]; Canadian Blood Services (CBS); Programme canadien des bourses de la francophonie studentship; CBS/CIHR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078655] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); National Institutes of Health of United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Blood Services (CBS); Programme canadien des bourses de la francophonie studentship; CBS/CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR CMI-72323), Heart and Stroke Foundation of Canada (PG-05-0313), National Institutes of Health of United States of America (RO1HL078655) and the Canadian Blood Services (CBS). HF was a recipient of the Programme canadien des bourses de la francophonie studentship and WL was a recipient of a CBS/CIHR fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; Aessopos A, 2005, CHEST, V127, P1523, DOI 10.1378/chest.127.5.1523; Aggeli C, 2005, INT J CARDIOL, V105, P80, DOI 10.1016/j.ijcard.2004.12.025; Butthep P, 2002, AM J HEMATOL, V70, P100, DOI 10.1002/ajh.10101; Chen SQ, 1996, AM J PHYSIOL-HEART C, V270, pH1951, DOI 10.1152/ajpheart.1996.270.6.H1951; Cheung YF, 2006, BRIT J HAEMATOL, V135, P732, DOI 10.1111/j.1365-2141.2006.06349.x; Cheung YF, 2002, CIRCULATION, V106, P2561, DOI 10.1161/01.CIR.0000037225.92759.A7; Day SM, 2003, CIRCULATION, V107, P2601, DOI 10.1161/01.CIR.0000066910.02844.D0; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Gedikli O, 2007, ECHOCARDIOGR-J CARD, V24, P830, DOI 10.1111/j.1540-8175.2007.00486.x; Gladwin Mark T, 2005, Hematology Am Soc Hematol Educ Program, P51; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Hahalis G, 2005, AM J MED, V118, P957, DOI 10.1016/j.amjmed.2005.02.021; Hovav T, 1999, BRIT J HAEMATOL, V106, P178; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Kassab-Chekir A, 2003, CLIN CHIM ACTA, V338, P79, DOI 10.1016/j.cccn.2003.07.010; Kyriakou DS, 2001, ANN HEMATOL, V80, P577; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Panigrahi I, 2007, THROMB RES, V120, P783, DOI 10.1016/j.thromres.2007.01.015; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Schiffrin EL, 1997, J HYPERTENS, V15, P571, DOI 10.1097/00004872-199715060-00002; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Stakos DA, 2009, INT J CARDIOL, V134, P207, DOI 10.1016/j.ijcard.2008.01.047; Stakos DA, 2009, EUR J HAEMATOL, V82, P477, DOI 10.1111/j.1600-0609.2009.01236.x; Stoyanova E, 2007, PHYSIOL GENOMICS, V29, P84, DOI 10.1152/physiolgenomics.00305.2005; Ulger Z, 2006, J PEDIAT HEMATOL ONC, V28, P647, DOI 10.1097/01.mph.0000212987.18694.5a; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770	35	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38089	10.1371/journal.pone.0038089	http://dx.doi.org/10.1371/journal.pone.0038089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723848	Green Submitted, Green Published, gold			2022-12-25	WOS:000305652700010
J	Winje, BA; Roald, B; Kristensen, NP; Froen, JF				Winje, Brita Askeland; Roald, Borghild; Kristensen, Nina Petrov; Froen, J. Frederik			Placental Pathology in Pregnancies with Maternally Perceived Decreased Fetal Movement - A Population-Based Nested Case-Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; FETUSES; BEHAVIOR; PREDICTION; SINGLETON; OUTCOMES; QUALITY; DEATH	Background: Decreased fetal movements (DFM) are associated with fetal growth restriction and stillbirth, presumably linked through an underlying placental dysfunction. Yet, the role of placental pathology has received limited attention in DFM studies. Our main objective was to explore whether maternal perceptions of DFM were associated with placental pathology in pregnancies recruited from a low-risk total population. Methods/Principal Findings: Placentas from 129 DFM and 191 non-DFM pregnancies were examined according to standardized macro- and microscopic protocols. DFM was defined as any maternal complaint of DFM leading to a hospital examination. Morphological findings were timed and graded according to their estimated onset and clinical importance, and classified in line with a newly constructed Norwegian classification system for reporting placental pathology. With our population-based approach we were unable to link DFM to an overall measure of all forms of placental pathology (OR 1.3, 95% CI 0.8-2.2, p = 0.249). However, placental pathology leading to imminent delivery could be a competing risk for DFM, making separate subgroup analyses more appropriate. Our study suggests a link between DFM and macroscopic placental pathology related to maternal, uteroplacental vessels, i.e. infarctions, placental lesions (intraplacental hematomas) and abruptions. Although not statistically significant separately, a compound measure showed a significant association with DFM (OR 2.4, 95% CI 1.1-5.0, p = 0.023). This association was strengthened when we accounted for relevant temporal aspects. More subtle microscopic materno-placental ischemic changes outside the areas of localized pathology showed no association with DFM (OR 0.5, 95% CI 0.2-1.4, p = 0.203). There was a strong association between placental pathology and neonatal complications (OR 2.9, 95% CI 1.6-5.1, p < 0.001). Conclusions: In our population-based study we were generally unable to link maternally perceived DFM to placental pathology. Some associations were seen for subgroups.	[Winje, Brita Askeland; Froen, J. Frederik] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Roald, Borghild] Univ Oslo, Ulleval Hosp, Ctr Pediat & Pregnancy Related Pathol, Dept Pathol, Oslo, Norway; [Roald, Borghild] Univ Oslo, Fac Med, Oslo, Norway; [Kristensen, Nina Petrov] Ostfold Hosp Trust, Dept Pathol, Fredrikstad, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Winje, BA (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.	brita.winje@fhi.no	Kristensen, Niels/A-8795-2013	Froen Froen, Jahn Frederik/0000-0001-9390-8509	Research Council of Norway [185927/V50]	Research Council of Norway(Research Council of Norway)	This project is funded in whole by the Research Council of Norway, 185927/V50, http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog B, 2011, PLACENTA, V32, P58, DOI 10.1016/j.placenta.2010.10.008; BEKEDAM DJ, 1985, AM J OBSTET GYNECOL, V153, P52, DOI 10.1016/0002-9378(85)90589-7; BEKEDAM DJ, 1985, EARLY HUM DEV, V12, P155, DOI 10.1016/0378-3782(85)90178-1; Bendon RW, 2001, PEDIATR DEVEL PATHOL, V4, P517, DOI 10.1007/s10024001-0084-4; Biswas S, 2008, EARLY HUM DEV, V84, P357, DOI 10.1016/j.earlhumdev.2007.09.017; Bocking AD, 2003, EUR J OBSTET GYN R B, V110, pS108, DOI 10.1016/S0301-2115(03)00180-5; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen J Frederik, 2005, Tidsskr Nor Laegeforen, V125, P2631; Froen JF, 2008, SEMIN PERINATOL, V32, P243, DOI 10.1053/j.semperi.2008.04.004; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Gilbert WM, 2003, AM J OBSTET GYNECOL, V188, P1596, DOI 10.1067/mob.2003.384; Gjessing HK, 2007, ULTRASOUND OBST GYN, V30, P19, DOI 10.1002/uog.4053; Heazell AEP, 2008, J OBSTET GYNAECOL, V28, P147, DOI 10.1080/01443610801912618; Heazell A E P, 2005, J Obstet Gynaecol, V25, P648; Heazell AEP, 2010, PLACENTA, V31, pA103; Kidron D, 2009, PLACENTA, V30, P700, DOI 10.1016/j.placenta.2009.05.009; Last J, 2008, DICT EPIDEMIOLOGY; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; MARI G, 1992, AM J OBSTET GYNECOL, V166, P1262, DOI 10.1016/S0002-9378(11)90620-6; Norwegian Institute of Public Health, 2011, MED BIRTH REG NORW; PEARSON JF, 1976, BRIT MED J, V1, P1305, DOI 10.1136/bmj.1.6021.1305; Redline RW, 2008, PLACENTA, V29, pS86, DOI 10.1016/j.placenta.2007.09.003; RIBBERT LSM, 1993, BRIT J OBSTET GYNAEC, V100, P653, DOI 10.1111/j.1471-0528.1993.tb14233.x; Roald B, 2010, PLACENTA, V31, pA20; Saastad E, 2008, J MIDWIFERY WOM HEAL, V53, P345, DOI 10.1016/j.jmwh.2008.03.001; Saastad Eli, 2010, BMC Res Notes, V3, P2, DOI 10.1186/1756-0500-3-2; SADOVSKY E, 1973, OBSTET GYNECOL, V41, P845; Salafia CM, 1997, CLIN OBSTET GYNECOL, V40, P740, DOI 10.1097/00003081-199712000-00008; Sergent F, 2005, Gynecol Obstet Fertil, V33, P861, DOI 10.1016/j.gyobfe.2005.07.041; SIVAL DA, 1992, EARLY HUM DEV, V28, P119, DOI 10.1016/0378-3782(92)90107-R; Tveit JVH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-49; Tveit JVH, 2009, ACTA OBSTET GYN SCAN, V88, P1345, DOI 10.3109/00016340903348375; Tveit JVH, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-32; VALENTIN L, 1986, ACTA OBSTET GYN SCAN, V65, P753, DOI 10.3109/00016348609161495; Vindla S, 1997, ULTRASOUND OBST GYN, V9, P302, DOI 10.1046/j.1469-0705.1997.09050302.x; Vindla S, 1999, FETAL DIAGN THER, V14, P156, DOI 10.1159/000020911; Warrander LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034851; Warrander LK, 2011, MED HYPOTHESES, V76, P17, DOI 10.1016/j.mehy.2010.08.020; WHITTY JE, 1991, AM J OBSTET GYNECOL, V165, P1084, DOI 10.1016/0002-9378(91)90476-8; Winje BA, 2011, BJOG-INT J OBSTET GY, V118, P1229, DOI 10.1111/j.1471-0528.2011.02993.x	43	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39259	10.1371/journal.pone.0039259	http://dx.doi.org/10.1371/journal.pone.0039259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723978	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700060
J	Aggarwal, R; Lu, JW; Kanji, S; Joseph, M; Das, M; Noble, GJ; McMichael, BK; Agarwal, S; Hart, RT; Sun, ZY; Lee, BS; Rosol, TJ; Jackson, R; Mao, HQ; Pompili, VJ; Das, H				Aggarwal, Reeva; Lu, Jingwei; Kanji, Suman; Joseph, Matthew; Das, Manjusri; Noble, Garrett J.; McMichael, Brooke K.; Agarwal, Sudha; Hart, Richard T.; Sun, Zongyang; Lee, Beth S.; Rosol, Thomas J.; Jackson, Rebecca; Mao, Hai-Quan; Pompili, Vincent J.; Das, Hiranmoy			Human Umbilical Cord Blood-Derived CD34(+) Cells Reverse Osteoporosis in NOD/SCID Mice by Altering Osteoblastic and Osteoclastic Activities	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MESENCHYMAL STEM-CELLS; BONE-FORMATION; IN-VITRO; PROGENITOR CELLS; HIP-FRACTURES; DIFFERENTIATION; EXPRESSION; OSTEOCALCIN; WNT	Background: Osteoporosis is a bone disorder associated with loss of bone mineral density and micro architecture. A balance of osteoblasts and osteoclasts activities maintains bone homeostasis. Increased bone loss due to increased osteoclast and decreased osteoblast activities is considered as an underlying cause of osteoporosis. Methods and Findings: The cures for osteoporosis are limited, consequently the potential of CD34+ cell therapies is currently being considered. We developed a nanofiber-based expansion technology to obtain adequate numbers of CD34(+) cells isolated from human umbilical cord blood, for therapeutic applications. Herein, we show that CD34(+) cells could be differentiated into osteoblastic lineage, in vitro. Systemically delivered CD34(+) cells home to the bone marrow and significantly improve bone deposition, bone mineral density and bone micro-architecture in osteoporotic mice. The elevated levels of osteocalcin, IL-10, GM-CSF, and decreased levels of MCP-1 in serum parallel the improvements in bone micro-architecture. Furthermore, CD34(+) cells improved osteoblast activity and concurrently impaired osteoclast differentiation, maturation and functionality. Conclusions: These findings demonstrate a novel approach utilizing nanofiber-expanded CD34(+) cells as a therapeutic application for the treatment of osteoporosis.	[Aggarwal, Reeva; Lu, Jingwei; Kanji, Suman; Joseph, Matthew; Das, Manjusri; Pompili, Vincent J.; Das, Hiranmoy] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Cardiovasc Stem Cell Res Lab, Columbus, OH 43210 USA; [Noble, Garrett J.; Hart, Richard T.] Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [McMichael, Brooke K.; Lee, Beth S.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Agarwal, Sudha; Sun, Zongyang] Ohio State Univ, Coll Dent, Dept Orthoped, Div Oral Biol, Columbus, OH 43210 USA; [Rosol, Thomas J.] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Jackson, Rebecca] Ohio State Univ, Coll Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Mao, Hai-Quan] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Johns Hopkins University	Aggarwal, R (corresponding author), Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Cardiovasc Stem Cell Res Lab, Columbus, OH 43210 USA.	hiranmoy.das@osumc.edu	Rosol, Thomas/G-9585-2011; Hart, Richard T/B-6932-2012; Lee, Beth S/E-9578-2010; Das, Hiranmoy/R-7452-2019	Rosol, Thomas/0000-0003-3737-1190; Lee, Beth S/0000-0002-1468-6387; Mao, Hai-Quan/0000-0002-4262-9988; Das, Hiranmoy/0000-0002-3343-0096	National Institutes of Health [K01 AR054114, SBIR R44 HL092706-01, R21 CA143787]; Ohio State University start-up fund; NATIONAL CANCER INSTITUTE [R21CA143787] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL092706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University start-up fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants, K01 AR054114 (NIAMS), SBIR R44 HL092706-01 (NHLBI), R21 CA143787 (NCI) and The Ohio State University start-up fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Al-Rasheed A, 2003, J DENT RES, V82, P632, DOI 10.1177/154405910308200812; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Borah B, 2000, J BONE MINER RES, V15, P1786, DOI 10.1359/jbmr.2000.15.9.1786; Chappard C, 2005, OSTEOPOROSIS INT, V16, P1193, DOI 10.1007/s00198-004-1829-5; Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017; Ciarelli TE, 2000, J BONE MINER RES, V15, P32, DOI 10.1359/jbmr.2000.15.1.32; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Das H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007325; Das H, 2009, CELL TRANSPLANT, V18, P305, DOI 10.3727/096368909788534870; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; GODSCHALK MF, 1988, J BONE MINER RES, V3, P113; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lien CY, 2009, J BONE MINER RES, V24, P837, DOI [10.1359/jbmr.081257, 10.1359/JBMR.081257]; MARIE PJ, 1993, J CLIN ENDOCR METAB, V77, P824, DOI 10.1210/jc.77.3.824; Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; McLaughlin F, 2002, BONE, V30, P924, DOI 10.1016/S8756-3282(02)00737-8; McMichael BK, 2010, J BIOL CHEM, V285, P9506, DOI 10.1074/jbc.M109.017269; Mifune Y, 2008, STEM CELLS, V26, P1395, DOI 10.1634/stemcells.2007-0820; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sheng MHC, 1999, BONE, V25, P421, DOI 10.1016/S8756-3282(99)00184-2; Taichman RS, 1996, EXP HEMATOL, V24, P509; Taichman RS, 1997, BLOOD, V89, P1165, DOI 10.1182/blood.V89.4.1165; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Wilting I, 2007, BONE, V40, P1252, DOI 10.1016/j.bone.2006.12.055; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746; Zhu W, 2011, J BIOL CHEM, V286, P26794, DOI 10.1074/jbc.M111.250985	50	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39365	10.1371/journal.pone.0039365	http://dx.doi.org/10.1371/journal.pone.0039365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724005	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300139
J	Owczarek-Lipska, M; Lauber, B; Molitor, V; Meury, S; Kierczak, M; Tengvall, K; Webster, MT; Jagannathan, V; Schlotter, Y; Willemse, T; Hendricks, A; Bergvall, K; Hedhammar, A; Andersson, G; Lindblad-Toh, K; Favrot, C; Roosje, P; Marti, E; Leeb, T				Owczarek-Lipska, Marta; Lauber, Beatrice; Molitor, Vivianne; Meury, Sabrina; Kierczak, Marcin; Tengvall, Katarina; Webster, Matthew T.; Jagannathan, Vidhya; Schlotter, Yvette; Willemse, Ton; Hendricks, Anke; Bergvall, Kerstin; Hedhammar, Ake; Andersson, Goran; Lindblad-Toh, Kerstin; Favrot, Claude; Roosje, Petra; Marti, Eliane; Leeb, Tosso			Two Loci on Chromosome 5 Are Associated with Serum IgE Levels in Labrador Retrievers	PLOS ONE			English	Article							CANINE ATOPIC-DERMATITIS; ACVD TASK-FORCE; GENOME-WIDE ASSOCIATION; IMMUNOGLOBULIN-E; DIAGNOSTIC-CRITERIA; MITE ALLERGENS; HOUSE-DUST; DOGS; DISEASE; ASTHMA	Crosslinking of immunoglobulin E antibodies (IgE) bound at the surface of mast cells and subsequent mediator release is considered the most important trigger for allergic reactions. Therefore, the genetic control of IgE levels is studied in the context of allergic diseases, such as asthma, atopic rhinitis, or atopic dermatitis (AD). We performed genome-wide association studies in 161 Labrador Retrievers with regard to total and allergen-specific immunoglobulin E (IgE) levels. We identified a genome-wide significant association on CFA 5 with the antigen-specific IgE responsiveness to Acarus siro. We detected a second genome-wide significant association with respect to the antigen-specific IgE responsiveness to Tyrophagus putrescentiae at a different locus on chromosome 5. A. siro and T. putrescentiae both belong to the family Acaridae and represent so-called storage or forage mites. These forage mites are discussed as major allergen sources in canine AD. No obvious candidate gene for the regulation of IgE levels is located under the two association signals. Therefore our studies offer a chance of identifying a novel mechanism controlling the host's IgE response.	[Owczarek-Lipska, Marta; Jagannathan, Vidhya; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Lauber, Beatrice; Marti, Eliane] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland; [Molitor, Vivianne; Roosje, Petra] Univ Bern, Vetsuisse Fac, Dept Clin Vet Med, Div Clin Dermatol, Bern, Switzerland; [Meury, Sabrina; Favrot, Claude] Univ Zurich, Vetsuisse Fac, Dermatol Unit, Clin Small Anim Internal Med, Zurich, Switzerland; [Kierczak, Marcin; Andersson, Goran] Swedish Univ Agr Sci, Dept Clin Sci, Computat Genet Grp, Uppsala, Sweden; [Tengvall, Katarina; Webster, Matthew T.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Schlotter, Yvette; Willemse, Ton] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Hendricks, Anke] Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England; [Bergvall, Kerstin; Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden	University of Bern; University of Bern; University of Bern; University of Zurich; Swedish University of Agricultural Sciences; Uppsala University; Utrecht University; University of London; University of London Royal Veterinary College; Swedish University of Agricultural Sciences	Owczarek-Lipska, M (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Andersson, Goran/AAK-6564-2020; Jagannathan, Vidhya/P-1055-2019; Tengvall, Katarina/L-1933-2019; Leeb, Tosso/G-3187-2014	Andersson, Goran/0000-0001-5131-3144; Jagannathan, Vidhya/0000-0002-8155-0041; Leeb, Tosso/0000-0003-0553-4880; Webster, Matthew/0000-0003-1141-2863; Hedhammar, Ake/0000-0001-7048-3851; FAVROT, Claude/0000-0002-0821-0956; Kierczak, Marcin/0000-0003-2629-5655	European Commission (LUPA) [GA-201370]; Albert-Heim Foundation	European Commission (LUPA)(European CommissionEuropean Commission Joint Research Centre); Albert-Heim Foundation	This work was funded thanks to grants from the European Commission (LUPA, GA-201370) and the Albert-Heim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian LG, 2003, AM J VET RES, V64, P32, DOI 10.2460/ajvr.2003.64.32; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bensignor E, 2002, VET DERMATOL, V13, P37, DOI 10.1046/j.0959-4493.2001.00270.x; Brazis P, 2008, VET DERMATOL, V19, P209, DOI 10.1111/j.1365-3164.2008.00676.x; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; DEBOER DJ, 1993, VET IMMUNOL IMMUNOP, V37, P183, DOI 10.1016/0165-2427(93)90193-8; DeBoer DJ, 2001, VET IMMUNOL IMMUNOP, V81, P271, DOI 10.1016/S0165-2427(01)00312-9; deWeck AL, 1997, INT ARCH ALLERGY IMM, V113, P55, DOI 10.1159/000237507; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Griffin CE, 2001, VET IMMUNOL IMMUNOP, V81, P255, DOI 10.1016/S0165-2427(01)00346-4; Halliwell REW, 2001, VET IMMUNOL IMMUNOP, V81, P159, DOI 10.1016/S0165-2427(01)00309-9; Hammerberg B, 1997, VET IMMUNOL IMMUNOP, V60, P33, DOI 10.1016/S0165-2427(97)00119-0; HANSON B, 1991, AM J HUM GENET, V48, P873; Jackola DR, 2002, MOL IMMUNOL, V39, P367, DOI 10.1016/S0161-5890(02)00108-6; Jackola DR, 2007, HUM IMMUNOL, V68, P839, DOI 10.1016/j.humimm.2007.07.006; Jackson HA, 2002, VET IMMUNOL IMMUNOP, V85, P225, DOI 10.1016/S0165-2427(02)00003-X; Jaeger K, 2010, VET DERMATOL, V21, P118, DOI 10.1111/j.1365-3164.2009.00845.x; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Lauber B, 2012, VET IMMUNOL IN PRESS; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; MAZZA G, 1994, RES VET SCI, V57, P133, DOI 10.1016/0034-5288(94)90048-5; McCall C, 2001, VET IMMUNOL IMMUNOP, V78, P231, DOI 10.1016/S0165-2427(00)00258-0; Meury S, 2011, VET DERMATOL, V22, P327, DOI 10.1111/j.1365-3164.2010.00950.x; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nodtvedt A, 2006, VET REC, V159, P241, DOI 10.1136/vr.159.8.241; Notvedt A, 2007, VET DERMATOL, V18, P309, DOI 10.1111/j.1365-3164.2007.00617.x; Nuttall TJ, 2006, VET DERMATOL, V17, P223, DOI 10.1111/j.1365-3164.2006.00532.x; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Potaczek DP, 2012, CLIN EXP ALLERGY, DOI [0.1111/j.1365-2222.2012.03953.x., DOI 10.1111/J.1365-2222.2012.03953.X]; Prelaud P, 1998, REV MED VET-TOULOUSE, V149, P1057; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Reedy LM, 1997, ALLERGIC SKIN DIS DO, P44; Roque JB, 2011, VET DERMATOL, V22, P257, DOI 10.1111/j.1365-3164.2010.00939.x; Schlotter YM, 2011, VET IMMUNOL IMMUNOP, V143, P20, DOI 10.1016/j.vetimm.2011.05.025; Sousa CA, 2001, VET IMMUNOL IMMUNOP, V81, P153, DOI 10.1016/S0165-2427(01)00297-5; Strachan DR, 2001, J ALLERGY CLIN IMMUN, V108, P901, DOI 10.1067/mai.2001.119408; Weidinger S, 2010, CURR OPIN ALLERGY CL, V10, P408, DOI 10.1097/ACI.0b013e32833d7d2d; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; WILLEMSE T, 1986, J SMALL ANIM PRACT, V27, P771, DOI 10.1111/j.1748-5827.1986.tb02119.x	41	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39176	10.1371/journal.pone.0039176	http://dx.doi.org/10.1371/journal.pone.0039176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720065	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000305350000046
J	Roecklein, KA; Schumacher, JA; Miller, MA; Ernecoff, NC				Roecklein, Kathryn A.; Schumacher, Julie A.; Miller, Megan A.; Ernecoff, Natalie C.			Cognitive and Behavioral Predictors of Light Therapy Use	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; ACUTE-PHASE TREATMENT; DEPRESSION OUTCOMES; REUPTAKE INHIBITORS; MAJOR DEPRESSION; MOOD DISORDERS; BRIGHT-LIGHT; METAANALYSIS; HOMEWORK; ADHERENCE	Objective: Although light therapy is effective in the treatment of seasonal affective disorder (SAD) and other mood disorders, only 53-79% of individuals with SAD meet remission criteria after light therapy. Perhaps more importantly, only 12-41% of individuals with SAD continue to use the treatment even after a previous winter of successful treatment. Method: Participants completed surveys regarding (1) social, cognitive, and behavioral variables used to evaluate treatment adherence for other health-related issues, expectations and credibility of light therapy, (2) a depression symptoms scale, and (3) self-reported light therapy use. Results: Individuals age 18 or older responded (n = 40), all reporting having been diagnosed with a mood disorder for which light therapy is indicated. Social support and self-efficacy scores were predictive of light therapy use (p's<.05). Conclusion: The findings suggest that testing social support and self-efficacy in a diagnosed patient population may identify factors related to the decision to use light therapy. Treatments that impact social support and self-efficacy may improve treatment response to light therapy in SAD.	[Roecklein, Kathryn A.; Miller, Megan A.; Ernecoff, Natalie C.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Schumacher, Julie A.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Mississippi; University of Mississippi Medical Center	Roecklein, KA (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	kroeck@pitt.edu	Roecklein, Kathryn A./G-2942-2014		NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCRR NIH HHS [UL1 RR024153] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abraham C, 1998, PSYCHOL HEALTH, V13, P569, DOI 10.1080/08870449808407420; Aloia Mark S, 2007, Behav Sleep Med, V5, P89; Austin JT, 1996, PSYCHOL BULL, V120, P338, DOI 10.1037/0033-2909.120.3.338; Bandura A, 1997, AM J HEALTH PROMOT, V12, P8, DOI 10.4278/0890-1171-12.1.8; Baundra A, 1986, SOCIAL FDN THOUGHT A; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; BURNS DD, 1987, BEHAV RES THER, V25, P223, DOI 10.1016/0005-7967(87)90049-0; BURNS DD, 1991, J CONSULT CLIN PSYCH, V59, P305, DOI 10.1037/0022-006X.59.2.305; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Conner M, 1996, APPETITE, V27, P135, DOI 10.1006/appe.1996.0041; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Fishbein M, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P3; Flory R, 2010, PSYCHIAT RES, V177, P101, DOI 10.1016/j.psychres.2008.08.011; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; Gyurcsik NC, 2011, J HEALTH PSYCHOL, V16, P530, DOI 10.1177/1359105310394229; Lam RW, 2010, INT CLIN PSYCHOPHARM, V25, P199, DOI 10.1097/YIC.0b013e32833948d8; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; Maddux JE, 1996, EXPECTANCIES SHAPE B, P17; MARCUS BH, 1992, HEALTH PSYCHOL, V11, P386, DOI 10.1037/0278-6133.11.6.386; MARCUS BH, 1992, RES Q EXERCISE SPORT, V63, P60, DOI 10.1080/02701367.1992.10607557; Mausbach BT, 2010, COGNITIVE THER RES, V34, P429, DOI 10.1007/s10608-010-9297-z; Michalak EE, 2002, J AFFECT DISORDERS, V68, P341, DOI 10.1016/S0165-0327(00)00320-7; Michalak EE, 2007, PSYCHIAT RES, V149, P315, DOI 10.1016/j.psychres.2006.05.005; Murray G., 2001, SEASONAL AFFECTIVE D, P55; Neimeyer Robert A., 2008, Cognitive Behaviour Therapy, V37, P199, DOI 10.1080/16506070801981240; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; Prochaska J. O., 2018, SYSTEMS PSYCHOTHERAP, V9th; PROCHASKA JO, 1988, J CONSULT CLIN PSYCH, V56, P520, DOI 10.1037/0022-006X.56.4.520; Prochaska JO, 1997, HLTH BEHAV HLTH ED T, P60; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rohan KJ, 2009, BEHAV THER, V40, P225, DOI 10.1016/j.beth.2008.06.004; Schwartz PJ, 1996, AM J PSYCHIAT, V153, P1028; Sheeran P, 2003, PERS SOC PSYCHOL B, V29, P205, DOI 10.1177/0146167202239046; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [10.1080/14792772143000003, DOI 10.1080/14792772143000003]; Sirey JA, 2010, AM J GERIAT PSYCHIAT, V18, P554, DOI 10.1097/JGP.0b013e3181cdeb7d; Stepnowsky Carl J Jr, 2002, Sleep Med, V3, P239, DOI 10.1016/S1389-9457(01)00162-9; TERMAN M, 1989, NEUROPSYCHOPHARMACOL, V2, P1, DOI 10.1016/0893-133X(89)90002-X; Thase ME, 2010, INT CLIN PSYCHOPHARM, V25, P189, DOI 10.1097/YIC.0b013e328330adb2; Tuunainen A, 2004, LIGHT THERAPY NONSEA; Watanabe N, 2008, J CLIN PSYCHIAT, V69, P1404, DOI 10.4088/JCP.v69n0908; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wilson GT, 2004, CLIN PSYCHOL REV, V24, P361, DOI 10.1016/j.cpr.2004.03.003; WORTHINGTON EL, 1986, J COUNS PSYCHOL, V33, P124; Yovel I, 2007, COGNITIVE THER RES, V31, P385, DOI 10.1007/s10608-006-9065-2	45	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39275	10.1371/journal.pone.0039275	http://dx.doi.org/10.1371/journal.pone.0039275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22720089	gold, Green Published			2022-12-25	WOS:000305341900093
J	Rosu-Myles, M; She, YM; Fair, J; Muradia, G; Mehic, J; Menendez, P; Prasad, SS; Cyr, TD				Rosu-Myles, Michael; She, Yi-Min; Fair, Joel; Muradia, Gauri; Mehic, Jelica; Menendez, Pablo; Prasad, Shiv S.; Cyr, Terry D.			Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ALDEHYDE DEHYDROGENASE-ACTIVITY; GROUP BOX-1 PROTEIN; BONE-MARROW; IN-VITRO; MYOCARDIAL-INFARCTION; TGF-BETA; GROWTH; MICE; DIFFERENTIATION	Bone marrow stromal cell cultures contain multipotent cells that may have therapeutic utility for tissue restoration; however, the identity of the cell that maintains this function remains poorly characterized. We have utilized a unique model of murine bone marrow stroma in combination with liquid chromatography mass spectrometry to compare the nuclear, cytoplasmic and membrane associated proteomes of multipotent (MSC) (CD105+) and non-multipotent (CD105-) stromal cells. Among the 25 most reliably identified proteins, 10 were verified by both real-time PCR and Western Blot to be highly enriched, in CD105+ cells and were members of distinct biological pathways and functional networks. Five of these proteins were also identified as potentially expressed in human MSC derived from both standard and serum free human stromal cultures. The quantitative amount of each protein identified in human stromal cells was only minimally affected by media conditions but varied highly between bone marrow donors. This study provides further evidence of heterogeneity among cultured bone marrow stromal cells and identifies potential candidate proteins that may prove useful for identifying and quantifying both murine and human MSC in vitro.	[Rosu-Myles, Michael; She, Yi-Min; Muradia, Gauri; Mehic, Jelica; Prasad, Shiv S.; Cyr, Terry D.] Hlth Canada, Ctr Vaccine Evaluat Biol & Genet Therapies Direct, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada; [Fair, Joel] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Menendez, Pablo] Pfizer Univ Granada, Andalusian Govt Ctr Genom & Oncol Res, Granada, Spain	Health Canada; University of Ottawa; Pfizer; University of Granada	Rosu-Myles, M (corresponding author), Hlth Canada, Ctr Vaccine Evaluat Biol & Genet Therapies Direct, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada.	michael.rosu-myles@hc-sc.gc.ca	Bujan, Pablo Menendez/W-3736-2017	Bujan, Pablo Menendez/0000-0001-9372-1007; She, Yi-Min/0000-0002-0571-4630	Federal Government of Canada	Federal Government of Canada	This work was funded entirely by the Federal Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bagley RG, 2009, INT J ONCOL, V34, P619, DOI 10.3892/ijo_00000187; Ball SG, 2007, J CELL MOL MED, V11, P1012, DOI 10.1111/j.1582-4934.2007.00120.x; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Capoccia BJ, 2009, BLOOD, V113, P5340, DOI 10.1182/blood-2008-04-154567; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ferrari S, 1996, GENOMICS, V35, P367, DOI 10.1006/geno.1996.0369; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Germani A, 2007, J LEUKOCYTE BIOL, V81, P41, DOI 10.1189/jlb.0306165; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Hartmann I, 2010, J IMMUNOL METHODS, V363, P80, DOI 10.1016/j.jim.2010.10.008; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; Lax S, 2007, FEBS LETT, V581, P3550, DOI 10.1016/j.febslet.2007.06.063; Lax S, 2010, EUR J IMMUNOL, V40, P1884, DOI 10.1002/eji.200939877; Lee CCI, 2010, EXP HEMATOL, V38, P46, DOI 10.1016/j.exphem.2009.11.001; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lim S, 2012, STEM CELLS      0424, V24; Lotfi R, 2011, EUR J IMMUNOL, V41, P2021, DOI 10.1002/eji.201041324; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Meng ER, 2008, STEM CELLS DEV, V17, P805, DOI 10.1089/scd.2008.0276; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Muraglia A, 2000, J CELL SCI, V113, P1161; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Pearce DJ, 2007, EXP HEMATOL, V35, P1437, DOI 10.1016/j.exphem.2007.06.002; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Remberger M, 2011, BIOL BLOOD MARROW TR, V17, P1688, DOI 10.1016/j.bbmt.2011.05.001; Rodriguez R, 2011, STEM CELLS, V29, P179, DOI 10.1002/stem.571; Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864; Rosu-Myles M, 2010, CYTOTHERAPY, V12, P818, DOI 10.3109/14653249.2010.501785; She YM, 2012, PROTEOMICS, V12, P369, DOI 10.1002/pmic.201100308; Spooncer E, 2008, MOL CELL PROTEOMICS, V7, P573, DOI 10.1074/mcp.M700292-MCP200; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Tian Ruijun, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M110.007252; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vanella L, 2011, PROSTAG OTH LIPID M, V96, P54, DOI 10.1016/j.prostaglandins.2011.07.005; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang J, 2012, STEM CELLS DEV  0420, V20; WEN L, 1989, NUCLEIC ACIDS RES, V17, P1197, DOI 10.1093/nar/17.3.1197; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x	60	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38954	10.1371/journal.pone.0038954	http://dx.doi.org/10.1371/journal.pone.0038954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719999	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900068
J	Granieri, L; Marnetto, F; Valentino, P; Frau, J; Patanella, AK; Nytrova, P; Sola, P; Capobianco, M; Jarius, S; Bertolotto, A				Granieri, Letizia; Marnetto, Fabiana; Valentino, Paola; Frau, Jessica; Patanella, Agata Katia; Nytrova, Petra; Sola, Patrizia; Capobianco, Marco; Jarius, Sven; Bertolotto, Antonio			Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology	PLOS ONE			English	Article							NMO-IGG; DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; AQUAPORIN-4; ANTIBODIES; RITUXIMAB; SPECTRUM; QUANTIFICATION; AUTOANTIBODIES; NATALIZUMAB	Background: Neuromyelitis optica (NMO) is a severely disabling autoimmune disorder of the central nervous system, which predominantly affects the optic nerves and spinal cord. In a majority of cases, NMO is associated with antibodies to aquaporin-4 (AQP4) (termed NMO-IgG). Aims: In this study, we evaluated a new multiparametric indirect immunofluorescence (IIF) assay for NMO serology. Methods: Sera from 20 patients with NMO, 41 patients with multiple sclerosis (MS), 30 healthy subjects, and a commercial anti-AQP4 IgG antibody were tested in a commercial composite immunofluorescence assay ("Neurology Mosaic 17"; Euroimmun, Germany), consisting of five different diagnostic substrates (HEK cells transfected with AQP4, non-transfected HEK cells, primate cerebellum, cerebrum, and optic nerve tissue sections). Results: We identified AQP4 specific and non-specific fluorescence staining patterns and established positivity criteria. Based on these criteria, this kit yielded a high sensitivity (95%) and specificity (100%) for NMO and had a significant positive and negative likelihood ratio (LR+=infinity, LR-=0.05). Moreover, a 100% inter- and intra-laboratory reproducibility was found. Conclusions: The biochip mosaic assay tested in this study is a powerful tool for NMO serology, fast to perform, highly sensitive and specific for NMO, reproducible, and suitable for inter-laboratory standardization as required for multi-centre clinical trials.	[Granieri, Letizia; Marnetto, Fabiana; Valentino, Paola; Capobianco, Marco; Bertolotto, Antonio] Univ Hosp San Luigi Gonzaga, Clin Neurobiol Unit, Reg Referring Multiple Sclerosis Ctr CReSM, Turin, Italy; [Granieri, Letizia; Marnetto, Fabiana; Valentino, Paola; Bertolotto, Antonio] Univ Turin, Neurosci Inst Cavalieri Ottolenghi NICO, Turin, Italy; [Frau, Jessica] Univ Cagliari, Multiple Sclerosis Ctr, Dept Cardiovasc & Neurol Sci, Cagliari, Italy; [Patanella, Agata Katia] Gemelli Hosp, Multiple Sclerosis Ctr, Dept Neurosci, Rome, Italy; [Nytrova, Petra] Gen Univ Hosp Prague, Dept Neurol, Prague, Czech Republic; [Nytrova, Petra] Gen Univ Hosp Prague, Ctr Clin Neurosci, Prague, Czech Republic; [Nytrova, Petra] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Sola, Patrizia] S Agostino Estense Hosp, Multiple Sclerosis Ctr, Modena, Italy; [Jarius, Sven] Heidelberg Univ, Div Mol Neuroimmunol, Dept Neurol, Heidelberg, Germany	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; General University Hospital Prague; General University Hospital Prague; Charles University Prague; Ruprecht Karls University Heidelberg	Granieri, L (corresponding author), Univ Hosp San Luigi Gonzaga, Clin Neurobiol Unit, Reg Referring Multiple Sclerosis Ctr CReSM, Turin, Italy.	letiziagranieri@libero.it	Bertolotto, Antonio/K-8346-2015; Frau, Jessica/AAC-1622-2019; Nytrova, Petra/O-9099-2017; Capobianco, Marco/AAC-2215-2022; VALENTINO, Paola/AAA-4243-2019; Valentino, Paola/K-6758-2016	Bertolotto, Antonio/0000-0002-7052-1907; Nytrova, Petra/0000-0003-4885-602X; Capobianco, Marco/0000-0003-2501-2932; VALENTINO, Paola/0000-0001-7863-9195; Valentino, Paola/0000-0003-3819-9409	Alenia Areonautica S.p.A.; FORB (Fondazione per la Ricerca Biomedica, ONLUS); Fondazione San Luigi ONLUS; Czech Ministry of Education [MSM 0021620849]; Grant Agency of Charles University [GAUK 132010]; Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Bayer Vital; Merck Serono; Alenia Aeronautica Spa; Euroimmun, Luebeck, Germany; Biogen Idec; Novartis; Roche; Bayer Schering; Sanofi-Aventis	Alenia Areonautica S.p.A.; FORB (Fondazione per la Ricerca Biomedica, ONLUS); Fondazione San Luigi ONLUS; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of Charles University; Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Bayer Vital(Bayer AG); Merck Serono(Merck & Company); Alenia Aeronautica Spa; Euroimmun, Luebeck, Germany; Biogen Idec(Biogen); Novartis(Novartis); Roche(Roche Holding); Bayer Schering(Bayer AG); Sanofi-Aventis(Sanofi-Aventis)	We also thank Alenia Areonautica S.p.A. for supporting the fellowship of FM.; Financial supports were obtained from the FORB (Fondazione per la Ricerca Biomedica, ONLUS) and from Fondazione San Luigi ONLUS. The work of PN was supported by the Czech Ministry of Education, Research Program MSM 0021620849 and Grant Agency of Charles University (grant GAUK 132010). The work of SJ was supported by a research grant from the Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and by grants from Bayer Vital and from Merck Serono. The work of FM was supported by Alenia Aeronautica Spa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LG and PV received a contribution for attending a scientific meeting from Euroimmun, Luebeck, Germany. PN received a contribution for a fellowship in Oxford by Euroimmun, Luebeck, Germany. LG, FM and PV received consultation fees from Biogen Idec and Merck Serono. MC received consultation fees from Biogen Idec, Merck Serono and Novartis. AB has been on steering committees in clinical trials sponsored by Biogen Idec, Roche, and has received speaker honoraria from Biogen Idec, Merck Serono, TEVA, Bayer Schering, Sanofi-aventis, and Novartis; and his institution has received grant support from Biogen Idec, Bayer Schering, Merck Serono and Sanofi-Aventis. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. The other authors have no financial links with Euroimmun, and they have no competing financial interests.	Banwell B, 2008, NEUROLOGY, V70, P344, DOI 10.1212/01.wnl.0000284600.80782.d5; Barnett MH, 2012, MULT SCLER J, V18, P108, DOI 10.1177/1352458511421185; Bedi GS, 2011, MULT SCLER J, V17, P1225, DOI 10.1177/1352458511404586; Costanzi C, 2011, NEUROLOGY, V77, P659, DOI 10.1212/WNL.0b013e31822a2780; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; De Vidi I, 2011, CLIN IMMUNOL, V138, P239, DOI 10.1016/j.clim.2010.11.012; Fazio R, 2009, MULT SCLER J, V15, P1153, DOI 10.1177/1352458509106851; Fazio R, 2011, J NEUROIMMUNOL, V231, P100, DOI 10.1016/j.jneuroim.2010.10.012; Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009; Hilliam RA, 2005, STAT MED, V24, P1219, DOI 10.1002/sim.1998; Jacob A, 2008, ARCH NEUROL-CHICAGO, V65, P1443, DOI 10.1001/archneur.65.11.noc80069; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Jarius S, 2007, NEUROLOGY, V68, P1076, DOI 10.1212/01.wnl.0000256822.01222.bd; Jarius S, 2012, CLIN NEUROL NEUROSUR, V114, P331, DOI 10.1016/j.clineuro.2011.10.048; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2011, MULT SCLER J, V17, P1067, DOI 10.1177/1352458511403958; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Kim SH, 2011, ARCH NEUROL-CHICAGO, V68, P1412, DOI 10.1001/archneurol.2011.154; Kim W, 2011, MULT S IN PRESS 0930; Kleiter I, 2012, ARCH NEUROL-CHICAGO, V69, P239, DOI 10.1001/archneurol.2011.216; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lotze TE, 2008, PEDIATRICS, V122, pE1039, DOI 10.1542/peds.2007-2758; Marignier R, 2008, MULT SCLER, V14, P440, DOI 10.1177/1352458507084595; Marnetto F, 2009, J NEUROIMMUNOL, V217, P74, DOI 10.1016/j.jneuroim.2009.10.002; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; McKeon A, 2009, ARCH NEUROL-CHICAGO, V66, P1134, DOI 10.1001/archneurol.2009.178; Min JH, 2012, MULT SCLER J, V18, P113, DOI 10.1177/1352458511431973; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Paul F, 2007, PLOS MED, V4, P669, DOI 10.1371/journal.pmed.0040133; Petzold A, 2010, J NEUROL NEUROSUR PS, V81, P109, DOI 10.1136/jnnp.2008.146894; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Wandinger KP, 2010, ARTHRITIS RHEUM-US, V62, P1198, DOI 10.1002/art.27337; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38896	10.1371/journal.pone.0038896	http://dx.doi.org/10.1371/journal.pone.0038896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719979	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000052
J	Long, JM; Ray, B; Lahiri, DK				Long, Justin M.; Ray, Balmiki; Lahiri, Debomoy K.			MicroRNA-153 Physiologically Inhibits Expression of Amyloid-beta Precursor Protein in Cultured Human Fetal Brain Cells and Is Dysregulated in a Subset of Alzheimer Disease Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY-BODY VARIANT; MESSENGER-RNA; ALPHA-SYNUCLEIN; POSTTRANSCRIPTIONAL REGULATION; 5'-UNTRANSLATED REGION; 3-UNTRANSLATED REGION; TARGET PREDICTION; COGNITIVE DECLINE; STEM-CELLS; GENE	Regulation of amyloid-beta (A beta) precursor protein (APP) expression is complex. MicroRNAs (miRNAs) are expected to participate in the molecular network that controls this process. The composition of this network is, however, still undefined. Elucidating the complement of miRNAs that regulate APP expression should reveal novel drug targets capable of modulating A beta production in AD. Here, we investigated the contribution of miR-153 to this regulatory network. A miR-153 target site within the APP 3'-untranslated region (3'-UTR) was predicted by several bioinformatic algorithms. We found that miR-153 significantly reduced reporter expression when co-transfected with an APP 3'-UTR reporter construct. Mutation of the predicted miR-153 target site eliminated this reporter response. miR-153 delivery in both HeLa cells and primary human fetal brain cultures significantly reduced APP expression. Delivery of a miR-153 antisense inhibitor to human fetal brain cultures significantly elevated APP expression. miR-153 delivery also reduced expression of the APP paralog APLP2. High functional redundancy between APP and APLP2 suggests that miR-153 may target biological pathways in which they both function. Interestingly, in a subset of human AD brain specimens with moderate AD pathology, miR-153 levels were reduced. This same subset also exhibited elevated APP levels relative to control specimens. Therefore, endogenous miR-153 inhibits expression of APP in human neurons by specifically interacting with the APP 3'-UTR. This regulatory interaction may have relevance to AD etiology, where low miR-153 levels may drive increased APP expression in a subset of AD patients.	[Long, Justin M.; Ray, Balmiki; Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lahiri, DK (corresponding author), Indiana Univ Sch Med, Dept Psychiat, 791 Union Dr, Indianapolis, IN 46202 USA.	dlahiri@iupui.edu	Lahiri, Debomoy/AAZ-3322-2020	Long, Justin/0000-0003-0769-604X	National Institutes of Health [AG18379, AG18884]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [R01AG018379, R01AG018884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG18379 and AG18884 (to D. K. L.). This work was also supported by the Alzheimer's Association (Zenith award and investigator-initiated research grant).	Baba M, 1998, AM J PATHOL, V152, P879; Bao BL, 2012, J NUTR BIOCHEM, V23, P635, DOI 10.1016/j.jnutbio.2011.03.007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Delay C, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-70; DESAUVAGE F, 1992, EMBO J, V11, P3099, DOI 10.1002/j.1460-2075.1992.tb05382.x; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FORSTL H, 1993, BRIT J PSYCHIAT, V162, P385, DOI 10.1192/bjp.162.3.385; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; HANSEN L, 1990, NEUROLOGY, V40, P1; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heyman A, 1999, NEUROLOGY, V52, P1839, DOI 10.1212/WNL.52.9.1839; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Kraybill ML, 2005, NEUROLOGY, V64, P2069, DOI 10.1212/01.WNL.0000165987.89198.65; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lahiri DK, 2003, J ALZHEIMERS DIS, V5, P81, DOI 10.3233/JAD-2003-5203; LAHIRI DK, 1991, MOL BRAIN RES, V9, P253, DOI 10.1016/0169-328X(91)90009-M; Lahiri DK, 2005, FASEB J, V19, P653, DOI 10.1096/fj.04-2900fje; Lahiri DK, 2005, NEUROBIOL AGING, V26, P1329, DOI 10.1016/j.neurobiolaging.2004.11.005; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lesne S, 2003, J BIOL CHEM, V278, P18408, DOI 10.1074/jbc.M300819200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang CL, 2012, BRAIN RES, V1455, P103, DOI 10.1016/j.brainres.2011.10.051; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Long JM, 2011, CURR MED CHEM, V18, P3314, DOI 10.2174/092986711796504592; Long JM, 2012, EXP NEUROL, V235, P402, DOI 10.1016/j.expneurol.2011.12.043; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Maloney B, 2004, FASEB J, V18, P1288, DOI 10.1096/fj.03-1703fje; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; Mbella EGM, 2000, MOL CELL BIOL, V20, P4572, DOI 10.1128/MCB.20.13.4572-4579.2000; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mukaetova-Ladinska EB, 2009, THESCIENTIFICWORLDJO, V9, P1463, DOI 10.1100/tsw.2009.151; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P1136, DOI 10.1097/nen.0b013e31815c5efb; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; POLLWEIN P, 1992, NUCLEIC ACIDS RES, V20, P63, DOI 10.1093/nar/20.1.63; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; QUITSCHKE WW, 1992, J BIOL CHEM, V267, P17362; Rajagopalan LE, 1998, NUCLEIC ACIDS RES, V26, P3418, DOI 10.1093/nar/26.14.3418; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Smith P, 2011, J NEUROCHEM, V116, P240, DOI 10.1111/j.1471-4159.2010.07097.x; Song WH, 1998, GENE, V217, P165, DOI 10.1016/S0378-1119(98)00340-0; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Westmark PR, 2006, NEUROBIOL AGING, V27, P787, DOI 10.1016/j.neurobiolaging.2006.03.003; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Xu JZ, 2011, INT J CANCER, V129, P2527, DOI 10.1002/ijc.25917; Xu JZ, 2010, INT J CANCER, V126, P1029, DOI 10.1002/ijc.24823; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24000; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007	91	139	148	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31298	31310		10.1074/jbc.M112.366336	http://dx.doi.org/10.1074/jbc.M112.366336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22733824	hybrid, Green Published			2022-12-25	WOS:000308791300041
J	Kitagawa, M; Takebe, A; Ono, Y; Imai, T; Nakao, K; Nishikawa, SI; Era, T				Kitagawa, Michinori; Takebe, Atsushi; Ono, Yuichi; Imai, Toshio; Nakao, Kazuki; Nishikawa, Shin-Ichi; Era, Takumi			Phf14, a Novel Regulator of Mesenchyme Growth via Platelet-derived Growth Factor (PDGF) Receptor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIFFERENTIATION CULTURE; PULMONARY-FIBROSIS; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; DEFICIENT MICE; LUNG FIBROSIS; UP-REGULATION; STEM-CELLS; IN-VIVO; BLEOMYCIN	The regulation of mesenchymal cell growth by signaling molecules plays an important role in maintaining tissue functions. Aberrant mesenchymal cell proliferation caused by disruption of this regulatory process leads to pathogenetic events such as fibrosis. In the current study we have identified a novel nuclear factor, Phf14, which controls the proliferation of mesenchymal cells by regulating PDGFR alpha expression. Phf14-null mice died just after birth due to respiratory failure. Histological analyses of the lungs of these mice showed interstitial hyperplasia with an increased number of PDGFR alpha(+) mesenchymal cells. PDGFR alpha expression was elevated in Phf14-null mesenchymal fibroblasts, resulting in increased proliferation. We demonstrated that Phf14 acts as a transcription factor that directly represses PDGFR alpha expression. Based on these results, we used an antibody against PDGFR alpha to successfully treat mouse lung fibrosis. This study shows that Phf14 acts as a negative regulator of PDGFR alpha expression in mesenchymal cells undergoing normal and abnormal proliferation, and is a potential target for new treatments of lung fibrosis.	[Kitagawa, Michinori; Era, Takumi] Kumamoto Univ, Dept Cell Modulat, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Kitagawa, Michinori] Hiroshima Univ, Div Integrated Med Sci, Programs Biomed Res, Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348553, Japan; [Takebe, Atsushi] Yodogawa Christians Hosp, Dept Surg, Higashi Yodogawa Ku, Osaka 5330032, Japan; [Ono, Yuichi; Imai, Toshio] KAN Res Inst Inc, 3F, Kobe MI R&D Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Nishikawa, Shin-Ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Nakao, Kazuki] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kumamoto University; Hiroshima University; KAN Research Institute; RIKEN; RIKEN	Era, T (corresponding author), Kumamoto Univ, Dept Cell Modulat, Inst Mol Embryol & Genet, 2-2-1 Honjo, Kumamoto 8600811, Japan.	tera@kumamoto-u.ac.jp	Kitagawa, Michinori/B-1792-2013	Kitagawa, Michinori/0000-0003-1660-6421	Ministry of Health, Labor, and Welfare of Japan; Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Afink G, 2004, BIOCHEM BIOPH RES CO, V315, P313, DOI 10.1016/j.bbrc.2004.01.056; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bleyl SB, 2007, EUR J HUM GENET, V15, P950, DOI 10.1038/sj.ejhg.5201872; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bonner JC, 1998, AM J PHYSIOL-LUNG C, V274, pL72, DOI 10.1152/ajplung.1998.274.1.L72; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Day RM, 2002, AM J PHYSIOL-LUNG C, V282, pL1349, DOI 10.1152/ajplung.00338.2001; ERA T, 1995, GENE CHROMOSOME CANC, V13, P25, DOI 10.1002/gcc.2870130105; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; Gurujeyalakshmi G, 1999, AM J PHYSIOL-LUNG C, V276, pL311, DOI 10.1152/ajplung.1999.276.2.L311; HAWLEY RG, 1994, GENE THER, V1, P136; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karlsson L, 1999, DEVELOPMENT, V126, P2611; KELLEY J, 1985, BIOCHEM BIOPH RES CO, V131, P836, DOI 10.1016/0006-291X(85)91315-4; Kitagawa M, 2010, INT J HEMATOL, V91, P373, DOI 10.1007/s12185-010-0518-8; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Lasky JA, 1998, AM J RESP CRIT CARE, V157, P1652, DOI 10.1164/ajrccm.157.5.9704116; Li J, 2001, DEV BIOL, V239, P338, DOI 10.1006/dbio.2001.0441; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Matsumoto T, 1999, J BIOL CHEM, V274, P13954, DOI 10.1074/jbc.274.20.13954; NAGAOKA I, 1990, J CLIN INVEST, V85, P2023, DOI 10.1172/JCI114669; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; OBERLEY LW, 1979, FEBS LETT, V97, P47, DOI 10.1016/0014-5793(79)80049-6; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Sun T, 2000, DEVELOPMENT, V127, P4519; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Wang XL, 2006, STEM CELLS, V24, P482, DOI 10.1634/stemcells.2005-0219; Wang YM, 2006, FEBS LETT, V580, P3787, DOI 10.1016/j.febslet.2006.05.065; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	49	24	25	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27983	27996		10.1074/jbc.M112.350074	http://dx.doi.org/10.1074/jbc.M112.350074			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730381	Green Published, hybrid			2022-12-25	WOS:000307840700072
J	Dejean, A; Delabie, JHC; Corbara, B; Azemar, F; Groc, S; Orivel, J; Leponce, M				Dejean, Alain; Delabie, Jacques H. C.; Corbara, Bruno; Azemar, Frederic; Groc, Sarah; Orivel, Jerome; Leponce, Maurice			The Ecology and Feeding Habits of the Arboreal Trap-Jawed Ant Daceton armigerum	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; AFRICAN WEAVER ANT; OECOPHYLLA-LONGINODA; PREDATORY BEHAVIOR; HYMENOPTERA; FORMICIDAE; FOOD	Here we show that Daceton armigerum, an arboreal myrmicine ant whose workers are equipped with hypertrophied trap-jaw mandibles, is characterized by a set of unexpected biological traits including colony size, aggressiveness, trophobiosis and hunting behavior. The size of one colony has been evaluated at ca. 952,000 individuals. Intra-and interspecific aggressiveness were tested and an equiprobable null model used to show how D. armigerum colonies react vis-a-vis other arboreal ant species with large colonies; it happens that D. armigerum can share trees with certain of these species. As they hunt by sight, workers occupy their hunting areas only during the daytime, but stay on chemical trails between nests at night so that the center of their home range is occupied 24 hours a day. Workers tend different Hemiptera taxa (i.e., Coccidae, Pseudococcidae, Membracidae and Aethalionidae). Through group-hunting, short-range recruitment and spreadeagling prey, workers can capture a wide range of prey (up to 94.12 times the mean weight of foraging workers).	[Dejean, Alain; Orivel, Jerome] Ecol Forets Guyane, CNRS, UMR 8172, Kourou, France; [Dejean, Alain; Azemar, Frederic] Univ Toulouse, UPS, Ecolab, Toulouse, France; [Delabie, Jacques H. C.] Convenio UESC CEPLAC, UPA Lab Mirmecol, Itabuna, BA, Brazil; [Corbara, Bruno] Univ Blaise Pascal, Lab Microorganismes Genome & Environm, CNRS, UMR 6023, Aubiere, France; [Corbara, Bruno] Univ Blaise Pascal LMGE, Clermont Univ, Clermont Ferrand, France; [Azemar, Frederic] CNRS, Lab Ecol Fonct & Environm, UMR 5245, Toulouse, France; [Groc, Sarah] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil; [Leponce, Maurice] Royal Belgian Inst Nat Sci, Biol Evaluat Sect, Brussels, Belgium	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universidade Estadual de Santa Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universidade Federal de Uberlandia; Royal Belgian Institute of Natural Sciences	Dejean, A (corresponding author), Ecol Forets Guyane, CNRS, UMR 8172, Campus Agron, Kourou, France.	alain.dejean@wanadoo.fr	Delabie, Jacques H C/F-3405-2010; Azémar, Frédéric/A-9041-2010	Delabie, Jacques H C/0000-0002-2695-1061; Azémar, Frédéric/0000-0002-3098-8676; Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248; CORBARA, Bruno/0000-0003-4232-8234	French CNRS; Region Guyane from the European Community [20072013]; CNPq	French CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Guyane from the European Community; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support for this study was provided by the Programme Amazonie II of the French CNRS (project 2ID), and the Programme Convergence 20072013, Region Guyane from the European Community (project DEGA). JHCD acknowledges his research grant by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azorsa F, 2008, ZOOTAXA, P27, DOI 10.11646/zootaxa.1749.1.3; BEUGNON G, 1992, INSECT SOC, V39, P341, DOI 10.1007/BF01323954; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; BLUM M. S., 1966, PSYCHE J ENTOMOL, V73, P150, DOI 10.1155/1966/16367; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Crawley W. C., 1916, Annals & Magazine of Natural History, V17; Davidson D. W., 1996, NEOTROPICAL BIODIVER, P127; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; DEJEAN A, 1990, PHYSIOL ENTOMOL, V15, P393, DOI 10.1111/j.1365-3032.1990.tb00528.x; DEJEAN A, 1990, WESTV STUD, P472; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2007, CR BIOL, V330, P701, DOI 10.1016/j.crvi.2007.06.005; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019837; Dejean A, 2010, NATURWISSENSCHAFTEN, V97, P925, DOI 10.1007/s00114-010-0710-y; Dejean A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011331; Dejean Alain, 1999, Selbyana, V20, P133; Djieto-Lordon C, 2001, SOCIOBIOLOGY, V38, P765; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, ECOSIM NULL MODELS S; Gronenberg W, 1996, J EXP BIOL, V199, P2021; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOLLDOBLER B, 1990, J CHEM ECOL, V16, P1207, DOI 10.1007/BF01021020; Holldobler B., 1990, pi; Madi Y., 2006, ENTOMOTROPICA, V21, P117; Mercier JL, 1996, INSECT SOC, V43, P17, DOI 10.1007/BF01253952; MOFFETT M W, 1991, Psyche (Cambridge), V98, P283, DOI 10.1155/1991/30265; MOFFETT MW, 1992, RES EXPLOR, V8, P220; MORGAN ED, 1992, J CHEM ECOL, V18, P2161, DOI 10.1007/BF00984943; Parr CL, 2010, ANT ECOLOGY, P77; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richard FJ, 2001, J INSECT BEHAV, V14, P271, DOI 10.1023/A:1007845929801; Rifflet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028571; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; WILSON EDWARD O., 1962, BULL MUS COMP ZOOL HARVARD UNIV, V127, P401; Wojtusiak J, 1995, TROP ZOOL, V8, P309, DOI 10.1080/03946975.1995.10539287; Yanoviak SP, 2005, NATURE, V433, P624, DOI 10.1038/nature03254	39	20	20	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e37683	10.1371/journal.pone.0037683	http://dx.doi.org/10.1371/journal.pone.0037683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737205	Green Published, gold, Green Submitted			2022-12-25	WOS:000305695100004
J	Jacquet, PO; Chambon, V; Borghi, AM; Tessari, A				Jacquet, Pierre O.; Chambon, Valerian; Borghi, Anna M.; Tessari, Alessia			Object Affordances Tune Observers' Prior Expectations about Tool-Use Behaviors	PLOS ONE			English	Article							LATERAL PREFRONTAL CORTEX; COGNITIVE CONTROL; MOTOR ACTIVATION; IMITATION; MEMORY; PERCEPTION; MECHANISMS; SELECTION; MODELS; GOALS	Learning about the function and use of tools through observation requires the ability to exploit one's own knowledge derived from past experience. It also depends on the detection of low-level local cues that are rooted in the tool's perceptual properties. Best known as 'affordances', these cues generate biomechanical priors that constrain the number of possible motor acts that are likely to be performed on tools. The contribution of these biomechanical priors to the learning of tool-use behaviors is well supported. However, it is not yet clear if, and how, affordances interact with higher-order expectations that are generated from past experience - i.e. probabilistic exposure - to enable observational learning of tool use. To address this question we designed an action observation task in which participants were required to infer, under various conditions of visual uncertainty, the intentions of a demonstrator performing tool-use behaviors. Both the probability of observing the demonstrator achieving a particular tool function and the biomechanical optimality of the observed movement were varied. We demonstrate that biomechanical priors modulate the extent to which participants' predictions are influenced by probabilistically-induced prior expectations. Biomechanical and probabilistic priors have a cumulative effect when they 'converge' (in the case of a probabilistic bias assigned to optimal behaviors), or a mutually inhibitory effect when they actively 'diverge' (in the case of probabilistic bias assigned to suboptimal behaviors).	[Jacquet, Pierre O.; Borghi, Anna M.; Tessari, Alessia] Univ Bologna, Dept Psychol, Bologna, Italy; [Jacquet, Pierre O.] ImpAct Team, Lyon Neurosci Res Ctr, Ctr Natl Rech Sci UMR 5292, Inst Natl Sante & Rech Med Unite 1028, Bron, France; [Chambon, Valerian] Univ Lyon, Ctr Neurosci Cognit, UMR 5229, Ctr Natl Rech Sci, Bron, France; [Borghi, Anna M.] CNR, Inst Cognit Sci & Technol, Rome, Italy	University of Bologna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Jacquet, PO (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	pierre.jacquet3@unibo.it	Chambon, Valerian/AAF-5482-2019; Jacquet, Pierre/GXF-8514-2022; Tessari, Alessia/K-3457-2013	Chambon, Valerian/0000-0002-2401-1906; Tessari, Alessia/0000-0002-6616-2454; Borghi, Anna M./0000-0001-9455-8408	European Commission [216125]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the FP7 project ROSSI, Emergence of communication in RObots through Sensorimotor and Social Interaction, European Commission grant agreement no. 216125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2012, CURR ZOOL, V58, P307, DOI 10.1093/czoolo/58.2.307; Acerbi A, 2011, LEARN BEHAV, V39, P104, DOI 10.3758/s13420-010-0009-z; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Barbalat G, 2011, BIOL PSYCHIAT, V70, P73, DOI 10.1016/j.biopsych.2011.02.009; Barbalat G, 2009, ARCH GEN PSYCHIAT, V66, P377, DOI 10.1001/archgenpsychiatry.2009.10; Borghi AM, 2007, NEUROSCI LETT, V411, P17, DOI 10.1016/j.neulet.2006.10.003; Buchsbaum D, 2011, COGNITION, V120, P331, DOI 10.1016/j.cognition.2010.12.001; Casler K, 2007, COGNITION, V103, P120, DOI 10.1016/j.cognition.2006.02.006; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Chambon V, 2011, BRAIN, V134, P3725, DOI 10.1093/brain/awr306; Chambon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017133; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Claidiere N, 2010, P R SOC B, V277, P651, DOI 10.1098/rspb.2009.1615; Clark A, 1998, BEING THERE PUTTING; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Csibra G, 2007, ACTA PSYCHOL, V124, P60, DOI 10.1016/j.actpsy.2006.09.007; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; DENNETT DC, 1982, THOUGHT OBJECT, P1; DESMURGET M, 1995, J NEUROPHYSIOL, V74, P905, DOI 10.1152/jn.1995.74.2.905; Ellis R, 2000, BRIT J PSYCHOL, V91, P451, DOI 10.1348/000712600161934; Franz M, 2010, P ROY SOC B-BIOL SCI, V277, P3363, DOI 10.1098/rspb.2010.0705; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Gergely G, 2007, INNATE MIND, V3, P170; Gibson JJ, 1979, ECOLOGICAL APPROACH; Gregory R.L., 1981, MIND SCI HIST EXPLAN; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Griffiths TL, 2008, CAMB HANDB PSYCHOL, P59; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Hernik M, 2009, CURR OPIN NEUROBIOL, V19, P34, DOI 10.1016/j.conb.2009.05.003; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jacquet PO, 2012, BEHAV BRAIN IN PRESS; Johnson-Frey SH, 2003, NEURON, V39, P201, DOI 10.1016/S0896-6273(03)00424-0; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Norman D., 1988, PSYCHOL EVERYDAY THI; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Osiurak F, 2010, PSYCHOL REV, V117, P517, DOI 10.1037/a0019004; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; Rosenbaum DA, 1996, ACTA PSYCHOL, V94, P59, DOI 10.1016/0001-6918(95)00062-3; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; Seed A, 2010, CURR BIOL, V20, pR1032, DOI 10.1016/j.cub.2010.09.042; Southgate V, 2008, COGNITION, V107, P1059, DOI 10.1016/j.cognition.2007.10.002; Southgate V, 2010, PSYCHOL SCI, V21, P355, DOI 10.1177/0956797610362058; Southgate V, 2009, BIOL LETTERS, V5, P769, DOI 10.1098/rsbl.2009.0474; St Amant R, 2008, ANIM BEHAV, V75, P1199, DOI 10.1016/j.anbehav.2007.09.028; Stefan K, 2008, EUR J NEUROSCI, V27, P730, DOI 10.1111/j.1460-9568.2008.06035.x; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Sterelny K, 2003, INNATE MIND, V2, P218; Sterelny K, 2003, THOUGHT HOSTILE WORL; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tessari A, 2006, EXP BRAIN RES, V173, P507, DOI 10.1007/s00221-006-0395-9; Vaesen K, 2012, BEHAV BRAIN IN PRESS; Weiss DJ, 2007, PSYCHOL SCI, V18, P1063, DOI 10.1111/j.1467-9280.2007.02026.x; World Medical Association, 2008, WORLD MED ASS DECL H	60	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39629	10.1371/journal.pone.0039629	http://dx.doi.org/10.1371/journal.pone.0039629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KY	22737249	Green Published, gold, Green Submitted			2022-12-25	WOS:000305695100048
J	Boudjeltia, KZ; Daher, J; Van Antwerpen, P; Moguilevsky, N; Delree, P; Ducobu, J; Raes, M; Badran, B; Vanhaeverbeek, M; Brohee, D; Remacle, C; Vanhamme, L				Boudjeltia, Karim Zouaoui; Daher, Jalil; Van Antwerpen, Pierre; Moguilevsky, Nicole; Delree, Paul; Ducobu, Jean; Raes, Martine; Badran, Bassam; Vanhaeverbeek, Michel; Brohee, Dany; Remacle, Claude; Vanhamme, Luc			Exposure of Endothelial Cells to Physiological Levels of Myeloperoxidase-Modified LDL Delays Pericellular Fibrinolysis	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; LOW-DENSITY-LIPOPROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; CARDIOVASCULAR RISK; GENE-EXPRESSION; RECEPTOR LOX-1; OXIDIZED LDL; LINE; ASSOCIATION; MECHANISMS	Background: Blood fluidity is maintained by a delicate balance between coagulation and fibrinolysis. The endothelial cell surface is a key player in this equilibrium and cell surface disruptions can upset the balance. We investigated the role of pericellular myeloperoxidase oxidized LDLs (Mox-LDLs) in this balance. Methods and Results: We designed a technical device that enabled us to monitor fibrinolysis in real-time at the surface of an endothelial cell line (EA.hy926), and showed that Mox-LDL decreased pericellular fibrinolysis. There were no changes in fibrinolysis when EA.hy926 endothelial cells were exposed to native LDL (24 hours) at doses of 10, 50, 100 and up to 1250 mu g/ml. However, treatment of EA.hy926 endothelial cells with 10 and 50 mg/ml of Mox-LDL (physiological serum concentrations) increased the lysis time by 15 and 13%, respectively (p<0.001), although this effect was not present at higher concentrations of 100 mg/ml. This effect was not correlated with any changes in PAI-1 or t-PA or PA Receptor (PAR) expression. No effect was observed at the surface of smooth muscle cells used as controls. Conclusion: Our data link the current favorite hypothesis that modified LDL has a causal role in atheroma plaque formation with an old suggestion that fibrin may also play a causal role. Our data help complete the paradigm of atherosclerosis: Modified LDL locally enhances fibrin deposition (present work); fibrin deposits enhance endothelial permeability; this effect allows subendothelial accumulation of lipid and foam cells.	[Boudjeltia, Karim Zouaoui; Ducobu, Jean; Vanhaeverbeek, Michel; Brohee, Dany] Univ Libre Bruxelles, Unit 222, CHU Charleroi, Expt Med Lab, A Vesale, Montigny Le Til, Belgium; [Daher, Jalil; Vanhamme, Luc] Univ Libre Bruxelles, Mol Parasitol Lab, IBMM, Fac Sci, Gosselies, Belgium; [Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem, Brussels, Belgium; [Moguilevsky, Nicole] Fac Univ Notre Dame Paix, Technol Transfer Off, B-5000 Namur, Belgium; [Delree, Paul] Pathol & Genet Inst, Gosselies, Belgium; [Raes, Martine] Fac Univ Notre Dame Paix, Lab Biochem & Cellular Biol, B-5000 Namur, Belgium; [Daher, Jalil; Badran, Bassam] Lebanese Univ, Fac Sci, Immunol Lab, Dept Biochem, Hadath Beirut, Lebanon; [Remacle, Claude] Catholic Univ Louvain, Lab Cellular Biol, Inst Life Sci, B-1348 Louvain, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Namur; University of Namur; Lebanese University; Universite Catholique Louvain	Boudjeltia, KZ (corresponding author), Univ Libre Bruxelles, Unit 222, CHU Charleroi, Expt Med Lab, A Vesale, Montigny Le Til, Belgium.	karim.zouaoui@chu-charleroi.be		Van Antwerpen, Pierre/0000-0002-4934-8863	Intercommunale de Sante Publique du Pays de Charleroi; Institut de Recherche en Pathologie et Genetique Gosselies	Intercommunale de Sante Publique du Pays de Charleroi; Institut de Recherche en Pathologie et Genetique Gosselies	LV is Research Director at the Belgian National Fund for scientific research. This work was supported by a grant from the Intercommunale de Sante Publique du Pays de Charleroi and Institut de Recherche en Pathologie et Genetique Gosselies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 1999, J MOL CELL CARDIOL, V31, P2101, DOI 10.1006/jmcc.1999.1041; Astrup T, 1956, LANCET, V2, P525; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; BERETZ A, 1989, BIOCHEM J, V259, P35, DOI 10.1042/bj2590035; Boudjeltia K Zouaoui, 2002, BMC Biotechnol, V2, P8, DOI 10.1186/1472-6750-2-8; Boudjeltia KZ, 2006, EUR J INTERN MED, V17, P102, DOI 10.1016/j.ejim.2005.11.002; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Carr AC, 2000, FEBS LETT, V487, P176, DOI 10.1016/S0014-5793(00)02227-4; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Cines DB, 1998, BLOOD, V91, P3527; DANG CV, 1985, SCIENCE, V227, P1487, DOI 10.1126/science.4038818; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; EDGELL CJS, 1990, IN VITRO CELL DEV B, V26, P1167; Ellis V, 1997, BLOOD, V90, P2312, DOI 10.1182/blood.V90.6.2312.2312_2312_2322; EMEIS JJ, 1988, BLOOD, V71, P1669; Fukao H, 1997, BIOCHIM BIOPHYS ACTA, V1536, P111; Grosjean A, 2005, CRIT CARE S1, pP155; HAJJAR KA, 1994, J CLIN INVEST, V93, P703, DOI 10.1172/JCI117023; HAJJAR KA, 1995, THROMB HAEMOSTASIS, V74, P294; Handt S, 1996, BLOOD, V87, P4204, DOI 10.1182/blood.V87.10.4204.bloodjournal87104204; Hoshikawa H, 1998, BIOCHEM BIOPH RES CO, V245, P841, DOI 10.1006/bbrc.1998.8526; Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062; Malle E, 2000, EUR J BIOCHEM, V267, P4495, DOI 10.1046/j.1432-1327.2000.01498.x; Mayerl C, 2006, VIRCHOWS ARCH, V449, P96, DOI 10.1007/s00428-006-0176-7; Mazzolai L, 2002, THROMB HAEMOSTASIS, V87, P1062; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Moguilevsky N, 2004, BIOCHEM BIOPH RES CO, V323, P1223, DOI 10.1016/j.bbrc.2004.08.220; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nagase M, 1998, J BIOL CHEM, V273, P33702, DOI 10.1074/jbc.273.50.33702; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Pahor M, 1999, ARCH INTERN MED, V159, P237, DOI 10.1001/archinte.159.3.237; Qi JF, 1997, BLOOD, V90, P3595, DOI 10.1182/blood.V90.9.3595; QI JF, 1995, J IMMUNOL, V155, P867; RIEBER AJ, 1993, THROMB HAEMOSTASIS, V69, P476; SALOMAA V, 1995, CIRCULATION, V91, P284, DOI 10.1161/01.CIR.91.2.284; Sanchez MC, 2001, ARCH BIOCHEM BIOPHYS, V389, P218, DOI 10.1006/abbi.2001.2329; SCHLEEF RR, 1984, ARTERIOSCLEROSIS, V4, P14, DOI 10.1161/01.ATV.4.1.14; SOBEL MI, 1995, AM J OBSTET GYNECOL, V173, P801, DOI 10.1016/0002-9378(95)90344-5; Sueishi K, 1998, SEMIN THROMB HEMOST, V24, P255, DOI 10.1055/s-2007-995851; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; URANO T, 1990, THROMB HAEMOSTASIS, V63, P82; William KJ, 1995, THROMB VASC BIOL, V15, P551; Woolf N, 1978, Adv Exp Med Biol, V104, P145; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38810	10.1371/journal.pone.0038810	http://dx.doi.org/10.1371/journal.pone.0038810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723891	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700032
J	el Azzouzi, H; Leptidis, S; Bourajjaj, M; van Bilsen, M; Martins, PAD; De Windt, LJ				el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; van Bilsen, Marc; Martins, Paula A. da Costa; De Windt, Leon J.			MEK1 Inhibits Cardiac PPAR alpha Activity by Direct Interaction and Prevents Its Nuclear Localization	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; CHRONIC PRESSURE-OVERLOAD; INDUCED HEART-FAILURE; HYPERTROPHIC GROWTH; GENE-EXPRESSION; CALCINEURIN; PROLIFERATION; METABOLISM; GAMMA; PHOSPHORYLATION	Background: The response of the postnatal heart to growth and stress stimuli includes activation of a network of signal transduction cascades, including the stress activated protein kinases such as p38 mitogen-activated protein kinase (MAPK), c-Jun NH2-terminal kinase (JNK) and the extracellular signal-regulated kinase (ERK1/2) pathways. In response to increased workload, the mitogen-activated protein kinase kinase (MAPKK) MEK1 has been shown to be active. Studies embarking on mitogen-activated protein kinase (MAPK) signaling cascades in the heart have indicated peroxisome-proliferators activated-receptors (PPARs) as downstream effectors that can be regulated by this signaling cascade. Despite the importance of PPAR alpha in controlling cardiac metabolism, little is known about the relationship between MAPK signaling and cardiac PPAR alpha signaling. Methodology/Principal Finding: Using co-immunoprecipitation and immunofluorescence approaches we show a complex formation of PPAR alpha with MEK1 and not with ERK1/2. Binding of PPAR alpha to MEK1 is mediated via a LXXLL motif and results in translocation from the nucleus towards the cytoplasm, hereby disabling the transcriptional activity of PPAR alpha. Mice subjected to voluntary running-wheel exercise showed increased cardiac MEK1 activation and complex formation with PPAR alpha, subsequently resulting in reduced PPAR alpha activity. Inhibition of MEK1, using U0126, blunted this effect. Conclusion: Here we show that activation of the MEK1-ERK1/2 pathway leads to specific inhibition of PPAR alpha transcriptional activity. Furthermore we show that this inhibitory effect is mediated by MEK1, and not by its downstream effector kinase ERK1/2, through a mechanism involving direct binding to PPAR alpha and subsequent stimulation of PPAR alpha export from the nucleus.	[el Azzouzi, Hamid; Leptidis, Stefanos; Bourajjaj, Meriem; Martins, Paula A. da Costa] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [el Azzouzi, Hamid; Leptidis, Stefanos; Martins, Paula A. da Costa; De Windt, Leon J.] Maastricht Univ, Dept Cardiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [van Bilsen, Marc] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Maastricht University; Maastricht University	el Azzouzi, H (corresponding author), Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands.	l.dewindt@maastrichtuniversity.nl	de Windt, Leon/AAO-6395-2020; van Bilsen, Marc/E-8342-2016; Leptidis, Stefanos/D-1455-2016	de Windt, Leon/0000-0002-7793-2856; Leptidis, Stefanos/0000-0003-0172-4193; el Azzouzi, Hamid/0000-0003-1242-9691	Netherlands Organization for Health Research and Development (ZonMW) [912-04-054, 912-04-017]; VIDI from The Netherlands Organization for Health Research and Development (ZonMW) [917-863-72]; Netherlands Heart Foundation [NHS2007B167]; European Union [LSHM-CT-2005-018833/EUGeneHeart]; Fondation Leducq Transatlantic Network of Excellence [08-CVD-03]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); VIDI from The Netherlands Organization for Health Research and Development (ZonMW); Netherlands Heart Foundation(Netherlands Heart Foundation); European Union(European Commission); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation)	This work was supported by grants 912-04-054, 912-04-017 and a VIDI award 917-863-72 from The Netherlands Organization for Health Research and Development (ZonMW); The Netherlands Heart Foundation grant NHS2007B167; the European Union Contract No. LSHM-CT-2005-018833/EUGeneHeart; and the Fondation Leducq Transatlantic Network of Excellence program 08-CVD-03 (to LDW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Badrian B, 2007, INT J BIOCHEM CELL B, V39, P349, DOI 10.1016/j.biocel.2006.09.002; Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Burgermeister E, 2003, J BIOMOL STRUCT DYN, V20, P623, DOI 10.1080/07391102.2003.10506879; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Finck BN, 2002, J MOL CELL CARDIOL, V34, P1249, DOI 10.1006/jmcc.2002.2061; Francis Gary S, 2003, Rev Cardiovasc Med, V4 Suppl 2, pS14; Gelinas R, 2008, AM J PHYSIOL-HEART C, V294, pH1571, DOI 10.1152/ajpheart.01340.2007; Hi R, 1999, J BIOL CHEM, V274, P35152, DOI 10.1074/jbc.274.49.35152; Iemitsu M, 2006, J APPL PHYSIOL, V101, P151, DOI 10.1152/japplphysiol.00392.2005; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Luptak I, 2005, CIRCULATION, V112, P2339, DOI 10.1161/CIRCULATIONAHA.105.534594; Marenda DR, 2006, DEVELOPMENT, V133, P43, DOI 10.1242/dev.02168; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Rybkin II, 2003, J BIOL CHEM, V278, P15927, DOI 10.1074/jbc.M213102200; Sack MN, 1997, P NATL ACAD SCI USA, V94, P6438, DOI 10.1073/pnas.94.12.6438; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Smeets PJH, 2008, PHYSIOL GENOMICS, V36, P15, DOI 10.1152/physiolgenomics.90296.2008; Sugden PH, 1999, CIRC RES, V84, P633, DOI 10.1161/01.RES.84.6.633; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Tolwinski NS, 1999, J BIOL CHEM, V274, P6168, DOI 10.1074/jbc.274.10.6168; van Empel VPM, 2006, J AM COLL CARDIOL, V48, P824, DOI 10.1016/j.jacc.2006.02.075; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e36799	10.1371/journal.pone.0036799	http://dx.doi.org/10.1371/journal.pone.0036799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723831	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700001
J	George, I; Cousillas, H; Richard, JP; Hausberger, M				George, Isabelle; Cousillas, Hugo; Richard, Jean-Pierre; Hausberger, Martine			Experience with Adults Shapes Multisensory Representation of Social Familiarity in the Brain of a Songbird	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; CENTRAL AUDITORY AREA; MALE ZEBRA FINCHES; BIRDS OWN SONG; NEURAL RESPONSE; EQUUS-CABALLUS; RECOGNITION; FOREBRAIN; SPEECH; FACES	Social animals learn to perceive their social environment, and their social skills and preferences are thought to emerge from greater exposure to and hence familiarity with some social signals rather than others. Familiarity appears to be tightly linked to multisensory integration. The ability to differentiate and categorize familiar and unfamiliar individuals and to build a multisensory representation of known individuals emerges from successive social interactions, in particular with adult, experienced models. In different species, adults have been shown to shape the social behavior of young by promoting selective attention to multisensory cues. The question of what representation of known conspecifics adult-deprived animals may build therefore arises. Here we show that starlings raised with no experience with adults fail to develop a multisensory representation of familiar and unfamiliar starlings. Electrophysiological recordings of neuronal activity throughout the primary auditory area of these birds, while they were exposed to audio-only or audiovisual familiar and unfamiliar cues, showed that visual stimuli did, as in wild-caught starlings, modulate auditory responses but that, unlike what was observed in wild-caught birds, this modulation was not influenced by familiarity. Thus, adult-deprived starlings seem to fail to discriminate between familiar and unfamiliar individuals. This suggests that adults may shape multisensory representation of known individuals in the brain, possibly by focusing the young's attention on relevant, multisensory cues. Multisensory stimulation by experienced, adult models may thus be ubiquitously important for the development of social skills (and of the neural properties underlying such skills) in a variety of species.	[George, Isabelle; Cousillas, Hugo; Richard, Jean-Pierre; Hausberger, Martine] Univ Rennes 1, CNRS, UMR6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	George, I (corresponding author), Univ Rennes 1, CNRS, UMR6552, Rennes, France.	Isabelle.George@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French ANR; University of Rennes 1; French CNRS	French ANR(French National Research Agency (ANR)); University of Rennes 1; French CNRS(Centre National de la Recherche Scientifique (CNRS))	This study has been supported by a grant of the French ANR entitled "Intermodality and imitation: behavioral and neuronal aspects (studies in human newborns and birds)'' (INTERIMIT). I.G., J.P.R., H.C. and M.H. were supported by the University of Rennes 1 and the French CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; Bertin A, 2009, J COMP PSYCHOL, V123, P195, DOI 10.1037/a0014050; BISCHOF HJ, 1985, BRAIN RES, V326, P370, DOI 10.1016/0006-8993(85)90048-4; Bolhuis JJ, 1999, ANIM BEHAV, V58, P1285, DOI 10.1006/anbe.1999.1266; Bourjade M, 2008, DEV PSYCHOBIOL, V50, P408, DOI 10.1002/dev.20301; Bourjade M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004888; Bovet D, 2000, BEHAV BRAIN RES, V109, P143, DOI 10.1016/S0166-4328(00)00146-7; Capsius B, 1999, HEARING RES, V136, P91, DOI 10.1016/S0378-5955(99)00112-4; Coulon M, 2011, INT J BEHAV DEV, V35, P282, DOI 10.1177/0165025410396765; Cousillas H, 2005, HEARING RES, V207, P10, DOI 10.1016/j.heares.2005.01.008; Cousillas H, 2006, NATURWISSENSCHAFTEN, V93, P588, DOI 10.1007/s00114-006-0148-4; Cousillas H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002194; Gentner TQ, 2004, ANN NY ACAD SCI, V1016, P282, DOI 10.1196/annals.1298.008; George I, 2005, NEUROSCIENCE, V136, P1, DOI 10.1016/j.neuroscience.2005.08.001; George I, 2003, J NEUROSCI METH, V125, P65, DOI 10.1016/S0165-0270(03)00025-6; George Isabelle, 2011, Frontiers in Behavioral Neuroscience, V4, P1, DOI 10.3389/fnbeh.2010.00193; George I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014347; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Green DM, 1966, SIGNAL DETECTION THE; Guellai B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018610; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Henry L, 1998, REV ECOL-TERRE VIE, V53, P347; Hernandez AM, 2004, J NEUROBIOL, V59, P247, DOI 10.1002/neu.10312; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Ikebuchi M, 1999, ZOOL SCI, V16, P63, DOI 10.2108/zsj.16.63; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; Lemasson A, 2005, APPL ANIM BEHAV SCI, V91, P289, DOI 10.1016/j.applanim.2004.10.011; Martinez L, 2009, ANIM COGN, V12, pS71, DOI 10.1007/s10071-009-0269-1; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Munhall KG, 1996, PERCEPT PSYCHOPHYS, V58, P351, DOI 10.3758/BF03206811; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Sankey C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018331; Setti A, 2011, NEUROSCI LETT, V492, P19, DOI 10.1016/j.neulet.2011.01.042; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; Solis MM, 1999, J NEUROSCI, V19, P4559; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Vatakis A, 2006, BRAIN RES, V1111, P134, DOI 10.1016/j.brainres.2006.05.078; Watanabe S, 2010, BEHAV BRAIN RES, V207, P61, DOI 10.1016/j.bbr.2009.09.041; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0	46	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38764	10.1371/journal.pone.0038764	http://dx.doi.org/10.1371/journal.pone.0038764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723887	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700030
J	Hashimoto, Y; Tazawa, H; Teraishi, F; Kojima, T; Watanabe, Y; Uno, F; Yano, S; Urata, Y; Kagawa, S; Fujiwara, T				Hashimoto, Yuuri; Tazawa, Hiroshi; Teraishi, Fuminori; Kojima, Toru; Watanabe, Yuichi; Uno, Futoshi; Yano, Shuya; Urata, Yasuo; Kagawa, Shunsuke; Fujiwara, Toshiyoshi			The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment	PLOS ONE			English	Article							REPLICATION-SELECTIVE VIROTHERAPY; INDUCIBLE FACTOR-I; CANCER STEM-CELLS; TUMOR HYPOXIA; HEPATOCELLULAR CARCINOMAS; DOWN-REGULATION; UP-REGULATION; TELOMERASE; RECEPTOR; EXPRESSION	Hypoxia is a microenvironmental factor that contributes to the invasion, progression and metastasis of tumor cells. Hypoxic tumor cells often show more resistance to conventional chemoradiotherapy than normoxic tumor cells, suggesting the requirement of novel antitumor therapies to efficiently eliminate the hypoxic tumor cells. We previously generated a tumor-specific replication-competent oncolytic adenovirus (OBP-301: Telomelysin), in which the human telomerase reverse transcriptase (hTERT) promoter drives viral E1 expression. Since the promoter activity of the hTERT gene has been shown to be upregulated by hypoxia, we hypothesized that, under hypoxic conditions, the antitumor effect of OBP-301 with the hTERT promoter would be more efficient than that of the wild-type adenovirus 5 (Ad5). In this study, we investigated the antitumor effects of OBP-301 and Ad5 against human cancer cells under a normoxic (20% oxygen) or a hypoxic (1% oxygen) condition. Hypoxic condition induced nuclear accumulation of the hypoxia-inducible factor-1 alpha and upregulation of hTERT promoter activity in human cancer cells. The cytopathic activity of OBP-301 was significantly higher than that of Ad5 under hypoxic condition. Consistent with their cytopathic activity, the replication of OBP-301 was significantly higher than that of Ad5 under the hypoxic condition. OBP-301-mediated E1A was expressed within hypoxic areas of human xenograft tumors in mice. These results suggest that the cytopathic activity of OBP-301 against hypoxic tumor cells is mediated through hypoxia-mediated activation of the hTERT promoter. Regulation of oncolytic adenoviruses by the hTERT promoter is a promising antitumor strategy, not only for induction of tumor-specific oncolysis, but also for efficient elimination of hypoxic tumor cells.	[Hashimoto, Yuuri; Tazawa, Hiroshi; Teraishi, Fuminori; Kojima, Toru; Watanabe, Yuichi; Uno, Futoshi; Yano, Shuya; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama, Japan; [Tazawa, Hiroshi] Okayama Univ Hosp, Ctr Gene & Cell Therapy, Okayama, Japan; [Urata, Yasuo] Oncolys BioPharma Inc, Tokyo, Japan	Okayama University; Okayama University; Oncolys BioPharma	Hashimoto, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama, Japan.	toshi_f@md.okayama-u.ac.jp	TAZAWA, Hiroshi/B-2247-2011; Yano, Shuya/AAL-8028-2020; Kagawa, Shunsuke/B-2189-2011	TAZAWA, Hiroshi/0000-0003-4658-1050; Kagawa, Shunsuke/0000-0002-3610-8211	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to TF and FT, http://www.mext.go.jp/english/) and by grants from the Ministry of Health, Labour and Welfare of Japan (to TF, http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Bauerschmitz GJ, 2008, CANCER RES, V68, P5533, DOI 10.1158/0008-5472.CAN-07-5288; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Castelo-Branco P, 2011, CLIN CANCER RES, V17, P111, DOI 10.1158/1078-0432.CCR-10-2075; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; Eriksson M, 2007, MOL THER, V15, P2088, DOI 10.1038/sj.mt.6300300; Guo ZS., 2011, VIRUS ADAPT TREAT, V3, P71, DOI DOI 10.2147/VAAT.S17832; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Hashimoto Y, 2008, CANCER SCI, V99, P385, DOI 10.1111/j.1349-7006.2007.00665.x; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hernandez-Alcoceba R, 2002, HUM GENE THER, V13, P1737, DOI 10.1089/104303402760293574; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kawashima T, 2004, CLIN CANCER RES, V10, P285, DOI 10.1158/1078-0432.CCR-1075-3; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Kuster K, 2010, CANCER GENE THER, V17, P141, DOI 10.1038/cgt.2009.49; Kwon OJ, 2010, CLIN CANCER RES, V16, P6071, DOI 10.1158/1078-0432.CCR-10-0664; Lacher MD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-91; Lacher MD, 2006, CANCER RES, V66, P1648, DOI 10.1158/0008-5472.CAN-05-2328; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Niu JX, 2007, EUR J CANCER PREV, V16, P517, DOI 10.1097/CEJ.0b013e3280145c00; Pipiya T, 2005, GENE THER, V12, P911, DOI 10.1038/sj.gt.3302459; Post DE, 2003, ONCOGENE, V22, P2065, DOI 10.1038/sj.onc.1206464; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; Shen BH, 2005, GENE THER, V12, P902, DOI 10.1038/sj.gt.3302448; Short JJ, 2009, MOL CANCER THER, V8, P2096, DOI 10.1158/1535-7163.MCT-09-0367; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Umeoka T, 2004, CANCER RES, V64, P6259, DOI 10.1158/0008-5472.CAN-04-1335; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yatabe N, 2004, ONCOGENE, V23, P3708, DOI 10.1038/sj.onc.1207460; Yoo YG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002072; Zhang XC, 2008, CLIN CANCER RES, V14, P2813, DOI 10.1158/1078-0432.CCR-07-1528	46	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39292	10.1371/journal.pone.0039292	http://dx.doi.org/10.1371/journal.pone.0039292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720091	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350000057
J	Chen, YZ; Chen, Z; Gong, YA; Ying, GG				Chen, Yong-Zi; Chen, Zhen; Gong, Yu-Ai; Ying, Guoguang			SUMOhydro: A Novel Method for the Prediction of Sumoylation Sites Based on Hydrophobic Properties	PLOS ONE			English	Article							AMINO-ACID PAIRS; RNA-BINDING SITES; PROTEIN SEQUENCES; WEB SERVER; PSI-BLAST; SUMO; INFORMATION; COLLOCATION; PLANTS; MOTIF	Sumoylation is one of the most essential mechanisms of reversible protein post-translational modifications and is a crucial biochemical process in the regulation of a variety of important biological functions. Sumoylation is also closely involved in various human diseases. The accurate computational identification of sumoylation sites in protein sequences aids in experimental design and mechanistic research in cellular biology. In this study, we introduced amino acid hydrophobicity as a parameter into a traditional binary encoding scheme and developed a novel sumoylation site prediction tool termed SUMOhydro. With the assistance of a support vector machine, the proposed method was trained and tested using a stringent non-redundant sumoylation dataset. In a leave-one-out cross-validation, the proposed method yielded an excellent performance with a correlation coefficient, specificity, sensitivity and accuracy equal to 0.690, 98.6%, 71.1% and 97.5%, respectively. In addition, SUMOhydro has been benchmarked against previously described predictors based on an independent dataset, thereby suggesting that the introduction of hydrophobicity as an additional parameter could assist in the prediction of sumoylation sites. Currently, SUMOhydro is freely accessible at http://protein.cau.edu.cn/others/SUMOhydro/.	[Chen, Yong-Zi; Gong, Yu-Ai; Ying, Guoguang] Tianjin Med Univ, Canc Inst & Hosp Tianjin, Canc Cell Biol Lab, Tianjin, Peoples R China; [Chen, Yong-Zi; Gong, Yu-Ai; Ying, Guoguang] Tianjin Municipal Sci & Technol Commiss, Tianjin Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Chen, Zhen] China Agr Univ, Coll Biol Sci, Bioinformat Ctr, Beijing 100094, Peoples R China	Tianjin Medical University; China Agricultural University	Chen, YZ (corresponding author), Tianjin Med Univ, Canc Inst & Hosp Tianjin, Canc Cell Biol Lab, Tianjin, Peoples R China.	yingguoguang@gmail.com		chen, yongzi/0000-0003-3396-7130; Chen, Zhen/0000-0002-9412-9774	National Basic Research Program of China [2010CB529403, 2011CB933100]; Tianjin TSTC [09ZCZDSF04300]; National Nature Science Foundation of China [NSFC30772528, NSFC81072158]; National Program for Changjiang Scholars and Innovative Research Team in University [IRT1076, IRT0743]	National Basic Research Program of China(National Basic Research Program of China); Tianjin TSTC; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Basic Research Program of China 2010CB529403, 2011CB933100, the Tianjin TSTC grant 09ZCZDSF04300, the National Nature Science Foundation of China NSFC30772528, NSFC81072158, and the National Program for Changjiang Scholars and Innovative Research Team in University IRT1076, IRT0743. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Gao JJ, 2009, LECT N BIOINFORMAT, V5462, P18; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayat M, 2011, J THEOR BIOL; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Miura K, 2007, CURR OPIN PLANT BIOL, V10, P495, DOI 10.1016/j.pbi.2007.07.002; Moschos SJ, 2006, J MOL HISTOL, V37, P309, DOI 10.1007/s10735-006-9030-0; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Song JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-124; Teng S, 2011, AMINO ACIDS; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang T, 2010, PROTEIN PEPTIDE LETT, V17, P32, DOI 10.2174/092986610789909494; Xu JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-8; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yan RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-416; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	35	45	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39195	10.1371/journal.pone.0039195	http://dx.doi.org/10.1371/journal.pone.0039195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720073	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347800055
J	Imai, S; Mamiya, T; Tsukada, A; Sakai, Y; Mouri, A; Nabeshima, T; Ebihara, S				Imai, Saki; Mamiya, Takayoshi; Tsukada, Akira; Sakai, Yasuyuki; Mouri, Akihiro; Nabeshima, Toshitaka; Ebihara, Shizufumi			Ubiquitin-Specific Peptidase 46 (Usp46) Regulates Mouse Immobile Behavior in the Tail Suspension Test through the GABAergic System	PLOS ONE			English	Article							TRAIT LOCUS ANALYSIS; CS MICE; RECEPTORS; DEPRESSION; MODEL; DESPAIR; RHYTHM; SLEEP	The tail suspension test (TST) is widely recognized as a useful experimental paradigm for assessing antidepressant activity and depression-like behavior. We have previously identified ubiquitin-specific peptidase 46 (Usp46) as a quantitative trait gene responsible for decreasing immobility time in the TST in mice. This Usp46 mutation has a 3-bp deletion coding for lysine in the open reading frame, and we indicated that Usp46 is implicated in the regulation of the GABAergic system. However, it is not known precisely how the immobile behavior is regulated by the GABAergic system. Therefore, in the present study, we examined whether the immobility time is influenced by drugs affecting the action mediated by GABA(A) receptor using both 3-bp deleted (the Usp46 mutant) and null Usp46 (Usp46 KO) mice. Nitrazepam, an agonist at the benzodiazepine-binding site of the GABA(A) receptor, which potentiates the action of GABA, produced a dose-dependent increase in TST immobility time in the Usp46 mutant mice without affecting general behaviors. The Usp46 KO mice exhibited short immobility times comparable to the Usp46 mutant mice, which was also increased by nitrazepam administration. The effects of nitrazepam in the Usp46 mutant and KO mice were antagonized by flumazenil. These results indicate that the 3-bp deleted Usp46 mutation causes a loss-of-function phenotype, and that the GABAA receptor might participate in the regulation of TST immobility time.	[Imai, Saki; Sakai, Yasuyuki; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan; [Mamiya, Takayoshi; Mouri, Akihiro; Nabeshima, Toshitaka] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi, Japan; [Tsukada, Akira] Nagoya Univ, Grad Sch Bioagr Sci, Div Appl Genet & Physiol, Nagoya, Aichi 4648601, Japan	Nagoya University; Meijo University; Nagoya University	Imai, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan.	ebihara@agr.nagoya-u.ac.jp			Takeda Science Foundation; Life Science Foundation of Japan	Takeda Science Foundation(Takeda Science Foundation (TSF)); Life Science Foundation of Japan(Life Science Foundation of Japan)	This research was supported in part by a Grant-in-Aid for Scientific Research (A), Grant-in-Aid for challenging Exploratory Research, Takeda Science Foundation, Life Science Foundation of Japan to S.E., and Grant-in-Aid for JSPS Fellows to S. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1999, J COMP PHYSIOL A, V184, P243, DOI 10.1007/s003590050322; Abe H, 2007, AM J PHYSIOL-REG I, V292, pR607, DOI 10.1152/ajpregu.00331.2006; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; Ebihara S, 2003, BRAIN RES, V980, P121, DOI 10.1016/S0006-8993(03)02947-0; Fiorelli R, 2008, BEHAV PHARMACOL, V19, P582, DOI 10.1097/FBP.0b013e32830dc0c7; Kowalski JR, 2011, J NEUROSCI, V31, P1341, DOI 10.1523/JNEUROSCI.4765-10.2011; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; Liu XQ, 2007, BIOL PSYCHIAT, V62, P81, DOI 10.1016/j.biopsych.2006.08.017; Miller BH, 2010, MAMM GENOME, V21, P247, DOI 10.1007/s00335-010-9266-6; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stork O, 2000, BRAIN RES, V865, P45, DOI 10.1016/S0006-8993(00)02206-X; Suzuki T, 2001, MAMM GENOME, V12, P272, DOI 10.1007/s003350010280; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Vollenweider I, 2011, BEHAV BRAIN RES, V217, P77, DOI 10.1016/j.bbr.2010.10.009; VOTEY SR, 1991, ANN EMERG MED, V20, P181, DOI 10.1016/S0196-0644(05)81219-3; WAMBEBE C, 1985, BRIT J PHARMACOL, V84, P185; Yoshikawa T, 2002, GENOME RES, V12, P357, DOI 10.1101/gr.222602; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026297	21	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39084	10.1371/journal.pone.0039084	http://dx.doi.org/10.1371/journal.pone.0039084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720038	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800043
J	Ke, W; Laurent, AH; Armstrong, MD; Chen, YC; Smith, WE; Liang, J; Wright, CM; Ostermeier, M; van den Akker, F				Ke, Wei; Laurent, Abigail H.; Armstrong, Morgan D.; Chen, Yuchao; Smith, William E.; Liang, Jing; Wright, Chapman M.; Ostermeier, Marc; van den Akker, Focco			Structure of an Engineered beta-Lactamase Maltose Binding Protein Fusion Protein: Insights into Heterotropic Allosteric Regulation	PLOS ONE			English	Article							DIRECTED EVOLUTION; UNRELATED PROTEINS; DOMAIN INSERTION; LIGAND-BINDING; ACTIVE-SITE; SWITCH; TEM1; CRYSTALLOGRAPHY; ANTITHROMBIN; LYSINE-234	Engineering novel allostery into existing proteins is a challenging endeavor to obtain novel sensors, therapeutic proteins, or modulate metabolic and cellular processes. The RG13 protein achieves such allostery by inserting a circularly permuted TEM-1 beta-lactamase gene into the maltose binding protein (MBP). RG13 is positively regulated by maltose yet is, serendipitously, inhibited by Zn2+ at low mu M concentration. To probe the structure and allostery of RG13, we crystallized RG13 in the presence of mM Zn2+ concentration and determined its structure. The structure reveals that the MBP and TEM-1 domains are in close proximity connected via two linkers and a zinc ion bridging both domains. By bridging both TEM-1 and MBP, Zn2+ acts to "twist tie'' the linkers thereby partially dislodging a linker between the two domains from its original catalytically productive position in TEM-1. This linker 1 contains residues normally part of the TEM-1 active site including the critical beta 3 and beta 4 strands important for activity. Mutagenesis of residues comprising the crystallographically observed Zn2+ site only slightly affected Zn2+ inhibition 2- to 4-fold. Combined with previous mutagenesis results we therefore hypothesize the presence of two or more inter-domain mutually exclusive inhibitory Zn2+ sites. Mutagenesis and molecular modeling of an intact TEM-1 domain near MBP within the RG13 framework indicated a close surface proximity of the two domains with maltose switching being critically dependent on MBP linker anchoring residues and linker length. Structural analysis indicated that the linker attachment sites on MBP are at a site that, upon maltose binding, harbors both the largest local C alpha distance changes and displays surface curvature changes, from concave to relatively flat becoming thus less sterically intrusive. Maltose activation and zinc inhibition of RG13 are hypothesized to have opposite effects on productive relaxation of the TEM-1 beta 3 linker region via steric and/or linker juxtapositioning mechanisms.	[Ke, Wei; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Laurent, Abigail H.; Armstrong, Morgan D.; Chen, Yuchao; Smith, William E.; Liang, Jing; Wright, Chapman M.; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Case Western Reserve University; Johns Hopkins University	Ke, W (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Ostermeier, Marc/A-2697-2010	Ostermeier, Marc/0000-0003-0900-3665	National Institutes of Health [R01 AI062968, R01 GM066972]; National Science Foundation [MCB 0919377]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0919377] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	FvdA is supported by National Institutes of Health (R01 AI062968). MO was supported by National Institutes of Health (R01 GM066972) and National Science Foundation (MCB 0919377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI H, 1991, J BIOL CHEM, V266, P3186; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Edwards WR, 2010, BIOCHEMISTRY-US, V49, P6541, DOI 10.1021/bi100793y; Edwards WR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn363; ELLERBY LM, 1990, BIOCHEMISTRY-US, V29, P5797, DOI 10.1021/bi00476a022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraz RM, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-15; Greene AC, 2008, BIOTECHNOL BIOENG, V101, P478, DOI 10.1002/bit.21927; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Guntas G, 2004, CHEM BIOL, V11, P1483, DOI 10.1016/j.chembiol.2004.08.020; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Helfand MS, 2002, J BIOL CHEM, V277, P47719, DOI 10.1074/jbc.M207271200; HIGAKI JN, 1990, BIOCHEMISTRY-US, V29, P8582, DOI 10.1021/bi00489a012; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Kim JR, 2006, ARCH BIOCHEM BIOPHYS, V446, P44, DOI 10.1016/j.abb.2005.11.014; Koide S, 2009, CURR OPIN BIOTECH, V20, P398, DOI 10.1016/j.copbio.2009.07.007; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LENFANT F, 1991, J BIOL CHEM, V266, P17187; Liang J, 2007, PROTEIN SCI, V16, P929, DOI 10.1110/ps.062706007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Sampson JM, 2011, ANTIMICROB AGENTS CH; SAVES I, 1995, BIOCHEMISTRY-US, V34, P11660, DOI 10.1021/bi00037a003; Schmidt AM, 1996, CHEM BIOL, V3, P645, DOI 10.1016/S1074-5521(96)90132-5; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Suetomi K, 2002, J BIOL CHEM, V277, P31563, DOI 10.1074/jbc.M204713200; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Telmer PG, 2005, J MOL BIOL, V354, P829, DOI 10.1016/j.jmb.2005.10.016; Thomson JM, 2006, J BIOL CHEM, V281, P26734, DOI 10.1074/jbc.M603222200; Totir MA, 2006, BIOCHEMISTRY-US, V45, P11895, DOI 10.1021/bi060990m; van den Akker F, 1999, ACTA CRYSTALLOGR D, V55, P206, DOI 10.1107/S0907444998007161; Wright CM, 2010, PROTEINS, V78, P1423, DOI 10.1002/prot.22657	37	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39168	10.1371/journal.pone.0039168	http://dx.doi.org/10.1371/journal.pone.0039168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720063	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800051
J	de Azua, IR; Nakajima, KI; Rossi, M; Cui, YH; Jou, W; Gavrilova, O; Wess, J				de Azua, Inigo Ruiz; Nakajima, Ken-ichiro; Rossi, Mario; Cui, Yinghong; Jou, William; Gavrilova, Oksana; Wess, Juergen			Spinophilin as a novel regulator of M-3 muscarinic receptor-mediated insulin release in vitro and in vivo	FASEB JOURNAL			English	Article						G-protein-coupled receptors; knockout mice; receptor regulation; signal transduction	GLUCAGON-LIKE PEPTIDE-1; ACETYLCHOLINE-RECEPTORS; PROTEIN INTERACTIONS; CELL-SURFACE; SECRETION; INSIGHTS; BINDING; RGS4; BETA-ARRESTIN2; STIMULATION	Spinophilin (SPL), a multidomain scaffolding protein known to modulate the activity of different G-protein-coupled receptors, regulates various central nervous system (CNS) functions. However, little is known about the role of SPL expressed in peripheral cell types including pancreatic beta cells. In this study, we examined the ability of SPL to modulate the activity of beta -cell M-3 muscarinic acetylcholine receptors (M3Rs), which play an important role in facilitating insulin release and maintaining normal blood glucose levels. We demonstrated, by using both in vitro and in vivo approaches (mouse insulinoma cells and SPL-deficient mice), that SPL is a potent negative regulator of M3R-mediated signaling and insulin release. Additional biochemical and biophysical studies, including the use of bioluminescence resonance energy transfer technology, suggested that SPL is able to recruit regulator of G-protein signaling 4 (RGS4) to the M3R signaling complex in an agonist-dependent fashion. Since RGS4 is a member of the RGS family of proteins that act to reduce the lifetime of activated G proteins, these findings support the concept that the inhibitory effects of SPL on M3R activity are mediated by RGS4. These data suggest that SPL or other G-protein-coupled receptor-associated proteins may serve as novel targets for drug therapy aimed at improving beta -cell function for the treatment of type 2 diabetes.-Ruiz de Azua, I., Nakajima, K.-I., Rossi, M., Cui, Y., Jou, W., Gavrilova, O., Wess, J. Spinophilin as a novel regulator of M-3 muscarinic receptor-mediated insulin release in vitro and in vivo. FASEB J. 26, 4275-4286 (2012). www.fasebj.org	[Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Jou, William; Gavrilova, Oksana] NIDDK, Mouse Metab Core Facil, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wess, J (corresponding author), NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bldg 8A,Rm B1A-05,8 Ctr Dr,MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov		Rossi, Mario/0000-0001-7004-0225; Nakajima, Ken-ichiro/0000-0003-1932-418X	U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002, ZIADK075021] Funding Source: NIH RePORTER	U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The authors thank Dr. Sara McMillin (NIDDK) and Drs. Diaz Gimenez and Vsevolod Gurevich (Vanderbilt University, Nashville, TN, USA) for their help setting up the BRET experiments. Dr. Paul Greengard (Rockefeller University, New York, NY, USA) generously provided the SPL<SUP>-/-</SUP> mice. Finally, the authors thank Drs. Patrick B. Allen (Yale University, New Haven, CT, USA) and Diaz Gimenez and Vsevolod Gurevich (Vanderbilt University), and Qin Wang (University of Alabama, Birmingham, AL, USA) for providing important reagents and plasmids used in this study. The authors declare no conflicts of interest.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Arakawa M, 2009, BIOCHEM BIOPH RES CO, V390, P809, DOI 10.1016/j.bbrc.2009.10.054; Balasubramanian R, 2010, BIOCHEM PHARMACOL, V79, P1317, DOI 10.1016/j.bcp.2009.12.026; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Charlton JJ, 2008, NEURON, V58, P238, DOI 10.1016/j.neuron.2008.02.006; de Azua IR, 2010, P NATL ACAD SCI USA, V107, P7999, DOI 10.1073/pnas.1003655107; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; FUKUDO S, 1989, DIABETES, V38, P1433, DOI 10.2337/diabetes.38.11.1433; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gautam D, 2010, ENDOCRINOLOGY, V151, P5185, DOI 10.1210/en.2010-0519; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Ishii M, 2005, BIOCHEM BIOPH RES CO, V338, P839, DOI 10.1016/j.bbrc.2005.10.026; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Kocan M, 2011, METHODS MOL BIOL, V746, P357, DOI 10.1007/978-1-61779-126-0_20; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Kurogi M, 2009, NEUROREPORT, V20, P1134, DOI 10.1097/WNR.0b013e32832fd93e; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Nag S, 2009, BEHAV BRAIN RES, V197, P457, DOI 10.1016/j.bbr.2008.09.036; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wang X, 2007, EMBO J, V26, P2768, DOI 10.1038/sj.emboj.7601701; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002	42	15	15	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4275	4286		10.1096/fj.12-204644	http://dx.doi.org/10.1096/fj.12-204644			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22730439	Green Published			2022-12-25	WOS:000309704000032
J	Eberhardt, MJ; Filipovic, MR; Leffler, A; de la Roche, J; Kistner, K; Fischer, MJ; Fleming, T; Zimmermann, K; Ivanovic-Burmazovic, I; Nawroth, PP; Bierhaus, A; Reeh, PW; Sauer, SK				Eberhardt, Mirjam J.; Filipovic, Milos R.; Leffler, Andreas; de la Roche, Jeanne; Kistner, Katrin; Fischer, Michael J.; Fleming, Thomas; Zimmermann, Katharina; Ivanovic-Burmazovic, Ivana; Nawroth, Peter P.; Bierhaus, Angelika; Reeh, Peter W.; Sauer, Susanne K.			Methylglyoxal Activates Nociceptors through Transient Receptor Potential Channel A1 (TRPA1) A POSSIBLE MECHANISM OF METABOLIC NEUROPATHIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAINFUL DIABETIC-NEUROPATHY; CHRONIC KIDNEY-DISEASE; GENE-RELATED PEPTIDE; SENSORY NEURONS; ION-CHANNEL; IN-VITRO; OXIDATIVE STRESS; PERIPHERAL-NERVE; COLD HYPERSENSITIVITY; COVALENT MODIFICATION	Neuropathic pain can develop as an agonizing sequela of diabetes mellitus and chronic uremia. A chemical link between both conditions of altered metabolism is the highly reactive compound methylglyoxal (MG), which accumulates in all cells, in particular neurons, and leaks into plasma as an index of the severity of the disorder. The electrophilic structure of this cytotoxic ketoaldehyde suggests TRPA1, a receptor channel deeply involved in inflammatory and neuropathic pain, as a molecular target. We demonstrate that extracellularly applied MG accesses specific intracellular binding sites of TRPA1, activating inward currents and calcium influx in transfected cells and sensory neurons, slowing conduction velocity in unmyelinated peripheral nerve fibers, and stimulating release of proinflammatory neuropeptides from and action potential firing in cutaneous nociceptors. Using a model peptide of the N terminus of human TRPA1, we demonstrate the formation of disulfide bonds based on MG-induced modification of cysteines as a novel mechanism. In conclusion, MG is proposed to be a candidate metabolite that causes neuropathic pain in metabolic disorders and thus is a promising target for medicinal chemistry.	[Zimmermann, Katharina; Reeh, Peter W.; Sauer, Susanne K.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Eberhardt, Mirjam J.; Filipovic, Milos R.; Ivanovic-Burmazovic, Ivana] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany; [Leffler, Andreas; de la Roche, Jeanne] Hannover Med Sch, Dept Anesthesiol & Intens Care, D-30625 Hannover, Germany; [Fleming, Thomas; Nawroth, Peter P.; Bierhaus, Angelika] Univ Heidelberg Hosp, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Hannover Medical School; Ruprecht Karls University Heidelberg	Sauer, SK (corresponding author), Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Univ Str 17, D-91054 Erlangen, Germany.	sauer@physiologie1.uni-erlangen.de	Sauer, Susanne/K-1145-2012; Leffler, Andreas/K-1191-2012; Filipovic, Milos/D-5482-2014; Reeh, Peter W./J-8981-2012; Fischer, Michael J.M./P-8715-2014	Leffler, Andreas/0000-0003-1121-6387; Filipovic, Milos/0000-0003-0060-0041; Reeh, Peter W./0000-0002-4367-094X; Sauer, Susanne Katharina/0000-0002-9734-885X; Zimmermann, Katharina/0000-0003-2529-0692; Fischer, Michael J.M./0000-0002-3811-7066	Emerging Fields Initiative (Medicinal Redox Inorganic Chemistry) of the University of Erlangen-Nuremberg; Dr. Robert Pfleger-Stiftung; Deutsche Forschungsgemeinschaft [BI-1281/3-1, NA 138/7-1, LU 728/3-1]; Dietmar-Hopp-Stiftung	Emerging Fields Initiative (Medicinal Redox Inorganic Chemistry) of the University of Erlangen-Nuremberg; Dr. Robert Pfleger-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dietmar-Hopp-Stiftung	This work was supported by the Emerging Fields Initiative (Medicinal Redox Inorganic Chemistry) of the University of Erlangen-Nuremberg; the Dr. Robert Pfleger-Stiftung (to K. K.); Deutsche Forschungsgemeinschaft Grants BI-1281/3-1 (to A. B.), NA 138/7-1 (to P. P. N.), and LU 728/3-1 (to P. W. R.); and the Dietmar-Hopp-Stiftung (to A. B. and P. P. N.).	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Axson JL, 2010, P NATL ACAD SCI USA, V107, P6687, DOI 10.1073/pnas.0912121107; Babes A, 2010, METHODS MOL BIOL, V617, P237, DOI 10.1007/978-1-60327-323-7_19; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Beisswenger PJ, 2001, DIABETES CARE, V24, P726, DOI 10.2337/diacare.24.4.726; Belvisi MG, 2011, CHEST, V140, P1040, DOI 10.1378/chest.10-3327; Bernardini N, 2004, NEUROSCIENCE, V126, P585, DOI 10.1016/j.neuroscience.2004.03.017; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Bremer M, 2011, GLIA, V59, P1022, DOI 10.1002/glia.21173; BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chaplen FWR, 1996, ANAL BIOCHEM, V238, P171, DOI 10.1006/abio.1996.0271; Cook LJ, 1998, BIOCHEM PHARMACOL, V55, P1361, DOI 10.1016/S0006-2952(97)00619-9; COURTEIX C, 1993, PAIN, V53, P81, DOI 10.1016/0304-3959(93)90059-X; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; de Arriba SG, 2006, FREE RADICAL BIO MED, V40, P779, DOI 10.1016/j.freeradbiomed.2005.09.038; De Col R, 2008, J PHYSIOL-LONDON, V586, P1089, DOI 10.1113/jphysiol.2007.145383; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Dhaun N, 2006, J AM SOC NEPHROL, V17, P943, DOI 10.1681/ASN.2005121256; Di Loreto S, 2004, BRAIN RES, V1006, P157, DOI 10.1016/j.brainres.2004.01.066; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; DOUGLAS WW, 1957, J PHYSIOL-LONDON, V138, P19, DOI 10.1113/jphysiol.1957.sp005835; Dubreuil AS, 2004, J NEUROSCI, V24, P8480, DOI 10.1523/JNEUROSCI.1598-04.2004; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Ergul A, 2011, PHARMACOL RES, V63, P477, DOI 10.1016/j.phrs.2011.01.012; Everaerts W, 2011, CURR BIOL, V21, P316, DOI 10.1016/j.cub.2011.01.031; Foulkes T, 2007, CHANNELS, V1, P154, DOI 10.4161/chan.4692; Fuchs D, 2010, PAIN, V151, P496, DOI 10.1016/j.pain.2010.08.010; Fukunaga M, 2004, BIOCHEM BIOPH RES CO, V320, P689, DOI 10.1016/j.bbrc.2004.06.011; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Jack MM, 2011, DIABETOLOGIA, V54, P2174, DOI 10.1007/s00125-011-2196-3; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Ji G, 2008, NEUROSCIENCE, V154, P1054, DOI 10.1016/j.neuroscience.2008.04.039; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Khan GM, 2002, NEUROSCIENCE, V114, P291, DOI 10.1016/S0306-4522(02)00372-X; Kikuchi S, 1999, J NEUROSCI RES, V57, P280, DOI 10.1002/(SICI)1097-4547(19990715)57:2<280::AID-JNR14>3.0.CO;2-U; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; KOOP DR, 1982, J BIOL CHEM, V257, P8472; Kramer HH, 2004, DIABETES CARE, V27, P2386, DOI 10.2337/diacare.27.10.2386; Krizner HE, 2009, J PHYS CHEM A, V113, P6994, DOI 10.1021/jp903213k; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Lapolla A, 2005, ANN NY ACAD SCI, V1043, P267, DOI 10.1196/annals.1333.032; LEPPALUOTO J, 1992, ANN MED, V24, P153, DOI 10.3109/07853899209147813; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; LO TWC, 1994, J BIOL CHEM, V269, P32299; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Messinger RB, 2009, PAIN, V145, P184, DOI 10.1016/j.pain.2009.06.012; Misawa S, 2009, J PERIPHER NERV SYST, V14, P279, DOI 10.1111/j.1529-8027.2009.00239.x; Miyata T, 1999, KIDNEY INT, V55, P389, DOI 10.1046/j.1523-1755.1999.00302.x; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Namer B, 2008, PAIN, V137, P41, DOI 10.1016/j.pain.2007.08.008; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nemet I, 2005, CLIN BIOCHEM, V38, P379, DOI 10.1016/j.clinbiochem.2004.12.008; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Sauer SK, 1999, NEUROSCIENCE, V92, P319, DOI 10.1016/S0306-4522(98)00731-3; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; SCOTT AR, 1987, CAN J PHYSIOL PHARM, V65, P1365, DOI 10.1139/y87-215; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suzuki Y, 2002, NEUROSCI RES, V43, P171, DOI 10.1016/S0168-0102(02)00033-0; Suzuki Y, 2002, PAIN, V99, P475, DOI 10.1016/S0304-3959(02)00244-0; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Talbot S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-36; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Toyokuni S, 2000, ANTIOXID REDOX SIGN, V2, P681, DOI 10.1089/ars.2000.2.4-681; Traverso N, 1998, DIABETOLOGIA, V41, P265, DOI 10.1007/s001250050902; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748; Wang R, 2011, J PHYSIOL-LONDON, V589, P2229, DOI 10.1113/jphysiol.2010.203463; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wei H, 2011, PAIN, V152, P582, DOI 10.1016/j.pain.2010.11.031; Wei H, 2010, NEUROSCI LETT, V479, P253, DOI 10.1016/j.neulet.2010.05.073; Weidner C, 2000, J PHYSIOL-LONDON, V527, P185, DOI 10.1111/j.1469-7793.2000.00185.x; Weller K, 2011, NEUROPEPTIDES, V45, P391, DOI 10.1016/j.npep.2011.07.011; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	90	145	151	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28291	28306		10.1074/jbc.M111.328674	http://dx.doi.org/10.1074/jbc.M111.328674			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740698	Green Published, hybrid			2022-12-25	WOS:000308074600007
J	Ramakrishnan, B; Boeggeman, E; Qasba, PK				Ramakrishnan, Boopathy; Boeggeman, Elizabeth; Qasba, Pradman K.			Binding of N-Acetylglucosamine (GlcNAc) beta 1-6-branched Oligosaccharide Acceptors to beta 4-Galactosyltransferase I Reveals a New Ligand Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LACTALBUMIN; CRYSTAL-STRUCTURE; LACTOSE SYNTHETASE; GALACTOSYLTRANSFERASE; BETA-1,4-GALACTOSYLTRANSFERASE-I; COMPLEX; MUTANT; IDENTIFICATION; SPECIFICITY; METASTASIS	N-Acetyllactosamine is the most prevalent disaccharide moiety in the glycans on the surface of mammalian cells and often found as repeat units in the linear and branched polylactosamines, known as i- and I-antigen, respectively. The beta 1-4-galactosyltransferase- I (beta 4Gal-T1) enzyme is responsible for the synthesis of the N-acetyllactosamine moiety. To understand its oligosaccharide acceptor specificity, we have previously investigated the binding of tri- and pentasaccharides of N-glycan with a GlcNAc at their nonreducing end and found that the extended sugar moiety in these acceptor substrates binds to the crevice present at the acceptor substrate binding site of the beta 4Gal-T1 molecule. Here we report seven crystal structures of beta 4Gal-T1 in complex with an oligosaccharide acceptor with a nonreducing end GlcNAc that has a beta 1-6-glycosidic link and that are analogous to either N-glycan or i/I-antigen. In the crystal structure of the complex of beta 4Gal-T1 with I-antigen analog pentasaccharide, the beta 1-6-branched GlcNAc moiety is bound to the sugar acceptor binding site of the beta 4Gal-T1 molecule in a way similar to the crystal structures described previously; however, the extended linear tetrasaccharide moiety does not interact with the previously found extended sugar binding site on the beta 4Gal-T1 molecule. Instead, it interacts with the different hydrophobic surface of the protein molecule formed by the residues Tyr-276, Trp-310, and Phe-356. Results from the present and previous studies suggest that beta 4Gal-T1 molecule has two different oligosaccharide binding regions for the binding of the extended oligosaccharide moiety of the acceptor substrate.	[Ramakrishnan, Boopathy; Boeggeman, Elizabeth; Qasba, Pradman K.] NIH, Struct Glycobiol Sect, SAIC Frederick Inc,Ctr Canc Res Nanobiol Program, Ctr Canc Res,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Ramakrishnan, Boopathy; Boeggeman, Elizabeth] NIH, Basic Sci Program, SAIC Frederick Inc,Ctr Canc Res Nanobiol Program, Ctr Canc Res,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Qasba, PK (corresponding author), Frederick Natl Lab, Struct Glycobiol Sect, CCRNP, CCR, Bldg 469,Rm 221, Frederick, MD 21702 USA.	qasba@helix.nih.gov			National Institutes of Health through the NCI [HHSN261200800001E]; National Institutes of Health, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010742, ZIABC009304] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Contract HHSN261200800001E through the NCI. This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, Frederick National Laboratory for Cancer Research.	Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Boeggeman E, 2009, BIOCONJUGATE CHEM, V20, P1228, DOI 10.1021/bc900103p; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; BRODBECK U, 1967, J BIOL CHEM, V242, P1391; Brown JR, 2009, J BIOL CHEM, V284, P4952, DOI 10.1074/jbc.M805782200; Chakraborty AK, 2003, CLIN EXP METASTAS, V20, P365, DOI 10.1023/A:1024007915938; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; KLEE WA, 1970, BIOCHEM BIOPH RES CO, V39, P833, DOI 10.1016/0006-291X(70)90398-0; Marcus SL, 2003, J BIOL CHEM, V278, P12403, DOI 10.1074/jbc.M212002200; MORRISON JF, 1971, J BIOL CHEM, V246, P3977; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; Ouzzine M, 2002, J BIOL CHEM, V277, P25439, DOI 10.1074/jbc.M201912200; POWELL JT, 1976, J BIOL CHEM, V251, P3653; PRIEELS JP, 1976, EUR J BIOCHEM, V66, P579, DOI 10.1111/j.1432-1033.1976.tb10584.x; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Ramakrishnan B, 2007, J MOL BIOL, V365, P570, DOI 10.1016/j.jmb.2006.10.034; Ramakrishnan B, 2010, CURR OPIN STRUC BIOL, V20, P536, DOI 10.1016/j.sbi.2010.07.004; Ramasamy V, 2005, J MOL BIOL, V353, P53, DOI 10.1016/j.jmb.2005.07.050; Ramasamy V, 2003, J MOL BIOL, V331, P1065, DOI 10.1016/S0022-2836(03)00790-3; Rao V.S.R., 1998, CONFORMATION CARBOHY, P131; Renkonen O, 2000, CELL MOL LIFE SCI, V57, P1423, DOI 10.1007/PL00000627; Shaper NL, 1997, J BIOL CHEM, V272, P31389, DOI 10.1074/jbc.272.50.31389; Stanley P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005199; Varki A., 2009, ESSENTIALS GLYCOBIOL, P1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	11	11	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28666	28674		10.1074/jbc.M112.373514	http://dx.doi.org/10.1074/jbc.M112.373514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740701	Green Published, hybrid			2022-12-25	WOS:000308074600040
J	Yan, S; Bleuler-Martinez, S; Plaza, DF; Kunzler, M; Aebi, M; Joachim, A; Razzazi-Fazeli, E; Jantsch, V; Geyer, R; Wilson, IBH; Paschinger, K				Yan, Shi; Bleuler-Martinez, Silvia; Plaza, David Fernando; Kuenzler, Markus; Aebi, Markus; Joachim, Anja; Razzazi-Fazeli, Ebrahim; Jantsch, Verena; Geyer, Rudolf; Wilson, Iain B. H.; Paschinger, Katharina			Galactosylated Fucose Epitopes in Nematodes INCREASED EXPRESSION IN A CAENORHABDITIS MUTANT ASSOCIATED WITH ALTERED LECTIN SENSITIVITY AND OCCURRENCE IN PARASITIC SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; LOBES GENE ENCODES; OESOPHAGOSTOMUM-DENTATUM; CORE FUCOSE; GLYCANS; ELEGANS; PHOSPHORYLCHOLINE; BETA; ACETYLGLUCOSAMINIDASE; GLYCOPROTEIN	The modification of alpha 1,6-linked fucose residues attached to the proximal (reducing-terminal) core N-acetylglucosamine residue of N-glycans by beta 1,4-linked galactose ("GalFuc" epitope) is a feature of a number of invertebrate species including the model nematode Caenorhabditis elegans. A pre-requisite for both core alpha 1,6-fucosylation and beta 1,4-galactosylation is the presence of a nonreducing terminal N-acetylglucosamine; however, this residue is normally absent from the final glycan structure in invertebrates due to the action of specific hexosaminidases. Previously, we have identified two hexosaminidases (HEX-2 and HEX-3) in C. elegans, which process N-glycans. In the present study, we have prepared a hex-2; hex-3 double mutant, which possesses a radically altered N-glycomic profile. Whereas in the double mutant core alpha 1,3-fucosylation of the proximal N-acetylglucosamine was abolished, the degree of galactosylation of core alpha 1,6-fucose increased, and a novel Gal alpha 1,2Fuc alpha 1,3 moiety attached to the distal core N-acetylglucosamine residue was detected. Both galactosylated fucose moieties were also found in two parasitic nematodes, Ascaris suum and Oesophagostomum dentatum. As core modifications of N-glycans are known targets for fungal nematotoxic lectins, the sensitivity of the C. elegans double hexosaminidase mutant was assessed. Although this mutant displayed hypersensitivity to the GalFuc-binding lectin CGL2 and the N-acetylglucosamine-binding lectin XCL, the mutant was resistant to CCL2, which binds core alpha 1,3-fucose. Thus, the use of C. elegans mutants aids the identification of novel N-glycan modifications and the definition of in vivo specificities of nematotoxic lectins with potential as anthelmintic agents.	[Yan, Shi; Wilson, Iain B. H.; Paschinger, Katharina] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria; [Bleuler-Martinez, Silvia; Plaza, David Fernando; Kuenzler, Markus; Aebi, Markus] Swiss Fed Inst Technol, Inst Mikrobiol, CH-8093 Zurich, Switzerland; [Joachim, Anja] Vet Med Univ, Inst Parasitol, A-1210 Vienna, Austria; [Razzazi-Fazeli, Ebrahim] Vet Med Univ, Vetom Core Facil Res, A-1210 Vienna, Austria; [Jantsch, Verena] Univ Vienna, Max F Perutz Labs, Dept Chromosome Biol, A-1030 Vienna, Austria; [Geyer, Rudolf] Univ Giessen, Fachbereich Med, Inst Biochem, D-35292 Giessen, Germany	University of Natural Resources & Life Sciences, Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Justus Liebig University Giessen	Wilson, IBH (corresponding author), Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Yan, Shi/H-9091-2013; Jantsch, Verena/A-3910-2017; Wilson, Iain/B-3326-2009	Yan, Shi/0000-0003-4949-9140; Jantsch, Verena/0000-0002-1978-682X; Wilson, Iain/0000-0001-8996-1518; Plaza, David Fernando/0000-0003-0366-4112; Paschinger, Katharina/0000-0002-3594-7136; Kunzler, Markus/0000-0003-1275-0629; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301	Fonds zur Forderung der wissenschaftlichen Forschung [P21946]; European Union Euroglycoarrays Initial Training Network [PITN-GA-2008-215536]; Swiss National Science Foundation [31003A-130671]; ETH Zurich; Austrian Science Fund (FWF) [P 21946] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); European Union Euroglycoarrays Initial Training Network; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Fonds zur Forderung der wissenschaftlichen Forschung Grant P21946 (to K. P.), European Union Euroglycoarrays Initial Training Network Grant PITN-GA-2008-215536, Swiss National Science Foundation Grant 31003A-130671, and the ETH Zurich.	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BRENNER S, 1974, GENETICS, V77, P71; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; GEYER R, 1994, METHOD ENZYMOL, V230, P86; Goodey T., 1924, Journal of Helminthology, V2, P1, DOI 10.1017/S0022149X00002960; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Haslam SM, 1996, J BIOL CHEM, V271, P30561, DOI 10.1074/jbc.271.48.30561; Haslam SM, 1999, J BIOL CHEM, V274, P20953, DOI 10.1074/jbc.274.30.20953; Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223; Haslam SM, 1997, MOL BIOCHEM PARASIT, V85, P53, DOI 10.1016/S0166-6851(96)02807-1; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Joachim A, 1997, PARASITOL RES, V83, P646, DOI 10.1007/s004360050313; Joachim A, 2001, PARASITOL INT, V50, P41, DOI 10.1016/S1383-5769(00)00070-2; Joachim A, 1999, PARASITOLOGY, V119, P491, DOI 10.1017/S0031182099004965; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Maduzia LL, 2011, J BIOL CHEM, V286, P4371, DOI 10.1074/jbc.M110.188581; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Morelle W, 2000, GLYCOBIOLOGY, V10, P941, DOI 10.1093/glycob/10.9.941; PARENTE JP, 1985, CARBOHYD RES, V141, P41, DOI 10.1016/S0008-6215(00)90753-5; Paschinger K, 2004, J BIOL CHEM, V279, P49588, DOI 10.1074/jbc.M408978200; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; Paschinger K, 2011, J MASS SPECTROM, V46, P561, DOI 10.1002/jms.1925; Poltl G, 2007, FEBS J, V274, P714, DOI 10.1111/j.1742-4658.2006.05615.x; Sarkar M, 2010, P NATL ACAD SCI USA, V107, P9677, DOI 10.1073/pnas.1004431107; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706; Shi H, 2006, METHOD ENZYMOL, V417, P359, DOI 10.1016/S0076-6879(06)17022-6; Singh RS, 2011, CRIT REV BIOTECHNOL, V31, P193, DOI 10.3109/07388551.2010.505911; Slotved HC, 1996, VET PARASITOL, V63, P237, DOI 10.1016/0304-4017(95)00916-7; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Takeuchi T, 2008, GLYCOBIOLOGY, V18, P882, DOI 10.1093/glycob/cwn077; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; van Stijn CMW, 2010, INT J PARASITOL, V40, P215, DOI 10.1016/j.ijpara.2009.07.009; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; Zeleny R, 1997, ANAL BIOCHEM, V246, P96, DOI 10.1006/abio.1996.9973; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153; Zhao S, 2009, ENVIRON TOXICOL PHAR, V28, P265, DOI 10.1016/j.etap.2009.05.003	44	37	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28276	28290		10.1074/jbc.M112.353128	http://dx.doi.org/10.1074/jbc.M112.353128			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733825	Green Published, hybrid			2022-12-25	WOS:000308074600006
J	Bali, M; Akabas, MH				Bali, Moez; Akabas, Myles H.			Gating-induced Conformational Rearrangement of the gamma-Aminobutyric Acid Type A Receptor beta-alpha Subunit Interface in the Membrane-spanning Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-LINING RESIDUES; GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; ANESTHETIC BINDING-SITE; X-RAY-STRUCTURE; GABA(A) RECEPTOR; M2 SEGMENT; PROTEIN MOBILITY; M1 SEGMENT; OPEN STATE	GABA(A) receptors mediate fast inhibitory synaptic transmission. The transmembrane ion channel is lined by a ring of five alpha helices, M2 segments, one from each subunit. An outer ring of helices comprising the alternating M1, M3, and M4 segments from each subunit surrounds the inner ring and forms the interface with the lipid bilayer. The structural rearrangements that follow agonist binding and culminate in opening of the ion pore remain incompletely characterized. Propofol and other intravenous general anesthetics bind at the beta M3-alpha M1 subunit interface. We sought to determine whether this region undergoes conformational changes during GABA activation. We measured the reaction rate of p-chloromercuribenzenesulfonate (pCMBS) with cysteines substituted in the GABA(A) receptor alpha 1M1 and beta 2M3 segments. In the presence of GABA, the pCMBS reaction rate increased significantly in a cluster of residues in the extracellular third of the alpha 1M1 segment facing the beta 2M3 segment. Mutation of the beta 2M2 segment 19' position, R269Q, altered the pCMBS reaction rate with several alpha 1M1 Cys, some only in the resting state and others only in the GABA-activated state. Thus, beta 2R269 is charged in both states. GABA activation induced disulfide bond formation between beta 2R269C and alpha 1I228C. The experiments demonstrate that alpha 1M1 moves in relationship to beta 2M2R269 during gating. Thus, channel gating does not involve rigid body movements of the entire transmembrane domain. Channel gating causes changes in the relative position of transmembrane segments both within a single subunit and relative to the neighboring subunits.	[Bali, Moez; Akabas, Myles H.] Yeshiva Univ, Dept Physiol & Biophys, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ, Dept Neurosci & Med, Albert Einstein Coll Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Akabas, MH (corresponding author), Yeshiva Univ, Dept Physiol & Biophys, Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	myles.akabas@einstein.yu.edu		Akabas, Myles/0000-0001-8781-7846	National Institutes of Health [R01 NS030808]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS030808 (to M. H. A.).	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1995, BIOCHEMISTRY-US, V34, P12496, DOI 10.1021/bi00039a002; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2007, J GEN PHYSIOL, V129, P145, DOI 10.1085/jgp.200609639; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bera AK, 2005, J BIOL CHEM, V280, P35506, DOI 10.1074/jbc.M504645200; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Goren EN, 2004, J BIOL CHEM, V279, P11198, DOI 10.1074/jbc.M314050200; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 2005, J BIOL CHEM, V280, P1573, DOI 10.1074/jbc.M410881200; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Rosen A, 2007, BIOPHYS J, V92, P3130, DOI 10.1529/biophysj.106.094490; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u	47	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27762	27770		10.1074/jbc.M112.363341	http://dx.doi.org/10.1074/jbc.M112.363341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730325	hybrid, Green Published			2022-12-25	WOS:000307840700050
J	Higuchi, S; Irie, K; Yamaguchi, R; Katsuki, M; Araki, M; Ohji, M; Hayakawa, K; Mishima, S; Akitake, Y; Matsuyama, K; Mishima, K; Mishima, K; Iwasaki, K; Fujiwara, M				Higuchi, Sei; Irie, Keiichi; Yamaguchi, Ryuji; Katsuki, Mai; Araki, Maiko; Ohji, Makiko; Hayakawa, Kazuhide; Mishima, Shohei; Akitake, Yoshiharu; Matsuyama, Kiyoshi; Mishima, Kenji; Mishima, Kenichi; Iwasaki, Katsunori; Fujiwara, Michihiro			Hypothalamic 2-Arachidonoylglycerol Regulates Multistage Process of High-Fat Diet Preferences	PLOS ONE			English	Article							CANNABINOID CB1 RECEPTORS; GLIAL-CELL METABOLISM; ENDOCANNABINOID SYSTEM; GLUTAMATE TRANSPORTERS; ENERGY-BALANCE; RAT-BRAIN; CORN-OIL; NEURONS; ASTROCYTES; MORPHINE	Background: In this study, we examined alterations in the hypothalamic reward system related to high-fat diet (HFD) preferences. We previously reported that hypothalamic 2-arachidonoylglycerol (2-AG) and glial fibrillary acid protein (GFAP) were increased after conditioning to the rewarding properties of a HFD. Here, we hypothesized that increased 2-AG influences the hypothalamic reward system. Methods: The conditioned place preference test (CPP test) was used to evaluate HFD preferences. Hypothalamic 2-AG was quantified by gas chromatography-mass spectrometry. The expression of GFAP was examined by immunostaining and western blotting. Results: Consumption of a HFD over either 3 or 7 days increased HFD preferences and transiently increased hypothalamic 2-AG levels. HFD consumption over 14 days similarly increased HFD preferences but elicited a long-lasting increase in hypothalamic 2-AG and GFAP levels. The cannabinoid 1 receptor antagonist O-2050 reduced preferences for HFDs after 3, 7, or 14 days of HFD consumption and reduced expression of GFAP after 14 days of HFD consumption. The astrocyte metabolic inhibitor Fluorocitrate blocked HFD preferences after 14 days of HFD consumption. Conclusions: High levels of 2-AG appear to induce HFD preferences, and activate hypothalamic astrocytes via the cannabinoid system. We propose that there may be two distinct stages in the development of HFD preferences. The induction stage involves a transient increase in 2-AG, whereas the maintenance stage involves a long lasting increase in 2-AG levels and activation of astrocytes. Accordingly, hypothalamic 2-AG may influence the development of HFD preferences.	[Higuchi, Sei; Irie, Keiichi; Yamaguchi, Ryuji; Katsuki, Mai; Araki, Maiko; Ohji, Makiko; Hayakawa, Kazuhide; Mishima, Shohei; Akitake, Yoshiharu; Mishima, Kenichi; Iwasaki, Katsunori; Fujiwara, Michihiro] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Fukuoka 81401, Japan; [Irie, Keiichi; Akitake, Yoshiharu; Mishima, Kenichi; Iwasaki, Katsunori] Fukuoka Univ, Inst Aging & Brain Sci, Fukuoka 81401, Japan; [Matsuyama, Kiyoshi; Mishima, Kenji] Fukuoka Univ, Fac Engn, Dept Chem Engn, Fukuoka 81401, Japan	Fukuoka University; Fukuoka University; Fukuoka University	Higuchi, S (corresponding author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, 8-19-1 Nanakuma, Fukuoka 81401, Japan.	kenichi@fukuoka-u.ac.jp		Higuchi, Sei/0000-0002-5134-8619; Matsuyama, Kiyoshi/0000-0002-9037-4908				Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Bisogno T, 2009, CHEMMEDCHEM, V4, P946, DOI 10.1002/cmdc.200800442; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2009, INT J OBESITY, V33, pS18, DOI 10.1038/ijo.2009.67; Di Marzo V, 2011, P NATL ACAD SCI USA, V108, P12567, DOI 10.1073/pnas.1109567108; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; ELIZALDE G, 1990, APPETITE, V15, P189, DOI 10.1016/0195-6663(90)90019-5; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Hayakawa K, 2010, J CEREBR BLOOD F MET, V30, P871, DOI 10.1038/jcbfm.2009.257; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Higuchi S, 2010, ANAL SCI, V26, P1199, DOI 10.2116/analsci.26.1199; Higuchi S, 2011, BEHAV BRAIN RES, V216, P477, DOI 10.1016/j.bbr.2010.08.042; Higuchi S, 2010, J PHARMACOL SCI, V112, P369, DOI 10.1254/jphs.09326SC; Imaizumi M, 2000, BRAIN RES, V870, P150, DOI 10.1016/S0006-8993(00)02416-1; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Le Foll B, 2008, NEUROSCI LETT, V443, P236, DOI 10.1016/j.neulet.2008.07.074; Le Foll B, 2008, ADDICT BIOL, V13, P239, DOI 10.1111/j.1369-1600.2008.00113.x; LEPORE M, 1995, LIFE SCI, V56, P2073, DOI 10.1016/0024-3205(95)00191-8; Meng ZQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007742; Miyatake M, 2005, EUR J NEUROSCI, V22, P1476, DOI 10.1111/j.1460-9568.2005.04325.x; Mizushige T, 2006, BIOMED RES-TOKYO, V27, P227, DOI 10.2220/biomedres.27.227; Mizushige T, 2009, LIFE SCI, V84, P760, DOI 10.1016/j.lfs.2009.03.003; Nakagawa T, 2001, EUR J PHARMACOL, V419, P39, DOI 10.1016/S0014-2999(01)00965-7; Narita M, 2005, J NEUROCHEM, V93, P1383, DOI 10.1111/j.1471-4159.2005.03097.x; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Ozawa T, 2001, BRAIN RES, V905, P254, DOI 10.1016/S0006-8993(01)02536-7; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PAULSEN RE, 1987, J NEUROCHEM, V48, P1377, DOI 10.1111/j.1471-4159.1987.tb05674.x; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Peyron C, 1998, J NEUROSCI, V18, P9996; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Rosin DL, 2003, J COMP NEUROL, V465, P593, DOI 10.1002/cne.10860; South T, 2007, BEHAV BRAIN RES, V181, P153, DOI 10.1016/j.bbr.2007.03.028; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Takeda M, 2001, LIFE SCI, V69, P847, DOI 10.1016/S0024-3205(01)01180-8; TOWER DB, 1973, J NEUROCHEM, V20, P269, DOI 10.1111/j.1471-4159.1973.tb12126.x; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Verty ANA, 2005, NEUROPHARMACOLOGY, V49, P1101, DOI 10.1016/j.neuropharm.2005.03.025; Wiskerke J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025856	56	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38609	10.1371/journal.pone.0038609	http://dx.doi.org/10.1371/journal.pone.0038609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737214	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100011
J	Huyghe, A; Horzinski, L; Henaut, A; Gaillard, M; Bertini, E; Schiffmann, R; Rodriguez, D; Dantal, Y; Boespflug-Tanguy, O; Fogli, A				Huyghe, Aurelia; Horzinski, Laetitia; Henaut, Alain; Gaillard, Marina; Bertini, Enrico; Schiffmann, Raphael; Rodriguez, Diana; Dantal, Yann; Boespflug-Tanguy, Odile; Fogli, Anne			Developmental Splicing Deregulation in Leukodystrophies Related to EIF2B Mutations	PLOS ONE			English	Article							VANISHING WHITE-MATTER; CENTRAL-NERVOUS-SYSTEM; ENDOPLASMIC-RETICULUM-STRESS; UNFOLDED PROTEIN RESPONSE; FIBRILLARY ACIDIC PROTEIN; CHILDHOOD ATAXIA; EIF2B-RELATED DISORDERS; GENE-EXPRESSION; PROTEOLIPID PROTEIN; MYELINATING CELLS	Leukodystrophies (LD) are rare inherited disorders that primarily affect the white matter (WM) of the central nervous system. The large heterogeneity of LD results from the diversity of the genetically determined defects that interfere with glial cells functions. Astrocytes have been identified as the primary target of LD with cystic myelin breakdown including those related to mutations in the ubiquitous translation initiation factor eIF2B. EIF2B is involved in global protein synthesis and its regulation under normal and stress conditions. Little is known about how eIF2B mutations have a major effect on WM. We performed a transcriptomic analysis using fibroblasts of 10 eIF2B-mutated patients with a severe phenotype and 10 age matched patients with other types of LD in comparison to control fibroblasts. ANOVA was used to identify genes that were statistically significantly differentially expressed at basal state and after ER-stress. The pattern of differentially expressed genes between basal state and ER-stress did not differ significantly among each of the three conditions. However, 70 genes were specifically differentially expressed in eIF2B-mutated fibroblasts whatever the stress conditions tested compared to controls, 96% being under-expressed. Most of these genes were involved in mRNA regulation and mitochondrial metabolism. The 13 most representative genes, including genes belonging to the Heterogeneous Nuclear Ribonucleoprotein (HNRNP) family, described as regulators of splicing events and stability of mRNA, were dysregulated during the development of eIF2B-mutated brains. HNRNPH1, F and C mRNA were over-expressed in foetus but under-expressed in children and adult brains. The abnormal regulation of HNRNP expression in the brain of eIF2B-mutated patients was concomitant with splicing dysregulation of the main genes involved in glial maturation such as PLP1 for oligodendrocytes and GFAP in astrocytes. These findings demonstrate a developmental deregulation of splicing events in glial cells that is related to abnormal production of HNRNP, in eIF2B-mutated brains.	[Huyghe, Aurelia; Horzinski, Laetitia; Gaillard, Marina; Dantal, Yann; Boespflug-Tanguy, Odile; Fogli, Anne] Soluscience, Fac Med, Clermont Ferrand, France; [Huyghe, Aurelia; Horzinski, Laetitia; Gaillard, Marina; Fogli, Anne] Univ Clermont Ferrand, UFR Med, Clermont Ferrand, France; [Henaut, Alain] Univ Paris 06, CNRS, Paris, France; [Bertini, Enrico] Bambino Gesu Pediat Hosp, Inst Ricovero & Cura Carattere Sci IRCCS, Div Neuromuscular & Neurodegenerat Disorders, Mol Med Lab,Dept Neurosci, Rome, Italy; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA; [Rodriguez, Diana] Hop Armand Trousseau, AP HP, Serv Neuropediat, Paris, France; [Rodriguez, Diana; Boespflug-Tanguy, Odile] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Boespflug-Tanguy, Odile] Hop Robert Debre, AP HP, Serv Neuropediat & Malad Metab, F-75019 Paris, France; [Boespflug-Tanguy, Odile] Univ Paris Diderot, Paris, France; [Fogli, Anne] Ctr Hosp Univ Clermont Ferrand, Serv Biochim Med & Biol Mol, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; IRCCS Bambino Gesu; Baylor Scott & White Health; Baylor University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand	Huyghe, A (corresponding author), Soluscience, Fac Med, Clermont Ferrand, France.	anne.fogli@u-clermont1.fr	Rodriguez, Diana/GVR-7668-2022; Bertini, Enrico/A-2284-2014; Huyghe, Aurélia/AAA-5203-2020; Bertini, Enrico/ABG-1278-2020; Fogli, Anne/AAL-6640-2020	Bertini, Enrico/0000-0001-9276-4590; Fogli, Anne/0000-0002-2651-7441	European Leukodystrophy Association (ELA) research foundation; Health European Framework Program 7 (Leukotreat) [241622]; French research Ministry (Ecole Doctorale "Sciences de la Vie et de la Sante", Clermont University, France)	European Leukodystrophy Association (ELA) research foundation; Health European Framework Program 7 (Leukotreat); French research Ministry (Ecole Doctorale "Sciences de la Vie et de la Sante", Clermont University, France)	This work was supported by a grant of the European Leukodystrophy Association (ELA) research foundation and of the Health European Framework Program 7 (Leukotreat, grant number 241622 coordinated by OBT). AuH was supported by a PhD grant from the French research Ministry (Ecole Doctorale "Sciences de la Vie et de la Sante", Clermont University, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boespflug-Tanguy O, 2008, CURR NEUROL NEUROSCI, V8, P217, DOI 10.1007/s11910-008-0034-x; Bugiani M, 2011, J NEUROPATH EXP NEUR, V70, P69, DOI 10.1097/NEN.0b013e318203ae74; CAMPAGNONI AT, 1988, J NEUROCHEM, V51, P1, DOI 10.1111/j.1471-4159.1988.tb04827.x; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chesnoy-Marchais D., 1999, PHYSL NEURONE; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Geva M, 2010, BRAIN, V133, P2448, DOI 10.1093/brain/awq180; Haak LL, 2000, CELL CALCIUM, V28, P297, DOI 10.1054/ceca.2000.0176; Hobson GM, 2002, ANN NEUROL, V52, P477, DOI 10.1002/ana.10320; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Iwata K, 2011, PSYCHIAT RES; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kantor L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003783; Kerr MK, 2001, GENET RES, V77, P123; Labauge P, 2009, BRAIN, V132, P2161, DOI 10.1093/brain/awp171; LEVINE SM, 1990, DEV NEUROSCI-BASEL, V12, P235, DOI 10.1159/000111853; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; LIU XD, 1995, GENE DEV, V9, P1766, DOI 10.1101/gad.9.14.1766; Lyons DA, 2009, NAT GENET, V41, P854, DOI 10.1038/ng.376; Marom L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026992; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mignot C, 2004, CELL MOL LIFE SCI, V61, P369, DOI 10.1007/s00018-003-3143-3; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Riva A, 2005, COMPUT BIOL CHEM, V29, P319, DOI 10.1016/j.compbiolchem.2005.08.006; Rodriguez D, 1999, ACTA NEUROPATHOL, V97, P469, DOI 10.1007/s004010051016; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Sporkel O, 2002, GLIA, V37, P19, DOI 10.1002/glia.10014; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; van der Voorn JP, 2005, J NEUROPATH EXP NEUR, V64, P770, DOI 10.1097/01.jnen.0000178446.41595.3a; Van Haren K, 2004, J NEUROPATH EXP NEUR, V63, P618, DOI 10.1093/jnen/63.6.618; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Vorstman JAS, 2011, MOL PSYCHIATR, V16, P442, DOI 10.1038/mp.2010.26; Wang EM, 2006, J CELL BIOCHEM, V97, P999, DOI 10.1002/jcb.20692; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wong K, 2000, ACTA NEUROPATHOL, V100, P635, DOI 10.1007/s004010000234; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74	54	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38264	10.1371/journal.pone.0038264	http://dx.doi.org/10.1371/journal.pone.0038264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737209	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100006
J	Kim, H; Phung, Y; Ho, M				Kim, Heungnam; Phung, Yen; Ho, Mitchell			Changes in Global Gene Expression Associated with 3D Structure of Tumors: An Ex Vivo Matrix-Free Mesothelioma Spheroid Model	PLOS ONE			English	Article							MULTICELLULAR SPHEROIDS; APOPTOTIC RESISTANCE; SOLID TUMORS; LUNG-CANCER; CELL-LINES; INHIBITORS; CYTOKINES; PATHWAY; KINASE; APRIL	Tumor microenvironments present significant barriers to anti-tumor agents. Molecules involved in multicellular tumor microenvironments, however, are difficult to study ex vivo. Here, we generated a matrix-free tumor spheroid model using the NCI-H226 mesothelioma cell line and compared the gene expression profiles of spheroids and monolayers using microarray analysis. Microarray analysis revealed that 142 probe sets were differentially expressed between tumor spheroids and monolayers. Gene ontology analysis revealed that upregulated genes were primarily related to immune response, wound response, lymphocyte stimulation and response to cytokine stimulation, whereas downregulated genes were primarily associated with apoptosis. Among the 142 genes, 27 are located in the membrane and related to biologic processes of cellular movement, cell-to-cell signaling, cellular growth and proliferation and morphology. Western blot analysis validated elevation of MMP2, BAFF/BLyS/TNFSF13B, RANTES/CCL5 and TNFAIP6/TSG-6 protein expression in spheroids as compared to monolayers. Thus, we have reported the first large scale comparison of the transcriptional profiles using an ex vivo matrix-free spheroid model to identify genes specific to the three-dimensional biological structure of tumors. The method described here can be used for gene expression profiling of tumors other than mesothelioma.	[Kim, Heungnam; Phung, Yen; Ho, Mitchell] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kim, H (corresponding author), NCI, Mol Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	homi@mail.nih.gov	Ho, Mitchell/F-5059-2015	Ho, Mitchell/0000-0002-9152-5405	National Institutes of Health (NIH), National Cancer Institute (NCI); Center for Cancer Research; NCI; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC010891] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), and Center for Cancer Research and by a NCI Director's Intramural Innovation Principal Investigator Award to MH. This work was also possible because of a Mesothelioma Applied Research Foundation Craig Kozicki Memorial Grant to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Carbone M, 2012, CLIN CANCER RES, V18, P598, DOI 10.1158/1078-0432.CCR-11-2259; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cukierman E, 2010, SEMIN CANCER BIOL, V20, P139, DOI 10.1016/j.semcancer.2010.04.004; Engbring JA, 2003, J PATHOL, V200, P465, DOI 10.1002/path.1396; Feng MQ, 2011, J CANCER, V2, P123, DOI 10.7150/jca.2.123; Hegmans JPJJ, 2006, EUR RESPIR J, V27, P1086, DOI 10.1183/09031936.06.00135305; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Kumagai-Takei N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/481439; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Phung YT, 2011, J CANCER, V2, P507, DOI 10.7150/jca.2.507; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Roomi MW, 2009, ONCOL REP, V22, P1283, DOI 10.3892/or_00000566; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xiang XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014640; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Zhong J, 2006, J CELL PHYSIOL, V207, P540, DOI 10.1002/jcp.20605	25	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39556	10.1371/journal.pone.0039556	http://dx.doi.org/10.1371/journal.pone.0039556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737246	gold, Green Published, Green Submitted			2022-12-25	WOS:000305695100045
J	Lindfield, R; Griffiths, U; Bozzani, F; Mumba, M; Munsanje, J				Lindfield, Robert; Griffiths, Ulla; Bozzani, Fiammetta; Mumba, Musonda; Munsanje, Joseph			A Rapid Assessment of Avoidable Blindness in Southern Zambia	PLOS ONE			English	Article							KENYA	Introduction: A rapid assessment of avoidable blindness (RAAB) was conducted in Southern Zambia to establish the prevalence and causes of blindness in order to plan effective services and advocate for support for eye care to achieve the goals of VISION 2020: the right to sight. Methods: Cluster randomisation was used to select villages in the survey area. These were further subdivided into segments. One segment was selected randomly and a survey team moved from house to house examining everyone over the age of 50 years. Each individual received a visual acuity assessment and simple ocular examination. Data was recorded on a standard proforma and entered into an established software programme for analysis. Results: 2.29% of people over the age of 50 were found to be blind (VA <3/60 in the better eye with available correction). The major cause of blindness was cataract (47.2%) with posterior segment disease being the next main cause (18.8%). 113 eyes had received cataract surgery with 30.1% having a poor outcome (VA <6/60) following surgery. Cataract surgical coverage showed that men (72%) received more surgery than women (65%). Discussion: The results from the RAAB survey in Zambia were very similar to the results from a similar survey in Malawi, where the main cause of blindness was cataract but posterior segment disease was also a significant contributor. Blindness in this part of Zambia is mainly avoidable and there is a need for comprehensive eye care services that can address both cataract and posterior segment disease in the population if the aim of VISION 2020 is to be achieved. Services should focus on quality and gender equity of cataract surgery.	[Lindfield, Robert] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England; [Griffiths, Ulla; Bozzani, Fiammetta] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Mumba, Musonda] Lusaka Eye Hosp, Lusaka, Zambia; [Munsanje, Joseph] S&S Dev Consultants, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Lindfield, R (corresponding author), London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England.	Robert.lindfield@lshtm.ac.uk			Sightsavers International	Sightsavers International	The study was funded by Sightsavers International (www.sightsavers.org). Sightsavers paid for the field work costs (equipment, consumables, costs for field staff and transport). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Statistical Office, 2003, ZAMB 2000 CENS POP H; Habiyakire C, 2010, OPHTHAL EPIDEMIOL, V17, P90, DOI 10.3109/09286580903453514; Kalua K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019226; Kuper Hannah, 2006, Community Eye Health, V19, P68; Lindfield R, 2009, BRIT J OPHTHALMOL, V93, P875, DOI 10.1136/bjo.2008.152744; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pizzarello L, 2004, ARCH OPHTHALMOL-CHIC, V122, P615, DOI 10.1001/archopht.122.4.615; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; UNDP, 2011, NAT HUM DEV REP ZAMB; WHO, 1998, INF CONS AN BLINDN P; WHO IAPB, 2006, VISION 2020 ACT PLAN; WHO Programme for the Prevention of Blindness, 1988, COD INSTR WHO PBL EY; Zulu F, 2005, SITUATION ANAL EYE C	15	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38483	10.1371/journal.pone.0038483	http://dx.doi.org/10.1371/journal.pone.0038483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737211	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000305695100008
J	Medugorac, I; Seichter, D; Graf, A; Russ, I; Blum, H; Gopel, KH; Rothammer, S; Forster, M; Krebs, S				Medugorac, Ivica; Seichter, Doris; Graf, Alexander; Russ, Ingolf; Blum, Helmut; Goepel, Karl Heinrich; Rothammer, Sophie; Foerster, Martin; Krebs, Stefan			Bovine Polledness - An Autosomal Dominant Trait with Allelic Heterogeneity	PLOS ONE			English	Article							CATTLE BREEDS; HORN; ASSOCIATION; INHERITANCE; DELETION; ALIGNMENT; INSIGHTS; LOCUS	The persistent horns are an important trait of speciation for the family Bovidae with complex morphogenesis taking place briefly after birth. The polledness is highly favourable in modern cattle breeding systems but serious animal welfare issues urge for a solution in the production of hornless cattle other than dehorning. Although the dominant inhibition of horn morphogenesis was discovered more than 70 years ago, and the causative mutation was mapped almost 20 years ago, its molecular nature remained unknown. Here, we report allelic heterogeneity of the POLLED locus. First, we mapped the POLLED locus to a similar to 381-kb interval in a multi-breed case-control design. Targeted re-sequencing of an enlarged candidate interval (547 kb) in 16 sires with known POLLED genotype did not detect a common allele associated with polled status. In eight sires of Alpine and Scottish origin (four polled versus four horned), we identified a single candidate mutation, a complex 202 bp insertion-deletion event that showed perfect association to the polled phenotype in various European cattle breeds, except Holstein-Friesian. The analysis of the same candidate interval in eight Holsteins identified five candidate variants which segregate as a 260 kb haplotype also perfectly associated with the POLLED gene without recombination or interference with the 202 bp insertion-deletion. We further identified bulls which are progeny tested as homozygous polled but bearing both, 202 bp insertion-deletion and Friesian haplotype. The distribution of genotypes of the two putative POLLED alleles in large semi-random sample (1,261 animals) supports the hypothesis of two independent mutations.	[Medugorac, Ivica; Graf, Alexander; Blum, Helmut; Krebs, Stefan] Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany; [Seichter, Doris; Russ, Ingolf] Tierzuchtforsch eV Munchen, Grub, Germany; [Goepel, Karl Heinrich] Gopel Genet GmbH, Herleshausen, Germany	University of Munich	Medugorac, I (corresponding author), Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany.	ivica.medjugorac@gen.vetmed.uni-muenchen.de		Rothammer, Sophie/0000-0001-5704-5814; Medugorac, Ivica/0000-0002-6891-3039; Seichter, Doris/0000-0002-0325-1134	German Research Foundation (DFG; Germany) [ME 3404/2-1]; German agriculture network PHANOMICS; Federal Ministry of Education and Research [0315536F]; Chair of Animal Genetics and Husbandry of the Ludwig-Maximilians-University Munich (TierALL, LMU Munich, Germany); Laboratory for Functional Genome Analysis (LAFUGA, Gene Center, LMU Munich, Germany); Tierzuchtforschung e.V. Munchen (TZF Grub, Germany); TierALL; LAFUGA; TZF	German Research Foundation (DFG; Germany)(German Research Foundation (DFG)); German agriculture network PHANOMICS; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Chair of Animal Genetics and Husbandry of the Ludwig-Maximilians-University Munich (TierALL, LMU Munich, Germany); Laboratory for Functional Genome Analysis (LAFUGA, Gene Center, LMU Munich, Germany); Tierzuchtforschung e.V. Munchen (TZF Grub, Germany); TierALL; LAFUGA; TZF	This work was funded by the German Research Foundation (DFG; Germany, ME 3404/2-1) and a grant from the German agriculture network PHANOMICS (funded by Federal Ministry of Education and Research funding reference number 0315536F) as well as by substantial budget funds from the Chair of Animal Genetics and Husbandry of the Ludwig-Maximilians-University Munich (TierALL, LMU Munich, Germany), the Laboratory for Functional Genome Analysis (LAFUGA, Gene Center, LMU Munich, Germany) and the Tierzuchtforschung e.V. Munchen (TZF Grub, Germany). The authors IM, SR, MF, SK, AG, HB, DS and IR are employed by TierALL, LAFUGA and TZF which supported this study by substantial budget funds but only the authors and not the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai M, 2004, ANIM GENET, V35, P34, DOI 10.1111/j.1365-2052.2003.01079.x; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Capitan A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-33; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Dove WF, 1935, J EXP ZOOL, V69, P347, DOI 10.1002/jez.1400690302; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Felius M., 1995, CATTLE BREEDS ENCY; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Graf B, 1999, APPL ANIM BEHAV SCI, V62, P153, DOI 10.1016/S0168-1591(98)00218-4; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McEvoy B, 2004, AM J HUM GENET, V75, P693, DOI 10.1086/424697; Medugorac I, 2011, ECOL EVOL, V1, P408, DOI 10.1002/ece3.39; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; Ramljak J, 2011, J ANIM BREED GENET, V128, P73, DOI 10.1111/j.1439-0388.2010.00905.x; Seichter D, 2012, ANIM GENET IN PRESS; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; Wood HM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq510; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	39	89	100	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39477	10.1371/journal.pone.0039477	http://dx.doi.org/10.1371/journal.pone.0039477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737241	Green Published, gold, Green Submitted			2022-12-25	WOS:000305695100040
J	Pashai, N; Hao, HP; All, A; Gupta, S; Chaerkady, R; De Los Angeles, A; Gearhart, JD; Kerr, CL				Pashai, Nikta; Hao, Haiping; All, Angelo; Gupta, Siddharth; Chaerkady, Raghothama; De Los Angeles, Alejandro; Gearhart, John D.; Kerr, Candace L.			Genome-Wide Profiling of Pluripotent Cells Reveals a Unique Molecular Signature of Human Embryonic Germ Cells	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; GENE-EXPRESSION PROFILES; STEM-CELLS; OVARIAN-CANCER; HOMOLOGOUS RECOMBINATION; EXCISION-REPAIR; DNA-DAMAGE; MOUSE; IDENTIFICATION; CYCLE	Human embryonic germ cells (EGCs) provide a powerful model for identifying molecules involved in the pluripotent state when compared to their progenitors, primordial germ cells (PGCs), and other pluripotent stem cells. Microarray and Principal Component Analysis (PCA) reveals for the first time that human EGCs possess a transcription profile distinct from PGCs and other pluripotent stem cells. Validation with qRT-PCR confirms that human EGCs and PGCs express many pluripotency-associated genes but with quantifiable differences compared to pluripotent embryonic stem cells (ESCs), induced pluripotent stem cells (IPSCs), and embryonal carcinoma cells (ECCs). Analyses also identified a number of target genes that may be potentially associated with their unique pluripotent states. These include IPO7, MED7, RBM26, HSPD1, and KRAS which were upregulated in EGCs along with other pluripotent stem cells when compared to PGCs. Other potential target genes were also found which may contribute toward a primed ESC-like state. These genes were exclusively upregulated in ESCs, IPSCs and ECCs including PARP1, CCNE1, CDK6, AURKA, MAD2L1, CCNG1, and CCNB1 which are involved in cell cycle regulation, cellular metabolism and DNA repair and replication. Gene classification analysis also confirmed that the distinguishing feature of EGCs compared to ESCs, ECCs, and IPSCs lies primarily in their genetic contribution to cellular metabolism, cell cycle, and cell adhesion. In contrast, several genes were found upregulated in PGCs which may help distinguish their unipotent state including HBA1, DMRT1, SPANXA1, and EHD2. Together, these findings provide the first glimpse into a unique genomic signature of human germ cells and pluripotent stem cells and provide genes potentially involved in defining different states of germ-line pluripotency.	[Pashai, Nikta; All, Angelo; Gupta, Siddharth] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Hao, Haiping] Johns Hopkins Univ, High Throughput Biol Ctr, Deep Sequencing & Microarray Core, Baltimore, MD USA; [All, Angelo] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Kerr, Candace L.] Johns Hopkins Univ, Stem Cell Program, Inst Cell Engn, Baltimore, MD USA; [Gearhart, John D.] Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Gearhart, John D.] Univ Penn, Dept Anim Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Kerr, Candace L.] Johns Hopkins Univ, Inst Cell Engn, Dept Gynecol & Obstet, Baltimore, MD USA; [Chaerkady, Raghothama] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [De Los Angeles, Alejandro] Childrens Hosp Boston, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA USA; [De Los Angeles, Alejandro] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [De Los Angeles, Alejandro] Harvard Stem Cell Inst, Cambridge, MA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University	Pashai, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	ckerr@jhmi.edu		Hao, Haiping/0000-0002-8826-1568	National Institute of Child Health and Human Development (NICHD) [R21 HD057487]; Maryland Stem Cell Research Funds [2007-MSCRFE-0210-01, 2008-MSCRFE-0129-00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057487] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Maryland Stem Cell Research Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was graciously supported by National Institute of Child Health and Human Development (NICHD) R21 HD057487 (CK) and Maryland Stem Cell Research Funds 2007-MSCRFE-0210-01 (CK) and by 2008-MSCRFE-0129-00 (CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Alagaratnam S, 2011, INT J ANDROL, V34, pE133, DOI 10.1111/j.1365-2605.2011.01169.x; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Assou S, 2007, STEM CELLS; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baharvand H, 2008, J PROTEOME RES, V7, P412, DOI 10.1021/pr700560t; Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Bignotti E, 2006, GYNECOL ONCOL, V103, P405, DOI 10.1016/j.ygyno.2006.03.056; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cai LY, 2007, LIFE SCI, V80, P1458, DOI 10.1016/j.lfs.2007.01.015; Chaerkady R, 2010, PROTEOMICS; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Corbet SW, 1999, ONCOGENE, V18, P1537, DOI 10.1038/sj.onc.1202436; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; DOLCI S, 1993, MOL REPROD DEV, V35, P134, DOI 10.1002/mrd.1080350206; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Gao FR, 2009, J BIOL CHEM, V284, P22263, DOI 10.1074/jbc.M109.033118; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gopalakrishnan S, 2009, MOL CANCER RES, V7, P1622, DOI 10.1158/1541-7786.MCR-09-0018; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guo YL, 2010, J MED GENET, V47, P616, DOI 10.1136/jmg.2009.074252; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; He ZP, 2005, REPRODUCTION, V130, P333, DOI 10.1530/rep.1.00694; Hiller M, 2010, STEM CELLS DEV; Hiller M, 2011, STEM CELLS DEV; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; Jaiswal AS, 2011, BIOCHEMISTRY-US, V50, P1901, DOI 10.1021/bi102000q; Juric D, 2005, P NATL ACAD SCI USA, V102, P17763, DOI 10.1073/pnas.0509082102; Kerr CL, 2008, HUM REPROD, V23, P589, DOI 10.1093/humrep/dem411; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; Kerr CL, 2006, SEMIN REPROD MED, V24, P304, DOI 10.1055/s-2006-952152; Kerr CL, 2006, METHOD ENZYMOL, V419, P400, DOI 10.1016/S0076-6879(06)19016-3; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kurisaki A, 2005, BIOCHEM BIOPH RES CO, V335, P667, DOI 10.1016/j.bbrc.2005.07.128; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Li Xiao Hong, 2002, Shi Yan Sheng Wu Xue Bao, V35, P142; Malki S, 2007, CANCER LETT, V255, P182, DOI 10.1016/j.canlet.2007.04.007; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; MCKAY DG, 1953, ANAT REC, V117, P201, DOI 10.1002/ar.1091170206; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Nagano K, 2005, PROTEOMICS, V5, P1346, DOI 10.1002/pmic.200400990; NAKAGAWA M, 2007, NAT BIOTECHNOL; Narayan S, 1997, J BIOL CHEM, V272, P30619, DOI 10.1074/jbc.272.49.30619; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2004, J BIOL CHEM; Onyango P, 2002, P NATL ACAD SCI USA, V99, P10599, DOI 10.1073/pnas.152327599; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Park IH, 2007, NATURE; Park JH, 2004, MOL CELLS, V17, P309; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; Prigione A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027352; Quinn MCJ, 2009, MOL CARCINOGEN, V48, P648, DOI 10.1002/mc.20511; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Rao RR, 2004, BIOTECHNOL BIOENG, V88, P273, DOI 10.1002/bit.20245; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Roos WP, 2007, CELL DEATH DIFFER, V14, P1422, DOI 10.1038/sj.cdd.4402136; Rossant J, 2007, NATURE, V448, P260, DOI 10.1038/448260a; RUOSLAHTI E, 1981, INT J CANCER, V27, P763, DOI 10.1002/ijc.2910270606; Sabour D, 2011, HUM MOL GENET, V20, P115, DOI 10.1093/hmg/ddq450; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorrentino E, 2007, GENE EXPR PATTERNS, V7, P714, DOI 10.1016/j.modgep.2007.02.002; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Tsunoda T, 2010, NEOPLASIA, V12, P397, DOI 10.1593/neo.10170; Turnpenny L, 2003, STEM CELLS, V21, P598, DOI 10.1634/stemcells.21-5-598; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Von Hoof D, 2006, EXPERT REV PROTEOMIC, V3, P427, DOI 10.1586/14789450.3.4.427; Wang L, 2010, TUMOR BIOL, V31, P225, DOI 10.1007/s13277-010-0036-6; WITSCHI E, 1963, OVARY, P1; Witschi Emil, 1948, CONTRIBUTIONS TO EMBRYOLOGY [CARNEGIE INST OF WASHINGTON PUBL], V32, P67; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292; Zhang L, 2007, CLIN CANCER RES, V13, P5314, DOI 10.1158/1078-0432.CCR-06-2660; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578; Zhang ZL, 2011, CHROMOSOMA, V120, P73, DOI 10.1007/s00412-010-0292-7; Zhu XF, 2011, MOL CELL BIOL, V31, P2413, DOI 10.1128/MCB.05242-11; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	112	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39088	10.1371/journal.pone.0039088	http://dx.doi.org/10.1371/journal.pone.0039088			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737227	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100026
J	da Silva, PGC; Benton, JL; Beltz, BS; Allodi, S				Chaves da Silva, Paula Grazielle; Benton, Jeanne L.; Beltz, Barbara S.; Allodi, Silvana			Adult Neurogenesis: Ultrastructure of a Neurogenic Niche and Neurovascular Relationships	PLOS ONE			English	Article							NEURAL STEM-CELLS; OLFACTORY PATHWAY; PANULIRUS-ARGUS; TIGHT JUNCTIONS; SUBCOMMISSURAL ORGAN; GLUTAMINE-SYNTHETASE; DECAPOD CRUSTACEANS; SEPTATE JUNCTIONS; REISSNERS FIBER; NERVOUS-SYSTEM	The first-generation precursors producing adult-born neurons in the crayfish (Procambarus clarkii) brain reside in a specialized niche located on the ventral surface of the brain. In the present work, we have explored the organization and ultrastructure of this neurogenic niche, using light-level, confocal and electron microscopic approaches. Our goals were to define characteristics of the niche microenvironment, examine the morphological relationships between the niche and the vasculature and observe specializations at the boundary between the vascular cavity located centrally in the niche. Our results show that the niche is almost fully encapsulated by blood vessels, and that cells in the vasculature come into contact with the niche. This analysis also characterizes the ultrastructure of the cell types in the niche. The Type I niche cells are by far the most numerous, and are the only cell type present superficially in the most ventral cell layers of the niche. More dorsally, Type I cells are intermingled with Types II, III and IV cells, which are observed far less frequently. Type I cells have microvilli on their apical cell surfaces facing the vascular cavity, as well as junctional complexes between adjacent cells, suggesting a role in regulating transport from the blood into the niche cells. These studies demonstrate a close relationship between the neurogenic niche and vascular system in P. clarkii. Furthermore, the specializations of niche cells contacting the vascular cavity are also typical of the interface between the blood/cerebrospinal fluid (CSF)-brain barriers of vertebrates, including cells of the subventricular zone (SVZ) producing new olfactory interneurons in mammals. These data indicate that tissues involved in producing adult-born neurons in the crayfish brain use strategies that may reflect fundamental mechanisms preserved in an evolutionarily broad range of species, as proposed previously. The studies described here extend our understanding of neurovascular relationships in the brain of P. clarkii by characterizing the organization and ultrastructure of the neurogenic niche and associated vascular tissues.	[Chaves da Silva, Paula Grazielle; Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Neurobiol, BR-21941 Rio De Janeiro, Brazil; [Chaves da Silva, Paula Grazielle; Allodi, Silvana] Univ Fed Rio de Janeiro, Programa Posgrad Ciencias Morfol, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Benton, Jeanne L.; Beltz, Barbara S.] Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Wellesley College	da Silva, PGC (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Neurobiol, BR-21941 Rio De Janeiro, Brazil.	sallodi@biof.ufrj.br	Allodi, Silvana/G-1781-2012; S, Allodi/AAR-7968-2020	Allodi, Silvana/0000-0002-3053-3866; Beltz, Barbara/0000-0001-5335-015X	National Science Foundation (NSF) [IOS 0818259]; NSF IOS [1121345]; Wellesley College	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF IOS(National Science Foundation (NSF)); Wellesley College	National Science Foundation (NSF) IOS 0818259. NSF IOS 1121345. Brachman Hoffman Fellowship from Wellesley College. Brazilian Financial Agencies FAPERJ, CNPq, FUJB/UFRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ABBOTT NJ, 1971, Z ZELLFORSCH MIK ANA, V120, P401, DOI 10.1007/BF00324900; Allodi S, 2006, GLIA, V53, P612, DOI 10.1002/glia.20317; Ayub N, 2011, DEV NEUROBIOL, V71, P351, DOI 10.1002/dneu.20864; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Bazin F, 1969, THESIS; Behr M, 2003, CLAUDIN MEGATRACHEA; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Beltz BS, 2011, EUR J NEUROSCI, V34, P870, DOI 10.1111/j.1460-9568.2011.07802.x; Beltz BS, 2001, P NATL ACAD SCI USA, V98, P12730, DOI 10.1073/pnas.231471298; Benton JL, 2008, GEN COMP ENDOCR, V158, P183, DOI 10.1016/j.ygcen.2008.07.016; Benton JL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-53; Benton JL, 2001, J NEUROBIOL, V46, P193, DOI 10.1002/1097-4695(20010215)46:3<193::AID-NEU1002>3.0.CO;2-8; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Chaves-Da-Silva PG, 2010, CELL TISSUE RES, V342, P179, DOI 10.1007/s00441-010-1045-x; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1997, J NEUROSCI, V17, P5046; Edens HA, 2000, ADV DRUG DELIVER REV, V41, P315, DOI 10.1016/S0169-409X(00)00049-1; FLOWER NE, 1975, J CELL SCI, V17, P221; FRANKE WW, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P14; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Gasparini F, 2007, DEV DYNAM, V236, P719, DOI 10.1002/dvdy.21073; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; HOSE JE, 1990, BIOL BULL, V178, P33, DOI 10.2307/1541535; Hoyo-Becerra C, 2006, CELL TISSUE RES, V326, P771, DOI 10.1007/s00441-006-0231-3; Hoyo-Becerra C, 2005, CELL TISSUE RES, V321, P429, DOI 10.1007/s00441-004-1040-1; Jilani SM, 2003, J HISTOCHEM CYTOCHEM, V51, P597, DOI 10.1177/002215540305100505; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; LANE NJ, 1994, TISSUE CELL, V26, P143, DOI 10.1016/0040-8166(94)90090-6; Linser PJ, 1997, GLIA, V20, P275; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Meiniel A, 2003, INT REV CYTOL, V230, P1, DOI 10.1016/S0074-7696(03)30001-4; Meiniel A, 2001, MICROSC RES TECHNIQ, V52, P484, DOI 10.1002/1097-0029(20010301)52:5<484::AID-JEMT1034>3.0.CO;2-0; NOIROTTIMOTHEE C, 1978, TISSUE CELL, V10, P125, DOI 10.1016/0040-8166(78)90011-3; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Peters AP, 1991, NEUROGLIAL CELLS FIN; Sandeman DC, 2009, DEV NEUROBIOL, V69, P530, DOI 10.1002/dneu.20722; Sandeman DCS, 1992, BIOL BULL, V183, P3044; Sandernan DC, 2011, ARTHROPOD STRUCT DEV, V40, P258, DOI 10.1016/j.asd.2011.03.001; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Schmidt M, 2007, J COMP NEUROL, V503, P64, DOI 10.1002/cne.21366; Schmidt M, 2011, J COMP NEUROL, V519, P2283, DOI 10.1002/cne.22657; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Sintoni S, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-1; Song CK, 2009, ARTHROPOD STRUCT DEV, V38, P339, DOI 10.1016/j.asd.2008.12.004; Sullivan JM, 2007, J MOL HISTOL, V38, P527, DOI 10.1007/s10735-007-9112-7; Sullivan JM, 2007, J COMP NEUROL, V500, P574, DOI 10.1002/cne.21187; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Wen CM, 2008, COMP BIOCHEM PHYS A, V149, P167, DOI 10.1016/j.cbpa.2007.11.005; Wiltrout C, 2007, NEUROCHEM INT, V50, P1028, DOI 10.1016/j.neuint.2007.04.011; WOOD RL, 1959, J BIOPHYS BIOCHEM CY, V6, P343, DOI 10.1083/jcb.6.3.343; Zhang Y, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-2; Zhang Y, 2009, DEV NEUROBIOL, V69, P415, DOI 10.1002/dneu.20717	57	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39267	10.1371/journal.pone.0039267	http://dx.doi.org/10.1371/journal.pone.0039267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723980	Green Published, gold			2022-12-25	WOS:000305652700062
J	Iglesias-Platas, I; Martin-Trujillo, A; Cirillo, D; Court, F; Guillaumet-Adkins, A; Camprubi, C; Bourc'his, D; Hata, K; Feil, R; Tartaglia, G; Arnaud, P; Monk, D				Iglesias-Platas, Isabel; Martin-Trujillo, Alex; Cirillo, Davide; Court, Franck; Guillaumet-Adkins, Amy; Camprubi, Cristina; Bourc'his, Deborah; Hata, Kenichiro; Feil, Robert; Tartaglia, Gian; Arnaud, Philippe; Monk, David			Characterization of Novel Paternal ncRNAs at the Plagl1 Locus, Including Hymai, Predicted to Interact with Regulators of Active Chromatin	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; LONG NONCODING RNAS; CONTROL REGION; ESTABLISHMENT; TRANSCRIPTION; METHYLATION; ZAC/PLAGL1; FAMILY; DOMAIN	Genomic imprinting is a complex epigenetic mechanism of transcriptional control that utilizes DNA methylation and histone modifications to bring about parent-of-origin specific monoallelic expression in mammals. Genes subject to imprinting are often organised in clusters associated with large non-coding RNAs (ncRNAs), some of which have cis-regulatory functions. Here we have undertaken a detailed allelic expression analysis of an imprinted domain on mouse proximal chromosome 10 comprising the paternally expressed Plagl1 gene. We identified three novel Plagl1 transcripts, only one of which contains protein-coding exons. In addition, we characterised two unspliced ncRNAs, Hymai, the mouse orthologue of HYMAI, and Plagl1it (Plagl1 intronic transcript), a transcript located in intron 5 of Plagl1. Imprinted expression of these novel ncRNAs requires DNMT3L-mediated maternal DNA methylation, which is also indispensable for establishing the correct chromatin profile at the Plagl1 DMR. Significantly, the two ncRNAs are retained in the nucleus, consistent with a potential regulatory function at the imprinted domain. Analysis with catRAPID, a protein-ncRNA association prediction algorithm, suggests that Hymai and Plagl1it RNAs both have potentially high affinity for Trithorax chromatin regulators. The two ncRNAs could therefore help to protect the paternal allele from DNA methylation by attracting Trithorax proteins that mediate H3 lysine-4 methylation.	[Iglesias-Platas, Isabel] Hosp St Joan de Deu, Fundacio St Joan de Deu, Serv Neonatol, Barcelona, Spain; [Martin-Trujillo, Alex; Court, Franck; Guillaumet-Adkins, Amy; Camprubi, Cristina; Monk, David] Bellvitge Inst Biomed Res, Canc Epigenet & Biol Program, Imprinting & Canc Grp, Lhospitalet De Llobregat, Catalonia, Spain; [Cirillo, Davide; Tartaglia, Gian] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona, Spain; [Bourc'his, Deborah] Inst Curie, Unite Genet & Biol Dev, INSERM, Paris, France; [Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Feil, Robert; Arnaud, Philippe] CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Feil, Robert; Arnaud, Philippe] Univ Montpellier, F-34059 Montpellier, France	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Iglesias-Platas, I (corresponding author), Hosp St Joan de Deu, Fundacio St Joan de Deu, Serv Neonatol, Barcelona, Spain.	dmonk@idibell.cat	Feil, Robert P/D-2087-2013; Arnaud, Philippe/O-9507-2015; Iglesias-Platas, Isabel/AGY-9649-2022; Tartaglia, Gian Gaetano/K-1229-2014	Feil, Robert P/0000-0002-5671-5860; Arnaud, Philippe/0000-0002-7937-8764; Iglesias-Platas, Isabel/0000-0003-1960-7614; court, franck/0000-0003-0327-9708; Tartaglia, Gian Gaetano/0000-0001-7524-6310; Bourc'his, Deborah/0000-0001-9499-7291	Ayuda Merck Serono- Fundacion Salud; Spanish Ministerio de Educacion y Ciencia [SAF2008-1578]; Centre National de la Recherche Scientifique [34622]; Agence National de la Recherche; 'Ligue Contre le Cancer'; Ligue contre le Cancer comite Herault and Association pour la Recherche sur la cancer-ARC [4980-]; FPU; BebeDue Spain	Ayuda Merck Serono- Fundacion Salud; Spanish Ministerio de Educacion y Ciencia(Spanish Government); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); 'Ligue Contre le Cancer'(Ligue nationale contre le cancer); Ligue contre le Cancer comite Herault and Association pour la Recherche sur la cancer-ARC; FPU(Spanish Government); BebeDue Spain	This work was supported by Ayuda Merck Serono- Fundacion Salud 2000 de Investigacion en Endocrinologia 2009 (to DM and IIP); Spanish Ministerio de Educacion y Ciencia (grant number SAF2008-1578 to DM); Centre National de la Recherche Scientifique "Projects for International Scientific Cooperation'' 34622 (to PA and DM); Agence National de la Recherche (to RF); 'Ligue Contre le Cancer' (to RF); Ligue contre le Cancer comite Herault and Association pour la Recherche sur la cancer-ARC no 4980- (for PA). DM is a Ramon y Cajal research fellow and AGA is funded by a FPU studentship. Research in the Neonatal Unit in Hospital Sant Joan de Deu is partially funded by an unrestricted grant from BebeDue Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, J BIOL CHEM, V278, P6041, DOI 10.1074/jbc.M210361200; Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Arima T, 2006, CYTOGENET GENOME RES, V113, P247, DOI 10.1159/000090839; Arima T, 2001, HUM MOL GENET, V10, P1475, DOI 10.1093/hmg/10.14.1475; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Bourc'his D., 2003, SCIENCE, V21, P2536; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hata K, 2002, DEVELOPMENT, V129, P1983; Henckel A, 2009, HUM MOL GENET, V18, P3375, DOI 10.1093/hmg/ddp277; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Mackay DJG, 2010, AM J MED GENET C, V154C, P335, DOI 10.1002/ajmg.c.30272; Mackay DJG, 2002, HUM GENET, V110, P139, DOI 10.1007/s00439-001-0671-5; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Monk D, 2010, BRIEF FUNCT GENOMICS, V9, P329, DOI 10.1093/bfgp/elq013; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Smith RJ, 2002, GENE, V292, P101, DOI 10.1016/S0378-1119(02)00666-2; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Valleley EM, 2007, HUM MOL GENET, V16, P972, DOI 10.1093/hmg/ddm041; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	30	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38907	10.1371/journal.pone.0038907	http://dx.doi.org/10.1371/journal.pone.0038907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723905	Green Published, gold			2022-12-25	WOS:000305652700039
J	Larrayoz, IM; de Luis, A; Rua, O; Velilla, S; Cabello, J; Martinez, A				Larrayoz, Ignacio M.; de Luis, Alberto; Rua, Oscar; Velilla, Sara; Cabello, Juan; Martinez, Alfredo			Molecular Effects of Doxycycline Treatment on Pterygium as Revealed by Massive Transcriptome Sequencing	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ENDOTHELIAL GROWTH-FACTOR; COLORECTAL-CANCER CELLS; RNA-SEQ; DIFFERENTIAL EXPRESSION; EPITHELIAL-CELLS; ACTIVATION; APOPTOSIS; NORMALIZATION	Pterygium is a lesion of the eye surface which involves cell proliferation, migration, angiogenesis, fibrosis, and extracellular matrix remodelling. Surgery is the only approved method to treat this disorder, but high recurrence rates are common. Recently, it has been shown in a mouse model that treatment with doxycycline resulted in reduction of the pterygium lesions. Here we study the mechanism(s) of action by which doxycycline achieves these results, using massive sequencing techniques. Surgically removed pterygia from 10 consecutive patients were set in short term culture and exposed to 0 (control), 50, 200, and 500 mg/ml doxycycline for 24 h, their mRNA was purified, reverse transcribed and sequenced through Illumina's massive sequencing protocols. Acquired data were subjected to quantile normalization and analyzed using cytoscape plugin software to explore the pathways involved. False discovery rate (FDR) methods were used to identify 332 genes which modified their expression in a dose-dependent manner upon exposure to doxycycline. The more represented cellular pathways included all mitochondrial genes, the endoplasmic reticulum stress response, integrins and extracellular matrix components, and growth factors. A high correlation was obtained when comparing ultrasequencing data with qRT-PCR and ELISA results. Doxycycline significantly modified the expression of important cellular pathways in pterygium cells, in a way which is consistent with the observed efficacy of this antibiotic to reduce pterygium lesions in a mouse model. Clinical trials are under way to demonstrate whether there is a benefit for human patients.	[Larrayoz, Ignacio M.; Cabello, Juan; Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain; [de Luis, Alberto] Ctr Biomed Res La Rioja CIBIR, Ultrasequencing & Bioinformat Core Facil, Logrono, Spain; [Rua, Oscar; Velilla, Sara] Hosp San Pedro, Ophthalmol Serv, Logrono, Spain		Larrayoz, IM (corresponding author), Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain.	amartinezr@riojasalud.es	Martinez, Alfredo/GQH-5998-2022; Cabello, Juan/AAM-1683-2020; Larrayoz, Ignacio M/I-5613-2012	Martinez, Alfredo/0000-0003-4882-4044; Cabello, Juan/0000-0002-3835-0116; Larrayoz, Ignacio M/0000-0003-1629-152X	Spain's Ministry of Health, Social Policy, and Equality [DIN-021]	Spain's Ministry of Health, Social Policy, and Equality	Supported by a Grant from Spain's Ministry of Health, Social Policy, and Equality, No. DIN-021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Besharati Mohammad Reza, 2011, Acta Med Iran, V49, P179; Bon G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1651; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Bradley JC, 2010, BRIT J OPHTHALMOL, V94, P815, DOI 10.1136/bjo.2008.151852; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Chui J, 2011, AM J PATHOL, V178, P817, DOI 10.1016/j.ajpath.2010.10.037; Coroneo M, 2011, EYE CONTACT LENS, V37, P214, DOI 10.1097/ICL.0b013e318223394e; Cox CA, 2010, OPHTHALMOLOGY, V117, P1782, DOI 10.1016/j.ophtha.2010.01.037; Di Girolamo N, 2004, PROG RETIN EYE RES, V23, P195, DOI 10.1016/j.preteyeres.2004.02.002; Di Girolamo N, 2002, INVEST OPHTH VIS SCI, V43, P3430; DUSHKU N, 1994, CURR EYE RES, V13, P473, DOI 10.3109/02713689408999878; Dzunic B, 2010, BOSNIAN J BASIC MED, V10, P307, DOI 10.17305/bjbms.2010.2677; Golub L M, 1998, Adv Dent Res, V12, P12; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaworski CJ, 2009, MOL VIS, V15, P2421; Jin J, 2003, CORNEA, V22, P473, DOI 10.1097/00003226-200307000-00015; John-Aryankalayil M, 2006, MOL VIS, V12, P55; Kandavel R, 2010, CORNEA, V29, P141, DOI 10.1097/ICO.0b013e3181b11630; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lai HC, 2010, EUR J PHARMACOL, V644, P176, DOI 10.1016/j.ejphar.2010.07.010; Lee CZ, 2004, STROKE, V35, P1715, DOI 10.1161/01.STR.0000129334.05181.b6; Liang D, 2008, CURR EYE RES, V33, P653, DOI 10.1080/02713680802245772; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Marcovich Arie L, 2010, Int Ophthalmol Clin, V50, P47, DOI 10.1097/IIO.0b013e3181e218f7; Mauro J, 2009, SEMIN OPHTHALMOL, V24, P130, DOI 10.1080/08820530902801106; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olgun A, 2007, ANN NY ACAD SCI, V1100, P241, DOI 10.1196/annals.1395.025; Onoda T, 2006, INT J CANCER, V118, P1309, DOI 10.1002/ijc.21447; Onoda T, 2004, J LAB CLIN MED, V143, P207, DOI 10.1016/j.lab.2003.12.012; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Riau AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014687; Rubins JB, 2001, J LAB CLIN MED, V138, P101, DOI 10.1067/mlc.2001.116591; Sagar J, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-31; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; Sourdeval M, 2006, FRONT BIOSCI-LANDMRK, V11, P3036, DOI 10.2741/2031; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tong L, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-14; Tsai YY, 2008, CORNEA, V27, P476, DOI 10.1097/ICO.0b013e3181644581; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wu J, 2006, CELL MOL LIFE SCI, V63, P949, DOI 10.1007/s00018-005-5565-6; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yeh YC, 2007, BIOCHEM PHARMACOL, V74, P969, DOI 10.1016/j.bcp.2007.06.031; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	54	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39359	10.1371/journal.pone.0039359	http://dx.doi.org/10.1371/journal.pone.0039359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724003	Green Submitted, Green Published, gold			2022-12-25	WOS:000305652700070
J	Rosa-Garrido, M; Ceballos, L; Alonso-Lecue, P; Abraira, C; Delgado, MD; Gandarillas, A				Rosa-Garrido, Manuel; Ceballos, Laura; Alonso-Lecue, Pilar; Abraira, Cristina; Dolores Delgado, M.; Gandarillas, Alberto			A Cell Cycle Role for the Epigenetic Factor CTCF-L/BORIS	PLOS ONE			English	Article							INSULATOR PROTEIN CTCF; DIFFERENTIAL EXPRESSION; NUCLEAR-ORGANIZATION; FACTOR BORIS; GENE; DNA; TRANSCRIPTION; SITES; CENTROSOME; NUCLEOLUS	CTCF is a ubiquitous epigenetic regulator that has been proposed as a master keeper of chromatin organisation. CTCF-like, or BORIS, is thought to antagonise CTCF and has been found in normal testis, ovary and a large variety of tumour cells. The cellular function of BORIS remains intriguing although it might be involved in developmental reprogramming of gene expression patterns. We here unravel the expression of CTCF and BORIS proteins throughout human epidermis. While CTCF is widely distributed within the nucleus, BORIS is confined to the nucleolus and other euchromatin domains. Nascent RNA experiments in primary keratinocytes revealed that endogenous BORIS is present in active transcription sites. Interestingly, BORIS also localises to interphase centrosomes suggesting a role in the cell cycle. Blocking the cell cycle at S phase or mitosis, or causing DNA damage, produced a striking accumulation of BORIS. Consistently, ectopic expression of wild type or GFP-BORIS provoked a higher rate of S phase cells as well as genomic instability by mitosis failure. Furthermore, down-regulation of endogenous BORIS by specific shRNAs inhibited both RNA transcription and cell cycle progression. The results altogether suggest a role for BORIS in coordinating S phase events with mitosis.	[Rosa-Garrido, Manuel; Ceballos, Laura; Alonso-Lecue, Pilar; Gandarillas, Alberto] Fdn Marques de Valdecilla, Cell Cycle Stem Cell Fate & Canc Lab, Inst Formac & Invest Marques de Valdecilla, Santander, Spain; [Rosa-Garrido, Manuel; Ceballos, Laura; Abraira, Cristina; Dolores Delgado, M.; Gandarillas, Alberto] Univ Cantabria, Dept Biol Mol, Inst Biomed & Biotecnol Cantabria, Consejo Super Invest Cient,SODERCAN, E-39005 Santander, Spain; [Gandarillas, Alberto] ADR Languedoc Roussillon, INSERM, Montpellier, France	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Rosa-Garrido, M (corresponding author), Fdn Marques de Valdecilla, Cell Cycle Stem Cell Fate & Canc Lab, Inst Formac & Invest Marques de Valdecilla, Santander, Spain.	ifimav.agandarillas@fmdv.org	Rosa-Garrido, Manuel/AAE-4188-2019; Delgado, M. Dolores/K-9056-2014	Rosa-Garrido, Manuel/0000-0002-2169-3972; Delgado, M. Dolores/0000-0003-4682-4040	Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (ISCIII-FIS; National Grants, Spain) [FIS-PI08/0829, FIS-PI11/00397]; Red Tematica de Investigacion Cooperativa en Cancer [RTICC-RD06/0020/017]; Programa Regiones Emergentes-EMER; Societe Francaise de Dermatologie (SFD, France; AG); Universidad de Cantabria-Fundacion Marques de Valdecilla-IFIMAV (Cantabria, Spain; Javier Leon-AG); University of Cantabria; Fundacion Leonardo Torres Quevedo; Fundacion Marque's de Valdecilla-IFIMAV;  [FIS-PI08/0890];  [FIS-PI11/02070]	Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (ISCIII-FIS; National Grants, Spain); Red Tematica de Investigacion Cooperativa en Cancer; Programa Regiones Emergentes-EMER; Societe Francaise de Dermatologie (SFD, France; AG); Universidad de Cantabria-Fundacion Marques de Valdecilla-IFIMAV (Cantabria, Spain; Javier Leon-AG); University of Cantabria; Fundacion Leonardo Torres Quevedo; Fundacion Marque's de Valdecilla-IFIMAV; ; 	This study was supported by the Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (ISCIII-FIS; National Grants, Spain): FIS-PI08/0829, FIS-PI11/00397 and Red Tematica de Investigacion Cooperativa en Cancer-RTICC-RD06/0020/017 (MDD); FIS-PI08/0890, FIS-PI11/02070 and Programa Regiones Emergentes-EMER (AG); by the Societe Francaise de Dermatologie (SFD, France; AG); and by a co-operative grant from Universidad de Cantabria-Fundacion Marques de Valdecilla-IFIMAV (Cantabria, Spain; Javier Leon-AG). MRG was recipient of a fellowship from University of Cantabria. Both MRG and PA were also funded by Fundacion Leonardo Torres Quevedo and Fundacion Marque's de Valdecilla-IFIMAV. AG is 'on leave' at the Institut National de la Sante et de la Recherche Medicale (INSERM, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Boisvert FM, 2000, J CELL BIOL, V148, P283, DOI 10.1083/jcb.148.2.283; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Campbell AE, 2010, BIOCH BIOPHYS RES CO; Casafont I, 2006, NEUROSCIENCE, V140, P453, DOI 10.1016/j.neuroscience.2006.02.030; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; Dazard JE, 2000, ONCOGENE, V19, P3693, DOI 10.1038/sj.onc.1203695; de Necochea-Campion R, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-213; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; Delgado MD, 1999, FEBS LETT, V444, P5, DOI 10.1016/S0014-5793(99)00013-7; Dundr M, 2002, MOL CELL, V9, P5, DOI 10.1016/S1097-2765(02)00433-1; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Fiorentino FP, 2011, J CELL PHYSL; Freije A, 2012, ONCOGENE, DOI [10. 1038/onc.2012.22, DOI 10.1038/ONC.2012.22.]; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gandarillas A, 2000, ONCOGENE, V19, P3278, DOI 10.1038/sj.onc.1203630; GEY GO, 1952, CANCER RES, V12, P264; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Hernandez-Hernandez A, 2012, CYTOGENET GENOME RES, V136, P89, DOI 10.1159/000335752; Hines WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009738; Hutten S, 2011, CHROMOSOMA, V120, P481, DOI 10.1007/s00412-011-0327-8; Jones TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022399; Kaiser BK, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-27; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Kholmanskikh O, 2008, INT J CANCER, V122, P777, DOI 10.1002/ijc.23140; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kovacs LAS, 2010, CELL CYCLE, V9, P1750, DOI 10.4161/cc.9.9.11792; Lewis A, 2004, CURR BIOL, V14, pR284, DOI 10.1016/j.cub.2004.03.026; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Monk M, 2008, MOL HUM REPROD, V14, P347, DOI 10.1093/molehr/gan025; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pugacheva EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013872; Rasko JEJ, 2001, CANCER RES, V61, P6002; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Recillas-Targa F, 2006, J CELL MOL MED, V10, P554, DOI 10.1111/j.1582-4934.2006.tb00420.x; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Rheinwald J. G, 1989, CELL GROWTH DIVISION; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Sluder G, 2010, CELL BIOL INT, V34, P1239, DOI 10.1042/CBI20100612; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Torrano V, 2005, J BIOL CHEM, V280, P28152, DOI 10.1074/jbc.M501481200; Torrano V, 2006, J CELL SCI, V119, P1746, DOI 10.1242/jcs.02890; van de Nobelen S, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-19; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Woloszynska-Read Anna, 2007, Cancer Immun, V7, P21; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zanet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015701; Zhang R, 2004, EXP CELL RES, V294, P86, DOI 10.1016/j.yexcr.2003.11.015; Zhang SS, 2004, J CELL SCI, V117, P3935, DOI 10.1242/jcs.01249; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195	73	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39371	10.1371/journal.pone.0039371	http://dx.doi.org/10.1371/journal.pone.0039371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724006	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700071
J	Runkel, F; Hintze, M; Griesing, S; Michels, M; Blanck, B; Fukami, K; Guenet, JL; Franz, T				Runkel, Fabian; Hintze, Maik; Griesing, Sebastian; Michels, Marion; Blanck, Birgit; Fukami, Kiyoko; Guenet, Jean-Louis; Franz, Thomas			Alopecia in a Viable Phospholipase C Delta 1 and Phospholipase C Delta 3 Double Mutant	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; HAIR FOLLICLE MORPHOGENESIS; KERATIN-ASSOCIATED PROTEINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; NUCLEAR PROCESSES; CELL-CYCLE; COMPREHENSIVE GUIDE; LABORATORY MICE; PLASMA-MEMBRANE; DOWN-REGULATION	Background: Inositol 1,4,5trisphosphate (IP3) and diacylglycerol (DAG) are important intracellular signalling molecules in various tissues. They are generated by the phospholipase C family of enzymes, of which phospholipase C delta (PLCD) forms one class. Studies with functional inactivation of Plcd isozyme encoding genes in mice have revealed that loss of both Plcd1 and Plcd3 causes early embryonic death. Inactivation of Plcd1 alone causes loss of hair (alopecia), whereas inactivation of Plcd3 alone has no apparent phenotypic effect. To investigate a possible synergy of Plcd1 and Plcd3 in postnatal mice, novel mutations of these genes compatible with life after birth need to be found. Methodology/Principal Findings: We characterise a novel mouse mutant with a spontaneously arisen mutation in Plcd3 (Plcd3(mNab)) that resulted from the insertion of an intracisternal A particle (IAP) into intron 2 of the Plcd3 gene. This mutation leads to the predominant expression of a truncated PLCD3 protein lacking the N-terminal PH domain. C3H mice that carry one or two mutant Plcd3(mNab) alleles are phenotypically normal. However, the presence of one Plcd3(mNab) allele exacerbates the alopecia caused by the loss of functional Plcd1 in Del(9)olt1Pas mutant mice with respect to the number of hair follicles affected and the body region involved. Mice double homozygous for both the Del(9) olt1Pas and the Plcd3(mNab) mutations survive for several weeks and exhibit total alopecia associated with fragile hair shafts showing altered expression of some structural genes and shortened phases of proliferation in hair follicle matrix cells. Conclusions/Significance: The Plcd3(mNab) mutation is a novel hypomorphic mutation of Plcd3. Our investigations suggest that Plcd1 and Plcd3 have synergistic effects on the murine hair follicle in specific regions of the body surface.	[Runkel, Fabian; Hintze, Maik; Griesing, Sebastian; Michels, Marion; Blanck, Birgit; Franz, Thomas] Univ Bonn, Inst Anat, Bonn, Germany; [Hintze, Maik; Griesing, Sebastian] LIMES, Bonn, Germany; [Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Hachioji, Tokyo 19203, Japan; [Guenet, Jean-Louis] Inst Pasteur, Dept Dev Biol, Paris, France	University of Bonn; University of Bonn; Tokyo University of Pharmacy & Life Sciences; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Runkel, F (corresponding author), Univ Klinikum Munster, Inst Anat, Munster, Germany.	thfranz@uni-bonn.de		Hintze, Maik/0000-0002-1066-6346				Akutagawa A, 2006, J BIOCHEM, V140, P619, DOI 10.1093/jb/mvj194; Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Awgulewitsch A, 2003, NATURWISSENSCHAFTEN, V90, P193, DOI 10.1007/s00114-003-0417-4; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Concepcion D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000484; Danielsen SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024419; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Fujii M, 2009, J CELL BIOCHEM, V108, P638, DOI 10.1002/jcb.22297; Fukami K, 2002, J BIOCHEM, V131, P293, DOI 10.1093/oxfordjournals.jbchem.a003102; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Fukami K, 2008, ADV ENZYME REGUL, V48, P261, DOI 10.1016/j.advenzreg.2007.11.010; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Godin CM, 2010, MOL PHARMACOL, V77, P388, DOI 10.1124/mol.109.061069; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Godwin AR, 1999, J INVEST DERM SYMP P, V4, P244, DOI 10.1038/sj.jidsp.5640221; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Hasdemir C, 2010, PACE, V33, P159, DOI 10.1111/j.1540-8159.2009.02606.x; Hirata M, 1998, JPN J PHARMACOL, V76, P255, DOI 10.1254/jjp.76.255; Hirata M, 2011, DIABETES, V60, P1926, DOI 10.2337/db10-1500; Hu XT, 2009, ONCOGENE, V28, P2466, DOI 10.1038/onc.2009.92; Ichinohe M, 2007, BIOCHEM BIOPH RES CO, V356, P912, DOI 10.1016/j.bbrc.2007.03.082; Irino Y, 2004, BIOCHEM BIOPH RES CO, V320, P537, DOI 10.1016/j.bbrc.2004.05.206; Ishikawa S, 1997, CYTOGENET CELL GENET, V78, P58, DOI 10.1159/000134629; Jave-Suarez LF, 2006, ARCH DERMATOL RES, V297, P372, DOI 10.1007/s00403-005-0623-3; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kaproth-Joslin KA, 2008, BIOCHEM J, V415, P439, DOI 10.1042/BJ20080233; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Kouchi Z, 2011, J BIOL CHEM, V286, P8459, DOI 10.1074/jbc.M110.171223; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Leung DW, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-15; Lien YC, 2006, CANCER RES, V66, P4329, DOI 10.1158/0008-5472.CAN-05-3424; Lin FG, 2001, BIOCHEM BIOPH RES CO, V286, P274, DOI 10.1006/bbrc.2001.5371; Liu NS, 1996, J BIOL CHEM, V271, P355, DOI 10.1074/jbc.271.1.355; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Magerl M, 2001, J INVEST DERMATOL, V116, P947, DOI 10.1046/j.0022-202x.2001.01368.x; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Mecklenburg L, 2004, J INVEST DERMATOL, V123, P1001, DOI 10.1111/j.0022-202X.2004.23442.x; Mecklenburg L, 2001, EXP MOL PATHOL, V71, P171, DOI 10.1006/exmp.2001.2386; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Naito Y, 2006, J BIOCHEM, V140, P785, DOI 10.1093/jb/mvj209; Nakamura M, 2001, EXP DERMATOL, V10, P369, DOI 10.1034/j.1600-0625.2001.100601.x; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Nakamura Y, 2009, PHYSIOLOGY, V24, P332, DOI 10.1152/physiol.00031.2009; Nebigil CG, 1997, BIOCHEMISTRY-US, V36, P15949, DOI 10.1021/bi971721m; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Okada M, 2010, NEUROSCI LETT, V472, P188, DOI 10.1016/j.neulet.2010.01.081; Paterson HF, 1995, BIOCHEM J, V312, P661, DOI 10.1042/bj3120661; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Pawelczyk T, 1998, EUR J BIOCHEM, V257, P169, DOI 10.1046/j.1432-1327.1998.2570169.x; Peterson RL, 2005, J INVEST DERM SYMP P, V10, P238, DOI 10.1111/j.1087-0024.2005.10114.x; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; Potter CS, 2011, J INVEST DERMATOL, V131, P828, DOI 10.1038/jid.2010.391; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Qin YR, 2008, INT J CANCER, V123, P826, DOI 10.1002/ijc.23577; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12742, DOI 10.1021/bi00166a005; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Resnick AC, 2008, FRONT BIOSCI-LANDMRK, V13, P856, DOI 10.2741/2726; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rogers MA, 2004, J INVEST DERMATOL, V122, P147, DOI 10.1046/j.0022-202X.2003.22128.x; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Runkel F, 2008, MAMM GENOME, V19, P691, DOI 10.1007/s00335-008-9150-9; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Seeds AM, 2007, ADV ENZYME REGUL, V47, P10, DOI 10.1016/j.advenzreg.2006.12.019; Seeds AM, 2007, BIOCHEM SOC SYMP, V74, P183, DOI 10.1042/BSS2007c16; Shimohama S, 1998, BIOCHEM BIOPH RES CO, V245, P722, DOI 10.1006/bbrc.1998.8307; Shimomura Y, 2005, J INVEST DERM SYMP P, V10, P230, DOI 10.1111/j.1087-0024.2005.10112.x; Sidhu RS, 2005, J BIOL CHEM, V280, P21933, DOI 10.1074/jbc.M412966200; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Sundberg JP, 2005, J INVEST DERM SYMP P, V10, P264, DOI 10.1111/j.1087-0024.2005.10126.x; Takabatake T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn235; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Wilson N, 1999, Exp Dermatol, V8, P367; Xiang TX, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12726; Yagisawa H, 2006, J CELL BIOCHEM, V97, P233, DOI 10.1002/jcb.20677; YAGISAWA H, 1994, J BIOL CHEM, V269, P20179; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417; Yagisawa H, 1999, BIOCHEM SOC T, V27, P652, DOI 10.1042/bst0270652; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014	98	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39203	10.1371/journal.pone.0039203	http://dx.doi.org/10.1371/journal.pone.0039203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723964	gold, Green Submitted, Green Published			2022-12-25	WOS:000305652700053
J	Sareen, D; Ebert, AD; Heins, BM; McGivern, JV; Ornelas, L; Svendsen, CN				Sareen, Dhruv; Ebert, Allison D.; Heins, Brittany M.; McGivern, Jered V.; Ornelas, Loren; Svendsen, Clive N.			Inhibition of Apoptosis Blocks Human Motor Neuron Cell Death in a Stem Cell Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							DIRECTED DIFFERENTIATION; MOUSE MODEL; IN-VITRO; SMN GENE; SURVIVAL; PROTEIN; SEVERITY; MICE; INDUCTION; RESVERATROL	Spinal muscular atrophy (SMA) is a genetic disorder caused by a deletion of the survival motor neuron 1 gene leading to motor neuron loss, muscle atrophy, paralysis, and death. We show here that induced pluripotent stem cell (iPSC) lines generated from two Type I SMA subjects-one produced with lentiviral constructs and the second using a virus-free plasmid-based approach-recapitulate the disease phenotype and generate significantly fewer motor neurons at later developmental time periods in culture compared to two separate control subject iPSC lines. During motor neuron development, both SMA lines showed an increase in Fas ligand-mediated apoptosis and increased caspase-8 and-3 activation. Importantly, this could be mitigated by addition of either a Fas blocking antibody or a caspase-3 inhibitor. Together, these data further validate this human stem cell model of SMA, suggesting that specific inhibitors of apoptotic pathways may be beneficial for patients.	[Sareen, Dhruv; Ornelas, Loren; Svendsen, Clive N.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Ebert, Allison D.; Heins, Brittany M.; McGivern, Jered V.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Cedars Sinai Medical Center; Medical College of Wisconsin	Sareen, D (corresponding author), Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA.	sareend@cshs.org; aebert@mcw.edu; Clive.Svendsen@cshs.org			National Institutes of Health [R21HD06899]; California Institute for Regenerative Medicine [219509]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by National Institutes of Health grant R21HD06899 (to ADE) and California Institute for Regenerative Medicine grant 219509 (to CNS, DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; BURGHES AHM, 1994, HUM GENET, V93, P305, DOI 10.1007/BF00212028; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Carter TA, 1997, HUM MOL GENET, V6, P229, DOI 10.1093/hmg/6.2.229; Chang T, 2011, STEM CELLS, V29, P2090, DOI 10.1002/stem.749; Cheah BC, 2010, IDRUGS, V13, P911; Choi K, 2011, J NEUROCHEM, V116, P438, DOI 10.1111/j.1471-4159.2010.07124.x; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Coovert DD, 2000, J MED GENET, V37, P536, DOI 10.1136/jmg.37.7.536; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Ebert AD, 2010, NAT REV DRUG DISCOV, V9, P1, DOI 10.1038/nrd3000; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ito Y, 2011, BRAIN DEV-JPN, V33, P321, DOI 10.1016/j.braindev.2010.06.009; Iwahashi H, 1997, NATURE, V390, P413, DOI 10.1038/37144; Jablonka S, 2000, J NEUROL, V247, P37, DOI 10.1007/s004150050555; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kerr DA, 2000, P NATL ACAD SCI USA, V97, P13312, DOI 10.1073/pnas.230364197; Lafont E, 2010, CELL DEATH DIFFER, V17, P642, DOI 10.1038/cdd.2009.130; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Lefebvre S, 1998, HUM MOL GENET, V7, P1531, DOI 10.1093/hmg/7.10.1531; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Luong MX, 2011, CELL STEM CELL, V8, P357, DOI 10.1016/j.stem.2011.03.002; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Naoi M, 2010, CURR PHARM DESIGN, V16, P2799, DOI 10.2174/138161210793176527; Ogier C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-68; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Parker GC, 2008, NEUROTOX RES, V13, P39, DOI 10.1007/BF03033366; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Sakla MS, 2008, HUM GENET, V122, P635, DOI 10.1007/s00439-007-0441-0; Sareen D, 2006, INVEST OPHTH VIS SCI, V47, P3708, DOI 10.1167/iovs.06-0119; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Sendtner M, 2010, NAT NEUROSCI, V13, P795, DOI 10.1038/nn.2565; Sureda FX, 2011, CURR PHARM DESIGN, V17, P230; Swoboda KJ, 2007, J CHILD NEUROL, V22, P957, DOI 10.1177/0883073807305665; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; The Huntington's Disease iPS Consortium, 2012, CELL STEM CE IN PRES; Trulzsch B, 2007, BRAIN RES, V1183, P1, DOI 10.1016/j.brainres.2007.09.025; Tsai LK, 2008, NEUROBIOL DIS, V31, P361, DOI 10.1016/j.nbd.2008.05.014; Tsai MS, 2006, MOL THER, V13, P1149, DOI 10.1016/j.ymthe.2006.02.008; Wang X, 2009, CNS NEUROSCI THER, V15, P345, DOI 10.1111/j.1755-5949.2009.00105.x; Watibayati MS, 2009, BRAIN DEV-JPN, V31, P42, DOI 10.1016/j.braindev.2008.08.012; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Ymlahi-Ouazzani Q, 2010, NEUROGENETICS, V11, P27, DOI 10.1007/s10048-009-0200-6; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550	58	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39113	10.1371/journal.pone.0039113	http://dx.doi.org/10.1371/journal.pone.0039113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723941	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700049
J	Xia, XY; Ge, M; Wang, ZX; Pan, XM				Xia, Xia-Yu; Ge, Meng; Wang, Zhi-Xin; Pan, Xian-Ming			Accurate Prediction of Protein Structural Class	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SECONDARY STRUCTURE PREDICTION; SEQUENCES; CLASSIFICATION; HOMOLOGY; DATABASE; REPRESENTATION; ALGORITHMS	Because of the increasing gap between the data from sequencing and structural genomics, the accurate prediction of the structural class of a protein domain solely from the primary sequence has remained a challenging problem in structural biology. Traditional sequence-based predictors generally select several sequence features and then feed them directly into a classification program to identify the structural class. The current best sequence-based predictor achieved an overall accuracy of 74.1% when tested on a widely used, non-homologous benchmark dataset 25PDB. In the present work, we built a multiple linear regression (MLR) model to convert the 440-dimensional (440D) sequence feature vector extracted from the Position Specific Scoring Matrix (PSSM) of a protein domain to a 4-dimensinal (4D) structural feature vector, which could then be used to predict the four major structural classes. We performed 10-fold cross-validation and jackknife tests of the method on a large non-homologous dataset containing 8,244 domains distributed among the four major classes. The performance of our approach outperformed all of the existing sequence-based methods and had an overall accuracy of 83.1%, which is even higher than the results of those predicted secondary structure-based methods.	[Xia, Xia-Yu; Ge, Meng; Wang, Zhi-Xin; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University	Xia, XY (corresponding author), Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing 100084, Peoples R China.	pan-xm@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022		Natural Science Foundation of China; Ministry of Science and Technology of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was funded by the Natural Science Foundation of China and the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bahar I, 1997, PROTEINS, V29, P172, DOI 10.1002/(SICI)1097-0134(199710)29:2<172::AID-PROT5>3.3.CO;2-D; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Bu WS, 1999, EUR J BIOCHEM, V266, P1043, DOI 10.1046/j.1432-1327.1999.00947.x; Cai YD, 2000, BIOCHIMIE, V82, P783, DOI 10.1016/S0300-9084(00)01161-5; Cai YD, 2003, J THEOR BIOL, V221, P115, DOI 10.1006/jtbi.2003.3179; Cai YD, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-3; Chou KC, 2004, BIOCHEM BIOPH RES CO, V321, P1007, DOI 10.1016/j.bbrc.2004.07.059; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 1998, PROTEINS, V31, P97, DOI 10.1002/(SICI)1097-0134(19980401)31:1<97::AID-PROT8>3.0.CO;2-E; Chou KC, 1999, BIOCHEM BIOPH RES CO, V264, P216, DOI 10.1006/bbrc.1999.1325; Costantini S, 2007, COMPUT BIOL CHEM, V31, P389, DOI 10.1016/j.compbiolchem.2007.08.010; Costantini S, 2009, BIOCHIMIE, V91, P226, DOI 10.1016/j.biochi.2008.09.005; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; Dong LH, 2006, J BIOMOL STRUCT DYN, V24, P239; Kedarisetti KD, 2006, BIOCHEM BIOPH RES CO, V348, P981, DOI 10.1016/j.bbrc.2006.07.141; Kurgan L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-226; Kurgan L, 2007, BIOCHEM BIOPH RES CO, V357, P453, DOI 10.1016/j.bbrc.2007.03.164; Kurgan LA, 2006, PATTERN RECOGN, V39, P2323, DOI 10.1016/j.patcog.2006.02.014; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZC, 2009, AMINO ACIDS, V37, P415, DOI 10.1007/s00726-008-0170-2; Liu T, 2011, AMINO ACIDS; Liu TG, 2010, BIOCHIMIE, V92, P1330, DOI 10.1016/j.biochi.2010.06.013; Liu TA, 2010, J THEOR BIOL, V267, P272, DOI 10.1016/j.jtbi.2010.09.007; Luo RY, 2002, EUR J BIOCHEM, V269, P4219, DOI 10.1046/j.1432-1033.2002.03115.x; Mizianty MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-414; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MUSKA SM, 1992, J MOL BIOL, V255, P713; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pan XM, 2001, PROTEINS, V43, P256, DOI 10.1002/prot.1036; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P577, DOI 10.1016/j.bbrc.2005.06.128; Wang ZX, 2000, PROTEINS, V38, P165, DOI 10.1002/(SICI)1097-0134(20000201)38:2<165::AID-PROT5>3.0.CO;2-V; Xiao X, 2006, J COMPUT CHEM, V27, P478, DOI 10.1002/jcc.20354; Xiao X, 2008, J COMPUT CHEM, V29, P2018, DOI 10.1002/jcc.20955; Yang JY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S9; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027	41	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e37653	10.1371/journal.pone.0037653	http://dx.doi.org/10.1371/journal.pone.0037653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723837	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700005
J	Bao, YY; Sakinc, T; Laverde, D; Wobser, D; Benachour, A; Theilacker, C; Hartke, A; Huebner, J				Bao, Yinyin; Sakinc, Tuerkan; Laverde, Diana; Wobser, Dominique; Benachour, Abdellah; Theilacker, Christian; Hartke, Axel; Huebner, Johannes			Role of mprF1 and mprF2 in the Pathogenicity of Enterococcus faecalis	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE RESISTANCE; BIOFILM FORMATION; TEICHOIC-ACIDS; CAPSULAR POLYSACCHARIDES; PROLONGED BACTEREMIA; EXTRACELLULAR DNA; VANCOMYCIN; SUSCEPTIBILITY; STREPTOCOCCUS; PHOSPHOLIPIDS	Background: Enterococcus faecalis is one of the leading causes of nosocomial infections. Due to its innate and acquired resistance to most antibiotics, identification of new targets for antimicrobial treatment of E. faecalis is a high priority. The multiple peptide resistance factor MprF, which was first described in Staphylococcus aureus, modifies phosphatidylglycerol with lysin and reduces the negative charge of the membrane, thus increasing resistance to cationic antimicrobial peptides. We studied the effect of mprF in E. faecalis regarding influence on bacterial physiology and virulence. Results: Two putative mprF paralogs (mprF1 and mprF2) were identified in E. faecalis by BLAST search using the well-described S. aureus gene as a lead. Two deletion mutants in E. faecalis 12030 were created by homologous recombination. Analysis of both mutants by thin-layer chromatography showed that inactivation of mprF2 abolishes the synthesis of three distinct amino-phosphatidylglycerols (PGs). In contrast, deletion of mprF1 did not interfere with the biosynthesis of amino-PG. Inactivation of mprF2 increased susceptibility against several antimicrobial peptides and resulted in a 42% increased biofilm formation compared to wild-type mprF. However, resistance to opsonic killing was increased in the mutant, while virulence in a mouse bacteremia model was unchanged. Conclusion: Our data suggest that only mprF2 is involved in the aminoacylation of PG in enterococci, and is probably responsible for synthesis of Lys-PG, Ala-PG, and Arg-PG, while mprF1 does not seem to have a role in aminoacylation. As in other Gram-positive pathogens, aminoacylation through MprF2 increases resistance against cationic antimicrobial peptides. Unlike mprF found in other bacteria, mprF2 does not seem to be a major virulence factor in enterococci.	[Bao, Yinyin; Sakinc, Tuerkan; Laverde, Diana; Wobser, Dominique; Theilacker, Christian; Huebner, Johannes] Univ Hosp, Dept Med, Div Infect Dis, Freiburg, Germany; [Bao, Yinyin; Benachour, Abdellah; Hartke, Axel] Univ Caen Basse Normandie, Stress Virulence EA4655 U2RM, Caen, France	University of Freiburg; Universite de Caen Normandie	Bao, YY (corresponding author), Univ Hosp, Dept Med, Div Infect Dis, Freiburg, Germany.	johannes.huebner@uniklinik-freiburg.de		Theilacker, Christian/0000-0003-0821-9202; Huebner, Johannes/0000-0003-1232-4646	German Ministry of Science and Education [0313933, 01 EO 0803]	German Ministry of Science and Education	Supported by grants from the German Ministry of Science and Education (ERA-Net PathoGenoMics 0313933 and BMBF 01 EO 0803). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Callegan MC, 1999, INFECT IMMUN, V67, P3348, DOI 10.1128/IAI.67.7.3348-3356.1999; Callegan MC, 1999, INFECT IMMUN, V67, P3357, DOI 10.1128/IAI.67.7.3357-3366.1999; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Fabretti F, 2005, INT J ARTIF ORGANS, V28, P1079, DOI 10.1177/039139880502801105; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Gould R M, 1967, Biochem Biophys Res Commun, V26, P512; Grande R, 2011, J APPL MICROBIOL, V110, P490, DOI 10.1111/j.1365-2672.2010.04911.x; Ho SW, 2008, EUR BIOPHYS J BIOPHY, V37, P421, DOI 10.1007/s00249-007-0227-2; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Huebner J, 2000, INFECT IMMUN, V68, P4631, DOI 10.1128/IAI.68.8.4631-4636.2000; Hufnagel M, 2004, J CLIN MICROBIOL, V42, P2548, DOI 10.1128/JCM.42.6.2548-2557.2004; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Johnston NC, 2004, FEMS MICROBIOL LETT, V233, P65, DOI 10.1016/j.femsle.2004.01.048; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Koch S, 2004, EXPERT OPIN BIOL TH, V4, P1519, DOI 10.1517/14712598.4.9.1519; Koten B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006424; Komatsuzawa H, 2001, FEMS MICROBIOL LETT, V203, P49, DOI 10.1111/j.1574-6968.2001.tb10819.x; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Kristian SA, 2003, INFECT IMMUN, V71, P546, DOI 10.1128/IAI.71.1.546-549.2003; Le Jeune A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009658; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Patel D, 2011, INT J ANTIMICROB AG, V38, P442, DOI 10.1016/j.ijantimicag.2011.06.010; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rigottier-Gois L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029023; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Ruzin A, 2003, BBA-GEN SUBJECTS, V1621, P117, DOI 10.1016/S0304-4165(03)00028-X; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Sambrook J., 2001, MOL CLONING; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Theilacker C, 2006, INFECT IMMUN, V74, P5703, DOI 10.1128/IAI.00570-06; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; Theilacker C, 2009, MOL MICROBIOL, V71, P1055, DOI [10.1111/j.1365-2958.2008.06587.x, 10.1111/j.1365-2958.2009.06587.x]; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005	57	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38458	10.1371/journal.pone.0038458	http://dx.doi.org/10.1371/journal.pone.0038458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723861	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300028
J	Biergans, SD; Jones, JC; Treiber, N; Galizia, CG; Szyszka, P				Biergans, Stephanie D.; Jones, Julia C.; Treiber, Nadine; Galizia, C. Giovanni; Szyszka, Paul			DNA Methylation Mediates the Discriminatory Power of Associative Long-Term Memory in Honeybees	PLOS ONE			English	Article							PROTEIN-KINASE; METHYLTRANSFERASE; INHIBITION; ODOR; PLASTICITY; CELLS; RECONSOLIDATION; ACTIVATION; NEURONS; CLONING	Memory is created by several interlinked processes in the brain, some of which require long-term gene regulation. Epigenetic mechanisms are likely candidates for regulating memory-related genes. Among these, DNA methylation is known to be a long lasting genomic mark and may be involved in the establishment of long-term memory. Here we demonstrate that DNA methyltransferases, which induce and maintain DNA methylation, are involved in a particular aspect of associative long-term memory formation in honeybees, but are not required for short-term memory formation. While long-term memory strength itself was not affected by blocking DNA methyltransferases, odor specificity of the memory (memory discriminatory power) was. Conversely, perceptual discriminatory power was normal. These results suggest that different genetic pathways are involved in mediating the strength and discriminatory power of associative odor memories and provide, to our knowledge, the first indication that DNA methyltransferases are involved in stimulus-specific associative long-term memory formation.	[Biergans, Stephanie D.; Treiber, Nadine; Galizia, C. Giovanni; Szyszka, Paul] Univ Konstanz, Dept Biol Neurobiol, Constance, Germany; [Jones, Julia C.] Univ Konstanz, Dept Biol Zool & Evolutionary Biol, Constance, Germany	University of Konstanz; University of Konstanz	Biergans, SD (corresponding author), Univ Konstanz, Dept Biol Neurobiol, Constance, Germany.	s.biergans@uq.edu.au	Galizia, C Giovanni/A-1771-2009; Jones, Julia/P-2339-2016; Szyszka, Paul/ABC-7508-2020; Biergans, Stephanie/H-4595-2019	Galizia, C Giovanni/0000-0001-8292-6031; Jones, Julia/0000-0002-3557-1941; Szyszka, Paul/0000-0003-2043-6656; Biergans, Stephanie/0000-0002-0120-1301	Bundesministerium fur Bildung und Forschung [01GQ0931]; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Bundesministerium fur Bildung und Forschung (01GQ0931 to P.S. and C.G.G.) and Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1985, P NATL ACAD SCI USA, V82, P2674, DOI 10.1073/pnas.82.9.2674; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Beumer JH, 2006, J CHROMATOGR B, V831, P147, DOI 10.1016/j.jchromb.2005.11.048; Champion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012388; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Denker M, 2010, EUR J NEUROSCI, V31, P119, DOI 10.1111/j.1460-9568.2009.07046.x; ERLANSON DA, 1993, J AM CHEM SOC, V115, P12583, DOI 10.1021/ja00079a047; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Faber T, 2001, NATURWISSENSCHAFTEN, V88, P472, DOI 10.1007/s001140100263; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Friedrich A, 2004, J NEUROSCI, V24, P4460, DOI 10.1523/JNEUROSCI.0669-04.2004; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Hourcade B, 2009, LEARN MEMORY, V16, P607, DOI 10.1101/lm.1445609; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Lockett GA, 2011, GENES BRAIN BEHAV; Lockett GA, 2010, NEUROREPORT, V21, P812, DOI 10.1097/WNR.0b013e32833ce5be; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Miklos GLG, 2011, HORM BEHAV, V59, P399, DOI 10.1016/j.yhbeh.2010.05.016; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Sandoz JC, 2003, NEUROSCIENCE, V120, P1137, DOI 10.1016/S0306-4522(03)00384-1; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Shi YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018808; SMITH BH, 1994, ANNU REV ENTOMOL, V39, P351, DOI 10.1146/annurev.en.39.010194.002031; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Szyszka P, 2011, J NEUROSCI, V31, P7229, DOI 10.1523/JNEUROSCI.6668-10.2011; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; van Bemmel DM, 2009, BIOCHEM PHARMACOL, V78, P633, DOI 10.1016/j.bcp.2009.05.017; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	50	52	55	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39349	10.1371/journal.pone.0039349	http://dx.doi.org/10.1371/journal.pone.0039349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724000	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300136
J	Cera, N; Delli Pizzi, S; Di Pierro, ED; Gambi, F; Tartaro, A; Vicentini, C; Galatioto, GP; Romani, GL; Ferretti, A				Cera, Nicoletta; Delli Pizzi, Stefano; Di Pierro, Ezio Domenico; Gambi, Francesco; Tartaro, Armando; Vicentini, Carlo; Galatioto, Giuseppe Paradiso; Romani, Gian Luca; Ferretti, Antonio			Macrostructural Alterations of Subcortical Grey Matter in Psychogenic Erectile Dysfunction	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; VISUAL SEXUAL STIMULI; MEDIAL PREOPTIC AREA; NUCLEUS-ACCUMBENS; MALE-RATS; BRAIN ACTIVATION; BEHAVIORAL-INHIBITION; HUMAN MALES; AROUSAL; HYPOTHALAMUS	Psychogenic erectile dysfunction (ED) has been defined as the persistent inability to attain and maintain an erection sufficient to permit sexual performance. It shows a high incidence and prevalence among men, with a significant impact on the quality of life. Few neuroimaging studies have investigated the cerebral basis of erectile dysfunctions observing the role played by prefrontal, cingulate, and parietal cortices during erotic stimulation. In spite of the well-known involvement of subcortical regions such as hypothalamus and caudate nucleus in male sexual response, and the key role of nucleus accumbens in pleasure and reward, poor attention was paid to their role in male sexual dysfunction. In this study, we determined the presence of grey matter (GM) atrophy patterns in subcortical structures such as amygdala, hippocampus, nucleus accumbens, caudate nucleus, putamen, pallidum, thalamus, and hypothalamus in patients with psychogenic ED and healthy men. After Rigiscan evaluation, urological, general medical, metabolic and hormonal, psychological and psychiatric assessment, 17 outpatients with psychogenic ED and 25 healthy controls were recruited for structural MRI session. Significant GM atrophy of nucleus accumbens was observed bilaterally in patients with respect to controls. Shape analysis showed that this atrophy was located in the left medial-anterior and posterior portion of accumbens. Left nucleus accumbens volumes in patients correlated with low erectile functioning as measured by IIEF-5 (International Index of Erectile Function). In addition, a GM atrophy of left hypothalamus was also observed. Our results suggest that atrophy of nucleus accumbens plays an important role in psychogenic erectile dysfunction. We believe that this change can influence the motivation-related component of sexual behavior. Our findings help to elucidate a neural basis of psychogenic erectile dysfunction.	[Cera, Nicoletta; Delli Pizzi, Stefano; Gambi, Francesco; Tartaro, Armando; Romani, Gian Luca; Ferretti, Antonio] Univ G DAnnunzio, Dept Neurosci & Imaging, ITAB, Chieti, Italy; [Di Pierro, Ezio Domenico; Vicentini, Carlo; Galatioto, Giuseppe Paradiso] Univ Aquila, Dept Hlth Sci, I-67100 Laquila, Italy; [Di Pierro, Ezio Domenico; Vicentini, Carlo; Galatioto, Giuseppe Paradiso] Hosp G Mazzini, Teramo, Italy	G d'Annunzio University of Chieti-Pescara; University of L'Aquila	Cera, N (corresponding author), Univ G DAnnunzio, Dept Neurosci & Imaging, ITAB, Chieti, Italy.	n.cera@unich.it	Pizzi, Stefano Delli/J-3935-2016; tartaro, armando at/K-2184-2016	Pizzi, Stefano Delli/0000-0003-4075-0132; tartaro, armando at/0000-0003-0095-2792; FERRETTI, Antonio/0000-0002-8459-0129; VICENTINI, Carlo/0000-0003-0776-0312; PARADISO GALATIOTO, Giuseppe/0000-0002-9453-7858; Cera, Nicoletta/0000-0002-2702-8789				Ambroggi F, 2011, J NEUROSCI, V31, P6820, DOI 10.1523/JNEUROSCI.6491-10.2011; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Argiolas A, 2004, PHYSIOL BEHAV, V83, P309, DOI 10.1016/j.physbeh.2004.08.019; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baroncini M, 2012, NEUROIMAGE, V59, P168, DOI 10.1016/j.neuroimage.2011.07.013; Becker JB, 2001, J NEUROSCI, V21, P3236, DOI 10.1523/JNEUROSCI.21-09-03236.2001; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; Derogatis LR, 1977, SCL 90R MANUAL 1 SCO; Dominguez JM, 2005, PHYSIOL BEHAV, V86, P356, DOI 10.1016/j.physbeh.2005.08.006; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; Frisoni GB, 2008, NEUROLOGY, V70, P2194, DOI 10.1212/01.wnl.0000313844.18381.a9; Georgiadis JR, 2010, NEUROIMAGE, V50, P208, DOI 10.1016/j.neuroimage.2009.12.034; Giuliano F, 2004, PHYSIOL BEHAV, V83, P189, DOI 10.1016/j.physbeh.2004.08.014; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Harte CB, 2008, J SEX MED, V5, P110, DOI 10.1111/j.1743-6109.2007.00637.x; Holle D, 2011, ANN NEUROL, V69, P533, DOI 10.1002/ana.22188; HOON EF, 1976, ARCH SEX BEHAV, V5, P291, DOI 10.1007/BF01542081; Hurtazo HA, 2008, NEUROSCIENCE, V152, P331, DOI 10.1016/j.neuroscience.2007.10.063; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE IN PRESS; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koch M, 1996, NEUROREPORT, V7, P1442, DOI 10.1097/00001756-199605310-00024; Kondo Y, 1998, BEHAV BRAIN RES, V91, P213; Lloyd SA, 1998, BRAIN RES, V463, P317; LUITEN PGM, 1987, PROG NEUROBIOL, V28, P1, DOI 10.1016/0301-0082(87)90004-9; Montorsi F, 2003, INT J IMPOT RES, V15, P203, DOI 10.1038/sj.ijir.3900999; Montorsi F, 2003, EUR UROL, V43, P405, DOI 10.1016/S0302-2838(03)00053-8; Paredes Raul G., 1997, V8, P68; Paredes RG, 1998, BRAIN RES, V813, P1, DOI 10.1016/S0006-8993(98)00914-7; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Redoute J, 2005, PSYCHONEUROENDOCRINO, V30, P461, DOI 10.1016/j.psyneuen.2004.12.003; Rosen R.C., 1988, PATTERNS SEXUAL AROU; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spielberg C, 1970, STATE TRAIT ANXIETY; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Wespes E, 2005, GUIDELINES ERECTILE; WEST CHK, 1992, BRAIN RES, V585, P49, DOI 10.1016/0006-8993(92)91189-L; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2; Zarei M, 2010, NEUROIMAGE, V49, P1, DOI 10.1016/j.neuroimage.2009.09.001; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	53	28	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39118	10.1371/journal.pone.0039118	http://dx.doi.org/10.1371/journal.pone.0039118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723943	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300096
J	Chue, CD; Wall, NA; Crabtree, NJ; Zehnder, D; Moody, WE; Edwards, NC; Steeds, RP; Townend, JN; Ferro, CJ				Chue, Colin D.; Wall, Nadezhda A.; Crabtree, Nicola J.; Zehnder, Daniel; Moody, William E.; Edwards, Nicola C.; Steeds, Richard P.; Townend, Jonathan N.; Ferro, Charles J.			Aortic Calcification and Femoral Bone Density Are Independently Associated with Left Ventricular Mass in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; VASCULAR CALCIFICATION; CARDIOVASCULAR RISK; PROGNOSTIC-SIGNIFICANCE; COMPUTED-TOMOGRAPHY; MINERAL DENSITY; STIFFNESS; OSTEOPOROSIS	Background: Vascular calcification and reduced bone density are prevalent in chronic kidney disease and linked to increased cardiovascular risk. The mechanism is unknown. We assessed the relationship between vascular calcification, femoral bone density and left ventricular mass in patients with stage 3 non-diabetic chronic kidney disease in a cross-sectional observational study. Methodology and Principal Findings: A total of 120 patients were recruited (54% male, mean age 55 +/- 14 years, mean glomerular filtration rate 50 +/- 13 ml/min/1.73 m(2)). Abdominal aortic calcification was assessed using lateral lumbar spine radiography and was present in 48%. Mean femoral Z-score measured using dual energy x-ray absorptiometry was 0.60 +/- 1.06. Cardiovascular magnetic resonance imaging was used to determine left ventricular mass. One patient had left ventricular hypertrophy. Subjects with aortic calcification had higher left ventricular mass compared to those without (56 +/- 16 vs. 48 +/- 12 g/m(2), P=0.002), as did patients with femoral Z-scores below zero (56 +/- 15 vs. 49 +/- 13 g/m(2), P=0.01). In univariate analysis presence of aortic calcification correlated with left ventricular mass (r=0.32, P=0.001); mean femoral Z-score inversely correlated with left ventricular mass (r= -0.28, P=0.004). In a multivariate regression model that included presence of aortic calcification, mean femoral Z-score, gender and 24-hour systolic blood pressure, 46% of the variability in left ventricular mass was explained (P < 0.001). Conclusions: In patients with stage 3 non-diabetic chronic kidney disease, lower mean femoral Z-score and presence of aortic calcification are independently associated with increased left ventricular mass. Further research exploring the pathophysiology that underlies these relationships is warranted.	[Chue, Colin D.; Moody, William E.; Edwards, Nicola C.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Chue, Colin D.; Moody, William E.; Edwards, Nicola C.; Steeds, Richard P.; Townend, Jonathan N.] Queen Elizabeth Hosp, Dept Cardiol, Birmingham B15 2TH, W Midlands, England; [Wall, Nadezhda A.] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Crabtree, Nicola J.] Birmingham Childrens Hosp, Dept Endocrinol, Birmingham, W Midlands, England; [Zehnder, Daniel] Univ Warwick, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Ferro, Charles J.] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Warwick; University of Birmingham	Chue, CD (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England.	charles.ferro@uhb.nhs.uk	Ferro, Charles J./O-8912-2016; ferro, charles/L-7250-2019	Ferro, Charles J./0000-0003-0577-7081; ferro, charles/0000-0003-0577-7081; Steeds, Richard/0000-0001-5687-2535	Genzyme Corporation; British Heart Foundation [PG/11/66/28982, FS/11/17/28700] Funding Source: researchfish; National Institute for Health Research [ACF-2010-09-008] Funding Source: researchfish	Genzyme Corporation(Sanofi-AventisGenzyme Corporation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by an unrestricted educational grant from Genzyme Corporation. Genzyme Corporation had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Adragao T, 2004, NEPHROL DIAL TRANSPL, V19, P1480, DOI 10.1093/ndt/gfh217; BANKS LM, 1994, EUR J CLIN INVEST, V24, P813, DOI 10.1111/j.1365-2362.1994.tb02024.x; Bellasi A, 2006, KIDNEY INT, V70, P1623, DOI 10.1038/sj.ki.5001820; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elder G, 2002, J BONE MINER RES, V17, P2094, DOI 10.1359/jbmr.2002.17.12.2094; Filgueira A, 2011, CLIN J AM SOC NEPHRO, V6, P1456, DOI 10.2215/CJN.10061110; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Gerber Y, 2011, CIRCULATION, V124, P297, DOI 10.1161/CIRCULATIONAHA.110.007195; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Haydar AA, 2004, KIDNEY INT, V65, P1790, DOI 10.1111/j.1523-1755.2004.00581.x; Inaba M, 2006, OSTEOPOROSIS INT, V17, P1506, DOI 10.1007/s00198-006-0154-6; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jankowska EA, 2009, EUR J HEART FAIL, V11, P28, DOI 10.1093/eurjhf/hfn004; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim Young-Hyo, 2010, Korean Circ J, V40, P573, DOI 10.4070/kcj.2010.40.11.573; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Moe SM, 2006, EUR J CLIN INVEST, V36, P51, DOI 10.1111/j.1365-2362.2006.01665.x; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Reinders A, 2006, BLOOD PRESS MONIT, V11, P293, DOI 10.1097/01.mbp.0000217998.96967.fb; Rix M, 1999, KIDNEY INT, V56, P1084, DOI 10.1046/j.1523-1755.1999.00617.x; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; SEEMAN E, 1989, NEW ENGL J MED, V320, P554, DOI 10.1056/NEJM198903023200903; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Sigrist M, 2006, NEPHROL DIAL TRANSPL, V21, P707, DOI 10.1093/ndt/gfi236; Taal MW, 2003, KIDNEY INT, V63, P1116, DOI 10.1046/j.1523-1755.2003.00837.x; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Toussain ND, 2008, NEPHROL DIAL TRANSPL, V23, P586, DOI 10.1093/ndt/gfm660; Turakhia MP, 2008, AM J CARDIOL, V102, P1131, DOI 10.1016/j.amjcard.2008.06.036; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Yildiz A, 2005, NEPHROL DIAL TRANSPL, V20, P760, DOI 10.1093/ndt/gfh611	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39241	10.1371/journal.pone.0039241	http://dx.doi.org/10.1371/journal.pone.0039241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723973	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300120
J	Dekeirsschieter, J; Stefanuto, PH; Brasseur, C; Haubruge, E; Focant, JF				Dekeirsschieter, Jessica; Stefanuto, Pierre-Hugues; Brasseur, Catherine; Haubruge, Eric; Focant, Jean-Francois			Enhanced Characterization of the Smell of Death by Comprehensive Two-Dimensional Gas Chromatography-Time-of-Flight Mass Spectrometry (GCxGC-TOFMS)	PLOS ONE			English	Article							HUMAN REMAINS; VOLATILE COMPOUNDS; HUMAN CADAVERS; DECOMPOSITION; DECAY; IDENTIFICATION; SEPARATIONS; EXTRACTION; SUCCESSION; DOTHIEPIN	Soon after death, the decay process of mammalian soft tissues begins and leads to the release of cadaveric volatile compounds in the surrounding environment. The study of postmortem decomposition products is an emerging field of study in forensic science. However, a better knowledge of the smell of death and its volatile constituents may have many applications in forensic sciences. Domestic pigs are the most widely used human body analogues in forensic experiments, mainly due to ethical restrictions. Indeed, decomposition trials on human corpses are restricted in many countries worldwide. This article reports on the use of comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GCxGC-TOFMS) for thanatochemistry applications. A total of 832 VOCs released by a decaying pig carcass in terrestrial ecosystem, i.e. a forest biotope, were identified by GCxGC-TOFMS. These postmortem compounds belong to many kinds of chemical class, mainly oxygen compounds (alcohols, acids, ketones, aldehydes, esters), sulfur and nitrogen compounds, aromatic compounds such as phenolic molecules and hydrocarbons. The use of GCxGC-TOFMS in study of postmortem volatile compounds instead of conventional GC-MS was successful.	[Dekeirsschieter, Jessica; Haubruge, Eric] Univ Liege, Gembloux Agrobio Tech, Dept Funct & Evolutionary Entomol, Gembloux, Belgium; [Stefanuto, Pierre-Hugues; Brasseur, Catherine; Focant, Jean-Francois] Univ Liege, Dept Chem Organ & Biol Analyt Chem, CART, Liege, Belgium	University of Liege; University of Liege	Dekeirsschieter, J (corresponding author), Univ Liege, Gembloux Agrobio Tech, Dept Funct & Evolutionary Entomol, Gembloux, Belgium.	JF.Focant@ulg.ac.be	Stefanuto, Pierre-Hugues/AAO-2390-2020	Stefanuto, Pierre-Hugues/0000-0002-1224-8869; Haubruge, Eric/0000-0002-8138-0476	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.), Belgium; Chemistry Department of the University of Liege	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.), Belgium(Fonds de la Recherche Scientifique - FNRS); Chemistry Department of the University of Liege	Jessica Dekeirsschieter was financially supported by a PhD grant from the Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (F.R.I.A.), Belgium. Catherine Brasseur and Pierre-Hugues Stefanuto were financially supported by a teaching assistant PhD grant from the Chemistry Department of the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam RE, 2007, J FORENSIC SCI, V52, P1007, DOI 10.1111/j.1556-4029.2007.00510.x; Akdeniz N, 2010, BIORESOURCE TECHNOL, V101, P71, DOI 10.1016/j.biortech.2009.07.076; Anderson Gail S., 2001, P143; Anderson GS, 1996, J FORENSIC SCI, V41, P617; Bornemissza G. F., 1957, Australian Journal of Zoology, V5, P1; Boumba VA, 2008, FORENSIC SCI INT, V174, P133, DOI 10.1016/j.forsciint.2007.03.018; CALLERY PS, 1984, J NEUROCHEM, V43, P1631, DOI 10.1111/j.1471-4159.1984.tb06088.x; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Cardeal ZL, 2008, TALANTA, V74, P793, DOI 10.1016/j.talanta.2007.07.021; CATTS EP, 1992, ANNU REV ENTOMOL, V37, P253, DOI 10.1146/annurev.en.37.010192.001345; Chen X, 2008, CHROMATOGRAPHIA, V68, P941, DOI 10.1365/s10337-008-0835-8; Clark M.A., 1997, FORENSIC TAPHONOMY P, P151; Cordero C, 2010, J CHROMATOGR A, V1217, P5848, DOI 10.1016/j.chroma.2010.07.006; DeGreeff LE, 2011, ANAL BIOANAL CHEM, V401, P1295, DOI 10.1007/s00216-011-5167-0; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dent BB, 2004, ENVIRON GEOL, V45, P576, DOI 10.1007/s00254-003-0913-z; Evans W.E.D, 1963, CHEM DEATH; Focant JF, 2005, J CHROMATOGR A, V1086, P45, DOI 10.1016/j.chroma.2005.05.090; Focant JF, 2005, J CHROMATOGR A, V1067, P265, DOI 10.1016/j.chroma.2004.10.095; Focant JF, 2004, TALANTA, V63, P1231, DOI 10.1016/j.talanta.2004.05.043; Focant JF, 2003, J CHROMATOGR A, V1019, P143, DOI 10.1016/j.chroma.2003.07.007; Frederickx C, 2011, BIOTECHNOL AGRON SOC, V15, P449; Galloway Alison, 1997, P139; Gennard DE, 2007, FORENSIC ENTOMOLOGY; GIDDINGS JC, 1984, ANAL CHEM, V56, P1258, DOI 10.1021/ac00276a003; Gill-King H., 1997, CHEM ULTRASTRUCTURAL, P93, DOI DOI 10.1201/9781439821923.SEC2; Goff ML, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P1, DOI 10.1007/978-1-4020-9684-6_1; Grassberger M, 2004, J MED ENTOMOL, V41, P511, DOI 10.1603/0022-2585-41.3.511; Hadrich C, 2010, INT J LEGAL MED, V124, P43, DOI 10.1007/s00414-009-0338-7; Harsanyi L., 1993, HISTOLOGY ANCIENT HU, P79; HART AJ, 2005, ANTENNA, V30, P159; Hoffman EM, 2009, FORENSIC SCI INT, V186, P6, DOI 10.1016/j.forsciint.2008.12.022; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; Kaliste E, 2007, WELF LAB AN, P3; Keller T, 2000, FORENSIC SCI INT, V109, P159, DOI 10.1016/S0379-0738(99)00234-0; Killam EW., 1990, DETECTION HUMAN REMA; Komar D, 1999, J FORENSIC SCI, V44, P405; Kovatsi L, 2011, J SEP SCI, V34, P1004, DOI 10.1002/jssc.201000921; Kusano M, 2011, ANAL BIOANAL CHEM, V400, P1817, DOI 10.1007/s00216-011-4950-2; LAMBOURN J, 1974, J INT MED RES, V2, P210, DOI 10.1177/030006057400200305; LeBlanc HN, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P205, DOI 10.1007/978-1-4020-9684-6_11; Leco, 2008, COMP FEAT CHROMATOF; Ledford EB, 2000, HRC-J HIGH RES CHROM, V23, P202; Notter SJ, 2008, EUR J LIPID SCI TECH, V110, P73, DOI 10.1002/ejlt.200700159; Oesterhelweg L, 2008, FORENSIC SCI INT, V174, P35, DOI 10.1016/j.forsciint.2007.02.031; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; Paterson S, 2004, J CHROMATOGR B, V813, P323, DOI 10.1016/j.jchromb.2004.10.036; Patterson DG, 2011, J CHROMATOGR A, V1218, P3274, DOI 10.1016/j.chroma.2010.10.084; Phillips JB, 1999, J CHROMATOGR A, V856, P331, DOI 10.1016/S0021-9673(99)00815-8; Prada PA, 2010, ANAL METHODS-UK, V2, P470, DOI 10.1039/b9ay00239a; Qu GL, 2008, ENVIRON MONIT ASSESS, V144, P277, DOI 10.1007/s10661-007-9991-9; REED H. B., 1958, AMER MIDLAND NAT, V59, P213, DOI 10.2307/2422385; Robards K, 1995, PRINCIPLES PRACTICE; RODRIGUEZ WC, 1983, J FORENSIC SCI, V28, P423, DOI 10.1520/JFS11524J; Schoenly KG, 2007, J MED ENTOMOL, V44, P881, DOI 10.1603/0022-2585(2007)44[881:CPACOF]2.0.CO;2; Schotsmans EMJ, 2012, FORENSIC SCI INT, V217, P50, DOI 10.1016/j.forsciint.2011.09.025; Semard G, 2009, COMP ANAL C, V55, P15, DOI 10.1016/S0166-526X(09)05502-0; Silva I, 2010, J CHROMATOGR A, V1217, P5511, DOI 10.1016/j.chroma.2010.06.050; Statheropoulos M, 2007, SCI TOTAL ENVIRON, V385, P221, DOI 10.1016/j.scitotenv.2007.07.003; Statheropoulos M, 2006, ANAL CHIM ACTA, V566, P207, DOI 10.1016/j.aca.2006.03.023; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Statheropoulos M, 2011, FORENSIC SCI INT, V210, P154, DOI 10.1016/j.forsciint.2011.02.023; Swann LM, 2010, ANAL CHIM ACTA, V682, P9, DOI 10.1016/j.aca.2010.09.052; van Deursen M, 2000, HRC-J HIGH RES CHROM, V23, P507; Vass A.A., 2001, MICROBIOL TODAY, V28, P190; Vass AA, 2002, J FORENSIC SCI, V47, P542; Vass AA, 2004, J FORENSIC SCI, V49, P760; VASS AA, 1992, J FORENSIC SCI, V37, P1236; Vass AA, 2008, J FORENSIC SCI, V53, P384, DOI 10.1111/j.1556-4029.2008.00680.x	69	89	89	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39005	10.1371/journal.pone.0039005	http://dx.doi.org/10.1371/journal.pone.0039005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723918	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300079
J	Manabe, YC; Hermans, SM; Lamorde, M; Castelnuovo, B; Mullins, CD; Kuznik, A				Manabe, Yukari C.; Hermans, Sabine M.; Lamorde, Mohammed; Castelnuovo, Barbara; Mullins, C. Daniel; Kuznik, Andreas			Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; 2 8-MONTH REGIMENS; RANDOMIZED-TRIAL; METAANALYSIS; OUTCOMES	Background: In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid plus rifampicin for 4 months (4HR) instead of 6HE. We compared the impact of a continuation phase using 6HE or 4HR on total cost and expected mortality from the perspective of the Ugandan national health system. Methodology/Principal Findings: Treatment costs and outcomes were determined by decision analysis. Median daily drug price was US$0.115 for HR and US$0.069 for HE. TB treatment failure or relapse and mortality rates associated with 6HE vs. 4HR were obtained from randomized trials and systematic reviews for HIV-negative (46% of TB cases; failure/relapse -6HE: 10.4% vs. 4HR: 5.2%; mortality -6HE: 5.6% vs. 4HR: 3.5%) and HIV-positive patients (54% of TB cases; failure or relapse -6HE: 13.7% vs. 4HR: 12.4%; mortality -6HE: 16.6% vs. 4HR: 10.5%). When the initial treatment is not successful, retreatment involves an additional 8-month drug-regimen at a cost of $110.70. The model predicted a mortality rate of 13.3% for patients treated with 6HE and 8.8% for 4HR; average treatment cost per patient was predicted at $26.07 for 6HE and $23.64 for 4HR. These results were robust to the inclusion of MDR-TB as an additional outcome after treatment failure or relapse. Conclusions/Significance: Combination therapy with 4HR in the continuation phase dominates 6HE as it is associated with both lower expected costs and lower expected mortality. These data support the WHO recommendation to transition to a continuation phase comprising 4HR.	[Manabe, Yukari C.; Hermans, Sabine M.; Lamorde, Mohammed; Castelnuovo, Barbara] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Hermans, Sabine M.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Lamorde, Mohammed] Trinity Coll Dublin, Dept Pharmacol & Therapeut, Dublin, Ireland; [Mullins, C. Daniel] Univ Maryland, Baltimore, MD 21201 USA; [Kuznik, Andreas] Pfizer Inc, New York, NY USA	Makerere University; Johns Hopkins University; Johns Hopkins Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Trinity College Dublin; University System of Maryland; University of Maryland Baltimore; Pfizer	Manabe, YC (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	ymanabe@jhmi.edu	Kawooya, Ismael/O-4541-2016	Kawooya, Ismael/0000-0002-7159-7153; Kuznik, Andreas/0000-0002-8634-8360; Lamorde, Mohammed/0000-0003-2218-6822; Mullins, C. Daniel/0000-0003-4322-2490; Hermans, Sabine/0000-0001-5146-2932	IDI; National Institutes of Health [N01AI90500C, IR24TW008886-02, 1R25TW009340-01]; Infectious Diseases Network for Treatment and Research in Africa (INTERACT) programme; Netherlands Organization for Scientific Research - WOTRO Science for Global Development: NACCAP [W 07.05.20100]; European Union [SANTE/2006/105-316]; Sewankambo Scholarship Programme at the IDI; Gilead Foundation; FOGARTY INTERNATIONAL CENTER [R24TW008886, R25TW009340] Funding Source: NIH RePORTER	IDI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infectious Diseases Network for Treatment and Research in Africa (INTERACT) programme; Netherlands Organization for Scientific Research - WOTRO Science for Global Development: NACCAP; European Union(European Commission); Sewankambo Scholarship Programme at the IDI; Gilead Foundation(Gilead Sciences); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by the IDI. The IDI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. YCM is receiving salary support from the National Institutes of Health (N01AI90500C, IR24TW008886-02, 1R25TW009340-01). SH receives monetary support from the Infectious Diseases Network for Treatment and Research in Africa (INTERACT) programme, financially supported by the Netherlands Organization for Scientific Research - WOTRO Science for Global Development: NACCAP [grant number W 07.05.20100] and the European Union [grant number SANTE/2006/105-316]. ML is supported by the Sewankambo Scholarship Programme at the IDI which is funded by Gilead Foundation.	[Anonymous], 2010, MOH UG CLIN GUID 201; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], 2008, GUID PROGR MAN DRUG; Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Hermans SM, 2012, J ACQUIR IM IN PRESS; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Kuznik A, TROPICAL DOCTOR, V42, P5; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Management Sciences for Health (MSH), 2008, INT DRUG PRIC IND GU; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; MOH, 2009, NAT ANT TREATM GUID; MoH, 2010, MIN HLTH MAN NAT TUB; Nunn AJ, 2011, INT J TUBERC LUNG D, V15, P741, DOI 10.5588/ijtld.10.0392; NUNN P, 1991, LANCET, V337, P627; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; WHO, 1991, WHOTUB91161; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, WHO TUB COUNTR PROF; World Health Organization, 1994, WHOTB94179; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd	26	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39187	10.1371/journal.pone.0039187	http://dx.doi.org/10.1371/journal.pone.0039187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723960	gold, Green Published			2022-12-25	WOS:000305583300113
J	Mayor, DJ; Thornton, B; Zuur, AF				Mayor, Daniel J.; Thornton, Barry; Zuur, Alain F.			Resource Quantity Affects Benthic Microbial Community Structure and Growth Efficiency in a Temperate Intertidal Mudflat	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; ORGANIC-MATTER; AUSTRALIAN ESTUARY; CARBON-DIOXIDE; FATTY-ACIDS; NITROGEN; METABOLISM; DEGRADATION; SEDIMENTS; ISOTOPE	Estuaries cover <1% of marine habitats, but the carbon dioxide (CO2) effluxes from these net heterotrophic systems contribute significantly to the global carbon cycle. Anthropogenic eutrophication of estuarine waterways increases the supply of labile substrates to the underlying sediments. How such changes affect the form and functioning of the resident microbial communities remains unclear. We employed a carbon-13 pulse-chase experiment to investigate how a temperate estuarine benthic microbial community at 6.5 degrees C responded to additions of marine diatom-derived organic carbon equivalent to 4.16, 41.60 and 416.00 mmol C m(-2). The quantities of carbon mineralized and incorporated into bacterial biomass both increased significantly, albeit differentially, with resource supply. This resulted in bacterial growth efficiency increasing from 0.40 +/- 0.02 to 0.55 +/- 0.04 as substrates became more available. The proportions of diatom-derived carbon incorporated into individual microbial membrane fatty acids also varied with resource supply. Future increases in labile organic substrate supply have the potential to increase both the proportion of organic carbon being retained within the benthic compartment of estuaries and also the absolute quantity of CO2 outgassing from these environments.	[Mayor, Daniel J.] Univ Aberdeen, Oceanlab, Inst Biol & Environm Sci, Aberdeen, Scotland; [Thornton, Barry] James Hutton Inst, Aberdeen, Scotland; [Zuur, Alain F.] Highland Stat Ltd, Newburgh, Aberdeen, Scotland	University of Aberdeen; James Hutton Institute	Mayor, DJ (corresponding author), Univ Aberdeen, Oceanlab, Inst Biol & Environm Sci, Aberdeen, Scotland.	dan.mayor@abdn.ac.uk	Mayor, Daniel/HDN-8520-2022	Mayor, Daniel/0000-0002-1295-0041	United Kingdom's Natural Environment Research Council [NE/G014744/1]; Rural and Environment Science and Analytical Services Division of the Scottish Government; Natural Environment Research Council [NE/G014744/1] Funding Source: researchfish; NERC [NE/G014744/1] Funding Source: UKRI	United Kingdom's Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Rural and Environment Science and Analytical Services Division of the Scottish Government; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DM is funded by the United Kingdom's Natural Environment Research Council (NE/G014744/1). BT received funding from the Rural and Environment Science and Analytical Services Division of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Arnosti C, 1998, MAR ECOL PROG SER, V165, P59, DOI 10.3354/meps165059; BAIRD D, 1981, ESTUAR COAST SHELF S, V13, P455, DOI 10.1016/S0302-3524(81)80041-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOETIUS A, 1994, MAR ECOL PROG SER, V104, P299, DOI 10.3354/meps104299; Borges AV, 2005, ESTUARIES, V28, P3, DOI 10.1007/BF02732750; Boschker HTS, 2002, FEMS MICROBIOL ECOL, V40, P85, DOI 10.1111/j.1574-6941.2002.tb00940.x; BRINCHIVERSEN J, 1990, FEMS MICROBIOL ECOL, V74, P345; Buhring SI, 2006, LIMNOL OCEANOGR, V51, P157; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Cook PLM, 2004, MAR ECOL PROG SER, V280, P39, DOI 10.3354/meps280039; Cook PLM, 2004, MAR ECOL PROG SER, V280, P25, DOI 10.3354/meps280025; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; del Giorgio PA, 2012, ENVIRON MICROBIOL, V14, P1296, DOI 10.1111/j.1462-2920.2012.02713.x; Edmonds JW, 2008, APPL ENVIRON MICROB, V74, P1836, DOI 10.1128/AEM.00854-07; Eyre BD, 2005, LIMNOL OCEANOGR, V50, P81, DOI 10.4319/lo.2005.50.1.0081; Fenchel T, 2000, BACTERIAL BIOGEOCHEM; FINDLAY S, 1982, MAR ECOL PROG SER, V8, P161, DOI 10.3354/meps008161; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Gazeau F, 2005, MAR ECOL PROG SER, V301, P23, DOI 10.3354/meps301023; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Gontikaki E, 2011, MAR ECOL PROG SER, V421, P39, DOI 10.3354/meps08892; Gontikaki E, 2011, DEEP-SEA RES PT I, V58, P160, DOI 10.1016/j.dsr.2010.11.011; Gribsholt B, 2003, LIMNOL OCEANOGR, V48, P2151, DOI 10.4319/lo.2003.48.6.2151; Grossart HP, 2001, LIMNOL OCEANOGR, V46, P267, DOI 10.4319/lo.2001.46.2.0267; GUCKERT JB, 1985, FEMS MICROBIOL ECOL, V31, P147, DOI 10.1111/j.1574-6968.1985.tb01143.x; GUCKERT JB, 1986, APPL ENVIRON MICROB, V52, P794, DOI 10.1128/AEM.52.4.794-801.1986; Harvey HR, 2006, AQUAT MICROB ECOL, V42, P105, DOI 10.3354/ame042105; Heip CHR, 1995, OCEANOGR MAR BIOL, V33, P1; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Hubas C, 2007, MAR ECOL PROG SER, V344, P39, DOI 10.3354/meps06947; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Jonkers HM, 2005, MICROBIAL ECOL, V49, P291, DOI 10.1007/s00248-004-0260-y; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; KELLEY CA, 1990, LIMNOL OCEANOGR, V35, P372, DOI 10.4319/lo.1990.35.2.0372; KELLY JR, 1984, MAR ECOL PROG SER, V17, P157, DOI 10.3354/meps017157; Kirchman DL, 2005, DEEP-SEA RES PT II, V52, P3386, DOI 10.1016/j.dsr2.2005.09.005; Kostka JE, 1999, MAR ECOL PROG SER, V180, P7, DOI 10.3354/meps180007; Lopez-Urrutia A, 2007, ECOLOGY, V88, P817, DOI 10.1890/06-1641; Mayor DJ, 2012, ISME J, V6, P1740, DOI 10.1038/ismej.2012.14; Mayor DJ, 2011, FUNCT ECOL, V25, P509, DOI 10.1111/j.1365-2435.2010.01791.x; Mayor DJ, 2010, ENVIRON SCI TECHNOL, V44, P2079, DOI 10.1021/es903073h; MIDDELBURG JJ, 1995, HYDROBIOLOGIA, V311, P57, DOI 10.1007/BF00008571; Midwood AJ, 2006, RAPID COMMUN MASS SP, V20, P3379, DOI 10.1002/rcm.2749; Moens T, 2007, POLAR BIOL, V31, P1, DOI 10.1007/s00300-007-0323-x; Moodley L, 2005, J MAR RES, V63, P457, DOI 10.1357/0022240053693662; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Porubsky WP, 2009, ESTUAR COAST SHELF S, V83, P392, DOI 10.1016/j.ecss.2009.04.012; TAYLOR J, 1983, J GEN MICROBIOL, V129, P3303; Thornton B, 2011, RAPID COMMUN MASS SP, V25, P2433, DOI 10.1002/rcm.5148; Urban-Malinga B, 2006, J SEA RES, V56, P239, DOI 10.1016/j.seares.2006.05.003; van Nugteren P, 2009, MAR BIOL, V156, P2277, DOI 10.1007/s00227-009-1255-5; van Oevelen D, 2006, J MAR RES, V64, P453, DOI 10.1357/002224006778189581; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	62	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38582	10.1371/journal.pone.0038582	http://dx.doi.org/10.1371/journal.pone.0038582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723867	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000305583300032
J	Sukseree, S; Mildner, M; Rossiter, H; Pammer, J; Zhang, CF; Watanapokasin, R; Tschachler, E; Eckhart, L				Sukseree, Supawadee; Mildner, Michael; Rossiter, Heidemarie; Pammer, Johannes; Zhang, Cheng-Feng; Watanapokasin, Ramida; Tschachler, Erwin; Eckhart, Leopold			Autophagy in the Thymic Epithelium Is Dispensable for the Development of Self-Tolerance in a Novel Mouse Model	PLOS ONE			English	Article							CELL; DIFFERENTIATION; MACROAUTOPHAGY; PROGENITOR; SELECTION; IMMUNITY; MICE	The thymic epithelium plays critical roles in the positive and negative selection of T cells. Recently, it was proposed that autophagy in thymic epithelial cells is essential for the induction of T cell tolerance to self antigens and thus for the prevention of autoimmune diseases. Here we have tested this hypothesis using mouse models in which autophagy was blocked specifically in epithelial cells expressing keratin 14 (K14), including the precursor of thymic epithelial cells. While the thymic epithelial cells of mice carrying the floxed Atg7 gene (ATG7 f/f) showed a high level of autophagy, as determined by LC3 Western blot analysis and fluorescence detection of the recombinant green fluorescent protein (GFP)-LC3 reporter protein on autophagosomes, autophagy in the thymic epithelium was efficiently suppressed by deletion of the Atg7 gene using the Cre-loxP system (ATG7 f/f K14-Cre). Suppression of autophagy led to the massive accumulation of p62/ sequestosome 1 (SQSTM1) in thymic epithelial cells. However, the structure of the thymic epithelium as well as the organization and the size of the thymus were not altered in mutant mice. The ratio of CD4 to CD8-positive T cells, as well as the frequency of activated (CD69+) CD4 T cells in lymphoid organs, did not differ between mice with autophagy-competent and autophagy-deficient thymic epithelium. Inflammatory infiltrating cells, potentially indicative of autoimmune reactions, were present in the liver, lung, and colon of a similar fraction of ATG7 f/f and ATG7 f/f K14-Cre mice. In contrast to previously reported mice, that had received an autophagy-deficient thymus transplant, ATG7 f/f K14-Cre mice did not suffer from autoimmunity-induced weight loss. In summary, the results of this study suggest that autophagy in the thymic epithelium is dispensable for negative selection of autoreactive T cells.	[Sukseree, Supawadee; Mildner, Michael; Rossiter, Heidemarie; Zhang, Cheng-Feng; Tschachler, Erwin; Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Dept Dermatol, Vienna, Austria; [Sukseree, Supawadee; Watanapokasin, Ramida] Srinakharinwirot Univ, Fac Med, Dept Biochem, Bangkok, Thailand; [Pammer, Johannes] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Zhang, Cheng-Feng] Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai 200433, Peoples R China	Medical University of Vienna; Srinakharinwirot University; Medical University of Vienna; Fudan University	Sukseree, S (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Dept Dermatol, Vienna, Austria.	leopold.eckhart@meduniwien.ac.at	Sukseree, Supawadee/AAT-6545-2020	Sukseree, Supawadee/0000-0002-7011-9352; Eckhart, Leopold/0000-0002-5645-2036; Mildner, Michael/0000-0002-6892-925X; Tschachler, Erwin/0000-0002-0248-1798	European Cooperation in Science and Technology Action [BM0903]; Austrian South-East Asian University Partnership Network (ASEA-UNINET)	European Cooperation in Science and Technology Action; Austrian South-East Asian University Partnership Network (ASEA-UNINET)	The study was partly supported by the European Cooperation in Science and Technology Action BM0903 (Skin Barrier in Atopic Diseases, SkinBAD) (http://www.cost.eu/domains_actions/bmbs/Actions/BM0903) and Austrian South-East Asian University Partnership Network (ASEA-UNINET) (http://www.oead.at/index.php?id=420&L=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Crotzer VL, 2010, IMMUNOLOGY, V131, P9, DOI 10.1111/j.1365-2567.2010.03321.x; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Fischer H, 2007, J INVEST DERMATOL, V127, P24, DOI 10.1038/sj.jid.5700503; Ichimura Y, 2011, EXP ANIM TOKYO, V60, P329, DOI 10.1538/expanim.60.329; Kasai M, 2009, J IMMUNOL, V183, P7278, DOI 10.4049/jimmunol.0804087; Klein L, 2011, TRENDS IMMUNOL, V32, P188, DOI 10.1016/j.it.2011.03.002; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Maronpot R, 1999, PATHOLOGY MOUSE; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Nedjic J, 2009, CURR OPIN IMMUNOL, V21, P92, DOI 10.1016/j.coi.2009.01.013; Nowell CS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002348; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Santambrogio L, 2011, AUTOPHAGY, V7, P652, DOI 10.4161/auto.7.6.15287; Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	24	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38933	10.1371/journal.pone.0038933	http://dx.doi.org/10.1371/journal.pone.0038933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719991	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300068
J	Zhang, X; Shi, MM; Shen, DW; Chen, XY				Zhang, Xin; Shi, Miao-Miao; Shen, Dong-Wei; Chen, Xiao-Yong			Habitat Loss other than Fragmentation per se Decreased Nuclear and Chloroplast Genetic Diversity in a Monoecious Tree	PLOS ONE			English	Article							RECENT POPULATION BOTTLENECKS; ALLELE FREQUENCY DATA; VAR. SIEBOLDII NAKAI; WIND-POLLINATED TREE; MICROSATELLITE MARKERS; ISLAND BIOGEOGRAPHY; PLANT-POPULATIONS; FOREST; POLLEN; DIFFERENTIATION	Generally, effect of fragmentation per se on biodiversity has not been separated from the effect of habitat loss. In this paper, using nDNA and cpDNA SSRs, we studied genetic diversity of Castanopsis sclerophylla (Lindl. & Paxton) Schotty populations and decoupled the effects of habitat loss and fragmentation per se. We selected seven nuclear and six cpDNA microsatellite loci and genotyped 460 individuals from mainland and island populations, which were located in the impoundment created in 1959. Number of alleles per locus of populations in larger habitats was significantly higher than that in smaller habitats. There was a significant relationship between the number of alleles per locus and habitat size. Based on this relationship, the predicted genetic diversity of an imaginary population of size equaling the total area of the islands was lower than that of the global population on the islands. Re-sampling demonstrated that low genetic diversity of populations in small habitats was caused by unevenness in sample size. Fisher's alpha index was similar among habitat types. These results indicate that the decreased nuclear and chloroplast genetic diversity of populations in smaller habitats was mainly caused by habitat loss. For nuclear and chloroplast microsatellite loci, values of F-ST were 0.066 and 0.893, respectively, and the calculated pollen/seed dispersal ratio was 162.2. When separated into pre-and post-fragmentation cohorts, pollen/seed ratios were 121.2 and 189.5, respectively. Our results suggest that habitat loss explains the early decrease in genetic diversity, while fragmentation per se may play a major role in inbreeding and differentiation among fragmented populations and later loss of genetic diversity.	[Zhang, Xin; Shi, Miao-Miao; Shen, Dong-Wei; Chen, Xiao-Yong] E China Normal Univ, Sch Resources & Environm Sci, Tiantong Natl Observat Stn Forest Ecosyst, Shanghai 200062, Peoples R China; [Zhang, Xin] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Shi, Miao-Miao] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany	East China Normal University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Zhang, X (corresponding author), E China Normal Univ, Sch Resources & Environm Sci, Tiantong Natl Observat Stn Forest Ecosyst, Shanghai 200062, Peoples R China.	xychen@des.ecnu.edu.cn	Chen, Xiao-Yong/B-1467-2009	Chen, Xiao-Yong/0000-0002-4795-8940	National Natural Science Foundation of China [30470287, 30970430]; Fundamental Research Funds for the Central Universities [78220028]; Sino-Swiss Science and Technology Cooperation [EG 33-032010]; "211 Projects'' of East China Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Sino-Swiss Science and Technology Cooperation; "211 Projects'' of East China Normal University	Field works and lab experiments were supported by the National Natural Science Foundation of China (30470287, 30970430) and the Fundamental Research Funds for the Central Universities (78220028). XYC was supported by the Sino-Swiss Science and Technology Cooperation (EG 33-032010) to visit University of Bern for partial data anlysis. "211 Projects'' of East China Normal University supported the equipment of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianoelina O, 2009, ANN BOT-LONDON, V104, P1231, DOI 10.1093/aob/mcp231; [Anonymous], 1997, TFPGA TOOLS POPULATI; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Broadhurst LM, 2008, BIOL CONSERV, V141, P2843, DOI 10.1016/j.biocon.2008.08.021; Chen XY, 2008, FOREST ECOL MANAG, V256, P1143, DOI 10.1016/j.foreco.2008.06.014; Chen XY, 2009, ECOLOGY, V90, P39, DOI 10.1890/08-1520.1; Chen XY, 2011, SCI CHINA LIFE SCI, V54, P1055, DOI 10.1007/s11427-011-4238-y; Chen XY, 2000, ACTA ECOL SIN, V20, P884; Cornuet JM, 1996, GENETICS, V144, P2001; Deguilloux MF, 2003, MOL ECOL NOTES, V3, P24, DOI 10.1046/j.1471-8286.2003.00339.x; Dubreuil M, 2008, AM J BOT, V95, P577, DOI 10.3732/ajb.2007320; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fan XX, 2004, BIOCHEM GENET, V42, P269, DOI 10.1023/B:BIGI.0000034431.15308.57; Fineschi S, 2002, CONSERV GENET, V3, P145, DOI 10.1023/A:1015222230887; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gavish Y, 2012, CONSERV BIOL, V26, P150, DOI 10.1111/j.1523-1739.2011.01799.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HASTINGS A, 1977, THEOR POPUL BIOL, V12, P37, DOI 10.1016/0040-5809(77)90034-X; Honnay O, 2006, BIOL CONSERV, V127, P411, DOI 10.1016/j.biocon.2005.09.006; Jump AS, 2006, P NATL ACAD SCI USA, V103, P8096, DOI 10.1073/pnas.0510127103; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Lu HP, 2006, GENETICA, V128, P409, DOI 10.1007/s10709-006-7542-x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; QUINN JF, 1988, OECOLOGIA, V75, P132, DOI 10.1007/BF00378826; R Development Core Team, 2012, R LANG ENV STAT COMP; R Development Core Team and contributors worldwide, 2009, R STATS PACK VERS 2; Sebastiani F, 2004, MOL ECOL NOTES, V4, P259, DOI 10.1111/j.1471-8286.2004.00635.x; Squirrell J, 2001, AM J BOT, V88, P1409, DOI 10.2307/3558447; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Trapnell DW, 2004, MOL ECOL, V13, P2655, DOI 10.1111/j.1365-294X.2004.02281.x; Ueno S, 2000, MOL ECOL, V9, P1188, DOI 10.1046/j.1365-294x.2000.00954-11.x; Ueno S, 2003, CONSERV GENET, V4, P813, DOI 10.1023/B:COGE.0000006120.99339.10; Wang R, 2011, MOL ECOL, V20, P4421, DOI 10.1111/j.1365-294X.2011.05293.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Williams DA, 2007, BIOL CONSERV, V138, P256, DOI 10.1016/j.biocon.2007.04.024; Wu, 1980, VEGETATION CHINA; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.2307/3868264; Xu G., 2005, FOR INVENTORY PLAN FOR INVENTORY PLAN, V30, P25; Yaacobi G, 2007, P ROY SOC B-BIOL SCI, V274, P2409, DOI 10.1098/rspb.2007.0674; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zhang X, 2006, THESIS E CHINA NORMA; [张欣 ZHANG Xin], 2007, [生态学报, Acta Ecologica Sinica], V27, P424, DOI 10.1016/S1872-2032(07)60014-6; Zhao AL, 2006, BIODIVERS CONSERV, V15, P1339, DOI 10.1007/s10531-005-4875-1	52	11	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39146	10.1371/journal.pone.0039146	http://dx.doi.org/10.1371/journal.pone.0039146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723951	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300105
J	Fitting, C; Parlato, M; Adib-Conquy, M; Memain, N; Philippart, F; Misset, B; Monchi, M; Cavaillon, JM; Adrie, C				Fitting, Catherine; Parlato, Marianna; Adib-Conquy, Minou; Memain, Nathalie; Philippart, Francois; Misset, Benoit; Monchi, Mehran; Cavaillon, Jean-Marc; Adrie, Christophe			DNAemia Detection by Multiplex PCR and Biomarkers for Infection in Systemic Inflammatory Response Syndrome Patients	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; CARDIAC-ARREST; ORGAN FAILURE; APACHE-II; SEPSIS; IDENTIFICATION; DIAGNOSIS; BACTERIAL; EPIDEMIOLOGY; PATHOGENS	Fast and reliable assays to precisely define the nature of the infectious agents causing sepsis are eagerly anticipated. New molecular biology techniques are now available to define the presence of bacterial or fungal DNA within the bloodstream of sepsis patients. We have used a new technique (VYOO (R)) that allows the enrichment of microbial DNA before a multiplex polymerase chain reaction (PCR) for pathogen detection provided by SIRS-Lab (Jena, Germany). We analyzed 72 sepsis patients and 14 non-infectious systemic inflammatory response syndrome (SIRS) patients. Among the sepsis patients, 20 had a positive blood culture and 35 had a positive microbiology in other biological samples. Of these, 51.4% were positive using the VYOO (R) test. Among the sepsis patients with a negative microbiology and the non-infectious SIRS, 29.4% and 14.2% were positive with the VYOO (R) test, respectively. The concordance in bacterial identification between microbiology and the VYOO (R) test was 46.2%. This study demonstrates that these new technologies offer great hopes, but improvements are still needed.	[Fitting, Catherine; Parlato, Marianna; Adib-Conquy, Minou; Cavaillon, Jean-Marc] Inst Pasteur, Dept Infect & Epidemiol, Unit Cytokines & Inflammat, Paris, France; [Memain, Nathalie] Delafontaine Hosp, Serv Reanimat, St Denis, France; [Philippart, Francois; Misset, Benoit] Univ Paris 05, Grp Hosp Paris St Joseph, Serv Reanimat Med Chirurg, Paris, France; [Monchi, Mehran] Jacques Cartier Hosp, Serv Soins Intensifs, Massy Palaiseau, France; [Adrie, Christophe] Univ Paris 05, Cochin Hosp, Serv Physiol & Explorat Fonct, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Jacques Cartier Private Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Fitting, C (corresponding author), Inst Pasteur, Dept Infect & Epidemiol, Unit Cytokines & Inflammat, Paris, France.	jean-marc.cavaillon@pasteur.fr	Parlato, Marianna/H-9467-2017; Philippart, Francois/AAF-2791-2019; Misset, Benoit/P-7817-2018	Philippart, Francois/0000-0002-7323-0742; Misset, Benoit/0000-0001-6466-0065				Adib-Conquy M, 2007, SHOCK, V28, P406, DOI 10.1097/shk.0b013e3180488154; Adrie C, 2005, J CRIT CARE, V20, P46, DOI 10.1016/j.jcrc.2004.10.005; Adrie C, 2000, INTENS CARE MED, V26, P364, DOI 10.1007/s001340051169; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Bauer M, 2010, INT J MED MICROBIOL, V300, P411, DOI 10.1016/j.ijmm.2010.04.006; Birmingham MC, 1997, PHARMACOECONOMICS, V12, P637, DOI 10.2165/00019053-199712060-00004; Bloos F, 2009, CRIT CARE S4, V13, P9; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Cleven BEE, 2006, J CLIN MICROBIOL, V44, P2389, DOI 10.1128/JCM.02291-05; Dark PM, 2009, CRIT CARE, V13, DOI 10.1186/cc7886; Funk DJ, 2011, CRIT CARE CLIN, V27, P53, DOI 10.1016/j.ccc.2010.09.008; Gebert S, 2008, J INFECTION, V57, P307, DOI 10.1016/j.jinf.2008.07.013; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jordan JA, 2009, J CLIN MICROBIOL, V47, P368, DOI 10.1128/JCM.01991-08; Jordan JA, 2005, J MOL DIAGN, V7, P105, DOI 10.1016/S1525-1578(10)60015-3; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kobayashi T, 2000, FEMS IMMUNOL MED MIC, V28, P49, DOI 10.1111/j.1574-695X.2000.tb01456.x; Kortgen A, 2009, INFECTION, V37, P44; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08; Lamoth F, 2010, J CLIN MICROBIOL, V48, P3510, DOI 10.1128/JCM.00147-10; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Louie RF, 2008, CRIT CARE MED, V36, P1487, DOI 10.1097/CCM.0b013e31816f487c; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maubon D, 2010, J INFECTION, V61, P335, DOI 10.1016/j.jinf.2010.07.004; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Morgenthaler NG, 2005, CRIT CARE, V9, pR37, DOI 10.1186/cc3015; Pasqualini L, 2012, J CLIN MICROBIOL; PHAM LH, 1991, AM REV RESPIR DIS, V143, P1055, DOI 10.1164/ajrccm/143.5_Pt_1.1055; Pletz MW, 2011, INTENS CARE MED, V37, P1069, DOI 10.1007/s00134-011-2245-x; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Sobel JD, 2005, URINARY TRACT INFECT; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; Struck J, 2004, PEPTIDES, V25, P1369, DOI 10.1016/j.peptides.2004.06.019; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Turnidge J, 2003, SCAND J INFECT DIS, V35, P677, DOI 10.1080/00365540310015953; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 1997, CRIT CARE MED, V25, P372, DOI 10.1097/00003246-199702000-00029; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x	48	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38916	10.1371/journal.pone.0038916	http://dx.doi.org/10.1371/journal.pone.0038916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719987	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000029
J	Malik, A; Singhal, DK; Albanyan, A; Husain, SA; Kar, P				Malik, Abdul; Singhal, Deepak Kumar; Albanyan, Abdulmajeed; Husain, Syed Akhtar; Kar, P.			Hepatitis B Virus Gene Mutations in Liver Diseases: A Report from New Delhi	PLOS ONE			English	Article							CORE PROMOTER MUTATIONS; HEPATOCELLULAR-CARCINOMA; E-ANTIGEN; HBV GENOTYPES; CLINICAL-SIGNIFICANCE; PRECORE MUTATIONS; RISK; REGIONS; INCREASE; RESISTANCE	Objectives: The study was designed to characterize the surface, core promoter, precore/core region sequences for the presence of mutations in hepatitis B virus (HBV) associated with different liver diseases. Methods: 567 HBV associated patients with different liver diseases were enrolled in this study. All samples were analyzed for HBV surface, core promoter, precore/core region mutations and genotypes using PCR and direct sequencing. Results: HBV genotype D (72.8%) was the predominant type followed by genotype A (27.2%). The serum viral load of HBV was highest in HBsAg carriers group and lowest in patients with hepatocellular carcinoma. 17.9% patients with cirrhosis and 24.6% hepatocellular carcinoma cases were ADV-resistant with rtA181T/V mutations in the S-gene. A1896T was found more frequently in fulminant hepatic failure compared to acute viral hepatitis patients (p = 0.038). T1753V mutation was significantly higher in patients with cirrhosis of liver (34.6%) than in chronic hepatitis (18.9%) and hepatocellular carcinoma patients (21.2%; p = 0.001). T1762/A1764 mutation was observed in all the groups. C1914G core gene mutation was associated with the hepatocellular carcinoma (32.2%) compared to other groups. HBV genotype D predominated in comparison to genotype A. An increased frequency of precore mutation and BCP double mutations amongst the population studied was also observed. Conclusion: Mutations such as T1762/A1764, T1753V and C1914G were usually associated with advanced forms of liver disease and had an increased risk of HCC. The nucleotide variability in the basal core promoter and precore regions possibly plays a role in the progression of HBV disease. Prospective studies on the sequence variations of the preC/C region of the HBV genome and the molecular mechanisms in relation to progression of liver disease would aid in better understanding of the biological significance of HBV strains in India.	[Malik, Abdul; Albanyan, Abdulmajeed] King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Malik, Abdul; Singhal, Deepak Kumar; Kar, P.] Univ Delhi, Maulana Azad Med Coll, Dept Med, New Delhi, India; [Malik, Abdul; Husain, Syed Akhtar] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India	King Saud University; Maulana Azad Medical College; University of Delhi; Jamia Millia Islamia	Malik, A (corresponding author), King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia.	abdul.ksu@gmail.com	Malik Moinuddin, Abdul/GQP-0935-2022	, Abdul Malik/0000-0001-9370-8224; husain, syed akhtar/0000-0002-6513-7759				Abbas Z, 2006, BMC GASTROENTEROL, P6; Aggarwal R, 2003, J HEPATOL, V38, P215, DOI 10.1016/S0168-8278(02)00382-3; AKAHANE Y, 1990, GASTROENTEROLOGY, V99, P1113, DOI 10.1016/0016-5085(90)90632-B; AKARCA US, 1994, HEPATOLOGY, V19, P1366; Angus P, 2003, GASTROENTEROLOGY, V125, P292, DOI 10.1016/S0016-5085(03)00939-9; Bartholomeusz A, 2006, J MED VIROL, V78, pS52, DOI 10.1002/jmv.20608; Bruix J, 2001, J EASL PANEL EXPERTS; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Chan HLY, 2000, HEPATOLOGY, V31, P763, DOI 10.1002/hep.510310330; Chan HLY, 1999, HEPATOLOGY, V29, P976, DOI 10.1002/hep.510290352; Chen CH, 2006, J HEPATOL, V44, P76, DOI 10.1016/j.jhep.2005.08.022; Chen CH, 2005, J CLIN MICROBIOL, V43, P6000, DOI 10.1128/JCM.43.12.6000-6006.2005; Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990; Chen CH, 2007, LIVER INT, V27, P806, DOI 10.1111/j.1478-3231.2007.01505.x; Du H, 2007, LIVER INT, V27, P240, DOI 10.1111/j.1478-3231.2006.01400.x; Fang ZL, 2008, AM J GASTROENTEROL, V103, P2254, DOI 10.1111/j.1572-0241.2008.01974.x; Gandhe SS, 2003, J VIRAL HEPATITIS, V10, P367, DOI 10.1046/j.1365-2893.2003.00445.x; Hannoun C, 2000, J GEN VIROL, V81, P75, DOI 10.1099/0022-1317-81-1-75; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Irshad M, 2006, WORLD J GASTROENTERO, V12, P2432, DOI 10.3748/wjg.v12.i15.2432; Jain R C, 1992, J Assoc Physicians India, V40, P390; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Kao JH, 2002, J CLIN MICROBIOL, V40, P1207, DOI 10.1128/JCM.40.4.1207-1209.2002; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Kidd-Ljunggren K, 2004, J CLIN MICROBIOL, V42, P5837, DOI 10.1128/JCM.42.12.5837-5841.2004; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; LIANG TJ, 1991, NEW ENGL J MED, V324, P1705, DOI 10.1056/NEJM199106133242405; Lin CL, 2007, J GASTROEN HEPATOL, V22, P1098, DOI 10.1111/j.1440-1746.2006.04515.x; Mital V N, 1980, J Indian Med Assoc, V74, P105; OKAMOTO H, 1990, J VIROL, V64, P1298, DOI 10.1128/JVI.64.3.1298-1303.1990; Olinger CM, 2007, MED MICROBIOL IMMUN, V196, P247, DOI 10.1007/s00430-007-0050-5; Rezende REF, 2005, J CLIN VIROL, V32, P53, DOI 10.1016/j.jcv.2004.08.001; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Tacke F, 2004, J VIROL, V78, P8524, DOI 10.1128/JVI.78.16.8524-8535.2004; Takahashi K, 1999, ARCH VIROL, V144, P1299, DOI 10.1007/s007050050588; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Tatti KM, 2002, ANTIVIR RES, V55, P141, DOI 10.1016/S0166-3542(02)00019-0; Tian YJ, 2007, J CLIN MICROBIOL, V45, P2971, DOI 10.1128/JCM.00508-07; Tong MJ, 2007, LIVER INT, V27, P1356, DOI 10.1111/j.1478-3231.2007.01585.x; Trey C, 1970, Prog Liver Dis, V3, P282; Tsai WL, 2008, SCAND J GASTROENTERO, V43, P196, DOI 10.1080/00365520701745693; Tyagarajan SP, 1996, HEPATITIS B INDIA PR, P5; Wang ZH, 2007, J CLIN MICROBIOL, V45, P1491, DOI 10.1128/JCM.02157-06; Xiao L, 2011, J MED VIROL, V83, P1544, DOI 10.1002/jmv.22159; Xu ZH, 2011, J GASTROENTEROL, V46, P391, DOI 10.1007/s00535-010-0315-4; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859	47	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39028	10.1371/journal.pone.0039028	http://dx.doi.org/10.1371/journal.pone.0039028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720023	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347800039
J	Burwell, AK; Thula-Mata, T; Gower, LB; Habeliz, S; Kurylo, M; Ho, SP; Chien, YC; Cheng, J; Cheng, NF; Gansky, SA; Marshall, SJ; Marshall, GW				Burwell, Anora K.; Thula-Mata, Taili; Gower, Laurie B.; Habeliz, Stefan; Kurylo, Michael; Ho, Sunita P.; Chien, Yung-Ching; Cheng, Jing; Cheng, Nancy F.; Gansky, Stuart A.; Marshall, Sally J.; Marshall, Grayson W.			Functional Remineralization of Dentin Lesions Using Polymer-Induced Liquid-Precursor Process	PLOS ONE			English	Article							DEMINERALIZED HUMAN DENTIN; IN-VITRO; MECHANICAL-PROPERTIES; COLLAGEN FIBRILS; CARIES LESIONS; PILP PROCESS; MINERALIZATION; INDENTATION; PERSPECTIVE; INHIBITORS	It was hypothesized that applying the polymer-induced liquid-precursor (PILP) system to artificial lesions would result in time-dependent functional remineralization of carious dentin lesions that restores the mechanical properties of demineralized dentin matrix. 140 mm deep artificial caries lesions were remineralized via the PILP process for 7-28 days at 37 degrees C to determine temporal remineralization characteristics. Poly-L-aspartic acid (27 KDa) was used as the polymeric process-directing agent and was added to the remineralization solution at a calcium-to-phosphate ratio of 2.14 (mol/mol). Nanomechanical properties of hydrated artificial lesions had a low reduced elastic modulus (E-R = 0.2 GPa) region extending about 70 mm into the lesion, with a sloped region to about 140 mm where values reached normal dentin (18-20 GPa). After 7 days specimens recovered mechanical properties in the sloped region by 51% compared to the artificial lesion. Between 7-14 days, recovery of the outer portion of the lesion continued to a level of about 10 GPa with 74% improvement. 28 days of PILP mineralization resulted in 91% improvement of E-R compared to the artificial lesion. These differences were statistically significant as determined from change-point diagrams. Mineral profiles determined by micro x-ray computed tomography were shallower than those determined by nanoindentation, and showed similar changes over time, but full mineral recovery occurred after 14 days in both the outer and sloped portions of the lesion. Scanning electron microscopy and energy dispersive x-ray analysis showed similar morphologies that were distinct from normal dentin with a clear line of demarcation between the outer and sloped portions of the lesion. Transmission electron microscopy and selected area electron diffraction showed that the starting lesions contained some residual mineral in the outer portions, which exhibited poor crystallinity. During remineralization, intrafibrillar mineral increased and crystallinity improved with intrafibrillar mineral exhibiting the orientation found in normal dentin or bone.	[Burwell, Anora K.; Habeliz, Stefan; Kurylo, Michael; Ho, Sunita P.; Chien, Yung-Ching; Cheng, Jing; Cheng, Nancy F.; Gansky, Stuart A.; Marshall, Sally J.; Marshall, Grayson W.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Thula-Mata, Taili; Gower, Laurie B.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA	University of California System; University of California San Francisco; State University System of Florida; University of Florida	Burwell, AK (corresponding author), Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA.	gw.marshall@ucsf.edu	Ho, Sunita P/B-1084-2008; Gower, Laurie B/A-5947-2008	Gower, Laurie B/0000-0003-2927-5406; Marshall, Grayson W/0000-0001-8921-3253; Ho, Sunita/0000-0001-9999-8226	NIH ARRA supplement [R01 DE016849-04S1, R01 DE016849]; NIH [S10 RR026645]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016849, R01DE022032] Funding Source: NIH RePORTER	NIH ARRA supplement; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH ARRA supplement to NIDCR grants R01 DE016849-04S1 and R01 DE016849. MicroXCT (TM) was carried out with support from NIH S10 RR026645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balooch M, 2008, J STRUCT BIOL, V162, P404, DOI 10.1016/j.jsb.2008.02.010; Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O; Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593; Bertassoni LE, 2011, J BIOMECH, V44, P176, DOI 10.1016/j.jbiomech.2010.09.005; Bertassoni LE, 2010, SCANNING, V32, P312, DOI 10.1002/sca.20199; Dai LJ, 2008, J NON-CRYST SOLIDS, V354, P1845, DOI 10.1016/j.jnoncrysol.2007.10.022; Dominicus A, 2008, STAT MED, V27, P5786, DOI 10.1002/sim.3380; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Guo WG, 2007, STAT APPL GENET MOL, V6; Ho SP, 2005, J STRUCT BIOL, V151, P69, DOI 10.1016/j.jsb.2005.05.003; Jee SS, 2010, ACTA BIOMATER, V6, P3676, DOI 10.1016/j.actbio.2010.03.036; Kim J, 2010, ACTA BIOMATER, V6, P2740, DOI 10.1016/j.actbio.2009.12.052; Kim YK, 2010, BIOMATERIALS, V31, P6618, DOI 10.1016/j.biomaterials.2010.04.060; Kinney JH, 2003, J DENT RES, V82, P957, DOI 10.1177/154405910308201204; Mai S, 2010, J DENT RES, V89, P405, DOI 10.1177/0022034510363662; Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6; Marshall GW, 2001, J DENT RES, V80, P1768, DOI 10.1177/00220345010800081701; Martin-De las Heras S, 2000, ARCH ORAL BIOL, V45, P757, DOI 10.1016/S0003-9969(00)00052-2; McIntyre JM, 2000, AUST DENT J, V45, P24, DOI 10.1111/j.1834-7819.2000.tb00238.x; Nascimento FD, 2011, J DENT RES, V90, P506, DOI 10.1177/0022034510391906; Nishitani Y, 2006, EUR J ORAL SCI, V114, P160, DOI 10.1111/j.1600-0722.2006.00342.x; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Olszta MJ, 2003, CONNECT TISSUE RES, V44, P326, DOI 10.1080/03008200390181852; Olszta MJ, 2003, CALCIFIED TISSUE INT, V72, P583, DOI 10.1007/s00223-002-1032-7; Pugach MK, 2009, J DENT RES, V88, P71, DOI 10.1177/0022034508327552; Sulkala M, 2001, J DENT RES, V80, P1545, DOI 10.1177/00220345010800061301; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001; ten Cate J M, 2008, Aust Dent J, V53, P281, DOI 10.1111/j.1834-7819.2008.00063.x; ten Cate JM, 2001, J DENT RES, V80, P1407, DOI 10.1177/00220345010800050401; Thula TT, 2011, ACTA BIOMATER, V7, P3158, DOI 10.1016/j.actbio.2011.04.014; Thula-Mata T, 2011, MRS P, DOI [10.1557/opl, DOI 10.1557/OPL]; van Strijp AJP, 2003, CARIES RES, V37, P58, DOI 10.1159/000068223; WHITE JM, 1994, J DENT RES, V73, P1560, DOI 10.1177/00220345940730091201; Zheng L, 2003, EUR J ORAL SCI, V111, P243, DOI 10.1034/j.1600-0722.2003.00038.x	36	85	89	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38852	10.1371/journal.pone.0038852	http://dx.doi.org/10.1371/journal.pone.0038852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719965	gold, Green Published			2022-12-25	WOS:000305341900055
J	Lin, SC; Lin, YF; Chong, P; Wu, SC				Lin, Shih-Chang; Lin, Yu-Fen; Chong, Pele; Wu, Suh-Chin			Broader Neutralizing Antibodies against H5N1 Viruses Using Prime-Boost Immunization of Hyperglycosylated Hemagglutinin DNA and Virus-Like Particles	PLOS ONE			English	Article							GRAM-NEGATIVE FLAGELLIN; INFLUENZA-VIRUS; VACCINE DESIGN; ANTIGENIC STRUCTURE; GP120; HIV-1; INDUCTION; RESPONSES; EPITOPE; IMMUNOGENICITY	Background: Highly pathogenic avian influenza (HPAI) H5N1 viruses and their transmission capability from birds to humans have raised global concerns about a potential human pandemic. The inherent nature of antigenic changes in influenza viruses has not been sufficiently taken into account in immunogen designs for broadly protective HPAI H5N1 vaccines. Methods: We designed a hyperglycosylated HA vaccine using N-linked glycan masking on highly variable sequences in the HA1 globular head. Immunization of these hyperglycosylated HA DNA vaccines followed by a flagellin-containing virus-like particle booster in mice was conducted to evaluate neutralizing antibody responses against various clades of HPAI H5N1 viruses. Results: We introduced nine N-X-S/T motifs in five HA1 regions: 83NNT, 86NNT, 94NFT, 127NSS, 138NRT, 156NTT, 161NRS, 182NDT, and 252NAT according to sequence alignment analyses from 163 HPAI H5N1 human isolates. Although no significant differences of anti-HA total IgG titers were found with these hyperglycosyalted HA compared to the wild-type control, the 83NNT and 127NSS mutants elicited significantly potent cross-clade neutralizing antibodies against HPAI H5N1 viruses. Conclusions: This finding may have value in terms of novel immunogen design for developing cross-protective H5N1 vaccines.	[Lin, Shih-Chang; Lin, Yu-Fen; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hisnchu, Taiwan; [Chong, Pele; Wu, Suh-Chin] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan	Wu, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hisnchu, Taiwan.	scwu@mx.nthu.edu.tw	Wu, Suh-Chin/AAV-6233-2021; Chong, Pele/E-3855-2010		National Science Council [NSC-99-2311-B-007-005-MY3, NSC-100-2321-B-007-005]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council (NSC-99-2311-B-007-005-MY3 and NSC-100-2321-B-007-005) and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2009, CURR TOP MICROBIOL, V333, P323, DOI 10.1007/978-3-540-92165-3_16; Barnett SW, 1997, VACCINE, V15, P869, DOI 10.1016/S0264-410X(96)00264-2; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chies MD, 2001, IMMUNOLOGY, V103, P172, DOI 10.1046/j.1365-2567.2001.01242.x; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Delves RJ, 1997, MOL MED TODAY, V3, P55, DOI 10.1016/S1357-4310(96)20036-X; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016563; Garrity RR, 1997, J IMMUNOL, V159, P279; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Moors MA, 2001, INFECT IMMUN, V69, P4424, DOI 10.1128/IAI.69.7.4424-4429.2001; Nara PL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000571; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Richmond JFL, 1998, J VIROL, V72, P9092, DOI 10.1128/JVI.72.11.9092-9100.1998; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Suguitan AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021942; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Wei HJ, 2011, VACCINE, V29, P7163, DOI 10.1016/j.vaccine.2011.05.077; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039	39	26	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39075	10.1371/journal.pone.0039075	http://dx.doi.org/10.1371/journal.pone.0039075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720032	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900079
J	Xie, Y; Tobin, LA; Camps, J; Wangsa, D; Yang, J; Rao, M; Witasp, E; Awad, KS; Yoo, N; Ried, T; Kwong, KF				Xie, Y.; Tobin, L. A.; Camps, J.; Wangsa, D.; Yang, J.; Rao, M.; Witasp, E.; Awad, K. S.; Yoo, N.; Ried, T.; Kwong, K. F.			MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells	ONCOGENE			English	Article						microRNA; cancer; XIAP	MODULATES MULTIDRUG-RESISTANCE; X-LINKED INHIBITOR; TARGETING BCL2; SUPPRESSES TUMORIGENICITY; STRUCTURAL BASIS; DOWN-REGULATION; UP-REGULATION; LUNG-CANCER; MIR-24; GENE	MicroRNAs have been implicated as important mediators of cancer cell homeostasis, and accumulating data suggest compelling roles for them in the apoptosis pathway. X-linked inhibitor of apoptosis protein (XIAP) is a potent caspase inhibitor and an important barrier to apoptotic cell death, but the mechanisms that determine the diverse range of XIAP expression seen in cancer remains unclear. In this study, we present evidence that miR-24 directly targets the 3'UTR of the XIAP messenger RNA (mRNA) to exert translational repression. Using a heuristic algorithm of bioinformatics analysis and in vitro screening, we identified miR-24 as a candidate regulator of XIAP expression. Array comparative genomic hybridization and spectral karyotype analysis reveal that genomic copy number loss at the miR-24 locus is concordant with the loss of endogenous miR-24 in cancer cells. Using a luciferase construct of the XIAP 3'UTR, we showed that miR-24 specifically coordinates to the XIAP mRNA. Interference with miR-24's binding of the critical seed region, resulting from site-directed mutagenesis of the 3'UTR, significantly abrogated miR-24's effects on XIAP expression. Moreover, miR-24 overexpression can overcome apoptosis resistance in cancer cells via downregulation of XIAP expression, and the resulting cancer cell death induced by tumor necrosis factor-related apoptosis-inducing ligand is executed by the canonical caspase-mediated apoptosis pathway. In summary, our data suggest a novel mechanism by which miR-24 directly modulates XIAP expression level and consequently the apoptosis threshold in cancer cells.	[Xie, Y.; Tobin, L. A.; Yang, J.; Rao, M.; Witasp, E.; Yoo, N.; Kwong, K. F.] NCI, Sect Thorac Oncol, Surg Branch, NIH, Bethesda, MD 20892 USA; [Camps, J.; Wangsa, D.; Ried, T.] NCI, Clin Genet Branch, NIH, Bethesda, MD 20892 USA; [Witasp, E.] Swedish Chem Agcy, Sundbyberg, Sweden; [Awad, K. S.] NCI, Dept Crit Care Med, NIH Clin Ctr, NIH, Bethesda, MD 20892 USA; [Kwong, K. F.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kwong, KF (corresponding author), NCI, Sect Thorac Oncol, Surg Branch, NIH, 10 Ctr Dr,MSC 1201, Bethesda, MD 20892 USA.	kwongk2@mail.nih.gov	Camps, Jordi/AAG-3080-2020; Yang, Jianhui/GQO-8030-2022	Camps, Jordi/0000-0002-3165-3640; 	National Institutes of Health; NIH; NATIONAL CANCER INSTITUTE [ZIABC011046, ZIABC010833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Steven A Rosenberg for reviewing the manuscript. This work was supported by the National Institutes of Health, Intramural Research Program (TR and KFK) and NIH Postdoctoral Cancer Research Training Awards (YX, JC, EW and KSA).	Adair SJ, 2009, CANCER IMMUNOL IMMUN, V58, P589, DOI 10.1007/s00262-008-0582-6; Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bao L, 2011, CANCER IMMUNOL IMMUN, V60, P1299, DOI 10.1007/s00262-011-1037-z; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dean EJ, 2007, CANCER TREAT REV, V33, P203, DOI 10.1016/j.ctrv.2006.11.002; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Diakos C, 2010, BLOOD, V116, P4885, DOI 10.1182/blood-2009-02-206706; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Geering B, 2011, BLOOD, V117, P5953, DOI 10.1182/blood-2010-11-322206; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Holcik M, 2003, ANN NY ACAD SCI, V1010, P249, DOI 10.1196/annals.1299.043; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kang HG, 2008, CANCER GENET CYTOGEN, V180, P6, DOI 10.1016/j.cancergencyto.2007.07.021; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Ku G, 2008, HUM GENE THER, V19, P17, DOI 10.1089/hum.2007.1226; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Macville M, 1999, CANCER RES, V59, P141; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Mashima T, 2005, DRUG RESIST UPDATE, V8, P339, DOI 10.1016/j.drup.2005.11.001; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Niederer F, 2012, ARTHRITIS RHEUM-US, V64, P1771, DOI 10.1002/art.34334; Padilla-Nash HM, 2006, NAT PROTOC, V1, P3129, DOI 10.1038/nprot.2006.358; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Riley A, 2010, NUCLEIC ACIDS RES, V38, P4665, DOI 10.1093/nar/gkq241; Saini S, 2011, CANCER RES, V71, P6208, DOI 10.1158/0008-5472.CAN-11-0073; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Tonon G, 2004, CANCER GENET CYTOGEN, V152, P15, DOI 10.1016/j.cancergencyto.2003.10.007; Ulybina YM, 2011, TUMORI, V97, P248, DOI 10.1700/667.7794; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025; Zhu W, 2012, CANCER CHEMOTH PHARM, V69, P723, DOI 10.1007/s00280-011-1752-3; Zhu W, 2010, INT J CANCER, V127, P2520, DOI 10.1002/ijc.25260	59	74	77	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 9	2013	32	19					2442	2451		10.1038/onc.2012.258	http://dx.doi.org/10.1038/onc.2012.258			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140ZL	22733138	Green Accepted			2022-12-25	WOS:000318694900008
J	Li, A; Zhang, C; Gao, S; Chen, F; Yang, C; Luo, R; Xiao, H				Li, A.; Zhang, C.; Gao, S.; Chen, F.; Yang, C.; Luo, R.; Xiao, H.			TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice	ONCOGENE			English	Article						TIP30; lung adenocarcinoma; EGFR signaling; tumor suppressor	EPIDERMAL-GROWTH-FACTOR; BRONCHIOALVEOLAR STEM-CELLS; FACTOR RECEPTOR; TARGETED THERAPIES; TUMOR-METASTASIS; MUTANT P53; C-MYC; K-RAS; CANCER; EXPRESSION	Lung adenocarcinoma, the most common type of human non-small cell lung cancer (NSCLC), frequently overexpresses epidermal growth factor receptor (EGFR). However, the mechanisms underlying EGFR overexpression are not completely understood. Recent studies have identified that decreased expression of TIP30 (30kDa HIV-1 Tat interacting protein) is associated with the metastasis of human NSCLCs, but a causative relationship between TIP30 deficiency and NSCLC development remains unclear. We show here that Tip30 deletion leads to spontaneous development of lung adenomas and adenocarcinomas in mice. Lung tumor development was preceded by aberrant expansion of bronchioalveolar stem/progenitor and alveolar type II (AT2) cells, and also increased expression of EGFR and its downstream signaling factors in the lung of Tip30(-/-) mice. Moreover, TIP30 knockdown in human lung adenocarcinoma cells resulted in prolonged EGFR activity in early endosomes, delayed EGFR degradation, increased EGFR nuclear localization, leading to upregulated pAKT and pERK1/2 expression. Importantly, in human lung adenocarcinomas, low TIP30 expression correlates with prolonged patient overall and post-progression survival times. Together, these results suggest that TIP30 functions as a tumor suppressor to inhibit EGFR cytoplasmic and nuclear signaling and suppress adenocarcinogenesis in the lung, and highlight the potential of therapeutic strategies aiming at inhibiting EGFR signaling for patients with low TIP30-expression lung adenocarcinoma.	[Li, A.; Zhang, C.; Gao, S.; Chen, F.; Yang, C.; Xiao, H.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Li, A.; Chen, F.; Luo, R.] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, C.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Gao, S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Southern Medical University - China; Michigan State University; Michigan State University	Luo, R (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Oncol, 1838 North Guangzhou Rd, Guangzhou 510515, Guangdong, Peoples R China.	luorc01@163.com; xiaoh@msu.edu	Zhang, Chengliang/E-6943-2016	Zhang, Chengliang/0000-0003-3798-4157; Zhang, Chengliang/0000-0001-6999-4670	NIDDK, NIH [RO1 DK066110-01, W81XWH-08-1-0377]; DOD [RO1 DK066110-01, W81XWH-08-1-0377]; Nanfang Hospital, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066110] Funding Source: NIH RePORTER	NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DOD(United States Department of Defense); Nanfang Hospital, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Jill Pecha for backcrossing Tip30 knockout gene into Balb/c mice, Ying Qin and Zuguo Li for histological examination of preneoplastic lesions and tumors, Eran Andrechek and Inez Yuwanita for helping patient survival analysis, and Sandra Z Haslam for critical reading of the manuscript. This work was supported by grants RO1 DK066110-01 and W81XWH-08-1-0377 (to HX) from NIDDK, NIH and DOD. AL is partly supported by a fellowship from Nanfang Hospital, China.	Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chen V, 2010, CELL CYCLE, V9, P4941, DOI 10.4161/cc.9.24.14230; Chen X, 2006, DIGEST DIS SCI, V55, P2219; Ehrhardt A, 2001, BRIT J CANCER, V84, P813, DOI 10.1054/bjoc.2000.1676; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fong S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-23; Gazdar AF, 2008, CANCER PREV RES, V1, P156, DOI 10.1158/1940-6207.CAPR-08-0080; Ito M, 2003, CANCER RES, V63, P8763; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Jiang C, 2004, J BIOL CHEM, V279, P27781, DOI 10.1074/jbc.M401809200; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; King FW, 2004, MOL CELL BIOL, V24, P7091, DOI 10.1128/MCB.24.16.7091-7101.2004; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pecha J, 2007, ONCOGENE, V26, P7423, DOI 10.1038/sj.onc.1210548; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; RUSCH V, 1993, CANCER RES, V53, P2379; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shtivelman E, 1997, ONCOGENE, V14, P2167, DOI 10.1038/sj.onc.1201059; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Tchou-Wong KM, 2002, AM J RESP CELL MOL, V27, P186, DOI 10.1165/ajrcmb.27.2.4799; Tong X, 2009, AM J PATHOL, V174, P1931, DOI 10.2353/ajpath.2009.080846; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Xiao H, 1998, P NATL ACAD SCI USA, V95, P2146, DOI 10.1073/pnas.95.5.2146; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; Zhang CL, 2011, J BIOL CHEM, V286, P9373, DOI 10.1074/jbc.M110.207720; Zhang CL, 2010, CANCER RES, V70, P10224, DOI 10.1158/0008-5472.CAN-10-3057; Zhao J, 2008, HEPATOLOGY, V48, P265, DOI 10.1002/hep.22280; Zhao J, 2007, HUM PATHOL, V38, P293, DOI 10.1016/j.humpath.2006.08.005	42	26	28	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2013	32	18					2273	2281		10.1038/onc.2012.253	http://dx.doi.org/10.1038/onc.2012.253			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22733137	Green Accepted			2022-12-25	WOS:000318683600004
J	Quistgaard, EM; Nordlund, P; Low, C				Quistgaard, Esben M.; Nordlund, Par; Low, Christian			High-resolution insights into binding of unfolded polypeptides by the PPIase chaperone SlpA	FASEB JOURNAL			English	Article						protein folding; peptidyl-prolyl cis/trans-isomerase; SlyD-like; crystal structure; ribosome assembly	CRYSTAL-STRUCTURE DETERMINATION; PROLYL ISOMERASE ACTIVITY; OUTER-MEMBRANE PORINS; FOLDING CATALYST SLYD; CIS-TRANS ISOMERASE; TRIGGER FACTOR; PROTEIN; IDENTIFICATION; DOMAIN; NMR	SlpA is a 2-domain protein consisting of an FK506-binding protein (FKBP) domain that harbors the peptidyl-prolyl cis/trans-isomerase (PPIase) active site and a small insert-in-flap (IF) domain that endows the protein with chaperone activity. We have determined the structure of SlpA from Escherichia coli at 1.35-angstrom resolution. The overall structure is similar to other known structures of the FKBP-IF subfamily. However, by serendipity, the linker region of the purification tag binds in the chaperone binding groove of the IF domain, making this the first structure of an FKBP-IF protein in complex with a mimic of an unfolded chaperone substrate. The linker binds by beta-sheet augmentation, thus completing the incomplete beta barrel of the IF domain and shielding a considerable hydrophobic surface area from the solvent. Interestingly, a proline residue in trans configuration appears to be specifically recognized in a small pocket within the binding groove. Hence, the IF domain can preselect and prealign substrates with proline residues, which may explain how it enhances the catalytic efficiency and modulates the specificity of the FKBP domain in addition to its chaperone function. Based on pulldown results, we suggest that SlpA is likely to be involved in ribosome assembly.-Quistgaard, E. M., Nordlund, P., Low, C. High-resolution insights into binding of unfolded polypeptides by the PPIase chaperone SlpA. FASEB J. 26, 4003-4013 (2012). www.fasebj.org	[Quistgaard, Esben M.; Nordlund, Par; Low, Christian] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Nordlund, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	par.nordlund@ki.se; christian.low@ki.se		Loew, Christian/0000-0003-0764-7483; Quistgaard, Esben/0000-0002-1381-3364	Danish Council for Independent Research (Medical Sciences) [271-09-0187]; European Molecular Biology Organization (EMBO) postdoctoral fellowship; Swedish Research Council; Swedish Cancer Society	Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); European Molecular Biology Organization (EMBO) postdoctoral fellowship; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	The authors thank Karthik Maddi for help with crystallization screening and Mirjam Klepsch for critical reading of the manuscript. The crystallographic experiments were carried out at beamline ID14-4 at the European Synchrotron Radiation Facility (Grenoble, France). E.M.Q. was supported by The Danish Council for Independent Research (Medical Sciences; grant 271-09-0187). C.L. was supported by a European Molecular Biology Organization (EMBO) postdoctoral fellowship. This research was supported by grants from the Swedish Research Council and Swedish Cancer Society. E.M.Q. and C.L. designed and performed research; E.M.Q., P.N., and C.L. analyzed data and wrote the manuscript.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Bartlow P, 2011, PROTEIN EXPRES PURIF, V78, P216, DOI 10.1016/j.pep.2011.04.021; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Cheng TF, 2012, J BIOL INORG CHEM, V17, P331, DOI 10.1007/s00775-011-0855-y; Delano W. L., 2003, PYMOL MOL GENETICS G; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson N, 2003, CURR OPIN STRUC BIOL, V13, P75, DOI 10.1016/S0959-440X(02)00009-X; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haupt C, 2011, BIOCHEMISTRY-US, V50, P7321, DOI 10.1021/bi2000627; Hesterkamp T, 1996, FEBS LETT, V385, P67, DOI 10.1016/0014-5793(96)00351-1; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Hottenrott S, 1997, J BIOL CHEM, V272, P15697, DOI 10.1074/jbc.272.25.15697; Hu KF, 2006, BIOCHEMISTRY-US, V45, P11983, DOI 10.1021/bi0607913; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kahra D, 2011, J MOL BIOL, V411, P781, DOI 10.1016/j.jmb.2011.05.002; Knappe TA, 2007, J MOL BIOL, V368, P1458, DOI 10.1016/j.jmb.2007.02.097; Kovermann M, 2011, BBA-PROTEINS PROTEOM, V1814, P873, DOI 10.1016/j.bbapap.2011.03.016; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Low C, 2010, J MOL BIOL, V398, P375, DOI 10.1016/j.jmb.2010.03.014; Martinez-Hackert E, 2011, J MOL BIOL, V407, P450, DOI 10.1016/j.jmb.2011.01.027; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Martino L, 2009, FEBS J, V276, P4529, DOI 10.1111/j.1742-4658.2009.07159.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Ramm K, 2001, J MOL BIOL, V310, P485, DOI 10.1006/jmbi.2001.4747; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; SCHINDLER T, 1995, NAT STRUCT BIOL, V2, P663, DOI 10.1038/nsb0895-663; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Suzuki R, 2003, J MOL BIOL, V328, P1149, DOI 10.1016/S0022-2836(03)00379-6; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weininger U, 2009, J MOL BIOL, V387, P295, DOI 10.1016/j.jmb.2009.01.034; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zoldak G, 2011, J MOL BIOL, V406, P176, DOI 10.1016/j.jmb.2010.12.010	53	8	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					4003	4013		10.1096/fj.12-208397	http://dx.doi.org/10.1096/fj.12-208397			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22735173				2022-12-25	WOS:000309704000008
J	Alvarez, L; Gonzalez-Iglesias, H; Garcia, M; Ghosh, S; Sanz-Medel, A; Coca-Prados, M				Alvarez, Lydia; Gonzalez-Iglesias, Hector; Garcia, Montserrat; Ghosh, Sikha; Sanz-Medel, Alfredo; Coca-Prados, Miguel			The Stoichiometric Transition from Zn6Cu1-Metallothionein to Zn-7-Metallothionein Underlies the Up-regulation of Metallothionein (MT) Expression QUANTITATIVE ANALYSIS OF MT-METAL LOAD IN EYE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROATOM-TAGGED PROTEOMICS; GROWTH-INHIBITORY FACTOR; HPLC-ICP-MS; INFLAMMATORY RESPONSE; SPECIATION ANALYSIS; BUFFERING CAPACITY; EPITHELIAL-CELLS; GENE-EXPRESSION; RAT-BRAIN; ZINC	We examined the profiling of gene expression of metallothioneins (MTs) in human tissues from cadaver eyes with microarray-based analysis. All MT1 isoforms, with the exception of MT1B, were abundantly expressed in lens and corneal tissue. Along with MT1B, MT4 was not detected in any tissues. Antibodies to MT1/2 labeled the corneal epithelial and endothelial cells, whereas MT3 label the retinal ganglion cells. We studied the effects of zinc and cytokines on the gene expression of MT isoforms in a corneal epithelial cell line (HCEsv). Zinc exerted an up-regulation of the expression of MT isoforms, and this effect was further potentiated in the presence of IL1 alpha or TNF alpha. Zinc also elicited a strong down-regulation of the expression of inflammatory cytokines, and this effect was blocked in the presence of TNF alpha or IL1 alpha. The concentration of MTs, bound zinc, and the metal stoichiometry of MTs in cultured HCEsv were determined by mass spectrometry. The total concentration of MTs was 0.24 +/- 0.03 mu M and, after 24 h of zinc exposure, increased to 0.96 +/- 0.01 mu M. The combination of zinc and IL1 alpha further enhanced the level of MTs to 1.13 +/- 0.03 mu M. The average metal stoichiometry of MTs was Zn6Cu1-MT, and after exposure to the different treatments, it changed to Zn-7-MT. Actinomycin D blocked transcription, and cycloheximide attenuated synthesis of MTs in the presence or absence of zinc, suggesting transcriptional regulation. Overall the data provide molecular and analytical evidence on the interplay between zinc, MTs, and proinflammatory cytokines in HCEsv cells, with potential implications on cell-based inflammatory eye diseases.	[Ghosh, Sikha; Coca-Prados, Miguel] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Alvarez, Lydia; Gonzalez-Iglesias, Hector; Garcia, Montserrat; Coca-Prados, Miguel] Fdn Invest Oftalmol, Inst Oftalmol Fernandez Vega, Oviedo 33012, Spain; [Sanz-Medel, Alfredo] Univ Oviedo, Dept Phys & Analyt Chem, E-33006 Oviedo, Spain	Yale University; University of Oviedo	Coca-Prados, M (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 300 George St,R8100A, New Haven, CT 06510 USA.	Miguel.Coca-Prados@yale.edu	Alvarez, Lydia/AAA-7736-2019; García Diaz, Montserrat/GXV-7857-2022; Garcia, Montserrat/AAA-7781-2019; Gonzalez-Iglesias, Hector/AAB-5993-2019; Gonzalez-Iglesias, Hector/K-2447-2014	Garcia, Montserrat/0000-0001-9983-546X; Gonzalez-Iglesias, Hector/0000-0001-5251-0967; Alvarez Fernandez, Lydia/0000-0002-0604-7411; /0000-0003-2899-1347	CENIT-CeyeC Research from the Spanish Ministry of Innovation and Development [CEN-20091021]; Fundacion de Investigacion Oftalmologica Fernandez-Vega; Fundacion M<SUP>a</SUP> Cristina Masaveu Paterson; Fundacion Rafael del Pino	CENIT-CeyeC Research from the Spanish Ministry of Innovation and Development; Fundacion de Investigacion Oftalmologica Fernandez-Vega; Fundacion M<SUP>a</SUP> Cristina Masaveu Paterson; Fundacion Rafael del Pino	This work was supported in part by a CENIT-CeyeC Research Grant CEN-20091021 from the Spanish Ministry of Innovation and Development, Fundacion de Investigacion Oftalmologica Fernandez-Vega, Fundacion M<SUP>a</SUP> Cristina Masaveu Paterson, and Fundacion Rafael del Pino.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Bell SG, 2009, CHEMBIOCHEM, V10, P55, DOI 10.1002/cbic.200800511; Benedicto A, 2011, J AGR FOOD CHEM, V59, P8829, DOI 10.1021/jf2002574; Bettmer J, 2010, ANAL BIOANAL CHEM, V397, P3495, DOI 10.1007/s00216-010-3861-y; Cabreiro F, 2008, EXP GERONTOL, V43, P483, DOI 10.1016/j.exger.2007.10.007; Carrasco J, 1998, EXP NEUROL, V153, P184, DOI 10.1006/exnr.1998.6861; Chung RS, 2008, J NEUROCHEM, V104, P14, DOI 10.1111/j.1171-4159.2007.05026.x; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Duncan KER, 2006, J INORG BIOCHEM, V100, P2101, DOI 10.1016/j.jinorgbio.2006.09.005; Finamore A, 2005, EUR J CLIN NUTR, V59, pS68, DOI 10.1038/sj.ejcn.1602302; Maltez HF, 2009, ANAL CHIM ACTA, V650, P234, DOI 10.1016/j.aca.2009.07.052; GALIN MA, 1962, INVEST OPHTH VISUAL, V1, P142; GASULL T, 1994, AM J PHYSIOL, V266, pE760, DOI 10.1152/ajpendo.1994.266.5.E760; Martinez-Sierra JG, 2010, J ANAL ATOM SPECTROM, V25, P989, DOI 10.1039/b925366a; Iglesias HG, 2007, ANAL BIOANAL CHEM, V389, P707, DOI 10.1007/s00216-007-1499-1; Gonzalez-Iglesias H., 2012, ELECTROPHOR IN PRESS; Hao Q, 2005, J ALZHEIMERS DIS, V8, P161; Infante HG, 2002, J ANAL ATOM SPECTROM, V17, P79, DOI 10.1039/b108354f; Kantorow M, 1998, INVEST OPHTH VIS SCI, V39, P2344; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kitabayashi C, 2010, INT IMMUNOL, V22, P375, DOI 10.1093/intimm/dxq017; Krezel A, 2007, J AM CHEM SOC, V129, P10911; Krezel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P188, DOI 10.1016/j.abb.2007.02.017; Krezel A, 2007, BIOCHEM J, V402, P551, DOI 10.1042/BJ20061044; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Li Y, 2008, J ANAL ATOM SPECTROM, V23, P1055, DOI 10.1039/b802220h; Lu HS, 2002, EXP EYE RES, V74, P83, DOI 10.1006/exer.2001.1101; Malavolta M, 2007, J ANAL ATOM SPECTROM, V22, P1193, DOI 10.1039/b704577h; Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret; MASTERS BA, 1994, J NEUROSCI, V14, P5844; Meija J, 2006, ANAL BIOANAL CHEM, V385, P486, DOI 10.1007/s00216-006-0298-4; Miceli MV, 1999, INVEST OPHTH VIS SCI, V40, P1238; Mocchegiani Eugenio, 2006, Immun Ageing, V3, P6, DOI 10.1186/1742-4933-3-6; Muniz CS, 2001, J ANAL ATOM SPECTROM, V16, P587, DOI 10.1039/b100947h; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Murgia C, 2011, NUTRIENTS, V3, P910, DOI 10.3390/nu3110910; NEWSOME DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P192; Oppermann B, 2001, INVEST OPHTH VIS SCI, V42, P188; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P29, DOI 10.1016/j.proghi.2008.10.001; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 2001, J NEUROTRAUM, V18, P447, DOI 10.1089/089771501750171056; Polec K, 2002, J INORG BIOCHEM, V88, P197, DOI 10.1016/S0162-0134(01)00380-4; Prange A, 2002, ANAL BIOANAL CHEM, V373, P441, DOI 10.1007/s00216-002-1350-7; Quintana A, 2007, J NEUROSCI RES, V85, P2668, DOI 10.1002/jnr.21126; Rodriguez-Cea A, 2003, J ANAL ATOM SPECTROM, V18, P1357, DOI 10.1039/b306746g; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; Sanz-Medel A, 2008, ANAL BIOANAL CHEM, V390, P3, DOI 10.1007/s00216-007-1615-2; Schaumloffel D, 2002, ANAL BIOANAL CHEM, V372, P155, DOI 10.1007/s00216-001-1164-z; Sensi SL, 2004, CURR MOL MED, V4, P87, DOI 10.2174/1566524043479211; Suemori S, 2006, INVEST OPHTH VIS SCI, V47, P3975, DOI 10.1167/iovs.06-0275; Szpunar J, 2005, ANALYST, V130, P442, DOI 10.1039/b418265k; Thiersch M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-73; Uchida Y, 2002, J BIOL CHEM, V277, P32353, DOI 10.1074/jbc.M111263200; Ugarte M, 2001, PROG NEUROBIOL, V64, P219, DOI 10.1016/S0301-0082(00)00057-5; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Varin A, 2008, EXP GERONTOL, V43, P472, DOI 10.1016/j.exger.2007.12.008; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Wang RY, 2007, ANAL CHEM, V79, P4433, DOI 10.1021/ac062309s; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Yamada M, 1996, BRAIN RES, V735, P257, DOI 10.1016/0006-8993(96)00586-0; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Zangger K., 2004, HDB METALLOPROTEINS, V3, P353	63	23	24	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28456	28469		10.1074/jbc.M112.365015	http://dx.doi.org/10.1074/jbc.M112.365015			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22722935	Green Published, hybrid			2022-12-25	WOS:000308074600021
J	Demirkhanyan, LH; Marin, M; Padilla-Parra, S; Zhan, CY; Miyauchi, K; Jean-Baptiste, M; Novitskiy, G; Lu, WY; Melikyan, GB				Demirkhanyan, Lusine H.; Marin, Mariana; Padilla-Parra, Sergi; Zhan, Changyou; Miyauchi, Kosuke; Jean-Baptiste, Maikha; Novitskiy, Gennadiy; Lu, Wuyuan; Melikyan, Gregory B.			Multifaceted Mechanisms of HIV-1 Entry Inhibition by Human alpha-Defensin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FLUORESCENCE CORRELATION SPECTROSCOPY; CORECEPTOR-BINDING-SITE; MEMBRANE-FUSION; INNATE IMMUNITY; IN-VITRO; TYPE-1 REPLICATION; PLASMA-MEMBRANE; THETA-DEFENSINS; PHORBOL ESTERS	The human neutrophil peptide 1 (HNP-1) is known to block the human immunodeficiency virus type 1 (HIV-1) infection, but the mechanism of inhibition is poorly understood. We examined the effect of HNP-1 on HIV-1 entry and fusion and found that, surprisingly, this alpha-defensin inhibited multiple steps of virus entry, including: (i) Env binding to CD4 and coreceptors; (ii) refolding of Env into the final 6-helix bundle structure; and (iii) productive HIV-1 uptake but not internalization of endocytic markers. Despite its lectin-like properties, HNP-1 could bind to Env, CD4, and other host proteins in a glycan- and serum-independent manner, whereas the fusion inhibitory activity was greatly attenuated in the presence of human or bovine serum. This demonstrates that binding of alpha-defensin to molecules involved in HIV-1 fusion is necessary but not sufficient for blocking the virus entry. We therefore propose that oligomeric forms of defensin, which may be disrupted by serum, contribute to the anti-HIV-1 activity perhaps through cross-linking virus and/or host glycoproteins. This notion is supported by the ability of HNP-1 to reduce the mobile fraction of CD4 and coreceptors in the plasma membrane and to precipitate a core subdomain of Env in solution. The ability of HNP-1 to block HIV-1 uptake without interfering with constitutive endocytosis suggests a novel mechanism for broad activity against this and other viruses that enter cells through endocytic pathways.	[Demirkhanyan, Lusine H.; Marin, Mariana; Padilla-Parra, Sergi; Melikyan, Gregory B.] Emory Univ, Dept Pediat Infect Dis, Childrens Ctr, Atlanta, GA 30322 USA; [Zhan, Changyou; Novitskiy, Gennadiy; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA; [Zhan, Changyou; Novitskiy, Gennadiy; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Miyauchi, Kosuke] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Jean-Baptiste, Maikha] Natl Parkinson Fdn Inc, Miami, FL 33136 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; RIKEN; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat Infect Dis, Childrens Ctr, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Padilla-Parra, Sergi/N-8725-2019; Zhan, Changyou/G-3667-2011; Lu, Wuyuan/J-8452-2017; Padilla-Parra, Sergi/S-3017-2018; Lu, Wuyuan/B-2268-2010	Padilla-Parra, Sergi/0000-0002-8010-9481; Lu, Wuyuan/0000-0003-1318-9968; 	National Institutes of Health [AI087453, AI072732]; Emory and Children's Pediatric Research Center Flow Cytometry Core; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087453, R01AI072732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory and Children's Pediatric Research Center Flow Cytometry Core; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI087453 (to G. B. M.) and AI072732 (to W. L.). This work was also supported by Emory and Children's Pediatric Research Center Flow Cytometry Core.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Biscone MJ, 2006, VIROLOGY, V351, P226, DOI 10.1016/j.virol.2006.03.017; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gong TX, 2010, ARCH VIROL, V155, P491, DOI 10.1007/s00705-010-0608-1; Guo CJ, 2004, AIDS, V18, P1217, DOI 10.1097/00002030-200405210-00020; HARRIS RJ, 1990, EUR J BIOCHEM, V194, P611, DOI 10.1111/j.1432-1033.1990.tb15660.x; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; HOXIE JA, 1988, J IMMUNOL, V140, P786; JACOBSON K, 1981, BIOCHEMISTRY-US, V20, P5268, DOI 10.1021/bi00521a027; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kuhn L, 2005, JAIDS-J ACQ IMM DEF, V39, P138; Kwaaitaal M, 2011, METHODS MOL BIOL, V779, P225, DOI 10.1007/978-1-61779-264-9_13; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lehrer RI, 2007, CURR OPIN HEMATOL, V14, P16, DOI 10.1097/00062752-200701000-00005; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mandal M, 2002, J PEPT RES, V59, P95, DOI 10.1034/j.1399-3011.2002.01945.x; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Murakami T, 1999, J VIROL, V73, P7489, DOI 10.1128/JVI.73.9.7489-7496.1999; NAKASHIMA H, 1993, AIDS, V7, P1129, DOI 10.1097/00002030-199308000-00019; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2012, J BIOL CHEM, V287, P8944, DOI 10.1074/jbc.M111.332205; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rodriguez-Garcia M, 2009, CLIN IMMUNOL, V131, P374, DOI 10.1016/j.clim.2009.01.012; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959; Tanabe H, 2004, J VIROL, V78, P11622, DOI 10.1128/JVI.78.21.11622-11631.2004; Thompson, 1991, FLUORESCENCE CORRELA, P337; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wang ZF, 2004, J BIOMED OPT, V9, P395, DOI 10.1117/1.1646416; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257	76	62	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28821	28838		10.1074/jbc.M112.375949	http://dx.doi.org/10.1074/jbc.M112.375949			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733823	Green Published, hybrid			2022-12-25	WOS:000308074600055
J	Stravalaci, M; Bastone, A; Beeg, M; Cagnotto, A; Colombo, L; Di Fede, G; Tagliavini, F; Cantu, L; Del Favero, E; Mazzanti, M; Chiesa, R; Salmona, M; Diomede, L; Gobbi, M				Stravalaci, Matteo; Bastone, Antonio; Beeg, Marten; Cagnotto, Alfredo; Colombo, Laura; Di Fede, Giuseppe; Tagliavini, Fabrizio; Cantu, Laura; Del Favero, Elena; Mazzanti, Michele; Chiesa, Roberto; Salmona, Mario; Diomede, Luisa; Gobbi, Marco			Specific Recognition of Biologically Active Amyloid-beta Oligomers by a New Surface Plasmon Resonance-based Immunoassay and an in Vivo Assay in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION PROTEIN; ALZHEIMERS-DISEASE; A-BETA(1-42); ASSEMBLIES; ANTIBODIES; LINK	Soluble oligomers of the amyloid-beta (A beta) peptide play a key role in the pathogenesis of Alzheimer's disease, but their elusive nature makes their detection challenging. Here we describe a novel immunoassay based on surface plasmon resonance (SPR) that specifically recognizes biologically active A beta oligomers. As a capturing agent, we immobilized on the sensor chip the monoclonal antibody 4G8, which targets a central hydrophobic region of A beta. This SPR assay allows specific recognition of oligomeric intermediates that rapidly appear and disappear during the incubation of synthetic A beta(1-42), discriminating them from monomers and higher order aggregates. The species recognized by SPR generate ionic currents in artificial lipid bilayers and inhibit the physiological pharyngeal contractions in Caenorhabditis elegans, a new method for testing the toxic potential of A beta oligomers. With these assays we found that the formation of biologically relevant A beta oligomers is inhibited by epigallocatechin gallate and increased by the A2V mutation, previously reported to induce early onset dementia. The SPR-based immunoassay provides new opportunities for detection of toxic A beta oligomers in biological samples and could be adapted to study misfolding proteins in other neurodegenerative disorders.	[Stravalaci, Matteo; Bastone, Antonio; Beeg, Marten; Cagnotto, Alfredo; Colombo, Laura; Chiesa, Roberto; Salmona, Mario; Diomede, Luisa; Gobbi, Marco] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy; [Chiesa, Roberto] Ist Ric Farmacol Mario Negri, Dulbecco Telethon Inst, I-20156 Milan, Italy; [Chiesa, Roberto] Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy; [Di Fede, Giuseppe; Tagliavini, Fabrizio] Fdn Ist Ricovero & Cura Carattere Sci, Ist Neurol Carlo Besta, I-20133 Milan, Italy; [Cantu, Laura; Del Favero, Elena] Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy; [Mazzanti, Michele] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Neurologico Besta; University of Milan; University of Milan	Gobbi, M (corresponding author), Ist Ric Farmacol Mario Negri, Dept Biochem & Mol Pharmacol, Lab Pharmacodynam & Pharmacokinet, Via La Masa 19, I-20156 Milan, Italy.	marco.gobbi@marionegri.it	Tagliavini, Fabrizio/AAO-7891-2021; Stravalaci, Matteo/AAB-8963-2019; Di Fede, Giuseppe/K-1394-2016; DEL FAVERO, ELENA/R-4991-2017; salmona, mario/AAA-7116-2020; Beeg, Marten/AAA-9269-2020; Gobbi, Marco/J-2638-2016; Di Fede, Giuseppe/O-7772-2016; salmona, mario/ABI-4066-2020; Di Fede, Giuseppe/A-4471-2019; Cagnotto, Alfredo/AAB-3083-2020; Diomede, Luisa/P-3417-2014; Chiesa, Roberto/G-1561-2017; colombo, laura/AAA-6716-2020; DEL FAVERO, ELENA/AAR-3567-2020	Tagliavini, Fabrizio/0000-0003-1039-7315; Stravalaci, Matteo/0000-0002-5636-4204; Di Fede, Giuseppe/0000-0003-3537-6713; DEL FAVERO, ELENA/0000-0002-6584-1869; salmona, mario/0000-0002-9098-9873; Beeg, Marten/0000-0001-7201-6704; Gobbi, Marco/0000-0003-1014-6225; Di Fede, Giuseppe/0000-0003-3537-6713; Di Fede, Giuseppe/0000-0003-3537-6713; Cagnotto, Alfredo/0000-0002-1390-8240; Diomede, Luisa/0000-0002-2258-0531; Chiesa, Roberto/0000-0002-3842-3733; colombo, laura/0000-0002-3243-0270; DEL FAVERO, ELENA/0000-0002-6584-1869; Mazzanti, Michele/0000-0002-1819-3811; Del Favero, jurgen/0000-0002-7427-7489	Cariplo Foundation [2009-2543]; Telethon Foundation [GGP10120]; MIUR [RPAB11FRE9]; Italian Ministry of Health [PS 2007.39]; Italian Ministry of University and Scientific Research [20078RWJBN]; Alzheimer's Association [NIRG-10-171655]; Mario Negri Foundation and Banca Intesa	Cariplo Foundation(Fondazione Cariplo); Telethon Foundation(Fondazione Telethon); MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Alzheimer's Association(Alzheimer's Association); Mario Negri Foundation and Banca Intesa	This work was supported in part by Cariplo Foundation Project 2009-2543, Telethon Foundation Project GGP10120, MIUR Grant RPAB11FRE9 (to F. T.), Italian Ministry of Health Grant PS 2007.39 (to F. T.), Italian Ministry of University and Scientific Research Grant 20078RWJBN (to M. M.), and Alzheimer's Association Project NIRG-10-171655, and by the Mario Negri Foundation and Banca Intesa.	[Anonymous], 2011, NAT NEUROSCI, V14, P399, DOI 10.1038/nn0411-399; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003529; Hong S, 2007, CHEM BIOL, V14, P107, DOI 10.1016/j.chembiol.2006.11.015; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kawahara Masahiro, 2011, Int J Alzheimers Dis, V2011, P304583, DOI 10.4061/2011/304583; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; LAGO P, 1993, REV SCI INSTRUM, V64, P1797, DOI 10.1063/1.1144013; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Paulis D, 2011, NEUROCHEM INT, V59, P168, DOI 10.1016/j.neuint.2011.04.008; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ramakrishnan M, 2009, BIOCHEMISTRY-US, V48, P10405, DOI 10.1021/bi900523q; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Shirwany Najeeb A, 2007, Neuropsychiatr Dis Treat, V3, P597; Sohma Y, 2005, J PEPT SCI, V11, P441, DOI 10.1002/psc.649; Stepanek J, 2006, SPRINGER SER CHEM SE, V4, P69, DOI 10.1007/5346_015; Stravalaci M, 2011, BIOSENS BIOELECTRON, V26, P2772, DOI 10.1016/j.bios.2010.10.038; Taniguchi A, 2009, CHEMBIOCHEM, V10, P710, DOI 10.1002/cbic.200800765; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x	45	45	47	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27796	27805		10.1074/jbc.M111.334979	http://dx.doi.org/10.1074/jbc.M111.334979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736768	Green Published, hybrid			2022-12-25	WOS:000307840700053
J	El Fatimy, R; Tremblay, S; Dury, AY; Solomon, S; De Koninck, P; Schrader, JW; Khandjian, EW				El Fatimy, Rachid; Tremblay, Sandra; Dury, Alain Y.; Solomon, Samuel; De Koninck, Paul; Schrader, John W.; Khandjian, Edouard W.			Fragile Mental Retardation Protein Interacts with the RNA-Binding Protein Caprin1 in Neuronal RiboNucleoProtein Complexes	PLOS ONE			English	Article							MESSENGER-RNA; NEGATIVE REGULATOR; X PROTEIN; FMRP; IDENTIFICATION; ASSOCIATION; GRANULES; TRANSLATION; KINESIN; POLYRIBOSOMES	Fragile X syndrome is caused by the absence of the Fragile X Mental Retardation Protein (FMRP), an RNA-binding protein. FMRP is associated with messenger RiboNucleoParticles (mRNPs) present in polyribosomes and its absence in neurons leads to alteration in synaptic plasticity as a result of translation regulation defects. The molecular mechanisms by which FMRP plays a role in translation regulation remain elusive. Using immunoprecipitation approaches with monoclonal Ab7G1-1 and a new generation of chicken antibodies, we identified Caprin1 as a novel FMRP-cellular partner. In vivo and in vitro evidence show that Caprin1 interacts with FMRP at the level of the translation machinery as well as in trafficking neuronal granules. As an RNA-binding protein, Caprin1 has in common with FMRP at least two RNA targets that have been identified as CaMKII alpha and Map1b mRNAs. In view of the new concept that FMRP species bind to RNA regardless of known structural motifs, we propose that protein interactors might modulate FMRP functions.	[El Fatimy, Rachid; Tremblay, Sandra; Dury, Alain Y.; De Koninck, Paul; Khandjian, Edouard W.] Inst Univ Sante Mentale, Ctr Rech, Quebec City, PQ, Canada; [El Fatimy, Rachid; Dury, Alain Y.; Khandjian, Edouard W.] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ G1K 7P4, Canada; [De Koninck, Paul] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Solomon, Samuel; Schrader, John W.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	Laval University; Laval University; Laval University; University of British Columbia	El Fatimy, R (corresponding author), Inst Univ Sante Mentale, Ctr Rech, Quebec City, PQ, Canada.	Edward.khandjian@crulrg.ulaval.ca	Fatimy, Rachid El/K-2822-2019	EL FATIMY, Rachid/0000-0002-7652-5562; Dury, Alain/0000-0002-0240-0441	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Jerome Lejeune Foundation, France	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Jerome Lejeune Foundation, France	EWK was supported by grants from the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Jerome Lejeune Foundation, France; JWS and PDK were supported by CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bechara E, 2007, NUCLEIC ACIDS RES, V35, P299, DOI 10.1093/nar/gkl1021; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Ceman Stephanie, 2003, Methods Mol Biol, V217, P345; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Darnell JC, 2011, CURR OPIN GENET DEV, V21, P465, DOI 10.1016/j.gde.2011.05.002; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidovic L, 2006, HUM MOL GENET, V15, P1525, DOI 10.1093/hmg/ddl074; Davidovic L, 2005, MOL BASIS FRAGILE X, P129; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Fahling M, 2009, J BIOL CHEM, V284, P4255, DOI 10.1074/jbc.M807354200; FALVEY AK, 1970, J MOL BIOL, V53, P1, DOI 10.1016/0022-2836(70)90042-2; Feng Y, 1997, J NEUROSCI, V17, P1539; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Hensold JO, 1996, J BIOL CHEM, V271, P23246, DOI 10.1074/jbc.271.38.23246; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kao DI, 2010, P NATL ACAD SCI USA, V107, P15601, DOI 10.1073/pnas.1010564107; Khandjian EW, 1999, BIOCHEM CELL BIOL, V77, P331, DOI 10.1139/bcb-77-4-331; KHANDJIAN EW, 1995, HUM MOL GENET, V4, P783, DOI 10.1093/hmg/4.5.783; Khandjian EW, 2005, CURR GENOMICS, V6, P515, DOI 10.2174/138920205775067701; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Khandjian EW, 2009, ENCY NEUROSCIENCE, V8, P389; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; MARTIN TE, 1970, J BIOL CHEM, V245, P1504; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Mientjes EJ, 2006, NEUROBIOL DIS, V21, P549, DOI 10.1016/j.nbd.2005.08.019; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Papoulas O, 2010, DEVELOPMENT, V137, P4201, DOI 10.1242/dev.055046; Piazzon N, 2008, J BIOL CHEM, V283, P5598, DOI 10.1074/jbc.M707304200; Salvetti A, 1998, DEV BIOL, V201, P217, DOI 10.1006/dbio.1998.8996; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 2010, J BIOL CHEM, V285, P24260, DOI 10.1074/jbc.M110.108944; Sofola O, 2008, J NEUROSCI, V28, P10200, DOI 10.1523/JNEUROSCI.2786-08.2008; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Wang B, 2005, J IMMUNOL, V175, P4274, DOI 10.4049/jimmunol.175.7.4274; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; ZYLBER EA, 1970, BIOCHIM BIOPHYS ACTA, V204, P221, DOI 10.1016/0005-2787(70)90505-8	60	42	42	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39338	10.1371/journal.pone.0039338	http://dx.doi.org/10.1371/journal.pone.0039338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737234	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100032
J	Eckmann-Scholz, C; Bens, S; Kolarova, J; Schneppenheim, S; Caliebe, A; Heidemann, S; von Kaisenberg, C; Kautza, M; Jonat, W; Siebert, R; Ammerpohl, O				Eckmann-Scholz, Christel; Bens, Susanne; Kolarova, Julia; Schneppenheim, Sina; Caliebe, Almuth; Heidemann, Simone; von Kaisenberg, Constantin; Kautza, Monika; Jonat, Walter; Siebert, Reiner; Ammerpohl, Ole			DNA-Methylation Profiling of Fetal Tissues Reveals Marked Epigenetic Differences between Chorionic and Amniotic Samples	PLOS ONE			English	Article							NONINVASIVE-PRENATAL-DIAGNOSIS; MATERNAL PLASMA; PATTERNS; TRISOMY-21; DISCOVERY; PLACENTA; INSIGHTS	Epigenetic mechanisms including DNA methylation are supposed to play a key role in fetal development. Here we have investigated fetal DNA-methylation levels of 27,578 CpG loci in 47 chorionic villi (CVS) and 16 amniotic cell (AC) samples. Methylation levels differed significantly between karyotypically normal AC and CVS for 2,014 genes. AC showed more extreme DNA-methylation levels of these genes than CVS and the differentially methylated genes are significantly enriched for processes characteristic for the different cell types sampled. Furthermore, we identified 404 genes differentially methylated in CVS with trisomy 21. These genes were significantly enriched for high CG dinucleotid (CpG) content and developmental processes associated with Down syndrome. Our study points to major tissue-specific differences of fetal DNA-methylation and gives rise to the hypothesis that part of the Down syndrome phenotype is epigenetically programmed in the first trimester of pregnancy.	[Eckmann-Scholz, Christel; von Kaisenberg, Constantin; Jonat, Walter] Univ Kiel, Dept Gynecol & Obstet, Kiel, Germany; [Eckmann-Scholz, Christel; Bens, Susanne; Kolarova, Julia; Schneppenheim, Sina; Caliebe, Almuth; Heidemann, Simone; von Kaisenberg, Constantin; Jonat, Walter; Siebert, Reiner; Ammerpohl, Ole] Univ Hosp Schleswig Holstein, Kiel, Germany; [Bens, Susanne; Kolarova, Julia; Schneppenheim, Sina; Caliebe, Almuth; Heidemann, Simone; Siebert, Reiner; Ammerpohl, Ole] Univ Kiel, Inst Human Genet, Kiel, Germany; [von Kaisenberg, Constantin] Hannover Med Sch, Dept Obstet Gynecol & Reprod Med, D-3000 Hannover, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Hannover Medical School	Eckmann-Scholz, C (corresponding author), Univ Kiel, Dept Gynecol & Obstet, Kiel, Germany.	oammerpohl@medgen.uni-kiel.de	Ammerpohl, Ole/G-2691-2010; Siebert, Reiner/A-8049-2010; Caliebe, Almuth/G-1248-2018; von Kaisenberg, Constantin/AAR-2756-2021	Caliebe, Almuth/0000-0003-2157-425X; 	Medical Faculty of the Christian-Albrechts-University Kiel	Medical Faculty of the Christian-Albrechts-University Kiel	This study was made possible by intramural funding of the Medical Faculty of the Christian-Albrechts-University Kiel to the involved institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, ANATOL J CARDIOL, V11, P183, DOI 10.5152/akd.2011.044; Ammerpohl O, 2012, LEUKEMIA, V26, P185, DOI 10.1038/leu.2011.194; Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Banister CE, 2011, EPIGENETICS-US, V6, P920, DOI 10.4161/epi.6.7.16079; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chowdhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016506; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Chu TJ, 2009, PRENATAL DIAG, V29, P1020, DOI 10.1002/pd.2335; Churakov G, 2009, GENOME RES, V19, P868, DOI 10.1101/gr.090647.108; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Gardner RJ, 2004, CHROMOSOME ABNORMALI; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; HOWARD CM, 1993, AM J HUM GENET, V53, P462; Joziasse IC, 2011, EUR J HUM GENET, V19, P389, DOI 10.1038/ejhg.2010.224; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Koch CM, 2012, AGING CELL, V11, P366, DOI 10.1111/j.1474-9726.2011.00784.x; Lambertini L, 2011, REPROD SCI, V18, P1111, DOI 10.1177/1933719111404611; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Poulsen P, 2007, PEDIATR RES, V61, p38R, DOI 10.1203/pdr.0b013e31803c7b98; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rexhaj E, 2011, AM J PHYSIOL-HEART C, V301, pH247, DOI 10.1152/ajpheart.01309.2010; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tsui DWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015069; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7	40	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39014	10.1371/journal.pone.0039014	http://dx.doi.org/10.1371/journal.pone.0039014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723920	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700043
J	Kaneko-Kawano, T; Takasu, F; Naoki, H; Sakumura, Y; Ishii, S; Ueba, T; Eiyama, A; Okada, A; Kawano, Y; Suzuki, K				Kaneko-Kawano, Takako; Takasu, Fugo; Naoki, Honda; Sakumura, Yuichi; Ishii, Shin; Ueba, Takahiro; Eiyama, Akinori; Okada, Aiko; Kawano, Yoji; Suzuki, Kenji			Dynamic Regulation of Myosin Light Chain Phosphorylation by Rho-kinase	PLOS ONE			English	Article							BINDING PROTEIN RHO; SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; POSITIVE-FEEDBACK; MOESIN PHOSPHORYLATION; IN-VIVO; PHOSPHATASE; SUBUNIT; THROMBIN; DIFFERENTIATION	Myosin light chain (MLC) phosphorylation plays important roles in various cellular functions such as cellular morphogenesis, motility, and smooth muscle contraction. MLC phosphorylation is determined by the balance between activities of Rho-associated kinase (Rho-kinase) and myosin phosphatase. An impaired balance between Rho-kinase and myosin phosphatase activities induces the abnormal sustained phosphorylation of MLC, which contributes to the pathogenesis of certain vascular diseases, such as vasospasm and hypertension. However, the dynamic principle of the system underlying the regulation of MLC phosphorylation remains to be clarified. Here, to elucidate this dynamic principle whereby Rho-kinase regulates MLC phosphorylation, we developed a mathematical model based on the behavior of thrombin-dependent MLC phosphorylation, which is regulated by the Rho-kinase signaling network. Through analyzing our mathematical model, we predict that MLC phosphorylation and myosin phosphatase activity exhibit bistability, and that a novel signaling pathway leading to the auto-activation of myosin phosphatase is required for the regulatory system of MLC phosphorylation. In addition, on the basis of experimental data, we propose that the auto-activation pathway of myosin phosphatase occurs in vivo. These results indicate that bistability of myosin phosphatase activity is responsible for the bistability of MLC phosphorylation, and the sustained phosphorylation of MLC is attributed to this feature of bistability.	[Kaneko-Kawano, Takako; Eiyama, Akinori; Okada, Aiko; Suzuki, Kenji] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga, Japan; [Takasu, Fugo] Nara Womens Univ, Dept Informat & Comp Sci, Nara 630, Japan; [Naoki, Honda; Ishii, Shin] Kyoto Univ, Dept Syst Sci, Grad Sch Informat, Uji, Kyoto, Japan; [Sakumura, Yuichi] Aichi Prefectural Univ, Dept Informat Sci & Technol, Nagakute, Aichi, Japan; [Ueba, Takahiro; Kawano, Yoji] Nara Inst Sci & Technol, Plant Mol Genet Lab, Nara 63001, Japan	Ritsumeikan University; Nara Womens University; Kyoto University; Nara Institute of Science & Technology	Kaneko-Kawano, T (corresponding author), Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga, Japan.	takanek@fc.ritsumei.ac.jp	Naoki, Honda/AAW-6284-2020; Naoki, Honda/N-5674-2017; Kawano, Yoji/C-7484-2011	Naoki, Honda/0000-0001-6816-9126; Naoki, Honda/0000-0001-6816-9126; Kawano, Yoji/0000-0003-0687-2777; Ishii, Shin/0000-0001-9385-8230	Astellas Foundation for Research on Metabolic Disorders (Japan); Nagoya University Foundation (Japan); Research Promoting Program of Ritsumeikan University Research Fundation (Japan); Ministry of Education, Culture, Sports, Science, and Technology (Japan) [S1001042]; Maekawa Houonkai Foundation (Japan); SEI Group CSR Foundation (Japan); Grants-in-Aid for Scientific Research [23770044, 23127509] Funding Source: KAKEN	Astellas Foundation for Research on Metabolic Disorders (Japan); Nagoya University Foundation (Japan); Research Promoting Program of Ritsumeikan University Research Fundation (Japan); Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Maekawa Houonkai Foundation (Japan); SEI Group CSR Foundation (Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from Astellas Foundation for Research on Metabolic Disorders (Japan), Nagoya University Foundation (Japan), Research Promoting Program of Ritsumeikan University Research Fundation (Japan), Strategic Research Foundation Grant-aided Project for Private Universities (S1001042) from Ministry of Education, Culture, Sports, Science, and Technology (Japan), Maekawa Houonkai Foundation (Japan), and SEI Group CSR Foundation (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Damron DS, 2002, AM J PHYSIOL-LUNG C, V283, pL1051, DOI 10.1152/ajplung.00345.2001; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Fujihara H, 1997, MOL BIOL CELL, V8, P2437, DOI 10.1091/mbc.8.12.2437; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hartel FV, 2007, CARDIOVASC RES, V74, P487, DOI 10.1016/j.cardiores.2007.02.013; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kiss A, 2008, CELL SIGNAL, V20, P2059, DOI 10.1016/j.cellsig.2008.07.018; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kolosova IA, 2004, AM J PHYSIOL-LUNG C, V287, pL970, DOI 10.1152/ajplung.00398.2003; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Maeda A, 2006, GENES CELLS, V11, P1071, DOI 10.1111/j.1365-2443.2006.01001.x; Manuck SB, 2002, PHYSIOL BEHAV, V77, P705, DOI 10.1016/S0031-9384(02)00922-8; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Miyazaki K, 2002, J BIOL CHEM, V277, P725, DOI 10.1074/jbc.M108568200; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Retzer M, 2000, CELL SIGNAL, V12, P645, DOI 10.1016/S0898-6568(00)00108-X; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Segel LA, 1998, BIOPHYS CHEM, V72, P223, DOI 10.1016/S0301-4622(98)00136-7; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smolen P, 1998, AM J PHYSIOL-CELL PH, V274, pC531, DOI 10.1152/ajpcell.1998.274.2.C531; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	50	41	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39269	10.1371/journal.pone.0039269	http://dx.doi.org/10.1371/journal.pone.0039269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723981	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700063
J	Mane, A; Nirmalkar, A; Risbud, AR; Vermund, SH; Mehendale, SM; Sahasrabuddhe, VV				Mane, Arati; Nirmalkar, Amit; Risbud, Arun R.; Vermund, Sten H.; Mehendale, Sanjay M.; Sahasrabuddhe, Vikrant V.			HPV Genotype Distribution in Cervical Intraepithelial Neoplasia among HIV-Infected Women in Pune, India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; RISK-FACTORS; POSITIVE WOMEN; PGMY PRIMERS; PREVALENCE; LESIONS; DNA; TERMINOLOGY; SAMPLES	Background: The distribution of HPV genotypes, their association with rigorously confirmed cervical precancer endpoints, and factors associated with HPV infection have not been previously documented among HIV-infected women in India. We conducted an observational study to expand this evidence base in this population at high risk of cervical cancer. Methods: HIV-infected women (N = 278) in Pune, India underwent HPV genotyping by Linear Array assay. Cervical intraepithelial neoplasia (CIN) disease ascertainment was maximized by detailed assessment using cytology, colposcopy, and histopathology and a composite endpoint. Results: CIN2+ was detected in 11.2% while CIN3 was present in 4.7% participants. HPV genotypes were present in 52.5% (146/278) and 'carcinogenic' HPV genotypes were present in 35.3% (98/278) HIV-infected women. 'Possibly carcinogenic' and 'non/unknown carcinogenic' HPV genotypes were present in 14.7% and 29.5% participants respectively. Multiple (>= 2) HPV genotypes were present in half (50.7%) of women with HPV, while multiple 'carcinogenic' HPV genotypes were present in just over a quarter (27.8%) of women with 'carcinogenic' HPV. HPV16 was the commonest genotype, present in 12% overall, as well as in 47% and 50% in CIN2+ and CIN3 lesions with a single carcinogenic HPV infection, respectively. The carcinogenic HPV genotypes in declining order of prevalence overall included HPV 16, 56, 18, 39, 35, 51, 31, 59, 33, 58, 68, 45 and 52. Factors independently associated with 'carcinogenic' HPV type detection were reporting >= 2 lifetime sexual partners and having lower CD4+ count. HPV16 detection was associated with lower CD4+ cell counts and currently receiving combination antiretroviral therapy. Conclusion: HPV16 was the most common HPV genotype, although a wide diversity and high multiplicity of HPV genotypes was observed. Type-specific attribution of carcinogenic HPV genotypes in CIN3 lesions in HIV-infected women, and etiologic significance of concurrently present non/unknown carcinogenic HPV genotypes await larger studies.	[Mane, Arati; Nirmalkar, Amit; Risbud, Arun R.] Natl AIDS Res Inst, Pune, Maharashtra, India; [Vermund, Sten H.; Sahasrabuddhe, Vikrant V.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Mehendale, Sanjay M.] Natl Inst Epidemiol, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Vanderbilt University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE)	Mane, A (corresponding author), Natl AIDS Res Inst, Pune, Maharashtra, India.	vikrant.sahasrabuddhe@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698	U.S. National Institutes of Health (NIH) [R21CA113465, D43TW001035]; Indian Council of Medical Research (ICMR); FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA113465] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research in this manuscript was supported by the U.S. National Institutes of Health (NIH) (through grants R21CA113465 and D43TW001035) and the Indian Council of Medical Research (ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollen LJM, 2006, SEX TRANSM DIS, V33, P259; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Broker T R, 2001, Dev Biol (Basel), V106, P443; Broker TR, 2001, DEV BIOL BASEL, V106, P452; Broker TR, 2001, DEV BIOL BASEL, V106, P465; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Coelho Lima BM, 2009, BRAZIL J INT ASS PHY, V8, P286; Coutlee F, 2002, J CLIN MICROBIOL, V40, P902, DOI 10.1128/JCM.40.3.902-907.2002; Coutlee F, 2006, J CLIN MICROBIOL, V44, P1998, DOI 10.1128/JCM.00104-06; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hankins C, 1999, CAN MED ASSOC J, V160, P185; Hawes SE, 2006, J NATL CANCER I, V98, P100, DOI 10.1093/jnci/djj010; Hernandez Brenda Y, 2008, Infect Agent Cancer, V3, P7, DOI 10.1186/1750-9378-3-7; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP, pv; Joshi SN, 2005, J MED VIROL, V76, P470, DOI 10.1002/jmv.20385; Kitchener H, 2007, INT J CANCER, V121, P2484, DOI 10.1002/ijc.22947; Kornegay JR, 2003, J CLIN MICROBIOL, V41, P1080, DOI 10.1128/JCM.41.3.1080-1086.2003; Levi JE, 2002, J CLIN MICROBIOL, V40, P3341, DOI 10.1128/JCM.40.9.3341-3345.2002; Luque AE, 2006, J INFECT DIS, V194, P428, DOI 10.1086/505876; Luque AE, 2010, INT J INFECT DIS, V14, pE810, DOI 10.1016/j.ijid.2010.03.016; McKenzie ND, 2010, GYNECOL ONCOL, V116, P572, DOI 10.1016/j.ygyno.2009.10.058; Melgaco FG, 2011, ARCH GYNECOL OBSTET, V283, P809, DOI 10.1007/s00404-010-1443-z; Moodley JR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-275; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Nicol AF, 2008, J CLIN PATHOL, V61, P84, DOI 10.1136/jcp.2007.047290; NUOVO GJ, 1991, AM J PATHOL, V138, P53; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Palefsky JM, 2003, JNCI MONOGRAPHS, V2003, P41, DOI DOI 10.1093/0XF0RDJ0URNALS.JNCIM0N0GRAPHS.A003481; Peedicayil A, 2009, J LOW GENIT TRACT DI, V13, P159, DOI 10.1097/LGT.0b013e31818fb40d; RICHART RM, 1990, OBSTET GYNECOL, V75, P131; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Sahasrabuddhe VV, 2011, FUTURE MICROBIOL, V6, P1083, DOI [10.2217/FMB.11.87, 10.2217/fmb.11.87]; Sahasrabuddhe VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008634; Sarkar K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-72; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stanley M, 2010, CURR OPIN INFECT DIS, V23, P70, DOI 10.1097/QCO.0b013e328334c0e1; Steinau M, 2008, J CLIN VIROL, V42, P412, DOI 10.1016/j.jcv.2008.03.004; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Strickler HD, 2008, INT J CANCER, V123, P1224, DOI 10.1002/ijc.23630; Tornesello ML, 2008, J GEN VIROL, V89, P1380, DOI 10.1099/vir.0.83553-0; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528	45	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38731	10.1371/journal.pone.0038731	http://dx.doi.org/10.1371/journal.pone.0038731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723879	Green Submitted, gold, Green Published			2022-12-25	WOS:000305652700023
J	Sikorski, C; Luppa, M; Schomerus, G; Werner, P; Konig, HH; Riedel-Heller, SG				Sikorski, Claudia; Luppa, Melanie; Schomerus, Georg; Werner, Perla; Koenig, Hans-Helmut; Riedel-Heller, Steffi G.			Public Attitudes towards Prevention of Obesity	PLOS ONE			English	Article							HEALTH; FUTURE; BURDEN; ADULTS; POLICY	Objective: To investigate obesity prevention support in the German general public and to assess determinants of general prevention support as well as support of specific prevention measures. Methods: This study was a cross-sectional analysis of a telephone based representative German study (3,003 subjects (52.8% women, mean age 51.9, s.d. = 18.0, range 18-97 years). Likert scale-based questions on general prevention support and support of specific measures were used. Furthermore willingness to take part in preventive programs and willingness to pay were assessed. Stigmatizing attitudes were assessed with the Fat Phobia Scale (FPS). Causation of obesity was differentiated in three dimensions (internal, e. g. lack of exercise; external, e. g. social surroundings; and genetic factors). Results: Obesity prevention was perceived as possible (98.2%), however, almost exclusively lifestyle changes were named. Participants with higher stigmatizing attitudes were less likely to believe obesity prevention is possible. The majority of participants would take part in preventive programs (59.6%) and pay at least partially themselves (86.9%). Factor analysis revealed three dimensions of preventive measures: promoting healthy eating, restrictive and financial, governmental prevention efforts. In regard to these, promoting healthy eating was the most supported measure. Higher age, female gender and external causation were associated with higher support for all three dimensions of preventive measures. Only for governmental regulation, higher age was associated with lower support. Conclusion: Obesity prevention support in Germany is high. Structural prevention efforts are supported by the majority of the general public in Germany. The vast majority proclaims willingness to pay themselves for programs of weight gain prevention. This could be an indication of higher perceived self-responsibility in the German system but also for risen "fear of fat" in the population due to media coverage. For Germany, the government and communities ought to be encouraged by these results to start the implementation of structural obesity prevention.	[Sikorski, Claudia] Univ Leipzig, Integrated Res & Treatment Ctr AdiposityDis, Leipzig, Germany; [Sikorski, Claudia; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany; [Schomerus, Georg] Ernst Moritz Arndt Univ Greifswald, Dept Psychiat & Psychotherapy, Stralsund, Germany; [Werner, Perla] Univ Haifa, Fac Social Welf & Hlth Sci, IL-31999 Haifa, Israel; [Koenig, Hans-Helmut] Hamburg Eppendorf Univ Med Ctr, Dept Med Sociol & Hlth Econ, Hamburg, Germany	Leipzig University; Leipzig University; Ernst Moritz Arndt Universitat Greifswald; University of Haifa; University of Hamburg; University Medical Center Hamburg-Eppendorf	Sikorski, C (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr AdiposityDis, Leipzig, Germany.	Claudia.Sikorski@medizin.uni-leipzig.de	Werner, Perla/G-6008-2012; König, Hans-Helmut/P-1211-2018; Schomerus, Georg/A-6568-2013; Riedel-Heller, Steffi/ABG-1537-2021; Luppa, Melanie/AAQ-7338-2021	König, Hans-Helmut/0000-0001-5711-6862; Schomerus, Georg/0000-0002-6752-463X; 	Federal Ministry of Education and Research (Bundesministerium fur Forschung und Bildung), Germany [FKZ: 01EO1001]	Federal Ministry of Education and Research (Bundesministerium fur Forschung und Bildung), Germany	This work was supported by the Federal Ministry of Education and Research (Bundesministerium fur Forschung und Bildung), Germany, FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Bundesanstalt fur Landwirtschaft und Ernahrung, 2011, IN FORM DTSCH LANDS; Bundesverband der Verbraucherzentralen und Verbraucherverbande-Verbraucherzentrale Bundesverband e. V, 2011, LEB; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; Crandall CS, 1996, PERS SOC PSYCHOL B, V22, P1165, DOI 10.1177/01461672962211007; CRANDALL CS, 1994, J RES PERS, V28, P461, DOI 10.1006/jrpe.1994.1033; Dube L, 2010, OBESITY PREVENTION: THE ROLE OF BRAIN AND SOCIETY ON INDIVIDUAL BEHAVIOR, P435, DOI 10.1016/B978-0-12-374387-9.00035-0; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Fussenegger D, 2008, OBES REV, V9, P76, DOI 10.1111/j.1467-789X.2007.00405.x; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Hilbert A, 2007, J EPIDEMIOL COMMUN H, V61, P585, DOI 10.1136/jech.2006.050906; Hilbert A, 2009, OBESITY FACTS, V2, P46, DOI 10.1159/000195697; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Konnopka A, 2011, EUR J HEALTH ECON, V12, P345, DOI 10.1007/s10198-010-0242-6; Kremers S, 2010, OBES REV, V11, P371, DOI 10.1111/j.1467-789X.2009.00598.x; Latner JD, 2009, J HEALTH PSYCHOL, V14, P190, DOI 10.1177/1359105308100203; Lehnert T, 2012, OBES REV, V13, P537, DOI 10.1111/j.1467-789X.2011.00980.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lund TB, 2011, OBESITY, V19, P1580, DOI 10.1038/oby.2011.84; Malterud K, 2010, PATIENT EDUC COUNS, V81, P47, DOI 10.1016/j.pec.2009.10.022; Muller MJ, 2010, OBES REV, V11, P101, DOI 10.1111/j.1467-789X.2009.00643.x; Raine KD, 2005, CAN J PUBLIC HEALTH, V96, pS8, DOI 10.1007/BF03405195; Ruggs EN, 2010, OBESITY FACTS, V3, P60, DOI 10.1159/000273208; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sacks G, 2009, OBES REV, V10, P76, DOI 10.1111/j.1467-789X.2008.00524.x; Schomerus G, 2008, J AFFECT DISORDERS, V106, P257, DOI 10.1016/j.jad.2007.06.013; Schomerus G, 2010, PSYCHIAT PRAX, V37, P111, DOI 10.1055/s-0029-1223438; Sikorski C, 2011, OBESITY SILVER UNPUB; Sikorski C, 2012, SCAND J PUB IN PRESS, V40; Sikorski C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-661; StataCorp, 2019, STATA STAT SOFTWARE; The International Obesity Taskforce, 2011, GLOB EP; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; World Health Organization Regional Office for Europe, 2011, DEV NEW EUR POL HLTH	40	21	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39325	10.1371/journal.pone.0039325	http://dx.doi.org/10.1371/journal.pone.0039325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723996	gold, Green Submitted, Green Published			2022-12-25	WOS:000305652700068
J	He, WG; Qin, QB; Liu, SJ; Li, TL; Wang, J; Xiao, J; Xie, LH; Zhang, C; Liu, Y				He, Weiguo; Qin, Qinbo; Liu, Shaojun; Li, Tangluo; Wang, Jing; Xiao, Jun; Xie, Lihua; Zhang, Chun; Liu, Yun			Organization and Variation Analysis of 5S rDNA in Different Ploidy-level Hybrids of Red Crucian Carp x Topmouth Culter	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; MOLECULAR-ORGANIZATION; NUCLEOTIDE-SEQUENCE; GENOMIC ORGANIZATION; CARASSIUS-AURATUS; POLYPLOID HYBRIDS; ATLANTIC SALMON; EVOLUTION; DNA; ELIMINATION	Through distant crossing, diploid, triploid and tetraploid hybrids of red crucian carp (Carassius auratus red var., RCC female, Cyprininae, 2n = 100) x topmouth culter (Erythroculter ilishaeformis Bleeker, TC male, Cultrinae, 2n = 48) were successfully produced. Diploid hybrids possessed 74 chromosomes with one set from RCC and one set from TC; triploid hybrids harbored 124 chromosomes with two sets from RCC and one set from TC; tetraploid hybrids had 148 chromosomes with two sets from RCC and two sets from TC. The 5S rDNA of the three different ploidy-level hybrids and their parents were sequenced and analyzed. There were three monomeric 5S rDNA classes (designated class I: 203 bp; class II: 340 bp; and class III: 477 bp) in RCC and two monomeric 5S rDNA classes (designated class IV: 188 bp, and class V: 286 bp) in TC. In the hybrid offspring, diploid hybrids inherited three 5S rDNA classes from their female parent (RCC) and only class IV from their male parent (TC). Triploid hybrids inherited class II and class III from their female parent (RCC) and class IV from their male parent (TC). Tetraploid hybrids gained class II and class III from their female parent (RCC), and generated a new 5S rDNA sequence (designated class I-N). The specific paternal 5S rDNA sequence of class V was not found in the hybrid offspring. Sequence analysis of 5S rDNA revealed the influence of hybridization and polyploidization on the organization and variation of 5S rDNA in fish. This is the first report on the coexistence in vertebrates of viable diploid, triploid and tetraploid hybrids produced by crossing parents with different chromosome numbers, and these new hybrids are novel specimens for studying the genomic variation in the first generation of interspecific hybrids, which has significance for evolution and fish genetics.	[He, Weiguo; Qin, Qinbo; Liu, Shaojun; Li, Tangluo; Wang, Jing; Xiao, Jun; Xie, Lihua; Zhang, Chun; Liu, Yun] Hunan Normal Univ, Key Lab Prot Chem & Fish Dev Biol, Educ Minist China, Coll Life Sci, Changsha, Hunan, Peoples R China	Hunan Normal University	Liu, SJ (corresponding author), Hunan Normal Univ, Key Lab Prot Chem & Fish Dev Biol, Educ Minist China, Coll Life Sci, Changsha, Hunan, Peoples R China.	lsj@hunnu.edu.cn	qin, qin x/GXG-6164-2022; Qin, Qin/GVT-5910-2022		National Natural Science Foundation of China [30930071, 30901100]; Natural Science Fund for Innovative Research Team of Hunan Province [10JJ7004]; National Special Fund for Scientific Research in public benefits [200903046]; Ministry of Education of China [20104306110004]; Natural Science Foundation of Hunan Province [IIJJ40220]; Key Discipline of Hunan Province and China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund for Innovative Research Team of Hunan Province; National Special Fund for Scientific Research in public benefits; Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Key Discipline of Hunan Province and China	This work was funded by the National Natural Science Foundation of China (Grant No. : 30930071 and 30901100), the Natural Science Fund for Innovative Research Team of Hunan Province (Grant No. : 10JJ7004), the National Special Fund for Scientific Research in public benefits (Grant No. : 200903046), the Doctoral Fund of Ministry of Education of China (Grant No. : 20104306110004), the Natural Science Foundation of Hunan Province (Grant No. : IIJJ40220), and the Construction Project of Key Discipline of Hunan Province and China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI A, 1991, NUCLEIC ACIDS RES, V19, P5073, DOI 10.1093/nar/19.18.5073; Arnold ML, 1996, NATURAL HYBRIDIZATIO; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Badaeva ED, 2002, PLANT SYST EVOL, V231, P163, DOI 10.1007/s006060200018; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; BULLINI L, 1994, TRENDS ECOL EVOL, V9, P422, DOI 10.1016/0169-5347(94)90124-4; Campo D, 2012, GENOME, V55, P33, DOI 10.1139/G11-074; Campo D, 2009, J MOL EVOL, V68, P208, DOI 10.1007/s00239-009-9207-8; CASSIDY JR, 1987, CURR GENET, V12, P33, DOI 10.1007/BF00420724; Chen L, 2009, MOL CELL PROBE, V23, P157, DOI 10.1016/j.mcp.2009.03.001; CIHLAR RL, 1980, NUCLEIC ACIDS RES, V8, P793; DELSENY M, 1990, GENOME, V33, P733, DOI 10.1139/g90-111; Fujiwara M, 2009, GENETICA, V135, P355, DOI 10.1007/s10709-008-9294-2; Gallardo MH, 1999, NATURE, V401, P341, DOI 10.1038/43815; GANAL MW, 1988, MOL GEN GENET, V213, P262, DOI 10.1007/BF00339590; Gornung E, 2007, GENOME, V50, P787, DOI 10.1139/G07-058; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Inafuku J, 2000, CHROMOSOME RES, V8, P193, DOI 10.1023/A:1009292610618; Kashkush K, 2002, GENETICS, V160, P1651; KOMIYA H, 1986, J BIOCHEM-TOKYO, V100, P369, DOI 10.1093/oxfordjournals.jbchem.a121723; Kotseruba V, 2003, GENOME, V46, P156, DOI 10.1139/G02-104; Kramer A, 1985, Dev Biol (N Y 1985), V1, P431; Le Comber SC, 2004, BIOL J LINN SOC, V82, P431; LEAH R, 1990, NUCLEIC ACIDS RES, V18, P7441, DOI 10.1093/nar/18.24.7441; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Liu SJ, 2007, GENETICS, V176, P1023, DOI 10.1534/genetics.107.071373; Liu SJ, 2001, AQUACULTURE, V192, P171, DOI 10.1016/S0044-8486(00)00451-8; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Mable BK, 2004, BIOL J LINN SOC, V82, P453, DOI 10.1111/j.1095-8312.2004.00332.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martins C, 2001, GENETICA, V111, P439, DOI 10.1023/A:1013799516717; Martins C, 2001, GENOME, V44, P903, DOI 10.1139/gen-44-5-903; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Moran P, 1996, CYTOGENET CELL GENET, V75, P145, DOI 10.1159/000134466; Negi MS, 2002, GENOME, V45, P1181, DOI 10.1139/G02-094; NELSON DW, 1985, GENE, V38, P245, DOI 10.1016/0378-1119(85)90224-0; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Pamela SS, 1991, SYSTEMATIC BOT, V16, P407; Pasolini P, 2006, J MOL EVOL, V62, P564, DOI 10.1007/s00239-005-0118-z; PENDAS AM, 1995, MOL ECOL, V4, P275, DOI 10.1111/j.1365-294X.1995.tb00220.x; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; Pennell W., 1996, PRINCIPLES SALMONID; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Pinhal D, 2009, GENET RES, V91, P61, DOI 10.1017/S0016672308009993; Qin QB, 2010, J EXP ZOOL PART B, V314B, P403, DOI 10.1002/jez.b.21346; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2001, CURR BIOL, V11, pR925, DOI 10.1016/S0960-9822(01)00556-5; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Robles F, 2005, GENOME, V48, P18, DOI 10.1139/G04-077; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Sajdak SL, 1998, J MOL EVOL, V46, P680, DOI 10.1007/PL00006348; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sola L, 2003, HEREDITAS, V139, P232, DOI 10.1111/j.1601-5223.2003.01814.x; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; SUZUKI H, 1994, MOL BIOL EVOL, V11, P704; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venkatesh B, 2003, CURR OPIN GENET DEV, V13, P588, DOI 10.1016/j.gde.2003.09.001; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Wasko AP, 2001, GENOME, V44, P893, DOI 10.1139/gen-44-5-893; Xiao J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-20; Yi MS, 2003, CHROMOSOME RES, V11, P665, DOI 10.1023/A:1025985625706; Yu XJ, 1989, CHROMOSOMES CHIMESE	65	47	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38976	10.1371/journal.pone.0038976	http://dx.doi.org/10.1371/journal.pone.0038976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22720007	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300074
J	Van de Sompel, D; Garai, E; Zavaleta, C; Gambhir, SS				Van de Sompel, Dominique; Garai, Ellis; Zavaleta, Cristina; Gambhir, Sanjiv Sam			A Hybrid Least Squares and Principal Component Analysis Algorithm for Raman Spectroscopy	PLOS ONE			English	Article							SUBTRACTION; CALIBRATION; REGRESSION	Raman spectroscopy is a powerful technique for detecting and quantifying analytes in chemical mixtures. A critical part of Raman spectroscopy is the use of a computer algorithm to analyze the measured Raman spectra. The most commonly used algorithm is the classical least squares method, which is popular due to its speed and ease of implementation. However, it is sensitive to inaccuracies or variations in the reference spectra of the analytes (compounds of interest) and the background. Many algorithms, primarily multivariate calibration methods, have been proposed that increase robustness to such variations. In this study, we propose a novel method that improves robustness even further by explicitly modeling variations in both the background and analyte signals. More specifically, it extends the classical least squares model by allowing the declared reference spectra to vary in accordance with the principal components obtained from training sets of spectra measured in prior characterization experiments. The amount of variation allowed is constrained by the eigenvalues of this principal component analysis. We compare the novel algorithm to the least squares method with a low-order polynomial residual model, as well as a state-of-the-art hybrid linear analysis method. The latter is a multivariate calibration method designed specifically to improve robustness to background variability in cases where training spectra of the background, as well as the mean spectrum of the analyte, are available. We demonstrate the novel algorithm's superior performance by comparing quantitative error metrics generated by each method. The experiments consider both simulated data and experimental data acquired from in vitro solutions of Raman-enhanced gold-silica nanoparticles.	[Van de Sompel, Dominique; Garai, Ellis; Zavaleta, Cristina; Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA	Stanford University	Van de Sompel, D (corresponding author), Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Zavaleta, Cristina/AAC-2306-2020	Zavaleta, Cristina/0000-0001-7314-2446	Susan G. Komen Postdoctoral Fellowship; Molecular Imaging Program at Stanford (MIPS); National Cancer Institute ICMIC [P50CA114747]; National Cancer Institute CCNE-T [U54 U54CA151459]; Doris Duke Foundation; Canary Foundation; Ben & Catherine Ivy Foundation; Sir Peter Michael Foundation; NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER	Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); Molecular Imaging Program at Stanford (MIPS); National Cancer Institute ICMIC; National Cancer Institute CCNE-T; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Canary Foundation; Ben & Catherine Ivy Foundation; Sir Peter Michael Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Van de Sompel is supported by a Susan G. Komen Postdoctoral Fellowship, as well as the Molecular Imaging Program at Stanford (MIPS). The authors would also like to acknowledge funding for the Gambhir laboratory from National Cancer Institute ICMIC P50CA114747, National Cancer Institute CCNE-T U54 U54CA151459, Doris Duke Foundation, Canary Foundation, Ben & Catherine Ivy Foundation, and the Sir Peter Michael Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hatab NA, 2007, APPL SPECTROSC, V61, P1116, DOI 10.1366/000370207782217842; Berger AJ, 1998, ANAL CHEM, V70, P623, DOI 10.1021/ac970721p; Faber K, 1997, J CHEMOMETR, V11, P181, DOI 10.1002/(SICI)1099-128X(199705)11:3<181::AID-CEM459>3.0.CO;2-7; Fortina P, 2005, TRENDS BIOTECHNOL, V23, P168, DOI 10.1016/j.tibtech.2005.02.007; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105; Kode K, 2011, J RAMAN SPE IN PRESS; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Lutz BR, 2008, ACS NANO, V2, P2306, DOI 10.1021/nn800243g; Zavaleta CL, 2011, J NUCL MED, V52, P1839, DOI 10.2967/jnumed.111.087775; Zavaleta CL, 2009, P NATL ACAD SCI USA, V106, P13511, DOI 10.1073/pnas.0813327106; Zhang ZM, 2010, ANALYST, V135, P1138, DOI 10.1039/b922045c; Zhao J, 2007, APPL SPECTROSC, V61, P1225, DOI 10.1366/000370207782597003	14	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38850	10.1371/journal.pone.0038850	http://dx.doi.org/10.1371/journal.pone.0038850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723895	Green Published, gold			2022-12-25	WOS:000305583300060
J	Henry, P; Sim, ZJ; Russello, MA				Henry, Philippe; Sim, Zijian; Russello, Michael A.			Genetic Evidence for Restricted Dispersal along Continuous Altitudinal Gradients in a Climate Change-Sensitive Mammal: The American Pika	PLOS ONE			English	Article							OCHOTONA-PRINCEPS; ENVIRONMENTAL-FACTORS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; GENOTYPING ERRORS; PATTERNS; EVOLUTIONARY; INFERENCE; PACKAGE; DRIVEN	When faced with rapidly changing environments, wildlife species are left to adapt, disperse or disappear. Consequently, there is value in investigating the connectivity of populations of species inhabiting different environments in order to evaluate dispersal as a potential strategy for persistence in the face of climate change. Here, we begin to investigate the processes that shape genetic variation within American pika populations from the northern periphery of their range, the central Coast Mountains of British Columbia, Canada. At these latitudes, pikas inhabit sharp elevation gradients ranging from sea level to 1500 m, providing an excellent system for studying the effects of local environmental conditions on pika population genetic structure and gene flow. We found low levels of neutral genetic variation compared to previous studies from more southerly latitudes, consistent with the relatively recent post-glacial colonization of the study location. Moreover, significant levels of inbreeding and marked genetic structure were detected within and among sites. Although low levels of recent gene flow were revealed among elevations within a transect, potentially admixed individuals and first generation migrants were identified using discriminant analysis of principal components between populations separated by less than five kilometers at the same elevations. There was no evidence for historical population decline, yet there was signal for recent demographic contractions, possibly resulting from environmental stochasticity. Correlative analyses revealed an association between patterns of genetic variation and annual heat-to-moisture ratio, mean annual precipitation, precipitation as snow and mean maximum summer temperature. Changes in climatic regimes forecasted for the region may thus potentially increase the rate of population extirpation by further reducing dispersal between sites. Consequently, American pika may have to rely on local adaptations or phenotypic plasticity in order to survive predicted climate changes, although additional studies are required to investigate the evolutionary potential of this climate change sensitive species.	[Henry, Philippe; Sim, Zijian; Russello, Michael A.] Univ British Columbia, Dept Biol, Kelowna, BC, Canada	University of British Columbia	Henry, P (corresponding author), Univ Calgary, Fac Environm Design & Vet Med, Calgary, AB, Canada.	phenry@alumni.ubc.ca	Henry, Philippe/C-6875-2009; Sim, Zijian/M-8413-2015	Henry, Philippe/0000-0002-6475-1714; Sim, Zijian/0000-0002-1585-8021	NSERC [341711-07]; Swiss National Science Foundation [PBSKP3_128523]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	An NSERC Discovery Grant # 341711-07 to Michael A. Russello provided funding for this work. Philippe Henry was partially supported by doctoral fellowship PBSKP3_128523 from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Dailianis T, 2011, MOL ECOL, V20, P3757, DOI 10.1111/j.1365-294X.2011.05222.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Fox J, 2005, J STAT SOFTW, V14; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Galbreath KE, 2010, J BIOGEOGR, V37, P344, DOI 10.1111/j.1365-2699.2009.02201.x; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gebremedhin B, 2009, ANIM CONSERV, V12, P107, DOI 10.1111/j.1469-1795.2009.00255.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Henry P, 2011, JOVE, V49; Henry P, NW SCI UNPUB; Henry P, 2011, EUR J WILDLIFE RES, V57, P429, DOI 10.1007/s10344-010-0449-y; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Jombart T, 2011, TUTORIAL DISCRIMINAT, V1, P3; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; Lovejoy TE, 2005, CLIMATE CHANGE BIODI, Vxiii; MACARTHUR RA, 1974, CAN J ZOOL, V52, P353, DOI 10.1139/z74-042; Manel S, 2010, MOL ECOL, V19, P3824, DOI 10.1111/j.1365-294X.2010.04716.x; Merideth SJ, 2002, IMPACT HABITAT SPATI; Mintenbeck K., 2022, CLIMATE CHANGE 2022; Morin PA, 2009, MOL ECOL RESOUR, V9, P498, DOI 10.1111/j.1755-0998.2008.02502.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peacock MM, 1997, OECOLOGIA, V112, P524, DOI 10.1007/s004420050341; Peacock MM, 2002, MOL ECOL NOTES, V2, P360, DOI 10.1046/j.1471-8286.2002.00249.x; Peacock MM, 1997, MOL ECOL, V6, P801; Peacock MM, 1997, BEHAV ECOL, V8, P340, DOI 10.1093/beheco/8.3.340; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; Smith A.T., 2004, SPECIES, V41, P4; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wilson GA, 2003, GENETICS, V163, P1177; Yin BF, 2009, MAMM BIOL, V74, P344, DOI 10.1016/j.mambio.2008.10.001; Zgurski JM, 2009, MOL ECOL RESOUR, V9, P867, DOI 10.1111/j.1755-0998.2008.02397.x	51	32	33	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39077	10.1371/journal.pone.0039077	http://dx.doi.org/10.1371/journal.pone.0039077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720034	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350000038
J	Hammond, JC; Meador-Woodruff, JH; Haroutunian, V; McCullumsmith, RE				Hammond, John C.; Meador-Woodruff, James H.; Haroutunian, Vahram; McCullumsmith, Robert E.			Ampa Receptor Subunit Expression in the Endoplasmic Reticulum in Frontal Cortex of Elderly Patients with Schizophrenia	PLOS ONE			English	Article							SYNAPSE-ASSOCIATED PROTEIN-97; ANTIPSYCHOTIC-DRUGS; PREFRONTAL CORTEX; TRAFFICKING; DENDRITES; NEURONS; BINDING	Several lines of evidence indicate altered trafficking of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors in schizophrenia. Previous reports have shown potential changes in the trafficking of AMPA receptors based on subunit expression of endosomes, subcellular organelles located near post-synaptic sites. We hypothesized that alterations in AMPA receptor trafficking through the endoplasmic reticulum (ER) may also be altered in schizophrenia. Accordingly, we developed a technique to isolate and measure content of the ER from postmortem brain tissue. We used Western blot and electron microscopy to show that we isolated an ER enriched fraction. We found no changes in the expression of the AMPA receptor subunits, GluR1-4, in the ER from the dorsolateral prefrontal cortex in schizophrenia. These data suggest that AMPA receptor trafficking through the ER is largely intact in schizophrenia.	[Hammond, John C.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Hammond, John C.; Meador-Woodruff, James H.; McCullumsmith, Robert E.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Haroutunian, Vahram] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Icahn School of Medicine at Mount Sinai	Hammond, JC (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	hammondj@uab.edu	McCullumsmith, Robert/GYR-1547-2022		NIMH [MH086257, MH53327, MH064673, MH066392, MH074016]; Doris Duke Clinical Scientist Award; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH074016, F30MH086257, R01MH064673, P50MH066392, R01MH053327] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Doris Duke Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided for by the NIMH grants by MH086257 (JCH), MH53327 (JMW), MH064673 (VH), MH066392 (VH), MH074016 (REM), and the Doris Duke Clinical Scientist Award (REM) (http://www.nimh.nih.gov) and (http://www.ddcf.org/Medical-Research/Program-Strategies/Clinical-Research/Clinical-Scientist-Development-Award/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneyto M, 2006, SYNAPSE, V60, P585, DOI 10.1002/syn.20329; Bond D, 2008, BIOL PROCED ONLINE, V10, P20, DOI 10.1251/bpo139; Bozidis Petros, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0327s37; BREESE CR, 1995, BRAIN RES, V674, P82, DOI 10.1016/0006-8993(94)01384-T; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; CONTRACTOR A, 2002, SCI STKE, pRE14; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; DAVID V, 1993, J BIOL CHEM, V268, P9585; Dong HL, 1999, ANN NY ACAD SCI, V868, P535, DOI 10.1111/j.1749-6632.1999.tb11323.x; FITZGERALD LW, 1995, J NEUROSCI, V15, P2453, DOI 10.1523/JNEUROSCI.15-03-02453.1995; Fumagalli F, 2008, MOL PHARMACOL, V73, P1484, DOI 10.1124/mol.107.043786; Funk AJ, 2009, NEUROREPORT, V20, P1019, DOI 10.1097/WNR.0b013e32832d30d9; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Hammond J, 2011, SCHIZOPHREN IN PRESS; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Hanley JG, 2010, BIOCHEM SOC T, V38, P460, DOI 10.1042/BST0380460; Healy DJ, 1997, MOL BRAIN RES, V47, P331, DOI 10.1016/S0169-328X(97)00064-8; Hirling H, 2008, NEUROSCIENCE; Jiang JX, 2006, NEUROSIGNALS, V15, P266, DOI 10.1159/000105517; Kantrowitz J, 2009, HDB NEUROCHEMISTRY M, V2; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kristiansen LV, 2010, SYNAPSE, V64, P495, DOI 10.1002/syn.20754; Meador-Woodruff JH, 2001, BRAIN RES BULL, V55, P631, DOI 10.1016/S0361-9230(01)00523-8; O'Connor JA, 2007, SCHIZOPHR RES, V90, P28, DOI 10.1016/j.schres.2006.10.004; Ramirez OA, 2011, BIOL RES, V44, P17, DOI 10.4067/S0716-97602011000100004; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Toyooka K, 2002, J NEUROCHEM, V83, P797, DOI 10.1046/j.1471-4159.2002.01181.x; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735	34	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39190	10.1371/journal.pone.0039190	http://dx.doi.org/10.1371/journal.pone.0039190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720072	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800054
J	Ivankovic, S; Dermic, D				Ivankovic, Sinisa; Dermic, Damir			DNA End Resection Controls the Balance between Homologous and Illegitimate Recombination in Escherichia coli	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; WERNER-SYNDROME PROTEIN; RECBCD ENZYME; RECA PROTEIN; EXONUCLEASE-I; BINDING-PROTEIN; REPAIR; HELICASE; MUTANTS; PATHWAY	Even a partial loss of function of human RecQ helicase analogs causes adverse effects such as a cancer-prone Werner, Bloom or Rothmund-Thompson syndrome, whereas a complete RecQ deficiency in Escherichia coli is not deleterious for a cell. We show that this puzzling difference is due to different mechanisms of DNA double strand break (DSB) resection in E. coli and humans. Coupled helicase and RecA loading activities of RecBCD enzyme, which is found exclusively in bacteria, are shown to be responsible for channeling recombinogenic 3' ending tails toward productive, homologous and away from nonproductive, aberrant recombination events. On the other hand, in recB1080/recB1067 mutants, lacking RecBCD's RecA loading activity while preserving its helicase activity, DSB resection is mechanistically more alike that in eukaryotes (by its uncoupling from a recombinase polymerization step), and remarkably, the role of RecQ also becomes akin of its eukaryotic counterparts in a way of promoting homologous and suppressing illegitimate recombination. The sickly phenotype of recB1080 recQ mutant was further exacerbated by inactivation of an exonuclease I, which degrades the unwound 3' tail. The respective recB1080 recQ xonA mutant showed poor viability, DNA repair and homologous recombination deficiency, and very increased illegitimate recombination. These findings demonstrate that the metabolism of the 3' ending overhang is a decisive factor in tuning the balance of homologous and illegitimate recombination in E. coli, thus highlighting the importance of regulating DSB resection for preserving genome integrity. recB mutants used in this study, showing pronounced RecQ helicase and exonuclease I dependence, make up a suitable model system for studying mechanisms of DSB resection in bacteria. Also, these mutants might be useful for investigating functions of the conserved RecQ helicase family members, and congruently serve as a simpler, more defined model system for human oncogenesis.	[Ivankovic, Sinisa] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Dermic, Damir] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia	Rudjer Boskovic Institute; Rudjer Boskovic Institute	Ivankovic, S (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	dermic@irb.hr		Dermic, Damir/0000-0002-5263-2750; Ivankovic, Sinisa/0000-0001-7551-5111	Croatian Ministry of Science, Education and Sports [098-0982913-2862]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This work was supported by the Croatian Ministry of Science, Education and Sports (grant no. 098-0982913-2862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLGOOD ND, 1991, GENETICS, V127, P671; Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; BRODY RS, 1986, J BIOL CHEM, V261, P7136; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Dermic D, 2006, GENETICS, V172, P2057, DOI 10.1534/genetics.105.052076; Dermic D, 2005, RES MICROBIOL, V156, P304, DOI 10.1016/j.resmic.2004.10.005; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; IKEDA H, 1995, ADV BIOPHYS, V31, P197, DOI 10.1016/0065-227X(95)99392-3; Ikeda H, 2004, ADV BIOPHYS, V38, P3, DOI 10.1016/S0065-227X(04)80031-5; Ivancic-Bace I, 2005, J BACTERIOL, V187, P1350, DOI 10.1128/JB.187.4.1350-1356.2005; Ivancic-Bace I, 2003, GENETICS, V163, P485; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Jockovich ME, 2001, MOL MICROBIOL, V41, P949, DOI 10.1046/j.1365-2958.2001.02573.x; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KUMAGAI M, 1991, MOL GEN GENET, V230, P60, DOI 10.1007/BF00290651; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov Andrei, 2005, P349; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; MENDONCA VM, 1995, J BACTERIOL, V177, P1326, DOI 10.1128/jb.177.5.1326-1335.1995; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; NAKAYAMA K, 1985, MOL GEN GENET, V200, P266, DOI 10.1007/BF00425434; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Opresko PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004825; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; SANDIGURSKY M, 1994, NUCLEIC ACIDS RES, V22, P247, DOI 10.1093/nar/22.2.247; SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Thoms B, 2008, J BACTERIOL, V190, P179, DOI 10.1128/JB.01052-07; Toczylowski T, 2006, J BIOL CHEM, V281, P33198, DOI 10.1074/jbc.M605044200; UMEZU K, 1994, J BIOL CHEM, V269, P30005; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; Viswanathan M, 1998, GENETICS, V149, P7; Yamaguchi H, 2000, GENES CELLS, V5, P101, DOI 10.1046/j.1365-2443.2000.00309.x; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127	57	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39030	10.1371/journal.pone.0039030	http://dx.doi.org/10.1371/journal.pone.0039030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720024	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347800040
J	Liu, SP; Li, LL; Zhang, YY; Zhang, YW; Zhao, Y; You, XN; Lin, ZH; Zhang, XD; Ye, LH				Liu, Shuangping; Li, Leilei; Zhang, Yingyi; Zhang, Yiwen; Zhao, Yu; You, Xiaona; Lin, Zhenhua; Zhang, Xiaodong; Ye, Lihong			The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTEN GENE; GASTRIC-CARCINOMA; BINDING-PROTEIN; DNA-BINDING; STAT4; PROLIFERATION; METHYLATION; METASTASIS; ACTIVATION; POPULATION	We have reported that hepatitis B X-interacting protein (HBXIP) promotes the proliferation and migration of breast cancer cells. However, the underlying mechanism is poorly understood. In this study, we report that HBXIP works in the event through up-regulating S100A4. We observed that HBXIP expression was positively correlated to that of S100A4 in 87 clinical breast cancer tissue samples. Then, we identified that HBXIP was able to up-regulate S100A4 expression in breast cancer cells. Notably, we observed the HBXIP nuclear localization, implying that HBXIP may be associated with the promoter of S100A4. Chromatin immunoprecipitation assay (ChIP) and electrophoretic mobility shift assay (EMSA) showed that HBXIP was able to bind to the nucleotides +200 similar to+239 region of S100A4 promoter, containing two putative recognition motif of transcription factor STAT4 and GR beta. It suggests that HBXIP is able to activate S100A4 promoter via interacting with STAT4 in breast cancer cells, leading to the up-regulation of S100A4. In addition, we identified another pathway of S100A4 up-regulation mediated by HBXIP. We found that HBXIP activated the PTEN/PI3K/AKT signaling by inducing DNA methylation of PTEN, which subsequently boosted S100A4 expression. In function, we demonstrated that HBXIP enhanced the growth or migration of breast cancer cells through S100A4 in vivo and in vitro. Collectively, we conclude that HBXIP up-regulates S100A4 through activating S100A4 promoter involving STAT4 and inducing PTEN/PI3K/AKT signaling to promote growth and migration of breast cancer cells. Our finding provides new insight into the mechanism of HBXIP in promotion of the development of breast cancer.	[Liu, Shuangping; Lin, Zhenhua] Yanbian Univ, Coll Med, Dept Pathol, Yanji 133002, Peoples R China; [Liu, Shuangping; Li, Leilei; Zhang, Yingyi; Zhang, Yiwen; Zhao, Yu; Ye, Lihong] Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China; [You, Xiaona; Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Inst Mol Biol, Dept Canc Res, Tianjin 300071, Peoples R China	Yanbian University; Nankai University; Nankai University	Lin, ZH (corresponding author), Yanbian Univ, Coll Med, Dept Pathol, Yanji 133002, Peoples R China.	zhlin720@ybu.edu.cn; zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	zhao, yu/AAD-9494-2021	Liu, Shuangping/0000-0001-6029-3245; You, Xiaona/0000-0001-9996-1466	National Basic Research Program of China (973 Program) [2011CB512113, 2009CB521702]; Natural Scientific Foundation of China [81071623, 81071624, 30960120]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Basic Research Program of China (973 Program, No. 2011CB512113, No. 2009CB521702) and the Natural Scientific Foundation of China (No. 81071623, No. 81071624, No. 30960120).	Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fan XP, 2010, MOL MED REP, V3, P775, DOI 10.3892/mmr.2010.337; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Goltsov A, 2012, CELL SIGNAL, V24, P493, DOI 10.1016/j.cellsig.2011.09.030; Hernan R, 2003, CANCER RES, V63, P140; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Ismail NI, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-12; Kawata T, 2011, DEV GROWTH DIFFER, V53, P548, DOI 10.1111/j.1440-169X.2010.01243.x; Kim ES, 2012, LIFE SCI, V90, P740, DOI 10.1016/j.lfs.2012.03.017; Kim TH, 2009, MOL CANCER RES, V7, P1605, DOI 10.1158/1541-7786.MCR-09-0102; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lupov IP, 2011, BLOOD, V118, P6097, DOI 10.1182/blood-2011-03-341867; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Minczuk M, 2005, FEBS J, V272, P5008, DOI 10.1111/j.1742-4658.2005.04910.x; Miranda KJ, 2010, J BIOL CHEM, V285, P31517, DOI 10.1074/jbc.M110.125898; Nguyen TTP, 2011, BREAST CANCER RES TR, V130, P73, DOI 10.1007/s10549-010-1304-2; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Rivard CJ, 2007, J BIOL CHEM, V282, P6644, DOI 10.1074/jbc.M609432200; Rizvi MMA, 2011, J CANCER RES CLIN, V137, P1255, DOI 10.1007/s00432-011-0994-0; Shan CL, 2011, CARCINOGENESIS, V32, P1190, DOI 10.1093/carcin/bgr106; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Torpey N, 2004, J BIOL CHEM, V279, P26789, DOI 10.1074/jbc.M401517200; Ushiku T, 2007, INT J CANCER, V120, P60, DOI 10.1002/ijc.22275; Wang FZ, 2008, ACTA PHARMACOL SIN, V29, P83, DOI 10.1111/j.1745-7254.2008.00729.x; Wang FZ, 2011, EXP BIOL MED, V236, P62, DOI 10.1258/ebm.2010.010179; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Wiencke JK, 2007, NEURO-ONCOLOGY, V9, P271, DOI 10.1215/15228517-2007-003; Yamamoto K, 1997, BIOCHEM BIOPH RES CO, V233, P126, DOI 10.1006/bbrc.1997.6415; Yang H, 2012, J INT MED RES, V40, P475, DOI 10.1177/147323001204000209; Yang J, 2012, INT J CANCER, V130, P959, DOI 10.1002/ijc.26095; Zhang GY, 2011, ASIAN PAC J CANCER P, V12, P2075	39	72	81	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30228	30239		10.1074/jbc.M112.343947	http://dx.doi.org/10.1074/jbc.M112.343947			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22740693	Green Published, hybrid			2022-12-25	WOS:000308579800017
J	Foster, JD; Yang, JW; Moritz, AE; ChallaSivaKanaka, S; Smith, MA; Holy, M; Wilebski, K; Sitte, HH; Vaughan, RA				Foster, James D.; Yang, Jae-Won; Moritz, Amy E.; ChallaSivaKanaka, Sathyavathi; Smith, Margaret A.; Holy, Marion; Wilebski, Kyle; Sitte, Harald H.; Vaughan, Roxanne A.			Dopamine Transporter Phosphorylation Site Threonine 53 Regulates Substrate Reuptake and Amphetamine-stimulated Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-DIRECTED PHOSPHORYLATION; INDUCED REVERSE TRANSPORT; CELL-SURFACE EXPRESSION; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; DEPENDENT MECHANISMS; EPITHELIAL-CELLS; COCAINE ANALOG; SYNTAXIN 1A; KINASE	In the central nervous system, levels of extraneuronal dopamine are controlled primarily by the action of the dopamine transporter (DAT). Multiple signaling pathways regulate transport activity, substrate efflux, and other DAT functions through currently unknown mechanisms. DAT is phosphorylated by protein kinase C within a serine cluster at the distal end of the cytoplasmic N terminus, whereas recent work in model cells revealed proline-directed phosphorylation of rat DAT at membrane-proximal residue Thr(53). In this report, we use mass spectrometry and a newly developed phospho-specific antibody to positively identify DAT phosphorylation at Thr(53) in rodent striatal tissue and heterologous expression systems. Basal phosphorylation of Thr(53) occurred with a stoichiometry of similar to 50% and was strongly increased by phorbol esters and protein phosphatase inhibitors, demonstrating modulation of the site by signaling pathways that impact DAT activity. Mutations of Thr(53) to prevent phosphorylation led to reduced dopamine transport V-max and total apparent loss of amphetamine-stimulated substrate efflux, supporting a major role for this residue in the transport kinetic mechanism.	[Foster, James D.; Moritz, Amy E.; ChallaSivaKanaka, Sathyavathi; Smith, Margaret A.; Wilebski, Kyle; Vaughan, Roxanne A.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA; [Yang, Jae-Won; Holy, Marion; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	University of North Dakota Grand Forks; Medical University of Vienna	Sitte, HH (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA.	harald.sitte@meduniwien.ac.at; roxanne.vaughan@med.und.edu	Sitte, Harald/O-7025-2019; ChallaSivaKanaka, Sathyavathi/AAL-7212-2021; Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; ChallaSivaKanaka, Sathyavathi/0000-0001-8487-5485; Sitte, Harald/0000-0002-1339-7444; Yang, Jae-Won/0000-0001-8928-0130	National Institutes of Health, NIDA [R01 DA13147]; ND EPSCoR IIG; COBRE program of National Center for Research Resources [P20 RR017699]; IDeA Networks of Biomedical Research Excellence (INBRE) program of National Center for Research Resources [P20 RR016741]; Austrian Research Funds/FWF Grants [F3506, P22893-B1, P23670-B09]; EPSCoR [0814442] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013147] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 23670, F 3506] Funding Source: researchfish	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ND EPSCoR IIG; COBRE program of National Center for Research Resources; IDeA Networks of Biomedical Research Excellence (INBRE) program of National Center for Research Resources; Austrian Research Funds/FWF Grants; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health, Grant R01 DA13147 from NIDA (to R. A. V.), ND EPSCoR IIG (to R. A. V. and J. D. F.), P20 RR017699 from the COBRE program of the National Center for Research Resources (to the University of North Dakota), and P20 RR016741 from the IDeA Networks of Biomedical Research Excellence (INBRE) program of the National Center for Research Resources (to the University of North Dakota). This work was also supported by Austrian Research Funds/FWF Grants F3506 and P22893-B1 (to H. H. S.) and P23670-B09 (to J.-W. Y.).	Ando S, 1997, J BIOCHEM, V122, P409; Bannon Michael J., 1995, P179; Bauman AL, 2000, J NEUROSCI, V20, P7571; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2006, HANDB EXP PHARM, V175, P197; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Foster JD, 2003, MOL BRAIN RES, V110, P100, DOI 10.1016/S0169-328X(02)00645-9; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Giambalvo CT, 2003, SYNAPSE, V49, P125, DOI 10.1002/syn.10223; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; GU H, 1994, J BIOL CHEM, V269, P7124; Guerrero C, 2001, AM J PHYSIOL-LUNG C, V281, pL79, DOI 10.1152/ajplung.2001.281.1.L79; Guptaroy B, 2011, MOL PHARMACOL, V79, P520, DOI 10.1124/mol.110.069039; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Hoover BR, 2007, J NEUROCHEM, V101, P1258, DOI 10.1111/j.1471-4159.2007.04522.x; Huff RA, 1997, J NEUROCHEM, V68, P225; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; LEVER JR, 1993, J LABELLED COMPD RAD, V33, P1131, DOI 10.1002/jlcr.2580331207; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lin ZC, 2000, FASEB J, V14, P715, DOI 10.1096/fasebj.14.5.715; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Mayer BJ, 2001, J CELL SCI, V114, P1253; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Moron JA, 2003, J NEUROSCI, V23, P8480; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Scholze P, 2001, NEUROSCI LETT, V309, P173, DOI 10.1016/S0304-3940(01)02058-4; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Shi X, 2006, NEUROSCIENCE, V138, P1289, DOI 10.1016/j.neuroscience.2005.12.024; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Steinkellner T, 2011, BIOL CHEM, V392, P103, DOI 10.1515/BC.2011.016; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Vaughan RA, 2004, J PHARMACOL EXP THER, V310, P1, DOI 10.1124/jpet.103.052423; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zheng JF, 2009, J PROTEOME RES, V8, P4479, DOI 10.1021/pr9002596	77	59	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29702	29712		10.1074/jbc.M112.367706	http://dx.doi.org/10.1074/jbc.M112.367706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22722938	hybrid, Green Published			2022-12-25	WOS:000308286900046
J	Glowacka, WK; Alberts, P; Ouchida, R; Wang, JY; Rotin, D				Glowacka, Wioletta K.; Alberts, Philipp; Ouchida, Rika; Wang, Ji-Yang; Rotin, Daniela			LAPTM5 Protein Is a Positive Regulator of Proinflammatory Signaling Pathways in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; TNF RECEPTOR-1; ENZYME A20; UBIQUITIN; RECRUITMENT; ACTIVATION; CANCER; ALPHA	LAPTM5 (lysosomal-associated protein transmembrane 5) is a protein that is preferentially expressed in immune cells, and it interacts with the Nedd4 family of ubiquitin ligases. Recent studies in T and B cells identified LAPTM5 as a negative regulator of T and B cell receptor levels at the plasma membrane. Here we investigated the function of LAPTM5 in macrophages. We demonstrate that expression of LAPTM5 is required for the secretion of proinflammatory cytokines in response to Toll-like receptor ligands. We also show that RAW264.7 cells knocked down for LAPTM5 or macrophages from LAPTM5(-/-) mice exhibit reduced activation of NF-kappa B and MAPK signaling pathways mediated by the TNF receptor, as well as multiple pattern recognition receptors in various cellular compartments. TNF stimulation of LAPTM5-deficient macrophages leads to reduced ubiquitination of RIP1 (receptor-interacting protein 1), suggesting a role for LAPTM5 at the receptor-proximate level. Interestingly, we find that macrophages from LAPTM5(-/-) mice display up-regulated levels of A20, a ubiquitin-editing enzyme responsible for deubiquitination of RIP1 and subsequent termination of NF-kappa B activation. Our studies thus indicate that, in contrast to its negative role in T and B cell activation, LAPTM5 acts as a positive modulator of inflammatory signaling pathways and hence cytokine secretion in macrophages. They also highlight a role for the endosomal/lysosomal system in regulating signaling via cytokine and pattern recognition receptors.	[Rotin, Daniela] Hosp Sick Children, TMDT MaRS, Cell Biol Program, Toronto, ON M5G 1L7, Canada; [Glowacka, Wioletta K.; Alberts, Philipp; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON M5G 1L7, Canada; [Ouchida, Rika; Wang, Ji-Yang] Riken Res Ctr Allergy & Immunol, Lab Immune Divers, Yokohama, Kanagawa 2300045, Japan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; RIKEN	Rotin, D (corresponding author), Hosp Sick Children, TMDT MaRS, Cell Biol Program, 11-305,101 Coll St, Toronto, ON M5G 1L7, Canada.	drotin@sickkids.ca			Canadian Institute of Health Research [MOP-13494]; Ontario Graduate Scholarship; RESTRACOMP (Research Training Competition) Award by the Hospital for Sick Children studentships	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); RESTRACOMP (Research Training Competition) Award by the Hospital for Sick Children studentships	This work was supported by the Canadian Institute of Health Research Grant MOP-13494 (to D. R.).; Supported by Ontario Graduate Scholarship and by RESTRACOMP (Research Training Competition) Award by the Hospital for Sick Children studentships.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brudzewsky D, 2009, SCAND J IMMUNOL, V69, P437, DOI 10.1111/j.1365-3083.2009.02243.x; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hogue DL, 1999, J BIOL CHEM, V274, P12877, DOI 10.1074/jbc.274.18.12877; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li LY, 2008, BBA-MOL CELL RES, V1783, P1140, DOI 10.1016/j.bbamcr.2008.01.029; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Myles MH, 2007, INFLAMM BOWEL DIS, V13, P822, DOI 10.1002/ibd.20138; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ouchida R, 2008, IMMUNITY, V29, P33, DOI 10.1016/j.immuni.2008.04.024; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Scott LM, 1996, BLOOD, V88, P2517, DOI 10.1182/blood.V88.7.2517.bloodjournal8872517; Seimiya M, 2003, INT J ONCOL, V22, P301; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	36	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27691	27702		10.1074/jbc.M112.355917	http://dx.doi.org/10.1074/jbc.M112.355917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733818	Green Published, hybrid			2022-12-25	WOS:000307840700043
J	Wirtz, M; Beard, KFM; Lee, CP; Boltz, A; Schwarzlander, M; Fuchs, C; Meyer, AJ; Heeg, C; Sweetlove, LJ; Ratcliffe, RG; Hell, R				Wirtz, Markus; Beard, Katherine F. M.; Lee, Chun Pong; Boltz, Achim; Schwarzlaender, Markus; Fuchs, Christopher; Meyer, Andreas J.; Heeg, Corinna; Sweetlove, Lee J.; Ratcliffe, R. George; Hell, Ruediger			Mitochondrial Cysteine Synthase Complex Regulates O-Acetylserine Biosynthesis in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE GENE FAMILY; SERINE ACETYLTRANSFERASE; KINETIC-PROPERTIES; THIOL LYASE; ARABIDOPSIS; PROTEIN; EXPRESSION; TRANSPORT; O-ACETYLSERINE(THIOL)LYASE; MECHANISM	Cysteine synthesis is catalyzed by serine acetyltransferase (SAT) and O-acetylserine (thiol) lyase (OAS-TL) in the cytosol, plastids, and mitochondria of plants. Biochemical analyses of recombinant plant SAT and OAS-TL indicate that the reversible association of the proteins in the cysteine synthase complex (CSC) controls cellular sulfur homeostasis. However, the relevance of CSC formation in each compartment for flux control of cysteine synthesis remains controversial. Here, we demonstrate the interaction between mitochondrial SAT3 and OAS-TL C in planta by FRET and establish the role of the mitochondrial CSC in the regulation of cysteine synthesis. NMR spectroscopy of isolated mitochondria from WT, serat2;2, and oastl-C plants showed the SAT-dependent export of OAS. The presence of cysteine resulted in reduced OAS export in mitochondria of oastl-C mutants but not in WT mitochondria. This is in agreement with the stronger in vitro feedback inhibition of free SAT by cysteine compared with CSC-bound SAT and explains the high OAS export rate of WT mitochondria in the presence of cysteine. The predominant role of mitochondrial OAS synthesis was validated in planta by feeding [H-3] serine to the WT and loss-of-function mutants for OAS-TLs in the cytosol, plastids, and mitochondria. On the basis of these results, we propose a new model in which the mitochondrial CSC acts as a sensor that regulates the level of SAT activity in response to sulfur supply and cysteine demand.	[Wirtz, Markus; Lee, Chun Pong; Boltz, Achim; Fuchs, Christopher; Meyer, Andreas J.; Heeg, Corinna; Hell, Ruediger] Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, D-69120 Heidelberg, Germany; [Beard, Katherine F. M.; Schwarzlaender, Markus; Sweetlove, Lee J.; Ratcliffe, R. George] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	Ruprecht Karls University Heidelberg; University of Oxford	Hell, R (corresponding author), Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Neuenheimer Feld 360, D-69120 Heidelberg, Germany.	ruediger.hell@cos.uni-heidelberg.de	Wirtz, Markus/G-5917-2010; Schwarzländer, Markus/HGE-3726-2022; Lee, Alex/AAZ-8602-2020; Lee, Chun Pong/G-6021-2010; Meyer, Andreas J/C-4734-2013; Hell, Ruediger/E-5436-2014; Lee, Chun Pong/AAZ-8558-2020	Wirtz, Markus/0000-0001-7790-4022; Lee, Alex/0000-0002-8760-5779; Meyer, Andreas J/0000-0001-8144-4364; Lee, Chun Pong/0000-0002-8760-5779; Hell, Ruediger/0000-0002-6238-4818; Schwarzlander, Markus/0000-0003-0796-8308; Ratcliffe, R. George/0000-0001-8394-1575; Doerner, Achim/0000-0002-4741-8039	Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQant Graduate School Molecular Machines); Schmeil-Stiftung (Heidelberg); Deutsche Forschungsgemeinschaft [He 1848/5-2, He 1848/13-1]; UK Biotechnology and Biological Sciences Research Council CASE studentship and Advanced Technologies (Cambridge, United Kingdom); New College Oxford Weston junior research fellowship	Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQant Graduate School Molecular Machines); Schmeil-Stiftung (Heidelberg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UK Biotechnology and Biological Sciences Research Council CASE studentship and Advanced Technologies (Cambridge, United Kingdom); New College Oxford Weston junior research fellowship	This work was supported by the Landesgraduiertenforderung Baden-Wurttemberg (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, BioQant Graduate School Molecular Machines), the Schmeil-Stiftung (Heidelberg), and Deutsche Forschungsgemeinschaft Grants He 1848/5-2 and He 1848/13-1) (to C.H.); a UK Biotechnology and Biological Sciences Research Council CASE studentship and Advanced Technologies (Cambridge, United Kingdom) (to K.F.M.B.); and a New College Oxford Weston junior research fellowship (to M.S.).	Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Birke H, 2012, BIOCHEM J, V445, P275, DOI 10.1042/BJ20120038; CAVALIERI AJ, 1980, PLANT PHYSIOL, V66, P588, DOI 10.1104/pp.66.4.588; CYBULSKI RL, 1977, BIOCHEMISTRY-US, V16, P5116, DOI 10.1021/bi00642a026; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; FLAVIN M, 1965, BIOCHEMISTRY-US, V4, P1370, DOI 10.1021/bi00883a022; FOX GG, 1989, J MAGN RESON, V82, P360, DOI 10.1016/0022-2364(89)90039-5; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Heeg C, 2008, PLANT CELL, V20, P168, DOI 10.1105/tpc.107.056747; Hell Rudiger, 2011, Arabidopsis Book, V9, pe0154, DOI 10.1199/tab.0154; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kawashima CG, 2005, PLANT PHYSIOL, V137, P220, DOI 10.1104/pp.104.045377; Khan MS, 2010, PLANT CELL, V22, P1216, DOI 10.1105/tpc.110.074088; Kopriva S, 2004, J EXP BOT, V55, P1775, DOI 10.1093/jxb/erh185; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Linka N, 2010, MOL PLANT, V3, P21, DOI 10.1093/mp/ssp108; Morgan MJ, 2008, PLANT PHYSIOL, V147, P101, DOI 10.1104/pp.107.113613; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; RUFFET ML, 1994, PLANT PHYSIOL, V104, P597, DOI 10.1104/pp.104.2.597; Saito K, 2000, CURR OPIN PLANT BIOL, V3, P188, DOI 10.1016/S1369-5266(00)00063-7; Sirko A, 2004, J EXP BOT, V55, P1881, DOI 10.1093/jxb/erh151; Smith A. M., 2004, THESIS U OXFORD; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Sweetlove Lee J, 2007, Methods Mol Biol, V372, P125, DOI 10.1007/978-1-59745-365-3_9; Watanabe M, 2008, PLANT CELL, V20, P2484, DOI 10.1105/tpc.108.060335; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2004, J EXP BOT, V55, P1785, DOI 10.1093/jxb/erh201; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Wirtz M, 2010, J BIOL CHEM, V285, P32810, DOI 10.1074/jbc.M110.157446; Wirtz M, 2010, AMINO ACIDS, V39, P1077, DOI 10.1007/s00726-010-0694-0	35	50	54	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27941	27947		10.1074/jbc.M112.372656	http://dx.doi.org/10.1074/jbc.M112.372656			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730323	Green Published, hybrid			2022-12-25	WOS:000307840700068
J	Cho, MK; Xiang, SQ; Kim, HY; Becker, S; Zweckstetter, M				Cho, Min-Kyu; Xiang, ShengQi; Kim, Hai-Young; Becker, Stefan; Zweckstetter, Markus			Cold-Induced Changes in the Protein Ubiquitin	PLOS ONE			English	Article							SUPERCOOLED WATER; HYDROGEN-BONDS; STRUCTURAL BIOLOGY; NMR-SPECTROSCOPY; DENATURATION; COUPLINGS; DYNAMICS; BIOMOLECULES; (3H)J(NC'); ENSEMBLE	Conformational changes are essential for protein-protein and protein-ligand recognition. Here we probed changes in the structure of the protein ubiquitin at low temperatures in supercooled water using NMR spectroscopy. We demonstrate that ubiquitin is well folded down to 263 K, although slight rearrangements in the hydrophobic core occur. However, amide proton chemical shifts show non-linear temperature dependence in supercooled solution and backbone hydrogen bonds become weaker in the region that is most prone to cold-denaturation. Our data suggest that the weakening of the hydrogen bonds in the beta-sheet of ubiquitin might be one of the first events that occur during cold-denaturation of ubiquitin. Interestingly, the same region is strongly involved in ubiquitin-protein complexes suggesting that this part of ubiquitin more easily adjusts to conformational changes required for complex formation.	[Cho, Min-Kyu; Xiang, ShengQi; Kim, Hai-Young; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany	Max Planck Society	Cho, MK (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany.	mzwecks@gwdg.de	Cho, Min-Kyu/H-1303-2011	Cho, Min-Kyu/0000-0003-0537-2340; Zweckstetter, Markus/0000-0002-2536-6581	Max Planck Society; DFG (Deutsche Forschungsgemeinschaft) [ZW 71/2-2, 3-2]	Max Planck Society(Max Planck Society); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the Max Planck Society and the DFG (Deutsche Forschungsgemeinschaft) (ZW 71/2-2 and 3-2 to MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrover M, 2010, J AM CHEM SOC, V132, P16240, DOI 10.1021/ja1070174; Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739; Ban D, 2011, ANGEW CHEM INT EDIT, V50, P11437, DOI 10.1002/anie.201105086; Baxter NJ, 1998, J MOL BIOL, V284, P1625, DOI 10.1006/jmbi.1998.2265; Cierpicki T, 2002, J MAGN RESON, V157, P178, DOI 10.1006/jmre.2002.2597; Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498; Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024; Davidovic M, 2009, J AM CHEM SOC, V131, P1025, DOI 10.1021/ja8056419; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Hilser VJ, 1996, J MOL BIOL, V262, P756, DOI 10.1006/jmbi.1996.0550; Kim HY, 2007, CHEMBIOCHEM, V8, P1671, DOI 10.1002/cbic.200700366; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Massi F, 2005, PROTEIN SCI, V14, P735, DOI 10.1110/ps.041139505; Mills JL, 2002, J BIOMOL NMR, V23, P63, DOI 10.1023/A:1015397305148; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Peti W, 2001, J BIOMOL NMR, V19, P153, DOI 10.1023/A:1008307323283; Pometun MS, 2006, J AM CHEM SOC, V128, P10652, DOI 10.1021/ja0628654; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Schroeder KT, 2005, RNA, V11, P1012, DOI 10.1261/rna.2270205; Shan B, 2010, J AM CHEM SOC, V132, P4669, DOI 10.1021/ja908104s; Shen Y, 2008, ANGEW CHEM INT EDIT, V47, P324, DOI 10.1002/anie.200702842; Sidhu A, 2011, J MOL BIOL, V411, P1037, DOI 10.1016/j.jmb.2011.06.044; Skalicky JJ, 2000, J AM CHEM SOC, V122, P3230, DOI 10.1021/ja9938884; Skalicky JJ, 2001, J AM CHEM SOC, V123, P388, DOI 10.1021/ja003220l; Szyperski Thomas, 2011, Journal of Structural and Functional Genomics, V12, P1, DOI 10.1007/s10969-011-9111-5; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Vertrees J, 2005, BIOINFORMATICS, V21, P3318, DOI 10.1093/bioinformatics/bti520; Zar JH., 1999, BIOSTAT ANAL; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	35	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e37270	10.1371/journal.pone.0037270	http://dx.doi.org/10.1371/journal.pone.0037270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737208	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100003
J	Kurth, A; Kohl, C; Brinkmann, A; Ebinger, A; Harper, JA; Wang, LF; Muhldorfer, K; Wibbelt, G				Kurth, Andreas; Kohl, Claudia; Brinkmann, Annika; Ebinger, Arnt; Harper, Jennifer A.; Wang, Lin-Fa; Muehldorfer, Kristin; Wibbelt, Gudrun			Novel Paramyxoviruses in Free-Ranging European Bats	PLOS ONE			English	Article							FRUIT BATS; NIPAH VIRUS; PTEROPID BATS; HENDRA VIRUS; INFECTION; GENOME; RESERVOIRS; INFERENCE; SEQUENCE; MRBAYES	The zoonotic potential of paramyxoviruses is particularly demonstrated by their broad host range like the highly pathogenic Hendra and Nipah viruses originating from bats. But while so far all bat-borne paramyxoviruses have been identified in fruit bats across Africa, Australia, South America, and Asia, we describe the detection and characterization of the first paramyxoviruses in free-ranging European bats. Moreover, we examined the possible impact of paramyxovirus infection on individual animals by comparing histo-pathological findings and virological results. Organs from deceased insectivorous bats of various species were sampled in Germany and tested for paramyxovirus RNA in parallel to a histo-pathological examination. Nucleic acids of three novel paramyxoviruses were detected, two viruses in phylogenetic relationship to the recently proposed genus Jeilongvirus and one closely related to the genus Rubulavirus. Two infected animals revealed subclinical pathological changes within their kidneys, suggestive of a similar pathogenesis as the one described in fruit bats experimentally infected with Hendra virus. Our findings indicate the presence of bat-born paramyxoviruses in geographic areas free of fruit bat species and therefore emphasize a possible virus-host co-evolution in European bats. Since these novel viruses are related to the very distinct genera Rubulavirus and Jeilongvirus, a similarly broad genetic diversity among paramyxoviruses in other Microchiroptera compared to Megachiroptera can be assumed. Given that the infected bats were either found in close proximity to heavily populated human habitation or areas of intensive agricultural use, a potential risk of the emergence of zoonotic paramyxoviruses in Europe needs to be considered.	[Kurth, Andreas; Kohl, Claudia; Brinkmann, Annika; Ebinger, Arnt] Robert Koch Inst, Ctr Biol Secur, Berlin, Germany; [Harper, Jennifer A.; Wang, Lin-Fa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Melbourne, Vic, Australia; [Muehldorfer, Kristin; Wibbelt, Gudrun] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Robert Koch Institute; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Leibniz Institut fur Zoo und Wildtierforschung	Kurth, A (corresponding author), Robert Koch Inst, Ctr Biol Secur, Berlin, Germany.	KurthA@rki.de	wang, lin/GSE-3040-2022	kohl, claudia/0000-0002-1480-8911; Wang, Lin-Fa/0000-0003-2752-0535	Konrad Adenauer Foundation; Isler-Stiftung; Clara-Samariter-Stiftung; FAZIT-Stiftung	Konrad Adenauer Foundation; Isler-Stiftung; Clara-Samariter-Stiftung; FAZIT-Stiftung	Funding was provided by the Konrad Adenauer Foundation (fellowship to CK) and by the Isler-Stiftung, Clara-Samariter-Stiftung and FAZIT-Stiftung (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2009, MOL PHYLOGENET EVOL, V53, P772, DOI 10.1016/j.ympev.2009.07.035; Bowden TR, 2012, J GEN VIROL, V93, P1007, DOI 10.1099/vir.0.038448-0; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Chua KB, 2001, VIROLOGY, V283, P215, DOI 10.1006/viro.2000.0882; Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Halpin K, 1999, VET MICROBIOL, V68, P83, DOI 10.1016/S0378-1135(99)00063-2; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; HENDERSON GW, 1995, J GEN VIROL, V76, P2509, DOI 10.1099/0022-1317-76-10-2509; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jack PJM, 2005, J VIROL, V79, P10690, DOI 10.1128/JVI.79.16.10690-10700.2005; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Lamb RA., 2005, VIRUS TAXONOMY, P655; Lau SKP, 2010, VIROLOGY, V404, P106, DOI 10.1016/j.virol.2010.03.049; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Z, 2006, VIROLOGY, V346, P219, DOI 10.1016/j.virol.2005.10.039; McCarthy AJ, 2010, INFECT GENET EVOL, V10, P97, DOI 10.1016/j.meegid.2009.11.002; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Muhldorfer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029773; Muhldorfer K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-61; PAVRI KM, 1971, AM J TROP MED HYG, V20, P125, DOI 10.4269/ajtmh.1971.20.125; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Wibbelt Gudrun, 2009, P775; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	36	46	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38688	10.1371/journal.pone.0038688	http://dx.doi.org/10.1371/journal.pone.0038688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737217	Green Published, gold			2022-12-25	WOS:000305695100016
J	Paakkanen, R; Vauhkonen, H; Eronen, KT; Jarvinen, A; Seppanen, M; Lokki, ML				Paakkanen, Riitta; Vauhkonen, Hanna; Eronen, Katja T.; Jarvinen, Asko; Seppanen, Mikko; Lokki, Marja-Liisa			Copy Number Analysis of Complement C4A, C4B and C4A Silencing Mutation by Real-Time Quantitative Polymerase Chain Reaction	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMPONENTS C4A; RCCX MODULES; NULL ALLELES; RISK-FACTORS; DEFICIENCY; GENE; POLYMORPHISM; DISEASE; POPULATIONS	Low protein levels and copy number variation (CNV) of the fourth component of human complement (C4A and C4B) have been associated with various diseases. High-throughput methods for analysing C4 CNV are available, but they commonly do not detect the most common C4A mutation, a silencing CT insertion (CTins) leading to low protein levels. We developed a SYBR (R) Green labelled real-time quantitative polymerase chain reaction (qPCR) with a novel concentration range approach to address C4 CNV and deficiencies due to CTins. This method was validated in three sample sets and applied to over 1600 patient samples. CTins caused C4A deficiency in more than 70% (76/105) of the carriers. Twenty per cent (76/381) of patients with a C4A deficiency would have been erroneously recorded as having none, if the CTins had not been assessed. C4A deficiency was more common in patients than a healthy reference population, (OR = 1.60, 95%CI = 1.02-2.52, p = 0.039). The number of functional C4 genes can be straightforwardly analyzed by real-time qPCR, also with SYBR (R) Green labelling. Determination of CTins increases the frequency of C4A deficiency and thus helps to elucidate the genotypic versus phenotypic disease associations.	[Paakkanen, Riitta; Vauhkonen, Hanna; Eronen, Katja T.; Lokki, Marja-Liisa] Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; [Paakkanen, Riitta] Univ Helsinki, Cent Hosp, Hosp Dist Helsinki & Uusimaa, Div Cardiol,Dept Med, Helsinki, Finland; [Jarvinen, Asko; Seppanen, Mikko] Univ Helsinki, Cent Hosp, Hosp Dist Helsinki & Uusimaa, Div Infect Dis,Dept Med, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Paakkanen, R (corresponding author), Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland.	riitta.paakkanen@helsinki.fi		Seppanen, Mikko/0000-0001-9733-3650	Finnish Foundation for Cardiovascular Research [DW3534297325]; Foundation for Paediatric Research; Maud Kuistila Foundation; Special Finnish Governmental Subsidy for Health Sciences Research [TYH2009307]; Helsinki Biomedical Graduate School	Finnish Foundation for Cardiovascular Research; Foundation for Paediatric Research; Maud Kuistila Foundation; Special Finnish Governmental Subsidy for Health Sciences Research; Helsinki Biomedical Graduate School	RP and MLL are supported by Finnish Foundation for Cardiovascular Research (grant DW3534297325), MLL and MS by Foundation for Paediatric Research, Maud Kuistila Foundation and Special Finnish Governmental Subsidy for Health Sciences Research TYH2009307, and RP by Helsinki Biomedical Graduate School. No commercial sponsors took part in the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBA G, 1993, J CLIN INVEST, V91, P1681, DOI 10.1172/JCI116377; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; Boteva L, 2012, AM J HUM GENET, V90, P445, DOI 10.1016/j.ajhg.2012.01.012; Boteva L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022128; BRAUN L, 1990, J EXP MED, V171, P129, DOI 10.1084/jem.171.1.129; Chung EK, 2002, AM J HUM GENET, V71, P810, DOI 10.1086/342778; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Fernando MMA, 2010, HUM MUTAT, V31, P866, DOI 10.1002/humu.21259; Gouas L, 2008, PATHOL BIOL, V56, P345, DOI 10.1016/j.patbio.2008.03.010; Hohler T, 2002, J HEPATOL, V37, P387, DOI 10.1016/S0168-8278(02)00205-2; Ittiprasert W, 2005, J AUTOIMMUN, V25, P77, DOI 10.1016/j.jaut.2005.04.004; Kainulainen L, 2012, HUM IMMUNOL, V73, P498, DOI 10.1016/j.humimm.2012.02.015; Lee JH, 2008, CYTOGENET GENOME RES, V123, P333, DOI 10.1159/000184725; Lokki ML, 1999, J IMMUNOL, V162, P3687; Mougey R, 2010, Immunohematology, V26, P30; Paakkanen R, 2012, ATHEROSCLEROSIS, V221, P461, DOI 10.1016/j.atherosclerosis.2012.01.024; Puah SM, 2007, LUPUS, V16, P750, DOI 10.1177/0961203307079454; Samano Eliana Sueco Tibana, 2004, Rev. Hosp. Clin., V59, P138, DOI 10.1590/S0041-87812004000300009; Scheurer Michael E, 2007, Infect Agent Cancer, V2, P8, DOI 10.1186/1750-9378-2-8; Senbagavalli P, 2011, HUM IMMUNOL, V72, P173, DOI 10.1016/j.humimm.2010.11.002; Seppanen M, 2007, SCAND J IMMUNOL, V65, P176, DOI 10.1111/j.1365-3083.2006.01886.x; SIM E, 1986, BIOCHEM J, V239, P763, DOI 10.1042/bj2390763; Sullivan KE, 1999, J RHEUMATOL, V26, P2144; Szilagyi A, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-1; Szilagyi A, 2008, CYTOGENET GENOME RES, V123, P118, DOI 10.1159/000184699; Wennerstrom A, 2012, HUM IMMUNOL, V73, P93, DOI 10.1016/j.humimm.2011.10.016; Wouters D, 2009, MOL IMMUNOL, V46, P592, DOI 10.1016/j.molimm.2008.07.028; Wu YL, 2009, GENES IMMUN, V10, P433, DOI 10.1038/gene.2009.10; Wu YL, 2008, CYTOGENET GENOME RES, V123, P131, DOI 10.1159/000184700; Wu YL, 2007, J IMMUNOL, V179, P3012, DOI 10.4049/jimmunol.179.5.3012; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1991, J IMMUNOL, V146, P1057; Zafar GI, 2009, J UROLOGY, V181, P1028, DOI 10.1016/j.juro.2008.11.013; ZHANG WJ, 1988, HUM IMMUNOL, V21, P165, DOI 10.1016/0198-8859(88)90068-7	35	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38813	10.1371/journal.pone.0038813	http://dx.doi.org/10.1371/journal.pone.0038813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737222	Green Published, gold, Green Submitted			2022-12-25	WOS:000305695100020
J	Chen, WHC; Kawasaki, N; Nycholat, CM; Han, SF; Pilotte, J; Crocker, PR; Paulson, JC				Chen, Weihsu C.; Kawasaki, Norihito; Nycholat, Corwin M.; Han, Shoufa; Pilotte, Julie; Crocker, Paul R.; Paulson, James C.			Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169	PLOS ONE			English	Article							LYMPH-NODE; B-CELLS; RECEPTOR SIALOADHESIN; IMMUNE-RESPONSES; BINDING-RECEPTOR; DENDRITIC CELLS; IN-VITRO; T-CELLS; LEWIS-X; LIGANDS	Sialoadhesin (Sn, Siglec-1, CD169) is a member of the sialic acid binding Ig-like lectin (siglec) family expressed on macrophages. Its macrophage specific expression makes it an attractive target for delivering antigens to tissue macrophages via Sn-mediated endocytosis. Here we describe a novel approach for delivering antigens to macrophages using liposomal nanoparticles displaying high affinity glycan ligands of Sn. The Sn-targeted liposomes selectively bind to and are internalized by Sn-expressing cells, and accumulate intracellularly over time. Our results show that ligand decorated liposomes are specific for Sn, since they are taken up by bone marrow derived macrophages that are derived from wild type but not Sn-/- mice. Importantly, the Sn-targeted liposomes dramatically enhance the delivery of antigens to macrophages for presentation to and proliferation of antigen-specific T cells. Together, these data provide insights into the potential of cell-specific targeting and delivery of antigens to intracellular organelles of macrophages using Sn-ligand decorated liposomal nanoparticles.	[Chen, Weihsu C.; Kawasaki, Norihito; Nycholat, Corwin M.; Han, Shoufa; Pilotte, Julie; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Chen, Weihsu C.; Kawasaki, Norihito; Nycholat, Corwin M.; Han, Shoufa; Pilotte, Julie; Paulson, James C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Crocker, Paul R.] Univ Dundee, Coll Life Sci, Wellcome Trust Bioctr, Dundee, Scotland	Scripps Research Institute; Scripps Research Institute; University of Dundee	Chen, WHC (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019	Crocker, Paul/0000-0001-6230-0293	National Institutes of Health [AI050143, CA13889, HL107151]; NATIONAL CANCER INSTITUTE [R01CA138891] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI050143, CA13889 and HL107151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanoudse CA, 2008, INT J CANCER, V122, P839, DOI 10.1002/ijc.23101; Adams EW, 2008, CHEMBIOCHEM, V9, P294, DOI 10.1002/cbic.200700310; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Blixt O, 2008, J AM CHEM SOC, V130, P6680, DOI 10.1021/ja801052g; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen WC, 2010, BLOOD, V115, P4778, DOI 10.1182/blood-2009-12-257386; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2008, BIOCHEM SOC T, V36, P1467, DOI 10.1042/BST0361467; Delputte PL, 2007, J INTERF CYTOK RES, V27, P757, DOI 10.1089/jir.2007.0001; Delputte PL, 2007, J VIROL, V81, P9546, DOI 10.1128/JVI.00569-07; Delputte PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016827; DiJoseph JF, 2007, LEUKEMIA, V21, P2240, DOI 10.1038/sj.leu.2404866; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Floyd H, 2000, J BIOL CHEM, V275, P861, DOI 10.1074/jbc.275.2.861; Gersuk GM, 2008, J IMMUNOL METHODS, V329, P157, DOI 10.1016/j.jim.2007.10.003; Graham SA, 2009, J BIOL CHEM, V284, P18537, DOI 10.1074/jbc.M109.012807; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Hudson SA, 2009, J PHARMACOL EXP THER, V330, P608, DOI 10.1124/jpet.109.152439; Ikehara Y, 2008, CANCER LETT, V260, P137, DOI 10.1016/j.canlet.2007.10.038; Irache JM, 2008, EXPERT OPIN DRUG DEL, V5, P703, DOI 10.1517/17425247.5.6.703 ; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Kawasaki N, 2011, J INNATE IMMUN, V3, P411, DOI 10.1159/000322375; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Kojima N, 2008, J CONTROL RELEASE; Li N, 2001, J BIOL CHEM, V276, P28106, DOI 10.1074/jbc.M100467200; Nakamura K, 2002, GLYCOBIOLOGY, V12, P209, DOI 10.1093/glycob/12.3.209; O'Reilly MK, 2011, J IMMUNOL, V186, P1554, DOI 10.4049/jimmunol.1003005; O'Reilly MK, 2010, METHOD ENZYMOL, V478, P343, DOI 10.1016/S0076-6879(10)78017-4; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Poderoso T, 2011, VACCINE, V29, P4813, DOI 10.1016/j.vaccine.2011.04.076; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Singh SK, 2011, EUR J IMMUNOL, V41, P916, DOI 10.1002/eji.201040762; Singh SK, 2009, MOL IMMUNOL, V47, P164, DOI 10.1016/j.molimm.2009.09.026; Tang CK, 2007, IMMUNOLOGY, V120, P325, DOI 10.1111/j.1365-2567.2006.02506.x; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yokoi H, 2008, J ALLERGY CLIN IMMUN, V121, P499, DOI 10.1016/j.jaci.2007.10.004; Zaccai NR, 2003, STRUCTURE, V11, P557, DOI 10.1016/S0969-2126(03)00073-X	47	296	300	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39039	10.1371/journal.pone.0039039	http://dx.doi.org/10.1371/journal.pone.0039039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723922	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700045
J	Kurosaki, T; Ueda, S; Ishida, T; Abe, K; Ohno, K; Matsuura, T				Kurosaki, Tatsuaki; Ueda, Shintaroh; Ishida, Takafumi; Abe, Koji; Ohno, Kinji; Matsuura, Tohru			The Unstable CCTG Repeat Responsible for Myotonic Dystrophy Type 2 Originates from an AluSx Element Insertion into an Early Primate Genome	PLOS ONE			English	Article							GENETIC INSTABILITY; EXPANSION; MUTATION; AMPLIFICATION; HAPLOTYPE; FAMILY	Myotonic dystrophy type 2 (DM2) is a subtype of the myotonic dystrophies, caused by expansion of a tetranucleotide CCTG repeat in intron 1 of the zinc finger protein 9 (ZNF9) gene. The expansions are extremely unstable and variable, ranging from 75-11,000 CCTG repeats. This unprecedented repeat size and somatic heterogeneity make molecular diagnosis of DM2 difficult, and yield variable clinical phenotypes. To better understand the mutational origin and instability of the ZNF9 CCTG repeat, we analyzed the repeat configuration and flanking regions in 26 primate species. The 39-end of an AluSx element, flanked by target site duplications (5'-ACTRCCAR-3' or 5'-ACTRCCARTTA-3'), followed the CCTG repeat, suggesting that the repeat was originally derived from the Alu element insertion. In addition, our results revealed lineage-specific repetitive motifs: pyrimidine (CT)-rich repeat motifs in New World monkeys, dinucleotide (TG) repeat motifs in Old World monkeys and gibbons, and dinucleotide (TG) and tetranucleotide (TCTG and/or CCTG) repeat motifs in great apes and humans. Moreover, these di-and tetra-nucleotide repeat motifs arose from the poly (A) tail of the AluSx element, and evolved into unstable CCTG repeats during primate evolution. Alu elements are known to be the source of microsatellite repeats responsible for two other repeat expansion disorders: Friedreich ataxia and spinocerebellar ataxia type 10. Taken together, these findings raise questions as to the mechanism(s) by which Alu-mediated repeats developed into the large, extremely unstable expansions common to these three disorders.	[Kurosaki, Tatsuaki; Ohno, Kinji; Matsuura, Tohru] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Ueda, Shintaroh; Ishida, Takafumi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Abe, Koji; Matsuura, Tohru] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama, Japan	Nagoya University; University of Tokyo; Okayama University	Kurosaki, T (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14627 USA.	tohrum@cc.okayama-u.ac.jp	Kurosaki, Tatsuaki/AAR-6251-2021; Ohno, Kinji/H-4020-2012; Ohno, Kinji/ABD-5787-2020; Kurosaki, Tatsuaki/F-9949-2014	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Kurosaki, Tatsuaki/0000-0003-3231-1359	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in Aid from the Ministry of Education, Culture, Sports, Science, and Technology as well as the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Bachinski LL, 2009, NEUROLOGY, V72, P490, DOI 10.1212/01.wnl.0000333665.01888.33; Bachinski LL, 2003, AM J HUM GENET, V73, P835, DOI 10.1086/378566; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Batzer MA, 1996, J MOL EVOL, V42, P3, DOI 10.1007/BF00163204; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chauhan C, 2002, J BIOMOL STRUCT DYN, V20, P253, DOI 10.1080/07391102.2002.10506841; Clark RM, 2004, GENOMICS, V83, P373, DOI 10.1016/j.ygeno.2003.09.001; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dere R, 2004, J BIOL CHEM, V279, P41715, DOI 10.1074/jbc.M406415200; Dere R, 2006, J MOL BIOL, V360, P21, DOI 10.1016/j.jmb.2006.05.012; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Justice CM, 2001, J MOL EVOL, V52, P232, DOI 10.1007/s002390010151; Kass DH, 1996, J MOL EVOL, V42, P7, DOI 10.1007/BF00163205; Kelkar YD, 2011, GENOME RES, V21, P2038, DOI 10.1101/gr.122937.111; Kim J, 1996, J MOL BIOL, V261, P322, DOI 10.1006/jmbi.1996.0464; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kurosaki T, 2009, MOL BIOL EVOL, V26, P2573, DOI 10.1093/molbev/msp172; Lam SL, 2011, NUCLEIC ACIDS RES, V39, P6260, DOI 10.1093/nar/gkr185; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liquori CL, 2003, AM J HUM GENET, V73, P849, DOI 10.1086/378720; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2004, AM J HUM GENET, V74, P1216, DOI 10.1086/421526; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Montermini L, 1997, NEUROLOGY, V49, P606, DOI 10.1212/WNL.49.2.606; Nakayama K, 2006, GENOME RES, V16, P485, DOI 10.1101/gr.4763906; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; Saito T, 2008, NEUROGENETICS, V9, P61, DOI 10.1007/s10048-007-0110-4; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schoser BGH, 2004, BRAIN, V127, P1868, DOI 10.1093/brain/awh210; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Udd B, 1997, NEUROMUSCULAR DISORD, V7, P217, DOI 10.1016/S0960-8966(97)00041-2; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109	44	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38379	10.1371/journal.pone.0038379	http://dx.doi.org/10.1371/journal.pone.0038379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723857	Green Submitted, gold, Green Published			2022-12-25	WOS:000305652700015
J	Meguro, A; Ideta, H; Ota, M; Ito, N; Ideta, R; Yonemoto, J; Takeuchi, M; Uemoto, R; Nishide, T; Iijima, Y; Kawagoe, T; Okada, E; Shiota, T; Hagihara, Y; Oka, A; Inoko, H; Mizuki, N				Meguro, Akira; Ideta, Hidenao; Ota, Masao; Ito, Norihiko; Ideta, Ryuichi; Yonemoto, Junichi; Takeuchi, Masaki; Uemoto, Riyo; Nishide, Tadayuki; Iijima, Yasuhito; Kawagoe, Tatsukata; Okada, Eiichi; Shiota, Tomoko; Hagihara, Yuta; Oka, Akira; Inoko, Hidetoshi; Mizuki, Nobuhisa			Common Variants in the COL4A4 Gene Confer Susceptibility to Lattice Degeneration of the Retina	PLOS ONE			English	Article							BENIGN FAMILIAL HEMATURIA; ASSOCIATION ANALYSIS; ALPORT-SYNDROME; DETACHMENT; MUTATIONS; COLLAGEN; DISEASE	Lattice degeneration of the retina is a vitreoretinal disorder characterized by a visible fundus lesion predisposing the patient to retinal tears and detachment. The etiology of this degeneration is still uncertain, but it is likely that both genetic and environmental factors play important roles in its development. To identify genetic susceptibility regions for lattice degeneration of the retina, we performed a genome-wide association study (GWAS) using a dense panel of 23,465 microsatellite markers covering the entire human genome. This GWAS in a Japanese cohort (294 patients with lattice degeneration and 294 controls) led to the identification of one microsatellite locus, D2S0276i, in the collagen type IV alpha 4 (COL4A4) gene on chromosome 2q36.3. To validate the significance of this observation, we evaluated the D2S0276i region in the GWAS cohort and in an independent Japanese cohort (280 patients and 314 controls) using D2S0276i and 47 single nucleotide polymorphisms covering the region. The strong associations were observed in D2S0276i and rs7558081 in the COL4A4 gene (Pc = 5.8x10(-6), OR = 0.63 and Pc = 1.0x10(-5), OR = 0.69 in a total of 574 patients and 608 controls, respectively). Our findings suggest that variants in the COL4A4 gene may contribute to the development of lattice degeneration of the retina.	[Meguro, Akira; Ito, Norihiko; Yonemoto, Junichi; Takeuchi, Masaki; Uemoto, Riyo; Nishide, Tadayuki; Iijima, Yasuhito; Kawagoe, Tatsukata; Shiota, Tomoko; Hagihara, Yuta; Mizuki, Nobuhisa] Yokohama City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Ideta, Hidenao; Ideta, Ryuichi] Ideta Eye Hosp, Kumamoto, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Okada, Eiichi] Okada Eye Clin, Yokohama, Kanagawa, Japan; [Oka, Akira; Inoko, Hidetoshi] Tokai Univ, Sch Med, Div Mol Life Sci, Dept Genet Informat, Isehara, Kanagawa 25911, Japan	Yokohama City University; Shinshu University; Tokai University	Meguro, A (corresponding author), Yokohama City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	mizunobu@med.yokohama-cu.ac.jp	Ito, Norihiko/ABD-3147-2021	Ota, Masao/0000-0002-6400-5658	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [16209052, 20592052]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (# 16209052, N. Mizuki; # 20592052, Y. Iijima; http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVSHALOM A, 1967, AM J OPHTHALMOL, V64, P387, DOI 10.1016/0002-9394(67)92001-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Buzza M, 2003, KIDNEY INT, V63, P447, DOI 10.1046/j.1523-1755.2003.00780.x; Byer N E, 1965, Trans Am Acad Ophthalmol Otolaryngol, V69, P1065; BYER NE, 1979, SURV OPHTHALMOL, V23, P213, DOI 10.1016/0039-6257(79)90048-1; Collins HE, 2000, HUM GENET, V106, P218, DOI 10.1007/s004390051031; FOOS RY, 1984, OPHTHALMOLOGY, V91, P452; Gross O, 2003, NEPHROL DIAL TRANSPL, V18, P1122, DOI 10.1093/ndt/gfg157; HEDRICK PW, 1987, GENETICS, V117, P331; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hui J, 2008, HUM GENET, V123, P297, DOI 10.1007/s00439-008-0477-9; Kawashima M, 2006, AM J HUM GENET, V79, P252, DOI 10.1086/505539; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; MADJAROV B, 1995, RETINA-J RET VIT DIS, V15, P282, DOI 10.1097/00006982-199515040-00002; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Michikawa Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-123; MURAKAMI F, 1982, OPHTHALMOLOGICA, V185, P136, DOI 10.1159/000309235; Oka A, 2003, TISSUE ANTIGENS, V61, P203, DOI 10.1034/j.1399-0039.2003.00007.x; Pescucci C, 2004, KIDNEY INT, V65, P1598, DOI 10.1111/j.1523-1755.2004.00560.x; Sato K, 1971, Nippon Ganka Gakkai Zasshi, V75, P635; Sato K, 1972, Mod Probl Ophthalmol, V10, P133; Shaikh S, 2003, RETINA-J RET VIT DIS, V23, P119, DOI 10.1097/00006982-200302000-00025; Slajpah M, 2007, KIDNEY INT, V71, P1287, DOI 10.1038/sj.ki.5002221; STRAATSMA BR, 1974, T AM ACAD OPHTHALMOL, V78, pOP87; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Vega BT, 2003, AM J KIDNEY DIS, V42, P952, DOI 10.1016/j.ajkd.2003.08.002; Yatsu K, 2007, HYPERTENSION, V49, P446, DOI 10.1161/01.HYP.0000257256.77680.02	28	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39300	10.1371/journal.pone.0039300	http://dx.doi.org/10.1371/journal.pone.0039300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723992	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700065
J	Sawada, D; Nishiyama, Y; Langan, P; Forsyth, VT; Kimura, S; Wada, M				Sawada, Daisuke; Nishiyama, Yoshiharu; Langan, Paul; Forsyth, V. Trevor; Kimura, Satoshi; Wada, Masahisa			Water in Crystalline Fibers of Dihydrate beta-Chitin Results in Unexpected Absence of Intramolecular Hydrogen Bonding	PLOS ONE			English	Article							SYNCHROTRON X-RAY; CELLULOSE-II; NEUTRON-DIFFRACTION; TRANSITION; INSIGHTS; SYSTEM; HYDRATION	The complete crystal structure (including hydrogen) of dihydrate beta-chitin, a homopolymer of N-acetylglucosamine hydrate, was determined using high-resolution X-ray and neutron fiber diffraction data collected from bathophilous tubeworm Lamellibrachia satsuma. Two water molecules per N-acetylglucosamine residue are clearly localized in the structure and these participate in most of the hydrogen bonds. The conformation of the labile acetamide groups and hydroxymethyl groups are similar to those found in anhydrous beta-chitin, but more relaxed. Unexpectedly, the intrachain O-3-H center dot center dot center dot O5 hydrogen bond typically observed for crystalline beta, 1-4 glycans is absent, providing important insights into its relative importance and its relationship to solvation.	[Sawada, Daisuke; Kimura, Satoshi; Wada, Masahisa] Univ Tokyo, Dept Biomat Sci, Grad Sch Agr & Life Sci, Tokyo, Japan; [Nishiyama, Yoshiharu] CNRS, Ctr Rech Macromol Vegetales, CERMAV, F-38041 Grenoble, France; [Langan, Paul] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN USA; [Forsyth, V. Trevor] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; [Forsyth, V. Trevor] Keele Univ, EPSAM, ISTM, Keele, Staffs, England; [Kimura, Satoshi; Wada, Masahisa] Kyung Hee Univ, Dept Plant & Environm New Resources, Coll Life Sci, Yongin, Gyeonggi Do, South Korea	University of Tokyo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); United States Department of Energy (DOE); Oak Ridge National Laboratory; Institut Laue-Langevin (ILL); Keele University; Kyung Hee University	Sawada, D (corresponding author), Univ Tokyo, Dept Biomat Sci, Grad Sch Agr & Life Sci, Tokyo, Japan.	utkspecial@hotmail.com	Nishiyama, Yoshiharu/A-3492-2012; Langan, Paul/N-5237-2015; Forsyth, V. Trevor/A-9129-2010	Nishiyama, Yoshiharu/0000-0003-4069-2307; Langan, Paul/0000-0002-0247-3122; Forsyth, V. Trevor/0000-0003-0380-3477	Japan Society for the Promotion of Science [21/1330]; Agence National de la Recherche [ANR-07-JCJC-21]; Office of Biological and Environmental Research, United States Department of Energy [FWP ERKP752]; Engineering and Physical Sciences Research Council [GR/R47950/01, GR/R99393/01, EP/C015452/1]; EPSRC [EP/C015452/1] Funding Source: UKRI	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agence National de la Recherche(French National Research Agency (ANR)); Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding provided by Japan Society for the Promotion of Science, under 21/1330 http://www.jsps.go.jp/english/index.html. Part of the study was financed by the Agence National de la Recherche (ANR-07-JCJC-21) http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/Genomic Science Program, Office of Biological and Environmental Research, United States Department of Energy, under Contract FWP ERKP752. http://genomicscience.energy.gov/. Engineering and Physical Sciences Research Council under grants GR/R47950/01, GR/R99393/01, EP/C015452/1. http://www.epsrc.ac.uk/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKWEL.J, 1969, BIOPOLYMERS, V7, P281, DOI 10.1002/bip.1969.360070302; BLACKWELL J, 1965, J MAR BIOL ASSOC UK, V45, P659, DOI 10.1017/S0025315400016489; BLACKWELL J, 1967, J MOL BIOL, V28, P383, DOI 10.1016/S0022-2836(67)80018-4; Blackwell J, 1973, BIOPOLYMERS, P464; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRARIS G, 1972, ACTA CRYSTALLOGR B, V28, P3572, DOI 10.1107/S0567740872008362; FORSYTH VT, 1989, INT J BIOL MACROMOL, V11, P236, DOI 10.1016/0141-8130(89)90075-5; French AD, 2005, TETRAHEDRON-ASYMMETR, V16, P577, DOI 10.1016/j.tetasy.2004.12.007; French AD, 2004, CELLULOSE, V11, P5, DOI 10.1023/B:CELL.0000014765.94239.fe; French AD, 1989, CELLULOSE WOOD CHEM; Fuller W, 2004, PHILOS T R SOC B, V359, P1237, DOI 10.1098/rstb.2004.1501; Gardner KH, 2004, MACROMOLECULES, V37, P9654, DOI 10.1021/ma048445l; Haupt M, 2011, ACTA CRYSTALLOGR F, V67, P1428, DOI 10.1107/S1744309111036244; ICHIKAWA K, 1991, MOL PHYS, V73, P79, DOI 10.1080/00268979100101071; Igarashi K, 2007, FEBS J, V274, P1785, DOI 10.1111/j.1742-4658.2007.05727.x; Jeffrey GA, 1994, HYDROGEN BONDING BIO; KAMIDE K, 1985, POLYM J, V17, P701, DOI 10.1295/polymj.17.701; Kobayashi K, 2011, CARBOHYD POLYM, V86, P975, DOI 10.1016/j.carbpol.2011.05.050; Kobayashi K, 2011, CARBOHYD POLYM, V83, P483, DOI 10.1016/j.carbpol.2010.08.006; Kobayashi K, 2010, CARBOHYD POLYM, V80, P491, DOI 10.1016/j.carbpol.2009.12.009; Kobayashi K, 2010, CARBOHYD POLYM, V79, P882, DOI 10.1016/j.carbpol.2009.10.020; Langan P, 1999, J AM CHEM SOC, V121, P9940, DOI 10.1021/ja9916254; Langan P, 1996, J APPL CRYSTALLOGR, V29, P383, DOI 10.1107/S0021889896002816; Langan P, 2001, BIOMACROMOLECULES, V2, P410, DOI 10.1021/bm005612q; LANGAN P, 1992, J BIOMOL STRUCT DYN, V10, P489, DOI 10.1080/07391102.1992.10508664; MAHENDRASINGAM A, 1992, PHYSICA B, V180, P528, DOI 10.1016/0921-4526(92)90813-8; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MO F, 1979, ACTA CHEM SCAND A, V33, P207, DOI 10.3891/acta.chem.scand.33a-0207; MO F, 1978, ACTA CRYSTALLOGR B, V34, P1562, DOI 10.1107/S0567740878006081; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Nishiyama Y, 2008, BIOMACROMOLECULES, V9, P3133, DOI 10.1021/bm800726v; Nishiyama Y, 2011, MACROMOLECULES, V44, P950, DOI 10.1021/ma102240r; Nishiyama Y, 2010, ACTA CRYSTALLOGR D, V66, P1172, DOI 10.1107/S0907444910032397; Noishiki Y, 2004, MACROMOLECULES, V37, P6839, DOI 10.1021/ma0489265; Parthasarathi R, 2011, J PHYS CHEM A, V115, P14191, DOI 10.1021/jp203620x; Rudall K. M., 1963, P257; Saito Y, 2000, INT J BIOL MACROMOL, V28, P81, DOI 10.1016/S0141-8130(00)00147-1; Saito Y., 1997, ADV CHITIN SCI, V2, P507; Sawada D, 2012, BIOMACROMOLECULES, V13, P288, DOI 10.1021/bm201512t; Sheldrick G. M., 1997, SHELX 97 PROGRAM REF; Shen TY, 2009, J AM CHEM SOC, V131, P14786, DOI 10.1021/ja9034158; Shotton MW, 1997, BIOPHYS CHEM, V69, P85, DOI 10.1016/S0301-4622(97)00090-2; Shotton MW, 1998, J APPL CRYSTALLOGR, V31, P758, DOI 10.1107/S0021889898005287; Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e; TANNER SF, 1990, MACROMOLECULES, V23, P3576, DOI 10.1021/ma00217a008; Thibaudeau C, 2004, J AM CHEM SOC, V126, P15668, DOI 10.1021/ja0306718; Tiggelaar SM, 2011, ACTA CRYSTALLOGR F, V67, P332, DOI 10.1107/S1744309111002351; Wada M, 2004, MACROMOLECULES, V37, P8548, DOI 10.1021/ma0485585; Wada M, 2006, MACROMOLECULES, V39, P2947, DOI 10.1021/ma060228s; Wada M, 2011, CELLULOSE, V18, P191, DOI 10.1007/s10570-010-9488-5; Wada M, 2009, CELLULOSE, V16, P943, DOI 10.1007/s10570-009-9338-5; Wada M, 2009, BIOMACROMOLECULES, V10, P302, DOI 10.1021/bm8010227	54	52	52	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39376	10.1371/journal.pone.0039376	http://dx.doi.org/10.1371/journal.pone.0039376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724007	Green Submitted, Green Published, gold			2022-12-25	WOS:000305652700072
J	Agren, J; Sundstrom, A; Hafstrom, T; Segerman, B				Agren, Joakim; Sundstrom, Anders; Hafstrom, Therese; Segerman, Bo			Gegenees: Fragmented Alignment of Multiple Genomes for Determining Phylogenomic Distances and Genetic Signatures Unique for Specified Target Groups	PLOS ONE			English	Article							BACILLUS-CEREUS GROUP; ANTHRACIS; SEQUENCE; THURINGIENSIS; OUTBREAK; STRAINS; FOOD	The rapid development of Next Generation Sequencing technologies leads to the accumulation of huge amounts of sequencing data. The scientific community faces an enormous challenge in how to deal with this explosion. Here we present a software tool, 'Gegenees', that uses a fragmented alignment approach to facilitate the comparative analysis of hundreds of microbial genomes. The genomes are fragmented and compared, all against all, by a multithreaded BLAST control engine. Ready-made alignments can be complemented with new genomes without recalculating the existing data points. Gegenees gives a phylogenomic overview of the genomes and the alignment can then be mined for genomic regions with conservation patterns matching a defined target group and absent from a background group. The genomic regions are given biomarker scores forming a uniqueness signature that can be viewed and explored, graphically and in tabular form. A primer/probe alignment tool is also included for specificity verification of currently used or new primers. We exemplify the use of Gegenees on the Bacillus cereus group, on Foot and Mouth Disease Viruses, and on strains from the 2011 Escherichia coli O104:H4 outbreak. Gegenees contributes towards an increased capacity of fast and efficient data mining as more and more genomes become sequenced.	[Agren, Joakim; Sundstrom, Anders; Hafstrom, Therese; Segerman, Bo] Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden; [Agren, Joakim] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Agren, J (corresponding author), Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden.	bo.segerman@sva.se			Swedish Civil Contingencies Agency; European Union [036272, Home/2009/ISEC/AG/191]	Swedish Civil Contingencies Agency; European Union(European Commission)	This work was supported by the Swedish Civil Contingencies Agency (www.MSB.se). The work was also supported by the European Union funded Integrated Project BIOTRACER [contract 036272] under the 6th RTD Framework and by/executed in the framework of the EU-project AniBioThreat [Grant Agreement: Home/2009/ISEC/AG/191] with the financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission - Directorate General Home Affairs. This publication reflects the views only of the authors, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; Daffonchio D, 2000, APPL ENVIRON MICROB, V66, P5460, DOI 10.1128/AEM.66.12.5460-5468.2000; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dubchak I, 2009, GENOME RES, V19, P682, DOI 10.1101/gr.081778.108; Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS129, DOI 10.1016/j.ijfoodmicro.2010.07.036; Guinebretiere MH, 2010, J CLIN MICROBIOL, V48, P3388, DOI 10.1128/JCM.00921-10; Gurumurthy CB, 2002, ARCH VIROL, V147, P85, DOI 10.1007/s705-002-8304-y; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hohl Michael, 2002, Bioinformatics, V18 Suppl 1, pS312; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Paten B, 2011, GENOME RES, V21, P1512, DOI 10.1101/gr.123356.111; Phillippy AM, 2007, PLOS COMPUT BIOL, V3, P887, DOI 10.1371/journal.pcbi.0030098; Rausch T, 2008, BIOINFORMATICS, V24, pI187, DOI 10.1093/bioinformatics/btn281; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Segerman B, 2011, INT J FOOD MICROBIOL, V145, pS167, DOI 10.1016/j.ijfoodmicro.2010.06.027; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; Takahashi H, 2011, PLASMID, V66, P112, DOI 10.1016/j.plasmid.2011.06.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Tourasse NJ, 2006, J APPL MICROBIOL, V101, P579, DOI 10.1111/j.1365-2672.2006.03087.x; Wielinga PR, 2011, INT J FOOD MICROBIOL, V145, pS137, DOI 10.1016/j.ijfoodmicro.2010.07.039	35	167	173	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39107	10.1371/journal.pone.0039107	http://dx.doi.org/10.1371/journal.pone.0039107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723939	gold, Green Submitted, Green Published			2022-12-25	WOS:000305583300094
J	Bongers, ML; Hogervorst, JGF; Schouten, LJ; Goldbohm, RA; Schouten, HC; van den Brandt, PA				Bongers, Mathilda L.; Hogervorst, Janneke G. F.; Schouten, Leo J.; Goldbohm, R. Alexandra; Schouten, Harry C.; van den Brandt, Piet A.			Dietary Acrylamide Intake and the Risk of Lymphatic Malignancies: The Netherlands Cohort Study on Diet and Cancer	PLOS ONE			English	Article							SCALE PROSPECTIVE COHORT; BREAST-CANCER; LYMPHOID NEOPLASMS; HEMOGLOBIN ADDUCTS; MULTIPLE-MYELOMA; CARCINOGENICITY; GENOTOXICITY; GLYCIDAMIDE; ESTROGEN; POLYMORPHISMS	Background: Acrylamide, a probable human carcinogen, is present in many everyday foods. Since the finding of its presence in foods in 2002, epidemiological studies have found some suggestive associations between dietary acrylamide exposure and the risk of various cancers. The aim of this prospective study is to investigate for the first time the association between dietary acrylamide intake and the risk of several histological subtypes of lymphatic malignancies. Methods: The Netherlands Cohort Study on diet and cancer includes 120,852 men and women followed-up since September 1986. The number of person years at risk was estimated by using a random sample of participants from the total cohort that was chosen at baseline (n = 5,000). Acrylamide intake was estimated from a food frequency questionnaire combined with acrylamide data for Dutch foods. Hazard ratios (HRs) were calculated for acrylamide intake as a continuous variable as well as in categories (quintiles and tertiles), for men and women separately and for never-smokers, using multivariable-adjusted Cox proportional hazards models. Results: After 16.3 years of follow-up, 1,233 microscopically confirmed cases of lymphatic malignancies were available for multivariable-adjusted analysis. For multiple myeloma and follicular lymphoma, HRs for men were 1.14 (95% CI: 1.01, 1.27) and 1.28 (95% CI: 1.03, 1.61) per 10 mu g acrylamide/day increment, respectively. For never-smoking men, the HR for multiple myeloma was 1.98 (95% CI: 1.38, 2.85). No associations were observed for women. Conclusion: We found indications that acrylamide may increase the risk of multiple myeloma and follicular lymphoma in men. This is the first epidemiological study to investigate the association between dietary acrylamide intake and the risk of lymphatic malignancies, and more research into these observed associations is warranted.	[Bongers, Mathilda L.; Hogervorst, Janneke G. F.; Schouten, Leo J.; van den Brandt, Piet A.] Maastricht Univ, Dept Epidemiol, Sch Oncol & Dev Biol GROW, Med Ctr, Maastricht, Netherlands; [Goldbohm, R. Alexandra] Netherlands Org Appl Sci Res TNO, Div Qual Life, Dept Prevent & Hlth, Leiden, Netherlands; [Schouten, Harry C.] Maastricht Univ, Div Hematol, Dept Internal Med, Med Ctr, Maastricht, Netherlands	Maastricht University; Netherlands Organization Applied Science Research; Maastricht University	Bongers, ML (corresponding author), Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands.	jgf.hogervorst@epid.unimaas.nl	Schouten, Leo J/AAB-2275-2019; Schouten, Leo J/G-3713-2012	Schouten, Leo J/0000-0003-3361-7560; van den Brandt, Piet/0000-0001-8781-8099	Dutch Cancer Society; World Cancer Research Fund	Dutch Cancer Society(KWF Kankerbestrijding); World Cancer Research Fund(World Cancer Research Fund International (WCRF))	The Netherlands Cohort Study on diet and cancer was sponsored by various grants from the Dutch Cancer Society and the World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besaratinia A, 2007, CARCINOGENESIS, V28, P519, DOI 10.1093/carcin/bgm006; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Dourson M, 2008, REGUL TOXICOL PHARM, V52, P264, DOI 10.1016/j.yrtph.2008.08.004; EVERAUS H, 1993, LEUKEMIA LYMPHOMA, V11, P453, DOI 10.3109/10428199309067940; Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+; Ghanayem BI, 2005, MUTAT RES-FUND MOL M, V578, P284, DOI 10.1016/j.mrfmmm.2005.05.004; GOLDBOHM RA, 1995, EUR J CLIN NUTR, V49, P420; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Goldbohm RA, 1994, TIJDSCHR SOC GEZONDH, V72, P80; Haber LT, 2009, REGUL TOXICOL PHARM, V53, P134, DOI 10.1016/j.yrtph.2008.12.008; HARTGE P, 2006, CANC EPIDEMIOLOGY PR; Hirvonen T, 2010, CANCER CAUSE CONTROL, V21, P2223, DOI 10.1007/s10552-010-9642-2; Hogervorst JG, 2008, AM J CLIN NUTR, V87, P1428, DOI 10.1093/ajcn/87.5.1428; Hogervorst JG, 2007, CANCER EPIDEM BIOMAR, V16, P2304, DOI 10.1158/1055-9965.EPI-07-0581; Hogervorst JGF, 2010, CRIT REV TOXICOL, V40, P485, DOI 10.3109/10408440903524254; Hogervorst JGF, 2009, JNCI-J NATL CANCER I, V101, P651, DOI 10.1093/jnci/djp077; *INT KANK, 1993, INT CLASS DIS ONC AD; International Agency for Research on Cancer, 1994, MON EV CARC RISK HUM; Jaffe ES, 2001, WHO CLASSIFICATION T; Klaunig JE, 2008, J AGR FOOD CHEM, V56, P5984, DOI 10.1021/jf8004492; Konings EJM, 2006, WOODHEAD PUBL FOOD S, P214, DOI 10.1533/9781845692018.2.214; Konings EJM, 2010, EUR J CLIN NUTR, V64, P534, DOI 10.1038/ejcn.2010.17; Konings EJM, 2003, FOOD CHEM TOXICOL, V41, P1569, DOI 10.1016/S0278-6915(03)00187-X; Lamy E, 2008, INT J HYG ENVIR HEAL, V211, P74, DOI 10.1016/j.ijheh.2007.04.004; Mei N, 2010, TOXICOL SCI, V115, P412, DOI 10.1093/toxsci/kfq069; Morton LM, 2007, BLOOD, V110, P695, DOI 10.1182/blood-2006-11-051672; Morton LM, 2009, INT J CANCER, V124, P2737, DOI 10.1002/ijc.24248; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; Olesen PT, 2008, INT J CANCER, V122, P2094, DOI 10.1002/ijc.23359; Pedersen GS, 2010, BREAST CANCER RES TR, V122, P199, DOI 10.1007/s10549-009-0642-4; Pylypchuk RD, 2009, AM J EPIDEMIOL, V170, P297, DOI 10.1093/aje/kwp123; Renoir JM, 2008, J MOL ENDOCRINOL, V40, P101, DOI 10.1677/JME-07-0143; Schettgen T, 2004, INT J HYG ENVIR HEAL, V207, P531, DOI 10.1078/1438-4639-00324; Schouten LJ, 2009, AM J EPIDEMIOL, V170, P873, DOI 10.1093/aje/kwp213; SEGERBACK D, 1995, CARCINOGENESIS, V16, P1161, DOI 10.1093/carcin/16.5.1161; Skibola CF, 2005, CANCER EPIDEM BIOMAR, V14, P2391, DOI 10.1158/1055-9965.EPI-05-0343; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Stygar D, 2006, CLIN ENDOCRINOL, V64, P74, DOI 10.1111/j.1365-2265.2005.02420.x; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; Vesper HW, 2008, J AGR FOOD CHEM, V56, P6046, DOI 10.1021/jf703750t; Wilson KM, 2010, CANCER EPIDEM BIOMAR, V19, P2503, DOI 10.1158/1055-9965.EPI-10-0391	42	27	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38016	10.1371/journal.pone.0038016	http://dx.doi.org/10.1371/journal.pone.0038016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723843	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300017
J	Godderis, L; Thomas, R; Hubbard, AE; Tabish, AM; Hoet, P; Zhang, LP; Smith, MT; Veulemans, H; McHale, CM				Godderis, Lode; Thomas, Reuben; Hubbard, Alan E.; Tabish, Ali M.; Hoet, Peter; Zhang, Luoping; Smith, Martyn T.; Veulemans, Hendrik; McHale, Cliona M.			Effect of Chemical Mutagens and Carcinogens on Gene Expression Profiles in Human TK6 Cells	PLOS ONE			English	Article							CANCER-RISK-ESTIMATION; NONGENOTOXIC CARCINOGENS; EXPOSED WORKERS; COMET ASSAY; P53 STATUS; GENOTOXICITY; RADIATION; STYRENE; LINES; MOUSE	Characterization of toxicogenomic signatures of carcinogen exposure holds significant promise for mechanistic and predictive toxicology. In vitro transcriptomic studies allow the comparison of the response to chemicals with diverse mode of actions under controlled experimental conditions. We conducted an in vitro study in TK6 cells to characterize gene expression signatures of exposure to 15 genotoxic carcinogens frequently used in European industries. We also examined the dose-responsive changes in gene expression, and perturbation of biochemical pathways in response to these carcinogens. TK6 cells were exposed at 3 dose levels for 24 h with and without S9 human metabolic mix. Since S9 had an impact on gene expression (885 genes), we analyzed the gene expression data from cells cultures incubated with S9 and without S9 independently. The ribosome pathway was affected by all chemical-dose combinations. However in general, no similar gene expression was observed among carcinogens. Further, pathways, i.e. cell cycle, DNA repair mechanisms, RNA degradation, that were common within sets of chemical-dose combination were suggested by clustergram. Linear trends in dose-response of gene expression were observed for Trichloroethylene, Benz[a]anthracene, Epichlorohydrin, Benzene, and Hydroquinone. The significantly altered genes were involved in the regulation of (anti-) apoptosis, maintenance of cell survival, tumor necrosis factor-related pathways and immune response, in agreement with several other studies. Similarly in S9+ cultures, Benz[a]pyrene, Styrene and Trichloroethylene each modified over 1000 genes at high concentrations. Our findings expand our understanding of the transcriptomic response to genotoxic carcinogens, revealing the alteration of diverse sets of genes and pathways involved in cellular homeostasis and cell cycle control.	[Godderis, Lode; Tabish, Ali M.; Hoet, Peter; Veulemans, Hendrik] Katholieke Univ Leuven, Louvain, Belgium; [Godderis, Lode] Idewe, External Serv Prevent & Protect Work, Heverlee, Belgium; [Thomas, Reuben; Zhang, Luoping; Smith, Martyn T.; McHale, Cliona M.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA	KU Leuven; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Godderis, L (corresponding author), Katholieke Univ Leuven, Louvain, Belgium.	Lode.Godderis@med.kuleuven.be	Hoet, Peter/H-9987-2013; Godderis, Lode/AAE-5880-2019	Hoet, Peter/0000-0002-0292-6603; Godderis, Lode/0000-0003-4764-8835	Research Fund K.U. Leuven; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	Research Fund K.U. Leuven(KU Leuven); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project could only be realized thanks to the financing by Research Fund K.U. Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Alexa A., 2007, ENCYCL SYST BIOL, V9, P589; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Andersen ME, 2010, TOXICOL SCI, V118, P716, DOI 10.1093/toxsci/kfq303; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bates D., 2007, LME4 PACKAGE R PACKA, P74; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2006, NAT BIOTECHNOL, V24, P1321, DOI 10.1038/nbt1106-1321; Bryce SM, 2010, ENVIRON MOL MUTAGEN, V51, P260, DOI 10.1002/em.20544; Daston GP, 2010, BIRTH DEFECTS RES C, V90, P110, DOI 10.1002/bdrc.20178; Dickinson DA, 2004, MUTAT RES-FUND MOL M, V549, P29, DOI 10.1016/j.mrfmmm.2004.01.009; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godderis L, 2004, ENVIRON MOL MUTAGEN, V44, P293, DOI 10.1002/em.20069; Godderis L, 2007, MUTAGENESIS, V22, P209, DOI 10.1093/mutage/gem005; Hamadeh HK, 2002, TOXICOL PATHOL, V30, P470, DOI 10.1080/01926230290105712; Hauptmann M, 2003, JNCI-J NATL CANCER I, V95, P1615, DOI 10.1093/jnci/djg083; Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145; Hu T, 2004, MUTAT RES-FUND MOL M, V549, P5, DOI 10.1016/j.mrfmmm.2003.11.012; Huang R, 2011, ENV HLTH PERSPECT, V119; Islaih M, 2005, MUTAT RES-FUND MOL M, V578, P100, DOI 10.1016/j.mrfmmm.2005.04.012; Islaih M, 2004, ENVIRON MOL MUTAGEN, V44, P401, DOI 10.1002/em.20065; Johansson F, 2004, MUTAT RES-GEN TOX EN, V563, P35, DOI 10.1016/j.mrgentox.2004.05.017; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kauppinen T, 2000, OCCUP ENVIRON MED, V57, P10, DOI 10.1136/oem.57.1.10; Kienhuis AS, 2011, TOXICOL APPL PHARM, V250, P96, DOI 10.1016/j.taap.2010.10.013; Kirsch-Volders M, 2003, MUTAT RES-GEN TOX EN, V540, P153, DOI 10.1016/j.mrgentox.2003.07.005; KOGEVINAS M, 1994, SCAND J WORK ENV HEA, V20, P251, DOI 10.5271/sjweh.1400; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Le Fevre AC, 2007, MUTAT RES-FUND MOL M, V619, P16, DOI 10.1016/j.mrfmmm.2006.12.007; Lee M, 2003, ENVIRON MOL MUTAGEN, V42, P91, DOI 10.1002/em.10177; Li HH, 2007, MUTAT RES-FUND MOL M, V623, P98, DOI 10.1016/j.mrfmmm.2007.03.013; LITTLE JB, 1995, J BIOL CHEM, V270, P11033, DOI 10.1074/jbc.270.19.11033; Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404; Mahadevan B, 2011, ENVIRON MOL MUTAGEN, V52, P339, DOI 10.1002/em.20653; Mathijs K, 2009, TOXICOL SCI, V112, P374, DOI 10.1093/toxsci/kfp229; McHale CM, 2009, GENOMICS, V93, P343, DOI 10.1016/j.ygeno.2008.12.006; McHale CM, 2010, ENV HLTH PERSPECT, V119; Moller P, 2005, BASIC CLIN PHARMACOL, V96, P9; Moore MM, 2002, ENVIRON MOL MUTAGEN, V40, P292, DOI 10.1002/em.10122; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Newton RK, 2004, ENVIRON HEALTH PERSP, V112, P420, DOI 10.1289/ehp.6709; NISHI Y, 1984, CANCER RES, V44, P3270; Sarma SN, 2011, ENVIRON TOXICOL PHAR, V32, P285, DOI 10.1016/j.etap.2011.06.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stang A, 2009, MUTAT RES-GEN TOX EN, V675, P5, DOI 10.1016/j.mrgentox.2009.01.007; Team RDC, 2009, R LANG ENV STAT COMP; Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44; Thomas RS, 2007, TOXICOL SCI, V98, P240, DOI 10.1093/toxsci/kfm092; TORNQVIST M, 1995, J OCCUP ENVIRON MED, V37, P1077; Tsuda S, 2000, MUTAT RES-GEN TOX EN, V467, P83, DOI 10.1016/S1383-5718(00)00014-0; van Dartel DAM, 2011, TOXICOLOGY IN PRESS; van Dartel DAM, 2010, TOXICOLOGY LETT; van Delft JHM, 2005, MUTAT RES-FUND MOL M, V575, P17, DOI 10.1016/j.mrfmmm.2005.02.006; van Delft JHM, 2004, CARCINOGENESIS, V25, P1265, DOI 10.1093/carcin/bgh108; van Leeuwen DM, 2005, TOXICOL SCI, V86, P200, DOI 10.1093/toxsci/kfi168; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005; WONG O, 1994, OCCUP ENVIRON MED, V51, P386, DOI 10.1136/oem.51.6.386; Wood DK, 2010, P NATL ACAD SCI USA, V107, P10008, DOI 10.1073/pnas.1004056107; XIA F, 1995, CANCER RES, V55, P12	67	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39205	10.1371/journal.pone.0039205	http://dx.doi.org/10.1371/journal.pone.0039205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723965	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300116
J	Quast, SA; Berger, A; Buttstadt, N; Friebel, K; Schonherr, R; Eberle, J				Quast, Sandra-Annika; Berger, Anja; Buttstaedt, Nicole; Friebel, Kristin; Schoenherr, Roland; Eberle, Juergen			General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC	PLOS ONE			English	Article							LIGAND-INDUCED APOPTOSIS; NF-KAPPA-B; UP-REGULATION; CYTOCHROME-C; ION CHANNELS; K+ CHANNELS; DEATH; RESISTANCE; PROTEINS; ACTIVATION	The death ligand TRAIL represents a promising therapeutic strategy for metastatic melanoma, however prevalent and inducible resistance limit its applicability. A new approach is presented here for sensitization to TRAIL. It is based on inhibition of the membrane potassium channel KCa3.1 (IK1), which serves fundamental cellular functions related to membrane potential. The selective inhibitor TRAM-34 did not induce apoptosis by itself but synergistically enhanced TRAIL sensitivity and overrode TRAIL resistance in a large panel of melanoma cell lines. Expression of IK1 was also found in mitochondria, and its inhibition resulted in mitochondrial membrane hyperpolarization and an early activation of Bax. The combination of TRAM-34 and TRAIL resulted in massive release of mitochondrial factors, cytochrome c, AIF and SMAC/DIABLO. Bax knockdown and Bcl-2 overexpression abolished apoptosis. Overexpression of XIAP diminished apoptosis by two-fold, and SMAC knockdown almost completely abolished apoptosis. These data uncover the existence of a rheostat in melanoma cells, consisting of inhibitor of apoptosis proteins and SMAC, which regulates TRAIL sensitivity. Thus, a new strategy is described based on mitochondrial membrane channels, which correspond to Bax activation. As both TRAIL and IK1 inhibitors had shown only minor side effects in clinical trials, a clinical application of this combination is conceivable.	[Quast, Sandra-Annika; Berger, Anja; Eberle, Juergen] Univ Med Ctr Charite, Skin Canc Ctr, Dept Dermatol & Allergy, Berlin, Germany; [Quast, Sandra-Annika] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Buttstaedt, Nicole; Friebel, Kristin; Schoenherr, Roland] Jena Univ Hosp, Dept Biophys, Ctr Mol Biomed, Jena, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Friedrich Schiller University of Jena	Quast, SA (corresponding author), Univ Med Ctr Charite, Skin Canc Ctr, Dept Dermatol & Allergy, Berlin, Germany.	juergen.eberle@charite.de	Schönherr, Roland/K-8713-2013	Schönherr, Roland/0000-0003-0633-0775; Eberle, Jurgen/0000-0001-8533-1519	German Cancer Aid (Deutsche Krebshilfe); Melanoma Research Network (Melanomverbund) [109716]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Melanoma Research Network (Melanomverbund)	This study was supported by the German Cancer Aid (Deutsche Krebshilfe), Melanoma Research Network (Melanomverbund), project number 109716. The funders had no role in study designe, data collection and analysis, decision to publish, or preparation of the manuskript.	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ataga KI, 2009, EXPERT OPIN INV DRUG, V18, P231, DOI [10.1517/13543780802708011, 10.1517/13543780802708011 ]; Berger A, 2010, BIOCH PHARM; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eberle J, 2003, ONCOGENE, V22, P9131, DOI 10.1038/sj.onc.1207228; Eberle J, 2007, DRUG RESIST UPDATE, V10, P218, DOI 10.1016/j.drup.2007.09.001; Elliott JL, 2003, EMBO REP, V4, P189, DOI 10.1038/sj.embor.embor722; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Hornle M, 2010, ONCOGENE; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Ivanov VN, 2008, EXP CELL RES, V314, P1163, DOI 10.1016/j.yexcr.2007.12.012; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; Kurbanov BM, 2005, J INVEST DERMATOL, V125, P1010, DOI 10.1111/j.0022-202X.2005.23900.x; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Lee EL, 2008, AM J PHYSIOL-CELL PH, V294, pC1398, DOI 10.1152/ajpcell.00428.2007; Lemke J, 2010, J MOL MED, V88, P729, DOI 10.1007/s00109-010-0619-0; Li Y, 2006, CANCER RES, V66, P8520, DOI 10.1158/0008-5472.CAN-05-4364; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Raisova M, 2001, J INVEST DERMATOL, V117, P168; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sassi N, 2010, BBA-BIOENERGETICS, V1797, P1260, DOI 10.1016/j.bbabio.2009.12.015; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; Schwab A, 1999, CELL PHYSIOL BIOCHEM, V9, P126, DOI 10.1159/000016309; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wickenden AD, 2002, PHARMACOL THERAPEUT, V94, P157, DOI 10.1016/S0163-7258(02)00201-2; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Zhang XD, 2006, CLIN CANCER RES, V12, P1355, DOI 10.1158/1078-0432.CCR-05-2084; Zhang XD, 2001, CANCER RES, V61, P7339	53	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39290	10.1371/journal.pone.0039290	http://dx.doi.org/10.1371/journal.pone.0039290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723988	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300129
J	Hightower, CM; Vazquez, BYS; Acharya, SA; Subramaniam, S; Intaglietta, M				Hightower, C. Makena; Salazar Vazquez, Beatriz Y.; Acharya, Seetharama A.; Subramaniam, Shankar; Intaglietta, Marcos			PEG-Albumin Plasma Expansion Increases Expression of MCP-1 Evidencing Increased Circulatory Wall Shear Stress: An Experimental Study	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; POLYETHYLENE GLYCOL-ALBUMIN; EXTREME HEMODILUTION; ENDOTHELIAL-CELLS; HEMORRHAGIC-SHOCK; SERUM-ALBUMIN; NITRIC-OXIDE; VISCOSITY; MOBILIZATION; PROTEIN-1	Treatment of blood loss with plasma expanders lowers blood viscosity, increasing cardiac output. However, increased flow velocity by conventional plasma expanders does not compensate for decreased viscosity in maintaining vessel wall shear stress (WSS), decreasing endothelial nitric oxide (NO) production. A new type of plasma expander using polyethylene glycol conjugate albumin (PEG-Alb) causes supra-perfusion when used in extreme hemodilution and is effective in treating hemorrhagic shock, although it is minimally viscogenic. An acute 40% hemodilution/exchange-transfusion protocol was used to compare 4% PEG-Alb to Ringer's lactate, Dextran 70 kDa and 6% Hetastarch (670 kDa) in unanesthetized CD-1 mice. Serum cytokine analysis showed that PEG-Alb elevates monocyte chemotactic protein-1 (MCP-1), a member of a small inducible gene family, as well as expression of MIP-1 alpha, and MIP-2. MCP-1 is specific to increased WSS. Given the direct link between increased WSS and production of NO, the beneficial resuscitation effects due to PEG-Alb plasma expansion appear to be due to increased WSS through increased perfusion and blood flow rather than blood viscosity.	[Hightower, C. Makena; Salazar Vazquez, Beatriz Y.; Subramaniam, Shankar; Intaglietta, Marcos] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Salazar Vazquez, Beatriz Y.] Univ Nacl Autonoma Mexico, Dept Expt Med, Fac Med, Hosp Gen Mexico, Mexico City 04510, DF, Mexico; [Acharya, Seetharama A.] Albert Einstein Coll Med, Dept Med Physiol & Biophys, Bronx, NY 10467 USA	University of California System; University of California San Diego; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Yeshiva University; Albert Einstein College of Medicine	Hightower, CM (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	mintagli@ucsd.edu			USPHS (United States Public Health Service) Bioengineering Research Partnership [R24-HL 064395, R01-HL 062354, R33-HL 08737503, T32-HL 007089]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL064395, T32HL007089, R01HL062354] Funding Source: NIH RePORTER	USPHS (United States Public Health Service) Bioengineering Research Partnership; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the USPHS (United States Public Health Service) Bioengineering Research Partnership grant R24-HL 064395 (MI), R01-HL 062354 (MI), R33-HL 08737503 (SS) and T32-HL 007089 (CMH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578; Acharya SA, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P345; Ananda K, 2012, ARTIF CELL BLOOD SUB, V40, P14, DOI 10.3109/10731199.2011.579568; Bao XP, 1999, ARTERIOSCL THROM VAS, V19, P996, DOI 10.1161/01.ATV.19.4.996; Broxmeyer HE, 2007, ANN NY ACAD SCI, V1106, P1, DOI 10.1196/annals.1392.013; Cabrales P, 2005, AM J PHYSIOL-HEART C, V289, pH2392, DOI 10.1152/ajpheart.00225.2005; Cabrales P, 2005, SHOCK, V24, P66, DOI 10.1097/01.shk.0000167111.80753.ef; Cabrales P, 2004, AM J PHYSIOL-HEART C, V287, pH363, DOI 10.1152/ajpheart.01039.2003; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Chien S, 2006, BIORHEOLOGY, V43, P95; de Jager SCA, 2008, J MOL CELL CARDIOL, V45, P446, DOI 10.1016/j.yjmcc.2008.06.003; ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841; FRIESENECKER B, 1994, AM J PHYSIOL-HEART C, V267, pH2204, DOI 10.1152/ajpheart.1994.267.6.H2204; Fujii T, 2006, ARTERIOSCL THROM VAS, V26, P2483, DOI 10.1161/01.ATV.0000244684.23499.bf; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Hangai-Hoger N, 2006, CRIT CARE MED, V34, P108, DOI 10.1097/01.CCM.0000190623.97200.82; Hsieh CH, 2008, J IMMUNOL, V181, P2806, DOI 10.4049/jimmunol.181.4.2806; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LIPOWSKY HH, 1980, MICROVASC RES, V19, P297, DOI 10.1016/0026-2862(80)90050-3; LORD BI, 1995, BLOOD, V85, P3412, DOI 10.1182/blood.V85.12.3412.bloodjournal85123412; Manjula BN, 2003, BIOCONJUGATE CHEM, V14, P464, DOI 10.1021/bc0200733; Martini J, 2008, CRIT CARE, V12, DOI 10.1186/cc6874; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Minamiyama Y, 1996, BIOCHEM BIOPH RES CO, V225, P112, DOI 10.1006/bbrc.1996.1138; Shepro D., 2006, MICROVASCULAR RES; SHYY YJ, 1994, P NATL ACAD SCI USA, V91, P4678, DOI 10.1073/pnas.91.11.4678; Tsai AG, 2005, AM J PHYSIOL-HEART C, V288, pH1730, DOI 10.1152/ajpheart.00998.2004; Tsai AG, 2007, TRANSFUS ALTERN TRAN, V9, P246, DOI DOI 10.1111/j.1778-428X.2007.00086.x; Villela NR, 2009, CURR OPIN ANESTHESIO, V22, P163, DOI 10.1097/ACO.0b013e328328d304; Wang JB, 1997, J LEUKOCYTE BIOL, V62, P503, DOI 10.1002/jlb.62.4.503; Xing H, 2001, Zhonghua Bing Li Xue Za Zhi, V30, P361; Yu HM, 2002, CLIN HEMORHEOL MICRO, V26, P199	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39111	10.1371/journal.pone.0039111	http://dx.doi.org/10.1371/journal.pone.0039111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720043	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800045
J	Betz, MJ; Bielohuby, M; Mauracher, B; Abplanalp, W; Muller, HH; Pieper, K; Ramisch, J; Tschop, MH; Beuschlein, F; Bidlingmaier, M; Slawik, M				Betz, Matthias J.; Bielohuby, Maximilian; Mauracher, Brigitte; Abplanalp, William; Mueller, Hans-Helge; Pieper, Korbinian; Ramisch, Juliane; Tschoep, Matthias H.; Beuschlein, Felix; Bidlingmaier, Martin; Slawik, Marc			Isoenergetic Feeding of Low Carbohydrate-High Fat Diets Does Not Increase Brown Adipose Tissue Thermogenic Capacity in Rats	PLOS ONE			English	Article							LOW PROTEIN DIETS; UNCOUPLING PROTEIN-1; WEIGHT-LOSS; ENERGY-EXPENDITURE; RANDOMIZED-TRIAL; BODY-WEIGHT; EXPRESSION; OBESITY; WHITE; RESISTANCE	Low-carbohydrate, high-fat (LC-HF) diets are popular for inducing weight loss in overweighed adults. Adaptive thermogenesis increased by specific effects of macronutrients on energy expenditure has been postulated to induce this weight loss. We studied brown adipose tissue (BAT) morphology and function following exposure to different LC-HF diets. Methods: Male Wistar rats were fed a standard control diet ad libitum or pair-fed isoenergetic amounts of three experimental diets for 4 weeks. The diets had the following macronutrient composition (% metabolizable energy: carbohydrates, fat, protein): control (64.3/16.7/19), LC-HF-low protein (LC-HF-LP, 1.7/92.8/5.5), LC-HF-normal-protein (LC-HF-NP, 2.2/78.7/19.1), and a high fat diet with carbohydrates ("high fat", 19.4/61.9/18.7). Results: Body weight gain was reduced in all pair-fed experimental groups as compared to rats fed the control diet, with more pronounced effect in rats on LC-HF diets than on the high fat diet with carbohydrates. High fat diets increased expression of PGC1 alpha and ADRB3 in BAT indicating higher SNS outflow. However, UCP1 mRNA expression and expression of UCP1 assessed by immunohistochemistry was not different between diet groups. In accordance, analysis of mitochondrial function in-vitro by extracellular flux analyser (Seahorse Bioscience) and measurement of inducible thermogenesis in vivo (primary endpoint), explored by indirect calorimetry following norepinephrine injection, did not show significant differences between groups. Histology of BAT revealed increased lipid droplet size in rats fed the high-fat diet and both LC-HF diets. Conclusion: All experimental diets upregulated expression of genes which are indicative for increased BAT activity. However, the functional measurements in vivo revealed no increase of inducible BAT thermogenesis. This indicates that lower body weight gain with LC-HF diets and a high fat diet in a pair-feeding setting is not caused by increased adaptive thermogenesis in BAT.	[Betz, Matthias J.; Bielohuby, Maximilian; Mauracher, Brigitte; Ramisch, Juliane; Beuschlein, Felix; Bidlingmaier, Martin; Slawik, Marc] Klin LMU, Med Klin & Poliklin 4, Endocrine Res Unit, Munich, Germany; [Abplanalp, William] Univ Cincinnati, Dept Med, Metab Dis Inst, Cincinnati, OH 45221 USA; [Mueller, Hans-Helge] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Pieper, Korbinian] Univ Munich, Ctr Clin Vet Med, Clin Small Anim Surg & Reprod, Munich, Germany; [Tschoep, Matthias H.] Helmholtz Ctr Hlth & Environm, Inst Diabet & Obes, Munich, Germany; [Tschoep, Matthias H.] Tech Univ, Munich, Germany	University of Munich; University System of Ohio; University of Cincinnati; University of Munich; University of Munich; Technical University of Munich	Betz, MJ (corresponding author), Klin LMU, Med Klin & Poliklin 4, Endocrine Res Unit, Munich, Germany.	Marc.Slawik@med.uni-muenchen.de	Tschoep, Matthias H/I-5443-2014; Bielohuby, Maximilian/A-2304-2015	Bielohuby, Maximilian/0000-0002-9859-8156; Beuschlein, Felix/0000-0001-7826-3984; Tschoep, Matthias/0000-0002-4744-371X; Bidlingmaier, Martin/0000-0002-4681-6668; Betz, Matthias Johannes/0000-0002-6946-1871				Adam-Perrot A, 2006, OBES REV, V7, P49, DOI 10.1111/j.1467-789X.2006.00222.x; Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Atkins RC, 1992, DR ATKINSNEW DIET RE; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Becerril S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010962; Bielohuby M, 2011, ENDOCRINOLOGY, V152, P1948, DOI 10.1210/en.2010-1423; Bielohuby M, 2011, AM J PHYSIOL-ENDOC M, V300, pE65, DOI 10.1152/ajpendo.00478.2010; Bielohuby M, 2010, BRIT J NUTR, V103, P1525, DOI 10.1017/S000711450999345X; Blessing W, 2012, PHYSIOL BEHAV, V105, P966, DOI 10.1016/j.physbeh.2011.11.009; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; BRITO MN, 1992, J NUTR, V122, P2081, DOI 10.1093/jn/122.11.2081; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Caton SJ, 2009, OBESITY, V17, P283, DOI 10.1038/oby.2008.529; Commins SP, 2000, J BIOL CHEM, V275, P33059, DOI 10.1074/jbc.M006328200; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; GOMEZSIERRA JM, 1993, ARCH INT PHYSIOL BIO, V101, P117, DOI 10.3109/13813459309008879; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kienbaum P, 2000, ANESTHESIOLOGY, V92, P94, DOI 10.1097/00000542-200001000-00019; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; MA SWY, 1989, CAN J PHYSIOL PHARM, V67, P376, DOI 10.1139/y89-061; MA SWY, 1988, CAN J PHYSIOL PHARM, V66, P1347, DOI 10.1139/y88-221; Moura MAF, 2001, METABOLISM, V50, P1493, DOI 10.1053/meta.2001.27197; Nomura S, 2008, J NUTR BIOCHEM, V19, P840, DOI 10.1016/j.jnutbio.2007.11.005; Ohlson KBE, 2004, BIOCHEM PHARMACOL, V68, P463, DOI 10.1016/j.bcp.2004.03.028; OHLSON KBE, 1994, ANESTHESIOLOGY, V81, P176, DOI 10.1097/00000542-199407000-00024; Petzke KJ, 2007, J NUTR BIOCHEM, V18, P400, DOI 10.1016/j.jnutbio.2006.07.005; Portillo MP, 1998, INT J OBESITY, V22, P974, DOI 10.1038/sj.ijo.0800706; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rodriguez AM, 2002, PFLUG ARCH EUR J PHY, V444, P484, DOI 10.1007/s00424-002-0829-6; Romestaing C, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-4; ROTHWELL NJ, 1983, METABOLISM, V32, P257, DOI 10.1016/0026-0495(83)90190-7; ROTHWELL NJ, 1987, J NUTR, V117, P1721, DOI 10.1093/jn/117.10.1721; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; SADURSKIS A, 1995, AM J PHYSIOL-ENDOC M, V269, pE351, DOI 10.1152/ajpendo.1995.269.2.E351; SCHWARTZ JH, 1983, J CLIN INVEST, V72, P361, DOI 10.1172/JCI110976; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; Takahashi Y, 2000, BRIT J NUTR, V84, P175; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Westman EC, 2006, INT J CARDIOL, V110, P212, DOI 10.1016/j.ijcard.2005.08.034; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066	53	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38997	10.1371/journal.pone.0038997	http://dx.doi.org/10.1371/journal.pone.0038997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720011	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900071
J	McCauley, DJ; Hoffmann, E; Young, HS; Micheli, F				McCauley, Douglas J.; Hoffmann, Eva; Young, Hillary S.; Micheli, Fiorenza			Night Shift: Expansion of Temporal Niche Use Following Reductions in Predator Density	PLOS ONE			English	Article							NORTHERN LINE ISLANDS; CORAL-REEF; ACTIVITY PATTERNS; FISH-ASSEMBLAGE; NEW-ZEALAND; EVOLUTION; POPULATION; EXTINCTION; HISTORY; RHYTHMS	Predation shapes many fundamental aspects of ecology. Uncertainty remains, however, about whether predators can influence patterns of temporal niche construction at ecologically relevant timescales. Partitioning of time is an important mechanism by which prey avoid interactions with predators. However, the traits that control a prey organism's capacity to operate during a particular portion of the diel cycle are diverse and complex. Thus, diel prey niches are often assumed to be relatively unlikely to respond to changes in predation risk at short timescales. Here we present evidence to the contrary. We report results that suggest that the anthropogenic depletion of daytime active predators (species that are either diurnal or cathemeral) in a coral reef ecosystem is associated with rapid temporal niche expansions in a multi-species assemblage of nocturnal prey fishes. Diurnal comparisons of nocturnal prey fish abundance in predator rich and predator depleted reefs at two atolls revealed that nocturnal fish were approximately six (biomass) and eight (density) times more common during the day on predator depleted reefs. Amongst these, the prey species that likely were the most specialized for nocturnal living, and thus the most vulnerable to predation (i.e. those with greatest eye size to body length ratio), showed the strongest diurnal increases at sites where daytime active predators were rare. While we were unable to determine whether these observed increases in diurnal abundance by nocturnal prey were the result of a numerical or behavioral response, either effect could be ecologically significant. These results raise the possibility that predation may play an important role in regulating the partitioning of time by prey and that anthropogenic depletions of predators may be capable of causing rapid changes to key properties of temporal community architecture.	[McCauley, Douglas J.; Hoffmann, Eva; Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Young, Hillary S.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA	Stanford University; Harvard University	McCauley, DJ (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mccauley@berkeley.edu	Young, Hillary/S-1514-2017	Micheli, Fiorenza/0000-0002-6865-1438	National Science Foundation; Woods Institute for the Environment	National Science Foundation(National Science Foundation (NSF)); Woods Institute for the Environment	Funding was provided by the National Science Foundation and the Woods Institute for the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; BROCK RE, 1982, B MAR SCI, V32, P269; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; CULP JM, 1993, OIKOS, V68, P242, DOI 10.2307/3544836; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FENN MGP, 1995, J MAMMAL, V76, P130, DOI 10.2307/1382321; Fishelson L, 2004, ANAT REC PART A, V277A, P249, DOI 10.1002/ar.a.20005; FLECKER AS, 1992, ECOLOGY, V73, P438, DOI 10.2307/1940751; Fraser DF, 2004, ECOLOGY, V85, P312, DOI 10.1890/03-3023; Goatley CHR, 2009, CORAL REEFS, V28, P449, DOI 10.1007/s00338-009-0477-9; Goatley CHR, 2010, PALEOBIOLOGY, V36, P415, DOI 10.1666/09035.1; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; HOLM S, 1979, SCAND J STAT, V6, P65; Hudgens BR, 2011, OECOLOGIA, V165, P699, DOI 10.1007/s00442-010-1761-7; Karpestam B, 2007, J EXP BIOL, V210, P2923, DOI 10.1242/jeb.002956; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kronfeld-Schor N, 2008, BIOL RHYTHM RES, V39, P193, DOI 10.1080/09291010701683268; Land M. F., 2002, ANIMAL EYES; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; McCauley DJ, ECOL APPL IN PRESS; McCauley DJ, 2012, ECOL APPL, V22, P385, DOI 10.1890/11-1059.1; McCauley DJ, 2010, MAR BIOL, V157, P2739, DOI 10.1007/s00227-010-1533-2; McIntosh AR, 1995, LIMNOL OCEANOGR, V40, P1508, DOI 10.4319/lo.1995.40.8.1508; Metcalfe NB, 1998, P ROY SOC B-BIOL SCI, V265, P1503, DOI 10.1098/rspb.1998.0464; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; NELSON BV, 1979, MAR BIOL, V51, P251, DOI 10.1007/BF00386805; Oliver MD, 2006, NEW ZEAL J MAR FRESH, V40, P605, DOI 10.1080/00288330.2006.9517449; PANKHURST NW, 1989, ENVIRON BIOL FISH, V26, P201, DOI 10.1007/BF00004816; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Roll U, 2006, EVOL ECOL, V20, P479, DOI 10.1007/s10682-006-0015-y; RYDELL J, 1995, BIOL J LINN SOC, V54, P183, DOI 10.1006/bijl.1995.0011; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Terborgh J., 2010, TROPHIC CASCADES PRE	39	22	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38871	10.1371/journal.pone.0038871	http://dx.doi.org/10.1371/journal.pone.0038871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719970	gold, Green Published			2022-12-25	WOS:000305341900058
J	Wiedower, EE; Kouba, AJ; Vance, CK; Hansen, RL; Stuth, JW; Tolleson, DR				Wiedower, Erin E.; Kouba, Andrew J.; Vance, Carrie K.; Hansen, Rachel L.; Stuth, Jerry W.; Tolleson, Douglas R.			Fecal Near Infrared Spectroscopy to Discriminate Physiological Status in Giant Pandas	PLOS ONE			English	Article							REFLECTANCE SPECTROSCOPY; AILUROPODA-MELANOLEUCA; FOLIVOROUS MARSUPIALS; QUALITY; PLANT; PREDICTOR; NUTRIENTS; FECES; DIETS; NIRS	Giant panda (Ailuropoda melanoleuca) monitoring and research often require accurate estimates of population size and density. However, obtaining these estimates has been challenging. Innovative technologies, such as fecal near infrared reflectance spectroscopy (FNIRS), may be used to differentiate between sex, age class, and reproductive status as has been shown for several other species. The objective of this study was to determine if FNIRS could be similarly used for giant panda physiological discriminations. Based on samples from captive animals in four U. S. zoos, FNIRS calibrations correctly identified 78% of samples from adult males, 81% from adult females, 85% from adults, 89% from juveniles, 75% from pregnant and 70% from non-pregnant females. However, diet had an impact on the success of the calibrations. When diet was controlled for plant part such that "leaf only" feces were evaluated, FNIRS calibrations correctly identified 93% of samples from adult males and 95% from adult females. These data show that FNIRS has the potential to differentiate between the sex, age class, and reproductive status in the giant panda and may be applicable for surveying wild populations.	[Wiedower, Erin E.] Texas A&M Univ, Blackland Res & Extens Ctr, Grazingland Anim Nutr Lab, Temple, TX USA; [Kouba, Andrew J.; Hansen, Rachel L.] Memphis Zool Soc, Dept Conservat & Res, Memphis, TN USA; [Vance, Carrie K.] Mississippi State Univ, Dept Biochem & Mol Biol, Mississippi State, MS USA; [Stuth, Jerry W.] Texas A&M Univ, Dept Rangeland Ecol & Management, College Stn, TX 77843 USA; [Tolleson, Douglas R.] Univ Arizona, Sch Nat Resources & Environm, Camp Verde, AZ USA	Texas A&M University System; Mississippi State University; Texas A&M University System; Texas A&M University College Station; University of Arizona	Wiedower, EE (corresponding author), Texas A&M Univ, Blackland Res & Extens Ctr, Grazingland Anim Nutr Lab, Temple, TX USA.	dougt@cals.arizona.edu	Vance, Carrie/AAC-6370-2020	Vance, Carrie/0000-0001-8466-6077	Memphis Zoological Society; U.S. Forest Service, International Programs, Asia-Pacific office	Memphis Zoological Society; U.S. Forest Service, International Programs, Asia-Pacific office	This research was supported by the Memphis Zoological Society and the U.S. Forest Service, International Programs, Asia-Pacific office. Memphis Zoo employees participated in all aspects of the project.	Andre J, 2003, MAR ECOL PROG SER, V257, P259, DOI 10.3354/meps257259; [Anonymous], 2010, BREEDING STRATEGY RE; BLACK HE, 1988, TOXICOL PATHOL, V16, P213, DOI 10.1177/019262338801600214; C?lix M., 2018, EUROPEAN RED LIST SA; Dixon R, 2009, J NEAR INFRARED SPEC, V17, P1, DOI 10.1255/jnirs.822; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Foley WJ, 2009, SPECTROSC EUR, V21, P6; Hansen RL, 2010, ZOO BIOL, V29, P470, DOI 10.1002/zoo.20280; He W, 2008, CONSERV GENET, V9, P1541, DOI 10.1007/s10592-007-9493-x; Hu YB, 2010, CONSERV GENET, V11, P2145, DOI 10.1007/s10592-010-0100-1; Kersey DC, 2010, REPROD FERT DEVELOP, V22, P901, DOI 10.1071/RD09178; Kersey DC, 2010, REPRODUCTION, V140, P183, DOI 10.1530/REP-10-0003; Lawler IR, 2006, J CHEM ECOL, V32, P1353, DOI 10.1007/s10886-006-9088-x; Lifeng Z, 2010, BMC GENET, V11, P72; LYONS RK, 1992, J RANGE MANAGE, V45, P238, DOI 10.2307/4002970; MAHALANOBIS PRASANTA CHANDRA, 1930, JOUR AND PROC ASIATIC SOC BENGAL, V26, P541; MAINKA SA, 1990, J ZOO WILDLIFE MED, V21, P334; Martens H., 2001, MULTIVARIATE ANAL QU; McIlwee AM, 2001, OECOLOGIA, V128, P539, DOI 10.1007/s004420100692; Moore BD, 2005, NATURE, V435, P488, DOI 10.1038/nature03551; Pan Wenshi, 2004, P81; Schaller G.B., 1985, GIANT PANDAS WOLONG; SHENK JS, 1991, CROP SCI, V31, P469, DOI 10.2135/cropsci1991.0011183X003100020049x; State Forestry Administration of China, 2006, 3 NAT GIANT PAND CEN; Steel RGD, 1980, PRINCIPLES PROCEDURE; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Stuth J, 2003, FIELD CROP RES, V84, P45, DOI 10.1016/S0378-4290(03)00140-0; Sutherland-Smith M, 2004, ZOO BIOL, V23, P449, DOI 10.1002/zoo.20022; Swaisgood R.R., 2003, INT J COMP PSYCHOL, V16, P65; Tolleson D.R., 2010, SHINING LIGHT MANURE, P81; Tolleson DR, 2005, SMALL RUMINANT RES, V57, P141, DOI 10.1016/j.smallrumres.2004.06.020; Volesky JD, 1996, J RANGE MANAGE, V49, P163, DOI 10.2307/4002688; Walker JW, 2007, J ANIM SCI, V85, P518, DOI 10.2527/jas.2006-202; Walker JW, 1998, J RANGE MANAGE, V51, P450, DOI 10.2307/4003333; Wallis IR, 2003, AUST J ZOOL, V51, P95, DOI 10.1071/ZO02027; Wiedower E, 2009, J NEAR INFRARED SPEC, V17, P265, DOI 10.1255/jnirs.848; Willis EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021159; Woolnough AP, 2002, WILDLIFE RES, V29, P91, DOI 10.1071/WR00050; Woolnough AP, 2001, OECOLOGIA, V129, P585, DOI 10.1007/s004420100771; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhu LF, 2010, CONSERV BIOL, V24, P1299, DOI 10.1111/j.1523-1739.2010.01499.x	41	14	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38908	10.1371/journal.pone.0038908	http://dx.doi.org/10.1371/journal.pone.0038908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719982	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900062
J	Hisano, Y; Kobayashi, N; Yamaguchi, A; Nishi, T				Hisano, Yu; Kobayashi, Naoki; Yamaguchi, Akihito; Nishi, Tsuyoshi			Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; MAST-CELLS; LYMPHOCYTE EGRESS; IMMUNOMODULATOR FTY720; PLATELETS; RECEPTOR; RELEASE; BLOOD; ERYTHROCYTES; METABOLISM	Sphingosine-1-phosphate (S1P), a sphingolipid metabolite that is produced inside the cells, regulates a variety of physiological and pathological responses via S1P receptors (S1P1-5). Signal transduction between cells consists of three steps; the synthesis of signaling molecules, their export to the extracellular space and their recognition by receptors. An S1P concentration gradient is essential for the migration of various cell types that express S1P receptors, such as lymphocytes, pre-osteoclasts, cancer cells and endothelial cells. To maintain this concentration gradient, plasma S1P concentration must be at a higher level. However, little is known about the molecular mechanism by which S1P is supplied to extracellular environments such as blood plasma. Here, we show that SPNS2 functions as an S1P transporter in vascular endothelial cells but not in erythrocytes and platelets. Moreover, the plasma S1P concentration of SPNS2-deficient mice was reduced to approximately 60% of wild-type, and SPNS2-deficient mice were lymphopenic. Our results demonstrate that SPNS2 is the first physiological S1P transporter in mammals and is a key determinant of lymphocyte egress from the thymus.	[Hisano, Yu; Kobayashi, Naoki; Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka, Japan; [Yamaguchi, Akihito; Nishi, Tsuyoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Osaka University; Osaka University	Hisano, Y (corresponding author), RIKEN, Lab Cardiovasc Mol Dynam, Quantitat Biol Ctr, Suita, Osaka, Japan.	tnishi@sanken.osaka-u.ac.jp			Management Expenses Grants for National Universities Corporations; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21200071, 21570137, 19109002]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21200071, 23790093, 21570137] Funding Source: KAKEN	Management Expenses Grants for National Universities Corporations; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Management Expenses Grants for National Universities Corporations, grant-in-aid for Scientific Research (S)(19109002), grants-in-aid for Scientific Research on Innovative area (21200071) and Scientific Research (C) (21570137) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Takeda Science Foundation (http://www.takeda-sci.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Anada Y, 2007, EUR J PHARMACOL, V568, P106, DOI 10.1016/j.ejphar.2007.04.053; Aoki S, 2005, J BIOCHEM, V138, P47, DOI 10.1093/jb/mvi100; Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; FINDLATER GS, 1993, J ANAT, V183, P121; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Honig SM, 2003, J CLIN INVEST, V111, P627, DOI 10.1172/JCI200316200; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kambe N, 2004, BLOOD, V103, P860, DOI 10.1182/blood-2003-04-1160; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Limaye V, 2008, ENDOTHELIUM-J ENDOTH, V15, P101, DOI 10.1080/10623320802125342; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Moritz DR, 1998, J IMMUNOL, V161, P4866; Nieuwenhuis B, 2009, J MOL MED, V87, P645, DOI 10.1007/s00109-009-0468-x; Papadopoulos EJ, 2000, EUR J IMMUNOL, V30, P2355, DOI 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pyne S, 2004, SEMIN CELL DEV BIOL, V15, P491, DOI 10.1016/j.semcdb.2004.05.007; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tanfin Z, 2011, CELL SIGNAL, V23, P1997, DOI 10.1016/j.cellsig.2011.07.010; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Yatomi Y, 2000, BLOOD, V96, P3431; Yatomi Y, 1997, J BIOCHEM, V121, P969; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	54	152	155	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38941	10.1371/journal.pone.0038941	http://dx.doi.org/10.1371/journal.pone.0038941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22723910	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000055
J	Hawkes, WC; Alkan, Z				Hawkes, Wayne Chris; Alkan, Zeynep			Delayed Cell Cycle Progression in Selenoprotein W-depleted Cells Is Regulated by a Mitogen-activated Protein Kinase Kinase 4-p38/c-Jun NH2-terminal Kinase-p53 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; MAP KINASES; SIGNAL INTEGRATION; INDUCED APOPTOSIS; EPITHELIAL-CELLS; P53; JNK; CANCER; PHOSPHORYLATION; STRESS	Selenoprotein W (SEPW1) is a ubiquitous, highly conserved thioredoxin-like protein whose depletion causes a transient p53- and p21(Cip1)-dependent G(1)-phase cell cycle arrest in breast and prostate epithelial cells. SEPW1 depletion increases phosphorylation of Ser-33 in p53, which is associated with decreased p53 ubiquitination and stabilization of p53. We report here that delayed cell cycle progression, Ser-33 phosphorylation, and p53 nuclear accumulation from SEPW1 depletion require mitogen-activated protein kinase kinase 4 (MKK4). Silencing MKK4 rescued G(1) arrest, Ser-33 phosphorylation, and nuclear accumulation of p53 induced by SEPW1 depletion, but silencing MKK3, MKK6, or MKK7 did not. SEPW1 silencing did not change the phosphorylation state of MKK4 but increased total MKK4 protein. Silencing p38 gamma, p38 delta, or JNK2 partially rescued G(1) arrest from SEPW1 silencing, suggesting they signal downstream from MKK4. These results imply that SEPW1 silencing increases MKK4, which activates p38 gamma, p38 delta, and JNK2 to phosphorylate p53 on Ser-33 and cause a transient G(1) arrest.	[Hawkes, Wayne Chris; Alkan, Zeynep] Univ Calif Davis, USDA, ARS, Western Human Nutr Res Ctr, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis	Hawkes, WC (corresponding author), Univ Calif Davis, USDA, ARS, Western Human Nutr Res Ctr, 430 W Hlth Sci Dr, Davis, CA 95616 USA.	wayne.hawkes@ars.usda.gov			United States Department of Agriculture CRIS Project [5306-51530-018-00D]	United States Department of Agriculture CRIS Project	This work was supported by United States Department of Agriculture CRIS Project 5306-51530-018-00D.	Aachmann FL, 2007, J BIOL CHEM, V282, P37036, DOI 10.1074/jbc.M705410200; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Bluher M, 2009, J CLIN ENDOCR METAB, V94, P2507, DOI 10.1210/jc.2009-0002; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Bruckmann A, 2007, J PROTEOME RES, V6, P1689, DOI 10.1021/pr0605522; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; Cunningham SC, 2010, AGING-US, V2, P752, DOI 10.18632/aging.100233; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Ge WW, 2007, MOL CELL NEUROSCI, V34, P80, DOI 10.1016/j.mcn.2006.10.001; Hawkes WC, 2012, J CELL BIOCHEM, V113, P61, DOI 10.1002/jcb.23328; Hawkes WC, 2011, BIOCHEM BIOPH RES CO, V413, P36, DOI 10.1016/j.bbrc.2011.08.032; Hawkes WC, 2009, BIOL TRACE ELEM RES, V131, P229, DOI 10.1007/s12011-009-8367-0; Hershko T, 2006, J BIOL CHEM, V281, P31309, DOI 10.1074/jbc.M601758200; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; Hu MCT, 1997, ONCOGENE, V15, P2277, DOI 10.1038/sj.onc.1201401; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Larance M, 2010, MOL CELL PROTEOMICS, V9, P682, DOI 10.1074/mcp.M900435-MCP200; Lee JH, 2011, J BIOL CHEM, V286, P5136, DOI 10.1074/jbc.M110.190470; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; McGonigle S, 2002, BIOCHEMISTRY-US, V41, P579, DOI 10.1021/bi011407z; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Molnar A, 1997, J BIOL CHEM, V272, P13229, DOI 10.1074/jbc.272.20.13229; Nguyen HT, 2006, NEPHRON EXP NEPHROL, V102, P49, DOI 10.1159/000088401; Nishina H, 1999, DEVELOPMENT, V126, P505; Nuntharatanapong N, 2005, AM J PHYSIOL-HEART C, V289, pH99, DOI 10.1152/ajpheart.00901.2004; O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004; Ria R, 2009, CLIN CANCER RES, V15, P5369, DOI 10.1158/1078-0432.CCR-09-0040; Robinson VL, 2008, MOL CANCER RES, V6, P501, DOI 10.1158/1541-7786.MCR-07-2075; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Schwacke JH, 2007, J THEOR BIOL, V246, P604, DOI 10.1016/j.jtbi.2006.12.035; She QB, 2002, ONCOGENE, V21, P1580, DOI 10.1038/sj.onc.1205239; Song LB, 2010, CELL SIGNAL, V22, P857, DOI 10.1016/j.cellsig.2010.01.009; Spillman MA, 2007, GYNECOL ONCOL, V105, P312, DOI 10.1016/j.ygyno.2006.12.017; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Szmulewitz RZ, 2012, INT J CANCER, V130, P509, DOI 10.1002/ijc.26005; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Taylor J. K., 1987, QUALITY ASSURANCE CH, P24; Todd DE, 2004, ONCOGENE, V23, P3284, DOI 10.1038/sj.onc.1207467; Topisirovic I, 2009, P NATL ACAD SCI USA, V106, P12676, DOI 10.1073/pnas.0900596106; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yu Y, 2011, J BIOL CHEM, V286, P15413, DOI 10.1074/jbc.M111.225946; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200; Zhang SS, 2003, CIRC RES, V93, P1026, DOI 10.1161/01.RES.0000104084.88317.91; Zheng QL, 2004, J BIOL CHEM, V279, P8787, DOI 10.1074/jbc.M310212200; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200; Zuo SA, 2010, J PROTEOME RES, V9, P3465, DOI 10.1021/pr9011377	67	25	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27371	27379		10.1074/jbc.M112.346593	http://dx.doi.org/10.1074/jbc.M112.346593			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730327	hybrid, Green Published			2022-12-25	WOS:000307840700009
J	Himmel, S; Zschiedrich, CP; Becker, S; Hsiao, HH; Wolff, S; Diethmaier, C; Urlaub, H; Lee, D; Griesinger, C; Stulke, J				Himmel, Sebastian; Zschiedrich, Christopher P.; Becker, Stefan; Hsiao, He-Hsuan; Wolff, Sebastian; Diethmaier, Christine; Urlaub, Henning; Lee, Donghan; Griesinger, Christian; Stuelke, Joerg			Determinants of Interaction Specificity of the Bacillus subtilis GlcT Antitermination Protein FUNCTIONALITY AND PHOSPHORYLATION SPECIFICITY DEPEND ON THE ARRANGEMENT OF THE REGULATORY DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; RNA-BINDING DOMAIN; PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; TRANSCRIPTIONAL ANTITERMINATOR; PHOSPHOPROTEIN HPR-SER46-P; SIGNAL-TRANSDUCTION; PTSGHI OPERON; BGL OPERON; LICT	The control of several catabolic operons in bacteria by transcription antitermination is mediated by RNA-binding proteins that consist of an RNA-binding domain and two reiterated phosphotransferase system regulation domains (PRDs). The Bacillus subtilis GlcT antitermination protein regulates the expression of the ptsG gene, encoding the glucose-specific enzyme II of the phosphotransferase system. In the absence of glucose, GlcT becomes inactivated by enzyme II-dependent phosphorylation at its PRD1, whereas the phosphotransferase HPr phosphorylates PRD2. However, here we demonstrate by NMR analysis and mass spectrometry that HPr also phosphorylates PRD1 in vitro but with low efficiency. Size exclusion chromatography revealed that non-phosphorylated PRD1 forms dimers that dissociate upon phosphorylation. The effect of HPr on PRD1 was also investigated in vivo. For this purpose, we used GlcT variants with altered domain arrangements or domain deletions. Our results demonstrate that HPr can target PRD1 when this domain is placed at the C terminus of the protein. In agreement with the in vitro data, HPr exerts a negative control on PRD1. This work provides the first insights into how specificity is achieved in a regulator that contains duplicated regulatory domains with distinct dimerization properties that are controlled by phosphorylation by different phosphate donors. Moreover, the results suggest that the domain arrangement of the PRD-containing antitermination proteins is under selective pressure to ensure the proper regulatory output, i.e. transcription antitermination of the target genes specifically in the presence of the corresponding sugar.	[Himmel, Sebastian; Becker, Stefan; Wolff, Sebastian; Lee, Donghan; Griesinger, Christian] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Hsiao, He-Hsuan; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Zschiedrich, Christopher P.; Diethmaier, Christine; Stuelke, Joerg] Univ Gottingen, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen	Griesinger, C (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany.	cigr@nmr.mpibpc.mpg.de; jstuelk@gwdg.de	Stülke, Jörg/AAD-1600-2021	Lee, Donghan/0000-0002-6530-8060; Stulke, Jorg/0000-0001-5881-5390; Lee, Donghan/0000-0002-3971-986X	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB860]; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Max Planck Society (to C. G.) and by Deutsche Forschungsgemeinschaft Grant SFB860 and the Fonds der Chemischen Industrie (to J. S. and C. G.).	AMSTERCHODER O, 1990, SCIENCE, V249, P540, DOI 10.1126/science.2200123; ARNAUD M, 1992, J BACTERIOL, V174, P3161, DOI 10.1128/jb.174.10.3161-3170.1992; Bachem S, 1998, J BACTERIOL, V180, P5319, DOI 10.1128/JB.180.20.5319-5326.1998; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Darbon E, 2002, MOL MICROBIOL, V43, P1039, DOI 10.1046/j.1365-2958.2002.02800.x; DEBARBOUILLE M, 1991, P NATL ACAD SCI USA, V88, P2212, DOI 10.1073/pnas.88.6.2212; Declerck N, 2001, J MOL BIOL, V314, P671, DOI 10.1006/jmbi.2001.5185; Demene H, 2008, J BIOL CHEM, V283, P30838, DOI 10.1074/jbc.M805955200; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Elsholz AKW, 2010, EMBO J, V29, P3621, DOI 10.1038/emboj.2010.228; Fieulaine S, 2002, P NATL ACAD SCI USA, V99, P13437, DOI 10.1073/pnas.192368699; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gorke B, 1999, EMBO J, V18, P3370, DOI 10.1093/emboj/18.12.3370; Gorke B, 2003, J BIOL CHEM, V278, P46219, DOI 10.1074/jbc.M308002200; Graille M, 2005, J BIOL CHEM, V280, P14780, DOI 10.1074/jbc.M414642200; Greenberg DB, 2002, RES MICROBIOL, V153, P519, DOI 10.1016/S0923-2508(02)01362-1; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Himmel S, 2010, ANGEW CHEM INT EDIT, V49, P8971, DOI 10.1002/anie.201003965; Hubner S, 2011, NUCLEIC ACIDS RES, V39, P4360, DOI 10.1093/nar/gkr021; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Langbein I, 1999, J MOL BIOL, V293, P795, DOI 10.1006/jmbi.1999.3176; Lindner C, 2002, J BACTERIOL, V184, P4819, DOI 10.1128/JB.184.17.4819-4828.2002; Lindner C, 1999, MOL MICROBIOL, V31, P995, DOI 10.1046/j.1365-2958.1999.01262.x; Manival X, 1997, EMBO J, V16, P5019, DOI 10.1093/emboj/16.16.5019; MARTINVERSTRAETE I, 1994, J MOL BIOL, V241, P178, DOI 10.1006/jmbi.1994.1487; Matthews KS, 1996, SCIENCE, V271, P1245, DOI 10.1126/science.271.5253.1245; Muller W, 2006, FEBS J, V273, P1251, DOI 10.1111/j.1742-4658.2006.05148.x; Pompeo F, 2007, J BACTERIOL, V189, P1154, DOI 10.1128/JB.01575-06; Poncet S, 2009, J BIOL CHEM, V284, P28188, DOI 10.1074/jbc.M109.046334; Raveh H, 2009, P NATL ACAD SCI USA, V106, P13523, DOI 10.1073/pnas.0902559106; Reizer J, 1998, MOL MICROBIOL, V27, P1157, DOI 10.1046/j.1365-2958.1998.00747.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schilling O, 2004, NUCLEIC ACIDS RES, V32, P2853, DOI 10.1093/nar/gkh611; Schilling O, 2006, NUCLEIC ACIDS RES, V34, P6102, DOI 10.1093/nar/gkl733; Schmalisch MH, 2003, J BIOL CHEM, V278, P51108, DOI 10.1074/jbc.M309972200; SCHNETZ K, 1990, P NATL ACAD SCI USA, V87, P5074, DOI 10.1073/pnas.87.13.5074; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Stulke J, 1998, MOL MICROBIOL, V28, P865, DOI 10.1046/j.1365-2958.1998.00839.x; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Tortosa P, 2001, MOL MICROBIOL, V41, P1381, DOI 10.1046/j.1365-2958.2001.02608.x; van Tilbeurgh H, 2001, CURR OPIN STRUC BIOL, V11, P685, DOI 10.1016/S0959-440X(01)00267-6; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C	48	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27731	27742		10.1074/jbc.M112.388850	http://dx.doi.org/10.1074/jbc.M112.388850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722928	Green Published, hybrid			2022-12-25	WOS:000307840700047
J	Rasooly, R; He, XH; Friedman, M				Rasooly, Reuven; He, Xiaohua; Friedman, Mendel			Milk Inhibits the Biological Activity of Ricin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-GROUND BEEF; SHIGA TOXIN; BINDING; LACTOSE; GALACTOSE; TOXICITY; CHAIN	Ricin is a highly toxic protein produced by the castor plant Ricinus communis. The toxin is relatively easy to isolate and can be used as a biological weapon. There is great interest in identifying effective inhibitors for ricin. In this study, we demonstrated by three independent assays that a component of reconstituted powdered milk has a high binding affinity to ricin. We discovered that milk can competitively bind to and reduce the amount of toxin available to asialofetuin type II, which is used as a model to study the binding of ricin to galactose cell-surface receptors. Milk also removes ricin bound to the microtiter plate. In parallel experiments, we demonstrated by activity assay and by immuno-PCR that milk can bind competitively to 1 ng/ml ricin, reducing the amount of toxin uptake by the cells, and thus inhibit the biological activity of ricin. The inhibitory effect of milk on ricin activity in Vero cells was at the same level as by anti-ricin antibodies. We also found that (a) milk did not inhibit ricin at concentrations of 10 or 100 ng/ml; (b) autoclaving 10 and 100 ng/ml ricin in DMEM at 121 degrees C for 30 min completely abolished activity; and (c) milk did not affect the activity of another ribosome inactivating protein, Shiga toxin type 2 (Stx2), produced by pathogenic Escherichia coli O157:H7. Unlike ricin, which is internalized into the cells via a galactose-binding site, Stx2 is internalized through the cell surface receptor glycolipid globotriasylceramides Gb3 and Gb4. These observations suggest that ricin toxicity may possibly be reduced at room temperature by a widely consumed natural liquid food.	[Rasooly, Reuven; He, Xiaohua] ARS, Foodborne Contaminants Unit, USDA, Albany, CA 94710 USA; [Friedman, Mendel] ARS, USDA, Unit Produce Safety & Microbiol Res, Albany, CA 94710 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Rasooly, R (corresponding author), ARS, Foodborne Contaminants Unit, USDA, Albany, CA 94710 USA.	reuven.rasooly@ars.usda.gov						Al Mijan M, 2011, KOREAN J FOOD SCI AN, V31, P631, DOI 10.5851/kosfa.2011.31.5.631; Bai Y, 2009, ARCH BIOCHEM BIOPHYS, V483, P23, DOI 10.1016/j.abb.2008.12.013; Barbieri L, 2004, FEBS LETT, V563, P219, DOI 10.1016/S0014-5793(04)00286-8; Benson JM, 2011, INHAL TOXICOL, V23, P247, DOI 10.3109/08958378.2011.565490; BLUM JS, 1991, J BIOL CHEM, V266, P22091; Brandon DL, 2011, TOXINS, V3, P398, DOI 10.3390/toxins3040398; Brown-Esters O, 2012, INT DAIRY J, V22, P98, DOI 10.1016/j.idairyj.2011.09.010; Casado B, 2009, J PROTEOMICS, V73, P196, DOI 10.1016/j.jprot.2009.09.018; El-Hawiet A, 2011, GLYCOBIOLOGY, V21, P1217, DOI 10.1093/glycob/cwr055; Forsum E., 1975, PROTEIN NUTRITIONA 2, P433; Garber EAE, 2008, J FOOD PROTECT, V71, P1875, DOI 10.4315/0362-028X-71.9.1875; Hartley MR, 2004, BBA-PROTEINS PROTEOM, V1701, P1, DOI 10.1016/j.bbapap.2004.06.004; He LL, 2011, J FOOD SCI, V76, pN49, DOI 10.1111/j.1750-3841.2011.02196.x; He XH, 2010, J FOOD PROTECT, V73, P695, DOI 10.4315/0362-028X-73.4.695; Horner TW, 2011, J DAIRY SCI, V94, P3242, DOI 10.3168/jds.2010-3742; Jackson LS, 2006, J AGR FOOD CHEM, V54, P7300, DOI 10.1021/jf061199n; Jasheway K, 2011, TOXINS, V3, P1233, DOI 10.3390/toxins3101233; Labuza T. P., 2011, ANN M INT ASS FOOD P; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017; Matsumura T, 2007, BIOCHEM BIOPH RES CO, V352, P867, DOI 10.1016/j.bbrc.2006.11.095; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; Nagatsuka T, 2010, ACS APPL MATER INTER, V2, P1081, DOI 10.1021/am900846r; Poore C, 2009, J HAZARD MATER, V172, P559, DOI 10.1016/j.jhazmat.2009.05.142; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Rao RD, 2004, J FOOD PROTECT, V67, P403, DOI 10.4315/0362-028X-67.2.403; Rasooly R, 2010, J AGR FOOD CHEM, V58, P9281, DOI 10.1021/jf101744z; Rasooly R, 2010, J FOOD SCI, V75, pM296, DOI 10.1111/j.1750-3841.2010.01615.x; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Wang ML, 2011, J AGR FOOD CHEM, V59, P9250, DOI 10.1021/jf202949v; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	32	17	18	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27924	27929		10.1074/jbc.M112.362988	http://dx.doi.org/10.1074/jbc.M112.362988			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733821	hybrid, Green Published			2022-12-25	WOS:000307840700066
J	Schaedler, TA; Tong, Z; van Veen, HW				Schaedler, Theresia A.; Tong, Zhen; van Veen, Hendrik W.			The Multidrug Transporter LmrP Protein Mediates Selective Calcium Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; LACTOCOCCUS-LACTIS; MEMBRANE-VESICLES; ESCHERICHIA-COLI; BINDING; RESISTANCE; ANTIPORTER; MECHANISM; FURA-2; SITE	LmrP is a major facilitator superfamily multidrug transporter from Lactococcus lactis that mediates the efflux of cationic amphiphilic substrates from the cell in a proton-motive force-dependent fashion. Interestingly, motif searches and docking studies suggested the presence of a putative Ca2+-binding site close to the interface between the two halves of inward facing LmrP. Binding experiments with radioactive Ca-45(2+) demonstrated the presence of a high affinity Ca2+-binding site in purified LmrP, with an apparent K-d of 7.2 mu M, which is selective for Ca2+ and Ba2+ but not for Mn2+, Mg2+, or Co2+. Consistent with our structure model and analogous to crystal structures of EF hand Ca2+-binding proteins, two carboxylates (Asp-235 and Glu-327) were found to be critical for Ca-45(2+) binding. Using Ca-45(2+) and a fluorescent Ca2+-selective probe, calcium transport measurements in intact cells, inside-out membrane vesicles, and proteoliposomes containing functionally reconstituted purified protein provided strong evidence for active efflux of Ca2+ by LmrP with an apparent K-t of 8.6 mu M via electrogenic exchange with three or more protons. These observations demonstrate for the first time that LmrP mediates selective calcium/proton antiport and raise interesting questions about the functional and physiological links between this reaction and that of multidrug transport.	[Schaedler, Theresia A.; Tong, Zhen; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077; Schaedler, Theresia/0000-0002-7247-4091	Biotechnology and Biological Sciences Research Council; Pembroke College; Cambridge European Trusts; Kurt Hahn Trust; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish; BBSRC [BB/I002383/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pembroke College; Cambridge European Trusts; Kurt Hahn Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council.; Recipient of awards from Pembroke College, the Cambridge European Trusts, and the Kurt Hahn Trust.	AMBUDKAR SV, 1986, J BIOL CHEM, V261, P5596; AMBUDKAR SV, 1984, J BIOL CHEM, V259, P6142; Bapna A, 2007, J MOL MICROB BIOTECH, V12, P197, DOI 10.1159/000099641; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; CHENG JB, 1994, J BIOL CHEM, V269, P27365; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; DRIESSEN AJM, 1986, EUR J BIOCHEM, V159, P149, DOI 10.1111/j.1432-1033.1986.tb09845.x; Fujisawa M, 2009, ARCH MICROBIOL, V191, P649, DOI 10.1007/s00203-009-0494-7; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Gbaguidi B, 2007, CELL MOL LIFE SCI, V64, P1571, DOI 10.1007/s00018-007-7031-0; Guffanti AA, 1998, J BIOL CHEM, V273, P26447, DOI 10.1074/jbc.273.41.26447; HAGIWARA S, 1974, J GEN PHYSIOL, V63, P564, DOI 10.1085/jgp.63.5.564; KOBAYASHI H, 1978, J BIOL CHEM, V253, P2085; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Lewinson O, 2004, P NATL ACAD SCI USA, V101, P14073, DOI 10.1073/pnas.0405375101; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; MATSUSHITA T, 1986, EUR J BIOCHEM, V156, P95, DOI 10.1111/j.1432-1033.1986.tb09553.x; MCDONOUGH PM, 1989, CELL CALCIUM, V10, P171, DOI 10.1016/0143-4160(89)90071-7; MOLENAAR D, 1992, J BACTERIOL, V174, P3118, DOI 10.1128/jb.174.10.3118-3124.1992; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; Peersen OB, 1997, PROTEIN SCI, V6, P794; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; PROCYSHYN RM, 1994, J BIOL CHEM, V269, P1641; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Putman M, 2001, MICROBIOL-SGM, V147, P2873, DOI 10.1099/00221287-147-10-2873; ROSEN BP, 1974, P NATL ACAD SCI USA, V71, P5042, DOI 10.1073/pnas.71.12.5042; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; Shilling R, 2005, FASEB J, V19, P1698, DOI 10.1096/fj.04-3558fje; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TISA LS, 1995, P NATL ACAD SCI USA, V92, P10777, DOI 10.1073/pnas.92.23.10777; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2000, PRACT APPROACH SER, P141; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Yang JJ, 2003, PROTEIN PEPTIDE LETT, V10, P331, DOI 10.2174/0929866033478852; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093; Yokota A, 2000, J BACTERIOL, V182, P5196, DOI 10.1128/JB.182.18.5196-5201.2000	45	20	22	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27682	27690		10.1074/jbc.M112.372334	http://dx.doi.org/10.1074/jbc.M112.372334			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730320	Green Published, hybrid			2022-12-25	WOS:000307840700042
J	Awasthi, M; Batra, J; Kateriya, S				Awasthi, Mayanka; Batra, Jyoti; Kateriya, Suneel			Disulphide Bridges of Phospholipase C of Chlamydomonas reinhardtii Modulates Lipid Interaction and Dimer Stability	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; MEMBRANE; BINDING; ACTIVATION; DIMERIZATION; REQUIRES; MODEL; STATE; BETA	Background: Phospholipase C (PLC) is an enzyme that plays pivotal role in a number of signaling cascades. These are active in the plasma membrane and triggers cellular responses by catalyzing the hydrolysis of membrane phospholipids and thereby generating the secondary messengers. Phosphatidylinositol-PLC (PI-PLC) specifically interacts with phosphoinositide and/or phosphoinositol and catalyzes specific cleavage of sn-3- phosphodiester bond. Several isoforms of PLC are known to form and function as dimer but very little is known about the molecular basis of the dimerization and its importance in the lipid interaction. Principal Findings: We herein report that, the disruption of disulphide bond of a novel PI-specific PLC of C. reinhardtii (CrPLC) can modulate its interaction affinity with a set of phospholipids and also the stability of its dimer. CrPLC was found to form a mixture of higher oligomeric states with monomer and dimer as major species. Dimer adduct of CrPLC disappeared in the presence of DTT, which suggested the involvement of disulphide bond(s) in CrPLC oligomerization. Dimer-monomer equilibrium studies with the isolated fractions of CrPLC monomer and dimer supported the involvement of covalent forces in the dimerization of CrPLC. A disulphide bridge was found to be responsible for the dimerization and Cys7 seems to be involved in the formation of the disulphide bond. This crucial disulphide bond also modulated the lipid affinity of CrPLC. Oligomers of CrPLC were also captured in in vivo condition. CrPLC was mainly found to be localized in the plasma membrane of the cell. The cell surface localization of CrPLC may have significant implication in the downstream regulatory function of CrPLC. Significance: This study helps in establishing the role of CrPLC (or similar proteins) in the quaternary structure of the molecule its affinities during lipid interactions.	[Awasthi, Mayanka; Batra, Jyoti; Kateriya, Suneel] Univ Delhi, Dept Biochem, New Delhi, India	University of Delhi	Awasthi, M (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	skateriya@south.du.ac.in	Batra, Jyoti/ABI-2086-2020; AWASTHI, MAYANKA/J-1219-2019	AWASTHI, MAYANKA/0000-0002-4395-0589; Kateriya, Suneel/0000-0001-5428-4297	DBT, Govt. of India [BT/PR9090/BRB/10/540/2007]	DBT, Govt. of India(Department of Biotechnology (DBT) India)	This study was carried out with the financial support of the DBT (http://dbtindia.nic.in/index.asp), Govt. of India to SK (BT/PR9090/BRB/10/540/2007) for carrying basic research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Arisz SA, 2011, J LIPID RES, V52, P2012, DOI 10.1194/jlr.M016873; BANNO Y, 1994, FEBS LETT, V340, P185, DOI 10.1016/0014-5793(94)80134-7; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Blazer-Yost BL, 2005, PFLUG ARCH EUR J PHY, V450, P75, DOI 10.1007/s00424-004-1371-5; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Dabdoub A, 1999, J NEUROSCI, V19, P10262; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; EICHWALD C, 1993, BIOPHYS J, V65, P2047, DOI 10.1016/S0006-3495(93)81236-0; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Fariselli P, 1999, PROTEINS, V36, P340; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Han JM, 2002, MOL BIOL CELL, V13, P3976, DOI 10.1091/mbc.E02-02-0100; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; HOKIN MR, 1953, J BIOL CHEM, V203, P967; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; Katan Matilda, 2005, Biochem J, V391, pe7; Kingma RL, 2002, EUR J BIOCHEM, V269, P2178, DOI 10.1046/j.1432-1033.2002.02873.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; MORIYAMA T, 1990, J BIOCHEM-TOKYO, V108, P414, DOI 10.1093/oxfordjournals.jbchem.a123215; Nomikos M, 2011, J CELL SCI, V124, P2582, DOI 10.1242/jcs.083485; Paterson HF, 1995, BIOCHEM J, V312, P661, DOI 10.1042/bj3120661; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; QUARMBY LM, 1992, J CELL BIOL, V116, P737, DOI 10.1083/jcb.116.3.737; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; ROMERO G, 1987, J BIOL CHEM, V262, P13476; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zhang X, 2004, J BIOL CHEM, V279, P20490, DOI 10.1074/jbc.M401016200	37	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39258	10.1371/journal.pone.0039258	http://dx.doi.org/10.1371/journal.pone.0039258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737232	gold, Green Published, Green Submitted			2022-12-25	WOS:000305695100030
J	Lin, F; Li, R; Pan, ZX; Zhou, B; Yu, DB; Wang, XG; Ma, XS; Han, J; Shen, M; Liu, HL				Lin, Fei; Li, Ran; Pan, Zeng Xiang; Zhou, Bo; Yu, De Bing; Wang, Xu Guang; Ma, Xue Shan; Han, Jing; Shen, Ming; Liu, Hong Lin			miR-26b Promotes Granulosa Cell Apoptosis by Targeting ATM during Follicular Atresia in Porcine Ovary	PLOS ONE			English	Article							PIG OVARIES; SKELETAL-MUSCLE; MICRORNA TRANSCRIPTOME; EXPRESSION; FOLLICLES; CANCER; DEATH; PROTEIN; LIGAND; DNA	More than 99% of ovarian follicles undergo atresia in mammals, but the mechanism of follicular atresia remains to be elucidated. In this study, we explored microRNA (miRNA) regulation of follicular atresia in porcine ovary. A miRNA expression profile was constructed for healthy, early atretic, and progressively atretic follicles, and the differentially expressed miRNAs were selected and analyzed. We found that miR-26b, which was upregulated during follicular atresia, increased the number of DNA breaks and promoted granulosa cell apoptosis by targeting the ataxia telangiectasia mutated gene directly in vitro.	[Lin, Fei; Li, Ran; Pan, Zeng Xiang; Zhou, Bo; Yu, De Bing; Wang, Xu Guang; Ma, Xue Shan; Han, Jing; Shen, Ming; Liu, Hong Lin] Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Lin, F (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China.	liuhonglin@263.net	Zhou, Bo/AFL-8720-2022; Lin, Fei/AEI-9957-2022; liu, honglin/HDN-0409-2022	Zhou, Bo/0000-0003-2857-8536; liu, honglin/0000-0002-1254-3163	Key Project of Chinese National Programs for Fundamental Research and Development (973 Program) [2007CB947403]; Chinese National Natural Science Fund [30901027]; Research Fund for the Doctoral Program of Higher Education of China [20090097120043]	Key Project of Chinese National Programs for Fundamental Research and Development (973 Program)(National Basic Research Program of China); Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by the Key Project of Chinese National Programs for Fundamental Research and Development (973 Program No. 2007CB947403). This work was also supported by Chinese National Natural Science Fund (No. 30901027); this activity was funded with a Research Fund for the Doctoral Program of Higher Education of China (No. 20090097120043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2005, SCIENCE, V308, P510, DOI 10.1126/science.1112069; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; ARENDS MJ, 1990, AM J PATHOL, V136, P593; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; BJERSING L, 1967, Z ZELLFORSCH MIK ANA, V82, P173, DOI 10.1007/BF01901700; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bortul R, 2003, LEUKEMIA, V17, P379, DOI 10.1038/sj.leu.2402793; CARSON RS, 1979, BIOL REPROD, V21, P75, DOI 10.1095/biolreprod21.1.75; Cheng Y, 2008, J REPROD DEVELOP, V54, P454, DOI 10.1262/jrd.20088; Chun SY, 1996, SEMIN REPROD ENDOCR, V14, P197, DOI 10.1055/s-2007-1016329; Craig J, 2007, FRONT BIOSCI-LANDMRK, V12, P3628, DOI 10.2741/2339; DAILEY RA, 1975, J ANIM SCI, V41, P835, DOI 10.2527/jas1975.413835x; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; GUTHRIE HD, 1995, BIOL REPROD, V52, P920, DOI 10.1095/biolreprod52.4.920; HAY MF, 1976, CELL TISSUE RES, V169, P515, DOI 10.1007/BF00218150; Hillier SG, 1997, BAILLIERE CLIN OB GY, V11, P249, DOI 10.1016/S0950-3552(97)80036-3; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; HUTZ RJ, 1990, J MED PRIMATOL, V19, P553; Inoue N, 2003, J REPROD DEVELOP, V49, P313; Inoue N, 2006, J REPROD DEVELOP, V52, P723, DOI 10.1262/jrd.18043; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim J, 2010, MOL BIOL REP, V37, P3567, DOI 10.1007/s11033-010-0005-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Ma Y. L, 2010, J CELL MOL MED; Maeda A, 2007, J REPROD DEVELOP, V53, P481, DOI 10.1262/jrd.18149; Makrigiannakis A, 2000, ANN NY ACAD SCI, V900, P46; Manabe N, 2008, REPROD DOMEST ANIM, V43, P268, DOI 10.1111/j.1439-0531.2008.01172.x; Manabe N, 1996, EXPERIENTIA, V52, P647, DOI 10.1007/BF01925566; Matsuda-Minehata F, 2006, J REPROD DEVELOP, V52, P695, DOI 10.1262/jrd.18069; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Nakayama M, 2003, BIOL REPROD, V68, P530, DOI 10.1095/biolreprod.102.004820; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rolaki A, 2005, REPROD BIOMED ONLINE, V11, P93, DOI 10.1016/S1472-6483(10)61304-1; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	52	106	127	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38640	10.1371/journal.pone.0038640	http://dx.doi.org/10.1371/journal.pone.0038640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737216	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100014
J	Zhang, FJ; Peng, DH; Ye, XB; Yu, ZQ; Hu, ZF; Ruan, LF; Sun, M				Zhang, Fengjuan; Peng, Donghai; Ye, Xiaobo; Yu, Ziquan; Hu, Zhenfei; Ruan, Lifang; Sun, Ming			In Vitro Uptake of 140 kDa Bacillus thuringiensis Nematicidal Crystal Proteins by the Second Stage Juvenile of Meloidogyne hapla	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; GREEN-FLUORESCENT PROTEIN; ARABIDOPSIS-THALIANA; FEEDING CELLS; RESISTANCE; PLANTS; EXPRESSION; TOXICITY; PARASITISM; INCOGNITA	Plant-parasitic nematodes (PPNs) are piercing/sucking pests, which cause severe damage to crops worldwide, and are difficult to control. The cyst and root-knot nematodes (RKN) are sedentary endoparasites that develop specialized multinucleate feeding structures from the plant cells called syncytia or giant cells respectively. Within these structures the nematodes produce feeding tubes, which act as molecular sieves with exclusion limits. For example, Heterodera schachtii is reportedly unable to ingest proteins larger than 28 kDa. However, it is unknown yet what is the molecular exclusion limit of the Meloidogyne hapla. Several types of Bacillus thuringiensis crystal proteins showed toxicity to M. hapla. To monitor the entry pathway of crystal proteins into M. hapla, second-stage juveniles (J2) were treated with NHS-rhodamine labeled nematicidal crystal proteins (Cry55Aa, Cry6Aa, and Cry5Ba). Confocal microscopic observation showed that these crystal proteins were initially detected in the stylet and esophageal lumen, and subsequently in the gut. Western blot analysis revealed that these crystal proteins were modified to different molecular sizes after being ingested. The uptake efficiency of the crystal proteins by the M. hapla J2 decreased with increasing of protein molecular mass, based on enzyme-linked immunosorbent assay analysis. Our discovery revealed 140 kDa nematicidal crystal proteins entered M. hapla J2 via the stylet, and it has important implications in designing a transgenic resistance approach to control RKN.	[Zhang, Fengjuan; Peng, Donghai; Ye, Xiaobo; Yu, Ziquan; Hu, Zhenfei; Ruan, Lifang; Sun, Ming] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Zhang, FJ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015; Peng, donghai/O-7259-2016	Ming, Sun/0000-0001-5465-5983; Peng, donghai/0000-0002-4918-2357	National High Technology Research and Development Program (863) of China [2011AA10A203, 2006AA02Z174]; National Basic Research Program (973) of China [2009CB118902]; National Natural Science Foundation of China [30870066]; Genetically Modified Organisms Breeding Major Projects of China [2009ZX08009-032B]; China 948 Program of Ministry of Agriculture [2011-G25]; Ministry of Forestry [2006-4-41]; Technology Program of Wuhan [200850731360]	National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China); National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Projects of China; China 948 Program of Ministry of Agriculture; Ministry of Forestry; Technology Program of Wuhan	This study was supported by the National High Technology Research and Development Program (863) of China (2011AA10A203 and 2006AA02Z174), the National Basic Research Program (973) of China (2009CB118902), the National Natural Science Foundation of China (30870066), the Genetically Modified Organisms Breeding Major Projects of China (2009ZX08009-032B), China 948 Program of Ministry of Agriculture (2011-G25) and Ministry of Forestry (2006-4-41) and the Technology Program of Wuhan (200850731360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MH, 1959, BACTERIOPHAGES, P446; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Bischof Larry J., 2006, V351, P139; BOCKENHOFF A, 1994, PARASITOLOGY, V109, P249, DOI 10.1017/S003118200007637X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JW, 2009, BIOCHEM J, V424, P191, DOI 10.1042/BJ20090730; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Curtis RHC, 2008, PARASITE, V15, P310, DOI 10.1051/parasite/2008153310; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; El-Alfy AT, 2002, TOXICOL SCI, V68, P381, DOI 10.1093/toxsci/68.2.381; Fang SL, 2009, APPL ENVIRON MICROB, V75, P5237, DOI 10.1128/AEM.00532-09; Goverse A, 1998, PHYSIOL MOL PLANT P, V52, P275, DOI 10.1006/pmpp.1998.0154; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Guo SX, 2008, APPL ENVIRON MICROB, V74, P6997, DOI 10.1128/AEM.01346-08; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; HUSSEY RS, 1991, PROTOPLASMA, V162, P99, DOI 10.1007/BF02562553; Li XQ, 2008, BIOL CONTROL, V47, P97, DOI 10.1016/j.biocontrol.2008.06.007; Li XQ, 2007, PLANT BIOTECHNOL J, V5, P455, DOI 10.1111/j.1467-7652.2007.00257.x; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Peng DH, 2011, MICROB BIOTECHNOL, V4, P794, DOI 10.1111/j.1751-7915.2011.00295.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Tian B, 2007, FEMS MICROBIOL ECOL, V61, P197, DOI 10.1111/j.1574-6941.2007.00349.x; Urwin PE, 1997, MOL PLANT MICROBE IN, V10, P394, DOI 10.1094/MPMI.1997.10.3.394; Urwin PE, 2000, MOL BREEDING, V6, P257, DOI 10.1023/A:1009669325944; Yu ZQ, 2008, J MICROBIOL BIOTECHN, V18, P1033	29	41	44	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38534	10.1371/journal.pone.0038534	http://dx.doi.org/10.1371/journal.pone.0038534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737212	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100009
J	Aliota, MT; Jones, SA; Dupuis, AP; Ciota, AT; Hubalek, Z; Kramer, LD				Aliota, Matthew T.; Jones, Susan A.; Dupuis, Alan P., II; Ciota, Alexander T.; Hubalek, Zdenek; Kramer, Laura D.			Characterization of Rabensburg Virus, a Flavivirus Closely Related to West Nile Virus of the Japanese Encephalitis Antigenic Group	PLOS ONE			English	Article							CULEX-PIPIENS DIPTERA; VECTOR COMPETENCE; VERTICAL TRANSMISSION; DC-SIGN; IDENTIFICATION; CULICIDAE; MOSQUITOS; ASSAY; GENE; GLYCOSYLATION	Rabensburg virus (RABV), a Flavivirus with similar to 76% nucleotide and 90% amino acid identity with representative members of lineage one and two West Nile virus (WNV), previously was isolated from Culex pipiens and Aedes rossicus mosquitoes in the Czech Republic, and phylogenetic and serologic analyses demonstrated that it was likely a new lineage of WNV. However, no direct link between RABV and human disease has been definitively established and the extent to which RABV utilizes the typical WNV transmission cycle is unknown. Herein, we evaluated vector competence and capacity for vertical transmission (VT) in Cx. pipiens; in vitro growth on avian, mammalian, and mosquito cells; and infectivity and viremia production in birds. RABV infection and replication only were detected on mosquito cells. Experimentally inoculated birds did not become infected. Cx. pipiens had poor peroral vector competence and a higher VT rate as compared to US-WNV in Cx. pipiens. As a result, we postulate that RABV is an intermediate between the mosquito-specific and horizontally transmitted flaviviruses.	[Aliota, Matthew T.; Jones, Susan A.; Dupuis, Alan P., II; Ciota, Alexander T.; Kramer, Laura D.] Hlth Wadsworth Ctr, Arbovirus Labs, New York State Dept, Slingerlands, NY USA; [Hubalek, Zdenek] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	Wadsworth Center; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Aliota, MT (corresponding author), Hlth Wadsworth Ctr, Arbovirus Labs, New York State Dept, Slingerlands, NY USA.	kramer@wadsworth.org	Hubalek, Zdenek/AAF-8071-2019; Aliota, Matthew/AAS-6376-2021; Hubalek, Zdenek/G-1111-2014; Ciota, Alexander/E-1634-2017	Hubalek, Zdenek/0000-0003-4732-0987; Ciota, Alexander/0000-0001-6589-4728; Aliota, Matthew/0000-0002-6902-9149; Dupuis, Alan/0000-0003-0703-9250	Wadsworth Center Biodefense and Emerging Infectious Disease postdoctoral fellowship, NIH [T32-AIO55429]	Wadsworth Center Biodefense and Emerging Infectious Disease postdoctoral fellowship, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MTA is supported by the Wadsworth Center Biodefense and Emerging Infectious Disease postdoctoral fellowship, NIH T32-AIO55429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2006, J INFECT DIS, V194, P1577, DOI 10.1086/508754; Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Blitvich BJ, 2001, J GEN VIROL, V82, P2251, DOI 10.1099/0022-1317-82-9-2251; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C; Charrel RN, 2003, VIROLOGY, V315, P381, DOI 10.1016/S0042-6822(03)00536-1; Ciota AT, 2008, J GEN VIROL, V89, P1633, DOI 10.1099/vir.0.2008/000893-0; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; Dohm DJ, 2002, J MED ENTOMOL, V39, P640, DOI 10.1603/0022-2585-39.4.640; Ebel GD, 2005, J MED ENTOMOL, V42, P838, DOI 10.1603/0022-2585(2005)042[0838:CRDCRA]2.0.CO;2; Ebel GD, 2002, EMERG INFECT DIS, V8, P979, DOI 10.3201/eid0809.020152; Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Gu WD, 2003, J MED ENTOMOL, V40, P595, DOI 10.1603/0022-2585-40.5.595; Hubalek Z, 2010, J MED ENTOMOL, V47, P466, DOI 10.1603/ME09219; Hubalek Z, 1998, ACTA VIROL, V42, P119; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P427, DOI 10.1089/vim.2000.13.427; Hubalek Z, 1999, EMERG INFECT DIS, V5, P594, DOI 10.3201/eid0504.990430; Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029; Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x; Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005; Kilpatrick AM, 2010, VECTOR-BORNE ZOONOT, V10, P377, DOI 10.1089/vbz.2009.0029; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lvov DK, 2004, ARCH VIROL, P85; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; MELNICK JL, 1951, P SOC EXP BIOL MED, V77, P661, DOI 10.3181/00379727-77-18884; Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Prilipov A. G., 2002, Voprosy Virusologii, V47, P36; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; SCHLESINGER S, 1985, VIRUS RES, V2, P139, DOI 10.1016/0168-1702(85)90244-8; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; vanDinten LC, 1997, P NATL ACAD SCI USA, V94, P991, DOI 10.1073/pnas.94.3.991; Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112	46	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39387	10.1371/journal.pone.0039387	http://dx.doi.org/10.1371/journal.pone.0039387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724010	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700075
J	Burger-van Paassen, N; Loonen, LMP; Witte-Bouma, J; Korteland-van Male, AM; de Bruijn, ACJM; van der Sluis, M; Lu, P; Van Goudoever, JB; Wells, JM; Dekker, J; Van Seuningen, I; Renes, IB				Burger-van Paassen, Nanda; Loonen, Linda M. P.; Witte-Bouma, Janneke; Korteland-van Male, Anita M.; de Bruijn, Adrianus C. J. M.; van der Sluis, Maria; Lu, Peng; Van Goudoever, Johannes B.; Wells, Jerry M.; Dekker, Jan; Van Seuningen, Isabelle; Renes, Ingrid B.			Mucin Muc2 Deficiency and Weaning Influences the Expression of the Innate Defense Genes Reg3 beta, Reg3 gamma and Angiogenin-4	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LECTIN REGIII-GAMMA; PANETH CELLS; INTERLEUKIN-10-DEFICIENT MICE; NECROTIZING ENTEROCOLITIS; GASTROINTESTINAL-TRACT; BACTERICIDAL LECTIN; EPITHELIAL-CELLS; SOLUBLE CD14; HUMAN-MILK	Background: Mucin Muc2 is the structural component of the intestinal mucus layer. Absence of Muc2 leads to loss of this layer allowing direct bacterial-epithelial interactions. We hypothesized that absence of the mucus layer leads to increased expression of innate defense peptides. Specifically, we aimed to study the consequence of Muc2 deficiency (Muc2(-/-)) on the expression of regenerating islet-derived protein 3 beta (Reg3 beta), regenerating islet-derived protein 3 gamma (Reg3 gamma), and angiogenin-4 (Ang4) in the intestine shortly before and after weaning. Methods: Intestinal tissues of Muc2(-/-) and wild-type (WT) mice were collected at postnatal day 14 (P14, i.e. pre-weaning) and P28 (i.e. post-weaning). Reg3 beta, Reg3 gamma, and Ang4 expression was studied by quantitative real-time PCR, Western-blot, in situ hybridization, and immunohistochemistry. Results: Reg3 beta and Reg3 gamma were expressed by diverging epithelial cell types; namely enterocytes, Paneth cells, and goblet cells. Additionally, Ang4 expression was confined to Paneth cells and goblet cells. Expression of Reg3 beta, Reg3 gamma, and Ang4 differed between WT and Muc2(-/-) mice before and after weaning. Interestingly, absence of Muc2 strongly increased Reg3 beta and Reg3 gamma expression in the small intestine and colon. Finally, morphological signs of colitis were only observed in the distal colon of Muc2(-/-) mice at P28, where and when expression levels of Reg3 beta, Reg3 gamma, and Ang4 were the lowest. Conclusions: Expression of Reg3 proteins and Ang4 by goblet cells point to an important role for goblet cells in innate defense. Absence of Muc2 results in up-regulation of Reg3 beta and Reg3 gamma expression, suggesting altered bacterial-epithelial signaling and an innate defense response in Muc2(-/-) mice. The inverse correlation between colitis development and Reg3 beta, Reg3 gamma, and Ang4 expression levels might point toward a role for these innate defense peptides in regulating intestinal inflammation.	[Burger-van Paassen, Nanda; Witte-Bouma, Janneke; Korteland-van Male, Anita M.; de Bruijn, Adrianus C. J. M.; van der Sluis, Maria; Lu, Peng; Van Goudoever, Johannes B.; Renes, Ingrid B.] Erasmus MC Sophia, Pediat Lab, Div Neonatol, Rotterdam, Netherlands; [Loonen, Linda M. P.; Wells, Jerry M.] Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands; [Loonen, Linda M. P.; Wells, Jerry M.; Dekker, Jan] Top Inst Food & Nutr, Wageningen, Netherlands; [Dekker, Jan] Wageningen UR, Dept Anim Sci, Wageningen, Netherlands; [Van Seuningen, Isabelle] Jean Pierre Aubert Res Ctr, Team Mucins Epithelial Differentiat & Carcinogene, INSERM, U837, Lille, France	Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Top Institute Food & Nutrition; Wageningen University & Research; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Burger-van Paassen, N (corresponding author), Erasmus MC Sophia, Pediat Lab, Div Neonatol, Rotterdam, Netherlands.	i.renes@erasmusmc.nl	VAN SEUNINGEN, Isabelle/N-6176-2016; van Goudoever, Johannes Bernard/Y-4520-2018; Renes, Ingrid/C-4801-2013	VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; Loonen, Linda MP/0000-0003-0935-2494				Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Dessein R, 2009, GUT, V58, P771, DOI 10.1136/gut.2008.168443; Filipp D, 2001, P NATL ACAD SCI USA, V98, P603, DOI 10.1073/pnas.98.2.603; Folch-Puy E, 2006, J IMMUNOL, V176, P3774, DOI 10.4049/jimmunol.176.6.3774; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; JACOBS LR, 1985, J CLIN INVEST, V75, P112, DOI 10.1172/JCI111662; Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jonckheere N, 2007, J BIOL CHEM, V282, P22638, DOI 10.1074/jbc.M700905200; Krimi RB, 2008, INFLAMM BOWEL DIS, V14, P931, DOI 10.1002/ibd.20420; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Labeta MO, 2000, J EXP MED, V191, P1807, DOI 10.1084/jem.191.10.1807; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Renes IB, 2002, J PATHOL, V198, P60, DOI 10.1002/path.1183; Rodenburg W, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-84; Schaart MW, 2009, J PEDIAT GASTROENTER; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Tytgat KMAJ, 1996, BIOCHEM BIOPH RES CO, V224, P397, DOI 10.1006/bbrc.1996.1039; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Ampting MTJ, 2012, INFECT IMMUN, V80, P1115, DOI 10.1128/IAI.06165-11; van Ampting MT, 2009, DIG DIS SCI; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Verburg M, 2000, AM J PHYSIOL-GASTR L, V279, pG1037, DOI 10.1152/ajpgi.2000.279.5.G1037; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	43	55	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38798	10.1371/journal.pone.0038798	http://dx.doi.org/10.1371/journal.pone.0038798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723890	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700031
J	Ma, RM; Yan, W; Zhang, GJ; Lv, H; Liu, ZZ; Fang, F; Zhang, W; Zhang, JX; Tao, T; You, YP; Jiang, T; Kang, XX				Ma, Ruimin; Yan, Wei; Zhang, Guojun; Lv, Hong; Liu, Zhizhong; Fang, Fang; Zhang, Wei; Zhang, Junxia; Tao, Tao; You, Yongping; Jiang, Tao; Kang, Xixiong			Upregulation of miR-196b Confers a Poor Prognosis in Glioblastoma Patients via Inducing a Proliferative Phenotype	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MICRORNA EXPRESSION; GLIOMA-CELLS; THERAPY; OVEREXPRESSION; PROFILES; PATHWAY; CANCER; GENES; MLL	Purpose: To explore the expression pattern, prognostic value and functional role of miR-196b in glioblastoma (GBM) patients using large cohorts. Experimental Design: MiR-196b expression was measured using the Human v2.0 miRNA Expression BeadChip (Illumina) in 198 frozen glioma tissues. The expression levels of miR-196b were also validated in an independent cohort containing 128 formalin-fixed paraffin-embedded (FFPE) glioma samples using qRT-PCR. The presence of other molecular prognostic indicators was assessed centrally in the glioma samples. Whole genome gene profiling was performed to investigate the underlying biological behavior. MiR-196b functional analyses were performed in U87 and U251 cell lines. Results: The expression levels of miR-196b were inversely correlated with overall survival in GBM patients. Gene set enrichment analysis (GSEA) showed that the gene sets relating to cell cycle were significantly enriched in the cases with miR-196b overexpression. Functional analyses in U87 and U251 cells revealed that miR-196b was involved in cell proliferation. Conclusions: MiR-196b is overexpressed and confers a poor prognosis via promoting cellular proliferation in GBM patients.	[Ma, Ruimin; Zhang, Guojun; Lv, Hong; Liu, Zhizhong; Fang, Fang; Kang, Xixiong] Capital Med Univ, Beijing Tiantan Hosp, Lab Diag Ctr, Beijing, Peoples R China; [Yan, Wei; Zhang, Wei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Zhang, Junxia; Tao, Tao; You, Yongping] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Capital Medical University; Capital Medical University; Nanjing Medical University	Ma, RM (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Lab Diag Ctr, Beijing, Peoples R China.	yypl9@njmu.edu.cn; taojiang1964@yahoo.com.cn; clinical_lab@126.com	jiang, tao/GWC-7108-2022; Jiang, Tao/N-8142-2014		National Key Project of Science and Technology Supporting Programs of China [2007BAI05B08]; National Natural Science Foundation of China [30772238, 30730035]	National Key Project of Science and Technology Supporting Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Key Project of Science and Technology Supporting Programs of China (No. 2007BAI05B08) and National Natural Science Foundation of China (No. 30772238 and 30730035, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bhatia S, 2011, MOL CELL BIOCHEM, V346, P103, DOI 10.1007/s11010-010-0597-0; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Coskun E, 2011, LEUKEMIA RES, V35, P208, DOI 10.1016/j.leukres.2010.05.007; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; Ganesan S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001946; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Liu AH, 2011, METHODS MOL BIOL, V724, P259, DOI 10.1007/978-1-61779-055-3_16; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Popovic R, 2009, BLOOD, V113, P3314, DOI 10.1182/blood-2008-04-154310; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schotte D, 2010, HAEMATOL-HEMATOL J, V95, P1675, DOI 10.3324/haematol.2010.023481; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Tin AS, 2011, ANTICANCER DRUGS; Tsai KW, 2010, GENE CHROMOSOME CANC, V49, P969, DOI 10.1002/gcc.20804; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Yan W, 2011, BRAIN RES, V1411, P108, DOI 10.1016/j.brainres.2011.07.002; Zhang W, 2009, CHINESE MED J-PEKING, V122, P1250, DOI 10.3760/cma.j.issn.0366-6999.2009.11.003; Zhou CZ, 2008, CHINESE MED J-PEKING, V121, P2479, DOI 10.1097/00029330-200812020-00003; Zuo Z, 2011, BLOOD, V118, P413, DOI 10.1182/blood-2011-01-330704	32	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38096	10.1371/journal.pone.0038096	http://dx.doi.org/10.1371/journal.pone.0038096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723849	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700011
J	Mohr, M; Nybo, L; Grantham, J; Racinais, S				Mohr, Magni; Nybo, Lars; Grantham, Justin; Racinais, Sebastien			Physiological Responses and Physical Performance during Football in the Heat	PLOS ONE			English	Article							PREMIER LEAGUE SOCCER; EXERCISE PERFORMANCE; SPRINT PERFORMANCE; MUSCLE TEMPERATURE; PROLONGED EXERCISE; SIDED GAMES; FATIGUE; TIME; HYPERTHERMIA; MATCHES	Purpose: To examine the impact of hot ambient conditions on physical performance and physiological responses during football match-play. Methods: Two experimental games were completed in temperate (similar to 21 degrees C; CON) and hot ambient conditions (similar to 43 degrees C; HOT). Physical performance was assessed by match analysis in 17 male elite players during the games and a repeated sprint test was conducted after the two game trials. Core and muscle temperature were measured and blood samples were obtained, before and after the games. Results: Muscle and core temperatures were similar to 1 degrees C higher (P<0.05) in HOT (40.3=0.1 and 39.5=0.1 degrees C, respectively) compared to CON (39.2=0.1 and 38.3=0.1 degrees C). Average heart rate, plasma lactate concentration, body weight loss as well as post-game sprint performance were similar between the two conditions. Total game distance declined (P<0.05) by 7% and high intensity running (>14 km.h(-1)) by 26% in HOT compared to CON), but peak sprint speed was 4% higher (P<0.05) in HOT than in CON, while there were no differences in the quantity or length of sprints (>24 km.h(-1)) between CON and HOT. In HOT, success rates for passes and crosses were 8 and 9% higher (P<0.05), respectively, compared to CON. Delta increase in core temperature and absolute core temperature in HOT were correlated to total game distance in the heat (r = 0.85 and r = 0.53, respectively; P<0.05), whereas, total and high intensity distance deficit between CON and HOT were not correlated to absolute or delta changes in muscle or core temperature. Conclusion: Total game distance and especially high intensity running were lower during a football game in the heat, but these changes were not directly related to the absolute or relative changes in core or muscle temperature. However, peak sprinting speed and execution of successful passes and crosses were improved in the HOT condition.	[Mohr, Magni] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Nybo, Lars] Univ Copenhagen, Sect Human Physiol, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Grantham, Justin; Racinais, Sebastien] Qatar Orthopaed & Sports Med Hosp, Res & Educ Ctr, Aspetar, Doha, Qatar	University of Exeter; University of Copenhagen; Aspetar Orthopaedic & Sports Medicine Hospital	Mohr, M (corresponding author), Univ Exeter, Coll Life & Environm Sci, St Lukes Campus, Exeter, Devon, England.	M.Mohr@exeter.ac.uk	Racinais, Sebastien/N-3052-2019; Nybo, Lars/P-6153-2014	Nybo, Lars/0000-0002-9090-1958	Aspetar, Qatar Orthopaedic and Sport Medicine Hospital	Aspetar, Qatar Orthopaedic and Sport Medicine Hospital	The study was funded and supported by Aspetar, Qatar Orthopaedic and Sport Medicine Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2008, J SPORT SCI, V26, P113, DOI 10.1080/02640410701422076; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bendiksen M, 2012, MED SCI SPORTS 0210; Bradley PS, 2011, J SPORT SCI, V29, P821, DOI 10.1080/02640414.2011.561868; Dellal A, 2011, J STRENGTH COND RES, V25, P2371, DOI 10.1519/JSC.0b013e3181fb4296; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Edwards B, 2002, CHRONOBIOL INT, V19, P579, DOI 10.1081/CBI-120004227; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; Gaoua N, 2011, INT J HYPERTHER, V27, P1, DOI 10.3109/02656736.2010.519371; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1165, DOI 10.1249/01.mss.0000222845.89262.cd; McKenna MJ, 2008, J APPL PHYSIOL, V104, P288, DOI 10.1152/japplphysiol.01037.2007; McKenzie JE, 2004, J THERM BIOL, V29, P605, DOI 10.1016/j.jtherbio.2004.08.020; Mohr M, 2006, EUR J APPL PHYSIOL, V97, P89, DOI 10.1007/s00421-006-0152-6; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Mohr M, 2004, SCAND J MED SCI SPOR, V14, P156, DOI 10.1111/j.1600-0838.2004.00349.x; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Mohr M, 2010, SCAND J MED SCI SPOR, V20, P125, DOI 10.1111/j.1600-0838.2010.01217.x; Mohr M, 2012, J STRENGTH IN PRESS; Morante SM, 2008, BRIT J SPORT MED, V42, P679, DOI 10.1136/bjsm.2007.042499; Nielsen B, 2003, SPORTS MED, V33, P1, DOI 10.2165/00007256-200333010-00001; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Nybo L, 2010, SCAND J MED SCI SPOR, V20, P71, DOI 10.1111/j.1600-0838.2010.01211.x; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; Nybo L, 2008, J APPL PHYSIOL, V104, P871, DOI 10.1152/japplphysiol.00910.2007; Owen AL, 2011, J STRENGTH COND RES, V25, P2104, DOI 10.1519/JSC.0b013e3181f0a8a3; Ozgunen KT, 2010, SCAND J MED SCI SPOR, V20, P140, DOI 10.1111/j.1600-0838.2010.01219.x; Racinais S, 2005, MED SCI SPORT EXER, V37, P256, DOI 10.1249/01.MSS.0000149885.82163.9F; Racinais S, 2004, CHRONOBIOL INT, V21, P485, DOI 10.1081/CBI-120038632; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P80, DOI 10.1111/j.1600-0838.2010.01212.x; Racinais S, 2012, PSYCHOPHYSIOLOG 0314; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Rampinini E, 2009, J SCI MED SPORT, V12, P227, DOI 10.1016/j.jsams.2007.10.002; Randers MB, 2010, J SPORT SCI, V28, P171, DOI 10.1080/02640410903428525; Tatterson A J, 2000, J Sci Med Sport, V3, P186; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4	38	117	118	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39202	10.1371/journal.pone.0039202	http://dx.doi.org/10.1371/journal.pone.0039202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723963	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700052
J	Xie, J; Xu, GH; Wang, J; Zhang, F; Zhang, YZ				Xie, Jun; Xu, Guanghua; Wang, Jing; Zhang, Feng; Zhang, Yizhuo			Steady-State Motion Visual Evoked Potentials Produced by Oscillating Newton's Rings: Implications for Brain-Computer Interfaces	PLOS ONE			English	Article							ADAPTATION; STIMULI; RESPONSES; TOOLBOX	In this study, we utilize a special visual stimulation protocol, called motion reversal, to present a novel steady-state motion visual evoked potential (SSMVEP)-based BCI paradigm that relied on human perception of motions oscillated in two opposite directions. Four Newton's rings with the oscillating expansion and contraction motions served as visual stimulators to elicit subjects' SSMVEPs. And four motion reversal frequencies of 8.1, 9.8, 12.25 and 14 Hz were tested. According to Canonical Correlation Analysis (CCA), the offline accuracy and ITR (mean +/- standard deviation) over six healthy subjects were 86.56+/-9.63% and 15.93+/-3.83 bits/min, respectively. All subjects except one exceeded the level of 80% mean accuracy. Circular Hotelling's T-Squared test (T-circ(2)) also demonstrated that most subjects exhibited significantly strong stimulus-locked SSMVEP responses. The results of declining exponential fittings exhibited low-adaptation characteristics over the 100-s stimulation sequences in most experimental conditions. Taken together, these results suggest that the proposed paradigm can provide comparable performance with low-adaptation characteristic and less visual discomfort for BCI applications.	[Xie, Jun; Xu, Guanghua; Wang, Jing; Zhang, Feng; Zhang, Yizhuo] Xi An Jiao Tong Univ, Sch Mech Engn, Xian 710049, Shaanxi, Peoples R China; [Xu, Guanghua; Wang, Jing] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Xie, J (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian 710049, Shaanxi, Peoples R China.	xugh@mail.xjtu.edu.cn			National Natural Science Foundation of China [51175412]; Research Fund for the Doctoral Program of Higher Education of China [20110201110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Natural Science Foundation of China (51175412) and the Research Fund for the Doctoral Program of Higher Education of China (20110201110022). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ales JM, 2009, J VISION, V9, DOI 10.1167/9.7.8; Bartley SH, 1939, PSYCHOL REV, V46, P337, DOI 10.1037/h0055565; Bell CJ, 2008, J NEURAL ENG, V5, P214, DOI 10.1088/1741-2560/5/2/012; Bergholz R, 2008, DOC OPHTHALMOL, V116, P217, DOI 10.1007/s10633-007-9085-6; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Capilla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014543; Chakor H, 2005, DOC OPHTHALMOL, V110, P163, DOI 10.1007/s10633-005-3694-8; Delon-Martin C, 2006, NEUROIMAGE, V31, P1567, DOI 10.1016/j.neuroimage.2006.02.013; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Guo F, 2008, J NEURAL ENG, V5, P477, DOI 10.1088/1741-2560/5/4/011; Heinrich S P, 2001, Doc Ophthalmol, V102, P141, DOI 10.1023/A:1017509717071; Heinrich SP, 2003, CLIN NEUROPHYSIOL, V114, P1359, DOI 10.1016/S1388-2457(03)00088-9; Heinrich SP, 2007, DOC OPHTHALMOL, V114, P83, DOI 10.1007/s10633-006-9043-8; Heinrich SP, 2010, DOC OPHTHALMOL, V120, P205, DOI 10.1007/s10633-010-9212-7; HO WA, 1988, VISION RES, V28, P1287, DOI 10.1016/0042-6989(88)90059-4; Hong B, 2009, CLIN NEUROPHYSIOL, V120, P1658, DOI 10.1016/j.clinph.2009.06.026; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Kremlacek J, 2004, DOC OPHTHALMOL, V109, P169, DOI 10.1007/s10633-004-4048-7; KUBA M, 1992, PHYSIOL RES, V41, P369; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Middendorf M, 2000, IEEE T REHABIL ENG, V8, P211, DOI 10.1109/86.847819; Nishiike S, 2002, NEUROREPORT, V13, P1805, DOI 10.1097/00001756-200210070-00023; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; Rebsamen B, 2010, IEEE T NEUR SYS REH, V18, P590, DOI 10.1109/TNSRE.2010.2049862; Regan D., 1989, HUMAN BRAIN ELECTROP; Snowden RJ, 2004, CURR BIOL, V14, pR828, DOI 10.1016/j.cub.2004.09.033; VICTOR JD, 1991, ELECTROEN CLIN NEURO, V78, P378, DOI 10.1016/0013-4694(91)90099-P; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Zhang Y, 2011, BIOMED SIGN IN PRESS; Zhang Y, 2011, LECT NOTES COMPUT SC, V7062, P287, DOI 10.1007/978-3-642-24955-6_35	32	56	62	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39707	10.1371/journal.pone.0039707	http://dx.doi.org/10.1371/journal.pone.0039707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724028	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700088
J	Lim, CK; Hassan, KA; Tetu, SG; Loper, JE; Paulsen, IT				Lim, Chee Kent; Hassan, Karl A.; Tetu, Sasha G.; Loper, Joyce E.; Paulsen, Ian T.			The Effect of Iron Limitation on the Transcriptome and Proteome of Pseudomonas fluorescens Pf-5	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; MESSENGER-RNA; STARVATION RESPONSE; SIGNAL-TRANSDUCTION; COTTON SEEDLINGS; GENOME SEQUENCE; GENE-EXPRESSION; FUMARASE C; AERUGINOSA	One of the most important micronutrients for bacterial growth is iron, whose bioavailability in soil is limited. Consequently, rhizospheric bacteria such as Pseudomonas fluorescens employ a range of mechanisms to acquire or compete for iron. We investigated the transcriptomic and proteomic effects of iron limitation on P. fluorescens Pf-5 by employing microarray and iTRAQ techniques, respectively. Analysis of this data revealed that genes encoding functions related to iron homeostasis, including pyoverdine and enantio-pyochelin biosynthesis, a number of Ton B-dependent receptor systems, as well as some inner-membrane transporters, were significantly up-regulated in response to iron limitation. Transcription of a ribosomal protein L36-encoding gene was also highly up-regulated during iron limitation. Certain genes or proteins involved in biosynthesis of secondary metabolites such as 2,4-diacetylphloroglucinol (DAPG), orfamide A and pyrrolnitrin, as well as a chitinase, were over-expressed under iron-limited conditions. In contrast, we observed that expression of genes involved in hydrogen cyanide production and flagellar biosynthesis were down-regulated in an iron-depleted culture medium. Phenotypic tests revealed that Pf-5 had reduced swarming motility on semi-solid agar in response to iron limitation. Comparison of the transcriptomic data with the proteomic data suggested that iron acquisition is regulated at both the transcriptional and post-transcriptional levels.	[Lim, Chee Kent; Hassan, Karl A.; Tetu, Sasha G.; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Loper, Joyce E.] Oregon State Univ, USDA ARS Hort Crops Res Lab, Corvallis, OR 97331 USA; [Loper, Joyce E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Macquarie University; Oregon State University; Oregon State University	Lim, CK (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	ian.paulsen@mq.edu.au	Tetu, Sasha/C-8760-2013; Paulsen, Ian T/K-3832-2012; Hassan, Karl/B-2802-2013	Paulsen, Ian T/0000-0001-9015-9418; Tetu, Sasha/0000-0002-8943-3499; Loper, Joyce/0000-0003-3501-5969; Hassan, Karl/0000-0003-2031-9679	Macquarie University Research Excellence Scholarship (CKL); Australian Research Council Discovery [DP110102680]	Macquarie University Research Excellence Scholarship (CKL); Australian Research Council Discovery(Australian Research Council)	This study was supported by a Macquarie University Research Excellence Scholarship (CKL) (http://www.hdr.mq.edu.au/information_abou/scholarships) and an Australian Research Council Discovery Grant DP110102680 (to ITP and KAH) (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Akiba N, 2010, APPL ENVIRON MICROB, V76, P3475, DOI 10.1128/AEM.00238-10; Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANGERER A, 1992, J BACTERIOL, V174, P1378, DOI 10.1128/jb.174.4.1378-1387.1992; Basler M, 2006, PROTEOMICS, V6, P6194, DOI 10.1002/pmic.200600312; Blumer C, 2000, MICROBIOL-SGM, V146, P2417, DOI 10.1099/00221287-146-10-2417; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Cha JY, 2012, BIOCHEM BIOPH RES CO, V417, P665, DOI 10.1016/j.bbrc.2011.11.124; Chong PK, 2007, PROTEOMICS, V7, P424, DOI 10.1002/pmic.200600746; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Dandekar T, 1998, BIOINFORMATICS, V14, P271, DOI 10.1093/bioinformatics/14.3.271; Delany I, 2003, MOL MICROBIOL, V50, P1329, DOI 10.1046/j.1365-2958.2003.03757.x; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; ESPUNY MJ, 1991, ANTON LEEUW INT J G, V60, P83, DOI 10.1007/BF00572696; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FUJIWARA T, 1992, J BIOCHEM, V112, P290, DOI 10.1093/oxfordjournals.jbchem.a123893; GarciaAlfonso C, 1996, ARCH ENVIRON CON TOX, V30, P431; Ghysels B, 2004, MICROBIOL-SGM, V150, P1671, DOI 10.1099/mic.0.27035-0; GRANDONI JA, 1989, J BIOL CHEM, V264, P6058; GROSS DC, 1985, J APPL BACTERIOL, V58, P167, DOI 10.1111/j.1365-2672.1985.tb01444.x; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Hard T, 2000, J MOL BIOL, V296, P169, DOI 10.1006/jmbi.1999.3433; Haritha Adhikarla, 2008, BMC Res Notes, V1, P88, DOI 10.1186/1756-0500-1-88; Hartney SL, 2011, BIOMETALS, V24, P193, DOI 10.1007/s10534-010-9385-2; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Hassett DJ, 1997, J BACTERIOL, V179, P1452, DOI 10.1128/jb.179.5.1452-1459.1997; Hassett DJ, 1997, J BACTERIOL, V179, P1442, DOI 10.1128/jb.179.5.1442-1451.1997; HERUTH DP, 1994, J BACTERIOL, V176, P3559, DOI 10.1128/JB.176.12.3559-3567.1994; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoegy F, 2009, J BIOL CHEM, V284, P14949, DOI 10.1074/jbc.M900606200; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; HOWELL CR, 1980, PHYTOPATHOLOGY, V70, P712, DOI 10.1094/Phyto-70-712; Huang X, 2002, FREE RADICAL BIO MED, V32, P84, DOI 10.1016/S0891-5849(01)00770-5; JURAND A, 1971, J EXP ZOOL, V177, P365, DOI 10.1002/jez.1401770311; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kimbrel JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-522; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LALUCAT J, 1982, INT J SYST BACTERIOL, V32, P332, DOI 10.1099/00207713-32-3-332; LINDSAY WL, 1982, J PLANT NUTR, V5, P821, DOI 10.1080/01904168209363012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; LOPER JE, 1991, MOL PLANT MICROBE IN, V4, P5, DOI 10.1094/MPMI-4-005; Loper JE, 2008, APPL ENVIRON MICROB, V74, P3085, DOI 10.1128/AEM.02848-07; Loper JE, 2007, PHYTOPATHOLOGY, V97, P233, DOI 10.1094/PHYTO-97-2-0233; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; MAKAROVA KS, 2001, GENOME BIOL, V2; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; Marschner P, 1998, SOIL BIOL BIOCHEM, V30, P1275, DOI 10.1016/S0038-0717(98)00039-X; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masuda T, 2009, MOL CELL PROTEOMICS, V8, P2770, DOI 10.1074/mcp.M900240-MCP200; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Molina MA, 2005, ENVIRON MICROBIOL, V7, P443, DOI 10.1111/j.1462-2920.2005.00720.x; MORGAN MK, 1988, J BACTERIOL, V170, P5689, DOI 10.1128/jb.170.12.5689-5697.1988; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; MULLIGAN CN, 1989, APPL ENVIRON MICROB, V55, P3016, DOI 10.1128/AEM.55.11.3016-3019.1989; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; NOWAKTHOMPSON B, 1994, CAN J MICROBIOL, V40, P1064, DOI 10.1139/m94-168; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Oglesby-Sherrouse AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009930; Palma M, 2003, ARCH MICROBIOL, V180, P374, DOI 10.1007/s00203-003-0602-z; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Pieper R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-30; Polack B, 1996, BIOCHEM BIOPH RES CO, V226, P555, DOI 10.1006/bbrc.1996.1393; POND FR, 1989, MICROBIOL REV, V53, P25, DOI 10.1128/MMBR.53.1.25-67.1989; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANDERS JD, 1994, INFECT IMMUN, V62, P4515, DOI 10.1128/IAI.62.10.4515-4525.1994; Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296; Schroder I, 2003, FEMS MICROBIOL REV, V27, P427, DOI 10.1016/S0168-6445(03)00043-3; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; Sharifi-Tehrani A, 1998, EUR J PLANT PATHOL, V104, P631, DOI 10.1023/A:1008672104562; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Somerville G, 1999, J BACTERIOL, V181, P1072, DOI 10.1128/JB.181.4.1072-1078.1999; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Stensjo K, 2007, J PROTEOME RES, V6, P621, DOI 10.1021/pr060517v; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suzuki I, 2006, J EXP BOT, V57, P1573, DOI 10.1093/jxb/erj148; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; Taguchi F, 2010, J BACTERIOL, V192, P117, DOI 10.1128/JB.00689-09; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tralau T, 2007, J BACTERIOL, V189, P6743, DOI 10.1128/JB.00889-07; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; WELLS B, 1983, MICRON MICROSC ACTA, V14, P329, DOI 10.1016/0047-7206(83)90004-3; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; XU GW, 1986, PHYTOPATHOLOGY, V76, P414, DOI 10.1094/Phyto-76-414; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200; Youard ZA, 2011, BIOMETALS, V24, P513, DOI 10.1007/s10534-010-9399-9; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zaini PA, 2008, J BACTERIOL, V190, P2368, DOI 10.1128/JB.01495-07; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	120	81	83	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39139	10.1371/journal.pone.0039139	http://dx.doi.org/10.1371/journal.pone.0039139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723948	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300101
J	Grin, B; Mahammad, S; Wedig, T; Cleland, MM; Tsai, L; Herrmann, H; Goldman, RD				Grin, Boris; Mahammad, Saleemulla; Wedig, Tatjana; Cleland, Megan M.; Tsai, Lester; Herrmann, Harald; Goldman, Robert D.			Withaferin A Alters Intermediate Filament Organization, Cell Shape and Behavior	PLOS ONE			English	Article							PROTEIN-KINASE; NEUROFILAMENT PROTEIN; PHOSPHORYLATION SITES; CULTURED FIBROBLASTS; DYNAMIC PROPERTIES; EPITHELIAL-CELLS; VIMENTIN; MICROTUBULES; APOPTOSIS; PERIPHERIN	Withaferin A (WFA) is a steroidal lactone present in Withania somnifera which has been shown in vitro to bind to the intermediate filament protein, vimentin. Based upon its affinity for vimentin, it has been proposed that WFA can be used as an anti-tumor agent to target metastatic cells which up-regulate vimentin expression. We show that WFA treatment of human fibroblasts rapidly reorganizes vimentin intermediate filaments (VIF) into a perinuclear aggregate. This reorganization is dose dependent and is accompanied by a change in cell shape, decreased motility and an increase in vimentin phosphorylation at serine-38. Furthermore, vimentin lacking cysteine-328, the proposed WFA binding site, remains sensitive to WFA demonstrating that this site is not required for its cellular effects. Using analytical ultracentrifugation, viscometry, electron microscopy and sedimentation assays we show that WFA has no effect on VIF assembly in vitro. Furthermore, WFA is not specific for vimentin as it disrupts the cellular organization and induces perinuclear aggregates of several other IF networks comprised of peripherin, neurofilament-triplet protein, and keratin. In cells co-expressing keratin IF and VIF, the former are significantly less sensitive to WFA with respect to inducing perinuclear aggregates. The organization of microtubules and actin/microfilaments is also affected by WFA. Microtubules become wavier and sparser and the number of stress fibers appears to increase. Following 24 hrs of exposure to doses of WFA that alter VIF organization and motility, cells undergo apoptosis. Lower doses of the drug do not kill cells but cause them to senesce. In light of our findings that WFA affects multiple IF systems, which are expressed in many tissues of the body, caution is warranted in its use as an anticancer agent, since it may have debilitating organism-wide effects.	[Grin, Boris; Mahammad, Saleemulla; Cleland, Megan M.; Tsai, Lester; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Wedig, Tatjana; Herrmann, Harald] German Canc Res Ctr, Div Biophys Macromol, D-6900 Heidelberg, Germany	Northwestern University; Feinberg School of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Grin, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	r-goldman@northwestern.edu		Harwig, Megan/0000-0003-2140-5739	National Institute of General Medical Science [1PO1GM096971]; NIH/NHLBI [T32HL076139]; German Research Foundation (DFG) [HE 1853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM096971] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institute of General Medical Science grant 1PO1GM096971. M.M.C. was supported in part by NIH/NHLBI training grant T32HL076139. H.H. was supported by grants from the German Research Foundation (DFG, HE 1853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	About Herbs Botanicals & Other Products: Ashwagandha, 2011, HERBS BOT OTH PROD A; Bandyopadhyay Debdutta, 2005, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1809s27; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; BLOOM GS, 1983, J CELL BIOL, V96, P1523, DOI 10.1083/jcb.96.6.1523; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chang L, 2009, J CELL SCI, V122, P2914, DOI 10.1242/jcs.046789; Chou YH, 1996, J CELL SCI, V109, P817; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; COCHARD P, 1984, J NEUROSCI, V4, P2080; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; ESCURAT M, 1990, J NEUROSCI, V10, P764; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Favre B, 2011, EUR J CELL BIOL, V90, P390, DOI 10.1016/j.ejcb.2010.11.013; FRANKE WW, 1979, J CELL BIOL, V81, P570, DOI 10.1083/jcb.81.3.570; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GILLARD BK, 1994, J CELL SCI, V107, P3545; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; GREEN KJ, 1986, CELL MOTIL CYTOSKEL, V6, P406, DOI 10.1002/cm.970060406; GREEN KJ, 1983, CELL MOTIL CYTOSKEL, V3, P283, DOI 10.1002/cm.970030402; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; LAMB NJC, 1989, J CELL BIOL, V108, P2409, DOI 10.1083/jcb.108.6.2409; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; MIGHELI A, 1993, LAB INVEST, V68, P185; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PENA SDJ, 1981, NEUROLOGY, V31, P1470, DOI 10.1212/WNL.31.11.1470; Prahlad V, 2000, J CELL SCI, V113, P3939; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Rudrabhatla P, 2011, FASEB J; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schepis A, 2007, CELL MICROBIOL, V9, P1960, DOI 10.1111/j.1462-5822.2007.00927.x; Schmidt RE, 1997, BRAIN RES, V769, P375, DOI 10.1016/S0006-8993(97)00806-8; SOLL DR, 1988, J CELL BIOCHEM, V37, P177, DOI 10.1002/jcb.240370205; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	58	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39065	10.1371/journal.pone.0039065	http://dx.doi.org/10.1371/journal.pone.0039065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720028	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350000036
J	Wu, T; Wang, Y; Yu, CJ; Chiarawipa, R; Zhang, XZ; Han, ZH; Wu, LH				Wu, Ting; Wang, Yi; Yu, Changjiang; Chiarawipa, Rawee; Zhang, Xinzhong; Han, Zhenhai; Wu, Lianhai			Carbon Sequestration by Fruit Trees - Chinese Apple Orchards as an Example	PLOS ONE			English	Article							BIOMASS; GROWTH; RESPIRATION; ECOSYSTEMS; EMISSIONS; FORESTS; BALANCE; STORAGE; SYSTEM; BUDGET	Apple production systems are an important component in the Chinese agricultural sector with 1.99 million ha plantation. The orchards in China could play an important role in the carbon (C) cycle of terrestrial ecosystems and contribute to C sequestration. The carbon sequestration capability in apple orchards was analyzed through identifying a set of potential assessment factors and their weighting factors determined by a field model study and literature. The dynamics of the net C sink in apple orchards in China was estimated based on the apple orchard inventory data from 1990s and the capability analysis. The field study showed that the trees reached the peak of C sequestration capability when they were 18 years old, and then the capability began to decline with age. Carbon emission derived from management practices would not be compensated through C storage in apple trees before reaching the mature stage. The net C sink in apple orchards in China ranged from 14 to 32 Tg C, and C storage in biomass from 230 to 475 Tg C between 1990 and 2010. The estimated net C sequestration in Chinese apple orchards from 1990 to 2010 was equal to 4.5% of the total net C sink in the terrestrial ecosystems in China. Therefore, apple production systems can be potentially considered as C sinks excluding the energy associated with fruit production in addition to provide fruits.	[Wu, Ting; Wang, Yi; Yu, Changjiang; Chiarawipa, Rawee; Zhang, Xinzhong; Han, Zhenhai] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Wu, Lianhai] Rothamsted Res, Wyke, Okehampton, England	China Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Wu, T (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China.	rschan@cau.edu.cn; lianhai.wu@rothamsted.ac.uk	Chiarawipa, Rawee/AAA-3313-2022	Chiarawipa, Rawee/0000-0001-9897-3756	State Science and Technology Support Program of China [NC2010BF0079]; Key Laboratory of Beijing Municipality of Stress Physiology and Molecular Biology for Fruit Trees of Ministry of Agriculture; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops (Nutrition and Physiology) of Ministry of Agriculture; BBSRC [BBS/E/C/00005740, BBS/E/C/00005746] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005740, BBS/E/C/00005746] Funding Source: researchfish	State Science and Technology Support Program of China; Key Laboratory of Beijing Municipality of Stress Physiology and Molecular Biology for Fruit Trees of Ministry of Agriculture; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops (Nutrition and Physiology) of Ministry of Agriculture; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was funded by the State Science and Technology Support Program of China (NC2010BF0079), and both the Key Laboratory of Beijing Municipality of Stress Physiology and Molecular Biology for Fruit Trees and the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops (Nutrition and Physiology) of Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, J JPN AGR SYST SOC; Blanke MM, 1996, ENVIRON EXP BOT, V36, P339, DOI 10.1016/0098-8472(96)01003-9; Blanke MM, 1997, ACTA HORTIC, P337, DOI 10.17660/ActaHortic.1997.451.39; Boden TA, 2001, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V02011p, DOI 10.3334/CDIAC/00001_V02011]; Brady NC, 2004, ELEMENTS NATURE PROP; CALDWELL MM, 1974, OECOLOGIA, V17, P123, DOI 10.1007/BF00346275; EBERT G, 1991, GARTENBAUWISSENSCHAF, V56, P130; Editorial C, 2010, CHINAS AGR YB; Falloon PD, 1998, BIOL FERT SOILS, V27, P236, DOI 10.1007/s003740050426; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Forshey C. G., 1989, Horticultural Reviews, V11, P229, DOI 10.1002/9781118060841.ch7; Grossman YL, 1998, J AM SOC HORTIC SCI, V123, P1058, DOI 10.21273/JASHS.123.6.1058; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; GUPTA RK, 1994, CURR SCI INDIA, V66, P378; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Joslin JD, 2006, NEW PHYTOL, V172, P523, DOI 10.1111/j.1469-8137.2006.01847.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; KERCKHOFFS LHJ, 2007, CARBON SEQUESTRATION, P1; Kimmins JP, 1997, FOREST ECOLOGY FDN S; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Lakso AN, 2001, ACTA HORTIC, P473, DOI 10.17660/ActaHortic.2001.557.63; Lakso AN, 1999, HORTSCIENCE, V34, P1040, DOI 10.21273/HORTSCI.34.6.1040; Lal R, 2002, LAND DEGRAD DEV, V13, P45, DOI 10.1002/ldr.477; Lauri PE, 1995, SCI HORTIC-AMSTERDAM, V64, P265, DOI 10.1016/0304-4238(95)00836-5; Lenz F., 2009, NUTR TRANSLOCATION G; Lu AF, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006198; Marini RP, 2000, HORTSCIENCE, V35, P837, DOI 10.21273/HORTSCI.35.5.837; Marsal J, 2002, EUR J AGRON, V17, P111, DOI 10.1016/S1161-0301(02)00002-3; Neto C, 2009, EUR J AGRON, V30, P34, DOI 10.1016/j.eja.2008.07.004; Page G, 2011, HORTSCIENCE, V46, P324, DOI 10.21273/HORTSCI.46.2.324; PALMER JW, 1988, J APPL ECOL, V25, P569, DOI 10.2307/2403845; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; PROCTOR JTA, 1976, J AM SOC HORTIC SCI, V101, P579; Ruess RW, 2003, ECOL MONOGR, V73, P643, DOI 10.1890/02-4032; Sekikawa S, 2003, ENV SCI, V16, P97; Sekikawa S., 2002, J JPN AGR SYS SOC, V18, P44; Sofo A, 2005, SCI HORTIC-AMSTERDAM, V107, P17, DOI 10.1016/j.scienta.2005.06.001; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; WIBBE ML, 1993, TREES-STRUCT FUNCT, V8, P56, DOI 10.1007/BF00240982; Zhang Q, 2001, AMBIO, V30, P351, DOI 10.1639/0044-7447(2001)030[0351:CEASPO]2.0.CO;2	41	39	44	9	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38883	10.1371/journal.pone.0038883	http://dx.doi.org/10.1371/journal.pone.0038883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719974	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000026
J	Munoz, P; Toscano, MG; Real, PJ; Benabdellah, K; Cobo, M; Bueno, C; Ramos-Mejia, V; Menendez, P; Anderson, P; Martin, F				Munoz, Pilar; Toscano, Miguel G.; Real, Pedro J.; Benabdellah, Karim; Cobo, Marien; Bueno, Clara; Ramos-Mejia, Veronica; Menendez, Pablo; Anderson, Per; Martin, Francisco			Specific Marking of hESCs-Derived Hematopoietic Lineage by WAS-Promoter Driven Lentiviral Vectors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-THERAPY; IN-VITRO; DIFFERENTIATION; EXPRESSION; TRANSDUCTION; DERIVATION; TRACKING; IDENTIFICATION; BLASTOCYSTS	Genetic manipulation of human embryonic stem cells (hESCs) is instrumental for tracing lineage commitment and to studying human development. Here we used hematopoietic-specific Wiskott-Aldrich syndrome gene (WAS)-promoter driven lentiviral vectors (LVs) to achieve highly specific gene expression in hESCs-derived hematopoietic cells. We first demonstrated that endogenous WAS gene was not expressed in undifferentiated hESCs but was evident in hemogenic progenitors (CD45(-)CD31(+)CD34(+)) and hematopoietic cells (CD45(+)). Accordingly, WAS-promoter driven LVs were unable to express the eGFP transgene in undifferentiated hESCs. eGFP(+) cells only appeared after embryoid body (EB) hematopoietic differentiation. The phenotypic analysis of the eGFP(+) cells showed marking of different subpopulations at different days of differentiation. At days 10-15, AWE LVs tag hemogenic and hematopoietic progenitors cells (CD45(-)CD31(+)CD34(dim) and CD45(+)CD31(+)CD34(dim)) emerging from hESCs and at day 22 its expression became restricted to mature hematopoietic cells (CD45(+)CD33(+)). Surprisingly, at day 10 of differentiation, the AWE vector also marked CD45(-)CD31(low/-)CD34(-) cells, a population that disappeared at later stages of differentiation. We showed that the eGFP(+)CD45(-)CD31(+) population generate 5 times more CD45(+) cells than the eGFP(-)CD45(-)CD31(+) indicating that the AWE vector was identifying a subpopulation inside the CD45(-)CD31(+) cells with higher hemogenic capacity. We also showed generation of CD45(+) cells from the eGFP(+)CD45(-)CD31(low/-)CD34(-) population but not from the eGFP(-)CD45(-)CD31(low/-)CD34(-) cells. This is, to our knowledge, the first report of a gene transfer vector which specifically labels hemogenic progenitors and hematopoietic cells emerging from hESCs. We propose the use of WAS-promoter driven LVs as a novel tool to studying human hematopoietic development.	[Munoz, Pilar; Toscano, Miguel G.; Benabdellah, Karim; Cobo, Marien; Anderson, Per; Martin, Francisco] Univ Granada, Human DNA Variabil Dept, Pfizer, Junta de Andalucia Ctr Genom & Oncol Res GENYO, Granada, Spain; [Real, Pedro J.; Bueno, Clara; Ramos-Mejia, Veronica; Menendez, Pablo] Univ Granada, Junta de Andalucia Ctr Genom & Oncol Res GENYO, Pfizer, Dept Oncol, Granada, Spain	Pfizer; University of Granada; Pfizer; University of Granada	Munoz, P (corresponding author), Univ Granada, Human DNA Variabil Dept, Pfizer, Junta de Andalucia Ctr Genom & Oncol Res GENYO, Granada, Spain.	francisco.martin@genyo.es	Bujan, Pablo Menendez/W-3736-2017; Ramos-Mejia, Veronica/C-4338-2017; Real, Pedro J./ABH-3493-2021; Benabdellah, karim/L-4569-2014; Martin, Francisco/K-8763-2014; Real, Pedro J./K-2994-2014; Munoz, Pilar/N-2277-2016; Benabdellah, karim/F-4209-2016; Toscano, Miguel G. G/I-1053-2015	Bujan, Pablo Menendez/0000-0001-9372-1007; Ramos-Mejia, Veronica/0000-0002-8013-4273; Benabdellah, karim/0000-0003-4673-2111; Martin, Francisco/0000-0003-1961-8612; Real, Pedro J./0000-0001-7968-5353; Munoz, Pilar/0000-0002-7985-9859; Benabdellah, karim/0000-0003-2790-562X; Toscano, Miguel G. G/0000-0002-6384-3123; Anderson, Per/0000-0002-0958-7990	Fondo de Investigaciones Sanitarias (FIS)/Fondo de Desarrollo Regional (FEDER) [PS09/00340]; Consejeria de Innovacion Ciencia y Empresa [P09-CTS-04532, PAIDI-Bio-326]; Consejeria de Salud from Junta de Andalucia [PI0001/2009]; Fondo de Cohesion Europeo (FSE) (Programa operative FEDER/FSE de Andalucia); FEDER; Fundacion Progreso y Salud (Consejeria de Salud - Junta de Andalucia); Fondo de Investigaciones Sanitarias (FIS) - Institute of health Carlos III [CP09/00228]; Junta de Andalucia/FEDER [P08-CTS-3678, SAS-111244, P10-CTS-6406]; FIS/FEDER [PI10/00449, PI11/00119]; MICINN [PLE-2009-0111]; Foundation "Spanish Association Against Cancer"/Junta Provincial de Albacete [CI110023]; ISCIII/Miguel Servet Program [CP07/00059, CP09/006]	Fondo de Investigaciones Sanitarias (FIS)/Fondo de Desarrollo Regional (FEDER); Consejeria de Innovacion Ciencia y Empresa; Consejeria de Salud from Junta de Andalucia(Junta de Andalucia); Fondo de Cohesion Europeo (FSE) (Programa operative FEDER/FSE de Andalucia); FEDER(European Commission); Fundacion Progreso y Salud (Consejeria de Salud - Junta de Andalucia)(Junta de Andalucia); Fondo de Investigaciones Sanitarias (FIS) - Institute of health Carlos III; Junta de Andalucia/FEDER(Junta de AndaluciaEuropean Commission); FIS/FEDER(Instituto de Salud Carlos IIIEuropean Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Foundation "Spanish Association Against Cancer"/Junta Provincial de Albacete; ISCIII/Miguel Servet Program	This work has been supported by the Fondo de Investigaciones Sanitarias (FIS)/Fondo de Desarrollo Regional (FEDER) (grant No. PS09/00340), by the Consejeria de Innovacion Ciencia y Empresa (grants No. P09-CTS-04532 and PAIDI-Bio-326) and Consejeria de Salud (grant No. PI0001/2009) from Junta de Andalucia thanks to the financial support of FEDER and Fondo de Cohesion Europeo (FSE) (Programa operative FEDER/FSE de Andalucia 2007-2013) to F. Martin. M. Cobo. and F. Martin are funded by Fundacion Progreso y Salud (Consejeria de Salud - Junta de Andalucia). K. Benabdellah and M.G. Toscano are financed by P09-CTS-04532 and PI0001/2009 grants, respectively. P. Anderson and P. Munoz have a Miguel Servet (CP09/00228) and Sara Borrell contracts respectively (Fondo de Investigaciones Sanitarias (FIS) - Institute of health Carlos III). P. Menendez's laboratory was funded by the Junta de Andalucia/FEDER (P08-CTS-3678) to P. Menendez and (SAS-111244 and P10-CTS-6406) to P.J. Real, the FIS/FEDER (PI10/00449) to P. Menendez and (PI11/00119) to C. Bueno, the MICINN (PLE-2009-0111) to P. Menendez, and the Foundation "Spanish Association Against Cancer"/Junta Provincial de Albacete (CI110023) to P. Menendez. C. Bueno and P.J. Real were supported by ISCIII/Miguel Servet Program (CP07/00059 to C. Bueno and CP09/006 to P.J. Real). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Ciraci E, 2011, BLOOD, V118, P2105, DOI 10.1182/blood-2010-10-316596; Cortes JL, 2009, HUM REPROD, V24, P1844, DOI 10.1093/humrep/dep107; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1026, DOI 10.1002/art.23283; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dravid G, 2011, MOL THER, V19, P768, DOI 10.1038/mt.2010.281; Frecha C, 2008, GENE THER, V15, P930, DOI 10.1038/gt.2008.20; Gallo P, 2008, GENE THER, V15, P161, DOI 10.1038/sj.gt.3303017; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Hagemann TL, 1999, BIOCHEM BIOPH RES CO, V256, P104, DOI 10.1006/bbrc.1999.0292; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Kaufman DS, 2009, BLOOD, V114, P3513, DOI 10.1182/blood-2009-03-191304; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Kraunus J, 2004, GENE THER, V11, P1568, DOI 10.1038/sj.gt.3302309; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Martin F, 2005, GENE THER, V12, P715, DOI 10.1038/sj.gt.3302457; Martin F, 1998, HUM GENE THER, V9, P737, DOI 10.1089/hum.1998.9.5-737; Menendez P, 2004, MOL THER, V10, P1109, DOI 10.1016/j.ymthe.2004.08.016; Menendez P, 2005, CURR GENE THER, V5, P375, DOI 10.2174/1566523054546198; Moreno-Gimeno I, 2010, FEBS J, V277, P5014, DOI 10.1111/j.1742-4658.2010.07926.x; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Parolini O, 1997, BLOOD, V90, P70; Petrella A, 1998, BLOOD, V91, P4554, DOI 10.1182/blood.V91.12.4554.412k26_4554_4560; Ramos-Mejia V, 2012, STEM CELLS DEV; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Stewart DM, 1996, J CLIN INVEST, V97, P2627, DOI 10.1172/JCI118712; Stewart R, 2008, REGEN MED, V3, P505, DOI 10.2217/17460751.3.4.505; Stojkovic M, 2004, STEM CELLS, V22, P790, DOI 10.1634/stemcells.22-5-790; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2006, STEM CELLS, V24, P1370, DOI 10.1634/stemcells.2005-0340; Toscano MG, 2011, GENE THER, V18, P117, DOI 10.1038/gt.2010.138; Toscano MG, 2004, GENE THER, V11, P956, DOI 10.1038/sj.gt.3302259; Toscano MG, 2008, HUM GENE THER, V19, P179, DOI 10.1089/hum.2007.098; Toscano MG, 2009, HUM GENE THER, V20, P1279, DOI 10.1089/hum.2009.118; Vodyanik Maxim A., 2007, V407, P275, DOI 10.1007/978-1-59745-536-7_19; Wang LS, 2006, METH MOL B, V331, P179; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wiznerowicz M, 2005, TRENDS BIOTECHNOL, V23, P42, DOI 10.1016/j.tibtech.2004.11.001; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	49	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39091	10.1371/journal.pone.0039091	http://dx.doi.org/10.1371/journal.pone.0039091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720040	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347800044
J	Valenti, A; De Felice, M; Perugino, G; Bizard, A; Nadal, M; Rossi, M; Ciaramella, M				Valenti, Anna; De Felice, Mariarita; Perugino, Giuseppe; Bizard, Anna; Nadal, Marc; Rossi, Mose; Ciaramella, Maria			Synergic and Opposing Activities of Thermophilic RecQ-like Helicase and Topoisomerase 3 Proteins in Holliday Junction Processing and Replication Fork Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON SULFOLOBUS-SOLFATARICUS; DNA-BINDING-PROTEIN; REVERSE GYRASE; III-ALPHA; STRAND-EXCHANGE; BLM; INTERACTS; MAINTENANCE; REGRESSION; RESOLUTION	RecQ family helicases and topoisomerase 3 enzymes form evolutionary conserved complexes that play essential functions in DNA replication, recombination, and repair, and in vitro, show coordinate activities on model recombination and replication intermediates. Malfunctioning of these complexes in humans is associated with genomic instability and cancer-prone syndromes. Although both RecQ-like and topoisomerase 3 enzymes are present in archaea, only a few of them have been studied, and no information about their functional interaction is available. We tested the combined activities of the RecQ-like helicase, Hel112, and the topoisomerase 3, SsTop3, from the thermophilic archaeon Sulfolobus solfataricus. Hel112 showed coordinate DNA unwinding and annealing activities, a feature shared by eukaryotic RecQ homologs, which resulted in processing of synthetic Holliday junctions and stabilization of model replication forks. SsTop3 catalyzed DNA relaxation and annealing. When assayed in combination, SsTop3 inhibited the Hel112 helicase activity on Holliday junctions and stimulated formation and stabilization of such structures. In contrast, Hel112 did not affect the SsTop3 DNA relaxation activity. RecQ-topoisomerase 3 complexes show structural similarity with the thermophile-specific enzyme reverse gyrase, which catalyzes positive supercoiling of DNA and was suggested to play a role in genome stability at high temperature. Despite such similarity and the high temperature of reaction, the SsTop3-Hel112 complex does not induce positive supercoiling and is thus likely to play different roles. We propose that the interplay between Hel112 and SsTop3 might regulate the equilibrium between recombination and anti-recombination activities at replication forks.	[Valenti, Anna; De Felice, Mariarita; Perugino, Giuseppe; Rossi, Mose; Ciaramella, Maria] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Bizard, Anna; Nadal, Marc] Univ Versailles St Quentin, F-78035 Versailles, France; [Bizard, Anna; Nadal, Marc] Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, F-91405 Orsay, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ciaramella, M (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.	m.ciaramella@ibp.cnr.it	Perugino, Giuseppe/P-8147-2016; Ciaramella, Maria/O-1152-2015	Ciaramella, Maria/0000-0003-1583-1694; Valenti, Anna/0000-0002-5278-3524; Perugino, Giuseppe/0000-0003-3266-4744; NADAL, Marc/0000-0001-9637-7694; Bizard, Anna/0000-0003-1858-3999	Ministero degli Affari Esteri [L.401/1990];  [RBNE08YFN3]	Ministero degli Affari Esteri(Ministry of Foreign Affairs and International Cooperation (Italy)); 	This work was supported in part by Merit Grant RBNE08YFN3 and Ministero degli Affari Esteri (Grant L.401/1990).	Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Bizard A, 2011, J MOL BIOL, V408, P839, DOI 10.1016/j.jmb.2011.03.030; Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Chen CF, 2010, EMBO J, V29, P1713, DOI 10.1038/emboj.2010.61; Chen L, 2006, MOL MICROBIOL, V60, P783, DOI 10.1111/j.1365-2958.2006.05133.x; Chester N, 2006, MOL CELL BIOL, V26, P6713, DOI 10.1128/MCB.00296-06; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Dai PG, 2003, J BACTERIOL, V185, P5500, DOI 10.1128/JB.185.18.5500-5507.2003; De Felice M, 2007, BIOCHEM J, V408, P87, DOI 10.1042/BJ20070134; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; Heine M, 2009, J MICROBIOL, V47, P229, DOI 10.1007/s12275-009-0019-8; Laine JP, 2003, CANCER RES, V63, P7136; Li XY, 2011, J GENET GENOMICS, V38, P253, DOI 10.1016/j.jgg.2011.05.001; Li Z, 2008, J BACTERIOL, V190, P3006, DOI 10.1128/JB.01662-07; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Nadal M, 2007, BIOCHIMIE, V89, P447, DOI 10.1016/j.biochi.2006.12.010; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Rezazadeh S, 2012, MOL BIOL REP, V39, P4527, DOI 10.1007/s11033-011-1243-y; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Russell B, 2011, CANCER RES, V71, P561, DOI 10.1158/0008-5472.CAN-10-1727; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sharma S, 2008, CELL CYCLE, V7, P989, DOI 10.4161/cc.7.8.5707; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Valenti A, 2010, J BIOL CHEM, V285, P36532, DOI 10.1074/jbc.M110.169029; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Vindigni A, 2010, BIOPHYS CHEM, V149, P67, DOI 10.1016/j.bpc.2010.03.012; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Woodman IL, 2009, BIOCHEM SOC T, V37, P74, DOI 10.1042/BST0370074; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216	49	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30282	30295		10.1074/jbc.M112.366377	http://dx.doi.org/10.1074/jbc.M112.366377			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22722926	Green Published, hybrid			2022-12-25	WOS:000308579800021
J	Eswarappa, SM; Estrela, S; Brown, SP				Eswarappa, Sandeepa M.; Estrela, Sylvie; Brown, Sam P.			Within-Host Dynamics of Multi-Species Infections: Facilitation, Competition and Virulence	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TYPHOID-FEVER; PATHOGEN INTERACTIONS; CONCURRENT MALARIA; PARASITE; SUSCEPTIBILITY; COINFECTION; EVOLUTION; CONSEQUENCES; REPLICATION	Host individuals are often infected with more than one parasite species (parasites defined broadly, to include viruses and bacteria). Yet, research in infection biology is dominated by studies on single-parasite infections. A focus on single-parasite infections is justified if the interactions among parasites are additive, however increasing evidence points to non-additive interactions being the norm. Here we review this evidence and theoretically explore the implications of non-additive interactions between co-infecting parasites. We use classic Lotka-Volterra two-species competition equations to investigate the within-host dynamical consequences of various mixes of competition and facilitation between a pair of co-infecting species. We then consider the implications of these dynamics for the virulence (damage to host) of co-infections and consequent evolution of parasite strategies of exploitation. We find that whereas one-way facilitation poses some increased virulence risk, reciprocal facilitation presents a qualitatively distinct destabilization of within-host dynamics and the greatest risk of severe disease.	[Eswarappa, Sandeepa M.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Estrela, Sylvie; Brown, Sam P.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Estrela, Sylvie; Brown, Sam P.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Brown, Sam P.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Cleveland Clinic Foundation; University of Edinburgh; University of Edinburgh; University of Oxford	Eswarappa, SM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA.	eswaras@ccf.org; sam.brown@ed.ac.uk	Eswarappa, Sandeep/AFG-1997-2022; Brown, Sam/B-5234-2009	Brown, Sam/0000-0003-1892-9275; Estrela, Sylvie/0000-0003-1946-3657; Eswarappa, Sandeep/0000-0002-7903-5198; Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354	Wellcome Trust [082273/Z/07/Z]; American Heart Association; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/33856/2009]	Wellcome Trust(Wellcome TrustEuropean Commission); American Heart Association(American Heart Association); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The resarch was supported by Wellcome Trust Grant 082273/Z/07/Z (to S.P.B.), American Heart Association's postdoctoral fellowship (to S.M.E.), and Fundacao para a Ciencia e Tecnologia, Portugal, SFRH/BD/33856/2009 (to S.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemi KO, 2007, J HEALTH POPUL NUTR, V25, P351; Alizon S, 2005, AM NAT, V165, pE155, DOI 10.1086/430053; Alizon S, 2008, AM NAT, V172, pE244, DOI 10.1086/592404; Ammah A, 1999, T ROY SOC TROP MED H, V93, P127, DOI 10.1016/S0035-9203(99)90282-1; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Bandilla M, 2006, INT J PARASITOL, V36, P987, DOI 10.1016/j.ijpara.2006.05.001; Brown SP, 2008, ECOL LETT, V11, P44, DOI 10.1111/j.1461-0248.2007.01125.x; Brown SP, 2009, EVOL APPL, V2, P32, DOI 10.1111/j.1752-4571.2008.00059.x; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Chowdhury F, 2010, J HEALTH POPUL NUTR, V28, P529; Collins HL, 2003, IMMUNOL LETT, V85, P193, DOI 10.1016/S0165-2478(02)00229-8; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Cunha BA, 2006, LANCET INFECT DIS, V6, P318, DOI 10.1016/S1473-3099(06)70472-8; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Egusa H, 2008, CURR HIV RES, V6, P485, DOI 10.2174/157016208786501445; Fenton A, 2010, PARASITOLOGY, V137, P1027, DOI 10.1017/S0031182009991788; Fenton A, 2010, ECOL LETT, V13, P606, DOI 10.1111/j.1461-0248.2010.01458.x; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Goletti D, 1996, J IMMUNOL, V157, P1271; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Inglis RF, 2009, P NATL ACAD SCI USA, V106, P5703, DOI 10.1073/pnas.0810850106; Kaplan JE, 1996, AM J TROP MED HYG, V55, P1; KAYE D, 1965, P SOC EXP BIOL MED, V120, P810, DOI 10.3181/00379727-120-30661; KAYE D, 1963, J IMMUNOL, V91, P518; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; LEDERMAN MM, 1994, J ACQ IMMUN DEF SYND, V7, P727; Lello J, 2008, PARASITOLOGY, V135, P825, DOI 10.1017/S0031182008000383; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Lello J, 2008, AM NAT, V171, P176, DOI 10.1086/525257; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Murray J.D., 2002, MATH BIOL; Otto SP, 2007, BIOL GUIDE MATH MODE; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Reece SE, 2009, EVOL APPL, V2, P11, DOI 10.1111/j.1752-4571.2008.00060.x; SHATTOCK RJ, 1993, RES VIROLOGY, V144, P7, DOI 10.1016/S0923-2516(06)80005-1; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Staves PA, 2010, EVOLUTION, V64, P2643, DOI 10.1111/j.1558-5646.2010.00999.x; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Thomas F, 2002, TRENDS PARASITOL, V18, P387, DOI 10.1016/S1471-4922(02)02339-5; Uneke C. J., 2008, Journal of Vector Borne Diseases, V45, P133; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924	52	33	33	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38730	10.1371/journal.pone.0038730	http://dx.doi.org/10.1371/journal.pone.0038730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737220	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100018
J	Lin, IC; Kuo, HC; Lin, YJ; Wang, FS; Wang, L; Huang, SC; Chien, SJ; Huang, CF; Wang, CL; Yu, HR; Chen, RF; Yang, KD				Lin, I-Chun; Kuo, Ho-Chang; Lin, Ying-Jui; Wang, Feng-Shen; Wang, Lin; Huang, Shun-Chen; Chien, Shao-Ju; Huang, Chien-Fu; Wang, Chih-Lu; Yu, Hong-Ren; Chen, Rong-Fu; Yang, Kuender D.			Augmented TLR2 Expression on Monocytes in both Human Kawasaki Disease and a Mouse Model of Coronary Arteritis	PLOS ONE			English	Article							GAMMA-GLOBULIN TREATMENT; LYMPH-NODE SYNDROME; CASEI CELL-WALLS; TRANSCRIPTIONAL REGULATION; IMMUNOGLOBULIN TREATMENT; SYSTEMIC INJECTION; AQUEOUS SUSPENSION; TREATMENT FAILURE; ANIMAL-MODEL; LESIONS	Background: Kawasaki disease (KD) of unknown immunopathogenesis is an acute febrile systemic vasculitis and the leading cause of acquired heart diseases in childhood. To search for a better strategy for the prevention and treatment of KD, this study compared and validated human KD immunopathogenesis in a mouse model of Lactobacillus casei cell wall extract (LCWE)-induced coronary arteritis. Methods: Recruited subjects fulfilled the criteria of KD and were admitted for intravenous gamma globulin (IVIG) treatment at the Kaohsiung Chang Gung Memorial Hospital from 2001 to 2009. Blood samples from KD patients were collected before and after IVIG treatment, and cardiovascular abnormalities were examined by transthoracic echocardiography. Wild-type male BALB/c mice (4-week-old) were intraperitoneally injected with LCWE (1 mg/mL) to induce coronary arteritis. The induced immune response in mice was examined on days 1, 3, 7, and 14 post injections, and histopathology studies were performed on days 7 and 14. Results: Both human KD patients and LCWE-treated mice developed coronary arteritis, myocarditis, valvulitis, and pericarditis, as well as elevated plasma levels of interleukin (IL)-2, IL-6, IL-10, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-alpha in acute phase. Most of these proinflammatory cytokines declined to normal levels in mice, whereas normal levels were achieved in patients only after IVIG treatment, with a few exceptions. Toll-like receptor (TLR)-2, but not TLR4 surface enhancement on circulating CD14(+) monocytes, was augmented in KD patients before IVIG treatment and in LCWE-treated mice, which declined in patients after IVIG treatment. Conclusion: This result suggests that that not only TLR2 augmentation on CD14(+) monocytes might be an inflammatory marker for both human KD patients and LCWE-induced CAL mouse model but also this model is feasible for studying therapeutic strategies of coronary arteritis in human KD by modulating TLR2-mediated immune activation on CD14(+) monocytes.	[Lin, I-Chun; Kuo, Ho-Chang; Lin, Ying-Jui; Wang, Lin; Chien, Shao-Ju; Huang, Chien-Fu; Yu, Hong-Ren] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Lin, I-Chun; Kuo, Ho-Chang; Lin, Ying-Jui; Wang, Feng-Shen; Wang, Lin; Huang, Shun-Chen; Chien, Shao-Ju; Huang, Chien-Fu; Yu, Hong-Ren] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Wang, Feng-Shen] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Huang, Shun-Chen] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Wang, Chih-Lu] Po Jen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Rong-Fu; Yang, Kuender D.] Show Chwan Mem Hosp Chang Bing, Dept Med Res, Changhua, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lin, IC (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	wangfs@ms33.hinet.net; yangkd.yeh@hotmail.com	于, 鴻仁/AAW-6827-2021; Kuo, Ho-Chang/AAQ-6644-2020; Chen, Rong-Fu/AAI-8593-2021	于, 鴻仁/0000-0003-1242-8760; Kuo, Ho-Chang/0000-0002-3295-2984; Chen, Rong-Fu/0000-0001-7529-5390; Lin, Ying-Jui/0000-0002-2395-5913; Lin, I-Chun/0000-0001-5425-7619	Kaohsiung Chang Gung Memorial Hospital [CMRPG881041, CMRPG881042]; Cardiac Children's Foundation Taiwan [CCF100-03, CCFT0805]; National Science Council [NSC 97-2314-B-182A-054-MY2, NSC 100-2314-B-182A-048-MY3]	Kaohsiung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Cardiac Children's Foundation Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This study was in part supported by grants CMRPG881041 and CMRPG881042 from Kaohsiung Chang Gung Memorial Hospital (URL: http://www.cgmh.org.tw/), grants CCF100-03 and CCFT0805 from Cardiac Children's Foundation Taiwan (URL: http://www.ccft.org.tw/htm/index.asp), and by grant NSC 97-2314-B-182A-054-MY2 and NSC 100-2314-B-182A-048-MY3 from the National Science Council (URL: http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron Karyl S., 1998, Current Opinion in Rheumatology, V10, P29, DOI 10.1097/00002281-199801000-00005; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; CULLEN S, 1989, IRISH J MED SCI, V158, P253, DOI 10.1007/BF02943701; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; FELSBURG PJ, 1992, CLIN IMMUNOL IMMUNOP, V65, P110, DOI 10.1016/0090-1229(92)90213-8; FUJIWARA H, 1978, PEDIATRICS, V61, P100; Haehnel V, 2002, J IMMUNOL, V168, P5629, DOI 10.4049/jimmunol.168.11.5629; Hirao J, 1997, INT ARCH ALLERGY IMM, V112, P152, DOI 10.1159/000237447; KATO H, 1986, J PEDIATR-US, V108, P923, DOI 10.1016/S0022-3476(86)80928-3; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kimura J, 2004, CLIN EXP IMMUNOL, V137, P444, DOI 10.1111/j.1365-2249.2004.02506.x; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Kuo Ho-Chang, 2007, Journal of Microbiology Immunology and Infection, V40, P395; Lehman T J, 1987, Prog Clin Biol Res, V250, P149; LEHMAN TJA, 1985, ARTHRITIS RHEUM, V28, P652, DOI 10.1002/art.1780280609; LEHMAN TJA, 1983, ARTHRITIS RHEUM, V26, P1259, DOI 10.1002/art.1780261013; LIN CY, 1992, J PEDIATR-US, V121, P924, DOI 10.1016/S0022-3476(05)80343-9; Lin IC, 2012, IMMUNOBIOLO IN PRESS; MURATA H, 1979, MICROBIOL IMMUNOL, V23, P825, DOI 10.1111/j.1348-0421.1979.tb02815.x; Nakamura Y, 2008, PEDIATR INT, V50, P287, DOI 10.1111/j.1442-200X.2008.02572.x; ONOUCHI Z, 1995, ANGIOLOGY, V46, P679, DOI 10.1177/000331979504600806; Philip S, 2004, PEDIATR RES, V55, P211, DOI 10.1203/01.PDR.0000104151.26375.E5; Rosenkranz ME, 2005, CIRCULATION, V112, P2966, DOI 10.1161/CIRCULATIONAHA.105.537530; Schulte DJ, 2009, J IMMUNOL, V183, P5311, DOI 10.4049/jimmunol.0901395; SUGIMURA T, 1992, J PEDIATR-US, V121, P684, DOI 10.1016/S0022-3476(05)81893-1; SUZUKI A, 1988, AM J CARDIOL, V61, P386, DOI 10.1016/0002-9149(88)90950-2; Suzuki A, 2000, CIRCULATION, V101, P2935, DOI 10.1161/01.CIR.101.25.2935; Takahashi K, 2004, INFLAMM RES, V53, P72, DOI 10.1007/s00011-003-1225-1; TAUBERT KA, 1994, PEDIATR INFECT DIS J, V13, P704, DOI 10.1097/00006454-199408000-00005; Terai M, 1997, J PEDIATR-US, V131, P888, DOI 10.1016/S0022-3476(97)70038-6; Terai M, 1999, J LEUKOCYTE BIOL, V65, P566, DOI 10.1002/jlb.65.5.566; Tsuda E, 2005, CARDIOL YOUNG, V15, P481, DOI 10.1017/S1047951105001344; Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78	36	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38635	10.1371/journal.pone.0038635	http://dx.doi.org/10.1371/journal.pone.0038635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737215	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100013
J	Paul, A; Jain, AK; Misra, SK; Maji, B; Muniyappa, K; Bhattacharya, S				Paul, Ananya; Jain, Akash K.; Misra, Santosh K.; Maji, Basudeb; Muniyappa, K.; Bhattacharya, Santanu			Binding of Gemini Bisbenzimidazole Drugs with Human Telomeric G-Quadruplex Dimers: Effect of the Spacer in the Design of Potent Telomerase Inhibitors	PLOS ONE			English	Article							INTRAMOLECULAR G-QUADRUPLEX; DNA-BINDING; K+ SOLUTION; DUPLEX-DNA; SEQUENCE; BIOLOGY; REPEAT; CHEMISTRY; INSIGHTS; TARGET	The study of anticancer agents that act via stabilization of telomeric G-quadruplex DNA (G4DNA) is important because such agents often inhibit telomerase activity. Several types of G4DNA binding ligands are known. In these studies, the target structures often involve a single G4 DNA unit formed by short DNA telomeric sequences. However, the 3'-terminal single-stranded human telomeric DNA can form higher-order structures by clustering consecutive quadruplex units (dimers or nmers). Herein, we present new synthetic gemini (twin) bisbenzimidazole ligands, in which the oligo-oxyethylene spacers join the two bisbenzimidazole units for the recognition of both monomeric and dimeric G4DNA, derived from d(T2AG3)4 and d(T2AG3) 8 human telomeric DNA, respectively. The spacer between the two bisbenzimidazoles in the geminis plays a critical role in the G4DNA stability. We report here (i) synthesis of new effective gemini anticancer agents that are selectively more toxic towards the cancer cells than the corresponding normal cells; (ii) formation and characterization of G4DNA dimers in solution as well as computational construction of the dimeric G4DNA structures. The gemini ligands direct the folding of the single-stranded DNA into an unusually stable parallel-stranded G4DNA when it was formed in presence of the ligands in KCl solution and the gemini ligands show spacer length dependent potent telomerase inhibition properties.	[Paul, Ananya; Jain, Akash K.; Misra, Santosh K.; Maji, Basudeb; Bhattacharya, Santanu] Indian Inst Sci, Dept Organ Chem, Bangalore 560012, Karnataka, India; [Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Bhattacharya, Santanu] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Chem Biol Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Paul, A (corresponding author), Indian Inst Sci, Dept Organ Chem, Bangalore 560012, Karnataka, India.	sb@orgchem.iisc.ernet.in	BHATTACHARYA, SANTANU/E-9739-2010; Bhattacharya, Santanu/N-6531-2019; Bhattacharya, Santanu/GRS-4780-2022; Mishra, Santosh/S-7516-2017	BHATTACHARYA, SANTANU/0000-0001-9040-8971; Bhattacharya, Santanu/0000-0001-9040-8971; Mishra, Santosh/0000-0001-8616-2606; Paul, Ananya/0000-0003-4592-3442; Misra, Santosh K./0000-0002-3313-4895; Maji, Basudeb/0000-0002-3885-5704	DST (Department of Science and Technology); DST, New Delhi	DST (Department of Science and Technology)(Department of Science & Technology (India)); DST, New Delhi(Department of Science & Technology (India))	This work was supported by a grant from DST (Department of Science and Technology) [J. C. Bose Fellowship (S.B.)]. A.K.J. is thankful to DST for a Fast Track Grant for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SB thanks DST, New Delhi for J. C. Bose Fellowship. Authors are thankful to the NMR Research Centre, IISc Bangalore for recording the NMR spectra of the ligands.	Antonacci C, 2007, BIOCHEMISTRY-US, V46, P4654, DOI 10.1021/bi602511p; Bhattacharjee AJ, 2011, BIOCHIMIE, V93, P1297, DOI 10.1016/j.biochi.2011.05.038; Bhattacharya S, 2008, CURR MED CHEM, V15, P1762, DOI 10.2174/092986708785133013; Bhattacharya S, 2010, BIOCONJUGATE CHEM, V21, P1148, DOI 10.1021/bc9003298; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cech TR, 2000, ANGEW CHEM INT EDIT, V39, P34, DOI 10.1002/(SICI)1521-3773(20000103)39:1<34::AID-ANIE34>3.0.CO;2-N; Chang CC, 2007, NUCLEIC ACIDS RES, V35, P2846, DOI 10.1093/nar/gkm155; Chaudhuri P, 2007, J MED CHEM, V50, P2536, DOI 10.1021/jm0610604; Corey DR, 2009, CHEM BIOL, V16, P1219, DOI 10.1016/j.chembiol.2009.12.001; Cummaro A, 2011, BIOCHIMIE, V93, P1392, DOI 10.1016/j.biochi.2011.04.005; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; De Cian A, 2007, METHODS, V42, P183, DOI 10.1016/j.ymeth.2006.10.004; Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079; Fu YT, 2009, BIOORGAN MED CHEM, V17, P2030, DOI 10.1016/j.bmc.2009.01.015; Gaynutdinov TI, 2009, BIOCHEMISTRY-US, V48, P11169, DOI 10.1021/bi901063g; Hansel R, 2011, NUCLEIC ACIDS RES, V39, P5768, DOI 10.1093/nar/gkr174; Haider S, 2008, BIOPHYS J, V95, P296, DOI 10.1529/biophysj.107.120501; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iida K, 2009, CHEM COMMUN, P6481, DOI 10.1039/b910242f; Jain AK, 2012, J MED CHEM, V55, P2981, DOI 10.1021/jm200860b; Jain AK, 2012, CURR PHARM DESIGN, V18, P1917; Jain AK, 2011, BIOCONJUGATE CHEM, V22, P2355, DOI 10.1021/bc200268a; Jain AK, 2010, BIOCONJUGATE CHEM, V21, P1389, DOI 10.1021/bc900247s; Jain AK, 2009, BIOCHEMISTRY-US, V48, P10693, DOI 10.1021/bi9003815; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kan ZY, 2007, NUCLEIC ACIDS RES, V35, P3646, DOI 10.1093/nar/gkm203; Kerwin SM, 2000, CURR PHARM DESIGN, V6, P441, DOI 10.2174/1381612003400849; Largy E, 2011, CHEM-EUR J, V17, P13274, DOI 10.1002/chem.201102300; Li GR, 2008, CHEM COMMUN, P4564, DOI 10.1039/b807916a; Liu Y, 2005, J ORG CHEM, V70, P1450, DOI 10.1021/jo047968o; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Martadinata H, 2011, BIOCHEMISTRY-US, V50, P6455, DOI 10.1021/bi200569f; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; MERGNY JL, 2009, CURR PROTOC NUCL ACI, V17; Misra SK, 2012, SMALL, V8, P131, DOI 10.1002/smll.201101640; Miyoshi D, 2005, ANGEW CHEM INT EDIT, V44, P3740, DOI 10.1002/anie.200462667; Miyoshi D, 2004, J AM CHEM SOC, V126, P165, DOI 10.1021/ja036721q; Monchaud D, 2008, ANGEW CHEM INT EDIT, V47, P4858, DOI 10.1002/anie.200800468; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Paul A, 2012, CURR SCI INDIA, V102, P212; Pedroso IA, 2007, BIOPOLYMERS, V87, P74, DOI 10.1002/bip.20790; Petraccone L, 2008, J AM CHEM SOC, V130, P16530, DOI 10.1021/ja8075567; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Read M, 2001, P NATL ACAD SCI USA, V98, P4844, DOI 10.1073/pnas.081560598; Reed J, 2008, ANAL BIOCHEM, V380, P99, DOI 10.1016/j.ab.2008.05.013; Romera C, 2011, BIOCHIMIE, V93, P1310, DOI 10.1016/j.biochi.2011.06.008; Tache S, 2006, SCAND J GASTROENTERO, V41, P730, DOI 10.1080/00365520500380668; Tawar U, 2003, J MED CHEM, V46, P3785, DOI 10.1021/jm030114w; Temime-Smaali N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006919; Uziel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009132; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xu L, 2010, CHEM COMMUN, V46, P743, DOI 10.1039/b918045a; Xue Y, 2007, J AM CHEM SOC, V129, P11185, DOI 10.1021/ja0730462; Yang DZ, 2010, FUTURE MED CHEM, V2, P619, DOI 10.4155/FMC.09.172; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029	60	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39467	10.1371/journal.pone.0039467	http://dx.doi.org/10.1371/journal.pone.0039467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737240	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000305695100039
J	Schulz, EC; Roth, HM; Ankri, S; Ficner, R				Schulz, Eike C.; Roth, Heide M.; Ankri, Serge; Ficner, Ralf			Structure Analysis of Entamoeba histolytica DNMT2 (EhMeth)	PLOS ONE			English	Article							DNA METHYLTRANSFERASE EHMETH; POISSON-BOLTZMANN EQUATION; TRANSFER-RNA; EVOLUTIONARY CONSERVATION; METHYLATION PATTERNS; CATALYTIC MECHANISM; DE-NOVO; PROTEIN; SEQUENCE; CONSURF	In eukaryotes, DNA methylation is an important epigenetic modification that is generally involved in gene regulation. Methyltransferases (MTases) of the DNMT2 family have been shown to have a dual substrate specificity acting on DNA as well as on three specific tRNAs (tRNA(Asp), tRNA(Val), tRNA(Gly)). Entamoeba histolytica is a major human pathogen, and expresses a single DNA MTase (EhMeth) that belongs to the DNMT2 family and shows high homology to the human enzyme as well as to the bacterial DNA MTase M.HhaI. The molecular basis for the recognition of the substrate tRNAs and discrimination of non-cognate tRNAs is unknown. Here we present the crystal structure of the cytosine-5-methyltransferase EhMeth at a resolution of 2.15 angstrom, in complex with its reaction product S-adenosyl-L-homocysteine, revealing all parts of a DNMT2 MTase, including the active site loop. Mobility shift assays show that in vitro the full length tRNA is required for stable complex formation with EhMeth.	[Schulz, Eike C.; Roth, Heide M.; Ficner, Ralf] Univ Gottingen, Inst Mikrobiol & Genet, Abt Mol Strukturbiol, Gottingen, Germany; [Ankri, Serge] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel	University of Gottingen; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Schulz, EC (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	rficner@gwdg.de		Resch, Heide Marie/0000-0001-9635-6340	State of Lower-Saxony; Volkswagen Foundation, Hannover, Germany; Deutsche Forschungsgemeinschaft (DFG); University Gottingen, Germany	State of Lower-Saxony; Volkswagen Foundation, Hannover, Germany(Volkswagen); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University Gottingen, Germany	This joint research project was financially supported by the State of Lower-Saxony and the Volkswagen Foundation, Hannover, Germany. The publication was financially supported by the Open-Access funding program of the Deutsche Forschungsgemeinschaft (DFG) and the publication fond of the University Gottingen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee S, 2005, MOL BIOCHEM PARASIT, V139, P91, DOI 10.1016/j.molbiopara.2004.10.003; Baxt LA, 2008, CURR OPIN INFECT DIS, V21, P489, DOI 10.1097/QCO.0b013e32830ce75f; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Delano W. L., 2003, PYMOL MOL GENETICS G; DERRICK WB, 1993, NUCLEIC ACIDS RES, V21, P4948, DOI 10.1093/nar/21.21.4948; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher O, 2004, NUCLEIC ACIDS RES, V32, P287, DOI 10.1093/nar/gkh161; Gerasimaite R, 2011, NUCLEIC ACIDS RES, V39, P3771, DOI 10.1093/nar/gkq1329; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; H G, 2009, DNA RNA MODIFICATION; Harony H, 2006, MOL BIOCHEM PARASIT, V147, P55, DOI 10.1016/j.molbiopara.2006.02.005; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Ishitani R, 2008, CURR OPIN STRUC BIOL, V18, P330, DOI 10.1016/j.sbi.2008.05.003; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liu YQ, 2000, P NATL ACAD SCI USA, V97, P8263, DOI 10.1073/pnas.97.15.8263; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Osawa T, 2011, NAT STRUCT MOL BIOL, V18, P1275, DOI 10.1038/nsmb.2144; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tovy A, 2010, J VISUALIZED EXPT JO; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WHO, 1997, B WORLD HEALTH ORGAN, V75, P291; WU JC, 1987, J BIOL CHEM, V262, P4778; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	64	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38728	10.1371/journal.pone.0038728	http://dx.doi.org/10.1371/journal.pone.0038728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737219	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100017
J	Sasayama, H; Shimamura, M; Tokuda, T; Azuma, Y; Yoshida, T; Mizuno, T; Nakagawa, M; Fujikake, N; Nagai, Y; Yamaguchi, M				Sasayama, Hiroshi; Shimamura, Mai; Tokuda, Takahiko; Azuma, Yumiko; Yoshida, Tomokatsu; Mizuno, Toshiki; Nakagawa, Masanori; Fujikake, Nobuhiro; Nagai, Yoshitaka; Yamaguchi, Masamitsu			Knockdown of the Drosophila Fused in Sarcoma (FUS) Homologue Causes Deficient Locomotive Behavior and Shortening of Motoneuron Terminal Branches	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; RNA-BINDING PROTEIN; TARDBP MUTATIONS; IN-VIVO; TDP-43; ALS; TLS; DISEASE; INCLUSIONS	Mutations in the fused in sarcoma/translated in liposarcoma gene (FUS/TLS, FUS) have been identified in sporadic and familial forms of amyotrophic lateral sclerosis (ALS). FUS is an RNA-binding protein that is normally localized in the nucleus, but is mislocalized to the cytoplasm in ALS, and comprises cytoplasmic inclusions in ALS-affected areas. However, it is still unknown whether the neurodegeneration that occurs in ALS is caused by the loss of FUS nuclear function, or by the gain of toxic function due to cytoplasmic FUS aggregation. Cabeza (Caz) is a Drosophila orthologue of human FUS. Here, we generated Drosophila models with Caz knockdown, and investigated their phenotypes. In wild-type Drosophila, Caz was strongly expressed in the central nervous system of larvae and adults. Caz did not colocalize with a presynaptic marker, suggesting that Caz physiologically functions in neuronal cell bodies and/or their axons. Fly models with neuron-specific Caz knockdown exhibited reduced climbing ability in adulthood and anatomical defects in presynaptic terminals of motoneurons in third instar larvae. Our results demonstrated that decreased expression of Drosophila Caz is sufficient to cause degeneration of motoneurons and locomotive disability in the absence of abnormal cytoplasmic Caz aggregates, suggesting that the pathogenic mechanism underlying FUS-related ALS should be ascribed more to the loss of physiological FUS functions in the nucleus than to the toxicity of cytoplasmic FUS aggregates. Since the Caz-knockdown Drosophila model we presented recapitulates key features of human ALS, it would be a suitable animal model for the screening of genes and chemicals that might modify the pathogenic processes that lead to the degeneration of motoneurons in ALS.	[Sasayama, Hiroshi; Tokuda, Takahiko; Azuma, Yumiko; Yoshida, Tomokatsu; Mizuno, Toshiki; Nakagawa, Masanori] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kamigyo Ku, Kyoto, Japan; [Shimamura, Mai; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan; [Shimamura, Mai; Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto 606, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Pathobiol Brain Dis, Kamigyo Ku, Kyoto, Japan; [Fujikake, Nobuhiro; Nagai, Yoshitaka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 187, Japan	Kyoto Prefectural University of Medicine; Kyoto Institute of Technology; Kyoto Institute of Technology; Kyoto Prefectural University of Medicine; National Center for Neurology & Psychiatry - Japan	Sasayama, H (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kamigyo Ku, Kyoto, Japan.	ttokuda@koto.kpu-m.ac.jp; myamaguc@kit.ac.jp	Mizuno, Toshiki/AAH-7155-2020	Mizuno, Toshiki/0000-0002-7907-8243; Yamaguchi, Masamitsu/0000-0002-6321-9750	Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [24406030, 23591252, 23390237] Funding Source: KAKEN	Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TT is supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Broustal O, 2010, J ALZHEIMERS DIS, V22, P765, DOI 10.3233/JAD-2010-100837; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; DeJesus-Hernandez M, 2010, HUM MUTAT, V31, pE1377, DOI 10.1002/humu.21241; Doi H, 2010, NEUROSCI RES, V66, P131, DOI 10.1016/j.neures.2009.10.004; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hewitt C, 2010, ARCH NEUROL-CHICAGO, V67, P455, DOI 10.1001/archneurol.2010.52; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Huang EJ, 2010, BRAIN PATHOL, V20, P1069, DOI 10.1111/j.1750-3639.2010.00413.x; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kasyapa CS, 2005, EXP CELL RES, V309, P78, DOI 10.1016/j.yexcr.2005.05.019; Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162; Kondo T, 2006, GENES GENET SYST, V81, P129, DOI 10.1266/ggs.81.129; Kovacs GG, 2009, MOVEMENT DISORD, V24, P1843, DOI 10.1002/mds.22697; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Miguel L, 2011, NEUROBIOL DIS, V41, P398, DOI 10.1016/j.nbd.2010.10.007; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Murphy JM, 2007, ARCH NEUROL-CHICAGO, V64, P530, DOI 10.1001/archneur.64.4.530; Nagai R, 2010, EXP CELL RES, V316, P272, DOI 10.1016/j.yexcr.2009.10.009; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; PRASAD DDK, 1994, ONCOGENE, V9, P3717; ROBERTSON HM, 1988, GENETICS, V118, P461; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Spradling A. C, 1986, DROSOPHILA PRACTICAL; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stewart BA, 2002, J NEUROBIOL, V51, P261, DOI 10.1002/neu.10059; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STOLOW DT, 1995, NUCLEIC ACIDS RES, V23, P835, DOI 10.1093/nar/23.5.835; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Takahashi Y, 1999, NUCLEIC ACIDS RES, V27, P510, DOI 10.1093/nar/27.2.510; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang JW, 2011, J CLIN INVEST, V121, P4118, DOI 10.1172/JCI57883; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zinszner H, 1997, J CELL SCI, V110, P1741	64	55	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39483	10.1371/journal.pone.0039483	http://dx.doi.org/10.1371/journal.pone.0039483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724023	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700086
J	Cai, Y; Zhu, HX; Li, JM; Luo, XG; Patrylo, PR; Rose, GM; Streeter, J; Hayes, R; Wang, KKW; Yan, XX; Jeromin, A				Cai, Yan; Zhu, Hai-Xia; Li, Jian-Ming; Luo, Xue-Gang; Patrylo, Peter R.; Rose, Gregory M.; Streeter, Jackson; Hayes, Ron; Wang, Kevin K. W.; Yan, Xiao-Xin; Jeromin, Andreas			Age-Related Intraneuronal Elevation of alpha II-Spectrin Breakdown Product SBDP120 in Rodent Forebrain Accelerates in 3 x Tg-AD Mice	PLOS ONE			English	Article							TRIPLE-TRANSGENIC MODEL; ALZHEIMERS-DISEASE; OLFACTORY-BULB; BRAIN SPECTRIN; MOUSE MODEL; CALPAIN; PROTEOLYSIS; BETA; ACTIVATION; MEMBRANE	Spectrins line the intracellular surface of plasmalemma and play a critical role in supporting cytoskeletal stability and flexibility. Spectrins can be proteolytically degraded by calpains and caspases, yielding breakdown products (SBDPs) of various molecular sizes, with SBDP120 being largely derived from caspase-3 cleavage. SBDPs are putative biomarkers for traumatic brain injury. The levels of SBDPs also elevate in the brain during aging and perhaps in Alzheimer's disease (AD), although the cellular basis for this change is currently unclear. Here we examined age-related SBDP120 alteration in forebrain neurons in rats and in the triple transgenic model of AD (3xTg-AD) relative to non-transgenic controls. SBDP120 immunoreactivity (IR) was found in cortical neuronal somata in aged rats, and was prominent in the proximal dendrites of the olfactory bulb mitral cells. Western blot and densitometric analyses in wild-type mice revealed an age-related elevation of intraneuronal SBDP120 in the forebrain which was more robust in their 3xTg-AD counterparts. The intraneuronal SBDP120 occurrence was not spatiotemporally correlated with transgenic amyloid precursor protein (APP) expression, beta-amyloid plaque development, or phosphorylated tau expression over various forebrain regions or lamina. No microscopically detectable in situ activated caspase-3 was found in the nuclei of SBDP120-containing neurons. The present study demonstrates the age-dependent intraneuronal presence of an alpha II-spectrin cleavage fragment in mammalian forebrain which is exacerbated in a transgenic model of AD. This novel neuronal alteration indicates that impairments in membrane protein metabolism, possibly due to neuronal calcium mishandling and/or enhancement of calcium sensitive proteolysis, occur during aging and in transgenic AD mice.	[Cai, Yan; Luo, Xue-Gang; Yan, Xiao-Xin] Cent S Univ, Dept Anat & Neurobiol, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [Zhu, Hai-Xia] Third Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Li, Jian-Ming] Changsha Med Univ, Neurosci Res Ctr, Changsha, Hunan, Peoples R China; [Patrylo, Peter R.; Rose, Gregory M.] So Illinois Univ, Sch Med, Dept Anat, Carbondale, IL 62901 USA; [Patrylo, Peter R.; Rose, Gregory M.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Patrylo, Peter R.; Rose, Gregory M.; Yan, Xiao-Xin] So Illinois Univ, Sch Med, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA; [Streeter, Jackson; Hayes, Ron; Wang, Kevin K. W.; Jeromin, Andreas] Banyan Biomarkers, Alachua, FL USA	Central South University; Central South University; Changsha Medical University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Banyan Biomarkers Inc.	Cai, Y (corresponding author), Cent S Univ, Dept Anat & Neurobiol, Xiangya Med Sch, Changsha, Hunan, Peoples R China.	yanxiaoxin@csu.edu.cn; ajeromin@banyanbio.com		Wang, Kevin/0000-0002-9343-6473	National Institute of Health [1R21NS056371]; National Natural Science Foundation of China [81171091]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056371] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (P.R.P., X.X.Y., 1R21NS056371), National Natural Science Foundation of China (X.X.Y., 81171091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Ayala-Grosso C, 2006, NEUROSCIENCE, V141, P863, DOI 10.1016/j.neuroscience.2006.04.041; BAHR BA, 1991, NEUROSCI LETT, V131, P237, DOI 10.1016/0304-3940(91)90622-Z; Baines AJ, 2010, TRANSFUS CLIN BIOL, V17, P95, DOI 10.1016/j.tracli.2010.06.008; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, J CELL BIOCHEM, V18, P49, DOI 10.1002/jcb.1982.240180106; Bernath E, 2006, NEUROBIOL AGING, V27, P624, DOI 10.1016/j.neurobiolaging.2005.02.013; BHATNAGAR KP, 1987, ANAT REC, V218, P73, DOI 10.1002/ar.1092180112; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cai Y, 2012, NEUROTOX RES, V21, P160, DOI 10.1007/s12640-011-9256-9; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; Cassano T, 2011, BEHAV BRAIN RES, V224, P408, DOI 10.1016/j.bbr.2011.06.029; Ennis M, 1998, ANN NY ACAD SCI, V855, P457, DOI 10.1111/j.1749-6632.1998.tb10606.x; Gaczynska M., 1992, Cytobios, V72, P197; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Grubb MS, 2010, CURR OPIN NEUROBIOL, V20, P481, DOI 10.1016/j.conb.2010.04.012; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Hwang IK, 2008, NEUROSCI LETT, V435, P251, DOI 10.1016/j.neulet.2008.02.050; ISAYAMA T, 1991, J NEUROSCI, V11, P3531; Keil U, 2006, J ALZHEIMERS DIS, V9, P139; Kudryashova I V, 2009, Neurosci Behav Physiol, V39, P13, DOI 10.1007/s11055-008-9089-z; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; Leissring MA, 2001, NEUROBIOL DIS, V8, P469, DOI 10.1006/nbdi.2001.0382; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Lopez JR, 2008, J NEUROCHEM, V105, P262, DOI 10.1111/j.1471-4159.2007.05135.x; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; MASLIAH E, 1990, BRAIN RES, V531, P36, DOI 10.1016/0006-8993(90)90755-Z; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Nath R, 2000, NEUROCHEM INT, V37, P351, DOI 10.1016/S0197-0186(00)00040-1; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Newcomb JK, 2000, METH MOL B, V144, P219; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; PETERSON C, 1991, NEUROSCI LETT, V121, P239, DOI 10.1016/0304-3940(91)90694-O; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Ramser EM, 2010, MOL CELL NEUROSCI, V45, P66, DOI 10.1016/j.mcn.2010.05.013; Resende R, 2008, FREE RADICAL BIO MED, V44, P2051, DOI 10.1016/j.freeradbiomed.2008.03.012; Rohn TT, 2008, REV NEUROSCIENCE, V19, P383; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Stankewich MC, 2010, P NATL ACAD SCI USA, V107, P6022, DOI 10.1073/pnas.1001522107; STRUBLE RG, 1992, NEUROBIOL AGING, V13, P469, DOI 10.1016/0197-4580(92)90074-8; Susuki K, 2011, P NATL ACAD SCI USA, V108, P8009, DOI 10.1073/pnas.1019600108; Tamada Y, 2005, BRAIN RES, V1050, P148, DOI 10.1016/j.brainres.2005.05.048; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Westphal D, 2010, J BIOL CHEM, V285, P42046, DOI 10.1074/jbc.M110.177147; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	58	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37599	10.1371/journal.pone.0037599	http://dx.doi.org/10.1371/journal.pone.0037599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723836	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300007
J	Zhan, JS; Yang, LN; Zhu, W; Shang, LP; Newton, AC				Zhan, Jiasui; Yang, Lina; Zhu, Wen; Shang, Liping; Newton, Adrian C.			Pathogen Populations Evolve to Greater Race Complexity in Agricultural Systems - Evidence from Analysis of Rhynchosporium secalis Virulence Data	PLOS ONE			English	Article							NEAR-ISOGENIC LINES; DISEASE RESISTANCE; BARLEY SCALD; MICROSATELLITE ANALYSES; PHYTOPHTHORA-INFESTANS; GENETIC DIVERSITY; DYNAMICS; TUNISIA; METAPOPULATION; RECOMBINATION	Fitness cost associated with pathogens carrying unnecessary virulence alleles is the fundamental assumption for preventing the emergence of complex races in plant pathogen populations but this hypothesis has rarely been tested empirically on a temporal and spatial scale which is sufficient to distinguish evolutionary signals from experimental error. We analyzed virulence characteristics of similar to 1000 isolates of the barley pathogen Rhynchosporium secalis collected from different parts of the United Kingdom between 1984 and 2005. We found a gradual increase in race complexity over time with a significant correlation between sampling date and race complexity of the pathogen (r(20) = 0.71, p = 0.0002) and an average loss of 0.1 avirulence alleles (corresponding to an average gain of 0.1 virulence alleles) each year. We also found a positive and significant correlation between barley cultivar diversity and R. secalis virulence variation. The conditions assumed to favour complex races were not present in the United Kingdom and we hypothesize that the increase in race complexity is attributable to the combination of natural selection and genetic drift. Host resistance selects for corresponding virulence alleles to fixation or dominant frequency. Because of the weak fitness penalty of carrying the unnecessary virulence alleles, genetic drift associated with other evolutionary forces such as hitch-hiking maintains the frequency of the dominant virulence alleles even after the corresponding resistance factors cease to be used.	[Zhan, Jiasui] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Zhan, Jiasui; Yang, Lina; Zhu, Wen; Shang, Liping] Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Key Lab Plant Virol, Fuzhou, Peoples R China; [Newton, Adrian C.] James Hutton Inst, Dundee, Scotland	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; James Hutton Institute	Zhan, JS (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	jiasui.zhan@fjau.edu.cn	Newton, Adrian C/H-4452-2011	Newton, Adrian C/0000-0003-0303-6706	Chinese National Science Foundation [31071655]; Scottish Government Rural and Environment Research and Analysis Directorate	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Scottish Government Rural and Environment Research and Analysis Directorate	The project was supported by Chinese National Science Foundation Grant no 31071655 and Scottish Government Rural and Environment Research and Analysis Directorate Barley Pathology Work package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abang MM, 2006, PHYTOPATHOLOGY, V96, P1214, DOI 10.1094/PHYTO-96-1214; ALI SM, 1974, AUST J AGR RES, V25, P21, DOI 10.1071/AR9740021; ANDRIVON D, 1994, CAN J BOT, V72, P1681, DOI 10.1139/b94-206; [Anonymous], 1975, STAT ANAL; Arabi MIE, 2008, J PLANT PATHOL, V90, P179; Bahri B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-26; BARUA UM, 1993, HEREDITY, V71, P177, DOI 10.1038/hdy.1993.122; BEVAN JR, 1993, PLANT PATHOL, V42, P622, DOI 10.1111/j.1365-3059.1993.tb01543.x; Bjornstad A, 2002, PHYTOPATHOLOGY, V92, P710, DOI 10.1094/PHYTO.2002.92.7.710; Bouajila A, 2006, AFR J BIOTECHNOL, V5, P570; Bouajila A, 2007, MYCOPATHOLOGIA, V163, P281, DOI 10.1007/s11046-007-9012-0; Bouajila A, 2010, FEMS MICROBIOL LETT, V305, P35, DOI 10.1111/j.1574-6968.2010.01909.x; Brown JKM, 2003, TRENDS GENET, V19, P667, DOI 10.1016/j.tig.2003.10.008; Cox CM, 2004, PHYTOPATHOLOGY, V94, P961, DOI 10.1094/PHYTO.2004.94.9.961; de Vallavieille-Pope C, 2012, PLANT DIS, V96, P131, DOI 10.1094/PDIS-02-11-0078; Forgan AH, 2007, PHYTOPATHOLOGY, V97, P650, DOI 10.1094/PHYTO-97-5-0650; Fraile A, 2011, MOL BIOL EVOL, V28, P1425, DOI 10.1093/molbev/msq327; GILMOUR J, 1973, NATURE, V242, P620, DOI 10.1038/242620a0; GOODWIN SB, 1994, PHYTOPATHOLOGY, V84, P1047, DOI 10.1094/Phyto-84-1047; GOODWIN SB, 1993, MYCOL RES, V97, P49, DOI 10.1016/S0953-7562(09)81112-X; GOODWIN SB, 1990, PHYTOPATHOLOGY, V80, P1330, DOI 10.1094/Phyto-80-1330; HOUSTON BR, 1957, PHYTOPATHOLOGY, V47, P525; Huang SP, 2001, GENETICS, V159, P1365; JACKSON LF, 1976, PHYTOPATHOLOGY, V66, P726, DOI 10.1094/Phyto-66-726; Jenner CE, 2002, VIRUS RES, V86, P1, DOI 10.1016/S0168-1702(02)00031-X; Kiros-Meles A, 2011, BIOL INVASIONS, V13, P321, DOI 10.1007/s10530-010-9808-6; KIYOSAWA S, 1982, ANNU REV PHYTOPATHOL, V20, P93, DOI 10.1146/annurev.py.20.090182.000521; Lannou C, 1997, THEOR APPL GENET, V94, P991, DOI 10.1007/s001220050506; Leach JE, 2001, ANNU REV PHYTOPATHOL, V39, P187, DOI 10.1146/annurev.phyto.39.1.187; MCDERMOTT JM, 1989, GENETICS, V122, P561; McDonald BA, 1999, PHYTOPATHOLOGY, V89, P639, DOI 10.1094/PHYTO.1999.89.8.639; Montarry J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-283; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEWMAN PL, 1985, PLANT PATHOL, V34, P338, DOI 10.1111/j.1365-3059.1985.tb01370.x; Ott R.L., 1992, INTRO STAT METHODS D; Rigby MC, 2002, TRENDS PARASITOL, V18, P116, DOI 10.1016/S1471-4922(01)02203-6; ROHE M, 1995, EMBO J, V14, P4168, DOI 10.1002/j.1460-2075.1995.tb00090.x; Salamati S, 2000, PHYTOPATHOLOGY, V90, P901, DOI 10.1094/PHYTO.2000.90.8.901; Schurch S, 2004, MOL PLANT MICROBE IN, V17, P1114, DOI 10.1094/MPMI.2004.17.10.1114; Shipton WA, 1974, ANN REV PLANT PATHOL, V53, P839; Szunics L, 2001, EUPHYTICA, V119, P143, DOI 10.1023/A:1017588816724; Thirugnanasambandam A, 2011, PLANT PATHOL, V60, P513, DOI 10.1111/j.1365-3059.2010.02393.x; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; United Kingdom Cereal Pathogen Virulence Survey Committee, 1984, ANN REP UK CER PATH; Williams K, 2003, AUSTRALAS PLANT PATH, V32, P257, DOI 10.1071/AP03008; Wolfe MS, 2000, NATURE, V406, P681, DOI 10.1038/35021152; WORKMAN PL, 1970, AM J HUM GENET, V22, P24; Xi K, 2000, PHYTOPATHOLOGY, V90, P94, DOI 10.1094/PHYTO.2000.90.1.94; Xi KN, 2003, MYCOL RES, V107, P1485, DOI 10.1017/S0953756203008748; Zaffarano PL, 2011, MYCOLOGIA, V103, P195, DOI 10.3852/10-119; Zhan J, 2008, PLANT PATHOL, V57, P1, DOI 10.1111/j.1365-3059.2007.01691.x; Zhan J, 2006, P 3 INT WORKSH BARL, P88; Zhang Q, 1987, PHYTOPATHOLOGY, V77, P352; ZHANG QF, 1992, PHYTOPATHOLOGY, V82, P798, DOI 10.1094/Phyto-82-798; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	56	14	15	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38611	10.1371/journal.pone.0038611	http://dx.doi.org/10.1371/journal.pone.0038611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723870	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300034
J	De Ingeniis, J; Kazanov, MD; Shatalin, K; Gelfand, MS; Osterman, AL; Sorci, L				De Ingeniis, Jessica; Kazanov, Marat D.; Shatalin, Konstantin; Gelfand, Mikhail S.; Osterman, Andrei L.; Sorci, Leonardo			Glutamine versus Ammonia Utilization in the NAD Synthetase Family	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; SALMONELLA-TYPHIMURIUM; COMPARATIVE GENOMICS; BACILLUS-SUBTILIS; ENZYME; DOMAIN; IDENTIFICATION; BIOSYNTHESIS	NAD is a ubiquitous and essential metabolic redox cofactor which also functions as a substrate in certain regulatory pathways. The last step of NAD synthesis is the ATP-dependent amidation of deamido-NAD by NAD synthetase (NADS). Members of the NADS family are present in nearly all species across the three kingdoms of Life. In eukaryotic NADS, the core synthetase domain is fused with a nitrilase-like glutaminase domain supplying ammonia for the reaction. This two-domain NADS arrangement enabling the utilization of glutamine as nitrogen donor is also present in various bacterial lineages. However, many other bacterial members of NADS family do not contain a glutaminase domain, and they can utilize only ammonia (but not glutamine) in vitro. A single-domain NADS is also characteristic for nearly all Archaea, and its dependence on ammonia was demonstrated here for the representative enzyme from Methanocaldococcus jannaschi. However, a question about the actual in vivo nitrogen donor for single-domain members of the NADS family remained open: Is it glutamine hydrolyzed by a committed (but yet unknown) glutaminase subunit, as in most ATP-dependent amidotransferases, or free ammonia as in glutamine synthetase? Here we addressed this dilemma by combining evolutionary analysis of the NADS family with experimental characterization of two representative bacterial systems: a two-subunit NADS from Thermus thermophilus and a single-domain NADS from Salmonella typhimurium providing evidence that ammonia (and not glutamine) is the physiological substrate of a typical single-domain NADS. The latter represents the most likely ancestral form of NADS. The ability to utilize glutamine appears to have evolved via recruitment of a glutaminase subunit followed by domain fusion in an early branch of Bacteria. Further evolution of the NADS family included lineage-specific loss of one of the two alternative forms and horizontal gene transfer events. Lastly, we identified NADS structural elements associated with glutamine-utilizing capabilities.	[De Ingeniis, Jessica; Kazanov, Marat D.; Osterman, Andrei L.; Sorci, Leonardo] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Kazanov, Marat D.; Gelfand, Mikhail S.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Shatalin, Konstantin] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Sorci, Leonardo] Polytech Univ Marche, Biochem Sect, Dept Clin Sci, Ancona, Italy	Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; New York University; Lomonosov Moscow State University; Marche Polytechnic University	De Ingeniis, J (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	osterman@sanfordburnham.org; l.sorci@univpm.it	Kazanov, Marat D/D-6381-2013; Gelfand, Mikhail S/F-3425-2012; SORCI, LEONARDO/AAD-7395-2019	Kazanov, Marat D/0000-0002-2314-5507; SORCI, LEONARDO/0000-0002-4356-8873; Gelfand, Mikhail/0000-0003-4181-0846	"Montalcini International Program'' through the Italian Ministry of Education, University and Research; National Institute of Allergy and Infectious Diseases (NIAID) [AI066244]; DOE-BER Genomic Science Program (GSP) as part of Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area; Program in Molecular and Cellular Biology of the Russian Academy of Sciences; Russian Foundation of Basic Research [10-04-00431, 09-04-92745];  [07.514.11.4007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066244] Funding Source: NIH RePORTER	"Montalcini International Program'' through the Italian Ministry of Education, University and Research; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOE-BER Genomic Science Program (GSP) as part of Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area; Program in Molecular and Cellular Biology of the Russian Academy of Sciences; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was partly supported by "Montalcini International Program'' through the Italian Ministry of Education, University and Research to LS, by the National Institute of Allergy and Infectious Diseases (NIAID) grant AI066244 and by the DOE-BER Genomic Science Program (GSP) as part of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area to ALO, and by the Program in Molecular and Cellular Biology of the Russian Academy of Sciences, grants 10-04-00431 and 09-04-92745 of the Russian Foundation of Basic Research and State contract 07.514.11.4007 to MSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bieganowski P, 2003, J BIOL CHEM, V278, P33056, DOI 10.1074/jbc.M302276200; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; BROACH J, 1976, J BACTERIOL, V128, P86, DOI 10.1128/JB.128.1.86-98.1976; Chuenchor W, 2012, BIOCHEM J, V443, P417, DOI 10.1042/BJ20112210; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Devedjiev Y, 2001, ACTA CRYSTALLOGR D, V57, P806, DOI 10.1107/S0907444901003523; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; Gerdes SY, 2006, J BACTERIOL, V188, P3012, DOI 10.1128/JB.188.8.3012-3023.2006; Gerlach G, 2006, J BACTERIOL, V188, P6719, DOI 10.1128/JB.00432-06; Hara N, 2003, J BIOL CHEM, V278, P10914, DOI 10.1074/jbc.M209203200; Huang N, 2008, STRUCTURE, V16, P196, DOI 10.1016/j.str.2007.11.017; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jauch R, 2005, J BIOL CHEM, V280, P15131, DOI 10.1074/jbc.M413195200; Kalinina OV, 2004, NUCLEIC ACIDS RES, V32, pW424, DOI 10.1093/nar/gkh391; Kang GB, 2005, PROTEINS, V58, P985, DOI 10.1002/prot.20377; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kurnasov OV, 2002, J BACTERIOL, V184, P6906, DOI 10.1128/JB.184.24.6906-6917.2002; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Maddison WP, 2017, MESQUITE MODULAR SYS; McDonald HM, 2007, ACTA CRYSTALLOGR D, V63, P891, DOI 10.1107/S0907444907029769; Moro WB, 2009, BIOORG MED CHEM LETT, V19, P2001, DOI 10.1016/j.bmcl.2009.02.034; NESSI C, 1995, J BIOL CHEM, V270, P6181, DOI 10.1074/jbc.270.11.6181; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Osterman AL, 2007, PROG DRUG RES, V64, p[131, 133], DOI DOI 10.1007/978-3-7643-7567-6_; Osterman Andrei L, 2007, Prog Drug Res, V64, P133; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Resto M, 2009, BBA-PROTEINS PROTEOM, V1794, P1648, DOI 10.1016/j.bbapap.2009.07.014; Rizzi M, 1996, EMBO J, V15, P5125, DOI 10.1002/j.1460-2075.1996.tb00896.x; Rizzi M, 1998, STRUCTURE, V6, P1129, DOI 10.1016/S0969-2126(98)00114-2; Schneider BL, 1998, J BACTERIOL, V180, P4739, DOI 10.1128/JB.180.17.4739-4741.1998; Sorci L, 2009, TARGETING NAD BIOSYN; Sorci L, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P213; Sorci L, 2010, J BIOL CHEM, V285, P39490, DOI 10.1074/jbc.M110.185629; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suda Y, 2003, YEAST, V20, P995, DOI 10.1002/yea.1008; Symersky J, 2002, ACTA CRYSTALLOGR D, V58, P1138, DOI 10.1107/S0907444902006698; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Veiga-Malta I, 2004, J BACTERIOL, V186, P419, DOI 10.1128/JB.186.2.419-426.2004; Velu SE, 2007, J MED CHEM, V50, P2612, DOI 10.1021/jm061349l; WILLISON JC, 1994, J BACTERIOL, V176, P3400, DOI 10.1128/jb.176.11.3400-3402.1994; Wojcik M, 2006, J BIOL CHEM, V281, P33395, DOI 10.1074/jbc.M607111200; Yamaguchi F, 2002, BIOSCI BIOTECH BIOCH, V66, P2052, DOI 10.1271/bbb.66.2052; Yanai I, 2002, GENOME BIOL, V3; ZALKIN H, 1985, METHOD ENZYMOL, V113, P297; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002318; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	60	32	31	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39115	10.1371/journal.pone.0039115	http://dx.doi.org/10.1371/journal.pone.0039115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720044	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000040
J	Li, BQ; Hu, LL; Chen, L; Feng, KY; Cai, YD; Chou, KC				Li, Bi-Qing; Hu, Le-Le; Chen, Lei; Feng, Kai-Yan; Cai, Yu-Dong; Chou, Kuo-Chen			Prediction of Protein Domain with mRMR Feature Selection and Analysis	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUBCELLULAR-LOCALIZATION; FUNCTIONAL DOMAIN; CLEAVAGE SITES; WEB-SERVER; SUBNUCLEAR LOCALIZATION; SOLVENT ACCESSIBILITY; AUTOMATED PREDICTION; SECONDARY STRUCTURE; BINDING SITES	The domains are the structural and functional units of proteins. With the avalanche of protein sequences generated in the postgenomic age, it is highly desired to develop effective methods for predicting the protein domains according to the sequences information alone, so as to facilitate the structure prediction of proteins and speed up their functional annotation. However, although many efforts have been made in this regard, prediction of protein domains from the sequence information still remains a challenging and elusive problem. Here, a new method was developed by combing the techniques of RF (random forest), mRMR (maximum relevance minimum redundancy), and IFS (incremental feature selection), as well as by incorporating the features of physicochemical and biochemical properties, sequence conservation, residual disorder, secondary structure, and solvent accessibility. The overall success rate achieved by the new method on an independent dataset was around 73%, which was about 28-40% higher than those by the existing method on the same benchmark dataset. Furthermore, it was revealed by an in-depth analysis that the features of evolution, codon diversity, electrostatic charge, and disorder played more important roles than the others in predicting protein domains, quite consistent with experimental observations. It is anticipated that the new method may become a high-throughput tool in annotating protein domains, or may, at the very least, play a complementary role to the existing domain prediction methods, and that the findings about the key features with high impacts to the domain prediction might provide useful insights or clues for further experimental investigations in this area. Finally, it has not escaped our notice that the current approach can also be utilized to study protein signal peptides, B-cell epitopes, HIV protease cleavage sites, among many other important topics in protein science and biomedicine.	[Hu, Le-Le; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing; Feng, Kai-Yan] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Maritime University	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; kcchou@gordonlifescience.org	Chen, Lei/A-2275-2011; Chou, Kuo-Chen/A-8340-2009	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from the National Basic Research Program of China (2011CB510102, 2011CB510101) and the Innovation Program of Shanghai Municipal Education Commission (12ZZ087).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Bondugula R, 2009, NUCLEIC ACIDS RES, V37, P452, DOI 10.1093/nar/gkn944; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; CAMPBELL ID, 1994, TRENDS BIOTECHNOL, V12, P168, DOI 10.1016/0167-7799(94)90078-7; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cheng J, 2007, NUCLEIC ACIDS RES, V35, pW354, DOI 10.1093/nar/gkm390; Cheng JL, 2006, DATA MIN KNOWL DISC, V13, P1, DOI 10.1007/s10618-005-0023-5; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Chou KC, 2005, BIOCHEM BIOPH RES CO, V331, P56, DOI 10.1016/j.bbrc.2005.03.123; Chou KC, 2004, BIOCHEM BIOPH RES CO, V321, P1007, DOI 10.1016/j.bbrc.2004.07.059; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 2004, BIOCHEM BIOPH RES CO, V316, P636, DOI 10.1016/j.bbrc.2004.02.098; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; CHOU KC, 1995, FEBS LETT, V363, P123, DOI 10.1016/0014-5793(95)00240-A; Chou KC, 2002, CURR PROTEIN PEPT SC, V3, P615, DOI 10.2174/1389203023380468; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEIN SCI, V4, P1365, DOI 10.1002/pro.5560040712; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Eickholt J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-43; ELHAMMER AP, 1993, J BIOL CHEM, V268, P10029; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; George RA, 2002, J MOL BIOL, V316, P839, DOI 10.1006/jmbi.2001.5387; Gewehr JE, 2006, BIOINFORMATICS, V22, P181, DOI 10.1093/bioinformatics/bti751; Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905; Gong S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-207; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Guerois R, 2001, CURR OPIN STRUC BIOL, V11, P101, DOI 10.1016/S0959-440X(00)00170-6; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Holland TA, 2006, J MOL BIOL, V361, P562, DOI 10.1016/j.jmb.2006.05.060; Holm L, 1998, PROTEINS, V33, P88, DOI 10.1002/(SICI)1097-0134(19981001)33:1<88::AID-PROT8>3.0.CO;2-H; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Ingolfsson Helgi, 2008, V426, P117, DOI 10.1007/978-1-60327-058-8_7; Jia SC, 2011, PROTEIN PEPTIDE LETT, V18, P609, DOI 10.2174/092986611795222777; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Li DD, 2010, PROTEIN PEPTIDE LETT, V17, P1566, DOI 10.2174/0929866511009011566; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li YD, 2009, PROTEIN PEPTIDE LETT, V16, P706, DOI 10.2174/092986609788490096; Li YX, 2011, PROTEIN PEPTIDE LETT, V18, P573, DOI 10.2174/092986611795222731; Lin J, 2011, PROTEIN PEPTIDE LETT, V18, P1219, DOI 10.2174/092986611797642797; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu JF, 2004, NUCLEIC ACIDS RES, V32, P3522, DOI 10.1093/nar/gkh684; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Mbamala EC, 2005, BIOPHYS J, V88, P1702, DOI 10.1529/biophysj.104.048132; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Moses AM, 2009, MOL BIOL EVOL, V26, P527, DOI 10.1093/molbev/msn286; Mundra P, 2007, PATTERN RECOGN LETT, V28, P1610, DOI 10.1016/j.patrec.2007.04.001; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagarajan N, 2004, BIOINFORMATICS, V20, P1335, DOI 10.1093/bioinformatics/bth086; Nielsen PK, 2001, J BIOL CHEM, V276, P10906, DOI 10.1074/jbc.M008743200; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; POORMAN RA, 1991, J BIOL CHEM, V266, P14554; Pugalenthi G, 2012, PROTEIN PEPTIDE LETT, V19, P50, DOI 10.2174/092986612798472875; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; Qiu ZJ, 2011, PROTEIN PEPTIDE LETT, V18, P1212, DOI 10.2174/092986611797642788; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Saffari B, 2008, PROTEIN PEPTIDE LETT, V15, P280; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shameer K, 2011, PROTEIN PEPTIDE LETT, V18, P1010, DOI 10.2174/092986611796378729; Shen HB, 2008, ANAL BIOCHEM, V375, P388, DOI 10.1016/j.ab.2008.01.012; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Suyama M, 2003, BIOINFORMATICS, V19, P673, DOI 10.1093/bioinformatics/btg031; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; von Ohsen N, 2004, BIOINFORMATICS, V20, P2228, DOI 10.1093/bioinformatics/bth232; Walsh I, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-195; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wang K, 2012, PROTEIN PEPTIDE LETT, V19, P15, DOI 10.2174/092986612798472820; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; WITTEN IH, 2005, DATA MINING PRACTICA; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xiao XA, 2011, MOL DIVERS, V15, P149, DOI 10.1007/s11030-010-9227-8; Xiao X, 2009, J APPL CRYSTALLOGR, V42, P169, DOI 10.1107/S0021889809002751; Xiao X, 2009, J COMPUT CHEM, V30, P1414, DOI 10.1002/jcc.21163; Yoon MK, 2009, PROTEIN SCI, V18, P337, DOI 10.1002/pro.34; Zhang YF, 2011, PROTEIN PEPTIDE LETT, V18, P7, DOI 10.2174/092986611794328717; Zhao W, 2011, PROTEIN PEPTIDE LETT, V18, P707, DOI 10.2174/092986611795446094; Zhou GP, 2011, PROTEIN PEPTIDE LETT, V18, P966, DOI 10.2174/0929866511107010966; Zhou GP, 2011, J THEOR BIOL, V284, P142, DOI 10.1016/j.jtbi.2011.06.006	113	79	83	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39308	10.1371/journal.pone.0039308	http://dx.doi.org/10.1371/journal.pone.0039308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720092	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000058
J	Bharati, A; Kar, M; Sabat, SC				Bharati, Adyasha; Kar, Monaranjan; Sabat, Surendra Chandra			Artemisinin Inhibits Chloroplast Electron Transport Activity: Mode of Action	PLOS ONE			English	Article							A FLUORESCENCE INDUCTION; PHOTOSYSTEM-II; CHLOROPHYLL-A; MECHANISMS; MEMBRANES; ANNUA; SITE	Artemisinin, a secondary metabolite produced in Artemisia plant species, besides having antimalarial properties is also phytotoxic. Although, the phytotoxic activity of the compound has been long recognized, no information is available on the mechanism of action of the compound on photosynthetic activity of the plant. In this report, we have evaluated the effect of artemisinin on photoelectron transport activity of chloroplast thylakoid membrane. The inhibitory effect of the compound, under in vitro condition, was pronounced in loosely and fully coupled thylakoids; being strong in the former. The extent of inhibition was drastically reduced in the presence of uncouplers like ammonium chloride or gramicidin; a characteristic feature described for energy transfer inhibitors. The compound, on the other hand, when applied to plants (in vivo), behaved as a potent inhibitor of photosynthetic electron transport. The major site of its action was identified to be the Q(B); the secondary quinone moiety of photosystemII complex. Analysis of photoreduction kinetics of para-benzoquinone and duroquinone suggest that the inhibition leads to formation of low pool of plastoquinol, which becomes limiting for electron flow through photosystemI. Further it was ascertained that the in vivo inhibitory effect appeared as a consequence of the formation of an unidentified artemisinin-metabolite rather than by the interaction of the compound per se. The putative metabolite of artemisinin is highly reactive in instituting the inhibition of photosynthetic electron flow eventually reducing the plant growth.	[Bharati, Adyasha; Sabat, Surendra Chandra] Inst Life Sci, Stress Biol Lab, Bhubaneswar, Odisha, India; [Kar, Monaranjan] Utkal Univ, Dept Bot, Bhubaneswar 751004, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Utkal University	Bharati, A (corresponding author), Inst Life Sci, Stress Biol Lab, Bhubaneswar, Odisha, India.	surendrachandra@gmail.com			Institute of Life Sciences	Institute of Life Sciences	The financial support was institutional, obtained from Director, Institute of Life Sciences, which is intramural. No extramural funding was used in this study. The intramural funding in the authors' case had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi G. D., 1998, Journal of Medicinal and Aromatic Plant Sciences, V20, P5; Bagchi GD, 1997, PHYTOCHEMISTRY, V45, P1131, DOI 10.1016/S0031-9422(97)00126-X; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; BOWES JM, 1981, ARCH BIOCHEM BIOPHYS, V209, P682, DOI 10.1016/0003-9861(81)90329-5; Bukhov NG, 2003, BBA-BIOENERGETICS, V1604, P115, DOI 10.1016/S0005-2728(03)00042-2; CHEN P K, 1987, Plant Physiology (Rockville), V83, P68; CHEN PK, 1990, J CHEM ECOL, V16, P1867, DOI 10.1007/BF01020500; Dayan FE, 1999, PHYTOCHEMISTRY, V50, P607, DOI 10.1016/S0031-9422(98)00568-8; Dayan FE, 2010, WEED SCI, V58, P340, DOI 10.1614/WS-09-092.1; DEAMER DW, 1967, BIOCHIM BIOPHYS ACTA, V131, P81, DOI 10.1016/0005-2728(67)90032-1; Dudekula S, 2006, J PHOTOCH PHOTOBIO B, V85, P177, DOI 10.1016/j.jphotobiol.2006.07.003; Duke S.O., 1988, ACS SYM SER, V380, P318; Duke SO, 2002, WEED SCI, V50, P138, DOI 10.1614/0043-1745(2002)050[0138:IPCFNF]2.0.CO;2; DUKE SO, 1987, WEED SCI, V35, P499, DOI 10.1017/S0043174500060458; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Izawa S., 1980, METHODS ENZYMOL    C, P413; JOSHI MK, 1995, J SCI IND RES INDIA, V54, P155; Kashino Y, 1996, PLANT CELL PHYSIOL, V37, P976, DOI 10.1093/oxfordjournals.pcp.a029047; Li W, 2005, PLOS GENET, V1, P329, DOI 10.1371/journal.pgen.0010036; Lydon J, 1997, WEED SCI, V45, P807, DOI 10.1017/S0043174500089001; NISHIO JN, 1991, PLANT PHYSIOL, V95, P522, DOI 10.1104/pp.95.2.522; Nixon PJ, 2000, PHILOS T R SOC B, V355, P1541, DOI 10.1098/rstb.2000.0714; Papageorgiou GC, 2007, PHOTOSYNTH RES, V94, P275, DOI 10.1007/s11120-007-9193-x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Robert A, 2005, ACS SYM SER, V903, P281; Rutherford AW, 2001, TRENDS BIOCHEM SCI, V26, P648, DOI 10.1016/S0968-0004(01)01953-3; SAHA S, 1971, J BIOL CHEM, V246, P3204; SATOH K, 1990, CURRENT RESEARCH IN PHOTOSYNTHESIS, VOLS 1-4, pA583; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser R.J., 2004, ANAL CHLOROPHYLL FLU, V19, DOI [10.1007/978-1-4020- 3218-9_12, DOI 10.1007/978-1-4020-3218-9_12]; Trebst A, 2007, PHOTOSYNTH RES, V92, P217, DOI 10.1007/s11120-007-9213-x; VANRENSEN JJS, 1989, SOC EXP BIOL SEM SER, V38, P21; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582	34	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38942	10.1371/journal.pone.0038942	http://dx.doi.org/10.1371/journal.pone.0038942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719995	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900066
J	Hirai, H; Firpo, M; Kikyo, N				Hirai, Hiroyuki; Firpo, Meri; Kikyo, Nobuaki			Establishment of LIF-Dependent Human iPS Cells Closely Related to Basic FGF-Dependent Authentic iPS Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; X-INACTIVATION; SELF-RENEWAL; PLURIPOTENCY; MOUSE; DERIVATION	Human induced pluripotent stem cells (iPSCs) can be divided into a leukemia inhibitory factor (LIF)-dependent naive type and a basic fibroblast growth factor (bFGF)-dependent primed type. Although the former are more undifferentiated than the latter, they require signal transduction inhibitors and sustained expression of the transgenes used for iPSC production. We used a transcriptionally enhanced version of OCT4 to establish LIF-dependent human iPSCs without the use of inhibitors and sustained transgene expression. These cells belong to the primed type of pluripotent stem cell, similar to bFGF-dependent iPSCs. Thus, the particular cytokine required for iPSC production does not necessarily define stem cell phenotypes as previously thought. It is likely that the bFGF and LIF signaling pathways converge on unidentified OCT4 target genes. These findings suggest that our LIF-dependent human iPSCs could provide a novel model to investigate the role of cytokine signaling in cellular reprogramming.	[Hirai, Hiroyuki; Firpo, Meri; Kikyo, Nobuaki] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Hirai, Hiroyuki; Kikyo, Nobuaki] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA; [Firpo, Meri] Univ Minnesota, Dept Med, Div Endocrinol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hirai, H (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.	kikyo001@umn.edu	Hirai, Hiroyuki/A-6866-2019	Hirai, Hiroyuki/0000-0001-7302-7587	Masonic Cancer Center grant from the U.S. National Institutes of Health [P30 CA077598-09]; Richard M. Schulze Family Foundation; U. S. National Institutes of Health [R01 DK082430]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082430] Funding Source: NIH RePORTER	Masonic Cancer Center grant from the U.S. National Institutes of Health; Richard M. Schulze Family Foundation; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Histological preparation and karyotyping were supported by a Masonic Cancer Center grant from the U.S. National Institutes of Health (P30 CA077598-09). M. F. and N.K were supported by the Richard M. Schulze Family Foundation. N.K. was supported by a grant from the U. S. National Institutes of Health (R01 DK082430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V7, P559, DOI 10.1016/j.stem.2010.10.007; Di Stefano B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016092; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hirai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034149; Hirai H, 2011, STEM CELLS, V29, P1349, DOI 10.1002/stem.684; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Kunath T, 2011, CELL STEM CELL, V8, P241, DOI 10.1016/j.stem.2011.02.009; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	20	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39022	10.1371/journal.pone.0039022	http://dx.doi.org/10.1371/journal.pone.0039022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720020	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900074
J	Koenig, CM; Walker, CK; Qi, LH; Pessah, IN; Berman, RF				Koenig, Claire M.; Walker, Cheryl K.; Qi, Lihong; Pessah, Isaac N.; Berman, Robert F.			Lack of Evidence for Neonatal Misoprostol Neurodevelopmental Toxicity in C57BL6/J Mice	PLOS ONE			English	Article							FETAL VALPROATE SYNDROME; SPECTRUM DISORDERS; LABOR INDUCTION; MOBIUS SEQUENCE; CELL-DEATH; PLUS-MAZE; IN-UTERO; AUTISM; RISK; IMMUNE	Misoprostol is a synthetic analogue of prostaglandin E1 that is administered to women at high doses to induce uterine contractions for early pregnancy termination and at low doses to aid in cervical priming during labor. Because of the known teratogenic effects of misoprostol when given during gestation and its effects on axonal growth in vitro, we examined misoprostol for its potential as a neurodevelopmental toxicant when administered to neonatal C57BL6/J mice. Mice were injected subcutaneously (s.c.) with 0.4, 4 or 40 mu g/kg misoprostol on postnatal day 7, the approximate developmental stage in mice of human birth, after which neonatal somatic growth, and sensory and motor system development were assessed. These doses were selected to span the range of human exposure used to induce labor. In addition, adult mice underwent a battery of behavioral tests relevant to neurodevelopmental disorders such as autism including tests for anxiety, stereotyped behaviors, social communication and interactions, and learning and memory. No significant effects of exposure were found for any measure of development or behavioral endpoints. In conclusion, the results of the present study in C57BL/6J mice do not provide support for neurodevelopmental toxicity after misoprostol administration approximating human doses and timed to coincide with the developmental stage of human birth.	[Koenig, Claire M.; Walker, Cheryl K.; Qi, Lihong; Pessah, Isaac N.; Berman, Robert F.] Univ Calif Davis, Ctr Childrens Environm Hlth, Davis, CA 95616 USA; [Koenig, Claire M.; Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Walker, Cheryl K.] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [Qi, Lihong] Univ Calif Davis, Dept Publ Hlth, Div Biostat, Davis, CA 95616 USA; [Pessah, Isaac N.] Univ Calif Davis, Dept VM Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Koenig, CM (corresponding author), Univ Calif Davis, Ctr Childrens Environm Hlth, Davis, CA 95616 USA.	rfberman@ucdavis.edu	Qi, LI/AAF-3389-2019; Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X; Koenig, Claire/0000-0003-2546-4031	National Institute of Environmental Health Sciences (NIEHS) [1 P01 ES11269]; U.S. Environmental Protection Agency (U.S. EPA) through the Science to Achieve Results (STAR) program [R833292, R829388]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269, R01ES020392] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Environmental Protection Agency (U.S. EPA) through the Science to Achieve Results (STAR) program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grant number National Institute of Environmental Health Sciences (NIEHS) 1 P01 ES11269, the U.S. Environmental Protection Agency (U.S. EPA) through the Science to Achieve Results (STAR) program award numbers R833292 and R829388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwood Paul, 2004, Clin Dev Immunol, V11, P165, DOI 10.1080/10446670410001722096; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Bandim JM, 2003, ARQ NEURO-PSIQUIAT, V61, P181, DOI 10.1590/S0004-282X2003000200004; Beard CM, 2011, MED HYPOTHESES, V77, P15, DOI 10.1016/j.mehy.2011.03.013; Bell Jericho, 2011, J Miss State Med Assoc, V52, P35; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; BORBE HO, 1990, J NEUR TR S, P131; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Choi EJ, 2008, BRAIN RES BULL, V77, P293, DOI 10.1016/j.brainresbull.2008.06.006; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Curran MP, 2011, PEDIATR DRUGS, V13, P197, DOI 10.2165/11207230-000000000-00000; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Dufour-Rainfray D, 2011, NEUROSCI BIOBEHAV R, V35, P1254, DOI 10.1016/j.neubiorev.2010.12.013; Dulawa SC, 2000, NEUROPHARMACOLOGY, V39, P2170, DOI 10.1016/S0028-3908(00)00030-7; Enoch J, 1999, Midwifery Today Int Midwife, P22; Evatt ML, 2009, NEUROLOGY, V73, P997, DOI 10.1212/WNL.0b013e3181af0b95; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Gillberg C, 1999, ACTA PSYCHIAT SCAND, V99, P399, DOI 10.1111/j.1600-0447.1999.tb00984.x; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Hallmayer J., 2011, ARCH GEN PSYCHIAT; HAYNES DR, 1992, IMMUNOLOGY, V76, P251; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Hultman CM, 2010, MOL PSYCHIAT; Irvine EE, 2001, PHARMACOL BIOCHEM BE, V68, P319, DOI 10.1016/S0091-3057(00)00449-4; Jaubert PJ, 2007, GENES BRAIN BEHAV, V6, P141, DOI 10.1111/j.1601-183X.2006.00240.x; Johansson M, 2001, DEV MED CHILD NEUROL, V43, P338, DOI 10.1017/S0012162201000627; Kovacs Z, 2011, J NEUROSCI METH, V197, P133, DOI 10.1016/j.jneumeth.2011.02.005; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Larson SJ, 2002, J GEN PSYCHOL, V129, P401, DOI 10.1080/00221300209602104; Lawler CP, 2004, MENT RETARD DEV D R, V10, P292, DOI 10.1002/mrdd.20043; LePage Keith T., 2005, Critical Reviews in Neurobiology, V17, P27; Li J, 2008, NEUROSCI LETT, V438, P210, DOI 10.1016/j.neulet.2008.04.054; LIM SP, 1994, DIGEST DIS SCI, V39, P1249; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McGovern V, 2007, ENVIRON HEALTH PERSP, V115, pA504, DOI 10.1289/ehp.115-a504a; Mehler MF, 1999, ADV PROTEIN CHEM, V52, P223; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Miller MT, 2009, BIRTH DEFECTS RES A, V85, P667, DOI 10.1002/bdra.20609; MILLER RC, 1994, RADIAT RES, V139, P109, DOI 10.2307/3578740; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nuthalapaty FS, 2005, AM J OBSTET GYNECOL, V193, P1065, DOI 10.1016/j.ajog.2005.05.087; Parker Charles W., 1995, Am J Ther, V2, P772, DOI 10.1097/00045391-199510000-00007; Paxinos G., 2001, MOUSE BRAIN STEROTAX; Pessah IN, 2008, NEUROTOXICOLOGY, V29, P532, DOI 10.1016/j.neuro.2008.02.006; Pottie K, 1999, CAN FAM PHYSICIAN, V45, P315; Reichenberg A, 2010, AM J PUBLIC HEALTH, V100, P772, DOI 10.2105/AJPH.2009.187708; Rice C, 2010, DISABIL HEALTH J, V3, P186, DOI 10.1016/j.dhjo.2009.10.008; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rus V., 1995, Am J Ther, V2, P911, DOI 10.1097/00045391-199512000-00002; Schmidt RJ, 2011, EPIDEMIOLOGY, V22, P476, DOI 10.1097/EDE.0b013e31821d0e30; SHIELD MJ, 1992, SCAND J RHEUMATOL, P31; Silverstein FE, 1998, DIGEST DIS SCI, V43, P447, DOI 10.1023/A:1018895417831; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Stromland Kerstin, 2002, Eur J Paediatr Neurol, V6, P35, DOI 10.1053/ejpn.2001.0540; Sullivan KM, 2008, ENVIRON HEALTH PERSP, V116, pA155, DOI [10.1289/elip.11010, 10.1289/ehp.11010]; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tamiji J, 2010, BIOCHEM BIOPH RES CO, V399, P565, DOI 10.1016/j.bbrc.2010.07.112; Tamiji J, 2010, BIOCHEM BIOPH RES CO, V398, P450, DOI 10.1016/j.bbrc.2010.06.098; Taniguchi H, 2011, NEUROSCI LETT, V504, P185, DOI 10.1016/j.neulet.2011.09.005; Volk HE, 2011, ENVIRON HEALTH PERSP, V119, P873, DOI 10.1289/ehp.1002835; WAHLSTEN D, 1974, BRAIN RES, V72, P251, DOI 10.1016/0006-8993(74)90863-4; Walker CKKP, 2008, 7 ANN INT M AUT RES; WALSH TJ, 1988, TOXICOLOGY, V49, P137, DOI 10.1016/0300-483X(88)90185-0; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Williams PG, 1997, DEV MED CHILD NEUROL, V39, P632; Wing DA, 1999, AM J OBSTET GYNECOL, V181, P339, DOI 10.1016/S0002-9378(99)70558-2; Wing DA, 2008, J REPROD MED, V53, P695; Witter FR, 2011, AM J OBSTET GYNECOL; Wong Vincent W S, 2005, ACP J Club, V142, P75; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]	77	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38911	10.1371/journal.pone.0038911	http://dx.doi.org/10.1371/journal.pone.0038911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719983	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341900063
J	Weeks, BK; Beck, BR				Weeks, Benjamin K.; Beck, Belinda R.			Are Bone and Muscle Changes from POWER PE, an 8-month In-school Jumping Intervention, Maintained at Three Years?	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; EXERCISE INTERVENTION; PHYSICAL-ACTIVITY; WAIST CIRCUMFERENCE; MASS; HEALTH; GIRLS; HIP; CHILDREN; MEN	Our aim was to determine if the musculoskeletal benefits of a twice-weekly, school-based, jumping regime in healthy adolescent boys and girls were maintained three years later. Subjects of the original POWER PE trial (n = 99) were contacted and asked to undergo retesting three years after cessation of the intervention. All original measures were completed including: sitting height, standing height, weight, calcaneal broadband ultrasound attenuation (BUA), whole body, hip and spine bone mineral content (BMC), lean tissue mass, and fat mass. Physical activity was recorded with the bone-specific physical activity questionnaire (BPAQ) and calcium intake was estimated with a calcium-focussed food questionnaire. Maturity was determined by Tanner staging and estimation of the age of peak height velocity (PHV). Twenty-nine adolescents aged 17.3+/-0.4 years agreed to participate. Three years after the intervention, there were no differences in subject characteristics between control and intervention groups (p>0.05). Three-year change in weight, lean mass, and fat mass were similar between groups (p>0.05). There were no significant group differences in three-year change in BUA or BMC at any site (p>0.05), although the between-group difference in femoral neck BMC at follow-up exceeded the least significant change. While significant group differences were not observed three years after cessation of the intervention, changes in bone parameters occurred in parallel for intervention and control groups such that the original benefits of the intervention observed within the treatment group were sustained.	[Weeks, Benjamin K.; Beck, Belinda R.] Griffith Univ, Ctr Musculoskeletal Res, Gold Coast, Qld, Australia	Griffith University	Weeks, BK (corresponding author), Griffith Univ, Ctr Musculoskeletal Res, Gold Coast, Qld, Australia.	b.weeks@griffith.edu.au	Beck, Belinda/B-9079-2008; Weeks, Benjamin K/B-9322-2008	Beck, Belinda/0000-0003-1295-6395; Weeks, Benjamin K/0000-0001-7335-6911	Arthritis Australia	Arthritis Australia	The study was supported by an Arthritis Australia Grant-in-Aid (www.arthritisaustralia.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Beck BR., 2010, J BONE MINER RES, V25, pS306; Binkley T, 2004, BONE, V35, P1383, DOI 10.1016/j.bone.2004.08.012; Fuchs RK, 2001, J BONE MINER RES, V16, P148, DOI 10.1359/jbmr.2001.16.1.148; Fuchs RK, 2002, J PEDIATR-US, V141, P357, DOI 10.1067/mpd.2002.127275; Gunter K, 2008, BONE, V42, P710, DOI 10.1016/j.bone.2008.01.002; Heinonen A, 2000, OSTEOPOROSIS INT, V11, P1010, DOI 10.1007/s001980070021; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Katzmarzyk PT, 2006, DIABETES CARE, V29, P404, DOI 10.2337/diacare.29.02.06.dc05-1636; Kontulainen SA, 2002, INT J SPORTS MED, V23, P575, DOI 10.1055/s-2002-35543; MacKelvie KJ, 2003, PEDIATRICS, V112, pE447, DOI 10.1542/peds.112.6.e447; McKay HA, 2005, BRIT J SPORT MED, V39, P521, DOI 10.1136/bjsm.2004.014266; McVey K., 2006, ONLINE CALCIUM INFOR; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Morris FL, 1997, J BONE MINER RES, V12, P1453, DOI 10.1359/jbmr.1997.12.9.1453; Reijman M, 2007, ANN RHEUM DIS, V66, P158, DOI 10.1136/ard.2006.053538; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Stear SJ, 2003, AM J CLIN NUTR, V77, P985, DOI 10.1093/ajcn/77.4.985; Van Langendonck L, 2003, AM J EPIDEMIOL, V158, P525, DOI 10.1093/aje/kwg170; Weeks BK, 2008, OSTEOPOROSIS INT, V19, P1567, DOI 10.1007/s00198-008-0606-2; Weeks B. K., 2011, Gazzetta Medica Italiana Archivio per le Scienze Mediche, V170, P229; Weeks B, 2011, SALUD CIENC, V18, P538; Weeks BK, 2008, J BONE MINER RES, V23, P1002, DOI 10.1359/JBMR.080226; Weeks BK, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/546593; Weeks BK, 2012, PEDIAT OBES IN PRESS, DOI [10.1111/j.2047-6310.1120, DOI 10.1111/J.2047-6310.1120]; Witzke KA, 2000, MED SCI SPORT EXER, V32, P1051, DOI 10.1097/00005768-200006000-00003	26	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39133	10.1371/journal.pone.0039133	http://dx.doi.org/10.1371/journal.pone.0039133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720051	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900085
J	Rodriguez-Blanco, J; Schilling, NS; Tokhunts, R; Giambelli, C; Long, J; Fei, DL; Singh, S; Black, KE; Wang, Z; Galimberti, F; Bejarano, PA; Elliot, S; Glassberg, MK; Nguyen, DM; Lockwood, WW; Lam, WL; Dmitrovsky, E; Capobianco, AJ; Robbins, DJ				Rodriguez-Blanco, J.; Schilling, N. S.; Tokhunts, R.; Giambelli, C.; Long, J.; Fei, D. Liang; Singh, S.; Black, K. E.; Wang, Z.; Galimberti, F.; Bejarano, P. A.; Elliot, S.; Glassberg, M. K.; Nguyen, D. M.; Lockwood, W. W.; Lam, W. L.; Dmitrovsky, E.; Capobianco, A. J.; Robbins, D. J.			The Hedgehog processing pathway is required for NSCLC growth and survival	ONCOGENE			English	Article						dispatched; lung cancer; hedgehog; hedgehog acyltransferase; skinny hedgehog	BASAL-CELL CARCINOMA; SMALL-MOLECULE MODULATION; HUMAN SONIC HEDGEHOG; LUNG-CANCER; SIGNALING PATHWAY; LONG-RANGE; CHROMOSOMAL IMBALANCES; ANIMAL DEVELOPMENT; GENE-EXPRESSION; HUMAN HOMOLOG	Considerable interest has been generated from the results of recent clinical trials using smoothened (SMO) antagonists to inhibit the growth of hedgehog (HH) signaling-dependent tumors. This interest is tempered by the discovery of SMO mutations mediating resistance, underscoring the rationale for developing therapeutic strategies that interrupt HH signaling at levels distinct from those inhibiting SMO function. Here, we demonstrate that HH-dependent non-small cell lung carcinoma (NSCLC) growth is sensitive to blockade of the HH pathway upstream of SMO, at the level of HH ligand processing. Individually, the use of different lentivirally delivered shRNA constructs targeting two functionally distinct HH-processing proteins, skinny hedgehog (SKN) or dispatched-1 (DISP-1), in NSCLC cell lines produced similar decreases in cell proliferation and increased cell death. Further, providing either an exogenous source of processed HH or a SMO agonist reverses these effects. The attenuation of HH processing, by knocking down either of these gene products, also abrogated tumor growth in mouse xenografts. Finally, we extended these findings to primary clinical specimens, showing that SKN is frequently overexpressed in NSCLC and that higher DISP-1 expression is associated with an unfavorable clinical outcome. Our results show a critical role for HH processing in HH-dependent tumors, identifies two potential druggable targets in the HH pathway, and suggest that similar therapeutic strategies could be explored to treat patients harboring HH ligand-dependent cancers.	[Rodriguez-Blanco, J.; Schilling, N. S.; Tokhunts, R.; Giambelli, C.; Long, J.; Fei, D. Liang; Singh, S.; Black, K. E.; Wang, Z.; Nguyen, D. M.; Capobianco, A. J.; Robbins, D. J.] Univ Miami, Dept Surg, Mol Oncol Program, Miami, FL 33136 USA; [Schilling, N. S.; Tokhunts, R.; Fei, D. Liang; Galimberti, F.; Dmitrovsky, E.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Bejarano, P. A.] Univ Miami, Dept Pathol, Miami, FL 33136 USA; [Elliot, S.] Univ Miami, Dept Surg, Lab Sex & Gender Differences Hlth & Dis, Miami, FL 33136 USA; [Glassberg, M. K.] Univ Miami, Jackson Mem Hosp, Dept Med, Miami, FL 33136 USA; [Glassberg, M. K.] Univ Miami, Jackson Mem Hosp, Dept Surg, Miami, FL 33136 USA; [Nguyen, D. M.; Capobianco, A. J.; Robbins, D. J.] Univ Miami, Miller Sch Med, Sylvester Canc Ctr, Miami, FL 33136 USA; [Lockwood, W. W.] NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA; [Lam, W. L.] British Columbia Canc Res Ctr, Dept Integrat Biol, Vancouver, BC V5Z 1L3, Canada; [Dmitrovsky, E.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Dmitrovsky, E.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Robbins, D. J.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami; Dartmouth College; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); British Columbia Cancer Agency; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; University of Miami	Robbins, DJ (corresponding author), Univ Miami, Miller Sch Med, Sylvester Canc Ctr, 1042 RMSB,1600 NW 10th Ave, Miami, FL 33136 USA.	drobbins@med.miami.edu	Long, Jun/S-2382-2019; Rodriguez, Jezabel/B-7613-2019; Singh, Samer/H-8468-2013; LONG, JUN/N-7270-2015; Lockwood, William W/A-2879-2009; Wang, Zhiqiang/O-6810-2014	Long, Jun/0000-0002-8229-9653; Rodriguez, Jezabel/0000-0003-1839-6181; Singh, Samer/0000-0002-0921-1686; Fei, Dennis Liang/0000-0002-1953-0584; Capobianco, Anthony/0000-0002-3706-6797	NIH [GM64011, R03-CA132166, R01-CA087546, R01-CA111422]; Samuel Waxman Cancer Research Foundation; American Lung Association/LUNGevity Foundation;  [FICYT-POST10-27]; NATIONAL CANCER INSTITUTE [R01CA087546, R03CA132166, P30CA023108, R01CA111422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064011, R56GM064011] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; American Lung Association/LUNGevity Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grants GM64011 (DJ Robbins), R03-CA132166 (E Dmitrovsky), R01-CA087546 (E Dmitrovsky) and R01-CA111422 (E Dmitrovsky); grants from the Samuel Waxman Cancer Research Foundation (E Dmitrovsky, A Capobianco); FICYT-POST10-27 (J Rodriguez-Blanco) and from the American Lung Association/LUNGevity Foundation (DJ Robbins). E Dmitrovsky is an American Cancer Society Professor supported by a generous gift from the FM Kirby Foundation.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Amanai K, 2001, DEVELOPMENT, V128, P5119; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Farzan SF, 2008, AM J PHYSIOL-GASTR L, V294, pG844, DOI 10.1152/ajpgi.00564.2007; Fei DL, 2010, CANCER RES, V70, P1981, DOI 10.1158/0008-5472.CAN-09-2898; Fernandez C, 2010, DEV NEUROSCI-BASEL, V32, P59, DOI 10.1159/000274458; Gialmanidis IP, 2009, LUNG CANCER, V66, P64, DOI 10.1016/j.lungcan.2009.01.007; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lockwood WW, 2010, PLOS MED, V7; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Ma Y, 2007, P NATL ACAD SCI USA, V104, P4089, DOI 10.1073/pnas.0606537104; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mas C, 2010, BIOCHEM PHARMACOL, V80, P712, DOI 10.1016/j.bcp.2010.04.016; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neal JW, 2010, CURR TREAT OPTION ON, V11, P36, DOI 10.1007/s11864-010-0120-6; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Petersen I, 1997, CANCER RES, V57, P2331; Petty WJ, 2005, J NATL CANCER I, V97, P1645, DOI 10.1093/jnci/dji371; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Quirk J, 1997, COLD SPRING HARB SYM, V62, P217; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Shen TL, 1999, HUM PATHOL, V30, P284, DOI 10.1016/S0046-8177(99)90006-0; Singh S, 2011, CANCER RES, V71, P4454, DOI 10.1158/0008-5472.CAN-10-2313; Singh S, 2009, HUM GENET, V125, P95, DOI 10.1007/s00439-008-0599-0; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Stanton BZ, 2010, MOL BIOSYST, V6, P44, DOI 10.1039/b910196a; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tai ALS, 2004, CANCER, V100, P1918, DOI 10.1002/cncr.20190; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xie JW, 1997, CANCER RES, V57, P2369; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	79	34	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2013	32	18					2335	2345		10.1038/onc.2012.243	http://dx.doi.org/10.1038/onc.2012.243			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22733134	Green Accepted			2022-12-25	WOS:000318683600010
J	Bernard, H; Garmy-Susini, B; Ainaoui, N; Van Den Berghe, L; Peurichard, A; Javerzat, S; Bikfalvi, A; Lane, DP; Bourdon, JC; Prats, AC				Bernard, H.; Garmy-Susini, B.; Ainaoui, N.; Van Den Berghe, L.; Peurichard, A.; Javerzat, S.; Bikfalvi, A.; Lane, D. P.; Bourdon, J. C.; Prats, A-C			The p53 isoform, Delta 133p53 alpha, stimulates angiogenesis and tumour progression	ONCOGENE			English	Article						angiogenesis; p53; isoform; cancer; glioblastoma	EXPRESSION; DELTA-113P53; SURVIVAL; CANCER; GENE	The tumour suppressor p53, involved in DNA repair, cell cycle arrest and apoptosis, also inhibits blood vessel formation, that is, angiogenesis, a process strongly contributing to tumour development. The p53 gene expresses 12 different proteins (isoforms), including TAp53 (p53 (or p53 alpha), p53 beta and p53 gamma) and Delta 133p53 isoforms (Delta 133p53 alpha, Delta 133p53 beta and Delta 133p53 gamma). The Delta 133p53 alpha isoform was shown to modulate p53 transcriptional activity and is overexpressed in various human tumours. However, its role in tumour progression is still unexplored. In the present study, we examined the involvement of Delta 133p53 isoforms in tumoural angiogenesis and tumour growth in the highly angiogenic human glioblastoma U87. Our data show that conditioned media from U87 cells depleted for Delta 133p53 isoforms block endothelial cell migration and tubulogenesis without affecting endothelial cell proliferation in vitro. The Delta 133p53 depletion in U2OS osteosarcoma cells resulted in a similar angiogenesis blockade. Furthermore, using conditioned media from U87 cells ectopically expressing each Delta 133p53 isoform, we determined that Delta 133p53 alpha and Delta 133p53 gamma but not Delta 133p53 beta, stimulate angiogenesis. Our in vivo data using the chicken chorio-allantoic membrane and mice xenografts establish that angiogenesis and growth of glioblastoma U87 tumours are inhibited upon depletion of Delta 133p53 isoforms. By TaqMan low-density array, we show that alteration of expression ratio of Delta 133p53 and TAp53 isoforms differentially regulates angiogenic gene expression with Delta 133p53 isoforms inducing pro-angiogenic gene expression and repressing anti-angiogenic gene expression. Oncogene (2013) 32, 2150-2160; doi:10.1038/onc.2012.242; published online 25 June 2012	[Bernard, H.; Garmy-Susini, B.; Ainaoui, N.; Van Den Berghe, L.; Peurichard, A.; Prats, A-C] Univ Toulouse, Lab Translat Control & Gene Therapy Vasc Dis, Inst Malad Metab & Cardiovasc, UPS,TRADGENE,EA4554, Toulouse, France; [Bernard, H.; Lane, D. P.; Bourdon, J. C.] Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland; [Garmy-Susini, B.] Fac Med Toulouse, INSERM, U1037, F-31073 Toulouse, France; [Van Den Berghe, L.] INSERM, U1048, F-31432 Toulouse, France; [Javerzat, S.; Bikfalvi, A.] INSERM, U920, Talence, France; [Javerzat, S.; Bikfalvi, A.] Univ Bordeaux 1, Angiogenesis & Canc Microenvironm Lab, F-33405 Talence, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Prats, AC (corresponding author), Univ Toulouse 3, Inst Malad Metab & Cardiovasc, Lab Translat Control & Gene Therapy Vasc Dis, TRADGENE,EA 4554, 1 Ave Jean Poulhes,BP 84225, F-31432 Toulouse 4, France.	Anne-Catherine.Prats@inserm.fr	VAN DEN BERGHE, Loïc/X-6705-2019; Prats, Anne-Catherine/E-5051-2016; Garmy-Susini, Barbara/B-9735-2014; Petibois, Cyril/L-9049-2014; JC, Bourdon/A-4439-2008	Prats, Anne-Catherine/0000-0002-5282-3776; Petibois, Cyril/0000-0001-9027-4192; JC, Bourdon/0000-0003-4623-9386; Lane, David/0000-0003-0551-3545; GARMY-SUSINI, Barbara/0000-0001-6100-2294	Association pour la Recherche sur le Cancer; Canceropole GSO; INCA; Fondation de l'Avenir; Association Francaise contre les Myopathies (AFM); Ligue Nationale Contre Le Cancer; ARC; Fondation pour la Recherche Medicale; AFM; Cancer Research UK [C8/A6613]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Canceropole GSO; INCA(Institut National du Cancer (INCA) France); Fondation de l'Avenir; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ligue Nationale Contre Le Cancer(Ligue nationale contre le cancer); ARC(Australian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); AFM(Association Francaise contre les Myopathies); Cancer Research UK(Cancer Research UK)	We thank A Delluc-Clavieres and F Pujol for technical assistance, Y Barreira, S Legonidec (animal production and phenotyping facilities of ANEXPLO platform, Inserm US006), F Gross (Vector facility), J-J Maoret (GeT TQ plateau of the Genotoul Genome-Transcriptome platform), M Pucelle (CAM facility) and C Touriol (ABAE and HUVEC cells). This work was supported by grants from Association pour la Recherche sur le Cancer, Canceropole GSO, INCA, Fondation de l'Avenir, Association Francaise contre les Myopathies (AFM). HB had a fellowship from the Ligue Nationale Contre Le Cancer, then from the ARC. BGS had a postdoc fellowship from the Fondation pour la Recherche Medicale, NA had a thesis fellowship from AFM. DPL and JCB were supported by Cancer Research UK (grant number: C8/A6613).	Aoubala M, 2011, CELL DEATH DIFFER, V18, P248, DOI 10.1038/cdd.2010.91; Bossard C, 2004, CANCER RES, V64, P7507, DOI 10.1158/0008-5472.CAN-04-0287; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Davidson WR, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-102; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Folkman Judah, 2006, Sci STKE, V2006, ppe35, DOI 10.1126/stke.3542006pe35; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Galy B, 2001, ONCOGENE, V20, P1669, DOI 10.1038/sj.onc.1204271; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Marcel V, 2010, ONCOGENE, V29, P2691, DOI 10.1038/onc.2010.26; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pal S, 2001, CANCER RES, V61, P6952; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Ravi R, 2000, GENE DEV, V14, P34; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; UEBA T, 1994, P NATL ACAD SCI USA, V91, P9009, DOI 10.1073/pnas.91.19.9009; Wong MLH, 2009, J CLIN NEUROSCI, V16, P1119, DOI 10.1016/j.jocn.2009.02.009	29	64	67	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 25	2013	32	17					2150	2160		10.1038/onc.2012.242	http://dx.doi.org/10.1038/onc.2012.242			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	132JD	22733133	Green Submitted			2022-12-25	WOS:000318062800004
J	Illing, AC; Shawki, A; Cunningham, CL; Mackenzie, B				Illing, Anthony C.; Shawki, Ali; Cunningham, Christopher L.; Mackenzie, Bryan			Substrate Profile and Metal-ion Selectivity of Human Divalent Metal-ion Transporter-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; CADMIUM ABSORPTION; CACO-2 CELLS; DIETARY IRON; INTESTINAL-ABSORPTION; PROXIMAL TUBULE; APICAL MEMBRANE; PLASMA-MEMBRANE; DMT1; MANGANESE	Divalent metal-ion transporter-1 (DMT1) is a H+-coupled metal-ion transporter that plays essential roles in iron homeostasis. DMT1exhibits reactivity (based on evoked currents) with a broad range of metal ions; however, direct measurement of transport is lacking for many of its potential substrates. We performed a comprehensive substrate-profile analysis for human DMT1 expressed in RNA-injected Xenopus oocytes by using radiotracer assays and the continuous measurement of transport by fluorescence with the metal-sensitive PhenGreen SK fluorophore. We provide validation for the use of PhenGreen SK fluorescence quenching as a reporter of cellular metal-ion uptake. We determined metal-ion selectivity under fixed conditions using the voltage clamp. Radiotracer and continuous measurement of transport by fluorescence assays revealed that DMT1 mediates the transport of several metal ions that were ranked in selectivity by using the ratio I-max/K-0.5 (determined from evoked currents at -70 mV): Cd2+ > Fe2+ > Co2+, Mn2+ >> Zn2+, Ni2+, VO2+. DMT1 expression did not stimulate the transport of Cr2+, Cr3+, Cu+, Cu2+, Fe3+, Ga3+, Hg2+, or VO+. Fe-55(2+) transport was competitively inhibited by Co2+ and Mn2+. Zn2+ only weakly inhibited Fe-55(2+) transport. Our data reveal that DMT1 selects Fe2+ over its other physiological substrates and provides a basis for predicting the contribution of DMT1 to intestinal, nasal, and pulmonary absorption of metal ions and their cellular uptake in other tissues. Whereas DMT1 is a likely route of entry for the toxic heavy metal cadmium, and may serve the metabolism of cobalt, manganese, and vanadium, we predict that DMT1 should contribute little if at all to the absorption or uptake of zinc. The conclusion in previous reports that copper is a substrate of DMT1 is not supported.	[Illing, Anthony C.; Shawki, Ali; Cunningham, Christopher L.; Mackenzie, Bryan] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Shawki, Ali] Univ Cincinnati, Coll Med, Syst Biol & Physiol Program, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Mackenzie, B (corresponding author), Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, POB 670576, Cincinnati, OH 45267 USA.	bryan.mackenzie@uc.edu		Mackenzie, Bryan/0000-0002-9661-8838; Cunningham, Christopher/0000-0002-9619-4190; Shawki, Ali/0000-0002-6413-5313	National Institutes of Health from USPHS [R01 DK080047]; National Institutes of Health from NIDDK [P30 DK078392]; National Institutes of Health PHS from the NCI [R24 CA086307]; NATIONAL CANCER INSTITUTE [R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080047, P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from NIDDK; National Institutes of Health PHS from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK080047 from USPHS (to B. M.).; We thank Sarah R. Anthony (University of Cincinnati) and students Matthew T. Coombs, Colin J. Mitchell, Eric J. Niespodzany, and Brian K. Sparkman (University of Cincinnati) for their help in the laboratory; Amy G. Aslamkhan and David S. Miller (NIEHS, National Institutes of Health, Research Triangle Park, NC) for help with preliminary experiments involving PGSK; and Chet Closson (Live Imaging Core, University of Cincinnati) for assistance with microscopy. The SIH used in this study was a gracious gift from Prem Ponka (McGill University). Part of this study was presented at Experimental Biology Meeting, April 28 to May 2, 2007, Washington, D. C. (73). The Digestive Health Center, Cincinnati Children's Hospital and University of Cincinnati was the recipient of National Institutes of Health Grant P30 DK078392 from NIDDK. The production of copper-64 at Washington University, St. Louis School of Medicine, was supported by National Institutes of Health PHS Grant R24 CA086307 from the NCI.	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/ajprenal.00198.2007; Aduayom I, 2005, J BIOCHEM MOL TOXIC, V19, P256, DOI 10.1002/jbt.20085; Akesson A, 2002, AM J PUBLIC HEALTH, V92, P284, DOI 10.2105/AJPH.92.2.284; Arredondo M, 2003, AM J PHYSIOL-CELL PH, V284, pC1525, DOI 10.1152/ajpcell.00480.2002; Bannon DI, 2003, AM J PHYSIOL-CELL PH, V284, pC44, DOI 10.1152/ajpcell.00184.2002; Bannon DI, 2002, BIOCHEM BIOPH RES CO, V295, P978, DOI 10.1016/S0006-291X(02)00756-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGLUND M, 1994, ENVIRON HEALTH PERSP, V102, P1058, DOI 10.2307/3431993; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Chua ACG, 1997, J COMP PHYSIOL B, V167, P361, DOI 10.1007/s003600050085; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; Conrad ME, 2000, AM J PHYSIOL-GASTR L, V279, pG767, DOI 10.1152/ajpgi.2000.279.4.G767; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Davidson T, 2005, MOL CELL BIOCHEM, V279, P157, DOI 10.1007/s11010-005-8288-y; Donovan A, 2006, PHYSIOLOGY, V21, P115, DOI 10.1152/physiol.00052.2005; EIDELMAN O, 1989, METHOD ENZYMOL, V172, P122; Elisma F, 2001, BIOCHEM BIOPH RES CO, V285, P662, DOI 10.1006/bbrc.2001.5245; Espinoza A, 2012, BIOL TRACE ELEM RES, V146, P281, DOI 10.1007/s12011-011-9243-2; FLANAGAN PR, 1978, GASTROENTEROLOGY, V74, P841; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Garrick Michael D, 2002, Methods Mol Biol, V196, P147; Garrick MD, 2006, BIOCHEM J, V398, P539, DOI 10.1042/BJ20051987; Garrick MD, 2011, GENES NUTR, V6, P45, DOI 10.1007/s12263-010-0184-8; Ghio AJ, 2005, AM J PHYSIOL-LUNG C, V289, pL460, DOI 10.1152/ajplung.00154.2005; Goyer RA, 1997, ANNU REV NUTR, V17, P37, DOI 10.1146/annurev.nutr.17.1.37; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haugland R. P., 2005, HDB GUIDE FLUORESCEN, P875; Heilig E, 2005, AM J PHYSIOL-LUNG C, V288, pL887, DOI 10.1152/ajplung.00382.2004; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Illing AC, 2007, FASEB J, V21, pA1325; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kim DW, 2007, ARCH TOXICOL, V81, P327, DOI 10.1007/s00204-006-0160-7; Kippler M, 2009, ENVIRON RES, V109, P914, DOI 10.1016/j.envres.2009.07.006; Knopfel M, 2005, BIOCHEMISTRY-US, V44, P3454, DOI 10.1021/bi048768; Knopfel M, 2005, BIOCHEM BIOPH RES CO, V330, P645, DOI 10.1016/j.bbrc.2005.03.023; Leazer TM, 2002, TOXICOL APPL PHARM, V185, P18, DOI 10.1006/taap.2002.9505; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Mackenzie B., 1999, BIOMEMBRANE TRANSPOR, P327; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Mukherjee B, 2004, TOXICOL LETT, V150, P135, DOI 10.1016/j.toxlet.2004.01.009; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Okubo M, 2003, TOXICOL APPL PHARM, V187, P162, DOI 10.1016/S0041-008X(02)00078-9; Park JD, 2002, TOXICOL SCI, V68, P288, DOI 10.1093/toxsci/68.2.288; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Reynolds IJ, 2004, ANN NY ACAD SCI, V1012, P27, DOI 10.1196/annals.1306.003; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Ryu DY, 2004, TOXICOL LETT, V152, P19, DOI 10.1016/j.toxlet.2004.03.015; Sacher A, 2001, J EXP BIOL, V204, P1053; SCHADE SG, 1970, J LAB CLIN MED, V75, P435; Segel I. H., 1975, BIOCH CALCULATIONS, P246; Shawki A, 2010, BIOCHEM BIOPH RES CO, V393, P471, DOI 10.1016/j.bbrc.2010.02.025; Shingles R, 2002, PLANT PHYSIOL, V128, P1022, DOI 10.1104/pp.010858; Shingles R, 2001, ANAL BIOCHEM, V296, P106, DOI 10.1006/abio.2001.5209; Takeno N., 2005, ATLAS EH PH DIAGRAMS; Tallkvist J, 2001, TOXICOL LETT, V122, P171, DOI 10.1016/S0378-4274(01)00363-0; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; THOMSON ABR, 1971, J CLIN INVEST, V50, P2384, DOI 10.1172/JCI106737; Tjalve H, 1999, NEUROTOXICOLOGY, V20, P181; Ueki T, 2011, BBA-GEN SUBJECTS, V1810, P457, DOI 10.1016/j.bbagen.2010.12.006; Van Winkle LJ., 1999, BIOMEMBRANE TRANSPOR, P65; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Zimnicka AM, 2011, AM J PHYSIOL-CELL PH, V300, pC588, DOI 10.1152/ajpcell.00054.2010	72	167	170	1	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30485	30496		10.1074/jbc.M112.364208	http://dx.doi.org/10.1074/jbc.M112.364208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22736759	Green Published, hybrid			2022-12-25	WOS:000308579800041
J	Hoffmann, F; Muller, W; Schutz, D; Penfold, ME; Wong, YH; Schulz, S; Stumm, R				Hoffmann, Frauke; Mueller, Wiebke; Schuetz, Dagmar; Penfold, Mark E.; Wong, Yung H.; Schulz, Stefan; Stumm, Ralf			Rapid Uptake and Degradation of CXCL12 Depend on CXCR7 Carboxyl-terminal Serine/Threonine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; BETA-ARRESTIN; INTERNALIZATION; MIGRATION; PHOSPHORYLATION; LIGANDS; SIGNALS; CELLS; SDF-1; MICE	CXCL12 signaling through G protein-coupled CXCR4 regulates cell migration during ontogenesis and disease states including cancer and inflammation. The second CXCL12-receptor CXCR7 modulates the CXCL12/CXCR4 pathway by acting as a CXCL12 scavenger and exerts G protein-independent functions. Given the distinct properties of CXCR4 and CXCR7, we hypothesized that the distinct C-terminal domains differently regulate receptor trafficking and stability. Here, we examined epitope-tagged wild type and C-terminal mutant receptors in human embryonic kidney cells (HEK293) with respect to trafficking, stability, I-125-CXCL12 degradation, and G protein-coupling. The 24CXCR7C-terminal residues were sufficient to promote rapid spontaneous internalization. Replacement of the CXCR7 C terminus with that of CXCR4 (CXCR7-4tail mutant) abolished spontaneous internalization but permitted ligand-induced internalization and phosphorylation at the heterologous domain. The reverse tail-swap caused ligand-independent internalization of the resulting CXCR4-7tail mutant. Receptormediated I-125-CXCL12 uptake and release of I-125-CXCL12 degradation products were accelerated with receptors bearing the CXCR7 C terminus and impaired after conversion of CXCR7 C-terminal serine/threonine residues into alanines. C-terminal lysine residues were dispensable for plasma membrane targeting and the CXCL12 scavenger function but involved in constitutive degradation of CXCR7. Although the CXCR7 C terminus abolished G protein coupling in the CXCR4-7tail mutant, replacement of the CXCR7C terminus, CXCR7 second intracellular loop, or both domains with the corresponding CXCR4 domain did not result in a G protein-coupled CXCR7 chimera. Taken together, we provide evidence that the CXCR7 C terminus influences the ligand-uptake/degradation rate, G protein coupling, and receptor stability. Regulatory pathways targeting CXCR7 C-terminal serine/threonine sites may control the CXCL12 scavenger activity of CXCR7.	[Hoffmann, Frauke; Mueller, Wiebke; Schuetz, Dagmar; Schulz, Stefan; Stumm, Ralf] Univ Jena, Inst Pharmacol & Toxicol, Jena Univ Hosp, D-07747 Jena, Germany; [Penfold, Mark E.] ChemoCentryx Inc, Mountain View, CA 94043 USA; [Wong, Yung H.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Wong, Yung H.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Friedrich Schiller University of Jena; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Stumm, R (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Jena Univ Hosp, Drackendorfer Str 1, D-07747 Jena, Germany.	ralf.stumm@med.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885; Wong, Yung Hou/0000-0002-0123-7697	Federal State Sachsen-Anhalt; European Fund for Regional Development Grant [EFRE 2007-2013]; Deutsche Forschungsgemeinschaft (DFG) [STU295/5-1]; Dr. Robert-Pfleger Stiftung	Federal State Sachsen-Anhalt; European Fund for Regional Development Grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dr. Robert-Pfleger Stiftung	This work was supported by Federal State Sachsen-Anhalt with the European Fund for Regional Development Grant EFRE 2007-2013, Deutsche Forschungsgemeinschaft (DFG) Grant STU295/5-1, and Dr. Robert-Pfleger Stiftung (all to R. S.).	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Barker BL, 2011, BIOCHEMISTRY-US, V50, P6933, DOI 10.1021/bi2005202; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Fischer T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004069; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kleemann P, 2008, N-S ARCH PHARMACOL, V378, P261, DOI 10.1007/s00210-008-0313-8; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu AMF, 2003, J BIOMOL SCREEN, V8, P39, DOI 10.1177/1087057102239665; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Mody SM, 2000, MOL PHARMACOL, V57, P13; Moepps B, 1997, EUR J IMMUNOL, V27, P2102, DOI 10.1002/eji.1830270839; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ray P, 2012, INT J BIOCHEM CELL B, V44, P669, DOI 10.1016/j.biocel.2012.01.007; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	44	65	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28362	28377		10.1074/jbc.M111.335679	http://dx.doi.org/10.1074/jbc.M111.335679			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22736769	hybrid, Green Published			2022-12-25	WOS:000308074600013
J	Yang, ZH; Zhang, YX; Kemper, JK; Wang, L				Yang, Zhihong; Zhang, Yuxia; Kemper, Jongsook Kim; Wang, Li			Cross-Regulation of Protein Stability by p53 and Nuclear Receptor SHP	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; NEGATIVE FEEDBACK-REGULATION; FATTY-ACID SYNTHASE; DIURNAL REGULATION; GENE-EXPRESSION; LIVER RECEPTOR; X RECEPTOR; ERR-GAMMA; INHIBITION; GROWTH	We report here a novel interplay between tumor suppressor p53 and nuclear receptor SHP that controls p53 and SHP stability. Overexpression of p53 causes rapid SHP protein degradation, which does not require the presence of Mdm2 and is mediated by the proteosome pathway. Overexpressing SHP alone does not affect p53 stability. However, SHP destabilizes p53 by augmentation of Mdm2 ubiquitin ligase activity toward p53. The single amino acid substitution in the SHP protein SHPK170R increases SHP binding to p53 relative to SHP wild-type, whereas SHPG171A variant shows a diminished p53 binding. As a result of the cross-regulation, the tumor suppressor function of p53 and SHP in inhibition of colon cancer growth is compromised. Our findings reveal a unique scenario for a cross-inhibition between two tumor suppressors to keep their expression and function in check.	[Yang, Zhihong; Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Yang, Zhihong; Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA; [Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Urbana-Champaign	Yang, ZH (corresponding author), Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	l.wang@hsc.utah.edu			Multidisciplinary Cancer Research Training Program (MCRTP) [T32CA092347]; NIH [DK080440]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095842, R01DK080440] Funding Source: NIH RePORTER	Multidisciplinary Cancer Research Training Program (MCRTP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Y.Z. was supported by T32CA092347 Multidisciplinary Cancer Research Training Program (MCRTP). This work was supported in part by NIH Grant DK080440 to L.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Datta S, 2006, J BIOL CHEM, V281, P807, DOI 10.1074/jbc.M511050200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kim DH, 2011, P NATL ACAD SCI USA, V108, P12266, DOI 10.1073/pnas.1019678108; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Matsukuma KE, 2006, J LIPID RES, V47, P2754, DOI 10.1194/jlr.M600342-JLR200; Neilsen PM, 2008, J CELL SCI, V121, P3541, DOI 10.1242/jcs.026351; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Park KG, 2007, DIABETES, V56, P431, DOI 10.2337/db06-0753; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, INT J CLIN EXP PATHO, V2, P275; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Suh JH, 2006, J BIOL CHEM, V281, P39169, DOI 10.1074/jbc.M605947200; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tabbi-Anneni I, 2010, AM J PHYSIOL-ENDOC M, V298, pE961, DOI 10.1152/ajpendo.00655.2009; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang L, 2006, MOL ENDOCRINOL, V20, P2671, DOI 10.1210/me.2006-0224; Yang ZH, 2012, FEBS LETT, V586, P1135, DOI 10.1016/j.febslet.2012.03.022; Yang ZH, 2012, BIOCHEM BIOPH RES CO, V417, P744, DOI 10.1016/j.bbrc.2011.12.027; Yang ZH, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-31; Zhang Y, 2012, NUCL ACIDS RES; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2011, BIOCHEM BIOPH RES CO, V416, P135, DOI 10.1016/j.bbrc.2011.11.011; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39789	10.1371/journal.pone.0039789	http://dx.doi.org/10.1371/journal.pone.0039789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737255	gold, Green Submitted, Green Published			2022-12-25	WOS:000305695100054
J	Jaager, K; Islam, S; Zajac, P; Linnarsson, S; Neuman, T				Jaeaeger, Kersti; Islam, Saiful; Zajac, Pawel; Linnarsson, Sten; Neuman, Toomas			RNA-Seq Analysis Reveals Different Dynamics of Differentiation of Human Dermis- and Adipose-Derived Stromal Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; BONE-MARROW; FIBROBLASTS EXHIBIT; CORD BLOOD; TISSUE; SKIN; IDENTIFICATION; PROFILE; LINES	Background: Tissue regeneration and recovery in the adult body depends on self-renewal and differentiation of stem and progenitor cells. Mesenchymal stem cells (MSCs) that have the ability to differentiate into various cell types, have been isolated from the stromal fraction of virtually all tissues. However, little is known about the true identity of MSCs. MSC populations exhibit great tissue-, location-and patient-specific variation in gene expression and are heterogeneous in cell composition. Methodology/Principal Findings: Our aim was to analyze the dynamics of differentiation of two closely related stromal cell types, adipose tissue-derived MSCs (AdMSCs) and dermal fibroblasts (FBs) along adipogenic, osteogenic and chondrogenic lineages using multiplex RNA-seq technology. We found that undifferentiated donor-matched AdMSCs and FBs are distinct populations that stay different upon differentiation into adipocytes, osteoblasts and chondrocytes. The changes in lineage-specific gene expression occur early in differentiation and persist over time in both AdMSCs and FBs. Further, AdMSCs and FBs exhibit similar dynamics of adipogenic and osteogenic differentiation but different dynamics of chondrogenic differentiation. Conclusions/Significance: Our findings suggest that stromal stem cells including AdMSCs and dermal FBs exploit different molecular mechanisms of differentiation to reach a common cell fate. The early mechanisms of differentiation are lineage-specific and are similar for adipogenic and osteogenic differentiation but are distinct for chondrogenic differentiation between AdMSCs and FBs.	[Jaeaeger, Kersti; Neuman, Toomas] Tallinn Univ Technol, Inst Gene Technol, Tallinn, Estonia; [Jaeaeger, Kersti] Cellin Technol LLC, Tallinn, Estonia; [Islam, Saiful; Zajac, Pawel; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Neuman, Toomas] Protobios LLC, Tallinn, Estonia	Tallinn University of Technology; Karolinska Institutet; Protobios LLC	Jaager, K (corresponding author), Tallinn Univ Technol, Inst Gene Technol, Tallinn, Estonia.	kersti.jaager@cellintechnologies.com	Linnarsson, Sten/HCH-3909-2022; Jaager, Kersti/G-2786-2017	Jaager, Kersti/0000-0002-0503-9292				Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Blasi A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-5; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hanson SE, 2010, LARYNGOSCOPE, V120, P546, DOI 10.1002/lary.20797; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaager K, 2011, STEM CELLS DEV, V20, P1327, DOI 10.1089/scd.2010.0258; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kuklick L, 2002, BLOOD, V100, p167B; Lin TM, 2007, BIOCHEM BIOPH RES CO, V361, P883, DOI 10.1016/j.bbrc.2007.07.116; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Song L, 2006, STEM CELLS, V24, P1707, DOI 10.1634/stemcells.2005-0604; Takashima A, 2001, Curr Protoc Cell Biol, VChapter 2, DOI 10.1002/0471143030.cb0201s00; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	32	41	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38833	10.1371/journal.pone.0038833	http://dx.doi.org/10.1371/journal.pone.0038833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723894	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700033
J	Xu, DZ; Huang, Y; Geng, QR; Guan, YX; Li, YF; Wang, W; Yuan, SQ; Sun, XW; Chen, YB; Li, W; Zhou, ZW; Zhan, YQ				Xu, Dazhi; Huang, Ying; Geng, Qirong; Guan, Yuanxiang; Li, Yuanfang; Wang, Wei; Yuan, Shuqiang; Sun, Xiaowei; Chen, Yingbo; Li, Wei; Zhou, Zhiwei; Zhan, Youqing			Effect of Lymph Node Number on Survival of Patients with Lymph Node-Negative Gastric Cancer according to the 7th Edition UICC TNM System	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; SINGLE-INSTITUTION; STAGING SYSTEM; RESECTION; MICROMETASTASIS; ADENOCARCINOMA; CLASSIFICATION; DISPARITIES; STATISTICS; DISSECTION	Background: For the patients with node-negative gastric cancer, the 7th edition classification does not define the minimum number of lymph nodes necessary. We aimed to explore the prognostic significance of examined lymph nodes and determine how many nodes must be examined. Methodology/Principal Findings: 435 patients underwent D2 gastrectomy with node-negative gastric cancer between December 1992 and December 2006 were obtained. Patients were classified into 4 groups by the number of negative LNs examined during surgery (1-6LNs, 7-10 LNs, 11-15 LNs, and >= 16 LNs). Stratified and Cox regression analyses were used to evaluate the association between survival and the number of negative LNs. Survival was significantly better in the >= 16 LNs, compared with the 1-5 LNs, 6-10 LNs and 11-15 LNs group in T2-4 patients; Multivariate analysis demonstrated tumor size, depth of invasion, 7th UICC stage and the number of examined nodes are strongly independent predictors of survival. Conclusions: This study first demonstrates that patients with lymph node-negative gastric cancer underwent D2 dissection should have at least 16 LNs examined, especially in advanced gastric cancer. These results are a reasonable supplement to our previous tumor-ratio-metastasis staging system and a stratification criterion in clinical pratice.	[Xu, Dazhi; Huang, Ying; Geng, Qirong; Guan, Yuanxiang; Li, Yuanfang; Wang, Wei; Yuan, Shuqiang; Sun, Xiaowei; Chen, Yingbo; Li, Wei; Zhou, Zhiwei; Zhan, Youqing] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Xu, Dazhi; Guan, Yuanxiang; Li, Yuanfang; Wang, Wei; Yuan, Shuqiang; Sun, Xiaowei; Chen, Yingbo; Li, Wei; Zhou, Zhiwei; Zhan, Youqing] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Ying] Sun Yat Sen Univ, Dept Radiotherapy, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Geng, Qirong] Sun Yat Sen Univ, Dept Hematol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xu, DZ (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	xudzh@sysucc.org.cn; zhanyq@sysucc.org.cn	Li, Yuan/GXV-1310-2022		Science and Technology Projects of Guangdong Province [2010B031600071]	Science and Technology Projects of Guangdong Province	This work was supported by Science and Technology Projects of Guangdong Province [Grant number 2010B031600071]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiocchi GL, 2010, ANN SURG, V252, P70, DOI 10.1097/SLA.0b013e3181e4585e; Bouvier AM, 2002, CANCER, V94, P2862, DOI 10.1002/cncr.10550; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Estes NC, 1998, AM SURGEON, V64, P680; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Grambsch PM, 1995, BIOMETRICS, V51, P1469, DOI 10.2307/2533277; Greenstein AJ, 2008, CANCER-AM CANCER SOC, V112, P1239, DOI 10.1002/cncr.23309; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Huang BJ, 2009, ANN SURG ONCOL, V16, P61, DOI 10.1245/s10434-008-0193-7; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KAJITANI T, 1981, JPN J SURG, V11, P127; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kasakura Y, 2002, J SURG RES, V103, P252, DOI 10.1006/jsre.2002.6368; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; Kim JH, 2008, J SURG ONCOL, V97, P125, DOI 10.1002/jso.20937; Kooby DA, 2003, ANN SURG, V237, P828, DOI 10.1097/00000658-200306000-00011; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Namikawa T, 2010, J GASTROINTEST SURG, V14, P52, DOI 10.1007/s11605-009-1059-4; Noda N, 1998, BRIT J SURG, V85, P831; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Roviello F, 2006, J SURG ONCOL, V94, P275, DOI 10.1002/jso.20566; Saito H, 2010, J SURG ONCOL, V101, P622, DOI 10.1002/jso.21562; Siewert J Rudiger, 2005, Gastric Cancer, V8, P59, DOI 10.1007/s10120-005-0323-x; Sobin LH., 2010, TNM CLASSIFICATION M; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.1093/biomet/77.1.147; Wang W, 2011, ANN ONCOL, V22, P2049, DOI 10.1093/annonc/mdq716; Wijnhoven BPL, 2007, ANN SURG, V245, P717, DOI 10.1097/01.sla.0000251703.35919.02; Wong SL, 2007, JAMA-J AM MED ASSOC, V298, P2149, DOI 10.1001/jama.298.18.2149; Wu ZY, 2007, WORLD J GASTROENTERO, V13, P4122, DOI 10.3748/wjg.v13.i30.4122; Xu DZ, 2010, ANN SURG ONCOL, V17, P659, DOI 10.1245/s10434-009-0793-x; Xu DZ, 2009, ANN SURG ONCOL, V16, P319, DOI 10.1245/s10434-008-0240-4; Yang HX, 2010, ANN SURG ONCOL, V17, P1901, DOI 10.1245/s10434-010-0948-9; Yasuda K, 2002, ANN SURG ONCOL, V9, P771, DOI 10.1245/ASO.2002.01.001	35	42	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38681	10.1371/journal.pone.0038681	http://dx.doi.org/10.1371/journal.pone.0038681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723875	gold, Green Submitted, Green Published			2022-12-25	WOS:000305652700020
J	Pellegrin, S; Heesom, KJ; Satchwell, TJ; Hawley, BR; Daniels, G; van den Akker, E; Toye, AM				Pellegrin, Stephanie; Heesom, Kate J.; Satchwell, Timothy J.; Hawley, Bethan R.; Daniels, Geoff; van den Akker, Emile; Toye, Ashley M.			Differential Proteomic Analysis of Human Erythroblasts Undergoing Apoptosis Induced by Epo-Withdrawal	PLOS ONE			English	Article							GROWTH-FACTOR WITHDRAWAL; ERYTHROID PROGENITOR CELLS; HEAT-SHOCK PROTEINS; ERYTHROPOIETIN RECEPTOR; JURKAT CELLS; CLEAVAGE; KINASE; PHOSPHORYLATION; ACTIVATION; PATHWAY	The availability of Erythropoietin (Epo) is essential for the survival of erythroid progenitors. Here we study the effects of Epo removal on primary human erythroblasts grown from peripheral blood CD34(+) cells. The erythroblasts died rapidly from apoptosis, even in the presence of SCF, and within 24 hours of Epo withdrawal 60% of the cells were Annexin V positive. Other classical hallmarks of apoptosis were also observed, including cytochrome c release into the cytosol, loss of mitochondrial membrane potential, Bax translocation to the mitochondria and caspase activation. We adopted a 2D DIGE approach to compare the proteomes of erythroblasts maintained for 12 hours in the presence or absence of Epo. Proteomic comparisons demonstrated significant and reproducible alterations in the abundance of proteins between the two growth conditions, with 18 and 31 proteins exhibiting altered abundance in presence or absence of Epo, respectively. We observed that Epo withdrawal induced the proteolysis of the multi-functional proteins Hsp90 alpha, Hsp90 beta, SET, 14-3-3 beta, 143-3 gamma, 14-3-3 epsilon, and RPSA, thereby targeting multiple signaling pathways and cellular processes simultaneously. We also observed that 14 proteins were differentially phosphorylated and confirmed the phosphorylation of the Hsp90 alpha and Hsp90 beta proteolytic fragments in apoptotic cells using Nano LC mass spectrometry. Our analysis of the global changes occurring in the proteome of primary human erythroblasts in response to Epo removal has increased the repertoire of proteins affected by Epo withdrawal and identified proteins whose aberrant regulation may contribute to ineffective erythropoiesis.	[Pellegrin, Stephanie; Satchwell, Timothy J.; Hawley, Bethan R.; Toye, Ashley M.] Univ Walk, Sch Biochem, Bristol, Avon, England; [Heesom, Kate J.] Univ Walk, Univ Bristol, Prote Facil, Bristol, Avon, England; [Daniels, Geoff; Toye, Ashley M.] NHS Blood & Transplant, Bristol Inst Transfus Sci, Bristol, Avon, England; [van den Akker, Emile] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands	University of Bristol; University of Bristol	Pellegrin, S (corresponding author), Univ Walk, Sch Biochem, Med Sci Bldg, Bristol, Avon, England.	ash.m.toye@bristol.ac.uk	Toye, Ashley Mark/AAV-7199-2021; Toye, Ashley Mark/AFO-2320-2022	Toye, Ashley Mark/0000-0003-4395-9396; Toye, Ashley Mark/0000-0003-4395-9396	National Health Service Blood and Transplant (NHSBT); National Institute for Health [RP-PG-0310-1004-AMT]; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Health Service Blood and Transplant (NHSBT); National Institute for Health; National Institute for Health Research(National Institute for Health Research (NIHR))	SP was funded by National Health Service Blood and Transplant (NHSBT) projects grants to GD and AMT. This work was funded in part by National Institute for Health Research programme grant to NHSBT (RP-PG-0310-1004-AMT). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abutin RM, 2009, EXP HEMATOL, V37, P151, DOI 10.1016/j.exphem.2008.10.008; Ando K, 2011, EXP HEMATOL, V39, P179, DOI 10.1016/j.exphem.2010.11.001; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Chen HH, 2009, MOL CELL BIOL, V29, P3657, DOI 10.1128/MCB.01640-08; Chepanoske CL, 2005, RAPID COMMUN MASS SP, V19, P9, DOI 10.1002/rcm.1741; Christian KJ, 2008, MOL PHARMACOL, V73, P1558, DOI 10.1124/mol.107.042507; Cornelis S, 2005, ONCOGENE, V24, P1552, DOI 10.1038/sj.onc.1208401; DAMEN JE, 1995, J BIOL CHEM, V270, P23402, DOI 10.1074/jbc.270.40.23402; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; de Thonel A, 2010, BLOOD, V116, P85, DOI 10.1182/blood-2009-09-241778; Deng HB, 2011, INT J BIOCHEM CELL B, V43, P409, DOI 10.1016/j.biocel.2010.11.011; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; HellstromLindberg E, 1997, LEUKEMIA RES, V21, P415, DOI 10.1016/S0145-2126(96)00110-5; Jelkmann WE, 2010, J PHYSL; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Kurokawa M, 2008, MOL CELL BIOL, V28, P5494, DOI 10.1128/MCB.00265-08; Kuzelova K, 2009, J CELL BIOCHEM, V106, P673, DOI 10.1002/jcb.22061; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Lui JCK, 2007, FEBS LETT, V581, P109, DOI 10.1016/j.febslet.2006.11.082; Malygin AA, 2011, BIOCHIMIE, V93, P612, DOI 10.1016/j.biochi.2010.12.005; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; MUTA K, 1994, J CLIN INVEST, V94, P34, DOI 10.1172/JCI117327; Ohtsuka R, 2007, EUR J HAEMATOL, V79, P114, DOI 10.1111/j.1600-0609.2007.00870.x; Polzien L, 2009, J BIOL CHEM, V284, P28004, DOI 10.1074/jbc.M109.010702; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Quelo I, 2004, BIOCHEMISTRY-US, V43, P2906, DOI 10.1021/bi036256+; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rudel T, 1998, J IMMUNOL, V160, P7; Samanta AK, 2009, ONCOGENE, V28, P1669, DOI 10.1038/onc.2009.7; Satchwell TJ, 2011, BLOOD, V118, P182, DOI 10.1182/blood-2010-10-314187; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Shay KP, 2005, MOL CANCER RES, V3, P170; Somervaille TCP, 2001, BLOOD, V98, P1374, DOI 10.1182/blood.V98.5.1374; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Vera J, 2006, ONCOGENE, V25, P260, DOI 10.1038/sj.onc.1209050; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wessely O, 1997, EMBO J, V16, P267, DOI 10.1093/emboj/16.2.267; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wojchowski DM, 2010, CURR OPIN HEMATOL, V17, P169, DOI 10.1097/MOH.0b013e328338008b; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Zhang J, 2009, CELL DEATH DIFFER, V16, P1460, DOI 10.1038/cdd.2009.87; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	61	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38356	10.1371/journal.pone.0038356	http://dx.doi.org/10.1371/journal.pone.0038356			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723854	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300024
J	Hirota, SK; Nitta, K; Kim, Y; Kato, A; Kawakubo, N; Yasumoto, AA; Yahara, T				Hirota, Shun K.; Nitta, Kozue; Kim, Yuni; Kato, Aya; Kawakubo, Nobumitsu; Yasumoto, Akiko A.; Yahara, Tetsukazu			Relative Role of Flower Color and Scent on Pollinator Attraction: Experimental Tests using F1 and F2 Hybrids of Daylily and Nightlily	PLOS ONE			English	Article							BUTTERFLY PAPILIO-XUTHUS; MANDUCA-SEXTA; HEMEROCALLIS-FULVA; INNATE PREFERENCES; REPRODUCTIVE ISOLATION; MACROGLOSSUM-STELLATARUM; NOCTURNAL HAWKMOTHS; NATURAL-SELECTION; VISUAL PIGMENTS; SWALLOWTAIL	The daylily (Hemerocallis fulva) and nightlily (H. citrina) are typical examples of a butterfly-pollination system and a hawkmoth-pollination system, respectively. H. fulva has diurnal, reddish or orange-colored flowers and is mainly pollinated by diurnal swallowtail butterflies. H. citrina has nocturnal, yellowish flowers with a sweet fragrance and is pollinated by nocturnal hawkmoths. We evaluated the relative roles of flower color and scent on the evolutionary shift from a diurnally flowering ancestor to H. citrina. We conducted a series of experiments that mimic situations in which mutants differing in either flower color, floral scent or both appeared in a diurnally flowering population. An experimental array of 666 potted plants, mixed with 24 plants of H. fulva and 12 plants of either F1 or F2 hybrids, were placed in the field, and visitations of swallowtail butterflies and nocturnal hawkmoths were recorded with camcorders. Swallowtail butterflies preferentially visited reddish or orange-colored flowers and hawkmoths preferentially visited yellowish flowers. Neither swallowtail butterflies nor nocturnal hawkmoths showed significant preferences for overall scent emission. Our results suggest that mutations in flower color would be more relevant to the adaptive shift from a diurnally flowering ancestor to H. citrina than that in floral scent.	[Hirota, Shun K.; Nitta, Kozue; Yasumoto, Akiko A.; Yahara, Tetsukazu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Kim, Yuni; Kato, Aya; Kawakubo, Nobumitsu] Gifu Univ, Fac Appl Biol Sci, Dept Environm Sci, Gifu, Japan	Kyushu University; Gifu University	Hirota, SK (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	shhirscb@kyushu-u.org		Yasumoto, Akiko/0000-0002-8997-6768; Yahara, Tetsukazu/0000-0001-5105-7152	Japan Society for the Promotion of Science [21370013, 22.3799]; Grants-in-Aid for Scientific Research [23128510] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by Grant-in-Aid for Scientific Research (B) (No. 21370013) and Grant-in-Aid for JSPS Fellows (22.3799) from Japan Society for the Promotion of Science. http://www.jsps.go.jp/english/index.html. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson R, 2002, P ROY SOC B-BIOL SCI, V269, P631, DOI 10.1098/rspb.2001.1928; Ando T, 2001, ANN BOT-LONDON, V88, P403, DOI 10.1006/anbo.2001.1485; ARIKAWA K, 1987, NATURWISSENSCHAFTEN, V74, P297, DOI 10.1007/BF00366422; Balkenius A, 2004, J EXP BIOL, V207, P3307, DOI 10.1242/jeb.01158; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Balkenius A, 2006, NATURWISSENSCHAFTEN, V93, P255, DOI 10.1007/s00114-006-0099-9; BENNETT RR, 1985, VISION RES, V25, P1771, DOI 10.1016/0042-6989(85)90002-1; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Campbell DR, 2004, NEW PHYTOL, V161, P83, DOI 10.1046/j.1469-8137.2003.00919.x; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; Darwin C., 1877, VARIOUS CONTRIVANCES; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Goyret J, 2008, NATURWISSENSCHAFTEN, V95, P569, DOI 10.1007/s00114-008-0350-7; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; Goyret J, 2009, P ROY SOC B-BIOL SCI, V276, P2739, DOI 10.1098/rspb.2009.0456; GRANT V, 1985, BOT GAZ, V146, P517, DOI 10.1086/337557; GRANT V, 1983, BOT GAZ, V144, P439, DOI 10.1086/337395; GRANT V, 1993, P NATL ACAD SCI USA, V90, P7729, DOI 10.1073/pnas.90.16.7729; Hasegawa M, 2006, J PLANT RES, V119, P63, DOI 10.1007/s10265-005-0241-3; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; Hodges SA, 2004, NEW PHYTOL, V161, P113, DOI 10.1046/j.1469-8137.2003.00950.x; HOGLUND G, 1973, J COMP PHYSIOL, V86, P265, DOI 10.1007/BF00696344; Ippolito A, 2004, EVOLUTION, V58, P2634, DOI 10.1111/j.0014-3820.2004.tb01617.x; Johnson SD, 2006, S AFR J BOT, V72, P24, DOI 10.1016/j.sajb.2005.04.002; JOHNSON SD, 1995, NORD J BOT, V15, P121, DOI 10.1111/j.1756-1051.1995.tb00128.x; JOHNSTON MO, 1991, EVOLUTION, V45, P1468, DOI [10.2307/2409893, 10.1111/j.1558-5646.1991.tb02649.x]; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kelber A, 2002, P ROY SOC B-BIOL SCI, V269, P2573, DOI 10.1098/rspb.2002.2201; Kelber A, 1997, J EXP BIOL, V200, P827; Kelber A, 2010, BEHAV ECOL, V21, P1093, DOI 10.1093/beheco/arq115; Kinoshita M, 1999, J EXP BIOL, V202, P95; Kinoshita M, 2000, J EXP BIOL, V203, P3521; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Maad J, 2000, EVOLUTION, V54, P112, DOI 10.1111/j.0014-3820.2000.tb00012.x; Miyake T, 1998, J PLANT RES, V111, P199, DOI 10.1007/BF02512170; Morinaga SI, 2009, POPUL ECOL, V51, P187, DOI 10.1007/s10144-008-0097-1; Nitta K, 2010, AM J BOT, V97, P261, DOI 10.3732/ajb.0900001; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; SCHWEMER J, 1973, J COMP PHYSIOL, V86, P215, DOI 10.1007/BF00696341; Sokal R. R., 2012, BIOMETRY; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; STANTON ML, 1989, EVOLUTION, V43, P335, DOI [10.1111/j.1558-5646.1989.tb04231.x, 10.2307/2409211]; SWIHART CA, 1970, ANIM BEHAV, V18, P60, DOI 10.1016/0003-3472(70)90071-0; Takeuchi Y, 2006, J EXP BIOL, V209, P2873, DOI 10.1242/jeb.02311; VANDERPIJL L, 1961, EVOLUTION, V15, P44, DOI 10.2307/2405842; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357; Weiss MR, 2003, ANIM BEHAV, V65, P425, DOI 10.1006/anbe.2003.2084; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Yasumoto AA, 2008, J PLANT RES, V121, P287, DOI 10.1007/s10265-008-0152-1; Yasumoto AA, 2006, J PLANT RES, V119, P617, DOI 10.1007/s10265-006-0028-1; Yokota S, 2012, PLANT SPEC BIOL, V27, P96, DOI 10.1111/j.1442-1984.2011.00336.x	56	43	44	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39010	10.1371/journal.pone.0039010	http://dx.doi.org/10.1371/journal.pone.0039010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720016	gold, Green Published			2022-12-25	WOS:000305350000034
J	Wang, HJ; Zhang, PJ; Chen, WJ; Feng, D; Jia, YH; Xie, LX				Wang, Huijuan; Zhang, Pengjun; Chen, Weijun; Feng, Dan; Jia, Yanhong; Xie, Lixin			Serum MicroRNA Signatures Identified by Solexa Sequencing Predict Sepsis Patients' Mortality: A Prospective Observational Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SEPTIC SHOCK; LUNG-CANCER; PROGNOSTIC MARKER; ORGAN FAILURE; T-CELLS; EXPRESSION; PROCALCITONIN; MICROVESICLES; FINGERPRINTS	Background: Sepsis is the leading cause of death in Intensive Care Units. Novel sepsis biomarkers and targets for treatment are needed to improve mortality from sepsis. MicroRNAs (miRNAs) have recently been used as finger prints for sepsis, and our goal in this prospective study was to investigate if serum miRNAs identified in genome-wide scans could predict sepsis mortality. Methodology/Principal Findings: We enrolled 214 sepsis patients (117 survivors and 97 non-survivors based on 28-day mortality). Solexa sequencing followed by quantitative reverse transcriptase polymerase chain reaction assays was used to test for differences in the levels of miRNAs between survivors and non-survivors. miR-223, miR-15a, miR-16, miR-122, miR-193*, and miR-483-5p were significantly differentially expressed. Receiver operating characteristic curves were generated and the areas under the curve (AUC) for these six miRNAs for predicting sepsis mortality ranged from 0.610 (95% CI: 0.523-0.697) to 0.790 (95% CI: 0.719-0.861). Logistic regression analysis showed that sepsis stage, Sequential Organ Failure Assessment scores, Acute Physiology and Chronic Health Evaluation II scores, miR-15a, miR-16, miR-193b*, and miR-483-5p were associated with death from sepsis. An analysis was done using these seven variables combined. The AUC for these combined variables' predictive probability was 0.953 (95% CI: 0.923-0.983), which was much higher than the AUCs for Acute Physiology and Chronic Health Evaluation II scores (0.782; 95% CI: 0.712-0.851), Sequential Organ Failure Assessment scores (0.752; 95% CI: 0.672-0.832), and procalcitonin levels (0.689; 95% CI: 0.611-0.784). With a cut-off point of 0.550, the predictive value of the seven variables had a sensitivity of 88.5% and a specificity of 90.4%. Additionally, miR-193b* had the highest odds ratio for sepsis mortality of 9.23 (95% CI: 1.20-71.16). Conclusion/Significance: Six serum miRNA's were identified as prognostic predictors for sepsis patients.	[Wang, Huijuan; Xie, Lixin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China; [Wang, Huijuan; Zhang, Pengjun] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Wang, Huijuan; Jia, Yanhong; Xie, Lixin] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Med, Beijing, Peoples R China; [Zhang, Pengjun] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China; [Chen, Weijun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Airport Ind B6, Beijing, Peoples R China; [Feng, Dan] Chinese Peoples Liberat Army Gen Hosp, Dept Med Stat, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese People's Liberation Army General Hospital	Wang, HJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Resp Med, Sanya, Hainan Province, Peoples R China.	xielx@263.net	Xie, li/HGE-6052-2022		Chinese National Science & Technology Pillar Program [2009BAI86B03]	Chinese National Science & Technology Pillar Program	This work was supported by the Chinese National Science & Technology Pillar Program (2009BAI86B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chen J, 2011, AM J PATHOL; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen SJ, 2011, INTERNAL MED, V50, P871, DOI 10.2169/internalmedicine.50.4312; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Fritz HG, 2003, ACTA ANAESTH SCAND, V47, P1276, DOI 10.1046/j.1399-6576.2003.00239.x; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hillas G, 2010, EUR RESPIR J, V35, P805, DOI 10.1183/09031936.00051309; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Kampmeier TG, 2010, MINERVA ANESTESIOL, V76, P844; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuguchi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015304; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Silvestre J, 2009, INTENS CARE MED, V35, P909, DOI 10.1007/s00134-009-1402-y; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Wang ZX, 2011, J SURG ONCOL; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Zhu EL, 2010, NUCLEIC ACIDS RES, V38, pW392, DOI 10.1093/nar/gkq393	37	103	122	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38885	10.1371/journal.pone.0038885	http://dx.doi.org/10.1371/journal.pone.0038885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719975	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350000027
J	Angell, AR; Pirozzi, I; de Nys, R; Paul, NA				Angell, Alex R.; Pirozzi, Igor; de Nys, Rocky; Paul, Nicholas A.			Feeding Preferences and the Nutritional Value of Tropical Algae for the Abalone Haliotis asinina	PLOS ONE			English	Article							SOUTH-AFRICAN ABALONE; DIETARY-PROTEIN LEVEL; BROWN-ALGAE; CHEMICAL DEFENSES; SEA-URCHIN; AUSTRALIAN ABALONE; JUVENILE ABALONE; GROWTH; MIDAE; EFFICIENCY	Understanding the feeding preferences of abalone (high-value marine herbivores) is integral to new species development in aquaculture because of the expected link between preference and performance. Performance relates directly to the nutritional value of algae - or any feedstock - which in turn is driven by the amino acid content and profile, and specifically the content of the limiting essential amino acids. However, the relationship between feeding preferences, consumption and amino acid content of algae have rarely been simultaneously investigated for abalone, and never for the emerging target species Haliotis asinina. Here we found that the tropical H. asinina had strong and consistent preferences for the red alga Hypnea pannosa and the green alga Ulva flexuosa, but no overarching relationship between protein content (sum of amino acids) and preference existed. For example, preferred Hypnea and Ulva had distinctly different protein contents (12.64 vs. 2.99 g 100 g(-1)) and the protein-rich Asparagopsis taxiformis (>15 g 100 g(-1) of dry weight) was one of the least preferred algae. The limiting amino acid in all algae was methionine, followed by histidine or lysine. Furthermore we demonstrated that preferences can largely be removed using carrageenan as a binder for dried alga, most likely acting as a feeding attractant or stimulant. The apparent decoupling between feeding preference and algal nutritive values may be due to a trade off between nutritive values and grazing deterrence associated with physical and chemical properties.	[Angell, Alex R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Angell, AR (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	alex.angell@my.jcu.edu.au	de Nys, Rocky/D-6741-2012; Paul, Nicholas/B-6496-2009	de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Advanced Manufacturing Cooperative Research Centre; Australian Government's Cooperative Research Centre Scheme	Advanced Manufacturing Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Advanced Manufacturing Cooperative Research Centre, funded through the Australian Government's Cooperative Research Centre Scheme. http://www.mbdenergy.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara LB, 2005, J SHELLFISH RES, V24, P1169; Allen VJ, 2006, AQUACULTURE, V257, P294, DOI 10.1016/j.aquaculture.2006.02.070; BARKAI R, 1988, J MOLLUS STUD, V54, P43, DOI 10.1093/mollus/54.1.43; Bautista-Teruel MN, 2003, AQUACULTURE, V219, P645, DOI 10.1016/S0044-8486(02)00410-6; Bautista-Teruel MN, 1999, AQUACULTURE, V178, P117, DOI 10.1016/S0044-8486(99)00121-0; Britz PJ, 1996, AQUACULTURE, V140, P55, DOI 10.1016/0044-8486(95)01198-6; Capinpin EC, 1996, AQUACULTURE, V144, P81, DOI 10.1016/S0044-8486(96)01332-4; Conover W.J., 1981, PRACTICAL NONPARAMET; Coote TA, 2000, AQUACULT NUTR, V6, P213, DOI 10.1046/j.1365-2095.2000.006004213.x; Cornwall CE, 2009, J SHELLFISH RES, V28, P589, DOI 10.2983/035.028.0323; Day EG, 2002, J EXP MAR BIOL ECOL, V276, P1, DOI 10.1016/S0022-0981(02)00204-6; DAY RW, 1995, MAR FRESHWATER RES, V46, P623, DOI 10.1071/MF9950623; Dunstan GA, 2010, AQUACULT NUTR, V16, P1, DOI 10.1111/j.1365-2095.2008.00629.x; Dworjanyn SA, 2007, AQUACULTURE, V273, P624, DOI 10.1016/j.aquaculture.2007.08.023; FLEMING AE, 1995, AQUACULTURE, V134, P279, DOI 10.1016/0044-8486(95)00055-7; FLEMING AE, 1995, AQUACULTURE, V132, P297, DOI 10.1016/0044-8486(94)00347-Q; FOALE S, 1992, AUST J MAR FRESH RES, V43, P1331; FOX JM, 1995, AQUACULTURE, V131, P279, DOI 10.1016/0044-8486(94)00348-R; Guzman del Proo Sergio A., 2003, Pacific Science, V57, P319, DOI 10.1353/psc.2003.0025; Hwang EK, 2008, J APPL PHYCOL, V20, P147, DOI 10.1007/s10811-007-9198-z; Lemire M, 1996, MAR BIOL, V127, P73, DOI 10.1007/BF00993646; Mai K, 1995, AQUACULTURE, V136, P165, DOI 10.1016/0044-8486(95)01041-6; Marsden ID, 1996, J SHELLFISH RES, V15, P401; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McDonald P., 2002, ANIMAL NUTR; MCSHANE PE, 1994, J EXP MAR BIOL ECOL, V178, P299; Myer RO, 2004, J APPL ANIM RES, V25, P85, DOI 10.1080/09712119.2004.9706482; NEIGHBORS MA, 1991, MAR BIOL, V108, P471, DOI 10.1007/BF01313657; Nose T., 1979, Finfish nutrition and fishfeed technology. Volume 1, P145; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Paul NA, 2006, MAR ECOL PROG SER, V323, P1, DOI 10.3354/meps323001; PENAFLORIDA VD, 1989, AQUACULTURE, V83, P319, DOI 10.1016/0044-8486(89)90043-4; POORE G C B, 1972, New Zealand Journal of Marine and Freshwater Research, V6, P11; Prince JS, 2004, OECOLOGIA, V138, P1, DOI 10.1007/s00442-003-1413-2; Qari R, 1988, J SCI IND RES INDIA, V31, P94; Reis RP, 2008, J APPL PHYCOL, V20, P1, DOI 10.1007/s10811-007-9173-8; Renaud SM, 2006, J APPL PHYCOL, V18, P381, DOI 10.1007/s10811-006-9034-x; Rogers CN, 2002, MAR ECOL PROG SER, V236, P241, DOI 10.3354/meps236241; SCHUPP PJ, 1994, ECOLOGY, V75, P1172, DOI 10.2307/1939440; Shepherd S.A., 1992, P169; Shpigel M, 1999, J SHELLFISH RES, V18, P227; STEINBERG PD, 1985, ECOL MONOGR, V55, P333, DOI 10.2307/1942581; STEINBERG PD, 1986, OECOLOGIA, V69, P628, DOI 10.1007/BF00410374; STEINBERG PD, 1990, MAR ECOL PROG SER, V58, P253; STEINBERG PD, 1991, MAR BIOL, V109, P335, DOI 10.1007/BF01319401; STENECK RS, 1982, MAR BIOL, V68, P299, DOI 10.1007/BF00409596; Stepto NK, 1996, J SHELLFISH RES, V15, P653; TAGHON GL, 1984, ECOLOGY, V65, P549, DOI 10.2307/1941417; Tahil AS, 1999, AQUAC RES, V30, P95, DOI 10.1046/j.1365-2109.1999.00294.x; Taylor Barbara, 1992, Journal of Shellfish Research, V11, P556; UKI N, 1986, B JPN SOC SCI FISH, V52, P1005; Van Alstyne KL, 2009, J EXP MAR BIOL ECOL, V379, P85, DOI 10.1016/j.jembe.2009.08.002; WELLS FE, 1989, AUST J MAR FRESH RES, V40, P187; WILSON RP, 1985, COMP BIOCHEM PHYS B, V80, P385, DOI 10.1016/0305-0491(85)90224-X; WINTER FC, 1992, J EXP MAR BIOL ECOL, V155, P263, DOI 10.1016/0022-0981(92)90067-K; Wood AD, 1996, S AFR J MARINE SCI, V17, P61	57	29	31	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38857	10.1371/journal.pone.0038857	http://dx.doi.org/10.1371/journal.pone.0038857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719967	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000305347800023
J	Chan, YS; Wong, JH; Fang, EF; Pan, WL; Ng, TB				Chan, Yau Sang; Wong, Jack Ho; Fang, Evandro Fei; Pan, Wenliang; Ng, Tzi Bun			Isolation of a Glucosamine Binding Leguminous Lectin with Mitogenic Activity towards Splenocytes and Anti-Proliferative Activity towards Tumor Cells	PLOS ONE			English	Article							PHASEOLUS-VULGARIS LECTIN; CYCAS-REVOLUTA THUNB.; FRENCH BEAN-SEEDS; ANTITUMOR-ACTIVITY; JAPANESE CYCAD; CANCER-CELLS; IN-VITRO; PURIFICATION; CARCINOMA; HEMAGGLUTININ	A dimeric 64-kDa glucosamine-specific lectin was purified from seeds of Phaseolus vulgaris cv. "brown kidney bean." The simple 2-step purification protocol involved affinity chromatography on Affi-gel blue gel and gel filtration by FPLC on Superdex 75. The lectin was absorbed on Affi-gel blue gel and desorbed using 1M NaCl in the starting buffer. Gel filtration on Superdex 75 yielded a major absorbance peak that gave a single 32-kDa band in SDS-PAGE. Hemagglutinating activity was completely preserved when the ambient temperature was in the range of 20 degrees C-60 degrees C. However, drastic reduction of the activity occurred at temperatures above 65 degrees C. Full hemagglutinating activity of the lectin was observed at an ambient pH of 3 to 12. About 50% activity remained at pH 0-2, and only residual activity was observed at pH 13-14. Hemagglutinating activity of the lectin was inhibited by glucosamine. The brown kidney bean lectin elicited maximum mitogenic activity toward murine splenocytes at 2.5 mu M. The mitogenic activity was nearly completely eliminated in the presence of 250 mM glucosamine. The lectin also increased mRNA expression of the cytokines IL-2, TNF-alpha and IFN-gamma. The lectin exhibited antiproliferative activity toward human breast cancer (MCF7) cells, hepatoma (HepG2) cells and nasopharyngeal carcinoma (CNE1 and CNE2) cells with IC50 of 5.12 mu M, 32.85 mu M, 3.12 mu M and 40.12 mu M respectively after treatment for 24 hours. Flow cytometry with Annexin V and propidum iodide staining indicated apoptosis of MCF7 cells. Hoechst 33342 staining also indicated formation of apoptotic bodies in MCF7 cells after exposure to brown kidney bean lectin. Western blotting revealed that the lectin-induced apoptosis involved ER stress and unfolded protein response.	[Chan, Yau Sang; Wong, Jack Ho; Pan, Wenliang; Ng, Tzi Bun] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Fang, Evandro Fei] NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA	Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chan, YS (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	b021770@mailserv.cuhk.edu.hk	Fang, Evandro Fei/AAC-5511-2019; Fang, Evandro Fei/AAV-4653-2020	Fang, Evandro Fei/0000-0003-0355-7202; WONG, Jack/0000-0002-9732-986X				Abdullaev FI, 1995, BIOFACTORS, V5, P133; Alizadeh H, 2011, PHYTOCHEMISTRY, V72, P94, DOI 10.1016/j.phytochem.2010.11.002; Beuth J., 1997, ANTI CANC DRUGS, V8, P53; BOCCI V, 1993, J BIOL REG HOMEOS AG, V7, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao X, 2010, J INSECT SCI, V10; Chan YS, 2011, PROTEIN PEPTIDE LETT, V18, P194; Chan YS, 2010, PROTEIN PEPTIDE LETT, V17, P823; Chang YH, 2009, BIOSCI BIOTECH BIOCH, V73, P2589, DOI 10.1271/bbb.90357; Deeni YY, 2002, J ETHNOPHARMACOL, V83, P235, DOI 10.1016/S0378-8741(02)00244-1; Dong Q, 2011, PHYTOMEDICINE, V18, P309, DOI 10.1016/j.phymed.2010.06.008; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Fabre C, 1998, BIOCHEM J, V329, P551, DOI 10.1042/bj3290551; Fang EF, 2012, CANCER PREV RES, V5, P109, DOI 10.1158/1940-6207.CAPR-11-0203; Fang EF, 2011, ARCH TOXICOL, V85, P1551, DOI 10.1007/s00204-011-0698-x; Ghosh D, 2007, IMMUNOBIOLOGY, V212, P589, DOI 10.1016/j.imbio.2007.03.005; Haraguchi T, 2006, BIOSCI BIOTECH BIOCH, V70, P2222, DOI 10.1271/bbb.60156; Huang L, 2008, IMMUNOL LETT, V121, P148, DOI 10.1016/j.imlet.2008.10.004; Kamemura K, 1996, BIOSCI BIOTECH BIOCH, V60, P608, DOI 10.1271/bbb.60.608; KOIKE T, 1995, J BIOCHEM-TOKYO, V118, P1205, DOI 10.1093/oxfordjournals.jbchem.a125008; Kovalchuk N. V., 2006, Ukrainskii Biokhimicheskii Zhurnal, V78, P130; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lam SK, 2010, BIOSCIENCE REP, V30, P307, DOI 10.1042/BSR20090059; Lam SK, 2009, BIOSCIENCE REP, V29, P293, DOI 10.1042/BSR20080110; Lei HY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-10; Leung EHW, 2008, J PEPT SCI, V14, P349, DOI 10.1002/psc.946; Lin P, 2008, ACTA BIOCH BIOPH SIN, V40, P1029, DOI 10.1111/j.1745-7270.2008.00488.x; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Liu B, 2009, AUTOPHAGY, V5, P253, DOI 10.4161/auto.5.2.7561; Mengs U, 1999, Wien Med Wochenschr, V149, P262; Nakagawa R, 1996, BIOSCI BIOTECH BIOCH, V60, P259, DOI 10.1271/bbb.60.259; OHTANI K, 1980, J BIOCHEM, V87, P407, DOI 10.1093/oxfordjournals.jbchem.a132761; Peumans WJ, 2001, ADV EXP MED BIOL, V491, P27; Rodriguez-Juan C, 2000, CYTOKINE, V12, P1284, DOI 10.1006/cyto.1999.0731; Seelentag WKF, 1998, CANCER RES, V58, P5559; SERAFINICESSI F, 1979, BIOCHEM J, V183, P381, DOI 10.1042/bj1830381; Sharma A, 2010, PROTEIN PEPTIDE LETT, V17, P221, DOI 10.2174/092986610790226067; Silva JA, 2001, J PROTEIN CHEM, V20, P1, DOI 10.1023/A:1011053002001; Subramanyam S, 2008, PLANT PHYSIOL, V147, P1412, DOI 10.1104/pp.108.116145; Valadez-Vega C, 2011, MOLECULES, V16, P2107, DOI 10.3390/molecules16032107; Wong JH, 2010, J SCI FOOD AGR, V90, P70, DOI 10.1002/jsfa.3782; Xu ZT, 2011, AM J CHINESE MED, V39, P579, DOI 10.1142/S0192415X11009044; Yagi F, 2002, EUR J BIOCHEM, V269, P4335, DOI 10.1046/j.1432-1033.2002.03127.x; Yan QJ, 2009, PHYTOMEDICINE, V16, P586, DOI 10.1016/j.phymed.2008.12.024; Yang Y, 2011, PHYTOMEDICINE, V18, P748, DOI 10.1016/j.phymed.2010.11.001	45	56	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38961	10.1371/journal.pone.0038961	http://dx.doi.org/10.1371/journal.pone.0038961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720002	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800032
J	Barros, LC; Santos, U; Zanuncio, JC; Dergam, JA				Barros, Lucas C.; Santos, Udson; Zanuncio, Jose C.; Dergam, Jorge A.			Plagioscion squamosissimus (Sciaenidae) and Parachromis managuensis (Cichlidae): A Threat to Native Fishes of the Doce River in Minas Gerais, Brazil	PLOS ONE			English	Article							FRESH-WATER FISH; CURRENT KNOWLEDGE; TELEOSTEI; IMPACTS	The middle section of the lake basin of the Doce River in Minas Gerais State, Brazil is plagued by grave environmental problems, including the introduction of non-native fish, which reduces the biodiversity of this region. This study reports the presence of two newly-detected non-native species in the Doce River Basin. Sampling efforts included gill nets with mesh size of 3 to 12 mm (measured diagonally) and trawling nets, both of which were used in independent field campaigns in 2002 and 2011. The two new invasive Perciform fishes, Plagioscion squamosissimus (Heckel 1840) and Parachromis managuensis (Gunther 1867) were collected in Caratinga and Rio Doce municipalities. These records and other reports on non-native fishes suggest favorable environmental conditions for the establishment of invasive species in this drainage. These invasive species have behavior and diet observed in other wide distribution exotic fish of Rio Doce Basin representing a threat to the 77 native fishes of this region, 37 of which are endangered.	[Barros, Lucas C.; Santos, Udson; Zanuncio, Jose C.; Dergam, Jorge A.] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil; [Santos, Udson] Univ Fed Ouro Preto, Dept Biodivers Evolucao & Meio Ambiente, Ouro Preto, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Ouro Preto	Barros, LC (corresponding author), Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil.	udsonsan@gmail.com	Dergam, Jorge/B-1522-2013; barros, lucas/GXG-6687-2022	Dergam, Jorge/0000-0003-1395-1377; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [PONE-D-12-01684R1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work (PONE-D-12-01684R1) was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CBM, 2007, REV-METHODS TECHNOL, V6, P291, DOI 10.1007/978-1-4020-6148-6_16; Barbosa JM, 2006, REV BRAS ENG PESCA, V1, P61; Bennemann Sirlei T., 2006, Iheringia, Sér. Zool., V96, P115, DOI 10.1590/S0073-47212006000100020; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; CLOUT M, 2004, ALIENS, V13, P3; CONKEL D, 1993, CICHLIDS N CENTRAL A; De Klemm C, 1996, INTRO NONNATIVE ORGA; Dergam JA, 2002, GENET MOL BIOL, V25, P379, DOI 10.1590/S1415-47572002000400005; Drummond GM, 2005, BIODIVERSIDADE MINAS, V2th; Duncan RP, 2002, NATURE, V417, P608, DOI 10.1038/417608a; Goudswaard PC, 2002, J FISH BIOL, V60, P838, DOI [10.1111/j.1095-8649.2002.tb02413.x, 10.1006/jfbi.2002.1888]; Gozlan RE, 2012, FISHERIES MANAG ECOL, V19, P89, DOI 10.1111/j.1365-2400.2012.00853.x; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Groom M.J., 2006, PRINCIPLES CONSERVAT; Hall S.R., 2000, Aquatic Ecosystem Health & Management, V3, P105, DOI 10.1080/14634980008656995; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Latini Anderson O., 2004, Lundiana, V5, P135; Latini AO, 2004, FISHERIES MANAG ECOL, V11, P71, DOI 10.1046/j.1365-2400.2003.00372.x; Lima FP, 2010, INTERCIENCIA, V35, P84; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Makrakis MC, 2008, J FISH BIOL, V72, P1690, DOI 10.1111/j.1095-8649.2008.01845.x; Martins CS, 1998, BIODIVERSIDADE MINAS, P44; *MMA SBF, 2000, AV AC PRIOR CONS BIO; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Myers JH, 2000, TREE, V15, P16; Paiva SR, 2006, HYDROBIOLOGIA, V560, P393, DOI 10.1007/s10750-005-9415-1; Pinto-Coelho RM, 2008, BRAZ J BIOL, V68, P1025, DOI 10.1590/S1519-69842008000500010; Reis R.E., 2003, CHECK LIST FISHES S; Ribeiro F, 2012, FISHERIES MANAG ECOL, V19, P142, DOI 10.1111/j.1365-2400.2011.00842.x; Rodriguez JP, 2001, BIODIVERS CONSERV, V10, P1983, DOI 10.1023/A:1013151722557; Rosa RS, 2005, LISTA FAUNA BRASILEI, P65; Vitule JRS, 2009, FISH FISH, V10, P98, DOI 10.1111/j.1467-2979.2008.00312.x; Vieira F., 2006, ICTIOFAUNA RIO SANTO; vonSperling M, 1994, ECOLOGY HUMAN IMPACT, P77; Wolter C, 2010, J APPL ICHTHYOL, V26, P19, DOI 10.1111/j.1439-0426.2010.01505.x; Ziller S. R, 2007, MODELO DESENVOLVIMEN	36	35	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39138	10.1371/journal.pone.0039138	http://dx.doi.org/10.1371/journal.pone.0039138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720053	gold, Green Published			2022-12-25	WOS:000305341900086
J	Nischang, M; Sutmuller, R; Gers-Huber, G; Audige, A; Li, D; Rochat, MA; Baenziger, S; Hofer, U; Schlaepfer, E; Regenass, S; Amssoms, K; Stoops, B; Van Cauwenberge, A; Boden, D; Kraus, G; Speck, RF				Nischang, Marc; Sutmuller, Roger; Gers-Huber, Gustavo; Audige, Annette; Li, Duo; Rochat, Mary-Aude; Baenziger, Stefan; Hofer, Ursula; Schlaepfer, Erika; Regenass, Stephan; Amssoms, Katie; Stoops, Bart; Van Cauwenberge, Anja; Boden, Daniel; Kraus, Guenter; Speck, Roberto F.			Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting AntiRetroviral Drugs for Treating HIV-1	PLOS ONE			English	Article							SCID-HU MOUSE; REVERSE-TRANSCRIPTASE; IN-VIVO; RAG2(-/-)GAMMA(-/-)(C) MICE; T-CELLS; VIRUS; MODEL; RILPIVIRINE; THERAPY; PHARMACOKINETICS	Background: Humanized mice generate a lymphoid system of human origin subsequent to transplantation of human CD34+ cells and thus are highly susceptible to HIV infection. Here we examined the efficacy of antiretroviral treatment (ART) when added to food pellets, and of long-acting (LA) antiretroviral compounds, either as monotherapy or in combination. These studies shall be inspiring for establishing a gold standard of ART, which is easy to administer and well supported by the mice, and for subsequent studies such as latency. Furthermore, they should disclose whether viral breakthrough and emergence of resistance occurs similar as in HIV-infected patients when ART is insufficient. Methods/Principal Findings: NOD/shi-scid/ccnull (NOG) mice were used in all experimentations. We first performed pharmacokinetic studies of the drugs used, either added to food pellets (AZT, TDF, 3TC, RTV) or in a LA formulation that permitted once weekly subcutaneous administration (TMC278: non-nucleoside reverse transcriptase inhibitor, TMC181: protease inhibitor). A combination of 3TC, TDF and TMC278-LA or 3TC, TDF, TMC278-LA and TMC181-LA suppressed the viral load to undetectable levels in 15/19 (79%) and 14/14 (100%) mice, respectively. In successfully treated mice, subsequent monotherapy with TMC278-LA resulted in viral breakthrough; in contrast, the two LA compounds together prevented viral breakthrough. Resistance mutations matched the mutations most commonly observed in HIV patients failing therapy. Importantly, viral rebound after interruption of ART, presence of HIV DNA in successfully treated mice and in vitro reactivation of early HIV transcripts point to an existing latent HIV reservoir. Conclusions/Significance: This report is a unique description of multiple aspects of HIV infection in humanized mice that comprised efficacy testing of various treatment regimens, including LA compounds, resistance mutation analysis as well as viral rebound after treatment interruption. Humanized mice will be highly valuable for exploring the antiviral potency of new compounds or compounds targeting the latent HIV reservoir.	[Nischang, Marc; Gers-Huber, Gustavo; Audige, Annette; Li, Duo; Rochat, Mary-Aude; Baenziger, Stefan; Hofer, Ursula; Schlaepfer, Erika; Speck, Roberto F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Sutmuller, Roger; Amssoms, Katie; Stoops, Bart; Van Cauwenberge, Anja; Boden, Daniel; Kraus, Guenter] Tibotec BVBA, Beerse, Belgium	University of Zurich; University Zurich Hospital; Johnson & Johnson	Nischang, M (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	roberto.speck@usz.ch	Speck, Roberto F/O-2433-2016	Rochat, Mary-Aude/0000-0003-3414-1330; Speck, Roberto/0000-0002-8453-1137	Swiss National Science Foundation; Flemish agency for Innovation by Science and Technology (IWT), Belgium; Tibotec BVBA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Flemish agency for Innovation by Science and Technology (IWT), Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Tibotec BVBA	This work was supported by the Swiss National Science Foundation and by the Flemish agency for Innovation by Science and Technology (IWT), Belgium. This work is a collaboration between the University of Zurich and Tibotec BVBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The following authors are employees from Tibotec BVBA, Belgium: KA, BS, AvC, GK, DB and RS. The laboratory from RFS has been financially supported by Tibotec BVBA; in addition, Tibotec BVBA provided reagents to the laboratory of RFS and performed a number of assays in the context of the collaboration between the laboratory of RFS and Tibotec BVBA. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data materials.	Althaus CF, 2010, J VIROL METHODS, V165, P151, DOI 10.1016/j.jviromet.2010.01.012; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Baert L, 2009, EUR J PHARM BIOPHARM, V72, P502, DOI 10.1016/j.ejpb.2009.03.006; Bazzoli C, 2010, CLIN PHARMACOKINET, V49, P17, DOI 10.2165/11318110-000000000-00000; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Bonyhadi ML, 1997, MOL MED TODAY, V3, P246, DOI 10.1016/S1357-4310(97)01046-0; Camacho Ricardo, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS3, DOI 10.1097/01.COH.0000410239.88517.00; Chittick GE, 2006, ANTIMICROB AGENTS CH, V50, P1304, DOI 10.1128/AAC.50.4.1304-1310.2006; Choudhary SK, 2012, J VIROL, V86, P114, DOI 10.1128/JVI.05590-11; Choudhary SK, 2009, J VIROL, V83, P8254, DOI 10.1128/JVI.00580-09; Christopherson C, 2000, J CLIN MICROBIOL, V38, P630, DOI 10.1128/JCM.38.2.630-634.2000; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Cordery DV, 2010, ANTIVIR THER, V15, P1035, DOI 10.3851/IMP1647; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Fletcher CV, 2000, AIDS, V14, P2137, DOI 10.1097/00002030-200009290-00010; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Goldstein H, 1996, Semin Immunol, V8, P223, DOI 10.1006/smim.1996.0028; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; Kaiser P, 2007, J VIROL, V81, P9693, DOI 10.1128/JVI.00492-07; Manrique A, 2007, J VIROL, V81, P8793, DOI 10.1128/JVI.00598-07; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miller CD, 2011, DRUG TODAY, V47, P5, DOI 10.1358/dot.2011.47.1.1583188; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; NAMIKAWA R, 1988, SCIENCE, V242, P1684, DOI 10.1126/science.3201256; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sango K, 2010, AIDS RES HUM RETROV, V26, P735, DOI 10.1089/aid.2009.0136; Schrijvers R, 2011, LANCET, V378, P201, DOI 10.1016/S0140-6736(11)60992-6; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000655; Taylor S, 2007, AIDS, V21, P1673, DOI 10.1097/QAD.0b013e3281c61394; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; van 't Klooster G, 2010, ANTIMICROB AGENTS CH, V54, P2042, DOI 10.1128/AAC.01529-09; Vandamme AM, 2011, AIDS REV, V13, P77; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; YV T. Pattery, 2012, INTERVIROLOGY, P138; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	43	53	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38853	10.1371/journal.pone.0038853	http://dx.doi.org/10.1371/journal.pone.0038853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719966	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000305341900056
J	Theriault, ME; Pare, ME; Maltais, F; Debigare, R				Theriault, Marie-Eve; Pare, Marie-Eve; Maltais, Francois; Debigare, Richard			Satellite Cells Senescence in Limb Muscle of Severe Patients with COPD	PLOS ONE			English	Article							TELOMERE LENGTH; SKELETAL-MUSCLE; OXIDATIVE STRESS; UBIQUITIN; WEAKNESS; REGENERATION; PERFORMANCE; LIMITATION; CAPACITY	Rationale: The maintenance of peripheral muscle mass may be compromised in chronic obstructive pulmonary disease (COPD) due to premature cellular senescence and exhaustion of the regenerative potential of the muscles. Methods: Vastus lateralis biopsies were obtained from patients with COPD (n = 16) and healthy subjects (n = 7). Satellite cell number and the proportion of central nuclei, as a marker of muscle regenerative events, were assessed on cryosections. Telomere lengths, used as a marker of cellular senescence, were determined using Southern blot analyses. Results: Central nuclei proportion was significantly higher in patients with COPD with a preserved muscle mass compared to controls and patients with COPD with muscle atrophy (p<0.001). In COPD, maximal telomere length was significantly decreased compared to controls (p<0.05). Similarly, minimal telomere length was significantly reduced in GOLD III-IV patients with muscle atrophy compared to controls (p<0.005). Minimal, mean and maximum telomere lengths correlated with mid-thigh muscle cross-sectional area (MTCSA) (R = 0.523, p = 0.005; R = 0.435, p = 0.019 and R = 0.491, p = 0.009, respectively). Conclusions: Evidence of increased regenerative events was seen in GOLD III-IV patients with preserved muscle mass. Shortening of telomeres in GOLD III-IV patients with muscle atrophy is consistent with an increased number of senescent satellite cells and an exhausted muscle regenerative capacity, compromising the maintenance of muscle mass in these individuals.	[Theriault, Marie-Eve; Pare, Marie-Eve; Maltais, Francois; Debigare, Richard] Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University	Theriault, ME (corresponding author), Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Richard.Debigare@rea.ulaval.ca			Canadian Lung Association; Reseau en Sante Respiratoire du Fond de la recherche en Sante du Quebec (FRSQ)	Canadian Lung Association; Reseau en Sante Respiratoire du Fond de la recherche en Sante du Quebec (FRSQ)	This work has been supported by an operating grant from the Canadian Lung Association. MET is supported by a scholarship from Reseau en Sante Respiratoire du Fond de la recherche en Sante du Quebec (FRSQ). RD is a research scholar of the FRSQ. FM holds a (GlaxoSmithKline/Canadian Institutes of Health Research) Research Chair on COPD at Universite Laval. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; [Anonymous], GLOB STRAT DIAGN MAN; Baird DM, 2008, EXP GERONTOL, V43, P15, DOI 10.1016/j.exger.2007.10.002; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; BLOMSTRAND E, 1984, ACTA PHYSIOL SCAND, V122, P545, DOI 10.1111/j.1748-1716.1984.tb07543.x; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; Cattan V, 2008, FREE RADICAL BIO MED, V44, P1592, DOI 10.1016/j.freeradbiomed.2008.01.007; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Couillard A, 2003, AM J RESP CRIT CARE, V167, P1664, DOI 10.1164/rccm.200209-1028OC; Couillard A, 2002, EUR RESPIR J, V20, P1123, DOI 10.1183/09031936.02.00014302; Debigare R, 2003, CHEST, V124, P83, DOI 10.1378/chest.124.1.83; Debigare R, 2008, J APPL PHYSIOL, V105, P751, DOI 10.1152/japplphysiol.90336.2008a; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429; Decramer M, 1996, AM J RESP CRIT CARE, V153, P1958, DOI 10.1164/ajrccm.153.6.8665061; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Eliason G, 2009, SCAND J MED SCI SPOR, V19, P865, DOI 10.1111/j.1600-0838.2008.00858.x; Gosker HR, 2003, EUR RESPIR J, V22, P280, DOI 10.1183/09031936.03.00012803; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HEYMSFIELD SB, 1994, JPEN-PARENTER ENTER, V18, P91, DOI 10.1177/014860719401800291; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Houben JMJ, 2009, RESP MED, V103, P230, DOI 10.1016/j.rmed.2008.09.003; Kim HC, 2010, TUBERC RESPIR DIS, V68, P125, DOI 10.4046/trd.2010.68.3.125; Lansdorp PM, 2005, TRENDS BIOCHEM SCI, V30, P388, DOI 10.1016/j.tibs.2005.05.004; Lindstrom M, 2009, HISTOCHEM CELL BIOL; LLovera M, 1998, INT J MOL MED, V2, P69; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mostert R, 2000, RESP MED, V94, P859, DOI 10.1053/rmed.2000.0829; Mui TSY, 2009, J AM GERIATR SOC, V57, P2372, DOI 10.1111/j.1532-5415.2009.02589.x; O'Connor MS, 2009, BIOTECHNOL PROG; Orozco-Levi M, 2001, AM J RESP CRIT CARE, V164, P1734, DOI 10.1164/ajrccm.164.9.2011150; Partridge TA, 2002, GENE THER, V9, P752, DOI 10.1038/sj.gt.3301764; Ponsot E, 2008, ELECTROPHORESIS, V29, P542, DOI 10.1002/elps.200700290; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabinovich RA, 2001, AM J RESP CRIT CARE, V164, P1114, DOI 10.1164/ajrccm.164.7.2103065; Rahman I, 1997, THORAX, V52, P565, DOI 10.1136/thx.52.6.565; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; SNOW MH, 1978, CELL TISSUE RES, V186, P535; TIAO G, 1994, J CLIN INVEST, V94, P2255, DOI 10.1172/JCI117588; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Van Helvoort HAC, 2006, MED SCI SPORT EXER, V38, P1543, DOI 10.1249/01.mss.0000228331.13123.53; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289	54	42	43	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39124	10.1371/journal.pone.0039124	http://dx.doi.org/10.1371/journal.pone.0039124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720047	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900083
J	Wang, P; Lei, JP; Li, MH; Yu, FH				Wang, Pu; Lei, Jing-Pin; Li, Mai-He; Yu, Fei-Hai			Spatial Heterogeneity in Light Supply Affects Intraspecific Competition of a Stoloniferous Clonal Plant	PLOS ONE			English	Article							SOIL NUTRIENT HETEROGENEITY; PHYSIOLOGICAL INTEGRATION; FRAGARIA-CHILOENSIS; ENVIRONMENTAL HETEROGENEITY; ROOT PROLIFERATION; HERB; GROWTH; PLASTICITY; PATTERN; AVAILABILITY	Spatial heterogeneity in light supply is common in nature. Many studies have examined the effects of heterogeneous light supply on growth, morphology, physiology and biomass allocation of clonal plants, but few have tested those effects on intraspecific competition. In a greenhouse experiment, we grew one (no competition) or nine ramets (with intraspecific competition) of a stoloniferous clonal plant, Duchesnea indica, in three homogeneous light conditions (high, medium and low light intensity) and two heterogeneous ones differing in patch size (large and small patch treatments). The total light in the two heterogeneous treatments was the same as that in the homogeneous medium light treatment. Both decreasing light intensity and intraspecific competition significantly decreased the growth (biomass, number of ramets and total stolon length) of D. indica. As compared with the homogeneous medium light treatment, the large patch treatment significantly increased the growth of D. indica without intraspecific competition. However, the growth of D. indica with competition did not differ among the homogeneous medium light, the large and the small patch treatments. Consequently, light heterogeneity significantly increased intraspecific competition intensity, as measured by the decreased log response ratio. These results suggest that spatial heterogeneity in light supply can alter intraspecific interactions of clonal plants.	[Wang, Pu; Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Lei, Jing-Pin] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China; [Li, Mai-He] Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland	Beijing Forestry University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Wang, P (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	feihaiyu@bjfu.edu.cn	Li, Mai-He/L-6390-2013; Wang, Pu/D-4111-2013; Yu, Fei-Hai/O-9395-2016	Li, Mai-He/0000-0002-7029-2841; Yu, Fei-Hai/0000-0001-5007-1745	Fundamental Research Funds for the Central Universities [JC2011-4]; National Science Foundation of China [31070371]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fundamental Research Funds for the Central Universities (Grant JC2011-4) and the National Science Foundation of China (Grant 31070371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Alpert P, 1999, PLANT ECOL, V141, P99, DOI 10.1023/A:1009823015170; [Anonymous], 1994, INVONOGRAPHIA CORMOP, P278; Baldocchi Dennis, 1994, P21; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; Bliss KM, 2002, NEW PHYTOL, V154, P409, DOI 10.1046/j.1469-8137.2002.00389.x; Chen JS, 2006, PLANT ECOL, V183, P147, DOI 10.1007/s11258-005-9013-3; Chen JS, 2004, FLORA, V199, P342, DOI 10.1078/0367-2530-00162; Chu Y, 2006, J INTEGR PLANT BIOL, V48, P400, DOI 10.1111/j.1744-7909.2006.00237.x; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; Day KJ, 2003, J ECOL, V91, P541, DOI 10.1046/j.1365-2745.2003.00799.x; Day KJ, 2003, J ECOL, V91, P305, DOI 10.1046/j.1365-2745.2003.00763.x; DONG M, 1993, NEW PHYTOL, V124, P291, DOI 10.1111/j.1469-8137.1993.tb03819.x; DONG M, 1995, OECOLOGIA, V101, P282, DOI 10.1007/BF00328813; Dong M, 2000, ACTA BOT SIN, V42, P518; Du J, 2009, ANN BOT-LONDON, V104, P335, DOI 10.1093/aob/mcp130; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027998; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Hodge A, 1999, PLANT CELL ENVIRON, V22, P811, DOI 10.1046/j.1365-3040.1999.00454.x; Hutchings M.J., 2000, ECOLOGICAL CONSEQUEN, P91; Hutchings MJ, 2003, ECOLOGY, V84, P2322, DOI 10.1890/02-0290; James JJ, 2007, OECOLOGIA, V152, P721, DOI 10.1007/s00442-007-0685-3; Janecek S, 2008, EVOL ECOL, V22, P325, DOI 10.1007/s10682-007-9203-7; Littschwager J, 2010, PLANT SOIL, V331, P105, DOI 10.1007/s11104-009-0236-2; Maestre FT, 2007, ECOLOGY, V88, P501, DOI 10.1890/06-0421; Naruhashi Naohiro, 1996, Plant Species Biology, V11, P173, DOI 10.1111/j.1442-1984.1996.tb00143.x; Rajaniemi TK, 2007, OECOLOGIA, V153, P145, DOI 10.1007/s00442-007-0706-2; Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431, DOI 10.1098/rspb.1999.0656; Roiloa SR, 2007, ENVIRON EXP BOT, V61, P1, DOI 10.1016/j.envexpbot.2007.02.006; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Saitoh T, 2002, J ECOL, V90, P78, DOI 10.1046/j.0022-0477.2001.00631.x; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; TOMASKO DA, 1989, MAR ECOL PROG SER, V54, P299, DOI 10.3354/meps054299; van der Waal C, 2011, OECOLOGIA, V165, P1095, DOI 10.1007/s00442-010-1899-3; van Kleunen M, 2001, OIKOS, V94, P515, DOI 10.1034/j.1600-0706.2001.940313.x; Wang ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025401; Wijesinghe DK, 1997, J ECOL, V85, P17, DOI 10.2307/2960624; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; Wijesinghe DK, 2005, J ECOL, V93, P99, DOI 10.1111/j.0022-0477.2004.00934.x; Wijesinghe DK, 1996, OIKOS, V77, P137, DOI 10.2307/3545593; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314	49	25	28	6	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39105	10.1371/journal.pone.0039105	http://dx.doi.org/10.1371/journal.pone.0039105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720041	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900081
J	Wang, Q; Xia, N; Li, T; Xu, Y; Zou, Y; Zuo, Y; Fan, Q; Bawa-Khalfe, T; Yeh, ETH; Cheng, J				Wang, Q.; Xia, N.; Li, T.; Xu, Y.; Zou, Y.; Zuo, Y.; Fan, Q.; Bawa-Khalfe, T.; Yeh, E. T. H.; Cheng, J.			SUMO-specific protease 1 promotes prostate cancer progression and metastasis	ONCOGENE			English	Article						SENP1; MMP; HIF1 alpha; prostate cancer; metastasis	MATRIX METALLOPROTEINASE-2; ANDROGEN RECEPTOR; EXPRESSION; DESUMOYLATION; TRANSCRIPTION; SUMOYLATION; HYPOXIA; SENP1; CELLS; ANGIOGENESIS	SUMO-specific protease 1 (SENP1) is a member of de-SUMOylation protease family and has an important role in the regulation of androgen receptor-dependent transcription and hypoxia signaling. This activity profile of SENP1 prompted us to investigate whether SENP1 is involved in the pathogenesis of prostate cancer. In previous studies, we have detected the overexpression of SENP1 in both precancerous prostate intraepithelial neoplasia (PIN) lesions and prostate cancer tissue samples from patients. Whereas our whole-animal model has demonstrated that SENP1 induction is critical for prostate cell transformation, the role of SENP1 in prostate cancer progression is still unknown. In this study, we show that SENP1 expression directly correlates with prostate cancer aggressiveness and reccurrence, by analyzing more than 150 prostate cancer specimens. Modulating SENP1 level dictates colony formation of prostate cancer cell lines, tumor growth in nude mice and also prostate cancer cell migration and invasion. Silencing SENP1 level in highly metastatic prostate cancer cells perturbs their ability to metastasize to the bone and initiates secondary tumors. Mechanistically, the expression of two critical bone remodeling proteins, matrix metalloproteinase 2 (MMP2) and MMP9, is regulated by SENP1 through the HIF1 alpha signaling pathway. All these results show the contribution of SENP1 to the progression of prostate cancer, and suggest that SENP1 may be a prognostic marker and a therapeutic target for metastasis in prostate cancer patients.	[Wang, Q.; Xia, N.; Xu, Y.; Zou, Y.; Zuo, Y.; Fan, Q.; Cheng, J.] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Wang, Q.; Xia, N.; Zou, Y.; Zuo, Y.; Fan, Q.; Cheng, J.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200025, Peoples R China; [Li, T.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Rui Jin Hosp, Shanghai 200025, Peoples R China; [Bawa-Khalfe, T.; Yeh, E. T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Yeh, E. T. H.; Cheng, J.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute	Cheng, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, 280 Chongqing South Rd, Shanghai 200025, Peoples R China.	jkcheng@shsmu.edu.cn	Xia, Nan/ABG-4600-2021		National Natural Science Foundation of China [81071665, 30900740]; National Basic Research Program of China (973 Program) [2010CB912104]; Shanghai Committee of Science and Technology [10140902000, 10410700900, 11XD1403200, 11DZ2260200]; United States Department of Defense [PC060932]; NIH [CA 239520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); United States Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr E Benveniste (The University of Alabama at Birmingham) for the MMP2-Luc plasmid. This work was supported in part by National Natural Science Foundation of China (81071665 to JC, 30900740 to YZ), National Basic Research Program of China (973 Program) (2010CB912104 to JC), Shanghai Committee of Science and Technology (10140902000, 10410700900, 11XD1403200 to JC, 11DZ2260200), United States Department of Defense Grants (PC060932 to JC) and NIH (CA 239520 to ETHY). ETHY is the McNair Scholar of the Texas Heart Institute/St Luke's Episcopal Hospital.	Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Bawa-Khalfe T, 2010, J BIOL CHEM, V285, P25859, DOI 10.1074/jbc.M110.134874; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Gohji K, 1998, INT J CANCER, V79, P96, DOI 10.1002/(SICI)1097-0215(19980220)79:1<96::AID-IJC18>3.0.CO;2-F; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Nemeth JA, 2002, J NATL CANCER I, V94, P17; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Sehgal G, 1998, AM J PATHOL, V152, P591; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Stearns M, 1996, ONCOL RES, V8, P69; Trudel D, 2003, CANCER RES, V63, P8511; Xu Y, 2010, J BIOL CHEM, V285, P36682, DOI 10.1074/jbc.M110.164236; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yu LY, 2010, J EXP MED, V207, P1183, DOI 10.1084/jem.20092215; Zhou LX, 2010, ASIAN J ANDROL, V12, P171, DOI 10.1038/aja.2009.81	23	93	105	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 9	2013	32	19					2493	2498		10.1038/onc.2012.250	http://dx.doi.org/10.1038/onc.2012.250			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140ZL	22733136				2022-12-25	WOS:000318694900013
J	Chen, J; Feng, WJ; Jiang, J; Deng, YQ; Huen, MSY				Chen, Jie; Feng, Wanjuan; Jiang, Jun; Deng, Yiqun; Huen, Michael S. Y.			Ring Finger Protein RNF169 Antagonizes the Ubiquitin-dependent Signaling Cascade at Sites of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE RNF8; 53BP1 RECRUITMENT; REPAIR; REPLICATION; BREAKS	Ubiquitin signals emanating from DNA double-strand breaks (DSBs) trigger the ordered assembly of DNA damage mediator and repair proteins. This highly orchestrated process is accomplished, in part, through the concerted action of the RNF8 and RNF168 E3 ligases, which have emerged as core signaling intermediates that promote DSB-associated ubiquitylation events. In this study, we report the identification of RNF169 as a negative regulator of the DNA damage signaling cascade. We found that RNF169 interacted with ubiquitin structures and relocalized to DSBs in an RNF8/RNF168-dependent manner. Moreover, ectopic expression of RNF169 attenuated ubiquitin signaling and compromised 53BP1 accumulation at DNA damage sites, suggesting that RNF169 antagonizes RNF168 functions at DSBs. Our study unveils RNF169 as a component in DNA damage signal transduction and adds to the complexity of regulatory ubiquitylation in genome stability maintenance.	[Feng, Wanjuan; Jiang, Jun; Deng, Yiqun] S China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China; [Feng, Wanjuan; Huen, Michael S. Y.] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Chen, Jie; Feng, Wanjuan; Huen, Michael S. Y.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Chen, Jie; Feng, Wanjuan; Huen, Michael S. Y.] Univ Hong Kong, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China	South China Agricultural University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Deng, YQ (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China.	yqdeng@scau.edu.cn; huen.michael@hku.hk	Deng, Yiqun/K-7709-2013; /GNW-5666-2022	Deng, Yiqun/0000-0002-6838-3779; /0000-0003-2752-2098; Huen, Michael Shing-Yan/0000-0003-1774-2425	University of Hong Kong Seed Fund Project [201009159006]; Research Grants Council General Research Fund Project [767811]; National Basic Research Program of China 973 Program [2009CB18802]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	University of Hong Kong Seed Fund Project; Research Grants Council General Research Fund Project; National Basic Research Program of China 973 Program(National Basic Research Program of China); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	This work supported by University of Hong Kong Seed Fund Project 201009159006 and Research Grants Council General Research Fund Project 767811 (to M. S. Y. H.), National Basic Research Program of China 973 Program Grant 2009CB18802 (to M. S. Y. H. and Y. D.), and the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2009) (to Y. D.).	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Devgan SS, 2011, CELL DEATH DIFFER, V18, P1500, DOI 10.1038/cdd.2011.18; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Luijsterburg MS, 2012, EMBO J, V31, P2511, DOI 10.1038/emboj.2012.104; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001	31	51	55	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27715	27722		10.1074/jbc.M112.373530	http://dx.doi.org/10.1074/jbc.M112.373530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733822	Green Published, hybrid			2022-12-25	WOS:000307840700045
J	Chong, URW; Abdul-Rahman, PS; Abdul-Aziz, A; Hashim, OH; Junit, SM				Chong, Ursula Rho Wan; Abdul-Rahman, Puteri Shafinaz; Abdul-Aziz, Azlina; Hashim, Onn Haji; Junit, Sarni Mat			Tamarindus indica Extract Alters Release of Alpha Enolase, Apolipoprotein A-I, Transthyretin and Rab GDP Dissociation Inhibitor Beta from HepG2 Cells	PLOS ONE			English	Article							CHOLESTEROL TRANSPORT; BINDING-PROTEIN; APOA-I; GTPASES; L.; HAMSTERS; PULP	Background: The plasma cholesterol and triacylglycerol lowering effects of Tamarindus indica extract have been previously described. We have also shown that the methanol extract of T. indica fruit pulp altered the expression of lipid-associated genes including ABCG5 and APOAI in HepG2 cells. In the present study, effects of the same extract on the release of proteins from the cells were investigated using the proteomics approach. Methodology/Principal Findings: When culture media of HepG2 cells grown in the absence and presence of the methanol extract of T. indica fruit pulp were subjected to 2-dimensional gel electrophoresis, the expression of seven proteins was found to be significantly different (p<0.03125). Five of the spots were subsequently identified as alpha enolase (ENO1), transthyretin (TTR), apolipoprotein A-I (ApoA-I; two isoforms), and rab GDP dissociation inhibitor beta (GDI-2). A functional network of lipid metabolism, molecular transport and small molecule biochemistry that interconnects the three latter proteins with the interactomes was identified using the Ingenuity Pathways Analysis software. Conclusion/Significance: The methanol extract of T. indica fruit pulp altered the release of ENO1, ApoA-I, TTR and GDI-2 from HepG2 cells. Our results provide support on the effect of T. indica extract on cellular lipid metabolism, particularly that of cholesterol.	[Chong, Ursula Rho Wan; Abdul-Rahman, Puteri Shafinaz; Abdul-Aziz, Azlina; Hashim, Onn Haji; Junit, Sarni Mat] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Abdul-Rahman, Puteri Shafinaz; Abdul-Aziz, Azlina; Hashim, Onn Haji; Junit, Sarni Mat] Univ Malaya, Fac Med, Med Biotechnol Lab, Ctr Prote Res, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Chong, URW (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	sarni@um.edu.my	Hashim, Onn H/B-9459-2010; Rahman, Puteri Shafinaz Akmar Binti Abdul/B-9511-2010; mat-junit, sarni/J-5838-2015; AZIZ, AZLINA ABDUL/B-8303-2010; MAT-JUNIT, SARNI/GXW-0277-2022	Hashim, Onn H/0000-0002-0196-6793; Rahman, Puteri Shafinaz Akmar Binti Abdul/0000-0002-1818-4552; AZIZ, AZLINA ABDUL/0000-0002-9210-5066; Mat Junit, Sarni/0000-0002-9813-452X	Ministry of Higher Education, Malaysia [H-20001-00-E000009]; University of Malaya [RG014-09AFR]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); University of Malaya(Universiti Malaya)	The present study was funded by the Ministry of Higher Education, Malaysia (H-20001-00-E000009) and the University of Malaya Research Grant (RG014-09AFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x; ALESHIRE SL, 1983, J HISTOCHEM CYTOCHEM, V31, P608, DOI 10.1177/31.5.6341455; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibitha B, 2002, INDIAN J MICROBIOL, V42, P361; Bottoni P, 2009, BBA-PROTEINS PROTEOM, V1794, P615, DOI 10.1016/j.bbapap.2009.01.006; Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094; Chisholm JW, 2002, J LIPID RES, V43, P36; HAGEN GA, 1974, ENDOCRINOLOGY, V95, P1398, DOI 10.1210/endo-95-5-1398; Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Iftekhar A S M Maruf, 2006, Pak J Pharm Sci, V19, P125; Jiao R, 2010, J NUTR BIOCHEM, V21, P1134, DOI 10.1016/j.jnutbio.2009.10.007; John J, 2004, ALLELOPATHY J, V14, P43; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Liz MA, 2007, J LIPID RES, V48, P2385, DOI 10.1194/jlr.M700158-JLR200; Martinello F, 2006, FOOD CHEM TOXICOL, V44, P810, DOI 10.1016/j.fct.2005.10.011; Metwali M. R., 2003, Egyptian Journal of Microbiology, V38, P105; Ohnsorg PM, 2011, J BIOL CHEM, V286, P7744, DOI 10.1074/jbc.M110.193524; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; RAZ A, 1969, J BIOL CHEM, V244, P3230; Razali N, 2010, GENES NUTR, V5, P331, DOI 10.1007/s12263-010-0187-5; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Stenmark H, 2001, GENOME BIOL, V2; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Sudjaroen Y, 2005, FOOD CHEM TOXICOL, V43, P1673, DOI 10.1016/j.fct.2005.05.013; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	28	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39476	10.1371/journal.pone.0039476	http://dx.doi.org/10.1371/journal.pone.0039476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724021	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700084
J	Becker, K; Eder, M; Ranft, A; von Meyer, L; Zieglgansberger, W; Kochs, E; Dodt, HU				Becker, Klaus; Eder, Matthias; Ranft, Andreas; von Meyer, Ludwig; Zieglgaensberger, Walter; Kochs, Eberhard; Dodt, Hans-Ulrich			Low Dose Isoflurane Exerts Opposing Effects on Neuronal Network Excitability in Neocortex and Hippocampus	PLOS ONE			English	Article							INTRINSIC OPTICAL SIGNALS; IN-VITRO; GENERAL-ANESTHESIA; PYRAMIDAL NEURONS; HALOTHANE; MECHANISMS; INDUCTION; SLICES; VIDEOMICROSCOPY; INTERNEURONS	The anesthetic excitement phase occurring during induction of anesthesia with volatile anesthetics is a well-known phenomenon in clinical practice. However, the physiological mechanisms underlying anesthetic-induced excitation are still unclear. Here we provide evidence from in vitro experiments performed on rat brain slices that the general anesthetic isoflurane at a concentration of about 0.1 mM can enhance neuronal network excitability in the hippocampus, while simultaneously reducing it in the neocortex. In contrast, isoflurane tissue concentrations above 0.3 mM expectedly caused a pronounced reduction in both brain regions. Neuronal network excitability was assessed by combining simultaneous multisite stimulation via a multielectrode array with recording intrinsic optical signals as a measure of neuronal population activity.	[Becker, Klaus; Dodt, Hans-Ulrich] Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria; [Becker, Klaus; Dodt, Hans-Ulrich] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Eder, Matthias; Zieglgaensberger, Walter] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Ranft, Andreas; Kochs, Eberhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80804 Munich, Germany; [von Meyer, Ludwig] Univ Munich, Inst Forens Med, Munich, Germany	Technische Universitat Wien; Medical University of Vienna; Max Planck Society; Technical University of Munich; University of Munich	Becker, K (corresponding author), Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria.	klaus.becker@meduniwien.ac.at		Eder, Matthias/0000-0002-2579-2628; Becker, Klaus/0000-0002-2406-0476				Antkowiak B, 2002, BRIT J ANAESTH, V89, P102, DOI 10.1093/bja/aef154; Becker K, 2005, NEUROREPORT, V16, P993, DOI 10.1097/00001756-200506210-00022; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cerne R, 2002, NEUROSCI LETT, V317, P147, DOI 10.1016/S0304-3940(01)02453-3; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Dodt HU, 1996, NEUROREPORT, V7, P1553, DOI 10.1097/00001756-199607080-00004; Eder M, 2003, J NEUROSCI, V23, P6660; FISHER DM, 1985, ANESTHESIOLOGY, V63, P647, DOI 10.1097/00000542-198512000-00015; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; GUEDEL, 1920, AM J SURG, V34, P53; Hall JE, 1997, BRIT J ANAESTH, V79, P285, DOI 10.1093/bja/79.3.285; HOLTHOFF K, 1994, NEUROSCI LETT, V180, P227, DOI 10.1016/0304-3940(94)90526-6; Ma JY, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0004.2002; MACIVER MB, 1988, BRIT J ANAESTH, V60, P680, DOI 10.1093/bja/60.6.680; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; MARTIN JT, 1959, ANESTHESIOLOGY, V20, P359, DOI 10.1097/00000542-195905000-00017; Nishikawa K, 2001, ANESTHESIOLOGY, V94, P340, DOI 10.1097/00000542-200102000-00025; Nishikawa K, 2000, J NEUROSCI, V20, P5915, DOI 10.1523/JNEUROSCI.20-16-05915.2000; Peixoto NLV, 2001, NEUROSCI LETT, V299, P89, DOI 10.1016/S0304-3940(01)01501-4; PEROUANSKY M, 1995, ANESTHESIOLOGY, V83, P109, DOI 10.1097/00000542-199507000-00014; Ranft A, 2004, EUR J NEUROSCI, V20, P1276, DOI 10.1111/j.1460-9568.2004.03603.x; Simon W, 2001, ANESTHESIOLOGY, V94, P1058, DOI 10.1097/00000542-200106000-00021; Sloan MH, 1996, ANESTH ANALG, V82, P528, DOI 10.1097/00000539-199603000-00018; Wakasugi M, 1999, ANESTH ANALG, V88, P676, DOI 10.1097/00000539-199903000-00039; WREN WS, 1985, ANAESTHESIA, V40, P315; Zschokke S, 1995, KLIN ELEKTROENZEPHAL	26	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39346	10.1371/journal.pone.0039346	http://dx.doi.org/10.1371/journal.pone.0039346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723999	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300135
J	Chen, DY; Wang, CY; Wen, MS; Lee, TH; Chu, Y; Hsieh, MJ; Chang, SH; Lee, CH; Wang, JL; Chen, CC; Lu, LS; Lee, MT; Yeh, SJ; Lin, FC; Hsieh, IC				Chen, Dong-Yi; Wang, Chao-Yung; Wen, Ming-Shien; Lee, Tsong-Hai; Chu, Yen; Hsieh, Ming-Jer; Chang, Shang-Hung; Lee, Cheng-Hung; Wang, Jian-Liang; Chen, Chun-Chi; Lu, Laing-Suei; Lee, Ming-Ta; Yeh, San-Jou; Lin, Fun-Chiung; Hsieh, I-Chang			Paraoxonase-1 Is Not a Major Determinant of Stent Thrombosis in a Taiwanese Population	PLOS ONE			English	Article							OF-FUNCTION POLYMORPHISM; PERCUTANEOUS CORONARY INTERVENTION; CLOPIDOGREL RESPONSIVENESS; RESPONSE VARIABILITY; PLATELET REACTIVITY; SEQUENCE VARIATIONS; CLINICAL-EFFICACY; GENE VARIANTS; CYP2C19; ASSOCIATION	Background: Clopidogrel is a prodrug that undergoes in vivo bioactivation to show its antiplatelet effects. Recent studies have shown that cytochrome P450 (CYP), ATP-binding cassette transporters (ABCB1), and paraoxonase-1 (PON1) play crucial roles in clopidogrel bioactivation. Here, we aim to determine the effects of genetic polymorphisms of CYP (CYP 2C19*2, CYP 2C19*3, and CYP 2C19*17), ABCB1 (ABCB1 3435C > T, ABCB1 129T > C, and ABCB1 2677G > T/A), and PON1 (PON1 Q192R, PON1 L55M, and PON1 108C > T) on the development of stent thrombosis (ST) in patients receiving clopidogrel after percutaneous coronary intervention (PCI). Methods and Results: We evaluated the incidence of ST (0.64%) in 4964 patients who were recruited in the CAPTAIN registry (Cardiovascular Atherosclerosis and Percutaneous TrAnsluminal INterventions). The presence of genetic polymorphisms was assessed in 20 subjects who developed ST after aspirin and clopidogrel therapy and in 40 age- and sex-matched control subjects who did not develop ST, which was documented after 9 months of angiographic follow-up. ST was acute in 5 subjects, subacute in 7, late in 7, and very late in 1. The presence of CYP 2C19*2 allele was significantly associated with ST (adjusted odds ratio [ORadj]: 4.20, 95% confidence interval [CI], 1.263-9.544; P=0.031). However, genetic variations in PON1 and ABCB1 showed no significant association with ST. Conclusion: We conclude that in a Taiwanese population, PON1 Q192R genotype is not associated with ST development after PCI. However, the presence of CYP 2C19*2 allele is a risk factor for ST development after PCI.	[Chen, Dong-Yi; Wang, Chao-Yung; Wen, Ming-Shien; Hsieh, Ming-Jer; Chang, Shang-Hung; Lee, Cheng-Hung; Wang, Jian-Liang; Chen, Chun-Chi; Yeh, San-Jou; Lin, Fun-Chiung; Hsieh, I-Chang] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med,Sect Cardiol 2, Tao Yuan, Taiwan; [Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Tao Yuan, Taiwan; [Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Stroke Ctr, Tao Yuan, Taiwan; [Chu, Yen] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Thorac & Cardiovasc Surg, Tao Yuan, Taiwan; [Lu, Laing-Suei; Lee, Ming-Ta] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Academia Sinica - Taiwan	Chen, DY (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med,Sect Cardiol 2, Tao Yuan, Taiwan.	ocean.laboratory@me.com	Hsieh, Ming-Jer/M-1340-2013; Wang, Chao-Yung/ABA-6757-2021	Hsieh, Ming-Jer/0000-0002-0148-8357; Wang, Chao-Yung/0000-0003-1546-7298; Chang, Shang-hung/0000-0003-0462-2344; Chu, Yen/0000-0002-7712-8331	National Health Research Institute [NHRI-EX100-9925SC]; National Science Council [98-2314-B-182A-082-MY3]; Chang Gung Memorial Hospital [CMRPG391861, CMRPG3A1071]; NRPB [101TM1033]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); NRPB	This work was supported by grants to Chao-Yung Wang from the National Health Research Institute (NHRI-EX100-9925SC), the National Science Council (98-2314-B-182A-082-MY3) and the Chang Gung Memorial Hospital (CMRPG391861) and to Ming-Shien Wen from NRPB (101TM1033) and the Chang Gung Memorial Hospital (CMRPG3A1071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Aynacioglu AS, 2000, INT J CARDIOL, V74, P33, DOI 10.1016/S0167-5273(00)00242-4; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Fontana P, 2007, J THROMB HAEMOST, V5, P2153, DOI 10.1111/j.1538-7836.2007.02722.x; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Hulot JS, 2011, CIRC-CARDIOVASC INTE, V4, P422, DOI 10.1161/CIRCINTERVENTIONS.111.963025; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Lewis JP, 2011, CLIN PHARMACOL THER, V90, P568, DOI 10.1038/clpt.2011.194; Li WF, 2006, ENVIRON HEALTH PERSP, V114, P1233, DOI 10.1289/ehp.9163; Luo Y, 2011, J INT MED RES, V39, P2012, DOI 10.1177/147323001103900548; Mangiacapra F, 2010, BIOMARK MED, V4, P421, DOI [10.2217/bmm.10.56, 10.2217/BMM.10.56]; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; O'Donoghue M, 2006, CIRCULATION, V114, pE600, DOI 10.1161/CIRCULATIONAHA.106.643171; Oliveira SA, 2004, INT J CARDIOL, V94, P73, DOI 10.1016/j.ijcard.2003.05.011; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Shi Y, 2011, FORENSIC SCI INT, V207, P183, DOI 10.1016/j.forsciint.2010.10.004; Shin BS, 2009, J KOREAN MED SCI, V24, P561, DOI 10.3346/jkms.2009.24.4.561; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Simon T, 2011, CLIN PHARMACOL THER, V90, P561, DOI 10.1038/clpt.2011.193; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Trenk D, 2011, CIRC CARDIOVASC GENE; Umemura K, 2008, J THROMB HAEMOST, V6, P1439, DOI 10.1111/j.1538-7836.2008.03050.x; Wang HH, 2009, PHARMACOGENOMICS, V10, P359, DOI 10.2217/14622416.10.3.359; Wang X, 2002, ARTERIOSCLER THROMB, V23, P328; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zabalza M, 2012, HEART, V98, P100, DOI 10.1136/hrt.2011.227652	37	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39178	10.1371/journal.pone.0039178	http://dx.doi.org/10.1371/journal.pone.0039178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723959	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300112
J	Chen, Z; Gallie, DR				Chen, Zhong; Gallie, Daniel R.			Induction of Monozygotic Twinning by Ascorbic Acid in Tobacco	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; QUIESCENT CENTER; DEHYDROASCORBATE REDUCTASE; WALL MICROTUBULES; GENE-EXPRESSION; CELL-CYCLE; VITAMIN-C; CAMV 35S; POLLEN; MUTANT	Embryo development in plants initiates following the transverse division of a zygote into an apical, proembryo cell and a basal cell that gives rise to the suspensor. Although mutants affected in embryo development through changes in cell division have been described, little is known about the control of the first zygotic division that gives rise to the proembryo. Ascorbic acid (Asc) promotes cell division by inducing G(1) to S progression but its role in embryo development has not been examined. In this study, we show that the level of dehydroascorbate reductase (DHAR) expression, which recycles Asc and regulates Asc pool size, affects the rate of monozygotic twinning and polycotyly. DHAR-induced twinning resulted from altered cell polarity and longitudinal instead of transverse cell division that generated embryos of equal size. Direct injection of Asc into ovaries phenocopied DHAR-induced twinning. Twinning induced by Asc was developmentally limited to the first two days after pollination whereas polycotyly was induced when the level of Asc was elevated just prior to cotyledon initiation. This work describes the first example of gene-directed monozygotic twinning and shows that Asc regulates cell polarity during embryo development.	[Chen, Zhong; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Chen, Z (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			University of California Agricultural Experiment Station	University of California Agricultural Experiment Station(University of California System)	The research was supported by the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGONI O, 1994, J BIOENERG BIOMEMBR, V26, P407, DOI 10.1007/BF00762782; ARRIGONI O, 1989, CARYOLOGIA, V42, P213, DOI 10.1080/00087114.1989.10796967; Arrigoni O, 2000, J PLANT PHYSIOL, V157, P481, DOI 10.1016/S0176-1617(00)80102-9; Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1987, PHOTOINHIBITION, P227; Asada K, 1994, PHOTOINHIBITION PHOT, P129; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Bicknell RA, 2004, PLANT CELL, V16, pS228, DOI 10.1105/tpc.017921; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Chen Z, 2005, PLANT PHYSIOL, V138, P1673, DOI 10.1104/pp.105.062000; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; CITTERIO S, 1994, PHYSIOL PLANTARUM, V92, P601; Clowes F. A. L., 1975, The development and function of roots (Third Cabot Symposium)., P3; Conner AJ, 1999, J EXP BOT, V50, P1471, DOI 10.1093/jexbot/50.338.1471; Coulter JM, 1903, MORPHOLOGY ANGIOSPER, P212; Davies M./ B., 1991, VITAMIN C ITS CHEM B; de Mesa MC, 2004, PLANT CELL REP, V23, P32, DOI 10.1007/s00299-004-0776-0; Eskling M, 1997, PHYSIOL PLANTARUM, V100, P806, DOI 10.1034/j.1399-3054.1997.1000407.x; Faure JE, 2002, PLANT J, V30, P481, DOI 10.1046/j.1365-313X.2002.01305.x; Fernando DD, 2000, PLANT CELL REP, V19, P224, DOI 10.1007/s002990050003; Franceschi VR, 2002, PLANT PHYSIOL, V130, P649, DOI 10.1104/pp.007062; GURDON JB, 1992, CELL, V68, P185, DOI 10.1016/0092-8674(92)90465-O; Haberlandt G, 1913, SITZBER K PREUSS AKA, P318; Horemans N, 1997, PLANT PHYSIOL, V114, P1247, DOI 10.1104/pp.114.4.1247; Horemans N, 2000, TRENDS PLANT SCI, V5, P263, DOI 10.1016/S1360-1385(00)01649-6; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P85; INNOCENTI AM, 1990, NEW PHYTOL, V114, P507, DOI 10.1111/j.1469-8137.1990.tb00418.x; Kato N, 1999, PHYSIOL PLANTARUM, V105, P321, DOI 10.1034/j.1399-3054.1999.105218.x; KERK NM, 1995, DEVELOPMENT, V121, P2825; KIRK MM, 1993, J CELL BIOL, V123, P191, DOI 10.1083/jcb.123.1.191; LISO R, 1984, EXP CELL RES, V150, P314, DOI 10.1016/0014-4827(84)90574-3; LISO R, 1988, NEW PHYTOL, V110, P469, DOI 10.1111/j.1469-8137.1988.tb00284.x; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; ODELL JT, 1994, PLANT PHYSIOL, V106, P447, DOI 10.1104/pp.106.2.447; Paciolla C, 2001, PLANT CELL PHYSIOL, V42, P857, DOI 10.1093/pcp/pce113; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Potters G, 2000, PLANT PHYSIOL, V124, P17, DOI 10.1104/pp.124.1.17; RAUTENKRANZ AAF, 1994, PLANT PHYSIOL, V106, P187, DOI 10.1104/pp.106.1.187; SCHWARTZ BW, 1994, DEVELOPMENT, V120, P3235; SHIBAOKA H, 1974, PLANT CELL PHYSIOL, V15, P255; SHIBAOKA H, 1977, BOT MAG TOKYO, V90, P317, DOI 10.1007/BF02489344; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; SMITH JJ, 1992, PHYTOCHEMISTRY, V31, P1485, DOI 10.1016/0031-9422(92)83092-D; Sunilkumar G, 2002, PLANT MOL BIOL, V50, P463, DOI 10.1023/A:1019832123444; Tabata K, 2001, PLANT J, V27, P139, DOI 10.1046/j.1365-313x.2001.01074.x; Tian HQ, 2005, SEX PLANT REPROD, V17, P243, DOI 10.1007/s00497-004-0233-9; Tisserat B, 1979, HORTIC REV, V1, p1B78; TWELL D, 1989, PLANT PHYSIOL, V91, P1270, DOI 10.1104/pp.91.4.1270; Uwer U, 1998, PLANT CELL, V10, P1277, DOI 10.1105/tpc.10.8.1277; van Overbeek J, 1941, SCIENCE, V94, P350, DOI 10.1126/science.94.2441.350; VERNON DM, 1994, DEV BIOL, V165, P566, DOI 10.1006/dbio.1994.1276; Vernon DM, 2001, AM J BOT, V88, P570, DOI 10.2307/2657055; WEERDENBURG C, 1986, CELL MOTIL CYTOSKEL, V6, P469, DOI 10.1002/cm.970060505; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wick SM, 1991, CURR OPIN CELL BIOL, V3, P253, DOI 10.1016/0955-0674(91)90149-S; Wilkinson JE, 1997, J EXP BOT, V48, P265, DOI 10.1093/jxb/48.2.265; YADEGARI R, 1994, PLANT CELL, V6, P1713, DOI 10.1105/tpc.6.12.1713; Young TE, 2004, PLANT J, V38, P910, DOI 10.1111/j.1365-313X.2004.02093.x; Zhang JZ, 1997, P NATL ACAD SCI USA, V94, P7349, DOI 10.1073/pnas.94.14.7349	67	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39147	10.1371/journal.pone.0039147	http://dx.doi.org/10.1371/journal.pone.0039147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723952	Green Published, gold			2022-12-25	WOS:000305583300106
J	Dzamko, N; Inesta-Vaquera, F; Zhang, JZ; Xie, CS; Cai, HB; Arthur, S; Tan, L; Choi, H; Gray, N; Cohen, P; Pedrioli, P; Clark, K; Alessi, DR				Dzamko, Nicolas; Inesta-Vaquera, Francisco; Zhang, Jiazhen; Xie, Chengsong; Cai, Huaibin; Arthur, Simon; Tan, Li; Choi, Hwanguen; Gray, Nathanael; Cohen, Philip; Pedrioli, Patrick; Clark, Kristopher; Alessi, Dario R.			The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; CYTOPLASMIC LOCALIZATION; CROHNS-DISEASE; 14-3-3 BINDING; CROSS-TALK; MUTATIONS; AUTOPHAGY; ALPHA; INFLAMMATION	Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. LRRK2 is highly expressed in immune cells and recent work points towards a link between LRRK2 and innate immunity. Here we demonstrate that stimulation of the Toll-Like Receptor (TLR) pathway by MyD88-dependent agonists in bone marrow-derived macrophages (BMDMs) or RAW264.7 macrophages induces marked phosphorylation of LRRK2 at Ser910 and Ser935, the phosphorylation sites that regulate the binding of 14-3-3 to LRRK2. Phosphorylation of these residues is prevented by knock-out of MyD88 in BMDMs, but not the alternative TLR adaptor protein TRIF. Utilising both pharmacological inhibitors, including a new TAK1 inhibitor, NG25, and genetic models, we provide evidence that both the canonical (IKK alpha and IKK beta) and IKK-related (IKK epsilon and TBK1) kinases mediate TLR agonist induced phosphorylation of LRRK2 in vivo. Moreover, all four IKK members directly phosphorylate LRRK2 at Ser910 and Ser935 in vitro. Consistent with previous work describing Ser910 and Ser935 as pharmacodynamic biomarkers of LRRK2 activity, we find that the TLR independent basal phosphorylation of LRRK2 at Ser910 and Ser935 is abolished following treatment of macrophages with LRRK2 kinase inhibitors. However, the increased phosphorylation of Ser910 and Ser935 induced by activation of the MyD88 pathway is insensitive to LRRK2 kinase inhibitors. Finally, employing LRRK2-deficient BMDMs, we present data indicating that LRRK2 does not play a major role in regulating the secretion of inflammatory cytokines induced by activation of the MyD88 pathway. Our findings provide the first direct link between LRRK2 and the IKKs that mediate many immune responses. Further work is required to uncover the physiological roles that phosphorylation of LRRK2 by IKKs play in controlling macrophage biology and to determine how phosphorylation of LRRK2 by IKKs impacts upon the use of Ser910 and Ser935 as pharmacodynamic biomarkers.	[Dzamko, Nicolas; Inesta-Vaquera, Francisco; Zhang, Jiazhen; Arthur, Simon; Cohen, Philip; Clark, Kristopher; Alessi, Dario R.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Xie, Chengsong; Cai, Huaibin] NIMH, Transgen Sect, Neurogenet Lab, Natl Inst Aging,Natl Inst Hlth, Bethesda, MD 20892 USA; [Tan, Li; Choi, Hwanguen; Gray, Nathanael] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Tan, Li; Choi, Hwanguen; Gray, Nathanael] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Pedrioli, Patrick] Univ Dundee, Coll Life Sci, Scottish Inst Life Sci, Dundee, Scotland	University of Dundee; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); NIH National Institute on Aging (NIA); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Dundee	Dzamko, N (corresponding author), Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dow St, Dundee, Scotland.	n.dzamko@neura.edu.au; d.r.alessi@dundee.ac.uk	Cai, Huaibin/H-3359-2013; Dzamko, Nicolas/AAD-6922-2019; Arthur, J. Simon/B-8058-2010	Cai, Huaibin/0000-0002-8596-6108; Arthur, J. Simon/0000-0002-8135-1958; Alessi, Dario/0000-0002-2140-9185; Tan, Li/0000-0002-1199-9046; Dzamko, Nicolas/0000-0002-9121-0294	Medical Research Council; Wellcome Trust UK Parkinsona(TM)s Disease Consortium; Michael J Fox Foundation; National Institute on Aging; NIH [1ZIAAG000944-04]; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Janssen Pharmaceutica; Merck KgaA; Pfizer; Medical Research Council [MC_EX_G0800765, MC_U127084348, G1100713, G0700656, MC_G1000735, MC_U127070193] Funding Source: researchfish; MRC [MC_G1000735, MC_U127070193, G0700656, MC_EX_G0800765, G1100713, MC_U127084348] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [ZIAAG000944, ZIAAG000928, ZIAAG000945] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust UK Parkinsona(TM)s Disease Consortium(Wellcome Trust); Michael J Fox Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KgaA; Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Medical Research Council (DRA, PC and SA), Wellcome Trust UK Parkinsona(sic)(TM) s Disease Consortium (DRA), Michael J Fox Foundation (DRA), the Intramural Research Program of National Institute on Aging, NIH (1ZIAAG000944-04 to HC). We also thank the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Janssen Pharmaceutica; Merck KgaA and Pfizer) for financial support. I can also confirm that the funders listed above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Collins LM, 2012, NEUROPHARMACOLOGY; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Doggett EA, 2011, J NEUROCHEM; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Galluzzi L, 2011, EMBO J, V30, P3213, DOI 10.1038/emboj.2011.244; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Ling ZD, 2006, EXP NEUROL, V199, P499, DOI 10.1016/j.expneurol.2006.01.010; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Pauls E, 2011, J BIOL CHEM; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Tong Y, 2010, P NATL ACAD SCI US; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Vancraenenbroeck R, 2012, BBA-PROTEINS PROTEOM, V1824, P450, DOI 10.1016/j.bbapap.2011.12.009; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Weischenfeldt J, 2008, CSH PROTOC, V2008; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	62	155	155	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39132	10.1371/journal.pone.0039132	http://dx.doi.org/10.1371/journal.pone.0039132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723946	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300099
J	Ramirez-Alvarado, M; Ward, CJ; Huang, BQ; Gong, X; Hogan, MC; Madden, BJ; Charlesworth, MC; Leung, N				Ramirez-Alvarado, Marina; Ward, Christopher J.; Huang, Bing Q.; Gong, Xun; Hogan, Marie C.; Madden, Benjamin J.; Charlesworth, M. Cristine; Leung, Nelson			Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)	PLOS ONE			English	Article							SYSTEMIC AMYLOIDOSIS; STATISTICAL-MODEL; CAST NEPHROPATHY; PROTEINS; PROTEOMICS; KIDNEY; CELLS; IDENTIFICATION; ASSOCIATION; ACCURACY	Renal involvement is a frequent consequence of plasma cell dyscrasias. The most common entities are light chain amyloidosis, monoclonal immunoglobulin deposition disease and myeloma cast nephropathy. Despite a common origin, each condition has its own unique histologic and pathophysiologic characteristic which requires a renal biopsy to distinguish. Recent studies have shown urinary exosomes containing kidney-derived membrane and cytosolic proteins that can be used to probe the proteomics of the entire urinary system from the glomerulus to the bladder. In this study, we analyzed urine exosomes to determine the differences between exosomes from patients with light chain amyloidosis, multiple myeloma, monoclonal gammopathy of undetermined significance, and non-paraproteinemia related kidney disease controls. In patients with light chain amyloidosis, multiple myeloma and monoclonal gammopathy of undetermined significance, immunoreactive proteins corresponding to monomeric light chains were found in exosomes by western blot. In all of the amyloidosis samples with active disease, high molecular weight immunoreactive species corresponding to a decamer were found which were not found in exosomes from the other diseases or in amyloidosis exosomes from patients in remission. Few or no light chains monomeric bands were found in non-paraproteinemia related kidney disease controls. Our results showed that urinary exosomes may have tremendous potential in furthering our understanding of the pathophysiology and diagnosis of plasma cell dyscrasia related kidney diseases.	[Ramirez-Alvarado, Marina] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ward, Christopher J.; Hogan, Marie C.; Leung, Nelson] Mayo Clin, Coll Med, Div Nephrol & Hypertens, Rochester, MN USA; [Huang, Bing Q.] Mayo Clin Rochester, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Gong, Xun] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Madden, Benjamin J.; Charlesworth, M. Cristine] Mayo Clin, Coll Med, Mayo Prote Res Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu; leung.nelson@mayo.edu		Leung, Nelson/0000-0002-5651-1411; Ramirez-Alvarado, Marina/0000-0003-2325-6773; Gong, Xun/0000-0003-4168-2768	National Institutes of Health (NIH) [GM071514, CA111345]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA111345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM071514, NIH CA111345 (MR-A) (http://www.nih.gov/), the generous support of patients with light chain amyloidosis and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Comenzo RL, 2009, BLOOD, V114, P3147, DOI 10.1182/blood-2009-04-202879; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gonzales P, 2008, NEPHROL DIAL TRANSPL, V23, P1799, DOI 10.1093/ndt/gfn058; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hoorn EJ, 2005, NEPHROLOGY, V10, P283, DOI 10.1111/j.1440-1797.2005.00387.x; IVANYI B, 1990, ARCH PATHOL LAB MED, V114, P986; Keeling J, 2004, LAB INVEST, V84, P1322, DOI 10.1038/labinvest.3700161; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knepper MA, 2007, KIDNEY INT, V72, P1043, DOI 10.1038/sj.ki.5002510; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Leung N, 2008, KIDNEY INT, V73, P1282, DOI 10.1038/ki.2008.108; Leung N, 2007, AM J KIDNEY DIS, V50, P155, DOI 10.1053/j.ajkd.2007.05.007; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Moon PG, 2011, PROTEOMICS, V11, P2459, DOI 10.1002/pmic.201000443; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; Soares SM, 2008, AM J KIDNEY DIS, V52, P1079, DOI 10.1053/j.ajkd.2008.05.022; SOLOMON A, 1991, NEW ENGL J MED, V324, P1845, DOI 10.1056/NEJM199106273242603; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; WINEARLS CG, 1995, KIDNEY INT, V48, P1347, DOI 10.1038/ki.1995.421; Zhou H, 2006, KIDNEY INT, V70, P1847, DOI 10.1038/sj.ki.5001874	30	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38061	10.1371/journal.pone.0038061	http://dx.doi.org/10.1371/journal.pone.0038061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723846	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300020
J	Buijsse, B; Lee, DH; Steffen, L; Erickson, RR; Luepker, RV; Jacobs, DR; Holtzman, JL				Buijsse, Brian; Lee, Duk-Hee; Steffen, Lyn; Erickson, Richard R.; Luepker, Russell V.; Jacobs, David R., Jr.; Holtzman, Jordan L.			Low Serum Glutathione Peroxidase Activity Is Associated with Increased Cardiovascular Mortality in Individuals with Low HDLc's	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN-PLASMA; LIPID PEROXIDES; RISK-FACTORS; TRENDS; PURIFICATION; CHOLESTEROL; DISEASE; STROKE	Background: Since oxidized LDL is thought to initiate atherosclerosis and the serum glutathione peroxidase (GPx3) reduces oxidized lipids, we investigated whether high GPx3 activity reduces cardiovascular disease (CVD) mortality. Methods: We determined GPx3 in stored samples from the Minnesota Heart Survey of 130 participants who after 5 to 12 years of follow-up had died of CVD and 240 controls. Participants were 26 to 85 years old and predominantly white. In a nested case-control, study we performed logistic regressions to calculate odds ratios (OR) adjusted for age, sex, baseline year, body mass index, smoking, alcohol intake, physical activity, total and HDL cholesterols, systolic blood pressure, serum glucose and gamma glutamyltransferase (GTT) activity. The referent was the quartile with the highest GPx3 activity (quartile 4). Results: OR's for CVD mortality for increasing quartiles of GPx3 were 2.37, 2.14, 1.83 and 1.00 (P for trend 0.02). This inverse correlation was confined to those with HDLc's below the median (P for interaction, 0.006). The OR's for increasing quartiles of GPx3 in this group were 6.08, 5.00, 3.64 and 1.00 (P for trend, 0.002). Conclusions: Individuals with both low HDLc and GPx3 activity are at markedly increased risk for death from CVD.	[Buijsse, Brian; Lee, Duk-Hee; Steffen, Lyn; Luepker, Russell V.; Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Buijsse, Brian] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Erickson, Richard R.; Holtzman, Jordan L.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Holtzman, Jordan L.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Holtzman, Jordan L.] Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN USA; [Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Div Prevent Med, Taegu, South Korea; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	University of Minnesota System; University of Minnesota Twin Cities; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Kyungpook National University; University of Oslo	Buijsse, B (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	holtz003@umn.edu		Buijsse, Brian/0000-0003-0026-9360; Jacobs, David/0000-0002-7232-0543; Steffen, Lyn M/0000-0002-4053-6729				Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Bierl C, 2004, J BIOL CHEM, V279, P26839, DOI 10.1074/jbc.M401907200; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bowman Thomas S., 2008, P25, DOI 10.1007/978-0-387-72347-1_3; Chen NQ, 2000, J LAB CLIN MED, V136, P58, DOI 10.1067/mlc.2000.107692; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Dogru-Abbasoglu S, 1999, CLIN BIOCHEM, V32, P671, DOI 10.1016/S0009-9120(99)00076-4; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Espinola-Klein C, 2007, AM J CARDIOL, V99, P808, DOI 10.1016/j.amjcard.2006.10.041; Holtzman Jordan L, 2002, Clin Lab, V48, P129; Holtzman Jordan L., 2008, P213; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Lee D-H, EUR J CARDIOVASC PRE, V16, P16; Luepker RV, 2006, AM J MED, V119, P42, DOI 10.1016/j.amjmed.2005.08.051; LUEPKER RV, 1985, J CHRON DIS, V38, P671, DOI 10.1016/0021-9681(85)90021-9; MADDIPATI KR, 1987, J BIOL CHEM, V262, P17398; MCMURRAY J, 1992, BRIT HEART J, V68, P454; Morrison JA, 1999, CIRCULATION, V100, P2244, DOI 10.1161/01.CIR.100.22.2244; National Heart Lung and Blood Institute, 1974, MAN LAB OP LIP RES C, V1, P75; OEN LH, 1992, INT J CLIN PHARM TH, V30, P77; PORTER M, 1992, CLIN SCI, V83, P343, DOI 10.1042/cs0830343; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; Upchurch GR, 1997, J BIOL CHEM, V272, P17012, DOI 10.1074/jbc.272.27.17012; Voetsch B, 2007, STROKE, V38, P41, DOI 10.1161/01.STR.0000252027.53766.2b; WARNICK GR, 1982, CLIN CHEM, V28, P1379	28	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38901	10.1371/journal.pone.0038901	http://dx.doi.org/10.1371/journal.pone.0038901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719980	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000028
J	Otsuka, T; Goto, M; Kawai, M; Togo, Y; Sato, K; Katoh, K; Furuse, M; Yasuo, S				Otsuka, Tsuyoshi; Goto, Mariko; Kawai, Misato; Togo, Yuki; Sato, Katsuyoshi; Katoh, Kazuo; Furuse, Mitsuhiro; Yasuo, Shinobu			Photoperiod Regulates Corticosterone Rhythms by Altered Adrenal Sensitivity via Melatonin-Independent Mechanisms in Fischer 344 Rats and C57BL/6J Mice	PLOS ONE			English	Article							GENE-EXPRESSION; ADRENOCORTICOTROPIC HORMONE; SIGNAL-TRANSDUCTION; CIRCADIAN-RHYTHM; ACTH; PLASMA; GLAND; RESPONSIVENESS; INNERVATION; RECEPTORS	Most species living in temperate zones adapt their physiology and behavior to seasonal changes in the environment by using the photoperiod as a primary cue. The mechanisms underlying photoperiodic regulation of stress-related functions are not well understood. In this study, we analyzed the effects of photoperiod on the hypothalamic-pituitary-adrenal axis in photoperiod-sensitive Fischer 344 rats. We first examined how photoperiod affects diurnal variations in plasma concentrations of adrenocorticotropic hormone (ACTH) and corticosterone. ACTH levels did not exhibit diurnal variations under long-and short-day conditions. On the other hand, corticosterone levels exhibited a clear rhythm under short-day condition with a peak during dark phase. This peak was not observed under long-day condition in which a significant rhythm was not detected. To analyze the mechanisms responsible for the photoperiodic regulation of corticosterone rhythms, ACTH was intraperitoneally injected at the onset of the light or dark phase in dexamethasone-treated rats maintained under long-and short-day conditions. ACTH induced higher corticosterone levels in rats examined at dark onset under short-day condition than those maintained under long-day condition. Next, we asked whether melatonin signals are involved in photoperiodic regulation of corticosterone rhythms, and rats were intraperitoneally injected with melatonin at late afternoon under long-day condition for 3 weeks. However, melatonin injections did not affect the corticosterone rhythms. In addition, photoperiodic changes in the amplitude of corticosterone rhythms were also observed in melatonin-deficient C57BL/6J mice, in which expression profiles of several clock genes and steroidgenesis genes in adrenal gland were modified by the photoperiod. Our data suggest that photoperiod regulates corticosterone rhythms by altered adrenal sensitivity through melatonin-independent mechanisms that may involve the adrenal clock.	[Otsuka, Tsuyoshi; Goto, Mariko; Kawai, Misato; Togo, Yuki; Furuse, Mitsuhiro; Yasuo, Shinobu] Kyushu Univ, Fac Agr, Lab Regulat Metab & Behav, Fukuoka 812, Japan; [Sato, Katsuyoshi; Katoh, Kazuo] Tohoku Univ, Fac Agr, Dept Anim Physiol, Sendai, Miyagi, Japan	Kyushu University; Tohoku University	Otsuka, T (corresponding author), Kyushu Univ, Fac Agr, Lab Regulat Metab & Behav, Fukuoka 812, Japan.	syasuo@brs.kyushu-u.ac.jp		Furuse, Mitsuhiro/0000-0002-7474-1165	Japanese Society for the Promotion of Science [22880026, 23248046]; Takeda Science Foundation; Sumitomo Foundation; Kyushu University; Grants-in-Aid for Scientific Research [24650490] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Kyushu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Research Activity Start-up to SY (No. 22880026) and in part by Grants-in Aid for Scientific Research (A) to MF (No. 23248046) from the Japanese Society for the Promotion of Science. This work was also supported by Life Science Research Grant from Takeda Science Foundation, Grant for Basic Science Research Projects from the Sumitomo Foundation, Kyushu University Interdisciplinary Program in Education and Projects in Research to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRAT Z, 1993, COMP BIOCHEM PHYS A, V104, P29, DOI 10.1016/0300-9629(93)90004-N; Arendt J., 1995, MELATONIN MAMMALIAN; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Ciarleglio CM, 2011, NEUROSCIENCE, V197, P8, DOI 10.1016/j.neuroscience.2011.09.036; DALLMAN MF, 1978, AM J PHYSIOL, V235, pR210, DOI 10.1152/ajpregu.1978.235.5.R210; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Demas GE, 2002, J NEUROENDOCRINOL, V14, P29, DOI 10.1046/j.0007-1331.2001.00736.x; EBIHARA S, 1986, SCIENCE, V231, P491, DOI 10.1126/science.3941912; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; ENGELAND WC, 1977, ENDOCRINOLOGY, V100, P138, DOI 10.1210/endo-100-1-138; Han ES, 1998, J NUTR, V128, P1415, DOI 10.1093/jn/128.9.1415; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Heideman PD, 1997, BIOL REPROD, V57, P134, DOI 10.1095/biolreprod57.1.134; HERMAN JP, 1993, MOL CELL NEUROSCI, V4, P181, DOI 10.1006/mcne.1993.1022; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; KANEKO M, 1981, ENDOCRINOLOGY, V109, P70, DOI 10.1210/endo-109-1-70; Katoh K, 2005, J ENDOCRINOL, V187, P249, DOI 10.1677/joe.1.06206; Lance SJ, 1998, BRAIN RES, V780, P342, DOI 10.1016/S0006-8993(97)01302-4; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; MEIER AH, 1976, ENDOCRINOLOGY, V98, P1475, DOI 10.1210/endo-98-6-1475; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nexon L, 2011, EUR J NEUROSCI, V33, P1308, DOI 10.1111/j.1460-9568.2010.07586.x; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; OTTENWELLER JE, 1987, AM J PHYSIOL, V253, pR321, DOI 10.1152/ajpregu.1987.253.2.R321; Pyter LM, 2007, ENDOCRINOLOGY, V148, P3402, DOI 10.1210/en.2006-1432; Reiter R J, 1980, Endocr Rev, V1, P109; Richter HG, 2008, ENDOCRINOLOGY, V149, P995, DOI 10.1210/en.2007-1009; Ronchi E, 1998, BRAIN RES, V780, P348, DOI 10.1016/S0006-8993(97)01303-6; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; Sage D, 2002, AM J PHYSIOL-ENDOC M, V282, pE458, DOI 10.1152/ajpendo.00287.2001; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Ulrich-Lai YM, 2006, AM J PHYSIOL-REG I, V290, pR1128, DOI 10.1152/ajpregu.00042.2003; von Gall C, 2002, CELL TISSUE RES, V309, P151, DOI 10.1007/s00441-002-0581-4; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2007, AM J PHYSIOL-REG I, V292, pR1315, DOI 10.1152/ajpregu.00396.2006; Yasuo S, 2009, J NEUROSCI, V29, P2885, DOI 10.1523/JNEUROSCI.0145-09.2009; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	42	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39090	10.1371/journal.pone.0039090	http://dx.doi.org/10.1371/journal.pone.0039090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720039	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000039
J	Shriner, SA; VanDalen, KK; Mooers, NL; Ellis, JW; Sullivan, HJ; Root, JJ; Pelzel, AM; Franklin, AB				Shriner, Susan A.; VanDalen, Kaci K.; Mooers, Nicole L.; Ellis, Jeremy W.; Sullivan, Heather J.; Root, J. Jeffrey; Pelzel, Angela M.; Franklin, Alan B.			Low-Pathogenic Avian Influenza Viruses in Wild House Mice	PLOS ONE			English	Article							A H5N1 VIRUS; MX1 GENE; INFECTION; TRANSMISSION; OUTBREAK; POULTRY; FERRETS; REPLICATION; PNEUMONIA; LETHALITY	Background: Avian influenza viruses are known to productively infect a number of mammal species, several of which are commonly found on or near poultry and gamebird farms. While control of rodent species is often used to limit avian influenza virus transmission within and among outbreak sites, few studies have investigated the potential role of these species in outbreak dynamics. Methodology/Principal Findings: We trapped and sampled synanthropic mammals on a gamebird farm in Idaho, USA that had recently experienced a low pathogenic avian influenza outbreak. Six of six house mice (Mus musculus) caught on the outbreak farm were presumptively positive for antibodies to type A influenza. Consequently, we experimentally infected groups of naive wild-caught house mice with five different low pathogenic avian influenza viruses that included three viruses derived from wild birds and two viruses derived from chickens. Virus replication was efficient in house mice inoculated with viruses derived from wild birds and more moderate for chicken-derived viruses. Mean titers (EID50 equivalents/mL) across all lung samples from seven days of sampling (three mice/day) ranged from 10(3.89) (H3N6) to 10(5.06) (H4N6) for the wild bird viruses and 10(2.08) (H6N2) to 10(2.85) (H4N8) for the chicken-derived viruses. Interestingly, multiple regression models indicated differential replication between sexes, with significantly (p<0.05) higher concentrations of avian influenza RNA found in females compared with males. Conclusions/Significance: Avian influenza viruses replicated efficiently in wild-caught house mice without adaptation, indicating mice may be a risk pathway for movement of avian influenza viruses on poultry and gamebird farms. Differential virus replication between males and females warrants further investigation to determine the generality of this result in avian influenza disease dynamics.	[Shriner, Susan A.; VanDalen, Kaci K.; Mooers, Nicole L.; Ellis, Jeremy W.; Sullivan, Heather J.; Root, J. Jeffrey; Pelzel, Angela M.; Franklin, Alan B.] USDA Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Agriculture (USDA)	Shriner, SA (corresponding author), USDA Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA.	Susan.A.Shriner@aphis.usda.gov		Shriner, Susan/0000-0003-0349-7182; Ellis, Jeremy/0000-0003-4512-0906; Franklin, Alan/0000-0001-9491-795X	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim AS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-25; Abolins SR, 2011, MOL ECOL, V20, P881, DOI 10.1111/j.1365-294X.2010.04910.x; Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; [Anonymous], 2010, R LANG ENV STAT COMP; Baek YH, 2010, VIRUS RES, V150, P119, DOI 10.1016/j.virusres.2010.03.002; Bailey CF, 1983, EXPT INFECT RACCOON; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; BERG M, 1990, ARCH VIROL, V113, P61, DOI 10.1007/BF01318353; BRUGH M, 1992, AVIAN DIS, V36, P968, DOI 10.2307/1591557; BRUGH M, 1986, AVIAN DIS, V30, P672, DOI 10.2307/1590566; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butler D, 2006, NATURE, V439, P773, DOI 10.1038/439773a; Cardona CJ, 2005, THREAT PANDEMIC INFL, P243; Chan KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013757; CHU CM, 1951, J GEN MICROBIOL, V5, P739, DOI 10.1099/00221287-5-4-739; Driskell EA, 2010, VIROLOGY, V399, P280, DOI 10.1016/j.virol.2010.01.005; GERACI JR, 1982, SCIENCE, V215, P1129; Gillim-Ross L, 2008, J VIROL, V82, P10854, DOI 10.1128/JVI.01206-08; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Hall JS, 2008, EMERG INFECT DIS, V14, P1842, DOI 10.3201/eid1412.071371; HALLER O, 1987, J INTERFERON RES, V7, P647, DOI 10.1089/jir.1987.7.647; Henzler DJ, 2003, AVIAN DIS, V47, P1022, DOI 10.1637/0005-2086-47.s3.1022; HINSHAW VS, 1984, J VIROL, V51, P863, DOI 10.1128/JVI.51.3.863-865.1984; HINSHAW VS, 1986, J VIROL, V58, P655, DOI 10.1128/JVI.58.2.655-656.1986; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Jin HK, 1998, BIOCHEM GENET, V36, P311, DOI 10.1023/A:1018741312058; JOHNSON DC, 1977, AVIAN DIS, V21, P167, DOI 10.2307/1589337; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1132, DOI 10.3201/eid1407.071468; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; KLINGEBORN B, 1985, ARCH VIROL, V86, P347, DOI 10.1007/BF01309839; Klopfleisch R, 2007, J COMP PATHOL, V137, P155, DOI 10.1016/j.jcpa.2007.06.001; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Kuiken T, 2006, NATURE, V440, P741, DOI 10.1038/440741a; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Leschnik M, 2007, EMERG INFECT DIS, V13, P243, DOI 10.3201/eid1302.060608; MAROIS P, 1971, CAN J COMPARAT MED, V35, P71; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; NETTLES VF, 1985, AVIAN DIS, V29, P733, DOI 10.2307/1590665; Ninomiya A, 2002, VET MICROBIOL, V88, P107, DOI 10.1016/S0378-1135(02)00105-0; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Pocock MJO, 2004, J ANIM ECOL, V73, P878, DOI 10.1111/j.0021-8790.2004.00863.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Reperant LA, 2008, EMERG INFECT DIS, V14, P1835, DOI 10.3201/eid1412.080470; Rigoni M, 2010, VET RES, V41, DOI 10.1051/vetres/2010038; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Roberton SI, 2006, P ROY SOC B-BIOL SCI, V273, P1729, DOI 10.1098/rspb.2006.3549; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Shortridge KF, 2000, VET MICROBIOL, V74, P141, DOI 10.1016/S0378-1135(00)00174-7; Sims L.D., 2016, AVIAN INFLUENZA, DOI 10.1002/9781118924341.ch12; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Subbarao K, 2000, CELL MOL LIFE SCI, V57, P1770, DOI 10.1007/PL00000657; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; U.S. Interagency Working Group, 2006, EARL DET SYST HIGHL; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; Vandalen KK, 2009, MAMMAL REV, V39, P167, DOI 10.1111/j.1365-2907.2009.00144.x; WILLIAMS K, 1977, J HYG-CAMBRIDGE, V79, P249, DOI 10.1017/S0022172400053067; Yee KS, 2009, VIROLOGY, V394, P19, DOI 10.1016/j.virol.2009.08.017; Yingst SL, 2006, EMERG INFECT DIS, V12, P1295, DOI 10.3201/eid1708.060264; [No title captured]	68	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39206	10.1371/journal.pone.0039206	http://dx.doi.org/10.1371/journal.pone.0039206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720076	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000050
J	Khademi, H; Radmard, AR; Malekzadeh, F; Kamangar, F; Nasseri-Moghaddam, S; Johansson, M; Byrnes, G; Brennan, P; Malekzadeh, R				Khademi, Hooman; Radmard, Amir-Reza; Malekzadeh, Fatemeh; Kamangar, Farin; Nasseri-Moghaddam, Siavosh; Johansson, Mattias; Byrnes, Graham; Brennan, Paul; Malekzadeh, Reza			Diagnostic Accuracy of Age and Alarm Symptoms for Upper GI Malignancy in Patients with Dyspepsia in a GI Clinic: A 7-Year Cross-Sectional Study	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; UPPER GASTROINTESTINAL MALIGNANCY; UNINVESTIGATED DYSPEPSIA; ENDOSCOPIC FINDINGS; PREDICTIVE MODELS; CANCER REGISTRY; GASTRIC-CANCER; MANAGEMENT; PREVALENCE; FEATURES	Objectives: We investigated whether using demographic characteristics and alarm symptoms can accurately predict cancer in patients with dyspepsia in Iran, where upper GI cancers and H. pylori infection are common. Methods: All consecutive patients referred to a tertiary gastroenterology clinic in Tehran, Iran, from 2002 to 2009 were invited to participate in this study. Each patient completed a standard questionnaire and underwent upper gastrointestinal endoscopy. Alarm symptoms included in the questionnaire were weight loss, dysphagia, GI bleeding, and persistent vomiting. We used logistic regression models to estimate the diagnostic value of each variable in combination with other ones, and to develop a risk-prediction model. Results: A total of 2,847 patients with dyspepsia participated in this study, of whom 87 (3.1%) had upper GI malignancy. Patients reporting at least one of the alarm symptoms constituted 66.7% of cancer patients compared to 38.9% in patients without cancer (p<0.001). Esophageal or gastric cancers in patients with dyspepsia was associated with older age, being male, and symptoms of weight loss and vomiting. Each single predictor had low sensitivity and specificity. Using a combination of age, alarm symptoms, and smoking, we built a risk-prediction model that distinguished between high-risk and low-risk individuals with an area under the ROC curve of 0.85 and acceptable calibration. Conclusions: None of the predictors demonstrated high diagnostic accuracy. While our risk-prediction model had reasonable accuracy, some cancer cases would have remained undiagnosed. Therefore, where available, low cost endoscopy may be preferable for dyspeptic older patient or those with history of weight loss.	[Khademi, Hooman; Radmard, Amir-Reza; Malekzadeh, Fatemeh; Kamangar, Farin; Nasseri-Moghaddam, Siavosh; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Univ Tehran, Tehran, Iran; [Khademi, Hooman; Johansson, Mattias; Byrnes, Graham; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA	Tehran University of Medical Sciences; University of Tehran; World Health Organization; International Agency for Research on Cancer (IARC); Morgan State University	Khademi, H (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Univ Tehran, Tehran, Iran.	malek@ams.ac.ir	Johansson, Mattias/ABF-3365-2020; Khademi, Hooman/AAZ-8798-2020; Malekzadeh, Reza/U-1382-2017	Malekzadeh, Reza/0000-0002-9820-6335; Byrnes, Graham/0000-0003-3893-7539; Malekzadeh, Reza/0000-0003-1043-3814; Johansson, Mattias/0000-0002-3116-5081				Andrews CN, 2005, GASTROENTEROLOGY, V128, pA456, DOI 10.1053/j.gastro.2005.09.020; [Anonymous], 1998, Gastroenterology, V114, P579; Armstrong D, 1996, GASTROENTEROLOGY, V111, P85, DOI 10.1053/gast.1996.v111.pm8698230; AXON ATR, 1995, BMJ-BRIT MED J, V310, P853, DOI 10.1136/bmj.310.6983.853; Ayoola EA, 1996, HEPATO-GASTROENTEROL, V43, P409; Babaei M, 2010, ASIAN PAC J CANCER P, V11, P595; Bai Y, 2010, GUT, V59, P722, DOI 10.1136/gut.2009.192401; Barazandeh Farhad, 2012, Middle East J Dig Dis, V4, P90; BARBARA L, 1989, DIGEST DIS SCI, V34, P1272, DOI 10.1007/BF01537277; Barkun AN, 2010, CAN J GASTROENTEROL, V24, P489, DOI 10.1155/2010/379583; Bazaldua OV, 1999, AM FAM PHYSICIAN, V60, P1773; Bramble MG, 2000, GUT, V46, P464, DOI 10.1136/gut.46.4.464; Bytzer P, 2001, ANN INTERN MED, V134, P815, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00004; Chen LQ, 1999, DIS ESOPHAGUS, V12, P161; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Delaney B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001961.pub2; Delaney BC, 2000, LANCET, V356, P1965, DOI 10.1016/S0140-6736(00)03308-0; Derakhshan MH, 2004, GUT, V53, P1262, DOI 10.1136/gut.2003.035857; Dickerson LM, 2004, AM FAM PHYSICIAN, V70, P107; Eisen GM, 2001, GASTROINTEST ENDOSC, V54, P815, DOI 10.1016/S0016-5107(01)70083-1; El-Serag HB, 2004, ALIMENT PHARM THER, V19, P643, DOI 10.1111/j.1365-2036.2004.01897.x; Fisher RS, 1998, NEW ENGL J MED, V339, P1376, DOI 10.1056/NEJM199811053391907; Ford AC, 2005, GASTROENTEROLOGY, V128, P1838, DOI 10.1053/j.gastro.2005.03.004; Ford AC, 2008, DIGEST DIS, V26, P225, DOI 10.1159/000121351; Ford AC, 2010, HELICOBACTER, V15, P1, DOI [10.1111/j.1523-5378.2010.00779.x, 10.1111/j.1523-5378.2011.00874.x]; Fransen GAJ, 2004, ALIMENT PHARM THERAP, V20, P1045, DOI 10.1111/j.1365-2036.2004.02251.x; Grund B, 2010, CURR OPIN HIV AIDS, V5, P473, DOI 10.1097/COH.0b013e32833ed742; HALLISSEY MT, 1990, BRIT MED J, V301, P513, DOI 10.1136/bmj.301.6751.513; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; HEIKKINEN M, 1995, SCAND J GASTROENTERO, V30, P519, DOI 10.3109/00365529509089783; Kapoor N, 2005, GUT, V54, P40, DOI 10.1136/gut.2004.039438; Kolahdoozan S, 2010, ARCH IRAN MED, V13, P143; Malekzadeh R, 2004, J CLIN PATHOL, V57, P37, DOI 10.1136/jcp.57.1.37; Malekzadeh R, 2009, ARCH IRAN MED, V12, P576; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; MANSI C, 1990, DIGEST DIS SCI, V35, P1452, DOI 10.1007/BF01540561; Moayyedi P, 2002, GUT, V50, P10, DOI 10.1136/gut.50.suppl_4.iv10; Moayyedi P, 1999, AM J GASTROENTEROL, V94, P3122, DOI 10.1111/j.1572-0241.1999.01502.x; Mohagheghi MA, 2009, ARCH IRAN MED, V12, P15; Nasseri-Moghaddam S, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-42; National Institute for Health and Clinical Excellence, 2004, DYSP MAN DYSP AD PRI, P17; Numans ME, 2001, SCAND J GASTROENTERO, V36, P437, DOI 10.1080/003655201300051379; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Sadjadi Alireza, 2005, Asian Pac J Cancer Prev, V6, P359; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schroeder BM, 2003, AM FAM PHYSICIAN, V68, P1215; Spechler SJ, 1999, GASTROENTEROLOGY, V117, P233, DOI 10.1016/S0016-5085(99)70573-1; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; TALLEY NJ, 1993, AM FAM PHYSICIAN, V47, P1407; Talley NJ, 1998, GASTROENTEROLOGY, V114, P582, DOI 10.1016/S0016-5085(98)70542-6; Thomson ABR, 2003, ALIMENT PHARM THER, V17, P1481, DOI 10.1046/j.1365-2036.2003.01646.x; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; Vakil N, 2009, CLIN GASTROENTEROL H, V7, P756, DOI 10.1016/j.cgh.2009.03.031; van Zanten SJOV, 2000, CAN MED ASSOC J, V162, pS3; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Voutilainen M, 2005, DIGEST LIVER DIS, V37, P526, DOI 10.1016/j.dld.2005.01.012; Wallace MB, 2001, GUT, V49, P29, DOI 10.1136/gut.49.1.29	64	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39173	10.1371/journal.pone.0039173	http://dx.doi.org/10.1371/journal.pone.0039173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720064	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900089
J	Kern, F; Doma, E; Rupp, C; Niault, T; Baccarini, M				Kern, F.; Doma, E.; Rupp, C.; Niault, T.; Baccarini, M.			Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis	ONCOGENE			English	Article						B-Raf; conditional ablation; epidermis; Raf-1; Ras-driven skin tumorigenesis	C-RAF; KERATINOCYTE DIFFERENTIATION; EPIDERMAL NEOPLASIA; BRAF INHIBITION; TUMOR-FORMATION; K-RAS; CARCINOGENESIS; KINASES; CANCER; CELLS	Ras-driven tumorigenesis is assumed to depend on Raf for ERK activation and proliferation; yet, an in vivo requirement for Raf as MEK/ERK activator in this setting has not been demonstrated to date. Here, we show that epidermis-restricted B-Raf ablation restrains the onset and stops the progression of established Ras-driven tumors by limiting MEK/ERK activation and proliferation. Concomitant elimination of B-Raf and Raf-1 enforces the abrupt regression of established tumors owing to the decrease in ERK activation and proliferation caused by B-Raf ablation combined with the ERK-independent increase in Rho-dependent kinase (Rok) signaling and differentiation triggered by Raf-1 inactivation. Thus, B-Raf and Raf-1 have non-redundant functions in Ras-driven tumorigenesis. Of note, Raf kinase inhibitors achieve impressive results in melanomas harboring oncogenic BRAF, but are ineffective against Ras-driven tumors; moreover, therapy-related skin tumors driven by a paradox ERK activation as well as primary and acquired resistance have been reported. Our results suggest that therapies targeting both Raf kinase-dependent and -independent pathways may be effective against a broader range of malignancies and reduce the risks of adverse effects and/or resistance.	[Kern, F.; Doma, E.; Rupp, C.; Niault, T.; Baccarini, M.] Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Baccarini, M (corresponding author), Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, Doktor Bohr Gasse 9, A-1030 Vienna, Austria.	manuela.baccarini@univie.ac.at	Baccarini, Manuela/B-6481-2014	Baccarini, Manuela/0000-0002-3033-391X	European Commission [LSH-CT-2003-506803]; Austrian Research Fund [P19530-B11]	European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Research Fund(Austrian Science Fund (FWF))	We thank Karin Ehrenreiter and the animal house team for excellent technical help, M Sibilia for the K5-SOS-F mice and P Chambon for the K5-Cre-er(T) animals. This work was supported by European Commission grant LSH-CT-2003-506803 and by Austrian Research Fund grant P19530-B11 (to MB).	Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Brower V, 2010, J NATL CANCER I, V102, P214, DOI 10.1093/jnci/djq037; Cichowski K, 2010, NATURE, V464, P358, DOI 10.1038/464358a; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Downward J, 2011, NAT MED, V17, P286, DOI 10.1038/nm0311-286; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Ehrenreiter K, 2009, CANCER CELL, V16, P149, DOI 10.1016/j.ccr.2009.06.008; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Honma M, 2006, MOL BIOL CELL, V17, P1888, DOI 10.1091/mbc.E05-12-1173; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Kern F, 2011, BRIT J CANCER, V104, P229, DOI 10.1038/sj.bjc.6606009; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Murayama K, 2007, ONCOGENE, V26, P4882, DOI 10.1038/sj.onc.1210274; Niault TS, 2010, CARCINOGENESIS, V31, P1165, DOI 10.1093/carcin/bgp337; Oki-Idouchi CE, 2007, CANCER RES, V67, P276, DOI 10.1158/0008-5472.CAN-06-3080; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Ridky TW, 2004, CELL CYCLE, V3, P621; Riva C, 1995, ORAL ONCOL, V31B, P384, DOI 10.1016/0964-1955(95)00045-3; Scholl FA, 2009, ONCOGENE, V28, P1485, DOI 10.1038/onc.2008.459; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Scholl FA, 2009, CANCER RES, V69, P3772, DOI 10.1158/0008-5472.CAN-08-1963; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Wang Z.A., 2010, ONCOGENE; Wimmer R, 2010, TRENDS BIOCHEM SCI, V35, P660, DOI 10.1016/j.tibs.2010.06.001	44	24	24	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 9	2013	32	19					2483	2492		10.1038/onc.2012.254	http://dx.doi.org/10.1038/onc.2012.254			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140ZL	22733131				2022-12-25	WOS:000318694900012
J	Curry, MC; Luk, NA; Kenny, PA; Roberts-Thomson, SJ; Monteith, GR				Curry, Merril C.; Luk, Nicole A.; Kenny, Paraic A.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			Distinct Regulation of Cytoplasmic Calcium Signals and Cell Death Pathways by Different Plasma Membrane Calcium ATPase Isoforms in MDA-MB-231 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; SPERM MOTILITY; CA2+ ATPASE; BCL-2; ACTIVATION; RESISTANCE; EXPRESSION; PMCA	Plasma membrane calcium ATPases (PMCAs) actively extrude Ca2+ from the cell and are essential components in maintaining intracellular Ca2+ homeostasis. There are four PMCA isoforms (PMCA1-4), and alternative splicing of the PMCA genes creates a suite of calcium efflux pumps. The role of these different PMCA isoforms in the control of calcium-regulated cell death pathways and the significance of the expression of multiple isoforms of PMCA in the same cell type are not well understood. In these studies, we assessed the impact of PMCA1 and PMCA4 silencing on cytoplasmic free Ca2+ signals and cell viability in MDA-MB-231 breast cancer cells. The PMCA1 isoform was the predominant regulator of global Ca2+ signals in MDA-MB-231 cells. PMCA4 played only a minor role in the regulation of bulk cytosolic Ca2+, which was more evident at higher Ca2+ loads. Although PMCA1 or PMCA4 knockdown alone had no effect on MDA-MB-231 cell viability, silencing of these isoforms had distinct consequences on caspase-independent (ionomycin) and -dependent (ABT-263) cell death. PMCA1 knockdown augmented necrosis mediated by the Ca2+ ionophore ionomycin, whereas apoptosis mediated by the Bcl-2 inhibitor ABT-263 was enhanced by PMCA4 silencing. PMCA4 silencing was also associated with an inhibition of NF kappa B nuclear translocation, and an NF kappa B inhibitor phenocopied the effects of PMCA4 silencing in promoting ABT-263-induced cell death. This study demonstrates distinct roles for PMCA1 and PMCA4 in the regulation of calcium signaling and cell death pathways despite the widespread distribution of these two isoforms. The targeting of some PMCA isoforms may enhance the effectiveness of therapies that act through the promotion of cell death pathways in cancer cells.	[Curry, Merril C.; Luk, Nicole A.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Kenny, Paraic A.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Queensland; Yeshiva University; Albert Einstein College of Medicine	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia.	gregm@uq.edu.au	Roberts-Thomson, Sarah/W-5676-2019; Roberts-Thomson, Sarah J/B-4282-2011; Monteith, Gregory/B-1626-2008	Roberts-Thomson, Sarah/0000-0001-8202-5786; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Monteith, Gregory/0000-0002-4345-530X	National Health and Medical Research Council [631347]; Susan G. Komen for the Cure [KG100888]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation)	This work was supported by National Health and Medical Research Council Grant 631347 and Susan G. Komen for the Cure Grant KG100888.	Aung CS, 2009, CARCINOGENESIS, V30, P1962, DOI 10.1093/carcin/bgp223; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Braunstein S, 2008, MOL CANCER RES, V6, P78, DOI 10.1158/1541-7786.MCR-07-0339; Brini M, 2000, EMBO J, V19, P4926, DOI 10.1093/emboj/19.18.4926; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Chu KY, 2010, J BIOL CHEM, V285, P32606, DOI 10.1074/jbc.M110.157172; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Davis FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023464; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Fernandes D, 2007, J NEUROCHEM, V102, P454, DOI 10.1111/j.1471-4159.2007.04592.x; Ghosh RN, 2005, J BIOMOL SCREEN, V10, P476, DOI 10.1177/1087057105274896; Gribbon P, 2003, DRUG DISCOV TODAY, V8, P1035, DOI 10.1016/S1359-6446(03)02895-2; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holton M, 2007, FEBS LETT, V581, P4115, DOI 10.1016/j.febslet.2007.07.054; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kurnellas MP, 2010, CELL DEATH DIFFER, V17, P1501, DOI 10.1038/cdd.2010.54; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411; Montagut C, 2006, ENDOCR-RELAT CANCER, V13, P607, DOI 10.1677/erc.1.01171; Monteith GR, 2005, TRENDS PHARMACOL SCI, V26, P218, DOI 10.1016/j.tips.2005.02.002; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pande J, 2008, J CELL MOL MED, V12, P1049, DOI 10.1111/j.1582-4934.2008.00140.x; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Prasad V, 2004, BIOCHEM BIOPH RES CO, V322, P1192, DOI 10.1016/j.bbrc.2004.07.156; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Schlotter CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2112; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Signorelli P, 2001, FASEB J, V15, P2401, DOI 10.1096/fj.01-0244com; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Suchanek KM, 2002, MOL CARCINOGEN, V34, P165, DOI 10.1002/mc.10061; Tahir SK, 2010, MOL CANCER THER, V9, P545, DOI 10.1158/1535-7163.MCT-09-0651; Tanaka A, 2006, CANCER RES, V66, P419, DOI 10.1158/0008-5472.CAN-05-0741; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tromp JM, 2012, CLIN CANCER RES, V18, P487, DOI 10.1158/1078-0432.CCR-11-1440; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; VanHouten J, 2010, P NATL ACAD SCI USA, V107, P11405, DOI 10.1073/pnas.0911186107; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warr MR, 2008, CURR ONCOL, V15, P256; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693	57	53	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28598	28608		10.1074/jbc.M112.364737	http://dx.doi.org/10.1074/jbc.M112.364737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733819	Green Published, hybrid			2022-12-25	WOS:000308074600034
J	Goetz, R; Ohnishi, M; Kir, S; Kurosu, H; Wang, L; Pastor, J; Ma, JH; Gai, WM; Kuro-o, M; Razzaque, MS; Mohammadi, M				Goetz, Regina; Ohnishi, Mutsuko; Kir, Serkan; Kurosu, Hiroshi; Wang, Lei; Pastor, Johanne; Ma, Jinghong; Gai, Weiming; Kuro-o, Makoto; Razzaque, Mohammed S.; Mohammadi, Moosa			Conversion of a Paracrine Fibroblast Growth Factor into an Endocrine Fibroblast Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT HYPOPHOSPHATEMIC RICKETS; C-TERMINAL TAIL; FGF RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BETA-KLOTHO; 3-DIMENSIONAL STRUCTURE; METABOLIC-ACTIVITY; PPAR-ALPHA; SPECIFICITY	FGFs 19, 21, and 23 are hormones that regulate in a Klotho co-receptor-dependent fashion major metabolic processes such as glucose and lipid metabolism (FGF21) and phosphate and vitamin D homeostasis (FGF23). The role of heparan sulfate glycosaminoglycan in the formation of the cell surface signaling complex of endocrine FGFs has remained unclear. Here we show that heparan sulfate is not a component of the signal transduction unit of FGF19 and FGF23. In support of our model, we convert a paracrine FGF into an endocrine ligand by diminishing heparan sulfate-binding affinity of the paracrine FGF and substituting its C-terminal tail for that of an endocrine FGF containing the Klotho co-receptor-binding site to home the ligand into the target tissue. In addition to serving as a proof of concept, the ligand conversion provides a novel strategy for engineering endocrine FGF-like molecules for the treatment of metabolic disorders, including global epidemics such as type 2 diabetes and obesity.	[Goetz, Regina; Ma, Jinghong; Gai, Weiming; Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Ohnishi, Mutsuko; Razzaque, Mohammed S.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Kir, Serkan] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Kurosu, Hiroshi; Wang, Lei; Pastor, Johanne; Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	New York University; Harvard University; Harvard School of Dental Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mohammadi, M (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 1st Ave, New York, NY 10016 USA.	Moosa.Mohammadi@nyumc.org	Mohammadi, Moosa/ABA-6745-2020; Razzaque, Mohammed S./K-4282-2019; kasaei, fahime/T-7197-2018; Goetz, Regina/M-2411-2019	Mohammadi, Moosa/0000-0003-2434-9437; Goetz, Regina/0000-0003-3681-4703	National Institutes of Health [DE13686, DK077276, AG019712, DK091392, P30 NS050276, DK067158]; Texas Higher Education Coordinating Board [NHRP 010019-0043-2009]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077276, R01DK067158, R01DK091392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Higher Education Coordinating Board; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DE13686 (to M. M.), DK077276 (to M. S. R.), and AG019712 and DK091392 (to M. K.). This work was also supported by Texas Higher Education Coordinating Board Grant NHRP 010019-0043-2009 (to M. K.) and National Institutes of Health Grant P30 NS050276 covering the maintenance of the Biacore 2000 SPR instrument.; Supported by National Institutes of Health Grant DK067158.	AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beenken A, 2012, ADV EXP MED BIOL, V728, P1, DOI 10.1007/978-1-4614-0887-1_1; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; FINZEL BC, 1989, J MOL BIOL, V209, P779, DOI 10.1016/0022-2836(89)90606-2; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2012, MOL CELL BIOL, V32, P1944, DOI 10.1128/MCB.06603-11; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kalinina J, 2009, MOL CELL BIOL, V29, P4663, DOI 10.1128/MCB.01780-08; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Nakatani T, 2009, FASEB J, V23, P3702, DOI 10.1096/fj.08-123992; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ohnishi M, 2011, FASEB J, V25, P2031, DOI 10.1096/fj.10-167056; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; ONESTI S, 1991, J MOL BIOL, V217, P153, DOI 10.1016/0022-2836(91)90618-G; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	65	68	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29134	29146		10.1074/jbc.M112.342980	http://dx.doi.org/10.1074/jbc.M112.342980			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733815	hybrid, Green Published			2022-12-25	WOS:000308074600079
J	Dong, M; Zhong, L; Chen, WQ; Ji, XP; Zhang, M; Zhao, YX; Li, L; Yao, GH; Zhang, PF; Zhang, C; Zhang, L; Zhang, Y				Dong, Mei; Zhong, Lin; Chen, Wen Qiang; Ji, Xiao Ping; Zhang, Mei; Zhao, Yu Xia; Li, Li; Yao, Gui Hua; Zhang, Peng Fei; Zhang, Cheng; Zhang, Lei; Zhang, Yun			Doxycycline Stabilizes Vulnerable Plaque via Inhibiting Matrix Metalloproteinases and Attenuating Inflammation in Rabbits	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSMS; ATHEROSCLEROTIC PLAQUES; EXPRESSION; RESTENOSIS; TRIAL; MICE; LDL	Enhanced matrix metalloproteinases (MMPs) activity is implicated in the process of atherosclerotic plaque instability. We hypothesized that doxycycline, a broad MMPs inhibitor, was as effective as simvastatin in reducing the incidence of plaque disruption. Thirty rabbits underwent aortic balloon injury and were fed a high-fat diet for 20 weeks. At the end of week 8, the rabbits were divided into three groups for 12-week treatment: a doxycycline-treated group that received oral doxycycline at a dose of 10 mg/kg/d, a simvastatin-treated group that received oral simvastatin at a dose of 5 mg/kg/d, and a control group that received no treatment. At the end of week 20, pharmacological triggering was performed to induce plaque rupture. Biochemical, ultrasonographic, pathologic, immunohistochemical and mRNA expression studies were performed. The results showed that oral administration of doxycycline resulted in a significant increase in the thickness of the fibrous cap of the aortic plaque whereas there was a substantial reduction of MMPs expression, local and systemic inflammation, and aortic plaque vulnerability. The incidence of plaque rupture with either treatment (0% for both) was significantly lower than that for controls (56.0%, P<0.05). There was no significant difference between doxycycline-treated group and simvastatin-treated group in any serological, ultrasonographic, pathologic, immunohistochemical and mRNA expression measurement except for the serum lipid levels that were higher with doxycycline than with simvastatin treatment. In conclusion, doxycycline at a common antimicrobial dose stabilizes atherosclerotic lesions via inhibiting matrix metalloproteinases and attenuating inflammation in a rabbit model of vulnerable plaque. These effects were similar to a large dose of simvastatin and independent of serum lipid levels.	[Dong, Mei; Chen, Wen Qiang; Ji, Xiao Ping; Zhang, Mei; Zhao, Yu Xia; Li, Li; Yao, Gui Hua; Zhang, Peng Fei; Zhang, Cheng; Zhang, Lei; Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Dong, Mei; Chen, Wen Qiang; Ji, Xiao Ping; Zhang, Mei; Zhao, Yu Xia; Li, Li; Yao, Gui Hua; Zhang, Peng Fei; Zhang, Cheng; Zhang, Lei; Zhang, Yun] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China; [Zhong, Lin] Yu Huang Ding Hosp, Yantai, Shandong, Peoples R China	Shandong University; Shandong University	Dong, M (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	zhangcheng8003@yahoo.cn; leilybao@163.com; zhangyun@sdu.edu.cn	Zhang, Pengfei/GPP-3564-2022	Zhang, Pengfei/0000-0001-8048-425X	National 973 Basic Research Program of China [2011CB503906, 2012CB518603]; National High-tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; State Key Program of National Natural Science of China [60831003]; National Natural Science Foundation of China [60971023, 30900607, 30873325, 30971096, 30972809, 81100206, 81173251]; Natural Science Foundation of Shandong Province [Y2007C064]	National 973 Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National 973 Basic Research Program of China (no. 2011CB503906, 2012CB518603), the National High-tech Research and Development Program of China (no. 2012AA02A510), the Program of Introducing Talents of Discipline to Universities (no. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (no. 81021001), the State Key Program of National Natural Science of China (no. 60831003), the grants of the National Natural Science Foundation of China (no. 60971023, 30900607, 30873325, 30971096, 30972809, 81100206, 81173251), and the grant of the Natural Science Foundation of Shandong Province (no. Y2007C064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axisa B, 2000, J CHROMATOGR B, V744, P359, DOI 10.1016/S0378-4347(00)00261-9; Axisa B, 2002, STROKE, V33, P2858, DOI 10.1161/01.STR.0000038098.04291.F6; Brown DL, 2004, ARTERIOSCL THROM VAS, V24, P733, DOI 10.1161/01.ATV.0000121571.78696.dc; Chen WQ, 2007, AM J PHYSIOL-HEART C, V293, pH2836, DOI 10.1152/ajpheart.00472.2007; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Kim YS, 2001, J BIOL CHEM, V276, P33736, DOI 10.1074/jbc.M101977200; Kirkwood KL, 1999, ANN NY ACAD SCI, V878, P667, DOI 10.1111/j.1749-6632.1999.tb07757.x; Liu J, 2003, J VASC SURG, V38, P1376, DOI 10.1016/S0741-5214(03)01022-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Ohshima S, 2010, J AM COLL CARDIOL, V55, P1240, DOI 10.1016/j.jacc.2009.11.056; Prescott MF, 1999, ANN NY ACAD SCI, V878, P179, DOI 10.1111/j.1749-6632.1999.tb07683.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Selvendiran K, 2009, J PHARMACOL EXP THER, V329, P959, DOI 10.1124/jpet.108.150367; Shapira L, 1996, INFECT IMMUN, V64, P825, DOI 10.1128/IAI.64.3.825-828.1996; Sheth RA, 2010, ATHEROSCLEROSIS, V212, P181, DOI 10.1016/j.atherosclerosis.2010.05.012; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Teixeira LR, 2002, CHEST, V121, P216, DOI 10.1378/chest.121.1.216; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009; Zhong L, 2008, J CELL MOL MED, V12, P2362, DOI 10.1111/j.1582-4934.2008.00261.x	24	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39695	10.1371/journal.pone.0039695	http://dx.doi.org/10.1371/journal.pone.0039695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737253	gold, Green Published, Green Submitted			2022-12-25	WOS:000305695100052
J	Bai, Y; Yang, WW; Yang, HX; Liao, QP; Ye, G; Fu, GD; Ji, L; Xu, P; Wang, H; Li, YX; Peng, C; Wang, YL				Bai, Yang; Yang, Weiwei; Yang, Hui-xia; Liao, Qinping; Ye, Gang; Fu, Guodong; Ji, Lei; Xu, Peng; Wang, Hao; Li, Yu-xia; Peng, Chun; Wang, Yan-ling			Downregulated miR-195 Detected in Preeclamptic Placenta Affects Trophoblast Cell Invasion via Modulating ActRIIA Expression	PLOS ONE			English	Article							SUPPRESSES TUMORIGENICITY; HEPATOCELLULAR-CARCINOMA; PROMOTES APOPTOSIS; ACTIVIN RECEPTORS; MICRORNA; PROLIFERATION; TARGET; PROFILE; GENES; LET-7	Background: Preeclampsia (PE) is a pregnancy-specific syndrome manifested by on-set of hypertension and proteinuria after 20 weeks of gestation. Abnormal placenta development has been generally accepted as initial cause of the disorder. Recently, miR-195 was found to be down-regulated in preeclamptic placentas compared with normal pregnant ones, indicating possible association of this small molecule with placental pathology of preeclampsia. By far the function of miR-195 in the development of placenta remains unknown. Methodology/Principal Findings: Bioinformatic assay predicted ActRIIA as one of the targets for miR-195. By using Real-time PCR, Western blotting and Dual Luciferase Assay, we validated that ActRIIA was the direct target of miR-195 in human trophoblast cells. Transwell insert invasion assay showed that miR-195 could promote cell invasion in trophoblast cell line, HTR8/SVneo cells, and the effect could be abrogated by overexpressed ActRIIA. In preeclamptic placenta tissues, pri-miR-195 and mature miR-195 expressions were down-regulated, whereas ActRIIA level appeared to be increased when compared with that in gestational-week-matched normal placentas. Conclusions/Significance: This is the first report on the function of miR-195 in human placental trophoblast cells which reveals an invasion-promoting effect of the small RNA via repressing ActRIIA. Aberrant expression of miR-195 may contribute to the occurrence of preeclampsia through interfering with Activin/Nodal signaling mediated by ActRIIA in human placenta.	[Bai, Yang; Yang, Weiwei; Ji, Lei; Xu, Peng; Wang, Hao; Li, Yu-xia; Wang, Yan-ling] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Yang, Hui-xia; Liao, Qinping] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Ye, Gang; Fu, Guodong; Peng, Chun] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Bai, Yang; Yang, Weiwei; Xu, Peng; Wang, Hao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Peking University; York University - Canada; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, Y (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	cpeng@yorku.ca; wangyl@ioz.ac.cn	Xu, Pengcheng/J-1429-2012; Fu, Guodong/AGF-1991-2022	Xu, Pengcheng/0000-0001-8651-208X; YANG, HUIXIA/0000-0001-9913-2721; Yang, Huixia/0000-0001-8954-2102	Chinese National Special Fund for Basic Research Project [2011CB944400]; National Natural Sciences Foundation [81025004, 3081120430]; Canadian Institutes of Health Research [CCI-92222, MOP-81370]	Chinese National Special Fund for Basic Research Project; National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Chinese National Special Fund for Basic Research Project (2011CB944400) (URL: http://www.973.gov.cn/English/Index.aspx), the National Natural Sciences Foundation (81025004 and 3081120430) (URL: http://www.nsfc.gov.cn/english/07fd/07.html), and Canadian Institutes of Health Research grants CCI-92222 and MOP-81370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bandera CA, 1998, ONCOGENE, V16, P3455, DOI 10.1038/sj.onc.1201901; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calame K, 2007, IMMUNITY, V27, P825, DOI 10.1016/j.immuni.2007.11.010; Caniggia I, 1997, ENDOCRINOLOGY, V138, P3976, DOI 10.1210/en.138.9.3976; Chelbi ST, 2008, MOL CELL ENDOCRINOL, V282, P120, DOI 10.1016/j.mce.2007.11.022; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Enquobahrie DA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.004; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu J, 2009, MOL ENDOCRINOL, V23, P1014, DOI 10.1210/me.2008-0451; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Ma GT, 2001, DEV BIOL, V236, P124, DOI 10.1006/dbio.2001.0334; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Munir S, 2004, J BIOL CHEM, V279, P31277, DOI 10.1074/jbc.M400641200; Nadeem L, 2011, AM J PATHOL, V178, P1177, DOI 10.1016/j.ajpath.2010.11.066; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Schneider-Kolsky ME, 2002, PLACENTA, V23, P294, DOI 10.1053/plac.2002.0787; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhang QQ, 2012, NEURO-ONCOLOGY, V14, P278, DOI 10.1093/neuonc/nor216; Zhang YQ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.057; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	39	71	82	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38875	10.1371/journal.pone.0038875	http://dx.doi.org/10.1371/journal.pone.0038875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723898	gold, Green Submitted, Green Published			2022-12-25	WOS:000305652700035
J	Awasthi, N; Zhang, CH; Ruan, W; Schwarz, MA; Schwarz, RE				Awasthi, Niranjan; Zhang, Changhua; Ruan, Winston; Schwarz, Margaret A.; Schwarz, Roderich E.			Evaluation of Poly-Mechanistic Antiangiogenic Combinations to Enhance Cytotoxic Therapy Response in Pancreatic Cancer	PLOS ONE			English	Article							ACTIVATING POLYPEPTIDE-II; ENDOTHELIAL-GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; CLINICAL-TRIALS; ANTITUMOR-ACTIVITY; TUMOR-GROWTH; PHASE-II; IN-VITRO; EMAP II; GEMCITABINE	Gemcitabine (Gem) has limited clinical benefits in pancreatic ductal adenocarcinoma (PDAC). The present study investigated combinations of gemcitabine with antiangiogenic agents of various mechanisms for PDAC, including bevacizumab (Bev), sunitinib (Su) and EMAP II. Cell proliferation and protein expression were analyzed by WST-1 assay and Western blotting. In vivo experiments were performed via murine xenografts. Inhibition of in vitro proliferation of AsPC-1 PDAC cells by gemcitabine (10 mu M), bevacizumab (1 mg/ml), sunitinib (10 mu M) and EMAP (10 mu M) was 35, 22, 81 and 6 percent; combination of gemcitabine with bevacizumab, sunitinib or EMAP had no additive effects. In endothelial HUVECs, gemcitabine, bevacizumab, sunitinib and EMAP caused 70, 41, 86 and 67 percent inhibition, while combination of gemcitabine with bevacizumab, sunitinib or EMAP had additive effects. In WI-38 fibroblasts, gemcitabine, bevacizumab, sunitinib and EMAP caused 79, 58, 80 and 29 percent inhibition, with additive effects in combination as well. Net in vivo tumor growth inhibition in gemcitabine, bevacizumab, sunitinib and EMAP monotherapy was 43, 38, 94 and 46 percent; dual combinations of Gem+Bev, Gem+Su and Gem+EMAP led to 69, 99 and 64 percent inhibition. Combinations of more than one antiangiogenic agent with gemcitabine were generally more effective but not superior to Gem+Su. Intratumoral proliferation, apoptosis and microvessel density findings correlated with tumor growth inhibition data. Median animal survival was increased by gemcitabine (26 days) but not by bevacizumab, sunitinib or EMAP monotherapy compared to controls (19 days). Gemcitabine combinations with bevacizumab, sunitinib or EMAP improved survival to similar extent (36 or 37 days). Combinations of gemcitabine with Bev+EMAP (43 days) or with Bev+Su+EMAP (46 days) led to the maximum survival benefit observed. Combination of antiangiogenic agents improves gemcitabine response, with sunitinib inducing the strongest effect. These findings demonstrate advantages of combining multi-targeting agents with standard gemcitabine therapy for PDAC.	[Awasthi, Niranjan; Zhang, Changhua; Ruan, Winston; Schwarz, Roderich E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Schwarz, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Awasthi, Niranjan; Zhang, Changhua; Ruan, Winston; Schwarz, Roderich E.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Awasthi, N (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA.	Roderich.Schwarz@utsouthwestern.edu						Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Awasthi N, 2011, HPB, V13, P597, DOI 10.1111/j.1477-2574.2011.00333.x; Awasthi N, 2011, CANCER CHEMOTH PHARM, V68, P571, DOI 10.1007/s00280-010-1514-7; Awasthi N, 2009, LAB INVEST, V89, P38, DOI 10.1038/labinvest.2008.106; Berger AC, 2000, MICROVASC RES, V60, P70, DOI 10.1006/mvre.2000.2249; Bold RJ, 1999, ANN SURG ONCOL, V6, P279, DOI 10.1007/s10434-999-0279-x; Bramhall SR, 2002, BRIT J CANCER, V87, P161, DOI 10.1038/sj.bjc.6600446; Brennan MF, 2004, SURG ONCOL CLIN N AM, V13, pvii; Brennan Murray F, 2004, Surg Oncol Clin N Am, V13, P555; Cabebe E, 2007, EXPERT OPIN INV DRUG, V16, P467, DOI 10.1517/13543784.16.4.467; Cao HST, 2010, MOL CANCER THER, V9, P2068, DOI 10.1158/1535-7163.MCT-10-0201; Chang YT, 2008, PANCREAS, V37, P145, DOI 10.1097/MPA.0b013e318164548a; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Costa R, 2009, J CELL BIOCHEM, V108, P1410, DOI 10.1002/jcb.22378; Crippa L, 2008, CANCER RES, V68, P1154, DOI 10.1158/0008-5472.CAN-07-2085; Cuneo KC, 2008, INT J RADIAT ONCOL, V71, P873, DOI 10.1016/j.ijrobp.2008.02.062; Dragovich T, 2008, AM J CLIN ONCOL-CANC, V31, P157, DOI 10.1097/COC.0b013e31815878c9; Fujimoto K, 1998, EUR J CANCER, V34, P1439, DOI 10.1016/S0959-8049(98)00069-0; Garcea G, 2004, EUR J CANCER, V40, P1302, DOI 10.1016/j.ejca.2004.02.015; Hayes AJ, 2000, WESTERN J MED, V172, P39, DOI 10.1136/ewjm.172.1.39; Itakura J, 2000, INT J CANCER, V85, P27; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Ko AH, 2008, INVEST NEW DRUG, V26, P463, DOI 10.1007/s10637-008-9127-2; KONNO H, 1995, INT J CANCER, V61, P268, DOI 10.1002/ijc.2910610221; Korc M, 2003, Mol Cancer, V2, P8, DOI 10.1186/1476-4598-2-8; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Laquente B, 2008, MOL CANCER THER, V7, P638, DOI 10.1158/1535-7163.MCT-07-2122; Lee JJ, 2007, J BIOPHARM STAT, V17, P461, DOI 10.1080/10543400701199593; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Luo JY, 2001, INT J CANCER, V92, P361, DOI 10.1002/ijc.1202; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Ogawa T, 2002, CANCER GENE THER, V9, P633, DOI 10.1038/sj.cgt.7700478; Reni M, 2005, LANCET ONCOL, V6, P369, DOI 10.1016/S1470-2045(05)70175-3; Reznikov A. G., 2007, Experimental Oncology, V29, P267; Rosewicz S, 1997, LANCET, V349, P485; Satoh H, 1998, ACTA ONCOL, V37, P85, DOI 10.1080/028418698423221; Schwarz MA, 1999, J EXP MED, V190, P341, DOI 10.1084/jem.190.3.341; Schwarz MA, 2005, EXP CELL RES, V311, P229, DOI 10.1016/j.yexcr.2005.09.008; Schwarz MA, 2000, MECH DEVELOP, V95, P123, DOI 10.1016/S0925-4773(00)00361-0; Schwarz RE, 2004, J SURG RES, V120, P64, DOI 10.1016/j.jss.2003.10.005; Schwarz RE, 1999, SURGERY, V126, P562, DOI 10.1016/S0039-6060(99)70099-1; Schwarz RE, 2010, CANCER BIOL THER, V9, P632, DOI 10.4161/cbt.9.8.11265; Schwarz RE, 2010, ANN SURG ONCOL, V17, P1442, DOI 10.1245/s10434-009-0879-5; Schwarz RE, 2009, SURGERY, V146, P241, DOI 10.1016/j.surg.2009.04.015; Seandel M, 2006, CLIN CANCER RES, V12, P6203, DOI 10.1158/1078-0432.CCR-06-1292; Wilkowski R, 2006, J PANCREAS, V7, P34; Yang F, 2010, MOL CANCER RES, V8, P35, DOI 10.1158/1541-7786.MCR-09-0220; Zhang HP, 2011, J RADIAT RES, V52, P1, DOI 10.1269/jrr.10013	56	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38477	10.1371/journal.pone.0038477	http://dx.doi.org/10.1371/journal.pone.0038477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723862	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300029
J	Corsetti, JP; Bakker, SJL; Sparks, CE; Dullaart, RPF				Corsetti, James P.; Bakker, Stephan J. L.; Sparks, Charles E.; Dullaart, Robin P. F.			Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; RECEPTOR-BINDING ACTIVITY; ISCHEMIC-HEART-DISEASE; ENDOTHELIAL LIPASE; HUMAN-PLASMA; LPA-I; POSTINFARCTION PATIENTS; ANTIOXIDANT PROPERTIES; APOA-II	Background: In a previous report by our group, high levels of apolipoprotein E (apoE) were demonstrated to be associated with risk of incident cardiovascular disease in women with high levels of C-reactive protein (CRP) in the setting of both low (designated as HR1 subjects) and high (designated as HR2 subjects) levels of high-density lipoprotein cholesterol (HDL-C). To assess whether apolipoprotein A-II (apoA-II) plays a role in apoE-associated risk in the two female groups. Methodology/Principal: Outcome event mapping, a graphical data exploratory tool; Cox proportional hazards multivariable regression; and curve-fitting modeling were used to examine apoA-II influence on apoE-associated risk focusing on HDL particles with apolipoprotein A-I (apoA-I) without apoA-II (LpA-I) and HDL particles with both apoA-I and apoA-II (LpA-I:A-II). Results of outcome mappings as a function of apoE levels and the ratio of apoA-II to apoA-I revealed within each of the two populations, a high-risk subgroup characterized in each situation by high levels of apoE and additionally: in HR1, by a low value of the apoA-II/apoA-I ratio; and in HR2, by a moderate value of the apoA-II/apoA-I ratio. Furthermore, derived estimates of LpA-I and LpA-I:A-II levels revealed for high-risk versus remaining subjects: in HR1, higher levels of LpA-I and lower levels of LpA-I:A-II; and in HR2 the reverse, lower levels of LpA-I and higher levels of LpA-I:A-II. Results of multivariable risk modeling as a function of LpA-I and LpA-I:A-II (dichotomized as highest quartile versus combined three lower quartiles) revealed association of risk only for high levels of LpA-I:A-II in the HR2 subgroup (hazard ratio 5.31, 95% CI 1.12-25.17, p = 0.036). Furthermore, high LpA-I: A-II levels interacted with high apoE levels in establishing subgroup risk. Conclusions/Significance: We conclude that apoA-II plays a significant role in apoE-associated risk of incident CVD in women with high levels of HDL-C and CRP.	[Corsetti, James P.; Sparks, Charles E.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14627 USA; [Bakker, Stephan J. L.] Univ Groningen, Dept Nephrol, Groningen, Netherlands; [Bakker, Stephan J. L.; Dullaart, Robin P. F.] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Dullaart, Robin P. F.] Univ Groningen, Dept Endocrinol, Groningen, Netherlands	University of Rochester; University of Groningen; University of Groningen; University of Groningen	Corsetti, JP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14627 USA.	James_Corsetti@urmc.rochester.edu	Bakker, Stephan J. L./J-4023-2015	Bakker, Stephan J. L./0000-0003-3356-6791	Netherlands Heart Foundation [2001.005]	Netherlands Heart Foundation(Netherlands Heart Foundation)	Grant 2001.005 (Netherlands Heart Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, CIRCULATION, V101, P1907, DOI 10.1161/01.CIR.101.16.1907; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Asztalos BF, 2006, ATHEROSCLEROSIS, V188, P59, DOI 10.1016/j.atherosclerosis.2005.10.018; ATMEH RF, 1990, J LIPID RES, V31, P1771; ATMEH RF, 1983, BIOCHIM BIOPHYS ACTA, V751, P175, DOI 10.1016/0005-2760(83)90172-8; BEKAERT ED, 1992, BIOCHIM BIOPHYS ACTA, V1126, P105, DOI 10.1016/0005-2760(92)90223-I; Birjmohun RS, 2007, CIRCULATION, V116, P2029, DOI 10.1161/CIRCULATIONAHA.107.704031; Bittner V, 2000, AM HEART J, V139, P288, DOI 10.1067/mhj.2000.101224; Blanco-Vaca F, 2001, J LIPID RES, V42, P1727; Boisfer E, 2002, J LIPID RES, V43, P732; Borggreve SE, 2006, J CLIN ENDOCR METAB, V91, P3382, DOI 10.1210/jc.2005-2322; Broedl UC, 2004, TRENDS CARDIOVAS MED, V14, P202, DOI 10.1016/j.tcm.2004.03.003; Brousseau ME, 2009, J LIPID RES, V50, P1456, DOI 10.1194/jlr.P800037-JLR200; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; Corsetti JP, 2008, ATHEROSCLEROSIS, V196, P461, DOI 10.1016/j.atherosclerosis.2006.12.007; Corsetti JP, 2011, ATHEROSCLEROSIS, V214, P373, DOI 10.1016/j.atherosclerosis.2010.11.029; Corsetti JP, 2010, ARTERIOSCL THROM VAS, V30, P1657, DOI 10.1161/ATVBAHA.110.207977; Corsetti JP, 2010, EUR J CLIN INVEST, V40, P483, DOI 10.1111/j.1365-2362.2010.02287.x; Corsetti JP, 2005, ATHEROSCLEROSIS, V183, P293, DOI 10.1016/j.atherosclerosis.2005.03.046; Corsetti JP, 2012, METABOLISM IN PRESS; de Backer G, 1998, ATHEROSCLEROSIS, V137, pS1, DOI 10.1016/S0021-9150(97)00310-9; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; deLemos AS, 2002, CIRCULATION, V106, P1321, DOI 10.1161/01.CIR.0000028423.07623.6A; Dugue-Pujol S, 2006, J LIPID RES, V47, P2631, DOI 10.1194/jlr.M600112-JLR200; Durbin DM, 1997, J BIOL CHEM, V272, P31333, DOI 10.1074/jbc.272.50.31333; El Harchaoui K, 2009, ANN INTERN MED, V150, P84, DOI 10.7326/0003-4819-150-2-200901200-00006; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Gnasso A, 2002, ATHEROSCLEROSIS, V164, P289, DOI 10.1016/S0021-9150(02)00070-9; Grundy SM, 1999, J LIPID RES, V40, P229; Hedrick CC, 2001, J LIPID RES, V42, P563; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; INNERARITY TL, 1978, J BIOL CHEM, V253, P6289; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Julve J, 2010, ARTERIOSCL THROM VAS, V30, P232, DOI 10.1161/ATVBAHA.109.198226; Kalopissis AD, 2003, CURR OPIN LIPIDOL, V14, P165, DOI 10.1097/00041433-200304000-00008; Kazlauskaite R, 2010, J CLIN LIPIDOL, V4, P113, DOI 10.1016/j.jacl.2010.01.006; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; LEROY A, 1993, J BIOL CHEM, V268, P4798; Ma K, 2003, P NATL ACAD SCI USA, V100, P2748, DOI 10.1073/pnas.0438039100; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martin-Campos JM, 2004, CURR OPIN LIPIDOL, V15, P247, DOI 10.1097/01.mol.0000130087.23887.97; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; NORFELDT PIP, 1981, EUR J BIOCHEM, V118, P1, DOI 10.1111/j.1432-1033.1981.tb05478.x; OHTA T, 1988, J LIPID RES, V29, P721; Onat A, 2011, METABOLISM, V60, P499, DOI 10.1016/j.metabol.2010.04.018; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; PUCHOIS P, 1987, ATHEROSCLEROSIS, V68, P35, DOI 10.1016/0021-9150(87)90091-8; Ragbir S, 2010, CURR ATHEROSCLER REP, V12, P343, DOI 10.1007/s11883-010-0091-x; Ribas V, 2004, CIRC RES, V95, P789, DOI 10.1161/01.RES.0000146031.94850.5f; Ruel IL, 2004, J LIPID RES, V45, P1528, DOI 10.1194/jlr.M400090-JLR200; Scanu AM, 2008, FASEB J, V22, P4044, DOI 10.1096/fj.08-117150; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shimoni N, 2003, ISR MED ASSOC J, V5, P702; Sich D, 1998, ATHEROSCLEROSIS, V138, P351, DOI 10.1016/S0021-9150(98)00030-6; Sviridov D, 2008, J ATHEROSCLER THROMB, V15, P52, DOI 10.5551/jat.E571; SYVANNE M, 1995, CIRCULATION, V92, P364, DOI 10.1161/01.CIR.92.3.364; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Thompson PA, 2008, INNATE IMMUN-LONDON, V14, P365, DOI 10.1177/1753425908099171; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; von Eckardstein A, 1999, CIRCULATION, V99, P1925; WEISGRABER KH, 1991, J BIOL CHEM, V266, P12029; Wroblewska M, 2010, BBA-MOL CELL BIOL L, V1801, P1323, DOI 10.1016/j.bbalip.2010.08.005	64	47	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39110	10.1371/journal.pone.0039110	http://dx.doi.org/10.1371/journal.pone.0039110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723940	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300095
J	Liu, L; Zeng, LL; Li, YM; Ma, QM; Li, BJ; Shen, H; Hu, DW				Liu, Li; Zeng, Ling-Li; Li, Yaming; Ma, Qiongmin; Li, Baojuan; Shen, Hui; Hu, Dewen			Altered Cerebellar Functional Connectivity with Intrinsic Connectivity Networks in Adults with Major Depressive Disorder	PLOS ONE			English	Article							DEFAULT MODE; CINGULATE CORTEX; BRAIN; MRI; CIRCUITS; DISTINCT; EMOTION; MOTION; FMRI	Background: Numerous studies have demonstrated the higher-order functions of the cerebellum, including emotion regulation and cognitive processing, and have indicated that the cerebellum should therefore be included in the pathophysiological models of major depressive disorder. The aim of this study was to compare the resting-state functional connectivity of the cerebellum in adults with major depression and healthy controls. Methods: Twenty adults with major depression and 20 gender-,age-, and education-matched controls were investigated using seed-based resting-state functional connectivity magnetic resonance imaging. Results: Compared with the controls, depressed patients showed significantly increased functional connectivity between the cerebellum and the temporal poles. However, significantly reduced cerebellar functional connectivity was observed in the patient group in relation to both the default-mode network, mainly including the ventromedial prefrontal cortex and the posterior cingulate cortex/precuneus, and the executive control network, mainly including the superior frontal cortex and orbitofrontal cortex. Moreover, the Hamilton Depression Rating Scale score was negatively correlated with the functional connectivity between the bilateral Lobule VIIb and the right superior frontal gyrus in depressed patients. Conclusions: This study demonstrated increased cerebellar coupling with the temporal poles and reduced coupling with the regions in the default-mode and executive control networks in adults with major depression. These differences between patients and controls could be associated with the emotional disturbances and cognitive control function deficits that accompany major depression. Aberrant cerebellar connectivity during major depression may also imply a substantial role for the cerebellum in the pathophysiological models of depression.	[Liu, Li] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China; [Zeng, Ling-Li; Ma, Qiongmin; Li, Baojuan; Shen, Hui; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Li, Yaming] China Med Univ, Affiliated Hosp 1, Dept Nucl Med, Shenyang, Liaoning, Peoples R China	China Medical University; National University of Defense Technology - China; China Medical University	Liu, L (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China.	lllyy2003@163.com	Hu, Dewen/D-1978-2015; Hu, Dewen/AAN-8511-2020	Zeng, Ling-Li/0000-0002-0515-256X	National Basic Research Program of China [2011CB707802]; National Science Foundation of China [60835005, 61003202]; Hunan Provincial Innovation Foundation [CX2011B015]; Graduate Innovation Fund of National University of Defense Technology [B110304]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation; Graduate Innovation Fund of National University of Defense Technology	This work was supported by the National Basic Research Program of China (Grant No 2011CB707802), National Science Foundation of China (Grant No 60835005, 61003202). Hunan Provincial Innovation Foundation (Grant No CX2011B015); Graduate Innovation Fund of National University of Defense Technology (Grant No B110304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alalade E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020035; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett C.M., 2010, J SERENDIPITOUS UNEX, V1, P1, DOI [DOI 10.1016/S1053-8119(09)71202-9, 10.1016/S1053-8119(09)71202-9]; Buckner RL, 2010, P NATL ACAD SCI USA, V107, P10769, DOI 10.1073/pnas.1005987107; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Desmond JE, 2010, BEHAV NEUROL, V23, P1, DOI 10.3233/BEN-2010-0272; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; Dolan RJ, 1998, BRAIN, V121, P545, DOI 10.1093/brain/121.4.545; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; First M. B., 2002, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2011, J AFFECT DISORDERS, V135, P326, DOI 10.1016/j.jad.2011.06.048; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hu DW, 2008, CEREBELLUM, V7, P304, DOI 10.1007/s12311-008-0031-2; Jiang AP, 1995, HUM BRAIN MAPP, V3, P224, DOI 10.1002/hbm.460030306; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Liu YD, 2008, IEEE J-STSP, V2, P870, DOI 10.1109/JSTSP.2008.2008495; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Naismith SL, 2010, J AFFECT DISORDERS, V125, P256, DOI 10.1016/j.jad.2010.02.114; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Teasdale JD, 1999, AM J PSYCHIAT, V156, P209; Timmann D, 2010, CORTEX, V46, P845, DOI 10.1016/j.cortex.2009.06.009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vasic N, 2009, PSYCHOL MED, V39, P977, DOI 10.1017/S0033291708004443; Walter H, 2007, NEUROIMAGE, V35, P1551, DOI 10.1016/j.neuroimage.2007.01.041; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	59	81	85	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39516	10.1371/journal.pone.0039516	http://dx.doi.org/10.1371/journal.pone.0039516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724025	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300143
J	Mata, R; Hau, R; Papassotiropoulos, A; Hertwig, R				Mata, Rui; Hau, Robin; Papassotiropoulos, Andreas; Hertwig, Ralph			DAT1 Polymorphism Is Associated with Risk Taking in the Balloon Analogue Risk Task (BART)	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; VARIABLE NUMBER; PERSONALITY-TRAIT; VNTR POLYMORPHISM; IMAGING GENETICS; AVAILABILITY; IMPULSIVITY; PROPENSITY; GENOTYPE; BRAIN	Twin-studies suggest that a significant portion of individual differences in the propensity to take risks resides in people's genetic make-up and there is evidence that variability in dopaminergic systems relates to individual differences in risky choice. We examined the link between risk taking in a risk taking task (the Balloon Analogue Risk Task, BART) and a variable number tandem repeat (VNTR) polymorphism in the 3'UTR of the dopamine transporter gene (SLC6A3/DAT1). Behavior in BART is known to be associated with activity in striatal reward-processing regions, and DAT1 is assumed to modulate striatal dopamine levels. We find that carriers of DAT1 alleles, which presumably result in lower striatal dopamine availability, showed more risk taking, relative to carriers of the alleles associated with higher striatal dopamine availability. Our analyses suggest that the mechanism underlying this association is diminished sensitivity to rewards among those who take more risks. Overall, our results support the notion that a behavioral genetic approach can be helpful in uncovering the basis of individual differences in risk taking.	[Mata, Rui; Hau, Robin; Hertwig, Ralph] Univ Basel, Dept Psychol, Ctr Cognit & Decis Sci, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Univ Psychiat Clin, Div Mol Neurosci, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, Basel, Switzerland; [Hertwig, Ralph] Max Planck Inst Human Dev, Berlin, Germany	University of Basel; University of Basel; University of Basel; University of Basel; Max Planck Society	Mata, R (corresponding author), Univ Basel, Dept Psychol, Ctr Cognit & Decis Sci, Basel, Switzerland.	rui.mata@unibas.ch	Hertwig, Ralph/B-3468-2015; Mata, Rui/K-8138-2015	Hertwig, Ralph/0000-0002-9908-9556; Mata, Rui/0000-0002-1679-906X; Papassotiropoulos, Andreas/0000-0002-2210-9651	Swiss National Science Foundation [100014-126558]; Swiss National Science Foundation Sinergia [CRSIK0_122691, CRSI33_130080]; European Union [HEALTH-F4-2009-242257]; National Center for Competence in Research synapsy	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); European Union(European Commission); National Center for Competence in Research synapsy	This work was funded by a grant from the Swiss National Science Foundation to Ralph Hertwig (100014-126558), the Swiss National Science Foundation Sinergia grants (CRSIK0_122691, CRSI33_130080), the 7th framework programme of the European Union (ADAMS project, HEALTH-F4-2009-242257), and the National Center for Competence in Research synapsy (www.nccr-synapsy.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokhin AP, 2009, TWIN RES HUM GENET, V12, P366, DOI 10.1375/twin.12.4.366; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bedard AC, 2010, NEUROIMAGE, V53, P935, DOI 10.1016/j.neuroimage.2009.12.041; Bishara AJ, 2009, J BEHAV DECIS MAKING, V22, P435, DOI 10.1002/bdm.641; Bornovalova MA, 2005, EXP CLIN PSYCHOPHARM, V13, P311, DOI 10.1037/1064-1297.13.4.311; Bornovalova MA, 2009, PHARMACOL BIOCHEM BE, V93, P258, DOI 10.1016/j.pbb.2008.10.023; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; BYERLEY W, 1993, HUM MOL GENET, V2, P335, DOI 10.1093/hmg/2.3.335; Cesarini D, 2011, MANAGEMENT SCI; Cesarini D, 2010, J FINANC, V65, P1725, DOI 10.1111/j.1540-6261.2010.01592.x; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Durston S, 2010, NEUROIMAGE, V53, P832, DOI 10.1016/j.neuroimage.2010.02.071; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Fein G, 2008, DRUG ALCOHOL DEPEN, V92, P141, DOI 10.1016/j.drugalcdep.2007.07.017; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Guo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009352; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Jaber M, 1997, MOVEMENT DISORD, V12, P629, DOI 10.1002/mds.870120502; Jacobsen LK, 2000, AM J PSYCHIAT, V157, P1700, DOI 10.1176/appi.ajp.157.10.1700; Jentsch JD, 2010, NEUROPSYCHOPHARMACOL, V35, P1797, DOI 10.1038/npp.2010.47; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484; Lejuez CW, 2004, ADDICT BEHAV, V29, P1643, DOI 10.1016/j.addbeh.2004.02.035; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lighthall N. R., 2011, SOCIAL COGNITIVE AFF, DOI 10.1093/scan/nsr026; Lynch DR, 2003, MOVEMENT DISORD, V18, P804, DOI 10.1002/mds.10430; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Mitchell RJ, 2000, HUM BIOL, V72, P295; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Nikolova YS, 2011, NEUROPSYCHOPHARMACOL, V36, P1940, DOI 10.1038/npp.2011.82; Pleskac TJ, 2008, EXP CLIN PSYCHOPHARM, V16, P555, DOI 10.1037/a0014245; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; Rao HY, 2010, MOVEMENT DISORD, V25, P1660, DOI 10.1002/mds.23147; Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020; Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Simon JR, 2011, BEHAV BRAIN RES, V216, P452, DOI 10.1016/j.bbr.2010.08.043; Simonson I, 2011, J CONSUM RES, V37, P951, DOI 10.1086/657022; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; van Dyck CH, 2005, J NUCL MED, V46, P745; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104; Zhong SF, 2012, NEUROIMAGE, V59, P540, DOI 10.1016/j.neuroimage.2011.07.031; Zhong SF, 2009, TWIN RES HUM GENET, V12, P103, DOI 10.1375/twin.12.1.103; Zyphur MJ, 2009, J BEHAV DECIS MAKING, V22, P367, DOI 10.1002/bdm.643	58	43	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39135	10.1371/journal.pone.0039135	http://dx.doi.org/10.1371/journal.pone.0039135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723947	gold, Green Published			2022-12-25	WOS:000305583300100
J	Moreira, F; Silva, JP; Estanque, B; Palmeirim, JM; Lecoq, M; Pinto, M; Leitao, D; Alonso, I; Pedroso, R; Santos, E; Catry, T; Silva, P; Henriques, I; Delgado, A				Moreira, Francisco; Silva, Joao P.; Estanque, Beatriz; Palmeirim, Jorge M.; Lecoq, Miguel; Pinto, Marcia; Leitao, Domingos; Alonso, Ivan; Pedroso, Rui; Santos, Eduardo; Catry, Teresa; Silva, Patricia; Henriques, Ines; Delgado, Ana			Mosaic-Level Inference of the Impact of Land Cover Changes in Agricultural Landscapes on Biodiversity: A Case-Study with a Threatened Grassland Bird	PLOS ONE			English	Article							BUSTARD TETRAX-TETRAX; HABITAT SELECTION; STEPPE BIRDS; POPULATION; DENSITIES; INTENSIFICATION; HETEROGENEITY	Changes in land useland cover are a major driver of biodiversity change in the Mediterranean region. Understanding how animal populations respond to these landscape changes often requires using landscape mosaics as the unit of investigation, but few previous studies have measured both response and explanatory variables at the land mosaic level. Here, we used a "whole-landscape'' approach to assess the influence of regional variation in the land cover composition of 81 farmland mosaics (mean area of 2900 ha) on the population density of a threatened bird, the little bustard (Tetrax tetrax), in southern Portugal. Results showed that ca. 50% of the regional variability in the density of little bustards could be explained by three variables summarising the land cover composition and diversity in the studied mosaics. Little bustard breeding males attained higher population density in land mosaics with a low land cover diversity, with less forests, and dominated by grasslands. Land mosaic composition gradients showed that agricultural intensification was not reflected in a loss of land cover diversity, as in many other regions of Europe. On the contrary, it led to the introduction of new land cover types in homogenous farmland, which increased land cover diversity but reduced overall landscape suitability for the species. Based on these results, the impact of recent land cover changes in Europe on the little bustard populations is evaluated.	[Moreira, Francisco; Silva, Joao P.; Henriques, Ines; Delgado, Ana] Univ Tecn Lisboa, Inst Agron, Ctr Appl Ecol Prof Baeta Neves, Lisbon, Portugal; [Silva, Joao P.; Estanque, Beatriz; Palmeirim, Jorge M.] Univ Lisbon, Ctr Environm Biol, Fac Sci, P-1699 Lisbon, Portugal; [Silva, Joao P.; Pinto, Marcia; Alonso, Ivan; Pedroso, Rui; Santos, Eduardo; Catry, Teresa] Inst Nat Conservat & Biodivers, Lisbon, Portugal; [Lecoq, Miguel; Leitao, Domingos; Silva, Patricia] SPEA Soc Protect & Study Birds, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Moreira, F (corresponding author), Univ Tecn Lisboa, Inst Agron, Ctr Appl Ecol Prof Baeta Neves, Lisbon, Portugal.	fmoreira@isa.utl.pt	Catry, Teresa/A-8082-2012; Palmeirim, Jorge M/A-1323-2014; Moreira, Francisco/B-2873-2008; Granadeiro, José Pedro/E-8060-2011; Silva, João P/L-6745-2013	Catry, Teresa/0000-0003-4047-9995; Palmeirim, Jorge M/0000-0003-4734-8162; Moreira, Francisco/0000-0003-4393-8018; Granadeiro, José Pedro/0000-0002-7207-3474; Silva, João P/0000-0002-1956-5779; Delgado, ana/0000-0002-0275-8734	Conservation of the little bustard in Alentejo [LIFE02NAT/P/8476]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/28805/2006]	Conservation of the little bustard in Alentejo; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Field work between 2004 and 2006 was financed by Project LIFE02NAT/P/8476: Conservation of the little bustard in Alentejo. JPS was partly supported by grant SFRH/BD/28805/2006 from Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi A, 2011, IBIS, V153, P875, DOI 10.1111/j.1474-919X.2011.01169.x; Batari A, 2011, FRONTIERS ECOLOGY EN, V9, P182; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bjornstad O., 2009, NCF SPATIAL NONPARAM; Campos B, 1996, CONSERVACION AVES ES, P201; Costa LT, 2003, ZONAS IMPORTANTES AY; De Juana Eduardo, 1996, Ardeola, V43, P157; Delgado A, 2000, AGR ECOSYST ENVIRON, V78, P65, DOI 10.1016/S0167-8809(99)00114-0; Delgado A, 2010, IBIS, V152, P633, DOI 10.1111/j.1474-919X.2010.01026.x; EEA, 2007, CORINE LAND COV 2006; Feranec J, 2010, APPL GEOGR, V30, P19, DOI 10.1016/j.apgeog.2009.07.003; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Freire S, 2005, P GIS PLAN 2005 2 IN; Garcia de la Morena E. L., 2006, SISON COMUN ESPANA; Garcia J, 2007, BIOL CONSERV, V137, P45, DOI 10.1016/j.biocon.2007.01.013; Goriup P, 1994, BIRDS EUROPE THEIR C, P236; Heymann Y., 1994, CORINE LAND COVER TE; Hill J, 2008, GLOBAL PLANET CHANGE, V64, P146, DOI 10.1016/j.gloplacha.2008.10.005; Inigo A, 2010, LITTLE BUSTARD TETRA; Jiguet F, 2001, BEHAV PROCESS, V55, P107, DOI 10.1016/S0376-6357(01)00173-5; Jiguet F, 2006, AM NAT, V168, P758, DOI 10.1086/508808; Jolivet Christophe, 2007, Ornithos, V14, P80; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; MARTINEZ C, 1994, BIOL CONSERV, V67, P125, DOI 10.1016/0006-3207(94)90357-3; Martinez C, 2000, ARDEOLA, V49, P301; Morales MB, 2008, ACTA OECOL, V34, P345, DOI 10.1016/j.actao.2008.06.009; Morales MB, 2006, REV ECOL-TERRE VIE, V61, P261; Morales MB, 2005, ANIM CONSERV, V8, P167, DOI 10.1017/S1367943005001988; Moreira F, 1999, BIRD STUDY, V46, P309, DOI 10.1080/00063659909461144; Moreira F, 2007, LANDSCAPE ECOL, V22, P1461, DOI 10.1007/s10980-007-9125-3; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Moreira Francisco, 2007, Airo, V17, P5; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2009, R FDN STAT COMP; Radford JQ, 2007, J APPL ECOL, V44, P737, DOI 10.1111/j.1365-2664.2007.01327.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salamolard M, 1999, BIRD STUDY, V46, P25, DOI 10.1080/00063659909461112; Santangeli A, 2011, EUR J WILDLIFE RES, V57, P805, DOI 10.1007/s10344-011-0492-3; Silva JP, 2007, BIOL CONSERV, V139, P186, DOI 10.1016/j.biocon.2007.06.013; Silva JP, 2010, BIOL CONSERV, V143, P2553, DOI 10.1016/j.biocon.2010.06.023; Silva JP, 2004, BIOL CONSERV, V117, P521, DOI 10.1016/j.biocon.2003.09.001; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Suarez Francisco, 1997, P297; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vila M, 2003, GLOBAL CHANGE BIOL, V9, P1234, DOI 10.1046/j.1365-2486.2003.00652.x; Wolff A, 2001, J APPL ECOL, V38, P963, DOI 10.1046/j.1365-2664.2001.00651.x; Zuur Alain F., 2009, P1	52	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38876	10.1371/journal.pone.0038876	http://dx.doi.org/10.1371/journal.pone.0038876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723899	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300063
J	Verhoeven, KJF; van Gurp, TP				Verhoeven, Koen J. F.; van Gurp, Thomas P.			Transgenerational Effects of Stress Exposure on Offspring Phenotypes in Apomictic Dandelion	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRICHOME DENSITY; PLASTICITY; RESPONSES; PLANTS; METHYLATION; HERBIVORY; CONSEQUENCES; INHERITANCE; MECHANISMS	Heritable epigenetic modulation of gene expression is a candidate mechanism to explain parental environmental effects on offspring phenotypes, but current evidence for environment-induced epigenetic changes that persist in offspring generations is scarce. In apomictic dandelions, exposure to various stresses was previously shown to heritably alter DNA methylation patterns. In this study we explore whether these induced changes are accompanied by heritable effects on offspring phenotypes. We observed effects of parental jasmonic acid treatment on offspring specific leaf area and on offspring interaction with a generalist herbivore; and of parental nutrient stress on offspring root-shoot biomass ratio, tissue P-content and leaf morphology. Some of the effects appeared to enhance offspring ability to cope with the same stresses that their parents experienced. Effects differed between apomictic genotypes and were not always consistently observed between different experiments, especially in the case of parental nutrient stress. While this context-dependency of the effects remains to be further clarified, the total set of results provides evidence for the existence of transgenerational effects in apomictic dandelions. Zebularine treatment affected the within-generation response to nutrient stress, pointing at a role of DNA methylation in phenotypic plasticity to nutrient environments. This study shows that stress exposure in apomictic dandelions can cause transgenerational phenotypic effects, in addition to previously demonstrated transgenerational DNA methylation effects.	[Verhoeven, Koen J. F.; van Gurp, Thomas P.] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Verhoeven, KJF (corresponding author), Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.	k.verhoeven@nioo.knaw.nl	Verhoeven, Koen JF/C-9920-2010; van Gurp, Thomas/B-4311-2012; KNAW, NIOO-KNAW/A-4320-2012	Verhoeven, Koen JF/0000-0003-3002-4102; van Gurp, Thomas/0000-0001-5622-2217; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research (NWO-VIDI) [864.10.008]	Netherlands Organisation for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO))	The study was supported by the Netherlands Organisation for Scientific Research (NWO-VIDI grant 864.10.008). NWO website: http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Baubec T, 2009, PLANT J, V57, P542, DOI 10.1111/j.1365-313X.2008.03699.x; Bilichak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030515; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; de Kovel CGF, 1999, PLANT BIOLOGY, V1, P541, DOI 10.1055/s-2007-978550; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 1996, MATERNAL ENV EFFECTS; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Galloway LF, 2001, ECOLOGY, V82, P2781, DOI 10.1890/0012-9658(2001)082[2781:PEEOLH]2.0.CO;2; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Houba VJG, 2004, PLANT ANAL PROCEDURE; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Latzel V, 2009, OIKOS, V118, P1669, DOI 10.1111/j.1600-0706.2009.17767.x; MIAO SL, 1991, ECOLOGY, V72, P1634, DOI 10.2307/1940963; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Munir J, 2001, AM J BOT, V88, P1240, DOI 10.2307/3558335; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Richards CL, 2011, NEW PHYTOL, V191, P7, DOI 10.1111/j.1469-8137.2011.03761.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; SCHMID B, 1994, EVOLUTION, V48, P1525, DOI 10.1111/j.1558-5646.1994.tb02194.x; SCHMITT J, 1992, AM NAT, V139, P451, DOI 10.1086/285338; Scoville AG, 2011, NEW PHYTOL, V191, P251, DOI 10.1111/j.1469-8137.2011.03656.x; Shea N, 2011, J EVOLUTION BIOL, V24, P1178, DOI 10.1111/j.1420-9101.2011.02235.x; Sultan SE, 1996, ECOLOGY, V77, P1791, DOI 10.2307/2265784; Van Dijk PJ, 1999, HEREDITY, V83, P715, DOI 10.1038/sj.hdy.6886200; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; WILSON JB, 1988, ANN BOT-LONDON, V61, P433, DOI 10.1093/oxfordjournals.aob.a087575	44	83	88	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38605	10.1371/journal.pone.0038605	http://dx.doi.org/10.1371/journal.pone.0038605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723869	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300033
J	Vong, L; Ferraz, JGP; Dufton, N; Panaccione, R; Beck, PL; Sherman, PM; Perretti, M; Wallace, JL				Vong, Linda; Ferraz, Jose G. P.; Dufton, Neil; Panaccione, Remo; Beck, Paul L.; Sherman, Philip M.; Perretti, Mauro; Wallace, John L.			Up-Regulation of Annexin-A1 and Lipoxin A(4) in Individuals with Ulcerative Colitis May Promote Mucosal Homeostasis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FORMYL-PEPTIDE RECEPTORS; APOPTOTIC NEUTROPHILS; PROSTAGLANDIN D-2; CUTTING EDGE; IN-VITRO; RESOLUTION; MACROPHAGES; IDENTIFICATION; ANALOGS	Background: One of the characteristics of an active episode of ulcerative colitis (UC) is the intense mucosal infiltration of leukocytes. The pro-resolution mediators Annexin-A1 (AnxA1) and lipoxin A(4) (LXA(4)) exert counter-regulatory effects on leukocyte recruitment, however to date, the dual/cumulative effects of these formyl peptide receptor-2 (FPR2/ALX) agonists in the context of human intestinal diseases are unclear. To define the contribution of these mediators, we measured their expression in biopsies from individuals with UC. Methods: Colonic mucosal biopsies were collected from two broad patient groups: healthy volunteers without ('Ctrl' n=20) or with a prior history of UC ('hx of UC' n=5); individuals with UC experiencing active disease ('active' n=8), or in medically-induced remission ('remission' n=16). We assessed the mucosal expression of LXA(4), AnxA1, and the FPR2/ALX receptor in each patient group using a combination of fluorescence microscopy, biochemical and molecular analyses. Results: Mucosal expression of LXA(4) was elevated exclusively in biopsies from individuals in remission (3-fold, P < 0.05 vs. Ctrl). Moreover, in this same group we observed an upregulation of AnxA1 protein expression (2.5-fold increase vs. Ctrl, P <.01), concurrent with an increased level of macrophage infiltration, and an elevation in FPR2/ALX mRNA (7-fold increase vs. Ctrl, P <.05). Importantly, AnxA1 expression was not limited to cells infiltrating the lamina propria but was also detected in epithelial cells lining the intestinal crypts. Conclusions: Our results demonstrate a specific up-regulation of this pro-resolution circuit in individuals in remission from UC, and suggest a significant role for LXA(4) and AnxA1 in promoting mucosal homeostasis.	[Vong, Linda; Sherman, Philip M.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Dufton, Neil; Wallace, John L.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Ferraz, Jose G. P.; Panaccione, Remo; Beck, Paul L.] Univ Calgary, Div Gastroenterol, Calgary, AB, Canada; [Perretti, Mauro] Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, Ctr Biochem Pharmacol, London EC1M 6BQ, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Calgary; University of London; Queen Mary University London	Vong, L (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	linda.vong@sickkids.ca	Dufton, Neil P/AAI-9571-2020; Wallace, John/AAL-3763-2021; Panaccione, Remo/ABC-1140-2021	Dufton, Neil P/0000-0002-6283-9210; Panaccione, Remo/0000-0002-5247-940X; Sherman, Philip/0000-0002-4733-6690	Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research; Canada Research Chair in Gastrointestinal Disease	Crohn's and Colitis Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Gastrointestinal Disease	This research was supported by a grant-in-aid from the Crohn's and Colitis Foundation of Canada (to J.G.P.F. and J.L.W.; http://www.ccfc.ca/site/c.ajIRK4NLLhJ0E/b.6319851/k.BDBF/Home.htm) and a grant from the Canadian Institutes of Health Research (to J.L.W; http://www.cihr-irsc.gc.ca/e/193.html). P.M.S is the recipient of a Canada Research Chair in Gastrointestinal Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bandeira-Melo C, 2000, J IMMUNOL, V164, P2267, DOI 10.4049/jimmunol.164.5.2267; Brancaleone V, 2011, J IMMUNOL; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Chavez-Pina AE, 2008, BRIT J PHARMACOL, V155, P857, DOI 10.1038/bjp.2008.316; Clish CB, 2000, ANN NY ACAD SCI, V905, P274; COLGAN SP, 1993, J CLIN INVEST, V92, P75, DOI 10.1172/JCI116601; CROXTALL JD, 1993, INT J CANCER, V54, P153, DOI 10.1002/ijc.2910540124; Croxtall JD, 1998, BRIT J PHARMACOL, V123, P975, DOI 10.1038/sj.bjp.0701679; der Weid PY, 2004, CIRCULATION, V110, P1320; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; EDENIUS C, 1990, FEBS LETT, V272, P25, DOI 10.1016/0014-5793(90)80440-T; FIORE S, 1990, J EXP MED, V172, P1451, DOI 10.1084/jem.172.5.1451; Fiorucci S, 2004, P NATL ACAD SCI USA, V101, P15736, DOI 10.1073/pnas.0404722101; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gewirtz AT, 1998, J CLIN INVEST, V101, P1860, DOI 10.1172/JCI1339; Gewirtz AT, 2002, J IMMUNOL, V168, P5260, DOI 10.4049/jimmunol.168.10.5260; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Goh J, 2001, J IMMUNOL, V167, P2772, DOI 10.4049/jimmunol.167.5.2772; GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2; Gronert K, 1998, J EXP MED, V187, P1285, DOI 10.1084/jem.187.8.1285; Jiang DF, 2003, PROTEOMICS, V3, P724, DOI 10.1002/pmic.200300411; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; LEE TH, 1990, AM REV RESPIR DIS, V141, P1453, DOI 10.1164/ajrccm/141.6.1453; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; MANCUSO F, 1995, J IMMUNOL, V155, P377; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Nusrat A, 1997, GASTROENTEROLOGY, V113, P1489, DOI 10.1053/gast.1997.v113.pm9352851; Pederzoli-Ribeil M, 2010, BLOOD, V116, P4288, DOI 10.1182/blood-2010-02-270520; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; RUGTVEIT J, 1995, GUT, V37, P367, DOI 10.1136/gut.37.3.367; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; Souza MHLP, 2003, AM J PHYSIOL-GASTR L, V285, pG54, DOI 10.1152/ajpgi.00525.2002; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Vergnolle N, 2004, INFLAMM BOWEL DIS, V10, P584, DOI 10.1097/00054725-200409000-00013; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	54	66	69	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39244	10.1371/journal.pone.0039244	http://dx.doi.org/10.1371/journal.pone.0039244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723974	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300121
J	Chen, SY; Yao, LH; Cunningham, TJ				Chen, Shuyan; Yao, Lihua; Cunningham, Timothy J.			Secreted Phospholipase A2 Involvement in Neurodegeneration: Differential Testing of Prosurvival and Anti-Inflammatory Effects of Enzyme Inhibition	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY; CELL-LINE; HL-60 CELLS; IN-VITRO; KAPPA-B; A(2); BRAIN; MACROPHAGES	There is increased interest in the contribution of secreted phospholipase A2 (sPLA2) enzymes to neurodegenerative diseases. Systemic treatment with the nonapeptide CHEC-9, a broad spectrum uncompetitive inhibitor of sPLA2, has been shown previously to inhibit neuron death and aspects of the inflammatory response in several models of neurodegeneration. A persistent question in studies of sPLA2 inhibitors, as for several other anti-inflammatory and neuroprotective compounds, is whether the cell protection is direct or due to slowing of the toxic aspects of the inflammatory response. To further explore this issue, we developed assays using SY5Y (neuronal cells) and HL-60 (monocytes) cell lines and examined the effects of sPLA2 inhibition on these homogeneous cell types in vitro. We found that the peptide inhibited sPLA2 enzyme activity in both SY5Y and HL-60 cultures. This inhibition provided direct protection to SY5Y neuronal cells and their processes in response to several forms of stress including exposure to conditioned medium from HL-60 cells. In cultures of HL-60 cells, sPLA2 inhibition had no effect on survival of the cells but attenuated their differentiation into macrophages, with regard to process development, phagocytic ability, and the expression of differentiation marker CD36, as well as the secretion of proinflammatory cytokines TNF-alpha and IL-6. These results suggest that sPLA2 enzyme activity organizes a cascade of changes comprising both cell degeneration and inflammation, processes that could theoretically operate independently during neurodegenerative conditions. The effectiveness of sPLA2 inhibitor CHEC-9 may be due to its ability to affect both processes in isolation. Testing potential anti-inflammatory/neuroprotective compounds with these human cell lines and their conditioned media may provide a useful screening tool prior to in vivo therapeutic applications.	[Chen, Shuyan; Yao, Lihua; Cunningham, Timothy J.] Drexel Univ, Dept Anat & Neurobiol, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Chen, SY (corresponding author), Drexel Univ, Dept Anat & Neurobiol, Coll Med, Philadelphia, PA 19104 USA.	tcunning@drexelmed.edu			Pennsylvania Department of Health, Commonwealth Universal Research Enhancement Program	Pennsylvania Department of Health, Commonwealth Universal Research Enhancement Program	This work was supported by Pennsylvania Department of Health, Commonwealth Universal Research Enhancement Program (http://www.portal.state.pa.us/portal/server.pt/community/health_research_program_cure/14189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; ASAOKA Y, 1993, P NATL ACAD SCI USA, V90, P716, DOI 10.1073/pnas.90.2.716; ASAOKA Y, 1993, P NATL ACAD SCI USA, V90, P4917, DOI 10.1073/pnas.90.11.4917; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Boyanovsky BB, 2010, CYTOKINE, V50, P50, DOI 10.1016/j.cyto.2009.12.009; Chakraborti S, 2003, CELL SIGNAL, V15, P637, DOI 10.1016/S0898-6568(02)00144-4; Chen S, 2008, SOC NEUR ABS, V38, P1465; COLLINS SJ, 1987, BLOOD, V70, P1233; Corke C, 2001, Crit Care Resusc, V3, P244; Cunningham T, 2009, OPEN ENZYME IN PRESS; Cunningham TJ, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-26; Cunningham TJ, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-25; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Cunningham TJ, 2004, J NEUROTRAUM, V21, P1683, DOI 10.1089/0897715042441792; Cunningham TJ, 2002, EXP NEUROL, V177, P32, DOI 10.1006/exnr.2002.7979; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Guy B, 2000, CLIN DIAGN LAB IMMUN, V7, P314, DOI 10.1128/CDLI.7.2.314-317.2000; HALL RE, 1983, CELL IMMUNOL, V76, P58, DOI 10.1016/0008-8749(83)90348-9; Hoda MN, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-21; Ibeas E, 2009, CARDIOVASC RES, V81, P54, DOI 10.1093/cvr/cvn234; Jensen MD, 2009, NEUROCHEM INT, V55, P362, DOI 10.1016/j.neuint.2009.04.002; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Kury P, 2004, FASEB J, V18, P398, DOI 10.1096/fj.04-1777fje; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Lucena A, 2008, SOC NEUR ABS, V38, P966; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Meyer MC, 2005, CURR PHARM DESIGN, V11, P1301, DOI 10.2174/1381612053507521; Moses GSD, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-28; Nakada-Tsukui K, 1999, J LEUKOCYTE BIOL, V66, P968, DOI 10.1002/jlb.66.6.968; NAKAHARA I, 1992, J NEUROSURG, V76, P244, DOI 10.3171/jns.1992.76.2.0244; Nanda BL, 2007, CURR TOP MED CHEM, V7, P765, DOI 10.2174/156802607780487623; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Thommesen L, 1998, J IMMUNOL, V161, P3421; Titsworth WL, 2008, CNS NEUROL DISORD-DR, V7, P254, DOI 10.2174/187152708784936671; Westley AM, 1996, J BIOL CHEM, V271, P5347, DOI 10.1074/jbc.271.10.5347; Xi D, 2011, NEUROPSYCHOPHARMACOL; Xi D, 2009, INT J NEUROPSYCHOPH, V12, P1395, DOI 10.1017/S146114570900042X; Xie B, 1998, J BIOL CHEM, V273, P11583, DOI 10.1074/jbc.273.19.11583	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39257	10.1371/journal.pone.0039257	http://dx.doi.org/10.1371/journal.pone.0039257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720084	gold, Green Published, Green Submitted			2022-12-25	WOS:000305350000053
J	Bruning-Richardson, A; Bond, J; Alsiary, R; Richardson, J; Cairns, DA; McCormac, L; Hutson, R; Burns, PA; Wilkinson, N; Hall, GD; Morrison, EE; Bell, SM				Bruening-Richardson, Anke; Bond, Jaqueline; Alsiary, Rawiah; Richardson, Julie; Cairns, David A.; McCormac, Luci; Hutson, Richard; Burns, Philip A.; Wilkinson, Nafisa; Hall, Geoff D.; Morrison, Ewan E.; Bell, Sandra M.			NuMA Overexpression in Epithelial Ovarian Cancer	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; MITOTIC APPARATUS; NUCLEAR-MATRIX; PROTEIN; EXPRESSION; PATHOGENESIS; SEGREGATION; ANEUPLOIDY; PATTERNS; PATHWAY	Highly aneuploid tumours are common in epithelial ovarian cancers (EOC). We investigated whether NuMA expression was associated with this phenomenon. NuMA protein levels in normal and tumour tissues, ovarian cell lines and primary cultures of malignant cells derived from ovarian ascitic fluids were analysed by Affymetrix microarray analysis, immunoblotting, immunohistochemistry (IHC) and immunofluorescence (IF), with results correlated to associated clinical data. Aneuploidy status in primary cultures was determined by FACS analysis. Affymetrix microarray data indicated that NuMA was overexpressed in tumour tissue, primary cultures and cell lines compared to normal ovarian tissue. IHC revealed low to weak NuMA expression in normal tissues. Expression was upregulated in tumours, with a significant association with disease stage in mucinous EOC subtypes (p = 0.009), lymph node involvement (p = 0.03) and patient age (p = 0.04). Additional discontinuous data analysis revealed that high NuMA levels in tumours decreased with grade (p = 0.02) but increased with disease stage (p = 0.04) in serous EOC. NuMA expression decreased in late disease stage 4 endometrioid EOCs. High NuMA levels decreased with increased tumour invasion in all subtypes (p = 0.03). IF of primary cultures revealed that high NuMA levels at mitotic spindle poles were significantly associated with a decreased proportion of cells in cytokinesis (p = 0.05), increased binucleation (p = 0.021) and multinucleation (p = 0.007), and aneuploidy (p = 0.008). NuMA is highly expressed in EOC tumours and high NuMA levels correlate with increases in mitotic defects and aneuploidy in primary cultures.	[Bruening-Richardson, Anke; Bond, Jaqueline; Alsiary, Rawiah; Richardson, Julie; Morrison, Ewan E.; Bell, Sandra M.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Cairns, David A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Oncol & Clin Res, Leeds, W Yorkshire, England; [McCormac, Luci; Burns, Philip A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Pathol & Tumour Biol, Leeds, W Yorkshire, England; [Hutson, Richard; Wilkinson, Nafisa; Hall, Geoff D.] St Jamess Inst Oncol, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Saint James's University Hospital	Bruning-Richardson, A (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England.	bgyar@leeds.ac.uk	Cairns, David/A-6577-2009; Hall, Geoff D/A-1717-2010	Cairns, David/0000-0002-2338-0179; Hall, Geoff D/0000-0002-8864-5932; Bell, Sandra/0000-0002-3022-9864; Bruning-Richardson, Anke/0000-0002-9862-9805	Yorkshire Cancer Research [L328]; University of Leeds; Breast Cancer Campaign [2007NovPR53]; Saudi Arabian Ministry of Higher Education; UK Medical Research Council [G0802416]; Oncolytics Biotech Inc, (Calgary, Canada); Leeds Teaching Hospitals NHS Trust; Cancer Research UK; Wellbeing of Women; MRC [G0802416] Funding Source: UKRI; Medical Research Council [G0802416] Funding Source: researchfish	Yorkshire Cancer Research; University of Leeds; Breast Cancer Campaign; Saudi Arabian Ministry of Higher Education; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oncolytics Biotech Inc, (Calgary, Canada); Leeds Teaching Hospitals NHS Trust; Cancer Research UK(Cancer Research UK); Wellbeing of Women(Wellbeing of Women (WoW)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work and Dr. Bruning-Richardson were funded by Yorkshire Cancer Research [L328]. The University of Leeds supports Dr. Bond, Dr. Burns, Dr. Hall and Dr. Morrison. Dr. Bell is supported by the Breast Cancer Campaign [2007NovPR53], Dr. Alsiary by a scholarship from the Saudi Arabian Ministry of Higher Education, Dr. Cairns by the UK Medical Research Council [G0802416], Dr. McCormac by Oncolytics Biotech Inc, (Calgary, Canada) and Dr. Wilkinson and Dr. Hutson by Leeds Teaching Hospitals NHS Trust. Dr. Bond, Dr. Burns, Dr. Wilkinson, Dr. Morrison and Dr. Bell hold funding from Yorkshire Cancer Research, GDH from Cancer Research UK, and Dr. Burns and Dr. Wilkinson from Wellbeing of Women. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad PC, 2007, MOL BIOL CELL, V18, P348, DOI 10.1091/mbc.E06-06-0551; Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bayani J, 2008, NEOPLASIA, V10, P1057, DOI 10.1593/neo.08584; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Bruning-Richardson A, 2011, BRIT J CANCER, V104, P1602, DOI 10.1038/bjc.2011.117; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Dynlacht JR, 2000, RADIAT RES, V154, P515, DOI 10.1667/0033-7587(2000)154[0515:DPODFA]2.0.CO;2; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Harborth J, 1999, CRIT REV EUKAR GENE, V9, P319, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.160; Hoglund M, 2003, CANCER RES, V63, P3378; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Landen CN, 2007, CLIN CANCER RES, V13, P4098, DOI 10.1158/1078-0432.CCR-07-0431; Lassus H, 2011, GYNECOL ONCOL, V120, P11, DOI 10.1016/j.ygyno.2010.09.003; LYDERSEN BK, 1980, CELL, V22, P489, DOI 10.1016/0092-8674(80)90359-1; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Ota J, 2003, ONCOGENE, V22, P5720, DOI 10.1038/sj.onc.1206855; Parrella P, 2003, MODERN PATHOL, V16, P636, DOI 10.1097/01.MP.0000076979.28106.ED; Peyre E, 2011, J CELL BIOL, V193, P141, DOI 10.1083/jcb.201101039; Pothuri B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010358; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; SPARKS CA, 1993, GENOMICS, V17, P222, DOI 10.1006/geno.1993.1307; Taimen P, 2000, EXP CELL RES, V256, P140, DOI 10.1006/excr.2000.4799; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Whitehurst AW, 2010, CANCER RES, V70, P7652, DOI 10.1158/0008-5472.CAN-10-0840; ZENG CQ, 1994, CELL MOTIL CYTOSKEL, V29, P167, DOI 10.1002/cm.970290208	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38945	10.1371/journal.pone.0038945	http://dx.doi.org/10.1371/journal.pone.0038945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719996	Green Published, Green Accepted, gold			2022-12-25	WOS:000305347800030
J	Maly, IV				Maly, Ivan V.			Equilibria of Idealized Confined Astral Microtubules and Coupled Spindle Poles	PLOS ONE			English	Article							CELL-DIVISION; CAENORHABDITIS-ELEGANS; DYNAMIC INSTABILITY; EMBRYOS; ORIENTATION; FORCE; POLARITY; MODEL	Positioning of the mitotic spindle through the interaction of astral microtubules with the cell boundary often determines whether the cell division will be symmetric or asymmetric. This process plays a crucial role in development. In this paper, a numerical model is presented that deals with the force exerted on the spindle by astral microtubules that are bent by virtue of their confinement within the cell boundary. It is found that depending on parameters, the symmetric position of the spindle can be stable or unstable. Asymmetric stable equilibria also exist, and two or more stable positions can exist simultaneously. The theory poses new types of questions for experimental research. Regarding the cases of symmetric spindle positioning, it is necessary to ask whether the microtubule parameters are controlled by the cell so that the bending mechanics favors symmetry. If they are not, then it is necessary to ask what forces external to the microtubule cytoskeleton counteract the bending effects sufficiently to actively establish symmetry. Conversely, regarding the cases with asymmetry, it is now necessary to investigate whether the cell controls the microtubule parameters so that the bending favors asymmetry apart from any forces that are external to the microtubule cytoskeleton.	Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Maly, IV (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	ivanvmaly@gmail.com						[Anonymous], 1987, LINEAR AGGREGATION T; Arkhipov SN, 2006, PHYS BIOL, V3, P209, DOI 10.1088/1478-3975/3/3/006; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; Baratt A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003861; BJERKNES M, 1986, SCIENCE, V234, P1413, DOI 10.1126/science.3787253; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Bray D., 2001, CELL MOVEMENTS; Cytrynbaum EN, 2003, BIOPHYS J, V84, P757, DOI 10.1016/S0006-3495(03)74895-4; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Gu B, 2009, ACTA MECH, V207, P195, DOI 10.1007/s00707-008-0121-8; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Holy TE, 1997, PHYS ASPECTS ASSEMBL; Howard J., 2001, MECH MOTOR PROTEINS; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kim MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000260; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Lillie FR, 1901, J MORPHOL, V17, P227, DOI 10.1002/jmor.1050170204; Maly VI, 2010, BIOPHYS J, V99, P2831, DOI 10.1016/j.bpj.2010.09.017; McCarthy EK, 2006, CURR OPIN CELL BIOL, V18, P79, DOI 10.1016/j.ceb.2005.12.006; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Rubinstein B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016005; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Segal M, 2000, MOL BIOL CELL, V11, P3689, DOI 10.1091/mbc.11.11.3689; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SYMES K, 1992, DEV BIOL, V150, P203, DOI 10.1016/0012-1606(92)90019-D; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; WADSWORTH P, 1986, J CELL BIOL, V102, P1032, DOI 10.1083/jcb.102.3.1032; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WHITTAKER JR, 1980, J EMBRYOL EXP MORPH, V55, P343	35	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38921	10.1371/journal.pone.0038921	http://dx.doi.org/10.1371/journal.pone.0038921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719988	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000305347800027
J	Fiete, D; Beranek, M; Baenziger, JU				Fiete, Dorothy; Beranek, Mary; Baenziger, Jacques U.			Peptide-specific Transfer of N-Acetylgalactosamine to O-Linked Glycans by the Glycosyltransferases beta 1,4-N-Acetylgalactosaminyl Transferase 3 (beta 4GalNAc-T3) and beta 4GalNAc-T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATORY HALF-LIFE; BETA 1,4GLCNAC BETA; MOLECULAR-CLONING; IN-VIVO; CORE 2; ASIALOGLYCOPROTEIN RECEPTOR; BOVINE PROOPIOMELANOCORTIN; DIFFERENTIAL EXPRESSION; GALNAC-TRANSFERASE; GAUSSIA LUCIFERASE	N- and O-linked oligosaccharides on pro-opiomelanocortin both bear the unique terminal sequence SO4-4-GalNAc beta 1, 4GlcNAc beta. We previously demonstrated that protein-specific transfer of GalNAc to N-linked oligosaccharides on glycoprotein substrates is dependent on the presence of both an oligosaccharide acceptor and a peptide recognition motif consisting of a cluster of basic amino acids. We characterized how two beta 1,4-N-acetylgalactosaminyltransferases, beta 4GalNAc-T3 and beta 4GalNAc-T4, require the presence of both the peptide recognition motif and the N-linked oligosaccharide acceptors to transfer GalNAc in beta 1,4-linkage to GlcNAc in vivo and in vitro. We now show that beta 4GalNAc-T3 and beta 4GalNAc-T4 are able to utilize the same peptide motif to selectively add GalNAc to beta 1,6-linked GlcNAc in core 2 O-linked oligosaccharide structures to form Gal beta 1,3(GalNAc beta 1,4GlcNAc beta 1,6)GalNAc alpha Ser/Thr. The beta 1,4-linked GalNAc can be further modified with 4-linked sulfate by either GalNAc-4-sulfotransferase 1 (GalNAc-4-ST1) (CHST8) or GalNAc-4-ST2 (CHST9) or with alpha 2,6-linked N-acetylneuraminic acid by alpha 2,6-sialyltransferase 1 (ST6Gal1), thus generating a family of unique GalNAc beta 1,4GlcNAc beta (Lac-diNAc)- containing structures on specific glycoproteins.	[Fiete, Dorothy; Beranek, Mary; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med St Louis, Dept Pathol, 660 S Euclid Ave, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health [R01-HD058474, R01-CA21923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA021923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HD058474 and R01-CA21923 (to J. U. B.).	BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; Baenziger JU, 2003, BIOCHEM SOC T, V31, P326, DOI 10.1042/BST0310326; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; Dell A, 2003, P NATL ACAD SCI USA, V100, P15631, DOI 10.1073/pnas.2635507100; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Fiete D, 2012, J BIOL CHEM, V287, P29194, DOI 10.1074/jbc.M112.371567; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; GLASGOW LR, 1977, J BIOL CHEM, V252, P8615; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; GREEN ED, 1985, J BIOL CHEM, V260, P5623; Hassan H, 2000, CARBOHYDRATES CHEM B, P273, DOI DOI 10.1002/9783527618255.CH55; Hiraoka N, 2001, GLYCOBIOLOGY, V11, P495, DOI 10.1093/glycob/11.6.495; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Kang HG, 2001, J BIOL CHEM, V276, P10861, DOI 10.1074/jbc.M011560200; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Ma JY, 1997, J BIOL CHEM, V272, P672; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Park EI, 2003, J BIOL CHEM, V278, P4597, DOI 10.1074/jbc.M210612200; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Schwientek T, 2000, J BIOL CHEM, V275, P11106, DOI 10.1074/jbc.275.15.11106; SICILIANO RA, 1993, GLYCOBIOLOGY, V3, P225, DOI 10.1093/glycob/3.3.225; SICILIANO RA, 1994, J BIOL CHEM, V269, P910; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Sugahara T, 1996, J BIOL CHEM, V271, P20797, DOI 10.1074/jbc.271.34.20797; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TORRES BV, 1988, ARCH BIOCHEM BIOPHYS, V262, P1, DOI 10.1016/0003-9861(88)90161-0; VANDENEIJNDEN DH, 1995, BIOCHEM SOC T, V23, P175, DOI 10.1042/bst0230175; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; Xia GQ, 2000, J BIOL CHEM, V275, P38402, DOI 10.1074/jbc.M007821200; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215	51	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29204	29212		10.1074/jbc.M112.371880	http://dx.doi.org/10.1074/jbc.M112.371880			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22722940	Green Published, hybrid			2022-12-25	WOS:000308074600086
J	Bager, R; Kristensen, TK; Jensen, JK; Szczur, A; Christensen, A; Andersen, LM; Johansen, JS; Larsen, N; Baatrup, E; Huang, MD; Ploug, M; Andreasen, PA				Bager, Rene; Kristensen, Thomas K.; Jensen, Jan K.; Szczur, Agnieszka; Christensen, Anni; Andersen, Lisbeth M.; Johansen, Jesper S.; Larsen, Niels; Baatrup, Erik; Huang, Mingdong; Ploug, Michael; Andreasen, Peter A.			Urokinase-type Plasminogen Activator-like Proteases in Teleosts Lack Genuine Receptor-binding Epidermal Growth Factor-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; EVOLUTION; SEQUENCE; GENOME; FISH; PATTERNS; MUTATION; BLOOD; CELLS; CHAIN	Plasminogen activation catalyzed by urokinase-type plasminogen activator (uPA) plays an important role in normal and pathological tissue remodeling processes. Since its discovery in the mid-1980s, the cell membrane-anchored urokinase-type plasminogen activator receptor (uPAR) has been believed to be central to the functions of uPA, as uPA-catalyzed plasminogen activation activity appeared to be confined to cell surfaces through the binding of uPA to uPAR. However, a functional uPAR has so far only been identified in mammals. We have now cloned, recombinantly produced, and characterized two zebrafish proteases, zfuPA-a and zfuPA-b, which by several criteria are the fish orthologs of mammalian uPA. Thus, both proteases catalyze the activation of fish plasminogen efficiently and both proteases are inhibited rapidly by plasminogen activator inhibitor-1 (PAI-1). But zfuPA-a differs from mammalian uPA by lacking the exon encoding the uPAR-binding epidermal growth factor-like domain; zfuPA-b differs from mammalian uPA by lacking two cysteines of the epidermal growth factor-like domain and a uPAR-binding sequence comparable with that found in mammalian uPA. Accordingly, no zfuPA-b binding activity could be found in fish white blood cells or fish cell lines. We therefore propose that the current consensus of uPA-catalyzed plasminogen activation taking place on cell surfaces, derived from observations with mammals, is too narrow. Fish uPAs appear incapable of receptor binding in the manner known from mammals and uPA-catalyzed plasminogen activation in fish may occur mainly in solution. Studies with nonmammalian vertebrate species are needed to obtain a comprehensive understanding of the mechanism of plasminogen activation.	[Bager, Rene; Kristensen, Thomas K.; Jensen, Jan K.; Szczur, Agnieszka; Christensen, Anni; Andersen, Lisbeth M.; Johansen, Jesper S.; Larsen, Niels; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Bager, Rene; Jensen, Jan K.; Szczur, Agnieszka; Christensen, Anni; Andersen, Lisbeth M.; Huang, Mingdong; Ploug, Michael; Andreasen, Peter A.] Aarhus Univ, Danish Chinese Ctr Proteases & Canc, DK-8000 Aarhus C, Denmark; [Baatrup, Erik] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, Fuzhou 350002, Peoples R China; [Ploug, Michael] Rigshosp, Finsen Lab, DK-2200 Copenhagen N, Denmark; [Ploug, Michael] Copenhagen Bioctr, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark	Aarhus University; Aarhus University; Aarhus University; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Rigshospitalet	Andreasen, PA (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, 10 Gustav Wieds Vej, DK-8000 Aarhus C, Denmark.	pa@mb.au.dk	Huang, Mingdong/J-4278-2017; Baatrup, Erik/B-5371-2010	Huang, Mingdong/0000-0003-0085-9141; Baatrup, Erik/0000-0002-5948-4519; Ploug, Michael/0000-0003-2215-4265	Danish Medical Research Council [2107040003]; Danish National Research Foundation [26-331-6]; Novo-Nordisk Foundation [R114-A11382]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo-Nordisk Foundation(Novo Nordisk Foundation)	This work was supported by Danish Medical Research Council Grant 2107040003, Danish National Research Foundation Grant 26-331-6, and Novo-Nordisk Foundation Grant R114-A11382 (to P. A. A.).	Alberti M, 2005, INT J ENVIRON AN CH, V85, P589, DOI 10.1080/03067310500145930; ANDREASEN PA, 1991, FIBRINOLYSIS, V5, P207, DOI 10.1016/0268-9499(91)90002-L; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; APPELLA E, 1987, J BIOL CHEM, V262, P4437; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Barnham KJ, 1998, PROTEIN SCI, V7, P1738, DOI 10.1002/pro.5560070808; Behrendt N, 1996, J BIOL CHEM, V271, P22885, DOI 10.1074/jbc.271.37.22885; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; Botkjaer KA, 2009, BIOCHEMISTRY-US, V48, P9606, DOI 10.1021/bi900510f; BRAUNNESJE R, 1981, J FISH DIS, V4, P141, DOI 10.1111/j.1365-2761.1981.tb01118.x; Carmeliet P, 1998, J CELL BIOL, V140, P233, DOI 10.1083/jcb.140.1.233; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Culp P. A., 1994, THESIS MIT; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Doolittle RF, 2009, COLD SH Q B, V74, P35, DOI 10.1101/sqb.2009.74.001; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GLIEMANN J, 1994, ANN NY ACAD SCI, V737, P20, DOI 10.1111/j.1749-6632.1994.tb44299.x; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JENSEN PH, 1990, CELL REGUL, V1, P1043, DOI 10.1091/mbc.1.13.1043; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; Madsen JB, 2010, BIOCHEMISTRY-US, V49, P4103, DOI 10.1021/bi100066j; Pebusque MJ, 1998, MOL BIOL EVOL, V15, P1145, DOI 10.1093/oxfordjournals.molbev.a026022; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; Pettersen EF, 2000, FISH SHELLFISH IMMUN, V10, P695, DOI 10.1006/fsim.2000.0284; Ploug M, 1998, BIOCHEMISTRY-US, V37, P3612, DOI 10.1021/bi972787k; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; SALLES FJ, 1990, EMBO J, V9, P2471, DOI 10.1002/j.1460-2075.1990.tb07425.x; Stempien-Otero A, 2006, J BIOL CHEM, V281, P15345, DOI 10.1074/jbc.M512818200; TAKAHASHI K, 1987, CELL STRUCT FUNCT, V12, P11, DOI 10.1247/csf.12.11; Tom Roseanne, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4977; VASSALLI JD, 1987, FEBS LETT, V214, P187, DOI 10.1016/0014-5793(87)80039-X; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005	49	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27526	27536		10.1074/jbc.M112.369207	http://dx.doi.org/10.1074/jbc.M112.369207			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733817	Green Published, hybrid			2022-12-25	WOS:000307840700028
J	Palombo, I; Daley, DO; Rapp, M				Palombo, Isolde; Daley, Daniel O.; Rapp, Mikaela			The Periplasmic Loop Provides Stability to the Open State of the CorA Magnesium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+ TRANSPORT PROTEIN; CRYSTAL-STRUCTURE; SALMONELLA-TYPHIMURIUM; CONSERVED RESIDUES; MEMBRANE DOMAIN; TOPOLOGY; MUTAGENESIS; HOMOLOG; MRS2P	Crystal structures of the CorA Mg2+ channel have suggested that metal binding in the cytoplasmic domain stabilizes the pentamer in a closed conformation. The open "metal free" state of the channel is, however, still structurally uncharacterized. Here, we have attempted to map conformational states of CorA from Thermotoga maritima by determining which residues support the pentameric structure in the presence or absence of Mg2+. We find that when Mg2+ is present, the pentamer is stabilized by the putative gating sites (M1/M2) in the cytoplasmic domain. Strikingly however, we find that the conserved and functionally important periplasmic loop is vital for the integrity of the pentamer when Mg2+ is absent from the M1/M2 sites. Thus, although the periplasmic loops were largely disordered in the x-ray structures of the closed channel, our data suggests a prominent role for the loops in stabilizing the open conformation of the CorA channels.	[Rapp, Mikaela] Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, S-17177 Stockholm, Sweden; [Palombo, Isolde; Daley, Daniel O.] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Rapp, M (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, S-17177 Stockholm, Sweden.	mikaela.rapp@ki.se	Rapp, Mikaela/K-2298-2015	Daley, Daniel/0000-0002-6425-5059; Rapp, Mikaela/0000-0002-4401-9518	Swedish Research Council; Jeanssons Stiftelse; Sven och Dagmar Salen; Magnus Bergwall; Helge Axson Johnsson; Lars Hiertas Stiftelser	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jeanssons Stiftelse; Sven och Dagmar Salen; Magnus Bergwall; Helge Axson Johnsson; Lars Hiertas Stiftelser	This work was supported by grants from the Swedish Research Council and Jeanssons Stiftelse ( to D. O. D.) and grants from the Sven och Dagmar Salen, Magnus Bergwall, Helge Axson Johnsson, and Lars Hiertas Stiftelser (to M. R.).	Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Dalmas O, 2010, STRUCTURE, V18, P868, DOI 10.1016/j.str.2010.04.009; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kehres D G, 1998, Microb Comp Genomics, V3, P151, DOI 10.1089/omi.1.1998.3.151; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Moomaw AS, 2010, BIOCHEMISTRY-US, V49, P5998, DOI 10.1021/bi1005656; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Smith RL, 1998, J BIOL CHEM, V273, P28663, DOI 10.1074/jbc.273.44.28663; Stenberg F, 2007, J MOL BIOL, V371, P765, DOI 10.1016/j.jmb.2007.05.045; Szegedy MA, 1999, J BIOL CHEM, V274, P36973, DOI 10.1074/jbc.274.52.36973; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233	19	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27547	27555		10.1074/jbc.M112.371484	http://dx.doi.org/10.1074/jbc.M112.371484			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722933	Green Published, hybrid			2022-12-25	WOS:000307840700030
J	Adams, J; Schott, S; Bern, A; Renz, M; Ikenberg, K; Garbe, C; Busch, C				Adams, Julia; Schott, Sarah; Bern, Arno; Renz, Matthias; Ikenberg, Kristian; Garbe, Claus; Busch, Christian			A Novel Role for Relaxin-2 in the Pathogenesis of Primary Varicosis	PLOS ONE			English	Article							SMOOTH-MUSCLE; VEINS; RECEPTORS; ESTROGEN; DISEASE	Background: Varicose veins affect up to 40% of men and up to 51% of women. The pathophysiology of primary varicosis is poorly understood. Theories ranging from incompetence of the venous valves to structural changes in the vein wall have been proposed. Methodology/Principal Findings: We analyzed the functional state of the intramural smooth muscle cells (n = 14 pairs matched for age and gender) and the expression of relaxin-2 and its receptors RXFP1 and RXFP2 in samples of varicose and healthy great saphenous veins (GSV) (n = 21 healthy GSV; n = 46 varicose GSV). Relaxin-2 and RXFP1 contents were determined in tissue samples (n = 9 samples per group). Pharmacological analyses were performed in a perfusion chamber. Morphometric determination of the nuclear size of the smooth muscle compartment yielded no significant difference in varicose GSV in comparison with the healthy controls. Relaxin-2 and its receptors were expressed in the muscular layer, endothelial cells and in blood vessels contained in the vein wall. Immunohistochemical expression of relaxin-2, RXFP1 and RXFP2 was significantly decreased in varicose GSV. Relaxin-2 and RXFP1 measured by ELISA and Western Blot were decreased in varicose GSV (relaxin-2 ELISA healthy vs. varicose GSV: 12.49 +/- 0.66 pg/mg versus 9.12 +/- 3.39 pg/mg of total protein; p = 0.01; Student's T-test). Contractions of vein samples induced by cholinergic or adrenergic stimulation were antagonized by relaxin-2. Conclusions/Significance: We report that relaxin-2 and its receptors RXFP1 and RXFP2 are expressed in GSV and that their expression is significantly decreased in varicose GSV. Further, we were able to demonstrate a functional pharmacological relaxin-2 system in varicose GSV. Our results suggest a novel role for relaxin-2 in the pathogenesis of primary varicosis, rendering relaxin-2 a novel possible pharmacological agent for the treatment of this widely prevailing venous disease.	[Adams, Julia; Renz, Matthias; Garbe, Claus; Busch, Christian] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Schott, Sarah] Univ Heidelberg, Dept Gynecol, Heidelberg, Germany; [Bern, Arno] Practice Clin Phlebol, Tubingen, Germany; [Ikenberg, Kristian] Univ Spital, Inst Pathol, Zurich, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Adams, J (corresponding author), Univ Tubingen, Dept Dermatol, Tubingen, Germany.	Christian.Busch@med.uni-tuebingen.de	Garbe, Claus/ABH-2128-2021; Schott, Sarah/D-5242-2018	Garbe, Claus/0000-0001-8530-780X; Schott, Sarah/0000-0002-1714-1147	German Phlebological Society	German Phlebological Society	This work was supported by a research grant from the German Phlebological Society to Christian Busch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccari MC, 2004, CURR PROTEIN PEPT SC, V5, P9, DOI 10.2174/1389203043486928; Bathgate RA, 2005, ANN NY ACAD SCI, V1041, P61, DOI 10.1196/annals.1282.010; BOGUTH E, 1951, Med Welt, V20, P408; Elsharawy Mohamed A, 2007, Interact Cardiovasc Thorac Surg, V6, P219; Feldner A, 2011, FASEB J, V25, P3613, DOI 10.1096/fj.11-185975; FETZER S, 1955, Z ZELLFORSCH MIK ANA, V43, P404; Knaapen MWM, 2005, J VASC RES, V42, P8, DOI 10.1159/000082723; Mashiah A, 1999, CARDIOVASC SURG, V7, P327, DOI 10.1016/S0967-2109(98)00132-X; Meissner MH, 2007, J VASC SURG, V46, p4S, DOI 10.1016/j.jvs.2007.09.043; Meissner MH, 2007, J VASC SURG, V46, p54S, DOI 10.1016/j.jvs.2007.08.038; Reisenauer C, 2008, INT UROGYNECOL J, V19, P383, DOI 10.1007/s00192-007-0447-0; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Somers P, 2006, ANGIOLOGY, V57, P546, DOI 10.1177/0003319706293115; Teichman Sam L, 2010, Curr Heart Fail Rep, V7, P75, DOI 10.1007/s11897-010-0010-z; Travers JP, 1996, EUR J VASC ENDOVASC, V11, P230, DOI 10.1016/S1078-5884(96)80058-X	16	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39021	10.1371/journal.pone.0039021	http://dx.doi.org/10.1371/journal.pone.0039021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737225	Green Accepted, Green Published, gold			2022-12-25	WOS:000305695100024
J	Xing, DQ; Oparil, S; Yu, H; Gong, KZ; Feng, WG; Black, J; Chen, YF; Nozell, S				Xing, Dongqi; Oparil, Suzanne; Yu, Hao; Gong, Kaizheng; Feng, Wenguang; Black, Jonathan; Chen, Yiu-Fai; Nozell, Susan			Estrogen Modulates NF kappa B Signaling by Enhancing I kappa B alpha Levels and Blocking p65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-beta	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RAT CAROTID ARTERIES; INJURED ARTERIES; ADHESION MOLECULE-1; NEOINTIMA FORMATION; DNA-BINDING; EXPRESSION; ACTIVATION; TRANSCRIPTION; ATHEROSCLEROSIS	Background: NF kappa B signaling is critical for expression of genes involved in the vascular injury response. We have shown that estrogen (17 beta-estradiol, E2) inhibits expression of these genes in an estrogen receptor (ER)-dependent manner in injured rat carotid arteries and in tumor necrosis factor (TNF)-alpha treated rat aortic smooth muscle cells (RASMCs). This study tested whether E2 inhibits NF kappa B signaling in RASMCs and defined the mechanisms. Methodology/Principal Findings: TNF-alpha treated RASMCs demonstrated rapid degradation of I kappa B alpha (10-30 min), followed by dramatic increases in I kappa B alpha mRNA and protein synthesis (40-60 min). E2 enhanced TNF-alpha induced I kappa B alpha synthesis without affecting I kappa B alpha degradation. Chromatin immunoprecipitation (ChIP) assays revealed that E2 pretreatment both enhanced TNF-alpha induced binding of NF kappa B p65 to the I kappa B alpha promoter and suppressed TNF-alpha induced binding of NF kappa B p65 to and reduced the levels of acetylated histone 3 at promoters of monocyte chemotactic protein (MCP)-1 and cytokine-induced neutrophil chemoattractant (CINC)-2 beta genes. ChIP analyses also demonstrated that ER beta can be recruited to the promoters of MCP-1 and CINC-2 beta during co-treatment with TNF-alpha and E2. Conclusions: These data demonstrate that E2 inhibits inflammation in RASMCs by two distinct mechanisms: promoting new synthesis of I kappa B alpha, thus accelerating a negative feedback loop in NF kappa B signaling, and directly inhibiting binding of NF kappa B to the promoters of inflammatory genes. This first demonstration of multifaceted modulation of NF kappa B signaling by E2 may represent a novel mechanism by which E2 protects the vasculature against inflammatory injury.	[Xing, Dongqi; Oparil, Suzanne; Gong, Kaizheng; Feng, Wenguang; Black, Jonathan; Chen, Yiu-Fai] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA; [Yu, Hao; Nozell, Susan] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Gong, Kaizheng] Yangzhou Univ, Clin Med Sch 2, Dept Cardiol, Yangzhou, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Yangzhou University	Xing, DQ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA.	dqxing@uab.edu		Black, Jonathan/0000-0002-0328-5537	National Heart, Lung, and Blood Institute [HL07457, HL75211, HL087980, HL080017, HL044195]; American Heart Association Greater Southeast Affiliate [09BGIA2250367]; UAB Diabetes Research and Training Center [P60 DK-079626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044195, T35HL007473, R01HL075211, R01HL087980, T32HL007457, R01HL080017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Greater Southeast Affiliate(American Heart Association); UAB Diabetes Research and Training Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung, and Blood Institute grants HL07457, HL75211, HL087980 (to S.O.); HL080017, HL044195 (to Y.F.C.), American Heart Association Greater Southeast Affiliate grant 09BGIA2250367 and UAB Diabetes Research and Training Center P60 DK-079626 (to D.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakir S, 2000, CIRCULATION, V101, P2342, DOI 10.1161/01.CIR.101.20.2342; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; Bu DX, 2005, FASEB J, V19, P1293, DOI 10.1096/fj.04-2645fje; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; Cerillo G, 1998, J STEROID BIOCHEM, V67, P79, DOI 10.1016/S0960-0760(98)00078-8; Chadwick CC, 2005, P NATL ACAD SCI USA, V102, P2543, DOI 10.1073/pnas.0405841102; Evans MJ, 2002, ENDOCRINOLOGY, V143, P2559, DOI 10.1210/en.143.7.2559; Galien R, 1997, NUCLEIC ACIDS RES, V25, P2424, DOI 10.1093/nar/25.12.2424; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrington WR, 2003, MOL CELL ENDOCRINOL, V206, P13, DOI 10.1016/S0303-7207(03)00255-7; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Kalaitzidis D, 2004, ONCOGENE, V23, P7580, DOI 10.1038/sj.onc.1207912; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Landry DB, 1997, AM J PATHOL, V151, P1085; Li GH, 2002, CIRCULATION, V106, P854, DOI 10.1161/01.CIR.0000024113.26985.CC; Li GH, 2000, CIRCULATION, V101, P1362, DOI 10.1161/01.CIR.101.12.1362; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; Liu H, 2005, CYTOKINE, V31, P251, DOI 10.1016/j.cyto.2004.12.008; McMurray RW, 2001, CYTOKINE, V14, P324, DOI 10.1006/cyto.2001.0900; Miller AP, 2007, MENOPAUSE, V14, P251, DOI 10.1097/01.gme.0000235366.39726.f6; Miller AP, 2004, CIRCULATION, V110, P1664, DOI 10.1161/01.CIR.0000142050.19488.C7; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Nozell S, 2006, J IMMUNOL, V177, P822, DOI 10.4049/jimmunol.177.2.822; Ohtsuka T, 1996, J BIOL CHEM, V271, P1651, DOI 10.1074/jbc.271.3.1651; Okamoto E, 2001, CIRCULATION, V104, P2228, DOI 10.1161/hc4301.097195; Oparil S, 1999, CARDIOVASC RES, V44, P608, DOI 10.1016/S0008-6363(99)00240-0; Oparil S, 1997, CIRCULATION, V95, P1301; Pelzer T, 2001, BIOCHEM BIOPH RES CO, V286, P1153, DOI 10.1006/bbrc.2001.5519; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rupec RA, 1999, IMMUNOGENETICS, V49, P395, DOI 10.1007/s002510050512; Ruusalepp A, 2006, CARDIOVASC DRUG THER, V20, P103, DOI 10.1007/s10557-006-6755-7; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; Speir E, 2000, CIRCULATION, V102, P2990; STEIN B, 1995, MOL CELL BIOL, V15, P4971; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sun WH, 1998, BIOCHEM BIOPH RES CO, V244, P691, DOI 10.1006/bbrc.1998.8324; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Wang XL, 2009, MOL IMMUNOL, V46, P2413, DOI 10.1016/j.molimm.2009.04.014; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Xing DQ, 2007, AM J PHYSIOL-HEART C, V292, pH2607, DOI 10.1152/ajpheart.01107.2006; Xing DQ, 2004, CIRCULATION, V109, P234, DOI 10.1161/01.CIR.0000105700.95607.49; Xing L, 2007, ANTIOXID REDOX SIGN, V9, P1979, DOI 10.1089/ars.2007.1921	55	81	82	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e36890	10.1371/journal.pone.0036890	http://dx.doi.org/10.1371/journal.pone.0036890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723832	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700002
J	Yuan, LZ; Tang, JH; Wang, XP; Li, CH				Yuan, Liuzheng; Tang, Jihua; Wang, Xiuping; Li, Chaohai			QTL Analysis of Shading Sensitive Related Traits in Maize under Two Shading Treatments	PLOS ONE			English	Article							ANTHESIS-SILKING INTERVAL; ZEA-MAYS L; PLANT HEIGHT; KERNEL NUMBER; MOLECULAR MARKERS; DROUGHT TOLERANCE; DIFFERENT TESTERS; WATER-DEFICIT; LOCI; IDENTIFICATION	During maize development and reproduction, shading stress is an important abiotic factor influencing grain yield. To elucidate the genetic basis of shading stress in maize, an F-2:3 population derived from two inbred lines, Zhong72 and 502, was used to evaluate the performance of six traits under shading treatment and full-light treatment at two locations. The results showed that shading treatment significantly decreased plant height and ear height, reduced stem diameter, delayed day-to-tassel (DTT) and day-to-silk (DTS), and increased anthesis-silking interval (ASI). Forty-three different QTLs were identified for the six measured traits under shading and full light treatment at two locations, including seven QTL for plant height, nine QTL for ear height, six QTL for stem diameter, seven QTL for day-to-tassel, six QTL for day-to-silk, and eight QTL for ASI. Interestingly, three QTLs, qPH4, qEH4a, and qDTT1b were detected under full sunlight and shading treatment at two locations simultaneously, these QTL could be used for selecting elite hybrids with high tolerance to shading and high plant density. And the two QTL, qPH10 and qDTS1a, were only detected under shading treatment at two locations, should be quit for selecting insensitive inbred line in maize breeding procedure by using MAS method.	[Yuan, Liuzheng; Tang, Jihua; Wang, Xiuping; Li, Chaohai] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China	Henan Agricultural University	Yuan, LZ (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China.	lichaohai2005@yahoo.com.cn			National Maize Industrial Technology RD system [NYCYTX-2]	National Maize Industrial Technology RD system	This work was supported by National Maize Industrial Technology R&D system (No.: NYCYTX-2). (http://www.moa.gov.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLER BSB, 1991, CROP SCI, V31, P267, DOI 10.2135/cropsci1991.0011183X003100020006x; Agrama HAS, 1996, EUPHYTICA, V91, P89, DOI 10.1007/BF00035278; Andrade FH, 1999, CROP SCI, V39, P453, DOI 10.2135/cropsci1999.0011183X0039000200026x; BEAVIS WD, 1991, THEOR APPL GENET, V83, P141, DOI 10.1007/BF00226242; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; BERKE TG, 1995, CROP SCI, V35, P1542, DOI 10.2135/cropsci1995.0011183X003500060004x; Doust AN, 2007, CURR OPIN PLANT BIOL, V10, P21, DOI 10.1016/j.pbi.2006.11.015; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; EARLEY EB, 1966, CROP SCI, V6, P1, DOI 10.2135/cropsci1966.0011183X000600010001x; EARLY EB, 1967, CROP SCI, V7, P151, DOI 10.2135/cropsci1967.0011183X000700020018x; Edmeades GO, 2000, CSSA SPEC PUBL, P43; Fournier C, 2000, ANN BOT-LONDON, V86, P1127, DOI 10.1006/anbo.2000.1280; GERAKIS PA, 1980, AGR METEOROL, V21, P129, DOI 10.1016/0002-1571(80)90059-X; HASHEMIDEZFOULI A, 1992, AGRON J, V84, P547, DOI 10.2134/agronj1992.00021962008400040001x; Hebert Y, 2001, CROP SCI, V41, P363, DOI 10.2135/cropsci2001.412363x; KARLEN DL, 1985, AGRON J, V77, P393, DOI 10.2134/agronj1985.00021962007700030010x; Khairallah MM, 1998, PLANT BREEDING, V117, P309, DOI 10.1111/j.1439-0523.1998.tb01947.x; KINIRY JR, 1985, AGRON J, V77, P711, DOI 10.2134/agronj1985.00021962007700050012x; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; KOESTER RP, 1993, CROP SCI, V33, P1209, DOI 10.2135/cropsci1993.0011183X003300060020x; Kozumplik V, 1996, MAYDICA, V41, P211; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liu WD, 2009, CROP SCI, V49, P1817, DOI 10.2135/cropsci2008.07.0423; Lubberstedt T, 1997, CROP SCI, V37, P921, DOI 10.2135/cropsci1997.0011183X003700030037x; Marino R, 2009, MOL GENET GENOMICS, V281, P163, DOI 10.1007/s00438-008-0401-y; Melchinger AE, 1998, GENETICS, V149, P383; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; MOSS DALE N., 1961, CROP SCI, V1, P416, DOI 10.2135/cropsci1961.0011183X000100060009x; Rebai A, 1997, THEOR APPL GENET, V95, P451, DOI 10.1007/s001220050582; REED AJ, 1988, CROP SCI, V28, P819, DOI 10.2135/cropsci1988.0011183X002800050020x; Ribaut JM, 1996, THEOR APPL GENET, V92, P905, DOI 10.1007/BF00221905; Salah HBH, 1996, J EXP BOT, V47, P1689, DOI 10.1093/jxb/47.11.1689; SCHMIDT WH, 1967, CROP SCI, V7, P137, DOI 10.2135/cropsci1967.0011183X000700020013x; SCHON CC, 1994, CROP SCI, V34, P378, DOI 10.2135/cropsci1994.0011183X003400020014x; SCHOPER JB, 1982, CROP SCI, V22, P1184, DOI 10.2135/cropsci1982.0011183X002200060023x; SETTER TL, 1989, ANN BOT-LONDON, V64, P481, DOI 10.1093/oxfordjournals.aob.a087867; Setter TL, 2001, CROP SCI, V41, P1530, DOI 10.2135/cropsci2001.4151530x; SINGH BK, 1984, AUST J PLANT PHYSIOL, V11, P151, DOI 10.1071/PP9840151; STINSON HARRY T., 1960, AGRON JOUR, V52, P482; STRUIK PC, 1983, NETH J AGR SCI, V31, P101; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; TOLLENAAR M, 1978, AGRON J, V70, P219, DOI 10.2134/agronj1978.00021962007000020003x; Tollenaar M., 1977, Maydica, V22, P49; VELDBOOM LR, 1994, THEOR APPL GENET, V88, P7, DOI 10.1007/BF00222387; Veldboom LR, 1996, CROP SCI, V36, P1320, DOI 10.2135/cropsci1996.0011183X003600050041x; WARD DA, 1986, PLANT CELL ENVIRON, V9, P261, DOI 10.1111/j.1365-3040.1986.tb01738.x; Welcker C, 2007, J EXP BOT, V58, P339, DOI 10.1093/jxb/erl227; Yuan LiuZheng, 2008, Journal of Maize Sciences, V16, P19; ZENG ZB, 1994, GENETICS, V136, P1457	49	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38696	10.1371/journal.pone.0038696	http://dx.doi.org/10.1371/journal.pone.0038696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723877	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700022
J	Belluzzi, E; Bisaglia, M; Lazzarini, E; Tabares, LC; Beltramini, M; Bubacco, L				Belluzzi, Elisa; Bisaglia, Marco; Lazzarini, Elisabetta; Tabares, Leandro C.; Beltramini, Mariano; Bubacco, Luigi			Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson's Disease	PLOS ONE			English	Article							HIGH-FIELD EPR; MANGANESE SUPEROXIDE DISMUTASES; RAT-BRAIN MITOCHONDRIA; ALPHA-SYNUCLEIN; TYROSINE-HYDROXYLASE; OXIDATIVE PATHWAYS; PATHOGENESIS; CATECHOLAMINES; IDENTIFICATION; NEUROTOXICITY	Mitochondrial dysfunction and oxidative stress are considered central in dopaminergic neurodegeneration in Parkinson's disease (PD). Oxidative stress occurs when the endogenous antioxidant systems are overcome by the generation of reactive oxygen species (ROS). A plausible source of oxidative stress, which could account for the selective degeneration of dopaminergic neurons, is the redox chemistry of dopamine (DA) and leads to the formation of ROS and reactive dopamine-quinones (DAQs). Superoxide dismutase 2 (SOD2) is a mitochondrial enzyme that converts superoxide radicals to molecular oxygen and hydrogen peroxide, providing a first line of defense against ROS. We investigated the possible interplay between DA and SOD2 in the pathogenesis of PD using enzymatic essays, site-specific mutagenesis, and optical and high-field-cw-EPR spectroscopies. Using radioactive DA, we demonstrated that SOD2 is a target of DAQs. Exposure to micromolar DAQ concentrations induces a loss of up to 50% of SOD2 enzymatic activity in a dose-dependent manner, which is correlated to the concomitant formation of protein aggregates, while the coordination geometry of the active site appears unaffected by DAQ modifications. Our findings support a model in which DAQ-mediated SOD2 inactivation increases mitochondrial ROS production, suggesting a link between oxidative stress and mitochondrial dysfunction.	[Belluzzi, Elisa; Bisaglia, Marco; Lazzarini, Elisabetta; Beltramini, Mariano; Bubacco, Luigi] Univ Padua, Dept Biol, Padua, Italy; [Tabares, Leandro C.] CEA, Inst Biol & Technol Saclay, Serv Bioenerget Biol Struct & Mecanismes, Gif Sur Yvette, France	University of Padua; CEA; UDICE-French Research Universities; Universite Paris Saclay	Belluzzi, E (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	mariano.beltramini@unipd.it; luigi.bubacco@unipd.it	Belluzzi, Elisa/K-4622-2016; Tabares, Leandro C/A-6368-2009; Bubacco, Luigi/B-5602-2012	Belluzzi, Elisa/0000-0003-1129-2574; Tabares, Leandro C/0000-0002-8906-6430; Bubacco, Luigi/0000-0001-7927-9208	Italian Ministry of Education, University and Research [PRIN2008-5SYP79]; University of Padova [PRAT2010-CPDA103503]; Bruno Kessler Foundation	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova; Bruno Kessler Foundation	This work was supported by grants from the Italian Ministry of Education, University and Research (PRIN2008-5SYP79), the University of Padova (PRAT2010-CPDA103503) and the Bruno Kessler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Attar F, 2006, APPL BIOCHEM MICRO+, V42, P101, DOI 10.1134/S0003683806010169; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Bisaglia M, 2010, BBA-MOL BASIS DIS, V1802, P699, DOI 10.1016/j.bbadis.2010.06.006; Bisaglia M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-41; Bisaglia M, 2010, BIOCHEM BIOPH RES CO, V394, P424, DOI 10.1016/j.bbrc.2010.03.044; BURGHAUS O, 1993, J PHYS CHEM-US, V97, P7639, DOI 10.1021/j100131a037; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Girotto S, 2012, J BIOL CHEM IN PRESS; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Greggio E, 2005, J NEUROCHEM, V93, P246, DOI 10.1111/j.1471-4159.2005.03019.x; Hastings TG, 2009, J BIOENERG BIOMEMBR, V41, P469, DOI 10.1007/s10863-009-9257-z; HASTINGS TG, 1994, J NEUROCHEM, V63, P1126; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuhn DM, 1999, J NEUROCHEM, V73, P1309, DOI 10.1046/j.1471-4159.1999.0731309.x; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; PAZ MA, 1991, J BIOL CHEM, V266, P689; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Tabares LC, 2006, BIOCHEMISTRY-US, V45, P1919, DOI 10.1021/bi051947m; Tabares LC, 2007, BIOCHEMISTRY-US, V46, P9320, DOI 10.1021/bi700438j; Tabares LC, 2010, BBA-PROTEINS PROTEOM, V1804, P308, DOI 10.1016/j.bbapap.2009.09.027; TSE DCS, 1976, J MED CHEM, V19, P37, DOI 10.1021/jm00223a008; Un S, 2004, J AM CHEM SOC, V126, P2720, DOI 10.1021/ja036503x; Un S, 2001, APPL MAGN RESON, V21, P341, DOI 10.1007/BF03162413; Un S, 2001, J AM CHEM SOC, V123, P10123, DOI 10.1021/ja016258m; Van Laar VS, 2008, NEUROBIOL DIS, V29, P477, DOI 10.1016/j.nbd.2007.11.007; Van Laar VS, 2009, NEUROBIOL DIS, V34, P487, DOI 10.1016/j.nbd.2009.03.004; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023	40	47	47	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38026	10.1371/journal.pone.0038026	http://dx.doi.org/10.1371/journal.pone.0038026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723845	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300019
J	Cosson, P; Schurdi-Levraud, V; Le, QH; Sicard, O; Caballero, M; Roux, F; Le Gall, O; Candresse, T; Revers, F				Cosson, Patrick; Schurdi-Levraud, Valerie; Le, Quang Hien; Sicard, Ophelie; Caballero, Melodie; Roux, Fabrice; Le Gall, Olivier; Candresse, Thierry; Revers, Frederic			The RTM Resistance to Potyviruses in Arabidopsis thaliana: Natural Variation of the RTM Genes and Evidence for the Implication of Additional Genes	PLOS ONE			English	Article							LONG-DISTANCE MOVEMENT; LETTUCE-MOSAIC-VIRUS; TOBACCO ETCH VIRUS; PLANT-RESISTANCE; DUPLICATED GENES; TERMINAL REGION; COMPLEX TRAITS; RESTRICTION; REPLICATION; EXPRESSION	Background: The non conventional RTM (Restricted Tobacco etch virus Movement) resistance which restricts long distance movement of some plant viruses in Arabidopsis thaliana is still poorly understood. Though at least three RTM genes have been identified, their precise role(s) in the process as well as whether other genes are involved needs to be elucidated. Methodology/Principal Findings: In this study, the natural variation of the RTM genes was analysed at the amino acid level in relation with their functionality to restrict the long distance movement of Lettuce mosaic potyvirus (LMV). We identified non-functional RTM alleles in LMV-susceptible Arabidopsis accessions as well as some of the mutations leading to the non-functionality of the RTM proteins. Our data also indicate that more than 40% of the resistant accessions to LMV are controlled by the RTM genes. In addition, two new RTM loci were genetically identified. Conclusions/Significance: Our results show that the RTM resistance seems to be a complex biological process which would involves at least five different proteins. The next challenges will be to understand how the different RTM protein domains are involved in the resistance mechanism and to characterise the new RTM genes for a better understanding of the blocking of the long distance transport of plant viruses.	[Cosson, Patrick; Schurdi-Levraud, Valerie; Le, Quang Hien; Sicard, Ophelie; Caballero, Melodie; Le Gall, Olivier; Candresse, Thierry; Revers, Frederic] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Cosson, Patrick; Schurdi-Levraud, Valerie; Caballero, Melodie; Le Gall, Olivier; Candresse, Thierry; Revers, Frederic] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Roux, Fabrice] Univ Sci & Technol Lille 1, Lab Genet & Evolut Populat Vegetales, FRE CNRS 3268, Villeneuve Dascq, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Universite de Lille - ISITE; Universite de Lille	Cosson, P (corresponding author), INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France.	revers@bordeaux.inra.fr	Revers, Frederic/A-9732-2009; Schurdi-Levraud, Valerie/P-5508-2019; Le Gall, Olivier/C-4820-2011	Revers, Frederic/0000-0002-6167-192X; Schurdi-Levraud, Valerie/0000-0001-5519-5800; Le Gall, Olivier/0000-0002-8547-6061; Fabrice, Roux/0000-0001-8059-5638; Candresse, Thierry/0000-0001-9757-1835	INRA's 'Jeune Equipe' program; Etablissement Public Regional Aquitaine [20000307004]; French Research Ministry; INRA (Plant Health and Plant Genetics divisions); Aquitaine regional council	INRA's 'Jeune Equipe' program; Etablissement Public Regional Aquitaine; French Research Ministry(Ministry of Research, France); INRA (Plant Health and Plant Genetics divisions); Aquitaine regional council(Region Nouvelle-Aquitaine)	This work was supported by grants from INRA's 'Jeune Equipe' program, from the Etablissement Public Regional Aquitaine (contract number 20000307004). QHL was supported by a "Haignere'' post-doctoral grant from the French Research Ministry. OS was funded by a Ph.D. fellowship from INRA (Plant Health and Plant Genetics divisions) and the Aquitaine regional council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Carrington JC, 1998, CURR OPIN PLANT BIOL, V1, P336, DOI 10.1016/1369-5266(88)80056-6; Chisholm ST, 2000, P NATL ACAD SCI USA, V97, P489, DOI 10.1073/pnas.97.1.489; Chisholm ST, 2001, PLANT PHYSIOL, V127, P1667, DOI 10.1104/pp.010479; Cosson P, 2010, PLANT PHYSIOL, V154, P222, DOI 10.1104/pp.110.155754; Decroocq V, 2006, MOL PLANT MICROBE IN, V19, P541, DOI 10.1094/MPMI-19-0541; Decroocq V, 2009, MOL PLANT MICROBE IN, V22, P1302, DOI 10.1094/MPMI-22-10-1302; Diaz-Pendon JA, 2004, MOL PLANT PATHOL, V5, P223, DOI [10.1111/j.1364-3703.2004.00223.x, 10.1111/J.1364-3703.2004.00223.X]; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; Holub EB, 1997, ADV BOT RES, V24, P227; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ishibashi K, 2007, P NATL ACAD SCI USA, V104, P13833, DOI 10.1073/pnas.0703203104; Ishibashi K, 2010, MOL PLANT MICROBE IN, V23, P1413, DOI 10.1094/MPMI-04-10-0102; Jeyaprakash AA, 2002, J MOL BIOL, V321, P637, DOI 10.1016/S0022-2836(02)00674-5; Krause-Sakate R, 2002, PHYTOPATHOLOGY, V92, P563, DOI 10.1094/PHYTO.2002.92.5.563; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Mahajan SK, 1998, PLANT J, V14, P177, DOI 10.1046/j.1365-313X.1998.00105.x; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Maule AJ, 2007, MOL PLANT PATHOL, V8, P223, DOI 10.1111/J.1364-3703.2007.00386.X; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Nei M, 1987, MOL EVOLUTIONARY GEN; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Revers F, 2003, MOL PLANT MICROBE IN, V16, P608, DOI 10.1094/MPMI.2003.16.7.608; Revers F, 1999, ARCH VIROL, V144, P1619, DOI 10.1007/s007050050615; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soosaar JLM, 2005, NAT REV MICROBIOL, V3, P789, DOI 10.1038/nrmicro1239; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wang S., 2011, WINDOWS QTL CARTOGRA; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Whitham SA, 1999, P NATL ACAD SCI USA, V96, P772, DOI 10.1073/pnas.96.2.772; Whitham SA, 2004, CURR OPIN PLANT BIOL, V7, P365, DOI 10.1016/j.pbi.2004.04.006; Whitham SA, 2000, PLANT CELL, V12, P569, DOI 10.1105/tpc.12.4.569; Xiang Y, 2011, J EXP BOT, V62, P5471, DOI 10.1093/jxb/err226; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	51	34	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39169	10.1371/journal.pone.0039169	http://dx.doi.org/10.1371/journal.pone.0039169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723957	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300111
J	Dainat, J; Paganini, J; Pontarotti, P; Gouret, P				Dainat, Jacques; Paganini, Julien; Pontarotti, Pierre; Gouret, Philippe			GLADX: An Automated Approach to Analyze the Lineage-Specific Loss and Pseudogenization of Genes	PLOS ONE			English	Article							UNITARY PSEUDOGENES; URATE OXIDASE; IDENTIFICATION; GENOME; DIVERGENCE; PATTERNS; SEQUENCE; MUTATION; SEARCH; HUMANS	A well-established ancestral gene can usually be found, in one or multiple copies, in different descendant species. Sometimes during the course of evolution, all the representatives of a well-established ancestral gene disappear in specific lineages; such gene losses may occur in the genome by deletion of a DNA fragment or by pseudogenization. The loss of an entire gene family in a given lineage may reflect an important phenomenon, and could be due either to adaptation, or to a relaxation of selection that leads to neutral evolution. Therefore, the lineage-specific gene loss analyses are important to improve the understanding of the evolutionary history of genes and genomes. In order to perform this kind of study from the increasing number of complete genome sequences available, we developed a unique new software module called GLADX in the DAGOBAH framework, based on a comparative genomic approach. The software is able to automatically detect, for all the species of a phylum, the presence/absence of a representative of a well-established ancestral gene, and by systematic steps of re-annotation, confirm losses, detect and analyze pseudogenes and find novel genes. The approach is based on the use of highly reliable gene phylogenies, of protein predictions and on the analysis of genomic mutations. All the evidence associated to evolutionary approach provides accurate information for building an overall view of the evolution of a given gene in a selected phylum. The reliability of GLADX has been successfully tested on a benchmark analysis of 14 reported cases. It is the first tool that is able to fully automatically study the lineage-specific losses and pseudogenizations. GLADX is available at http://ioda.univ-provence.fr/IodaSite/gladx/.	[Dainat, Jacques; Paganini, Julien; Pontarotti, Pierre; Gouret, Philippe] Aix Marseille Univ, Lab Anal, Probabilites LATP, CNRS,Equipe Evolut Biol & Modelisat,UMR 7353, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Dainat, J (corresponding author), Aix Marseille Univ, Lab Anal, Probabilites LATP, CNRS,Equipe Evolut Biol & Modelisat,UMR 7353, Marseille, France.	jacques.dainat@gmail.com	, pontarotti/ABB-1753-2021	Pierre, Pontarotti/0000-0001-7202-3648; Dainat, Jacques/0000-0002-6629-0173	French Ministry of Research; French National Research Agency [ANR-07-BLAN-0054]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); French National Research Agency(French National Research Agency (ANR))	JD was funded by a PhD fellowship from the French Ministry of Research. This work was supported by the French National Research Agency [EvolHHupro: ANR-07-BLAN-0054]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Brawand D, 2008, PLOS BIOL, V6, P507, DOI 10.1371/journal.pbio.0060063; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Eulenstein O, 1997, MATH HIERARCHIES BIO, P71; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Freimuth RR, 2004, PHARMACOGENOMICS J, V4, P54, DOI 10.1038/sj.tpj.6500223; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Gouret P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-198; Gouret P, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P71, DOI 10.1007/978-3-642-20763-1_5; Gouret P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-298; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hughes AL, 2005, EVOL DEV, V7, P196, DOI 10.1111/j.1525-142X.2005.05022.x; Hughes AL, 2004, J MOL EVOL, V59, P827, DOI 10.1007/s00239-004-0115-7; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Kuraku S, 2011, GENOME BIOL EVOL, P1; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mitchell A, 2005, J MOL EVOL, V61, P795, DOI 10.1007/s00239-004-0235-0; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Paganini J, 2012, EVOLUTIONAR IN PRESS; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANKOFF D, 1975, MATH PROGRAM, V9, P240, DOI 10.1007/BF01681346; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26; Zhu JC, 2007, PLOS COMPUT BIOL, V3, P2498, DOI 10.1371/journal.pcbi.0030247; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38792	10.1371/journal.pone.0038792	http://dx.doi.org/10.1371/journal.pone.0038792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723889	Green Published, gold			2022-12-25	WOS:000305583300050
J	McKnite, AM; Perez-Munoz, ME; Lu, L; Williams, EG; Brewer, S; Andreux, PA; Bastiaansen, JWM; Wang, XS; Kachman, SD; Auwerx, J; Williams, RW; Benson, AK; Peterson, DA; Ciobanu, DC				McKnite, Autumn M.; Perez-Munoz, Maria Elisa; Lu, Lu; Williams, Evan G.; Brewer, Simon; Andreux, Penelope A.; Bastiaansen, John W. M.; Wang, Xusheng; Kachman, Stephen D.; Auwerx, Johan; Williams, Robert W.; Benson, Andrew K.; Peterson, Daniel A.; Ciobanu, Daniel C.			Murine Gut Microbiota Is Defined by Host Genetics and Modulates Variation of Metabolic Traits	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GENOME-WIDE ASSOCIATION; INBRED MOUSE STRAINS; INNATE IMMUNITY; INDUCED OBESITY; MICE; DIET; EXPRESSION; WEIGHT; LOCI	The gastrointestinal tract harbors a complex and diverse microbiota that has an important role in host metabolism. Microbial diversity is influenced by a combination of environmental and host genetic factors and is associated with several polygenic diseases. In this study we combined next-generation sequencing, genetic mapping, and a set of physiological traits of the BXD mouse population to explore genetic factors that explain differences in gut microbiota and its impact on metabolic traits. Molecular profiling of the gut microbiota revealed important quantitative differences in microbial composition among BXD strains. These differences in gut microbial composition are influenced by host-genetics, which is complex and involves many loci. Linkage analysis defined Quantitative Trait Loci (QTLs) restricted to a particular taxon, branch or that influenced the variation of taxa across phyla. Gene expression within the gastrointestinal tract and sequence analysis of the parental genomes in the QTL regions uncovered candidate genes with potential to alter gut immunological profiles and impact the balance between gut microbial communities. A QTL region on Chr 4 that overlaps several interferon genes modulates the population of Bacteroides, and potentially Bacteroidetes and Firmicutes-the predominant BXD gut phyla. Irak4, a signaling molecule in the Toll-like receptor pathways is a candidate for the QTL on Chr15 that modulates Rikenellaceae, whereas Tgfb3, a cytokine modulating the barrier function of the intestine and tolerance to commensal bacteria, overlaps a QTL on Chr 12 that influence Prevotellaceae. Relationships between gut microflora, morphological and metabolic traits were uncovered, some potentially a result of common genetic sources of variation.	[McKnite, Autumn M.; Ciobanu, Daniel C.] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68583 USA; [Perez-Munoz, Maria Elisa; Benson, Andrew K.; Peterson, Daniel A.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Lu, Lu; Wang, Xusheng; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Williams, Evan G.; Andreux, Penelope A.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Brewer, Simon] Univ Utah, Dept Geog, Salt Lake City, UT USA; [Bastiaansen, John W. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Kachman, Stephen D.] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Peterson, Daniel A.] Johns Hopkins Univ Sch Med, Dept Pathol, Baltimore, MD USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Tennessee System; University of Tennessee Health Science Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Utah System of Higher Education; University of Utah; Wageningen University & Research; University of Nebraska System; University of Nebraska Lincoln; Johns Hopkins University	McKnite, AM (corresponding author), Univ Nebraska, Dept Anim Sci, Lincoln, NE 68583 USA.	dciobanu2@unl.edu	Bastiaansen, John WM/A-5733-2010; Auwerx, Johan/ABE-9307-2021; Williams, Evan/M-7539-2017; Williams, Robert W./H-8789-2016	Bastiaansen, John WM/0000-0002-6562-176X; Williams, Evan/0000-0002-9746-376X; Benson, Andrew/0000-0001-6330-0252; Williams, Robert W./0000-0001-8924-4447; Kachman, Stephen/0000-0003-0506-513X; Auwerx, Johan/0000-0002-5065-5393; McKnite, Autumn/0000-0001-7985-2991; Brewer, Simon/0000-0002-6810-1911	Office of Research of the University of Nebraska-Lincoln; Nebraska Tobacco Settlement Biomedical Research Development Funds; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; European Research Council Ideas Programme [ERC-2008-AdG23118]; NIAAA [U01AA013499, U01AA014425, P20-DA 21131]; NIDA; UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA014425, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	Office of Research of the University of Nebraska-Lincoln; Nebraska Tobacco Settlement Biomedical Research Development Funds; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council Ideas Programme; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a Layman Award from the Office of Research of the University of Nebraska-Lincoln, the Nebraska Tobacco Settlement Biomedical Research Development Funds, the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, the European Research Council Ideas Programme (Sirtuins; ERC-2008-AdG23118), NIAAA (U01AA013499, U01AA014425), NIDA and NIAAA (P20-DA 21131), and the UT Center for Integrative and Translational Genomics. The Nebraska Tobacco Settlement Biomedical. Research Development Funds is not a profit making body and there are no commercial connections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Barbosa T, 2010, WIRES SYST BIOL MED, V2, P80, DOI 10.1002/wsbm.48; Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bird AR, 2000, J NUTR, V130, P1780, DOI 10.1093/jn/130.7.1780; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2007, LETT APPL MICROBIOL, V44, P343, DOI 10.1111/j.1472-765X.2007.02129.x; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gatti D, 2007, HEPATOLOGY, V46, P548, DOI 10.1002/hep.21682; Geisert EE, 2009, MOL VIS, V15, P1730; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; LANDER ES, 1989, GENETICS, V121, P185; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Macfarlane GT, 1997, CARBOHYDRATE FERMENT; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Malis C, 2005, OBES RES, V13, P2139, DOI 10.1038/oby.2005.265; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Meijerink E, 2000, IMMUNOGENETICS, V52, P129, DOI 10.1007/s002510000263; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Niu X, 2011, ANIMAL GENETICS; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; PLANCHON SM, 1994, J IMMUNOL, V153, P5730; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rosen GD, 2009, GENES BRAIN BEHAV, V8, P296, DOI 10.1111/j.1601-183X.2009.00473.x; Scarpellini E, 2010, INTERN EMERG MED, V5, pS53, DOI 10.1007/s11739-010-0450-1; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Stylianou IM, 2006, MAMM GENOME, V17, P22, DOI 10.1007/s00335-005-0091-2; Suhir H, 2010, CLIN REV ALLERG IMMU, V38, P11, DOI 10.1007/s12016-009-8135-0; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tortoriello DV, 2004, ENDOCRINOLOGY, V145, P1238, DOI 10.1210/en.2003-1406; Tsang SL, 2007, CYTOKINE, V37, P138, DOI 10.1016/j.cyto.2007.03.002; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VERNAY M, 1987, BRIT J NUTR, V57, P371, DOI 10.1079/BJN19870045; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Williams RW, 2001, GENOME BIOL, V2; WOLEVER TMS, 1989, AM J GASTROENTEROL, V84, P1027; Yang H, 2011, NAT GENET; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006	71	149	156	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39191	10.1371/journal.pone.0039191	http://dx.doi.org/10.1371/journal.pone.0039191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723961	Green Published, gold			2022-12-25	WOS:000305583300114
J	Pante, E; France, SC; Couloux, A; Cruaud, C; McFadden, CS; Samadi, S; Watling, L				Pante, Eric; France, Scott C.; Couloux, Arnaud; Cruaud, Corinne; McFadden, Catherine S.; Samadi, Sarah; Watling, Les			Deep-Sea Origin and In-Situ Diversification of Chrysogorgiid Octocorals	PLOS ONE			English	Article							RIBOSOMAL-RNA; MITOCHONDRIAL GENOME; PHENOTYPIC PLASTICITY; PHYLOGENETIC ANALYSES; DNA-SEQUENCES; ANTHOZOA; CNIDARIA; CORALS; GENUS; ALIGNMENT	The diversity, ubiquity and prevalence in deep waters of the octocoral family Chrysogorgiidae Verrill, 1883 make it noteworthy as a model system to study radiation and diversification in the deep sea. Here we provide the first comprehensive phylogenetic analysis of the Chrysogorgiidae, and compare phylogeny and depth distribution. Phylogenetic relationships among 10 of 14 currently-described Chrysogorgiidae genera were inferred based on mitochondrial (mtMutS, cox1) and nuclear (18S) markers. Bathymetric distribution was estimated from multiple sources, including museum records, a literature review, and our own sampling records (985 stations, 2345 specimens). Genetic analyses suggest that the Chrysogorgiidae as currently described is a polyphyletic family. Shallow-water genera, and two of eight deep-water genera, appear more closely related to other octocoral families than to the remainder of the monophyletic, deep-water chrysogorgiid genera. Monophyletic chrysogorgiids are composed of strictly (Iridogorgia Verrill, 1883, Metallogorgia Versluys, 1902, Radicipes Stearns, 1883, Pseudochrysogorgia Pante & France, 2010) and predominantly (Chrysogorgia Duchassaing & Michelotti, 1864) deep-sea genera that diversified in situ. This group is sister to gold corals (Primnoidae Milne Edwards, 1857) and deep-sea bamboo corals (Keratoisidinae Gray, 1870), whose diversity also peaks in the deep sea. Nine species of Chrysogorgia that were described from depths shallower than 200 m, and mtMutS haplotypes sequenced from specimens sampled as shallow as 101 m, suggest a shallow-water emergence of some Chrysogorgia species.	[Pante, Eric; France, Scott C.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Couloux, Arnaud; Cruaud, Corinne] Ctr Natl Sequencage, GENOSCOPE, Evry, France; [McFadden, Catherine S.] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA; [Samadi, Sarah] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR UPMC IRD MNHN CNRS UR IRD 148 7138, F-75231 Paris, France; [Watling, Les] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Watling, Les] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	University of Louisiana Lafayette; Claremont Colleges; Harvey Mudd College; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Hawaii System; University of Hawaii Manoa; University of Maine System; University of Maine Orono	Pante, E (corresponding author), Univ La Rochelle, CNRS, UMR 7266, La Rochelle, France.	pante.eric@gmail.com	Pante, Eric/C-4230-2011; samadi, sarah/G-5011-2010	Pante, Eric/0000-0001-7680-2112; samadi, sarah/0000-0003-0725-9368; France, Scott/0000-0002-2114-5968; Couloux, Arnaud/0000-0003-2356-0062; Cruaud, Corinne/0000-0002-4752-7278	National Science Foundation (NSF) [OCE-0624601, EF-0531570, EF-0531779]; National Oceanic and Atmospheric Administration (NOAA)/National Marine Fisheries Service Auke Bay Laboratory [NFFS7400-5-00022]; NOAA [NA05OAR4301001, NA66RU0186]; NOAA-OER [NA05OAR4601061, NA03OAR4600116, NA08OAR4600756]; French National Agency for Research (ANR); Sigma Xi [GIAR G20061021830514629]; American Museum of Natural History; University of Louisiana at Lafayette Graduate Student Organization; New Zealand Foundation for Research, Science and Technology; New Zealand Ministry of Fisheries; Australian National Oceans Office; NOAA-OE; Woods Hole Oceanographic Institution; Scripps Institution of Oceanography; University of Hawaii; Consortium National de Recherche en Genomique; Service de Systematique Moleculaire; Museum national d'Histoire naturelle (MNHN) (CNRS) [UMS 2700]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Oceanic and Atmospheric Administration (NOAA)/National Marine Fisheries Service Auke Bay Laboratory; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA-OER; French National Agency for Research (ANR)(French National Research Agency (ANR)); Sigma Xi; American Museum of Natural History; University of Louisiana at Lafayette Graduate Student Organization; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Ministry of Fisheries; Australian National Oceans Office; NOAA-OE; Woods Hole Oceanographic Institution; Scripps Institution of Oceanography(University of California System); University of Hawaii; Consortium National de Recherche en Genomique(General Electric); Service de Systematique Moleculaire; Museum national d'Histoire naturelle (MNHN) (CNRS)	Support for this research was provided by funding to SCF from National Science Foundation's (NSF) Ocean Sciences Division-Biological Oceanography Program (OCE-0624601; http://www.nsf.gov/funding/pgm_ summ.jsp?pims_ id = 11696), National Oceanic and Atmospheric Administration (NOAA)/National Marine Fisheries Service Auke Bay Laboratory (NFFS7400-5-00022; http://www.afsc.noaa.gov/abl/), NOAA's National Undersea Research Program (NA05OAR4301001, NA66RU0186), NOAA-OER (NA05OAR4601061, NA03OAR4600116, NA08OAR4600756; http://explore.noaa.gov/), and NSF's "Assembling the Cnidarian Tree of Life" (sub-contract on EF-0531570 to CSM and EF-0531779 to Paulyn Cartwright; http://www.nsf.gov/funding/pgm_ summ.jsp?pims_ id = 5129& org = DEB& from = home); to Philippe Grandcolas from the French National Agency for Research (ANR Bioneocal; http://www.agence-nationalerecherche.fr/); to EGP from Sigma Xi (GIAR G20061021830514629; http://www.sigmaxi.org/programs/giar/), the American Museum of Natural History (Lerner Gray Fund; http://rggs.amnh.org/pages/academics_ and_ research/fellowship_ and_ grant_ opportunities), and the University of Louisiana at Lafayette Graduate Student Organization. Specimens from New Zealand were provided by the National Institute of Water and Atmospheric (NIWA) Research Invertebrate Collection, and were collected during voyages undertaken by the NIWA (www.niwa.co.nz) with funding from the New Zealand Foundation for Research, Science and Technology (www.msi.govt.nz), with additional funding from the New Zealand Ministry of Fisheries (www.fish.govt.nz) and the Australian National Oceans Office (voyage TAN0308), as well as NOAA-OE (http://explore.noaa.gov/), Woods Hole Oceanographic Institution (www.whoi.edu), Scripps Institution of Oceanography (sio.ucsd.edu), and the University of Hawaii (www.hawaii.edu) (voyage RENEWZ I-NEW ZEEPS). This work was supported by the "Consortium National de Recherche en Genomique," and the "Service de Systematique Moleculaire" of the Museum national d'Histoire naturelle (MNHN) (CNRS UMS 2700; http://www.genoscope.cns.fr/spip/). It is part of the agreement n. 2005/67 between the Genoscope and the MNHN on the project "Macrophylogeny of life" directed by Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Aurivillius M, 1931, KUNGLIGA SVENSKA VET, V9, P1; BAYER F M, 1979, Proceedings of the Biological Society of Washington, V92, P876; Bayer F. M., 1956, P166; BAYER F M, 1974, Micronesica, V10, P257; BAYER FM, 1988, P BIOL SOC WASH, V101, P257; Bayer Frederick M., 1994, Senckenbergiana Biologica, V74, P21; BAYER FREDERICK M., 1955, PROC U S NATL MUS, V105, P207; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Berntson EA, 2001, MAR BIOL, V138, P235, DOI 10.1007/s002270000457; Bilewitch JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-228; BOUCHET P, 2008, TROPICAL DEEP SEA BE, V0025, P00009; Brugler MR, 2008, J MOL EVOL, V67, P125, DOI 10.1007/s00239-008-9116-2; Cairns SD, 2002, P BIOL SOC WASH, V115, P217; Cairns SD, 2001, P BIOL SOC WASH, V114, P746; Cairns Stephen D., 2009, Smithsonian Contributions to Zoology, P1; Cairns Stephen D., 2007, Proceedings of the California Academy of Sciences, V58, P511; Calderon I, 2006, J EXP MAR BIOL ECOL, V336, P184, DOI 10.1016/j.jembe.2006.05.006; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Concepcion GT, 2008, CORAL REEFS, V27, P323, DOI 10.1007/s00338-007-0323-x; de Pourtales LF, 1868, B MUS COMP ZOOL HARV, V1, P121; DEICHMANN ELISABETH, 1936, MEM MUS COMP ZOOL, V53, P1; Duenas LF, 2009, MAR ECOL PROG SER, V397, P11, DOI 10.3354/meps08307; Fabricius K, 2001, SOFT CORALS SEA FANS; France SC, 2002, HYDROBIOLOGIA, V471, P149, DOI 10.1023/A:1016517724749; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; France SC, 2007, B MAR SCI, V81, P323; France Scott C., 2001, Bulletin of the Biological Society of Washington, P110; Grasshoff M, 1995, P 6 INT C COEL BIOL, P195; Grasshoff M, 1985, PEUPLEMENTS PROFONDS, P299; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heifetz J, 2005, FISH OCEANOGR, V14, P131, DOI 10.1111/j.1365-2419.2005.00371.x; Herrera S, 2010, MOL PHYLOGENET EVOL, V55, P123, DOI 10.1016/j.ympev.2009.12.007; HESSLER RR, 1975, MAR BIOL, V32, P155, DOI 10.1007/BF00388508; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KUSSAKIN OG, 1973, MAR BIOL, V23, P19, DOI 10.1007/BF00394108; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Madsen F. J., 1944, Danish Ingolf-Expedition, V5, P1; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; McFadden CS, 2004, MAR BIOTECHNOL, V6, P516, DOI 10.1007/s10126-002-0102-1; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; Miller M, 2011, 20090804 CIPRES; Nutting C, 1910, SIBOGA EXPEDITIE MON; Nutting C C., 1912, P US NATL MUS, V43, P1, DOI DOI 10.5479/SI.00963801.43-1923.1; Nutting Charles C., 1908, Proceedings of the United States National Museum Smithsonian Institution Washington, V34; Pante E, 2011, J MARINE BIOL ASS UK; Pante E, 2010, ZOOSYSTEMA, V32, P595, DOI 10.5252/z2010n4a4; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasternak F.A., 1981, P40; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; R Development Core Team, 2012, R LANG ENV STAT COMP; Sanchez JA, 2003, MOL PHYLOGENET EVOL, V29, P31, DOI 10.1016/S1055-7903(03)00090-3; Sanchez JA, 2003, MAR BIOL, V142, P975, DOI 10.1007/s00227-003-1018-7; Sanchez JA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-122; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Stone RP, 2006, CORAL REEFS, V25, P229, DOI 10.1007/s00338-006-0091-z; Strychar KB, 2005, ERLANGEN EARTH C SER, P679, DOI 10.1007/3-540-27673-4_34; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; Thomson JA, 1906, ACCOUNT ALCYONARIA 1; Verrill A, 1883, B MUSEUM COMP ZOOLOG, V11; Versluys J., 1902, MONOGRAPHIE SIBOGA E, V1; Wating L, 2011, ADV MAR BIOL, V60, P41, DOI 10.1016/B978-0-12-385529-9.00002-0; Watling L, 2007, J MAR BIOL ASSOC UK, V87, P393, DOI 10.1017/S002531540705535X; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; West JM, 1997, BIOL BULL, V192, P279, DOI 10.2307/1542721; WEST JM, 1993, MAR ECOL PROG SER, V94, P61, DOI 10.3354/meps094061; Wright E. P., 1889, Report of the Scientific Results Voyage HMS 'Challenger' Zool, Vxxxi, pUnpaginated; Young CM, 1997, MAR ECOL PROG SER, V154, P197, DOI 10.3354/meps154197	75	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38357	10.1371/journal.pone.0038357	http://dx.doi.org/10.1371/journal.pone.0038357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723855	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300025
J	Vogel, V; Falquet, L; Calderon-Copete, SP; Basset, P; Blanc, DS				Vogel, Valerie; Falquet, Laurent; Calderon-Copete, Sandra P.; Basset, Patrick; Blanc, Dominique S.			Short Term Evolution of a Highly Transmissible Methicillin-Resistant Staphylococcus aureus Clone (ST228) in a Tertiary Care Hospital	PLOS ONE			English	Article							GEOGRAPHIC AREA; SEQUENCE; VIRULENCE; ALIGNMENT; INSIGHTS; STRAINS; MRSA; EPIDEMIOLOGY; ALGORITHM; GENOMICS	Staphylococcus aureus is recognized as one of the major human pathogens and is by far one of the most common nosocomial organisms. The genetic basis for the emergence of highly epidemic strains remains mysterious. Studying the microevolution of the different clones of S. aureus is essential for identifying the forces driving pathogen emergence and spread. The aim of the present study was to determine the genetic changes characterizing a lineage belonging to the South German clone (ST228) that spread over ten years in a tertiary care hospital in Switzerland. For this reason, we compared the whole genome of eight isolates recovered between 2001 and 2008 at the Lausanne hospital. The genetic comparison of these isolates revealed that their genomes are extremely closely related. Yet, a few more important genetic changes, such as the replacement of a plasmid, the loss of large fragments of DNA, or the insertion of transposases, were observed. These transfers of mobile genetic elements shaped the evolution of the ST228 lineage that spread within the Lausanne hospital. Nevertheless, although the strains analyzed differed in their dynamics, we have not been able to link a particular genetic element with spreading success. Finally, the present study showed that new sequencing technologies improve considerably the quality and quantity of information obtained for a single strain; but this information is still difficult to interpret and important investments are required for the technology to become accessible for routine investigations.	[Vogel, Valerie; Basset, Patrick; Blanc, Dominique S.] Univ Lausanne Hosp, Serv Hosp Prevent Med, Lausanne, Switzerland; [Falquet, Laurent; Calderon-Copete, Sandra P.; Basset, Patrick] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics	Vogel, V (corresponding author), Univ Lausanne Hosp, Serv Hosp Prevent Med, Lausanne, Switzerland.	valerie.vogel@gmail.com	Basset, Patrick/C-6232-2013; Falquet, Laurent/C-2541-2013	Basset, Patrick/0000-0002-2924-4821; Falquet, Laurent/0000-0001-8102-7579; Blanc, Dominique/0000-0002-0324-8437	Swiss National Foundation for Research [3100A0-113346]	Swiss National Foundation for Research(Swiss National Science Foundation (SNSF))	This work was supported by a grant # 3100A0-113346 of the Swiss National Foundation for Research. The SIB Swiss Institute of Bioinformatics is an independent non-profit foundation recognised of public utility. More details on the SIB are available at http://www.isb-sib.ch/aboutsib/organisation.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Aziz RK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000713; Backman C, 2011, AM J INFECT CONTROL, V39, P368, DOI 10.1016/j.ajic.2010.07.017; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Blanc DS, 2007, J CLIN MICROBIOL, V45, P3729, DOI 10.1128/JCM.00511-07; Blanc DS, 1999, CLIN INFECT DIS, V29, P1512, DOI 10.1086/313522; Blanc DS, 2001, J CLIN MICROBIOL, V39, P2287, DOI 10.1128/JCM.39.6.2287-2290.2001; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Calderon-Copete SP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S7; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson RW, 2011, TRENDS GENET, V27, P32, DOI 10.1016/j.tig.2010.10.001; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kuhn G, 2007, J CLIN MICROBIOL, V45, P54, DOI 10.1128/JCM.01457-06; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazarevic V, 2011, FUTURE MICROBIOL, V6, P513, DOI [10.2217/FMB.11.38, 10.2217/fmb.11.38]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Massouras A, 2010, NAT METHODS, V7, P485, DOI [10.1038/nmeth.f.308, 10.1038/NMETH.f.308]; Mato R, 2004, MICROB DRUG RESIST, V10, P106, DOI 10.1089/1076629041310109; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Wannet WJB, 2004, J CLIN MICROBIOL, V42, P3077, DOI 10.1128/JCM.42.7.3077-3082.2004; Willems RJL, 2011, FEMS MICROBIOL REV, V35, P872, DOI 10.1111/j.1574-6976.2011.00284.x; Witte Wolfgang, 1997, Clin Microbiol Infect, V3, P414, DOI 10.1111/j.1469-0691.1997.tb00277.x; Woodford N, 2005, CLIN MICROBIOL INFEC, V11, P2, DOI 10.1111/j.1469-0691.2005.01140.x	51	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38969	10.1371/journal.pone.0038969	http://dx.doi.org/10.1371/journal.pone.0038969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22720005	gold, Green Submitted, Green Published			2022-12-25	WOS:000305583300072
J	Qi, YL; Operario, DJ; Georas, SN; Mosmann, TR				Qi, Yilin; Operario, Darwin J.; Georas, Steve N.; Mosmann, Tim R.			The Acute Environment, Rather than T Cell Subset Pre-Commitment, Regulates Expression of the Human T Cell Cytokine Amphiregulin	PLOS ONE			English	Article							GAMMA-SECRETING CELLS; GROWTH-FACTOR-BETA; HUMAN MAST-CELLS; IFN-GAMMA; GENE-EXPRESSION; CHEMOKINE RECEPTORS; PROSTAGLANDIN E-2; EPITHELIAL-CELLS; DISTINCT ROLES; HELPER TYPE-1	Cytokine expression patterns of T cells can be regulated by pre-commitment to stable effector phenotypes, further modification of moderately stable phenotypes, and quantitative changes in cytokine production in response to acute signals. We showed previously that the epidermal growth factor family member Amphiregulin is expressed by T cell receptor-activated mouse CD4 T cells, particularly Th2 cells, and helps eliminate helminth infection. Here we report a detailed analysis of the regulation of Amphiregulin expression by human T cell subsets. Signaling through the T cell receptor induced Amphiregulin expression by most or all T cell subsets in human peripheral blood, including naive and memory CD4 and CD8 T cells, Th1 and Th2 in vitro T cell lines, and subsets of memory CD4 T cells expressing several different chemokine receptors and cytokines. In these different T cell types, Amphiregulin synthesis was inhibited by an antagonist of protein kinase A, a downstream component of the cAMP signaling pathway, and enhanced by ligands that increased cAMP or directly activated protein kinase A. Prostaglandin E2 and adenosine, natural ligands that stimulate adenylyl cyclase activity, also enhanced Amphiregulin synthesis while reducing synthesis of most other cytokines. Thus, in contrast to mouse T cells, Amphiregulin synthesis by human T cells is regulated more by acute signals than pre-commitment of T cells to a particular cytokine pattern. This may be appropriate for a cytokine more involved in repair than attack functions during most inflammatory responses.	[Qi, Yilin; Operario, Darwin J.; Mosmann, Tim R.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Georas, Steve N.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Qi, YL (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu			NIH [AI054953]; American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI054953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH AI054953 and American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2004, J IMMUNOL, V173, P4847, DOI 10.4049/jimmunol.173.8.4847; Alam MS, 2009, MUCOSAL IMMUNOL, V2, P232, DOI 10.1038/mi.2009.4; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Berquin IM, 2001, ONCOGENE, V20, P4019, DOI 10.1038/sj.onc.1204537; BETZ M, 1991, J IMMUNOL, V146, P108; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Borger P, 1998, J ALLERGY CLIN IMMUN, V101, P231, DOI 10.1016/S0091-6749(98)70388-4; Borger P, 1996, BLOOD, V87, P691, DOI 10.1182/blood.V87.2.691.bloodjournal872691; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; Johansson CC, 2004, AIDS, V18, P171, DOI 10.1097/00002030-200401230-00005; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; LEDBETTER JA, 1986, J IMMUNOL, V137, P3299; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Matsumoto K, 2009, INT ARCH ALLERGY IMM, V149, P39, DOI 10.1159/000210652; MINAKUCHI R, 1990, J IMMUNOL, V145, P2616; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okano M, 2006, IMMUNOLOGY, V118, P343, DOI 10.1111/j.1365-2567.2006.02376.x; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; PALIOGIANNI F, 1993, J EXP MED, V178, P1813, DOI 10.1084/jem.178.5.1813; Qi Y, 2010, J ALLERGY CLIN IMMUN; Quast S, 2005, CELL IMMUNOL, V237, P28, DOI 10.1016/j.cellimm.2005.09.002; Riese DJ, 1996, J BIOL CHEM, V271, P20047, DOI 10.1074/jbc.271.33.20047; SAD S, 1994, J IMMUNOL, V153, P3514; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; WALKER C, 1983, J IMMUNOL, V130, P1770; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	50	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39072	10.1371/journal.pone.0039072	http://dx.doi.org/10.1371/journal.pone.0039072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720031	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347800041
J	Akhtar, S; Yousif, MHM; Chandrasekhar, B; Benter, IF				Akhtar, Saghir; Yousif, Mariam H. M.; Chandrasekhar, Bindu; Benter, Ibrahim F.			Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; CARDIAC DEVELOPMENT; VENTRICULAR MYOCYTES; VASCULAR DYSFUNCTION; NEUREGULIN RECEPTOR; PROTEIN-KINASE; MESSENGER-RNA; HUMAN CANCER	This study characterized the effects of diabetes and/or ischemia on epidermal growth factor receptor, EGFR, and/or erbB2 signaling pathways on cardiac function. Isolated heart perfusion model of global ischemia was used to study the effect of chronic inhibition or acute activation of EGFR/erbB2 signaling on cardiac function in a rat model of type-1 diabetes. Induction of diabetes with streptozotocin impaired recovery of cardiac function (cardiac contractility and hemodynamics) following 40 minutes of global ischemia in isolated hearts. Chronic treatment with AG825 or AG1478, selective inhibitors of erbB2 and EGFR respectively, did not affect hyperglycemia but led to an exacerbation whereas acute administration of the EGFR ligand, epidermal growth factor (EGF), led to an improvement in cardiac recovery in diabetic hearts. Diabetes led to attenuated dimerization and phosphorylation of cardiac erbB2 and EGFR receptors that was associated with reduced signaling via extracellular-signal-regulated kinase 1/2 (ERK1/2), p38 mitogen activated protein (MAP) kinase and AKT (protein kinase B). Ischemia was also associated with reduced cardiac signaling via these molecules whereas EGF-treatment opposed diabetes and/or ischemia induced changes in ERK1/2, p38 MAP kinase, and AKT-FOXO signaling. Losartan treatment improved cardiac function in diabetes but also impaired EGFR phosphorylation in diabetic heart. Co-administration of EGF rescued Losartan-mediated reduction in EGFR phosphorylation and significantly improved cardiac recovery more than with either agent alone. EGFR/erbB2 signaling is an important cardiac survival pathway whose activation, particularly in diabetes, ischemia or following treatment with drugs that inhibit this cascade, significantly improves cardiac function. These findings may have clinical relevance particularly in the treatment of diabetes-induced cardiac dysfunction.	[Akhtar, Saghir; Yousif, Mariam H. M.; Chandrasekhar, Bindu; Benter, Ibrahim F.] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Kuwait, Kuwait	Kuwait University	Akhtar, S (corresponding author), Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Kuwait, Kuwait.	Saghir@hsc.edu.kw	Benter, Ibrahim Fadil/AAY-2527-2020	Yousif, Mariam/0000-0002-6464-031X; Akhtar, Saghir/0000-0003-3177-946X	Kuwait University [MR02/09]	Kuwait University	This research was funded by a Kuwait University grant (MR02/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2012, BRIT J PHARMACOL, V165, P1390, DOI 10.1111/j.1476-5381.2011.01613.x; Barrick CJ, 2008, TOXICOL APPL PHARM, V228, P315, DOI 10.1016/j.taap.2007.12.012; Benter IF, 2007, AM J PHYSIOL-HEART C, V292, pH666, DOI 10.1152/ajpheart.00372.2006; Benter IF, 2009, VASC PHARMACOL, V51, P236, DOI 10.1016/j.vph.2009.06.008; Benter IF, 2005, MOL CELL BIOCHEM, V268, P175, DOI 10.1007/s11010-005-3895-1; Benter IF, 2005, J VASC RES, V42, P284, DOI 10.1159/000085904; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Coulson JM, 1996, MOL PHARMACOL, V50, P314; De Keulenaer GW, 2010, CIRC RES, V106, P35, DOI 10.1161/CIRCRESAHA.109.205906; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Ewer MS, 1999, SEMIN ONCOL, V26, P96; Fisman EZ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-38; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gordon LI, 2009, J BIOL CHEM, V284, P2080, DOI 10.1074/jbc.M804570200; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lorita J, 2009, GROWTH FACTORS, V27, P203, DOI 10.1080/08977190902913731; McKeage K, 2002, DRUGS, V62, P209, DOI 10.2165/00003495-200262010-00008; Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1; Pareja M, 2003, AM J PHYSIOL-REG I, V285, pR455, DOI 10.1152/ajpregu.00588.2002; Patel R, 2012, CURR PHARM IN PRESS; Petch AK, 2003, BIOCHEM PHARMACOL, V66, P819, DOI 10.1016/S0006-2952(03)00407-6; Portbury AL, 2012, J MOL CELL CARDIOL, V52, P526, DOI 10.1016/j.yjmcc.2011.10.023; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Sanchez-Soria P, 2010, SEMIN CELL DEV BIOL, V21, P929, DOI 10.1016/j.semcdb.2010.09.011; Sawyer DB, 2011, J MOL CELL CARDIOL, V51, P501, DOI 10.1016/j.yjmcc.2011.06.016; Schneider JW, 2001, SEMIN ONCOL, V28, P18, DOI 10.1053/sonc.2001.28546; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Spector NL, 2007, P NATL ACAD SCI USA, V104, P10607, DOI 10.1073/pnas.0701286104; Srinivasan R, 1998, J PATHOL, V185, P236, DOI 10.1002/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Uray IP, 2002, J HEART LUNG TRANSPL, V21, P771, DOI 10.1016/S1053-2498(02)00390-X; Watanabe K, 2010, CURR CARDIOL REV, V6, P280, DOI 10.2174/157340310793566145; Williams-Pritchard G, 2011, AM J PHYSIOL-HEART C, V300, pH2161, DOI 10.1152/ajpheart.00639.2010; Zhao YY, 1999, CIRC RES, V84, P1380; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	40	56	57	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39066	10.1371/journal.pone.0039066	http://dx.doi.org/10.1371/journal.pone.0039066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720029	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900078
J	Li, X; Jadlowiec, C; Guo, YY; Protack, CD; Ziegler, KR; Lv, W; Yang, CZ; Shu, C; Dardik, A				Li, Xin; Jadlowiec, Caroline; Guo, Yuanyuan; Protack, Clinton D.; Ziegler, Kenneth R.; Lv, Wei; Yang, Chenzi; Shu, Chang; Dardik, Alan			Pericardial Patch Angioplasty Heals via an Ephrin-B2 and CD34 Positive Cell Mediated Mechanism	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; VEIN GRAFT ADAPTATION; CAROTID-ENDARTERECTOMY; ANGIOGENESIS; RESTENOSIS; RECEPTORS; IDENTITY; LIGANDS; LIMB	Objective: Pericardial patches are commonly used in vascular surgery to close arteriotomies. The mechanism of early healing after patch implantation is still not well defined. We used a rat aortic patch model to assess pericardial patch healing and examined Ephrin-B2, a marker of arterial identity, expression within the post-implantation patch. We also determined whether endothelial progenitor cells (EPC) are associated with early patch healing in the arterial environment. Methods: Wistar rats (200-250 grams) underwent infrarenal aortic arteriotomy and then closure via bovine or porcine pericardial patch angioplasty. Control groups included subcutaneously implanted patches. Patches were harvested at 0-30 days and analyzed by histology, immunohistochemistry, immunofluorescence and Western blot as well as quantitative PCR. Results: Prior to implantation, pericardial patches are largely composed of collagen and are acellular. Following arterial implantation, increasing numbers of CD68-positive cells as well as Ephrin-B2 and CD34 dual-positive cells are found within both bovine and porcine pericardial patches, whereas the infiltrating cells are negative for vWF and a-actin. Porcine patches have a luminal monolayer of cells at day 7, compared to bovine patches that have fewer luminal cells. Subcutaneously implanted patches do not attract Ephrin-B2/CD34-positive cells. By day 30, both bovine and porcine pericardial patches develop a neointima that contains Ephrin-B2, CD34, and VEGFR2-positive cells. Conclusion: Both CD68-positive and Ephrin-B2 and CD34 dual-positive cells infiltrate the pericardial patch early after implantation. Arteriotomy closure via pericardial patch angioplasty shows patch adaptation to the arterial environment that may involve a foreign body response as well as localization of EPC. Arterial remodeling of pericardial patches support endothelialization and may represent a paradigm of healing of scaffolds used for tissue engineering.	[Li, Xin; Jadlowiec, Caroline; Guo, Yuanyuan; Protack, Clinton D.; Ziegler, Kenneth R.; Lv, Wei; Yang, Chenzi; Dardik, Alan] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Li, Xin; Jadlowiec, Caroline; Guo, Yuanyuan; Protack, Clinton D.; Ziegler, Kenneth R.; Lv, Wei; Yang, Chenzi; Dardik, Alan] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT USA; [Li, Xin; Guo, Yuanyuan; Yang, Chenzi; Shu, Chang] Cent S Univ, Xiangya Hosp 2, Dept Vasc Surg, Changsha, Hunan, Peoples R China; [Lv, Wei] Shandong Univ, Sch Med, Dept Vasc Surg, Jinan 250100, Shandong, Peoples R China; [Dardik, Alan] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA	Yale University; Yale University; Central South University; Shandong University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Li, X (corresponding author), Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA.	alan.dardik@yale.edu	Ziegler, Kenneth/Z-1197-2019	Dardik, Alan/0000-0001-5022-7367; Ziegler, Kenneth/0000-0003-4568-8817	National Institute of Health [R01-HL095498-01]; American Vascular Association William J. von Liebig Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095498] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Vascular Association William J. von Liebig Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health (R01-HL095498-01 to AD); the American Vascular Association William J. von Liebig Award; as well as with the resources and the use of facilities at the Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bond R, 2004, J VASC SURG, V40, P1126, DOI 10.1016/j.jvs.2004.08.048; Bond R, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000160.PUB2; Braun J, 2011, ARTERIOSCL THROM VAS, V31, P297, DOI 10.1161/ATVBAHA.110.217646; Burt RK, BONE MARROW TRANSPLA, V45, P111; Dardik A, 2011, REGENERATIVE MEDICINE USING PREGNANCY-SPECIFIC BIOLOGICAL SUBSTANCES, P189, DOI 10.1007/978-1-84882-718-9_19; DARDIK H, 1988, J VASC SURG, V7, P336, DOI 10.1067/mva.1988.avs0070336; Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Hristov M, 2008, PHARMACOL RES, V58, P148, DOI 10.1016/j.phrs.2008.07.008; Inoue T, 2007, CIRCULATION, V115, P553, DOI 10.1161/CIRCULATIONAHA.106.621714; Kim GE, 2001, CARDIOVASC SURG, V9, P458, DOI 10.1016/S0967-2109(01)00042-4; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kondo Y, 2011, J SURG RES, V171, pE149, DOI 10.1016/j.jss.2011.06.036; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Li X, 2011, ANN VASC SURG; Magri D, 2007, VASCULAR, V15, P384, DOI 10.2310/6670.2007.00058; Matsagas MI, 2006, ANN VASC SURG, V20, P614, DOI 10.1007/s10016-006-9102-3; Muto A, 2011, J EXP MED, V208, P561, DOI 10.1084/jem.20101854; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Muto A, 2009, J VASC SURG, V50, P206, DOI 10.1016/j.jvs.2009.01.062; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; SHORE DF, 1983, J CARDIOVASC SURG, V24, P132; Siddique Aurangzeb, 2010, J Angiogenes Res, V2, P6, DOI 10.1186/2040-2384-2-6; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Umashankar PR, 2011, J BIOMED MATER RES A, V97A, P311, DOI 10.1002/jbm.a.33061; Wei HJ, 2010, CHIN J TRAUMATOL, V13, P316, DOI 10.3760/cma.j.issn.1008-1275.2010.05.013	32	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38844	10.1371/journal.pone.0038844	http://dx.doi.org/10.1371/journal.pone.0038844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719962	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900053
J	Zhang, Z; Zhou, LH; Yang, XW; Wang, YC; Zhang, P; Hou, LH; Hu, XB; Xing, Y; Liu, YF; Li, W; Han, H				Zhang, Zhuo; Zhou, Lanhua; Yang, Xinwei; Wang, Yaochun; Zhang, Ping; Hou, Lihong; Hu, Xinbin; Xing, Ying; Liu, Yufeng; Li, Wei; Han, Hua			Notch-RBP-J-Independent Marginal Zone B Cell Development in IgH Transgenic Mice with V-H Derived from a Natural Polyreactive Antibody	PLOS ONE			English	Article							POSITIVE SELECTION; LYMPHOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; FATE DECISION; IN-VIVO; KAPPA-B; RECEPTOR; MOUSE; BAFF; PROLIFERATION	Both the B cell antigen receptor (BCR) signaling and Notch signaling pathway play important roles in marginal zone (MZ) B cell development; however, if and how these two signaling pathways engage in crosstalk with each other remain unclear. In the present study, IgH transgenic mice (TgV(H)3B4) were crossed with mice with Notch downstream transcription factor RBP-J floxed alleles (RBP-J(f/f)) and Mx-Cre transgene. Subsequently, MZ B cell development was analyzed in 3B4/Cre/RBP-J(f/f) mice that expressed the transgenic 3B4 IgH and exhibited a deficiency in Notch signaling in B cells upon poly (I:C) injection. We observed that MZ B cell numbers were severely reduced, but still detectable in 3B4/Cre/RBP-J(f/f) mice, in contrast to increased numbers of MZ B cells in TgVH3B4 mice and almost no MZ B cells in Cre/RBP-J(f/f) mice. The majority of the MZ B cells in the 3B4/Cre/RBP-J(f/f) mice had the same antigen specificity with that of 3B4 antibody, indicating that a particular BCR specificity might direct MZ B cell development in the absence of Notch signaling. The number of MZ B precursor (MZP) cells was reduced sharply in 3B4/Cre/RBP-J(f/f) mice, and the number of transitional stage 1 and transitional stage 2 cells did not change that much, indicating that the interaction between BCR and Notch signaling likely occurred during the T2-MZP stage. Based on the transgenic mouse model, our data indicate that MZ B cells with certain BCR specificity can develop in a Notch-RBP-J independent manner.	[Zhang, Zhuo; Zhou, Lanhua; Xing, Ying; Liu, Yufeng; Li, Wei; Han, Hua] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Yang, Xinwei; Wang, Yaochun; Zhang, Ping; Hou, Lihong; Hu, Xinbin; Xing, Ying; Li, Wei; Han, Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Zhang, Zhuo] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Peoples R China; [Zhou, Lanhua] Air Force, Inst Aviat Med, Affiliated Hosp, Dept Dermatol, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force General Hospital PLA	Zhang, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China.	liwei1@fmmu.edu.cn; huahan@fmmu.edu.cn	Hu, XB/U-8501-2019		National Natural Science Foundation of China [30771949, 31070793, 30872299, 30972641]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30771949 and 31070793 for W. Li; 30872299 and 30972641 for Y.F. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Artavanis T, 1995, SCIENCE, V268, P225; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; He F, 2009, LEUKEMIA RES, V33, P798, DOI 10.1016/j.leukres.2008.09.016; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Huang Z, 2004, MOL CELL BIOL, V24, P8951, DOI 10.1128/MCB.24.20.8951-8962.2004; Li W, 2007, CELL MICROBIOL, V9, P306, DOI 10.1111/j.1462-5822.2006.00786.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Roark JH, 1998, J IMMUNOL, V160, P3121; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Srivastava B, 2005, SEMIN IMMUNOL, V17, P175, DOI 10.1016/j.smim.2005.02.008; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Su TT, 2004, IMMUNOL REV, V197, P161, DOI 10.1111/j.0105-2896.2004.0102.x; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomas M, 2007, BLOOD, V109, P3342, DOI 10.1182/blood-2006-09-046698; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; Wang HS, 2004, CURR OPIN IMMUNOL, V16, P246, DOI 10.1016/j.coi.2004.01.006; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Xing Y, 2009, MOL IMMUNOL, V46, P1120, DOI 10.1016/j.molimm.2008.10.031	44	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38894	10.1371/journal.pone.0038894	http://dx.doi.org/10.1371/journal.pone.0038894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719978	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900061
J	Jansen, EJR; van Bakel, NHM; Loohuis, NFMO; Hafmans, TGM; Arentsen, T; Coenen, AJM; Scheenen, WJJM; Martens, GJM				Jansen, Eric J. R.; van Bakel, Nick. H. M.; Loohuis, Nikkie F. M. Olde; Hafmans, Theo G. M.; Arentsen, Tim; Coenen, Anthon J. M.; Scheenen, Wim J. J. M.; Martens, Gerard J. M.			Identification of Domains within the V-ATPase Accessory Subunit Ac45 Involved in V-ATPase Transport and Ca2+-dependent Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PRECURSOR PROTEIN APP; SECRETORY PATHWAY; XENOPUS-LAEVIS; MELANOTROPE CELLS; GRANULAR ACIDIFICATION; FURIN; DETERMINANTS; INTERACT; RELEASE	The vacuolar (H+)-ATPase (V-ATPase) is crucial for maintenance of the acidic microenvironment in intracellular organelles, whereas its membrane-bound V-0-sector is involved in Ca2+-dependent membrane fusion. In the secretory pathway, the V-ATPase is regulated by its type I transmembrane and V-0-associated accessory subunit Ac45. To execute its function, the intact-Ac45 protein is proteolytically processed to cleaved-Ac45 thereby releasing its N-terminal domain. Here, we searched for the functional domains within Ac45 by analyzing a set of deletion mutants close to the in vivo situation, namely in transgenic Xenopus intermediate pituitary melanotrope cells. Intact-Ac45 was poorly processed and accumulated in the endoplasmic reticulum of the transgenic melanotrope cells. In contrast, cleaved-Ac45 was efficiently transported through the secretory pathway, caused an accumulation of the V-ATPase at the plasma membrane and reduced dopaminergic inhibition of Ca2+-dependent peptide secretion. Surprisingly, removal of the C-tail from intact-Ac45 caused cellular phenotypes also found for cleaved-Ac45, whereas C-tail removal from cleaved-Ac45 still allowed its transport to the plasma membrane, but abolished V-ATPase recruitment into the secretory pathway and left dopaminergic inhibition of the cells unaffected. We conclude that domains located in the N- and C-terminal portions of the Ac45 protein direct its trafficking, V-ATPase recruitment and Ca2+-dependent-regulated exocytosis.	[Martens, Gerard J. M.] Radboud Univ Nijmegen, Fac Sci, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol,Ctr Neurosci, NL-6525 GA Nijmegen, Netherlands; [Scheenen, Wim J. J. M.] Radboud Univ Nijmegen, Fac Sci, Donders Inst Brain Cognit & Behav, Dept Cellular Anim Physiol, NL-6525 GA Nijmegen, Netherlands; [Martens, Gerard J. M.] Radboud Univ Nijmegen, Fac Sci, NCMLS, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Martens, GJM (corresponding author), Radboud Univ Nijmegen, Fac Sci, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol,Ctr Neurosci, RT 282,Geert Grootepl Zuid 28, NL-6525 GA Nijmegen, Netherlands.	g.martens@ncmls.ru.nl	Martens, Gerard JM/D-1925-2010; van Bakel, Nick/A-3187-2013; Scheenen, Wim/E-3674-2012; Jansen, Eric J.R./A-3158-2013					Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Beggah AT, 1997, ANN NY ACAD SCI, V834, P537, DOI 10.1111/j.1749-6632.1997.tb52311.x; Berghs CAFM, 1997, J HISTOCHEM CYTOCHEM, V45, P1673, DOI 10.1177/002215549704501211; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Collin RWJ, 2006, BRAIN RES, V1087, P41, DOI 10.1016/j.brainres.2006.02.101; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Cuppen E, 1999, J CELL SCI, V112, P3299; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Getlawi F, 1996, NEUROSCI LETT, V219, P13, DOI 10.1016/S0304-3940(96)13151-7; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Holthuis JCM, 1999, EUR J BIOCHEM, V262, P484, DOI 10.1046/j.1432-1327.1999.00396.x; HOLTHUIS JCM, 1995, J CELL SCI, V108, P3295; Jansen EJR, 1998, J CELL SCI, V111, P2999; Jansen EJR, 2012, CURR PROTEIN PEPT SC, V13, P124; Jansen EJR, 2010, MOL BIOL CELL, V21, P3330, DOI 10.1091/mbc.E10-04-0274; Jansen EJR, 2008, BBA-MOL CELL RES, V1783, P2301, DOI 10.1016/j.bbamcr.2008.06.020; Jenks BG, 2003, GEN COMP ENDOCR, V131, P210, DOI 10.1016/S0016-6480(03)00120-5; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kuan YH, 2006, J BIOL CHEM, V281, P40114, DOI 10.1074/jbc.M605407200; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Lieste JR, 1998, J BIOL CHEM, V273, P25686, DOI 10.1074/jbc.273.40.25686; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Mains RE, 1999, J BIOL CHEM, V274, P2929, DOI 10.1074/jbc.274.5.2929; MARTENS GJM, 1986, NUCLEIC ACIDS RES, V14, P3791, DOI 10.1093/nar/14.9.3791; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Qin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027155; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Roubos EW, 1997, COMP BIOCHEM PHYS A, V118, P533, DOI 10.1016/S0300-9629(97)00035-2; SCHEENEN WJJM, 1994, CELL CALCIUM, V15, P36, DOI 10.1016/0143-4160(94)90102-3; Schoonderwoert VTG, 2000, EUR J BIOCHEM, V267, P5646, DOI 10.1046/j.1432-1327.2000.01648.x; Schoonderwoert VTG, 2002, EUR J BIOCHEM, V269, P1844, DOI 10.1046/j.1432-1033.2002.02831.x; SHIBUYA I, 1993, ENDOCRINOLOGY, V132, P2166, DOI 10.1210/en.132.5.2166; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; SUPEK F, 1994, J BIOL CHEM, V269, P24102; Tanaka S, 1997, J HISTOCHEM CYTOCHEM, V45, P425, DOI 10.1177/002215549704500310; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Van Herp F, 2005, J MICROSC-OXFORD, V218, P79, DOI 10.1111/j.1365-2818.2005.01456.x; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Zhang HY, 2005, J NEUROENDOCRINOL, V17, P1, DOI 10.1111/j.1365-2826.2005.01267.x; Zhang W, 2008, J BIOL CHEM, V283, P294, DOI 10.1074/jbc.M708058200	51	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27537	27546		10.1074/jbc.M112.356105	http://dx.doi.org/10.1074/jbc.M112.356105			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736765	Green Published, hybrid			2022-12-25	WOS:000307840700029
J	Derivery, E; Helfer, E; Henriot, V; Gautreau, A				Derivery, Emmanuel; Helfer, Emmanuele; Henriot, Veronique; Gautreau, Alexis			Actin Polymerization Controls the Organization of WASH Domains at the Surface of Endosomes	PLOS ONE			English	Article							DIAPHANOUS-RELATED FORMIN; N-WASP; MEMBRANE-FUSION; ARP2/3 COMPLEX; RAB5; PROTEIN; RECRUITMENT; DYNAMICS; CURVATURE; ACTIVATOR	Sorting of cargoes in endosomes occurs through their selective enrichment into sorting platforms, where transport intermediates are generated. The WASH complex, which directly binds to lipids, activates the Arp2/3 complex and hence actin polymerization onto such sorting platforms. Here, we analyzed the role of actin polymerization in the physiology of endosomal domains containing WASH using quantitative image analysis. Actin depolymerization is known to enlarge endosomes. Using a novel colocalization method that is insensitive to the heterogeneity of size and shape of endosomes, we further show that preventing the generation of branched actin networks induces endosomal accumulation of the WASH complex. Moreover, we found that actin depolymerization induces a dramatic decrease in the recovery of endosomal WASH after photobleaching. This result suggests a built-in turnover, where the actin network, i.e. the product of the WASH complex, contributes to the dynamic exchange of the WASH complex by promoting its detachment from endosomes. Our experiments also provide evidence for a role of actin polymerization in the lateral compartmentalization of endosomes: several WASH domains exist at the surface of enlarged endosomes, however, the WASH domains coalesce upon actin depolymerization or Arp2/3 depletion. Branched actin networks are thus involved in the regulation of the size of WASH domains. The potential role of this regulation in membrane scission are discussed.	[Derivery, Emmanuel; Helfer, Emmanuele; Henriot, Veronique; Gautreau, Alexis] CNRS, UPR3082, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Derivery, E (corresponding author), Univ Sci II, Dept Biochem, Geneva, Switzerland.	alexis.gautreau@lebs.cnrs-gif.fr	Gautreau, Alexis/AAT-2751-2020	Gautreau, Alexis/0000-0002-2369-4362; Helfer, Emmanuele/0000-0001-8123-0964	Agence Nationale pour la Recherche [ANR-08-BLAN-0012-03, ANR-08-PCVI-0010-03, ANR-09-JCJC-0040]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants (ANR-08-BLAN-0012-03, ANR-08-PCVI-0010-03, and ANR-09-JCJC-0040) from Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; CARLIER MF, 1986, J BIOL CHEM, V261, P2041; Carnell M, 2011, J CELL BIOL, V193, P831, DOI 10.1083/jcb.201009119; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Drengk A, 2003, CURR BIOL, V13, P1814, DOI 10.1016/j.cub.2003.09.037; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gautier JJ, 2011, J CELL SCI, V124, P3414, DOI 10.1242/jcs.081083; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Guerin I, 2000, EUR J CELL BIOL, V79, P735, DOI 10.1078/0171-9335-00092; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jahraus A, 2001, MOL BIOL CELL, V12, P155, DOI 10.1091/mbc.12.1.155; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Kjeken R, 2004, MOL BIOL CELL, V15, P345, DOI 10.1091/mbc.e03-05-0334; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Millius A, 2012, J CELL SCI; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Ohashi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019942; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Zech T, 2011, J CELL SCI, V124, P3753, DOI 10.1242/jcs.080986; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	55	44	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39774	10.1371/journal.pone.0039774	http://dx.doi.org/10.1371/journal.pone.0039774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737254	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100053
J	Jansen, T; Kristensen, K; Payne, M; Edwards, M; Schrum, C; Pitois, S				Jansen, Teunis; Kristensen, Kasper; Payne, Mark; Edwards, Martin; Schrum, Corinna; Pitois, Sophie			Long-Term Retrospective Analysis of Mackerel Spawning in the North Sea: A New Time Series and Modeling Approach to CPR Data	PLOS ONE			English	Article							CONTINUOUS PLANKTON RECORDER; SCOMBER-SCOMBRUS L; FISH; LARVAE; TEMPERATURE; CONSISTENCY; ABUNDANCE	We present a unique view of mackerel (Scomber scombrus) in the North Sea based on a new time series of larvae caught by the Continuous Plankton Recorder (CPR) survey from 1948-2005, covering the period both before and after the collapse of the North Sea stock. Hydrographic backtrack modelling suggested that the effect of advection is very limited between spawning and larvae capture in the CPR survey. Using a statistical technique not previously applied to CPR data, we then generated a larval index that accounts for both catchability as well as spatial and temporal autocorrelation. The resulting time series documents the significant decrease of spawning from before 1970 to recent depleted levels. Spatial distributions of the larvae, and thus the spawning area, showed a shift from early to recent decades, suggesting that the central North Sea is no longer as important as the areas further west and south. These results provide a consistent and unique perspective on the dynamics of mackerel in this region and can potentially resolve many of the unresolved questions about this stock.	[Jansen, Teunis; Kristensen, Kasper; Payne, Mark] Tech Univ Denmark DTU AQUA, Natl Inst Aquat Resources Charlottenlund, Charlottenlund, Denmark; [Edwards, Martin] Sir Alister Hardy Fdn Ocean Sci SAHFOS, Plymouth, Devon, England; [Schrum, Corinna] Univ Bergen, Inst Geophys, Bergen, Norway	Technical University of Denmark; University of Bergen	Jansen, T (corresponding author), Tech Univ Denmark DTU AQUA, Natl Inst Aquat Resources Charlottenlund, Charlottenlund, Denmark.	Tej@aqua.dtu.dk	Payne, Mark/C-6844-2008	Payne, Mark/0000-0001-5795-2481; Kristensen, Kasper/0000-0003-3425-3762; Jansen, Teunis/0000-0001-8722-4493	EURO-BASIN [264933]; Department of Environment, Fisheries and Rural Affairs (Defra) [MF1101]; EU-MEECE [212085]; Norwegian Research Council; NERC [SAH01001] Funding Source: UKRI; Natural Environment Research Council [SAH01001] Funding Source: researchfish	EURO-BASIN; Department of Environment, Fisheries and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); EU-MEECE; Norwegian Research Council(Research Council of NorwayEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Research was funded by EURO-BASIN (FP7 #264933) and Department of Environment, Fisheries and Rural Affairs (Defra) who funded the analysis of fish larvae samples from 1979 to 2005 through project MF1101. The long-term ECOSMO model simulation was funded by the projects EU-MEECE (FP7# 212085) and the Norwegian Research Council (MarinEra project ECODRIVE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTSCH J, 1989, NATURE, V340, P632, DOI 10.1038/340632a0; Bartsch J, 2002, FISH OCEANOGR, V11, P310, DOI 10.1046/j.1365-2419.2002.00208.x; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Bazilchuk N, 2010, FRONT ECOL ENVIRON, V8, P397; Cendrowicz L, 2010, TIME MAG        0827, P1; Christensen A, 2008, CAN J FISH AQUAT SCI, V65, P1498, DOI 10.1139/F08-073; Christensen A, 2007, MAR ECOL PROG SER, V347, P221, DOI 10.3354/meps06980; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P123; COOMBS SH, 1981, J MAR BIOL ASSOC UK, V61, P343, DOI 10.1017/S0025315400046993; Dickey-Collas M, 2009, MAR ECOL PROG SER, V390, P183, DOI 10.3354/meps08172; Hamre J., 1978, RAPP P V REUN CONS I, V172, P197; HAYS GC, 1993, J MAR BIOL ASSOC UK, V73, P967, DOI 10.1017/S0025315400034846; Hillgruber N, 2001, HELGOLAND MAR RES, P149; ICES, 2005, 2005ACFM08 ICES CM; ICES, 2008, 2008ACOM13 ICES CM; ICES, 1979, 1979H5 ICES CM; ICES, 2019, ICES SCI REPORTS, V1, DOI 10.17895/ices.pub.4982; ICES, 2008, ICES, P10; Iversen S. A., 1989, 1989H20 ICES CM; Iversen SA, 1983, 1983H46 ICES CM; Jansen T, MIXING METAPOP UNPUB; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Lewy P, 2009, CAN J FISH AQUAT SCI, V66, P1809, DOI 10.1139/F09-114; Lockwood SJ, 1988, MACKEREL ITS BIOL AS; Mendiola D, 2006, FISH RES, V80, P158, DOI 10.1016/j.fishres.2006.05.004; POSTUMA KH, 1972, J CONSEIL, V34, P455; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; ROPKE A, 1989, MEERESFORSCHUNG, V32, P192; Schrum C, 1999, TELLUS A, V51, P526, DOI 10.1034/j.1600-0870.1992.00006.x; Schrum C, 2003, ICES MAR SCI S, V219, P121; Schrum C, 2006, J MARINE SYST, V61, P79, DOI 10.1016/j.jmarsys.2006.01.005; Skogen M, 1998, FISKEN HAVET, V18, P1; SKOGEN MD, 1995, ESTUAR COAST SHELF S, V41, P545, DOI 10.1016/0272-7714(95)90026-8; Trenkel VM, 2012, PROG OCEANO IN PRESS; [No title captured]	35	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38758	10.1371/journal.pone.0038758	http://dx.doi.org/10.1371/journal.pone.0038758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737221	Green Published, gold, Green Accepted			2022-12-25	WOS:000305695100019
J	Bond, JE; Hendrixson, BE; Hamilton, CA; Hedin, M				Bond, Jason E.; Hendrixson, Brent E.; Hamilton, Chris A.; Hedin, Marshal			A Reconsideration of the Classification of the Spider Infraorder Mygalomorphae (Arachnida: Araneae) Based on Three Nuclear Genes and Morphology	PLOS ONE			English	Article							TRAPDOOR SPIDERS; PHYLOGENY; ANTRODIAETIDAE; INFERENCE; BIOGEOGRAPHY; SYSTEMATICS; DIVERGENCE; EVOLUTION; EFFICACY; PROGRAM	Background: The infraorder Mygalomorphae (i.e., trapdoor spiders, tarantulas, funnel web spiders, etc.) is one of three main lineages of spiders. Comprising 15 families, 325 genera, and over 2,600 species, the group is a diverse assemblage that has retained a number of features considered primitive for spiders. Despite an evolutionary history dating back to the lower Triassic, the group has received comparatively little attention with respect to its phylogeny and higher classification. The few phylogenies published all share the common thread that a stable classification scheme for the group remains unresolved. Methods and Findings: We report here a reevaluation of mygalomorph phylogeny using the rRNA genes 18S and 28S, the nuclear protein-coding gene EF-1 gamma, and a morphological character matrix. Taxon sampling includes members of all 15 families representing 58 genera. The following results are supported in our phylogenetic analyses of the data: (1) the Atypoidea (i.e., antrodiaetids, atypids, and mecicobothriids) is a monophyletic group sister to all other mygalomorphs; and (2) the families Mecicobothriidae, Hexathelidae, Cyrtaucheniidae, Nemesiidae, Ctenizidae, and Dipluridae are not monophyletic. The Microstigmatidae is likely to be subsumed into Nemesiidae. Nearly half of all mygalomorph families require reevaluation of generic composition and placement. The polyphyletic family Cyrtaucheniidae is most problematic, representing no fewer than four unrelated lineages. Conclusions: Based on these analyses we propose the following nomenclatural changes: (1) the establishment of the family Euctenizidae (NEW RANK); (2) establishment of the subfamily Apomastinae within the Euctenizidae; and (3) the transfer of the cyrtaucheniid genus Kiama to Nemesiidae. Additional changes include relimitation of Domiothelina and Theraphosoidea, and the establishment of the Euctenizoidina clade (Idiopidae + Euctenizidae). In addition to these changes, we propose a "road map" for future sampling across the infraorder with the aim of solving many remaining questions that hinder mygalomorph systematics.	[Bond, Jason E.; Hamilton, Chris A.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Bond, Jason E.; Hamilton, Chris A.] Auburn Univ, Museum Nat Hist, Auburn, AL 36849 USA; [Hendrixson, Brent E.] Millsaps Coll, Dept Biol, Jackson, MS 39210 USA; [Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Millsaps College; California State University System; San Diego State University	Bond, JE (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	jbond@auburn.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 0108575, DEB 0236020]; Direct For Biological Sciences [1153218] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by National Science Foundation grants DEB 0108575 (to JEB and MH) and DEB 0236020 (to JEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; Bond JE, 2006, MOL PHYLOGENET EVOL, V41, P70, DOI 10.1016/j.ympev.2006.04.026; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2006, INVERTEBR SYST, V20, P1, DOI 10.1071/IS05041; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; Chamberlin Ralph V., 1945, ANN ENT SOC AMERICA, V38, P549; Coddington JA, 2004, ASSEMBLING THE TREE OF LIFE, P296; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; COYLE F A, 1986, P269; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eskov K., 1990, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V178, P325; Fourie R, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.95.745; Gallon Richard C., 2002, Bulletin of the British Arachnological Society, V12, P201; Gertsch W.J., 1980, AM MUS NOVIT, V2704, P1; Gertsch W.J., 1979, AM MUS NOVIT, V2687, P1; Goloboff P.A., 1993, American Museum Novitates, P1; Griswold Charles E., 2001, Occasional Papers California Academy of Sciences, V151, P1; Hamilton CA, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026207, 10.1371/journal.pone.0020156]; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2011, ZOOTAXA, P55; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2007, MOL PHYLOGENET EVOL, V42, P738, DOI 10.1016/j.ympev.2006.09.010; Hendrixson BE, 2009, MOL PHYLOGENET EVOL, V53, P300, DOI 10.1016/j.ympev.2009.06.001; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kraus O., 1974, Abhandlungen Verh naturw Ver Hamburg, VNo. 17, P85; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maddison WP, 2017, MESQUITE MODULAR SYS; Miller JA, 1996, J ARACHNOL, V24, P201; Platnick NI, WORLD SPIDER CATALOG; Rash LD, 2000, BRIT J PHARMACOL, V130, P1817, DOI 10.1038/sj.bjp.0703494; Raven R.J., 1980, Bulletin of the British Arachnological Society, V5, P43; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; RAVEN RJ, 1980, J ARACHNOL, V8, P251; Raven RJ, 2008, RAFFLES B ZOOL, V56, P29; Reichling Steven B., 1997, Bulletin of the British Arachnological Society, V10, P337; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025355; Selden PA, 2010, BIOL REV, V85, P171, DOI 10.1111/j.1469-185X.2009.00099.x; Selden PA, 2009, AFR INVERTEBR, V50, P105, DOI 10.5733/afin.050.0103; Simon E., 1892, Histoire naturelle des araignees, V1, P1; Simon Eugene, 1903, P669; Smith Chas. Piper, 1908, Annals of the Entomological Society of America, V1; Stamatakis A, 2005, CONCURR COMP-PRACT E, V17, P1705, DOI 10.1002/cpe.954; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x	47	89	95	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38753	10.1371/journal.pone.0038753	http://dx.doi.org/10.1371/journal.pone.0038753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723885	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700028
J	Fan, J; McLeod, CB; Koehoorn, M				Fan, Jonathan; McLeod, Christopher B.; Koehoorn, Mieke			Descriptive Epidemiology of Serious Work-Related Injuries in British Columbia, Canada	PLOS ONE			English	Article							NONFATAL OCCUPATIONAL INJURIES; AGE-RELATED DIFFERENCES; UNITED-STATES; OLDER-ADULTS; EMERGENCY-DEPARTMENTS; GENDER-DIFFERENCES; FALLS; COMPENSATION; HEALTH; FRACTURES	Objective: This study examined the rates and distribution of serious work-related injuries by demographic, work and injury characteristics in British Columbia, Canada from 2002-2008, using population-based data. Methods: Claims for workers with a serious injury were extracted from workers' compensation data. Serious injuries were defined by long duration, high cost, serious medical diagnosis, or fatality. Workforce estimates were used to calculate stratum-specific rates. Rate-ratios (RR) and 95% CIs were calculated using negative binomial regression for the comparison of rates, adjusting for gender, age and occupation. Results: Women had a lower overall serious injury rate compared to men (RR: 0.93, 95% CI: 0.87-0.99). The 35-44 age group had the highest overall rate compared to the youngest age group. The rate for severe strains/sprains was similarly high for men and women in the 35-44 age group, although there was a differential pattern by gender for other injury types: the rate of fracture was similar across age groups for men, but increased with age for women (RR: 2.7, 95% CI: 2.2-3.3); and the rate of severe falls increased with age for men and women, with a larger three-fold increase for older women (men: RR: 1.8, 95% CI: 1.7-2.1; women: RR: 3.2, 95% CI: 2.7-3.7). Conclusions: The risk of serious injuries is higher among specific age groups with different patterns emerging for men and women. Variations persisted within similar injury types and occupation groups in our adjusted models. These results provide evidence for the burden of serious injuries and a basis for future analytic research. Given projected demographic shifts and increasing workforce participation of older workers, intervention programs should be carefully implemented with consideration to demographic groups at risk for serious injuries in the workplace.	[McLeod, Christopher B.; Koehoorn, Mieke] Univ British Columbia, Sch Populat & Publ Hlth, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [McLeod, Christopher B.] Univ British Columbia, Coll Interdisciplinary Studies, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Fan, J (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada.	jfan@chspr.ubc.ca	McLeod, Christopher B/D-7767-2012	McLeod, Christopher/0000-0001-9268-3694	WorkSafeBC (the Workers' Compensation Board of British Columbia); Michael Smith Foundation for Health Research; Social Sciences and Humanities Research Council of Canada	WorkSafeBC (the Workers' Compensation Board of British Columbia); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This study was funded by WorkSafeBC (the Workers' Compensation Board of British Columbia; http://www.worksafebc.com), through the Partnership for Work, Health and Safety. M Koehoorn was supported in-part by a Michael Smith Foundation for Health Research Senior Scholar Award (http://www.msfhr.org). CB McLeod was supported in-part by a post-doctoral fellowship from the Social Sciences and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. The administrative data on workers' compensation claims used for this study was collected and controlled by WorkSafeBC, and access to this data was provided under a data access agreement between the University of British Columbia and WorkSafeBC governing the privacy and confidentiality conditions for use of the data for research purposes.	Alamgir H, 2006, OCCUP ENVIRON MED, V63, P290, DOI 10.1136/oem.2005.026047; Alamgir H, 2011, OCCUP MED-OXFORD, V61, P234, DOI 10.1093/occmed/kqr025; Association of Workers' Compensation Boards of Canada, 2010, NUMB ACC TIM LOSS IN; Breslin C, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e10; Breslin FC, 2005, AM J IND MED, V48, P50, DOI 10.1002/ajim.20185; Cherry N, 2005, OCCUP MED-OXFORD, V55, P292, DOI 10.1093/occmed/kqi118; Choi BCK, 1996, J OCCUP ENVIRON MED, V38, P379, DOI 10.1097/00043764-199604000-00016; Crawford JO, 2010, OCCUP MED-OXFORD, V60, P184, DOI 10.1093/occmed/kqq028; Eng A, 2011, OCCUP ENVIRON MED, V68, P888, DOI 10.1136/oem.2010.064097; Ferrao V, 2007, PARTICIPATION OLDER; Grandjean Cynthia K, 2006, Nurs Health Sci, V8, P103, DOI 10.1111/j.1442-2018.2006.00260.x; Hu GQ, 2010, INJURY PREV, V16, P26, DOI 10.1136/ip.2009.023481; Islam SS, 2001, J OCCUP ENVIRON MED, V43, P140, DOI 10.1097/00043764-200102000-00013; Jacoby SF, 2006, J NURS SCHOLARSHIP, V38, P133, DOI 10.1111/j.1547-5069.2006.00090.x; Kemmlert K, 2001, APPL ERGON, V32, P149, DOI 10.1016/S0003-6870(00)00051-X; Layne L, 1997, J OCCUP ENVIRON MED, V29, P855; Layne LA, 2004, AM J IND MED, V46, P32, DOI 10.1002/ajim.20038; Liberty Mutual Research Institute for Safety, 2011, 2010 LIB MUT WORKPL; Martel L, 2007, RAPID AGING WORKING; MITCHELL OS, 1988, MON LABOR REV, V111, P8; Orces CH, 2011, INJURY PREV, V17, P33, DOI 10.1136/ip.2010.026799; Paulozzi LJ, 2006, J SAFETY RES, V37, P277, DOI 10.1016/j.jsr.2006.02.004; Rosenman KD, 2000, J OCCUP ENVIRON MED, V42, P25, DOI 10.1097/00043764-200001000-00008; Salminen S, 2004, J SAFETY RES, V35, P513, DOI 10.1016/j.jsr.2004.08.005; Shannon HS, 2002, AM J IND MED, V42, P467, DOI 10.1002/ajim.10142; StataCorp, 2008, STAT STAT SOFTW REL; [Statistics Canada Statistics Canada Labour Statistics Division], 2011, GUID LAB FORC SURV; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; The Health and Safety Executive, 2011, STAT 2009 2010; TheHealth & SafetyExecutive, 2010, SLIPS TRIPS FALLS CO; United States Department of Labor, 2011, FAT OCC INJ NONF OCC; WorkSafeBC, 2010, STAT 2009; WorkSafeBC, 2011, 2010 ANN REP 2011 20; World Health Organization, 2007, GLOB REP FALLS PREV; Wuellner Sara E., 2011, Morbidity and Mortality Weekly Report, V60, P503	37	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38750	10.1371/journal.pone.0038750	http://dx.doi.org/10.1371/journal.pone.0038750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723884	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700027
J	Crane, MJ; Gaddi, PJ; Salazar-Mather, TP				Crane, Meredith J.; Gaddi, Pamela J.; Salazar-Mather, Thais P.			UNC93B1 Mediates Innate Inflammation and Antiviral Defense in the Liver during Acute Murine Cytomegalovirus Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; IFN-ALPHA-BETA; PATTERN-RECOGNITION RECEPTORS; PLASMACYTOID DENDRITIC CELLS; NATURAL-KILLER; CYTOKINE RESPONSES; IMMUNE-RESPONSES; VIRAL-INFECTIONS; CUTTING EDGE; STRANDED-RNA	Antiviral defense in the liver during acute infection with the hepatotropic virus murine cytomegalovirus (MCMV) involves complex cytokine and cellular interactions. However, the mechanism of viral sensing in the liver that promotes these cytokine and cellular responses has remained unclear. Studies here were undertaken to investigate the role of nucleic acid-sensing Toll-like receptors (TLRs) in initiating antiviral immunity in the liver during infection with MCMV. We examined the host response of UNC93B1 mutant mice, which do not signal properly through TLR3, TLR7 and TLR9, to acute MCMV infection to determine whether liver antiviral defense depends on signaling through these molecules. Infection of UNC93B1 mutant mice revealed reduced production of systemic and liver proinflammatory cytokines including IFN-alpha, IFN-gamma, IL-12 and TNF-alpha when compared to wild-type. UNC93B1 deficiency also contributed to a transient hepatitis later in acute infection, evidenced by augmented liver pathology and elevated systemic alanine aminotransferase levels. Moreover, viral clearance was impaired in UNC93B1 mutant mice, despite intact virus-specific CD8+ T cell responses in the liver. Altogether, these results suggest a combined role for nucleic acid-sensing TLRs in promoting early liver antiviral defense during MCMV infection.	[Crane, Meredith J.; Gaddi, Pamela J.; Salazar-Mather, Thais P.] Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	Brown University	Crane, MJ (corresponding author), Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Thais_Mather@brown.edu			Centers for Disease Control and Prevention [1R36PS001439-01]; National Institutes of Health [CA102708, AA018772]; Department of Education Predoctoral Training [P200A000117]; NATIONAL CANCER INSTITUTE [R01CA102708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [R36PS001439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018772] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education Predoctoral Training; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Centers for Disease Control and Prevention Grant 1R36PS001439-01 (to MJC), and in part by National Institutes of Health Grants CA102708 and AA018772 (to TPS-M) and Department of Education Predoctoral Training Grant P200A000117 (to MJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Cavanaugh VJ, 2003, J VIROL, V77, P1703, DOI 10.1128/JVI.77.3.1703-1717.2003; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672; DeFilippis VR, 2010, J VIROL, V84, P8913, DOI 10.1128/JVI.00169-10; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Finberg RW, 2009, IMMUNITY, V30, P173, DOI 10.1016/j.immuni.2009.02.001; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Held KS, 2008, VIRAL IMMUNOL, V21, P173, DOI 10.1089/vim.2008.0014; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Hokeness-Antonelli KL, 2007, J IMMUNOL, V179, P6176, DOI 10.4049/jimmunol.179.9.6176; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; John B, 2002, J IMMUNOL, V169, P2545, DOI 10.4049/jimmunol.169.5.2545; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mitrovic M, 2012, J VIROL, V86, P2165, DOI 10.1128/JVI.06042-11; Munks MW, 2006, J IMMUNOL, V176, P3760, DOI 10.4049/jimmunol.176.6.3760; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; OLVER SD, 1994, CLIN EXP IMMUNOL, V98, P375; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Orange JS, 1996, J IMMUNOL, V156, P4746; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Ruzek MC, 1997, J EXP MED, V185, P1185, DOI 10.1084/jem.185.7.1185; Salazar-Mather TP, 2006, CURR TOP MICROBIOL, V303, P29, DOI 10.1007/978-3-540-33397-5_2; Salazar-Mather TP, 2000, J CLIN INVEST, V105, P985, DOI 10.1172/JCI9232; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Su HC, 2001, AID IMMU3048 62 3 0; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Trgovcich J, 2000, ARCH VIROL, V145, P2601, DOI 10.1007/s007050070010; Wick MJ, 2002, CRIT REV IMMUNOL, V22, P47; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zucchini N, 2008, INT IMMUNOL, V20, P45, DOI 10.1093/intimm/dxm119; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	62	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39161	10.1371/journal.pone.0039161	http://dx.doi.org/10.1371/journal.pone.0039161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723955	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300109
J	Yao, J; He, XY; Wang, AZ; Chen, W; Li, XY; Lewis, BJ; Lv, XT				Yao, Jing; He, Xingyuan; Wang, Anzhi; Chen, Wei; Li, Xiaoyu; Lewis, Bernard J.; Lv, Xiaotao			Influence of Forest Management Regimes on Forest Dynamics in the Upstream Region of the Hun River in Northeastern China	PLOS ONE			English	Article							GREAT XINGAN MOUNTAINS; SEED DISPERSAL; SPECIES-DIVERSITY; PINUS-KORAIENSIS; LANDSCAPE MODEL; PLANT DIVERSITY; FIRE REGIMES; RESTORATION; SIMULATION; SUCCESSION	Balancing forest harvesting and restoration is critical for forest ecosystem management. In this study, we used LANDIS, a spatially explicit forest landscape model, to evaluate the effects of 21 alternative forest management initiatives which were drafted for forests in the upstream region of the Hun River in northeastern China. These management initiatives included a wide range of planting and harvest intensities for Pinus koraiensis, the historically dominant tree species in the region. Multivariate analysis of variance, Shannon's Diversity Index, and planting efficiency (which indicates how many cells of the target species at the final year benefit from per-cell of the planting trees) estimates were used as indicators to analyze the effects of planting and harvesting regimes on forests in the region. The results showed that the following: (1) Increased planting intensity, although augmenting the coverage of P. koraiensis, was accompanied by decreases in planting efficiency and forest diversity. (2) While selective harvesting could increase forest diversity, the abrupt increase of early succession species accompanying this method merits attention. (3) Stimulating rapid forest succession may not be a good management strategy, since the climax species would crowd out other species which are likely more adapted to future climatic conditions in the long run. In light of the above, we suggest a combination of 30% planting intensity with selective harvesting of 50% and 70% of primary and secondary timber species, respectively, as the most effective management regime in this area. In the long run this would accelerate the ultimate dominance of P. koraiensis in the forest via a more effective rate of planting, while maintaining a higher degree of forest diversity. These results are particularly useful for forest managers constrained by limited financial and labor resources who must deal with conflicts between forest harvesting and restoration.	[Yao, Jing; He, Xingyuan; Wang, Anzhi; Chen, Wei; Li, Xiaoyu; Lewis, Bernard J.; Lv, Xiaotao] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yao, Jing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yao, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	avril_y@foxmail.com; hexy@iae.ac.cn	Lu (ü), Xiao-Tao/B-3905-2008	Lu (ü), Xiao-Tao/0000-0001-5571-1895	National Forestry Public Benefit Research Foundation of China [200804001]; National Natural Science Foundation of China [40971272]	National Forestry Public Benefit Research Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financed by the National Forestry Public Benefit Research Foundation of China (No. 200804001) and the National Natural Science Foundation of China (No. 40971272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HD, 2010, CAN J FOREST RES, V40, P716, DOI 10.1139/X10-029; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Bent GC, 2001, FOREST ECOL MANAG, V143, P115, DOI 10.1016/S0378-1127(00)00511-9; Berry NJ, 2008, LANDSCAPE ECOL, V23, P915, DOI 10.1007/s10980-008-9248-1; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bhatti JS, 2000, FOREST ECOL MANAG, V138, P413, DOI 10.1016/S0378-1127(00)00427-8; Bonell M, 2010, J HYDROL, V391, P49, DOI 10.1016/j.jhydrol.2010.07.004; Bu R, 2008, FOREST ECOL MANAG, V254, P407, DOI 10.1016/j.foreco.2007.09.080; Cairns DM, 2008, LANDSCAPE ECOL, V23, P403, DOI 10.1007/s10980-008-9198-7; Carlson M, 2010, FOREST CHRON, V86, P434, DOI 10.5558/tfc86434-4; Chang Y, 2008, FOREST ECOL MANAG, V254, P445, DOI 10.1016/j.foreco.2007.04.050; Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Chen XW, 2003, FOREST ECOL MANAG, V177, P503, DOI 10.1016/S0378-1127(02)00455-3; Donath TW, 2003, APPL VEG SCI, V6, P13, DOI 10.1111/j.1654-109X.2003.tb00560.x; Duncan RS, 2003, FOREST ECOL MANAG, V173, P235, DOI 10.1016/S0378-1127(02)00009-9; Elliott KJ, 2005, FOREST ECOL MANAG, V211, P296, DOI 10.1016/j.foreco.2005.02.064; Feyrer LJ, 2011, HYDROBIOLOGIA, V678, P37, DOI 10.1007/s10750-011-0816-z; Franklin J, 2005, ECOSYSTEMS, V8, P885, DOI 10.1007/s10021-005-0017-6; Gustafson EJ, 2000, CAN J FOREST RES, V30, P32, DOI 10.1139/cjfr-30-1-32; Hall SJ, 2008, WETLANDS, V28, P776, DOI 10.1672/07-231.1; Hao Z., 2001, CHINESE J APPL ECOLO, V12, P653; He HS, 1999, ECOL MODEL, V119, P1, DOI 10.1016/S0304-3800(99)00041-1; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; He HS, 2002, ECOL MODEL, V156, P153, DOI 10.1016/S0304-3800(02)00104-7; He HS, 1999, ECOLOGY, V80, P81, DOI 10.1890/0012-9658(1999)080[0081:SEASSO]2.0.CO;2; He HS, 1999, ECOSYSTEMS, V2, P308, DOI 10.1007/s100219900082; He J, 2009, FOREST ECOL MANAG, V257, P2010, DOI 10.1016/j.foreco.2009.01.041; Leng WF, 2008, FOREST ECOL MANAG, V254, P420, DOI 10.1016/j.foreco.2007.08.031; Li J, 2003, ACTA ECOLOGICA SINIC, P23; Li JingWen, 2005, Scientia Silvae Sinicae, V41, P72; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; Liu GH, 2001, J NATURAL RESOURCES, V16, P71; Mehta S, 2004, ECOL MODEL, V180, P73, DOI 10.1016/j.ecolmodel.2004.01.019; Mladenoff DJ, 2004, ECOL MODEL, V180, P7, DOI 10.1016/j.ecolmodel.2004.03.016; Moss EH, 1937, BOT GAZ, V99, P529; Pietsch SA, 2002, FOREST ECOL MANAG, V159, P111, DOI 10.1016/S0378-1127(01)00714-9; Ravenscroft C, 2010, ECOL APPL, V20, P327, DOI 10.1890/08-1698.1; Schumann ME, 2003, FOREST ECOL MANAG, V176, P543, DOI 10.1016/S0378-1127(02)00233-5; Shin JH, 2004, FOREST ECOL MANAG, V201, P43, DOI 10.1016/j.foreco.2004.06.020; Shinneman DJ, 2010, FOREST ECOL MANAG, V259, P446, DOI 10.1016/j.foreco.2009.10.042; Steenberg JWN, 2011, FOREST ECOL MANAG, V262, P2316, DOI 10.1016/j.foreco.2011.08.027; TAUSCH RJ, 1993, J RANGE MANAGE, V46, P439, DOI 10.2307/4002664; van Loon AH, 2011, BIOL CONSERV, V144, P1025, DOI 10.1016/j.biocon.2010.12.021; Wang J, 2010, FORESTRY SCI TECHNOL, V35, P10; Wang XG, 2006, FOREST ECOL MANAG, V225, P82, DOI 10.1016/j.foreco.2005.12.029; Weiss G, 2004, FOREST ECOL MANAG, V195, P1, DOI 10.1016/j.foreco.2004.03.019; Will R, 2010, FOREST SCI, V56, P437; Wu Jing-Lian, 2009, Yingyong Shengtai Xuebao, V20, P235; Xu CG, 2004, ECOL MODEL, V180, P57, DOI 10.1016/j.ecolmodel.2004.01.018; Xu C, 2009, GLOBAL CHANGE BIOL, V15, P116, DOI 10.1111/j.1365-2486.2008.01705.x; Yosi CK, 2011, FOREST ECOL MANAG, V262, P895, DOI 10.1016/j.foreco.2011.06.007; Youngblood A, 2006, FOREST ECOL MANAG, V234, P143, DOI 10.1016/j.foreco.2006.06.033; Yu M, 2011, ANN BOT-LONDON, V108, P885, DOI 10.1093/aob/mcr218; Yu XiaoMei, 2009, Journal of Northeast Forestry University, V37, P18; Yu XM, 2009, J NE FORESTRY U, V37, P53; Zerbe S, 2002, FOREST ECOL MANAG, V167, P27, DOI 10.1016/S0378-1127(01)00686-7; Zhang Jian, 2007, Yingyong Shengtai Xuebao, V18, P1681; Zhao DS, 2007, CHINESE GEOGR SCI, V17, P317, DOI 10.1007/s11769-007-0317-1; Zhu Jiao-jun, 2008, Yingyong Shengtai Xuebao, V19, P695	59	4	4	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39058	10.1371/journal.pone.0039058	http://dx.doi.org/10.1371/journal.pone.0039058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723930	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300088
J	Chisti, MJ; Ahmed, T; Ashraf, H; Faruque, ASG; Bardhan, PK; Dey, SK; Huq, S; Das, SK; Salam, MA				Chisti, Mohammod J.; Ahmed, Tahmeed; Ashraf, Hasan; Faruque, A. S. G.; Bardhan, Pradip K.; Dey, Sanjoy Kumer; Huq, Sayeeda; Das, Sumon Kumar; Salam, Mohammed A.			Clinical Predictors and Outcome of Metabolic Acidosis in Under-Five Children Admitted to an Urban Hospital in Bangladesh with Diarrhea and Pneumonia	PLOS ONE			English	Article							SEVERELY MALNOURISHED CHILDREN; INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK; DEHYDRATION; MANAGEMENT; MORTALITY; INFANTS; MALNUTRITION; FEATURES; SEPSIS	Background: Clinical features of metabolic acidosis and pneumonia frequently overlap in young diarrheal children, resulting in differentiation from each other very difficult. However, there is no published data on the predictors of metabolic acidosis in diarrheal children also having pneumonia. Our objective was to evaluate clinical predictors of metabolic acidosis in under-five diarrheal children with radiological pneumonia, and their outcome. Methods: We prospectively enrolled all under-five children (n = 164) admitted to the Special Care Ward (SCW) of the Dhaka Hospital of icddr, b between September and December 2007 with diarrhea and radiological pneumonia who also had their total serum carbon-dioxide estimated. We compared the clinical features and outcome of children with radiological pneumonia and diarrhea with (n = 98) and without metabolic acidosis (n = 66). Results: Children with metabolic acidosis more often had higher case-fatality (16% vs. 5%, p = 0.039) compared to those without metabolic acidosis on admission. In logistic regression analysis, after adjusting for potential confounders such as age of the patient, fever on admission, and severe wasting, the independent predictors of metabolic acidosis in under-five diarrheal children having pneumonia were clinical dehydration (OR 3.57, 95% CI 1.62-7.89, p = 0.002), and low systolic blood pressure even after full rehydration (OR 1.02, 95% CI 1.01-1.04, p = 0.005). Proportions of children with cough, respiratory rate/minute, lower chest wall indrawing, nasal flaring, head nodding, grunting respiration, and cyanosis were comparable (p>0.05) among the groups. Conclusion and Significance: Under-five diarrheal children with radiological pneumonia having metabolic acidosis had frequent fatal outcome than those without acidosis. Clinical dehydration and persistent systolic hypotension even after adequate rehydration were independent clinical predictors of metabolic acidosis among the children. However, metabolic acidosis in young diarrheal children had no impact on the diagnostic clinical features of radiological pneumonia which underscores the importance of early initiation of appropriate antibiotics to combat morbidity and deaths in such population.	[Chisti, Mohammod J.; Bardhan, Pradip K.] Bangladesh icddr b, Int Ctr Diarhoeal Dis Res, CS, Dhaka, Bangladesh; [Chisti, Mohammod J.; Ahmed, Tahmeed; Ashraf, Hasan; Faruque, A. S. G.; Bardhan, Pradip K.; Huq, Sayeeda; Das, Sumon Kumar] Icddr b, CNFS, Dhaka, Bangladesh; [Dey, Sanjoy Kumer] BSMMU, Dept Neonatol, Dhaka, Bangladesh; [Salam, Mohammed A.] Icddr b, RAS, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); Bangabandhu Sheikh Mujib Medical University (BSMMU); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Bangladesh icddr b, Int Ctr Diarhoeal Dis Res, CS, Dhaka, Bangladesh.	chisti@icddrb.org	Das, Sumon Kumar/AAD-1551-2019; Das, Sumon Kumar/T-6384-2019; Chisti, Mohammod J/A-7216-2018; Dey, Sanjoy Kumer/AAN-6937-2020		Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR) [Gr-00233]	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR)	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SM, 1986, SCAND J INFECT DIS, V18, P65, DOI 10.3109/00365548609032308; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chisti MJ, 2011, ANN TROP PAEDIATR, V31, P311, DOI 10.1179/1465328111Y.0000000033; Chisti MJ, 2010, ANN TROP PAEDIATR, V30, P311, DOI 10.1179/146532810X12858955921230; Chisti MJ, 2012, TROP MED INT HLTH; Chisti MJ, 2011, ACTA PAEDIATR, V100, pE275, DOI 10.1111/j.1651-2227.2011.02368.x; Chisti MJ, 2010, TROP MED INT HEALTH, V15, P1322, DOI 10.1111/j.1365-3156.2010.02619.x; Chisti MJ, 2010, PEDIATR CRIT CARE ME, V11, P92, DOI 10.1097/PCC.0b013e3181b063e1; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Ebrahim GJ, 2011, J TROP PEDIATRICS, V57, P77, DOI 10.1093/tropej/fmr022; Greenbaum LA, 2012, NELSON TXB PAEDIAT, P267; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; NATHOO KJ, 1987, CENT AFR J MED, V33, P200; RICHARDS L, 1993, PEDIATR INFECT DIS J, V12, P5, DOI 10.1097/00006454-199301000-00003; Said M, 1980, Paediatr Indones, V20, P68; Salam MA, 2002, SAN DIEG CA 42 INT C; Suskind DMK, 1990, MALNOURISHED CHILD; Vega RM, 1997, PEDIATR EMERG CARE, V13, P179, DOI 10.1097/00006565-199706000-00001; WANG F, 1986, NEW ENGL J MED, V315, P1591, DOI 10.1056/NEJM198612183152506; World Health Organization, 1990, AC RESP INF CHILDR C; World Health Organization, 1999, MAN SEV MALN MAN PHY	26	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39164	10.1371/journal.pone.0039164	http://dx.doi.org/10.1371/journal.pone.0039164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720060	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350000045
J	Suchodolski, JS; Dowd, SE; Wilke, V; Steiner, JM; Jergens, AE				Suchodolski, Jan S.; Dowd, Scot E.; Wilke, Vicky; Steiner, Joerg M.; Jergens, Albert E.			16S rRNA Gene Pyrosequencing Reveals Bacterial Dysbiosis in the Duodenum of Dogs with Idiopathic Inflammatory Bowel Disease	PLOS ONE			English	Article							MOLECULAR-PHYLOGENETIC CHARACTERIZATION; TOLL-LIKE RECEPTORS; SMALL-INTESTINE; CHRONIC ENTEROPATHIES; FECAL BACTERIAL; GUT MICROBIOTA; HEALTHY DOGS; ASSOCIATION; COMMUNITIES; POPULATIONS	Background: Canine idiopathic inflammatory bowel disease (IBD) is believed to be caused by a complex interaction of genetic, immunologic, and microbial factors. While mucosa-associated bacteria have been implicated in the pathogenesis of canine IBD, detailed studies investigating the enteric microbiota using deep sequencing techniques are lacking. The objective of this study was to evaluate mucosa-adherent microbiota in the duodenum of dogs with spontaneous idiopathic IBD using 16 S rRNA gene pyrosequencing. Methodology/Principal Findings: Biopsy samples of small intestinal mucosa were collected endoscopically from healthy dogs (n = 6) and dogs with moderate IBD (n = 7) or severe IBD (n = 7) as assessed by a clinical disease activity index. Total RNA was extracted from biopsy specimens and 454-pyrosequencing of the 16 S rRNA gene was performed on aliquots of cDNA from each dog. Intestinal inflammation was associated with significant differences in the composition of the intestinal microbiota when compared to healthy dogs. PCoA plots based on the unweighted UniFrac distance metric indicated clustering of samples between healthy dogs and dogs with IBD (ANOSIM, p<0.001). Proportions of Fusobacteria (p = 0.010), Bacteroidaceae (p = 0.015), Prevotellaceae (p = 0.022), and Clostridiales (p = 0.019) were significantly more abundant in healthy dogs. In contrast, specific bacterial genera within Proteobacteria, including Diaphorobacter (p = 0.044) and Acinetobacter (p = 0.040), were either more abundant or more frequently identified in IBD dogs. Conclusions/Significance: In conclusion, dogs with spontaneous IBD exhibit alterations in microbial groups, which bear resemblance to dysbiosis reported in humans with chronic intestinal inflammation. These bacterial groups may serve as useful targets for monitoring intestinal inflammation.	[Suchodolski, Jan S.; Steiner, Joerg M.] Texas A&M Univ, Gastrointestinal Lab, Dept Small Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Wilke, Vicky] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Jergens, Albert E.] Iowa State Univ, Coll Vet Med, Ames, IA USA	Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University	Suchodolski, JS (corresponding author), Texas A&M Univ, Gastrointestinal Lab, Dept Small Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	jsuchodolski@cvm.tamu.edu	Dowd, Scot E/M-5386-2017; Fiumefreddo, Andrea/T-2977-2019	Dowd, Scot E/0000-0002-6296-1427; Suchodolski, Jan/0000-0002-2176-6932	American Kennel Club Canine Health Foundation	American Kennel Club Canine Health Foundation	This study was funded by a grant from the American Kennel Club Canine Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BATT RM, 1992, AM J VET RES, V53, P1935; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNO Y, 1992, J VET MED SCI, V54, P703, DOI 10.1292/jvms.54.703; Buddington RK, 2003, AM J VET RES, V64, P646, DOI 10.2460/ajvr.2003.64.646; Burgener IA, 2008, J VET INTERN MED, V22, P553, DOI 10.1111/j.1939-1676.2008.0093.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Craven M, 2004, J SMALL ANIM PRACT, V45, P336, DOI 10.1111/j.1748-5827.2004.tb00245.x; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; JERGENS AE, 1992, J AM VET MED ASSOC, V201, P1603; Kathrani A, 2011, TISSUE ANTIGENS, V78, P94, DOI 10.1111/j.1399-0039.2011.01707.x; Kathrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015740; Khan ST, 2002, J GEN APPL MICROBIOL, V48, P299; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Simpson JM, 2002, MICROB ECOL, V44, P186, DOI 10.1007/s00248-002-0001-z; Simpson KW, 2011, VET CLIN N AM-SMALL, V41, P381, DOI 10.1016/j.cvsm.2011.02.003; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Suchodolski JS, 2008, VET MICROBIOL, V132, P379, DOI 10.1016/j.vetmic.2008.05.017; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Washabau RJ, 2010, J VET INTERN MED, V24, P10, DOI 10.1111/j.1939-1676.2009.0443.x; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x	36	143	144	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39333	10.1371/journal.pone.0039333	http://dx.doi.org/10.1371/journal.pone.0039333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720094	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350000059
J	Bender, S; Resch, F; Klein, C; Renner, T; Fallgatter, AJ; Weisbrod, M; Romanos, M				Bender, Stephan; Resch, Franz; Klein, Christoph; Renner, Tobias; Fallgatter, Andreas J.; Weisbrod, Matthias; Romanos, Marcel			Influence of Stimulant Medication and Response Speed on Lateralization of Movement-Related Potentials in Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; CONTINGENT NEGATIVE-VARIATION; CONTINUOUS PERFORMANCE-TEST; SLOW CORTICAL POTENTIALS; ANTICIPATORY MECHANISMS; MOTOR PREPARATION; TIC DISORDER; CHILDREN; ADHD; METHYLPHENIDATE	Background: Hyperactivity is one of the core symptoms in attention deficit hyperactivity disorder (ADHD). However, it remains unclear in which way the motor system itself and its development are affected by the disorder. Movement-related potentials (MRP) can separate different stages of movement execution, from the programming of a movement to motor post-processing and memory traces. Pre-movement MRP are absent or positive during early childhood and display a developmental increase of negativity. Methods: We examined the influences of response-speed, an indicator of the level of attention, and stimulant medication on lateralized MRP in 16 children with combined type ADHD compared to 20 matched healthy controls. Results: We detected a significantly diminished lateralisation of MRP over the pre-motor and primary motor cortex during movement execution (initial motor potential peak, iMP) in patients with ADHD. Fast reactions (indicating increased visuo-motor attention) led to increased lateralized negativity during movement execution only in healthy controls, while in children with ADHD faster reaction times were associated with more positive amplitudes. Even though stimulant medication had some effect on attenuating group differences in lateralized MRP, this effect was insufficient to normalize lateralized iMP amplitudes. Conclusions: A reduced focal (lateralized) motor cortex activation during the command to muscle contraction points towards an immature motor system and a maturation delay of the (pre-) motor cortex in children with ADHD. A delayed maturation of the neuronal circuitry, which involves primary motor cortex, may contribute to ADHD pathophysiology.	[Bender, Stephan] Tech Univ Dresden, Child & Adolscent Psychiat Hosp, Sect Clin Neurophysiol & Multimodal NeuroImaging, Dresden, Germany; [Resch, Franz] Heidelberg Univ, Dept Child & Adolescent Psychiat, Heidelberg, Germany; [Klein, Christoph] Univ Bangor, Sch Psychol, Bangor, Gwynedd, Wales; [Renner, Tobias; Romanos, Marcel] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Wurzburg, Germany; [Fallgatter, Andreas J.] Univ Tubingen, Dept Psychiat, Tubingen, Germany; [Weisbrod, Matthias] Heidelberg Univ, Hosp Psychiat, Sect Expt Psychopathol, Heidelberg, Germany; [Weisbrod, Matthias] Hosp Psychiat, SRH, Karlsbad, Germany; [Romanos, Marcel] Univ Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany	Technische Universitat Dresden; Ruprecht Karls University Heidelberg; Bangor University; University of Wurzburg; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; University of Munich	Bender, S (corresponding author), Tech Univ Dresden, Child & Adolscent Psychiat Hosp, Sect Clin Neurophysiol & Multimodal NeuroImaging, Dresden, Germany.	Stephan.Bender@uniklinikum-dresden.de	Bender, Stephan/AAT-1266-2021; Romanos, Marcel/D-7695-2017; Renner, Tobias J/I-2120-2013	Romanos, Marcel/0000-0001-7628-8299; 	Deutsche Forschungsgemeinschaft [KFO 125]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was performed within the framework of the Clinical Research Program Attention Deficit Hyperactivity Disorder (KFO 125), supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMABILE G, 1986, ELECTROEN CLIN NEURO, V64, P521, DOI 10.1016/0013-4694(86)90189-6; Banaschewski T, 2008, BIOL PSYCHOL, V77, P53, DOI 10.1016/j.biopsycho.2007.09.003; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; Bender S, 2005, ANN NEUROL, V58, P58, DOI 10.1002/ana.20521; Bender S, PLOS ONE IN PRESS; Bender S, 2007, PAIN, V127, P221, DOI 10.1016/j.pain.2006.08.017; Bender S, 2006, NEUROIMAGE, V32, P333, DOI 10.1016/j.neuroimage.2006.03.009; Bender S, 2010, CLIN NEUROPHYSIOL, V121, P2044, DOI 10.1016/j.clinph.2010.05.008; Bruckmann S, BRAIN IN PRESS; Buchmann J, 2007, BIOL PSYCHIAT, V62, P963, DOI 10.1016/j.biopsych.2007.05.010; CHIARENZA GA, 1983, ELECTROEN CLIN NEURO, V56, P373, DOI 10.1016/0013-4694(83)90263-8; Doehnert M, 2010, BIOL PSYCHIAT, V67, P608, DOI 10.1016/j.biopsych.2009.07.038; Epstein JN, 2010, J INT NEUROPSYCH SOC, V16, P138, DOI 10.1017/S1355617709991111; Fallgatter AJ, 1997, BRAIN TOPOGR, V9, P295, DOI 10.1007/BF01464484; Fallgatter AJ, 2004, CLIN NEUROPHYSIOL, V115, P973, DOI 10.1016/j.clinph.2003.11.036; Fernandez A, 2009, BIOL PSYCHIAT, V65, P571, DOI 10.1016/j.biopsych.2008.10.046; Hallett M, 1994, Electromyogr Clin Neurophysiol, V34, P5; Heinrich H, 2004, BIOL PSYCHIAT, V55, P772, DOI 10.1016/j.biopsych.2003.11.013; Hennighausen K, 2000, Z KINDER JUG-PSYCH, V28, P239, DOI 10.1024//1422-4917.28.4.239; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Klein C, 1996, PSYCHOPHYSIOLOGY, V33, P426, DOI 10.1111/j.1469-8986.1996.tb01068.x; Klein C, 1998, PSYCHOPHYSIOLOGY, V35, P272, DOI 10.1017/S0048577298961212; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Kratz O, 2011, INT J PSYCHOPHYSIOL, V81, P82, DOI 10.1016/j.ijpsycho.2011.05.008; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P199, DOI 10.1111/1469-7610.00711; Linssen AM, 2011, PSYCHOPHARMACOLOGY B; Linssen AMW, 2011, PSYCHOPHARMACOLOGY, V218, P533, DOI 10.1007/s00213-011-2345-x; Masaki H, 2004, PSYCHOPHYSIOLOGY, V41, P220, DOI 10.1111/j.1469-8986.2004.00150.x; Moll GH, 2001, ANN NEUROL, V49, P393, DOI 10.1002/ana.77; Mordkoff JT, 2001, PSYCHOPHYSIOLOGY, V38, P777, DOI 10.1017/S0048577201000464; Mostofsky SH, 2006, BIOL PSYCHIAT, V59, P48, DOI 10.1016/j.biopsych.2005.06.011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OTTO D, 1984, ANN NY ACAD SCI, V425, P377, DOI 10.1111/j.1749-6632.1984.tb23559.x; Perchet C, 2005, CLIN NEUROPHYSIOL, V116, P1906, DOI 10.1016/j.clinph.2005.03.022; Perchet C, 2001, BIOL PSYCHIAT, V50, P44, DOI 10.1016/S0006-3223(00)01119-7; Praamstra P, 1999, COGNITIVE BRAIN RES, V8, P77, DOI 10.1016/S0926-6410(99)00008-7; Rammsayer T, 2006, PSYCHOPHARMACOLOGY, V187, P36, DOI 10.1007/s00213-006-0400-9; Richter MM, 2007, NEUROSCI LETT, V419, P137, DOI 10.1016/j.neulet.2007.04.024; Rothenberger A., 1986, CEREB PSYCHOPHYSIOL, V38, P496; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Seifert J, 2003, J NEURAL TRANSM, V110, P821, DOI 10.1007/s00702-003-0818-8; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2009, CURR PSYCHIAT REP, V11, P393, DOI 10.1007/s11920-009-0059-0; SOMMER W, 1994, PSYCHOPHYSIOLOGY, V31, P503, DOI 10.1111/j.1469-8986.1994.tb01054.x; Spencer SV, 2009, J ABNORM CHILD PSYCH, V37, P805, DOI 10.1007/s10802-009-9316-2; Steger J, 2000, CLIN NEUROPHYSIOL, V111, P1141, DOI 10.1016/S1388-2457(00)00311-4; Thiemann U, 2011, NEUROIMAGE; van Turennout M, 1998, SCIENCE, V280, P572, DOI 10.1126/science.280.5363.572; Verleger R, 1999, CLIN NEUROPHYSIOL, V110, P1175, DOI 10.1016/S1388-2457(99)00023-1; WARREN C, 1984, ANN NY ACAD SCI, V425, P489, DOI 10.1111/j.1749-6632.1984.tb23572.x; Wascher E, 1997, BRAIN, V120, P1355, DOI 10.1093/brain/120.8.1355; Werner J, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-38; Yordanova J, 1997, BIOL PSYCHIAT, V41, P585, DOI 10.1016/S0006-3223(96)00096-0; Zillessen KE, 2001, CLIN NEUROPHYSIOL, V112, P1166, DOI 10.1016/S1388-2457(01)00535-1	57	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39012	10.1371/journal.pone.0039012	http://dx.doi.org/10.1371/journal.pone.0039012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720017	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800037
J	Hebestreit, K; Grottrup, S; Emden, D; Veerkamp, J; Ruckert, C; Klein, HU; Muller-Tidow, C; Dugas, M				Hebestreit, Katja; Groettrup, Soeren; Emden, Daniel; Veerkamp, Jannis; Ruckert, Christian; Klein, Hans-Ulrich; Mueller-Tidow, Carsten; Dugas, Martin			Leukemia Gene Atlas - A Public Platform for Integrative Exploration of Genome-Wide Molecular Data	PLOS ONE			English	Article							CANCER; HEMATOPOIESIS; MUTATIONS; PATHWAYS; ONCOLOGY; RUNX1	Leukemias are exceptionally well studied at the molecular level and a wealth of high-throughput data has been published. But further utilization of these data by researchers is severely hampered by the lack of accessible integrative tools for viewing and analysis. We developed the Leukemia Gene Atlas (LGA) as a public platform designed to support research and analysis of diverse genomic data published in the field of leukemia. With respect to leukemia research, the LGA is a unique resource with comprehensive search and browse functions. It provides extensive analysis and visualization tools for various types of molecular data. Currently, its database contains data from more than 5,800 leukemia and hematopoiesis samples generated by microarray gene expression, DNA methylation, SNP and next generation sequencing analyses. The LGA allows easy retrieval of large published data sets and thus helps to avoid redundant investigations. It is accessible at www.leukemia-gene-atlas.org.	[Hebestreit, Katja; Groettrup, Soeren; Emden, Daniel; Veerkamp, Jannis; Ruckert, Christian; Klein, Hans-Ulrich; Dugas, Martin] Univ Munster, Inst Med Informat, Munster, Germany; [Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol & Oncol, Munster, Germany	University of Munster; University of Munster	Hebestreit, K (corresponding author), Univ Munster, Inst Med Informat, Munster, Germany.	dugas@uni-muenster.de	Klein, Hans-Ulrich/O-5118-2019; Klein, Hans-Ulrich/A-7801-2013; Hebestreit, Katja/A-7906-2013; Dugas, Martin/F-5454-2011; Ruckert, Christian/A-8732-2013; Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014	Klein, Hans-Ulrich/0000-0002-6382-9428; Klein, Hans-Ulrich/0000-0002-6382-9428; Ruckert, Christian/0000-0001-9915-1287; Müller-Tidow, Carsten/0000-0002-7166-5232; 	Jose Carreras Foundation [DJCLS 09/04]; COST Action [BM0801]	Jose Carreras Foundation; COST Action(European Cooperation in Science and Technology (COST))	The Leukemia Gene Atlas is supported by the Jose Carreras Foundation (DJCLS 09/04) and COST Action BM0801 Translating genomic and epigenetic studies of MDS and AML (EuGESMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluteau D, 2011, BLOOD, V118, P6310, DOI 10.1182/blood-2010-12-325555; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cronin M, 2011, BIOMARK MED, V5, P293, DOI [10.2217/BMM.11.37, 10.2217/bmm.11.37]; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gadaleta E, 2011, BRIEF BIOINFORM, V12, P52, DOI 10.1093/bib/bbq010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Huret JL, 2001, NUCLEIC ACIDS RES, V29, P303, DOI 10.1093/nar/29.1.303; Klein HU, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-422; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Neff T, 2009, LEUKEMIA, V23, P1243, DOI 10.1038/leu.2009.40; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Theilgaard-Monch K, 2011, LEUKEMIA, V25, P909, DOI 10.1038/leu.2011.48; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299	24	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39148	10.1371/journal.pone.0039148	http://dx.doi.org/10.1371/journal.pone.0039148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720055	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347800047
J	Hudson, RP; Chong, PA; Protasevich, II; Vernon, R; Noy, E; Bihler, H; An, JL; Kalid, O; Sela-Culang, I; Mense, M; Senderowitz, H; Brouillette, CG; Forman-Kay, JD				Hudson, Rhea P.; Chong, P. Andrew; Protasevich, Irina I.; Vernon, Robert; Noy, Efrat; Bihler, Hermann; An, Jian Li; Kalid, Ori; Sela-Culang, Inbal; Mense, Martin; Senderowitz, Hanoch; Brouillette, Christie G.; Forman-Kay, Julie D.			Conformational Changes Relevant to Channel Activity and Folding within the first Nucleotide Binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; DELTA-F508 CFTR; IN-VITRO; R-DOMAIN; HIGH-THROUGHPUT; PROTEIN-KINASE; CL-CHANNEL; MUTATION; PHOSPHORYLATION; IDENTIFICATION	Deletion of Phe-508 (F508del) in the first nucleotide binding domain (NBD1) of the cystic fibrosis transmembrane conductance regulator (CFTR) leads to defects in folding and channel gating. NMR data on human F508del NBD1 indicate that an H620Q mutant, shown to increase channel open probability, and the dual corrector/potentiator CFFT-001 similarly disrupt interactions between beta-strands S3, S9, and S10 and the C-terminal helices H8 and H9, shifting a preexisting conformational equilibrium from helix to coil. CFFT-001 appears to interact with beta-strands S3/S9/S10, consistent with docking simulations. Decreases in T-m from differential scanning calorimetry with H620Q or CFFT-001 suggest direct compound binding to a less thermostable state of NBD1. We hypothesize that, in full-length CFTR, shifting the conformational equilibrium to reduce H8/H9 interactions with the uniquely conserved strands S9/S10 facilitates release of the regulatory region from the NBD dimerization interface to promote dimerization and thereby increase channel open probability. These studies enabled by our NMR assignments for F508del NBD1 provide a window into the conformational fluctuations within CFTR that may regulate function and contribute to folding energetics.	[Hudson, Rhea P.; Chong, P. Andrew; Vernon, Robert; Forman-Kay, Julie D.] Univ Toronto, Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5S 1A8, Canada; [Hudson, Rhea P.; Chong, P. Andrew; Vernon, Robert; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Protasevich, Irina I.; An, Jian Li; Brouillette, Christie G.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Noy, Efrat; Senderowitz, Hanoch] Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel; [Bihler, Hermann; Mense, Martin] Cyst Fibrosis Fdn Therapeut, Bedford, MA 01730 USA; [Brouillette, Christie G.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Kalid, Ori; Sela-Culang, Inbal] Epix Pharmaceut, Lexington, MA 02421 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Alabama System; University of Alabama Birmingham; Bar Ilan University; Cystic Fibrosis Foundation; University of Alabama System; University of Alabama Birmingham	Forman-Kay, JD (corresponding author), Hosp Sick Children, Rm 3401,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	forman@sickkids.ca		Bihler, Hermann/0000-0002-8167-1548; Forman-Kay, Julie/0000-0001-8265-972X	Cystic Fibrosis Foundation Therapeutics [FORMAN05XX0, BROUIL08XX0, BROUIL07XX0, SENDER09XX0]; Cystic Fibrosis Canada	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Canada	This work was supported by Cystic Fibrosis Foundation Therapeutics Grants FORMAN05XX0 (to J. D. F.-K.), BROUIL08XX0 and BROUIL07XX0 (to C. G. B.), and SENDER09XX0 (to H. S.) and Cystic Fibrosis Canada (J. D. F.-K.).	Accelrys, 2005, DISC STUD MOD ENV; Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, SCHROD SUIT 2010 IND; [Anonymous], 2010, MAESTR VERS 9 1; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Billet A, 2010, J BIOL CHEM, V285, P22132, DOI 10.1074/jbc.M110.120683; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Chang P., 2010, Patent WO, Patent No. [2010/151747 A1, 2010151747]; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2004, P NATL ACAD SCI USA, V101, P390, DOI 10.1073/pnas.0303411101; Chong P. A., 2012, CYSTIC FIBROSIS MOL; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Csanady L, 2005, J GEN PHYSIOL, V125, P43, DOI 10.1085/jgp.200409174; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Goddard T. D., 2008, SPARKY 3 VERSION 3; Hadida R. S., 2007, Patent WO, Patent No. [2007/021982 A2, 2007021982]; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanelis V, 2011, METHODS MOL BIOL, V741, P377, DOI 10.1007/978-1-61779-117-8_25; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rule GS, 2006, FUNDAMENTALS PROTEIN; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Seavilleklein G, 2008, AM J PHYSIOL-CELL PH, V295, pC1366, DOI 10.1152/ajpcell.00034.2008; Sharma S, 2007, BIOPHYS J, V92, P1457, DOI 10.1529/biophysj.106.094805; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Van Goor F, 2011, PEDIATR PULM, P215; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vankeerberghen A, 1998, FEBS LETT, V437, P1, DOI 10.1016/S0014-5793(98)01042-4; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wei L, 1998, FEBS LETT, V439, P121, DOI 10.1016/S0014-5793(98)01351-9; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	69	40	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28480	28494		10.1074/jbc.M112.371138	http://dx.doi.org/10.1074/jbc.M112.371138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22722932	Green Published, hybrid			2022-12-25	WOS:000308074600023
J	Motter, AL; Ahern, GP				Motter, Arianne L.; Ahern, Gerard P.			TRPA1 Is a Polyunsaturated Fatty Acid Sensor in Mammals	PLOS ONE			English	Article							ION-CHANNEL TRPA1; IRRITANT RECEPTOR TRPA1; COVALENT MODIFICATION; DIRECT ACTIVATION; CALCIUM-IONS; SECRETION; CELLS; PAIN; INFLAMMATION; NOCICEPTION	Fatty acids can act as important signaling molecules regulating diverse physiological processes. Our understanding, however, of fatty acid signaling mechanisms and receptor targets remains incomplete. Here we show that Transient Receptor Potential Ankyrin 1 (TRPA1), a cation channel expressed in sensory neurons and gut tissues, functions as a sensor of polyunsaturated fatty acids (PUFAs) in vitro and in vivo. PUFAs, containing at least 18 carbon atoms and three unsaturated bonds, activate TRPA1 to excite primary sensory neurons and enteroendocrine cells. Moreover, behavioral aversion to PUFAs is absent in TRPA1-null mice. Further, sustained or repeated agonism with PUFAs leads to TRPA1 desensitization. PUFAs activate TRPA1 non-covalently and independently of known ligand binding domains located in the N-terminus and 5th transmembrane region. PUFA sensitivity is restricted to mammalian (rodent and human) TRPA1 channels, as the drosophila and zebrafish TRPA1 orthologs do not respond to DHA. We propose that PUFA-sensing by mammalian TRPA1 may regulate pain and gastrointestinal functions.	[Motter, Arianne L.; Ahern, Gerard P.] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC 20057 USA	Georgetown University	Motter, AL (corresponding author), Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC 20057 USA.	gpa3@georgetown.edu			National Institute of Neurological Disorders and Stroke; American Recovery and Reinvestment Act	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Recovery and Reinvestment Act	This work was supported by grants from National Institute of Neurological Disorders and Stroke and the American Recovery and Reinvestment Act 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Boesmans W, 2011, BRIT J PHARMACOL, V162, P18, DOI 10.1111/j.1476-5381.2010.01009.x; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Cattaruzza F, 2010, AM J PHYSIOL-GASTR L, V298, pG81, DOI 10.1152/ajpgi.00221.2009; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; CLANDININ MT, 1989, ACTA PAEDIATR SCAND, P63; Cordero-Morales JF, 2011, P NATL ACAD SCI US; CRAWFORD MA, 1989, J INTERN MED, V225, P159, DOI 10.1111/j.1365-2796.1989.tb01450.x; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Doihara H, 2009, N-S ARCH PHARMACOL, V380, P353, DOI 10.1007/s00210-009-0435-7; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; GONZALEZ MJ, 1992, J NUTR, V122, P2190, DOI 10.1093/jn/122.11.2190; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kondo T, 2009, GUT, V58, P1342, DOI 10.1136/gut.2008.175901; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leaf A, 2003, PHARMACOL THERAPEUT, V98, P355, DOI 10.1016/S0163-7258(03)00039-1; Lindquist S, 2010, CURR OPIN CLIN NUTR, V13, P314, DOI 10.1097/MCO.0b013e328337bbf0; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Matta JA, 2007, J PHYSIOL-LONDON, V578, P397, DOI 10.1113/jphysiol.2006.121988; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Poole DP, 2011, GASTROENTEROLOGY; Purhonen AK, 2008, FEBS LETT, V582, P229, DOI 10.1016/j.febslet.2007.12.005; Refsgaard HHF, 2000, J AGR FOOD CHEM, V48, P3280, DOI 10.1021/jf000021c; Sculptoreanu A, 2010, J PHARMACOL EXP THER, V333, P883, DOI 10.1124/jpet.109.163154; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; Spiller RC, 2001, CURR OPIN GASTROEN, V17, P99, DOI 10.1097/00001574-200103000-00001; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	58	51	53	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38439	10.1371/journal.pone.0038439	http://dx.doi.org/10.1371/journal.pone.0038439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723860	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700016
J	Ma, YJ; Liu, DX				Ma, Yongjie; Liu, Dexi			Activation of Pregnane X Receptor by Pregnenolone 16 alpha-carbonitrile Prevents High-Fat Diet-Induced Obesity in AKR/J Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; NUCLEAR RECEPTOR; INSULIN-RESISTANCE; MOUSE STRAINS; PPAR-GAMMA; CROSS-TALK; METABOLISM; PXR; EXPRESSION; GENE	Pregnane X receptor (PXR) is known to function as a xenobiotic sensor to regulate xenobiotic metabolism through selective transcription of genes responsible for maintaining physiological homeostasis. Here we report that the activation of PXR by pregnenolone 16 alpha-carbonitrile (PCN) in AKR/J mice can prevent the development of high-fat diet-induced obesity and insulin resistance. The beneficial effects of PCN treatment are seen with reduced lipogenesis and gluconeogenesis in the liver, and lack of hepatic accumulation of lipid and lipid storage in the adipose tissues. RT-PCR analysis of genes involved in gluconeogenesis, lipid metabolism and energy homeostasis reveal that PCN treatment on high-fat diet-fed mice reduces expression in the liver of G6Pase, Pepck, Cyp7a1, Cd36, L-Fabp, Srebp, and Fas genes and slightly enhances expression of Cyp27a1 and Abca1 genes. RT-PCR analysis of genes involved in adipocyte differentiation and lipid metabolism in white adipose tissue show that PCN treatment reduces expression of Ppar gamma 2, Acc1, Cd36, but increases expression of Cpt1b and Ppar alpha genes in mice fed with high-fat diet. Similarly, PCN treatment of animals on high-fat diet increases expression in brown adipose tissue of Ppar alpha, Hsl, Cpt1b, and Cd36 genes, but reduces expression of Acc1 and Scd-1 genes. PXR activation by PCN in high-fat diet fed mice also increases expression of genes involved in thermogenesis in brown adipose tissue including Dio2, Pgc-1 alpha, Pgc-1 beta, Cidea, and Ucp-3. These results verify the important function of PXR in lipid and energy metabolism and suggest that PXR represents a novel therapeutic target for prevention and treatment of obesity and insulin resistance.	[Ma, Yongjie; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Ma, YJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	dliu@uga.edu	MA, YONGJIE/O-3861-2015		NIH [RO1EB007357, RO1HL098295]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work is supported in part by NIH Grants (RO1EB007357, RO1HL098295]. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; EIRIS JM, 1995, NEUROLOGY, V45, P1155, DOI 10.1212/WNL.45.6.1155; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; He JH, 2011, GASTROENTEROLOGY, V140, P2095, DOI 10.1053/j.gastro.2011.02.055; HIMMSHAGEN J, 1985, ANNU REV NUTR, V5, P69, DOI 10.1146/annurev.nu.05.070185.000441; Hossain P, 2007, NEW ENGL J MED, V356, P973; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; KHOGALI AM, 1974, TUBERCLE, V55, P231, DOI 10.1016/0041-3879(74)90050-6; Kim Y, 2010, BIOTECHNOL J, V5, P99, DOI 10.1002/biot.200900228; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Kodama S, 2007, BIOCHEM J, V407, P373, DOI 10.1042/BJ20070481; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Li TG, 2005, AM J PHYSIOL-GASTR L, V288, pG74, DOI 10.1152/ajpgi.00258.2004; Montminy M, 2004, NATURE, V432, P958, DOI 10.1038/432958a; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664	39	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38734	10.1371/journal.pone.0038734	http://dx.doi.org/10.1371/journal.pone.0038734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723881	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300045
J	Roland, MCP; Friis, CM; Voldner, N; Godang, K; Bollerslev, J; Haugen, G; Henriksen, T				Roland, Marie Cecilie Paasche; Friis, Camilla M.; Voldner, Nanna; Godang, Kristin; Bollerslev, Jens; Haugen, Guttorm; Henriksen, Tore			Fetal Growth versus Birthweight: The Role of Placenta versus Other Determinants	PLOS ONE			English	Article							MACROSOMIA; OVERWEIGHT; NUTRITION; COHORT; SIZE; RISK	Introduction: Birthweight is used as an indicator of intrauterine growth, and determinants of birthweight are widely studied. Less is known about determinants of deviating patterns of growth in utero. We aimed to study the effects of maternal characteristics on both birthweight and fetal growth in third trimester and introduce placental weight as a possible determinant of both birthweight and fetal growth in third trimester. Methods: The STORK study is a prospective cohort study including 1031 healthy pregnant women of Scandinavian heritage with singleton pregnancies. Maternal determinants (age, parity, body mass index (BMI), gestational weight gain and fasting plasma glucose) of birthweight and fetal growth estimated by biometric ultrasound measures were explored by linear regression models. Two models were fitted, one with only maternal characteristics and one which included placental weight. Results: Placental weight was a significant determinant of birthweight. Parity, BMI, weight gain and fasting glucose remained significant when adjusted for placental weight. Introducing placental weight as a covariate reduced the effect estimate of the other variables in the model by 62% for BMI, 40% for weight gain, 33% for glucose and 22% for parity. Determinants of fetal growth were parity, BMI and weight gain, but not fasting glucose. Placental weight was significant as an independent variable. Parity, BMI and weight gain remained significant when adjusted for placental weight. Introducing placental weight reduced the effect of BMI on fetal growth by 23%, weight gain by 14% and parity by 17%. Conclusion: In conclusion, we find that placental weight is an important determinant of both birthweight and fetal growth. Our findings indicate that placental weight markedly modifies the effect of maternal determinants of both birthweight and fetal growth. The differential effect of third trimester glucose on birthweight and growth parameters illustrates that birthweight and fetal growth are not identical entities.	[Roland, Marie Cecilie Paasche; Friis, Camilla M.; Voldner, Nanna; Haugen, Guttorm; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Dept Specialized Endocrinol, Oslo, Norway; [Bollerslev, Jens; Haugen, Guttorm; Henriksen, Tore] Univ Oslo, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Roland, MCP (corresponding author), Oslo Univ Hosp, Dept Obstet, Oslo, Norway.	mcpaasche@hotmail.com			University of Oslo; Thematic research: Perinatal nutrition; Oslo University Hospital, Department of Obstetrics; Norwegian Health Association; Norwegian Extrafoundation for Health and Rehabilitation	University of Oslo; Thematic research: Perinatal nutrition; Oslo University Hospital, Department of Obstetrics; Norwegian Health Association; Norwegian Extrafoundation for Health and Rehabilitation	This project has been financially supported by: University of Oslo; Thematic research: Perinatal nutrition. Oslo University Hospital, Department of Obstetrics. The Norwegian Health Association. The Norwegian Extrafoundation for Health and Rehabilitation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Baptiste-Roberts Kesha, 2008, BMC Pregnancy Childbirth, V8, P44, DOI 10.1186/1471-2393-8-44; Barker DJP, 1997, CLIN OBSTET GYNECOL, V40, P853, DOI 10.1097/00003081-199712000-00019; Baumann MU, 2002, ENDOCRINE, V19, P13, DOI 10.1385/ENDO:19:1:13; Cetin I, 2005, ACTA PAEDIATR, V94, P7, DOI 10.1080/08035320510043709; COMBS CA, 1993, OBSTET GYNECOL, V82, P365; Dietz PM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.051; Dietz PM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.045; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Friis CM, 2010, J DEV ORIG HLTH DIS, V1, P310, DOI 10.1017/S204017441000036X; Froslie KF, 2011, CLIN BIOCHEM, V44, P1483, DOI 10.1016/j.clinbiochem.2011.08.1150; GARROW JS, 1971, J OBSTET GYN BR COMM, V78, P22; Hafner E, 2000, ULTRASOUND OBST GYN, V16, P625, DOI 10.1046/j.1469-0705.2000.00290.x; Haggarty P, 2010, ANNU REV NUTR, V30, P237, DOI 10.1146/annurev.nutr.012809.104742; Jansson T, 2001, PEDIATR RES, V49, P141, DOI 10.1203/00006450-200102000-00003; Johnsen SL, 2006, ACTA OBSTET GYN SCAN, V85, P286, DOI 10.1080/00016340600569133; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Leary SD, 2003, PLACENTA, V24, P276, DOI 10.1053/plac.2002.0888; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; MOLTENI RA, 1984, SEMIN PERINATOL, V8, P94; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; PEDERSEN J, 1952, Nord Med, V47, P1049; Salafia CM, 2008, PAEDIATR PERINAT EP, V22, P229, DOI 10.1111/j.1365-3016.2008.00935.x; Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007; Schaefer-Graf UM, 2003, DIABETES CARE, V26, P193, DOI 10.2337/diacare.26.1.193; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Stettler N, 2000, AM J CLIN NUTR, V72, P378; Thame M, 2004, EUR J CLIN NUTR, V58, P894, DOI 10.1038/sj.ejcn.1601909; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Voldner N, 2010, J MATERN-FETAL NEO M, V23, P74, DOI 10.3109/14767050903121472; Voldner N, 2009, ACTA OBSTET GYN SCAN, V88, P550, DOI 10.1080/00016340902818162; 2010, BJOG INT J OBSTET GY, V117, P575	34	102	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39324	10.1371/journal.pone.0039324	http://dx.doi.org/10.1371/journal.pone.0039324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723995	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300132
J	Roy, A; Ghosh, A; Jana, A; Liu, XJ; Brahmachari, S; Gendelman, HE; Pahan, K				Roy, Avik; Ghosh, Anamitra; Jana, Arundhati; Liu, Xiaojuan; Brahmachari, Saurav; Gendelman, Howard E.; Pahan, Kalipada			Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HISTONE DEACETYLASE INHIBITORS; NF-KAPPA-B; PRIMARY ASTROCYTES; NADPH OXIDASE; UP-REGULATION; NEUTRAL SPHINGOMYELINASE; OXIDATIVE STRESS; ACTIVATION; INDUCTION	Neuroinflammation and oxidative stress underlie the pathogenesis of various neurodegenerative disorders. Here we demonstrate that sodium phenylbutyrate (NaPB), an FDA-approved therapy for reducing plasma ammonia and glutamine in urea cycle disorders, can suppress both proinflammatory molecules and reactive oxygen species (ROS) in activated glial cells. Interestingly, NaPB also decreased the level of cholesterol but involved only intermediates, not the end product of cholesterol biosynthesis pathway for these functions. While inhibitors of both geranylgeranyl transferase (GGTI) and farnesyl transferase (FTI) inhibited the activation of NF-kappa B, inhibitor of GGTI, but not FTI, suppressed the production of ROS. Accordingly, a dominant-negative mutant of p21(rac), but not p21(ras), attenuated the production of ROS from activated microglia. Inhibition of both p21(ras) and p21(rac) activation by NaPB in microglial cells suggests that NaPB exerts anti-inflammatory and antioxidative effects via inhibition of these small G proteins. Consistently, we found activation of both p21(ras) and p21(rac) in vivo in the substantia nigra of acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Oral administration of NaPB reduced nigral activation of p21(ras) and p21(rac), protected nigral reduced glutathione, attenuated nigral activation of NF-kappa B, inhibited nigral expression of proinflammatory molecules, and suppressed nigral activation of glial cells. These findings paralleled dopaminergic neuronal protection, normalized striatal neurotransmitters, and improved motor functions in MPTP-intoxicated mice. Consistently, FTI and GGTI also protected nigrostriata in MPTP-intoxicated mice. Furthermore, NaPB also halted the disease progression in a chronic MPTP mouse model. These results identify novel mode of action of NaPB and suggest that NaPB may be of therapeutic benefit for neurodegenerative disorders.	[Roy, Avik; Ghosh, Anamitra; Jana, Arundhati; Brahmachari, Saurav; Pahan, Kalipada] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Liu, Xiaojuan; Pahan, Kalipada] Univ Nebraska, Med Ctr, Coll Dent, Sect Neurosci, Lincoln, NE 68583 USA; [Gendelman, Howard E.] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	Rush University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Roy, A (corresponding author), Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu	Ghosh, Anamitra/C-5118-2015; Gendelman, Howard E/G-8242-2012	Ghosh, Anamitra/0000-0001-9740-2070	National Institutes of Health [NS48923, NS64564, NS71479]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064564, R21NS071479, R21NS048923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the National Institutes of Health (NS48923, NS64564 and NS71479). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; GIULIAN D, 1986, J NEUROSCI, V6, P2163; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Jana A, 2004, J BIOL CHEM, V279, P51451, DOI 10.1074/jbc.M404635200; Jana A, 2004, J NEUROSCI, V24, P9531, DOI 10.1523/JNEUROSCI.3085-04.2004; Jana M, 2005, FREE RADICAL BIO MED, V38, P655, DOI 10.1016/j.freeradbiomed.2004.11.021; Jana M, 2001, J BIOL CHEM, V276, P44527, DOI 10.1074/jbc.M106771200; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; KIKUCHI A, 1994, J BIOL CHEM, V269, P20054; Lahaie-Collins V, 2008, OXID MED CELL LONGEV, V1, P54, DOI 10.4161/oxim.1.1.6958; Liu XJ, 2002, J BIOL CHEM, V277, P39312, DOI 10.1074/jbc.M205107200; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Meredith Gloria E, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS112, DOI 10.1016/j.parkreldis.2008.04.012; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; OURESHI GA, 1995, NEUROREPORT, V6, P1642, DOI 10.1097/00001756-199508000-00013; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Pahan K, 2000, J NEUROCHEM, V74, P2288, DOI 10.1046/j.1471-4159.2000.0742288.x; Phuphanich S, 2005, NEURO-ONCOLOGY, V7, P177, DOI 10.1215/S1152851704000183; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Roy A, 2011, NEUROSCIENTIST, V17, P244, DOI 10.1177/1073858410385006; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Saha RN, 2006, NEUROCHEM INT, V49, P154, DOI 10.1016/j.neuint.2006.04.007; THIBAULT A, 1994, CANCER RES, V54, P1690; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje; Zhang X, 2012, MOL NEURODEGENER S1, V7, pS24; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029	50	77	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38113	10.1371/journal.pone.0038113	http://dx.doi.org/10.1371/journal.pone.0038113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723850	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300021
J	Soderberg, CAG; Lambert, W; Kjellstrom, S; Wiegandt, A; Wulff, RP; Mansson, C; Rutsdottir, G; Emanuelsson, C				Soderberg, Christopher A. G.; Lambert, Wietske; Kjellstrom, Sven; Wiegandt, Alena; Wulff, Ragna Peterson; Mansson, Cecilia; Rutsdottir, Gudrun; Emanuelsson, Cecilia			Detection of Crosslinks within and between Proteins by LC-MALDI-TOFTOF and the Software FINDX to Reduce the MSMS-Data to Acquire for Validation	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MASS-SPECTROMETRY; PEPTIDES; IDENTIFICATION; COMPLEXES; MODEL; TOOL	Lysine-specific chemical crosslinking in combination with mass spectrometry is emerging as a tool for the structural characterization of protein complexes and protein-protein interactions. After tryptic digestion of crosslinked proteins there are thousands of peptides amenable to MSMS, of which only very few are crosslinked peptides of interest. Here we describe how the advantage offered by off-line LC-MALDI-TOF/TOF mass spectrometry is exploited in a two-step workflow to focus the MSMS-acquisition on crosslinks mainly. In a first step, MS-data are acquired and all the peak list files from the LC-separated fractions are merged by the FINDX software and screened for presence of crosslinks which are recognized as isotope-labeled doublet peaks. Information on the isotope doublet peak mass and intensity can be used as search constraints to reduce the number of false positives that match randomly to the observed peak masses. Based on the MS-data a precursor ion inclusion list is generated and used in a second step, where a restricted number of MSMS-spectra are acquired for crosslink validation. The decoupling of MS and MSMS and the peptide sorting with FINDX based on MS-data has the advantage that MSMS can be restricted to and focused on crosslinks of Type 2, which are of highest biological interest but often lowest in abundance. The LC-MALDI-TOF/TOF workflow here described is applicable to protein multisubunit complexes and using N-14/N-15 mixed isotope strategy for the detection of inter-protein crosslinks within protein oligomers.	[Soderberg, Christopher A. G.; Lambert, Wietske; Kjellstrom, Sven; Wiegandt, Alena; Wulff, Ragna Peterson; Mansson, Cecilia; Rutsdottir, Gudrun; Emanuelsson, Cecilia] Lund Univ, Inst Chem & Chem Engn, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden	Lund University	Soderberg, CAG (corresponding author), Lund Univ, Inst Chem & Chem Engn, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden.	Cecilia.Emanuelsson@biochemistry.lu.se	Söderberg, Christopher/E-1819-2013	Kjellstrom, Sven/0000-0003-4646-5279	Carl Tryggers Foundation [CTS 09:96]	Carl Tryggers Foundation	Funding for the study was provided by the Carl Tryggers Foundation (CTS 09:96). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrman E, 2007, PROTEIN SCI, V16, P1464, DOI 10.1110/ps.072831607; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Lambert W, 2011, PROTEIN SCI, V20, P291, DOI 10.1002/pro.560; Lambert W, 2011, PROTEIN SCI, V20, P1682, DOI 10.1002/pro.699; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Mayne SLN, 2011, BRIEF BIOINFORM, V12, P660, DOI 10.1093/bib/bbq087; Muller DR, 2001, ANAL CHEM, V73, P1927, DOI 10.1021/ac001379a; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Painter AJ, 2008, CHEM BIOL, V15, P246, DOI 10.1016/j.chembiol.2008.01.009; Peri S, 2001, TRENDS BIOCHEM SCI, V26, P687, DOI 10.1016/S0968-0004(01)01954-5; Petrotchenko EV, 2010, MASS SPECTROM REV, V29, P862, DOI 10.1002/mas.20293; Rasmussen MI, 2011, J PROTEOMICS, V74, P1871, DOI 10.1016/j.jprot.2011.04.019; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Singh P, 2010, ANAL CHEM, V82, P2636, DOI 10.1021/ac1000724; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Stengel F, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.R111.014027; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Taverner T, 2002, J BIOL CHEM, V277, P46487, DOI 10.1074/jbc.M207370200; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Zhang RJ, 2001, ANAL CHEM, V73, P5142, DOI 10.1021/ac010583a	27	19	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38927	10.1371/journal.pone.0038927	http://dx.doi.org/10.1371/journal.pone.0038927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723907	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300067
J	Inostroza, M; Cid, E; de la Prida, LM; Sandi, C				Inostroza, Marion; Cid, Elena; Menendez de la Prida, Liset; Sandi, Carmen			Different Emotional Disturbances in Two Experimental Models of Temporal Lobe Epilepsy in Rats	PLOS ONE			English	Article							KAINIC ACID; STATUS EPILEPTICUS; SEIZURES; DEPRESSION; ANXIETY; PILOCARPINE; BEHAVIOR; INJURY; IMPAIRMENT; ACTIVATION	Affective symptoms such as anxiety and depression are frequently observed in patients with epilepsy. The mechanisms of comorbidity of epilepsy and affective disorders, however, remain unclear. Diverse models are traditionally used in epilepsy research, including the status epilepticus (SE) model in rats, which are aimed at generating chronic epileptic animals; however, the implications of different SE models and rat strains in emotional behaviors has not been reported. To address this issue, we examined the emotional sequelae of two SE models of temporal lobe epilepsy (TLE) - the lithium-pilocarpine (LIP) model and the kainic acid (KA) model - in two different rat strains (Wistar and Sprague-Dawley), which differ significantly in the pattern and extent of TLE-associated brain lesions. We found differences between LIP-and KA-treated animals in tests for depression-like and anxiety-like behaviors, as well as differences in plasma corticosterone levels. Whereas only LIP-treated rats displayed increased motivation to consume saccharin, both SE models led to reduced motivation for social contact, with LIP-treated animals being particularly affected. Evaluation of behavior in the open field test indicated very low levels of anxiety in LIP-treated rats and a mild decrease in KA-treated rats compared to controls. After exposure to a battery of behavioral tests, plasma corticosterone levels were increased only in LIP-treated animals. This hyperactivity in the hypothalamus-pituitary-adrenocortical (HPA) axis was highly correlated with performance in the open field test and the social interaction test, suggesting that comorbidity of epilepsy and emotional behaviors might also be related to other factors such as HPA axis function. Our results indicate that altered emotional behaviors are not inherent to the epileptic condition in experimental TLE; instead, they likely reflect alterations in anxiety levels related to model-dependent dysregulation of the HPA axis.	[Inostroza, Marion; Cid, Elena; Menendez de la Prida, Liset] CSIC, Inst Cajal, Madrid, Spain; [Inostroza, Marion] Univ Chile, Dept Psicol, Santiago, Chile; [Sandi, Carmen] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, CH-1015 Lausanne, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad de Chile; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Inostroza, M (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany.	carmen.sandi@epfl.ch	de la Prida, Liset M/O-1342-2013; Cid, Elena/N-5072-2014; Inostroza, Marion/R-9394-2018	de la Prida, Liset M/0000-0002-0160-6472; Cid, Elena/0000-0003-4852-595X; Inostroza, Marion/0000-0003-3483-1905; Sandi, Carmen/0000-0001-7713-8321	EU [201600]	EU(European Commission)	This work was supported by a FP7 EU grant (MemStick, No 201600; http://cordis.europa.eu/fp7/home_en.html) to CS and LMP. MI was a PhD student fellow from CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica; www.conicyt.cl), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2004, BRAIN RES, V1024, P44, DOI 10.1016/j.brainres.2004.06.074; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; Cardoso A, 2011, BEHAV BRAIN RES, V225, P538, DOI 10.1016/j.bbr.2011.07.057; Cardoso A, 2009, EPILEPSY BEHAV, V14, P293, DOI 10.1016/j.yebeh.2008.11.004; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; DANIELS WMU, 1990, NEUROCHEM RES, V15, P495, DOI 10.1007/BF00966206; Del Rio JA, 2002, PROG BRAIN RES, V135, P149; Detour J, 2005, EPILEPSIA, V46, P499, DOI 10.1111/j.0013-9580.2005.38704.x; dos Santos NF, 2000, BRAIN RES REV, V32, P269, DOI 10.1016/S0165-0173(99)00089-2; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; GALLAGHER BB, 1987, YALE J BIOL MED, V60, P93; Hannesson DK, 2001, J NEUROSCI, V21, P4443, DOI 10.1523/JNEUROSCI.21-12-04443.2001; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hort J, 2000, BEHAV BRAIN RES, V112, P77, DOI 10.1016/S0166-4328(00)00163-7; Inostroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022372; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Kanner AM, 2003, BIOL PSYCHIAT, V54, P388, DOI 10.1016/S0006-3223(03)00469-4; Kanner AM, 2007, EPILEPSIA, V48, P20, DOI 10.1111/j.1528-1167.2007.01395.x; Kondziella D, 2007, J NEUROCHEM, V103, P2136, DOI 10.1111/j.1471-4159.2007.04926.x; Kubova H, 2004, EUR J NEUROSCI, V19, P3255, DOI 10.1111/j.0953-816X.2004.03410.x; Lai MC, 2006, EPILEPSY RES, V68, P123, DOI 10.1016/j.eplepsyres.2005.10.005; Landgraf R, 2003, STRESS, V6, P111, DOI 10.1080/1025389031000104193; Loscher W, 1998, EXP NEUROL, V154, P551, DOI 10.1006/exnr.1998.6948; Marin JCM, 2008, EPILEPSY BEHAV, V13, P43, DOI 10.1016/j.yebeh.2008.03.004; Marquez C, 2006, BEHAV BRAIN RES, V168, P13, DOI 10.1016/j.bbr.2005.10.004; Mazarati A, 2008, BRAIN, V131, P2071, DOI 10.1093/brain/awn117; Mazarati AM, 2009, NEUROBIOL DIS, V34, P457, DOI 10.1016/j.nbd.2009.02.018; MELLANBY J, 1981, J NEUROL NEUROSUR PS, V44, P1084, DOI 10.1136/jnnp.44.12.1084; Motte J, 1998, BRAIN RES, V793, P61, DOI 10.1016/S0006-8993(98)00135-8; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Piazzini A, 2001, EPILEPSY BEHAV, V2, P481, DOI 10.1006/ebeh.2001.0247; Pineda E, 2010, EPILEPSIA, V51, P110, DOI 10.1111/j.1528-1167.2010.02623.x; PUCILOWSKI O, 1993, BRAIN RES BULL, V32, P471, DOI 10.1016/0361-9230(93)90293-K; Racine RJ, 2003, NEUROPHARMACOLOGY, V45, P918, DOI 10.1016/S0028-3908(03)00252-1; Romeas T, 2009, PSYCHOPHARMACOLOGY, V205, P293, DOI 10.1007/s00213-009-1539-y; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Sandi C, 2007, NEURAL PLAST, DOI [10.1155/2077/78970, DOI 10.1155/2077/78970]; Sayin U, 2004, EPILEPSIA, V45, P1539, DOI 10.1111/j.0013-9580.2004.54903.x; Shaw FZ, 2009, NEUROSCIENCE, V160, P382, DOI 10.1016/j.neuroscience.2009.02.053; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; SZAFARCZYK A, 1986, EXP NEUROL, V92, P583, DOI 10.1016/0014-4886(86)90300-6; Tchekalarova J, 2011, EPILEPSY BEHAV, V20, P277, DOI 10.1016/j.yebeh.2010.12.021; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Wintink AJ, 2003, BEHAV NEUROSCI, V117, P632, DOI 10.1037/0735-7044.117.3.632; Xu B, 2004, EUR J NEUROSCI, V20, P403, DOI 10.1111/j.1460-9568.2004.03489.x; Yu S, 2008, J STEROID BIOCHEM, V108, P300, DOI 10.1016/j.jsbmb.2007.09.014; Zobel A, 2004, EUR ARCH PSY CLIN N, V254, P303, DOI 10.1007/s00406-004-0499-9	51	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38959	10.1371/journal.pone.0038959	http://dx.doi.org/10.1371/journal.pone.0038959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720001	gold, Green Published			2022-12-25	WOS:000305350000031
J	Liu, Y; Dang, HX; Li, D; Pang, W; Hammock, BD; Zhu, Y				Liu, Yan; Dang, Huaixin; Li, Dan; Pang, Wei; Hammock, Bruce D.; Zhu, Yi			Inhibition of Soluble Epoxide Hydrolase Attenuates High-Fat-Diet-Induced Hepatic Steatosis by Reduced Systemic Inflammatory Status in Mice	PLOS ONE			English	Article							BLOOD-PRESSURE REGULATION; HUMAN CYTOCHROMES P450; ADIPOSE-TISSUE; INSULIN-RESISTANCE; LIVER-DISEASE; DOCOSAHEXAENOIC ACID; ARACHIDONIC-ACID; TNF-ALPHA; IN-VIVO; OBESITY	Non-alcoholic fatty liver disease is associated with obesity and considered an inflammatory disease. Soluble epoxide hydrolase (sEH) is a major enzyme hydrolyzing epoxyeicosatrienoic acids and attenuates their cardiovascular protective and anti-inflammatory effects. We examined whether sEH inhibition can protect against high-fat (HF)-diet-induced fatty liver in mice and the underlying mechanism. Compared with wild-type littermates, sEH-null mice showed lower diet-induced lipid accumulation in liver, as seen by Oil-red O staining and triglycerides levels. We studied the effect of sEH inhibition on diet-induced fatty liver by feeding C57BL/6 mice an HF diet for 8 weeks (short-term) or 16 weeks (long-term) and administering t-AUCB, a selective sEH inhibitor. sEH inhibition had no effect on the HF-diet-increased body and adipose tissue weight or impaired glucose tolerance but alleviated the diet-induced hepatic steatosis. Adenovirus-mediated overexpression of sEH in liver increased the level of triglycerides in liver and the hepatic inflammatory response. Surprisingly, the induced expression of sEH in liver occurred only with the long-term but not short-term HF diet, which suggests a secondary effect of HF diet on regulating sEH expression. Furthermore, sEH inhibition attenuated the HF-diet-induced increase in plasma levels of proinflammatory cytokines and their mRNA upregulation in adipose tissue, which was accompanied by increased macrophage infiltration. Therefore, sEH inhibition could alleviate HF-diet-induced hepatic steatosis, which might involve its anti-inflammatory effect in adipose tissue and direct inhibition in liver. sEH may be a therapeutic target for HF-diet-induced hepatic steatosis in inhibiting systemic inflammation.	[Liu, Yan; Dang, Huaixin; Li, Dan; Pang, Wei; Zhu, Yi] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci,Educ Minist, Beijing 100871, Peoples R China; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA	Peking University; University of California System; University of California Davis; University of California System; University of California Davis	Liu, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci,Educ Minist, Beijing 100871, Peoples R China.	zhuyi@hsc.pku.edu.cn	Li, Dan/B-6565-2018		Major National Basic Research Grant of China [2010BC912504]; National Natural Science Foundation of China [81130002, 30971063, 81121061]; "111" plan of China	Major National Basic Research Grant of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" plan of China(Ministry of Education, China - 111 Project)	This work was supported in part by grants from the Major National Basic Research Grant of China [No. 2010BC912504], and the National Natural Science Foundation of China [81130002, 30971063, 81121061], the "111" plan of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; Ai D, 2009, P NATL ACAD SCI USA, V106, P564, DOI 10.1073/pnas.0811022106; Busch L, 2009, INFLAMM RES, V58, P423, DOI 10.1007/s00011-009-0008-8; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P967, DOI 10.1111/j.1440-1746.2007.04995.x; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; De Taeye BM, 2009, OBESITY SILVER SPRIN, V18, P489; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Endo M, 2007, EXP BIOL MED, V232, P614; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Fishbein MH, 2006, J PEDIATR GASTR NUTR, V42, P83; Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Iyer A, 2012, EXP DIABETES RES, DOI 10.1155/2012/758614; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Liu JY, 2010, P NATL ACAD SCI USA, V107, P17017, DOI 10.1073/pnas.1011278107; Liu JY, 2009, BRIT J PHARMACOL, V156, P284, DOI 10.1111/j.1476-5381.2008.00009.x; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Pantanetti P, 2004, CLIN EXP HYPERTENS, V26, P387, DOI 10.1081/CEH-120034142; Sato K, 2004, J HUM GENET, V49, P29, DOI 10.1007/s10038-003-0103-6; Scarborough PE, 1999, DRUG METAB REV, V31, P205, DOI 10.1081/DMR-100101915; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolf NM, 2006, ANAL BIOCHEM, V355, P71, DOI 10.1016/j.ab.2006.04.045; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Zhang LN, 2009, ARTERIOSCL THROM VAS, V29, P1265, DOI 10.1161/ATVBAHA.109.186064	41	85	89	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39165	10.1371/journal.pone.0039165	http://dx.doi.org/10.1371/journal.pone.0039165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720061	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347800049
J	Dammanahalli, KJ; Stevens, S; Terkeltaub, R				Dammanahalli, K. Jagadeesha; Stevens, Stephanie; Terkeltaub, Robert			Vanin-1 Pantetheinase Drives Smooth Muscle Cell Activation in Post-Arterial Injury Neointimal Hyperplasia	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASES; GROWTH-FACTOR; PPAR-GAMMA; TRANSCRIPTION FACTOR; NAD(P)H OXIDASE; MMP-9 ACTIVITY; IN-VITRO; EXPRESSION; RECEPTOR	The pantetheinase vanin-1 generates cysteamine, which inhibits reduced glutathione (GSH) synthesis. Vanin-1 promotes inflammation and tissue injury partly by inducing oxidative stress, and partly by peroxisome proliferator-activated receptor gamma (PPAR gamma) expression. Vascular smooth muscle cells (SMCs) contribute to neointimal hyperplasia in response to injury, by multiple mechanisms including modulation of oxidative stress and PPAR gamma. Therefore, we tested the hypothesis that vanin-1 drives SMC activation and neointimal hyperplasia. We studied reactive oxygen species (ROS) generation and functional responses to platelet-derived growth factor (PDGF) and the pro-oxidant diamide in cultured mouse aortic SMCs, and also assessed neointima formation after carotid artery ligation in vanin-1 deficiency. Vnn1(-/-) SMCs demonstrated decreased oxidative stress, proliferation, migration, and matrix metalloproteinase 9 (MMP-9) activity in response to PDGF and/or diamide, with the effects on proliferation linked, in these studies, to both increased GSH levels and PPAR gamma expression. Vnn1(-/-) mice displayed markedly decreased neointima formation in response to carotid artery ligation, including decreased intima: media ratio and cross-sectional area of the neointima. We conclude that vanin-1, via dual modulation of GSH and PPAR gamma, critically regulates the activation of cultured SMCs and development of neointimal hyperplasia in response to carotid artery ligation. Vanin-1 is a novel potential therapeutic target for neointimal hyperplasia following revascularization.	[Dammanahalli, K. Jagadeesha] Univ Calif San Diego, San Diego VA Healthcare Syst, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Dammanahalli, KJ (corresponding author), Univ Calif San Diego, San Diego VA Healthcare Syst, San Diego, CA 92103 USA.	rterkeltaub@ucsd.edu			Veterans Affairs Research Service; NIH [HL077360, HL087252]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077360, R01HL087252] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Veterans Affairs Research Service and NIH (HL077360, HL087252) awards to Robert Terkeltaub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Berry C, 2001, CURR OPIN NEPHROL HY, V10, P247, DOI 10.1097/00041552-200103000-00014; Bhanoori M, 2003, ONCOGENE, V22, P117, DOI 10.1038/sj.onc.1206065; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Bruemmer D, 2003, AM J MED, V115, P87, DOI 10.1016/j.amjmed.2003.09.014; Chinetti G, 2001, Z Kardiol, V90 Suppl 3, P125; Ciudin A, 2012, CURR TOP MED CHEM, V12, P585, DOI 10.2174/156802612799436632; Datla SR, 2010, HYPERTENSION, V56, P325, DOI 10.1161/HYPERTENSIONAHA.109.142422; Doenhoff MJ, 2002, PARASITOLOGY, V125, P415, DOI 10.1017/S0031182002002275; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Feng WG, 2010, HYPERTENSION, V55, P1381, DOI 10.1161/HYPERTENSIONAHA.110.150995; Ferguson HE, 2006, AM J PHYSIOL-LUNG C, V291, pL19; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Garat CV, 2006, MOL CELL BIOL, V26, P4934, DOI 10.1128/MCB.02477-05; Goetze S, 2001, ATHEROSCLEROSIS, V159, P93, DOI 10.1016/S0021-9150(01)00497-X; Goetze S, 2001, J CARDIOVASC PHARM, V38, P909, DOI 10.1097/00005344-200112000-00013; Gong KW, 1996, J VASC RES, V33, P42, DOI 10.1159/000159130; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gurjar MV, 1999, ARTERIOSCL THROM VAS, V19, P2871, DOI 10.1161/01.ATV.19.12.2871; Hattori Y, 2000, BIOCHEM BIOPH RES CO, V273, P1144, DOI 10.1006/bbrc.2000.3084; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hsueh WA, 2001, DIABETES CARE, V24, P392, DOI 10.2337/diacare.24.2.392; HultgardhNilsson A, 1996, CIRC RES, V78, P589, DOI 10.1161/01.RES.78.4.589; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Johnson KA, 2008, AM J PATHOL, V172, P440, DOI 10.2353/ajpath.2008.070753; Kaskow BJ, 2012, BIOCHEM BIOPH RES CO, V417, P653, DOI 10.1016/j.bbrc.2011.11.099; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Martin F, 2001, IMMUNOGENETICS, V53, P296, DOI 10.1007/s002510100327; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Pouyet L, 2010, INFLAMM BOWEL DIS, V16, P96, DOI 10.1002/ibd.21031; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Ruan BH, 2010, ANAL BIOCHEM, V399, P284, DOI 10.1016/j.ab.2009.12.010; Saghaei F, 2010, EXP TOXICOL PATHOL; Shi Y, 2001, ARTERIOSCL THROM VAS, V21, P739, DOI 10.1161/01.ATV.21.5.739; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Zhang B, 2011, BLOOD, V117, P4569, DOI 10.1182/blood-2010-09-304931	43	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39106	10.1371/journal.pone.0039106	http://dx.doi.org/10.1371/journal.pone.0039106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720042	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900082
J	Wan, ZT; Lu, YM; Liao, QJ; Wu, Y; Chen, XL				Wan, Zhitao; Lu, Yimei; Liao, Qingjiao; Wu, Yang; Chen, Xulin			Fangchinoline Inhibits Human Immunodeficiency Virus Type 1 Replication by Interfering with gp160 Proteolytic Processing	PLOS ONE			English	Article							ANTI-HIV ACTIVITY; ENVELOPE GLYCOPROTEINS; ANTIRETROVIRAL THERAPY; SYNCYTIUM FORMATION; CLEAVAGE SEQUENCE; BETULINIC ACID; PEPTIDE; INFECTION; PRECURSOR; FURIN	The introduction of highly active antiretroviral therapy has led to a significant reduction in the morbidity and mortality of acquired immunodeficiency syndrome patients. However, the emergence of drug resistance has resulted in the failure of treatments in large numbers of patients and thus necessitates the development of new classes of anti-HIV drugs. In this study, more than 200 plant-derived small-molecule compounds were evaluated in a cell-based HIV-1 antiviral screen, resulting in the identification of a novel HIV-1 inhibitor (fangchinoline). Fangchinoline, a bisbenzylisoquinoline alkaloid isolated from Radix Stephaniae tetrandrae, exhibited antiviral activity against HIV-1 laboratory strains NL4-3, LAI and BaL in MT-4 and PM1 cells with a 50% effective concentration ranging from 0.8 to 1.7 mu M. Mechanism-of-action studies showed that fangchinoline did not exhibit measurable antiviral activity in TZM-b1 cells but did inhibit the production of infectious virions in HIV-1 cDNA transfected 293T cells, which suggests that the compound targets a late event in infection cycle. Furthermore, the antiviral effect of fangchinoline seems to be HIV-1 envelope-dependent, as the production of infectious HIV-1 particles packaged with a heterologous envelope, the vesicular stomatitis virus G glycoprotein, was unaffected by fangchinoline. Western blot analysis of HIV envelope proteins expressed in transfected 293T cells and in isolated virions showed that fangchinoline inhibited HIV-1 gp160 processing, resulting in reduced envelope glycoprotein incorporation into nascent virions. Collectively, our results demonstrate that fangchinoline inhibits HIV-1 replication by interfering with gp160 proteolytic processing. Fangchinoline may serve as a starting point for developing a new HIV-1 therapeutic approach.	[Wan, Zhitao; Lu, Yimei; Liao, Qingjiao; Wu, Yang; Chen, Xulin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wan, ZT (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.	chenxl@wh.iov.cn			Important National Science & Technology Specific Projects [2009ZX09301-014, 2008ZX10001-002]	Important National Science & Technology Specific Projects	This work was jointly funded by the Important National Science & Technology Specific Projects 2009ZX09301-014 and 2008ZX10001-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Aiken C, 2005, TRENDS MOL MED, V11, P31, DOI 10.1016/j.molmed.2004.11.001; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Barbouche R, 2000, VIROLOGY, V273, P169, DOI 10.1006/viro.2000.0368; Barbouche R, 1998, VIROLOGY, V247, P137, DOI 10.1006/viro.1998.9239; Blair WS, 2007, ANTIMICROB AGENTS CH, V51, P3554, DOI 10.1128/AAC.00643-07; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Blair WS, 2009, ANTIMICROB AGENTS CH, V53, P5080, DOI 10.1128/AAC.00759-09; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; DEWAR RL, 1989, J VIROL, V63, P2452, DOI 10.1128/JVI.63.6.2452-2456.1989; FUJIOKA T, 1994, J NAT PROD, V57, P243, DOI 10.1021/np50104a008; GRUTERS RA, 1987, NATURE, V330, P74, DOI 10.1038/330074a0; Jiang Y, 2011, CURR MED CHEM, V18, P16, DOI 10.2174/092986711793979751; Jose ES, 1997, VIROLOGY, V239, P303, DOI 10.1006/viro.1997.8872; Kibler KV, 2004, J BIOL CHEM, V279, P49055, DOI 10.1074/jbc.M403394200; Kim HS, 1997, J ETHNOPHARMACOL, V58, P117, DOI 10.1016/S0378-8741(97)00092-5; Li F, 2003, P NATL ACAD SCI USA, V100, P13555, DOI 10.1073/pnas.2234683100; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Miyake A, 2010, MICROBES INFECT, V12, P400, DOI 10.1016/j.micinf.2010.02.004; Montessori V, 2004, CAN MED ASSOC J, V170, P229; MOULARD M, 1994, FEBS LETT, V338, P281, DOI 10.1016/0014-5793(94)80284-X; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; PAL R, 1989, P NATL ACAD SCI USA, V86, P3384, DOI 10.1073/pnas.86.9.3384; PAL R, 1988, P NATL ACAD SCI USA, V85, P9283, DOI 10.1073/pnas.85.23.9283; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Sabatier JM, 1996, VIROLOGY, V223, P406, DOI 10.1006/viro.1996.0496; Saklani A, 2008, DRUG DISCOV TODAY, V13, P161, DOI 10.1016/j.drudis.2007.10.010; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vlietinck AJ, 1998, PLANTA MED, V64, P97, DOI 10.1055/s-2006-957384; WALKER BD, 1987, P NATL ACAD SCI USA, V84, P8120, DOI 10.1073/pnas.84.22.8120; Wan H, 2010, J CLIN MICROBIOL, V48, P2186, DOI 10.1128/JCM.02034-09	35	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39225	10.1371/journal.pone.0039225	http://dx.doi.org/10.1371/journal.pone.0039225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720080	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900091
J	Tenbusch, M; Ignatius, R; Nchinda, G; Trumpfheller, C; Salazar, AM; Topfer, K; Sauermann, U; Wagner, R; Hannaman, D; Tenner-Racz, K; Racz, P; Stahl-Hennig, C; Uberla, K				Tenbusch, Matthias; Ignatius, Ralf; Nchinda, Godwin; Trumpfheller, Christine; Salazar, Andres M.; Toepfer, Katharina; Sauermann, Ulrike; Wagner, Ralf; Hannaman, Drew; Tenner-Racz, Klara; Racz, Paul; Stahl-Hennig, Christiane; Ueberla, Klaus			Immunogenicity of DNA Vaccines Encoding Simian Immunodeficiency Virus Antigen Targeted to Dendritic Cells in Rhesus Macaques	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; IMMUNE-RESPONSES; T-CELLS; NONHUMAN-PRIMATES; HIV GAG; DEC-205 RECEPTOR; SURVIVAL-TIME; PLASMID DNA; PROTEIN; VACCINATION	Background: Targeting antigens encoded by DNA vaccines to dendritic cells (DCs) in the presence of adjuvants enhances their immunogenicity and efficacy in mice. Methodology/Principal Findings: To explore the immunogenicity of this approach in non-human primates, we generated a single chain antibody to the antigen uptake receptor DEC-205 expressed on rhesus macaque DCs. DNA vaccines encoding this single chain antibody fused to the SIV capsid protein were delivered to six monkeys each by either intramuscular electroporation or conventional intramuscular injection co-injected or not with poly ICLC, a stabilized poly I: C analogue, as adjuvant. Antibodies to capsid were induced by the DC-targeting and non-targeting control DNA delivered by electroporation while conventional DNA immunization at a 10-fold higher dose of DNA failed to induce detectable humoral immune responses. Substantial cellular immune responses were also observed after DNA electroporation of both DNAs, but stronger responses were induced by the non-targeting vaccine. Conventional immunization with the DC-targeting DNA at a 10-fold higher dose did not give rise to substantial cellular immune responses, neither when co-injected with poly ICLC. Conclusions/Significance: The study confirms the potent immunogenicity of DNA vaccines delivered by electroporation. Targeting the DNA via a single chain antibody to DEC-205 expressed by DCs, however, does not improve the immunogenicity of the antigens in non-human primates.	[Tenbusch, Matthias; Ueberla, Klaus] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany; [Ignatius, Ralf] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Nchinda, Godwin; Trumpfheller, Christine] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA; [Toepfer, Katharina; Sauermann, Ulrike; Stahl-Hennig, Christiane] German Primate Ctr, Unit Infect Models, Gottingen, Germany; [Wagner, Ralf] Geneart, Regensburg, Germany; [Hannaman, Drew] Ichor Med Syst, San Diego, CA USA; [Tenner-Racz, Klara; Racz, Paul] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rockefeller University; Deutsches Primatenzentrum (DPZ); Bernhard Nocht Institut fur Tropenmedizin	Tenbusch, M (corresponding author), Ruhr Univ Bochum, Dept Mol & Med Virol, Univ Str 150, Bochum, Germany.	klaus.ueberla@rub.de			Wilhelm Sander Foundation [2004.107.2]; European Commission [LSHP-CT-2005-018685]; H.W. & J. Hector Foundation; Bill and Melinda Gates GHRC-CAVD Project; EC FP7 program	Wilhelm Sander Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); H.W. & J. Hector Foundation; Bill and Melinda Gates GHRC-CAVD Project; EC FP7 program(European Commission)	This work was supported by grants from the Wilhelm Sander Foundation (2004.107.2), the European Commission FP6 program (DEC-VAC, LSHP-CT-2005-018685 and Europrise Network of Excellence), the H.W. & J. Hector Foundation. In addition, the Centre for AIDS Reagents, NIBSC HPA UK, from which we obtained reference reagents, was funded by the EC FP7 program (Next Generation HIV-1 Immunogens inducing broadly reactive Neutralising antibodies) and the Bill and Melinda Gates GHRC-CAVD Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Capone S, 2006, J IMMUNOL, V177, P7462, DOI 10.4049/jimmunol.177.10.7462; Cheong C, 2010, BLOOD, V116, P3828, DOI 10.1182/blood-2010-06-288068; Do Y, 2010, EUR J IMMUNOL, V40, P2791, DOI 10.1002/eji.201040511; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Grossmann C, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-43; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hirao LA, 2011, J INFECT DIS, V203, P95, DOI 10.1093/infdis/jiq017; Hirao LA, 2010, MOL THER, V18, P1568, DOI 10.1038/mt.2010.112; Jasny E, 2008, J IMMUNOL, V180, P6629, DOI 10.4049/jimmunol.180.10.6629; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Liu JY, 2008, J VIROL, V82, P5643, DOI 10.1128/JVI.02564-07; Livingston BD, 2010, VACCINE, V28, P1056, DOI 10.1016/j.vaccine.2009.10.111; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; Mehlhop E, 2002, J IMMUNOL METHODS, V260, P219, DOI 10.1016/S0022-1759(01)00544-0; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Park SH, 2008, J IMMUNOL METHODS, V331, P27, DOI 10.1016/j.jim.2007.10.012; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Stahl-Hennig C, 2007, J VIROL, V81, P13180, DOI 10.1128/JVI.01400-07; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Stolte-Leeb N, 2006, VIRAL IMMUNOL, V19, P448, DOI 10.1089/vim.2006.19.448; Suh YS, 2006, VACCINE, V24, P1811, DOI 10.1016/j.vaccine.2005.10.026; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105	42	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39038	10.1371/journal.pone.0039038	http://dx.doi.org/10.1371/journal.pone.0039038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720025	Green Published, Green Submitted, gold			2022-12-25	WOS:000305340000063
J	Tominaga, M; Kojima, H; Yokota, E; Nakamori, R; Anson, M; Shimmen, T; Oiwa, K				Tominaga, Motoki; Kojima, Hiroaki; Yokota, Etsuo; Nakamori, Rinna; Anson, Michael; Shimmen, Teruo; Oiwa, Kazuhiro			Calcium-induced Mechanical Change in the Neck Domain Alters the Activity of Plant Myosin XI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN ORGANIZATION; CULTURED BY-2 CELLS; ENDOPLASMIC-RETICULUM; MOLECULAR MOTORS; ATPASE ACTIVITY; TAIL DOMAIN; IQ MOTIFS; CALMODULIN; BINDING; CA-2+	Plant myosin XI functions as a motor that generates cytoplasmic streaming in plant cells. Although cytoplasmic streaming is known to be regulated by intracellular Ca2+ concentration, the molecular mechanism underlying this control is not fully understood. Here, we investigated the mechanism of regulation of myosin XI by Ca2+ at the molecular level. Actin filaments were easily detached from myosin XI in an in vitro motility assay at high Ca2+ concentration (pCa 4) concomitant with the detachment of calmodulin light chains from the neck domains. Electron microscopic observations showed that myosin XI at pCa 4 shortened the neck domain by 30%. Single-molecule analysis revealed that the step size of myosin XI at pCa 4 was shortened to 27 nm under low load and to 22 nm under high load compared with 35 nm independent of the load for intact myosin XI. These results indicate that modulation of the mechanical properties of the neck domain is a key factor for achieving the Ca2+-induced regulation of cytoplasmic streaming.	[Tominaga, Motoki; Kojima, Hiroaki; Nakamori, Rinna; Oiwa, Kazuhiro] Natl Inst Informat & Communicat Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan; [Yokota, Etsuo; Shimmen, Teruo; Oiwa, Kazuhiro] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Harima, Hyogo 6781297, Japan; [Anson, Michael] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England	National Institute of Information & Communications Technology (NICT) - Japan; University of Hyogo; MRC National Institute for Medical Research	Oiwa, K (corresponding author), Natl Inst Informat & Communicat Technol, Adv ICT Res Inst, Kobe, Hyogo 6512492, Japan.	oiwa@nict.go.jp	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X	Ministry of Education, Science, and Culture of Japan; Grants-in-Aid for Scientific Research [20001009] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on the priority area "Regulation of Nano-systems in Cells" by the Ministry of Education, Science, and Culture of Japan.	Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; DOREE M, 1980, EXPERIENTIA, V36, P1291; FLICKER PF, 1983, J MOL BIOL, V169, P723, DOI 10.1016/S0022-2836(83)80167-3; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Howard J., 2001, MECH MOTOR PROTEINS; KAMIYA N, 1981, ANNU REV PLANT PHYS, V32, P205, DOI 10.1146/annurev.pp.32.060181.001225; KOHNO T, 1988, J CELL BIOL, V106, P1539, DOI 10.1083/jcb.106.5.1539; Koide H, 2006, BIOCHEMISTRY-US, V45, P11598, DOI 10.1021/bi0613877; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Liao WQ, 2010, J BIOL CHEM, V285, P24933, DOI 10.1074/jbc.M110.101105; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lu HL, 2006, J BIOL CHEM, V281, P31987, DOI 10.1074/jbc.M605181200; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; MUTO S, 1984, Z PFLANZENPHYSIOL, V114, P421, DOI 10.1016/S0044-328X(84)80062-8; Nguyen H, 2005, NAT STRUCT MOL BIOL, V12, P127, DOI 10.1038/nsmb894; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Peremyslov VV, 2010, PLANT CELL, V22, P1883, DOI 10.1105/tpc.110.076315; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Reddy ASN, 2001, INT REV CYTOL, V204, P97, DOI 10.1016/S0074-7696(01)04004-9; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; SHIMMEN T, 1994, INT REV CYTOL, V155, P97, DOI 10.1016/S0074-7696(08)62097-5; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; Stoffler HE, 1998, J BIOL CHEM, V273, P14605, DOI 10.1074/jbc.273.23.14605; TAKAGI S, 1986, PLANT CELL PHYSIOL, V27, P953; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; WOODS CM, 1984, PROTOPLASMA, V121, P17, DOI 10.1007/BF01279748; Yokota E, 1999, PLANT PHYSIOL, V121, P525, DOI 10.1104/pp.121.2.525; Yokota E, 1999, PLANT PHYSIOL, V119, P231, DOI 10.1104/pp.119.1.231; Yokota E, 2009, J EXP BOT, V60, P197, DOI 10.1093/jxb/ern280; Yokota E, 2011, PLANT PHYSIOL, V156, P129, DOI 10.1104/pp.111.175018	43	29	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30711	30718		10.1074/jbc.M112.346668	http://dx.doi.org/10.1074/jbc.M112.346668			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22740687	Green Published, hybrid			2022-12-25	WOS:000308579800060
J	Spindler, SR; Li, R; Dhahbi, JM; Yamakawa, A; Mote, P; Bodmer, R; Ocorr, K; Williams, RT; Wang, YS; Ablao, KP				Spindler, Stephen R.; Li, Rui; Dhahbi, Joseph M.; Yamakawa, Amy; Mote, Patricia; Bodmer, Rolf; Ocorr, Karen; Williams, Renee T.; Wang, Yinsheng; Ablao, Kenneth P.			Statin Treatment Increases Lifespan and Improves Cardiac Health in Drosophila by Decreasing Specific Protein Prenylation	PLOS ONE			English	Article							COENZYME-Q LEVELS; CALORIC RESTRICTION; ATRIAL-FIBRILLATION; PLASMA; SUPPLEMENTATION; ISOPRENOIDS; CHOLESTEROL; REGULATOR; CELLS; Q(10)	Statins such as simvastatin are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors and standard therapy for the prevention and treatment of cardiovascular diseases in mammals. Here we show that simvastatin significantly increased the mean and maximum lifespan of Drosophila melanogaster (Drosophila) and enhanced cardiac function in aging flies by significantly reducing heart arrhythmias and increasing the contraction proportion of the contraction/relaxation cycle. These results appeared independent of internal changes in ubiquinone or juvenile hormone levels. Rather, they appeared to involve decreased protein prenylation. Simvastatin decreased the membrane association (prenylation) of specific small Ras GTPases in mice. Both farnesyl (L744832) and type 1 geranylgeranyl transferase (GGTI-298) inhibitors increased Drosophila lifespan. These data are the most direct evidence to date that decreased protein prenylation can increase cardiac health and lifespan in any metazoan species, and may explain the pleiotropic (non-cholesterol related) health effects of statins.	[Spindler, Stephen R.; Li, Rui; Dhahbi, Joseph M.; Yamakawa, Amy; Mote, Patricia; Ablao, Kenneth P.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Bodmer, Rolf; Ocorr, Karen] Sanford Burnham Med Res Inst, Dev & Aging Program, La Jolla, CA USA; [Williams, Renee T.; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Riverside	Spindler, SR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	spindler@ucr.edu			Alva LLC, a private, basic research foundation; ALVA LLC.	Alva LLC, a private, basic research foundation; ALVA LLC.	The research was supported by Alva LLC, a private, basic research foundation. Alva has no web site. Its funder, a high net worth individual, prefers to remain anonymous. The funder has explicitly asked (several times) that nothing commercial be entangled in any way in the funds from ALVA LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chen WT, 2010, J THORAC CARDIOV SUR, V140, P364, DOI 10.1016/j.jtcvs.2010.02.042; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; DRIVER CJI, 1986, EXP GERONTOL, V21, P497, DOI 10.1016/0531-5565(86)90002-1; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; FOLKERS K, 1990, P NATL ACAD SCI USA, V87, P8931, DOI 10.1073/pnas.87.22.8931; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; GHIRLANDA G, 1993, J CLIN PHARMACOL, V33, P226, DOI 10.1002/j.1552-4604.1993.tb03948.x; Hinson DD, 1997, J LIPID RES, V38, P2216; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jafari M, 2006, CURR DRUG TARGETS, V7, P1479, DOI 10.2174/1389450110607011479; Kulik A, 2010, AM J CARDIOL, V105, P1655, DOI 10.1016/j.amjcard.2010.01.341; LANG JK, 1986, ANAL BIOCHEM, V157, P106, DOI 10.1016/0003-2697(86)90203-4; Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lonnrot K, 1998, BIOCHEM MOL BIOL INT, V44, P727; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Ma S, 2011, CYTOKINE GROWTH F R, V22, P167, DOI 10.1016/j.cytogfr.2011.05.004; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Montecucco F, 2009, SEMIN IMMUNOPATHOL, V31, P127, DOI 10.1007/s00281-009-0150-y; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Palmer MR, 2003, AGING CELL, V2, P335, DOI 10.1046/j.1474-9728.2003.00065.x; Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002; Salat David, 2009, Expert Rev Cardiovasc Ther, V7, P1219, DOI 10.1586/erc.09.52; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Sohal RS, 2006, FREE RADICAL BIO MED, V40, P480, DOI 10.1016/j.freeradbiomed.2005.08.037; Spindler SR, 2011, AGE DORDR, V34, P111; Spindler SR, 2007, GERONTOLOGY, V53, P306, DOI 10.1159/000103924; Spindler SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029782; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; WILLIS RA, 1990, P NATL ACAD SCI USA, V87, P8928, DOI 10.1073/pnas.87.22.8928; Zhao JJ, 2000, J MASS SPECTROM, V35, P1133, DOI 10.1002/1096-9888(200009)35:9<1133::AID-JMS42>3.0.CO;2-X	47	40	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39581	10.1371/journal.pone.0039581	http://dx.doi.org/10.1371/journal.pone.0039581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737247	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100046
J	Albanese, E; Lombardo, FL; Dangour, AD; Guerra, M; Acosta, D; Huang, YQ; Jacob, KS; Rodriguez, JDL; Salas, A; Schonborn, C; Sosa, AL; Williams, J; Prince, MJ; Ferri, CP				Albanese, Emiliano; Lombardo, Flavia L.; Dangour, Alan D.; Guerra, Mariella; Acosta, Daisy; Huang, Yueqin; Jacob, K. S.; Llibre Rodriguez, Juan de Jesus; Salas, Aquiles; Schoenborn, Claudia; Luisa Sosa, Ana; Williams, Joseph; Prince, Martin J.; Ferri, Cleusa P.			No Association between Fish Intake and Depression in over 15,000 Older Adults from Seven Low and Middle Income Countries-The 10/66 Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LATE-LIFE DEPRESSION; POPULATION-BASED COHORT; GERIATRIC MENTAL STATE; CROSS-SECTIONAL SURVEY; EURO-D SCALE; LATIN-AMERICA; DIETARY FISH; RISK-FACTORS; POSTPARTUM DEPRESSION	Background: Evidence on the association between fish consumption and depression is inconsistent and virtually nonexistent from low-and middle-income countries. Using a standard protocol, we aim to assess the association of fish consumption and late-life depression in seven low-and middle-income countries. Methodology/Findings: We used cross-sectional data from the 10/66 cohort study and applied two diagnostic criteria for late-life depression to assess the association between categories of weekly fish consumption and depression according to ICD-10 and the EURO-D depression symptoms scale scores, adjusting for relevant confounders. All-catchment area surveys were carried out in Cuba, Dominican Republic, Venezuela, Peru, Mexico, China, and India, and over 15,000 community-dwelling older adults (65+) were sampled. Using Poisson models the adjusted association between categories of fish consumption and ICD-10 depression was positive in India (p for trend = 0.001), inverse in Peru (p = 0.025), and not significant in all other countries. We found a linear inverse association between fish consumption categories and EURO-D scores only in Cuba (p for trend = 0.039) and China (p<0.001); associations were not significant in all other countries. Between-country heterogeneity was marked for both ICD-10 (I-2>61%) and EURO-D criteria (I-2>66%). Conclusions: The associations of fish consumption with depression in large samples of older adults varied markedly across countries and by depression diagnosis and were explained by socio-demographic and lifestyle variables. Experimental studies in these settings are needed to confirm our findings.	[Albanese, Emiliano; Schoenborn, Claudia; Prince, Martin J.; Ferri, Cleusa P.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Lombardo, Flavia L.] Italian Natl Inst Hlth, Dept Epidemiol, Rome, Italy; [Dangour, Alan D.] London Sch Hyg & Trop Med, Dept Nutr & Publ Hlth Intervent Res, London WC1, England; [Guerra, Mariella] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Acosta, Daisy] UNPHU, Dept Internal Med, Santo Domingo, Dominican Rep; [Huang, Yueqin] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Jacob, K. S.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Llibre Rodriguez, Juan de Jesus] Med Univ Havana, Fac Med Finley Albarran, Havana, Cuba; [Salas, Aquiles] Cent Univ Venezuela, Fac Med, Caracas, Venezuela; [Luisa Sosa, Ana] Natl Inst Neurol & Neurosurg Mexico, Mexico City, DF, Mexico; [Williams, Joseph] Inst Community Hlth, Madras, Tamil Nadu, India	University of London; King's College London; Istituto Superiore di Sanita (ISS); University of London; London School of Hygiene & Tropical Medicine; Universidad Nacional Pedro Henriquez Urena; Peking University; Christian Medical College & Hospital (CMCH) Vellore; University of Central Venezuela	Albanese, E (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	emiliano.albanese@nih.gov	Rodriguez, Juan J Llibre/D-2380-2010; Ferri, Cleusa Pinheiro/B-2922-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Lombardo, Flavia/AAA-9723-2021; Prince, Martin J/A-9170-2010	Rodriguez, Juan J Llibre/0000-0002-8215-3160; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Prince, Martin J/0000-0003-1379-7146; Guerra, Mariella/0000-0001-8923-349X; Lombardo, Flavia Lucia/0000-0001-6183-0735; Dangour, Alan/0000-0001-6908-1273; Schonborn, Claudia/0000-0002-4524-7192	Wellcome Trust (UK) [GR066133]; World Health Organization (WHO); U.S. Alzheimer's Association [IIRG-04-1286]; Fondo Nacional de Ciencia Y Tecnologia; Consejo de Desarollo Cientifico Y Humanistico; Universidad Central de Venezuela (Venezuela); Rockerfeller Foundation; Alzheimer's Disease International (ADI); GaxoSmithKline; Novartis; Lundbeck; Pfizer; Eisai; Intramural Research Program of the National Institute on Aging, National Institutes of Health	Wellcome Trust (UK)(Wellcome Trust); World Health Organization (WHO)(World Health Organization); U.S. Alzheimer's Association(Alzheimer's Association); Fondo Nacional de Ciencia Y Tecnologia; Consejo de Desarollo Cientifico Y Humanistico; Universidad Central de Venezuela (Venezuela); Rockerfeller Foundation; Alzheimer's Disease International (ADI); GaxoSmithKline; Novartis(Novartis); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Eisai(Eisai Co Ltd); Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The 10/66 Dementia Research Group population-based surveys were funded by the Wellcome Trust (UK) (GR066133); the World Health Organization (WHO); the U.S. Alzheimer's Association (IIRG-04-1286); and the Fondo Nacional de Ciencia Y Tecnologia, Consejo de Desarollo Cientifico Y Humanistico, Universidad Central de Venezuela (Venezuela). The Rockerfeller Foundation supported a dissemination meeting in their Bellagio Centre. Alzheimer's Disease International (ADI) has provided support for networking and infrastructure. The 10/66 Dementia Research Group works closely with ADI, which is a non-profit federation of 77 Alzheimer associations around the world. ADI is committed to strengthening Alzheimer associations worldwide, raising awareness regarding dementia and Alzheimer's disease, and advocating for more and better services for people with dementia and their caregivers. ADI is supported in part by grants from GaxoSmithKline, Novartis, Lundbeck, Pfizer, and Eisai. Dr. Emiliano Albanese is supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese E, 2009, AM J CLIN NUTR, V90, P392, DOI 10.3945/ajcn.2009.27580; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Appleton KM, 2007, J AFFECT DISORDERS, V104, P217, DOI 10.1016/j.jad.2007.03.012; Appleton KM, 2007, SOC PSYCH PSYCH EPID, V42, P100, DOI 10.1007/s00127-006-0142-3; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Barberger-Gateau P, 2005, EUR J CLIN NUTR, V59, P817, DOI 10.1038/sj.ejcn.1602145; BEEKMAN ATF, 1995, SOC PSYCH PSYCH EPID, V30, P32, DOI 10.1007/BF00784432; Beekman ATF, 1995, J AFFECT DISORDERS, V36, P65, DOI 10.1016/0165-0327(95)00061-5; Bremmer MA, 2008, J AFFECT DISORDERS, V106, P249, DOI 10.1016/j.jad.2007.07.002; BROE GA, 1976, J NEUROL NEUROSUR PS, V39, P362, DOI 10.1136/jnnp.39.4.362; Brookes KJ, 2006, BIOL PSYCHIAT, V60, P1053, DOI 10.1016/j.biopsych.2006.04.025; Burdge GC, 2003, BRIT J NUTR, V90, P311, DOI 10.1079/BJN2003901; Calder PC, 2003, NUTRITION, V19, P472, DOI 10.1016/S0899-9007(02)01042-0; Castro-Costa E, 2007, BRIT J PSYCHIAT, V191, P393, DOI 10.1192/bjp.bp.107.036772; Castro-Costa E, 2008, INT J METH PSYCH RES, V17, P12, DOI 10.1002/mpr.236; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Colangelo LA, 2009, NUTRITION, V25, P1011, DOI 10.1016/j.nut.2008.12.008; Copeland JRM, 2002, INT J GERIATR PSYCH, V17, P729, DOI 10.1002/gps.667; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Covault J, 2004, AM J MED GENET B, V127B, P42, DOI 10.1002/ajmg.b.20156; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; *DUK U, 1978, MULT FUNCT ASS OARS; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Grenyer BFS, 2007, PROG NEURO-PSYCHOPH, V31, P1393, DOI 10.1016/j.pnpbp.2007.06.004; Guerra M, 2009, BRIT J PSYCHIAT, V195, P510, DOI 10.1192/bjp.bp.109.064055; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hakkarainen R, 2004, AM J PSYCHIAT, V161, P567, DOI 10.1176/appi.ajp.161.3.567; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofler M, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-11; Hostenkamp G, 2009, PUBLIC HEALTH NUTR, P1; Jacka E, 2004, NUTR NEUROSCI, V7, P101, DOI 10.1080/10284150410001710438; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Jotheeswaran AT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-366; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Sosa AL, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-48; MACLURE M, 1992, AM J EPIDEMIOL, V135, P96; Margetts B, 1997, DESIGN COCEPTS NUTR; MENDLEWICZ J, 1976, J GERONTOL, V31, P300; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Miyake Y, 2006, PSYCHOL MED, V36, P1727, DOI 10.1017/S0033291706008701; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Noaghiul S, 2003, AM J PSYCHIAT, V160, P2222, DOI 10.1176/appi.ajp.160.12.2222; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Peet M, 2004, BRIT J PSYCHIAT, V184, P404, DOI 10.1192/bjp.184.5.404; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Prince M, 2004, BRIT J PSYCHIAT, V185, P429, DOI 10.1192/bjp.185.5.429; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Reynolds CF, 1999, PSYCHIAT SERV, V50, P1167, DOI 10.1176/ps.50.9.1167; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Silvers KM, 2002, PUBLIC HEALTH NUTR, V5, P427, DOI 10.1079/PHN2001308; Suominen-Taipale AL, 2010, INT J EPIDEMIOL, V39, P494, DOI 10.1093/ije/dyp386; Suzuki S, 2004, BRIT J CANCER, V90, P787, DOI 10.1038/sj.bjc.6601621; Tanskanen A, 2001, PSYCHIATR SERV, V52, P529, DOI 10.1176/appi.ps.52.4.529; Tanskanen A, 2001, ARCH GEN PSYCHIAT, V58, P512, DOI 10.1001/archpsyc.58.5.512; Tiemeier H, 2003, EUR J EPIDEMIOL, V18, P745; Timonen M, 2004, J AFFECT DISORDERS, V82, P447, DOI 10.1016/j.jad.2004.02.002; Tracy M, 2008, ANN EPIDEMIOL, V18, P447, DOI 10.1016/j.annepidem.2007.12.004; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; Virtanen JK, 2008, AM J CLIN NUTR, V88, P1618, DOI 10.3945/ajcn.2007.25816; Visioli F, 2003, LIPIDS, V38, P415, DOI 10.1007/s11745-003-1077-x; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; *WHO, 1987, 10 REV INT CLASS DIS; WHO, 2008, MHGAP MENTAL HLTH GA; Whyte EM, 2006, INT J GERIATR PSYCH, V21, P746, DOI 10.1002/gps.1555; Yao JK, 2003, PROSTAG LEUKOTR ESS, V69, P429, DOI 10.1016/j.plefa.2003.08.015	74	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38879	10.1371/journal.pone.0038879	http://dx.doi.org/10.1371/journal.pone.0038879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	963VI	22723900	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700036
J	Kumari, S; Mehta, SL; Li, PA				Kumari, Santosh; Mehta, Suresh L.; Li, P. Andy			Glutamate Induces Mitochondrial Dynamic Imbalance and Autophagy Activation: Preventive Effects of Selenium	PLOS ONE			English	Article							NEURONAL CELL-DEATH; OXIDATIVE STRESS; PARKINSONS-DISEASE; FISSION; ISCHEMIA; FUSION; RAT; PROTECTS; INJURY; OVEREXPRESSION	Glutamate-induced cytotoxicity is partially mediated by enhanced oxidative stress. The objectives of the present study are to determine the effects of glutamate on mitochondrial membrane potential, oxygen consumption, mitochondrial dynamics and autophagy regulating factors and to explore the protective effects of selenium against glutamate cytotoxicity in murine neuronal HT22 cells. Our results demonstrated that glutamate resulted in cell death in a dose-dependent manner and supplementation of 100 nM sodium selenite prevented the detrimental effects of glutamate on cell survival. The glutamate induced cytotoxicity was associated with mitochondrial hyperpolarization, increased ROS production and enhanced oxygen consumption. Selenium reversed these alterations. Furthermore, glutamate increased the levels of mitochondrial fission protein markers pDrp1 and Fis1 and caused increase in mitochondrial fragmentation. Selenium corrected the glutamate-caused mitochondrial dynamic imbalance and reduced the number of cells with fragmented mitochondria. Finally, glutamate activated autophagy markers Beclin 1 and LC3-II, while selenium prevented the activation. These results suggest that glutamate targets the mitochondria and selenium supplementation within physiological concentration is capable of preventing the detrimental effects of glutamate on the mitochondria. Therefore, adequate selenium supplementation may be an efficient strategy to prevent the detrimental glutamate toxicity and further studies are warranted to define the therapeutic potentials of selenium in animal disease models and in human.	[Kumari, Santosh] N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst, Durham, NC USA; N Carolina Cent Univ, Technol Enterprise, Durham, NC USA	University of North Carolina; North Carolina Central University; University of North Carolina; North Carolina Central University	Kumari, S (corresponding author), N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst, Durham, NC USA.	pli@nccu.edu		/0000-0002-5634-5230	National Institute of Health [7R01DK075476]; Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075476] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from National Institute of Health to PAL (7R01DK075476). The Biomanufacturing Research Institute and Technology Enterprise is partially funded by the Golden Leaf Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Ansari MA, 2004, BIOL TRACE ELEM RES, V101, P73, DOI 10.1385/BTER:101:1:73; Ben Jilani KE, 2007, INT J BIOL SCI, V3, P198; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Blandini F, 1996, FUNCT NEUROL, V11, P3; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Gupta R, 2003, PHARMACOL RES, V48, P209, DOI 10.1016/S1043-6618(03)00102-6; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Islam F, 2002, BIOL TRACE ELEM RES, V90, P203, DOI 10.1385/BTER:90:1-3:203; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim H, 2009, BIOCHEM BIOPH RES CO, V388, P339, DOI 10.1016/j.bbrc.2009.08.007; Liu CL, 2010, J NEUROCHEM, V115, P68, DOI 10.1111/j.1471-4159.2010.06905.x; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; Mendelev N, 2011, MITOCHONDRION, V11, P76, DOI 10.1016/j.mito.2010.07.007; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Ouyang YB, 2002, FREE RADICAL BIO MED, V33, P544, DOI 10.1016/S0891-5849(02)00912-7; Panee J, 2007, INT J BIOL SCI, V3, P335; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Sagara Y, 2002, J BIOL CHEM, V277, P36204, DOI 10.1074/jbc.M203895200; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Tirosh O, 2007, NUTRITION, V23, P878, DOI 10.1016/j.nut.2007.08.019; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Venardos K, 2004, J TRACE ELEM MED BIO, V18, P81, DOI 10.1016/j.jtemb.2004.01.001; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zafar KS, 2003, J NEUROCHEM, V84, P438, DOI 10.1046/j.1471-4159.2003.01531.x	41	93	98	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39382	10.1371/journal.pone.0039382	http://dx.doi.org/10.1371/journal.pone.0039382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724008	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700073
J	Morandi, B; Mortara, L; Chiossone, L; Accolla, RS; Mingari, MC; Moretta, L; Moretta, A; Ferlazzo, G				Morandi, Barbara; Mortara, Lorenzo; Chiossone, Laura; Accolla, Roberto S.; Mingari, Maria Cristina; Moretta, Lorenzo; Moretta, Alessandro; Ferlazzo, Guido			Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response	PLOS ONE			English	Article							NK CELL; MAMMARY ADENOCARCINOMA; CROSS-TALK; IFN-GAMMA; IN-VIVO; RECEPTORS; INNATE; TISSUES; POLARIZATION; EXPRESSION	Over the last decade, several studies have extensively reported that activated natural killer (NK) cells can kill autologous immature dendritic cells (DCs) in vitro, whereas they spare fully activated DCs. This led to the proposal that activated NK cells might select a more immunogenic subset of DCs during a protective immune response. However, there is no demonstration that autologous DC killing by NK cells is an event occurring in vivo and, consequently, the functional relevance of this killing remains elusive. Here we report that a significant decrease of CD11c(+) DCs was observed in draining lymph nodes of mice inoculated with MHC-devoid cells as NK cell targets able to induce NK cell activation. This in vivo DC editing by NK cells was perforin-dependent and it was functionally relevant, since residual lymph node DCs displayed an improved capability to induce T cell proliferation. In addition, in a model of anti-cancer vaccination, the administration of MHC-devoid cells together with tumor cells increased the number of tumor-specific CTLs and resulted in a significant increase in survival of mice upon challenge with a lethal dose of tumor cells. Depletion of NK cells or the use of perforin knockout mice strongly decreased the tumor-specific CTL expansion and its protective role against tumor cell challenge. As a whole, our data support the hypothesis that NK cell-mediated DC killing takes place in vivo and is able to promote expansion of cancer-specific CTLs. Our results also indicate that cancer vaccines could be improved by strategies aimed at activating NK cells.	[Morandi, Barbara; Mingari, Maria Cristina; Moretta, Alessandro] Univ Genoa, Dept Expt Med, Genoa, Italy; [Mortara, Lorenzo] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Chiossone, Laura; Moretta, Lorenzo] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Accolla, Roberto S.] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Mingari, Maria Cristina] San Martino IST Ist Nazl Ric Canc, Ist Ricovero & Cura Carattere Sci AOU, Genoa, Italy; [Ferlazzo, Guido] Univ Messina, Dept Human Pathol, Messina, Italy	University of Genoa; University of Insubria; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Insubria; University of Genoa; IRCCS AOU San Martino IST; University of Messina	Morandi, B (corresponding author), Univ Genoa, Dept Expt Med, Genoa, Italy.	guido.ferlazzo@unime.it	Moretta, Lorenzo/AAA-7239-2020; Mingari, Maria Cristina/AAB-1315-2019; Chiossone, Laura/D-3062-2011	Moretta, Lorenzo/0000-0003-4658-1747; Chiossone, Laura/0000-0002-9097-5869; Ferlazzo, Guido/0000-0002-3874-8554; Accolla, Roberto/0000-0003-2493-7378	Associazione Italiana Ricerca sul Cancro [IG5624, IG11650, IG 8862]; Ministero Italiano della Salute - Programma Strategico Ricerca Oncologica; Fondazione Cariplo [2008-2230]; Ministero Italiano dell' Istruzione, Universita', Ricerca, - Progetto Rilevanza Nazionale [2008-WXF7KK]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute - Programma Strategico Ricerca Oncologica; Fondazione Cariplo(Fondazione Cariplo); Ministero Italiano dell' Istruzione, Universita', Ricerca, - Progetto Rilevanza Nazionale	This work has been supported by Associazione Italiana Ricerca sul Cancro http://www.airc.it) IG5624 and IG11650 to GF and IG 8862 to RSA; by Ministero Italiano della Salute - Programma Strategico Ricerca Oncologica (http://www.ministerosalute.it/) to GF; by Fondazione Cariplo 2008-2230 (www.fondazionecariplo.it) and by Ministero Italiano dell' Istruzione, Universita', Ricerca, - Progetto Rilevanza Nazionale (http://prin.miur.it/) 2008-WXF7KK to RSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Alter G, 2010, J CLIN INVEST, V120, P1905, DOI 10.1172/JCI40913; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Bellora F, 2010, P NATL ACAD SCI USA, V107, P21659, DOI 10.1073/pnas.1007654108; Chiesa MD, 2003, EUR J IMMUNOL, V33, P1657, DOI 10.1002/eji.200323986; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Ferlazzo G, 2005, IMMUNOL LETT, V101, P12, DOI 10.1016/j.imlet.2005.04.015; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Laffont S, 2008, BLOOD, V112, P661, DOI 10.1182/blood-2007-10-120089; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mailliard RB, 2005, J EXP MED, V202, P941, DOI 10.1084/hem.20050128; Marcenaro E, 2009, BLOOD, V114, P4108, DOI 10.1182/blood-2009-05-222265; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Melki MT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000862; Mocikat R, 2003, IMMUNITY, V19, P561, DOI 10.1016/S1074-7613(03)00264-4; Morandi B, 2006, EUR J IMMUNOL, V36, P2394, DOI 10.1002/eji.200636290; Moretta A, 2005, TRENDS IMMUNOL, V26, P668, DOI 10.1016/j.it.2005.09.008; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; MORETTA L, 1992, IMMUNOL TODAY, V13, P300, DOI 10.1016/0167-5699(92)90042-6; MORETTA L, 1994, ADV IMMUNOL, V55, P341; Mortara L, 2006, CLIN CANCER RES, V12, P3435, DOI 10.1158/1078-0432.CCR-06-0165; NANNI P, 1983, CLIN EXP METASTAS, V1, P373, DOI 10.1007/BF00121199; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Persson CM, 2008, SCAND J IMMUNOL, V67, P30, DOI 10.1111/j.1365-3083.2007.02034.x; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Romagnani C, 2010, BLOOD1, V16, P1299; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145	43	82	85	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39170	10.1371/journal.pone.0039170	http://dx.doi.org/10.1371/journal.pone.0039170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723958	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700051
J	Prohaska, TA; Wahlmuller, FC; Furtmuller, M; Geiger, M				Prohaska, Thomas A.; Wahlmueller, Felix C.; Furtmueller, Margareta; Geiger, Margarethe			Interaction of Protein C Inhibitor with the Type II Transmembrane Serine Protease Enteropeptidase	PLOS ONE			English	Article							HEPARIN-BINDING; TISSUE KALLIKREIN; CELL MIGRATION; HUMAN-PLASMA; SERPIN; EXPRESSION; PCI; PANCREATITIS; TRYPSIN; KERATINOCYTES	The serine protease inhibitor protein C inhibitor (PCI) is expressed in many human tissues and exhibits broad protease reactivity. PCI binds glycosaminoglycans and certain phospholipids, which modulate its inhibitory activity. Enteropeptidase (EP) is a type II transmembrane serine protease mainly found on the brush border membrane of epithelial cells in the duodenum, where it activates trypsinogen to initiate the digestion of food proteins. Some active EP is also present in duodenal fluid and has been made responsible for causing pancreatitis in case of duodeno-pancreatic reflux. Together with its substrate trypsinogen, EP is furthermore present in the epidermis and in some cancer cells. In this report, we show that PCI inhibited EP with an apparent 2nd order rate constant of 4.48x10(4) M-1 s(-1). Low molecular weight (LMWH) and unfractionated heparin (UFH) slightly reduced the inhibitory effect of PCI. The SI (stoichiometry of inhibition) value for the inhibition of EP by PCI was 10.8 in the absence and 17.9 in the presence of UFH (10 U/ml). By inhibiting trypsin, chymotrypsin, and additionally EP, PCI might play a role in the protection of the pancreas from autodigestion. Furthermore the interaction of PCI with EP may influence the regulation of epithelial differentiation.	[Prohaska, Thomas A.; Wahlmueller, Felix C.; Furtmueller, Margareta; Geiger, Margarethe] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Prohaska, TA (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	margarethe.geiger@meduniwien.ac.at		Geiger, Margarethe/0000-0003-2021-5319; Prohaska, Thomas/0000-0002-1406-692X; Furtmuller, Margareta/0000-0002-2572-6401	FWF-Austrian Science Fund [P20248-B09, P22160-B09, P20386-B09]; Austrian Science Fund (FWF) [P 20386, P 22792] Funding Source: researchfish	FWF-Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the FWF-Austrian Science Fund grant P20248-B09 to MG, grant P22160-B09 to MG, and grant P20386-B09 to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2007, INT J CANCER, V121, P955, DOI 10.1002/ijc.22773; Bijsmans ITGW, 2011, MODERN PATHOL, V24, P463, DOI 10.1038/modpathol.2010.214; Cao Y, 2003, PROSTATE, V57, P196, DOI 10.1002/pros.10296; COOPER ST, 1995, BBA-PROTEIN STRUCT M, V1246, P29, DOI 10.1016/0167-4838(94)00185-J; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; ECKE S, 1992, J BIOL CHEM, V267, P7048; Ecke S, 1997, EUR J BIOCHEM, V248, P475, DOI 10.1111/j.1432-1033.1997.00475.x; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; ESPANA F, 1993, THROMB HAEMOSTASIS, V70, P989; FERNANDEZDELCASTILLO C, 1994, SURGERY, V116, P497; FONSECA P, 1982, BIOPHYS J, V37, P44, DOI 10.1016/S0006-3495(82)84590-6; Fortenberry YM, 2010, BBA-GEN SUBJECTS, V1800, P580, DOI 10.1016/j.bbagen.2010.03.003; GEIGER M, 1989, BLOOD, V74, P722; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hayashi T, 2004, J THROMB HAEMOST, V2, P949, DOI 10.1111/j.1538-7836.2004.00733.x; HERMANS JM, 1993, BIOCHEM J, V295, P239, DOI 10.1042/bj2950239; HERMANS JM, 1994, BIOCHEMISTRY-US, V33, P5440, DOI 10.1021/bi00184a012; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Huntington J, 2009, CELL MOL LIFE SCI, V66, P113, DOI 10.1007/s00018-008-8371-0; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Imamura T, 2003, AM J PHYSIOL-GASTR L, V285, pG1235, DOI 10.1152/ajpgi.00198.2003; KOIVUNEN E, 1991, CANCER RES, V51, P2107; Krebs M, 1999, J INVEST DERMATOL, V113, P32, DOI 10.1046/j.1523-1747.1999.00644.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURELL M, 1992, J CLIN INVEST, V89, P1094, DOI 10.1172/JCI115689; Li W, 2008, J BIOL CHEM, V283, P36039, DOI 10.1074/jbc.M805974200; Lu DS, 1997, J BIOL CHEM, V272, P31293, DOI 10.1074/jbc.272.50.31293; Lukkonen A, 2000, INT J CANCER, V86, P577, DOI 10.1002/(SICI)1097-0215(20000515)86:4<577::AID-IJC21>3.3.CO;2-A; Luo LY, 2006, BIOL CHEM, V387, P813, DOI 10.1515/BC.2006.103; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; MATSUSHIMA M, 1994, J BIOL CHEM, V269, P19976; McCutcheon AD, 2000, ARCH SURG-CHICAGO, V135, P278, DOI 10.1001/archsurg.135.3.278; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Mona B, 2010, FERTIL STERIL, V93, P277, DOI 10.1016/j.fertnstert.2009.07.984; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; PRATT CW, 1992, J BIOL CHEM, V267, P8789; Radtke KP, 1996, INT S CHEM BIOL SERP, P123; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Schechter NM, 2004, METHODS, V32, P159, DOI 10.1016/S1046-2023(03)00207-X; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Suzuki K, 2008, J THROMB HAEMOST, V6, P2017, DOI 10.1111/j.1538-7836.2008.03181.x; SUZUKI K, 1983, J BIOL CHEM, V258, P163; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Vilen ST, 2008, EXP CELL RES, V314, P914, DOI 10.1016/j.yexcr.2007.10.025; Vonlaufen A, 2008, J GASTROEN HEPATOL, V23, P1339, DOI 10.1111/j.1440-1746.2008.05520.x; Wakita T, 2004, INT J CANCER, V108, P516, DOI 10.1002/ijc.11594; ZechmeisterMachhart M, 1996, IMMUNOPHARMACOLOGY, V32, P96, DOI 10.1016/0162-3109(95)00062-3; Zhang C, 2007, ACTA HISTOCHEM, V109, P461, DOI 10.1016/j.acthis.2007.04.007; Zheng X Long, 2009, Front Biosci (Elite Ed), V1, P242; ZHENG XL, 1994, AM J PHYSIOL, V267, pC466, DOI 10.1152/ajpcell.1994.267.2.C466	56	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39262	10.1371/journal.pone.0039262	http://dx.doi.org/10.1371/journal.pone.0039262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723979	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700061
J	Cohen, N; Margalit, R; Pevsner-Fischer, M; Yona, S; Jung, S; Eisenbach, L; Cohen, IR				Cohen, Noam; Margalit, Raanan; Pevsner-Fischer, Meirav; Yona, Simon; Jung, Steffen; Eisenbach, Lea; Cohen, Irun R.			Mouse Dendritic Cells Pulsed with Capsular Polysaccharide Induce Resistance to Lethal Pneumococcal Challenge: Roles of T Cells and B Cells	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; VIRULENCE FACTORS; IMMUNE-RESPONSES; MICE; PATHWAY; GAMMA; IMMUNIZATION; PATHOGENESIS; MACROPHAGES	Mice are exceedingly sensitive to intra-peritoneal (IP) challenge with some virulent pneumococci (LD50=1 bacterium). To investigate how peripheral contact with bacterial capsular polysaccharide (PS) antigen can induce resistance, we pulsed bone marrow dendritic cells (BMDC) of C57BL/6 mice with type 4 or type 3 PS, injected the BMDC intra-foot pad (IFP) and challenged the mice IP with supra-lethal doses of pneumococci. We examined the responses of T cells and B cells in the draining popliteal lymph node and measured the effects on the bacteria in the peritoneum and blood. We now report that: 1) The PS co-localized with MHC molecules on the BMDC surface; 2) PS-specific T and B cell proliferation and IFN gamma secretion was detected in the draining popliteal lymph nodes on day 4; 3) Type-specific resistance to lethal IP challenge was manifested only after day 5; 4) Type-specific IgM and IgG antibodies were detected in the sera of only some of the mice, but B cells were essential for resistance; 5) Control mice vaccinated with a single injection of soluble PS did not develop a response in the draining popliteal lymph node and were not protected; 6) Mice injected with unpulsed BMDC also did not resist challenge: In unprotected mice, pneumococci entered the blood shortly after IP inoculation and multiplied exponentially in both blood and peritoneum killing the mice within 20 hours. Mice vaccinated with PS-pulsed BMDC trapped the bacteria in the peritoneum. The trapped bacteria proliferated exponentially IP, but died suddenly at 1820 hours. Thus, a single injection of PS antigen associated with intact BMDC is a more effective vaccine than the soluble PS alone. This model system provides a platform for studying novel aspects of PS-targeted vaccination.	[Cohen, Noam; Margalit, Raanan; Pevsner-Fischer, Meirav; Yona, Simon; Jung, Steffen; Eisenbach, Lea; Cohen, Irun R.] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Cohen, N (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	irun.cohen@weizmann.ac.il	Yona, Simon/ABE-6572-2020; Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716; Eisenbach, Lea R/0000-0002-4816-1968; Yona, Simon/0000-0002-3984-2008	Center for the Study of Emerging Diseases	Center for the Study of Emerging Diseases	The financial support for this study was obtained from the Center for the Study of Emerging Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; Amir-Kroll H, 2003, J IMMUNOL, V170, P6165, DOI 10.4049/jimmunol.170.12.6165; BROWN EJ, 1983, REV INFECT DIS, V5, pS797; Calbo E, 2011, CURR OPIN INFECT DIS, V24, P241, DOI 10.1097/QCO.0b013e3283463e45; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Cohen N, 2008, J IMMUNOL, V180, P2409, DOI 10.4049/jimmunol.180.4.2409; Dallaire F, 2001, J INFECT DIS, V184, P292, DOI 10.1086/322021; DOUGLAS RM, 1983, J INFECT DIS, V148, P131, DOI 10.1093/infdis/148.1.131; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Garcia E, 1997, FEMS MICROBIOL LETT, V149, P1; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; HILLEMAN MR, 1978, B WORLD HEALTH ORGAN, V56, P371; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lai ZZ, 2009, VACCINE, V27, P3137, DOI 10.1016/j.vaccine.2009.03.064; Meltzer U, 2006, INFECT IMMUN, V74, P1890, DOI 10.1128/IAI.74.3.1890-1895.2006; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muthukkumar S, 2004, VACCINE, V22, P1290, DOI 10.1016/j.vaccine.2003.08.047; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; Saeki H, 1999, J IMMUNOL, V162, P2472; SCHIFFMAN G, 1983, P SOC EXP BIOL MED, V174, P309; Schweitzer AN, 1997, J IMMUNOL, V158, P2713; Selman S, 2000, Manag Care, V9, P49; SELMAN S, 2000, MANAG CARE, V9, P54; SELMAN S, 2000, MANAG CARE, V9, P56; SMIT P, 1977, JAMA-J AM MED ASSOC, V238, P2613, DOI 10.1001/jama.238.24.2613; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stephen TL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030032; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tuomanen EI, 1997, PEDIATR RES, V42, P253, DOI 10.1203/00006450-199709000-00001; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; WATSON DA, 1995, EUR J CLIN MICROBIOL, V14, P479, DOI 10.1007/BF02113425; Yanez DM, 1999, INFECT IMMUN, V67, P446	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39193	10.1371/journal.pone.0039193	http://dx.doi.org/10.1371/journal.pone.0039193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723962	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300115
J	Orenstein, JM; Shulman, ST; Fox, LM; Baker, SC; Takahashi, M; Bhatti, TR; Russo, PA; Mierau, GW; de Chadarevian, JP; Perlman, EJ; Trevenen, C; Rotta, AT; Kalelkar, MB; Rowley, AH				Orenstein, Jan Marc; Shulman, Stanford T.; Fox, Linda M.; Baker, Susan C.; Takahashi, Masato; Bhatti, Tricia R.; Russo, Pierre A.; Mierau, Gary W.; de Chadarevian, Jean Pierre; Perlman, Elizabeth J.; Trevenen, Cynthia; Rotta, Alexandre T.; Kalelkar, Mitra B.; Rowley, Anne H.			Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study	PLOS ONE			English	Article							INTRAVENOUS GAMMA-GLOBULIN; INFANTILE PERIARTERITIS-NODOSA; CYTOPLASMIC INCLUSION-BODIES; CORONARY-ARTERY LESIONS; INTRAVASCULAR ULTRASOUND; ADVENTITIAL FIBROBLASTS; YOUNG-ADULTS; ANEURYSMS; LONG; PATHOLOGY	Background: Kawasaki disease is recognized as the most common cause of acquired heart disease in children in the developed world. Clinical, epidemiologic, and pathologic evidence supports an infectious agent, likely entering through the lung. Pathologic studies proposing an acute coronary arteritis followed by healing fail to account for the complex vasculopathy and clinical course. Methodology/Principal Findings: Specimens from 32 autopsies, 8 cardiac transplants, and an excised coronary aneurysm were studied by light (n = 41) and transmission electron microscopy (n = 7). Three characteristic vasculopathic processes were identified in coronary (CA) and non-coronary arteries: acute self-limited necrotizing arteritis (NA), subacute/chronic (SA/C) vasculitis, and luminal myofibroblastic proliferation (LMP). NA is a synchronous neutrophilic process of the endothelium, beginning and ending within the first two weeks of fever onset, and progressively destroying the wall into the adventitia causing saccular aneurysms, which can thrombose or rupture. SA/C vasculitis is an asynchronous process that can commence within the first two weeks onward, starting in the adventitia/perivascular tissue and variably inflaming/damaging the wall during progression to the lumen. Besides fusiform and saccular aneurysms that can thrombose, SA/C vasculitis likely causes the transition of medial and adventitial smooth muscle cells (SMC) into classic myofibroblasts, which combined with their matrix products and inflammation create progressive stenosing luminal lesions (SA/C-LMP). Remote LMP apparently results from circulating factors. Veins, pulmonary arteries, and aorta can develop subclinical SA/C vasculitis and SA/C-LMP, but not NA. The earliest death (day 10) had both CA SA/C vasculitis and SA/C-LMP, and an "eosinophilic-type'' myocarditis. Conclusions/Significance: NA is the only self-limiting process of the three, is responsible for the earliest morbidity/mortality, and is consistent with acute viral infection. SA/C vasculitis can begin as early as NA, but can occur/persist for months to years; LMP causes progressive arterial stenosis and thrombosis and is composed of unique SMC-derived pathologic myofibroblasts.	[Orenstein, Jan Marc] George Washington Univ, Sch Med, Dept Pathol, Washington, DC 20052 USA; [Shulman, Stanford T.; Rowley, Anne H.] Northwestern Univ, Childrens Mem Hosp, Dept Pediat, Feinberg Sch Med, Chicago, IL 60614 USA; [Perlman, Elizabeth J.] Northwestern Univ, Childrens Mem Hosp, Dept Pathol, Feinberg Sch Med, Chicago, IL 60614 USA; [Rowley, Anne H.] Northwestern Univ, Childrens Mem Hosp, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60614 USA; [Fox, Linda M.] Loyola Univ, Stritch Sch Med, Dept Pathol, Maywood, IL 60153 USA; [Baker, Susan C.] Loyola Univ, Stritch Sch Med, Dept Microbiol Immunol, Maywood, IL 60153 USA; [Takahashi, Masato] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Sch Med, Los Angeles, CA 90089 USA; [Bhatti, Tricia R.; Russo, Pierre A.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mierau, Gary W.] Childrens Hosp Colorado, Dept Pathol, Aurora, CO USA; [de Chadarevian, Jean Pierre] Drexel Univ, St Christophers Hosp Children, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Trevenen, Cynthia] Alberta Childrens Prov Gen Hosp, Dept Pathol & Lab Med, Calgary, AB, Canada; [Rotta, Alexandre T.] Indiana Univ Hlth, Dept Pediat, Riley Hosp Children, Indianapolis, IN USA; [Kalelkar, Mitra B.] Cook Cty Inst Forens Med, Off Med Examiner, Chicago, IL USA	George Washington University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Loyola University Chicago; Children's Hospital Los Angeles; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Colorado; Drexel University; Alberta Childrens Hospital; University of Calgary; Indiana University System; James Whitcomb Riley Hospital Children	Orenstein, JM (corresponding author), George Washington Univ, Sch Med, Dept Pathol, Washington, DC 20052 USA.	jmo@gwu.edu		Rowley, Anne/0000-0003-4695-6676; Rotta, Alexandre/0000-0002-4406-2276; Perlman, Elizabeth/0000-0001-6853-6221	National Institutes of Health [R01HL63771, R21HL109955, R21HL089526]; Max Goldenberg Foundation; Children's Memorial Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109955, R01HL063771, R21HL089526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Goldenberg Foundation; Children's Memorial Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health grant R01HL63771, R21HL109955, R21HL089526, the Max Goldenberg Foundation, and the Kawasaki Disease Fund of the Children's Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO S, 1980, ACTA PATHOL JAPON, V30, P681; AMANO S, 1979, JPN CIRC J, V43, P633, DOI 10.1253/jcj.43.633; Ashrafi AH, 2007, PEDIATR DEVEL PATHOL, V10, P491, DOI 10.2350/06-10-0172.1; Barbaro G, 2003, RHEUMATOLOGY, V42, P1427, DOI 10.1093/rheumatology/keg365; Blanchard JN, 2003, CLIN INFECT DIS, V36, P105, DOI 10.1086/345465; Brenner JL, 2000, CAN J CARDIOL, V16, P1017; Burke AP, 1998, PEDIATRICS, V101, P108, DOI 10.1542/peds.101.1.108; Burns JC, 2008, J PEDIATR-US, V153, P833, DOI 10.1016/j.jpeds.2008.06.011; Checchia PA, 2001, PEDIATR CARDIOL, V22, P102, DOI 10.1007/s002460010170; Checchia PA, 1997, PEDIATRICS, V100, P695, DOI 10.1542/peds.100.4.695; de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X; Fleenor BS, 2009, AM J PHYSIOL-HEART C, V296, pH1532, DOI 10.1152/ajpheart.00566.2008; Forte A, 2010, CARDIOVASC RES, V88, P395, DOI 10.1093/cvr/cvq224; FUJIWARA H, 1978, PEDIATRICS, V61, P100; FUJIWARA T, 1988, CIRCULATION, V78, P345, DOI 10.1161/01.CIR.78.2.345; Fukushige J, 1996, PEDIATR CARDIOL, V17, P71, DOI 10.1007/BF02505086; FURUSHO K, 1984, LANCET, V2, P1055; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Han RK, 2000, ARCH PEDIAT ADOL MED, V154, P694, DOI 10.1001/archpedi.154.7.694; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hunsaker Donna M, 2003, J Ky Med Assoc, V101, P233; Iemura M, 2000, HEART, V83, P307, DOI 10.1136/heart.83.3.307; Ishii M, 2001, PEDIATR INT, V43, P211, DOI 10.1046/j.1442-200x.2001.01373.x; JOHNSON DE, 1989, J HEART TRANSPLANT, V8, P349; Johnson RM, 2001, CLIN INFECT DIS, V32, P1628, DOI 10.1086/320523; JOSHI V V, 1987, Pediatric Pathology, V7, P261; Kawasaki T, 1967, Arerugi, V16, P178; Kobayashi T, 1998, CIRCULATION, V98, P92, DOI 10.1161/01.CIR.98.1.92; Landing B H, 1987, Am J Cardiovasc Pathol, V1, P218; LANDING BH, 1977, PEDIATRICS, V59, P651; Levy DM, 2005, J RHEUMATOL, V32, P928; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Manlhiot C, 2010, PEDIATR CARDIOL, V31, P242, DOI 10.1007/s00246-009-9599-7; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mitani Y, 2009, CIRCULATION, V119, P2829, DOI 10.1161/CIRCULATIONAHA.108.818609; Moran AM, 2000, AM HEART J, V139, P217, DOI 10.1016/S0002-8703(00)90229-1; Nakamura Y, 2010, J EPIDEMIOL; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; NEWBURGER JW, 1989, CIRCULATION, V79, P1237, DOI 10.1161/01.CIR.79.6.1237; Porneuf M, 1996, INT J DERMATOL, V35, P292, DOI 10.1111/j.1365-4362.1996.tb03007.x; Rowley AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001582; Rowley AH, 2008, NAT REV MICROBIOL, V6, P394, DOI 10.1038/nrmicro1853; Rowley AH, 2011, J INFECT DIS, V203, P1021, DOI 10.1093/infdis/jiq136; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; SASAGURI Y, 1982, J PEDIATR-US, V100, P225, DOI 10.1016/S0022-3476(82)80639-2; Senzaki H, 2008, CIRCULATION, V118, P2763, DOI 10.1161/CIRCULATIONAHA.107.749515; Siow RCM, 2003, CARDIOVASC RES, V59, P212, DOI 10.1016/S0008-6363(03)00292-X; Stankovic K, 2007, J INFECTION, V55, P488, DOI 10.1016/j.jinf.2007.09.005; SUNDEL RP, 1993, J PEDIATR-US, V123, P657, DOI 10.1016/S0022-3476(05)80972-2; Suzuki A, 2000, JPN HEART J, V41, P245; Suzuki A, 2000, CIRCULATION, V101, P2935, DOI 10.1161/01.CIR.101.25.2935; Takahashi K, 2001, PEDIATR CARDIOL, V22, P138, DOI 10.1007/s002460010180; Takahashi K, 2007, PATHOLOGY CASE REV, V12, P193; Takahashi Kei, 2010, Ann Vasc Dis, V3, P173, DOI 10.3400/avd.sasvp01003; TAKAHASHI M, 1989, CIRCULATION, V79, P1398, DOI 10.1161/01.CIR.79.6.1398; TAKAHASHI M, 1987, CIRCULATION, V75, P387, DOI 10.1161/01.CIR.75.2.387; TANAKA N, 1976, ARCH PATHOL LAB MED, V100, P81; Terashima M, 2002, CIRCULATION, V106, P887, DOI 10.1161/01.CIR.0000030708.86783.92; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Tsuda E, 2002, PEDIATR CARDIOL, V23, P9, DOI 10.1007/s00246-001-0004-4; VIRMANI R, 1986, HUM PATHOL, V17, P575, DOI 10.1016/S0046-8177(86)80129-0; Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78; YOGANATHAN K, 1995, J INFECTION, V30, P165, DOI 10.1016/S0163-4453(95)80014-X; YUTANI C, 1981, ARCH PATHOL LAB MED, V105, P470; Zalewski A, 2002, CIRC RES, V91, P652, DOI 10.1161/01.RES.0000038996.97287.9A	68	202	212	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38998	10.1371/journal.pone.0038998	http://dx.doi.org/10.1371/journal.pone.0038998			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723916	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300078
J	Zhao, YY; Li, YP; Lou, GY; Zhao, L; Xu, ZZ; Zhang, Y; He, FT				Zhao, Yuanyin; Li, Yuping; Lou, Guiyu; Zhao, Li; Xu, Zhizhen; Zhang, Yan; He, Fengtian			MiR-137 Targets Estrogen-Related Receptor Alpha and Impairs the Proliferative and Migratory Capacity of Breast Cancer Cells	PLOS ONE			English	Article							INDEPENDENT TRANSCRIPTIONAL ACTIVATION; ERR-ALPHA; GENE-EXPRESSION; MICRORNA TARGETS; ORPHAN RECEPTOR; IDENTIFICATION; GROWTH; RNAS; COACTIVATOR-1-ALPHA; DIFFERENTIATION	ERR alpha is an orphan nuclear receptor emerging as a novel biomarker of breast cancer. Over-expression of ERR alpha in breast tumor is considered as a prognostic factor of poor clinical outcome. The mechanisms underlying the dysexpression of this nuclear receptor, however, are poorly understood. MicroRNAs (miRNAs) regulate gene expression at the post-transcriptional level and play important roles in tumor initiation and progression. In the present study, we have identified that the expression of ERR alpha is regulated by miR-137, a potential tumor suppressor microRNA. The bioinformatics search revealed two putative and highly conserved target-sites for miR-137 located within the ERR alpha 3'UTR at nt 480-486 and nt 596-602 respectively. Luciferase-reporter assay demonstrated that the two predicted target sites were authentically functional. They mediated the repression of reporter gene expression induced by miR-137 in an additive manner. Moreover, ectopic expression of miR-137 down-regulated ERR alpha expression at both protein level and mRNA level, and the miR-137 induced ERR alpha-knockdown contributed to the impaired proliferative and migratory capacity of breast cancer cells. Furthermore, transfection with miR-137mimics suppressed at least two downstream target genes of ERR alpha-CCNE1 and WNT11, which are important effectors of ERR alpha implicated in tumor proliferation and migration. Taken together, our results establish a role of miR-137 in negatively regulating ERR alpha expression and breast cancer cell proliferation and migration. They suggest that manipulating the expression level of ERR alpha by microRNAs has the potential to influence breast cancer progression.	[Zhao, Yuanyin; Li, Yuping; Lou, Guiyu; Zhao, Li; Xu, Zhizhen; Zhang, Yan; He, Fengtian] Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Chongqing, Peoples R China	Army Medical University	Zhao, YY (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Chongqing, Peoples R China.	yupingli1999@yahoo.com; hefengtian06@yahoo.com.cn	Li, Yuping/J-3138-2018; He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744	National Natural Science Foundation of China [30800638, 81072155]; Natural Science Foundation of Chongqing [CSTC2008BB5019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This work was funded by grants from National Natural Science Foundation of China (No. 30800638; No. 81072155) and Natural Science Foundation of Chongqing (No. CSTC2008BB5019) to YPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Ariazi EA, 2002, CANCER RES, V62, P6510; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bieche I, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-37; Busch BB, 2004, J MED CHEM, V47, P5593, DOI 10.1021/jm049334f; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Chen QJ, 2011, DIGEST DIS SCI, V56, P2009, DOI 10.1007/s10620-010-1536-3; Chen XY, 2011, INVEST OPHTH VIS SCI, V52, P1193, DOI 10.1167/iovs.10-5272; Chisamore MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005624; Chisarnore MJ, 2009, MOL CANCER THER, V8, P672, DOI 10.1158/1535-7163.MCT-08-1028; Deblois G, 2011, BBA-MOL BASIS DIS, V1812, P1032, DOI 10.1016/j.bbadis.2010.12.009; Deblois G, 2010, CANCER RES, V70, P10277, DOI 10.1158/0008-5472.CAN-10-2840; Deblois G, 2009, CANCER RES, V69, P6149, DOI 10.1158/0008-5472.CAN-09-1251; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jahanzeb M, 2008, CLIN BREAST CANCER, V8, P324, DOI 10.3816/CBC.2008.n.037; Jarzabek K, 2009, J STEROID BIOCHEM, V113, P127, DOI 10.1016/j.jsbmb.2008.12.005; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Kirikoshi H, 2001, INT J MOL MED, V8, P651; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; LAW ML, 1987, P NATL ACAD SCI USA, V84, P2877, DOI 10.1073/pnas.84.9.2877; Le Quesne J, 2010, MOL ONCOL, V4, P230, DOI 10.1016/j.molonc.2010.04.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu DX, 2003, ENDOCRINOLOGY, V144, P4894, DOI 10.1210/en.2003-0432; Liu M, 2011, INT J CANCER, V128, P1269, DOI 10.1002/ijc.25452; Moelans CB, 2010, MODERN PATHOL, V23, P1029, DOI 10.1038/modpathol.2010.84; O'Day E, 2011, BREAST CANCER RES, V12, P201; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Seely J, 2005, ENDOCRINOLOGY, V146, P3605, DOI 10.1210/en.2004-1619; Sieuwerts AM, 2006, CLIN CANCER RES, V12, P3319, DOI 10.1158/1078-0432.CCR-06-0225; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Uysal-Onganer P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-55; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Yang C, 1999, CANCER RES, V59, P4519; Yang C, 1998, CANCER RES, V58, P5695	57	97	107	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39102	10.1371/journal.pone.0039102	http://dx.doi.org/10.1371/journal.pone.0039102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723937	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300092
J	Yamamoto, E; Kataoka, K; Dong, YF; Koibuchi, N; Toyama, K; Sueta, D; Katayama, T; Yasuda, O; Ogawa, H; Kim-Mitsuyama, S				Yamamoto, Eiichiro; Kataoka, Keiichiro; Dong, Yi-Fei; Koibuchi, Nobutaka; Toyama, Kensuke; Sueta, Daisuke; Katayama, Tetsuji; Yasuda, Osamu; Ogawa, Hisao; Kim-Mitsuyama, Shokei			Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats	PLOS ONE			English	Article							MECHANISMS; SENSITIVITY; PRESSURE; DISEASE; INJURY	The combination therapy of an angiotensin receptor blocker (ARB) with a calcium channel blocker (CCB) or with a diuretic is favorably recommended for the treatment of hypertension. However, the difference between these two combination therapies is unclear. The present work was undertaken to examine the possible difference between the two combination therapies in vascular protection. Salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP) were divided into 6 groups, and they were orally administered (1) vehicle, (2) olmesartan, an ARB, (3) azelnidipine, a CCB, (4) hydrochlorothiazide, a diuretic, (5) olmesartan combined with azelnidipine, or (6) olmesartan combined with hydrochlorothiazide. Olmesartan combined with either azelnidipine or hydrochlorothiazide ameliorated vascular endothelial dysfunction and remodeling in SHRSP more than did monotherapy with either agent. However, despite a comparable blood pressure lowering effect between the two treatments, azelnidipine enhanced the amelioration of vascular endothelial dysfunction and remodeling by olmesartan to a greater extent than did hydrochlorothiazide in salt-loaded SHRSP. The increased enhancement by azelnidipine of olmesartan-induced vascular protection than by hydrochlorothiazide was associated with a greater amelioration of vascular nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation, superoxide, mitogen-activated protein kinase activation, and with a greater activation of the Akt/endothelial nitric oxide synthase (eNOS) pathway. These results provided the first evidence that a CCB potentiates the vascular protective effects of an ARB in salt-sensitive hypertension, compared with a diuretic, and provided a novel rationale explaining the benefit of the combination therapy with an ARB and a CCB.	[Yamamoto, Eiichiro; Kataoka, Keiichiro; Dong, Yi-Fei; Koibuchi, Nobutaka; Toyama, Kensuke; Sueta, Daisuke; Katayama, Tetsuji; Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan; [Yamamoto, Eiichiro; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Dong, Yi-Fei] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Nanchang, Peoples R China; [Yasuda, Osamu] Kumamoto Univ Hosp, Dept Cardiovasc Clin & Translat Res, Kumamoto, Japan	Kumamoto University; Kumamoto University; Nanchang University; Kumamoto University	Yamamoto, E (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan.	kimmitsu@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [23390058]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (23390058). http://www.mext.go.jp/english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Force T, 1996, CIRC RES, V78, P947, DOI 10.1161/01.RES.78.6.947; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nakamura T, 2008, HYPERTENSION, V51, P296, DOI 10.1161/HYPERTENSIONAHA.107.099044; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429; Yamamoto E, 2007, ARTERIOSCL THROM VAS, V27, P2569, DOI 10.1161/ATVBAHA.107.153692; Yamamoto E, 2007, HYPERTENSION, V50, P657, DOI 10.1161/HYPERTENSIONAHA.107.095315	17	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39162	10.1371/journal.pone.0039162	http://dx.doi.org/10.1371/journal.pone.0039162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720058	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800048
J	Gupta, G; Qin, HN; Song, JX				Gupta, Garvita; Qin, Haina; Song, Jianxing			Intrinsically Unstructured Domain 3 of Hepatitis C Virus NS5A Forms a "Fuzzy Complex" with VAPB-MSP Domain Which Carries ALS-Causing Mutations	PLOS ONE			English	Article							OXYSTEROL-BINDING-PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; RNA REPLICATION COMPLEX; NONSTRUCTURAL PROTEINS; ENDOPLASMIC-RETICULUM; DISORDERED PROTEIN; CRYSTAL-STRUCTURE; NMR; IDENTIFICATION; MEMBRANE	Hepatitis C virus (HCV) affects nearly 200 million people worldwide and is a leading factor for serious chronic liver diseases. For replicating HCV genome, the membrane-associated replication machinery needs to be formed by both HCV nonstructural proteins including NS5A and human host factors. Recently NS5A has been identified to bind ER-anchored human VAP proteins and consequently this interaction may serve as a novel target for design of anti-HCV drugs. So far no biophysical characterization of this interaction has been reported. Here, we dissected the 243-residue VAPB into 4 and 447-residue NS5A into 10 fragments, followed by CD and NMR characterization of their structural properties. Subsequently, binding interactions between these fragments have been extensively assessed by NMR HSQC titration which is very powerful in detecting even very weak binding. The studies lead to three important findings: 1). a "fuzzy complex" is formed between the intrinsically-unstructured third domain (D3) of NS5A and the well-structured MSP domain of VAPB, with an average dissociation constant (Kd) of similar to 5 mu M. 2). The binding-important residues on both NS5A-D3 and VAPB-MSP have been successfully mapped out, which provided experimental constraints for constructing the complex structure. In the complex, unstructured D3 binds to three surface pockets on one side of the MSP structure. Interestingly, two ALS-causing mutations T46I and P56S are also located on the D3-MSP interface. Moreover, NS5A-D3, FFAT-containing proteins and EphA4 appear to have overlapped binding interfaces on the MSP domain. 3). NS5A-D3 has been experimentally confirmed to competes with EphA4 in binding to the MSP domain, and T46I mutation of MSP dramatically abolishes its binding ability to D3. Our study not only provides essential foundation for further deciphering structure and function of the HCV replication machinery, but may also shed light on rationalizing a recent observation that a chronic HCV patient surprisingly developed ALS-like syndrome.	[Gupta, Garvita; Qin, Haina; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore; [Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.	bchsj@nus.edu.sg	Song, Jianxing/H-8026-2012; Qin, Haina/AAB-7486-2020	Song, Jianxing/0000-0003-0224-6322; Haina, Qin/0000-0002-9175-8014	Ministry of Education (MOE) of Singapore Tier 2 Grant [MOE2011-T2-1-096]; National Medical Research Council (NMRC) grant [R154-000-454-213]	Ministry of Education (MOE) of Singapore Tier 2 Grant; National Medical Research Council (NMRC) grant	This study is supported by Ministry of Education (MOE) of Singapore Tier 2 Grant MOE2011-T2-1-096 and National Medical Research Council (NMRC) grant R154-000-454-213 to Jianxing Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Akhvlediani T, 2009, Georgian Med News, P70; Ali N, 2002, J VIROL, V76, P12001, DOI 10.1128/JVI.76.23.12001-12007.2002; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Asselah T, 2011, J HEPATOL, V54, P1069, DOI 10.1016/j.jhep.2010.11.033; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Bastos AF, 2011, NEUROL INT, V3, P12, DOI 10.4081/ni.2011.e4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buhler S, 2012, LIVER INT, V32, P9, DOI 10.1111/j.1478-3231.2011.02701.x; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Hanoulle X, 2010, PROTEIN PEPTIDE LETT, V17, P1012, DOI 10.2174/092986610791498920; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Hardy RW, 2003, J VIROL, V77, P2029, DOI 10.1128/JVI.77.3.2029-2037.2003; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Lim SP, 2001, VIRUS GENES, V23, P89, DOI 10.1023/A:1011143731677; Liu JX, 2008, BIOCHEM BIOPH RES CO, V366, P585, DOI 10.1016/j.bbrc.2007.12.022; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Lohmann V, 1996, J HEPATOL, V24, P11; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Lua SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027072; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Miao LL, 2011, FEBS LETT, V585, P3126, DOI 10.1016/j.febslet.2011.08.048; Moriishi Kohji, 2003, Antiviral Chemistry & Chemotherapy, V14, P285; Nachreiner T, 2010, BIOCHEM BIOPH RES CO, V394, P703, DOI 10.1016/j.bbrc.2010.03.055; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Qin HN, 2008, BIOCHEMISTRY-US, V47, P13647, DOI 10.1021/bi8017976; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Rice Charles M, 2011, Top Antivir Med, V19, P117; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Song JX, 2009, FEBS LETT, V583, P953, DOI 10.1016/j.febslet.2009.02.022; Song JX, 2001, J BIOL CHEM, V276, P41205, DOI 10.1074/jbc.M103449200; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yamasaki LHT, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-14; Yang G, 2004, J VIROL, V78, P10202, DOI 10.1128/JVI.78.18.10202-10205.2004; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	84	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39261	10.1371/journal.pone.0039261	http://dx.doi.org/10.1371/journal.pone.0039261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720086	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900092
J	Langevin, C; Blanco, M; Martin, SAM; Jouneau, L; Bernardet, JF; Houel, A; Lunazzi, A; Duchaud, E; Michel, C; Quillet, E; Boudinot, P				Langevin, Christelle; Blanco, Mar; Martin, Samuel A. M.; Jouneau, Luc; Bernardet, Jean-Francois; Houel, Armel; Lunazzi, Aurelie; Duchaud, Eric; Michel, Christian; Quillet, Edwige; Boudinot, Pierre			Transcriptional Responses of Resistant and Susceptible Fish Clones to the Bacterial Pathogen Flavobacterium psychrophilum	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; INNATE IMMUNE-RESPONSE; RAINBOW-TROUT; EXPERIMENTAL-INFECTION; INTRAOVUM INFECTION; PURIFICATION; COMPLEMENT; WALBAUM; DISEASE; METALLOPROTEASE	Flavobacterium psychrophilum is a bacterial species that represents one of the most important pathogens for aquaculture worldwide, especially for salmonids. To gain insights into the genetic basis of the natural resistance to F. psychrophilum, we selected homozygous clones of rainbow trout with contrasted susceptibility to the infection. We compared the transcriptional response to the bacteria in the pronephros of a susceptible and a resistant line by micro-array analysis five days after infection. While the basal transcriptome of healthy fish was significantly different in the resistant and susceptible lines, the transcriptome modifications induced by the bacteria involved essentially the same genes and pathways. The response to F. psychrophilum involved antimicrobial peptides, complement, and a number of enzymes and chemokines. The matrix metalloproteases mmp9 and mmp13 were among the most highly induced genes in both genetic backgrounds. Key genes of both pro- and anti-inflammatory response such as IL1 and IL10, were up-regulated with a greater magnitude in susceptible animals where the bacterial load was also much higher. While higher resistance to F. psychrophilum does not seem to be based on extensive differences in the orientation of the immune response, several genes including complement C3 showed stronger induction in the resistant fish. They may be important for the variation of susceptibility to the infection.	[Quillet, Edwige] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Langevin, Christelle; Jouneau, Luc; Bernardet, Jean-Francois; Houel, Armel; Lunazzi, Aurelie; Duchaud, Eric; Michel, Christian; Boudinot, Pierre] INRA, Mol Virol & Immunol, Domaine Vilvert, Jouy En Josas, France; [Blanco, Mar] Univ Complutense, Fac Vet Sci, Dept Anim Hlth, E-28040 Madrid, Spain; [Martin, Samuel A. M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Complutense University of Madrid; University of Aberdeen	Langevin, C (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	Pierre.Boudinot@jouy.inra.fr	Jouneau, Luc/AAC-4711-2020; Martin, Samuel A/K-5396-2012; boudinot, pierre/L-4246-2016	boudinot, pierre/0000-0002-7490-9677; Langevin, Christelle/0000-0002-6013-4460; Martin, Samuel/0000-0003-0289-6317; BLANCO, MARIA DEL MAR/0000-0003-4335-4346	Institut National Recherche Agronomique; Agence Nationale de la Recherche [ANR-513 07-GANI-002]	Institut National Recherche Agronomique; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work has been supported by Institut National Recherche Agronomique and the Agence Nationale de la Recherche (ANR-513 07-GANI-002 FLAVORES project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardet J.F., 1988, Bulletin of the European Association of Fish Pathologists, V8, P104; Bernardet J.F., 2011, BERGEYS MANUAL SYSTE, V4, P112; Bernardet J.-F., 2006, PROKARYOTES, P481, DOI [10.1007/0-387-30747-8_17, DOI 10.1007/0-387-30747-8_17]; Bertolini J. M., 1994, Journal of Aquatic Animal Health, V6, P224, DOI 10.1577/1548-8667(1994)006&lt;0224:EDOPFS&gt;2.3.CO;2; Casel Pierrot, 2009, BMC Proc, V3 Suppl 4, pS3, DOI 10.1186/1753-6561-3-S4-S3; Cipriano RC, 2005, J AQUAT ANIM HEALTH, V17, P275, DOI 10.1577/H05-003.1; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; Dalsgaard I., 1993, Annual Review of Fish Diseases, V3, P127, DOI 10.1016/0959-8030(93)90032-7; Decostere A, 2001, J FISH DIS, V24, P481, DOI 10.1046/j.1365-2761.2001.00322.x; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Ekman E, 2003, J FISH DIS, V26, P529, DOI 10.1046/j.1365-2761.2003.00487.x; Faruk MAR, 2000, THESIS U STIRLING ST; Garcia C, 2000, DIS AQUAT ORGAN, V42, P191, DOI 10.3354/dao042191; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Hadidi S, 2008, J IMMUNOL, V180, P4156, DOI 10.4049/jimmunol.180.6.4156; Holt R. A., 1993, P3; Holt RA, 1988, THESIS OREGON STATE; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Koller G, 2009, CURR PHARM DESIGN, V15, P2272, DOI 10.2174/138161209788682361; Kondo M, 2002, MICROBES INFECT, V4, P279, DOI 10.1016/S1286-4579(02)01539-3; Kumagai A, 2010, FISH PATHOL, V45, P115, DOI 10.3147/jsfp.45.115; Kumagai A, 2010, FISH PATHOL, V45, P31, DOI 10.3147/jsfp.45.31; LEHMANN J, 1991, DIS AQUAT ORGAN, V10, P217, DOI 10.3354/dao010217; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Merle C, 2003, J APPL MICROBIOL, V94, P1120, DOI 10.1046/j.1365-2672.2003.01946.x; Moller JD, 2005, J FISH DIS, V28, P391, DOI 10.1111/j.1365-2761.2005.00639.x; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Nematollahi A, 2003, DIS AQUAT ORGAN, V55, P101, DOI 10.3354/dao055101; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Ostland VE, 2000, J FISH DIS, V23, P329, DOI 10.1046/j.1365-2761.2000.00251.x; Ostland VE, 1997, J FISH DIS, V20, P443, DOI 10.1046/j.1365-2761.1997.00323.x; Ostland VE, 1999, J FISH DIS, V22, P351, DOI 10.1046/j.1365-2761.1999.00181.x; Otis EJ, 1984, THESIS U RHODE ISLAN; Overturf K, 2006, J FISH DIS, V29, P215, DOI 10.1111/j.1365-2761.2006.00707.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell MK, 2011, FISH SHELLFISH IMMUN, V30, P84, DOI 10.1016/j.fsi.2010.09.007; Quillet E, 2007, FISH SHELLFISH IMMUN, V22, P510, DOI 10.1016/j.fsi.2006.07.002; Rahman MH, 2002, FISH SHELLFISH IMMUN, V12, P169, DOI 10.1006/fsim.2001.0362; Raida MK, 2009, DEV COMP IMMUNOL, V33, P35, DOI 10.1016/j.dci.2008.07.001; Ramadoss P, 2010, J BIOL CHEM, V285, P16453, DOI 10.1074/jbc.M109.066936; Rangdale RE, 1999, VET REC, V144, P251; Salem M, 2008, J FISH BIOL, V72, P2187, DOI 10.1111/j.1095-8649.2008.01860.x; Secades P, 2003, FEMS MICROBIOL LETT, V226, P273, DOI 10.1016/S0378-1097(03)00599-8; Secades P, 2001, APPL ENVIRON MICROB, V67, P2436, DOI 10.1128/AEM.67.6.2436-2444.2001; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Sundell K, 2011, J FISH DIS, V34, P373, DOI 10.1111/j.1365-2761.2011.01250.x; Sunyer JO, 1996, P NATL ACAD SCI USA, V93, P8546, DOI 10.1073/pnas.93.16.8546; Tacchi L, 2011, PHYSIOL GENOMICS, V43, P1241, DOI 10.1152/physiolgenomics.00086.2011; Tanaka Y, 2012, MOD RHEUMATOL, V22, P128, DOI 10.1007/s10165-011-0475-y; Vatsos IN, 2001, LETT APPL MICROBIOL, V33, P178, DOI 10.1046/j.1472-765x.2001.00980.x; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Wiklund T, 2002, FISH SHELLFISH IMMUN, V12, P141, DOI 10.1006/fsim.2001.0360	54	37	37	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39126	10.1371/journal.pone.0039126	http://dx.doi.org/10.1371/journal.pone.0039126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720048	gold, Green Published, Green Submitted			2022-12-25	WOS:000305341900084
J	Wiemuth, D; Sahin, H; Falkenburger, BH; Lefevre, CMT; Wasmuth, HE; Grunder, S				Wiemuth, Dominik; Sahin, Hacer; Falkenburger, Bjoern H.; Lefevre, Catherine M. T.; Wasmuth, Hermann E.; Gruender, Stefan			BASIC-a bile acid-sensitive ion channel highly expressed in bile ducts	FASEB JOURNAL			English	Article						BLINaC; cholangiocyte; ENaC	3 HOMOLOGOUS SUBUNITS; NA+ CHANNEL; LARGE-CONDUCTANCE; FUNCTIONAL EXPRESSION; SODIUM-CHANNEL; K+ CHANNELS; INTESTINE; CLONING; CELLS; RAT	Brain liver intestine Na+ channel (BLINaC) is an ion channel of the DEG/ENaC gene family of unknown function. BLINaC from rats (rBLINaC) and humans (INaC) is inactive at rest, and its mode of activation has remained unclear. Here, we show that the BLINaC protein localizes to cholangiocytes, epithelial cells that line bile ducts. Moreover, we provide evidence that rBLINaC and INaC are robustly activated by bile acids, in particular chenodeoxycholic acid and hyodeoxycholic acid (EC50 =2.1 +/- 0.05 mM). Thus, BLINaC appears to be an epithelial cation channel of bile ducts sensitive to physiological concentrations of bile acids. BLINaC is related to acid-sensing ion channels (ASICs) and to the epithelial Na+ channel (ENaC) and shares ligand activation with ASICs and epithelial localization with ENaC. Therefore, based on the close homology of BLINaC to ASICs and its activation by bile acids, we propose to rename BLINaC bile acid-sensitive ion channel (BASIC).-Wiemuth, D., Sahin, H., Falkenburger, B. H., Lefevre, C. M. T., Wasmuth, H. E., Grunder, S. BASIC-a bile acid-sensitive ion channel highly expressed in bile ducts. FASEB J. 26, 4122-4130 (2012). www.fasebj.org	[Wiemuth, Dominik; Lefevre, Catherine M. T.; Gruender, Stefan] Rhein Westfal TH Aachen, Dept Physiol, D-52074 Aachen, Germany; [Sahin, Hacer; Wasmuth, Hermann E.] Rhein Westfal TH Aachen, Dept Med 3, D-52074 Aachen, Germany; [Falkenburger, Bjoern H.] Rhein Westfal TH Aachen, Dept Neurol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University	Wiemuth, D (corresponding author), Rhein Westfal TH Aachen, Dept Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	dwiemuth@ukaachen.de; sgruender@ukaachen.de	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883; Falkenburger, Bjoern/0000-0002-2387-526X	START program of the Faculty of Medicine of Rheinisch-Westfaelische Technische Hochschule (RWTH) Aachen University; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University [N5-1, N6]; Deutsche Forschungsgemeinschaft [WA 2557/2-1, SFB-TRR57]; Else Kroner-Fresenius-Stiftung	START program of the Faculty of Medicine of Rheinisch-Westfaelische Technische Hochschule (RWTH) Aachen University; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung	The authors thank H. Kalbacher for helpful discussions, M. Pusch for comments on the manuscript, and A. Oslender-Bujotzek, S. Lenz, and S. Hamm for expert technical assistance. This project was supported by the START program of the Faculty of Medicine of Rheinisch-Westfaelische Technische Hochschule (RWTH) Aachen University (D.W.). B.H.F. and S.G. are supported by a grant from the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University (projects N5-1 and N6); H.E.W. is supported by the Deutsche Forschungsgemeinschaft (WA 2557/2-1, SFB-TRR57) and the Else Kroner-Fresenius-Stiftung.	Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; Bukiya AN, 2011, P NATL ACAD SCI USA, V108, P20207, DOI 10.1073/pnas.1112901108; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; COHN JA, 1993, GASTROENTEROLOGY, V105, P1857, DOI 10.1016/0016-5085(93)91085-V; Dopico AM, 2002, J GEN PHYSIOL, V119, P251, DOI 10.1085/jgp.119.3.251; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; FISHER MM, 1973, CAN MED ASSOC J, V109, P190; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Grunder S, 2000, NEUROREPORT, V11, P1607; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; HASLEWOOD GA, 1971, BIOCHEM J, V123, P15, DOI 10.1042/bj1230015; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hofmann AF, 2009, HEPATOLOGY, V49, P1403, DOI 10.1002/hep.22789; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; PAUMGART.G, 1971, N-S ARCH PHARMAKOL, V270, P98, DOI 10.1007/BF00997305; Qiao X, 2011, J CHROMATOGR A, V1218, P107, DOI 10.1016/j.chroma.2010.10.116; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Talalay P., 1963, ENZYMES, V7, P177; Voronina SG, 2005, J BIOL CHEM, V280, P1764, DOI 10.1074/jbc.M410230200; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wiemuth D, 2010, J BIOL CHEM, V285, P30404, DOI 10.1074/jbc.M110.153064	31	31	31	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2012	26	10					4122	4130		10.1096/fj.12-207043	http://dx.doi.org/10.1096/fj.12-207043			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22735174				2022-12-25	WOS:000309704000019
J	Sivaramakrishnan, V; Fountain, SJ				Sivaramakrishnan, Venketesh; Fountain, Samuel J.			A Mechanism of Intracellular P2X Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSPORTER; CONTRACTILE VACUOLE COMPLEX; DENSITY-SENSING FACTOR; DICTYOSTELIUM-DISCOIDEUM; ATP; IDENTIFICATION; MEMBRANE; PROTEIN; OSMOREGULATION; CALMODULIN	P2X receptors (P2XRs) are ATP-activated calcium-permeable ligand-gated ion channels traditionally viewed as sensors of extracellular ATP during diverse physiological processes including pain, inflammation, and taste. However, in addition to a cell surface residency P2XRs also populate the membranes of intracellular compartments, including mammalian lysosomes, phagosomes, and the contractile vacuole (CV) of the amoeba Dictyostelium. The function of intracellular P2XRs is unclear and represents a major gap in our understanding of ATP signaling. Here, we exploit the genetic versatility of Dictyostelium to investigate the effects of physiological concentrations of ATP on calcium signaling in isolated CVs. Within the CV, an acidic calcium store, P2XRs are orientated to sense luminal ATP. Application of ATP to isolated vacuoles leads to luminal translocation of ATP and release of calcium. Mechanisms of luminal ATP translocation and ATP-evoked calcium release share common pharmacology, suggesting that they are linked processes. The ability of ATP to mobilize stored calcium is reduced in vacuoles isolated from P2X(A)R knock-out amoeba and ablated in cells devoid of P2XRs. Pharmacological inhibition of luminal ATP translocation or depletion of CV calcium attenuates CV function in vivo, manifesting as a loss of regulatory cell volume decrease following osmotic swelling. We propose that intracellular P2XRs regulate vacuole activity by acting as calcium release channels, activated by translocation of ATP into the vacuole lumen.	[Sivaramakrishnan, Venketesh; Fountain, Samuel J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Fountain, SJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	s.j.fountain@uea.ac.uk	Sivaramakrishnan, Venketesh/J-2025-2012; Fountain, Samuel J/C-2142-2011	Sivaramakrishnan, Venketesh/0000-0003-3094-5905; 	Biotechnology and Biological Sciences Research Council (BBSRC) through a BBSRC David Phillips Fellowship	Biotechnology and Biological Sciences Research Council (BBSRC) through a BBSRC David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) through a BBSRC David Phillips Fellowship personal award (to S. J. F.).	Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Becker M, 1999, EMBO J, V18, P3305, DOI 10.1093/emboj/18.12.3305; BERGQUIST BL, 1989, T AM MICROSC SOC, V108, P369, DOI 10.2307/3226267; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Bush J, 1996, MOL BIOL CELL, V7, P1623, DOI 10.1091/mbc.7.10.1623; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Clarke CE, 2000, J PHYSIOL-LONDON, V523, P697, DOI 10.1111/j.1469-7793.2000.00697.x; Deery WJ, 2002, J BIOL CHEM, V277, P31972, DOI 10.1074/jbc.M204539200; Fountain SJ, 2008, J BIOL CHEM, V283, P15122, DOI 10.1074/jbc.M801512200; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2009, PURINERG SIGNAL, V5, P269, DOI 10.1007/s11302-008-9127-x; Gabriel D, 1999, J CELL SCI, V112, P3995; Gualix J, 1999, RECEPTOR CHANNEL, V6, P449; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Heuser J, 2006, EUR J CELL BIOL, V85, P859, DOI 10.1016/j.ejcb.2006.05.011; JAIN R, 1994, J BIOL CHEM, V269, P9128; Jedlitschky G, 2004, BLOOD, V104, P3603, DOI 10.1182/blood-2003-12-4330; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kuehnel MP, 2009, J CELL SCI, V122, P499, DOI 10.1242/jcs.034199; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Leroch M, 2008, PLANT CELL, V20, P438, DOI 10.1105/tpc.107.057554; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Loukin S, 2008, FASEB J, V22, P2405, DOI 10.1096/fj.07-101410; Ludlow MJ, 2009, J BIOL CHEM, V284, P35227, DOI 10.1074/jbc.M109.045674; Malchow D, 2008, CELL CALCIUM, V43, P521, DOI 10.1016/j.ceca.2007.08.002; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; MAY T, 1991, MECH DEVELOP, V33, P147, DOI 10.1016/0925-4773(91)90081-G; NOLTA KV, 1994, J BIOL CHEM, V269, P2225; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; ROONEY EK, 1994, CELL CALCIUM, V16, P509, DOI 10.1016/0143-4160(94)90081-7; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Stokes L, 2009, EUR J IMMUNOL, V39, P986, DOI 10.1002/eji.200838818; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Ulrich PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018013; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347; zur Nedden S, 2009, ANAL BIOCHEM, V388, P108, DOI 10.1016/j.ab.2009.02.017	43	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28315	28326		10.1074/jbc.M112.372565	http://dx.doi.org/10.1074/jbc.M112.372565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22736763	Green Published, hybrid			2022-12-25	WOS:000308074600009
J	She, K; Ferreira, JS; Carvalho, AL; Craig, AM				She, Kevin; Ferreira, Joana S.; Carvalho, Ana Luisa; Craig, Ann Marie			Glutamate Binding to the GluN2B Subunit Controls Surface Trafficking of N-Methyl-D-aspartate (NMDA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM RETENTION; LIGAND-BINDING; HIPPOCAMPAL-NEURONS; QUALITY-CONTROL; MOLECULAR DETERMINANTS; DIFFERENTIAL ROLES; AMPA RECEPTORS; ACID RECEPTORS; NR2 SUBUNIT; GLYCINE	Trafficking of NMDA receptors to the surface of neurons and to synapses is critical for proper brain function and activity-dependent plasticity. Recent evidence suggests that surface trafficking of other ionotropic glutamate receptors requires ligand binding for exit from the endoplasmic reticulum. Here, we show that glutamate binding to GluN2 is required for trafficking of NMDA receptors to the cell surface. We expressed a panel of GluN2B ligand binding mutants in heterologous cells with GluN1 or in rat cultured neurons and found that surface expression correlates with glutamate efficacy. Such a correlation was found even in the presence of dominant negative dynamin to inhibit endocytosis and surface expression correlated with Golgi localization, indicating differences in forward trafficking. Co-expression of wild type GluN2B did not enhance surface expression of the mutants, suggesting that glutamate must bind to both GluN2 subunits in a tetramer and that surface expression is limited by the least avid of the two glutamate binding sites. Surface trafficking of a constitutively closed cleft GluN2B was indistinguishable from that of wild type, suggesting that glutamate concentrations are typically not limiting for forward trafficking. YFP-GluN2B expressed in hippocampal neurons from GluN2B(-/-) mice rescued synaptic accumulation at similar levels to wild type. Under these conditions, surface synaptic accumulation of YFP-GluN2B mutants also correlated with apparent glutamate affinity. Altogether, these results indicate that glutamate controls forward trafficking of NMDA receptors to the cell surface and to synapses and raise the intriguing idea that NMDA receptors may be functional at intracellular sites.	[She, Kevin; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [She, Kevin; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Ferreira, Joana S.; Carvalho, Ana Luisa] Univ Coimbra, Dept Life Sci, P-3004517 Coimbra, Portugal; [Ferreira, Joana S.; Carvalho, Ana Luisa] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal	University of British Columbia; University of British Columbia; Universidade de Coimbra; Universidade de Coimbra	Craig, AM (corresponding author), Univ British Columbia, Brain Res Ctr, Rm F149,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	acraig@mail.ubc.ca	Carvalho, Ana Luisa/K-6367-2013; Ferreira, Joana/AAY-8702-2020; Ferreira, Joana/I-9447-2014; Craig, Ann Marie/M-2054-2014	Carvalho, Ana Luisa/0000-0001-8368-6666; Ferreira, Joana/0000-0002-1049-8063; Ferreira, Joana/0000-0002-1049-8063; 	Canadian Institutes of Health Research (CIHR) [MOP-69096]; Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-NEU/099440/2008]; Canada Research Chair; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-69096 (to A. M. C.), by the Portuguese Foundation for Science and Technology (FCT) Grant PTDC/SAU-NEU/099440/2008 (to A. L. C.), and by salary awards CIHR Frederick Banting and Charles Best Canada Graduate Scholarship (to K. S.) and Canada Research Chair (to A. M. C.).	BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; BERGER SJ, 1977, J NEUROCHEM, V28, P149, DOI 10.1111/j.1471-4159.1977.tb07720.x; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Ferreira JS, 2011, J BIOL CHEM, V286, P28331, DOI 10.1074/jbc.M111.222539; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mammen AL, 1997, J NEUROSCI, V17, P7351; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nolt MJ, 2011, J NEUROSCI, V31, P5353, DOI 10.1523/JNEUROSCI.0282-11.2011; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Rao A, 1998, J NEUROSCI, V18, P1217; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Storey GP, 2011, J NEUROSCI, V31, P6311, DOI 10.1523/JNEUROSCI.5553-10.2011; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200	46	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27432	27445		10.1074/jbc.M112.345108	http://dx.doi.org/10.1074/jbc.M112.345108			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740692	Green Published, hybrid			2022-12-25	WOS:000307840700016
J	Sholukh, AM; Mukhtar, MM; Humbert, M; Essono, SS; Watkins, JD; Vyas, HK; Shanmuganathan, V; Hemashettar, G; Kahn, M; Hu, SL; Montefiori, DC; Polonis, VR; Schur, PH; Ruprecht, RM				Sholukh, Anton M.; Mukhtar, Muhammad M.; Humbert, Michael; Essono, Sosthene S.; Watkins, Jennifer D.; Vyas, Hemant K.; Shanmuganathan, Vivekanandan; Hemashettar, Girish; Kahn, Maria; Hu, Shiu-Lok; Montefiori, David C.; Polonis, Victoria R.; Schur, Peter H.; Ruprecht, Ruth M.			Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity	PLOS ONE			English	Article							HUMAN IMMUNE-RESPONSE; NEUTRALIZING ANTIBODIES; REPLICATION-COMPETENT; RHESUS MACAQUES; B-CELLS; VIRUS; HIV-1; VACCINE; BINDING; BROAD	Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We devised a direct approach to isolate mAbs with predetermined conformational epitope specificity, using epitope mimetics (mimotopes) that reflect the three-dimensional structure of given antigen subdomains. We performed differential biopanning using bacteriophages encoding random peptide libraries and polyclonal antibodies (Abs) that had been affinity-purified with either native or denatured antigen. This strategy yielded conformational mimotopes. We then generated mimotope-fluorescent protein fusions, which were used as baits to isolate single memory B cells from rhesus monkeys (RMs). To amplify RM immunoglobulin variable regions, we developed RM-specific PCR primers and generated chimeric simian-human mAbs with predicted epitope specificity. We established proof-of-concept of our strategy by isolating mAbs targeting the conformational V3 loop crown of HIV Env; the new mAbs cross-neutralized viruses of different clades. The novel technology allows isolating mAbs from RMs or other hosts given experimental immunogens or infectious agents.	[Sholukh, Anton M.; Mukhtar, Muhammad M.; Humbert, Michael; Essono, Sosthene S.; Watkins, Jennifer D.; Vyas, Hemant K.; Shanmuganathan, Vivekanandan; Hemashettar, Girish; Ruprecht, Ruth M.] Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA; [Sholukh, Anton M.; Mukhtar, Muhammad M.; Humbert, Michael; Essono, Sosthene S.; Watkins, Jennifer D.; Vyas, Hemant K.; Shanmuganathan, Vivekanandan; Hemashettar, Girish; Ruprecht, Ruth M.] Dana Farber Canc Inst, AIDS, Boston, MA 02115 USA; [Sholukh, Anton M.; Mukhtar, Muhammad M.; Humbert, Michael; Essono, Sosthene S.; Watkins, Jennifer D.; Vyas, Hemant K.; Schur, Peter H.; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Kahn, Maria; Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Hu, Shiu-Lok] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Montefiori, David C.] Duke Univ, Sch Med, Dept Surg, Durham, NC USA; [Polonis, Victoria R.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD USA; [Schur, Peter H.] Brigham & Womens Hosp, Dept Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Brigham & Women's Hospital	Sholukh, AM (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu	Sholukh, Anton/AAU-2338-2021; Hu, Shiu-Lok/A-3196-2008	Sholukh, Anton/0000-0003-0498-9162; Hu, Shiu-Lok/0000-0003-4336-7964	NIH [P01 AI048240, P01 AI048240-08s1, R37 AI034266, P30 AI060354]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, P01AI048240, R37AI034266, P01AI082282] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants P01 AI048240, P01 AI048240-08s1, R37 AI034266, and P30 AI060354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayash-Rashkovsky M, 2007, INFECT IMMUN, V75, P1751, DOI 10.1128/IAI.01703-06; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Corti D, 2011, CURR OPIN IMMUNOL, V23, P430, DOI 10.1016/j.coi.2011.04.006; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Hioe CE, 2011, PLOS ONE, V5; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; JULIUS MH, 1972, P NATL ACAD SCI USA, V69, P1934, DOI 10.1073/pnas.69.7.1934; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KLANIECKI J, 1991, AIDS RES HUM RETROV, V7, P791, DOI 10.1089/aid.1991.7.791; Kwong PD, 2009, CELL HOST MICROBE, V6, P292, DOI 10.1016/j.chom.2009.09.008; Margolin DH, 2006, J IMMUNOL, V177, P1108, DOI 10.4049/jimmunol.177.2.1108; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Parren PWHI, 1996, J VIROL, V70, P9046, DOI 10.1128/JVI.70.12.9046-9050.1996; POSNER MR, 1991, J IMMUNOL, V146, P4325; Rasmussen RA, 2007, AIDS, V21, P1841, DOI 10.1097/QAD.0b013e32828684ea; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Robinson JE, 2010, J VIROL, V84, P3443, DOI 10.1128/JVI.02617-09; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38943	10.1371/journal.pone.0038943	http://dx.doi.org/10.1371/journal.pone.0038943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737224	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100023
J	Kanga, S; Bernard, D; Mager-Heckel, AM; Erpapazoglou, Z; Mattiroli, F; Sixma, TK; Leon, S; Urban-Grimal, D; Tarassov, I; Haguenauer-Tsapis, R				Kanga, Sophie; Bernard, Delphine; Mager-Heckel, Anne-Marie; Erpapazoglou, Zoi; Mattiroli, Francesca; Sixma, Titia K.; Leon, Sebastien; Urban-Grimal, Daniele; Tarassov, Ivan; Haguenauer-Tsapis, Rosine			A Deubiquitylating Complex Required for Neosynthesis of a Yeast Mitochondrial ATP Synthase Subunit	PLOS ONE			English	Article							TRANSFER-RNA IMPORT; DEUBIQUITINATING ENZYME; SACCHAROMYCES-CEREVISIAE; PROTEIN; UBIQUITIN; DEGRADATION; REGULATOR; VERSATILE; TURNOVER; DEFECTS	The ubiquitin system is known to be involved in maintaining the integrity of mitochondria, but little is known about the role of deubiquitylating (DUB) enzymes in such functions. Budding yeast cells deleted for UBP13 and its close homolog UBP9 displayed a high incidence of petite colonies and slow respiratory growth at 37 degrees C. Both Ubp9 and Ubp13 interacted directly with Duf1 (DUB-associated factor 1), a WD40 motif-containing protein. Duf1 activates the DUB activity of recombinant Ubp9 and Ubp13 in vitro and deletion of DUF1 resulted in the same respiratory phenotype as the deletion of both UBP9 and UBP13. We show that the mitochondrial defects of these mutants resulted from a strong decrease at 37 degrees C in the de novo biosynthesis of Atp9, a membrane-bound component of ATP synthase encoded by mitochondrial DNA. The defect appears at the level of ATP9 mRNA translation, while its maturation remained unchanged in the mutants. This study describes a new role of the ubiquitin system in mitochondrial biogenesis.	[Kanga, Sophie; Bernard, Delphine; Erpapazoglou, Zoi; Leon, Sebastien; Urban-Grimal, Daniele; Haguenauer-Tsapis, Rosine] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR7592, Paris, France; [Mattiroli, Francesca; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, Amsterdam, Netherlands; [Mager-Heckel, Anne-Marie; Tarassov, Ivan] Univ Strasbourg, CNRS, UMR Genet Mol Genom Microbiol GMGM 7156, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Netherlands Cancer Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kanga, S (corresponding author), Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR7592, Paris, France.	haguenauer.rosine@ijm.univ-paris-diderot.fr	Mattiroli, Francesca/AAT-1489-2020; Erpapazoglou, Zoi/X-8497-2019; LEON, Sebastien/A-5441-2008	Mattiroli, Francesca/0000-0002-1574-7217; LEON, Sebastien/0000-0002-2536-8595; Tarassov, Ivan/0000-0001-8763-6703; Bernard, Delphine/0000-0002-9439-5482; Sixma, Titia K/0000-0001-6180-0632	Centre National de la Recherche Scientifique (CNRS), Paris 6-Denis Diderot University; Centre National de la Recherche Scientifique (CNRS), Paris 7-Denis Diderot University; Association pour la Recherche contre le Cancer (ARC) [3298]; Ligue Nationale Contre le Cancer (Comite de Paris) [RS09/75-26]; French Ministry of Research (ACI BCMS) (RHT's lab); EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (RHT lab); EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (TS lab); FRM (Fondation pour la Recherche Medicale); ANR (Agence Nationale de la Recherche); National Program "Investissements d'Avenir" (LabEx "MitoCross); French Ministry of Research; Ligue Nationale Contre le Cancer; Pierre et Marie Curie University; UBIREGULATORS network; RUBICON network	Centre National de la Recherche Scientifique (CNRS), Paris 6-Denis Diderot University; Centre National de la Recherche Scientifique (CNRS), Paris 7-Denis Diderot University; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Ligue Nationale Contre le Cancer (Comite de Paris); French Ministry of Research (ACI BCMS) (RHT's lab); EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (RHT lab); EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (TS lab); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); National Program "Investissements d'Avenir" (LabEx "MitoCross)(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Pierre et Marie Curie University; UBIREGULATORS network; RUBICON network	This work was supported by the Centre National de la Recherche Scientifique (CNRS), Paris 6 and Paris 7-Denis Diderot Universities, and by grants from the Association pour la Recherche contre le Cancer (ARC, grant 3298), the Ligue Nationale Contre le Cancer (Comite de Paris, grant RS09/75-26), the French Ministry of Research (ACI BCMS) (RHT's lab), the EU 6th Framework Programme (Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation: RUBICON, and the Marie Curie network UBIREGULATORS) (RHT and TS labs), and by Agence Nationale de la Recherche (ANR). AMMG and IT were supported by the FRM (Fondation pour la Recherche Medicale), the ANR (Agence Nationale de la Recherche) and the National Program "Investissements d'Avenir" (LabEx "MitoCross). SK was supported by the French Ministry of Research and the Ligue Nationale Contre le Cancer. DB was supported by Pierre et Marie Curie University. ZE received fellowships from the UBIREGULATORS and RUBICON networks. FM received a fellowship from the UBIREGULATORS network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HADIKUSUMO RG, 1988, BIOCHIM BIOPHYS ACTA, V933, P212, DOI 10.1016/0005-2728(88)90072-2; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kamenski P, 2007, MOL CELL, V26, P625, DOI 10.1016/j.molcel.2007.04.019; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kinner A, 2003, FEBS LETT, V549, P135, DOI 10.1016/S0014-5793(03)00801-9; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Lockington RA, 2002, MOL MICROBIOL, V43, P1173, DOI 10.1046/j.1365-2958.2002.02811.x; Lockington RA, 2001, MOL MICROBIOL, V40, P1311, DOI 10.1046/j.1365-2958.2001.02474.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malc E, 2009, MUTAT RES-FUND MOL M, V669, P95, DOI 10.1016/j.mrfmmm.2009.05.008; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; RICHTERRUOFF B, 1994, FEBS LETT, V354, P50, DOI 10.1016/0014-5793(94)01085-4; Rinaldi T, 2002, GENE, V286, P43, DOI 10.1016/S0378-1119(01)00799-5; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zoladek T, 1997, GENETICS, V145, P595	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38071	10.1371/journal.pone.0038071	http://dx.doi.org/10.1371/journal.pone.0038071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723847	Green Published, gold			2022-12-25	WOS:000305652700009
J	Matragrano, LL; Beaulieu, M; Phillip, JO; Rae, AI; Sanford, SE; Sockman, KW; Maney, DL				Matragrano, Lisa L.; Beaulieu, Michael; Phillip, Jessica O.; Rae, Ali I.; Sanford, Sara E.; Sockman, Keith W.; Maney, Donna L.			Rapid Effects of Hearing Song on Catecholaminergic Activity in the Songbird Auditory Pathway	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE PHOSPHORYLATION; WHITE-THROATED SPARROWS; ESTRADIOL-DEPENDENT MODULATION; SEASONALLY BREEDING SONGBIRD; FEMALE EUROPEAN STARLINGS; MALE COURTSHIP SONG; MALE ZEBRA FINCHES; LOCUS-COERULEUS; DOPAMINE RELEASE; GENE-EXPRESSION	Catecholaminergic (CA) neurons innervate sensory areas and affect the processing of sensory signals. For example, in birds, CA fibers innervate the auditory pathway at each level, including the midbrain, thalamus, and forebrain. We have shown previously that in female European starlings, CA activity in the auditory forebrain can be enhanced by exposure to attractive male song for one week. It is not known, however, whether hearing song can initiate that activity more rapidly. Here, we exposed estrogen-primed, female white-throated sparrows to conspecific male song and looked for evidence of rapid synthesis of catecholamines in auditory areas. In one hemisphere of the brain, we used immunohistochemistry to detect the phosphorylation of tyrosine hydroxylase (TH), a rate-limiting enzyme in the CA synthetic pathway. We found that immunoreactivity for TH phosphorylated at serine 40 increased dramatically in the auditory forebrain, but not the auditory thalamus and midbrain, after 15 min of song exposure. In the other hemisphere, we used high pressure liquid chromatography to measure catecholamines and their metabolites. We found that two dopamine metabolites, dihydroxyphenylacetic acid and homovanillic acid, increased in the auditory forebrain but not the auditory midbrain after 30 min of exposure to conspecific song. Our results are consistent with the hypothesis that exposure to a behaviorally relevant auditory stimulus rapidly induces CA activity, which may play a role in auditory responses.	[Matragrano, Lisa L.; Phillip, Jessica O.; Rae, Ali I.; Sanford, Sara E.; Maney, Donna L.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Beaulieu, Michael; Sockman, Keith W.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Sockman, Keith W.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA	Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matragrano, LL (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.	dmaney@emory.edu	Maney, Donna L/G-3706-2011; Beaulieu, Michaël/A-5261-2011	Maney, Donna L/0000-0002-1006-2358; Beaulieu, Michaël/0000-0002-9948-269X	NINDS [R01 NS055125]; NSF [IBN-0346984]; Center for Behavioral Neuroscience [IBN-9876754]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055125] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); Center for Behavioral Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NINDS R01 NS055125 to KWS (www.ninds.nih.gov), NSF IBN-0346984 to DLM (www.nsf.gov), and the Center for Behavioral Neuroscience IBN-9876754 (www.cbn-atl.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Amin N, 2010, J NEUROPHYSIOL, V104, P784, DOI 10.1152/jn.00128.2010; Appeltants D, 2005, BEHAV PROCESS, V69, P331, DOI 10.1016/j.beproc.2005.01.010; Appeltants D, 2002, NEUROREPORT, V13, P649, DOI 10.1097/00001756-200204160-00023; Appeltants D, 2002, BEHAV BRAIN RES, V133, P221, DOI 10.1016/S0166-4328(02)00005-0; Appeltants D, 2001, CELL TISSUE RES, V304, P237, DOI 10.1007/s004410100360; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Avey MT, 2005, BEHAV BRAIN RES, V165, P247, DOI 10.1016/j.bbr.2005.07.002; BAILHACHE T, 1993, J COMP NEUROL, V329, P230, DOI 10.1002/cne.903290206; Balthazart J, 1996, BELG J ZOOL, V126, P65; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BEAUDET A, 1978, NEUROSCIENCE, V3, P851, DOI 10.1016/0306-4522(78)90115-X; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bharati IS, 2006, NEUROSCIENCE, V143, P661, DOI 10.1016/j.neuroscience.2006.08.046; BOTTJER SW, 1993, J NEUROBIOL, V24, P51, DOI 10.1002/neu.480240105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN EE, 1991, J NEUROCHEM, V57, P701, DOI 10.1111/j.1471-4159.1991.tb03802.x; Cardin JA, 2004, J NEUROSCI, V24, P7745, DOI 10.1523/JNEUROSCI.1951-04.2004; Castelino CB, 2010, J CHEM NEUROANAT, V39, P96, DOI 10.1016/j.jchemneu.2009.08.003; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; COMMISSIONG JW, 1985, BIOCHEM PHARMACOL, V34, P1127, DOI 10.1016/0006-2952(85)90484-8; Cransac H, 1998, HEARING RES, V118, P151, DOI 10.1016/S0378-5955(98)00031-8; Curtis AL, 2012, NEUROPHARMACOLOGY, V62, P1737, DOI 10.1016/j.neuropharm.2011.11.020; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Falls J.B., 1994, Birds of North America, V128, P1; Fujisawa H, 2005, BIOCHEM BIOPH RES CO, V338, P271, DOI 10.1016/j.bbrc.2005.07.183; Gale SD, 2010, J NEUROSCI, V30, P1027, DOI 10.1523/JNEUROSCI.3585-09.2010; Gammie SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001974; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Goodson JL, 2009, P NATL ACAD SCI USA, V106, P8737, DOI 10.1073/pnas.0811821106; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRESCH PJ, 1994, J NEUROCHEM, V63, P575; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hurley LM, 2011, HEARING RES, V279, P74, DOI 10.1016/j.heares.2010.12.015; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; KARTEN HARVEY J., 1967, BRAIN RES, V6, P409, DOI 10.1016/0006-8993(67)90055-8; KILTS CD, 1981, J CHROMATOGR, V225, P347, DOI 10.1016/S0378-4347(00)80283-2; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lake JI, 2008, GEN COMP ENDOCR, V156, P426, DOI 10.1016/j.ygcen.2007.12.009; LeBlanc MM, 2007, BRAIN RES, V1171, P93, DOI 10.1016/j.brainres.2007.06.086; Leviel V, 2001, NEUROCHEM INT, V38, P83, DOI 10.1016/S0197-0186(00)00076-0; Logerot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020686; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; Maney DL, 2003, J NEUROBIOL, V56, P163, DOI 10.1002/neu.10227; Maney DL, 2005, HORM BEHAV, V48, P196, DOI 10.1016/j.yhbeh.2005.03.004; Maney DL, 2003, J COMP PHYSIOL A, V189, P667, DOI 10.1007/s00359-003-0441-z; Maney DL, 2001, NEUROSCI LETT, V311, P189, DOI 10.1016/S0304-3940(01)02157-7; Maney DL, 2008, J COMP NEUROL, V511, P173, DOI 10.1002/cne.21830; Maney DL, 2007, ENDOCRINOLOGY, V148, P5614, DOI 10.1210/en.2007-0879; Maney DL, 2011, FRONT NEUROENDOCRIN, V32, P287, DOI 10.1016/j.yfrne.2010.12.002; Maney DL, 2009, HORM BEHAV, V55, P113, DOI 10.1016/j.yhbeh.2008.09.002; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; Matragrano LL, 2012, BEHAV NEUROSCI, V126, P110, DOI 10.1037/a0025586; Matragrano LL, 2011, EUR J NEUROSCI, V34, P416, DOI 10.1111/j.1460-9568.2011.07751.x; Metzger M, 1996, J COMP NEUROL, V376, P1, DOI 10.1002/(SICI)1096-9861(19961202)376:1<1::AID-CNE1>3.0.CO;2-7; Miranda JA, 2009, HEARING RES, V252, P21, DOI 10.1016/j.heares.2009.04.014; MOONS L, 1994, J COMP NEUROL, V346, P97, DOI 10.1002/cne.903460107; MOORE KE, 1986, ANN NY ACAD SCI, V473, P303; MOORE MC, 1983, J ZOOL, V199, P137, DOI 10.1111/j.1469-7998.1983.tb02085.x; Niu XZ, 2002, HEARING RES, V174, P124, DOI 10.1016/S0378-5955(02)00646-9; Nordeen EJ, 2009, EUR J NEUROSCI, V30, P662, DOI 10.1111/j.1460-9568.2009.06849.x; Olsson C, 2008, J COMP NEUROL, V508, P756, DOI 10.1002/cne.21705; Ong LK, 2011, NEUROSCIENCE, V192, P20, DOI 10.1016/j.neuroscience.2011.06.087; Ong LK, 2011, NEUROCHEM RES, V36, P27, DOI 10.1007/s11064-010-0255-7; Pawlisch BA, 2011, NEUROSCI LETT, V496, P20, DOI 10.1016/j.neulet.2011.03.078; Pawlisch BA, 2010, BRAIN RES, V1353, P113, DOI 10.1016/j.brainres.2010.07.003; Phan ML, 2010, P NATL ACAD SCI USA, V107, P2301, DOI 10.1073/pnas.0900091107; Pinaud R, 2008, J BIOSCIENCES, V33, P145, DOI 10.1007/s12038-008-0030-y; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; READER TA, 1979, BRAIN RES, V160, P217, DOI 10.1016/0006-8993(79)90420-7; Reiner A., 1994, P135; Riters LV, 2007, GEN COMP ENDOCR, V154, P137, DOI 10.1016/j.ygcen.2007.05.029; Riters LV, 2007, BRAIN RES, V1149, P127, DOI 10.1016/j.brainres.2007.02.059; Roberts TF, 2001, J COMP NEUROL, V429, P436, DOI 10.1002/1096-9861(20010115)429:3<436::AID-CNE6>3.0.CO;2-H; ROBINSON PJ, 1985, J NEUROCHEM, V44, P338, DOI 10.1111/j.1471-4159.1985.tb05422.x; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Sanford SE, 2010, DEV NEUROBIOL, V70, P73, DOI 10.1002/dneu.20757; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SHANK MAX C., 1959, AUK, V76, P44; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; SOARESDASILVA P, 1987, J PHARM PHARMACOL, V39, P127, DOI 10.1111/j.2042-7158.1987.tb06958.x; SOARESDASILVA P, 1990, NEUROPHARMACOLOGY, V29, P869, DOI 10.1016/0028-3908(90)90135-E; Sockman KW, 2008, DEV NEUROBIOL, V68, P656, DOI 10.1002/dneu.20611; Sockman KW, 2002, P ROY SOC B-BIOL SCI, V269, P2479, DOI 10.1098/rspb.2002.2180; Soha JA, 1996, J NEUROBIOL, V29, P473, DOI 10.1002/(SICI)1097-4695(199604)29:4<473::AID-NEU5>3.0.CO;2-5; Stark H, 1997, J NEUROCHEM, V68, P691; Tremere LA, 2009, J NEUROSCI, V29, P5949, DOI 10.1523/JNEUROSCI.0774-09.2009; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Vyas A, 2008, BEHAV NEUROSCI, V122, P1148, DOI 10.1037/0735-7044.122.5.1148; WOLFSON A, 1958, J EXP ZOOL, V139, P349, DOI 10.1002/jez.1401390207; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Xu ZQ, 1998, NEUROSCIENCE, V82, P727; Zeng SJ, 2007, BRAIN BEHAV EVOLUT, V70, P1, DOI 10.1159/000101066; ZETTERSTROM T, 1988, EUR J PHARMACOL, V148, P327, DOI 10.1016/0014-2999(88)90110-0	99	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39388	10.1371/journal.pone.0039388	http://dx.doi.org/10.1371/journal.pone.0039388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724011	gold, Green Published			2022-12-25	WOS:000305652700076
J	London, JM; Hoef, JMV; Jeffries, SJ; Lance, MM; Boveng, PL				London, Josh M.; Hoef, Jay M. Ver; Jeffries, Steven J.; Lance, Monique M.; Boveng, Peter L.			Haul-Out Behavior of Harbor Seals (Phoca vitulina) in Hood Canal, Washington	PLOS ONE			English	Article							RICHARDSI; PATTERNS; ALASKA; CALIFORNIA; ABUNDANCE; OREGON; DISTURBANCE; TRENDS; ISLAND; SITE	The goal of this study was to model haul-out behavior of harbor seals (Phoca vitulina) in the Hood Canal region of Washington State with respect to changes in physiological, environmental, and temporal covariates. Previous research has provided a solid understanding of seal haul-out behavior. Here, we expand on that work using a generalized linear mixed model (GLMM) with temporal autocorrelation and a large dataset. Our dataset included behavioral haul-out records from archival and VHF radio tag deployments on 25 individual seals representing 61,430 seal hours. A novel application for increased computational efficiency allowed us to examine this large dataset with a GLMM that appropriately accounts for temporal autocorellation. We found significant relationships with the covariates hour of day, day of year, minutes from high tide and year. Additionally, there was a significant effect of the interaction term hour of day : day of year. This interaction term demonstrated that seals are more likely to haul out during nighttime hours in August and September, but then switch to predominantly daylight haul-out patterns in October and November. We attribute this change in behavior to an effect of human disturbance levels. This study also examined a unique ecological event to determine the role of increased killer whale (Orcinus orca) predation on haul-out behavior. In 2003 and 2005 these harbor seals were exposed to unprecedented levels of killer whale predation and results show an overall increase in haul-out probability after exposure to killer whales. The outcome of this study will be integral to understanding any changes in population abundance as a result of increased killer whale predation.	[London, Josh M.; Hoef, Jay M. Ver; Boveng, Peter L.] NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Jeffries, Steven J.; Lance, Monique M.] Washington Dept Fish & Wildlife, Tacoma, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Washington Department of Fish & Wildlife (WDFW)	London, JM (corresponding author), NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	josh.london@noaa.gov	Ver Hoef, Jay/C-8577-2017	Ver Hoef, Jay/0000-0003-4302-6895; London, Josh/0000-0002-3647-5046	Washington Department of Fish and Wildlife; Washington Cooperative Fish and Wildlife Research Unit; Alaska Fisheries Science Center's National Marine Mammal Laboratory; United States Marine Mammal Commission; Pacific States Marine Fisheries Commission; Northwest Fisheries Science Center	Washington Department of Fish and Wildlife; Washington Cooperative Fish and Wildlife Research Unit; Alaska Fisheries Science Center's National Marine Mammal Laboratory; United States Marine Mammal Commission; Pacific States Marine Fisheries Commission; Northwest Fisheries Science Center	The authors would like to acknowledge the support from the Washington Department of Fish and Wildlife, the Washington Cooperative Fish and Wildlife Research Unit and the Alaska Fisheries Science Center's National Marine Mammal Laboratory. The field component of the project benefited greatly from the contributions of B. Murphie, S. Murphie, D. Lambourn, A. Galloway and other members of the capture crew. Special consideration goes to G. VanBlaricom for his advice and support as the primary author's graduate advisor. M. Simpkins and J. Laake provided valuable feedback during the analysis and manuscript preparation.; The authors would like to acknowledge the financial and logistical support from the Washington Department of Fish and Wildlife, the Washington Cooperative Fish and Wildlife Research Unit and the Alaska Fisheries Science Center's National Marine Mammal Laboratory. Signicant funding was also provided by the United States Marine Mammal Commission, the Pacific States Marine Fisheries Commission and the Northwest Fisheries Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SG, 1984, FISH B-NOAA, V82, P493; Bengtson JL, 2005, POLAR BIOL, V28, P833, DOI 10.1007/s00300-005-0009-1; Boveng PL, 2003, MAR MAMMAL SCI, V19, P111, DOI 10.1111/j.1748-7692.2003.tb01096.x; Brown RE, 2005, MAR MAMMAL SCI, V21, P657, DOI 10.1111/j.1748-7692.2005.tb01258.x; BROWN RF, 1983, FISH B-NOAA, V81, P291; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Calambokidis J.A., 1979, Murrelet, V60, P110, DOI 10.2307/3534278; Daniel RG, 2003, MAR MAMMAL SCI, V19, P128, DOI 10.1111/j.1748-7692.2003.tb01097.x; DASILVA J, 1988, ANIM BEHAV, V36, P1309, DOI 10.1016/S0003-3472(88)80199-4; EVERITT R D, 1980, Northwest Science, V54, P281; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Frost KJ, 1999, MAR MAMMAL SCI, V15, P494, DOI 10.1111/j.1748-7692.1999.tb00815.x; Grigg EK, 2002, CALIF FISH GAME, V88, P15; Hayes SA, 2004, MAR MAMMAL SCI, V20, P639, DOI 10.1111/j.1748-7692.2004.tb01184.x; Huber HR, 2001, MAR MAMMAL SCI, V17, P276, DOI 10.1111/j.1748-7692.2001.tb01271.x; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; London JM, 2006, THESIS U WASHINGTON; McCullagh P, 1989, GEN LINEAR MODELS; Nordstrom CA, 2002, MAR MAMMAL SCI, V18, P194, DOI 10.1111/j.1748-7692.2002.tb01028.x; PAULI B D, 1987, Aquatic Mammals, V13, P93; Reder S, 2003, POLAR BIOL, V27, P6, DOI 10.1007/s00300-003-0557-1; SCHNEIDER DC, 1983, J MAMMAL, V64, P518, DOI 10.2307/1380370; Simpkins MA, 2003, MAR MAMMAL SCI, V19, P791, DOI 10.1111/j.1748-7692.2003.tb01130.x; STEWART B S, 1984, Bulletin Southern California Academy of Sciences, V83, P121; SULLIVAN RM, 1981, J MAMMAL, V62, P825, DOI 10.2307/1380606; Suryan RM, 1999, FISH B-NOAA, V97, P332; Team RDC, 2006, R LANG ENV STAT COMP; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; THOMPSON PM, 1989, J ZOOL, V217, P281, DOI 10.1111/j.1469-7998.1989.tb02488.x; Ver Hoef Jay M., 2001, P214; Ver Hoef JM, 2010, COMPUTATION STAT, V25, P39; Watts P, 1996, J ZOOL, V240, P175, DOI 10.1111/j.1469-7998.1996.tb05494.x; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; YOCHEM PK, 1987, MAR MAMMAL SCI, V3, P323, DOI 10.1111/j.1748-7692.1987.tb00319.x	37	32	32	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							38180	10.1371/journal.pone.0038180	http://dx.doi.org/10.1371/journal.pone.0038180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723851	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300022
J	Mistri, M; Tamhankar, PM; Sheth, F; Sanghavi, D; Kondurkar, P; Patil, S; Idicula-Thomas, S; Gupta, S; Sheth, J				Mistri, Mehul; Tamhankar, Parag M.; Sheth, Frenny; Sanghavi, Daksha; Kondurkar, Pratima; Patil, Swapnil; Idicula-Thomas, Susan; Gupta, Sarita; Sheth, Jayesh			Identification of Novel Mutations in HEXA Gene in Children Affected with Tay Sachs Disease from India	PLOS ONE			English	Article							BETA-HEXOSAMINIDASE; 2ND; POPULATION; JEWISH; ALLELE	Tay Sachs disease (TSD) is a neurodegenerative disorder due to beta-hexosaminidase A deficiency caused by mutations in the HEXA gene. The mutations leading to Tay Sachs disease in India are yet unknown. We aimed to determine mutations leading to TSD in India by complete sequencing of the HEXA gene. The clinical inclusion criteria included neuroregression, seizures, exaggerated startle reflex, macrocephaly, cherry red spot on fundus examination and spasticity. Neuroimaging criteria included thalamic hyperdensities on CT scan/T1W images of MRI of the brain. Biochemical criteria included deficiency of hexosaminidase A (less than 2% of total hexosaminidase activity for infantile patients). Total leukocyte hexosaminidase activity was assayed by 4-methylumbelliferyl-N-acetyl-beta-D-glucosamine lysis and hexosaminidase A activity was assayed by heat inactivation method and 4-methylumbelliferyl-N-acetyl-beta-D-glucosamine-6-sulphate lysis method. The exons and exon-intron boundaries of the HEXA gene were bidirectionally sequenced using an automated sequencer. Mutations were confirmed in parents and looked up in public databases. In silico analysis for mutations was carried out using SIFT, Polyphen2, MutationT@ster and Accelrys Discovery Studio softwares. Fifteen families were included in the study. We identified six novel missense mutations, c.340 G>A (p.E114K), c.964 G>A (p.D322N), c.964 G>T (p.D322Y), c.1178C>G (p.R393P) and c.1385A>T (p.E462V), c.1432 G>A (p.G478R) and two previously reported mutations. c.1277_1278insTATC and c.508C>T (p.R170W). The mutation p.E462V was found in six unrelated families from Gujarat indicating a founder effect. A previously known splice site mutation c.805+1 G>C and another intronic mutation c.672+ 30 T>G of unknown significance were also identified. Mutations could not be identified in one family. We conclude that TSD patients from Gujarat should be screened for the common mutation p.E462V.	[Mistri, Mehul; Sheth, Frenny; Sheth, Jayesh] FRIGE Inst Human Genet, Ahmadabad, Gujarat, India; [Tamhankar, Parag M.; Sanghavi, Daksha; Kondurkar, Pratima] Natl Inst Res Reprod Hlth, ICMR Genet Res Ctr, Bombay, Maharashtra, India; [Patil, Swapnil; Idicula-Thomas, Susan] Natl Inst Res Reprod Hlth, Biomed Informat Ctr, Bombay, Maharashtra, India; [Gupta, Sarita] MS Univ, Dept Biochem, Vadodara, Gujarat, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Maharaja Sayajirao University Baroda	Mistri, M (corresponding author), FRIGE Inst Human Genet, Ahmadabad, Gujarat, India.	tamhankarp@nirrh.res.in; jshethad1@gmail.com	Mistri, Mehul/X-8097-2019; Sheth, Jayesh J./L-9966-2013	Mistri, Mehul/0000-0003-1872-291X; 	Indian council of medical research (ICMR) [BMS: 54/2010]	Indian council of medical research (ICMR)(Indian Council of Medical Research (ICMR))	The work at FRIGE was supported by grant from Indian council of medical research (ICMR), project no BMS: 54/2010. The work at Genetic Research Center, NIRRH (National Institute for Research in Reproductive Health) was supported by intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akerman B, 1991, AM J HUM GENET, V49, P1041; AKLI S, 1993, HUM MOL GENET, V2, P61, DOI 10.1093/hmg/2.1.61; AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; CAO Z, 1993, AM J HUM GENET, V53, P1198; Fernandes JA, 2004, ARCH NEUROL-CHICAGO, V61, P1466, DOI 10.1001/archneur.61.9.1466; Fernandes Maria, 1992, Human Molecular Genetics, V1, P759, DOI 10.1093/hmg/1.9.759; Gravel RA, 1995, METABOLIC MOL BASES, P3827; Haghighi A, 2011, J HUM GENET, V56, P682, DOI 10.1038/jhg.2011.78; HECHTMAN P, 1992, HUM GENET, V90, P402, DOI 10.1007/BF00220467; KABACK M, 1993, JAMA-J AM MED ASSOC, V270, P2307, DOI 10.1001/jama.270.19.2307; Kaback M M, 1999, GENEREVIEWS, P1993; KAPLAN F, 1991, J INHERIT METAB DIS, V14, P707, DOI 10.1007/BF01799939; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Matsuzawa F, 2003, J HUM GENET, V48, P582, DOI 10.1007/s10038-003-0082-7; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1986, SCIENCE, V232, P1646, DOI 10.1126/science.3754980; Nalini A, 2004, J CHILD NEUROL, V19, P447, DOI 10.1177/088307380401900610; Ohno K, 2008, MOL GENET METAB, V94, P2; Ozkara HA, 1998, MOL GENET METAB, V65, P250, DOI 10.1006/mgme.1998.2742; RIBEIRO MG, 1995, BBA-MOL BASIS DIS, V1270, P44, DOI 10.1016/0925-4439(94)00070-7; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Stockley Tracy L, 2003, Methods Mol Biol, V217, P131; Tanaka A, 1999, J HUM GENET, V44, P91, DOI 10.1007/s100380050116; TRIGGSRAINE B, 1995, AM J HUM GENET, V56, P870; Wendeler M, 2009, GLYCOCONJUGATE J, V26, P945, DOI 10.1007/s10719-008-9137-5	28	29	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39122	10.1371/journal.pone.0039122	http://dx.doi.org/10.1371/journal.pone.0039122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723944	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300097
J	Sun, Y; Li, H; Yang, MF; Shu, W; Sun, MJ; Xu, Y				Sun, Ying; Li, Hui; Yang, Mi-Fang; Shu, Wei; Sun, Meng-Jun; Xu, Yan			Effects of Aging on Endotoxin Tolerance Induced by Lipopolysaccharides Derived from Porphyromonas gingivalis and Escherichia coli	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NEGATIVE REGULATION; CYTOKINE PRODUCTION; IMMUNE-SYSTEM; TNF-ALPHA; INNATE; ACTIVATION; CELLS; LPS; PERIODONTITIS	Background: Periodontitis is a bacterially induced chronic inflammatory disease. Exposure of the host to periodontal pathogens and their virulence factors induces a state of hyporesponsiveness to subsequent stimulations, termed endotoxin tolerance. Aging has a profound effect on immune response to bacteria challenge. The aim of this study was to explore the effects of aging on endotoxin tolerance induced by Porphyromonas gingivalis (P. gingivalis) lipopolysaccharide (LPS) and Escherichia coli (E. coli) LPS in murine peritoneal macrophages. Methodology/Principal Findings: We studied the cytokine production (TNF-alpha and IL-10) and Toll-like receptor 2, 4 (TLR2, 4) gene and protein expressions in peritoneal macrophages from young (2-month-old) and middle-aged (12-month-old) ICR mice following single or repeated P. gingivalis LPS or E. coli LPS stimulation. Pretreatment of peritoneal macrophages with P. gingivalis LPS or E. coli LPS resulted in a reduction in TNF-alpha production and an increase in IL-10 production upon secondary stimulation (p < 0.05), and the markedly lower levels of TNF-alpha and higher levels of IL-10 were observed in macrophages from young mice compared with those from middle-aged mice (p < 0.05). In addition, LPS restimulations also led to the significantly lower expression levels of TLR2, 4 mRNA and protein in macrophages from young mice (p < 0.05). Conclusions/Significance: Repeated LPS stimulations triggered endotoxin tolerance in peritoneal macrophages and the ability to develop tolerance in young mice was more excellent. The impaired ability to develop endotoxin tolerance resulted from aging might be related to TLR2, 4 and might lead to the incontrollable periodontal inflammation in older adults.	[Sun, Ying; Li, Hui; Yang, Mi-Fang; Sun, Meng-Jun; Xu, Yan] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Sun, Ying; Li, Hui; Shu, Wei; Sun, Meng-Jun; Xu, Yan] Nanjing Med Univ, Dept Periodontol, Stomatol Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, Y (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	yanxu@njmu.edu.cn		Sun, Ying/0000-0003-3996-9946	National Natural Science Foundation of China [81000444]; Natural Science Foundation of Jiangsu Province [BK2008363]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China through Project 81000444 (https://isis.nsfc.gov.cn), the Natural Science Foundation of Jiangsu Province through Project BK2008363 (http://www.jskjjh.gov.cn/) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTIZ ME, 1995, CRIT CARE MED, V23, P9, DOI 10.1097/00003246-199501000-00006; Barksby HE, 2009, CLIN EXP IMMUNOL, V156, P479, DOI 10.1111/j.1365-2249.2009.03920.x; BECK JD, 1984, COMMUNITY DENT ORAL, V12, P17, DOI 10.1111/j.1600-0528.1984.tb01403.x; Ben-Othman R, 2009, MOL IMMUNOL, V46, P3438, DOI 10.1016/j.molimm.2009.05.337; Biswas SK, 2007, INT J BIOCHEM CELL B, V39, P1582, DOI 10.1016/j.biocel.2007.04.021; Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389; Braga RRR, 2010, ANAEROBE, V16, P234, DOI 10.1016/j.anaerobe.2010.02.007; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Cardoso CR, 2008, J LEUKOCYTE BIOL, V84, P311, DOI 10.1189/jlb.0108014; Chang J, 2009, P NATL ACAD SCI USA, V106, P18327, DOI 10.1073/pnas.0905815106; Chelvarajan RL, 2006, J LEUKOCYTE BIOL, V79, P1314, DOI 10.1189/jlb.0106024; Silva Paulo Tadeu da, 2008, Braz. Dent. J., V19, P228, DOI 10.1590/S0103-64402008000300010; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Desai A, 2010, J LEUKOCYTE BIOL, V87, P1001, DOI 10.1189/jlb.0809542; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Gaddis DE, 2009, MOL IMMUNOL, V46, P2493, DOI 10.1016/j.molimm.2009.05.022; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Gelani V, 2009, J PERIODONTOL, V80, P2010, DOI 10.1902/jop.2009.090198; Goldstein DR, 2010, VIRULENCE, V1, P295, DOI 10.4161/viru.1.4.12009; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Gutierrez-Venegas G, 2006, LIFE SCI, V78, P2577, DOI 10.1016/j.lfs.2005.10.033; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Kim HG, 2008, J IMMUNOL, V180, P2553, DOI 10.4049/jimmunol.180.4.2553; Komiya Ito Akiyo, 2010, Bull Tokyo Dent Coll, V51, P139; Krustrup U, 2006, ACTA ODONTOL SCAND, V64, P65, DOI 10.1080/00016350500377859; Lehner MD, 2001, INFECT IMMUN, V69, P463, DOI 10.1128/IAI.69.1.463-471.2001; Liu QY, 2011, IMMUNOBIOLOGY, V216, P47, DOI 10.1016/j.imbio.2010.03.005; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Mahbub Shegufta, 2011, Current Immunology Reviews, V7, P104, DOI 10.2174/157339511794474181; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Murciano C, 2007, FEMS IMMUNOL MED MIC, V51, P327, DOI 10.1111/j.1574-695X.2007.00309.x; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; Oliver RC, 1998, J PERIODONTOL, V69, P269, DOI 10.1902/jop.1998.69.2.269; Pan HJ, 2010, J IMMUNOL, V184, P5502, DOI 10.4049/jimmunol.0901601; Parker LC, 2005, J LEUKOCYTE BIOL, V78, P1301, DOI 10.1189/jlb.0405236; Perkins DJ, 2010, MBIO, V1, DOI 10.1128/mBio.00239-10; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; Qu J, 2003, SCAND J IMMUNOL, V58, P613, DOI 10.1111/j.1365-3083.2003.01339.x; Roberts HC, 2008, EUR J ORAL SCI, V116, P207, DOI 10.1111/j.1600-0722.2008.00535.x; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schroder M, 2003, J IMMUNOL, V170, P5260, DOI 10.4049/jimmunol.170.10.5260; Sun Y, 2010, ORAL DIS, V16, P343, DOI 10.1111/j.1601-0825.2009.01630.x; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Suzuki T, 2004, INFECT IMMUN, V72, P1856, DOI 10.1128/IAI.72.4.1856-1865.2004; Teng YTA, 2006, J DENT RES, V85, P198, DOI 10.1177/154405910608500301; Tesar BM, 2006, AGING CELL, V5, P473, DOI 10.1111/j.1474-9726.2006.00245.x; Wang JH, 2002, J BIOL CHEM, V277, P36068, DOI 10.1074/jbc.M205584200; Yang Q, 2011, MATH BIOSCI, V232, P151, DOI 10.1016/j.mbs.2011.05.005; Yoshimura A, 1997, J PERIODONTAL RES, V32, P279, DOI 10.1111/j.1600-0765.1997.tb00535.x; Zhang J, 2009, ACTA PHARMACOL SIN, V30, P582, DOI 10.1038/aps.2009.34	53	28	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39224	10.1371/journal.pone.0039224	http://dx.doi.org/10.1371/journal.pone.0039224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723968	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300117
J	Toomey, JS; Bhatia, S; Moon, LT; Orchard, EA; Tainter, KH; Lokitz, SJ; Terry, T; Mathis, JM; Penman, AD				Toomey, James S.; Bhatia, Shilpa; Moon, La'Wanda T.; Orchard, Elysse A.; Tainter, Kerrie H.; Lokitz, Stephen J.; Terry, Tracee; Mathis, J. Michael; Penman, Andrew D.			PET Imaging a MPTP-Induced Mouse Model of Parkinson's Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [F-18]-DTBZ (AV-133)	PLOS ONE			English	Article							VESICULAR MONOAMINE TRANSPORTER; POSITRON-EMISSION-TOMOGRAPHY; BETA-CELL MASS; IN-VIVO; DOPAMINE DEPLETION; ANIMAL-MODELS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; TYROSINE-HYDROXYLASE; MICE; F-18-FP-(+)-DTBZ	Parkinson's disease (PD) is characterized by the loss of dopamine-producing neurons in the nigrostriatal system. Numerous researchers in the past have attempted to track the progression of dopaminergic depletion in PD. We applied a quantitative non-invasive PET imaging technique to follow this degeneration process in an MPTP-induced mouse model of PD. The VMAT2 ligand F-18-DTBZ (AV-133) was used as a radioactive tracer in our imaging experiments to monitor the changes of the dopaminergic system. Intraperitoneal administrations of MPTP (a neurotoxin) were delivered to mice at regular intervals to induce lesions consistent with PD. Our results indicate a significant decline in the levels of striatal dopamine and its metabolites (DOPAC and HVA) following MPTP treatment as determined by HPLC method. Images obtained by positron emission tomography revealed uptake of F-18-DTBZ analog in the mouse striatum. However, reduction in radioligand binding was evident in the striatum of MPTP lesioned animals as compared with the control group. Immunohistochemical analysis further confirmed PET imaging results and indicated the progressive loss of dopaminergic neurons in treated animals compared with the control counterparts. In conclusion, our findings suggest that MPTP induced PD in mouse model is appropriate to follow the degeneration of dopaminergic system and that F-18-DTBZ analog is a potentially sensitive radiotracer that can used to diagnose changes associated with PD by PET imaging modality.	[Toomey, James S.; Moon, La'Wanda T.; Penman, Andrew D.] So Res Inst, Birmingham, AL 35255 USA; [Orchard, Elysse A.; Terry, Tracee] Louisiana State Univ, Hlth Sci Ctr, Dept Anim Resources, Shreveport, LA 71105 USA; [Bhatia, Shilpa; Mathis, J. Michael] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Orchard, Elysse A.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA; [Bhatia, Shilpa; Terry, Tracee; Mathis, J. Michael] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, Shreveport, LA 71105 USA; [Bhatia, Shilpa; Mathis, J. Michael] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Tainter, Kerrie H.; Lokitz, Stephen J.] Biomed Res Inst NW Louisiana, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Toomey, JS (corresponding author), So Res Inst, Birmingham, AL 35255 USA.	jmathi@lsuhsc.edu	Mathis, J. Michael/J-1379-2018	Mathis, J. Michael/0000-0001-5528-5195	Louisiana Gene Therapy Research Consortium; Biomedical Research Institute of Northwest Louisiana	Louisiana Gene Therapy Research Consortium; Biomedical Research Institute of Northwest Louisiana	This work was supported by the Louisiana Gene Therapy Research Consortium and the Biomedical Research Institute of Northwest Louisiana. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Balkowiec-Iskra E, 2007, INFLAMM RES, V56, P311, DOI 10.1007/s00011-007-6128-0; Blesa J, 2010, NEUROBIOL DIS, V38, P456, DOI 10.1016/j.nbd.2010.03.006; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; DONZANTI BA, 1988, PHARMACOL BIOCHEM BE, V30, P795, DOI 10.1016/0091-3057(88)90102-5; Eriksson O, 2010, NUCL MED BIOL, V37, P357, DOI 10.1016/j.nucmedbio.2009.12.004; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Frey KA, 2001, ADV NEUROL, V86, P237; Goswami R, 2006, NUCL MED BIOL, V33, P685, DOI 10.1016/j.nucmedbio.2006.05.006; Harris PE, 2008, J MOL MED, V86, P5, DOI 10.1007/s00109-007-0242-x; Hattori N, 2007, NEUROPATHOLOGY, V27, P479, DOI 10.1111/j.1440-1789.2007.00842.x; Heise CE, 2005, ANAT EMBRYOL, V210, P287, DOI 10.1007/s00429-005-0053-1; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; Honer M, 2006, NUCL MED BIOL, V33, P607, DOI 10.1016/j.nucmedbio.2006.04.005; Horowitz MP, 2010, CLIN PHARMACOL THER, V88, P467, DOI 10.1038/clpt.2010.138; Jakowec MW, 2004, J NEUROSCI RES, V76, P539, DOI 10.1002/jnr.20114; Kung MP, 2008, J NUCL MED, V49, P1171, DOI 10.2967/jnumed.108.051680; Kung MP, 2007, NUCL MED BIOL, V34, P239, DOI 10.1016/j.nucmedbio.2006.12.005; Lin KJ, 2010, J NUCL MED, V51, P1480, DOI 10.2967/jnumed.110.078196; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Okamura N, 2010, J NUCL MED, V51, P223, DOI 10.2967/jnumed.109.070094; Partridge M, 2006, NUCL INSTRUM METH A, V568, P933, DOI 10.1016/j.nima.2006.09.035; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Simpson NR, 2006, NUCL MED BIOL, V33, P855, DOI 10.1016/j.nucmedbio.2006.07.002; Singhal T, 2011, MOL IMAGING BIOL, V13, P973, DOI 10.1007/s11307-010-0406-x; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Taylor TN, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/124165; Tsao HH, 2011, NUCL MED BIOL, V38, P1029, DOI 10.1016/j.nucmedbio.2011.03.006; Veluthakal R, 2010, CURR PHARM DESIGN, V16, P1568, DOI 10.2174/138161210791164180; Vergo S, 2007, BRAIN RES, V1185, P18, DOI 10.1016/j.brainres.2007.09.028; Wang JL, 2010, NUCL MED BIOL, V37, P479, DOI 10.1016/j.nucmedbio.2010.01.006; Youdim MBH, 2007, J NEURAL TRANSM, V114, P205, DOI 10.1007/s00702-006-0499-1; Zhu L, 2010, NUCL MED BIOL, V37, P133, DOI 10.1016/j.nucmedbio.2009.10.005	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39041	10.1371/journal.pone.0039041	http://dx.doi.org/10.1371/journal.pone.0039041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723923	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300081
J	Oppliger, LV; Correa, JA; Engelen, AH; Tellier, F; Vieira, V; Faugeron, S; Valero, M; Gomez, G; Destombe, C				Valeria Oppliger, L.; Correa, Juan A.; Engelen, Aschwin H.; Tellier, Florence; Vieira, Vasco; Faugeron, Sylvain; Valero, Myriam; Gomez, Gonzalo; Destombe, Christophe			Temperature Effects on Gametophyte Life-History Traits and Geographic Distribution of Two Cryptic Kelp Species	PLOS ONE			English	Article							RANGE; PHAEOPHYCEAE; LAMINARIALES; GROWTH; BOUNDARIES; SURVIVAL; SEAWEEDS; REPRODUCTION; POPULATIONS; ALARIACEAE	A major determinant of the geographic distribution of a species is expected to be its physiological response to changing abiotic variables over its range. The range of a species often corresponds to the geographic extent of temperature regimes the organism can physiologically tolerate. Many species have very distinct life history stages that may exhibit different responses to environmental factors. In this study we emphasized the critical role of the haploid microscopic stage (gametophyte) of the life cycle to explain the difference of edge distribution of two related kelp species. Lessonia nigrescens was recently identified as two cryptic species occurring in parapatry along the Chilean coast: one located north and the other south of a biogeographic boundary at latitude 29-30 degrees S. Six life history traits from microscopic stages were identified and estimated under five treatments of temperature in eight locations distributed along the Chilean coast in order to (1) estimate the role of temperature in the present distribution of the two cryptic L. nigrescens species, (2) compare marginal populations to central populations of the two cryptic species. In addition, we created a periodic matrix model to estimate the population growth rate (lambda) at the five temperature treatments. Differential tolerance to temperature was demonstrated between the two species, with the gametophytes of the Northern species being more tolerant to higher temperatures than gametophytes from the south. Second, the two species exhibited different life history strategies with a shorter haploid phase in the Northern species contrasted with considerable vegetative growth in the Southern species haploid stage. These results provide strong ecological evidence for the differentiation process of the two cryptic species and show local adaptation of the life cycle at the range limits of the distribution. Ecological and evolutionary implications of these findings are discussed.	[Valeria Oppliger, L.; Correa, Juan A.; Faugeron, Sylvain; Gomez, Gonzalo] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile; [Valeria Oppliger, L.; Valero, Myriam; Destombe, Christophe] BEDIM, UPMC Stn Biol Roscoff, Equipe Biol Evolut & Divers Marine, UMR 7144, Roscoff, France; [Valeria Oppliger, L.; Valero, Myriam; Destombe, Christophe] BEDIM, Equipe Biol Evolut & Divers Marine, CNRS Stn Biol Roscoff, UMR 7144, Roscoff, France; [Engelen, Aschwin H.; Vieira, Vasco] Univ Algarve, Ctr Marine Sci CCMAR, CIMAR Lab Associado, Faro, Portugal; [Tellier, Florence] Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol, Concepcion, Chile	Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universidade do Algarve; Universidad Catolica de la Santisima Concepcion	Oppliger, LV (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Adv Studies Ecol & Biodivers, Alameda 340, Santiago, Chile.	destombe@sb-roscoff.fr	Valero, Myriam/C-7550-2011; Gomez, Gonzalo I/N-6443-2019; Destombe, Christophe/G-5317-2012; Tellier, Florence/E-1380-2015; Valero, Myriam/M-6052-2019; Teliler, Florence/Y-9505-2019; Engelen, Aschwin H/M-3432-2013	Valero, Myriam/0000-0002-9000-1423; Gomez, Gonzalo I/0000-0001-7761-8675; Tellier, Florence/0000-0002-9436-0095; Valero, Myriam/0000-0002-9000-1423; Teliler, Florence/0000-0002-9436-0095; Engelen, Aschwin H/0000-0002-9579-9606; Faugeron, Sylvain/0000-0001-7258-5229; Destombe, Christophe/0000-0001-5656-9659; Vieira, Vasco/0000-0001-9858-6254	CONICYT-FRENCH EMBASSADY; French Ministry of Education and Research; College Doctoral Franco-Chilien; "ARCUS'' of the French Ministry of Foreign Affairs; FCT-CNRS; FCT scholarships [SFRH/BPD/7153/2001, SFRH/BPD/63703/2009]	CONICYT-FRENCH EMBASSADY; French Ministry of Education and Research; College Doctoral Franco-Chilien; "ARCUS'' of the French Ministry of Foreign Affairs; FCT-CNRS(Centre National de la Recherche Scientifique (CNRS)Portuguese Foundation for Science and Technology); FCT scholarships(Portuguese Foundation for Science and Technology)	Support from the following programs is acknowledged: CONICYT-FRENCH EMBASSADY (PhD grant to LVO), French Ministry of Education and Research (PhD grant to FT), "College Doctoral Franco-Chilien'', "ARCUS'' of the French Ministry of Foreign Affairs and FCT-CNRS collaborative funding. This study is part of the research programs FONDAP 1501-0001 6 Program 7, ANR ECOKELP (ANR BDIV 012), Pole Mer Bretagne, FONDECYT 1060493, Laboratoire International Associe "Dispersal and Adaptation of Marine Species" (LIA DIAMS), and FCT scholarships SFRH/BPD/7153/2001 and SFRH/BPD/63703/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo R, 2011, J PHYCOL, V47, P451, DOI 10.1111/j.1529-8817.2011.00986.x; AVILA M, 1985, Revista Chilena de Historia Natural, V58, P71; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BOLTON JJ, 1987, MAR BIOL, V96, P293, DOI 10.1007/BF00427029; BOLTON JJ, 1983, MAR BIOL, V73, P131, DOI 10.1007/BF00406880; BOLTON JJ, 1985, MAR BIOL, V87, P131, DOI 10.1007/BF00539420; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; BREEMAN AM, 1988, HELGOLANDER MEERESUN, V42, P199, DOI 10.1007/BF02366043; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; CASWELL H, 1994, ECOLOGY, V75, P1299, DOI 10.2307/1937455; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Darwin C, 1859, ORIGINS SPECIES MEAN; DEKROON H, 1986, ECOLOGY, V67, P1427, DOI 10.2307/1938700; Dennis R. L., 1993, BUTTERFLIES CLIMATE; Destombe C, 2011, CAH BIOL MAR, V52, P385; DIECK IT, 1993, MAR ECOL PROG SER, V100, P253; DIECK IT, 1992, PHYCOLOGIA, V31, P147, DOI 10.2216/i0031-8884-31-2-147.1; Efron B., 1994, INTRO BOOTSTRAP; Engelen A, 2009, J ECOL, V97, P675, DOI 10.1111/j.1365-2745.2009.01501.x; GERARD VA, 1988, MAR BIOL, V97, P575, DOI 10.1007/BF00391054; Graham MH, 2007, P NATL ACAD SCI USA, V104, P16576, DOI 10.1073/pnas.0704778104; Hautekeete NC, 2009, ACTA OECOL, V35, P104, DOI 10.1016/j.actao.2008.08.004; Hautekeete NC, 2002, J ECOL, V90, P508, DOI 10.1046/j.1365-2745.2002.00688.x; HERSTEINSSON P, 1992, OIKOS, V64, P505, DOI 10.2307/3545168; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; Hill MO, 2002, J APPL ECOL, V39, P708, DOI 10.1046/j.1365-2664.2002.00746.x; HOFFMANN AJ, 1982, J EXP MAR BIOL ECOL, V60, P77, DOI 10.1016/0022-0981(81)90182-9; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; Jahns H. M., 1995, ALGAE INTRO PHYCOLOG; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; LUNING K, 1978, Z PFLANZENPHYSIOL, V89, P333; Luning K, 1990, SEAWEEDS THEIR ENV B; Martinez EA, 2003, J PHYCOL, V39, P504, DOI 10.1046/j.1529-8817.2003.02191.x; Martinez Enrique A., 1999, Pacific Science, V53, P74; Matson PG, 2007, MAR BIOL, V151, P1941, DOI 10.1007/s00227-007-0630-3; Mills LS, 1999, CONSERV BIOL, V13, P815, DOI 10.1046/j.1523-1739.1999.98232.x; Muller R, 2008, CLIM RES, V37, P203, DOI 10.3354/cr00762; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Munoz V, 2004, REV CHIL HIST NAT, V77, P639; Oppliger LV, 2011, J PHYCOL, V47, P5, DOI 10.1111/j.1529-8817.2010.00930.x; Perry AL, 2005, SCIENCE, V308, p1837a; PETERS AF, 1993, MAR BIOL, V115, P143, DOI 10.1007/BF00349396; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sauvageau C, 1918, MEM ACAD SCI I FR, V56, P1; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sokal RR, 1995, BIOMETRY; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Tapia FJ, 2009, PROG OCEANOGR, V83, P278, DOI 10.1016/j.pocean.2009.07.035; Tellier F, 2011, J PHYCOL, V47, P894, DOI 10.1111/j.1529-8817.2011.01019.x; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; TILLBOTTRAUD I, 1990, J EVOLUTION BIOL, V3, P205, DOI 10.1046/j.1420-9101.1990.3030205.x; Van Kleunen M, 2007, CONSERV BIOL, V21, P1537, DOI 10.1111/j.1523-1739.2007.00765.x; Viejo RM, 2011, ECOGRAPHY, V34, P75, DOI 10.1111/j.1600-0587.2010.06365.x; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060; YOUNG TP, 1981, AM NAT, V118, P27, DOI 10.1086/283798	65	43	43	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39289	10.1371/journal.pone.0039289	http://dx.doi.org/10.1371/journal.pone.0039289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723987	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300128
J	Yu, ZG; Jia, CX; Liu, LY; Geng, CZ; Tang, JH; Zhang, J; Zhang, Q; Li, YY; Ma, ZB				Yu, Zhi-Gang; Jia, Cun-Xian; Liu, Li-Yuan; Geng, Cui-Zhi; Tang, Jin-Hai; Zhang, Jin; Zhang, Qiang; Li, Yu-Yang; Ma, Zhong-Bing			The Prevalence and Correlates of Breast Cancer among Women in Eastern China	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; RISK-FACTORS; DIABETES-MELLITUS; INDUCED-ABORTION; YOUNG-WOMEN; COHORT; METAANALYSIS; ASSOCIATION; ESTROGEN; OBESITY	The purpose was to investigate the prevalence rate, characteristics and related factors of breast cancer among women in Eastern China. A total of 122,058 female subjects completed the study, with 320 confirmed cases of breast cancer (crude prevalence: 262.5/100,000; standardized prevalence: 207.7/100,000). Among all of the identified breast cancer cases, 91.6% were diagnosed after the age of 35 and 60.0% were diagnosed before menopause. The odds ratios (95% confidence interval) of those breast cancer risk factors as selected through multivariate logistic regression were as follows: 5.438 (1.553-19.004) for family history of breast cancer, 3.556 (1.880-6.728) for high behavior intervention score, 3.556 (0.904-13.994) for history of diabetes, 3.357 (1.131-9.969) for history of benign breast tumors, 2.196 (1.355-3.556) for poor overall life satisfaction, 1.826 (0.995-3.350) for premenopause of breast cancer, 1.528 (1.083-2.155) for high BMI index, 1.500 (0.920-2.446) for poor financial status, 1.497 (1.014-2.211) for multiple miscarriages/abortions, and 1.231 (0.972-1.559) for infrequent consumption of garlic (frequent garlic consumption is a protective factor). There were significantly more cases of breast cancer diagnosed prior to menopause than after menopause, and most of the patients were diagnosed after the age of 35. These findings suggest that attention should be focused on the incidence of breast cancer among premenopausal women older than 35.	[Yu, Zhi-Gang; Zhang, Qiang; Li, Yu-Yang; Ma, Zhong-Bing] Shandong Univ, Dept Breast Dis, Hosp 2, Jinan 250100, Peoples R China; [Jia, Cun-Xian; Liu, Li-Yuan] Shandong Univ, Inst Epidemiol, Sch Publ Hlth, Jinan 250100, Peoples R China; [Jia, Cun-Xian] SUNY Buffalo, Dept Sociol, Buffalo, NY 14260 USA; [Geng, Cui-Zhi] Hebei Med Univ, Dept Breast Dis, Hosp 4, Shijiazhuang, Peoples R China; [Tang, Jin-Hai] Jiangsu Canc Hosp, Dept Breast Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Jin] Tianjin Canc Hosp, Dept Breast Dis, Tianjin, Peoples R China	Shandong University; Shandong University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hebei Medical University; Nanjing Medical University; Tianjin Medical University	Yu, ZG (corresponding author), Shandong Univ, Dept Breast Dis, Hosp 2, Jinan 250100, Peoples R China.	yuzgsd@yeah.net	YU, ZHIGANG/AAA-4679-2022	liu, liyuan/0000-0002-9862-7471	Novartis China; Ministry of Health of the People's Republic of China [07090122]	Novartis China(Novartis); Ministry of Health of the People's Republic of China	At the outset the programme was sponsored by Novartis China. The study sponsors played no role in any aspect of the study design; in the collection, analysis, and interpretation of data; or in the development of the manuscript. The authors would also like to thank all survey participants for their involvement, as well as the members of the Centres of Disease Control and Prevention and the Family Planning Departments of Shandong, Hebei, JiangSu, and Tianjin Hospitals for their collaboration and cooperation.; This study was granted funding from the minister-affiliated hospital key project of the Ministry of Health of the People's Republic of China (NO: 07090122). At the outset the programme was sponsored by Novartis China. The study sponsors played no role in any aspect of the study design; in the collection, analysis, and interpretation of data; or in the development of the manuscript.	Alokail MS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-33; [Anonymous], WHO GLOB BURD DIS 20; Brewster DH, 2005, J EPIDEMIOL COMMUN H, V59, P283, DOI 10.1136/jech.2004.026393; Brind J, 1996, J EPIDEMIOL COMMUN H, V50, P481, DOI 10.1136/jech.50.5.481; Chen WY, 2004, CANCER, V101, P1490, DOI 10.1002/cncr.20499; COLE P, 1978, AM J EPIDEMIOL, V108, P112, DOI 10.1093/oxfordjournals.aje.a112594; Collaborative Group on Hormonal Factors in Breast Cancer, 2011, LANCET, V358, P1389; Couzin J, 2003, SCIENCE, V299, P1498; Daling JR, 2003, CANCER EPIDEM BIOMAR, V12, P1175; [方亚 Fang Ya], 2009, [中国卫生统计, Chinese Journal of Health Statistics], V26, P241; Feigelson HS, 2004, CANCER EPIDEM BIOMAR, V13, P220, DOI 10.1158/1055-9965.EPI-03-0301; GAJALAKSHMI CK, 1991, ACTA ONCOL, V30, P569, DOI 10.3109/02841869109092419; Han Ding-fen, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P256; Hao YY, 2005, ENDEMIC DIS B, V20, P38; Horn-Ross PL, 2004, CANCER EPIDEM BIOMAR, V13, P405; Horner MJ, 2009, SEER CANC STAT REV 1; La Vecchia C, 2011, ONCOLOGIST, V16, P726, DOI 10.1634/theoncologist.2011-0050; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Li HJ, 2007, CHIN RURAL HLTH SERV, V7, P556; Li J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-364; Liao SC, 2010, ASIAN PAC J CANCER P, V11, P933; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Michels KB, 2007, ARCH INTERN MED, V167, P814, DOI 10.1001/archinte.167.8.814; Papadimitriou Konstantinos, 2010, J Thorac Dis, V2, P160, DOI 10.3978/j.issn.2072-1439.2010.02.03.8; Pike MC, 2002, CANCER EPIDEM BIOMAR, V11, P795; PIKE MC, 1981, BRIT J CANCER, V43, P72, DOI 10.1038/bjc.1981.10; *SOC AC, 2005, BREAST CANC FACTS FI; Tao HL, 2009, CHIN ONCOL, V18, P446; Vachon CM, 2002, CANCER EPIDEM BIOMAR, V11, P1382; Valerie B, 2002, LANCET, V360, P187; WANG QJ, 2000, CHIN J EPIDEMIOL, V21, P216; Xu Yali, 2010, J Thorac Dis, V2, P171, DOI 10.3978/j.issn.2072-1439.2010.02.03.9; Yang DH, 2012, GLAND SURG, V1, P33, DOI [10.3978/j.issn.2227-684X.2012.04.01, 10.3978/j.issn.2227-684X.2012.04.07]; Zheng W, 2001, CANCER EPIDEM BIOMAR, V10, P89; BREAST CANC STAT INC	36	30	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37784	10.1371/journal.pone.0037784	http://dx.doi.org/10.1371/journal.pone.0037784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723840	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300012
J	Brettschneider, J; Toledo, JB; Van Deerlin, VM; Elman, L; McCluskey, L; Lee, VMY; Trojanowski, JQ				Brettschneider, Johannes; Toledo, Jon B.; Van Deerlin, Vivianna M.; Elman, Lauren; McCluskey, Leo; Lee, Virginia M. -Y.; Trojanowski, John Q.			Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; HEXANUCLEOTIDE REPEAT EXPANSION; WEIGHT NEUROFILAMENT PROTEIN; WILD-TYPE MICROGLIA; SPINAL-CORD TISSUE; TDP-43 PROTEINOPATHIES; MOUSE MODEL; SUPEROXIDE-DISMUTASE; BINDING PROTEIN; FAMILIAL ALS	Background/Aims: We evaluated clinicopathological correlates of upper motor neuron (UMN) damage in amyotrophic lateral sclerosis (ALS), and analyzed if the presence of the C9ORF72 repeat expansion was associated with alterations in microglial inflammatory activity. Methods: Microglial pathology was assessed by IHC with 2 different antibodies (CD68, Iba1), myelin loss by Kluver-Barrera staining and myelin basic protein (MBP) IHC, and axonal loss by neurofilament protein (TA51) IHC, performed on 59 autopsy cases of ALS including 9 cases with C9ORF72 repeat expansion. Results: Microglial pathology as depicted by CD68 and Iba1 was significantly more extensive in the corticospinal tract (CST) of ALS cases with a rapid progression of disease. Cases with C9ORF72 repeat expansion showed more extensive microglial pathology in the medulla and motor cortex which persisted after adjusting for disease duration in a logistic regression model. Higher scores on the clinical UMN scale correlated with increasing microglial pathology in the cervical CST. TDP-43 pathology was more extensive in the motor cortex of cases with rapid progression of disease. Conclusions: This study demonstrates that microglial pathology in the CST of ALS correlates with disease progression and is linked to severity of UMN deficits.	[Brettschneider, Johannes; Toledo, Jon B.; Lee, Virginia M. -Y.; Trojanowski, John Q.] Univ Penn, Sch Med, CNDR, Philadelphia, PA 19104 USA; [Toledo, Jon B.; Van Deerlin, Vivianna M.; Lee, Virginia M. -Y.; Trojanowski, John Q.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Elman, Lauren; McCluskey, Leo] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Brettschneider, Johannes] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Ulm University	Brettschneider, J (corresponding author), Univ Penn, Sch Med, CNDR, Philadelphia, PA 19104 USA.	Johannes.brettschneider@uni-ulm.de		Toledo, Jon/0000-0003-4366-9268	NIH [AG033101, AG17586, AG10124, AG32953]; Koller Family Foundation; Deutsche Forschungsgemeinschaft DFG [AOBJ586910]; Fundacion Alfonso Martin Escudero; NATIONAL INSTITUTE ON AGING [P01AG017586, P30AG010124, K08AG033101, P01AG032953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koller Family Foundation; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Fundacion Alfonso Martin Escudero; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIH (AG033101, AG17586, AG10124, AG32953), and the Koller Family Foundation. VMYL is the John H. Ware, 3rd, Professor of Alzheimer's Disease Research. JQT is the William Maul Measey-Truman G. Schnabel, Jr., Professor of Geriatric Medicine and Gerontology. JB is supported by a grant of the Deutsche Forschungsgemeinschaft DFG (AOBJ586910). JBT is supported by a grant of the Fundacion Alfonso Martin Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Arnold SE, 2000, NEUROBIOL AGING, V21, P913, DOI 10.1016/S0197-4580(00)00173-1; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bigio EH, 2011, ACTA NEUROPATHOL, V122, P653, DOI 10.1007/s00401-011-0919-7; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Brettschneider J, 2012, ACTA NEUROPATHOL; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; FAMBROUGH DM, 1988, J CELL BIOL, V106, P61, DOI 10.1083/jcb.106.1.61; Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; HICKEY WF, 1983, J HISTOCHEM CYTOCHEM, V31, P1126, DOI 10.1177/31.9.6193166; HOLNESS CL, 1993, BLOOD, V81, P1607; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ince PG, 2011, ACTA NEUROPATHOL, V122, P657, DOI 10.1007/s00401-011-0913-0; Ince PG, 2003, NEUROLOGY, V60, P1252, DOI 10.1212/01.WNL.0000058901.75728.4E; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; ITOH T, 1992, ACTA NEUROPATHOL, V83, P240, DOI 10.1007/BF00296785; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Lasiene J, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/718987; Lloyd CM, 2000, BRAIN, V123, P2289, DOI 10.1093/brain/123.11.2289; McGeer EG, 2005, BIODRUGS, V19, P31, DOI 10.2165/00063030-200519010-00004; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mosley RL, 2010, EXP NEUROL, V222, P1, DOI 10.1016/j.expneurol.2009.12.018; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Ohsawa K, 2000, J CELL SCI, V113, P3073; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Pena EA, 2006, J AM STAT ASSOC, V101, P341, DOI 10.1198/016214505000000637; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; Smith RA, 2004, AMYOTROPH LATERAL SC, V5, P99, DOI 10.1080/17434470410020058; SOBUE G, 1990, ACTA NEUROPATHOL, V79, P402, DOI 10.1007/BF00308716; Stewart H., 2012, ACTA NEUROPATHOL; Troakes C, 2011, NEUROPATHOLOGY; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Van Damme P, 2007, P NATL ACAD SCI USA, V104, P14825, DOI 10.1073/pnas.0705046104; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Zhao WH, 2006, J NEUROCHEM, V99, P1176, DOI 10.1111/j.1471-4159.2006.04172.x; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	68	150	154	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39216	10.1371/journal.pone.0039216	http://dx.doi.org/10.1371/journal.pone.0039216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720079	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347800058
J	Li, TF; Bourgeois, JP; Celli, S; Glacial, F; Le Sourd, AM; Mecheri, S; Weksler, B; Romero, I; Couraud, PO; Rougeon, F; Lafaye, P				Li, Tengfei; Bourgeois, Jean-Pierre; Celli, Susanna; Glacial, Fabienne; Le Sourd, Anne-Marie; Mecheri, Salah; Weksler, Babette; Romero, Ignacio; Couraud, Pierre-Olivier; Rougeon, Francois; Lafaye, Pierre			Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging	FASEB JOURNAL			English	Article						intrabodies; central nervous system; BBB; camelids; fluobodies; nanobodies	SINGLE-DOMAIN ANTIBODY; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; INTRABODIES; FRAGMENTS; DELIVERY; EXPRESSION; TRANSPORT; PEPTIDE; TRANSDUCTION	Antibodies normally do not cross the blood-brain barrier (BBB) and cannot bind an intracellular cerebral antigen. We demonstrate here for the first time that a new class of antibodies can cross the BBB without treatment. Camelids produce native homodimeric heavy-chain antibodies, the paratope being composed of a single-variable domain called VHH. Here, we used recombinant VHH directed against human glial fibrillary acidic protein (GFAP), a specific marker of astrocytes. Only basic VHHs (e.g., pI=9.4) were able to cross the BBB in vitro (7.8 vs. 0% for VHH with pI=7.7). By intracarotid and intravenous injections into live mice, we showed that these basic VHHs are able to cross the BBB in vivo, diffuse into the brain tissue, penetrate into astrocytes, and specifically label GFAP. To analyze their ability to be used as a specific transporter, we then expressed a recombinant fusion protein VHH-green fluorescent protein (GFP). These "fluobodies" specifically labeled GFAP on murine brain sections, and a basic variant (pI=9.3) of the fusion protein VHH-GFP was able to cross the BBB and to label astrocytes in vivo. The potential of VHHs as diagnostic or therapeutic agents in the central nervous system now deserves attention. Li, T., Bourgeois, J.-P., Celli, S., Glacial, F., Le Sourd, A.-M., Mecheri, S., Weksler, B., Romero, I., Couraud, P.-O., Rougeon, F., and Lafaye, P. Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging. FASEB J. 26, 3969-3979 (2012). www.fasebj.org	[Bourgeois, Jean-Pierre; Le Sourd, Anne-Marie] Inst Pasteur, Unite Genes Synapses & Cognit, CNRS, URA 2182, F-75724 Paris 15, France; [Celli, Susanna] Inst Pasteur, Unite Dynam Reponses Immunes, INSERM, U668, F-75724 Paris 15, France; [Mecheri, Salah] Inst Pasteur, CNRS, U2581, Unite Biol Interact Hote Parasites, F-75724 Paris 15, France; [Rougeon, Francois] Inst Pasteur, Unite Genet & Biochim Dev, F-75724 Paris 15, France; [Glacial, Fabienne; Couraud, Pierre-Olivier] Inst Cochin, U1016, INSERM, Paris, France; [Glacial, Fabienne; Couraud, Pierre-Olivier] CNRS, UMR 8104, Paris, France; [Glacial, Fabienne; Couraud, Pierre-Olivier] Univ Paris 05, Paris, France; [Weksler, Babette] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA; [Romero, Ignacio] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Cornell University; Open University - UK	Lafaye, P (corresponding author), Inst Pasteur, PF Prod Prot Recombinantes & Anticorps, 25 Rue Dr Roux, F-75724 Paris 15, France.	plafaye@pasteur.fr	Mecheri, Salah/M-8315-2013; Celli, Susanna/M-7138-2014	Romero, Ignacio/0000-0002-0322-9180				Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Achour I, 2008, J IMMUNOL, V181, P2001, DOI 10.4049/jimmunol.181.3.2001; ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; Beghdadi W, 2008, J EXP MED, V205, P395, DOI 10.1084/jem.20071548; Beghdadi W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006004; Bickel U, 2001, ADV DRUG DELIVER REV, V46, P247, DOI 10.1016/S0169-409X(00)00139-3; BIOCCA S, 1995, BIO-TECHNOL, V13, P1110, DOI 10.1038/nbt1095-1110; Cao GD, 2002, J NEUROSCI, V22, P5423; Demangel C, 1996, MOL IMMUNOL, V33, P909, DOI 10.1016/S0161-5890(96)00058-2; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Doyle PJ, 2009, J BIOL CHEM, V284, P35029, DOI 10.1074/jbc.M109.045047; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; INOUYE S, 1994, FEBS LETT, V351, P211, DOI 10.1016/0014-5793(94)00859-0; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; Jones DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009804; Kvam E, 2010, PROTEIN ENG DES SEL, V23, P489, DOI 10.1093/protein/gzq022; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Luissint AC, 2012, J CEREBR BLOOD F MET, V32, P860, DOI 10.1038/jcbfm.2011.202; MARASCO WA, 1995, IMMUNOTECHNOLOGY, V1, P1, DOI 10.1016/1380-2933(95)00001-1; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Olichon A, 2007, J BIOL CHEM, V282, P36314, DOI 10.1074/jbc.M704908200; PARDRIDGE WM, 1995, J PHARM SCI-US, V84, P943, DOI 10.1002/jps.2600840808; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Perruchini C, 2009, ACTA NEUROPATHOL, V118, P685, DOI 10.1007/s00401-009-0572-6; Proba K, 1998, J MOL BIOL, V275, P245, DOI 10.1006/jmbi.1997.1457; Proba K, 1997, J MOL BIOL, V265, P161, DOI 10.1006/jmbi.1996.0726; RAPOPORT SI, 1980, AM J PHYSIOL, V238, pR421, DOI 10.1152/ajpregu.1980.238.5.R421; Rapoport SI, 2000, CELL MOL NEUROBIOL, V20, P217, DOI 10.1023/A:1007049806660; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; Rutgers KS, 2011, NEUROSCIENCE, V190, P37, DOI 10.1016/j.neuroscience.2011.05.076; Schwalbach G, 2000, PROTEIN EXPRES PURIF, V18, P121, DOI 10.1006/prep.1999.1185; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Serruys B, 2009, HEPATOLOGY, V49, P39, DOI 10.1002/hep.22609; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Tanaka T, 2003, EMBO J, V22, P1025, DOI 10.1093/emboj/cdg106; TRIGUERO D, 1989, P NATL ACAD SCI USA, V86, P4761, DOI 10.1073/pnas.86.12.4761; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; VORBRODT AW, 1989, J NEUROCYTOL, V18, P359, DOI 10.1007/BF01190839; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795	45	121	135	3	65	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					3969	3979		10.1096/fj.11-201384	http://dx.doi.org/10.1096/fj.11-201384			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22730440				2022-12-25	WOS:000309704000005
J	LaRock, DL; Brzovic, PS; Levin, I; Blanc, MP; Miller, SI				LaRock, Doris L.; Brzovic, Peter S.; Levin, Itay; Blanc, Marie-Pierre; Miller, Samuel I.			A Salmonella typhimurium-translocated Glycerophospholipid: Cholesterol Acyltransferase Promotes Virulence by Binding to the RhoA Protein Switch Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFECTOR RECOGNITION; ACTIVATION; SSEJ; SIFA; SPECIFICITY; DYNAMICS; INSIGHTS; GTPASE; SYSTEM	Salmonella enterica serovar typhimurium translocates a glycerophospholipid: cholesterol acyltransferase (SseJ) into the host cytosol after its entry into mammalian cells. SseJ is recruited to the cytoplasmic face of the host cell phagosome membrane where it is activated upon binding the small GTPase, RhoA. SseJ is regulated similarly to cognate eukaryotic effectors, as only the GTP-bound form of RhoA family members stimulates enzymatic activity. Using NMR and biochemistry, this work demonstrates that SseJ competes effectively with Rhotekin, ROCK, and PKN1 in binding to a similar RhoA surface. The RhoA surface that binds SseJ includes the regulatory switch regions that control activation of mammalian effectors. These data were used to create RhoA mutants with altered SseJ binding and activation. This structure-function analysis supports a model in which SseJ activation occurs predominantly through binding to residues within switch region II. We further defined the nature of the interaction between SseJ and RhoA by constructing SseJ mutants in the RhoA binding surface. These data indicate that SseJ binding to RhoA is required for recruitment of SseJ to the endosomal network and for full Salmonella virulence for inbred susceptible mice, indicating that regulation of SseJ by small GTPases is an important virulence strategy of this bacterial pathogen. The dependence of a bacterial effector on regulation by a mammalian GTPase defines further how intimately host pathogen interactions have coevolved through similar and divergent evolutionary strategies.	[LaRock, Doris L.; Levin, Itay; Blanc, Marie-Pierre; Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brzovic, Peter S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Blanc, Marie-Pierre] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Miller, SI (corresponding author), Univ Washington, Dept Microbiol, 1959 NE Pacific St, Seattle, WA 98195 USA.	millersi@u.washington.edu		LaRock, Doris/0000-0002-2661-6853	National Institutes of Health [R01 AI048683]; NIGMS (National Institutes of Health) [T32 GM07270]; NIAID (National Institutes of Health) [U54 AI057141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, R01AI048683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported, in whole or in part, by National Institutes of Health Grant R01 AI048683.; Supported in part by National Research Service Award T32 GM07270 from NIGMS (National Institutes of Health).; Supported in part by NIAID (National Institutes of Health) Grant U54 AI057141 for the NWRCE for Biodefense and Emerging Infectious Diseases Research.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Christen M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000430; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Hutchinson CL, 2011, BIOCHEMISTRY-US, V50, P2860, DOI 10.1021/bi200039u; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Lossi NS, 2008, MICROBIOL-SGM, V154, P2680, DOI 10.1099/mic.0.2008/019075-0; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ohlson MB, 2005, INFECT IMMUN, V73, P6249, DOI 10.1128/IAI.73.10.6249-6259.2005; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Walker SJ, 2002, J BIOL CHEM, V277, P26260, DOI 10.1074/jbc.M201811200; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	30	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29654	29663		10.1074/jbc.M112.363598	http://dx.doi.org/10.1074/jbc.M112.363598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22740689	Green Published, hybrid			2022-12-25	WOS:000308286900041
J	Matsui, T; Ohbayashi, N; Fukuda, M				Matsui, Takahide; Ohbayashi, Norihiko; Fukuda, Mitsunori			The Rab Interacting Lysosomal Protein (RILP) Homology Domain Functions as a Novel Effector Domain for Small GTPase Rab36 Rab36 REGULATES RETROGRADE MELANOSOME TRANSPORT IN MELANOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOSOME DISTRIBUTION; CRITICAL DETERMINANT; STRUCTURAL BASIS; MAMMALIAN RABS; BINDING; TRANSPORT; SLAC2-A/MELANOPHILIN; SPECIFICITY; TRAFFICKING; KINESIN-1	Small GTPase Rab functions as a molecular switch that drives membrane trafficking through specific interaction with its effector molecule. Thus, identification of its specific effector domain is crucial to revealing the molecular mechanism that underlies Rab-mediated membrane trafficking. Because of the large numbers of Rab isoforms in higher eukaryotes, however, the effector domains of most of the vertebrate-or mammalian-specific Rabs have yet to be determined. In this study we screened for effector molecules of Rab36, a previously uncharacterized Rab isoform that is largely conserved in vertebrates, and we succeeded in identifying nine Rab36-binding proteins, including RILP (Rab interacting lysosomal protein) family members. Sequence comparison revealed that five of nine Rab36-binding proteins, i.e. RILP, RILP-L1, RILP-L2, and JIP3/4, contain a conserved coiled-coil domain. We identified the coiled-coil domain as a RILP homology domain (RHD) and characterized it as a common Rab36-binding site. Site-directed mutagenesis of the RHD of RILP revealed the different contributions by amino acids in the RHD to binding activity toward Rab7 and Rab36. Expression of RILP in melanocytes, but not expression of its Rab36 binding-deficient mutants, induced perinuclear aggregation of melanosomes, and this effect was clearly attenuated by knockdown of endogenous Rab36 protein. Moreover, knockdown of Rab36 in Rab27A-deficient melanocytes, which normally exhibit perinuclear melanosome aggregation because of increased retrograde melanosome transport activity, caused dispersion of melanosomes from the perinucleus to the cell periphery, but knockdown of Rab7 did not. Our findings indicated that Rab36 mediates retrograde melanosome transport in melanocytes through interaction with RILP.	[Matsui, Takahide; Ohbayashi, Norihiko; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mechanisms, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mechanisms, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015; Matsui, Takahide/S-4986-2018	Fukuda, MItsunori/0000-0002-8620-5853; Matsui, Takahide/0000-0002-3342-0170	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [24570206, 20113006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to N. O. and M. F.).	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chen L, 2010, MOL MEMBR BIOL, V27, P23, DOI 10.3109/09687680903417470; Daniele T, 2011, TRAFFIC, V12, P902, DOI 10.1111/j.1600-0854.2011.01194.x; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2010, HISTOL HISTOPATHOL, V25, P1473, DOI 10.14670/HH-25.1473; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Huang SH, 2011, J NEUROSCI, V31, P10602, DOI 10.1523/JNEUROSCI.0436-11.2011; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; James P, 1996, GENETICS, V144, P1425; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Mori T, 1999, BIOCHEM BIOPH RES CO, V254, P594, DOI 10.1006/bbrc.1998.9968; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Piccione M, 2011, AM J MED GENET A, V155A, P3054, DOI 10.1002/ajmg.a.34275; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sun FN, 2011, EMBO J, V30, P3416, DOI 10.1038/emboj.2011.229; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Wang TL, 2004, MOL BIOL CELL, V15, P815, DOI 10.1091/mbc.E03-06-0413	45	50	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28619	28631		10.1074/jbc.M112.370544	http://dx.doi.org/10.1074/jbc.M112.370544			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740695	hybrid, Green Published			2022-12-25	WOS:000308074600036
J	Beltrami, M; Medina-Munoz, MC; Del Pino, F; Ferveur, JF; Godoy-Herrera, R				Beltrami, Marcial; Cristina Medina-Munoz, Maria; Del Pino, Francisco; Ferveur, Jean-Francois; Godoy-Herrera, Raul			Chemical Cues Influence Pupation Behavior of Drosophila simulans and Drosophila buzzatii in Nature and in the Laboratory	PLOS ONE			English	Article							MELANOGASTER; LARVAE	In the wild, larvae of several species of Drosophila develop in heterogeneous and rapidly changing environments sharing resources as food and space. In this scenario, sensory systems contribute to detect, localize and recognize congeners and heterospecifics, and provide information about the availability of food and chemical features of environments where animals live. We investigated the behavior of D. simulans and D. buzzatii larvae to chemicals emitted by conspecific and heterospecific larvae. Our goal was to understand the role of these substances in the selection of pupation sites in the two species that cohabit within decaying prickly pear fruits (Opuntia ficus-indica). In these breeding sites, larvae of D. simulans and D. buzzatii detect larvae of the other species changing their pupation site preferences. Larvae of the two species pupated in the part of the fruit containing no or few heterospecifics, and spent a longer time in/on spots marked by conspecifics rather than heterospecifics. In contrast, larvae of the two species reared in isolation from conspecifics pupated randomly over the substrate and spent a similar amount of time on spots marked by conspecifics and by heterospecifics. Our results indicate that early chemically-based experience with conspecific larvae is critical for the selection of the pupation sites in D. simulans and D. buzzatii, and that pupation site preferences of Drosophila larvae depend on species-specific chemical cues. These preferences can be modulate by the presence of larvae of the same or another species.	[Beltrami, Marcial] Univ Metropolitana Ciencias Educ, Fac Ciencias Nat & Exactas, Dept Biol, Santiago, Chile; [Cristina Medina-Munoz, Maria] Univ Playa Ancha Ciencias Educ, Fac Ciencias Nat & Exactas, Dept Biol, Valparaiso, Chile; [Del Pino, Francisco] Univ Chile, Fac Med, Programa Genet Humana, ICBM, Santiago 7, Chile; [Ferveur, Jean-Francois] Univ Bourgogne, Ctr Sci Gout & Alimentat, Unite Mixte Rech 6265, Associee Ctr Natl Rech Sci,Fac Sci, Dijon, France; [Godoy-Herrera, Raul] Univ Bio Bio, Fac Ciencias, Dept Ciencias Basicas, Chillan, Chile	Universidad Metropolitana de Ciencias de la Educacion (UMCE); Universidad de Chile; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Universidad del Bio-Bio	Beltrami, M (corresponding author), Univ Metropolitana Ciencias Educ, Fac Ciencias Nat & Exactas, Dept Biol, Santiago, Chile.	raulgodoy.herrera@gmail.com	Corrêa, Marcio N Nunes/D-1034-2019	Corrêa, Marcio N Nunes/0000-0003-0855-2750	Centre National de la Recherche Scientifique (CNRS); Burgundy Regional Council; Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT) [1100110]; Comite de Evaluacion-Orientacion de la Cooperacion Cientifica Chile-France (ECOS-CONICYT) [08 B03]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comite de Evaluacion-Orientacion de la Cooperacion Cientifica Chile-France (ECOS-CONICYT)	JFF's funding was provided in part by the Centre National de la Recherche Scientifique (CNRS) and the Burgundy Regional Council. This work was supported by Fondo Nacional de Investigacion Cientifica y Tecnologica (FONDECYT No1100110) to RG-H and by Comite de Evaluacion-Orientacion de la Cooperacion Cientifica Chile-France (ECOS-CONICYT NoC08 B03) to RG-H and JFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; BRNCIC D, 1985, Z ZOOL SYST EVOL, V23, P90; Burdick A. B., 1954, DROSOPH INF SERV, V28, P170; Del Pino F, 2012, BEHAV GENET, V42, P162, DOI 10.1007/s10519-011-9490-1; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Hendel T, 2005, J COMP PHYSIOL A, V191, P265, DOI 10.1007/s00359-004-0574-8; KAMBYSELLIS MP, 1971, AM NAT, V105, P31, DOI 10.1086/282700; LEVINS RICHARD, 1968; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106; Medina-Munoz MC, 2005, BEHAV ECOL, V16, P316, DOI 10.1093/beheco/arh125; Mery F, 2004, EVOLUTION, V58, P757; POWELL JR, 1997, PROGR PROSPECT EVOLU; Reaume CJ, 2006, CURR BIOL, V16, pR623, DOI 10.1016/j.cub.2006.07.042; Sisodia S, 2005, J GENET, V84, P195, DOI 10.1007/BF02715846; Zar JH, 1999, BIOSTATISTICAL ANAL	17	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39393	10.1371/journal.pone.0039393	http://dx.doi.org/10.1371/journal.pone.0039393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737236	Green Published, gold, Green Submitted			2022-12-25	WOS:000305695100035
J	Papakrivos, J; Sa, JM; Wellems, TE				Papakrivos, Janni; Sa, Juliana M.; Wellems, Thomas E.			Functional Characterization of the Plasmodium falciparum Chloroquine-Resistance Transporter (PfCRT) in Transformed Dictyostelium discoideum Vesicles	PLOS ONE			English	Article							ANTIMALARIAL-DRUG RESISTANCE; TRANSMEMBRANE PROTEIN PFCRT; MALARIA PARASITES; DIGESTIVE VACUOLE; FERRIPROTOPORPHYRIN-IX; REVERSING AGENTS; MUTATIONS; MECHANISM; PH; SUSCEPTIBILITY	Background: Chloroquine (CQ)-resistant Plasmodium falciparum malaria has been a global health catastrophe, yet much about the CQ resistance (CQR) mechanism remains unclear. Hallmarks of the CQR phenotype include reduced accumulation of protonated CQ as a weak base in the digestive vacuole of the erythrocyte-stage parasite, and chemosensitization of CQ-resistant (but not CQ-sensitive) P. falciparum by agents such as verapamil. Mutations in the P. falciparum CQR transporter (PfCRT) confer CQR; particularly important among these mutations is the charge-loss substitution K -> T at position 76. Dictyostelium discoideum transformed with mutant PfCRT expresses key features of CQR including reduced drug accumulation and verapamil chemosensitization. Methodology and Findings: We describe the isolation and characterization of PfCRT-transformed, hematin-free vesicles from D. discoideum cells. These vesicles permit assessments of drug accumulation, pH, and membrane potential that are difficult or impossible with hematin-containing digestive vacuoles from P. falciparum-infected erythrocytes. Mutant PfCRT-transformed D. discoideum vesicles show features of the CQR phenotype, and manipulations of vesicle membrane potential by agents including ionophores produce large changes of CQ accumulation that are dissociated from vesicular pH. PfCRT in its native or mutant form blunts the ability of valinomycin to reduce CQ accumulation in transformed vesicles and decreases the ability of K+ to reverse membrane potential hyperpolarization caused by valinomycin treatment. Conclusion: Isolated vesicles from mutant-PfCRT-transformed D. discoideum exhibit features of the CQR phenotype, consistent with evidence that the drug resistance mechanism operates at the P. falciparum digestive vacuole membrane in malaria. Membrane potential apart from pH has a major effect on the PfCRT-mediated CQR phenotype of D. discoideum vesicles. These results support a model of PfCRT as an electrochemical potential-driven transporter in the drug/metabolite superfamily that (appropriately mutated) acts as a saturable simple carrier for the facilitated diffusion of protonated CQ.	[Papakrivos, Janni; Sa, Juliana M.; Wellems, Thomas E.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Papakrivos, J (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twellems@niaid.nih.gov			NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000483] Funding Source: NIH RePORTER	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOBENSON M, 1986, CELL IMMUNOL, V103, P417, DOI 10.1016/0008-8749(86)90101-2; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; AUBRY L, 1993, J CELL SCI, V105, P861; Bala S, 2001, BBA-BIOMEMBRANES, V1510, P258, DOI 10.1016/S0005-2736(00)00357-6; Baro NK, 2011, BIOCHEMISTRY-US, V50, P6701, DOI 10.1021/bi200922g; BITONTI AJ, 1988, SCIENCE, V242, P1301, DOI 10.1126/science.3057629; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; Bray PG, 2005, BIOCHEM PHARMACOL, V70, P1158, DOI 10.1016/j.bcp.2005.07.021; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; DAVIES L, 1993, CELL, V75, P321, DOI 10.1016/0092-8674(93)80073-N; Davis TME, 2005, DRUGS, V65, P75, DOI 10.2165/00003495-200565010-00004; Ekland EH, 2007, CURR OPIN MICROBIOL, V10, P363, DOI 10.1016/j.mib.2007.07.007; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; FERRARI V, 1987, J PHARM SCI, V76, P554, DOI 10.1002/jps.2600760714; FERRARI V, 1990, BIOCHEM PHARMACOL, V39, P753, DOI 10.1016/0006-2952(90)90155-E; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1970, SCIENCE, V169, P289, DOI 10.1126/science.169.3942.289; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Flaadt H, 2000, J BIOSCIENCES, V25, P243, DOI 10.1007/BF02703931; GINSBURG H, 1990, PARASITOL TODAY, V6, P334, DOI 10.1016/0169-4758(90)90178-7; Jenne N, 1998, J CELL SCI, V111, P61; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Mehlotra RK, 2001, P NATL ACAD SCI USA, V98, P12689, DOI 10.1073/pnas.221440898; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Nessler S, 2004, J BIOL CHEM, V279, P39438, DOI 10.1074/jbc.M404671200; NILSEN A, 1988, EXP LUNG RES, V14, P197, DOI 10.3109/01902148809115124; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Paguio MF, 2009, BIOCHEMISTRY-US, V48, P9482, DOI 10.1021/bi901035j; PETERS W, 1989, LANCET, V2, P334, DOI 10.1016/S0140-6736(89)90522-9; Rasoanaivo P, 1996, CURR MED CHEM, V3, P1; Roepe PD, 2011, BIOCHEMISTRY-US, V50, P163, DOI 10.1021/bi101638n; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sanchez CP, 2011, MOL MICROBIOL, V82, P865, DOI 10.1111/j.1365-2958.2011.07855.x; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; Summers RL, 2010, VIRULENCE, V1, P304, DOI 10.4161/viru.1.4.12012; Temesvari LA, 1996, J CELL SCI, V109, P1479; THAYER WS, 1975, J BIOL CHEM, V250, P5336; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; Ursing J, 2008, TRENDS PARASITOL, V24, P49, DOI 10.1016/j.pt.2007.11.002; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Warhurst DC, 2002, LANCET, V360, P1527, DOI 10.1016/S0140-6736(02)11577-7; YAYON A, 1985, P NATL ACAD SCI USA, V82, P2784, DOI 10.1073/pnas.82.9.2784; Zhang HB, 2004, BIOCHEMISTRY-US, V43, P8290, DOI 10.1021/bi049137i	56	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39569	10.1371/journal.pone.0039569	http://dx.doi.org/10.1371/journal.pone.0039569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724026	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700087
J	Surls, J; Nazarov-Stoica, C; Kehl, M; Olsen, C; Casares, S; Brumeanu, TD				Surls, Jacqueline; Nazarov-Stoica, Cristina; Kehl, Margaret; Olsen, Cara; Casares, Sofia; Brumeanu, Teodor-D.			Increased Membrane Cholesterol in Lymphocytes Diverts T-Cells toward an Inflammatory Response	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTORS; LIPID-RAFTS; PLASMA-MEMBRANE; INTERLEUKIN-2 RECEPTOR; CELLULAR CHOLESTEROL; SIGNAL-TRANSDUCTION; DOWN-REGULATION; TH2 CELLS; ACTIVATION; MICRODOMAINS	Cell signaling for T-cell growth, differentiation, and apoptosis is initiated in the cholesterol-rich microdomains of the plasma membrane known as lipid rafts. Herein, we investigated whether enrichment of membrane cholesterol in lipid rafts affects antigen-specific CD4 T-helper cell functions. Enrichment of membrane cholesterol by 40-50% following squalene administration in mice was paralleled by an increased number of resting CD4 T helper cells in periphery. We also observed sensitization of the Th1 differentiation machinery through co-localization of IL-2R alpha, IL-4R alpha, and IL-12R beta 2 subunits with GM1 positive lipid rafts, and increased STAT-4 and STAT-5 phosphorylation following membrane cholesterol enrichment. Antigen stimulation or CD3/CD28 polyclonal stimulation of membrane cholesterol-enriched, resting CD4 T-cells followed a path of Th1 differentiation, which was more vigorous in the presence of increased IL-12 secretion by APCs enriched in membrane cholesterol. Enrichment of membrane cholesterol in antigen-specific, autoimmune Th1 cells fostered their organ-specific reactivity, as confirmed in an autoimmune mouse model for diabetes. However, membrane cholesterol enrichment in CD4(+) Foxp3(+) T-reg cells did not alter their suppressogenic function. These findings revealed a differential regulatory effect of membrane cholesterol on the function of CD4 T-cell subsets. This first suggests that membrane cholesterol could be a new therapeutic target to modulate the immune functions, and second that increased membrane cholesterol in various physiopathological conditions may bias the immune system toward an inflammatory Th1 type response.	[Surls, Jacqueline; Nazarov-Stoica, Cristina; Kehl, Margaret; Olsen, Cara; Casares, Sofia; Brumeanu, Teodor-D.] Uniformed Serv Univ Hlth Sci, Dept Med, Div Immunol, Bethesda, MD 20814 USA; [Surls, Jacqueline; Nazarov-Stoica, Cristina; Kehl, Margaret; Olsen, Cara; Casares, Sofia; Brumeanu, Teodor-D.] Uniformed Serv Univ Hlth Sci, Biostat Counseling Ctr, Bethesda, MD 20814 USA; [Casares, Sofia] USN, Infect Dis Directorate, Malaria Program, Med Res Ctr, Silver Spring, MD USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Navy	Surls, J (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Div Immunol, Room A3060, Bethesda, MD 20814 USA.	tbrumeanu@usuhs.edu	Brumeanu, Teodor/AAB-1965-2020		Uniformed Services University of Health Sciences (USUHS) [RO83-ZK]	Uniformed Services University of Health Sciences (USUHS)	This work was supported (grant # RO83-ZK) by the Uniformed Services University of Health Sciences (USUHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Bot A, 1998, J IMMUNOL, V160, P4500; Brumeanu TD, 2006, CLIN IMMUNOL, V119, P1, DOI 10.1016/j.clim.2005.11.007; Brumeanu TD, 2007, MOL IMMUNOL, V44, P530, DOI 10.1016/j.molimm.2006.02.008; Canda-Sanchez A, 2009, J MEMBRANE BIOL, V227, P1, DOI 10.1007/s00232-008-9127-3; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CANTRELL DA, 1988, IMMUNOLOGY, V65, P343; Casares S, 1997, PROTEIN ENG, V10, P1295, DOI 10.1093/protein/10.11.1295; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; CASTANHO MARB, 1992, J BIOL CHEM, V267, P204; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CUTHBERT JA, 1986, J BIOL CHEM, V261, P3620; CUTHBERT JA, 1987, INT J TISSUE REACT, V9, P447; CUTHBERT JA, 1987, J BIOL CHEM, V262, P7808; de Mello Coelho V, 2004, BMC IMMUNOL, V5, P2; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Ebert PJR, 2000, J IMMUNOL, V165, P5435, DOI 10.4049/jimmunol.165.10.5435; EIDINOFF ML, 1958, J CLIN INVEST, V37, P655, DOI 10.1172/JCI103650; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Fisson S, 2006, EUR J IMMUNOL, V36, P817, DOI 10.1002/eji.200535445; Fulop T, 2005, DRUG AGING, V22, P589, DOI 10.2165/00002512-200522070-00005; Fulop T, 2001, MECH AGEING DEV, V122, P1413, DOI 10.1016/S0047-6374(01)00274-3; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Ghazizadeh R, 2011, AM J MED SCI, V341, P394, DOI 10.1097/MAJ.0b013e3181ff8eeb; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; Goebel J, 2002, J LEUKOCYTE BIOL, V72, P199; Goldman F, 1996, BLOOD, V88, P4611, DOI 10.1182/blood.V88.12.4611.bloodjournal88124611; Gombos I, 2004, IMMUNOL LETT, V92, P117, DOI 10.1016/j.imlet.2003.11.022; Harikumar KG, 2005, J BIOL CHEM, V280, P2176, DOI 10.1074/jbc.M410385200; Hillyard DZ, 2004, ATHEROSCLEROSIS, V175, P305, DOI 10.1016/j.atherosclerosis.2004.03.018; HO YK, 1976, J CLIN INVEST, V58, P1465, DOI 10.1172/JCI108603; Horejsi V, 2005, MICROBES INFECT, V7, P310, DOI 10.1016/j.micinf.2004.12.004; Jury EC, 2006, J IMMUNOL, V177, P7416, DOI 10.4049/jimmunol.177.10.7416; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; LEHOUX JG, 1985, ENDOCRINOLOGY, V117, P1462, DOI 10.1210/endo-117-4-1462; Leitenberg D, 2001, SEMIN IMMUNOL, V13, P129, DOI 10.1006/smim.2000.0304; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li QR, 2005, TRANSPL P, V37, P2395, DOI 10.1016/j.transproceed.2005.03.115; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; LOUD AV, 1958, J BIOL CHEM, V233, P37; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Marmor MD, 2001, BLOOD, V98, P1489, DOI 10.1182/blood.V98.5.1489; Matko J, 2002, IMMUNOL LETT, V82, P3, DOI 10.1016/S0165-2478(02)00011-1; Matko J, 2002, EUR J BIOCHEM, V269, P1199, DOI 10.1046/j.0014-2956.2002.02759.x; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Mitchell JS, 2002, J IMMUNOL, V168, P2737, DOI 10.4049/jimmunol.168.6.2737; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MULLER CP, 1984, CYTOMETRY, V5, P42, DOI 10.1002/cyto.990050108; MURAKOSHI M, 1992, INT J CANCER, V52, P950, DOI 10.1002/ijc.2910520620; Nazarov-Stoica C, 2009, J IMMUNOL, V182, P102, DOI 10.4049/jimmunol.182.1.102; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V311, P277, DOI 10.1006/abbi.1994.1238; Nguyen DH, 2004, MECH AGEING DEV, V125, P641, DOI 10.1016/j.mad.2004.08.002; Nix M, 2000, CELL DEATH DIFFER, V7, P413, DOI 10.1038/sj.cdd.4400666; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Rao CV, 1998, CARCINOGENESIS, V19, P287, DOI 10.1093/carcin/19.2.287; Rao R, 2004, CYTOKINE GROWTH F R, V15, P103, DOI 10.1016/j.cytogfr.2004.01.003; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Senthilkumar S, 2006, CLIN CHIM ACTA, V364, P335, DOI 10.1016/j.cca.2005.07.032; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Surls J, 2010, VACCINE, V28, P7319, DOI 10.1016/j.vaccine.2010.08.074; Tani-ichi S, 2005, INT IMMUNOL, V17, P749, DOI 10.1093/intimm/dxh257; Thomas S, 2004, ARCH IMMUNOL THER EX, V52, P215; Thomas S, 2003, J IMMUNOL METHODS, V275, P161, DOI 10.1016/S0022-1759(03)00014-0; TILVIS RS, 1983, LIPIDS, V18, P32, DOI 10.1007/BF02534687; Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803; VANDUUREN BL, 1976, JNCI-J NATL CANCER I, V56, P1237, DOI 10.1093/jnci/56.6.1237; Verhoeye FR, 1996, J LIPID RES, V37, P1377; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zeyda M, 2006, PROG LIPID RES, V45, P187, DOI 10.1016/j.plipres.2006.01.002; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	81	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38733	10.1371/journal.pone.0038733	http://dx.doi.org/10.1371/journal.pone.0038733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723880	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700024
J	Yang, G; Yang, L; Zhao, Z; Wang, JJ; Zhang, XB				Yang, Geng; Yang, Lu; Zhao, Zhe; Wang, Jiajia; Zhang, Xiaobo			Signature miRNAs Involved in the Innate Immunity of Invertebrates	PLOS ONE			English	Article							MIR-155; TRANSCRIPTION	The innate immune system, including the cell-based immunity (mainly apoptosis and phagocytosis) and the humoral immunity (such as pro-phenoloxidase system), is the first defense line of animals against the infection of pathogens in a nonspecific manner, which is fine regulated through the gene expression regulations. The microRNAs (miRNAs) are recognized as important regulators of gene expression. To date, however, a comprehensive view about the regulation of innate immunity by miRNAs is not available. To address this issue, the signature miRNAs involved in the innate immunity were characterized in this study. The phagocytosis, apoptosis and phenoloxidase (PO), a key enzyme in the pro-phenoloxidase system, of invertebrate shrimp were activated or inhibited, followed by the small RNA sequencing. The results showed that a total of 24 miRNAs took great effects on phagocytosis, apoptosis or the pro-phenoloxidase system, which were further confirmed by Northern blots. Among the 24 innate immunity-associated miRNAs, 21 miRNAs were conserved in animals, suggesting that these miRNAs might share the similar or the same functions in different species of animals. Based on degradome sequencing and prediction of target genes, it was found that the miRNAs might mediate the regulations of phagocytosis, apoptosis or pro-phenoloxidase system by targeting different genes. Therefore our study presented the first comprehensive view of the miRNAs associated with innate immunity, which would facilitate to reveal the molecular events in the regulation of innate immunity.	[Yang, Geng] Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Key Lab Conservat Biol Endangered Wildlife,Minist, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University	Yang, G (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Key Lab Conservat Biol Endangered Wildlife,Minist, Hangzhou 310003, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Yang, Lu/0000-0002-8338-1616	National Natural Science Foundation of China [30830084]; Hi-Tech Research and Development Program of China (863 program of China) [2010AA09Z403, 2011AA10A216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China (863 program of China)(National High Technology Research and Development Program of China)	This work was financially supported by National Natural Science Foundation of China (30830084) and Hi-Tech Research and Development Program of China (863 program of China) (2010AA09Z403, 2011AA10A216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bejarano F, 2010, DEV BIOL, V338, P63, DOI 10.1016/j.ydbio.2009.11.025; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bracken CP, 2011, NUCLEIC ACIDS RES, V39, P5658, DOI 10.1093/nar/gkr110; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen M, 2010, IMMUNOL REV, V236, P11, DOI 10.1111/j.1600-065X.2010.00916.x; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Eleftherianos I, 2010, TRENDS MICROBIOL, V18, P552, DOI 10.1016/j.tim.2010.09.006; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Mortensen K, 2003, CELL MOL LIFE SCI, V60, P1007, DOI 10.1007/s00018-003-3022-x; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Sheedy FJ, 2011, NAT IMMUNOL, V11, P141; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	29	62	67	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39015	10.1371/journal.pone.0039015	http://dx.doi.org/10.1371/journal.pone.0039015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723921	gold, Green Published			2022-12-25	WOS:000305652700044
J	Hoshika, Y; Omasa, K; Paoletti, E				Hoshika, Yasutomo; Omasa, Kenji; Paoletti, Elena			Whole-Tree Water Use Efficiency Is Decreased by Ambient Ozone and Not Affected by O-3-Induced Stomatal Sluggishness	PLOS ONE			English	Article							ETHYLENEDIUREA EDU; AIR-POLLUTION; CLIMATE-CHANGE; GAS-EXCHANGE; PLANTS; FOREST; PHOTOSYNTHESIS; CONDUCTANCE; EXPOSURE; GROWTH	Steady-state and dynamic gas exchange responses to ozone visible injury were investigated in an ozone-sensitive poplar clone under field conditions. The results were translated into whole tree water loss and carbon assimilation by comparing trees exposed to ambient ozone and trees treated with the ozone-protectant ethylenediurea (EDU). Steady-state stomatal conductance and photosynthesis linearly decreased with increasing ozone visible injury. Dynamic responses simulated by severing of a leaf revealed that stomatal sluggishness increased until a threshold of 5% injury and was then fairly constant. Sluggishness resulted from longer time to respond to the closing signal and slower rate of closing. Changes in photosynthesis were driven by the dynamics of stomata. Whole-tree carbon assimilation and water loss were lower in trees exposed to ambient O-3 than in trees protected by EDU, both under steady-state and dynamic conditions. Although stomatal sluggishness is expected to increase water loss, lower stomatal conductance and premature leaf shedding of injured leaves aggravated O-3 effects on whole tree carbon gain, while compensating for water loss. On average, WUE of trees exposed to ambient ozone was 2-4% lower than that of EDU-protected control trees in September and 6-8% lower in October.	[Hoshika, Yasutomo; Omasa, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Paoletti, Elena] CNR, Inst Plant Protect, Florence, Italy	University of Tokyo; Consiglio Nazionale delle Ricerche (CNR)	Hoshika, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	e.paoletti@ipp.cnr.it	Paoletti, Elena/B-8974-2009; Paoletti, Elena/AAS-5316-2021; Hoshika, Yasutomo/AAA-9477-2020; Hoshika, Yasutomo/D-4441-2016	Paoletti, Elena/0000-0001-5324-7769; Paoletti, Elena/0000-0001-5324-7769; Hoshika, Yasutomo/0000-0002-5263-2945; Hoshika, Yasutomo/0000-0002-5263-2945	JSPS Fellowships for Young Scientists	JSPS Fellowships for Young Scientists	JSPS Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; Cieslik S, 2009, PLANT BIOLOGY, V11, P24, DOI 10.1111/j.1438-8677.2009.00262.x; De Kok LJ, 1998, RESPONSES PLANT META; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Grulke NE, 2007, ENVIRON POLLUT, V146, P640, DOI 10.1016/j.envpol.2006.04.014; Grulke NE, 2007, NEW PHYTOL, V173, P100, DOI 10.1111/j.1469-8137.2006.01872.x; Heath RL, 2008, ENVIRON POLLUT, V155, P453, DOI 10.1016/j.envpol.2008.03.010; HEBER U, 1986, PLANTA, V167, P554, DOI 10.1007/BF00391232; Hoshika Y, 2013, ENVIRON EXP BOT, V88, P19, DOI 10.1016/j.envexpbot.2011.12.004; Huttunen S., 2004, P M FOR CHANG CLIM E, P85; Innes JL., 2001, OZONE BROADLEAVED SP; KERSTIENS G, 1989, NEW PHYTOL, V112, P13, DOI 10.1111/j.1469-8137.1989.tb00303.x; Koziol M. J., 1984, GASEOUS AIR POLLUTAN; Manning WJ, 2011, ENVIRON POLLUT, V159, P3283, DOI 10.1016/j.envpol.2011.07.005; Mansfield TA, 1998, ENVIRON POLLUT, V101, P1, DOI 10.1016/S0269-7491(98)00076-1; Marzuoli R, 2009, TREE PHYSIOL, V29, P67, DOI 10.1093/treephys/tpn012; McLaughlin SB, 2007, NEW PHYTOL, V174, P109, DOI 10.1111/j.1469-8137.2007.02018.x; Mills G, 2009, GLOBAL CHANGE BIOL, V15, P1522, DOI 10.1111/j.1365-2486.2008.01798.x; NIES, 1984, STUD EFF AIR POLL 1; NIES, 1984, STUD EFF AIR POLL 2; NIES (National Institute for Environmental Studies), 1980, STUD EFF AIR POLL PL; Novak K, 2005, ENVIRON POLLUT, V136, P33, DOI 10.1016/j.envpol.2004.12.018; Omasa K., 1979, Journal of Agricultural Meteorology, V35, P77, DOI 10.2480/agrmet.35.77; OMASA K, 1981, Environment Control in Biology, V19, P85; OMASA K, 1990, Journal of Agricultural Meteorology, V45, P251; Omasa K, 2002, AIR POLLUTION PLANT; Paoletti E, 2005, ENVIRON POLLUT, V137, P483, DOI 10.1016/j.envpol.2005.01.035; Paoletti E, 2007, ENVIRON POLLUT, V145, P869, DOI 10.1016/j.envpol.2006.05.005; Paoletti E, 2005, ENVIRON POLLUT, V134, P439, DOI 10.1016/j.envpol.2004.09.011; Paoletti E, 2011, IFOREST, V4, P66, DOI 10.3832/ifor0569-004; Paoletti E., 2007, CAB REV PERSPECTIVES, V2; Paoletti E, 2009, SCI TOTAL ENVIRON, V407, P1631, DOI 10.1016/j.scitotenv.2008.11.061; Paoletti E, 2007, ENVIRON POLLUT, V150, P85, DOI 10.1016/j.envpol.2007.06.037; Paoletti E, 2010, ENVIRON POLLUT, V158, P2664, DOI 10.1016/j.envpol.2010.04.024; Paoletti E, 2009, ENVIRON POLLUT, V157, P1453, DOI 10.1016/j.envpol.2008.09.021; Paoletti E, 2009, ENVIRON POLLUT, V157, P865, DOI 10.1016/j.envpol.2008.11.009; PELL EJ, 1992, NEW PHYTOL, V120, P397, DOI 10.1111/j.1469-8137.1992.tb01080.x; REICH PB, 1984, PLANT CELL ENVIRON, V7, P661, DOI 10.1111/1365-3040.ep11571645; REILING K, 1995, NEW PHYTOL, V129, P587, DOI 10.1111/j.1469-8137.1995.tb03026.x; Robinson MF, 1998, J EXP BOT, V49, P461, DOI 10.1093/jexbot/49.suppl_1.461; Samuel MA, 2005, J EXP BOT, V56, P2195, DOI 10.1093/jxb/eri219; Sandermann H., 1997, FOREST DECLINE OZONE; Schulte-Hostede S, 1987, AIR POLLUTION PLANT; Serengil Y, 2011, IFOREST, V4, P44, DOI 10.3832/ifor0566-004; TINGEY DT, 1976, ATMOS ENVIRON, V10, P969, DOI 10.1016/0004-6981(76)90204-3; TINOCOOJANGUREN C, 1993, OECOLOGIA, V94, P395, DOI 10.1007/BF00317115; Tuomainen J, 1997, PLANT J, V12, P1151, DOI 10.1046/j.1365-313X.1997.12051151.x; *UNECE, 2004, MAPP CRIT LEV VEG, pCH3; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; VOLZ A, 1988, NATURE, V332, P240, DOI 10.1038/332240a0; Wieser G., 2008, Italian Journal of Agronomy, V3, P35; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Wittig VE, 2009, GLOBAL CHANGE BIOL, V15, P396, DOI 10.1111/j.1365-2486.2008.01774.x; YUNUS M, 1996, PLANT RESPONSE AIR P; Zhang J., 2000, ENVIRON POLLUT, V113, P117	57	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39270	10.1371/journal.pone.0039270	http://dx.doi.org/10.1371/journal.pone.0039270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723982	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300123
J	Lu, Y; Li, XG; Wang, M; Li, X; Zhang, F; Li, Y; Zhang, M; Da, YW; Yu, J; Jia, JP				Lu, Yan; Li, Xingang; Wang, Min; Li, Xin; Zhang, Feng; Li, Yun; Zhang, Meng; Da, Yuwei; Yu, Jun; Jia, Jianping			A Novel Autosomal Dominant Inclusion Body Myopathy Linked to 7q22.1-31.1	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; DISTAL MYOPATHY; FRONTOTEMPORAL DEMENTIA; RIMMED VACUOLES; PAGET-DISEASE; GENE; MAPS; DISORDER; MUTATION; MYOTILIN	We describe a novel autosomal dominant hereditary inclusion body myopathy (HIBM) that clinically mimics limb girdle muscular dystrophy in a Chinese family. We performed a detailed clinical assessment of 36 individuals spanning four generations. The age of onset ranged from the 30s to the 50s. Hip girdle, neck flexion and axial muscle weakness were involved at an early stage. This disease progressed slowly, and a shoulder girdle weakness appeared later in the disease course. Muscle biopsies showed necrotic, regenerating, and rimmed vacuolated fibers as well as congophilic inclusions in some of the fibers. Electron micrograph revealed cytoplasmic inclusions of 15-21 nm filaments. A genomewide scan and haplotype analyses were performed using an Illumina Linkage-12 DNA Analysis Kit (average spacing 0.58 cM), which traced the disease to a new locus on chromosome 7q22.1-31.1 with a maximum multi-point LOD score of 3.65. The critical locus for this unique disorder, which is currently referred to as hereditary inclusion body myopathy 4 (HIBM4), spans 8.78 Mb and contains 65 genes. This localization raises the possibility that one of the genes clustered within this region may be involved in this disorder.	[Lu, Yan; Wang, Min; Li, Yun; Da, Yuwei; Jia, Jianping] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Li, Xingang; Li, Xin; Zhang, Feng; Zhang, Meng; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Li, Xingang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lu, Y (corresponding author), Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China.	dayuwei100@hotmail.com; junyu@big.ac.cn		Li, Xingang/0000-0003-0252-154X; Jia, Jianping/0000-0003-4624-0336	"215" high-level personnel construction from Beijing Municipal Health Bureau, 215 Healthy and Technical Project [2009-3-58]	"215" high-level personnel construction from Beijing Municipal Health Bureau, 215 Healthy and Technical Project	Funding of this study is from "215" high-level personnel construction from Beijing Municipal Health Bureau, 215 Healthy and Technical Project (grant no. 2009-3-58). website: http://bjwsrc.org/hhr/new/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Argov Z, 2003, NEUROLOGY, V60, P1519, DOI 10.1212/01.WNL.0000061617.71839.42; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Argov Z, 2002, STRUCTURAL MOL BASIS, P274; Darin N, 1998, ANN NEUROL, V44, P242, DOI 10.1002/ana.410440215; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg I, 2001, EUR J HUM GENET, V9, P501, DOI 10.1038/sj.ejhg.5200665; GILCHRIST JM, 1988, NEUROLOGY, V38, P5, DOI 10.1212/WNL.38.1.5; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Hackman P, 2011, NEUROMUSCULAR DISORD, V21, P338, DOI 10.1016/j.nmd.2011.02.008; Harms MB, 2012, ANN NEUROL, DOI 1002/ana.22683; Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141; HOROWITZ SH, 1994, MUSCLE NERVE, V17, P151, DOI 10.1002/mus.880170204; Jay CM, 2009, GENE REGUL SYST BIO, V3, P181; JONGEN PJH, 1995, NEUROMUSCULAR DISORD, V5, P31, DOI 10.1016/0960-8966(94)E0019-5; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Martinsson T, 1999, AM J HUM GENET, V64, P1420, DOI 10.1086/302375; Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597; Motozaki Y, 2007, EUR J NEUROL, V14, pE14, DOI 10.1111/j.1468-1331.2007.01905.x; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Saavedra-Matiz CA, 2000, HUM HERED, V50, P166, DOI 10.1159/000022908; Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329; Sandell S, 2010, J NEUROL NEUROSUR PS, V81, P834, DOI 10.1136/jnnp.2009.192351; Starling A, 2004, EUR J HUM GENET, V12, P1033, DOI 10.1038/sj.ejhg.5201289; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009	28	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39288	10.1371/journal.pone.0039288	http://dx.doi.org/10.1371/journal.pone.0039288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723986	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300127
J	Martin-Lopez, B; Iniesta-Arandia, I; Garcia-Llorente, M; Palomo, I; Casado-Arzuaga, I; Del Amo, DG; Gomez-Baggethun, E; Oteros-Rozas, E; Palacios-Agundez, I; Willaarts, B; Gonzalez, JA; Santos-Martin, F; Onaindia, M; Lopez-Santiago, C; Montes, C				Martin-Lopez, Berta; Iniesta-Arandia, Irene; Garcia-Llorente, Marina; Palomo, Ignacio; Casado-Arzuaga, Izaskun; Garcia Del Amo, David; Gomez-Baggethun, Erik; Oteros-Rozas, Elisa; Palacios-Agundez, Igone; Willaarts, Barbara; Gonzalez, Jose A.; Santos-Martin, Fernando; Onaindia, Miren; Lopez-Santiago, Cesar; Montes, Carlos			Uncovering Ecosystem Service Bundles through Social Preferences	PLOS ONE			English	Article							PROTECTED AREAS; VALUATION; KNOWLEDGE; CONSERVATION; PERCEPTIONS; GENDER; BIODIVERSITY; DIVERSITY; TRENDS; VALUES	Ecosystem service assessments have increasingly been used to support environmental management policies, mainly based on biophysical and economic indicators. However, few studies have coped with the social-cultural dimension of ecosystem services, despite being considered a research priority. We examined how ecosystem service bundles and trade-offs emerge from diverging social preferences toward ecosystem services delivered by various types of ecosystems in Spain. We conducted 3,379 direct face-to-face questionnaires in eight different case study sites from 2007 to 2011. Overall, 90.5% of the sampled population recognized the ecosystem's capacity to deliver services. Formal studies, environmental behavior, and gender variables influenced the probability of people recognizing the ecosystem's capacity to provide services. The ecosystem services most frequently perceived by people were regulating services; of those, air purification held the greatest importance. However, statistical analysis showed that socio-cultural factors and the conservation management strategy of ecosystems (i.e., National Park, Natural Park, or a non-protected area) have an effect on social preferences toward ecosystem services. Ecosystem service trade-offs and bundles were identified by analyzing social preferences through multivariate analysis (redundancy analysis and hierarchical cluster analysis). We found a clear trade-off among provisioning services (and recreational hunting) versus regulating services and almost all cultural services. We identified three ecosystem service bundles associated with the conservation management strategy and the rural-urban gradient. We conclude that socio-cultural preferences toward ecosystem services can serve as a tool to identify relevant services for people, the factors underlying these social preferences, and emerging ecosystem service bundles and trade-offs.	[Martin-Lopez, Berta; Iniesta-Arandia, Irene; Garcia-Llorente, Marina; Palomo, Ignacio; Garcia Del Amo, David; Gomez-Baggethun, Erik; Oteros-Rozas, Elisa; Gonzalez, Jose A.; Santos-Martin, Fernando; Lopez-Santiago, Cesar; Montes, Carlos] Univ Autonoma Madrid, Dept Ecol, Social Ecol Syst Lab, Madrid, Spain; [Iniesta-Arandia, Irene] Univ Almeria, Dept Plant Biol & Ecol, Almeria, Spain; [Casado-Arzuaga, Izaskun; Palacios-Agundez, Igone; Onaindia, Miren] Univ Pais Vasco UPV EHU, Plant Biol & Ecol Dept, Bizkaia, Spain; [Gomez-Baggethun, Erik] Univ Autonoma Barcelona, Inst Environm Sci & Technol, Fac Sci, Bellaterra, Spain; [Willaarts, Barbara] Univ Politecn Madrid, Res Ctr Management Agr & Environm Risks CEIGRAM, Madrid, Spain	Autonomous University of Madrid; Universidad de Almeria; University of Basque Country; Autonomous University of Barcelona; Universidad Politecnica de Madrid	Martin-Lopez, B (corresponding author), Univ Autonoma Madrid, Dept Ecol, Social Ecol Syst Lab, Madrid, Spain.	berta.martin@uam.es	Oteros-Rozas, Elisa/L-8633-2014; Montes, Carlos/M-1449-2014; Martin-Lopez, Berta/R-9397-2017; González, José/K-1321-2014; Iniesta-Arandia, Irene/B-4528-2017; García-Llorente, Marina/L-3550-2014; López-Santiago, Cesar A./D-8528-2011; Llorente, Marina Garcia/P-1644-2017; López-Santiago, Cesar Agustin/P-7786-2019; GARCIA, MARINA/AAH-8893-2019; Garcia del Amo, David/GXM-6035-2022; PALOMO, IGNACIO/D-4398-2014; Palacios-Agundez, Igone/L-5084-2014; Onaindia, Miren/L-7082-2014	Oteros-Rozas, Elisa/0000-0003-4313-3041; Montes, Carlos/0000-0001-9280-2083; Martin-Lopez, Berta/0000-0003-2622-0135; González, José/0000-0001-5917-9314; Iniesta-Arandia, Irene/0000-0002-1304-3232; García-Llorente, Marina/0000-0002-3527-9318; López-Santiago, Cesar A./0000-0003-3681-1529; Llorente, Marina Garcia/0000-0002-3527-9318; López-Santiago, Cesar Agustin/0000-0003-3681-1529; GARCIA, MARINA/0000-0002-3527-9318; PALOMO, IGNACIO/0000-0002-4573-5989; Palacios-Agundez, Igone/0000-0001-9683-6977; Onaindia, Miren/0000-0003-1040-0131; Santos Martin, Fernando/0000-0002-2301-5876; Willaarts, Barbara Anna/0000-0001-6589-1543; Garcia del Amo, David/0000-0002-0598-5465	Department of Innovation, Science, and Enterprise of Andalusian Government [P08-RNM-03945]; Ministry of the Environment and Rural and Marine Affairs of Spain [018/2009, 079/RN08/02.1]; Department of Education, University and Research of the Basque Government [BFI09.231]; Environment Department of the Regional Government of Bizkaia; Biodiversity Foundation	Department of Innovation, Science, and Enterprise of Andalusian Government; Ministry of the Environment and Rural and Marine Affairs of Spain; Department of Education, University and Research of the Basque Government; Environment Department of the Regional Government of Bizkaia; Biodiversity Foundation	Funding for the Andalusian case studies came from the Department of Innovation, Science, and Enterprise of Andalusian Government (project P08-RNM-03945) and the Ministry of the Environment and Rural and Marine Affairs of Spain (project 018/2009). The study of the Conquense Drove Road was funded by the Ministry of the Environment and Rural and Marine Affairs of Spain (project #079/RN08/02.1). The Bilbao Metropolitan Greenbelt study was funded by the Department of Education, University and Research of the Basque Government through the doctoral grant received by I. Casado-Arzuaga (BFI09.231), and the Environment Department of the Regional Government of Bizkaia through the project "Millennium Ecosystem Assessment in Bizkaia.'' This paper was further supported by the Biodiversity Foundation through the Spanish Millennium Ecosystem Assessment project (http://www.ecomilenio.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbenyega O, 2009, LAND USE POLICY, V26, P551, DOI 10.1016/j.landusepol.2008.08.011; Anton C, 2010, BIODIVERS CONSERV, V19, P2979, DOI 10.1007/s10531-010-9853-6; Arnaez J, 2011, LAND DEGRAD DEV, V22, P537, DOI 10.1002/ldr.1032; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Blondel J, 2010, MEDITERRANEAN REGION; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; BROWN TC, 1984, LAND ECON, V60, P231, DOI 10.2307/3146184; Bryan BA, 2010, LANDSCAPE URBAN PLAN, V97, P111, DOI 10.1016/j.landurbplan.2010.05.002; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Burham K. P., 2002, MODEL SELECTION MULT; Butzer KW, 2005, J ARCHAEOL SCI, V32, P1773, DOI 10.1016/j.jas.2005.06.001; Calvet-Mir L, 2012, ECOL ECON, V74, P153, DOI 10.1016/j.ecolecon.2011.12.011; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Castro AJ, 2011, J ARID ENVIRON, V75, P1201, DOI 10.1016/j.jaridenv.2011.05.013; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Chiu SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021837; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; de Groot R, 2006, LANDSCAPE URBAN PLAN, V75, P175, DOI 10.1016/j.landurbplan.2005.02.016; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dietz T, 2002, SOC SCI QUART, V83, P353, DOI 10.1111/1540-6237.00088; Fagerholm N, 2012, ECOL INDIC, V18, P421, DOI 10.1016/j.ecolind.2011.12.004; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Folke C, 1997, AMBIO, V26, P167; Folke C, 2006, CONSERV BIOL, V20, P686, DOI 10.1111/j.1523-1739.2006.00446.x; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Garcia-Llorente M, 2011, ECOL APPL, V21, P3083, DOI 10.1890/10-1744.1; Garcia-Llorente M, 2011, ENVIRON SCI POLICY, V14, P76, DOI 10.1016/j.envsci.2010.11.004; Gomez-Baggethun E, 2010, CONSERV BIOL, V24, P721, DOI 10.1111/j.1523-1739.2009.01401.x; Gonzalez C, 2009, ECOL SOC, V14; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Gutman P, 2007, ECOL ECON, V62, P383, DOI 10.1016/j.ecolecon.2007.02.027; Hartter J, 2010, SOC NATUR RESOUR, V23, P207, DOI 10.1080/08941920903360372; Iftekhar M. S., 2008, Wetlands Ecology and Management, V16, P119, DOI 10.1007/s11273-007-9060-8; Kim KS, 2007, TRANSPORT RES D-TR E, V12, P275, DOI 10.1016/j.trd.2007.03.002; Kroll F, 2012, LAND USE POLICY, V29, P521, DOI 10.1016/j.landusepol.2011.07.008; Kumar M, 2008, ECOL ECON, V64, P808, DOI 10.1016/j.ecolecon.2007.05.008; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; Lamarque P, 2011, CR BIOL, V334, P441, DOI 10.1016/j.crvi.2010.11.007; Lewan L, 2002, ECOL ECON, V42, P459, DOI 10.1016/S0921-8009(02)00127-1; Luck GW, 2009, BIOSCIENCE, V59, P223, DOI 10.1525/bio.2009.59.3.7; Martin-Lopez B, 2007, ENVIRON CONSERV, V34, P215, DOI 10.1017/S0376892907004067; Martin-Lopez B, 2011, ECOL ECON, V70, P1481, DOI 10.1016/j.ecolecon.2011.03.009; Martino D, 2008, ENVIRON MANAGE, V41, P654, DOI 10.1007/s00267-008-9069-7; McDonald R., 2009, J CONSERVAT PLANN, V5, P1; Menzel S, 2010, CONSERV BIOL, V24, P907, DOI 10.1111/j.1523-1739.2009.01347.x; Millennium Ecosystem Assessment (MA), 2005, EC HUM WELL SYNTH; Millennium Ecosystem Assessment of Spain, 2011, MILL EC ASS SPAIN EM; Ministerio de Medio Ambiente y Medio Rural y Marino, 2011, DIAGN LGUALD GEN MED; Observatorio de la Sostenibilidad en Espana, 2011, SOST ESP 2010; Paetzold A, 2010, ECOL COMPLEX, V7, P273, DOI 10.1016/j.ecocom.2009.11.003; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Pfeiffer Jeanine M., 2005, Journal of Ethnobiology, V25, P240, DOI 10.2993/0278-0771(2005)25[240:ACAEVI]2.0.CO;2; Phillipson J, 2009, J APPL ECOL, V46, P261, DOI 10.1111/j.1365-2664.2009.01625.x; Pilgrim S, 2007, ECOL APPL, V17, P1742, DOI 10.1890/06-1358.1; Pyke CR, 2007, ECOL SOC, V12; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reyes-Garcia V, 2010, ECON BOT, V64, P235, DOI 10.1007/s12231-010-9124-1; Rodriguez JP, 2006, ECOL SOC, V11; Ronnback P, 2007, ENVIRON CONSERV, V34, P313, DOI 10.1017/S0376892907004225; Schneiders A, 2012, ECOL INDIC, V21, P123, DOI 10.1016/j.ecolind.2011.06.021; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P1175, DOI 10.1007/s10531-009-9745-9; Tengo M, 2004, ECOL SOC, V9; The Economics of Ecosystems and Biodiversity (TEEB), 2010, EC EC BIOD EC EC FDN; Vihervaara P, 2010, AMBIO, V39, P314, DOI 10.1007/s13280-010-0048-x; Vilardy SP, 2011, HYDROLOG SCI J, V56, P1423, DOI 10.1080/02626667.2011.631497; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warren-Rhodes K, 2011, ENVIRON CONSERV, V38, P485, DOI 10.1017/S0376892911000373; Zelezny LC, 2000, J SOC ISSUES, V56, P443, DOI 10.1111/0022-4537.00177; Zhen L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015001	74	583	615	35	483	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38970	10.1371/journal.pone.0038970	http://dx.doi.org/10.1371/journal.pone.0038970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22720006	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305583300073
J	Na, YS; Yang, SJ; Kim, SM; Jung, KA; Moon, JH; Shin, JS; Yoon, DH; Hong, YS; Ryu, MH; Lee, JL; Lee, JS; Kim, TW				Na, Young-Soon; Yang, Soo-Jin; Kim, Seung-Mi; Jung, Kyung-Ah; Moon, Jai-Hee; Shin, Jae-Sik; Yoon, Dok Hyun; Hong, Yong Sang; Ryu, Min-Hee; Lee, Jae-Lyun; Lee, Jung Shin; Kim, Tae Won			YM155 Induces EGFR Suppression in Pancreatic Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MOLECULE SURVIVIN SUPPRESSANT; PROTEIN-KINASE; NUCLEAR TRANSLOCATION; INHIBITS APOPTOSIS; SIGNALING PATHWAYS; ANTITUMOR-ACTIVITY; TARGETED THERAPY; DRUG DISCOVERY; LUNG-CANCER	YM155, which inhibits the anti-apoptotic protein survivin, is known to exert anti-tumor effects in various cancers, including prostate and lung cancer. However, there are few reports describing the inhibitory effect of YM155 on human pancreatic cancers that highly express survivin. Here, we tested the effects of YM155 on a variety of cancer cell lines, including pancreatic cancer cells. We found that YM155 exerts an anti-proliferative effect in pancreatic cancer cells, inducing cell death through suppression of XIAP (X-linked inhibitor of apoptosis) as well as survivin without affecting the anti-apoptotic proteins Bcl-xL or Mcl-1. YM155 also inhibited tumor growth in vivo, reducing the size of pancreatic cancer cell line MIAPaCa-2 xenografts by 77.1% on day 31. Western blot analyses further showed that YM155 downregulated phosphoinoside 3-kinase (PI3K) expression and reduced the levels of phosphorylated (activated) extracellular signal-regulated kinase (ERK) and STAT3 (signal transducer and activator of transcription 3) in PANC-1 cells. Interestingly, we also found that YM155 downregulated the epidermal growth factor receptor (EGFR) in various cancer cell lines and induced the EGFR phosphorylation and ubiquitination of EGFR in PANC-1 cells. YM155 also modestly promoted the ubiquitination of survivin and XIAP. Therefore, YM155 acts through modulation of EGFR and survivin expression to subsequently reduce survival. We suggest that YM155 has potential as a therapeutic agent in the treatment of pancreatic cancer.	[Na, Young-Soon; Yang, Soo-Jin; Kim, Seung-Mi; Jung, Kyung-Ah; Moon, Jai-Hee; Shin, Jae-Sik; Hong, Yong Sang; Lee, Jae-Lyun; Lee, Jung Shin; Kim, Tae Won] Asan Med Ctr, Inst Innovate Canc Res, Seoul, South Korea; [Yoon, Dok Hyun; Hong, Yong Sang; Ryu, Min-Hee; Lee, Jae-Lyun; Lee, Jung Shin; Kim, Tae Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Na, YS (corresponding author), Asan Med Ctr, Inst Innovate Canc Res, Seoul, South Korea.	twkimmd@amc.seoul.kr			Ministry of Health, Welfare, and Family Affairs, Republic of Korea [A062254]	Ministry of Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Korea Health 21 R&D Project, Ministry of Health, Welfare, and Family Affairs, Republic of Korea (A062254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan A, 2010, CANCER RES, V70, P2862, DOI 10.1158/0008-5472.CAN-09-4294; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Asanuma H, 2005, CANCER RES, V65, P11018, DOI 10.1158/0008-5472.CAN-05-0491; Asanuma K, 2000, JPN J CANCER RES, V91, P1204, DOI 10.1111/j.1349-7006.2000.tb00906.x; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bondar VM, 2002, MOL CANCER THER, V1, P989; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Iwasa T, 2010, BRIT J CANCER, V103, P36, DOI 10.1038/sj.bjc.6605713; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Kim HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005933; Kleespies A, 2006, DRUG RESIST UPDATE, V9, P1, DOI 10.1016/j.drup.2006.02.002; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lewis KD, 2011, INVEST NEW DRUG, V29, P161, DOI 10.1007/s10637-009-9333-6; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakahara T, 2011, ANTI-CANCER DRUG, V22, P454, DOI 10.1097/CAD.0b013e328344ac68; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pangburn HA, 2010, CANCER PREV RES, V3, P560, DOI 10.1158/1940-6207.CAPR-09-0159; Qiao JG, 2004, WORLD J GASTROENTERO, V10, P2759, DOI 10.3748/wjg.v10.i18.2759; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Siddiqa A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-129; Tang HK, 2011, BIOCHEM PHARMACOL, V82, P1066, DOI 10.1016/j.bcp.2011.07.064; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Xiong HQ, 2002, SEMIN ONCOL, V29, P31, DOI 10.1053/sonc.2002.35645; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001	41	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38625	10.1371/journal.pone.0038625	http://dx.doi.org/10.1371/journal.pone.0038625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723871	gold, Green Submitted, Green Published			2022-12-25	WOS:000305583300035
J	Ekoff, M; Lyberg, K; Krajewska, M; Arvidsson, M; Rak, S; Reed, JC; Harvima, I; Nilsson, G				Ekoff, Maria; Lyberg, Katarina; Krajewska, Maryla; Arvidsson, Monica; Rak, Sabina; Reed, John C.; Harvima, Ilkka; Nilsson, Gunnar			Anti-Apoptotic Bfl-1 Is the Major Effector in Activation-Induced Human Mast Cell Survival	PLOS ONE			English	Article							IGE-RECEPTOR ACTIVATION; BCL-2 FAMILY-MEMBER; FC-GAMMA-RI; SELICICLIB CYC202; PROMOTES SURVIVAL; MULTIPLE-MYELOMA; DOWN-REGULATION; TNF-ALPHA; EXPRESSION; DEGRANULATION	Mast cells are best known for their role in allergic reactions, where aggregation of FceRI leads to the release of mast cell mediators causing allergic symptoms. The activation also induces a survival program in the cells, i.e., activation-induced mast cell survival. The aim of the present study was to investigate how the activation-induced survival is mediated. Cord blood-derived mast cells and the mast cell line LAD-2 were activated through FceRI crosslinking, with or without addition of chemicals that inhibit the activity or expression of selected Bcl-2 family members (ABT-737; roscovitine). Cell viability was assessed using staining and flow cytometry. The expression and function of Bcl-2 family members BFL-1 and MCL-1 were investigated using real-time quantitative PCR and siRNA treatment. The mast cell expression of Bfl-1 was investigated in skin biopsies. FceRI crosslinking promotes activation-induced survival of human mast cells and this is associated with an upregulation of the anti-apoptotic Bcl-2 family member Bfl-1. ABT-737 alone or in combination with roscovitine decreases viability of human mast cells although activation-induced survival is sustained, indicating a minor role for Bcl-X-L, Bcl-2, Bcl-w and Mcl-1. Reducing BFL-1 but not MCL-1 levels by siRNA inhibited activation-induced mast cell survival. We also demonstrate that mast cell expression of Bfl-1 is elevated in birch-pollen-provocated skin and in lesions of atopic dermatitis and psoriasis patients. Taken together, our results highlight Bfl-1 as a major effector in activation-induced human mast cell survival.	[Ekoff, Maria; Lyberg, Katarina; Nilsson, Gunnar] Karolinska Inst, Ctr Allergy Res, Dept Med, Stockholm, Sweden; [Krajewska, Maryla; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Arvidsson, Monica; Rak, Sabina] Sahlgrens Univ Hosp, Dept Resp Med & Allergol, Gothenburg, Sweden; [Harvima, Ilkka] Kuopio Univ Hosp, Dept Dermatol, SF-70210 Kuopio, Finland; [Harvima, Ilkka] Univ Eastern Finland, Kuopio, Finland	Karolinska Institutet; Sanford Burnham Prebys Medical Discovery Institute; Sahlgrenska University Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Ekoff, M (corresponding author), Karolinska Inst, Ctr Allergy Res, Dept Med, Stockholm, Sweden.	maria.ekoff@ki.se		Lyberg, Katarina/0000-0003-3507-7983; Nilsson, Gunnar/0000-0001-6795-5512	Swedish Research Council-Medicine; Centre for Allergy Research at Karolinska Institutet; Swedish Heart Lung Foundation; Ellen, Walter and Lennart Hesselmans foundation for scientific research; Ollie and Elof Ericsson's foundation; King Gustav V's 80-years foundation, Sweden; Kuopio University Hospital; Abbot, Finland	Swedish Research Council-Medicine(Swedish Research Council); Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Ellen, Walter and Lennart Hesselmans foundation for scientific research; Ollie and Elof Ericsson's foundation; King Gustav V's 80-years foundation, Sweden; Kuopio University Hospital; Abbot, Finland	This study was supported by grants from the Swedish Research Council-Medicine, the Centre for Allergy Research at Karolinska Institutet, the Swedish Heart Lung Foundation, the Swedish Cancer Society, Ellen, Walter and Lennart Hesselmans foundation for scientific research, Ollie and Elof Ericsson's foundation, King Gustav V's 80-years foundation, Sweden, Kuopio University Hospital and Abbot, Finland. The authors also acknowledge support from the COST Action BM1007 (Mast cells and basophils - targets for innovative therapies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann L, 1998, ARCH DERMATOL RES, V290, P353, DOI 10.1007/s004030050317; Alfredsson J, 2006, SCAND J IMMUNOL, V63, P1, DOI 10.1111/j.1365-3083.2006.01704.x; Alfredsson J, 2005, CELL DEATH DIFFER, V12, P136, DOI 10.1038/sj.cdd.4401537; BARKER JNWN, 1991, LANCET, V338, P227, DOI 10.1016/0140-6736(91)90357-U; Berent-Maoz B, 2008, ALLERGY, V63, P333, DOI 10.1111/j.1398-9995.2007.01598.x; Diaconu NC, 2007, CANCER IMMUNOL IMMUN, V56, P1407, DOI 10.1007/s00262-007-0290-7; DVORAK AM, 1987, CELL IMMUNOL, V105, P199, DOI 10.1016/0008-8749(87)90068-2; Fischer M, 2006, J CLIN INVEST, V116, P2748, DOI 10.1172/JCI24274; Galli SJ, 2000, CURR BIOL, V10, pR93, DOI 10.1016/S0960-9822(00)00322-5; Ishizaka T, 1984, MAST CELL ACTIVATION, P188; Karlberg M, 2008, J CLIN IMMUNOL, V28, P250, DOI 10.1007/s10875-007-9153-4; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kitaura J, 2004, J IMMUNOL, V173, P4317, DOI 10.4049/jimmunol.173.7.4317; KOBAYASI T, 1969, ACTA DERM-VENEREOL, V49, P369; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Moller C, 2003, CLIN EXP ALLERGY, V33, P1135, DOI 10.1046/j.1365-2222.2003.01728.x; Nilsson G, 1996, IMMUNOLOGY, V88, P308, DOI 10.1111/j.1365-2567.1996.tb00020.x; NILSSON G, 1999, INFLAMMATION BASIC P, P97; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ortiz-Ferron G, 2008, CELL RES, V18, P664, DOI 10.1038/cr.2008.54; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; SAITO H, 1995, INT ARCH ALLERGY IMM, V107, P63, DOI 10.1159/000236932; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Tkaczyk C, 2002, MOL IMMUNOL, V38, P1289, DOI 10.1016/S0161-5890(02)00077-9; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Xiang Z, 2006, ALLERGY, V61, P1040, DOI 10.1111/j.1398-9995.2006.01024.x; Xiang Z, 2001, J EXP MED, V194, P1561, DOI 10.1084/jem.194.11.1561; Yoshikawa H, 1999, J IMMUNOL, V162, P6162	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39117	10.1371/journal.pone.0039117	http://dx.doi.org/10.1371/journal.pone.0039117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720045	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350000041
J	Faerch, K; Bergman, B; Perreault, L				Faerch, Kristine; Bergman, Bryan; Perreault, Leigh			Does Insulin Resistance Drive the Association between Hyperglycemia and Cardiovascular Risk?	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; ALL-CAUSE; MORTALITY; PIOGLITAZONE; EVENTS; COMPLICATIONS; PROGRESSION; PREVENTION; FRAMINGHAM	Background: Several studies have shown associations between hyperglycemia and risk of cardiovascular disease (CVD) and mortality, yet glucose-lowering treatment does little to mitigate this risk. We examined whether associations between hyperglycemia and CVD risk were explained by underlying insulin resistance. Methods: In 60 middle-aged individuals without diabetes we studied the associations of fasting plasma glucose, 2-hour post oral glucose tolerance test plasma glucose, insulin sensitivity as well as body fat percentage with CVD risk. Insulin sensitivity was measured as the glucose infusion rate during a euglycemic hyperinsulinemic clamp, body fat percentage was measured by dual X-ray absorptiometry, and CVD risk was estimated using the Framingham risk score. Associations of fasting plasma glucose, 2-hour plasma glucose, insulin sensitivity and body fat percentage with the Framingham risk score were assessed in linear regression models. Results: Both fasting and 2-hour plasma glucose levels were associated with higher Framingham risk score (fasting glucose: r(2) = 0.21; 2-hour glucose: r(2) = 0.24; P<0.001 for both), and insulin sensitivity with lower Framingham risk score (r(2) = 0.36; P<0.001). However, adjustment for insulin sensitivity and 2-hour glucose made the effect of fasting glucose non-significant (P = 0.060). Likewise, when adjusting for insulin sensitivity and fasting glucose, the association between 2-hour glucose and Framingham risk score disappeared (P = 0.143). In contrast, insulin sensitivity was still associated with Framingham risk score after adjusting for glucose levels (P<0.001). Body fat was not associated with Framingham risk score when taking insulin sensitivity into account (P = 0.550). Conclusion: The association between plasma glucose levels and CVD risk is mainly explained by insulin resistance, which raises the question of whether glucose lowering per se without changes in the processes that underlie hyperglycemia should be the sole clinical paradigm in the treatment of type 2 diabetes or its prevention.	[Faerch, Kristine] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Bergman, Bryan; Perreault, Leigh] Univ Colorado, Aurora, CO USA	Steno Diabetes Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Faerch, K (corresponding author), Steno Diabet Ctr, DK-2820 Gentofte, Denmark.	krif@steno.dk	Bergman, Bryan/T-8055-2019	Faerch, Kristine/0000-0002-6127-0448; Bergman, Bryan/0000-0002-9561-1052	National Institutes of Health [DK064811, DK059739, RR00036]; Fonden til Laegevidenskabens Fremme; Novo Nordisk Foundation; Novo Nordisk A/S; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK064811, F32DK059739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonden til Laegevidenskabens Fremme; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk A/S(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The National Institutes of Health (DK064811, DK059739, RR00036) and Fonden til Laegevidenskabens Fremme funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors have read the journal's policy and have the following conflicts: KF is employed by Steno Diabetes Center A/S, a research hospital working in the Danish National Health Service and which is owned by Novo Nordisk A/S. Steno Diabetes Center A/S receives part of its core funding from unrestricted grants from the Novo Nordisk Foundation and Novo Nordisk A/S. K. F. owns shares in Novo Nordisk A/S. No other potential conflicts of interest relevant to this article were reported. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Chamnan P, 2009, DIABETOLOGIA, V52, P2001, DOI 10.1007/s00125-009-1454-0; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Faerch K, 2009, DIABETOLOGIA, V52, P1714, DOI 10.1007/s00125-009-1443-3; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goldberg RB, 2009, DIABETES CARE, V32, P726, DOI 10.2337/dc08-0494; Haffner SM, 2000, CIRCULATION, V101, P975, DOI 10.1161/01.CIR.101.9.975; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hills SA, 2004, DIABETOLOGIA, V47, P566, DOI 10.1007/s00125-004-1335-5; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kengne AP, 2010, DIABETOLOGIA, V53, P821, DOI 10.1007/s00125-010-1681-4; Kodama S, 2012, J ATHEROSCLER THROMB; Linton MF, 2003, AM J CARDIOL, V92, p19I, DOI 10.1016/S0002-9149(03)00505-8; Neiberg RH, 2012, OBESITY, V20, P2048, DOI 10.1038/oby.2012.33; Ning F, 2010, DIABETES CARE, V33, P2211, DOI 10.2337/dc09-2328; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Perreault L, 2004, J APPL PHYSIOL, V97, P1013, DOI 10.1152/japplphysiol.00186.2004; Perreault L, 2008, AM J PHYSIOL-ENDOC M, V295, pE428, DOI 10.1152/ajpendo.90354.2008; Ray KK, 2009, NAT REV ENDOCRINOL, V5, P302, DOI 10.1038/nrendo.2009.100; Reddigan JI, 2012, DIABETOLOGIA, V55, P632, DOI 10.1007/s00125-011-2374-3; Smith NL, 2002, ARCH INTERN MED, V162, P209, DOI 10.1001/archinte.162.2.209; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Zoungas S, 2009, DIABETES CARE, V32, P2068, DOI 10.2337/dc09-0959	31	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39260	10.1371/journal.pone.0039260	http://dx.doi.org/10.1371/journal.pone.0039260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720085	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350000054
J	Hansen, S; Vulic, M; Min, JK; Yen, TJ; Schumacher, MA; Brennan, RG; Lewis, K				Hansen, Sonja; Vulic, Marin; Min, Jungki; Yen, Tien-Jui; Schumacher, Maria A.; Brennan, Richard G.; Lewis, Kim			Regulation of the Escherichia coli HipBA Toxin-Antitoxin System by Proteolysis	PLOS ONE			English	Article							BACTERIAL PERSISTENCE; MULTIDRUG TOLERANCE; CRYSTAL-STRUCTURE; STRESS-RESPONSE; INORGANIC POLYPHOSPHATE; PSEUDOMONAS-AERUGINOSA; DEPENDENT PROTEASE; AFFECTS LETHALITY; AFFECTS FREQUENCY; MUREIN SYNTHESIS	Bacterial populations produce antibiotic-tolerant persister cells. A number of recent studies point to the involvement of toxin/antitoxin (TA) modules in persister formation. hipBA is a type II TA module that codes for the HipB antitoxin and the HipA toxin. HipA is an EF-Tu kinase, which causes protein synthesis inhibition and dormancy upon phosphorylation of its substrate. Antitoxins are labile proteins that are degraded by one of the cytosolic ATP-dependent proteases. We followed the rate of HipB degradation in different protease deficient strains and found that HipB was stabilized in a lon(-) background. These findings were confirmed in an in vitro degradation assay, showing that Lon is the main protease responsible for HipB proteolysis. Moreover, we demonstrated that degradation of HipB is dependent on the presence of an unstructured carboxy-terminal stretch of HipB that encompasses the last 16 amino acid residues. Further, substitution of the conserved carboxy-terminal tryptophan of HipB to alanine or even the complete removal of this 16 residue fragment did not alter the affinity of HipB for hipBA operator DNA or for HipA indicating that the major role of this region of HipB is to control HipB degradation and hence HipA-mediated persistence.	[Hansen, Sonja; Vulic, Marin; Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA; [Min, Jungki; Yen, Tien-Jui; Schumacher, Maria A.; Brennan, Richard G.] Duke Univ, Sch Med, Dept Biochem, Durham, NC USA	Northeastern University; Duke University	Hansen, S (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu	Yen, Tien-Jui/AGF-8092-2022	Brennan, Richard/0000-0001-7647-485X; Min, Jungki/0000-0003-1860-3064	National Institutes of Health [R01 GM061162]; Robert A. Welch Foundation [G-0040]; MD Anderson Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); MD Anderson Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM061162 (to KL), the Robert A. Welch Foundation grant G-0040 (to RGB), and MD Anderson Fellowship (to MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brooun A, 2000, ANTIMICROB AGENTS CH, V44, P640, DOI 10.1128/AAC.44.3.640-646.2000; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; CHARETTE MF, 1981, P NATL ACAD SCI-BIOL, V78, P4728, DOI 10.1073/pnas.78.8.4728; Cherny I, 2007, BIOCHEMISTRY-US, V46, P12152, DOI 10.1021/bi701037e; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Evdokimov A, 2009, ACTA CRYSTALLOGR D, V65, P875, DOI 10.1107/S0907444909018800; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; HANSEN S, 2008, ANTIMICROB AGENTS CH; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Langklotz S, 2011, MOL MICROBIOL, V80, P1313, DOI 10.1111/j.1365-2958.2011.07646.x; Lewis K., 2010, ANN REV MICROBIOL; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maisonneuve E, 2011, P NATL ACAD SCI US; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nomura K, 2004, J BIOL CHEM, V279, P34406, DOI 10.1074/jbc.M404725200; Ojangu EL, 2000, J BACTERIOL, V182, P6707, DOI 10.1128/JB.182.23.6707-6713.2000; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pruteanu M, 2007, J BACTERIOL, V189, P3017, DOI 10.1128/JB.01531-06; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; SCHERRER R, 1988, J BACTERIOL, V170, P3321, DOI 10.1128/jb.170.8.3321-3326.1988; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	59	63	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39185	10.1371/journal.pone.0039185	http://dx.doi.org/10.1371/journal.pone.0039185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720069	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350000047
J	Bierne, H; Travier, L; Mahlakoiv, T; Tailleux, L; Subtil, A; Lebreton, A; Paliwal, A; Gicquel, B; Staeheli, P; Lecuit, M; Cossart, P				Bierne, Helene; Travier, Laetitia; Mahlakoiv, Tanel; Tailleux, Ludovic; Subtil, Agathe; Lebreton, Alice; Paliwal, Anupam; Gicquel, Brigitte; Staeheli, Peter; Lecuit, Marc; Cossart, Pascale			Activation of Type III Interferon Genes by Pathogenic Bacteria in Infected Epithelial Cells and Mouse Placenta	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS RHINOSINUSITIS; LISTERIA-MONOCYTOGENES; MYCOBACTERIUM-TUBERCULOSIS; LAMBDA-INTERFERONS; SHIGELLA-FLEXNERI; DENDRITIC CELLS; VIRUS-INFECTION; IN-VIVO; EXPRESSION; VIRULENCE	Bacterial infections trigger the expression of type I and II interferon genes but little is known about their effect on type III interferon (IFN-lambda) genes, whose products play important roles in epithelial innate immunity against viruses. Here, we studied the expression of IFN-lambda genes in cultured human epithelial cells infected with different pathogenic bacteria and in the mouse placenta infected with Listeria monocytogenes. We first showed that in intestinal LoVo cells, induction of IFN-lambda genes by L. monocytogenes required bacterial entry and increased further during the bacterial intracellular phase of infection. Other Gram-positive bacteria, Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis, also induced IFN-lambda genes when internalized by LoVo cells. In contrast, Gram-negative bacteria Salmonella enterica serovar Typhimurium, Shigella flexneri and Chlamydia trachomatis did not substantially induce IFN-lambda. We also found that IFN-lambda genes were up-regulated in A549 lung epithelial cells infected with Mycobacterium tuberculosis and in HepG2 hepatocytes and BeWo trophoblastic cells infected with L. monocytogenes. In a humanized mouse line permissive to fetoplacental listeriosis, IFN-lambda 2/lambda 3 mRNA levels were enhanced in placentas infected with L. monocytogenes. In addition, the feto-placental tissue was responsive to IFN-lambda 2. Together, these results suggest that IFN-lambda may be an important modulator of the immune response to Gram-positive intracellular bacteria in epithelial tissues.	[Bierne, Helene; Lebreton, Alice; Paliwal, Anupam; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France; [Bierne, Helene; Lebreton, Alice; Paliwal, Anupam; Cossart, Pascale] INSERM, U604, Paris, France; [Bierne, Helene; Lebreton, Alice; Paliwal, Anupam; Cossart, Pascale] INRA, USC2020, Paris, France; [Travier, Laetitia; Lecuit, Marc] Inst Pasteur, Grp Microorganismes & Barriere Hote, Paris, France; [Travier, Laetitia; Lecuit, Marc] INSERM, Avenir U604, Paris, France; [Mahlakoiv, Tanel; Staeheli, Peter] Univ Freiburg, Dept Virol, D-79106 Freiburg, Germany; [Mahlakoiv, Tanel] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Tailleux, Ludovic; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Subtil, Agathe] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France; [Lecuit, Marc] Univ Paris 05, Hop Necker Enfants Malades, Serv Malad Infect & Trop, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Freiburg; University of Freiburg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bierne, H (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, Paris, France.	hbierne@pasteur.fr	Lecuit, Marc/M-4126-2019; Lebreton, Alice/M-8764-2015; Subtil, Agathe/C-7464-2017; Lecuit, Marc/J-4073-2013	Lecuit, Marc/0000-0002-4491-1063; Lebreton, Alice/0000-0002-6643-902X; Subtil, Agathe/0000-0002-7481-4846; Lecuit, Marc/0000-0002-4491-1063; Mahlakoiv, Tanel/0000-0001-9059-0486; Bierne, Helene/0000-0002-0525-0848; Tailleux, Ludovic/0000-0003-3931-1052	Institut Pasteur; Institut National de la Recherche Agronomique (AO blanc, MICA); Institut National de la Sante et de la Recherche Medicale; French National Research Agency [ANR 11 BSV3 003 01, EPILIS]; ERA-NET (Listress); French Ligue Nationale Contre le Cancer [LNCC RS10/75-76]; La Fondation Le Roch-Les Mousquetaires; Deutsche Forschungsgemeinschaft [SFB 620]	Institut Pasteur(European Commission); Institut National de la Recherche Agronomique (AO blanc, MICA); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency(French National Research Agency (ANR)); ERA-NET (Listress); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); La Fondation Le Roch-Les Mousquetaires; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Institut Pasteur, Institut National de la Recherche Agronomique (AO blanc 2011, MICA), Institut National de la Sante et de la Recherche Medicale, the French National Research Agency (ANR 11 BSV3 003 01, EPILIS), ERA-NET (Listress), the French Ligue Nationale Contre le Cancer (LNCC RS10/75-76), La Fondation Le Roch-Les Mousquetaires, and the Deutsche Forschungsgemeinschaft (SFB 620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Aubry C, 2011, J INFECT DIS, V204, P731, DOI 10.1093/infdis/jir396; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Gallagher G, 2010, J INTERF CYTOK RES, V30, P603, DOI 10.1089/jir.2010.0081; Hamon M, 2012, TRENDS MICR IN PRESS; He SH, 2011, GASTROENTEROLOGY, V141, P249, DOI 10.1053/j.gastro.2011.04.006; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Hess BJ, 2003, J SURG RES, V114, P42, DOI 10.1016/S0022-4804(03)00314-7; Hessle CC, 2005, CYTOKINE, V30, P311, DOI 10.1016/j.cyto.2004.05.008; Iversen MB, 2010, J INTERF CYTOK RES, V30, P573, DOI 10.1089/jir.2010.0063; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Lebreton A, 2012, VIRULENCE, V3, P87, DOI 10.4161/viru.3.1.18531; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Li Xianglu, 2009, Int J Microbiol, V2009, P753278, DOI 10.1155/2009/753278; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Nagarajan UM, 2011, CRIT REV IMMUNOL, V31, P459, DOI 10.1615/CritRevImmunol.v31.i6.20; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; Pietila TE, 2010, J LEUKOCYTE BIOL, V88, P665, DOI 10.1189/jlb.1009651; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Steen HC, 2010, J INTERF CYTOK RES, V30, P597, DOI 10.1089/jir.2010.0058; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Thomson SJP, 2009, P NATL ACAD SCI USA, V106, P11564, DOI 10.1073/pnas.0904477106; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Wolk K, 2010, J INTERF CYTOK RES, V30, P617, DOI 10.1089/jir.2010.0064	60	70	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39080	10.1371/journal.pone.0039080	http://dx.doi.org/10.1371/journal.pone.0039080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720036	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800042
J	Kar, S; Kavdia, M				Kar, Saptarshi; Kavdia, Mahendra			Local Oxidative and Nitrosative Stress Increases in the Microcirculation during Leukocytes-Endothelial Cell Interactions	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-TYROSINE NITRATION; CREMASTER MUSCLE ARTERIOLES; COMPUTATIONAL MODEL; MICROVESSEL PERMEABILITY; SUPEROXIDE-DISMUTASE; HUMAN NEUTROPHILS; NADPH OXIDASE; VASCULAR-PERMEABILITY; ISCHEMIA-REPERFUSION	Leukocyte-endothelial cell interactions and leukocyte activation are important factors for vascular diseases including nephropathy, retinopathy and angiopathy. In addition, endothelial cell dysfunction is reported in vascular disease condition. Endothelial dysfunction is characterized by increased superoxide (O-2(center dot-)) production from endothelium and reduction in NO bioavailability. Experimental studies have suggested a possible role for leukocyte-endothelial cell interaction in the vessel NO and peroxynitrite levels and their role in vascular disorders in the arterial side of microcirculation. However, anti-adhesion therapies for preventing leukocyte-endothelial cell interaction related vascular disorders showed limited success. The endothelial dysfunction related changes in vessel NO and peroxynitrite levels, leukocyte-endothelial cell interaction and leukocyte activation are not completely understood in vascular disorders. The objective of this study was to investigate the role of endothelial dysfunction extent, leukocyte-endothelial interaction, leukocyte activation and superoxide dismutase therapy on the transport and interactions of NO, O-2(center dot-) and peroxynitrite in the microcirculation. We developed a biotransport model of NO, O-2(center dot-) and peroxynitrite in the arteriolar microcirculation and incorporated leukocytes-endothelial cell interactions. The concentration profiles of NO, O-2(center dot-) and peroxynitrite within blood vessel and leukocytes are presented at multiple levels of endothelial oxidative stress with leukocyte activation and increased superoxide dismutase accounted for in certain cases. The results showed that the maximum concentrations of NO decreased similar to 0.6 fold, O-2(center dot-) increased similar to 27 fold and peroxynitrite increased similar to 30 fold in the endothelial and smooth muscle region in severe oxidative stress condition as compared to that of normal physiologic conditions. The results show that the onset of endothelial oxidative stress can cause an increase in O-2(center dot-) and peroxynitrite concentration in the lumen. The increased O-2(center dot-) and peroxynitrite can cause leukocytes priming through peroxynitrite and leukocytes activation through secondary stimuli of O-2(center dot-) in bloodstream without endothelial interaction. This finding supports that leukocyte rolling/adhesion and activation are independent events.	[Kar, Saptarshi; Kavdia, Mahendra] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA	Wayne State University	Kar, S (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	s.kar@wayne.edu	Kar, Saptarshi/H-5166-2014	Kar, Saptarshi/0000-0002-3788-372X	National Institute of Health [NIH R01 HL084337]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084337] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institute of Health grant NIH R01 HL084337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Nabah YN, 2005, MICROCIRCULATION, V12, P443, DOI 10.1080/10739680590960962; Adrie C, 2000, AM J PHYSIOL-CELL PH, V279, pC452, DOI 10.1152/ajpcell.2000.279.2.C452; Akamine EH, 2006, J VASC RES, V43, P309, DOI 10.1159/000093196; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BELLAVITE P, 1988, FREE RADICAL BIO MED, V4, P225, DOI 10.1016/0891-5849(88)90044-5; Bertuglia S, 2003, AM J PHYSIOL-HEART C, V285, pH1064, DOI 10.1152/ajpheart.00124.2003; Buerk DG, 2003, FREE RADICAL BIO MED, V34, P1488, DOI 10.1016/S0891-5849(03)00178-3; Casillan AJ, 2003, J APPL PHYSIOL, V94, P2313, DOI 10.1152/japplphysiol.00047.2002; Ceriello A, 1996, DIABETES, V45, P471, DOI 10.2337/diabetes.45.4.471; Chen XW, 2006, J APPL PHYSIOL, V100, P482, DOI 10.1152/japplphysiol.00633.2005; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; COULTER NA, 1949, AM J PHYSIOL, V159, P401, DOI 10.1152/ajplegacy.1949.159.2.401; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Damiano ER, 1996, CIRC RES, V79, P1122, DOI 10.1161/01.RES.79.6.1122; Deonikar P, 2010, MICROVASC RES, V80, P464, DOI 10.1016/j.mvr.2010.09.004; Deonikar P, 2010, ANN BIOMED ENG, V38, P357, DOI 10.1007/s10439-009-9823-x; El-Remessy AB, 2010, EXP DIABETES RES, DOI 10.1155/2010/247861; ELLSWORTH ML, 1988, MICROVASC RES, V35, P341, DOI 10.1016/0026-2862(88)90089-1; Feng L, 2011, J SURG RES, V166, P298, DOI 10.1016/j.jss.2009.04.005; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Frisbee JC, 2001, AM J PHYSIOL-HEART C, V281, pH1304, DOI 10.1152/ajpheart.2001.281.3.H1304; Fuhrman B, 2004, FREE RADICAL BIO MED, V37, P259, DOI 10.1016/j.freeradbiomed.2004.04.026; Gagnon C, 1998, FEBS LETT, V431, P107, DOI 10.1016/S0014-5793(98)00741-8; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; Gujral JS, 2004, AM J PHYSIOL-GASTR L, V287, pG243, DOI 10.1152/ajpgi.00287.2003; Gupte S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011800; Hayashi T, 2007, BBA-MOL BASIS DIS, V1772, P364, DOI 10.1016/j.bbadis.2006.11.011; He PN, 2006, AM J PHYSIOL-HEART C, V291, pH591, DOI 10.1152/ajpheart.01228.2005; He PN, 2010, CARDIOVASC RES, V87, P281, DOI 10.1093/cvr/cvq140; Hink U, 2001, CIRC RES, V88, pE14; Huang J, 2008, J VASC SURG, V47, P599, DOI 10.1016/j.jvs.2007.11.006; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Jariyapongskul A, 2006, CLIN HEMORHEOL MICRO, V34, P283; Jebelovszki E, 2008, AM J PHYSIOL-HEART C, V294, pH2558, DOI 10.1152/ajpheart.01198.2007; Julius U, 2009, EXP CLIN ENDOCR DIAB, V117, P72, DOI 10.1055/s-2008-1078710; Kar S, 2011, FREE RADICAL BIO MED, V51, P1411, DOI 10.1016/j.freeradbiomed.2011.06.009; Kaul DK, 2004, AM J PHYSIOL-HEART C, V287, pH293, DOI 10.1152/ajpheart.01150.2003; Kavdia M, 2006, AM J PHYSIOL-HEART C, V290, pH716, DOI 10.1152/ajpheart.00776.2005; Kavdia M, 2004, J APPL PHYSIOL, V97, P293, DOI 10.1152/japplphysiol.00049.2004; Kavdia M, 2003, MICROVASC RES, V66, P49, DOI 10.1016/S0026-2862(03)00008-6; Kavdia M, 2002, AM J PHYSIOL-HEART C, V282, pH2245, DOI 10.1152/ajpheart.00972.2001; Kavdia M, 2006, ANTIOXID REDOX SIGN, V8, P1103, DOI 10.1089/ars.2006.8.1103; KUBES P, 1990, AM J PHYSIOL, V259, pG859, DOI 10.1152/ajpgi.1990.259.5.G859; Kubes P, 2001, NEWS PHYSIOL SCI, V16, P76; Kunkel EJ, 1997, AM J PHYSIOL-HEART C, V272, pH1391, DOI 10.1152/ajpheart.1997.272.3.H1391; Liu PT, 1998, J PHARMACOL EXP THER, V284, P1139; Lu JJ, 2011, ANTIOXID REDOX SIGN, V15, P2301, DOI 10.1089/ars.2010.3792; Lyczkowski RW, 2009, ANN BIOMED ENG, V37, P1516, DOI 10.1007/s10439-009-9729-7; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Mastej K, 2008, ACTA DIABETOL, V45, P183, DOI 10.1007/s00592-008-0040-0; MUROHARA T, 1994, ARTERIOSCLER THROMB, V14, P1509, DOI 10.1161/01.ATV.14.9.1509; Nagaoka T, 2008, INVEST OPHTH VIS SCI, V49, P2053, DOI 10.1167/iovs.07-1387; Nalwaya N, 2004, J THEOR BIOL, V226, P409, DOI 10.1016/j.jtbi.2003.09.015; Nalwaya N, 2003, CHEM RES TOXICOL, V16, P920, DOI 10.1021/tx025664w; Okamoto E, 2001, CIRCULATION, V104, P2228, DOI 10.1161/hc4301.097195; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paolocci N, 2001, J MOL CELL CARDIOL, V33, P671, DOI 10.1006/jmcc.2000.1334; Pfeiffer S, 2002, FASEB J, V16, P1854, DOI 10.1096/fj.02-0953lte; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Potdar S, 2009, MICROVASC RES, V78, P191, DOI 10.1016/j.mvr.2009.04.001; Rohn TT, 1999, J LEUKOCYTE BIOL, V65, P59, DOI 10.1002/jlb.65.1.59; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; Segui J, 2005, INFLAMM BOWEL DIS, V11, P872, DOI 10.1097/01.MIB.0000183420.25186.7a; Steiner L, 1997, DIABETOLOGIA, V40, P150, DOI 10.1007/s001250050656; SUEMATSU M, 1994, AM J PHYSIOL, V266, pH2410, DOI 10.1152/ajpheart.1994.266.6.H2410; Sumagin R, 2008, AM J PHYSIOL-HEART C, V295, pH969, DOI 10.1152/ajpheart.00400.2008; Sumagin R, 2007, AM J PHYSIOL-HEART C, V293, pH2786, DOI 10.1152/ajpheart.00720.2007; Sumagin R, 2006, AM J PHYSIOL-HEART C, V291, pH2116, DOI 10.1152/ajpheart.00248.2006; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Thorlacius H, 1997, AM J PHYSIOL-HEART C, V272, pH1725, DOI 10.1152/ajpheart.1997.272.4.H1725; TINGBEALL HP, 1993, BLOOD, V81, P2774; Tsukimori K, 2005, HYPERTENSION, V46, P696, DOI 10.1161/01.HYP.0000184197.11226.71; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705; VEDDER NB, 1990, P NATL ACAD SCI USA, V87, P2643, DOI 10.1073/pnas.87.7.2643; Wang Q, 2000, J IMMUNOL, V164, P6487, DOI 10.4049/jimmunol.164.12.6487; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479; Yang H, 2009, ATHEROSCLEROSIS, V207, P51, DOI 10.1016/j.atherosclerosis.2009.03.052; Zeng M, 2002, AM J PHYSIOL-HEART C, V283, pH2420, DOI 10.1152/ajpheart.00787.2001; Zhang CH, 2006, J MOL CELL CARDIOL, V40, P247, DOI 10.1016/j.yjmcc.2005.11.010; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH1331, DOI 10.1152/ajpheart.00802.2004; ZIMMERLI W, 1986, J CLIN INVEST, V77, P925, DOI 10.1172/JCI112391; Zou MH, 2007, PROSTAG OTH LIPID M, V82, P119, DOI 10.1016/j.prostaglandins.2006.05.005	89	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38912	10.1371/journal.pone.0038912	http://dx.doi.org/10.1371/journal.pone.0038912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719984	gold, Green Submitted, Green Published			2022-12-25	WOS:000305347800026
J	Xie, JY; Kiryluk, K; Wang, WM; Wang, ZH; Guo, SM; Shen, PY; Ren, H; Pan, XX; Chen, XN; Zhang, W; Li, X; Shi, H; Li, YF; Gharavi, AG; Chen, N				Xie, Jingyuan; Kiryluk, Krzysztof; Wang, Weiming; Wang, Zhaohui; Guo, Shanmai; Shen, Pingyan; Ren, Hong; Pan, Xiaoxia; Chen, Xiaonong; Zhang, Wen; Li, Xiao; Shi, Hao; Li, Yifu; Gharavi, Ali G.; Chen, Nan			Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; IMMUNOGLOBULIN-A NEPHROPATHY; TERM-FOLLOW-UP; NATURAL-HISTORY; ASSOCIATION; PROGNOSIS; CHINESE	IgA nephropathy (IgAN) is a common cause of end-stage renal disease (ESRD) in Asia. In this study, based on a large cohort of Chinese patients with IgAN, we aim to identify independent predictive factors associated with disease progression to ESRD. We collected retrospective clinical data and renal outcomes on 619 biopsy-diagnosed IgAN patients with a mean follow-up time of 41.3 months. In total, 67 individuals reached the study endpoint defined by occurrence of ESRD necessitating renal replacement therapy. In the fully adjusted Cox proportional hazards model, there were four baseline variables with a significant independent effect on the risk of ESRD. These included: eGFR [HR = 0.96(0.95-0.97)], serum albumin [HR = 0.47(0.32-0.68)], hemoglobin [HR = 0.79(0.72-0.88)], and SBP [HR = 1.02(1.00-1.03)]. Based on these observations, we developed a 4-variable equation of a clinical risk score for disease progression. Our risk score explained nearly 22% of the total variance in the primary outcome. Survival ROC curves revealed that the risk score provided improved prediction of ESRD at 24th, 60th and 120th month of follow-up compared to the three previously proposed risk scores. In summary, our data indicate that IgAN patients with higher systolic blood pressure, lower eGFR, hemoglobin, and albumin levels at baseline are at a greatest risk of progression to ESRD. The new progression risk score calculated based on these four baseline variables offers a simple clinical tool for risk stratification.	[Xie, Jingyuan; Wang, Weiming; Wang, Zhaohui; Guo, Shanmai; Shen, Pingyan; Ren, Hong; Pan, Xiaoxia; Chen, Xiaonong; Zhang, Wen; Li, Xiao; Shi, Hao; Chen, Nan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai 200030, Peoples R China; [Xie, Jingyuan; Kiryluk, Krzysztof; Li, Yifu; Gharavi, Ali G.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY USA	Shanghai Jiao Tong University; Columbia University	Xie, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai 200030, Peoples R China.	ag2239@columbia.edu; cnrj100@126.com	xie, jing/GRY-1689-2022; Xie, Jingyuan/AAX-2708-2021	LI, YIFU/0000-0002-7077-7689	National Basic Research Program of China 973 Program [2012CB517600, 2012CB517604]; National Natural Science Foundation of China [81000295]; Schrier Family Fellowship from the International Society of Nephrology (ISN); National Institutes of Health [K23DK090207]; Leading Academic Discipline Project of Shanghai Health Bureau [05III 001, 2003ZD002]; Shanghai Leading Academic Discipline Project [T0201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK090207] Funding Source: NIH RePORTER	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Schrier Family Fellowship from the International Society of Nephrology (ISN); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leading Academic Discipline Project of Shanghai Health Bureau; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Basic Research Program of China 973 Program No. 2012CB517600 (No. 2012CB517604), the National Natural Science Foundation of China (No. 81000295). XJ is supported by the Schrier Family Fellowship from the International Society of Nephrology (ISN). KK is supported by the National Institutes of Health grant K23DK090207 (NIDDK). This work was also supported by the Leading Academic Discipline Project of Shanghai Health Bureau (05III 001 and 2003ZD002) and Shanghai Leading Academic Discipline Project (T0201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; DAMICO G, 1987, SEMIN NEPHROL, V7, P355; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Kaartinen K, 2008, NEPHROL DIAL TRANSPL, V23, P1285, DOI 10.1093/ndt/gfm782; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kiryluk K, 2011, KIDNEY INT, V80, P79, DOI 10.1038/ki.2011.16; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Leehey David J, 2005, BMC Nephrol, V6, P8, DOI 10.1186/1471-2369-6-8; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Li LS, 1996, KIDNEY INT, V49, P287, DOI 10.1038/ki.1996.41; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Lv JC, 2008, NEPHROLOGY, V13, P242, DOI 10.1111/j.1440-1797.2007.00898.x; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mackinnon B, 2008, NEPHRON CLIN PRACT, V109, pC148, DOI 10.1159/000145458; Mohanram A, 2004, KIDNEY INT, V66, P1131, DOI 10.1111/j.1523-1755.2004.00863.x; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; National Kidney Foundation, 2002, OFFICIAL J NATL KIDN, V39, pS1; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Staples AO, 2010, CLIN J AM SOC NEPHRO, V5, P2172, DOI 10.2215/CJN.07851109; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Therneau PGaT, 1994, BIOMETRIKA, V81, P11; Yokoyama H, 1997, DIABETOLOGIA, V40, P405, DOI 10.1007/s001250050694	38	86	104	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38904	10.1371/journal.pone.0038904	http://dx.doi.org/10.1371/journal.pone.0038904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719981	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800025
J	Uner, NE; Nishikawa, Y; Okuno, D; Nakano, M; Yokoyama, K; Noji, H				Uner, Naciye Esma; Nishikawa, Yoshihiro; Okuno, Daichi; Nakano, Masahiro; Yokoyama, Ken; Noji, Hiroyuki			Single-molecule Analysis of Inhibitory Pausing States of V-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS; F-1 MOTOR; V-ATPASE; ROTATION; F-1-ATPASE; SUBUNIT; ATPASE/SYNTHASE; HYDROLYSIS; CATALYSIS	V-1-ATPase, the hydrophilic V-ATPase domain, is a rotary motor fueled by ATP hydrolysis. Here, we found that Thermus thermophilus V-1-ATPase shows two types of inhibitory pauses interrupting continuous rotation: a short pause (SP, 4.2 s) that occurred frequently during rotation, and a long inhibitory pause (LP, > 30 min) that terminated all active rotations. Both pauses occurred at the same angle for ATP binding and hydrolysis. Kinetic analysis revealed that the time constants of inactivation into and activation from the SP were too short to represent biochemically predicted ADP inhibition, suggesting that SP is a newly identified inhibitory state of V-1-ATPase. The time constant of inactivation into LP was 17 min, consistent with one of the two time constants governing the inactivation process observed in bulk ATPase assay. When forcibly rotated in the forward direction, V-1 in LP resumed active rotation. Solution ADP suppressed the probability of mechanical activation, suggesting that mechanical rotation enhanced inhibitory ADP release. These features were highly consistent with mechanical activation of ADP-inhibited F-1, suggesting that LP represents the ADP-inhibited state of V-1-ATPase. Mechanical activation largely depended on the direction and angular displacement of forced rotation, implying that V-1-ATPase rotation modulates the off rate of ADP.	[Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Uner, Naciye Esma; Nishikawa, Yoshihiro] Osaka Univ, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Okuno, Daichi] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650874, Japan; [Nakano, Masahiro] Inst Ind & Sci Res, Osaka 5650874, Japan; [Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan	University of Tokyo; Osaka University; RIKEN; Kyoto Sangyo University	Noji, H (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Yokoyama, Ken/AAJ-3582-2020	Yokoyama, Ken/0000-0002-6813-1096; Tirtom, Naciye Esma/0000-0003-4637-8466	Ministry of Education, Culture, Sports, Science and Technology, Japan;  [18074005]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by Grant-in-aid for Scientific Research 18074005 (to H. N.) and by a Special Education and Research Expenses grant (to H. N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imashimizu M, 2011, J BIOL CHEM, V286, P26595, DOI 10.1074/jbc.M111.234138; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pavlova P, 2004, J BIOL CHEM, V279, P9685, DOI 10.1074/jbc.C400014200; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Takeda M, 2009, BIOPHYS J, V96, P1210, DOI 10.1016/j.bpj.2008.10.031; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504	28	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28327	28335		10.1074/jbc.M112.381194	http://dx.doi.org/10.1074/jbc.M112.381194			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22736762	hybrid, Green Published			2022-12-25	WOS:000308074600010
J	Kravets, E; Degrandi, D; Weidtkamp-Peters, S; Ries, B; Konermann, C; Felekyan, S; Dargazanli, JM; Praefcke, GJK; Seidel, CAM; Schmitt, L; Smits, SHJ; Pfeffer, K				Kravets, Elisabeth; Degrandi, Daniel; Weidtkamp-Peters, Stefanie; Ries, Britta; Konermann, Carolin; Felekyan, Suren; Dargazanli, Julia M.; Praefcke, Gerrit J. K.; Seidel, Claus A. M.; Schmitt, Lutz; Smits, Sander H. J.; Pfeffer, Klaus			The GTPase Activity of Murine Guanylate-binding Protein 2 (mGBP2) Controls the Intracellular Localization and Recruitment to the Parasitophorous Vacuole of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNITY-RELATED GTPASE; NUCLEOTIDE-BINDING; ENDOPLASMIC-RETICULUM; DYNAMIN SUPERFAMILY; RESISTANCE GTPASES; CELLULAR-RESPONSE; MOUSE RESISTANCE; DOMAIN MUTANTS; P47 GTPASES; INTERFERON	One of the most abundantly IFN-gamma-induced protein families different cell types is the 65-kDa guanylate-binding protein family that is recruited to the parasitophorous vacuole of the intracellular parasite Toxoplasma gondii. Here, we elucidate the relationship between biochemistry and cellular host defense functions of mGBP2 in response to Toxoplasma gondii. The wild type protein exhibits low affinities to guanine nucleotides, self-assembles upon GTP binding, forming tetramers in the activated state, and stimulates the GTPase activity in a cooperative manner. The products of the two consecutive hydrolysis reactions are both GDP and GMP. The biochemical characterization of point mutants in the GTP-binding motifs of mGBP2 revealed amino acid residues that decrease the GTPase activity by orders of magnitude and strongly impair nucleotide binding and multimerization ability. Live cell imaging employing multiparameter fluorescence image spectroscopy (MFIS) using a Homo-FRET assay shows that the inducible multimerization of mGBP2 is dependent on a functional GTPase domain. The consistent results indicate that GTP binding, self-assembly, and stimulated hydrolysis activity are required for physiological localization of the protein in infected and uninfected cells. Ultimately, we show that the GTPase domain regulates efficient recruitment to T. gondii in response to IFN-gamma.	[Kravets, Elisabeth; Degrandi, Daniel; Konermann, Carolin; Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Weidtkamp-Peters, Stefanie] Univ Dusseldorf, Ctr Adv Imaging, D-40225 Dusseldorf, Germany; [Ries, Britta; Schmitt, Lutz; Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Felekyan, Suren; Seidel, Claus A. M.] Univ Dusseldorf, Chair Mol Phys Chem, D-40225 Dusseldorf, Germany; [Dargazanli, Julia M.; Praefcke, Gerrit J. K.] Univ Cologne, Inst Genet, Ctr Mol Med Cologne, D-50674 Cologne, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Cologne	Pfeffer, K (corresponding author), Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany.	klaus.pfeffer@hhu.de	Seidel, Claus A.M./A-3682-2012	Seidel, Claus A.M./0000-0002-5171-149X; Praefcke, Gerrit/0000-0001-8818-1499; Weidtkamp-Peters, Stefanie/0000-0001-7734-3771; Pfeffer, Klaus/0000-0002-5652-6330	Deutsche Forschungsgemeinschaft [PF259/4-1, FOR 729, GRK 1045, SFB 590]; Jurgen Manchot Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jurgen Manchot Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants PF259/4-1, FOR 729, GRK 1045, and SFB 590 (to K. P. and C. A. M. S.) and the Jurgen Manchot Foundation.	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Balasubramanian S., 2010, J INTERFERON CYTOKIN, V31, P291; BECKER W, 2005, SPRINGER SERIES CHEM, V81, P1; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boehm U, 1998, J IMMUNOL, V161, P6715; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Britzen-Laurent N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014246; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHENG YSE, 1991, MOL CELL BIOL, V11, P4717, DOI 10.1128/MCB.11.9.4717; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Duan ZF, 2006, CANCER CHEMOTH PHARM, V57, P25, DOI 10.1007/s00280-005-0026-3; Fres JM, 2010, J LIPID RES, V51, P2454, DOI 10.1194/jlr.D005397; Fux B, 2003, INFECT IMMUN, V71, P6392, DOI 10.1128/IAI.71.11.6392-6401.2003; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; Herrmann C, 1996, PROG BIOPHYS MOL BIO, V66, P1, DOI 10.1016/S0079-6107(96)00015-6; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; KOSHIOKA M, 1995, APPL SPECTROSC, V49, P224, DOI 10.1366/0003702953963652; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Kudryavtsev V, 2007, ANAL BIOANAL CHEM, V387, P71, DOI 10.1007/s00216-006-0917-0; Kunzelmann S, 2005, METHOD ENZYMOL, V404, P512, DOI 10.1016/S0076-6879(05)04045-0; Kunzelmann S, 2006, J BIOL CHEM, V281, P28627, DOI 10.1074/jbc.M604911200; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; MacMicking JD, 2005, CURR OPIN MICROBIOL, V8, P74, DOI 10.1016/j.mib.2004.12.012; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Neun R, 1996, FEBS LETT, V390, P69, DOI 10.1016/0014-5793(96)00628-X; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; OTERO AD, 1990, BIOCHEM PHARMACOL, V39, P1399; Pawlowski N, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-7; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Praefcke GJK, 1999, J MOL BIOL, V292, P321, DOI 10.1006/jmbi.1999.3062; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Schaffer J, 1999, J PHYS CHEM A, V103, P331, DOI 10.1021/jp9833597; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Vestal DJ, 2005, J INTERF CYTOK RES, V25, P435, DOI 10.1089/jir.2005.25.435; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; Vopel T, 2010, J MOL BIOL, V400, P63, DOI 10.1016/j.jmb.2010.04.053; Vopel T, 2009, FEBS LETT, V583, P1923, DOI 10.1016/j.febslet.2009.05.027; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wehner M, 2012, FEBS J, V279, P203, DOI 10.1111/j.1742-4658.2011.08415.x; Wehner M, 2010, FEBS J, V277, P1597, DOI 10.1111/j.1742-4658.2010.07586.x; Weidtkamp-Peters S, 2009, PHOTOCH PHOTOBIO SCI, V8, P470, DOI 10.1039/b903245m; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Widengren J, 2006, ANAL CHEM, V78, P2039, DOI 10.1021/ac0522759; Zhao YO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008648; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	90	39	39	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27452	27466		10.1074/jbc.M112.379636	http://dx.doi.org/10.1074/jbc.M112.379636			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730319	Green Published, hybrid			2022-12-25	WOS:000307840700022
J	Beckett, EL; Phipps, S; Starkey, MR; Horvat, JC; Beagley, KW; Foster, PS; Hansbro, PM				Beckett, Emma L.; Phipps, Simon; Starkey, Malcolm R.; Horvat, Jay C.; Beagley, Kenneth W.; Foster, Paul S.; Hansbro, Philip M.			TLR2, but Not TLR4, Is Required for Effective Host Defence against Chlamydia Respiratory Tract Infection in Early Life	PLOS ONE			English	Article							ALLERGIC AIRWAYS DISEASE; MYELOID DENDRITIC CELLS; TRANSCUTANEOUS IMMUNIZATION; PNEUMONIAE INFECTION; MURIDARUM INFECTION; PROTECTIVE IMMUNITY; TH2 IMMUNITY; RECEPTOR; INDUCTION; ASTHMA	Chlamydia pneumoniae commonly causes respiratory tract infections in children, and epidemiological investigations strongly link infection to the pathogenesis of asthma. The immune system in early life is immature and may not respond appropriately to pathogens. Toll-like receptor (TLR)2 and 4 are regarded as the primary pattern recognition receptors that sense bacteria, however their contribution to innate and adaptive immunity in early life remains poorly defined. We investigated the role of TLR2 and 4 in the induction of immune responses to Chlamydia muridarum respiratory infection, in neonatal wild-type (Wt) or TLR2-deficient ((-/-)), 4(-/-) or 2/4(-/-) BALB/c mice. Wt mice had moderate disease and infection. TLR2(-/-) mice had more severe disease and more intense and prolonged infection compared to other groups. TLR4(-/-) mice were asymptomatic. TLR2/4(-/-) mice had severe early disease and persistent infection, which resolved thereafter consistent with the absence of symptoms in TLR4(-/-) mice. Wt mice mounted robust innate and adaptive responses with an influx of natural killer (NK) cells, neutrophils, myeloid (mDCs) and plasmacytoid (pDCs) dendritic cells, and activated CD4(+) and CD8(+) T-cells into the lungs. Wt mice also had effective production of interferon (IFN)gamma in the lymph nodes and lung, and proliferation of lymph node T-cells. TLR2(-/-) mice had more intense and persistent innate (particularly neutrophil) and adaptive cell responses and IL-17 expression in the lung, however IFN gamma responses and T-cell proliferation were reduced. TLR2/4(-/-) mice had reduced innate and adaptive responses. Most importantly, neutrophil phagocytosis was impaired in the absence of TLR2. Thus, TLR2 expression, particularly on neutrophils, is required for effective control of Chlamydia respiratory infection in early life. Loss of control of infection leads to enhanced but ineffective TLR4-mediated inflammatory responses that prolong disease symptoms. This indicates that TLR2 agonists may be beneficial in the treatment of early life Chlamydia infections and associated diseases.	[Beckett, Emma L.; Starkey, Malcolm R.; Horvat, Jay C.; Foster, Paul S.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Beckett, Emma L.; Starkey, Malcolm R.; Horvat, Jay C.; Foster, Paul S.; Hansbro, Philip M.] Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Phipps, Simon] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Phipps, Simon] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Queensland; University of Queensland; Queensland University of Technology (QUT)	Beckett, EL (corresponding author), Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia.	Paul.Foster@newcastle.edu.au; Philip.Hansbro@newcastle.edu.au	Phipps, Simon/F-9170-2010; Hansbro, Phil/G-7486-2013; Beagley, Kenneth/J-1129-2012; Beckett, Emma/AAU-8537-2021; Foster, Paul/G-5057-2013	Phipps, Simon/0000-0002-7388-3612; Hansbro, Phil/0000-0002-4741-3035; Beagley, Kenneth/0000-0003-3112-6557; Beckett, Emma/0000-0002-8888-3789; Starkey, Malcolm/0000-0002-7359-7464; , Paul/0000-0002-0827-8299; Horvat, Jay/0000-0002-8526-0631	National Health and Medical Research Council of Australia [569219]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by grants from the National Health and Medical Research Council of Australia (Grant #569219, http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins P, 2001, J IMMUNOL, V166, P918, DOI 10.4049/jimmunol.166.2.918; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Beagley KW, 2009, CRIT REV IMMUNOL, V29, P275, DOI 10.1615/CritRevImmunol.v29.i4.10; Belland RJ, 2004, CELL MICROBIOL, V6, P117, DOI 10.1046/j.1462-5822.2003.00352.x; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Blasi F, 2000, CURR OPIN INFECT DIS, V13, P161, DOI 10.1097/00001432-200004000-00011; Cheng CM, 2011, VACCINE, V29, P6641, DOI 10.1016/j.vaccine.2011.06.105; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Essilfie A, 2012, THORAX IN PRESS; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Feng HP, 2005, J IMMUNOL, V175, P421, DOI 10.4049/jimmunol.175.1.421; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; Hansbro PM, 2011, BRIT J PHARMACOL, V163, P81, DOI 10.1111/j.1476-5381.2011.01219.x; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; He XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020846; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Horvat JC, 2010, J IMMUNOL, V184, P4159, DOI 10.4049/jimmunol.0902287; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Jupelli M, 2008, J IMMUNOL, V180, P4148, DOI 10.4049/jimmunol.180.6.4148; Jupelli M, 2011, LAB INVEST, V91, P1530, DOI 10.1038/labinvest.2011.103; Kaiko GE, 2008, J IMMUNOL, V180, P2225, DOI 10.4049/jimmunol.180.4.2225; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kovarik J, 1998, IMMUNOL TODAY, V19, P150, DOI 10.1016/S0167-5699(97)01230-9; Lambrecht BN, 2001, EUR RESPIR J, V18, P692; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Oyoshi MK, 2007, IMMUNOLOGY, V120, P303, DOI 10.1111/j.1365-2567.2006.02499.x; Penttila JM, 1998, INFECT IMMUN, V66, P3290; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034; Principi Nicola, 2001, Clinical Infectious Diseases, V32, P1281, DOI 10.1086/319981; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rothfuchs AG, 2004, J IMMUNOL, V172, P2407, DOI 10.4049/jimmunol.172.4.2407; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Shin S, 2008, FASEB J, V22, P5; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Takenaka S, 2007, J IMMUNOL, V178, P7984, DOI 10.4049/jimmunol.178.12.7984; Thorburn AN, 2010, THORAX, V65, P1053, DOI 10.1136/thx.2009.131508; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; Webley WC, 2009, EUR RESPIR J, V33, P360, DOI 10.1183/09031936.00019508; Webley WC, 2005, AM J RESP CRIT CARE, V171, P1083, DOI 10.1164/rccm.200407-917OC; Williams DM, 1997, INFECT IMMUN, V65, P2876, DOI 10.1128/IAI.65.7.2876-2882.1997; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	56	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39460	10.1371/journal.pone.0039460	http://dx.doi.org/10.1371/journal.pone.0039460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724018	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700081
J	Haring, R; Rosvall, M; Volker, U; Volzke, H; Kroemer, H; Nauck, M; Wallaschofski, H				Haring, Robin; Rosvall, Martin; Voelker, Uwe; Voelzke, Henry; Kroemer, Heyo; Nauck, Matthias; Wallaschofski, Henri			A Network-Based Approach to Visualize Prevalence and Progression of Metabolic Syndrome Components	PLOS ONE			English	Article							INCIDENT CARDIOVASCULAR EVENTS; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; SYNDROME CRITERIA; RISK-FACTORS; PRIME-TIME; MORTALITY; MEN; HEALTH; ASSOCIATION	Background: The additional clinical value of clustering cardiovascular risk factors to define the metabolic syndrome (MetS) is still under debate. However, it is unclear which cardiovascular risk factors tend to cluster predominately and how individual risk factor states change over time. Methods & Results: We used data from 3,187 individuals aged 20-79 years from the population-based Study of Health in Pomerania for a network-based approach to visualize clustered MetS risk factor states and their change over a five-year follow-up period. MetS was defined by harmonized Adult Treatment Panel III criteria, and each individual's risk factor burden was classified according to the five MetS components at baseline and follow-up. We used the map generator to depict 32 (2(5)) different states and highlight the most important transitions between the 1,024 (32(2)) possible states in the weighted directed network. At baseline, we found the largest fraction (19.3%) of all individuals free of any MetS risk factors and identified hypertension (15.4%) and central obesity (6.3%), as well as their combination (19.0%), as the most common MetS risk factors. Analyzing risk factor flow over the five-year follow-up, we found that most individuals remained in their risk factor state and that low high-density lipoprotein cholesterol (HDL) (6.3%) was the most prominent additional risk factor beyond hypertension and central obesity. Also among individuals without any MetS risk factor at baseline, low HDL (3.5%), hypertension (2.1%), and central obesity (1.6%) were the first risk factors to manifest during follow-up. Conclusions: We identified hypertension and central obesity as the predominant MetS risk factor cluster and low HDL concentrations as the most prominent new onset risk factor.	[Haring, Robin; Nauck, Matthias; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Rosvall, Martin] Umea Univ, Dept Phys, Umea, Sweden; [Voelker, Uwe] Univ Med Greifswald, Dept Funct Genom, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Kroemer, Heyo] Univ Med Greifswald, Inst Pharmacol, Greifswald, Germany	Greifswald Medical School; Umea University; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Haring, R (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.	robin.haring@uni-greifswald.de	Rosvall, Martin/ABD-6411-2020; Wilkening, Robin/J-5535-2018; Rosvall, Martin/A-9488-2015	Wilkening, Robin/0000-0002-8332-5016; Rosvall, Martin/0000-0002-7181-9940; Volker, Uwe/0000-0002-5689-3448	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg, West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania [03IS2061A]; Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania, Germany; Swedish Research Council [2009-5344]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg, West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania, Germany; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Study of Health in Pomerania is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg, West Pomerania. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg - West Pomerania (03IS2061A). This study was carried out in collaboration with the German Centre for Cardiovascular Research which is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania, Germany. MR was supported by Swedish Research Council grant 2009-5344. RH is the guarantor of this work, had full access to all the data, and takes full responsibility for the integrity of data and the accuracy of data analysis. Furthermore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Borch-Johnsen K, 2010, DIABETOLOGIA, V53, P597, DOI 10.1007/s00125-010-1659-2; Chimonas T, 2010, METAB SYNDR RELAT D, V8, P523, DOI 10.1089/met.2010.0023; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Franco OH, 2009, CIRCULATION, V120, P1943, DOI 10.1161/CIRCULATIONAHA.109.855817; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hannemann A, 2011, EUR J ENDOCRINOL, V164, P751, DOI 10.1530/EJE-10-1074; Haring R, 2010, EXP CLIN ENDOCR DIAB, V118, P685, DOI 10.1055/s-0030-1261876; Haring R, 2012, OMICS, V16, P231, DOI 10.1089/omi.2011.0108; Haring R, 2011, EUR J CARDIOV PREV R, V18, P86, DOI 10.1097/HJR.0b013e32833c1a8d; Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Katzmarzyk PT, 2005, DIABETES CARE, V28, P391, DOI 10.2337/diacare.28.2.391; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Lidfeldt J, 2003, DIABETES OBES METAB, V5, P106, DOI 10.1046/j.1463-1326.2003.00250.x; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Nagaretani H, 2001, DIABETES CARE, V24, P2127, DOI 10.2337/diacare.24.12.2127; NAUCK M, 1995, CLIN CHEM, V41, P1761; Preiss D, 2009, DIABETIC MED, V26, P457, DOI 10.1111/j.1464-5491.2009.02717.x; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Qiao Q, 2009, STROKE, V40, P337, DOI 10.1161/STROKEAHA.108.518878; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Sattar N, 2008, INT J OBESITY, V32, pS30, DOI 10.1038/ijo.2008.33; Sattar N, 2005, EUR HEART J, V26, P1249, DOI 10.1093/eurheartj/ehi296; Schipf S, 2010, DIABETOL STOFFWECHS, V5, P161, DOI 10.1055/s-0030-1247406; Scuteri A, 2010, EUR HEART J, V31, P602, DOI 10.1093/eurheartj/ehp491; Scuteri A, 2009, J GERONTOL A-BIOL, V64, P590, DOI 10.1093/gerona/glp004; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Tuomilehto J, 2011, DIABETES CARE, V34, pS210, DOI 10.2337/dc11-s222; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	43	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39461	10.1371/journal.pone.0039461	http://dx.doi.org/10.1371/journal.pone.0039461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724019	gold, Green Published			2022-12-25	WOS:000305652700082
J	Laitinen, EM; Tommiska, J; Sane, T; Vaaralahti, K; Toppari, J; Raivio, T				Laitinen, Eeva-Maria; Tommiska, Johanna; Sane, Timo; Vaaralahti, Kirsi; Toppari, Jorma; Raivio, Taneli			Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations	PLOS ONE			English	Article							KALLMANN-SYNDROME; CHARGE SYNDROME; HORMONE RECEPTOR; LUTEINIZING-HORMONE; DELAYED PUBERTY; HOMOZYGOUS MUTATION; FERTILE EUNUCH; NEURAL CREST; GONADOTROPIN; TESTOSTERONE	Background: Congenital hypogonadotropic hypogonadism (HH) is a rare cause for delayed or absent puberty. These patients may recover from HH spontaneously in adulthood. To date, it is not possible to predict who will undergo HH reversal later in life. Herein we investigated whether Finnish patients with reversal of congenital hypogonadotropic hypogonadism (HH) have common phenotypic or genotypic features. Methods and Findings: Thirty-two male HH patients with anosmia/hyposmia (Kallmann Syndrome, KS; n = 26) or normal sense of smell (nHH; n = 6) were enrolled (age range, 18-61 yrs). The patients were clinically examined, and reversal of HH was assessed after treatment withdrawal. KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, WDR11, GNRHR, GNRH1, KISS1R, KISS1, TAC3, TACR3, and LH beta were screened for mutations. Six HH patients (2 KS, 4 nHH) were verified to have reversal of HH. In the majority of cases, reversal occurred early in adulthood (median age, 23 yrs; range, 21-39 yrs). All had spontaneous testicular growth while on testosterone replacement therapy (TRT). One nHH subject was restarted on TRT due to a decline in serum T. Two reversal variants had a same GNRHR mutation (R262Q), which was accompanied by another GNRHR mutation (R139H or del309F). In addition, both of the KS patients had a mutation in CHD7 (p.Q51X) or FGFR1 (c.91+2T>A). Conclusions: Considerable proportion of patients with HH (8% of KS probands) may recover in early adulthood. Spontaneous testicular enlargement during TRT was highly suggestive for reversal of HH. Those with the GNRHR mutation R262Q accompanied by another GNRHR mutation may be prone to reversal, although even patients with a truncating mutation in CHD7 or a splice-site mutation in FGFR1 can recover. We recommend that all adolescents and young adults with congenital HH should be informed on the possibility of reversal.	[Laitinen, Eeva-Maria; Tommiska, Johanna; Vaaralahti, Kirsi; Raivio, Taneli] Univ Helsinki, Inst Biomed Physiol, Biomedicum Helsinki, Helsinki, Finland; [Tommiska, Johanna; Vaaralahti, Kirsi; Raivio, Taneli] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Sane, Timo] Univ Helsinki, Cent Hosp, Div Endocrinol, Dept Med, Helsinki, Finland; [Toppari, Jorma] Univ Turku, Dept Physiol, Turku, Finland; [Toppari, Jorma] Univ Turku, Dept Pediat, Turku, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku	Laitinen, EM (corresponding author), Univ Helsinki, Inst Biomed Physiol, Biomedicum Helsinki, Helsinki, Finland.	taneli.raivio@helsinki.fi		Raivio, Taneli/0000-0001-5385-434X; Tommiska, Johanna/0000-0001-7958-8262	Helsinki University Central Hospital; Academy of Finland; Sigrid Juselius Foundation; Foundation for Pediatric Research; Emil Aaltonen Foundation; Research Foundation of the University of Helsinki; Finnish Cultural Foundation	Helsinki University Central Hospital; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Foundation for Pediatric Research; Emil Aaltonen Foundation; Research Foundation of the University of Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by grants from the Helsinki University Central Hospital Research Funds, Academy of Finland, Sigrid Juselius Foundation, Foundation for Pediatric Research, Emil Aaltonen Foundation, Research Foundation of the University of Helsinki, and Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard C, 2009, NEW ENGL J MED, V361, P1856, DOI 10.1056/NEJMoa0805792; BAGATELL CJ, 1994, FERTIL STERIL, V61, P392; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; BAUMAN A, 1986, J ANDROL, V7, P224; Bergman JEH, 2011, J PEDIATR-US, V158, P474, DOI 10.1016/j.jpeds.2010.08.032; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; Cariboni A, 2006, CELL MOL LIFE SCI, V63, P2512, DOI 10.1007/s00018-005-5604-3; Dauber A, 2010, PEDIATRICS, V126, pE1594, DOI 10.1542/peds.2010-0164; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dewailly D, 2002, FERTIL STERIL, V77, P1288, DOI 10.1016/S0015-0282(02)03102-3; Feret H, 2010, 60 ANN M AM SOC HUM; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Han TS, 2010, CLIN ENDOCRINOL, V72, P731, DOI 10.1111/j.1365-2265.2009.03746.x; Jongmans MCJ, 2009, CLIN GENET, V75, P65, DOI 10.1111/j.1399-0004.2008.01107.x; Kadva A, 1996, CLIN ENDOCRINOL, V44, P103, DOI 10.1046/j.1365-2265.1996.00650.x; Kim HG, 2008, AM J HUM GENET, V83, P511, DOI 10.1016/j.ajhg.2008.09.005; Koenigkam-Santos M, 2011, NEUROENDOCRINOLOGY, V94, P209, DOI 10.1159/000328437; Laitinen EM, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-41; Layman WS, 2011, HUM MOL GENET, V20, P3138, DOI 10.1093/hmg/ddr216; Lin L, 2006, J CLIN ENDOCR METAB, V91, P5117, DOI 10.1210/jc.2006-0807; MATSUMOTO AM, 1990, J CLIN ENDOCR METAB, V70, P282, DOI 10.1210/jcem-70-1-282; Morelli A, 2009, J SEX MED, V6, P397, DOI 10.1111/j.1743-6109.2008.01084.x; Pinto G, 2005, J CLIN ENDOCR METAB, V90, P5621, DOI 10.1210/jc.2004-2474; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P1317, DOI 10.1210/jc.2004-1361; Pitteloud N, 2001, J CLIN ENDOCR METAB, V86, P2470, DOI 10.1210/jc.86.6.2470; Quinton R, 1999, CLIN ENDOCRINOL, V50, P481; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; Raivio T, 2009, J CLIN ENDOCR METAB, V94, P4380, DOI 10.1210/jc.2009-0179; Rezvani I., 1975, PAEDIAT RES, V9, P224; Ribeiro RS, 2007, EUR J ENDOCRINOL, V156, P285, DOI 10.1530/eje.1.02342; ROGOL AD, 1980, J CLIN ENDOCR METAB, V51, P275, DOI 10.1210/jcem-51-2-275; ROWE RC, 1983, FERTIL STERIL, V40, P400; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Sinisi AA, 2008, HUM REPROD, V23, P2380, DOI 10.1093/humrep/den247; Teixeira L, 2010, J CLIN INVEST, V120, P3668, DOI 10.1172/JCI43699; Vaaralahti K, 2011, FERTIL STERIL, V95, P2756, DOI 10.1016/j.fertnstert.2010.12.059; Wortsman J, 1996, AM J MED SCI, V311, P135, DOI 10.1097/00000441-199603000-00005; Zenaty D, 2006, MOL CELL ENDOCRINOL, V254, P78, DOI 10.1016/j.mce.2006.04.006	40	50	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39450	10.1371/journal.pone.0039450	http://dx.doi.org/10.1371/journal.pone.0039450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724017	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700080
J	Calahorro, F; Ruiz-Rubio, M				Calahorro, Fernando; Ruiz-Rubio, Manuel			Functional Phenotypic Rescue of Caenorhabditis elegans Neuroligin-Deficient Mutants by the Human and Rat NLGN1 Genes	PLOS ONE			English	Article							SWISS-MODEL; C. ELEGANS; TOUCH SENSITIVITY; PROTEIN; AUTISM; NEUREXIN; EXPRESSION; COMPLEX; SYNAPSE; INTERFERENCE	Neuroligins are cell adhesion proteins that interact with neurexins at the synapse. This interaction may contribute to differentiation, plasticity and specificity of synapses. In humans, single mutations in neuroligin encoding genes lead to autism spectrum disorder and/or mental retardation. Caenorhabditis elegans mutants deficient in nlg-1, an orthologue of human neuroligin genes, have defects in different behaviors. Here we show that the expression of human NLGN1 or rat Nlgn1 cDNAs in C. elegans nlg-1 mutants rescues the fructose osmotic strength avoidance and gentle touch response phenotypes. Two specific point mutations in NLGN3 and NLGN4 genes, involved in autistic spectrum disorder, were further characterized in this experimental system. The R451C allele described in NLGN3, was analyzed with both human NLGN1 (R453C) and worm NLG-1 (R437C) proteins, and both were not functional in rescuing the osmotic avoidance behavior and the gentle touch response phenotype. The D396X allele described in NLGN4, which produces a truncated protein, was studied with human NLGN1 (D432X) and they did not rescue any of the behavioral phenotypes analyzed. In addition, RNAi feeding experiments measuring gentle touch response in wild type strain and worms expressing SID-1 in neurons (which increases the response to dsRNA), both fed with bacteria expressing dsRNA for nlg-1, provided evidence for a postsynaptic in vivo function of neuroligins both in muscle cells and neurons, equivalent to that proposed in mammals. This finding was further confirmed generating transgenic nlg-1 deficient mutants expressing NLG-1 under pan-neuronal (nrx-1) or pan-muscular (myo-3) specific promoters. All these results suggest that the nematode could be used as an in vivo model for studying particular synaptic mechanisms with proteins orthologues of humans involved in pervasive developmental disorders.	[Calahorro, Fernando; Ruiz-Rubio, Manuel] Univ Cordoba, Fac Ciencias, Dept Genet, E-14004 Cordoba, Spain; [Calahorro, Fernando; Ruiz-Rubio, Manuel] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain	Universidad de Cordoba	Calahorro, F (corresponding author), Univ Cordoba, Fac Ciencias, Dept Genet, E-14004 Cordoba, Spain.	ge1rurum@uco.es	Ruiz-Rubio, Manuel/K-5591-2014; Calahorro, Fernando/H-3294-2013	Ruiz-Rubio, Manuel/0000-0001-8733-4377; Alejandre Duran, Encarnacion/0000-0002-0476-3393	Consejeria de Salud, Junta de Andalucia Spain [PI0197]	Consejeria de Salud, Junta de Andalucia Spain(Junta de Andalucia)	The research work has been supported by grant number PI0197 to MRR from Consejeria de Salud, Junta de Andalucia Spain, http://www.juntadeandalucia.es/salud/sites/csalud/portal/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asikainen S, 2005, NEUROREPORT, V16, P1995, DOI 10.1097/00001756-200512190-00005; BARGMANN CI, 1990, COLD SH Q B, V55, P529; Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Bolliger MF, 2008, P NATL ACAD SCI USA, V105, P6421, DOI 10.1073/pnas.0801383105; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BRENNER S, 1974, GENETICS, V77, P71; Calahorro F, 2009, J VIS EXP, V34; Calahorro F, 2011, INVERTEBR NEUROSCI, V11, P73, DOI 10.1007/s10158-011-0126-1; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; CHALFIE M, 1985, J NEUROSCI, V5, P956; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; CULOTTI JG, 1978, GENETICS, V90, P243; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190; Giordano-Santini R, 2010, NAT METHODS, V7, P721, DOI 10.1038/nmeth.1494; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haklai-Topper L, 2011, GENE EXPR PATTERNS, V11, P144, DOI 10.1016/j.gep.2010.10.008; Hunter JW, 2010, DIS MODEL MECH, V3, P366, DOI 10.1242/dmm.003442; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shatsky M, 2002, PROTEINS, V48, P242, DOI 10.1002/prot.10100; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Talebizadeh Z, 2004, J AUTISM DEV DISORD, V34, P735, DOI 10.1007/s10803-004-5295-x; Teng MS, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-22; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629; Ylisaukko-oja T, 2005, EUR J HUM GENET, V13, P1285, DOI 10.1038/sj.ejhg.5201474; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39277	10.1371/journal.pone.0039277	http://dx.doi.org/10.1371/journal.pone.0039277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723984	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000305583300125
J	Leversen, JSR; Haga, M; Sigmundsson, H				Leversen, Jonas S. R.; Haga, Monika; Sigmundsson, Hermundur			From Children to Adults: Motor Performance across the Life-Span	PLOS ONE			English	Article							GROUP SELECTION THEORY; BRAIN-DEVELOPMENT; PROCESSING-SPEED; WORKING-MEMORY; OLDER-ADULTS; AGE; CONNECTION	The life-span approach to development provides a theoretical framework to examine the general principles of life-long development. This study aims to investigate motor performance across the life span. It also aims to investigate if the correlations between motor tasks increase with aging. A cross-sectional design was used to describe the effects of aging on motor performance across age groups representing individuals from childhood to young adult to old age. Five different motor tasks were used to study changes in motor performance within 338 participants (7-79 yrs). Results showed that motor performance increases from childhood (7-9) to young adulthood (19-25) and decreases from young adulthood (19-25) to old age (66-80). These results are mirroring results from cognitive research. Correlation increased with increasing age between two fine motor tasks and two gross motor tasks. We suggest that the findings might be explained, in part, by the structural changes that have been reported to occur in the developing and aging brain and that the theory of Neural Darwinism can be used as a framework to explain why these changes occur.	[Leversen, Jonas S. R.; Sigmundsson, Hermundur] Norwegian Univ Sci & Technol, Dept Psychol, N-7034 Trondheim, Norway; [Haga, Monika] Sor Trondelag Univ Coll, Dept Physiotherapy, Fac Hlth & Social Work, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Leversen, JSR (corresponding author), Norwegian Univ Sci & Technol, Dept Psychol, N-7034 Trondheim, Norway.	hermundurs@svt.ntnu.no	Sigmundsson, Hermundur/R-7796-2019					Adler CH, 2002, PARKINSONISM RELAT D, V9, P103, DOI 10.1016/S1353-8020(02)00012-3; BALTES PB, 1987, DEV PSYCHOL, V23, P611, DOI 10.1037/0012-1649.23.5.611; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; CRAIK FIM, 1994, CURR DIR PSYCHOL SCI, V3, P155, DOI 10.1111/1467-8721.ep10770653; Edelman G.M., 1992, BRIGHT AIR BRILLIANT; Edelman GM, 1987, NEURAL DARWINISM THE; Escorial A, 2003, PERSONALITY INDIVIDU, V34, P1525; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Garrett HE, 1946, AM PSYCHOL, V1, P372, DOI 10.1037/h0056380; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gottlieb G, 2000, CURR DIR PSYCHOL SCI, V9, P93, DOI 10.1111/1467-8721.00068; Hadders-Algra M, 2000, DEV MED CHILD NEUROL, V42, P707, DOI 10.1017/S0012162200001316; Hadders-Algra M, 2002, INFANT BEHAV DEV, V25, P433, DOI 10.1016/S0163-6383(02)00144-3; Hadders-Algra M, 2000, DEV MED CHILD NEUROL, V42, P566, DOI 10.1017/S0012162200001067; Hadders-Algra Mijna, 2001, Neural Plasticity, V8, P31, DOI 10.1155/NP.2001.31; Haga M, 2008, CHILD CARE HLTH DEV, V34, P245, DOI 10.1111/j.1365-2214.2007.00793.x; HAUG H, 1991, NEUROBIOL AGING, V12, P336, DOI 10.1016/0197-4580(91)90013-A; Haywood K., 2020, HUMAN KINETICS; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Lindenberger U, 2001, PSYCHOL AGING, V16, P196, DOI 10.1037//0882-7974.16.2.196; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Miall RC, 2007, NAT NEUROSCI, V10, P940, DOI 10.1038/nn0807-940; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; PARKER H., 2002, DEV COORDINATION DIS, P235; Posthuma D, 2003, TWIN RES, V6, P131, DOI 10.1375/twin.6.2.131; Rabbitt P, 2007, NEUROPSYCHOLOGY, V21, P363, DOI 10.1037/0894-4105.21.3.363; Resnick SM, 2003, J NEUROSCI, V23, P3295; Revie G, 1993, ADAPT PHYS ACT Q, V10, P29, DOI DOI 10.1123/APAQ.10.1.29; Sachdev PS, 2005, J NEUROL NEUROSUR PS, V76, P362, DOI 10.1136/jnnp.2004.042945; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schaie K.W., 1993, CURR DIR PSYCHOL SCI, V2, P171, DOI DOI 10.1111/1467-8721.EP; Sigmundsson H, 2005, TEST MOTOR COM UNPUB; Smith CD, 1999, NEUROLOGY, V53, P1458, DOI 10.1212/WNL.53.7.1458; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Thelen E., 1994, DYNAMIC SYSTEMS APPR; THOMAS JR, 1987, PERCEPT MOTOR SKILL, V64, P503, DOI 10.2466/pms.1987.64.2.503; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; Ward NS, 2006, AGEING RES REV, V5, P239, DOI 10.1016/j.arr.2006.04.003	48	58	58	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38830	10.1371/journal.pone.0038830	http://dx.doi.org/10.1371/journal.pone.0038830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22719958	Green Published, gold			2022-12-25	WOS:000305583300058
J	Liu, B; Staron, M; Li, ZH				Liu, Bei; Staron, Matthew; Li, Zihai			Murine but Not Human Basophil Undergoes Cell-Specific Proteolysis of a Major Endoplasmic Reticulum Chaperone	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; UNFOLDED PROTEIN RESPONSE; ANTIGEN-CAPTURING CELLS; MAST-CELL; SERINE-PROTEASE; B-CELLS; GP96; EXPRESSION; IMMUNITY; GRP94	Introduction: Basophil has been implicated in anti-parasite defense, allergy and in polarizing T(H)2 response. Mouse model has been commonly used to study basophil function although the difference between human and mouse basophils is underappreciated. As an essential chaperone for multiple Toll-like receptors and integrins in the endoplasmic reticulum, gp96 also participates in general protein homeostasis and in the ER unfolded protein response to ensure cell survival during stress. The roles of gp96 in basophil development are unknown. Methods: We genetically delete gp96 in mice and examined the expression of gp96 in basophils by Western blot and flow cytometry. We compared the expression pattern of gp96 between human and mouse basophils. Results: We found that gp96 was dispensable for murine basophil development. Moreover, gp96 was cleaved by serine protease(s) in murine but not human basophils leading to accumulation of a nun-functional N-terminal similar to 50 kDa fragment and striking induction of the unfolded protein response. The alteration of gp96 was unique to basophils and was not observed in any other cell types including mast cells. We also demonstrated that the ectopic expression of a mouse-specific tryptase mMCP11 does not lead to gp96 cleavage in human basophils. Conclusions: Our study revealed a remarkable biochemical event of gp96 silencing in murine but not human basophils, highlighting the need for caution in using mouse models to infer the function of basophils in human immune response. Our study also reveals a novel mechanism of shutting down gp96 post-translationally in regulating its function.	[Liu, Bei; Staron, Matthew; Li, Zihai] Med Univ S Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina	Liu, B (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA.	liube@musc.edu			National Institutes of Health [KL2 RR029880, AI070603, AI076468, HL097391]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000060] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (http://nih.gov) grant KL2 RR029880 (to B.L.), AI070603, AI076468, and HL097391 (to Z.L.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arock M, 2002, J LEUKOCYTE BIOL, V71, P557; Bell J, 2003, J EXP MED, V197, P1233, DOI 10.1084/jem.20020270; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; Bieneman AP, 2005, J ALLERGY CLIN IMMUN, V115, P295, DOI 10.1016/j.jaci.2004.10.018; Chen TY, 2009, J FOOD DRUG ANAL, V17, P363; de Bruin EC, 2003, CELL DEATH DIFFER, V10, P1204, DOI 10.1038/sj.cdd.4401296; Falcone FH, 2000, BLOOD, V96, P4028; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hosoi T, 2007, EUR J PHARMACOL, V554, P8, DOI 10.1016/j.ejphar.2006.09.063; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Komiya A, 2006, INT ARCH ALLERGY IMM, V140, P23, DOI 10.1159/000092707; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lee JJ, 2007, BLOOD, V109, P859, DOI 10.1182/blood-2006-06-027490; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; Lunderius C, 2001, IMMUNOGENETICS, V53, P225, DOI 10.1007/s002510100316; Mack M, 2005, J IMMUNOL, V174, P735, DOI 10.4049/jimmunol.174.2.735; Maquarre E, 2005, LEUKEMIA, V19, P2296, DOI 10.1038/sj.leu.2403944; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Nagasaka A, 2008, EUR J IMMUNOL, V38, P489, DOI 10.1002/eji.200737057; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; QU DF, 1994, DNA CELL BIOL, V13, P117, DOI 10.1089/dna.1994.13.117; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; VALENT P, 1989, BLOOD, V73, P1763; Vogen S, 2002, J BIOL CHEM, V277, P40742, DOI 10.1074/jbc.M205323200; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Yanagihara Y, 1998, CLIN EXP IMMUNOL, V111, P136; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39442	10.1371/journal.pone.0039442	http://dx.doi.org/10.1371/journal.pone.0039442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724016	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300141
J	Peterson, SH; Lance, MM; Jeffries, SJ; Acevedo-Gutierrez, A				Peterson, Sarah H.; Lance, Monique M.; Jeffries, Steven J.; Acevedo-Gutierrez, Alejandro			Long Distance Movements and Disjunct Spatial Use of Harbor Seals (Phoca vitulina) in the Inland Waters of the Pacific Northwest	PLOS ONE			English	Article							FORAGING ACTIVITY; WASHINGTON-STATE; MARINE PREDATOR; ARGOS LOCATIONS; MORAY FIRTH; HOME-RANGE; GREY SEALS; RICHARDSI; ALASKA; OREGON	Background: Worldwide, adult harbor seals (Phoca vitulina) typically limit their movements and activity to <50 km from their primary haul-out site. As a result, the ecological impact of harbor seals is viewed as limited to relatively small spatial scales. Harbor seals in the Pacific Northwest are believed to remain <30 km from their primary haul-out site, one of several contributing factors to the current stock designation. However, movement patterns within the region are not well understood because previous studies have used radio-telemetry, which has range limitations. Our objective was to use satellite-telemetry to determine the regional spatial scale of movements. Methodology/Principal Findings: Satellite tags were deployed on 20 adult seals (n = 16 males and 4 females) from two rocky reefs and a mudflat-bay during April-May 2007. Standard filtering algorithms were used to remove outliers, resulting in an average (+/- SD) of 693 (+/- 377) locations per seal over 110 (+/- 32) days. A particle filter was implemented to interpolate locations temporally and decrease erroneous locations on land. Minimum over-water distances were calculated between filtered locations and each seal's capture site to show movement of seals over time relative to their capture site, and we estimated utilization distributions from kernel density analysis to reflect spatial use. Eight males moved > 100 km from their capture site at least once, two of which traveled round trip to and from the Pacific coast, a total distance >400 km. Disjunct spatial use patterns observed provide new insight into general harbor seal behavior. Conclusions/Significance: Long-distance movements and disjunct spatial use of adult harbor seals have not been reported for the study region and are rare worldwide in such a large proportion of tagged individuals. Thus, the ecological influence of individual seals may reach farther than previously assumed.	[Peterson, Sarah H.; Acevedo-Gutierrez, Alejandro] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Lance, Monique M.; Jeffries, Steven J.] Washington Dept Fish & Wildlife, Wildlife Sci Program, Lakewood, WA USA	Western Washington University; Washington Department of Fish & Wildlife (WDFW)	Peterson, SH (corresponding author), Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95064 USA.	saepeter@ucsc.edu		Acevedo-Gutierrez, Alejandro/0000-0002-9128-826X; Peterson, Sarah/0000-0003-2773-3901	National Science Foundation; Padilla Bay National Estuarine Research; Western Washington University BiologyDepartment; Office of Research for Sponsored Programs; Washington Department of Fish and Wildlife	National Science Foundation(National Science Foundation (NSF)); Padilla Bay National Estuarine Research; Western Washington University BiologyDepartment; Office of Research for Sponsored Programs; Washington Department of Fish and Wildlife	This project was supported in part by Award #0550443 from the National Science Foundation (http://www.nsf.gov/) (A.A.) and by funds from a Research Assistantship in Estuarine Science and Coastal Zone Management from the Padilla Bay National Estuarine Research Reserve (http://www.padillabay.gov/) (S.P.), a GK-12 Fellowship from the National Science Foundation (http://www.gk12.org/) (S.P.), the Western Washington University BiologyDepartment (http://www.biol.wwu.edu/biology/ (S.P.), the Office of Research for Sponsored Programs (http://www.wwu.edu/rsp/) (S.P.) and the Washington Department of Fish and Wildlife (http://wdfw.wa.gov) (S.J. and M.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SG, 1987, US DEP COMMERCE TECH, V5; Argos, 2007, US MAN; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bigg MA, 1969, HARBOUR SEAL BRIT CO; BROWN RF, 1983, FISH B-NOAA, V81, P291; Burg TM, 1999, CAN J ZOOL, V77, P930, DOI 10.1139/cjz-77-6-930; Cordes LS, 2011, ANIM CONSERV, V14, P430, DOI 10.1111/j.1469-1795.2011.00445.x; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Cottrell PE, 1995, DIET ACTIVITY BUDGET; Cunningham L, 2009, AQUAT CONSERV, V19, P398, DOI 10.1002/aqc.983; Duffy EJ, 2005, ESTUAR COAST SHELF S, V64, P94, DOI 10.1016/j.ecss.2005.02.009; Fowler SL, 2007, MAR MAMMAL SCI, V23, P598, DOI 10.1111/j.1748-7692.2007.00134.x; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Greig D.J., 2002, PREGNANCY PARTURITIO; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Harkonen T, 2001, CAN J ZOOL, V79, P2115, DOI 10.1139/cjz-79-12-2115; Hauser Donna D. W., 2008, Aquatic Mammals, V34, P303, DOI 10.1578/AM.34.3.2008.303; Hay D. E., 1985, CANADIAN J FISHERIES, V42, ps111, DOI DOI 10.1139/F85-267; Herreman JK, 2009, CAN J ZOOL, V87, P498, DOI 10.1139/Z09-033; Huber HR, 2010, CAN J ZOOL, V88, P280, DOI 10.1139/Z09-141; Huber HR, 2001, MAR MAMMAL SCI, V17, P276, DOI 10.1111/j.1748-7692.2001.tb01271.x; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jeffries S, 1986, SEASONAL MOVEMENTS P; Jeffries S. J., 2000, ATLAS SEAL SEA LION; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Johnson A, 2007, CAN J ZOOL, V85, P290, DOI 10.1139/Z06-213; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Lamont MM, 1996, MAR MAMMAL SCI, V12, P402, DOI 10.1111/j.1748-7692.1996.tb00592.x; Lance M.M., 2007, TEMPORAL SPATIAL VAR; Lance MM, 2006, ESTIMATING IMPORTANC; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Lesage W, 2004, CAN J ZOOL, V82, P1070, DOI 10.1139/Z04-084; London JM, 2001, OBSERVATIONS HARBOR; Lowry LF, 2001, MAR MAMMAL SCI, V17, P835, DOI 10.1111/j.1748-7692.2001.tb01301.x; Luxa K, 2008, FOOD HABITS HARBOR S; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; McLanahan EC, 1984, RADIOBIOTELEMETRY IN; Orr AJ, 2004, FISH B-NOAA, V102, P108; Perry MJ, 2008, LIMNOL OCEANOGR, V53, P2169, DOI 10.4319/lo.2008.53.5_part_2.2169; Reuland K, 2008, SEASONAL VARIATION F; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Sackmann B, 2004, DEEP-SEA RES PT II, V51, P945, DOI 10.1016/j.dsr2.2003.09.004; Scheffer TH, 1944, AM MIDL NAT, V32, P373; Small RJ, 2005, MAR MAMMAL SCI, V21, P671, DOI 10.1111/j.1748-7692.2005.tb01259.x; STEWART BS, 1989, MAR MAMMAL SCI, V5, P361, DOI 10.1111/j.1748-7692.1989.tb00348.x; Suryan RM, 1998, MAR MAMMAL SCI, V14, P361, DOI 10.1111/j.1748-7692.1998.tb00728.x; TEMTE JL, 1991, J ZOOL, V224, P617, DOI 10.1111/j.1469-7998.1991.tb03790.x; Thomas AC, 2011, MAR ECOL PROG SER, V441, P225, DOI 10.3354/meps09370; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; Thompson PM, 1996, J APPL ECOL, V33, P1572, DOI 10.2307/2404795; THOMPSON PM, 1990, J APPL ECOL, V27, P492, DOI 10.2307/2404296; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; Tougaard J, 2003, SATELLITE TRACKING H; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; WALKER BG, 1993, J ZOOL, V231, P423, DOI 10.1111/j.1469-7998.1993.tb01929.x; Wand M. P., 1994, KERNEL SMOOTHING; Ward EJ, 2012, CONSERV LETT, V5, P37, DOI 10.1111/j.1755-263X.2011.00210.x; WILLIAMS TM, 1985, PHYSIOL ZOOL, V58, P576, DOI 10.1086/physzool.58.5.30158584; Wright BE, 2007, ECOL APPL, V17, P338, DOI 10.1890/05-1941	60	37	38	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39046	10.1371/journal.pone.0039046	http://dx.doi.org/10.1371/journal.pone.0039046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723925	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300083
J	Grose, WE; Clark, KR; Griffin, D; Malik, V; Shontz, KM; Montgomery, CL; Lewis, S; Brown, RH; Janssen, PML; Mendell, JR; Rodino-Klapac, LR				Grose, William E.; Clark, K. Reed; Griffin, Danielle; Malik, Vinod; Shontz, Kimberly M.; Montgomery, Chrystal L.; Lewis, Sarah; Brown, Robert H., Jr.; Janssen, Paul M. L.; Mendell, Jerry R.; Rodino-Klapac, Louise R.			Homologous Recombination Mediates Functional Recovery of Dysferlin Deficiency following AAV5 Gene Transfer	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; DEFECTIVE MEMBRANE REPAIR; SKELETAL-MUSCLE; PACKAGING CAPACITY; MIYOSHI MYOPATHY; EXPRESSION; MUTATIONS; THERAPY; MICE; MDX	The dysferlinopathies comprise a group of untreatable muscle disorders including limb girdle muscular dystrophy type 2B, Miyoshi myopathy, distal anterior compartment syndrome, and rigid spine syndrome. As with other forms of muscular dystrophy, adeno-associated virus (AAV) gene transfer is a particularly auspicious treatment strategy, however the size of the DYSF cDNA (6.5 kb) negates packaging into traditional AAV serotypes known to express well in muscle (i.e. rAAV1, 2, 6, 8, 9). Potential advantages of a full cDNA versus a mini-gene include: maintaining structural-functional protein domains, evading protein misfolding, and avoiding novel epitopes that could be immunogenic. AAV5 has demonstrated unique plasticity with regards to packaging capacity and recombination of virions containing homologous regions of cDNA inserts has been implicated in the generation of full-length transcripts. Herein we show for the first time in vivo that homologous recombination following AAV5. DYSF gene transfer leads to the production of full length transcript and protein. Moreover, gene transfer of full-length dysferlin protein in dysferlin deficient mice resulted in expression levels sufficient to correct functional deficits in the diaphragm and importantly in skeletal muscle membrane repair. Intravascular regional gene transfer through the femoral artery produced high levels of transduction and enabled targeting of specific muscle groups affected by the dysferlinopathies setting the stage for potential translation to clinical trials. We provide proof of principle that AAV5 mediated delivery of dysferlin is a highly promising strategy for treatment of dysferlinopathies and has far-reaching implications for the therapeutic delivery of other large genes.	[Grose, William E.; Clark, K. Reed; Griffin, Danielle; Malik, Vinod; Shontz, Kimberly M.; Montgomery, Chrystal L.; Lewis, Sarah; Mendell, Jerry R.; Rodino-Klapac, Louise R.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Mendell, Jerry R.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Janssen, Paul M. L.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Grose, William E.; Clark, K. Reed; Griffin, Danielle; Malik, Vinod; Shontz, Kimberly M.; Montgomery, Chrystal L.; Lewis, Sarah; Mendell, Jerry R.; Rodino-Klapac, Louise R.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Grose, WE (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.	Jerry.Mendell@nationwidechildrens.org; Louise.Rodino-Klapac@nationwidechildrens.org	Rodino-Klapac, Louise/E-3968-2011; Clark, Kelly/E-2900-2011; Janssen, Paul ML/E-3307-2011	Janssen, Paul/0000-0002-9682-3014; Rodino-Klapac, Louise/0000-0002-8966-5177	Day Foundation; MDA; Jesse's Journey Foundation for Gene and Cell Therapy; National Institutes of Health (NIH) [P30 NS045758]; National Center For Research Resources [UL1RR025755]; NIH [1F32AR055008]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR055008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758] Funding Source: NIH RePORTER	Day Foundation; MDA(Muscular Dystrophy Association); Jesse's Journey Foundation for Gene and Cell Therapy; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Day Foundation, MDA, and Jesse's Journey Foundation for Gene and Cell Therapy. The muscle physiology core is supported by National Institutes of Health (NIH) P30 NS045758. The project described was also supported by Award Number UL1RR025755 from the National Center For Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health. Dr. Rodino-Klapac was supported by an NIH sponsored NRSA Fellowship (1F32AR055008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Bushby K M D, 2003, Neuromuscul Disord, V13, P80, DOI 10.1016/S0960-8966(02)00183-9; Cenacchi G, 2005, J CLIN PATHOL, V58, P190, DOI 10.1136/jcp.2004.018978; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; Dong BA, 2010, MOL THER, V18, P87, DOI 10.1038/mt.2009.258; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Duan DS, 2000, NAT MED, V6, P595, DOI 10.1038/75080; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Ghosh A, 2007, MOL THER, V15, P750, DOI 10.1038/sj.mt.6300081; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hermonat PL, 1997, FEBS LETT, V407, P78, DOI 10.1016/S0014-5793(97)00311-6; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Klinge L, 2008, NEUROMUSCULAR DISORD, V18, P288, DOI 10.1016/j.nmd.2008.01.004; Krahn M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000951; Lai Y, 2010, MOL THER, V18, P75, DOI 10.1038/mt.2009.256; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, GENOMICS, V49, P23, DOI 10.1006/geno.1998.5204; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Martin PT, 2009, AM J PHYSIOL-CELL PH, V296, pC476, DOI 10.1152/ajpcell.00456.2008; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mendell JR, 2009, ANN NEUROL, V66, P290, DOI 10.1002/ana.21732; Moore SA, 2006, J NEUROPATH EXP NEUR, V65, P995, DOI 10.1097/01.jnen.0000235854.77716.6c; Nagashima T, 2004, NEUROPATHOLOGY, V24, P341, DOI 10.1111/j.1440-1789.2004.00573.x; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Rafael-Fortney JA, 2011, CIRCULATION, V124, P582, DOI 10.1161/CIRCULATIONAHA.111.031716; Roche JA, 2011, J HISTOCHEM CYTOCHEM, V59, P964, DOI 10.1369/0022155411423274; Rodino-Klapac LR, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-45; Rodino-Klapac LR, 2010, MOL THER, V18, P109, DOI 10.1038/mt.2009.254; Rosales XQ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-39; Rosales XQ, 2010, MUSCLE NERVE, V42, P14, DOI 10.1002/mus.21650; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Seror P, 2008, MUSCLE NERVE, V37, P410, DOI 10.1002/mus.20910; Takahashi T, 2003, NEUROLOGY, V60, P1799, DOI 10.1212/01.WNL.0000068333.43005.12; Therrien C, 2006, J NEUROL SCI, V250, P71, DOI 10.1016/j.jns.2006.07.004; WELLS DJ, 1995, HUM MOL GENET, V4, P1245, DOI 10.1093/hmg/4.8.1245; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255	48	45	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39233	10.1371/journal.pone.0039233	http://dx.doi.org/10.1371/journal.pone.0039233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720081	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000052
J	Wang, XL; Tu, F; Zhu, YP; Gao, GX				Wang, Xinlu; Tu, Fan; Zhu, Yiping; Gao, Guangxia			Zinc-Finger Antiviral Protein Inhibits XMRV Infection	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; VIRAL MESSENGER-RNAS; PROSTATE-CANCER; RETROVIRUS XMRV; NO EVIDENCE; CELLS; SUSCEPTIBILITY; REPLICATION; HELICASE	Background: The zinc-finger antiviral protein (ZAP) is a host factor that specifically inhibits the replication of certain viruses, including Moloney murine leukemia virus (MoMLV), HIV-1, and certain alphaviruses and filoviruses. ZAP binds to specific viral mRNAs and recruits cellular mRNA degradation machinery to degrade the target RNA. The common features of ZAP-responsive RNA sequences remain elusive and thus whether a virus is susceptible to ZAP can only be determined experimentally. Xenotropic murine leukemia virus-related virus (XMRV) is a recently identified gamma-retrovirus that was originally thought to be involved in prostate cancer and chronic fatigue syndrome but recently proved to be a laboratory artefact. Nonetheless, XMRV as a new retrovirus has been extensively studied. Since XMRV and MoMLV share only 67.9% sequence identity in the 3'UTRs, which is the target sequence of ZAP in MoMLV, whether XMRV is susceptible to ZAP remains to be determined. Findings: We constructed an XMRV-luc vector, in which the coding sequences of Gag-Pol and part of Env were replaced with luciferase-coding sequence. Overexpression of ZAP potently inhibited the expression of XMRV-luc in a ZAP expression-level-dependent manner, while downregulation of endogenous ZAP rendered cells more sensitive to infection. Furthermore, ZAP inhibited the spreading of replication-competent XMRV. Consistent with the previously reported mechanisms by which ZAP inhibits viral infection, ZAP significantly inhibited the accumulation of XMRV-luc mRNA in the cytoplasm. The ZAP-responsive element in XMRV mRNA was mapped to the 3'UTR. Conclusions: ZAP inhibits XMRV replication by preventing the accumulation of viral mRNA in the cytoplasm. Documentation of ZAP inhibiting XMRV helps to broaden the spectrum of ZAP's antiviral activity. Comparison of the target sequences of ZAP in XMRV and MoMLV helps to better understand the features of ZAP-responsive elements.	[Wang, Xinlu; Tu, Fan; Zhu, Yiping; Gao, Guangxia] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Tu, Fan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XL (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	gaogx@moon.ibp.ac.cn			National Science Foundation [30530020, 81028011]; Ministry of Science and Technology (973 Program) of China	National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology (973 Program) of China(National Basic Research Program of China)	This work was supported by grants to Guangxia Gao from the National Science Foundation (30530020 and 81028011), and the Ministry of Science and Technology (973 Program 2012CB910203) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Chen S, 2012, NAT STRUCT MOL BIOL; Cote M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033734; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; GOFF S, 1981, J VIROL, V38, P239, DOI 10.1128/JVI.38.1.239-248.1981; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Li M, 2011, NAT STRUCT MOL BIOL, V18, P227, DOI 10.1038/nsmb.1964; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; Nakayama EE, 2010, REV MED VIROL, V20, P77, DOI 10.1002/rmv.637; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-70; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	35	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39159	10.1371/journal.pone.0039159	http://dx.doi.org/10.1371/journal.pone.0039159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720057	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000044
J	Rossi, E; Giorda, R; Bonaglia, MC; Di Candia, S; Grechi, E; Franzese, A; Soli, F; Rivieri, F; Patricelli, MG; Saccilotto, D; Bonfante, A; Giglio, S; Beri, S; Rocchi, M; Zuffardi, O				Rossi, Elena; Giorda, Roberto; Bonaglia, Maria Clara; Di Candia, Stefania; Grechi, Elena; Franzese, Adriana; Soli, Fiorenza; Rivieri, Francesca; Patricelli, Maria Grazia; Saccilotto, Donatella; Bonfante, Aldo; Giglio, Sabrina; Beri, Silvana; Rocchi, Mariano; Zuffardi, Orsetta			De Novo Unbalanced Translocations in Prader-Willi and Angelman Syndrome Might Be the Reciprocal Product of inv dup(15)s	PLOS ONE			English	Article							RECEPTOR-GENE CLUSTERS; INVERTED DUPLICATIONS; MARKER CHROMOSOMES; MOLECULAR CHARACTERIZATION; 15Q11-Q13 REARRANGEMENTS; INVERSION POLYMORPHISMS; SEGMENTAL DUPLICATIONS; JUMPING TRANSLOCATION; UNIPARENTAL DISOMY; ARRAY-CGH	The 15q11-q13 region is characterized by high instability, caused by the presence of several paralogous segmental duplications. Although most mechanisms dealing with cryptic deletions and amplifications have been at least partly characterized, little is known about the rare translocations involving this region. We characterized at the molecular level five unbalanced translocations, including a jumping one, having most of 15q transposed to the end of another chromosome, whereas the der(15)(pter->q11-q13) was missing. Imbalances were associated either with Prader-Willi or Angelman syndrome. Array-CGH demonstrated the absence of any copy number changes in the recipient chromosome in three cases, while one carried a cryptic terminal deletion and another a large terminal deletion, already diagnosed by classical cytogenetics. We cloned the breakpoint junctions in two cases, whereas cloning was impaired by complex regional genomic architecture and mosaicism in the others. Our results strongly indicate that some of our translocations originated through a prezygotic/postzygotic two-hit mechanism starting with the formation of an acentric 15qter->q1::q1->qter representing the reciprocal product of the inv dup(15) supernumerary marker chromosome. An embryo with such an acentric chromosome plus a normal chromosome 15 inherited from the other parent could survive only if partial trisomy 15 rescue would occur through elimination of part of the acentric chromosome, stabilization of the remaining portion with telomere capture, and formation of a derivative chromosome. All these events likely do not happen concurrently in a single cell but are rather the result of successive stabilization attempts occurring in different cells of which only the fittest will finally survive. Accordingly, jumping translocations might represent successful rescue attempts in different cells rather than transfer of the same 15q portion to different chromosomes. We also hypothesize that neocentromerization of the original acentric chromosome during early embryogenesis may be required to avoid its loss before cell survival is finally assured.	[Rossi, Elena; Zuffardi, Orsetta] Univ Pavia, I-27100 Pavia, Italy; [Giorda, Roberto; Bonaglia, Maria Clara; Beri, Silvana] Sci Inst Eugenio Medea, Bosisio Parini, Lecco, Italy; [Di Candia, Stefania; Grechi, Elena] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Pediat, Milan, Italy; [Franzese, Adriana] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Soli, Fiorenza; Rivieri, Francesca] APSS Trento, Dept Med Genet, Trento, Italy; [Patricelli, Maria Grazia] San Raffaele SPA, Biol Mol Clin & Citogenet Diagnost & Ric, Milan, Italy; [Saccilotto, Donatella; Bonfante, Aldo] Osped Civile, Bassano Del Grappa, Italy; [Giglio, Sabrina] Univ Florence, Meyer Childrens Hosp, Med Genet Unit, Florence, Italy; [Rocchi, Mariano] Univ Bari, Dept Biol, Bari, Italy; [Zuffardi, Orsetta] IRCCS C Mondino Natl Neurol Inst Fdn, Pavia, Italy	University of Pavia; IRCCS Eugenio Medea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Naples Federico II; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Universita degli Studi di Bari Aldo Moro; IRCCS Fondazione Casimiro Mondino	Rossi, E (corresponding author), Univ Pavia, Via Palestro 3, I-27100 Pavia, Italy.	zuffardi@unipv.it	Rossi, Elena/O-1664-2016; Bonaglia, Maria Clara/K-2775-2016; Giorda, Roberto/Q-6010-2019; Giorda, Roberto/J-1052-2014; Giglio, Sabrina Rita/ABB-1093-2020; Giglio, Sabrina SG/K-9109-2016	Rossi, Elena/0000-0001-9152-435X; Bonaglia, Maria Clara/0000-0002-7121-7712; Giorda, Roberto/0000-0001-8175-9606; Giorda, Roberto/0000-0001-8175-9606; Giglio, Sabrina Rita/0000-0002-3954-326X; Giglio, Sabrina SG/0000-0002-3954-326X; zuffardi, orsetta/0000-0002-1466-4559; Rocchi, Mariano/0000-0002-9451-5616	Cassa di Risparmio delle Provincie Lombarde [CARIPLO:2007.5197]; Ministry of Health [RF-AOM-2007-636538]	Cassa di Risparmio delle Provincie Lombarde(Fondazione Cariplo); Ministry of Health	Orsetta Zuffardi is funded by Cassa di Risparmio delle Provincie Lombarde(CARIPLO:2007.5197, bando 2007) and by Ministry of Health Grant (RF-AOM-2007-636538 "Genomic structural variation studies in mentally retarded and normal individuals in Italy''). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, USER B, V02, P1; BLENNOW E, 1994, AM J HUM GENET, V54, P877; Boyd L, 2005, AM J MED GENET A, V138A, P181, DOI 10.1002/ajmg.a.30819; Carrozzo R, 1997, AM J HUM GENET, V61, P228, DOI 10.1086/513907; CROLLA JA, 1995, HUM GENET, V95, P161; Devriendt K, 1997, J MED GENET, V34, P395, DOI 10.1136/jmg.34.5.395; FRACCARO M, 1983, HUM GENET, V64, P388, DOI 10.1007/BF00292373; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Hasson D, 2011, CHROMOSOMA, V120, P621, DOI 10.1007/s00412-011-0337-6; Horsthemke B, 2003, HUM MOL GENET, V12, P2723, DOI 10.1093/hmg/ddg291; Kleefstra T, 2010, AM J MED GENET A, V152A, P2221, DOI 10.1002/ajmg.a.33529; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Liehr T, 2005, EUR J MED GENET, V48, P175, DOI 10.1016/j.ejmg.2005.01.004; Liehr T, 2010, CYTOGENET GENOME RES, V128, P189, DOI 10.1159/000271471; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Makoff A, 2009, EUR J HUM GENET, V17, P149, DOI 10.1038/ejhg.2008.189; Makoff AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r114; MARASCHIO P, 1981, HUM GENET, V57, P345, DOI 10.1007/BF00281681; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Mignon-Ravix C, 2007, EUR J HUM GENET, V15, P432, DOI 10.1038/sj.ejhg.5201775; Murmann AE, 2009, HUM MOL GENET, V18, P2241, DOI 10.1093/hmg/ddp160; Oracova E, 2009, J ANDROL, V30, P233, DOI 10.2164/jandrol.108.006783; Pasantes JJ, 2012, CYTOGENET GENOME RES, V136, P157, DOI 10.1159/000335705; Pramparo T, 2004, EUR J HUM GENET, V12, P713, DOI 10.1038/sj.ejhg.5201240; Pujana MA, 2002, EUR J HUM GENET, V10, P26, DOI 10.1038/sj.ejhg.5200760; Reddy KS, 2010, AM J MED GENET A, V152A, P2924, DOI 10.1002/ajmg.a.33710; RIVERA H, 1990, AM J MED GENET, V37, P311, DOI 10.1002/ajmg.1320370304; Roberts SE, 2003, AM J HUM GENET, V73, P1061, DOI 10.1086/379155; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; Robinson WP, 1998, J MED GENET, V35, P130, DOI 10.1136/jmg.35.2.130; Sahoo T, 2007, EUR J HUM GENET, V15, P943, DOI 10.1038/sj.ejhg.5201859; Saitoh S, 2007, CLIN GENET, V72, P378, DOI 10.1111/j.1399-0004.2007.00860.x; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Soler A, 2003, PRENATAL DIAG, V23, P319, DOI 10.1002/pd.590; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Wandstrat AE, 2000, CHROMOSOMA, V109, P498, DOI 10.1007/s004120000103; Wang NJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-2; Wang NJ, 2004, AM J HUM GENET, V75, P267, DOI 10.1086/422854; Webb T, 1998, CLIN GENET, V53, P34, DOI 10.1034/j.1399-0004.1998.531530107.x; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601; Zuffardi O, 2009, CLIN GENET, V75, P505, DOI 10.1111/j.1399-0004.2009.01187.x	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39180	10.1371/journal.pone.0039180	http://dx.doi.org/10.1371/journal.pone.0039180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720067	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347800052
J	Nakamura, GR; Fonseca, DPAJ; O'Rourke, SM; Vollrath, AL; Berman, PW				Nakamura, Gerald R.; Fonseca, Dora P. A. J.; O'Rourke, Sara M.; Vollrath, Aaron L.; Berman, Phillip W.			Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of alpha 4 beta 7 Binding	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECOMBINANT GLYCOPROTEIN-120 VACCINE; PREVENT HIV-1 INFECTION; T-CELL-ACTIVATION; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; V1/V2 DOMAIN; INTEGRIN ALPHA(4)BETA(7); EFFICACY TRIAL; UNITED-STATES	Background: Recombinant gp120 (MN-rgp120) was a major component of the AIDSVAX B/E vaccine used in the RV144 trial. This was the first clinical trial to show that vaccination could prevent HIV infection in humans. A recent RV144 correlates of protection study found that protection correlated with the presence of antibodies to the V2 domain. It has been proposed that antibodies to the alpha 4 beta 7 binding site in the V2 domain might prevent HIV-1 infection by blocking the ability of virions to recognize alpha 4 beta 7 on activated T-cells. In this study we investigated the specificity of monoclonal antibodies (MAbs) to the V2 domain of MN-rgp120 and examined the possibility that these antibodies could inhibit the binding of MN-rgp120 to the alpha 4 beta 7 integrin. Methodology/Principal Findings: Nine MAbs to the V2 domain were isolated from mice immunized with recombinant envelope proteins. The ability of these MAbs to inhibit HIV infection, block the binding of gp120 to CD4, and block the binding of MN-rgp120 to the alpha 4 beta 7 integrin was measured. Mutational analysis showed that eight of the MAbs recognized two immunodominant clusters of amino acids (166-168 and 178-183) located at either end of the C strand within the four-strand anti-parallel sheet structure comprising the V1/V2 domain. Conclusions/Significance: These studies showed that the antigenic structure of the V2 domain is exceedingly complex and that MAbs isolated from mice immunized with MN-rgp120 exhibited a high level of strain specificity compared to MAbs to the V2 domain isolated from HIV-infected humans. We found that immunization with MN-rgp120 readily elicits antibodies to the V2 domain and some of these were able to block the binding of MN-rgp120 to the alpha 4 beta 7 integrin.	[Nakamura, Gerald R.] Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA; [Fonseca, Dora P. A. J.; O'Rourke, Sara M.; Vollrath, Aaron L.; Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	Roche Holding; Genentech; University of California System; University of California Santa Cruz	Nakamura, GR (corresponding author), Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA.	pwb@soe.ucsc.edu						Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; BELSHE RB, 1994, JAMA-J AM MED ASSOC, V272, P475, DOI 10.1001/jama.272.6.475; Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; Berman PW, 1996, J INFECT DIS, V173, P52, DOI 10.1093/infdis/173.1.52; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; Berman PW, 1997, J INFECT DIS, V176, P384, DOI 10.1086/514055; BERMAN PW, 1992, J VIROL, V66, P4464, DOI 10.1128/JVI.66.7.4464-4469.1992; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Callaway E., 2011, NATURENEWS, DOI [10.1038/news.2011.541, DOI 10.1038/NEWS.2011.541]; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; ERLE DJ, 1994, J IMMUNOL, V153, P517; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Francis DP, 1998, AIDS RES HUM RETROV, V14, pS325; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; GOWDA SD, 1989, J IMMUNOL, V142, P773; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GURGO C, 1988, VIROLOGY, V164, P531, DOI 10.1016/0042-6822(88)90568-5; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Honnen WJ, 2007, J VIROL, V81, P1424, DOI 10.1128/JVI.02054-06; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; MCKEATING JA, 1993, J VIROL, V67, P4932, DOI 10.1128/JVI.67.8.4932-4944.1993; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori D, 2012, J INFECT DI IN PRESS; Montefiori D.C., 2004, CURRENT PROTOCOLS IM; MOORE JP, 1993, J VIROL, V67, P3656, DOI 10.1128/JVI.67.6.3656-3659.1993; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; NAKAMURA GR, 1992, AIDS RES HUM RETROV, V8, P1875, DOI 10.1089/aid.1992.8.1875; NAKAMURA GR, 1993, J VIROL, V67, P6179, DOI 10.1128/JVI.67.10.6179-6191.1993; NAKANE PK, 1975, ANN NY ACAD SCI, V254, P203, DOI 10.1111/j.1749-6632.1975.tb29170.x; O'Rourke SM, 2010, J VIROL, V84, P11200, DOI 10.1128/JVI.00790-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Perez-Losada M, 2010, MOL BIOL EVOL, V27, P417, DOI 10.1093/molbev/msp254; Pinter A, 2005, J VIROL, V79, P6909, DOI 10.1128/JVI.79.11.6909-6917.2005; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; SHOTTON C, 1995, J VIROL, V69, P222, DOI 10.1128/JVI.69.1.222-230.1995; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; STUPACK DG, 1991, SCAND J IMMUNOL, V34, P761, DOI 10.1111/j.1365-3083.1991.tb01601.x; Tidswell M, 1997, J IMMUNOL, V159, P1497; VijhWarrier S, 1996, J VIROL, V70, P4466, DOI 10.1128/JVI.70.7.4466-4473.1996; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2011, NATURE; WU Z, 1995, J VIROL, V69, P2271, DOI 10.1128/JVI.69.4.2271-2278.1995; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zolla-Pazner S, 2012, J VIROL IN PRESS; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	60	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39045	10.1371/journal.pone.0039045	http://dx.doi.org/10.1371/journal.pone.0039045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720026	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900077
J	Song, ZQ; Li, Y; Liu, Y; Xin, JQ; Zou, XH; Sun, WJ				Song, Zhiqiang; Li, Yuan; Liu, Yang; Xin, Jiuqing; Zou, Xiaohui; Sun, Wenjing			alpha-Enolase, an Adhesion-Related Factor of Mycoplasma bovis	PLOS ONE			English	Article							PLASMINOGEN; SURFACE; BINDS; FERMENTANS; PNEUMONIA; MASTITIS; INVASION; PROTEIN; CELLS	Mycoplasma bovis is the causative agent of Mycoplasma bovis-associated disease (MbAD). Although the mechanisms underlying M. bovis adherence to host cells is not clear, recent studies have shown that the cell surface protein alpha-enolase facilitates bacterial invasion and dissemination in the infected host. In this study, we cloned, expressed and purified recombinant M. bovis alpha-enolase and induced polyclonal anti-alpha-enolase antibodies in rabbits. M. bovis alpha-enolase was detected in the cytoplasmic and membrane protein fractions by these antibodies. Triple immunofluorescence labeling combined with confocal laser scanning microscopy (CLSM) revealed that the plasminogen (Plg) enhanced the adherence of M. bovis to embryonic bovine lung (EBL) cells; the values obtained for adherence and inhibition are consistent with this finding. Interestingly, we found that trace amounts of trypsin acted as a more effective enhancer of cell adherence than Plg. Hence, our data indicate that surface-associated M. bovis alpha-enolase is an adhesion-related factor of M. bovis that contributes to adherence by binding Plg.	[Song, Zhiqiang; Li, Yuan; Xin, Jiuqing; Zou, Xiaohui; Sun, Wenjing] CAAS, Harbin Vet Res Inst, State Key Lab Vet Biotechnol,Div Bacterial Dis, Natl Contagious Bovine Pleuropneumonia Reference, Harbin, Peoples R China; [Liu, Yang] Natl Engn Res Ctr Vet Biolog, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Song, ZQ (corresponding author), CAAS, Harbin Vet Res Inst, State Key Lab Vet Biotechnol,Div Bacterial Dis, Natl Contagious Bovine Pleuropneumonia Reference, Harbin, Peoples R China.	xinjiuqing2001@126.com			National Natural Science Foundations of China [31072131]; Harbin Science and Technology Program, China [2010AA6AN019]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology Program, China	This work was supported by National Natural Science Foundations of China No. 31072131 (http://www.nsfc.gov.cn/Portal0/default152.htm) and by Harbin Science and Technology Program, China, No. 2010AA6AN019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammersbach M, 2008, VET PATHOL, V45, P663, DOI 10.1354/vp.45-5-663; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Gao Y, 2011, CHINESE J PREVENTIVE, V33, P225; HALE HH, 1962, CORNELL VET, V52, P582; Jones MN, 2007, BIOCHEM BIOPH RES CO, V364, P924, DOI 10.1016/j.bbrc.2007.10.098; Kornspan JD, 2010, INFECT IMMUN, V78, P611, DOI 10.1128/IAI.01017-09; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; Lottenberg R, 1997, TRENDS MICROBIOL, V5, P466, DOI 10.1016/S0966-842X(97)01171-2; Maunsell FP, 2009, VET CLIN N AM-FOOD A, V25, P139, DOI 10.1016/j.cvfa.2008.10.011; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; Nicholas RAJ, 2002, VACCINE, V20, P3569, DOI 10.1016/S0264-410X(02)00340-7; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pfutzner H, 1996, REV SCI TECH OIE, V15, P1477, DOI 10.20506/rst.15.4.987; Radaelli E, 2008, RES VET SCI, V85, P282, DOI 10.1016/j.rvsc.2007.11.012; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Thomas A, 2003, MICROB PATHOGENESIS, V34, P141, DOI 10.1016/S0882-4010(03)00003-2; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Winner F, 2000, INFECT IMMUN, V68, P4238, DOI 10.1128/IAI.68.7.4238-4244.2000; Xin JiuQing, 2008, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V30, P661; Yavlovich A, 2004, INFECT IMMUN, V72, P5004, DOI 10.1128/IAI.72.9.5004-5011.2004; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	24	47	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38836	10.1371/journal.pone.0038836	http://dx.doi.org/10.1371/journal.pone.0038836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719960	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900052
J	Padro, T; Lugano, R; Garcia-Arguinzonis, M; Badimon, L				Padro, Teresa; Lugano, Roberta; Garcia-Arguinzonis, Maisa; Badimon, Lina			LDL-Induced Impairment of Human Vascular Smooth Muscle Cells Repair Function Is Reversed by HMG-CoA Reductase Inhibition	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; MYOSIN LIGHT-CHAIN; AGGREGATED LDL; SULFATE PROTEOGLYCANS; STATIN THERAPY; HEART-DISEASE; RISK-FACTORS; RHO-GTPASES	Growing human atherosclerotic plaques show a progressive loss of vascular smooth muscle cells (VSMC) becoming soft and vulnerable. Lipid loaded-VSMC show impaired vascular repair function and motility due to changes in cytoskeleton proteins involved in cell-migration. Clinical benefits of statins reducing coronary events have been related to repopulation of vulnerable plaques with VSMC. Here, we investigated whether HMG-CoA reductase inhibition with rosuvastatin can reverse the effects induced by atherogenic concentrations of LDL either in the native (nLDL) form or modified by aggregation (agLDL) on human VSMC motility. Using a model of wound repair, we showed that treatment of human coronary VSMC with rosuvastatin significantly prevented (and reversed) the inhibitory effect of nLDL and agLDL in the repair of the cell depleted areas. In addition, rosuvastatin significantly abolished the agLDL-induced dephosphorylation of myosin regulatory light chain as demonstrated by 2DE-electrophoresis and mass spectrometry. Besides, confocal microscopy showed that rosuvastatin enhances actin-cytoskeleton reorganization during lipid-loaded-VSMC attachment and spreading. The effects of rosuvastatin on actin-cytoskeleton dynamics and cell migration were dependent on ROCK-signalling. Furthermore, rosuvastatin caused a significant increase in RhoA-GTP in the cytosol of VSMC. Taken together, our study demonstrated that inhibition of HMG-CoA reductase restores the migratory capacity and repair function of VSMC that is impaired by native and aggregated LDL. This mechanism may contribute to the stabilization of lipid-rich atherosclerotic plaques afforded by statins.	[Padro, Teresa; Lugano, Roberta; Garcia-Arguinzonis, Maisa; Badimon, Lina] Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain; [Padro, Teresa; Lugano, Roberta; Garcia-Arguinzonis, Maisa; Badimon, Lina] Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain; [Lugano, Roberta; Garcia-Arguinzonis, Maisa; Badimon, Lina] Inst Carlos III, CiberOBN, Barcelona, Spain; [Badimon, Lina] Autonomous Univ Barcelona, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Autonomous University of Barcelona	Padro, T (corresponding author), Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain.	lbadimon@csic-iccc.org	BADIMON, LINA/S-2950-2019; BADIMON, LINA/O-4711-2014	BADIMON, LINA/0000-0002-9162-2459; Padro, Teresa/0000-0003-1921-954X; Lugano, Roberta/0000-0002-7294-345X	Spanish Ministery of Science [SAF SAF2010-16549]; Instituto Carlos III (Spanish Ministry of Health) [FIS-PI071070, FISPI10-01115]; CIBEROBN [CB06/03]; REDINSCOR [RD06/0003/0015]; TERCEL [RD06/0010/0017]; Spanish Society of Atherosclerosis (SEA); Fundacion Jesus Serra; CIBEROBN; ICCC	Spanish Ministery of Science(Spanish Government); Instituto Carlos III (Spanish Ministry of Health)(Instituto de Salud Carlos IIISpanish Government); CIBEROBN; REDINSCOR; TERCEL; Spanish Society of Atherosclerosis (SEA); Fundacion Jesus Serra; CIBEROBN; ICCC	This work was supported by grants from the Spanish Ministery of Science (SAF SAF2010-16549 to LB); from the Instituto Carlos III (Spanish Ministry of Health), FIS-PI071070 and FISPI10-01115 (to TP), CIBEROBN CB06/03 (to LB), REDINSCOR RD06/0003/0015 (to TP), TERCEL RD06/0010/0017 (to LB); Spanish Society of Atherosclerosis (SEA) and "Fundacion Jesus Serra". This project is part of the PROMISE European Training Program (Germany and Spain). RL is recipient of a predoctoral grant from the CIBEROBN (2008-2009) and ICCC (2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Badimon L, 2006, CURR MOL MED, V6, P439, DOI 10.2174/156652406778018725; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bentzon JF, 2007, CIRCULATION, V116, P2053, DOI 10.1161/CIRCULATIONAHA.107.722355; Brookes ZLS, 2009, BRIT J ANAESTH, V103, P99, DOI 10.1093/bja/aep149; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Burke AP, 2001, HERZ, V26, P239, DOI 10.1007/PL00002026; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Camejo G, 1998, ATHEROSCLEROSIS, V139, P205, DOI 10.1016/S0021-9150(98)00107-5; Camino-Lopez S, 2007, CARDIOVASC RES, V73, P208, DOI 10.1016/j.cardiores.2006.10.017; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Corti R, 2001, CIRCULATION, V104, P249, DOI 10.1161/01.CIR.104.3.249; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FLUGELMAN MY, 1993, CIRCULATION, V88, P2493, DOI 10.1161/01.CIR.88.6.2493; Garcia-Arguinzonis M, 2010, ARTERIOSCL THROM VAS, V30, P1212, DOI 10.1161/ATVBAHA.109.198440; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gronros J, 2008, AM J PHYSIOL-HEART C, V295, pH2046, DOI 10.1152/ajpheart.00133.2008; GUYTON JR, 1991, J LIPID RES, V32, P953; Heasman Sarah J, 2010, Small GTPases, V1, P174, DOI 10.4161/sgtp.1.3.14724; Hirano Katsuya, 2004, Journal of Smooth Muscle Research, V40, P219, DOI 10.1540/jsmr.40.219; Kadoglou NPE, 2010, J VASC SURG, V51, P114, DOI 10.1016/j.jvs.2009.07.119; Kiyan J, 2007, ATHEROSCLEROSIS, V195, P254, DOI 10.1016/j.atherosclerosis.2006.12.030; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Llorente-Cortes V, 1998, ARTERIOSCL THROM VAS, V18, P738, DOI 10.1161/01.ATV.18.5.738; Llorente-Cortes V, 2004, EUR J CLIN INVEST, V34, P182, DOI 10.1111/j.1365-2362.2004.01316.x; Llorente-Cortes V, 2002, CIRCULATION, V106, P3104, DOI 10.1161/01.CIR.0000041434.28573.0B; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P1905, DOI 10.1161/01.ATV.0000035391.46201.9A; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P387, DOI 10.1161/hq0302.105367; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Llorente-Cortes V, 2011, EUR J CLIN INVEST, V41, P1087, DOI 10.1111/j.1365-2362.2011.02513.x; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; LUPU F, 1994, ARTERIOSCLER THROMB, V14, P1438, DOI 10.1161/01.ATV.14.9.1438; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Menna PL, 2009, MOL MED REP, V2, P97, DOI 10.3892/mmr_00000068; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Oorni K, 2000, J LIPID RES, V41, P1703; Padro T, 2008, CARDIOVASC RES, V77, P211, DOI 10.1093/cvr/cvm045; PEDERSEN TR, 1994, LANCET, V344, P1383; Pentikainen MO, 1996, J LIPID RES, V37, P2638; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Schafer K, 2005, THROMB HAEMOSTASIS, V93, P145, DOI 10.1160/TH04-07-0415; Seasholtz TM, 2004, MOL INTERV, V4, P348, DOI 10.1124/mi.4.6.8; Sendra J, 2008, CARDIOVASC RES, V78, P581, DOI 10.1093/cvr/cvn043; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Suzuki Hideo, 2003, J Atheroscler Thromb, V10, P109; Turner SJ, 2008, BIOCHEM PHARMACOL, V75, P405, DOI 10.1016/j.bcp.2007.08.031; Underhill HR, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.018; Watanabe K, 2005, J AM COLL CARDIOL, V46, P2022, DOI 10.1016/j.jacc.2005.04.070; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Weiss S, 2007, J VASC RES, V44, P149, DOI 10.1159/000099141; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Williams KJ, 2001, CURR OPIN LIPIDOL, V12, P477, DOI 10.1097/00041433-200110000-00002; Wu Chuanshen, 2011, Commun Integr Biol, V4, P703; Yamagami H, 2008, ULTRASOUND MED BIOL, V34, P1353, DOI 10.1016/j.ultrasmedbio.2008.01.019	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38935	10.1371/journal.pone.0038935	http://dx.doi.org/10.1371/journal.pone.0038935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719992	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340000054
J	Valton, J; Daboussi, F; Leduc, S; Molina, R; Redondo, P; Macmaster, R; Montoya, G; Duchateau, P				Valton, Julien; Daboussi, Fayza; Leduc, Sophie; Molina, Rafael; Redondo, Pilar; Macmaster, Rachel; Montoya, Guillermo; Duchateau, Philippe			5 '-Cytosine-Phosphoguanine (CpG) Methylation Impacts the Activity of Natural and Engineered Meganucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMING ENDONUCLEASE; MOLECULAR REPLACEMENT; IN-VITRO; DNA; GENE; DERIVATIVES; BINDING; COMPACTION; SITE; PPOI	In this study, we asked whether CpG methylation could influence the DNA binding affinity and activity of meganucleases used for genome engineering applications. A combination of biochemical and structural approaches enabled us to demonstrate that CpG methylation decreases I-CreI DNA binding affinity and inhibits its endonuclease activity in vitro. This inhibition depends on the position of the methylated cytosine within the DNA target and was almost total when it is located inside the central tetrabase. Crystal structures of I-CreI bound to methylated cognate target DNA suggested a molecular basis for such inhibition, although the precise mechanism still has to be specified. Finally, we demonstrated that the efficacy of engineered meganucleases can be diminished by CpG methylation of the targeted endogenous site, and we proposed a rational design of the meganuclease DNA binding domain to alleviate such an effect. We conclude that although activity and sequence specificity of engineered meganucleases are crucial parameters, target DNA epigenetic modifications need to be considered for successful gene editions.	[Valton, Julien; Daboussi, Fayza; Leduc, Sophie; Macmaster, Rachel; Duchateau, Philippe] CELLECTIS SA, F-75012 Paris, France; [Molina, Rafael; Redondo, Pilar; Montoya, Guillermo] Spanish Natl Canc Res Ctr, Macromol Crystallog Grp, Struct Biol & Biocomp Programme, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Valton, J (corresponding author), CELLECTIS SA, 8 Rue Croix Jarry, F-75012 Paris, France.	julien.valton@cellectis.com; philippe.duchateau@cellectis.com	Redondo, Pilar/L-7612-2014; Molina, Rafael/L-6203-2016; Molina, Rafael/AAG-6552-2019	Redondo, Pilar/0000-0002-6723-0818; Molina, Rafael/0000-0002-6443-4989; Molina, Rafael/0000-0002-6443-4989; Valton, Julien/0000-0003-0826-5401; Daboussi, Fayza/0000-0001-7689-7975	Fundacion Ramon Areces; Ministerio de Ciencia e Innovacion [JCI-2011-09308, BFU2011-23815/BMC]	Fundacion Ramon Areces; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Supported by Fundacion Ramon Areces and Ministerio de Ciencia e Innovacion Grant JCI-2011-09308.; Supported by Grant BFU2011-23815/BMC from Ministerio de Ciencia e Innovacion.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Arosio D, 2004, J BIOL CHEM, V279, P42826, DOI 10.1074/jbc.M406529200; Bolduc JM, 2003, GENE DEV, V17, P2875, DOI 10.1101/gad.1109003; BRYK M, 1993, EMBO J, V12, P4040, DOI 10.1002/j.1460-2075.1993.tb06082.x; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chapdelaine P, 2010, GENE THER, V17, P846, DOI 10.1038/gt.2010.26; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; Chevalier BS, 2001, NAT STRUCT BIOL, V8, P312, DOI 10.1038/86181; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Daboussi F, 2012, NUCLEIC ACIDS RES, V40, P6367, DOI 10.1093/nar/gks268; ELLISON EL, 1993, MOL CELL BIOL, V13, P7531, DOI 10.1128/MCB.13.12.7531; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Hoshaw JP, 2010, METHODS MOL BIOL, V649, P299, DOI 10.1007/978-1-60761-753-2_19; Hudson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020587; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karymov MA, 2001, FASEB J, V15, P2631, DOI 10.1096/fj.01-0345com; Lakowicz, 2006, PRINCIPLES FLUORESCE, P366; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McMahon MA, 2012, NAT METHODS, V9, P28, DOI 10.1038/nmeth.1811; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Molina R, 2012, NUCLEIC ACIDS RES, V40, P6936, DOI 10.1093/nar/gks320; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767; Werner E, 2002, NUCLEIC ACIDS RES, V30, P3962, DOI 10.1093/nar/gkf523	47	18	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30139	30150		10.1074/jbc.M112.379966	http://dx.doi.org/10.1074/jbc.M112.379966			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22740697	hybrid, Green Published			2022-12-25	WOS:000308579800009
J	Foulongne, V; Sauvage, V; Hebert, C; Dereure, O; Cheval, J; Gouilh, MA; Pariente, K; Segondy, M; Burguiere, A; Manuguerra, JC; Caro, V; Eloit, M				Foulongne, Vincent; Sauvage, Virginie; Hebert, Charles; Dereure, Olivier; Cheval, Justine; Gouilh, Meriadeg Ar; Pariente, Kevin; Segondy, Michel; Burguiere, Ana; Manuguerra, Jean-Claude; Caro, Valerie; Eloit, Marc			Human Skin Microbiota: High Diversity of DNA Viruses Identified on the Human Skin by High Throughput Sequencing	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; HUMAN-PAPILLOMAVIRUS INFECTIONS; GENOMIC CHARACTERIZATION; MOLECULAR ANALYSIS; SAMPLES; PREVALENCE; SPECTRUM; INSIGHTS	The human skin is a complex ecosystem that hosts a heterogeneous flora. Until recently, the diversity of the cutaneous microbiota was mainly investigated for bacteria through culture based assays subsequently confirmed by molecular techniques. There are now many evidences that viruses represent a significant part of the cutaneous flora as demonstrated by the asymptomatic carriage of beta and gamma-human papillomaviruses on the healthy skin. Furthermore, it has been recently suggested that some representatives of the Polyomavirus genus might share a similar feature. In the present study, the cutaneous virome of the surface of the normal-appearing skin from five healthy individuals and one patient with Merkel cell carcinoma was investigated through a high throughput metagenomic sequencing approach in an attempt to provide a thorough description of the cutaneous flora, with a particular focus on its viral component. The results emphasize the high diversity of the viral cutaneous flora with multiple polyomaviruses, papillomaviruses and circoviruses being detected on normal-appearing skin. Moreover, this approach resulted in the identification of new Papillomavirus and Circovirus genomes and confirmed a very low level of genetic diversity within human polyomavirus species. Although viruses are generally considered as pathogen agents, our findings support the existence of a complex viral flora present at the surface of healthy-appearing human skin in various individuals. The dynamics and anatomical variations of this skin virome and its variations according to pathological conditions remain to be further studied. The potential involvement of these viruses, alone or in combination, in skin proliferative disorders and oncogenesis is another crucial issue to be elucidated.	[Foulongne, Vincent; Dereure, Olivier; Segondy, Michel] Univ Montpellier I, Montpellier Univ Hosp, INSERM, Dept Biol & Pathol,Lab Virol,U1058, Montpellier, France; [Foulongne, Vincent; Dereure, Olivier; Segondy, Michel] Dept Dermatol, Montpellier, France; [Sauvage, Virginie; Gouilh, Meriadeg Ar; Burguiere, Ana; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France; [Hebert, Charles; Cheval, Justine; Pariente, Kevin; Eloit, Marc] Pathoquest, Paris, France; [Eloit, Marc] ANSES, INRA, Ecole Natl Vet Alfort, UMR Virol ENVA 1161, Maisons Alfort, France; [Eloit, Marc] Inst Pasteur, Dept Virol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Foulongne, V (corresponding author), Univ Montpellier I, Montpellier Univ Hosp, INSERM, Dept Biol & Pathol,Lab Virol,U1058, Montpellier, France.	marc.eloit@pasteur.fr	Gouilh, Meriadeg Ar/E-4896-2017; Gouilh, Meriadeg Ar/O-4357-2019	Gouilh, Meriadeg Ar/0000-0002-3672-9974; Gouilh, Meriadeg Ar/0000-0002-3672-9974	Institut de Veille Sanitaire (Saint-Maurice, France); region Ile de France; Montpellier University Hospital [AOI 2008, UF8425]	Institut de Veille Sanitaire (Saint-Maurice, France); region Ile de France(Region Ile-de-France); Montpellier University Hospital	The platform "Genotyping of Pathogens and Public Health" is supported in part by the Institut de Veille Sanitaire (Saint-Maurice, France). This study was partly supported by grants from both region Ile de France and the Programme Hospitalier de Recherche Clinique of the Montpellier University Hospital (AOI 2008, Protocole UF8425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2003, J CLIN MICROBIOL, V41, P2509, DOI 10.1128/JCM.41.6.2509-2514.2003; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Arron ST, 2011, BRIT J DERMATOL, V164, P1201, DOI 10.1111/j.1365-2133.2011.10322.x; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Biagini P, 2004, VET MICROBIOL, V98, P95, DOI 10.1016/j.vetmic.2003.10.004; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Calder KB, 2010, ADV ANAT PATHOL, V17, P155, DOI 10.1097/PAP.0b013e3181d97836; Chen ACH, 2008, J GEN VIROL, V89, P2891, DOI 10.1099/vir.0.2008/003665-0; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubina M, 2009, AM J DERMATOPATH, V31, P561, DOI 10.1097/DAD.0b013e3181a58234; Duncavage EJ, 2011, J CUTAN PATHOL, V38, P790, DOI 10.1111/j.1600-0560.2011.01765.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0; Foulongne V, 2010, EMERG INFECT DIS, V16, P685, DOI 10.3201/eid1604.091278; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Giardina E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-159; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hsu JYC, 2009, J MED VIROL, V81, P1444, DOI 10.1002/jmv.21529; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Kohler A, 2010, VIROLOGY, V399, P129, DOI 10.1016/j.virol.2009.12.023; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Li LL, 2011, J GEN VIROL, V92, P768, DOI 10.1099/vir.0.028704-0; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Li SK, 2011, CLIN MICROBIOL  1004, DOI [10.1111/j.1469-0691.2011.03690, DOI 10.1111/J.1469-0691.2011.03690]; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Sauvage V, 2011, EMERG INFECT DIS, V17, P1364, DOI 10.3201/eid1708.110278; Sauvage V, 2011, J VIROL, V85, P7948, DOI 10.1128/JVI.00639-11; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Schrama D, 2012, J INVEST DERMATOL, V132, P239, DOI 10.1038/jid.2011.261; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Weissenborn SJ, 2009, J VIROL METHODS, V161, P280, DOI 10.1016/j.jviromet.2009.06.024; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575	44	255	260	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38499	10.1371/journal.pone.0038499	http://dx.doi.org/10.1371/journal.pone.0038499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723863	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700017
J	Shang, L; Xu, WJ; Ozer, S; Gutell, RR				Shang, Lei; Xu, Weijia; Ozer, Stuart; Gutell, Robin R.			Structural Constraints Identified with Covariation Analysis in Ribosomal RNA	PLOS ONE			English	Article							HIGHER-ORDER STRUCTURE; SIGNAL RECOGNITION PARTICLE; PHENYLALANINE TRANSFER-RNA; SECONDARY STRUCTURE MODEL; CRYSTAL-STRUCTURE; BASE-TRIPLES; SEQUENCE; INFORMATION; PATTERNS; DOMAIN	Covariation analysis is used to identify those positions with similar patterns of sequence variation in an alignment of RNA sequences. These constraints on the evolution of two positions are usually associated with a base pair in a helix. While mutual information (MI) has been used to accurately predict an RNA secondary structure and a few of its tertiary interactions, early studies revealed that phylogenetic event counting methods are more sensitive and provide extra confidence in the prediction of base pairs. We developed a novel and powerful phylogenetic events counting method (PEC) for quantifying positional covariation with the Gutell lab's new RNA Comparative Analysis Database (rCAD). The PEC and MI-based methods each identify unique base pairs, and jointly identify many other base pairs. In total, both methods in combination with an N-best and helix-extension strategy identify the maximal number of base pairs. While covariation methods have effectively and accurately predicted RNAs secondary structure, only a few tertiary structure base pairs have been identified. Analysis presented herein and at the Gutell lab's Comparative RNA Web (CRW) Site reveal that the majority of these latter base pairs do not covary with one another. However, covariation analysis does reveal a weaker although significant covariation between sets of nucleotides that are in proximity in the three-dimensional RNA structure. This reveals that covariation analysis identifies other types of structural constraints beyond the two nucleotides that form a base pair.	[Shang, Lei; Gutell, Robin R.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Xu, Weijia] Univ Texas Austin, Texas Adv Comp Ctr, Austin, TX 78712 USA; [Ozer, Stuart] Microsoft Corp, Redmond, WA 98052 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Microsoft	Shang, L (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	robin.gutell@mail.utexas.edu			Microsoft Research; National Institutes of Health [GM067317, GM085337]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085337, R01GM067317] Funding Source: NIH RePORTER	Microsoft Research(Microsoft); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded by an External Research grant from Microsoft Research (awarded to RRG), and the National Institutes of Health (GM067317(awarded to RRG) and GM085337(awarded to RRG and WX)). Lei Shang was supported by NIH grants GM067317 and GM085337. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. While Stuart Ozer is an employee of Microsoft, no one else at Microsoft / Microsoft Research was involved with any aspect of this manuscript. No additional external funding received for this study.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNHART SH, 2008, BMC BIOINFORMATICS, V9; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CHARGAFF E, 1951, J CELL COMPAR PHYSL, V38, P41, DOI 10.1002/jcp.1030380406; CHARGAFF E, 1950, EXPERIENTIA, V6, P201, DOI 10.1007/BF02173653; CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Conn GL, 1998, BIOCHEMISTRY-US, V37, P11980, DOI 10.1021/bi980825+; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; FOX GE, 1975, NATURE, V256, P505, DOI 10.1038/256505a0; Gautheret D, 1997, NUCLEIC ACIDS RES, V25, P1559, DOI 10.1093/nar/25.8.1559; GAUTHERET D, 1995, J MOL BIOL, V248, P27, DOI 10.1006/jmbi.1995.0200; GUTELL RR, 1993, CURR OPIN STRUC BIOL, V3, P313, DOI 10.1016/S0959-440X(05)80101-0; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1990, P NATL ACAD SCI USA, V87, P663, DOI 10.1073/pnas.87.2.663; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; GUTELL RR, 1986, EMBO J, V5, P1111, DOI 10.1002/j.1460-2075.1986.tb04330.x; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; Hainzl T, 2002, NATURE, V417, P767, DOI 10.1038/nature00768; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; HOLLEY RW, 1965, SCIENCE, V147, P1462, DOI 10.1126/science.147.3664.1462; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kazantsev AV, 2005, P NATL ACAD SCI USA, V102, P13392, DOI 10.1073/pnas.0506662102; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Lee JC, 2004, J MOL BIOL, V344, P1225, DOI 10.1016/j.jmb.2004.09.072; Lindgreen S, 2006, BIOINFORMATICS, V22, P2988, DOI 10.1093/bioinformatics/btl514; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; MICHEL F, 1990, NATURE, V347, P578, DOI 10.1038/347578a0; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; Olsen GJ, 1983, COMP ANAL NUCLEOTIDE; Ozer S, 2011, 7 IEEE INT C E SCI; PACE NR, 1989, GENE, V82, P65, DOI 10.1016/0378-1119(89)90031-0; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Sadowski MI, 2011, COMPUT BIOL CHEM, V35, P323, DOI 10.1016/j.compbiolchem.2011.08.002; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SUDDATH FL, 1974, NATURE, V248, P20, DOI 10.1038/248020a0; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Tuffery P, 2000, MOL BIOL EVOL, V17, P1753, DOI 10.1093/oxfordjournals.molbev.a026273; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Williams KP, 1996, RNA, V2, P1306; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; Xu WJ, 2009, LECT NOTES COMPUT SC, V5566, P200; Yeang CH, 2007, MOL BIOL EVOL, V24, P2119, DOI 10.1093/molbev/msm142; ZWIEB C, 1985, NUCLEIC ACIDS RES, V13, P6105, DOI 10.1093/nar/13.17.6105	69	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39383	10.1371/journal.pone.0039383	http://dx.doi.org/10.1371/journal.pone.0039383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724009	gold, Green Submitted, Green Published			2022-12-25	WOS:000305652700074
J	Mayr, LM; Powell, RL; Ngai, JN; Takang, WA; Nadas, A; Nyambi, PN				Mayr, Luzia M.; Powell, Rebecca L.; Ngai, Johnson N.; Takang, William A.; Nadas, Arthur; Nyambi, Phillipe N.			Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus	PLOS ONE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; PROXIMAL EXTERNAL REGION; TYPE-1 INFECTION; MONOCLONAL-ANTIBODIES; GENETIC SUBTYPES; CHIMERIC VIRUS; IN-DEPTH; GP120; PROTECTION; SEROTYPES	Recent studies have demonstrated that both the potency and breadth of the humoral anti-HIV-1 immune response in generating neutralizing antibodies (nAbs) against heterologous viruses are significantly enhanced after superinfection by discordant HIV-1 subtypes, suggesting that repeated exposure of the immune system to highly diverse HIV-1 antigens can significantly improve anti-HIV-1 immunity. Thus, we investigated whether sequential plasma from these subjects superinfected with discordant HIV-1 subtypes, who exhibit broad nAbs against heterologous viruses, also neutralize their discordant early autologous viruses with increasing potency. Comparing the neutralization capacities of sequential plasma obtained before and after superinfection of 4 subjects to those of matched plasma obtained from 4 singly infected control subjects, no difference in the increase in neutralization capacity was observed between the two groups (p = 0.328). Overall, a higher increase in neutralization over time was detected in the singly infected patients (mean change in IC50 titer from first to last plasma sample: 183.4) compared to the superinfected study subjects (mean change in IC50 titer from first to last plasma sample: 66.5). Analysis of the Breadth-Potency Scores confirmed that there was no significant difference in the increase in superinfected and singly infected study subjects (p = 0.234). These studies suggest that while superinfection by discordant subtypes induces antibodies with enhanced neutralizing breadth and potency against heterologous viruses, the potency to neutralize their autologous viruses is not better than those seen in singly infected patients.	[Mayr, Luzia M.; Nyambi, Phillipe N.] NYU, Sch Med, Dept Pathol, New York, NY 10012 USA; [Powell, Rebecca L.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ngai, Johnson N.; Takang, William A.] Med Diagnost Ctr, Serol Unit, Yaounde, Cameroon; [Takang, William A.] Univ Yaounde, Teaching Hosp, Dept Obstet & Gynaecol, Yaounde, Cameroon; [Nadas, Arthur] NYU, Sch Med, Inst Environm Med, New York, NY USA; [Nyambi, Phillipe N.] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	New York University; New York University; University of Yaounde I; New York University	Mayr, LM (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10012 USA.	phillipe.nyambi@nyumc.org			National Institute of Allergy and Infectious Diseases (NIAID) [AI083142]; National Cancer Institute (NCI) [CA153726]; Fogarty International Center (FIC) [TW01409]; Department of Veterans Affairs; FOGARTY INTERNATIONAL CENTER [D43TW001409] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083142, R01AI083142] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Veterans Affairs(US Department of Veterans Affairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI083142 from the National Institute of Allergy and Infectious Diseases (NIAID), CA153726 from the National Cancer Institute (NCI), TW01409 from Fogarty International Center (FIC), and funds from the Department of Veterans Affairs (Merit Review Award and the Research Enhancement Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; Barin F, 2004, J INFECT DIS, V189, P322, DOI 10.1086/380099; Beirnaert E, 2000, J MED VIROL, V62, P14, DOI 10.1002/1096-9071(200009)62:1&lt;14::AID-JMV3&gt;3.0.CO;2-L; Blish CA, 2008, J VIROL; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cortez V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002611; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; DOWBENKO D, 1988, J VIROL, V62, P4703, DOI 10.1128/JVI.62.12.4703-4711.1988; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; GAUDUIN MC, 1995, J INFECT DIS, V171, P1203, DOI 10.1093/infdis/171.5.1203; Geffin R, 2003, VIROLOGY, V310, P207, DOI 10.1016/S0042-6822(03)00137-5; Gerhardt M, 2005, J VIROL, V79, P8249, DOI 10.1128/JVI.79.13.8249-8261.2005; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; GOUDSMIT J, 1988, AIDS, V2, pS41, DOI 10.1097/00002030-198800001-00006; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kostrikis LG, 1996, AIDS RES HUM RETROV, V12, P1667, DOI 10.1089/aid.1996.12.1667; Kostrikis LG, 1996, J VIROL, V70, P445, DOI 10.1128/JVI.70.1.445-458.1996; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; Legrand E, 1997, AIDS RES HUM RETROV, V13, P1383, DOI 10.1089/aid.1997.13.1383; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Louisirirotchanakul S, 1998, J ACQ IMMUN DEF SYND, V19, P315, DOI 10.1097/00042560-199812010-00001; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McCutchan FE, 2005, J VIROL, V79, P11693, DOI 10.1128/JVI.79.18.11693-11704.2005; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; Moore JP, 2001, J VIROL, V75, P5721, DOI 10.1128/JVI.75.13.5721-5729.2001; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nyambi PN, 1996, J VIROL, V70, P6235, DOI 10.1128/JVI.70.9.6235-6243.1996; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Powell RLR, 2010, J VIROL, V84, P9415, DOI 10.1128/JVI.02732-09; Powell RLR, 2010, AIDS RES HUM RETROV, V26, P253, DOI 10.1089/aid.2009.0174; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Powell RLR, 2008, HIGH FREQUENCY HIV 1; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Staden R, 2000, Methods Mol Biol, V132, P115; Weber J, 1996, J VIROL, V70, P7827, DOI 10.1128/JVI.70.11.7827-7832.1996; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38989	10.1371/journal.pone.0038989	http://dx.doi.org/10.1371/journal.pone.0038989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720009	Green Published, gold			2022-12-25	WOS:000305347800034
J	Park, KE; Inerowicz, HD; Wang, X; Li, YF; Koser, S; Cabot, RA				Park, Ki-Eun; Inerowicz, H. Dorota; Wang, Xin; Li, Yanfang; Koser, Stephanie; Cabot, Ryan A.			Identification of Karyopherin alpha 1 and alpha 7 Interacting Proteins in Porcine Tissue	PLOS ONE			English	Article							IMPORTIN-ALPHA; NUCLEAR IMPORT; PIG OOCYTES; IN-VITRO; TRANSPORT; FAMILY; FERTILIZATION; SUBTYPE; SIGNALS; MEMBERS	Specialized trafficking systems in eukaryotic cells serve a critical role in partitioning intracellular proteins between the nucleus and cytoplasm. Cytoplasmic proteins (including chromatin remodeling enzymes and transcription factors) must gain access to the nucleus to exert their functions to properly program fundamental cellular events ranging from cell cycle progression to gene transcription. Knowing that nuclear import mediated by members of the karyopherin alpha family of transport receptors plays a critical role in regulating development and differentiation, we wanted to determine the identity of proteins that are trafficked by this karyopherin alpha pathway. To this end, we performed a GST pull-down assay using porcine orthologs of karyopherin alpha 1 (KPNA1) and karyopherin alpha 7 (KPNA7) and prey protein derived from porcine fibroblast cells and used a liquid chromatography and tandem mass spectrometry (LC-MS/MS) approach to determine the identity of KPNA1 and KPNA7 interacting proteins. Our screen revealed that the proteins that interact with KPNA1 and KPNA7 are generally nuclear proteins that possess nuclear localization signals. We further validated two candidate proteins from this screen and showed that they are able to be imported into the nucleus in vivo and also interact with members of the karyopherin alpha family of proteins in vitro. Our results also reveal the utility of using a GST pull-down approach coupled with LC-MS/MS to screen for protein interaction partners in a non-traditional model system.	[Park, Ki-Eun; Wang, Xin; Li, Yanfang; Koser, Stephanie; Cabot, Ryan A.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Inerowicz, H. Dorota] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Park, KE (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	rcabot@purdue.edu	Li, Yanfang/X-2055-2019		Agriculture and Food Research Initiative Competitive grant from the USDA National Institute of Food and Agriculture [2009-65203-05667]	Agriculture and Food Research Initiative Competitive grant from the USDA National Institute of Food and Agriculture	This project was supported in part by Agriculture and Food Research Initiative Competitive grant no. 2009-65203-05667 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abeydeera LR, 1997, BIOL REPROD, V57, P729, DOI 10.1095/biolreprod57.4.729; Abeydeera LR, 1998, BIOL REPROD, V58, P1316, DOI 10.1095/biolreprod58.5.1316; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Cabot RA, 2003, MOL REPROD DEV, V64, P292, DOI 10.1002/mrd.10238; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fukumoto M, 2011, CELL STRUCT FUNCT, V36, P57, DOI 10.1247/csf.10026; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hogarth CA, 2006, DEV DYNAM, V235, P253, DOI 10.1002/dvdy.20569; Jimenez C., 1998, CURRENT PROTOCOLS PR; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Ly-Huynh JD, 2011, BIOL REPROD, V85, P1191, DOI 10.1095/biolreprod.111.091686; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Pumroy RA, 2012, J BIOL CHEM, V287, P2022, DOI 10.1074/jbc.M111.315838; Rother F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018310; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Shmidt T, 2007, NAT CELL BIOL, V9, P1337, DOI 10.1038/ncb1207-1337; Talcott B, 2000, J BIOL CHEM, V275, P10099, DOI 10.1074/jbc.275.14.10099; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Wang X, 2012, REPROD FERT DEVELOP, V24, P382, DOI 10.1071/RD11119; Welch K, 1999, MOL CELL BIOL, V19, P8400; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38990	10.1371/journal.pone.0038990	http://dx.doi.org/10.1371/journal.pone.0038990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720010	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900070
J	Holz-Schietinger, C; Matje, DM; Reich, NO				Holz-Schietinger, Celeste; Matje, Doug M.; Reich, Norbert O.			Mutations in DNA Methyltransferase (DNMT3A) Observed in Acute Myeloid Leukemia Patients Disrupt Processive Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; BINDING; 3A; MECHANISM; OLIGOMERIZATION; ESTABLISHMENT; DECITABINE; EXPRESSION; PATTERNS; MODEL	DNA methylation is a key regulator of gene expression and changes in DNA methylation occur early in tumorigenesis. Mutations in the de novo DNA methyltransferase gene, DNMT3A, frequently occur in adult acute myeloid leukemia patients with poor prognoses. Most of the mutations occur within the dimer or tetramer interface, including Arg-882. We have identified that the most prevalent mutation, R882H, and three additional mutants along the tetramer interface disrupt tetramerization. The processive methylation of multiple CpG sites is disrupted when tetramerization is eliminated. Our results provide a possible mechanism that accounts for how DNMT3A mutations may contribute to oncogenesis and its progression.	[Holz-Schietinger, Celeste; Reich, Norbert O.] Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA; [Matje, Doug M.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Interdept Program Biomol Sci & Engn, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu						Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; CHITAMBAR CR, 1991, AM J HEMATOL, V37, P100, DOI 10.1002/ajh.2830370207; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Hata K, 2002, DEVELOPMENT, V129, P1983; Hiller DA, 2003, BIOCHEMISTRY-US, V42, P14375, DOI 10.1021/bi035520w; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holz-Schietinger C, 2011, J BIOL CHEM, V286, P41479, DOI 10.1074/jbc.M111.284687; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Hsieh Chih-Lin, 2005, BMC Biochem, V6, P6, DOI 10.1186/1471-2091-6-6; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; Markova J, 2012, EUR J HAEMATOL, V88, P128, DOI 10.1111/j.1600-0609.2011.01716.x; Matje DM, 2011, BIOCHEMISTRY-US, V50, P1465, DOI 10.1021/bi101446g; Metzeler KH, 2012, LEUKEMIA, V26, P1106, DOI 10.1038/leu.2011.342; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Moarefi AH, 2011, J MOL BIOL, V409, P758, DOI 10.1016/j.jmb.2011.04.050; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Senyuk V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020793; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Shah MY, 2011, NAT GENET, V43, P289, DOI 10.1038/ng0411-289; Sharma V, 2005, J BIOMOL STRUCT DYN, V22, P533, DOI 10.1080/07391102.2005.10507023; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Svedruzic ZM, 2011, PROG MOL BIOL TRANSL, V101, P221, DOI 10.1016/B978-0-12-387685-0.00006-8; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Thol F, 2011, HAEMATOL-HEMATOL J, V96, P1238, DOI 10.3324/haematol.2011.046839; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhao ZJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737535	60	93	97	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					30941	30951		10.1074/jbc.M112.366625	http://dx.doi.org/10.1074/jbc.M112.366625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22722925	Green Published, hybrid			2022-12-25	WOS:000308791300008
J	Aziz, A; Hess, JF; Budamagunta, MS; Voss, JC; Kuzin, AP; Huang, YPJ; Xiao, R; Montelione, GT; FitzGerald, PG; Hunt, JF				Aziz, Atya; Hess, John F.; Budamagunta, Madhu S.; Voss, John C.; Kuzin, Alexandre P.; Huang, Yuanpeng J.; Xiao, Rong; Montelione, Gaetano T.; FitzGerald, Paul G.; Hunt, John F.			The Structure of Vimentin Linker 1 and Rod 1B Domains Characterized by Site-directed Spin-labeling Electron Paramagnetic Resonance (SDSL-EPR) and X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT STRUCTURE; EPIDERMAL KERATIN; ATOMIC-STRUCTURE; CDNA SEQUENCE; CROSS-LINKING; MODEL; MECHANISM; LEVEL; CONSERVATION; DIVERSITY	Despite the passage of similar to 30 years since the complete primary sequence of the intermediate filament (IF) protein vimentin was reported, the structure remains unknown for both an individual protomer and the assembled filament. In this report, we present data describing the structure of vimentin linker 1 (L1) and rod 1B. Electron paramagnetic resonance spectra collected from samples bearing site-directed spin labels demonstrate that L1 is not a flexible segment between coiled-coils (CCs) but instead forms a rigid, tightly packed structure. Anx-ray crystal structure of a construct containing L1 and rod 1B shows that it forms a tetramer comprising two equivalent parallel CC dimers that interact with one another in the form of a symmetrical anti-parallel dimer. Remarkably, the parallel CC dimers are themselves asymmetrical, which enables them to tetramerize rather than undergoing higher order oligomerization. This functionally vital asymmetry in the CC structure, encoded in the primary sequence of rod 1B, provides a striking example of evolutionary exploitation of the structural plasticity of proteins. EPR and crystallographic data consistently suggest that a very short region within L1 represents a minor local distortion in what is likely to be a continuous CC from the end of rod 1A through the entirety of rod 1B. The concordance of this structural model with previously published cross-linking and spectral data supports the conclusion that the crystallographic oligomer represents a native biological structure.	[Aziz, Atya; Hess, John F.; FitzGerald, Paul G.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Kuzin, Alexandre P.; Huang, Yuanpeng J.; Xiao, Rong; Montelione, Gaetano T.; Hunt, John F.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Kuzin, Alexandre P.; Montelione, Gaetano T.; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Huang, Yuanpeng J.; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	University of California System; University of California Davis; University of California System; University of California Davis; Columbia University; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	FitzGerald, PG (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, 1 Shields Ave, Davis, CA 95616 USA.	pgfitzgerald@ucdavis.edu	Budamagunta, Madhu S/C-4628-2011	Montelione, Gaetano/0000-0002-9440-3059; Voss, John/0000-0001-9279-209X	National Institutes of Health (NIH) [EY015560]; NEI, NIH [P30-EY012576]; NIH [AG029246, U54-GM094597]; National Center for Research Resources, NIH [C06 RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015560, P30EY012576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant EY015560 (to P. G. F.); NEI, NIH, Core Facilities Grant P30-EY012576 (to the University of California Davis); NIH Grant AG029246 (to J. C. V.), and NIH Grant U54-GM094597 (to G. T. M., J. F. H., and the Northeast Structural Genomics Consortium). Work at the University of California Davis was conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR-12088-01 from the National Center for Research Resources, NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Aziz A, 2009, J BIOL CHEM, V284, P7330, DOI 10.1074/jbc.M809029200; Bansal M, 2000, J BIOMOL STRUCT DYN, V17, P811, DOI 10.1080/07391102.2000.10506570; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; CREWTHER WG, 1983, INT J BIOL MACROMOL, V5, P267, DOI 10.1016/0141-8130(83)90040-5; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1992, EUR J BIOCHEM, V206, P841, DOI 10.1111/j.1432-1033.1992.tb16992.x; HANUKOGLU I, 1982, CELL, V31, P243, DOI 10.1016/0092-8674(82)90424-X; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y; Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200; Jansson M, 1996, J BIOMOL NMR, V7, P131; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry D. A. D., 1995, INTERMEDIATE FILAMEN, P2; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; PARRY DAD, 1990, CELLULAR MOL BIOL IN, P175; Parry DAD, 2006, J STRUCT BIOL, V155, P370, DOI 10.1016/j.jsb.2006.03.017; RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X; Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438; STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41; STEINERT PM, 1984, J CELL BIOL, V99, pS22, DOI 10.1083/jcb.99.1.22s; STEINERT PM, 1993, J BIOL CHEM, V268, P24916; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; STEINERT PM, 1985, CELL, V42, P411, DOI 10.1016/0092-8674(85)90098-4; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STEINERT PM, 1976, BIOCHEM BIOPH RES CO, V70, P221, DOI 10.1016/0006-291X(76)91131-1; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Strelkov SV, 1999, MOL BIOL CELL, V10, p13A; WEBER K, 1985, ANN NY ACAD SCI, V455, P126, DOI 10.1111/j.1749-6632.1985.tb50408.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	47	46	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28349	28361		10.1074/jbc.M111.334011	http://dx.doi.org/10.1074/jbc.M111.334011			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740688	Green Published, hybrid			2022-12-25	WOS:000308074600012
J	Masaoka, A; Gassman, NR; Kedar, PS; Prasad, R; Hou, EW; Horton, JK; Bustin, M; Wilson, SH				Masaoka, Aya; Gassman, Natalie R.; Kedar, Padmini S.; Prasad, Rajendra; Hou, Esther W.; Horton, Julie K.; Bustin, Michael; Wilson, Samuel H.			HMGN1 Protein Regulates Poly(ADP-ribose) Polymerase-1 (PARP-1) Self-PARylation in Mouse Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; OXIDATIVE DNA-DAMAGE; CHROMOSOMAL-PROTEINS; MAMMALIAN-CELLS; CHROMATIN INTERACTIONS; NUCLEAR FUNCTIONS; GLYCOSYLASE-II; LIGASE-III; BETA; EXPRESSION	In mammalian cells, the nucleosome-binding protein HMGN1 (high mobility group N1) affects the structure and function of chromatin and plays a role in repair of damaged DNA. HMGN1 affects the interaction of DNA repair factors with chromatin and their access to damaged DNA; however, not all of the repair factors affected have been identified. Here, we report that HMGN1 affects the self-poly(ADP-ribosyl)ation (i.e., PARylation) of poly(ADP-ribose) polymerase-1 (PARP-1), a multifunctional and abundant nuclear enzyme known to recognize DNA lesions and promote chromatin remodeling, DNA repair, and other nucleic acid transactions. The catalytic activity of PARP-1 is activated by DNA with a strand break, and this results in self-PARylation and PARylation of other chromatin proteins. Using cells obtained from Hmgn1(-/-) and Hmgn1(+/+) littermate mice, we find that in untreated cells, loss of HMGN1 protein reduces PARP-1 self-PARylation. A similar result was obtained after MMS treatment of these cells. In imaging experiments after low energy laser-induced DNA damage, less PARylation at lesion sites was observed in Hmgn1(-/-) than in Hmgn1(+/+) cells. The HMGN1 regulation of PARP-1 activity could be mediated by direct protein-protein interaction as HMGN1 and PARP-1 were found to interact in binding assays. Purified HMGN1 was able to stimulate self-PARylation of purified PARP-1, and in experiments with cell extracts, self-PARylation was greater in Hmgn1(+/+) than in Hmgn1(-/-) extract. The results suggest a regulatory role for HMGN1 in PARP-1 activation.	[Masaoka, Aya; Gassman, Natalie R.; Kedar, Padmini S.; Prasad, Rajendra; Hou, Esther W.; Horton, Julie K.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Bustin, Michael] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233,MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019; Bustin, Michael/G-6155-2015	Wilson, Samuel H/0000-0002-1702-5293; Gassman, Natalie/0000-0002-8488-2332; Bustin, Michael/0000-0002-5147-7242	Intramural Research Program of the National Institutes of Health, NIEHS [Z01-ES050158, Z01-ES050159]; NATIONAL CANCER INSTITUTE [ZIABC004496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050159, ZIAES050159, Z01ES050158, ZIAES050158] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NIEHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Research Projects Z01-ES050158 and Z01-ES050159 in the Intramural Research Program of the National Institutes of Health, NIEHS.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Asagoshi K, 2011, CURR CANCER RES, P297, DOI 10.1007/978-1-61737-995-6_14; Asagoshi K, 2010, MOL CANCER RES, V8, P204, DOI 10.1158/1541-7786.MCR-09-0253; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; CRIPPA MP, 1991, J BIOL CHEM, V266, P2712; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; Gagnon SN, 2003, MOL CELL BIOCHEM, V243, P15, DOI 10.1023/A:1021645327079; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hamann I, 2012, MUTAT RES-FUND MOL M, V736, P56, DOI 10.1016/j.mrfmmm.2011.05.006; Hill DA, 2005, J BIOL CHEM, V280, P41777, DOI 10.1074/jbc.M509637200; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Horton JK, 2003, DNA REPAIR, V2, P27, DOI 10.1016/S1568-7864(02)00184-2; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Kedar PS, 2008, DNA REPAIR, V7, P1787, DOI 10.1016/j.dnarep.2008.07.006; Kedar PS, 2012, MOL CANCER RES, V10, P360, DOI 10.1158/1541-7786.MCR-11-0477; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Lim JH, 2004, METHOD ENZYMOL, V375, P323; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masaoka A, 1999, J BIOL CHEM, V274, P25136, DOI 10.1074/jbc.274.35.25136; Masaoka A, 2009, DNA REPAIR, V8, P1290, DOI 10.1016/j.dnarep.2009.08.004; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Moreno-Villanueva M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-39; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Oei SL, 2005, BIOCHEM CELL BIOL, V83, P263, DOI 10.1139/o05-039; Offer H, 1999, FEBS LETT, V450, P197, DOI 10.1016/S0014-5793(99)00505-0; PASH JM, 1990, J BIOL CHEM, V265, P4197; Pogna EA, 2010, BBA-GENE REGUL MECH, V1799, P93, DOI 10.1016/j.bbagrm.2009.11.018; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Schroder Heinz C, 2006, Methods Mol Biol, V314, P287; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; SRIVASTAVA DK, 1995, J BIOL CHEM, V270, P16402, DOI 10.1074/jbc.270.27.16402; Sukhanova MV, 2005, NUCLEIC ACIDS RES, V33, P1222, DOI 10.1093/nar/gki266; TANUMA S, 1983, J BIOL CHEM, V258, P4067; Terato H, 2002, NUCLEIC ACIDS RES, V30, P4975, DOI 10.1093/nar/gkf630; West KL, 2004, BIOCHEM SOC T, V32, P918, DOI 10.1042/BST0320918; Wilson SH, 2010, CELL MOL LIFE SCI, V67, P3633, DOI 10.1007/s00018-010-0489-1; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914	60	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27648	27658		10.1074/jbc.M112.370759	http://dx.doi.org/10.1074/jbc.M112.370759			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736760	Green Published, hybrid			2022-12-25	WOS:000307840700039
J	Venditti, V; Clore, GM				Venditti, Vincenzo; Clore, G. Marius			Conformational Selection and Substrate Binding Regulate the Monomer/Dimer Equilibrium of the C-terminal domain of Escherichia coli Enzyme I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR PHOSPHOTRANSFERASE SYSTEM; RESIDUAL DIPOLAR COUPLINGS; CHEMICAL-EXCHANGE; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; PHOSPHOENOLPYRUVATE; TRANSPORT; MACROMOLECULES; RELAXATION	The bacterial phosphotransferase system (PTS) is a signal transduction pathway that couples phosphoryl transfer to active sugar transport across the cell membrane. The PTS is initiated by the binding of phosphoenolpyruvate (PEP) to the C-terminal domain (EIC) of enzyme I (EI), a highly conserved protein that is common to all sugar branches of the PTS. EIC exists in a dynamic monomer/dimer equilibrium that is modulated by ligand binding and is thought to regulate the overall PTS. Isolation of EIC has proven challenging, and conformational dynamics within the EIC domain during the catalytic cycle are still largely unknown. Here, we present a robust protocol for expression and purification of recombinant EIC from Escherichia coli and show that isolated EIC is capable of hydrolyzing PEP. NMR analysis and residual dipolar coupling measurements indicate that the isolated EIC domain in solution adopts a stable tertiary fold and quaternary structure that is consistent with previously reported crystallographic data. NMR relaxation dispersion measurements indicate that residues around the PEP binding site and in the beta 3 alpha 3 turn (residues 333-366), which is located at the dimer interface, undergo a rapid transition on the sub-millisecond time scale (with an exchange rate constant of similar to 1500 s(-1)) between major open (similar to 97%) and minor closed (similar to 3%) conformations. Upon PEP binding, the beta 3 alpha 3 turn is effectively locked in the closed state by the formation of salt bridges between the phosphate group of PEP and the side chains of Lys(340) and Arg(358), thereby stabilizing the dimer.	[Venditti, Vincenzo; Clore, G. Marius] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@mail.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018; Venditti, Vincenzo/A-9411-2013	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; 	National Institutes of Health, NIDDK; Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of the National Institutes of Health, NIDDK, and the Intramural AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G.M.C.).	Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; CHAUVIN F, 1994, J BIOL CHEM, V269, P20270; Chauvin F, 1996, RES MICROBIOL, V147, P471, DOI 10.1016/0923-2508(96)84001-0; Chauvin F, 1996, P NATL ACAD SCI USA, V93, P7028, DOI 10.1073/pnas.93.14.7028; Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/NCHEMBIO.685, 10.1038/nchembio.685]; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; LICALSI C, 1991, J BIOL CHEM, V266, P19519; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Marquez JA, 2006, J BIOL CHEM, V281, P32508, DOI 10.1074/jbc.M513721200; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Meadow ND, 2005, BIOCHEMISTRY-US, V44, P12790, DOI 10.1021/bi0502846; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Mukhija S, 1997, MOL MICROBIOL, V25, P1159, DOI 10.1046/j.1365-2958.1997.5501910.x; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Navdaeva V, 2011, BIOCHEMISTRY-US, V50, P1184, DOI 10.1021/bi101721f; Oberholzer AE, 2005, J MOL BIOL, V346, P521, DOI 10.1016/j.jmb.2004.11.077; Oberholzer AE, 2009, J BIOL CHEM, V284, P33169, DOI 10.1074/jbc.M109.057612; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Patel HV, 2006, J BIOL CHEM, V281, P17579, DOI 10.1074/jbc.M508966200; Patel HV, 2006, J BIOL CHEM, V281, P17570, DOI 10.1074/jbc.M508965200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; Rohwer JM, 2000, J BIOL CHEM, V275, P34909, DOI 10.1074/jbc.M002461200; SAIER MH, 1980, J BIOL CHEM, V255, P8579; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2010, J AM CHEM SOC, V132, P13026, DOI 10.1021/ja105485b; Seok YJ, 1996, P NATL ACAD SCI USA, V93, P347, DOI 10.1073/pnas.93.1.347; Seok YJ, 1998, BIOCHEM BIOPH RES CO, V250, P381, DOI 10.1006/bbrc.1998.9323; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Takayama Y, 2011, J AM CHEM SOC, V133, P424, DOI 10.1021/ja109866w; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Venditti V, 2012, J BIOMOL NMR, V52, P191, DOI 10.1007/s10858-012-9606-9; WAYGOOD EB, 1979, ANAL BIOCHEM, V95, P293, DOI 10.1016/0003-2697(79)90219-7; WEIGEL N, 1982, J BIOL CHEM, V257, P4461; WEIGEL N, 1982, J BIOL CHEM, V257, P4477; Yip GNB, 2004, J MAGN RESON, V171, P25, DOI 10.1016/j.jmr.2004.06.021	53	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					26989	26998		10.1074/jbc.M112.382291	http://dx.doi.org/10.1074/jbc.M112.382291			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22722931	hybrid, Green Published			2022-12-25	WOS:000307386000046
J	Angot, E; Steiner, JA; Tome, CML; Ekstrom, P; Mattsson, B; Bjorklund, A; Brundin, P				Angot, Elodie; Steiner, Jennifer A.; Tome, Carla M. Lema; Ekstrom, Peter; Mattsson, Bengt; Bjorklund, Anders; Brundin, Patrik			Alpha-Synuclein Cell-to-Cell Transfer and Seeding in Grafted Dopaminergic Neurons In Vivo	PLOS ONE			English	Article							SPORADIC PARKINSONS-DISEASE; LEWY BODY PATHOLOGY; DEATH; INCLUSIONS; MUTATION; TRIPLICATION; DUPLICATION; ENDOCYTOSIS; CLEARANCE; RESPONSES	Several people with Parkinson's disease have been treated with intrastriatal grafts of fetal dopaminergic neurons. Following autopsy, 10-22 years after surgery, some of the grafted neurons contained Lewy bodies similar to those observed in the host brain. Numerous studies have attempted to explain these findings in cell and animal models. In cell culture, alpha-synuclein has been found to transfer from one cell to another, via mechanisms that include exosomal transport and endocytosis, and in certain cases seed aggregation in the recipient cell. In animal models, transfer of alpha-synuclein from host brain cells to grafted neurons has been shown, but the reported frequency of the event has been relatively low and little is known about the underlying mechanisms as well as the fate of the transferred alpha-synuclein. We now demonstrate frequent transfer of alpha-synuclein from a rat brain engineered to overexpress human alpha-synuclein to grafted dopaminergic neurons. Further, we show that this model can be used to explore mechanisms underlying cell-to-cell transfer of alpha-synuclein. Thus, we present evidence both for the involvement of endocytosis in alpha-synuclein uptake in vivo, and for seeding of aggregation of endogenous alpha-synuclein in the recipient neuron by the transferred alpha-synuclein. Finally, we show that, at least in a subset of the studied cells, the transmitted alpha-synuclein is sensitive to proteinase K. Our new model system could be used to test compounds that inhibit cell-to-cell transfer of alpha-synuclein and therefore might retard progression of Parkinson neuropathology.	[Angot, Elodie; Steiner, Jennifer A.; Tome, Carla M. Lema; Brundin, Patrik] Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden; [Steiner, Jennifer A.; Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI USA; [Ekstrom, Peter] ImaGene iT, Lund, Sweden; [Mattsson, Bengt; Bjorklund, Anders] Lund Univ, Neurobiol Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden	Lund University; Van Andel Institute; Lund University	Angot, E (corresponding author), Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden.	Elodie.Angot@med.lu.se	Björklund, Anders/ABA-1326-2020	Bjorklund, Anders/0000-0002-5676-6203; Angot, Elodie/0000-0002-5041-4485	Michael J. Fox Foundation for Parkinson's Research; Swedish Brain Foundation; Swedish Parkinson Foundation; Soderberg's Foundation; Swedish Research Council; Anna-Lisa Rosenberg Foundation; European Research Area Network of European Funding for Neuroscience Research Program MIPROTRAN; Human Frontier Science Program; European Research Council; Strong Research Environment Multipark (Multidisciplinary research in Parkinson's disease at Lund University)	Michael J. Fox Foundation for Parkinson's Research; Swedish Brain Foundation; Swedish Parkinson Foundation; Soderberg's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Anna-Lisa Rosenberg Foundation; European Research Area Network of European Funding for Neuroscience Research Program MIPROTRAN; Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Strong Research Environment Multipark (Multidisciplinary research in Parkinson's disease at Lund University)	This work was supported by the Michael J. Fox Foundation for Parkinson's Research; Swedish Brain Foundation; Swedish Parkinson Foundation; Soderberg's Foundation; Swedish Research Council, including the Linnaeus grant Bagadilico; Anna-Lisa Rosenberg Foundation; European Research Area Network of European Funding for Neuroscience Research Program MIPROTRAN; Human Frontier Science Program; a European Research Council Advanced Award and a private donation from Mr. Sven Astell. All authors are active in the Strong Research Environment Multipark (Multidisciplinary research in Parkinson's disease at Lund University), and EA and JAS are both recipients of personal fellowships from this program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; BRUNDIN P, 1986, DEV BRAIN RES, V24, P77, DOI 10.1016/0165-3806(86)90174-4; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chu YP, 2010, ANN NY ACAD SCI, V1184, P55, DOI 10.1111/j.1749-6632.2009.05229.x; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Decressac M, 2011, NEUROBIOL D IN PRESS; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; DUAN WM, 1995, EXP BRAIN RES, V104, P227; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Emgard M, 1999, EXP NEUROL, V160, P279, DOI 10.1006/exnr.1999.7198; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Grimm D, 2002, METHODS, V28, P146, DOI 10.1016/S1046-2023(02)00219-0; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hawkes CH, 2009, ANN NY ACAD SCI, V1170, P615, DOI 10.1111/j.1749-6632.2009.04365.x; Jang A, 2010, J NEUROCHEM, V113, P1263, DOI 10.1111/j.1471-4159.2010.06695.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2011, NEUROBIOL DIS, V43, P552, DOI 10.1016/j.nbd.2011.05.001; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurowska Z, 2011, J PARKINSON DIS, V1, P83, DOI 10.3233/JPD-2011-11004; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li JY, 2010, MOVEMENT DISORD, V25, P1091, DOI 10.1002/mds.23012; Luk KC, 2012, J EXPT MED; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Mougenot A. L., 2011, NEUROBIOL AGING; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Terada S, 2003, ACTA NEUROPATHOL, V105, P163, DOI 10.1007/s00401-002-0622-9; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	45	186	189	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39465	10.1371/journal.pone.0039465	http://dx.doi.org/10.1371/journal.pone.0039465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737239	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100038
J	Ho, JR; Chapeaublanc, E; Kirkwood, L; Nicolle, R; Benhamou, S; Lebret, T; Allory, Y; Southgate, J; Radvanyi, F; Goud, B				Ho, Joel R.; Chapeaublanc, Elodie; Kirkwood, Lisa; Nicolle, Remy; Benhamou, Simone; Lebret, Thierry; Allory, Yves; Southgate, Jennifer; Radvanyi, Francois; Goud, Bruno			Deregulation of Rab and Rab Effector Genes in Bladder Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; EXCHANGE FACTOR; BREAST-CANCER; UROPLAKIN-IB; PPAR-GAMMA; EXPRESSION; MUTATIONS; PROTEIN; FGFR3; PROLIFERATION	Growing evidence indicates that Rab GTPases, key regulators of intracellular transport in eukaryotic cells, play an important role in cancer. We analysed the deregulation at the transcriptional level of the genes encoding Rab proteins and Rab-interacting proteins in bladder cancer pathogenesis, distinguishing between the two main progression pathways so far identified in bladder cancer: the Ta pathway characterized by a high frequency of FGFR3 mutation and the carcinoma in situ pathway where no or infrequent FGFR3 mutations have been identified. A systematic literature search identified 61 genes encoding Rab proteins and 223 genes encoding Rab-interacting proteins. Transcriptomic data were obtained for normal urothelium samples and for two independent bladder cancer data sets corresponding to 152 and 75 tumors. Gene deregulation was analysed with the SAM (significant analysis of microarray) test or the binomial test. Overall, 30 genes were down-regulated, and 13 were up-regulated in the tumor samples. Five of these deregulated genes (LEPRE1, MICAL2, RAB23, STXBP1, SYTL1) were specifically deregulated in FGFR3-non-mutated muscle-invasive tumors. No gene encoding a Rab or Rab-interacting protein was found to be specifically deregulated in FGFR3-mutated tumors. Cluster analysis showed that the RAB27 gene cluster (comprising the genes encoding RAB27 and its interacting partners) was deregulated and that this deregulation was associated with both pathways of bladder cancer pathogenesis. Finally, we found that the expression of KIF20A and ZWINT was associated with that of proliferation markers and that the expression of MLPH, MYO5B, RAB11A, RAB11FIP1, RAB20 and SYTL2 was associated with that of urothelial cell differentiation markers. This systematic analysis of Rab and Rab effector gene deregulation in bladder cancer, taking relevant tumor subgroups into account, provides insight into the possible roles of Rab proteins and their effectors in bladder cancer pathogenesis. This approach is applicable to other group of genes and types of cancer.	[Ho, Joel R.; Chapeaublanc, Elodie; Nicolle, Remy; Radvanyi, Francois; Goud, Bruno] Inst Curie, Ctr Rech, Paris, France; [Ho, Joel R.; Chapeaublanc, Elodie; Nicolle, Remy; Radvanyi, Francois; Goud, Bruno] CNRS, UMR 144, Paris, France; [Kirkwood, Lisa; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; [Nicolle, Remy] Univ Evry, ISSB, Evry, France; [Benhamou, Simone] Inst Cancerol Gustave Roussy, UMR 8200, CNRS, Villejuif, France; [Benhamou, Simone] INSERM, U946, Paris, France; [Lebret, Thierry] Hop Foch, Dept Urol, Suresnes, France; [Allory, Yves] Grp Hosp Henri Mondor, AP HP, Dept Pathol, Creteil, France; [Allory, Yves] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of York - UK; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ho, JR (corresponding author), Inst Curie, Ctr Rech, Paris, France.	bruno.goud@curie.fr	Benhamou, Simone/K-6554-2015; Nicolle, Rémy/P-7983-2019; Southgate, Jennifer/AAJ-9089-2021; Goud, Bruno/GWC-4807-2022; Benhamou, Simone/ABD-2590-2020	Nicolle, Rémy/0000-0001-8084-1173; Southgate, Jennifer/0000-0002-0135-480X; BENHAMOU, Simone/0000-0001-5853-8047; Radvanyi, Francois/0000-0002-5696-6424; Chapeaublanc, Elodie/0000-0002-9668-7753	Centre national de la recherche scientifique (CNRS); Institut Curie; La Ligue Nationale Contre le Cancer ("Equipe labellisee'')	Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; La Ligue Nationale Contre le Cancer ("Equipe labellisee'')	The work was supported by grants from the Centre national de la recherche scientifique (CNRS) and the Institut Curie. The Molecular Oncology team is supported by La Ligue Nationale Contre le Cancer ("Equipe labellisee''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, TRAFFIC, V10, P1561, DOI 10.1111/j.1600-0854.2009.00969.x; Amillet JM, 2006, HUM PATHOL, V37, P256, DOI 10.1016/j.humpath.2005.10.017; Andrade VCC, 2010, LEUKEMIA LYMPHOMA, V51, P1543, DOI 10.3109/10428194.2010.491136; Ashida S, 2006, CLIN CANCER RES, V12, P2767, DOI 10.1158/1078-0432.CCR-05-1995; Bellmunt J, 2003, CRIT REV ONCOL HEMAT, V46, pS85, DOI 10.1016/S1040-8428(03)00067-2; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Croizet-Berger K, 2002, P NATL ACAD SCI USA, V99, P8277, DOI 10.1073/pnas.122187699; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; deMedina SGD, 1997, ONCOGENE, V14, P323, DOI 10.1038/sj.onc.1200830; Deng FM, 2002, J CELL BIOL, V159, P685, DOI 10.1083/jcb.200204102; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Fang ZY, 2010, J CELL BIOCHEM, V110, P1130, DOI 10.1002/jcb.22626; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Fukui K, 2007, HEPATOL RES, V37, P957, DOI 10.1111/j.1872-034X.2007.00143.x; Gebhardt C, 2005, AM J PATHOL, V167, P243, DOI 10.1016/S0002-9440(10)62969-0; GERDES J, 1991, AM J PATHOL, V138, P867; Goi T, 2002, ONCOL REP, V9, P1189; Goldenring JR, 2011, BRIT J CANCER, V104, P33, DOI 10.1038/sj.bjc.6605983; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; HENEY NM, 1983, J UROLOGY, V130, P1083, DOI 10.1016/S0022-5347(17)51695-X; Hou QS, 2008, CANCER RES, V68, P4623, DOI 10.1158/0008-5472.CAN-07-5870; Izumi T, 2007, ENDOCR J, V54, P649, DOI 10.1507/endocrj.KR-78; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Kim Kyong Rae, 2007, Korean J Gastroenterol, V49, P209; Kimura T, 2001, CANCER-AM CANCER SOC, V92, P2555, DOI 10.1002/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; Kotzsch M, 2008, BREAST CANCER RES TR, V111, P229, DOI 10.1007/s10549-007-9782-6; LANKATBUTTGEREIT B, 1994, PANCREAS, V9, P434, DOI 10.1097/00006676-199407000-00004; Liu YJ, 2007, WORLD J GASTROENTERO, V13, P1010, DOI 10.3748/wjg.v13.i7.1010; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; Lu Y, 2011, AM J TRANSL RES, V3, P8; Luis NM, 2007, CLIN TRANSL ONCOL, V9, P5, DOI 10.1007/s12094-007-0003-x; Milstein M, 2007, CANCER RES, V67, P11510, DOI 10.1158/0008-5472.CAN-07-1147; Mostofi FK, 1973, INT HISTOLOGICAL CLA; Neef R, 2005, METHOD ENZYMOL, V403, P618, DOI 10.1016/S0076-6879(05)03054-5; Ng EL, 2009, J CELL PHYSIOL, V221, P716, DOI 10.1002/jcp.21911; Olsburgh J, 2003, J PATHOL, V199, P41, DOI 10.1002/path.1252; Olsburgh J, 2002, BBA-GENE STRUCT EXPR, V1576, P163, DOI 10.1016/S0167-4781(02)00304-4; Pei L, 2002, CANCER RES, V62, P5420; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Starr DA, 2000, J CELL SCI, V113, P1939; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tang BL, 2010, TUMOR BIOL, V31, P359, DOI 10.1007/s13277-010-0030-z; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Vallot C, 2011, JNCI-J NATL CANCER I, V103, P47, DOI 10.1093/jnci/djq470; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; van Rhijn BWG, 2003, J CLIN ONCOL, V21, P1912, DOI 10.1200/JCO.2003.05.073; Varley CL, 2009, CELL DEATH DIFFER, V16, P103, DOI 10.1038/cdd.2008.116; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Wang Y, 2006, TRAFFIC, V7, P746, DOI 10.1111/j.1600-0854.2006.00416.x; Wu CY, 2009, LUNG CANCER, V63, P360, DOI 10.1016/j.lungcan.2008.06.014; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810; Zieger K, 2005, CLIN CANCER RES, V11, P7709, DOI 10.1158/1078-0432.CCR-05-1130	77	81	87	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39469	10.1371/journal.pone.0039469	http://dx.doi.org/10.1371/journal.pone.0039469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724020	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700083
J	Jugessur, A; Skare, O; Lie, RT; Wilcox, AJ; Christensen, K; Christiansen, L; Nguyen, TT; Murray, JC; Gjessing, HK				Jugessur, Astanand; Skare, Oivind; Lie, Rolv T.; Wilcox, Allen J.; Christensen, Kaare; Christiansen, Lene; Truc Trung Nguyen; Murray, Jeffrey C.; Gjessing, Hakon K.			X-Linked Genes and Risk of Orofacial Clefts: Evidence from Two Population-Based Studies in Scandinavia	PLOS ONE			English	Article							CASE-PARENT TRIADS; FAMILY-BASED ASSOCIATION; ORAL CLEFTS; TRANSMISSION/DISEQUILIBRIUM TEST; SUSCEPTIBILITY LOCI; MENTAL-RETARDATION; LIP/CLEFT PALATE; TBX22 MUTATIONS; FREQUENT CAUSE; LINKAGE	Background: Orofacial clefts are common birth defects of complex etiology, with an excess of males among babies with cleft lip and palate, and an excess of females among those with cleft palate only. Although genes on the X chromosome have been implicated in clefting, there has been no association analysis of X-linked markers. Methodology/Principal Findings: We added new functionalities in the HAPLIN statistical software to enable association analysis of X-linked markers and an exploration of various causal scenarios relevant to orofacial clefts. Genotypes for 48 SNPs in 18 candidate genes on the X chromosome were analyzed in two population-based samples from Scandinavia (562 Norwegian and 235 Danish case-parent triads). For haplotype analysis, we used a sliding-window approach and assessed isolated cleft lip with or without cleft palate (iCL/P) separately from isolated cleft palate only (iCPO). We tested three statistical models in HAPLIN, allowing for: i) the same relative risk in males and females, ii) sex-specific relative risks, and iii) X-inactivation in females. We found weak but consistent associations with the oral-facial-digital syndrome 1 (OFD1) gene (formerly known as CXORF5) in the Danish iCL/P samples across all models, but not in the Norwegian iCL/P samples. In sex-specific analyses, the association with OFD1 was in male cases only. No analyses showed associations with iCPO in either the Norwegian or the Danish sample. Conclusions: The association of OFD1 with iCL/P is plausible given the biological relevance of this gene. However, the lack of replication in the Norwegian samples highlights the need to verify these preliminary findings in other large datasets. More generally, the novel analytic methods presented here are widely applicable to investigations of the role of X-linked genes in complex traits.	[Jugessur, Astanand; Skare, Oivind; Gjessing, Hakon K.] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Jugessur, Astanand] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Skare, Oivind; Lie, Rolv T.; Gjessing, Hakon K.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Lie, Rolv T.; Truc Trung Nguyen] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Wilcox, Allen J.] Natl Inst Environm Hlth Sci, Epidemiol Branch, NIH, Durham, NC USA; [Christensen, Kaare; Christiansen, Lene] Univ So Denmark, Dept Epidemiol, Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Murray, Jeffrey C.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Biol Sci, Iowa City, IA USA	Norwegian Institute of Public Health (NIPH); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Bergen; Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Iowa; University of Iowa; University of Iowa	Jugessur, A (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.	astanand.jugessur@fhi.no	Wilcox, Allen J/C-7723-2019; Skare, Øivind/C-6330-2016; Christensen, Kaare/C-2360-2009; Gjessing, Hakon K/A-5871-2012	Wilcox, Allen J/0000-0002-3376-1311; Skare, Øivind/0000-0001-8043-2820; Christensen, Kaare/0000-0002-5429-5292; 	Center for Inherited Disease Research (CIDR); National Institutes of Health (NIH) [N01-HG-65403, DE08559, P60 DE13076, NIH P30 ES05605, RO1 DE-11948-04]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; Norwegian Research Council [NFR 177522]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027] Funding Source: NIH RePORTER	Center for Inherited Disease Research (CIDR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Center for Inherited Disease Research (CIDR) is fully funded through a federal contract from the National Institutes of Health (NIH) to The Johns Hopkins University, Contract Number N01-HG-65403. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; by NIH grants DE08559, P60 DE13076, NIH P30 ES05605, and RO1 DE-11948-04; and by the Norwegian Research Council (NFR 177522). The authors also thank the United States National Institute of Dental and Craniofacial Research for underwriting a significant proportion of the genotyping costs by CIDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi FE, 2007, CLIN GENET, V72, P19, DOI 10.1111/j.1399-0004.2007.00817.x; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Bille C, 2005, CLEFT PALATE-CRAN J, V42, P255, DOI 10.1597/03-139.1; Braybrook C, 2002, HUM MOL GENET, V11, P2793, DOI 10.1093/hmg/11.22.2793; Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; Burkhardt J, 2009, J RHEUMATOL, V36, P2149, DOI 10.3899/jrheum.090059; Chung RH, 2007, AM J HUM GENET, V80, P59, DOI 10.1086/510630; Ding J, 2006, AM J HUM GENET, V79, P567, DOI 10.1086/507609; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Fisher R.A., 1958, STAT METHODS RES WOR; Gjessing HK, 2006, ANN HUM GENET, V70, P382, DOI 10.1111/j.1469-1809.2005.00218.x; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Grosen D, 2011, EPIDEMIOLOGY, V22, P313, DOI 10.1097/EDE.0b013e3182125f9c; Grosen D, 2010, J MED GENET, V47, P162, DOI 10.1136/jmg.2009.069385; Ho GYF, 2000, AM J HUM GENET, V66, P1158, DOI 10.1086/302822; Horvath S, 2000, AM J HUM GENET, V66, P1161, DOI 10.1086/302823; Johnston JJ, 2010, AM J HUM GENET, V86, P743, DOI 10.1016/j.ajhg.2010.04.007; Jones KL, 2006, ORAL FACIAL DIGITAL; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Knapp M, 2001, THEOR POPUL BIOL, V60, P141, DOI 10.1006/tpbi.2001.1540; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; Lu LY, 2009, CANCER EPIDEM BIOMAR, V18, P2132, DOI 10.1158/1055-9965.EPI-08-1221; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Mangold E, 2009, AM J MED GENET A, V149A, P2680, DOI 10.1002/ajmg.a.33136; Marcano ACB, 2004, J MED GENET, V41, P68, DOI 10.1136/jmg.2003.010868; Migeon BR, 2011, HUM GENET, V130, P281, DOI 10.1007/s00439-011-1016-7; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; Mossey P., 2002, CLEFT LIP PALATE, P127; Ohman M, 2000, J CLIN ENDOCR METAB, V85, P3183, DOI 10.1210/jc.85.9.3183; Pankratz N, 2003, HUM MOL GENET, V12, P2599, DOI 10.1093/hmg/ddg270; Pauws E, 2009, HUM MOL GENET, V18, P4171, DOI 10.1093/hmg/ddp368; PAWITAN Y., 2001, ALL LIKELIHOOD; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; R Development Core Team, 2006, R LANG ENV STAT COMP; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Scapoli L, 2008, EUR J ORAL SCI, V116, P507, DOI 10.1111/j.1600-0722.2008.00574.x; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; StataCorp, 2009, STAT REL 1 1 STAT SO; Strauss RP, 1999, CLEFT PALATE-CRAN J, V36, P189, DOI 10.1597/1545-1569(1999)036<0189:TOADOC>2.3.CO;2; Suphapeetiporn K, 2007, CLIN GENET, V72, P478, DOI 10.1111/j.1399-0004.2007.00891.x; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Umbach DH, 2000, AM J HUM GENET, V66, P251, DOI 10.1086/302707; Umbach DM, 1997, STAT MED, V16, P1731, DOI 10.1002/(SICI)1097-0258(19970815)16:15<1731::AID-SIM595>3.0.CO;2-S; Wehby GL, 2010, ORAL DIS, V16, P3, DOI 10.1111/j.1601-0825.2009.01588.x; Weinberg CR, 2000, AM J EPIDEMIOL, V152, P197, DOI 10.1093/aje/152.3.197; Weinberg CR, 2005, AM J HUM GENET, V77, P627, DOI 10.1086/496900; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Weinberg CR, 2003, AM J EPIDEMIOL, V158, P401, DOI 10.1093/aje/kwg151; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Zhang L, 2008, GENET EPIDEMIOL, V32, P370, DOI 10.1002/gepi.20311; Zhang L, 2009, AM J HUM GENET, V84, P431, DOI 10.1016/j.ajhg.2009.02.010; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	61	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39240	10.1371/journal.pone.0039240	http://dx.doi.org/10.1371/journal.pone.0039240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723972	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700057
J	McFarland, HI; Puig, M; Grajkowska, LT; Tsuji, K; Lee, JP; Mason, KP; Verthelyi, D; Rosenberg, AS				McFarland, Hugh I.; Puig, Montserrat; Grajkowska, Lucja T.; Tsuji, Kazuhide; Lee, Jay P.; Mason, Karen P.; Verthelyi, Daniela; Rosenberg, Amy S.			Regulatory T Cells in gamma Irradiation-Induced Immune Suppression	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; CD4(+)CD25(+); LYMPHOCYTES; DISEASE; TRANSPLANTATION; PROLIFERATION; LYMPHOPENIA; EXPRESSION; RESPONSES; EXPOSURE	Sublethal total body gamma irradiation (TBI) of mammals causes generalized immunosuppression, in part by induction of lymphocyte apoptosis. Here, we provide evidence that a part of this immune suppression may be attributable to dysfunction of immune regulation. We investigated the effects of sublethal TBI on T cell memory responses to gain insight into the potential for loss of vaccine immunity following such exposure. We show that in mice primed to an MHC class I alloantigen, the accelerated graft rejection T memory response is specifically lost several weeks following TBI, whereas identically treated naive mice at the same time point had completely recovered normal rejection kinetics. Depletion in vivo with anti-CD4 or anti-CD25 showed that the mechanism involved cells consistent with a regulatory T cell (T reg) phenotype. The loss of the T memory response following TBI was associated with a relative increase of CD4+CD25+Foxp3+ expressing T regs, as compared to the CD8+ T effector cells requisite for skin graft rejection. The radiation-induced T memory suppression was shown to be antigen-specific in that a third party ipsilateral graft rejected with normal kinetics. Remarkably, following the eventual rejection of the first MHC class I disparate skin graft, the suppressive environment was maintained, with markedly prolonged survival of a second identical allograft. These findings have potential importance as regards the immunologic status of T memory responses in victims of ionizing radiation exposure and apoptosis-inducing therapies.	[McFarland, Hugh I.; Puig, Montserrat; Grajkowska, Lucja T.; Tsuji, Kazuhide; Lee, Jay P.; Mason, Karen P.; Verthelyi, Daniela; Rosenberg, Amy S.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	McFarland, HI (corresponding author), US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	hugh.mcfarland@fda.hhs.gov	McFarland, Hugh I/K-1503-2016	McFarland, Hugh I/0000-0002-3322-038X	U.S. Food and Drug Administration	U.S. Food and Drug Administration	This work was funded by the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA M, 1983, RADIAT RES, V93, P572, DOI 10.2307/3576036; AKIYAMA M, 1989, RADIAT RES, V117, P26, DOI 10.2307/3577274; Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573; Baeva E V, 1998, Radiats Biol Radioecol, V38, P893; Chen X, 2004, EUR J IMMUNOL, V34, P859, DOI 10.1002/eji.200324506; Chernyshov VP, 1997, CLIN IMMUNOL IMMUNOP, V84, P122, DOI 10.1006/clin.1997.4369; Clark FJ, 2004, BLOOD, V103, P2410, DOI 10.1182/blood-2003-06-2073; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; Hansal SA, 1998, J IMMUNOL, V161, P1063; Hirahara K, 2006, J IMMUNOL, V177, P4488, DOI 10.4049/jimmunol.177.7.4488; Hudak S, 2002, J IMMUNOL, V169, P1189, DOI 10.4049/jimmunol.169.3.1189; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Kusunoki Y, 2001, RADIAT RES, V155, P81, DOI 10.1667/0033-7587(2001)155[0081:TCRTMI]2.0.CO;2; Kusunoki Y, 2008, INT J RADIAT BIOL, V84, P1, DOI 10.1080/09553000701616106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McFarland HI, 2009, CURRENT PROTOCOLS IM, V84, P441; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; Moxham VF, 2008, J IMMUNOL, V180, P3910, DOI 10.4049/jimmunol.180.6.3910; Nomura M, 2006, TRANSPL IMMUNOL, V15, P311, DOI 10.1016/j.trim.2006.01.003; Qu YY, 2010, CELL MOL IMMUNOL, V7, P419, DOI 10.1038/cmi.2010.45; Qu YY, 2010, RADIAT RES, V173, P148, DOI 10.1667/RR0978.1; ROSENBERG AS, 1987, J EXP MED, V165, P1296, DOI 10.1084/jem.165.5.1296; SASAKI H, 1991, J RADIAT RES, V32, P310, DOI 10.1269/jrr.32.SUPPLEMENT_310; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sharma S, 2006, J IMMUNOL, V177, P8348, DOI 10.4049/jimmunol.177.12.8348; Simone R, 2008, J LEUKOCYTE BIOL, V84, P1454, DOI 10.1189/jlb.0907627; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Tago F, 2008, RADIAT RES, V169, P59, DOI 10.1667/RR1013.1; Torkabadi E, 2007, IRAN J ALLERGY ASTHM, V6, P181; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Winstead CJ, 2008, J IMMUNOL, V180, P7305, DOI 10.4049/jimmunol.180.11.7305; Xing SJ, 2010, JAIDS-J ACQ IMM DEF, V54, P455, DOI 10.1097/QAI.0b013e3181e453b9; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312	37	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39092	10.1371/journal.pone.0039092	http://dx.doi.org/10.1371/journal.pone.0039092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723935	Green Submitted, Green Published, gold			2022-12-25	WOS:000305652700047
J	Osorio, J; Carvajal, A; Naharro, G; La, T; Phillips, ND; Rubio, P; Hampson, DJ				Osorio, Jesus; Carvajal, Ana; Naharro, German; La, Tom; Phillips, Nyree D.; Rubio, Pedro; Hampson, David J.			Dissemination of Clonal Groups of Brachyspira hyodysenteriae amongst Pig Farms in Spain, and Their Relationships to Isolates from Other Countries	PLOS ONE			English	Article							SERPULINA-HYODYSENTERIAE; SWINE-DYSENTERY; GENE-TRANSFER; IDENTIFICATION; VSH-1	Background: Swine dysentery (SD) is a widespread diarrhoeal disease of pigs caused by infection of the large intestine with the anaerobic intestinal spirochaete Brachyspira hyodysenteriae. Understanding the dynamics of SD, and hence being able to develop more effective measures to counter its spread, depends on the ability to characterise B. hyodysenteriae variants and trace relationships of epidemic strains. Methodology/Principal Findings: A collection of 51 Spanish and 1 Portuguese B. hyodysenteriae isolates was examined using a multilocus sequence typing (MLST) scheme based on the sequences of seven conserved genomic loci. The isolates were allocated to 10 sequence types (STs) in three major groups of descent. Isolates in four of the STs were widely distributed in farms around Spain. One farm was infected with isolates from more than one ST. Sequence data obtained from PubMLST for 111 other B. hyodysenteriae strains from other countries then were included in the analysis. Two of the predominant STs that were found in Spain also were present in other European countries. The 73 STs were arranged in eleven clonal complexes (Cc) containing between 2 and 26 isolates. A population snapshot based on amino acid types (AATs) placed 75% of the isolates from 32 of the 48 AATs into one major cluster. The founder type AAT9 included 22 isolates from 10 STs that were recovered in Spain, Australia, Sweden, Germany, Belgium, the UK, Canada, and the USA. Conclusions/Significance: This MLST scheme provided sufficient resolution power to unambiguously characterise B. hyodysenteriae isolates, and can be recommended as a routine typing tool that rapidly enables comparisons of isolates. Using this method it was shown that some of the main genetic lineages of B. hyodysenteriae in Spain also occurred in other countries, providing further evidence for international transmission. Finally, analysis of AATs appeared useful for deducing putative ancestral relationships between strains.	[Osorio, Jesus; Carvajal, Ana; Naharro, German; Rubio, Pedro] Univ Leon, Fac Vet Sci, Dept Anim Hlth, E-24071 Leon, Spain; [La, Tom; Phillips, Nyree D.; Hampson, David J.] Murdoch Univ, Sch Vet & Biomed Sci, Murdoch, WA 6150, Australia	Universidad de Leon; Murdoch University	Osorio, J (corresponding author), Univ Leon, Fac Vet Sci, Dept Anim Hlth, E-24071 Leon, Spain.	d.hampson@murdoch.edu.au	Naharro, Germán/AAA-6572-2019; Hampson, David J/A-9464-2008; Carvajal, Ana/P-2351-2017; Hampson, David/AAE-3666-2019	Naharro, Germán/0000-0002-7391-4378; Hampson, David J/0000-0002-7729-0427; Carvajal, Ana/0000-0001-8961-636X; Rubio, Pedro/0000-0002-4267-5650	FPU from the Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation) [AP 2003-3438]; Australian Cooperative Research Centre for an Internationally Competitive Pork Industry (the Pork CRC)	FPU from the Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation); Australian Cooperative Research Centre for an Internationally Competitive Pork Industry (the Pork CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was the result of an ongoing international collaboration between the University of Leon, Spain, and Murdoch University, Perth, Australia. Jesus Osorio was in receipt of an FPU Research Fellowship AP 2003-3438 from the Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation) allowing him to undertake the MLST analysis at Murdoch University. Part of the work conducted in Australia was supported by funds from the Australian Cooperative Research Centre for an Internationally Competitive Pork Industry (the Pork CRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atyeo RF, 1999, EPIDEMIOL INFECT, V123, P133, DOI 10.1017/S0950268899002691; Carvajal A, 2006, VET REC, V158, P700, DOI 10.1136/vr.158.20.700; COMBS BG, 1992, VET MICROBIOL, V31, P273, DOI 10.1016/0378-1135(92)90085-8; Dugourd D, 1996, VET MICROBIOL, V48, P305, DOI 10.1016/0378-1135(95)00149-2; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fellstrom C., 2005, Svensk Veterinartidning, V57, P19; Fellstrom C, 1999, VET MICROBIOL, V70, P225, DOI 10.1016/S0378-1135(99)00146-7; Fisher LN, 1997, CLIN DIAGN LAB IMMUN, V4, P681, DOI 10.1128/CDLI.4.6.681-686.1997; Gresham ACJ, 1998, VET REC, V143, P619; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hampson D. J., 1997, P175; Hampson DJ, 2012, DIS SWINE, P680; HAREL J, 1994, CAN J VET RES, V58, P302; Hidalgo A, 2010, EPIDEMIOL INFECT, V138, P76, DOI 10.1017/S0950268809002817; Hidalgo A, 2010, J CLIN MICROBIOL, V48, P2859, DOI 10.1128/JCM.00348-10; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Karlsson M, 2004, J MED MICROBIOL, V53, P281, DOI 10.1099/jmm.0.05395-0; La T, 2009, VET MICROBIOL, V138, P330, DOI 10.1016/j.vetmic.2009.03.025; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE JI, 1993, VET MICROBIOL, V34, P35, DOI 10.1016/0378-1135(93)90005-R; Leser TD, 1997, MOL CELL PROBE, V11, P363, DOI 10.1006/mcpr.1997.0129; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Matson EG, 2005, J BACTERIOL, V187, P5885, DOI 10.1128/JB.187.17.5885-5892.2005; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Phillips ND, 2010, VET MICROBIOL, V143, P246, DOI 10.1016/j.vetmic.2009.10.020; Rasback T, 2007, MICROBIOL-SGM, V153, P4074, DOI 10.1099/mic.0.2007/008540-0; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stanton TB, 2008, APPL ENVIRON MICROB, V74, P2950, DOI 10.1128/AEM.00189-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson J. R., 2001, Animal Health Research Reviews, V2, P31; Trott DJ, 1997, MICROBIOL-SGM, V143, P3357, DOI 10.1099/00221287-143-10-3357; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006	33	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39082	10.1371/journal.pone.0039082	http://dx.doi.org/10.1371/journal.pone.0039082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723934	Green Published, gold			2022-12-25	WOS:000305652700046
J	Vielsmeier, V; Strutz, J; Kleinjung, T; Schecklmann, M; Kreuzer, PM; Landgrebe, M; Langguth, B				Vielsmeier, Veronika; Strutz, Juergen; Kleinjung, Tobias; Schecklmann, Martin; Kreuzer, Peter Michael; Landgrebe, Michael; Langguth, Berthold			Temporomandibular Joint Disorder Complaints in Tinnitus: Further Hints for a Putative Tinnitus Subtype	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; MECHANISMS; PLASTICITY; HYPERACTIVITY; MODULATION; DEPRESSION; SYMPTOMS; COMPLEX; INPUTS	Objective: Tinnitus is considered to be highly heterogeneous with respect to its etiology, its comorbidities and the response to specific interventions. Subtyping is recommended, but it remains to be determined which criteria are useful, since it has not yet been clearly demonstrated whether and to which extent etiologic factors, comorbid states and interventional response are related to each other and are thus applicable for subtyping tinnitus. Analyzing the Tinnitus Research Initiative Database we differentiated patients according to presence or absence of comorbid temporomandibular joint (TMJ) disorder complaints and compared the two groups with respect to etiologic factors. Methods: 1204 Tinnitus patients from the Tinnitus Research Initiative (TRI) Database with and without subjective TMJ complaints were compared with respect to demographic, tinnitus and audiological characteristics, questionnaires, and numeric ratings. Data were analysed according to a predefined statistical analysis plan. Results: Tinnitus patients with TMJ complaints (22% of the whole group) were significantly younger, had a lower age at tinnitus onset, and were more frequently female. They could modulate or mask their tinnitus more frequently by somatic maneuvers and by music or sound stimulation. Groups did not significantly differ for tinnitus duration, type of onset (gradual/abrupt), onset related events (whiplash etc.), character (pulsatile or not), hyperacusis, hearing impairment, tinnitus distress, depression, quality of life and subjective ratings (loudness etc.). Conclusion: Replicating previous work in tinnitus patients with TMJ complaints, classical risk factors for tinnitus like older age and male gender are less relevant in tinnitus patients with TMJ complaints. By demonstrating group differences for modulation of tinnitus by movements and sounds our data further support the notion that tinnitus with TMJ complaints represents a subgroup of tinnitus with clinical features that are highly relevant for specific therapeutic management.	[Vielsmeier, Veronika; Strutz, Juergen] Univ Regensburg, Dept Otorhinolaryngol, Regensburg, Germany; [Kleinjung, Tobias] Univ Zurich, Dept Otorhinolaryngol, Zurich, Switzerland; [Schecklmann, Martin; Kreuzer, Peter Michael; Landgrebe, Michael; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany	University of Regensburg; University of Zurich; University of Regensburg	Vielsmeier, V (corresponding author), Univ Regensburg, Dept Otorhinolaryngol, Regensburg, Germany.	veronika.vielsmeier@klinik.uni-regensburg.de	Kleinjung, Tobias/AAJ-3141-2020; Langguth, Berthold/AAP-2638-2021	Kleinjung, Tobias/0000-0003-3867-234X; 	Tinnitus Research Initiative	Tinnitus Research Initiative	The study was funded by the Tinnitus Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt O, 2011, J ORAL REHABIL; Biesinger E, 2008, HNO, V56, P673, DOI 10.1007/s00106-008-1721-2; Biesinger E, 2010, J PSYCHOSOM RES, V69, P299, DOI 10.1016/j.jpsychores.2010.04.013; Chandra RK, 2009, OTOLARYNG HEAD NECK, V141, P136, DOI 10.1016/j.otohns.2009.03.030; CHOLE RA, 1992, ARCH OTOLARYNGOL, V118, P817; Costen JB, 1997, ANN OTO RHINOL LARYN, V106, P805, DOI 10.1177/000348949710601002; Dehmel S, 2008, AM J AUDIOL, V17, pS193, DOI 10.1044/1059-0889(2008/07-0045); Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; DOLOWITZ D A, 1964, Laryngoscope, V74, P790; Kaltenbach JA, 2007, PROG BRAIN RES, V166, P89, DOI 10.1016/S0079-6123(07)66009-9; Kaltenbach JA, 2006, ACTA OTO-LARYNGOL, V126, P20, DOI 10.1080/03655230600895309; Kapoula Zoi, 2011, Front Neurol, V2, P35, DOI 10.3389/fneur.2011.00035; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2011, WORLD J BIOL PSYCHIA; Langguth B, 2011, EVAL HLTH PROF; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Langguth B, 2011, OTOLARYNG HEAD NECK, V145, P519, DOI 10.1177/0194599811411851; Lanting CP, 2010, HEARING RES, V267, P78, DOI 10.1016/j.heares.2010.04.006; Latifpour David Homayoun, 2009, Int Tinnitus J, V15, P94; Levine RA, 2007, PROG BRAIN RES, V166, P195, DOI 10.1016/S0079-6123(07)66017-8; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Moller AR, 2007, PROG BRAIN RES, V166, P37, DOI 10.1016/S0079-6123(07)66003-8; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; MOLLER AR, 1992, LARYNGOSCOPE, V102, P1165; MOLLER AR, 1992, LARYNGOSCOPE, V102, P187; Nam EC, 2010, J NEUROL NEUROSUR PS, V81, P456, DOI 10.1136/jnnp.2009.173104; Pinchoff RJ, 1998, AM J OTOL, V19, P785; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Sanchez TG, 2002, AUDIOL NEURO-OTOL, V7, P370, DOI 10.1159/000066155; Shore SE, 2011, HEARING RES, V281, P38, DOI 10.1016/j.heares.2011.05.001; Shore SE, 2011, HEAR RES; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Tyler R, 2008, AM J AUDIOL, V17, pS176, DOI 10.1044/1059-0889(2008/07-0044); Tzounopoulos T, 2008, AM J AUDIOL, V17, pS170, DOI 10.1044/1059-0889(2008/07-0030); Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vernon JA, 2003, OTOLARYNG CLIN N AM, V36, P307, DOI 10.1016/S0030-6665(02)00163-9; Vielsmeier V, 2011, OTOLARYNGOL HEAD NEC; Wright EF, 2007, QUINTESSENCE INT, V38; Wright EF, 1997, J AM DENT ASSOC, V128, P1424, DOI 10.14219/jada.archive.1997.0062; Zhou JX, 2004, J NEUROSCI RES, V78, P901, DOI 10.1002/jnr.20343	41	37	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38887	10.1371/journal.pone.0038887	http://dx.doi.org/10.1371/journal.pone.0038887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723902	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305652700037
J	Jadaliha, M; Lee, HJ; Pakzad, M; Fathi, A; Jeong, SK; Cho, SY; Baharvand, H; Paik, YK; Salekdeh, GH				Jadaliha, Mahdieh; Lee, Hyoung-Joo; Pakzad, Mohammad; Fathi, Ali; Jeong, Seul-Ki; Cho, Sang-Yun; Baharvand, Hossein; Paik, Young-Ki; Salekdeh, Ghasem Hosseini			Quantitative Proteomic Analysis of Human Embryonic Stem Cell Differentiation by 8-Plex iTRAQ Labelling	PLOS ONE			English	Article							SELF-RENEWAL; NEURAL DIFFERENTIATION; GROWTH; PROTEIN; PLURIPOTENCY; TRANSLATION; NANOG; LINES	Analysis of gene expression to define molecular mechanisms and pathways involved in human embryonic stem cells (hESCs) proliferation and differentiations has allowed for further deciphering of the self-renewal and pluripotency characteristics of hESC. Proteins associated with hESCs were discovered through isobaric tags for relative and absolute quantification (iTRAQ). Undifferentiated hESCs and hESCs in different stages of spontaneous differentiation by embryoid body (EB) formation were analyzed. Using the iTRAQ approach, we identified 156 differentially expressed proteins involved in cell proliferation, apoptosis, transcription, translation, mRNA processing, and protein synthesis. Proteins involved in nucleic acid binding, protein synthesis, and integrin signaling were downregulated during differentiation, whereas cytoskeleton proteins were upregulated. The present findings added insight to our understanding of the mechanisms involved in hESC proliferation and differentiation.	[Jadaliha, Mahdieh; Fathi, Ali; Salekdeh, Ghasem Hosseini] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran; [Jadaliha, Mahdieh] Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran; [Lee, Hyoung-Joo; Jeong, Seul-Ki; Cho, Sang-Yun; Paik, Young-Ki] Yonsei Univ, Dept Biochem, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; [Lee, Hyoung-Joo; Jeong, Seul-Ki; Cho, Sang-Yun; Paik, Young-Ki] Yonsei Univ, Biomed Proteome Res Ctr, Seoul 120749, South Korea; [Pakzad, Mohammad; Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, ACECR, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran	Academic Center for Education, Culture & Research (ACECR); University of Tehran; Yonsei University; Yonsei University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Jadaliha, M (corresponding author), ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Mol Syst Biol, Tehran, Iran.	paikyk@yonsei.ac.kr; salekdeh@royaninstitute.org	Salekdeh, Ghasem Hosseini/E-4198-2012; Jadaliha, Mahdieh/ABI-6109-2020; Pakzad, Mohammad/AAD-8905-2022	Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Pakzad, Mohammad/0000-0003-1494-3619	Royan Institute of Iran; Yonsei Proteome Research Center	Royan Institute of Iran; Yonsei Proteome Research Center	This project was funded by grants from the Royan Institute of Iran to G.H.S. and from the Yonsei Proteome Research Center to Y-K.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Baharvand H, 2008, J PROTEOME RES, V7, P412, DOI 10.1021/pr700560t; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhattacharya B, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-22; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chaerkady R, 2009, J PROTEOME RES, V8, P1315, DOI 10.1021/pr8006667; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Fassler R, 1996, CURR OPIN CELL BIOL, V8, P641, DOI 10.1016/S0955-0674(96)80105-0; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ivanova M, 2005, MOL CELL BIOL, V25, P2995, DOI 10.1128/MCB.25.8.2995-3006.2005; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Kurisaki A, 2005, BIOCHEM BIOPH RES CO, V335, P667, DOI 10.1016/j.bbrc.2005.07.128; Larijani MR, 2011, STEM CELLS DEV, V20, P1911, DOI 10.1089/scd.2010.0517; Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li H, 2009, STEM CELLS, V27, P1244, DOI 10.1002/stem.55; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nasrabadi D, 2009, J PROTEOME RES, V8, P1527, DOI 10.1021/pr800880v; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; O'Brien RN, 2010, MOL CELL PROTEOMICS, V9, P2238, DOI 10.1074/mcp.M110.000281; Oesterreich S, 2003, J CELL BIOCHEM, V90, P653, DOI 10.1002/jcb.10685; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ray S., 1999, P 4 INT C ADV PATTER, P137; Rousseeuw P.J., 1990, FINDING GROUPS DATA; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Wang DJ, 2005, PROTEOMICS, V5, P4414, DOI 10.1002/pmic.200401304; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yocum AK, 2008, MOL CELL PROTEOMICS, V7, P750, DOI 10.1074/mcp.M700399-MCP200	41	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38532	10.1371/journal.pone.0038532	http://dx.doi.org/10.1371/journal.pone.0038532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723866	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300031
J	Lee, J; van Hummelen, P; Go, C; Palescandolo, E; Jang, J; Park, HY; Kang, SY; Park, JO; Kang, WK; MacConaill, L; Kim, KM				Lee, Jeeyun; van Hummelen, Paul; Go, Christina; Palescandolo, Emanuele; Jang, Jiryeon; Park, Ha Young; Kang, So Young; Park, Joon Oh; Kang, Won Ki; MacConaill, Laura; Kim, Kyoung-Mee			High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma	PLOS ONE			English	Article							CANCER; GENE; PIK3CA; P53	Background: Gastric cancer is one of the leading cancer types in incidence and mortality, especially in Asia. In order to improve survival, identification of a catalogue of molecular alterations underlying gastric cancer is a critical step for developing and designing genome-directed therapies. Methodology/Principal Findings: The Center for Cancer Genome Discovery (CCGD) at the Dana-Farber Cancer Institute (DFCI) has adapted a high-throughput genotyping platform to determine the mutation status of a large panel of known cancer genes. The mutation detection platform, termed OncoMap v4, interrogates 474 "hotspot'' mutations in 41 genes that are relevant for cancer. We performed OncoMap v4 in formalin-fixed paraffin-embedded (FFPE) tissue specimens from 237 gastric adenocarcinomas. Using OncoMap v4, we found that 34 (14.4%) of 237 gastric cancer patients harbored mutations. Among mutations we screened, PIK3CA mutations were the most frequent (5.1%) followed by p53 (4.6%), APC (2.5%), STK11 (2.1%), CTNNB1 (1.7%), and CDKN2A (0.8%). Six samples harbored concomitant somatic mutations. Mutations of CTNNB1 were significantly more frequent in EBV-associated gastric carcinoma (P=0.046). Our study led to the detection of potentially druggable mutations in gastric cancer which may guide novel therapies in subsets of gastric cancer patients. Conclusions/Significance: Using high throughput mutation screening platform, we identified that PIK3CA mutations were the most frequently observed target for gastric adenocarcinoma.	[Lee, Jeeyun; Jang, Jiryeon; Park, Joon Oh; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [van Hummelen, Paul; Go, Christina; Palescandolo, Emanuele; MacConaill, Laura] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [van Hummelen, Paul; Go, Christina; Palescandolo, Emanuele; MacConaill, Laura] Harvard Univ, Sch Med, Boston, MA USA; [Park, Ha Young; Kang, So Young; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea.	kkmkys@skku.edu	Lee, Jee Yun/C-9646-2011; Go, Christina/I-6475-2018; Lee, Jeeyun/I-7171-2015	Go, Christina/0000-0002-7716-8720; van hummelen, paul/0000-0002-4801-8600	Korea Healthcare Technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea [A092255, A101130]; Samsung Biomedical Research Institute [SBRI-CB11031, SBRICB02202]; Sungkyunkwan University [S-2009-1181-000]	Korea Healthcare Technology RD Project; Ministry for Health & Welfare Affairs, Republic of Korea; Samsung Biomedical Research Institute(Samsung); Sungkyunkwan University	This paper was supported by the grant from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea (A092255 & A101130), Samsung Biomedical Research Institute grant (# SBRI-CB11031, SBRICB02202) & Sungkyunkwan University grant (# S-2009-1181-000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; HORII A, 1992, CANCER RES, V52, P6696; Hsieh LL, 1998, CANCER LETT, V129, P125, DOI 10.1016/S0304-3835(98)00111-6; Kim Jin C, 2004, Fam Cancer, V3, P129; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li VSW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-29; MacConaill LE, 2011, CANCER DISCOV, V1, P297, DOI 10.1158/2159-8290.CD-11-0110; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Matulonis UA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024433; Oki E, 2009, DIGESTION, V79, P33, DOI 10.1159/000167864; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Song HJ, 2010, GASTROENTEROLOGY, V139, P84, DOI 10.1053/j.gastro.2010.04.002; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang YP, 1998, HUM HERED, V48, P87, DOI 10.1159/000022786; Zang ZJ, 2012, NAT GENET	19	62	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38892	10.1371/journal.pone.0038892	http://dx.doi.org/10.1371/journal.pone.0038892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723903	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300065
J	Lee, YC; Yang, YC; Huang, CL; Kuo, TY; Lin, JH; Yang, DM; Huang, NK				Lee, Yi-Chao; Yang, Ying-Chen; Huang, Chuen-Lin; Kuo, Tsun-Yung; Lin, Jung-Hsin; Yang, De-Ming; Huang, Nai-Kuei			When Cytokinin, a Plant Hormone, Meets the Adenosine A(2A) Receptor: A Novel Neuroprotectant and Lead for Treating Neurodegenerative Disorders?	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; PROTEIN-KINASE-A; HUNTINGTONS-DISEASE; GASTRODIA-ELATA; PC12 CELLS; KINETIN; MODEL; PATHOPHYSIOLOGY; THERAPEUTICS; ACTIVATION	It is well known that cytokinins are a class of phytohormones that promote cell division in plant roots and shoots. However, their targets, biological functions, and implications in mammalian systems have rarely been examined. In this study, we show that one cytokinin, zeatin riboside, can prevent pheochromocytoma (PC12) cells from serum deprivation-induced apoptosis by acting on the adenosine A(2A) receptor (A(2A)-R), which was blocked by an A(2A)-R antagonist and a protein kinase A (PKA)inhibitor, demonstrating the functional ability of zeatin riboside by mediating through A(2A)-R signaling event. Since the A(2A)-R was implicated as a therapeutic target in treating Huntington's disease (HD), a cellular model of HD was applied by transfecting mutant huntingtin in PC12 cells. By using filter retardation assay and confocal microscopy we found that zeatin riboside reversed mutant huntingtin (Htt)-induced protein aggregations and proteasome deactivation through A(2A)-R signaling. PKA inhibitor blocked zeatin riboside-induced suppression of mutant Htt aggregations. In addition, PKA activated proteasome activity and reduced mutant Htt protein aggregations. However, a proteasome inhibitor blocked both zeatin riboside- and PKA activator-mediated suppression of mutant Htt aggregations, confirming mediation of the A(2A)-R/PKA/proteasome pathway. Taken together, zeatin riboside might have therapeutic potential as a novel neuroprotectant and a lead for treating neurodegenerative disorders.	[Lee, Yi-Chao] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Yang, Ying-Chen; Kuo, Tsun-Yung] Natl Ilan Univ, Dept Anim Sci, Ilan, Taiwan; [Huang, Chuen-Lin] Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Huang, Chuen-Lin] Natl Def Med Ctr, Grad Inst Physiol, Taipei, Taiwan; [Huang, Chuen-Lin] Natl Def Med Ctr, Dept Physiol & Biophys, Taipei, Taiwan; [Kuo, Tsun-Yung] Natl Ilan Univ, Inst Biotechnol, Ilan, Taiwan; [Lin, Jung-Hsin] Natl Taiwan Univ, Sch Pharm, Taipei 10764, Taiwan; [Lin, Jung-Hsin] Acad Sinica, Div Mech, Res Ctr Appl Sci, Taipei 115, Taiwan; [Lin, Jung-Hsin] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yang, De-Ming] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Yang, De-Ming; Huang, Nai-Kuei] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Huang, Nai-Kuei] Natl Res Inst Chinese Med, Taipei, Taiwan	Taipei Medical University; National Ilan University; Cardinal Tien Hospital; National Defense Medical Center; National Defense Medical Center; National Ilan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine	Lee, YC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan.	andrew@nricm.edu.tw	Lin, Jung-Hsin/T-7390-2019; Lin, Jung-Hsin/B-7512-2012; Yang, De-Ming/AAW-9886-2020	Lin, Jung-Hsin/0000-0002-6712-4994; Yang, De-Ming/0000-0002-6923-4855; Lee, Yi-Chao/0000-0003-3451-183X	Cardinal Tien Hospital [CTH-98-1-2A18]; National Research Institute of Chinese Medicine [NRICM99-DBCM-07]; National Science Council, R.O.C. [NSC99-2320-B-077-006]	Cardinal Tien Hospital; National Research Institute of Chinese Medicine; National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by Cardinal Tien Hospital (CTH-98-1-2A18), the National Research Institute of Chinese Medicine (NRICM99-DBCM-07), and the National Science Council, R.O.C. (NSC99-2320-B-077-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2008, ANN NY ACAD SCI, P1147; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Bifulco M, 2008, ANTI-CANCER AGENT ME, V8, P200, DOI 10.2174/187152008783497028; Blum D, 2003, LANCET NEUROL, V2, P366, DOI 10.1016/S1474-4422(03)00411-3; Brusa L, 2009, MOVEMENT DISORD, V24, P126, DOI 10.1002/mds.22376; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Chen JB, 2011, CHEMMEDCHEM, V6, P1390, DOI 10.1002/cmdc.201100126; Chen PJ, 2009, AM J CHINESE MED, V37, P1113, DOI 10.1142/S0192415X09007533; Choi SJ, 2009, J MED FOOD, V12, P271, DOI 10.1089/jmf.2007.0678; Choi YS, 2009, NEUROBIOL DIS, V36, P259, DOI 10.1016/j.nbd.2009.07.014; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Froldi G, 1999, PLANTA MED, V65, P245, DOI 10.1055/s-1999-13987; Fukui H, 2007, HUM MOL GENET, V16, P783, DOI 10.1093/hmg/ddm023; Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Guillon-Munos A, 2005, APOPTOSIS, V10, P1031, DOI 10.1007/s10495-005-0741-6; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Hartig K, 2006, PLANT BIOLOGY, V8, P389, DOI 10.1055/s-2006-923797; Havlicek L, 1997, J MED CHEM, V40, P408, DOI 10.1021/jm960666x; Honma Y, 2002, LEUKEMIA LYMPHOMA, V43, P1729, DOI 10.1080/1042819021000006493; Huang CL, 2011, J ETHNOPHARMACOL, V138, P162, DOI 10.1016/j.jep.2011.08.075; Huang NK, 2007, J NAT PROD, V70, P571, DOI 10.1021/np0605182; Huang NK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020934; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; JAYABASKARAN C, 1981, J BIOSCIENCE, V3, P269, DOI 10.1007/BF02702937; Kaiser SM, 1999, DRUG DISCOV TODAY, V4, P542, DOI 10.1016/S1359-6446(99)01421-X; Kim MJ, 2008, BIOSCI BIOTECH BIOCH, V72, P577, DOI 10.1271/bbb.70480; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mievis S, 2011, NEUROBIOL DIS, V41, P570, DOI 10.1016/j.nbd.2010.09.021; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Olsen A, 1999, BIOCHEM BIOPH RES CO, V265, P499, DOI 10.1006/bbrc.1999.1669; Popoli P, 2007, PROG NEUROBIOL, V81, P331, DOI 10.1016/j.pneurobio.2006.12.005; Ralevic V, 1998, PHARMACOL REV, V50, P413; RATTAN SIS, 1994, BIOCHEM BIOPH RES CO, V201, P665, DOI 10.1006/bbrc.1994.1752; Simons C, 2005, CURR TOP MED CHEM, V5, P1191, DOI 10.2174/156802605774463051; Spichal L, 2007, J BIOL CHEM, V282, P14356, DOI 10.1074/jbc.M609750200; Stone Trevor W, 2009, Handb Exp Pharmacol, P535, DOI 10.1007/978-3-540-89615-9_17; Tiedemann RE, 2008, J CLIN INVEST, V118, P1750, DOI 10.1172/JCI34149; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Verbeke P, 2000, BIOCHEM BIOPH RES CO, V276, P1265, DOI 10.1006/bbrc.2000.3616; Vieira Helena L. A., 2002, Oncogene, V21, P1963, DOI 10.1038/sj.onc.1205270; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wellington CL, 1997, BRAIN PATHOL, V7, P979, DOI 10.1111/j.1750-3639.1997.tb00897.x; Williams M, 2000, BIOCHEM PHARMACOL, V59, P1173, DOI 10.1016/S0006-2952(99)00341-X; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	57	16	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38865	10.1371/journal.pone.0038865	http://dx.doi.org/10.1371/journal.pone.0038865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719969	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300061
J	Polimeni, M; Valente, E; Aldieri, E; Khadjavi, A; Giribaldi, G; Prato, M				Polimeni, Manuela; Valente, Elena; Aldieri, Elisabetta; Khadjavi, Amina; Giribaldi, Giuliana; Prato, Mauro			Haemozoin Induces Early Cytokine-Mediated Lysozyme Release from Human Monocytes through p38 MAPK- and NF-kappaB-Dependent Mechanisms	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN ADHERENT MONOCYTES; PLASMODIUM-FALCIPARUM; MALARIAL PIGMENT; IN-VITRO; FACTOR-ALPHA; MATRIX METALLOPROTEINASES; INFLAMMATORY RESPONSE; CEREBRAL MALARIA; IMMUNE-RESPONSE	Malarial pigment (natural haemozoin, HZ) is a ferriprotoporphyrin IX crystal produced by Plasmodium parasites after haemoglobin catabolism. HZ-fed human monocytes are functionally compromised, releasing increased amounts of pro-inflammatory molecules, including cytokines, chemokines and cytokine-related proteolytic enzyme Matrix Metalloproteinase-9 (MMP-9), whose role in complicated malaria has been recently suggested. In a previous work HZ was shown to induce through TNFalpha production the release of monocytic lysozyme, an enzyme stored in gelatinase granules with MMP-9. Here, the underlying mechanisms were investigated. Results showed that HZ lipid moiety promoted early but not late lysozyme release. HZ-dependent lysozyme induction was abrogated by anti-TNFalpha/IL-1beta/MIP-1alpha blocking antibodies and mimicked by recombinant cytokines. Moreover, HZ early activated either p38 MAPK or NF-kappaB pathways by inducing: p38 MAPK phosphorylation; cytosolic I-kappaBalpha phosphorylation and degradation; NF-kappaB nuclear translocation and DNA-binding. Inhibition of both routes through selected molecules (SB203580, quercetin, artemisinin, parthenolide) prevented HZ-dependent lysozyme release. These data suggest that HZ-triggered overproduction of TNFalpha, IL-1beta and MIP-1alpha mediates induction of lysozyme release from human monocytes through activation of p38 MAPK and NF-kappaB pathways, providing new evidence on mechanisms underlying the HZ-enhanced monocyte degranulation in falciparum malaria and the potential role for lysozyme as a new affordable marker in severe malaria.	[Polimeni, Manuela; Valente, Elena; Aldieri, Elisabetta; Khadjavi, Amina; Giribaldi, Giuliana; Prato, Mauro] Univ Turin, Dipartimento Genet Biol & Biochim, Fac Med & Chirurg, Turin, Italy	University of Turin	Polimeni, M (corresponding author), Univ Turin, Dipartimento Genet Biol & Biochim, Fac Med & Chirurg, Turin, Italy.	mauro.prato@unito.it	Giribaldi, Giuliana/I-8115-2018; Aldieri, Elisabetta/AAX-7129-2020	Giribaldi, Giuliana/0000-0003-1374-1919; ALDIERI, Elisabetta/0000-0002-0236-6175	Intramural Funds from Universita degli Studi di Torino; Charity Funds; Universita degli Studi di Torino; Azienda Sanitaria Locale-19 [ASL-19]	Intramural Funds from Universita degli Studi di Torino; Charity Funds; Universita degli Studi di Torino; Azienda Sanitaria Locale-19	This study was supported by Intramural Funds from Universita degli Studi di Torino to Giuliana Giribaldi, and by Charity Funds from Mrs. Franca Squazza to Mauro Prato. Mauro Prato holds a professorship granted by Universita degli Studi di Torino and Azienda Sanitaria Locale-19 (ASL-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldieri E, 2003, FEBS LETT, V552, P141, DOI 10.1016/S0014-5793(03)00905-0; Amina K, 2010, ASIAN PAC J TROP MED, V3, P412, DOI 10.1016/S1995-7645(10)60101-0; [Anonymous], ADV INTEGRATED PEST; BERGER M, 1988, BLOOD, V71, P151; Billig EMW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-64; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Cambos M, 2010, INT J PARASITOL, V40, P1003, DOI 10.1016/j.ijpara.2010.02.007; Ciacci C, 2010, J INVERTEBR PATHOL, V105, P49, DOI 10.1016/j.jip.2010.05.010; D'Alessandro S, 2012, ASIAN PAC J IN PRESS; Das B. S., 2008, Journal of Vector Borne Diseases, V45, P83; Dasari P, 2011, BLOOD, V118, P4946, DOI 10.1182/blood-2011-05-353920; Dell'Agli M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-208; Di Mari JF, 2007, AM J PHYSIOL-GASTR L, V293, pG719, DOI 10.1152/ajpgi.00117.2007; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; FIORI PL, 1993, PARASITE IMMUNOL, V15, P647, DOI 10.1111/j.1365-3024.1993.tb00579.x; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Giribaldi G, 2004, HAEMATOLOGICA, V89, P492; Giribaldi G, 2011, ASIAN PAC J TROP MED, V4, P925, DOI 10.1016/S1995-7645(11)60220-4; Giribaldi G, 2010, INFECT IMMUN, V78, P4912, DOI 10.1128/IAI.00455-10; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; Kajla MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019649; KHALID SA, 1986, J ETHNOPHARMACOL, V15, P201, DOI 10.1016/0378-8741(86)90156-X; Lapcharoen P, 2012, DEV COMP IMMUNOL, V36, P104, DOI 10.1016/j.dci.2011.06.010; LEWIS CE, 1990, IMMUNOLOGY, V69, P402; Lu ZY, 2006, J IMMUNOL, V177, P6344, DOI 10.4049/jimmunol.177.9.6344; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Mauro P, 2010, ASIAN PAC J TROP MED, V3, P85, DOI 10.1016/S1995-7645(10)60041-7; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mohamed AO, 1996, T ROY SOC TROP MED H, V90, P277, DOI 10.1016/S0035-9203(96)90246-1; Mohammed AO, 2003, ACTA TROP, V87, P279, DOI 10.1016/S0001-706X(03)00116-5; Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179; Nair MP, 2006, CLIN VACCINE IMMUNOL, V13, P319, DOI 10.1128/CVI.13.3.319-328.2006; PETERS CWB, 1989, EUR J BIOCHEM, V182, P507, DOI 10.1111/j.1432-1033.1989.tb14857.x; Prato M, 2005, J IMMUNOL, V175, P6436, DOI 10.4049/jimmunol.175.10.6436; Prato M, 2009, ASIAN PAC J TROP MED, V2, P35; Prato M, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/628435; Prato M, 2011, ASIAN PAC J TROP MED, V4, P756, DOI 10.1016/S1995-7645(11)60187-9; Prato M, 2011, CELL MICROBIOL, V13, P1275, DOI 10.1111/j.1462-5822.2011.01620.x; Prato M, 2010, ASIAN PAC J TROP MED, V3, P934, DOI 10.1016/S1995-7645(11)60003-5; Prato M, 2010, CELL MICROBIOL, V12, P1780, DOI 10.1111/j.1462-5822.2010.01508.x; Prato M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-157; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Schwarzer E, 2003, BLOOD, V101, P722, DOI 10.1182/blood-2002-03-0979; Scorza T, 1999, PARASITE IMMUNOL, V21, P545, DOI 10.1046/j.1365-3024.1999.00254.x; Serghides L, 2009, J INFECT DIS, V199, P1536, DOI 10.1086/598222; Shio MT, 2010, MICROBES INFECT, V12, P889, DOI 10.1016/j.micinf.2010.07.001; SueAQuan AK, 1997, J CELL PHYSIOL, V172, P94, DOI 10.1002/(SICI)1097-4652(199707)172:1<94::AID-JCP11>3.0.CO;2-O; Urban Britta C, 2006, J Biol, V5, P4, DOI 10.1186/jbiol37; Van LP, 1996, BIOCHEM J, V313, P39; Were T, 2009, MICROBES INFECT, V11, P811, DOI 10.1016/j.micinf.2009.04.021; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	58	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39497	10.1371/journal.pone.0039497	http://dx.doi.org/10.1371/journal.pone.0039497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724024	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300142
J	Wey, S; Luo, BQ; Lee, AS				Wey, Shiuan; Luo, Biquan; Lee, Amy S.			Acute Inducible Ablation of GRP78 Reveals Its Role in Hematopoietic Stem Cell Survival, Lymphogenesis and Regulation of Stress Signaling	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ER; IL-7; APOPTOSIS; MICE; PROLIFERATION; ACTIVATION; INDUCTION; SECRETION; CHEMOKINE	GRP78, a master regulator of the unfolded protein response (UPR) and cell signaling, is required for inner cell mass survival during early embryonic development. However, little is known about its role in adult hematopoietic stem cells (HSCs) and hematopoiesis. Here we generated a conditional knockout mouse model that acutely deletes Grp78 in the adult hematopoietic system. Acute GRP78 ablation resulted in a significant reduction of HSCs, common lymphoid and myeloid progenitors, and lymphoid cell populations in the mutant mice. The GRP78-null induced reduction of the HSC pool could be attributed to increased apoptosis. Chimeric mice with Grp78 deletion only in the hematopoietic cells also showed a loss of HSCs and lymphopenia, suggesting a cell intrinsic effect. Analysis of GRP78 deficient bone marrow (BM) cells showed constitutive activation of all the major UPR signaling pathways, including activation of eIF2 alpha, ATF6, xbp-1 splicing, as well as caspase activation. A multiplex cytokine assay further revealed alteration in select cytokine and chemokine serum levels in the mutant mice. Collectively, these studies demonstrate that GRP78 plays a pleiotropic role in BM cells and contributes to HSC survival and the maintenance of the lymphoid lineage.	[Wey, Shiuan; Luo, Biquan; Lee, Amy S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Wey, S (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	National Institutes of Health [CA027607]; National Cancer Institute [P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA027607, R37CA027607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant CA027607 (A.S.L.). The USC core facilities described were supported by National Institutes of Health P30 CA014089 from the National Cancer Institute. URL: http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; CERRETTI DP, 1986, P NATL ACAD SCI USA, V83, P3223, DOI 10.1073/pnas.83.10.3223; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Choong ML, 2004, CYTOKINE, V25, P239, DOI 10.1016/j.cyto.2003.11.002; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DORNER AJ, 1994, BIOLOGICALS, V22, P103, DOI 10.1006/biol.1994.1016; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hetz C, 2009, LEUKEMIA RES, V33, P880, DOI 10.1016/j.leukres.2009.02.017; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Koh YT, 2009, PROSTATE, V69, P571, DOI 10.1002/pros.20906; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Luo B, 2012, ONCOGENE IN PRESS; Luo BQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020364; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Murray R, 1989, Int Immunol, V1, P526, DOI 10.1093/intimm/1.5.526; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Ota J, 2003, ONCOGENE, V22, P5720, DOI 10.1038/sj.onc.1206855; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Qian YC, 2007, AM J PHYSIOL-CELL PH, V293, pC897, DOI 10.1152/ajpcell.00059.2007; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosati E, 2010, BLOOD, V116, P2713, DOI 10.1182/blood-2010-03-275628; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Uckun FM, 2011, BRIT J HAEMATOL, V153, P741, DOI 10.1111/j.1365-2141.2011.08671.x; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	41	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39047	10.1371/journal.pone.0039047	http://dx.doi.org/10.1371/journal.pone.0039047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723926	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300084
J	Liu, HL; Xu, R; Feng, LL; Guo, WJ; Cao, N; Qian, C; Teng, P; Wang, L; Wu, XF; Sun, Y; Li, JX; Shen, Y; Xu, Q				Liu, Hailiang; Xu, Rui; Feng, Lili; Guo, Wenjie; Cao, Ning; Qian, Cheng; Teng, Peng; Wang, Lu; Wu, Xuefeng; Sun, Yang; Li, Jianxin; Shen, Yan; Xu, Qiang			A Novel Chromone Derivative with Anti-Inflammatory Property via Inhibition of ROS-Dependent Activation of TRAF6-ASK1-p38 Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; KINASE INHIBITOR; PROTEIN; SEPSIS; EXPRESSION; APOPTOSIS; RECOGNITION; MACROPHAGES; INDUCTION	The p38 MAPK signaling pathway plays a pivotal role in inflammation. Targeting p38 MAPK may be a potential strategy for the treatment of inflammatory diseases. In the present study, we show that a novel chromone derivative, DCO-6, significantly reduced lipopolysaccharide (LPS)-induced production of nitric oxide, IL-1 beta and IL-6, decreased the levels of iNOS, IL-1 beta and IL-6 mRNA expression in both RAW264.7 cells and mouse primary peritoneal macrophages, and inhibited LPS-induced activation of p38 MAPK but not of JNK, ERK. Moreover, DCO-6 specifically inhibited TLR4-dependent p38 activation without directly inhibiting its kinase activity. LPS-induced production of intracellular reactive oxygen species (ROS) was remarkably impaired by DCO-6, which disrupted the formation of the TRAF6-ASK1 complex. Administering DCO-6 significantly protected mice from LPS-induced septic shock in parallel with the inhibition of p38 activation and ROS production. Our results indicate that DCO-6 showed anti-inflammatory properties through inhibition of ROS-dependent activation of TRAF6-ASK1-p38 pathway. Blockade of the upstream events required for p38 MAPK action by DCO-6 may provide a new therapeutic option in the treatment of inflammatory diseases.	[Liu, Hailiang; Xu, Rui; Feng, Lili; Guo, Wenjie; Cao, Ning; Qian, Cheng; Wang, Lu; Wu, Xuefeng; Sun, Yang; Shen, Yan; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Teng, Peng; Li, Jianxin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Liu, HL (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	shenyan@nju.edu.cn; molpharm@163.com	Guo, Wenjie/AAQ-7553-2020; Teng, Peng/K-1046-2015; Qian, Cheng/ACI-6931-2022; Teng, Peng/AAS-4575-2020	Teng, Peng/0000-0002-7412-9646; Qian, Cheng/0000-0001-7573-3717; Teng, Peng/0000-0002-7412-9646	National Natural Science Foundation of China [30730107, 90913023, 30973546]; Natural Science Foundation of Jiangsu Province [BK2008022, BK2009238]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (Nos. 30730107, 90913023 and 30973546) and the Natural Science Foundation of Jiangsu Province (Nos. BK2008022, BK2009238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cohen S, 2010, CURR OPIN RHEUMATOL, V22, P330, DOI 10.1097/BOR.0b013e3283378e6f; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; Dyrager C, 2011, J MED CHEM; Funakoshi-Tago M, 2003, EUR J BIOCHEM, V270, P1257, DOI 10.1046/j.1432-1033.2003.03487.x; Guan ZH, 1998, J BIOL CHEM, V273, P12901, DOI 10.1074/jbc.273.21.12901; Haschemi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026376; Ho FM, 2004, BRIT J PHARMACOL, V141, P1037, DOI 10.1038/sj.bjp.0705700; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kirkwood KL, 2009, CURR DRUG METAB, V10, P55, DOI 10.2174/138920009787048347; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Liu GB, 2010, BIOORGAN MED CHEM, V18, P2864, DOI 10.1016/j.bmc.2010.03.020; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ramos L, 2010, J IMMUNOL, V185, P709, DOI 10.4049/jimmunol.1000273; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Sharma SK, 2011, CURR MED CHEM, V18, P3825; Song R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004450; Takatsuna H, 2003, J BIOL CHEM, V278, P12144, DOI 10.1074/jbc.M300720200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Wang L, 2009, MOL PHARMACOL, V76, P1238, DOI 10.1124/mol.109.059105; Xu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027165; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	37	30	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e37168	10.1371/journal.pone.0037168	http://dx.doi.org/10.1371/journal.pone.0037168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720096	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000003
J	Li, LK; Wen, L; Gong, Y; Mei, GQ; Liu, JS; Chen, YL; Peng, T				Li, Leike; Wen, Luan; Gong, Yu; Mei, Guoqiang; Liu, Jinsong; Chen, Yonglong; Peng, Tao			Xenopus as a Model System for the Study of GOLPH2/GP73 Function: Xenopus golph2 Is Required for Pronephros Development	PLOS ONE			English	Article							GOLGI MEMBRANE-PROTEIN; KIDNEY DEVELOPMENT; LIVER-DISEASE; BARTTER-SYNDROME; DISTAL TUBULE; EXPRESSION; GP73; GENES; NOTCH; EMBRYOS	GOLPH2 is a highly conserved protein. It is upregulated in a number of tumors and is being considered as an emerging biomarker for related diseases. However, the function of GOLPH2 remains unknown. The Xenopus model is used to study the function of human proteins. We describe the isolation and characterization of Xenopus golph2, which dimerizes and localizes to the Golgi in a manner similar to human GOLPH2. Xenopus golph2 is expressed in the pronephros during early development. The morpholino-mediated knockdown of golph2 results in edema formation. Additionally, Nephrin expression is enhanced in the glomus, and the expression of pronephric marker genes, such as atp1b1, ClC-K, NKCC2, and NBC1, is diminished in the tubules and duct. Expression patterns of the transcription factors WT1, Pax2, Pax8, Lim1, GATA3, and HNF1 beta are also examined in the golph2 knockdown embryos, the expression of WT1 is increased in the glomus and expanded laterally in the pronephric region. We conclude that the deletion of golph2 causes an increase in the expression of WT1, which may promote glomus formation and inhibit pronephric tubule differentiation.	[Li, Leike; Gong, Yu; Mei, Guoqiang; Liu, Jinsong; Peng, Tao] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Leike; Mei, Guoqiang; Peng, Tao] Univ Sci & Technol, Hefei, Peoples R China; [Wen, Luan; Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Wen, Luan] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, Program Cellular Regulat & Metab,NIH, Bethesda, MD USA	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Li, LK (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chen_yonglong@gibh.ac.cn; peng_tao@gibh.ac.cn	Wen, Luan/ABH-3991-2020	Wen, Luan/0000-0001-9408-8709; Li, Leike/0000-0002-1379-1396; Peng, Tao/0000-0001-5260-7128; Wen, Luan/0000-0001-5080-0469	National Science Foundation [309701647]; National Basic Research Program (973) [2009CB522300, 2009CB941202]; Chinese Academy of Sciences [KSCX2-YW-R-083]	National Science Foundation(National Science Foundation (NSF)); National Basic Research Program (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Science Foundation (309701647), National Basic Research Program (973) (Grant No. 2009CB522300 and 2009CB941202), Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-YW-R-083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2007, TRAFFIC, V8, P1415, DOI 10.1111/j.1600-0854.2007.00621.x; Bettinelli A, 2005, PEDIATR RES, V58, P1269, DOI 10.1203/01.pdr.0000185267.95466.41; Carroll TJ, 1996, DEV DYNAM, V206, P131, DOI 10.1002/(SICI)1097-0177(199606)206:2<131::AID-AJA2>3.3.CO;2-I; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fritzsche Florian Rudolf, 2008, BMC Urol, V8, P15, DOI 10.1186/1471-2490-8-15; Gerth VE, 2005, DEV DYNAM, V233, P1131, DOI 10.1002/dvdy.20415; Gong Y, 2012, BIOCH BIOPHYS RES CO; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Howland RB, 1916, P NATL ACAD SCI USA, V2, P231, DOI 10.1073/pnas.2.4.231; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Jones EA, 2005, J AM SOC NEPHROL, V16, P313, DOI 10.1681/ASN.2004070617; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Li XJ, 2010, DEV DYNAM, V239, P2742, DOI 10.1002/dvdy.22401; McLaughlin KA, 2000, DEV BIOL, V227, P567, DOI 10.1006/dbio.2000.9913; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; Romano PR, 2003, HEPATOLOGY, V38, p768A; RYAN G, 1995, DEVELOPMENT, V121, P867; Saxen L., 1987, ORGANOGENESIS KIDNEY; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; Taelman V, 2006, DEVELOPMENT, V133, P2961, DOI 10.1242/dev.02458; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Van Campenhout C, 2006, DEV BIOL, V294, P203, DOI 10.1016/j.ydbio.2006.02.040; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; Vize PD, 2003, GENE EXPR PATTERNS, V3, P347, DOI 10.1016/S1567-133X(03)00032-2; Wei SZ, 2008, PROSTATE, V68, P1387, DOI 10.1002/pros.20806; Wen LA, 2010, DEV DYNAM, V239, P2198, DOI 10.1002/dvdy.22356; Wessely O, 2011, PEDIAT NEPHROLOGY; Wild W, 2000, P NATL ACAD SCI USA, V97, P4695, DOI 10.1073/pnas.080010897; Wright LM, 2009, INT J CLIN EXP PATHO, V2, P34; Yamazaki H, 2009, PEDIATR NEPHROL, V24, P415, DOI 10.1007/s00467-008-0999-3; Zhang FF, 2010, CLIN BIOCHEM, V43, P983, DOI 10.1016/j.clinbiochem.2010.05.010; Zhou XL, 2004, DEV BIOL, V271, P322, DOI 10.1016/j.ydbio.2004.03.036; Zhou Y, 2011, MOL BIOL REP, V38, P1457, DOI 10.1007/s11033-010-0251-7	46	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38939	10.1371/journal.pone.0038939	http://dx.doi.org/10.1371/journal.pone.0038939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22719994	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800029
J	Ellison, AM; Butler, ED; Hicks, EJ; Naczi, RFC; Calie, PJ; Bell, CD; Davis, CC				Ellison, Aaron M.; Butler, Elena D.; Hicks, Emily Jean; Naczi, Robert F. C.; Calie, Patrick J.; Bell, Charles D.; Davis, Charles C.			Phylogeny and Biogeography of the Carnivorous Plant Family Sarraceniaceae	PLOS ONE			English	Article							RIBOSOMAL DNA-SEQUENCES; FLORAL EVOLUTION; PURPUREA SARRACENIACEAE; MOLECULAR PHYLOGENETICS; GEOGRAPHIC RANGE; CARIBBEAN REGION; TREE SELECTION; PITCHER PLANT; HELIAMPHORA; ERICALES	The carnivorous plant family Sarraceniaceae comprises three genera of wetland-inhabiting pitcher plants: Darlingtonia in the northwestern United States, Sarracenia in eastern North America, and Heliamphora in northern South America. Hypotheses concerning the biogeographic history leading to this unusual disjunct distribution are controversial, in part because genus-and species-level phylogenies have not been clearly resolved. Here, we present a robust, species-rich phylogeny of Sarraceniaceae based on seven mitochondrial, nuclear, and plastid loci, which we use to illuminate this family's phylogenetic and biogeographic history. The family and genera are monophyletic: Darlingtonia is sister to a clade consisting of Heliamphora+Sarracenia. Within Sarracenia, two clades were strongly supported: one consisting of S. purpurea, its subspecies, and S. rosea; the other consisting of nine species endemic to the southeastern United States. Divergence time estimates revealed that stem group Sarraceniaceae likely originated in South America 44-53 million years ago (Mya) (highest posterior density [HPD] estimate = 47 Mya). By 25-44 (HPD = 35) Mya, crown-group Sarraceniaceae appears to have been widespread across North and South America, and Darlingtonia (western North America) had diverged from Heliamphora+Sarracenia (eastern North America+South America). This disjunction and apparent range contraction is consistent with late Eocene cooling and aridification, which may have severed the continuity of Sarraceniaceae across much of North America. Sarracenia and Heliamphora subsequently diverged in the late Oligocene, 14-32 (HPD = 23) Mya, perhaps when direct overland continuity between North and South America became reduced. Initial diversification of South American Heliamphora began at least 8 Mya, but diversification of Sarracenia was more recent (2-7, HPD = 4 Mya); the bulk of southeastern United States Sarracenia originated co-incident with Pleistocene glaciation, <3 Mya. Overall, these results suggest climatic change at different temporal and spatial scales in part shaped the distribution and diversity of this carnivorous plant clade.	[Ellison, Aaron M.; Butler, Elena D.; Davis, Charles C.] Harvard Univ, Petersham, MA USA; [Hicks, Emily Jean; Calie, Patrick J.] Eastern Kentucky Univ, Richmond, KY 40475 USA; [Hicks, Emily Jean] Univ Kentucky, Regulatory Serv, Lexington, KY USA; [Naczi, Robert F. C.] New York Bot Garden, Bronx, NY 10458 USA; [Bell, Charles D.] Univ New Orleans, New Orleans, LA 70148 USA	Harvard University; University of Kentucky; New York Botanical Garden; University of Louisiana System; University of New Orleans	Ellison, AM (corresponding author), Harvard Univ, Petersham, MA USA.	aellison@fas.harvard.edu; cdavis@oeb.harvard.edu		Ellison, Aaron/0000-0003-4151-6081; Butler, Elena/0000-0002-0147-5150	Harvard University Herbaria; Harvard College Research Program; NSF [EF 04-31242, DEB 05-41680]; NSF-Kentucky EPSCoR Program, NIH/NCRR [P20 RR16481]; L. R. Hesler Award from the University of Tennessee Department of Ecology and Evolutionary Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER	Harvard University Herbaria; Harvard College Research Program; NSF(National Science Foundation (NSF)); NSF-Kentucky EPSCoR Program, NIH/NCRR; L. R. Hesler Award from the University of Tennessee Department of Ecology and Evolutionary Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Grant-in-Aid of Undergraduate Research from the Harvard University Herbaria; the Harvard College Research Program; NSF grants EF 04-31242 and DEB 05-41680 http://www.nsf.gov/; NSF-Kentucky EPSCoR Program, NIH/NCRR grant P20 RR16481 http://www.nih.gov/; and the L. R. Hesler Award from the University of Tennessee Department of Ecology and Evolutionary Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT VA, 1992, SCIENCE, V257, P1491, DOI 10.1126/science.1523408; Anderberg AA, 2002, AM J BOT, V89, P677, DOI 10.3732/ajb.89.4.677; Arber A, 1941, ANN BOT-LONDON, V5, P563, DOI 10.1093/oxfordjournals.aob.a087407; Baum DA, 1998, SYST BIOL, V47, P181, DOI 10.1080/106351598260879; Bayer RJ, 1996, SYST BOT, V21, P121, DOI 10.2307/2419743; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bromham L, 2002, EVOLUTION, V56, P1921; Cameron KM, 2001, AM J BOT, V88, P1847, DOI 10.2307/3558361; Croizat L., 1960, PRINCIPIA BOT BEGINN; Darwin C., 1875, INSECTIVOROUS PLANTS; Davis CC, 2002, AM J BOT, V89, P699, DOI 10.3732/ajb.89.4.699; Davis CC, 2007, SCIENCE, V315, P1812, DOI 10.1126/science.1135260; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Elansary HOM, 2010, AQUAT BOT, V92, P214, DOI 10.1016/j.aquabot.2009.12.002; Ellison AM, 2011, OIKOS, V120, P1721, DOI 10.1111/j.1600-0706.2011.19604.x; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Ellison AM, 2002, AM J BOT, V89, P1024, DOI 10.3732/ajb.89.6.1024; Ellison AM, 2001, AM J BOT, V88, P429, DOI 10.2307/2657107; Fleischmann A, 2010, MOL PHYLOGENET EVOL, V56, P768, DOI 10.1016/j.ympev.2010.03.009; Fleischmann Andreas, 2009, Willdenowia, V39, P273, DOI 10.3372/wi.39.39206; Fleischmann A, 2009, ANAL JARDIN BOT MAD, V66, P209, DOI 10.3989/ajbm.2198; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Graham A, 2003, SYST BOT, V28, P378; Graham A., 2011, NATURAL HIST NEW WOR; Heads Michael, 1984, TUATARA, V27, P26; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Hicks EJ, 2010, THESIS E KENTUCKY U; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Jobson RW, 2003, SYST BOT, V28, P157; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Juniper B.E., 1989, CARNIVOROUS PLANTS; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Kuzoff RK, 1998, MOL BIOL EVOL, V15, P251, DOI 10.1093/oxfordjournals.molbev.a025922; Li HQ, 2005, ACTA BOT GALLICA, V152, P227, DOI 10.1080/12538078.2005.10515473; MacPhee R. D. E., 1995, American Museum Novitates, V0, P1; MAGUIRE B, 1970, Biotropica, V2, P85, DOI 10.2307/2989766; Maguire B., 1978, MEMOIRS NEW YORK BOT, V29, P36; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Mathews S, 2000, INT J PLANT SCI, V161, pS41, DOI 10.1086/317582; MCDANIEL S, 1966, THESIS FLORIDA STATE; McDaniel S., 1971, B TALL TIMBERS RES S, V9, P1; Meindl George A., 2011, Madrono, V58, P22, DOI 10.3120/0024-9637-58.1.22; Mellichamp T.L., 2009, FLORA N AM N MEXICO, V8, P348; Mellichamp TL, 1983, NAT HIST, V4, P47; Miller M.A., 2009, CIPRES PORTALS CIPRE; Naczi Robert F. C., 1999, SIDA Contributions to Botany, V18, P1183; Ne'eman G, 2006, AM J BOT, V93, P1660, DOI 10.3732/ajb.93.11.1660; Neyland Ray, 2006, Madrono, V53, P223, DOI 10.3120/0024-9637(2006)53[223:SROSIF]2.0.CO;2; Oswald WW, 2011, RHODORA, V113, P235, DOI 10.3119/0035-4902-113.955.235; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; RENNER SS, 1989, PLANT SYST EVOL, V163, P21, DOI 10.1007/BF00936149; Rivadavia F, 2003, AM J BOT, V90, P123, DOI 10.3732/ajb.90.1.123; Rutherford S, 2000, NATURE, V408, P72, DOI 10.1038/35040533; Santos JOS, 2003, GEOL SOC AM BULL, V115, P331, DOI 10.1130/0016-7606(2003)115<0331:ASARSO>2.0.CO;2; SCHNELL D E, 1976, Castanea, V41, P165; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Schonenberger J, 2005, INT J PLANT SCI, V166, P265, DOI 10.1086/427198; Schonenberger J, 2010, PHILOS T R SOC B, V365, P437, DOI 10.1098/rstb.2009.0247; SCHUBERT C, 1994, QUATERN INT, V21, P81, DOI DOI 10.1016/1040-6182%2894%2990022-1; SCHWAEGERLE KE, 1983, OHIO J SCI, V83, P19; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THANIKAIMONI G, 1972, Pollen et Spores, V14, P143; Wang ZF, 2004, J HERED, V95, P234, DOI 10.1093/jhered/esh043; WEAKLEY A. S, 2011, FLORA SO MI IN PRESS; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wurdack KJ, 2009, AM J BOT, V96, P1551, DOI 10.3732/ajb.0800207; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhu XY, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-217	78	39	39	8	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39291	10.1371/journal.pone.0039291	http://dx.doi.org/10.1371/journal.pone.0039291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720090	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900094
J	Masan, P; Simpson, C; Perotti, MA; Braig, HR				Masan, Peter; Simpson, Christopher; Perotti, M. Alejandra; Braig, Henk R.			Mites Parasitic on Australasian and African Spiders Found in the Pet Trade; a Redescription of Ljunghia pulleinei Womersley	PLOS ONE			English	Article							ARANEAE; ACARI	Parasitic mites associated with spiders are spreading world-wide through the trade in tarantulas and other pet species. Ljunghia pulleinei Womersley, a mesostigmatic laelapid mite originally found in association with the mygalomorph spider Selenocosmia stirlingi Hogg (Theraphosidae) in Australia, is redescribed and illustrated on the basis of specimens from the African theraphosid spider Pterinochilus chordatus (Gerstacker) kept in captivity in the British Isles (Wales). The mite is known from older original descriptions of Womersley in 1956; the subsequent redescription of Domrow in 1975 seems to be questionable in conspecificity of treated specimens with the type material. Some inconsistencies in both descriptions are recognised here as intraspecific variability of the studied specimens. The genus Arachnyssus Ma, with species A. guangxiensis (type) and A. huwenae, is not considered to be a valid genus, and is included in synonymy with Ljunghia Oudemans. A new key to world species of the genus Ljunghia is provided.	[Masan, Peter; Simpson, Christopher; Braig, Henk R.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Masan, Peter] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Perotti, M. Alejandra] Univ Reading, Sch Biol Sci, Reading, Berks, England	Bangor University; Slovak Academy of Sciences; University of Reading	Masan, P (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	peter.masan@savba.sk	Braig, Henk/I-5477-2013; Mašán, Peter/HGA-1690-2022	Braig, Henk/0000-0001-9592-1141; 				Baker A., 1991, Bulletin of the British Arachnological Society, V8, P219; Baker A.S., 1992, P126; Casanueva Maria E., 1993, Gayana Zoologia, V57, P21; DOMROW R, 1975, Records of the South Australian Museum (Adelaide), V17, P31; Dunlop JA, 2012, BIOL LETTERS, V8, P457, DOI 10.1098/rsbl.2011.0923; Ebermann Ernst, 2002, Acarologia (Paris), V42, P173; FAIN A, 1991, Records of the Western Australian Museum, V15, P69; FAIN A, 1991, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V61, P183; FAIN A, 1991, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V61, P199; FAIN A, 1989, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V59, P157; Finnegan S, 1933, P ZOOL SOC LOND, V1993, P413; Gallon Richard C., 2002, Bulletin of the British Arachnological Society, V12, P201; Lindquist E. E., 1965, Mem ent Soc Canada Ottawa, VNo. 47, P1; Ma Liming, 2002, Acta Arachnologica Sinica, V11, P8; Moraza ML, 2009, ZOOSYSTEMA, V31, P117, DOI 10.5252/z2009n1a6; OUDEMANS A. C., 1932, TIJDSCHR ENT [AMSTERDAM], V75 (suppl.), P202; Pizzi Romain, 2009, Journal of Exotic Pet Medicine, V18, P283, DOI 10.1053/j.jepm.2009.09.006; Schwendinger PJ, 2011, REV SUISSE ZOOL, V118, P599; WELBOURN WC, 1988, J ARACHNOL, V16, P373; Womersley H., 1956, Journal of the Linnean Society London Zoology, V42, P505; Wunderlich Joerg, 2004, Beitraege zur Araneologie, V3B, P1761; Zhu MS, 2008, J ARACHNOL, V36, P425, DOI 10.1636/CA07-94.1	22	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39019	10.1371/journal.pone.0039019	http://dx.doi.org/10.1371/journal.pone.0039019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720019	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000305341900073
J	D'Addario, C; Di Francesco, A; Arosio, B; Gussago, C; Dell'Osso, B; Bari, M; Galimberti, D; Scarpini, E; Altamura, AC; Mari, D; Maccarrone, M				D'Addario, Claudio; Di Francesco, Andrea; Arosio, Beatrice; Gussago, Cristina; Dell'Osso, Bernardo; Bari, Monica; Galimberti, Daniela; Scarpini, Elio; Altamura, A. Carlo; Mari, Daniela; Maccarrone, Mauro			Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease	PLOS ONE			English	Article							CANNABINOID RECEPTOR-BINDING; CENTRAL-NERVOUS-SYSTEM; ENDOCANNABINOID SYSTEM; DNA METHYLATION; MESSENGER-RNA; ANANDAMIDE; EXPRESSION; CELLS; BRAIN; CB1	Objective: Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerative processes. Methods: We have studied the gene expression status and the epigenetic regulation of ECS components in peripheral blood mononuclear cells (PBMCs) of subjects with late-onset AD (LOAD) and age-matched controls (CT). Results: We found an increase in fatty acid amide hydrolase (faah) gene expression in LOAD subjects (2.30 +/- 0.48) when compared to CT (1.00 +/- 0.14; *p<0.05) and no changes in the mRNA levels of any other gene of ECS elements. Consistently, we also observed in LOAD subjects an increase in FAAH protein levels (CT: 0.75 +/- 0.04; LOAD: 1.11 +/- 0.15; *p<0.05) and activity (pmol/min per mg protein CT: 103.80 +/- 8.73; LOAD: 125.10 +/- 4.00; *p<0.05), as well as a reduction in DNA methylation at faah gene promoter (CT: 55.90 +/- 4.60%; LOAD: 41.20 +/- 4.90%; *p<0.05). Conclusions: Present findings suggest the involvement of FAAH in the pathogenesis of AD, highlighting the importance of epigenetic mechanisms in enzyme regulation; they also point to FAAH as a new potential biomarker for AD in easily accessible peripheral cells.	[D'Addario, Claudio; Di Francesco, Andrea; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Arosio, Beatrice; Gussago, Cristina; Mari, Daniela] Univ Milan, Geriatr Unit, Dept Med Sci & Community Hlth, Fdn Ca Granda,IRCCS Osped Maggiore Policlin, Milan, Italy; [Dell'Osso, Bernardo; Altamura, A. Carlo] Univ Milan, Dept Psychiat, Fdn Ca Granda, IRCCS Osped Maggiore Policlin, Milan, Italy; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, Fdn Ca Granda,IRCCS Osped Maggiore Policlin, Milan, Italy; [Bari, Monica] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy; [Bari, Monica; Maccarrone, Mauro] IRCCS Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy	University of Teramo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Rome Tor Vergata; IRCCS Santa Lucia	D'Addario, C (corresponding author), Univ Teramo, Dept Biomed Sci, Teramo, Italy.	mmaccarrone@unite.it	Mari, Daniela/K-5663-2016; Dell'Osso, Bernardo/K-8030-2016; DAddario, Claudio/A-5970-2010; Galimberti, Daniela/N-7209-2019; Di Francesco, Andrea/G-8016-2011; Maccarrone, Mauro/K-5398-2012; Scarpini, Elio/K-6547-2016	Mari, Daniela/0000-0002-6950-0789; Galimberti, Daniela/0000-0002-9284-5953; Maccarrone, Mauro/0000-0002-3990-2963; Di Francesco, Andrea/0000-0001-6867-8203; Gussago, Cristina/0000-0002-2708-3112; Arosio, Beatrice/0000-0002-0615-3580; Scarpini, Elio/0000-0002-6395-2119; dell'osso, bernardo/0000-0001-9370-5365; d'addario, claudio/0000-0002-1275-098X	Fondazione TERCAS	Fondazione TERCAS	This investigation was partially supported by Fondazione TERCAS (grant 2009-2012 to MM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arosio B, 2012, NEURODEGENER DIS, V10, P207, DOI 10.1159/000333799; Arosio B, 2004, NEUROBIOL AGING, V25, P1009, DOI 10.1016/j.neurobiolaging.2003.10.009; Benito C, 2003, J NEUROSCI, V23, P11136; Benito C, 2007, MOL NEUROBIOL, V36, P75, DOI 10.1007/s12035-007-8006-8; Bisogno T, 2008, CURR PHARM DESIGN, V14, P2299, DOI 10.2174/138161208785740027; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Catani MV, 2010, CELL MOL LIFE SCI, V67, P601, DOI 10.1007/s00018-009-0198-9; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; D'Addario C, 2012, NEUROPSYCHOPHARMACOL, V37, P1647, DOI 10.1038/npp.2012.10; Dangond F, 1998, BIOCHEM BIOPH RES CO, V247, P833, DOI 10.1006/bbrc.1998.8891; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Feng JA, 2007, PEDIATR RES, V61, p58R, DOI 10.1203/pdr.0b013e3180457635; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavin DP, 2010, NEUROSCI BIOBEHAV R, V34, P882, DOI 10.1016/j.neubiorev.2009.10.010; Grunblatt E, 2009, J ALZHEIMERS DIS, V16, P627, DOI 10.3233/JAD-2009-0996; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Jung KM, 2012, NEUROBIOL AGING, V33, P1522, DOI 10.1016/j.neurobiolaging.2011.03.012; Koppel J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-2; Lee JH, 2010, NEUROCHEM INT, V57, P985, DOI 10.1016/j.neuint.2010.10.010; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; Maccarrone M, 2002, BLOOD, V100, P4040, DOI 10.1182/blood-2002-05-1444; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; MAILLEUX P, 1992, NEUROSCI LETT, V147, P179, DOI 10.1016/0304-3940(92)90589-Y; Marchalant Y, 2008, NEUROBIOL AGING, V29, P1894, DOI 10.1016/j.neurobiolaging.2007.04.028; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mechoulam R, 2000, CHEM PHYS LIPIDS, V108, P1, DOI 10.1016/S0009-3084(00)00184-5; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Nunez E, 2008, NEUROSCIENCE, V151, P104, DOI 10.1016/j.neuroscience.2007.10.029; Paradisi A, 2006, CURR DRUG TARGETS, V7, P1539, DOI 10.2174/1389450110607011539; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pidsley R, 2011, BIOL PSYCHIAT, V69, P146, DOI 10.1016/j.biopsych.2010.03.029; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pisani A, 2005, ANN NEUROL, V57, P777, DOI 10.1002/ana.20462; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; RICHFIELD EK, 1994, ANN NEUROL, V36, P577, DOI 10.1002/ana.410360406; Romero J, 1998, SYNAPSE, V30, P298, DOI 10.1002/(SICI)1098-2396(199811)30:3<298::AID-SYN7>3.0.CO;2-6; Romero J, 2002, MOL BRAIN RES, V100, P85; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Scarpa S, 2006, J ALZHEIMERS DIS, V9, P407; Solinas M, 2008, BRIT J PHARMACOL, V154, P369, DOI 10.1038/bjp.2008.130; Szekely Christine A, 2007, Subcell Biochem, V42, P229; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Wan Y, 2007, BIOSENS BIOELECTRON, V22, P2415, DOI 10.1016/j.bios.2006.08.033; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; WESTLAKE TM, 1994, NEUROSCIENCE, V63, P637, DOI 10.1016/0306-4522(94)90511-8; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	55	64	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39186	10.1371/journal.pone.0039186	http://dx.doi.org/10.1371/journal.pone.0039186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720070	Green Submitted, Green Published, gold			2022-12-25	WOS:000305340000068
J	Kaveh, DA; Whelan, AO; Hogarth, PJ				Kaveh, Daryan A.; Whelan, Adam O.; Hogarth, Philip J.			The Duration of Antigen-Stimulation Significantly Alters the Diversity of Multifunctional CD4 T Cells Measured by Intracellular Cytokine Staining	PLOS ONE			English	Article							TUBERCULOSIS VACCINE; PROTEIN ANTIGENS; FLOW-CYTOMETRY; BREFELDIN-A; PROTECTION; OPTIMIZATION; RESPONSES; MEMORY; EFFECTOR; MUCOSAL	The assessment of antigen-specific T cell responses by intracellular cytokine staining (ICS) has become a routine technique in studies of vaccination and immunity. Here, we highlight how the duration of in vitro antigen pre-stimulation, combined with the cytokine accumulation period, are critical parameters of these methods. The effect of varying these parameters upon the diversity and frequency of multifunctional CD4 T cell subsets has been investigated using a murine model of TB vaccination and in cattle naturally infected with Mycobacterium bovis. We demonstrate a substantial influence of the duration of the antigen pre-stimulation period on the repertoire of the antigen-specific CD4 T cell responses. Increasing pre-stimulation from 2 to 6 hours amplified the diversity of the seven potential multifunctional CD4 T cell subsets that secreted any combination of IFN-gamma, IL-2 and TNF-alpha. However, increasing pre-stimulation from 6 to 16 hours markedly altered the multifunctional CD4 T cell repertoire to a dominant IFN-gamma(+) only response. This was observed in both murine and cattle models. Whilst these data are of particular relevance to the measurement of vaccine and infection induced immunity in TB, more generally, they demonstrate the importance of the empirical determination of the optimum duration of the individual culture steps of ICS assays for any model. We highlight the potential significance of variations in these parameters, particularly when comparing data between studies and/or models including clinical trials.	[Kaveh, Daryan A.; Whelan, Adam O.; Hogarth, Philip J.] AHVLA, TB Res Grp, Surrey, England		Kaveh, DA (corresponding author), AHVLA, TB Res Grp, Surrey, England.	philip.hogarth@ahvla.gsi.gov.uk	Hogarth, Philip/C-6085-2011; Whelan, Adam O/C-9497-2011	Hogarth, Philip/0000-0002-6343-7846; Kaveh, Daryan/0000-0002-1451-0082	Department for Environment, Food and Rural Affairs, United Kingdom	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs, United Kingdom (www.defra.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; ADORINI L, 1990, NATURE, V346, P63, DOI 10.1038/346063a0; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Billeskov R, 2010, EUR J IMMUNOL, V40, P1342, DOI 10.1002/eji.200939830; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Combadiere B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010818; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Gauduin MC, 2004, J IMMUNOL METHODS, V288, P61, DOI 10.1016/j.jim.2004.02.007; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Llanos-Cuentas A, 2010, VACCINE, V28, P7427, DOI 10.1016/j.vaccine.2010.08.092; MACHAMER CE, 1984, P NATL ACAD SCI-BIOL, V81, P1287, DOI 10.1073/pnas.81.5.1287; Madhun AS, 2011, VACCINE, V29, P4973, DOI 10.1016/j.vaccine.2011.04.094; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Meier S, 2008, CYTOM PART A, V73A, P1035, DOI 10.1002/cyto.a.20640; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Nomura L, 2008, CYTOM PART A, V73A, P984, DOI 10.1002/cyto.a.20602; Nomura LE, 2000, CYTOMETRY, V40, P60, DOI 10.1002/(SICI)1097-0320(20000501)40:1<60::AID-CYTO8>3.0.CO;2-J; O'Neil-Andersen NJ, 2002, CLIN DIAGN LAB IMMUN, V9, P243, DOI 10.1128/CDLI.9.2.243-250.2001; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Perfetto Stephen P, 2010, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0934s53; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sopp P, 2001, VET IMMUNOL IMMUNOP, V81, P85, DOI 10.1016/S0165-2427(01)00334-8; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Vordermeier HM, 2009, CLIN VACCINE IMMUNOL, V16, P1443, DOI 10.1128/CVI.00229-09; Vordermeier HM, 2001, CLIN DIAGN LAB IMMUN, V8, P571, DOI 10.1128/CDLI.8.3.571-578.2001; Weynants V, 1998, VET IMMUNOL IMMUNOP, V66, P309, DOI 10.1016/S0165-2427(98)00205-0; Whelan AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029194; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266	47	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38926	10.1371/journal.pone.0038926	http://dx.doi.org/10.1371/journal.pone.0038926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719990	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000053
J	Lameu, C; Trujillo, CA; Schwindt, TT; Negraes, PD; Pillat, MM; Morais, KLP; Lebrun, I; Ulrich, H				Lameu, Claudiana; Trujillo, Cleber A.; Schwindt, Telma T.; Negraes, Priscilla D.; Pillat, Micheli M.; Morais, Katia L. P.; Lebrun, Ivo; Ulrich, Henning			Interactions between the NO-Citrulline Cycle and Brain-derived Neurotrophic Factor in Differentiation of Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ARGININOSUCCINATE SYNTHETASE; S-NITROSYLATION; GENE-EXPRESSION; RAT-BRAIN; IN-VITRO; INCREASES PROLIFERATION; RECEPTOR EXPRESSION; PROTEIN EXPRESSION; PRECURSOR CELLS	The diffusible messenger NO plays multiple roles in neuroprotection, neurodegeneration, and brain plasticity. Argininosuccinate synthase (AS) is a ubiquitous enzyme in mammals and the key enzyme of the NO-citrulline cycle, because it provides the substrate L-arginine for subsequent NO synthesis by inducible, endothelial, and neuronal NO synthase (NOS). Here, we provide evidence for the participation of AS and of the NO-citrulline cycle in the progress of differentiation of neural stem cells (NSC) into neurons, astrocytes, and oligodendrocytes. AS expression and activity and neuronal NOS expression, as well as L-arginine and NOx production, increased along neural differentiation, whereas endothelial NOS expression was augmented in conditions of chronic NOS inhibition during differentiation, indicating that this NOS isoform is amenable to modulation by extracellular cues. AS and NOS inhibition caused a delay in the progress of neural differentiation, as suggested by the decreased percentage of terminally differentiated cells. On the other hand, BDNF reversed the delay of neural differentiation of NSC caused by inhibition of NOx production. Alikely cause is the lack of NO, which up-regulated p75 neurotrophin receptor expression, a receptor required for BDNF-induced differentiation of NSC. We conclude that the NO-citrulline cycle acts together with BDNF for maintaining the progress of neural differentiation.	[Lameu, Claudiana; Trujillo, Cleber A.; Schwindt, Telma T.; Negraes, Priscilla D.; Pillat, Micheli M.; Ulrich, Henning] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508900 Sao Paulo, Brazil; [Morais, Katia L. P.; Lebrun, Ivo] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Ulrich, H (corresponding author), Univ Sao Paulo, Dept Bioquim, Inst Quim, Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, Brazil.	henning@iq.usp.br	Lameu, Claudiana/B-9089-2012; Ulrich, Henning/AAX-8586-2021; Pillat, Micheli/AAW-3423-2020; Ulrich, Henning/C-5245-2013	Lameu, Claudiana/0000-0002-6874-5864; Ulrich, Henning/0000-0002-2114-3815; Pillat, Micheli/0000-0002-6753-6083; Ulrich, Henning/0000-0002-2114-3815; Morais, Katia/0000-0001-8877-5887	Brazilian Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/61285-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Brazilian Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 06/61285-9 and by funds from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of Brazil (to H. U.).; Supported by fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.; Recipients of fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Flam BR, 2001, NITRIC OXIDE-BIOL CH, V5, P187, DOI 10.1006/niox.2001.0340; Flam BR, 2007, NITRIC OXIDE-BIOL CH, V17, P115, DOI 10.1016/j.niox.2007.07.001; Foster JA, 2000, J COMP NEUROL, V427, P417, DOI 10.1002/1096-9861(20001120)427:3<417::AID-CNE8>3.0.CO;2-W; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; Hosomi S, 2003, BIOCHEM BIOPH RES CO, V301, P1011, DOI 10.1016/S0006-291X(03)00077-9; Hsieh HY, 2010, J NEUROSCI RES, V88, P1285, DOI 10.1002/jnr.22291; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Inglis FM, 1998, J NEUROSCI, V18, P10493; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kim SJ, 2008, CELL RES, V18, P686, DOI 10.1038/cr.2008.48; Kumar A, 2006, MOL CELL BIOCHEM, V286, P43, DOI 10.1007/s11010-005-9083-5; Lameu C, 2010, HYPERTENS RES, V33, P1283, DOI 10.1038/hr.2010.208; Lameu Claudiana, 2009, Recent Pat CNS Drug Discov, V4, P137; Larsson E, 2002, EXP NEUROL, V177, P1, DOI 10.1006/exnr.2002.7992; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Li TS, 2009, NEUROREPORT, V20, P295, DOI 10.1097/WNR.0b013e32832000c8; Li YF, 2006, ACTA PHARMACOL SIN, V27, P1395, DOI 10.1111/j.1745-7254.2006.00429.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; Madhusoodanan KS, 2007, NEUROCHEM RES, V32, P681, DOI 10.1007/s11064-006-9167-y; Martins AH, 2008, CYTOM PART A, V73A, P361, DOI 10.1002/cyto.a.20519; Matarredona ER, 2004, BRAIN RES, V995, P274, DOI 10.1016/j.brainres.2003.10.010; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Moroz LL, 1999, J EXP BIOL, V202, P333; Northington Frances J., 1996, Developmental Brain Research, V95, P1, DOI 10.1016/0165-3806(96)00051-X; OLMOS G, 1994, BRIT J PHARMACOL, V111, P997, DOI 10.1111/j.1476-5381.1994.tb14842.x; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; PrugininBluger M, 1997, MECH DEVELOP, V61, P99, DOI 10.1016/S0925-4773(96)00623-5; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0; Regunathan S, 2000, J NEUROCHEM, V74, P2201, DOI 10.1046/j.1471-4159.2000.0742201.x; Reis DJ, 1999, ANN NY ACAD SCI, V881, P65, DOI 10.1111/j.1749-6632.1999.tb09343.x; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Schwindt TT, 2011, J MOL NEUROSCI, V44, P141, DOI 10.1007/s12031-010-9417-y; Shen LJ, 2005, BIOCHEM PHARMACOL, V69, P97, DOI 10.1016/j.bcp.2004.09.003; Stoop R, 1996, PROG BRAIN RES, V109, P359; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Trujillo CA, 2009, CYTOM PART A, V75A, P38, DOI 10.1002/cyto.a.20666; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Wu WT, 1996, EXP NEUROL, V141, P190, DOI 10.1006/exnr.1996.0153; WU WT, 1994, EXP NEUROL, V129, P335, DOI 10.1006/exnr.1994.1176; Xie LJ, 1997, J BIOL CHEM, V272, P16624, DOI 10.1074/jbc.272.26.16624; Xiong HB, 1999, EUR J NEUROSCI, V11, P1567, DOI 10.1046/j.1460-9568.1999.00567.x; Ye SH, 1997, J CLIN INVEST, V99, P540, DOI 10.1172/JCI119191; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007	56	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29690	29701		10.1074/jbc.M111.338095	http://dx.doi.org/10.1074/jbc.M111.338095			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22730318	Green Published, hybrid			2022-12-25	WOS:000308286900045
J	Sorensen, DM; Moller, AB; Jakobsen, MK; Jensen, MK; Vangheluwe, P; Buch-Pedersen, MJ; Palmgren, MG				Sorensen, Danny Mollerup; Moller, Annette B.; Jakobsen, Mia K.; Jensen, Michael K.; Vangheluwe, Peter; Buch-Pedersen, Morten J.; Palmgren, Michael G.			Ca2+ Induces Spontaneous Dephosphorylation of a Novel P5A-type ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; P-TYPE ATPASES; SECRETORY PATHWAY; CATION-BINDING; RETICULUM; CALCIUM; GENE; ION; CA2+-ATPASE; ARABIDOPSIS	P5 ATPases constitute the least studied group of P-type ATPases, an essential family of ion pumps in all kingdoms of life. Although P5 ATPases are present in every eukaryotic genome analyzed so far, they have remained orphan pumps, and their biochemical function is obscure. We show that a P5A ATPase from barley, HvP5A1, locates to the endoplasmic reticulum and is able to rescue knock-out mutants of P5A genes in both Arabidopsis thaliana and Saccharomyces cerevisiae. HvP5A1 spontaneously forms a phosphorylated reaction cycle intermediate at the catalytic residue Asp-488, whereas, among all plant nutrients tested, only Ca2+ triggers dephosphorylation. Remarkably, Ca2+-induced dephosphorylation occurs at high apparent [Ca2+] (K-i = 0.25 mM) and is independent of the phosphatase motif of the pump and the putative binding site for transported ligands located in M4. Taken together, our results rule out that Ca2+ is a transported substrate but indicate the presence of a cytosolic low affinity Ca2+-binding site, which is conserved among P-type pumps and could be involved in pump regulation. Our work constitutes the first characterization of a P5 ATPase phosphoenzyme and points to Ca2+ as a modifier of its function.	[Sorensen, Danny Mollerup; Moller, Annette B.; Jakobsen, Mia K.; Jensen, Michael K.; Vangheluwe, Peter; Buch-Pedersen, Morten J.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant Biol & Biotechnol, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis,PUMPKIN, DK-1871 Frederiksberg C, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Palmgren, MG (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis,PUMPKIN, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@life.ku.dk	Palmgren, Michael/A-9808-2013; Vangheluwe, Peter/P-5476-2017	Palmgren, Michael/0000-0002-9982-6114; Vangheluwe, Peter/0000-0002-7822-2944; Jensen, Michael Krogh/0000-0001-7574-4707				Ando A, 2005, MOL GENET GENOMICS, V273, P497, DOI 10.1007/s00438-005-1153-6; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; Ekberg K, 2010, P NATL ACAD SCI USA, V107, P21400, DOI 10.1073/pnas.1010416107; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Habtemichael N, 2002, GENE, V283, P271, DOI 10.1016/S0378-1119(01)00881-2; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; KINOSHITA T, 1995, PLANT CELL, V7, P1333; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Lustoza ACDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027843; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; POST RL, 1973, J BIOL CHEM, V248, P6993; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Runions J, 2006, J EXP BOT, V57, P43, DOI 10.1093/jxb/eri289; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Sorin A, 1997, J BIOL CHEM, V272, P9895; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Suzuki C, 2001, YEAST, V18, P1471, DOI 10.1002/yea.791; Suzuki C, 2001, BIOSCI BIOTECH BIOCH, V65, P2405, DOI 10.1271/bbb.65.2405; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Usenovic M., 2012, HUM MOL GEN IN PRESS; VARA F, 1982, J BIOL CHEM, V257, P2826; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925	58	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28336	28348		10.1074/jbc.M112.387191	http://dx.doi.org/10.1074/jbc.M112.387191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22730321	hybrid, Green Published			2022-12-25	WOS:000308074600011
J	Calix, JJ; Porambo, RJ; Brady, AM; Larson, TR; Yother, J; Abeygunwardana, C; Nahm, MH				Calix, Juan J.; Porambo, Richard J.; Brady, Allison M.; Larson, Thomas R.; Yother, Janet; Abeygunwardana, Chitrananda; Nahm, Moon H.			Biochemical, Genetic, and Serological Characterization of Two Capsule Subtypes among Streptococcus pneumoniae Serotype 20 Strains DISCOVERY OF A NEW PNEUMOCOCCAL SEROTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSACCHARIDE VACCINE; ASSAY; BIOSYNTHESIS; SEROGROUP-6; ANTIBODIES; CARRIAGE; CHILDREN; DISEASE; LOCUS; WCJE	The bacterial pathogen Streptococcus pneumoniae expresses one of over 90 structurally distinct polysaccharide (PS) capsule serotypes. Prior PS structural analyses of the vaccine-associated serotype 20 do not agree with reports describing the genes that mediate capsule synthesis. Furthermore, using immunized human sera-based assays, serological differences were recently noted among strains typed as serotype 20. We examined the capsule structures of two serologically dissimilar serotype 20 strains, 20 alpha and 20 beta, by extensive biochemical analysis. 20 alpha PS was composed of the previously described serotype 20 hexasaccharide repeat unit, whereas the 20 beta PS was composed of a novel heptasaccharide repeat unit containing an extra branching alpha-glucose residue. Genetic analysis of the subtypes revealed that 20 alpha may have arisen from a 20 beta progenitor following loss of function mutation to the glycosyltransferase gene whaF. Conventional serotyping methods using rabbit polyclonal or mouse monoclonal antibodies were unable to distinguish the subtypes. However, genetic analysis of multiple "serotype 20" clinical isolates revealed that all strains contain the 20 beta genotype. We propose naming bacteria that express the previously described 20 alpha capsule structure 20A and bacteria that express the novel 20 beta capsule structure 20B, a new pneumococcal serotype.	[Calix, Juan J.; Brady, Allison M.; Larson, Thomas R.; Yother, Janet; Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Abeygunwardana, Chitrananda] Merck & Co Inc, Merck Res Labs, Dept Vaccine Regulatory, West Point, PA 19486 USA; [Porambo, Richard J.; Abeygunwardana, Chitrananda] Merck & Co Inc, Merck Res Labs, Dept Vaccine Analyt Dev, West Point, PA 19486 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Merck & Company; Merck & Company	Nahm, MH (corresponding author), BBRB 614,1530 3rd Ave S, Birmingham, AL 35294 USA.	nahm@uab.edu		Nahm, Moon/0000-0002-6922-1042; Brady, Allison/0000-0003-0606-1384	National Institutes of Health [AI-93103, AI007051, AI-28457, AI-31473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI031473, T32AI007051, F31AI093103, R01AI031473, R01AI028457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-93103 (to J. J. C.), AI007051 (to A. M. B.), AI-28457 (to J. Y.), and AI-31473 (to M. H. N.).	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Abeygunawardana C, 2000, ANAL BIOCHEM, V279, P226, DOI 10.1006/abio.1999.4470; Abeygunawardana C, 1993, ADV BIOPHYSICAL CHEM, V3, P199; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Beynon LM, 1997, EUR J BIOCHEM, V250, P163, DOI 10.1111/j.1432-1033.1997.00163.x; Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Burton RL, 2012, CLIN VACCINE IMMUNOL, V19, P835, DOI 10.1128/CVI.00086-12; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Calix JJ, 2012, J BIOL CHEM, V287, P13996, DOI 10.1074/jbc.M112.346924; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J INFECT DIS, V204, P1585, DOI 10.1093/infdis/jir593; Calix JJ, 2011, J BACTERIOL, V193, P5271, DOI 10.1128/JB.05034-11; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Isaacman DJ, 2007, VACCINE, V25, P2420, DOI 10.1016/j.vaccine.2006.09.011; Lee H, 2009, CLIN VACCINE IMMUNOL, V16, P376, DOI 10.1128/CVI.00344-08; Lemercinier X, 2006, CARBOHYD RES, V341, P68, DOI 10.1016/j.carres.2005.10.014; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; RICHARDS JC, 1983, CAN J BIOCHEM CELL B, V61, P178, DOI 10.1139/o83-026; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Yu JG, 2005, J CLIN MICROBIOL, V43, P156, DOI 10.1128/JCM.43.1.156-162.2005	28	109	117	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27885	27894		10.1074/jbc.M112.380451	http://dx.doi.org/10.1074/jbc.M112.380451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736767	hybrid, Green Published			2022-12-25	WOS:000307840700062
J	Nieto, JD; Fisher, M; Cook, S; Laderach, P; Lundy, M				Nieto, Jacqueline Diaz; Fisher, Myles; Cook, Simon; Laederach, Peter; Lundy, Mark			Weather Indices for Designing Micro-Insurance Products for Small-Holder Farmers in the Tropics	PLOS ONE			English	Article							DROUGHT; RISK; AMERICA; DEMAND	Agriculture is inherently risky. Drought is a particularly troublesome hazard that has a documented adverse impact on agricultural development. A long history of decision-support tools have been developed to try and help farmers or policy makers manage risk. We offer site-specific drought insurance methodology as a significant addition to this process. Drought insurance works by encapsulating the best available scientific estimate of drought probability and severity at a site within a single number-the insurance premium, which is offered by insurers to insurable parties in a transparent risk-sharing agreement. The proposed method is demonstrated in a case study for dry beans in Nicaragua.	[Nieto, Jacqueline Diaz] Univ Sheffield, Kroto Res Inst, Catchment Sci Ctr, Sheffield, S Yorkshire, England; [Fisher, Myles; Cook, Simon; Laederach, Peter; Lundy, Mark] Ctr Int Agr Trop, Cali, Colombia	University of Sheffield; Alliance; International Center for Tropical Agriculture - CIAT	Nieto, JD (corresponding author), Univ Sheffield, Kroto Res Inst, Catchment Sci Ctr, North Campus, Sheffield, S Yorkshire, England.	p.laderach@cgiar.org	Cook, Simon/R-7762-2017	Cook, Simon/0000-0003-0902-1476; Laderach, Peter/0000-0001-8708-6318	German Federal Ministry for Economic Cooperation and Development (BMZ); Climate Change, Agriculture and Food Security Program (CCAFS)	German Federal Ministry for Economic Cooperation and Development (BMZ); Climate Change, Agriculture and Food Security Program (CCAFS)	The authors acknowledge partial funding from the German Federal Ministry for Economic Cooperation and Development (BMZ) and support from the Climate Change, Agriculture and Food Security Program (CCAFS/ http://ccafs.cgiar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltodano ME, 2001, LINEA BASE SITIO REF; Barrett CB, 2001, NONFARM INCOME DIVER; Binswanger-Mkhize HP, 2011, J DEV STUDIES; Bird K, 2002, 13 CPD U BITM; Brown W., 1999, PROVIDING INSURANC 1; Bryla E, 2003, RISK MANAGEMENT PRIC; Cohen M., 2006, PROTECTING POOR MICR, VProtecting the poor: A microinsurance compendium, P25; Collier B., 2010, STATE KNOWLEDGE REPO; Davidson B. R., 1965, NO MYTH STUDY PHYS E; Dercon S, 2001, INCOME RISK COPING S; Dercon S., 2008, LIT REV MICROINSURAN; Em-dat, 2004, INT DIS DAT; Giannini A, 2009, 0901 IRI ARD WORD BA; Hazell P, 2000, WEATHER INSURANCE PR; Hess U, 2003, 9 WORLD BANK AGR RUR; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaramillo PM, 1989, CULTIVO FRIOL; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Jones PG, 2000, AGRON J, V92, P445, DOI 10.2134/agronj2000.923445x; Jones PG, 2002, MARKSIM COMPUTER BAS; Laderach P., 2011, EC SOCIAL POLITICAL; Liu BC, 2010, AGRIC AGRIC SCI PROC, V1, P179, DOI 10.1016/j.aaspro.2010.09.022; Magana V, 1999, J CLIMATE, V12, P1577, DOI 10.1175/1520-0442(1999)012<1577:TMDOMA>2.0.CO;2; Ministerio Agropecuario y Forestal, 2001, ATL RUR NIC; Miranda M, 2001, AM J AGR ECON, V83, P650, DOI 10.1111/0002-9092.00185; Miranda MJ, 1997, AM J AGR ECON, V79, P206, DOI 10.2307/1243954; Morduch J, 1999, WORLD BANK RES OBSER, V14, P187, DOI 10.1093/wbro/14.2.187; MORDUCH J, 1995, J ECON PERSPECT, V9, P103, DOI 10.1257/jep.9.3.103; MOSLEY P, 1995, J DEV STUD, V31, P428, DOI 10.1080/00220389508422371; Nieto JD, 2010, CLIM DEV, V2, P233, DOI 10.3763/cdev.2010.0050; Osgood D, 2007, 0702 IRI ARD WORK BA; Pandey S, 2001, RICE RES FOOD SECURI, P67; Patt A, 2010, GLOBAL ENVIRON CHANG, V20, P153, DOI 10.1016/j.gloenvcha.2009.10.007; Quintana JO, 1983, SUELOS FERTILIZACION; Rios MJ, 2002, FRIJOL PHASEOLUS VUL; ROSENZWEIG MR, 1993, ECON J, V103, P56, DOI 10.2307/2234337; Sakurai T, 1997, AM J AGR ECON, V79, P1193, DOI 10.2307/1244277; Skees J.R., 2001, 2577 WPS WORLD BANK; Skees JR, 2008, POTENTIAL WEATHER IN; Skees JR, 2003, RISK MANAGEMENT CHAL; Stoppa A., 2003, INT C AGR POL REF WT; Turvey C. G., 2001, Review of Agricultural Economics, V23, P333, DOI 10.1111/1467-9353.00065; van Oppen C, 2001, J INSUR RES PRAC; Varangis P, 2003, WEATHER INDEXES DEV; Voysest O., 1991, Common beans: research for crop improvement., P119; Webb P., 1992, Quarterly Journal of International Agriculture, V31, P230; Wenner M, 2003, PAV WAY FORW RUR FIN; World Bank, 2001, INN MAN CAT RISKS CA; World Bank, 2000, 20448LAC WORLD BANK	49	7	7	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38281	10.1371/journal.pone.0038281	http://dx.doi.org/10.1371/journal.pone.0038281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	964KY	22737210	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100007
J	Persson, LJP; Aanerud, M; Hiemstra, PS; Hardie, JA; Bakke, PS; Eagan, TML				Persson, Louise Jeanette Pauline; Aanerud, Marianne; Hiemstra, Pieter Sicco; Hardie, Jon Andrew; Bakke, Per Sigvald; Eagan, Tomas Mikal Lind			Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; 3RD NATIONAL-HEALTH; D DEFICIENCY; DEPRESSIVE SYMPTOMS; LUNG-FUNCTION; SMOKING; INDUCER; MARKERS; COPD; D-3	Introduction: COPD patients may be at increased risk for vitamin D (25(OH)D) deficiency, but risk factors for deficiency among COPD patients have not been extensively reported. Methods: Serum 25(OH)D levels were measured by liquid chromatography double mass spectrometry in subjects aged 4076 years from Western Norway, including 433 COPD patients (GOLD stage II-IV) and 325 controls. Levels <20 ng/mL defined deficiency. Season, sex, age, body mass index (BMI), smoking, GOLD stage, exacerbation frequency, arterial oxygen tension (PaO2), respiratory symptoms, depression (CES-D score >= 16), comorbidities (Charlson score), treatment for osteoporosis, use of inhaled steroids, and total white blood count were examined for associations with 25(OH)D in both linear and logistic regression models. Results: COPD patients had an increased risk for vitamin D deficiency compared to controls after adjustment for seasonality, age, smoking and BMI. Variables associated with lower 25(OH)D levels in COPD patients were obesity (=-6.63), current smoking (=-4.02), GOLD stage III-IV (=-4.71, =-5.64), and depression (=-3.29). Summertime decreased the risk of vitamin D deficiency (OR = 0.22). Conclusion: COPD was associated with an increased risk of vitamin D deficiency, and important disease characteristics were significantly related to 25(OH)D levels.	[Persson, Louise Jeanette Pauline; Aanerud, Marianne; Hardie, Jon Andrew; Eagan, Tomas Mikal Lind] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway; [Hardie, Jon Andrew; Bakke, Per Sigvald; Eagan, Tomas Mikal Lind] Univ Bergen, Inst Med, Bergen, Norway; [Hiemstra, Pieter Sicco] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	University of Bergen; Haukeland University Hospital; University of Bergen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Persson, LJP (corresponding author), Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway.	louise.persson@med.uib.no	Eagan, Tomas ML/P-3554-2014; Eagan, Tomas Mikal/AHC-9127-2022; Hiemstra, Pieter S/K-8587-2018; /V-8478-2019	Eagan, Tomas ML/0000-0001-8725-9960; Hiemstra, Pieter S/0000-0002-0238-5982; 	Foundation for Respiratory Research, University of Bergen, Bergen, Norway; Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway; Norwegian ExtraFoundation for Health and Rehabilitation [2007/2/0039]; Bergen medical research foundation	Foundation for Respiratory Research, University of Bergen, Bergen, Norway; Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway; Norwegian ExtraFoundation for Health and Rehabilitation; Bergen medical research foundation	The sampling of the cohort study was funded by unrestricted grants from The Foundation for Respiratory Research, University of Bergen, Bergen, Norway and by grants from the Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway. This manuscript takes part of a PhD project (grant number 2007/2/0039), funded by the Norwegian ExtraFoundation for Health and Rehabilitation (www.extrastiftelsen.no). An additional grant from the Bergen medical research foundation (www.bmfstiftelse.no) was used to fund the Vitamin D analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Bjerk S, 2011, AM J RESP CRIT CARE, V183; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Brot C, 1999, EUR J CLIN NUTR, V53, P920, DOI 10.1038/sj.ejcn.1600870; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cosio BG, 2010, AM J RESP CRIT CARE, V181, P655, DOI 10.1164/rccm.201001-0111UP; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Forli L, 2004, J INTERN MED, V256, P56, DOI 10.1111/j.1365-2796.2004.01337.x; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; LEMIRE JM, 1985, J IMMUNOL, V134, P3032; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Milaneschi Y, 2010, J CLIN ENDOCR METAB, V95, P3225, DOI 10.1210/jc.2010-0347; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saure EW, 2011, CLIN RESP J; Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Timms PM, 2002, QJM-INT J MED, V95, P787, DOI 10.1093/qjmed/95.12.787; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Williams AF, 2007, UPDATE VITAMIN D POS; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	34	107	109	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38934	10.1371/journal.pone.0038934	http://dx.doi.org/10.1371/journal.pone.0038934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737223	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100022
J	Cardona, A; Saalfeld, S; Schindelin, J; Arganda-Carreras, I; Preibisch, S; Longair, M; Tomancak, P; Hartenstein, V; Douglas, RJ				Cardona, Albert; Saalfeld, Stephan; Schindelin, Johannes; Arganda-Carreras, Ignacio; Preibisch, Stephan; Longair, Mark; Tomancak, Pavel; Hartenstein, Volker; Douglas, Rodney J.			TrakEM2 Software for Neural Circuit Reconstruction	PLOS ONE			English	Article							IMAGE DATA; TOMOGRAPHY; MICROSCOPY; VISUALIZATION; REGISTRATION; SYSTEM	A key challenge in neuroscience is the expeditious reconstruction of neuronal circuits. For model systems such as Drosophila and C. elegans, the limiting step is no longer the acquisition of imagery but the extraction of the circuit from images. For this purpose, we designed a software application, TrakEM2, that addresses the systematic reconstruction of neuronal circuits from large electron microscopical and optical image volumes. We address the challenges of image volume composition from individual, deformed images; of the reconstruction of neuronal arbors and annotation of synapses with fast manual and semi-automatic methods; and the management of large collections of both images and annotations. The output is a neural circuit of 3d arbors and synapses, encoded in NeuroML and other formats, ready for analysis.	[Cardona, Albert; Longair, Mark; Douglas, Rodney J.] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Cardona, Albert; Longair, Mark; Douglas, Rodney J.] ETH, Zurich, Switzerland; [Saalfeld, Stephan; Schindelin, Johannes; Preibisch, Stephan; Tomancak, Pavel] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Arganda-Carreras, Ignacio] MIT, Boston, MA USA; [Hartenstein, Volker] Univ Calif Los Angeles, Mol Cell & Dev Biol Dept, Los Angeles, CA USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles	Cardona, A (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	sapristi@gmail.com	Arganda-Carreras, Ignacio/L-4605-2014; Tomancak, Pavel/C-2109-2009	Arganda-Carreras, Ignacio/0000-0003-0229-5722; Tomancak, Pavel/0000-0002-2222-9370; Cardona, Albert/0000-0003-4941-6536; Saalfeld, Stephan/0000-0002-4106-1761; Longair, Mark/0000-0002-2192-438X; Preibisch, Stephan/0000-0002-0276-494X	Institute of Neuroinformatics; University of Zurich; ETH Zurich;  [NIH 1-R01 NS054814-05];  [SNSF 31003A_132969]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054814] Funding Source: NIH RePORTER	Institute of Neuroinformatics; University of Zurich; ETH Zurich(ETH Zurich); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded primarily by Kevan A. Martin and the Institute of Neuroinformatics, University of Zurich and ETH Zurich; and also by grant NIH 1-R01 NS054814-05 to VH and grant SNSF 31003A_132969 to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Botha D, 1987, J PHYSIOL-LONDON, V394; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Briggman K, 2011, CURR OPIN NEUROBIOL; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Cardona A, 2010, J NEUROSCI, V30, P7538, DOI 10.1523/JNEUROSCI.0186-10.2010; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; da Costa NM, 2011, J NEUROSCI, V31, P2925, DOI 10.1523/JNEUROSCI.5961-10.2011; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Geinisman Y, 1996, J NEUROCYTOL, V25, P805, DOI 10.1007/BF02284843; GLASER JR, 1990, COMPUT MED IMAG GRAP, V14, P307, DOI 10.1016/0895-6111(90)90105-K; Gleeson P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000815; Grigorian M, 2011, DEV BIOL, V353, P105, DOI 10.1016/j.ydbio.2011.02.024; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Kaynig V, 2010, P IEEE COMP SOC C CO; Kaynig V, 2010, J STRUCT BIOL, V171, P163, DOI 10.1016/j.jsb.2010.04.012; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kreshuk A, 2011, AUTOMATED SEGMENTATI; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Longair M, 2011, BIOINFORMATICS; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Oberti D, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00024; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Saalfeld S, 2012, NATURE METH IN PRESS; Saalfeld S, 2010, BIOINFORMATICS, V26, pi57, DOI 10.1093/bioinformatics/btq219; Schindelin J, 2012, NATURE METH IN PRESS; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; Soto G E, 1994, Neuroimage, V1, P230, DOI 10.1006/nimg.1994.1008; Stevens B J, 1979, Methods Enzymol, V56, P718; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Veeraraghavan A, 2010, P IEEE COMP SOC C CO; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	42	545	548	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38011	10.1371/journal.pone.0038011	http://dx.doi.org/10.1371/journal.pone.0038011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723842	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000305652700008
J	Kishore, M; Ma, L; Cornish, G; Nourshargh, S; Marelli-Berg, FM				Kishore, Madhav; Ma, Liang; Cornish, Georgina; Nourshargh, Sussan; Marelli-Berg, Federica M.			Primed T Cell Responses to Chemokines Are Regulated by the Immunoglobulin-Like Molecule CD31	PLOS ONE			English	Article							LYMPHOCYTE TRANSENDOTHELIAL MIGRATION; VERSUS-HOST-DISEASE; CLONAL EXPANSION; ADHESION; PECAM-1; RECEPTOR; POLYMORPHISM; REQUIREMENTS; ASSOCIATION; TRANSPLANT	CD31, an immunoglobulin-like molecule expressed by leukocytes and endothelial cells, is thought to contribute to the physiological regulation T cell homeostasis due to the presence of two immunotyrosine-based inhibitory motifs in its cytoplasmic tail. Indeed, loss of CD31 expression leads to uncontrolled T cell-mediated inflammation in a variety of experimental models of disease and certain CD31 polymorphisms correlate with increased disease severity in human graft-versus-host disease and atherosclerosis. The molecular mechanisms underlying CD31-mediated regulation of T cell responses have not yet been clarified. We here show that CD31-mediated signals attenuate T cell chemokinesis both in vitro and in vivo. This effect selectively affects activated/memory T lymphocytes, in which CD31 is clustered on the cell membrane where it segregates to the leading edge. We provide evidence that this molecular segregation, which does not occur in naive T lymphocytes, might lead to cis-CD31 engagement on the same membrane and subsequent interference with the chemokine-induced PI3K/Akt signalling pathway. We propose that CD31-mediated modulation of memory T cell chemokinesis is a key mechanism by which this molecule contributes to the homeostatic regulation of effector T cell immunity.	[Kishore, Madhav; Nourshargh, Sussan; Marelli-Berg, Federica M.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Ma, Liang; Cornish, Georgina; Marelli-Berg, Federica M.] Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Immunol, London, England	University of London; Queen Mary University London; Imperial College London	Kishore, M (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	f.marelli-berg@qmul.ac.uk		Cornish, Georgina/0000-0002-1984-6677; Nourshargh, Sussan/0000-0001-5677-1806	British Heart Foundation [PG/05/136/19997, RG/09/002]; British Heart Foundation [RG/09/002/26425] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by funds from the British Heart Foundation (Ref: PG/05/136/19997 and RG/09/002 to FM-B) and facilitated by National Institute For Health Research Cardiovascular Biomedical Research Unit at Barts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer Johann, 2003, Am J Pharmacogenomics, V3, P317, DOI 10.2165/00129785-200303050-00003; Balduini CL, 2001, BRIT J HAEMATOL, V114, P951, DOI 10.1046/j.1365-2141.2001.03035.x; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Behar E, 1996, NEW ENGL J MED, V334, P286, DOI 10.1056/NEJM199602013340502; BIRD IN, 1993, IMMUNOLOGY, V80, P553; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Cavanagh G, 2005, TRANSPLANTATION, V79, P602, DOI 10.1097/01.TP.0000153153.94195.87; David R, 2009, BLOOD, V113, P3696, DOI 10.1182/blood-2008-09-176511; Donath C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-84; Duncan GS, 1999, J IMMUNOL, V162, P3022; El-Chennawi FA, 2006, HEMATOLOGY, V11, P227, DOI 10.1080/10245330600954189; Elrayess MA, 2004, ATHEROSCLEROSIS, V177, P127, DOI 10.1016/j.atherosclerosis.2004.06.009; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fornasa G, 2010, J IMMUNOL; Goodman RS, 2008, TRANSPLANTATION, V85, P471, DOI 10.1097/TP.0b013e3181622d65; Goodman RS, 2005, BONE MARROW TRANSPL, V36, P151, DOI 10.1038/sj.bmt.1705013; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Groyer E, 2007, J AM COLL CARDIOL, V50, P344, DOI 10.1016/j.jacc.2007.04.040; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Harris SJ, 2011, J IMMUNOL, V186, P4936, DOI 10.4049/jimmunol.1002350; Jarmin SJ, 2008, J CLIN INVEST, V118, P1154, DOI 10.1172/JCI33267; Ma LA, 2010, P NATL ACAD SCI USA, V107, P19461, DOI 10.1073/pnas.1011748107; Manes TD, 2010, J IMMUNOL, V184, P5186, DOI 10.4049/jimmunol.0902938; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Marelli-Berg FM, 2004, BLOOD, V103, P3111, DOI 10.1182/blood-2003-08-2717; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Pumphrey NJ, 1999, FEBS LETT, V450, P77, DOI 10.1016/S0014-5793(99)00446-9; Ross EA, 2011, J IMMUNOL, V187, P1553, DOI 10.4049/jimmunol.1000502; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; Tada Y, 2003, ARTHRITIS RHEUM-US, V48, P3280, DOI 10.1002/art.11268; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wong MX, 2005, J CLIN IMMUNOL, V25, P19, DOI 10.1007/s10875-005-0354-7; Wu Y, 2005, J IMMUNOL, V175, P3484, DOI 10.4049/jimmunol.175.6.3484; Zhao TM, 2001, J CELL BIOL, V152, P65, DOI 10.1083/jcb.152.1.65	38	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39433	10.1371/journal.pone.0039433	http://dx.doi.org/10.1371/journal.pone.0039433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724015	gold, Green Published			2022-12-25	WOS:000305652700079
J	Williams, AJ; Farley, JH; Hoyle, SD; Davies, CR; Nicol, SJ				Williams, Ashley J.; Farley, Jessica H.; Hoyle, Simon D.; Davies, Campbell R.; Nicol, Simon J.			Spatial and Sex-Specific Variation in Growth of Albacore Tuna (Thunnus alalunga) across the South Pacific Ocean	PLOS ONE			English	Article							BLUEFIN TUNA; FOOD AVAILABILITY; FISH GROWTH; COUNTERGRADIENT VARIATION; DEMOGRAPHIC VARIATION; POPULATION-STRUCTURE; AGE; MACCOYII; DIFFERENTIATION; PATTERNS	Spatial variation in growth is a common feature of demersal fish populations which often exist as discrete adult sub-populations linked by a pelagic larval stage. However, it remains unclear whether variation in growth occurs at similar spatial scales for populations of highly migratory pelagic species, such as tuna. We examined spatial variation in growth of albacore Thunnus alalunga across 90 degrees of longitude in the South Pacific Ocean from the east coast of Australia to the Pitcairn Islands. Using length-at-age data from a validated ageing method we found evidence for significant variation in length-at-age and growth parameters (L-infinity and k) between sexes and across longitudes. Growth trajectories were similar between sexes up until four years of age, after which the length-at-age for males was, on average, greater than that for females. Males reached an average maximum size more than 8 cm larger than females. Length-at-age and growth parameters were consistently greater at more easterly longitudes than at westerly longitudes for both females and males. Our results provide strong evidence that finer spatial structure exists within the South Pacific albacore stock and raises the question of whether the scale of their "highly migratory" nature should be re-assessed. Future stock assessment models for South Pacific albacore should consider sex-specific growth curves and spatial variation in growth within the stock.	[Williams, Ashley J.; Hoyle, Simon D.; Nicol, Simon J.] Secretariat Pacific Commun, Ocean Fisheries Programme, Noumea, New Caledonia; [Farley, Jessica H.; Davies, Campbell R.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Williams, AJ (corresponding author), Secretariat Pacific Commun, Ocean Fisheries Programme, Noumea, New Caledonia.	Ashleyw@spc.int	Williams, Ashley/ABA-5921-2020; Hoyle, Simon D/G-1201-2015; Williams, Ashley J/J-7565-2013; Williams, Ashley J/G-2017-2014; Farley, Jessica/E-4957-2014; Davies, Campbell R/N-8086-2013	Williams, Ashley/0000-0002-5530-0073; Hoyle, Simon D/0000-0002-1787-6565; Williams, Ashley J/0000-0002-5530-0073; Farley, Jessica/0000-0002-5047-746X; Davies, Campbell R/0000-0002-2028-1060; Nicol, Simon/0000-0001-8193-8719	9th European Union Development Fund (SCIFISH project); Australian Fisheries Research and Development Corporation; CSIRO Wealth from Oceans Flaship [2009/012]; Western Central Pacific Fisheries Commission	9th European Union Development Fund (SCIFISH project); Australian Fisheries Research and Development Corporation; CSIRO Wealth from Oceans Flaship; Western Central Pacific Fisheries Commission	This work was supported by funding from the 9th European Union Development Fund (SCIFISH project), the Australian Fisheries Research and Development Corporation and the CSIRO Wealth from Oceans Flaship (Project # 2009/012). Additional funding was provided by the Western Central Pacific Fisheries Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain V, 2010, 6 SCI COMM M W CENTR; [Anonymous], QUANTITATIVE FISHERI; Arrizabalaga H, 2004, MAR ECOL PROG SER, V282, P245, DOI 10.3354/meps282245; BOEHLERT GW, 1980, MAR ECOL PROG SER, V3, P1, DOI 10.3354/meps003001; BRANDT SB, 1993, ESTUARIES, V16, P142, DOI 10.2307/1352771; BRANDT SB, 1981, MAR ECOL PROG SER, V6, P19, DOI 10.3354/meps006019; Bromhead D, 2009, 5 SCI COMM M W CENTR; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Childers J, 2011, FISH OCEANOGR, V20, P157, DOI 10.1111/j.1365-2419.2011.00575.x; Clear NP, 2000, FISH B-NOAA, V98, P25; CLIFTON KE, 1995, MAR ECOL PROG SER, V116, P39, DOI 10.3354/meps116039; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Conover DO, 1997, CAN J FISH AQUAT SCI, V54, P2401, DOI 10.1139/cjfas-54-10-2401; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; Davies CA, 2011, MAR BIOL, V158, P2727, DOI 10.1007/s00227-011-1772-x; Domokos R, 2007, FISH OCEANOGR, V16, P555, DOI 10.1111/j.1365-2419.2007.00451.x; Farley J., 2011, W CENTR PAC FISH COM; Farley JH, 2006, MAR FRESHWATER RES, V57, P713, DOI 10.1071/MF05255; Gompertz B., 1825, PHILOS T ROYAL SOC A, V115, P515, DOI DOI 10.1098/RSTL.1825.0026; Griffiths SP, 2010, ICES J MAR SCI, V67, P125, DOI 10.1093/icesjms/fsp223; Gulland J. A., 1988, FISH POPULATION DYNA; Gunn JS, 2008, FISH RES, V92, P207, DOI 10.1016/j.fishres.2008.01.018; Gust N, 2002, MAR BIOL, V140, P1039, DOI 10.1007/s00227-001-0773-6; Haddon M., 2011, MODELLING QUANTITATI; Harley S, 2011, 11 SECR PAC COMM TUN; Hoyle S, 2011, 7 SCI COMM M W CENTR; Hoyle S, 2008, 4 SCI COMM M W CENTR; ISSF, 2011, 201105 ISSF; JONES GP, 1986, OECOLOGIA, V70, P136, DOI 10.1007/BF00377123; Katsanevakis S, 2008, FISH FISH, V9, P178, DOI 10.1111/j.1467-2979.2008.00279.x; KERRIGAN BA, 1994, MAR ECOL PROG SER, V111, P7, DOI 10.3354/meps111007; Kritzer J.P., 2006, MARINE METAPOPULATIO; Kritzer JP, 2005, ECOL MODEL, V182, P49, DOI 10.1016/j.ecolmodel.2004.07.010; LABELLE M, 1993, FISH B-NOAA, V91, P649; Labelle M, 2003, 16 STAND COMM TUN BE; Langley A, 2005, 1 M SCI COMM W CENTR; LAURS RM, 1981, FISH B-NOAA, V79, P293; Lee Liang-Kang, 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V60, P443; Lin Yu-Ting, 2010, Journal of the Fisheries Society of Taiwan, V37, P135; Meekan MG, 2001, MAR ECOL PROG SER, V212, P223, DOI 10.3354/meps212223; Megalofonou P, 2000, J FISH BIOL, V57, P700, DOI 10.1006/jfbi.2000.1345; Neilson JD, 2008, CAN J FISH AQUAT SCI, V65, P1523, DOI 10.1139/F08-127; PARRISH RH, 1985, FISH B-NOAA, V83, P483; Pauly D., 1979, THESIS U KIEL KIEL; PITCHER CR, 1992, AUST J MAR FRESH RES, V43, P1129; Punt AE, 2003, FISH RES, V65, P391, DOI 10.1016/j.fishres.2003.09.028; Qiu B, 2004, J PHYS OCEANOGR, V34, P1515, DOI 10.1175/1520-0485(2004)034<1515:SMITEF>2.0.CO;2; Quinn T. J., 1999, BIOL RES MANAG SER; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramon D, 1996, FISH B-NOAA, V94, P725; Reid JL, 1997, PROG OCEANOGR, V39, P263, DOI 10.1016/S0079-6611(97)00012-8; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Ricker W. E., 1975, B FISHERIES RES BOAR, P191; Robertson DR, 2005, MAR ECOL PROG SER, V295, P229, DOI 10.3354/meps295229; Santiago J, 2005, ICES J MAR SCI, V62, P740, DOI 10.1016/j.icesjms.2005.01.015; Sassa C, 2002, FISH OCEANOGR, V11, P193, DOI 10.1046/j.1365-2419.2002.00199.x; SCHNUTE JT, 1990, CAN J FISH AQUAT SCI, V47, P24, DOI 10.1139/f90-003; Takagi M, 2001, FISH B-NOAA, V99, P697; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Weatherley AH, 1987, BIOL FISH GROWTH; Wu GCC, 2009, FISH RES, V95, P125, DOI 10.1016/j.fishres.2008.07.014; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2	65	48	53	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39318	10.1371/journal.pone.0039318	http://dx.doi.org/10.1371/journal.pone.0039318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723993	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700066
J	Appleby, BS; Rincon-Beardsley, TD; Appleby, KK; Wallin, MT				Appleby, Brian S.; Rincon-Beardsley, Tonya D.; Appleby, Kristin K.; Wallin, Mitchell T.			Racial and Ethnic Differences in Individuals with Sporadic Creutzfeldt-Jakob Disease in the United States of America	PLOS ONE			English	Article							HUMAN PRION DISEASES; SURVEILLANCE; JAPAN	Background: Little is known about racial and ethnic differences in individuals with sporadic Creutzfeldt-Jakob disease (sCJD). The authors sought to examine potential clinical, diagnostic, genetic, and neuropathological differences in sCJD patients of different races/ethnicities. Methodology/Principal Findings: A retrospective study of 116 definite and probable sCJD cases from Johns Hopkins and the Department of Veterans Affairs Healthcare Systems was conducted that examined differences in demographic, clinical, diagnostic, genetic, and neuropathological characteristics among racial/ethnic groups. Age at disease onset differed among racial/ethnic groups. Non-Hispanic Whites had a significantly older age at disease onset compared to the other groups (65 vs. 60, p = 0.036). Non-Whites were accurately diagnosed more rapidly than Whites (p = 0.008) and non-Hispanic Whites were more likely to have normal appearing basal ganglia on brain magnetic resonance imaging (MRI) compared to minorities (p = 0.02). Whites were also more likely to undergo post-mortem evaluation compared to non-Whites (p = 0.02). Conclusions/Significance: Racial/ethnic groups affected by sCJD demonstrated differences in age at disease onset, time to correct diagnosis, clinical presentation, and diagnostic test results. Whites were more likely to undergo autopsy compared to non-Whites. These results have implications in regards to case ascertainment, diagnosis, and surveillance of sCJD and possibly other human prion diseases.	[Appleby, Brian S.] Cleveland Clin Fdn, Dept Psychiat & Psychol, Lou Ruvo Ctr Brain Hlth, Neurol Inst, Cleveland, OH 44195 USA; [Appleby, Brian S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21205 USA; [Rincon-Beardsley, Tonya D.] Johns Hopkins Univ, Sch Arts & Sci, Adv Acad Programs, Baltimore, MD USA; [Appleby, Kristin K.; Wallin, Mitchell T.] Vet Affairs Healthcare Syst, Dept Neurol, Washington, DC USA; [Appleby, Kristin K.] Cleveland Clin, Ctr Reg Neurol, Neurol Inst, Cleveland, OH 44106 USA; [Wallin, Mitchell T.] Georgetown Univ Hosp, Dept Neurol, Washington, DC 20007 USA	Cleveland Clinic Foundation; Johns Hopkins University; Johns Hopkins University; Cleveland Clinic Foundation; Georgetown University	Appleby, BS (corresponding author), Cleveland Clin Fdn, Dept Psychiat & Psychol, Lou Ruvo Ctr Brain Hlth, Neurol Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	applebb@ccf.org	Appleby, Brian/A-3390-2008; Wallin, Mitchell T./J-8190-2019; Weiderpass, Elisabete/AAP-2747-2021	Wallin, Mitchell T./0000-0003-1061-5714; Weiderpass, Elisabete/0000-0003-2237-0128	Richmond Family Foundation for Alzheimer's and Related Diseases; Stempler Dementia Fund	Richmond Family Foundation for Alzheimer's and Related Diseases; Stempler Dementia Fund	This research was partially supported by the Richmond Family Foundation for Alzheimer's and Related Diseases and the Stempler Dementia Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DEM PROF MIL COMM; Appleby BS, 2007, J NEUROPSYCH CLIN N, V19, P428, DOI 10.1176/appi.neuropsych.19.4.428; Appleby BS, 2009, ARCH NEUROL-CHICAGO, V66, P208, DOI 10.1001/archneurol.2008.533; DESLYS JP, 1994, J GEN VIROL, V75, P23, DOI 10.1099/0022-1317-75-1-23; Gelpi E, 2008, NEUROEPIDEMIOLOGY, V30, P215, DOI 10.1159/000126915; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Holman RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008521; Lai CH, 2009, NEUROEPIDEMIOLOGY, V33, P247, DOI 10.1159/000229779; Mercier G, 2008, HUM BIOL, V80, P181, DOI 10.3378/1534-6617(2008)80[181:PDOTMA]2.0.CO;2; Nagoshi K, 2011, J EPIDEMIOL, V21, P255, DOI 10.2188/jea.JE20100085; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; Office of the Deputy Under Secretary of Defense, 2009, DEM 2009 PROF MIL CO; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Stoeck K, 2008, J NEUROL, V255, P1464, DOI 10.1007/s00415-008-0900-0; Wallin M, 2012, BRAIN IN PRESS; WHO, 1998, GLOBAL SURVEILLANCE; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38884	10.1371/journal.pone.0038884	http://dx.doi.org/10.1371/journal.pone.0038884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723901	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300064
J	Kebede, B; Kemal, T; Abera, S				Kebede, Biruktawit; Kemal, Temam; Abera, Solomon			Oral Health Status of Patients with Mental Disorders in Southwest Ethiopia	PLOS ONE			English	Article							DENTAL-CARIES; PATTERNS; ISRAEL	Background: Psychiatric disorders are known to be a risk factor for the development of different oral health problems especially for dental caries and periodontal diseases. In spite of this fact, no study has been conducted to reveal its magnitude in Ethiopia. Hence, this study was conducted to determine the oral health status of psychiatric patients at Jimma University Specialized Hospital (JUSH), Psychiatric Clinic. Methods: A hospital based cross-sectional study was used from January to May 2011. A total of 240 participants were included in the study. Dental examination was done to measure indices of oral health: decayed, missing, and filled teeth (DMFT) index and community periodontal index (CPI). Oral examination was performed using mirror, probe and explorer by experienced dental doctors. A simple random sampling technique was implemented to collect data. ANOVA test, binary logistic and multinomial logistic regression analyses were done using SPSS 16.0 statistical software. Results: The mean DMFT score among the psychiatric patients was 1.94 +/- 2.12 (mean +/- SD) with 1.28 +/- 1.69, 0.51 +/- 1.19 and 0.14 +/- 0.48 (mean +/- SD) for decayed, missed and filled teeth respectively. Only about 24% of the psychiatric patients had a healthy CPI score. Incorrect tooth brushing technique was significantly associated with a DMFT score greater than 2 (AOR=3.58; 95% CI: 1.65, 7.79). The habit of sweet intake was also associated with dental caries (AOR=2.91; 95% CI: 1.43, 5.95). Similarly, patients with a smoking habit also demonstrated statistically significant association with dental caries (AOR=18.98; 95% CI: 5.06, 71.24). Conclusion: The oral health status of the psychiatric patients was poor. Thus, health education about oral hygiene should be given for psychiatric patients so they can avoid the frequent intake of sweets, smoking and learn correct tooth brushing technique.	[Kebede, Biruktawit; Kemal, Temam] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Dent, Jimma, Ethiopia; [Abera, Solomon] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Abera, Solomon] Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia	Jimma University; Jimma University; Addis Ababa University	Kebede, B (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Dent, Jimma, Ethiopia.	bruktawit.kebede@ju.edu.et			Jimma University (JU); JU	Jimma University (JU); JU	The authors acknowledge Jimma University (JU) for the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the study participants and their guardians/care-givers for their participation in the study and provision of necessary information. We also acknowledge JU for the grant.	Adeniyi AA, 2011, SPEC CARE DENT, V31, P134, DOI 10.1111/j.1754-4505.2011.00193.x; [Anonymous], J HLTH SCI; Bardow A, 2001, ARCH ORAL BIOL, V46, P413, DOI 10.1016/S0003-9969(01)00003-6; Chu KY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-482; Clifton A, 2011, SCHIZOPHRENIA BULL, V37, P464, DOI 10.1093/schbul/sbq169; Cullinan MP, 2009, AUST DENT J, V54, pS62, DOI 10.1111/j.1834-7819.2009.01144.x; Funk M., 2008, INT MENT HLTH PRIM C; Girma E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-138; Jared H., 2008, J DENT HYG, V82, P24; Jovanovic S, 2010, CROAT MED J, V51, P443, DOI 10.3325/cmj.2010.51.443; Kumar Manish, 2006, Indian J Dent Res, V17, P171; Lewis S, 2001, Spec Care Dentist, V21, P182, DOI 10.1111/j.1754-4505.2001.tb00252.x; Millar WJ, 2007, J CAN DENT ASSOC, V73, P2; Mirza I., 2001, PSYCHIATRI B, V25, P143, DOI DOI 10.1192/PB.25.4.143; Petersen PE, 2005, COMMUNITY DENT HLTH, V22, P71; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ramon T, 2003, EUR PSYCHIAT, V18, P101, DOI 10.1016/S0924-9338(03)00023-3; Ravald N, 2012, J CLIN PERIODONTOL, V39, P73, DOI 10.1111/j.1600-051X.2011.01811.x; Rekha R, 2002, J Indian Soc Pedod Prev Dent, V20, P63; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Stevens T, 2010, PSYCHIATR BULL, V34, P518, DOI 10.1192/pb.bp.109.029157; Terezakis E, 2011, J CLIN PERIODONTOL, V38, P628, DOI 10.1111/j.1600-051X.2011.01727.x; Vered Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-345; *WHO, 2003, WHO PUBL; WHO, 2008, MHGAP MENTAL HLTH GA; World Health Organization, 2003, INV MENT HLTH; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th; World Health Organization, 2006, OR HLTH AG SOC INT O; Zusman SP, 2010, SPEC CARE DENT, V30, P18, DOI 10.1111/j.1754-4505.2009.00118.x	29	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39142	10.1371/journal.pone.0039142	http://dx.doi.org/10.1371/journal.pone.0039142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	962XO	22723950	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300103
J	Orr, ME; Pitstick, R; Canine, B; Ashe, KH; Carlson, GA				Orr, Miranda E.; Pitstick, Rose; Canine, Brenda; Ashe, Karen H.; Carlson, George A.			Genotype-Specific Differences between Mouse CNS Stem Cell Lines Expressing Frontotemporal Dementia Mutant or Wild Type Human Tau	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HELICAL FILAMENT-TAU; MICROTUBULE-BINDING; ALZHEIMERS-DISEASE; TRANSGENIC MICE; IN-VITRO; DENDRITIC FILOPODIA; HIPPOCAMPAL-NEURONS; FTDP-17 MUTATIONS; PROTEIN-TAU	Stem cell (SC) lines that capture the genetics of disease susceptibility provide new research tools. To assess the utility of mouse central nervous system (CNS) SC-containing neurosphere cultures for studying heritable neurodegenerative disease, we compared neurosphere cultures from transgenic mice that express human tau with the P301L familial frontotemporal dementia (FTD) mutation, rTg(tau(P301L)) 4510, with those expressing comparable levels of wild type human tau, rTg(tau(wt)) 21221. rTg( tau(P301L)) 4510 mice express the human tau(P301L) variant in their forebrains and display cellular, histological, biochemical and behavioral abnormalities similar to those in human FTD, including age-dependent differences in tau phosphorylation that distinguish them from rTg(tau(wt)) 21221 mice. We compared FTD-hallmark tau phosphorylation in neurospheres from rTg(tau(P301L)) 4510 mice and from rTg(tau(wt)) 21221 mice. The tau genotype-specific phosphorylation patterns in neurospheres mimicked those seen in mice, validating use of neurosphere cultures as models for studying tau phosphorylation. Genotype-specific tau phosphorylation was observed in 35 independent cell lines from individual fetuses; tau in rTg(tau(P301L)) 4510 cultures was hypophosphorylated in comparison with rTg(tau(wt)) 21221 as was seen in young adult mice. In addition, there were fewer human tau-expressing cells in rTg(tau(P301L)) 4510 than in rTg(tau(wt)) 21221 cultures. Following differentiation, neuronal filopodia-spine density was slightly greater in rTg(tau(P301L)) 4510 than rTg(tau(wt)) 21221 and control cultures. Together with the recapitulation of genotype-specific phosphorylation patterns, the observation that neurosphere lines maintained their cell line-specific-differences and retained SC characteristics over several passages supports the utility of SC cultures as surrogates for analysis of cellular disease mechanisms.	[Orr, Miranda E.; Pitstick, Rose; Canine, Brenda; Carlson, George A.] McLaughlin Res Inst, Great Falls, MT USA; [Orr, Miranda E.] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Ashe, Karen H.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Ashe, Karen H.] Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN 55455 USA	McLaughlin Research Institute for Biomedical Sciences, Inc.; Montana State University System; Montana State University Bozeman; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Orr, ME (corresponding author), McLaughlin Res Inst, Great Falls, MT USA.	gac@mri.montana.edu			National Institutes of Health, USPHS [P01NS04199, R01AG026252]; NIH [F31AG031630]; NATIONAL INSTITUTE ON AGING [R01AG026252, F31AG031630] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants P01NS04199 and R01AG026252 from the National Institutes of Health, USPHS. MEO was supported by NIH predoctoral fellowship award F31AG031630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Barten DM, J ALZHEIMERS DIS S2, V24, P127; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; BRION JP, 1994, NEUROSCIENCE, V63, P895, DOI 10.1016/0306-4522(94)90533-9; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; CACERES A, 1984, J NEUROSCI, V4, P394; Ciccolini F, 2001, MOL CELL NEUROSCI, V17, P895, DOI 10.1006/mcne.2001.0980; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gilley J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.014; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Haas MA, 2007, CELL MOTIL CYTOSKEL, V64, P274, DOI 10.1002/cm.20182; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hundelt M, 2011, NEUROBIOL AGING, V32, P991, DOI 10.1016/j.neurobiolaging.2009.06.007; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jessberger S, 2007, STEM CELLS, V25, P871, DOI 10.1634/stemcells.2006-0620; Kempf M, 1996, J NEUROSCI, V16, P5583; KLEIMAN R, 1994, J NEUROSCI, V14, P1130, DOI 10.1523/JNEUROSCI.14-03-01130.1994; Klein C, 2005, DEVELOPMENT, V132, P4497, DOI 10.1242/dev.02037; Klein C, 2004, DEV NEUROSCI-BASEL, V26, P82, DOI 10.1159/000082129; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Lovestone S, 1997, NEUROSCIENCE, V78, P309; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Mroz K, 1999, DEV BIOL, V207, P229, DOI 10.1006/dbio.1998.9160; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; PAPA M, 1995, J NEUROSCI, V15, P1; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; ROCHER AB, 2009, EXP NEUROL; Sakaue F, 2005, J BIOL CHEM, V280, P31522, DOI 10.1074/jbc.M504792200; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Thurston VC, 1997, CELL MOTIL CYTOSKEL, V38, P100, DOI 10.1002/(SICI)1097-0169(1997)38:1<100::AID-CM9>3.0.CO;2-C; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Urbach A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004175; Vandebroek T, 2006, J BIOL CHEM, V281, P25388, DOI 10.1074/jbc.M602792200; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	91	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39328	10.1371/journal.pone.0039328	http://dx.doi.org/10.1371/journal.pone.0039328			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723997	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300133
J	Wang, D; Su, LY; Zhang, AM; Li, YY; Li, XA; Chen, LL; Long, H; Yao, YG				Wang, Dong; Su, Ling-Yan; Zhang, A-Mei; Li, Yu-Ye; Li, Xiao-An; Chen, Ling-Ling; Long, Heng; Yao, Yong-Gang			Mitochondrial DNA Copy Number, but Not Haplogroup, Confers a Genetic Susceptibility to Leprosy in Han Chinese from Southwest China	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; CLINICAL EXPRESSION; SURVIVAL; SEPSIS; ASSOCIATION; SEQUENCE; CELLS; RISK	Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an unculturable pathogen with an exceptionally eroded genome. The high level of inactivation of gene function in M. leprae, including many genes in its metabolic pathways, has led to a dependence on host energy production and nutritional products. We hypothesized that host cellular powerhouse - the mitochondria - may affect host susceptibility to M. leprae and the onset of clinical leprosy, and this may be reflected by mitochondrial DNA (mtDNA) background and mtDNA copy number. Methods: We analyzed the mtDNA sequence variation of 534 leprosy patients and 850 matched controls from Yunnan Province and classified each subject by haplogroup. mtDNA copy number, taken to be proportional to mtDNA content, was measured in a subset of these subjects (296 patients and 231 controls) and 12 leprosy patients upon diagnosis. Results: Comparison of matrilineal components of the case and control populations revealed no significant difference. However, measurement of mtDNA copy number showed that lepromatous leprosy patients had a significantly higher mtDNA content than controls (P = 0.008). Past medical treatments had no effect on the alteration of mtDNA copy number. Conclusions: Our results suggested that mtDNA content, but not haplogroup, affects leprosy and this influence is limited to the clinical subtype of lepromatous leprosy.	[Wang, Dong; Su, Ling-Yan; Zhang, A-Mei; Yao, Yong-Gang] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Li, Yu-Ye; Chen, Ling-Ling] Kunming Med Coll, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Li, Xiao-An] Yuxi City Ctr Dis Control & Prevent, Yuxi, Yunnan, Peoples R China; [Long, Heng] Wenshan Inst Dermatol, Wenshan, Yunnan, Peoples R China; [Wang, Dong; Su, Ling-Yan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, D (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; Chen, Ling-Ling/AAY-3547-2021	Yao, Yong-Gang/0000-0002-2955-0693; 	Ministry of Science and Technology of China [2011CB910900]; National Natural Science Foundation of China [30925021]; Yunnan Province [2009CI119]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province	This work was supported by the Ministry of Science and Technology of China (2011CB910900), the National Natural Science Foundation of China (30925021), and Yunnan Province (2009CI119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021029; Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006; Alter A, 2011, MAMM GENOME, V22, P19, DOI 10.1007/s00335-010-9287-1; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P337; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bi R, 2010, HUM MUTAT, V31, P538, DOI 10.1002/humu.21220; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cote HC, 2007, CRIT CARE, V11, DOI 10.1186/cc6096; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Garcia-Alvarez M, 2011, AIDS, V25, P1619, DOI 10.1097/QAD.0b013e328349820f; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Huebinger RM, 2010, SHOCK, V33, P19, DOI 10.1097/SHK.0b013e3181a99508; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Li YY, 2011, LEPROSY REV, V82, P6; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Misch EA, 2010, MICROBIOL MOL BIOL R, V74, P589, DOI 10.1128/MMBR.00025-10; Modlin RL, 2010, CURR OPIN IMMUNOL, V22, P48, DOI 10.1016/j.coi.2009.12.001; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Montoya D, 2010, ADV IMMUNOL, V105, P1, DOI 10.1016/S0065-2776(10)05001-7; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Pyle A, 2010, INTENS CARE MED, V36, P956, DOI 10.1007/s00134-010-1823-7; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rotig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Soriano A, 2005, NEW ENGL J MED, V353, P2305, DOI 10.1056/NEJM200511243532123; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Walker SL, 2006, BRIT MED BULL, V77-78, P103, DOI 10.1093/bmb/ldl010; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; WHO, 1982, WHO TECHN REP SER; World Health Organization, 1988, WHO TECHN REP SER, V768; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yang Y, 2008, GENET MED, V10, P187, DOI 10.1097/GIM.0b013e318163c343; Yao YG, 2007, STEM CELLS, V25, P2670, DOI 10.1634/stemcells.2007-0269; Zhang AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027750	44	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38848	10.1371/journal.pone.0038848	http://dx.doi.org/10.1371/journal.pone.0038848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719964	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300059
J	Al-Houqani, M; Ali, R; Hajat, C				Al-Houqani, Mohammed; Ali, Raghib; Hajat, Cother			Tobacco Smoking Using Midwakh Is an Emerging Health Problem - Evidence from a Large Cross-Sectional Survey in the United Arab Emirates	PLOS ONE			English	Article							PREVALENCE	Introduction: Accurate information about the prevalence and types of tobacco use is essential to deliver effective public health policy. We aimed to study the prevalence and modes of tobacco consumption in the United Arab Emirates (UAE), particularly focusing on the use of Midwakh (Arabic traditional pipe). Methods: We studied 170,430 UAE nationals aged >= 18 years (44% males and 56% females) in the Weqaya population-based screening program in Abu Dhabi residents during the period April 2008-June 2010. Self-reported smoking status, type, quantity and duration of tobacco smoked were recorded. Descriptive statistics were used to describe the study findings; prevalence rates used the screened sample as the denominator. Result: The prevalence of smoking overall was 24.3% in males and 0.8% in females and highest in males aged 20-39. Mean age (SD) of smokers was 32.8 (11.1) years, 32.7 (11.1) in males and 35.7 (12.1) in females. Cigarette smoking was the commonest form of tobacco use (77.4% of smokers), followed by Midwakh (15.0%), shisha (waterpipe) (6.8%), and cigar (0.66%). The mean durations of smoking for cigarettes, Midwakh, shisha and cigars were 11.4, 9.3, 7.6 and 11.0 years, respectively. Conclusions: Smoking is most common among younger UAE national men. The use of Midwakh and the relatively young age of onset of Midwakh smokers is of particular concern as is the possibility of the habit spreading to other countries. Comprehensive tobacco control laws targeting the young and the use of Midwakh are needed.	[Al-Houqani, Mohammed; Ali, Raghib] UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Ali, Raghib] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Hajat, Cother] Hlth Author Abu Dhabi, Publ Hlth & Res Dept, Abu Dhabi, U Arab Emirates	United Arab Emirates University; University of Oxford	Al-Houqani, M (corresponding author), UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	alhouqani@uaeu.ac.ae		Al-Houqani, Mohammed/0000-0003-4481-3911; Hajat, Cother/0000-0002-1763-3010				Akl EA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-244; Al Zaabi A, 2011, RESP MED, V105, P566, DOI 10.1016/j.rmed.2010.12.008; Al-Hamdan N., 2009, Eastern Mediterranean Health Journal, V15, P600; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Enviromental Health & Saftey & Risk Management Services, 2007, ENV HLTH SAFT RISK M; Fendrich M, 2005, ADDICTION, V100, P143, DOI 10.1111/j.1360-0443.2005.00993.x; Freund K M, 1993, Ann Epidemiol, V3, P417, DOI 10.1016/1047-2797(93)90070-K; Hajat C, 2012, AM J PUBLIC HEALTH, V102, P909, DOI 10.2105/AJPH.2011.300290; Hajat C, 2010, PROG CARDIOVASC DIS, V53, P28, DOI 10.1016/j.pcad.2010.05.002; Health Authority-Abu Dhabi, 2011, HLTH STAT; Jayakumary M, 2010, ASIAN PAC J CANCER P, V11, P1547; Mandil Ahmed, 2010, J Infect Public Health, V3, P179, DOI 10.1016/j.jiph.2010.10.003; Maziak W, 2005, PUBLIC HEALTH, V119, P400, DOI 10.1016/j.puhe.2004.08.002; McCormick LK, 1999, J SCHOOL HEALTH, V69, P95, DOI 10.1111/j.1746-1561.1999.tb07215.x; Muslim Nina, 2006, GULFNEWS TEENAGERS R; Nakkash RT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-315; Olrate O, 2011, KHALEEJ TIMES CAPITA; Parra GR, 2003, PSYCHOL ADDICT BEHAV, V17, P211, DOI 10.1037/0893-164X.17.3.211; Saeed A A, 1996, Tob Control, V5, P215, DOI 10.1136/tc.5.3.215; Shafey O, 2009, TOBACCO ATLAS, V3, P37; Sohn Sunghwan, 2009, AMIA Annu Symp Proc, V2009, P619; US Department of State, 2011, BACKGR NOT UN AR EM; WHO Tobacco Free Initiative (TFI), 2009, GATS GLOB AD TOB SUR; WHO Tobacco Free Initiative (TFI), 2002, GLOB YOUTH TOB SURV; World Health Organization, 2010, GLOB SCH BAS STUD HL; World Health Organization, 2019, WHO REPORT GLOBAL TO	26	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39189	10.1371/journal.pone.0039189	http://dx.doi.org/10.1371/journal.pone.0039189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WX	22720071	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350000048
J	McGorry, RW; Lin, JH				McGorry, Raymond W.; Lin, Jia-Hua			Flexion Relaxation and Its Relation to Pain and Function over the Duration of a Back Pain Episode	PLOS ONE			English	Article							LUMBAR FLEXION; SURFACE ELECTROMYOGRAPHY; ERECTORES SPINAE; MUSCLE ACTIVATION; HEALTHY CONTROLS; TRUNK FLEXION; BEHAVIOR; MOVEMENTS; EXTENSION; PATTERNS	Background: Relaxation of the erector spinae often occurs in healthy individuals as full trunk flexion is achieved when bending forward from standing. This phenomenon, referred to as flexion relaxation is often absent or disrupted (EMG activity persists) in individuals reporting low back pain (LBP). Methods and Results: Self-reported pain and disability scores were compared to EMG measures related to the flexion relaxation (FR) phenomenon by 33 participants with LBP at up to eight sessions over a study period of up to eight weeks. Fourteen participants served as a control group. In the protocol, starting from standing participants bent forward to a fully flexed posture, and then extended the trunk to return to standing position. A thoracic inclinometer was used to measure trunk posture. Surface electrodes located at the L2 and L5 levels recorded EMG amplitudes of the erector spinae. Ratios of EMG amplitudes recorded during forward bending to amplitudes at full flexion, and ratios of extension to full flexion were calculated. EMG amplitudes and their ratios were compared between control and LBP groups at the initial visit. No significant differences between groups were found except at the L5 location at full flexion. Correlations of the ratios to pain and function scores recorded in repeated sessions over the LBP episode also were compared between LBP group participants classified as having transient, recurrent or chronic symptoms. In another analysis participants were grouped by whether their symptoms resolved over the study period. Conclusions: The transient LBP group had significantly stronger correlations between pain and function to both ratios, than did those with more chronic LBP symptoms. Participants who experienced symptom resolution generally had stronger correlations of ratios to both pain and function than those with partial or no resolution. Improved understanding of these relationships may provide insight in clinical management of LBP.	[McGorry, Raymond W.; Lin, Jia-Hua] Liberty Mutual Res Inst Safety, Hopkinton, MA USA	Liberty Mutual Research Institute for Safety	McGorry, RW (corresponding author), Liberty Mutual Res Inst Safety, Hopkinton, MA USA.	Raymond.mcgorry@libertymutual.com		Lin, Jia-Hua/0000-0001-8908-9328				ADAMS MA, 1980, SPINE, V5, P245, DOI 10.1097/00007632-198005000-00007; AHERN DK, 1988, PAIN, V34, P153, DOI 10.1016/0304-3959(88)90160-1; AHERN DK, 1990, SPINE, V15, P92, DOI 10.1097/00007632-199002000-00008; Alschuler Kevin N, 2009, Clin J Pain, V25, P760, DOI 10.1097/AJP.0b013e3181b56db6; Ambroz C, 2000, J OCCUP ENVIRON MED, V42, P660, DOI 10.1097/00043764-200006000-00018; Descarreau M, 2008, BMC MUSCULOSKEL DIS, V24, P10; FLOYD WF, 1955, J PHYSIOL-LONDON, V129, P184, DOI 10.1113/jphysiol.1955.sp005347; Geisser ME, 2005, J PAIN, V6, P711, DOI 10.1016/j.jpain.2005.06.008; HAIG AJ, 1993, SPINE, V18, P926, DOI 10.1097/00007632-199306000-00020; Hides JA, 1996, SPINE, V21, P2763, DOI 10.1097/00007632-199612010-00011; Holleran K, 1995, Iowa Orthop J, V15, P24; JENSEN MP, 1992, CLIN J PAIN, V8, P123, DOI 10.1097/00002508-199206000-00010; Kaigle AM, 1998, J SPINAL DISORD, V11, P163; KIPPERS V, 1984, SPINE, V9, P740, DOI 10.1097/00007632-198410000-00015; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Mannion AF, 2001, SPINE, V26, P897, DOI 10.1097/00007632-200104150-00013; Marshall P, 2006, SPINE, V31, pE877, DOI 10.1097/01.brs.0000244557.56735.05; Matheron E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018110; Mayer TG, 2009, SPINE, V34, P2458, DOI 10.1097/BRS.0b013e3181b20070; MCGILL SM, 1994, SPINE, V19, P2190, DOI 10.1097/00007632-199410000-00013; Murphy BA, 2010, SPINE, V35, P2103, DOI 10.1097/BRS.0b013e3181cbc7d8; Neblett R, 2003, SPINE, V28, P1435, DOI 10.1097/00007632-200307010-00015; Neblett R, 2010, CLIN J PAIN, V26, P403, DOI 10.1097/AJP.0b013e3181d2bd8c; Olson MW, 2004, CLIN BIOMECH, V19, P769, DOI 10.1016/j.clinbiomech.2004.05.007; PAQUET N, 1994, SPINE, V19, P596, DOI 10.1097/00007632-199403000-00016; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; Sarti M A, 2001, Spine (Phila Pa 1976), V26, pE421, DOI 10.1097/00007632-200109150-00019; SCHULTZ AB, 1985, J ORTHOPAED RES, V3, P189, DOI 10.1002/jor.1100030208; SHIRADO O, 1995, AM J PHYS MED REHAB, V74, P139, DOI 10.1097/00002060-199503000-00010; SIHVONEN T, 1991, ARCH PHYS MED REHAB, V72, P1080; Solomonow M, 2003, CLIN BIOMECH, V18, P273, DOI 10.1016/S0268-0033(03)00024-X; Stratford PW, 2000, SPINE, V25, P2095, DOI 10.1097/00007632-200008150-00015; TANII K, 1985, ERGONOMICS, V28, P883, DOI 10.1080/00140138508963209; Thomas JS, 2008, EUR SPINE J, V17, P97, DOI 10.1007/s00586-007-0532-6; TRIANO JJ, 1987, SPINE, V12, P561, DOI 10.1097/00007632-198707000-00010; VONKORFF M, 1994, SPINE, V19, pS2041; Wallbom AS, 2009, AM J PHYS MED REHAB, V88, P302, DOI 10.1097/PHM.0b013e318198b6ed; Watson PJ, 1997, CLIN BIOMECH, V12, P165, DOI 10.1016/S0268-0033(97)00065-X	38	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39207	10.1371/journal.pone.0039207	http://dx.doi.org/10.1371/journal.pone.0039207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720077	gold, Green Submitted, Green Published			2022-12-25	WOS:000305350000051
J	Hong, S; Cheng, TY; Layre, E; Sweet, L; Young, DC; Posey, JE; Butler, WR; Moody, DB				Hong, Sunhee; Cheng, Tan-Yun; Layre, Emilie; Sweet, Lindsay; Young, David C.; Posey, James E.; Butler, W. Ray; Moody, D. Branch			Ultralong C100 Mycolic Acids Support the Assignment of Segniliparus as a New Bacterial Genus	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; OUTER-MEMBRANE; BIOSYNTHESIS; RUGOSUS	Mycolic acid-producing bacteria isolated from the respiratory tract of human and non-human mammals were recently assigned as a distinct genus, Segniliparus, because they diverge from rhodococci and mycobacteria in genetic and chemical features. Using high accuracy mass spectrometry, we determined the chemical composition of 65 homologous mycolic acids in two Segniliparus species and separately analyzed the three subclasses to measure relative chain length, number and stereochemistry of unsaturations and cyclopropyl groups within each class. Whereas mycobacterial mycolate subclasses are distinguished from one another by R groups on the meromycolate chain, Segniliparus species synthesize solely non-oxygenated alpha-mycolates with high levels of cis unsaturation. Unexpectedly Segniliparus alpha-mycolates diverge into three subclasses based on large differences in carbon chain length with one bacterial culture producing mycolates that range from C58 to C100. Both the overall chain length (C100) and the chain length diversity (C42) are larger than previously seen for mycolic acid-producing organisms and provide direct chemical evidence for assignment of Segniliparus as a distinct genus. Yet, electron microscopy shows that the long and diverse mycolates pack into a typical appearing membrane. Therefore, these new and unexpected extremes of mycolic acid chemical structure raise questions about the modes of mycolic acid packing and folding into a membrane.	[Hong, Sunhee; Cheng, Tan-Yun; Layre, Emilie; Sweet, Lindsay; Young, David C.; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hong, Sunhee; Cheng, Tan-Yun; Layre, Emilie; Sweet, Lindsay; Young, David C.; Moody, D. Branch] Harvard Univ, Sch Med, Boston, MA USA; [Posey, James E.; Butler, W. Ray] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Centers for Disease Control & Prevention - USA	Hong, S (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	wrb1@cdc.gov; bmoody@rics.bwh.harvard.edu		Layre, Emilie/0000-0001-8024-8513; Layre, Emilie/0000-0003-3044-1299	National Institutes of Health [AI RO1 071155, AI RO1 049393]; Burroughs Wellcome Fund Program in Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Program in Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants: AI RO1 071155 and AI RO1 049393 and the Burroughs Wellcome Fund Program in Translational Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Gutierrez J, 2009, APPL ENVIRON MICROB, V75, P3407, DOI 10.1128/AEM.01776-08; Asselineau C, 2002, PROG LIPID RES, V41, P501, DOI 10.1016/S0163-7827(02)00008-5; Barkan D, 2009, CHEM BIOL, V16, P499, DOI 10.1016/j.chembiol.2009.04.001; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Butler WR, 2007, J CLIN MICROBIOL, V45, P3449, DOI 10.1128/JCM.00765-07; Butler WR, 2005, INT J SYST EVOL MICR, V55, P1615, DOI 10.1099/ijs.0.63465-0; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Evans RH, 2011, EMERG INFECT DIS, V17, P311, DOI 10.3201/eid1702.101511; GOODFELLOW M, 1976, J GEN MICROBIOL, V96, P351, DOI 10.1099/00221287-96-2-351; Hansen T, 2009, EMERG INFECT DIS, V15, P611, DOI 10.3201/eid1504.081479; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hsu FF, 2011, ANAL BIOCHEM, V409, P112, DOI 10.1016/j.ab.2010.10.006; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; Marrakchi H, 2008, MYCOBACTERIAL CELL ENVELOPE, P41; Mederos L, 2007, MICROBIOL-SGM, V153, P4159, DOI 10.1099/mic.0.2007/011262-0; MINNIKIN DE, 1980, J CHROMATOGR, V188, P221, DOI 10.1016/S0021-9673(00)88433-2; Minnikin DE, 1998, BACTERIAL CELL SURFA, P125; Quemard A, 1997, EUR J BIOCHEM, V250, P758, DOI 10.1111/j.1432-1033.1997.00758.x; Schroeder BG, 2001, BIOORG CHEM, V29, P164, DOI 10.1006/bioo.2001.1207; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; Sommerville J., 1987, ELECT MICROSCOPY MOL; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Villeneuve M, 2005, BBA-BIOMEMBRANES, V1715, P71, DOI 10.1016/j.bbamem.2005.07.005; Villeneuve M, 2007, BBA-BIOMEMBRANES, V1768, P1717, DOI 10.1016/j.bbamem.2007.04.003; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	28	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39017	10.1371/journal.pone.0039017	http://dx.doi.org/10.1371/journal.pone.0039017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720018	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800038
J	Sluik, D; Boeing, H; Montonen, J; Kaaks, R; Lukanova, A; Sandbaek, A; Overvad, K; Arriola, L; Ardanaz, E; Saieva, C; Grioni, S; Tumino, R; Sacerdote, C; Mattiello, A; Spijkerman, AMW; van der A, DL; Beulens, JWJ; van Dieren, S; Nilsson, PM; Groop, LC; Franks, PW; Rolandsson, O; Bueno-de-Mesquita, B; Nothlings, U				Sluik, Diewertje; Boeing, Heiner; Montonen, Jukka; Kaaks, Rudolf; Lukanova, Annekatrin; Sandbaek, Annelli; Overvad, Kim; Arriola, Larraitz; Ardanaz, Eva; Saieva, Calogero; Grioni, Sara; Tumino, Rosario; Sacerdote, Carlotta; Mattiello, Amalia; Spijkerman, Annemieke M. W.; van der A, Daphne L.; Beulens, Joline W. J.; van Dieren, Susan; Nilsson, Peter M.; Groop, Leif C.; Franks, Paul W.; Rolandsson, Olov; Bueno-de-Mesquita, Bas; Noethlings, Ute			HbA(1c) Measured in Stored Erythrocytes Is Positively Linearly Associated with Mortality in Individuals with Diabetes Mellitus	PLOS ONE			English	Article							WHOLE-BLOOD SAMPLES; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; FOLLOW-UP; GLYCATED HEMOGLOBIN; CLINICAL-RESEARCH; NATURAL-HISTORY; GLUCOSE CONTROL; HEART-DISEASE	Introduction: Observational studies have shown that glycated haemoglobin (HbA(1c)) is related to mortality, but the shape of the association is less clear. Furthermore, disease duration and medication may modify this association. This observational study explored the association between HbA(1c) measured in stored erythrocytes and mortality. Secondly, it was assessed whether disease duration and medication use influenced the estimates or were independently associated with mortality. Methods: Within the European Prospective Investigation into Cancer and Nutrition a cohort was analysed of 4,345 individuals with a confirmed diagnosis of diabetes at enrolment. HbA(1c) was measured in blood samples stored up to 19 years. Multivariable Cox proportional hazard regression models for all-cause mortality investigated HbA(1c) in quartiles as well as per 1% increment, diabetes medication in seven categories of insulin and oral hypoglycaemic agents, and disease duration in quartiles. Results: After a median follow-up of 9.3 years, 460 participants died. Higher HbA(1c) was associated with higher mortality: Hazard Ratio for 1%-increase was 1.11 (95% CI 1.06, 1.17). This association was linear (P-nonlinearity = 0.15) and persistent across categories of medication use, disease duration, and co-morbidities. Compared with metformin, other medication types were not associated with mortality. Longer disease duration was associated with mortality, but not after adjustment for HbA(1c) and medication. Conclusion: This prospective study showed that persons with lower HbA(1c) had better survival than those with higher HbA(1c). The association was linear and independent of disease duration, type of medication use, and presence of co-morbidities. Any improvement of HbA(1c) appears to be associated with reduced mortality risk.	[Sluik, Diewertje; Boeing, Heiner; Montonen, Jukka; Noethlings, Ute] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Kaaks, Rudolf; Lukanova, Annekatrin] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Sandbaek, Annelli] Aarhus Univ, Sch Publ Hlth, Dept Gen Practice, Aarhus, Denmark; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Arriola, Larraitz] Basque Govt, Publ Hlth Dept Gipuzkoa, San Sebastian, Spain; [Arriola, Larraitz] Consortium Biomed Res Epidemiol & Publ Hlth, San Sebastian, Spain; [Ardanaz, Eva] Consortium Biomed Res Epidemiol & Publ Hlth, Pamplona, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst, Pamplona, Spain; [Saieva, Calogero] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Grioni, Sara] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy; [Sacerdote, Carlotta] Piedmont Ctr Canc Prevent, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn, Turin, Italy; [Mattiello, Amalia] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Beulens, Joline W. J.; van Dieren, Susan] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Div Med, Umea, Sweden; [Franks, Paul W.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Franks, Paul W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Bueno-de-Mesquita, Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Noethlings, Ute] Univ Kiel, Inst Expt Med, Epidemiol Sect, Kiel, Germany; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Div Nutr Res, Umea, Sweden	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ); Aarhus University; Aarhus University; Basque Government; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; University of Naples Federico II; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Umea University; Lund University; Skane University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Utrecht University; Utrecht University Medical Center; University of Kiel; Umea University	Sluik, D (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	Diewertje.Sluik@dife.de	Franks, Paul/AAA-3300-2020; Grioni, Sara/K-5320-2016; Mattiello, Amalia AM/K-5112-2016; Nöthlings, Ute/B-2713-2010; Saieva, Calogero/AAC-2611-2019	Grioni, Sara/0000-0002-5891-8426; Mattiello, Amalia AM/0000-0003-3676-7353; Saieva, Calogero/0000-0002-0117-1608; Franks, Paul/0000-0002-0520-7604; Beulens, Joline/0000-0002-4181-0937; tumino, rosario/0000-0003-2666-414X; Overvad, Kim/0000-0001-6429-7921; Arriola, Larraitz/0000-0001-8487-7181; Sluik, Diewertje/0000-0001-6304-0913; Montonen, Jukka/0000-0002-4366-9439; Sacerdote, Carlotta/0000-0002-8008-5096	European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant	European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant	This study was supported by a European Foundation for the Study of Diabetes (EFSD)/Sanofi-Aventis grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Cox D. R., 1984, ANAL SURVIVAL DATA; Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Dale AC, 2009, EUR HEART J, V30, P1372, DOI 10.1093/eurheartj/ehp039; Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Gale EAM, 2008, DIABETIC MED, V25, P9, DOI 10.1111/j.1464-5491.2008.02503.x; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; *IDF CLIN GUID TAS, 2005, GLOB GUID TYP 2 DIAB; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Kleinbaum DG, 2011, COX PROPORTIONAL HAZ, P139; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Landman GW, 2010, BRIT J GEN PRACT, V60, P172, DOI 10.3399/bjgp10X483517; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Levitan EB, 2008, DIABETOLOGIA, V51, P267, DOI 10.1007/s00125-007-0882-y; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Milicevic Z, 2008, DIABETES CARE, V31, pS155, DOI 10.2337/dc08-s240; MOSS SE, 1994, ARCH INTERN MED, V154, P2473; Nothlings U, 2011, EUR J CLIN NUTR, V65, P635, DOI 10.1038/ejcn.2011.11; Pfister R, 2011, DIABETOLOGIA; Ramlo-Halsted BA, 1999, PRIMARY CARE, V26, P771, DOI 10.1016/S0095-4543(05)70130-5; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Rolandsson O, 2004, METABOLISM, V53, P1496, DOI 10.1016/j.metabol.2004.04.015; Saydah S, 2009, DIABETES CARE, V32, P1440, DOI 10.2337/dc09-0117; Selvin E, 2005, DIABETIC MED, V22, P1726, DOI 10.1111/j.1464-5491.2005.01705.x; Selvin E, 2010, J DIABETES, V2, P118, DOI 10.1111/j.1753-0407.2010.00070.x; Sluik D, 2011, AM J EPIDEMIOL, V174, P22, DOI 10.1093/aje/kwr048; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tzoulaki I, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4731; Verma M, 2006, INDIAN J CLIN BIOCHE, V21, P142, DOI 10.1007/BF02913083; Yu PC, 2010, DIABETES RES CLIN PR, V89, P1, DOI 10.1016/j.diabres.2009.12.009	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38877	10.1371/journal.pone.0038877	http://dx.doi.org/10.1371/journal.pone.0038877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719972	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900059
J	Mordecai, EA				Mordecai, Erin A.			Soil Moisture and Fungi Affect Seed Survival in California Grassland Annual Plants	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; MAINTENANCE; COEXISTENCE; MORTALITY; LOSSES; BANKS	Survival of seeds in the seed bank is important for the population dynamics of many plant species, yet the environmental factors that control seed survival at a landscape level remain poorly understood. These factors may include soil moisture, vegetation cover, soil type, and soil pathogens. Because many soil fungi respond to moisture and host species, fungi may mediate environmental drivers of seed survival. Here, I measure patterns of seed survival in California annual grassland plants across 15 species in three experiments. First, I surveyed seed survival for eight species at 18 grasslands and coastal sage scrub sites ranging across coastal and inland Santa Barbara County, California. Species differed in seed survival, and soil moisture and geographic location had the strongest influence on survival. Grasslands had higher survival than coastal sage scrub sites for some species. Second, I used a fungicide addition and exotic grass thatch removal experiment in the field to tease apart the relative impact of fungi, thatch, and their interaction in an invaded grassland. Seed survival was lower in the winter (wet season) than in the summer (dry season), but fungicide improved winter survival. Seed survival varied between species but did not depend on thatch. Third, I manipulated water and fungicide in the laboratory to directly examine the relationship between water, fungi, and survival. Seed survival declined from dry to single watered to continuously watered treatments. Fungicide slightly improved seed survival when seeds were watered once but not continually. Together, these experiments demonstrate an important role of soil moisture, potentially mediated by fungal pathogens, in driving seed survival.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Mordecai, EA (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	Mordecai@lifesci.ucsb.edu		Mordecai, Erin/0000-0002-4402-5547	Mildred E. Mathias Foundation; United States Department of Agriculture (USDA) National Research Initiative [2005-02252]	Mildred E. Mathias Foundation; United States Department of Agriculture (USDA) National Research Initiative(United States Department of Agriculture (USDA))	Funding was provided by the Mildred E. Mathias Foundation and United States Department of Agriculture (USDA) National Research Initiative Grant 2005-02252 (http://www.csrees.usda.gov/funding rfas/nri_rfa.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Beckstead J, 2007, ANN BOT-LONDON, V99, P907, DOI 10.1093/aob/mcm028; Blaney CS, 2001, J APPL ECOL, V38, P1104, DOI 10.1046/j.1365-2664.2001.00663.x; BROWN JS, 1986, AM NAT, V127, P31, DOI 10.1086/284465; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CRIST TO, 1993, ECOLOGY, V74, P2231, DOI 10.2307/1939576; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Fenner M., 2000, SEEDS ECOLOGY REGENE; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; KIRKPATRICK BL, 1979, J APPL ECOL, V16, P515, DOI 10.2307/2402526; KREMER RJ, 1993, ECOL APPL, V3, P42, DOI 10.2307/1941791; Levine JM, 2008, J ECOL, V96, P795, DOI 10.1111/j.1365-2745.2008.01375.x; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; O'Hanlon-Manners DL, 2006, PLANT ECOL, V187, P49, DOI 10.1007/s11258-006-9132-5; Orrock JL, 2005, J TORREY BOT SOC, V132, P613, DOI 10.3159/1095-5674(2005)132[613:FMOSOT]2.0.CO;2; Pake CE, 1996, ECOLOGY, V77, P1427, DOI 10.2307/2265540; Schafer M, 2004, PLANT ECOL, V175, P19, DOI 10.1023/B:VEGE.0000048096.00772.23; Schafer M, 2003, ACTA OECOL, V24, P255, DOI 10.1016/j.actao.2003.09.001; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048069, 10.1371/journal.pone.0051667, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0032405, 10.1371/journal.pone.0036274]	25	42	45	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39083	10.1371/journal.pone.0039083	http://dx.doi.org/10.1371/journal.pone.0039083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720037	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000065
J	Mohibi, S; Gurumurthy, CB; Nag, A; Wang, J; Mirza, S; Mian, Y; Quinn, M; Katafiasz, B; Eudy, J; Pandey, S; Guda, C; Naramura, M; Band, H; Band, V				Mohibi, Shakur; Gurumurthy, Channabasavaiah Basavaraju; Nag, Alo; Wang, Jun; Mirza, Sameer; Mian, Yousaf; Quinn, Meghan; Katafiasz, Bryan; Eudy, James; Pandey, Sanjit; Guda, Chittibabu; Naramura, Mayumi; Band, Hamid; Band, Vimla			Mammalian Alteration/Deficiency in Activation 3 (Ada3) Is Essential for Embryonic Development and Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; HUMAN STAGA COMPLEX; TRANSCRIPTIONAL ADAPTER; CDK INHIBITORS; S-PHASE; DISTINCT; GCN5; PROLIFERATION; ACETYLATION; ONCOPROTEIN	Ada3 protein is an essential component of histone acetyl transferase containing coactivator complexes conserved from yeast to human. We show here that germline deletion of Ada3 in mouse is embryonic lethal, and adenovirus-Cre mediated conditional deletion of Ada3 in Ada3(FL/FL) mouse embryonic fibroblasts leads to a severe proliferation defect which was rescued by ectopic expression of human Ada3. A delay in G(1) to S phase of cell cycle was also seen that was due to accumulation of Cdk inhibitor p27 which was an indirect effect of c-myc gene transcription control by Ada3. We further showed that this defect could be partially reverted by knocking down p27. Additionally, drastic changes in global histone acetylation and changes in global gene expression were observed in microarray analyses upon loss of Ada3. Lastly, formation of abnormal nuclei, mitotic defects and delay in G(2)/M to G(1) transition was seen in Ada3 deleted cells. Taken together, we provide evidence for a critical role of Ada3 in embryogenesis and cell cycle progression as an essential component of HAT complex.	[Mohibi, Shakur; Gurumurthy, Channabasavaiah Basavaraju; Wang, Jun; Mirza, Sameer; Quinn, Meghan; Katafiasz, Bryan; Eudy, James; Pandey, Sanjit; Guda, Chittibabu; Band, Hamid; Band, Vimla] Univ Nebraska, Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Coll Med, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Coll Med, Dept Pharmacol & Neurosci, Omaha, NE 68198 USA; [Naramura, Mayumi; Band, Hamid; Band, Vimla] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Gurumurthy, Channabasavaiah Basavaraju; Nag, Alo; Mian, Yousaf; Naramura, Mayumi; Band, Hamid; Band, Vimla] Northwestern Univ, Evanston NW Healthcare Res Inst, Dept Med, Evanston, IL 60201 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Northwestern University	Band, V (corresponding author), Univ Nebraska, Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, 985805 Nebraska Med Ctr, Omaha, NE 68198 USA.	vband@unmc.edu	Mohibi, Shakur/AAR-7017-2021; Band, Hamid/AAF-4701-2020; Pandey, Sanjit/D-5049-2015; Gurumurthy, Channabasavaiah B/H-8268-2016; Gurumurthy, Channabasavaiah B/E-7205-2011	Mohibi, Shakur/0000-0001-5539-0841; Pandey, Sanjit/0000-0001-7304-3376; Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; Naramura, Mayumi/0000-0003-3658-0767	National Institutes of Health [CA96844, CA144027, CA87986, CA99163, CA105489, CA116552, NCI 5U01CA151806-02]; Department of Defense [W81XWH-07-1-0351, W81XWH-11-1-0171]; Susan G. Komen Postdoctoral Fellowship [KG111248]; National Center for Research Resources [5P20RR016469]; NIGMS, a component of the National Institutes of Health [8P20GM103427]; NATIONAL CANCER INSTITUTE [R01CA096844, R01CA105489, R01CA099163, U01CA151806, R01CA087986, R01CA116552, R01CA144027] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, a component of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA96844 and CA144027 (to V. B.) and CA87986, CA99163, CA105489, CA116552 and NCI 5U01CA151806-02 (to H. B.). This work was also supported by Department of Defense Grants W81XWH-07-1-0351 and W81XWH-11-1-0171 (to V. B.).; Supported by Susan G. Komen Postdoctoral Fellowship KG111248.; We acknowledge technical assistance from Valerie Tran and Poonam Joshi as well as assistance with time-lapse microscopy from Tom Dao. The University of Nebraska Medical Center (UNMC) DNA Microarray Core facility is supported by grants from the National Center for Research Resources (5P20RR016469) and the NIGMS (8P20GM103427), a component of the National Institutes of Health.	Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Germaniuk-Kurowska A, 2007, CANCER RES, V67, P11789, DOI 10.1158/0008-5472.CAN-07-2721; Grau B, 2008, MOL CELL BIOL, V28, P376, DOI 10.1128/MCB.01307-07; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 2002, MOL CELL BIOL, V22, P5801, DOI 10.1128/MCB.22.16.5801-5812.2002; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Nag A, 2007, J BIOL CHEM, V282, P8812, DOI 10.1074/jbc.M610443200; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; PINA B, 1993, MOL CELL BIOL, V13, P5981, DOI 10.1128/MCB.13.10.5981; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Saleh A, 1997, J BIOL CHEM, V272, P5571, DOI 10.1074/jbc.272.9.5571; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Torok MS, 2004, ADV PROTEIN CHEM, V67, P181; Vernarecci S, 2008, MOL CELL BIOL, V28, P988, DOI 10.1128/MCB.01366-07; Wang T, 2001, EMBO J, V20, P6404, DOI 10.1093/emboj/20.22.6404; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang M, 2008, INDIAN J TRADIT KNOW, V7, P3; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zeng MS, 2002, J BIOL CHEM, V277, P45611, DOI 10.1074/jbc.M208447200; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	47	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29442	29456		10.1074/jbc.M112.378901	http://dx.doi.org/10.1074/jbc.M112.378901			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22736770	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000308286900022
J	Fiete, D; Beranek, M; Baenziger, JU				Fiete, Dorothy; Beranek, Mary; Baenziger, Jacques U.			Molecular Basis for Protein-specific Transfer of N-Acetylgalactosamine to N-Linked Glycans by the Glycosyltransferases beta 1,4-N-Acetylgalactosaminyl Transferase 3 (beta 4GalNAc-T3) and beta 4GalNAc-T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLATION MUTANTS; GALNAC-TRANSFERASE; GAUSSIA LUCIFERASE; IN-VIVO; OLIGOSACCHARIDES; EXPRESSION; HORMONE; N,N'-DIACETYLLACTOSEDIAMINE; GALNAC-4-SULFOTRANSFERASE; PURIFICATION	Two closely related beta 1,4-N-acetylgalactosaminyltransferases, beta 4GalNAc-T3 and beta 4GalNAc-T4, are thought to account for the protein-specific addition of beta 1,4-linked GalNAc to Asn-linked oligosaccharides on a number of glycoproteins including the glycoprotein hormone luteinizing hormone and carbonic anhydrase-6 (CA6). We have utilized soluble, secreted forms of beta 4GalNAc-T3 and beta 4GalNAc-T4 to define the basis for protein-specific GalNAc transfer in vitro to chimeric substrates consisting of Gaussia luciferase followed by a glycoprotein substrate. Transfer of GalNAc by beta 4GalNAc-T3 and beta 4GalNAc-T4 to terminal GlcNAc is divalent cation-dependent. Transfer of GalNAc to glycoprotein acceptors that contain a peptide recognition determinant is maximal between 0.5 and 1.0 mM MnCl2; however, transfer is increasingly inhibited by concentrations of MnCl2 above 1 mM and by anion concentrations above 15 mM. In contrast, transfer of GalNAc to the simple sugar acceptor N-acetylglucosamine-beta-p-nitrophenol (GlcNAc beta-pNP) is not inhibited by concentrations of MnCl2 or anions that would inhibit transfer to glycoprotein acceptors by >90%. This finding indicates that interaction with the peptide recognition determinant in the substrate is sensitive to the anion concentration. beta 4GalNAc-T3 and beta 4GalNAc-T4 have similar but distinct specificities, resulting in a 42-fold difference in the IC50 for transfer of GalNAc to chimeric glycoprotein substrates by agalacto human chorionic gonadotropin, comprising 29 nM for beta 4GalNAc-T3 and 1.2 mu M for beta 4GalNAc-T4. Our in vitro analysis indicates that enzymatic recognition of the peptide determinant and the oligosaccharide acceptor are independent events.	[Fiete, Dorothy; Beranek, Mary; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 S Euclid Ave, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health [R01-HD058474, R01-CA21923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA021923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HD058474 and R01-CA21923 (to J. U. B.).	BAENZIGER JU, 1991, BIOL CARBOHYDRATES, V3, P1; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; HOOPER LV, 1995, J BIOL CHEM, V270, P16327, DOI 10.1074/jbc.270.27.16327; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; NYAME K, 1989, J BIOL CHEM, V264, P3235; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; REITMAN ML, 1984, METHOD ENZYMOL, V107, P163; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200	25	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29194	29203		10.1074/jbc.M112.371567	http://dx.doi.org/10.1074/jbc.M112.371567			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22722937	Green Published, hybrid			2022-12-25	WOS:000308074600085
J	Barry, ZT; Platt, MO				Barry, Zachary T.; Platt, Manu O.			Cathepsin S Cannibalism of Cathepsin K as a Mechanism to Reduce Type I Collagen Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROSIS; CYSTEINE PROTEASES; ENDOTHELIAL-CELLS; DEFICIENT MICE; SHEAR-STRESS; EXPRESSION; PROTEINASES; PROGRESSION; INHIBITION; SPLEEN	Cathepsins S and K are potent mammalian proteases secreted into the extracellular space and have been implicated in elastin and collagen degradation in diseases such as atherosclerosis and osteoporosis. Studies of individual cathepsins hydrolyzing elastin or collagen have provided insight into their binding and kinetics, but cooperative or synergistic activity between cathepsins K and S is less described. Using fluorogenic substrate assays, Western blotting, cathepsin zymography, and computational analyses, we uncovered cathepsin cannibalism, a novel mechanism by which cathepsins degrade each other as well as the substrate, with cathepsin S predominantly degrading cathepsin K. As a consequence of these proteolytic interactions, a reduction in total hydrolysis of elastin and type I collagen was measured compared with computationally predicted values derived from individual cathepsin assays. Furthermore, type I collagen was preserved from hydrolysis when a 10-fold ratio of cathepsin S cannibalized the highly collagenolytic cathepsin K, preventing its activity. Elastin was not preserved due to strong elastinolytic ability of both enzymes. Together, these results provide new insight into the combined proteolytic activities of cathepsins toward substrates and each other and present kinetic models to consider for more accurate predictions and descriptions of these systems.	[Platt, Manu O.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Platt, Manu O.] Emory Univ, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Platt, MO (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 315 Ferst Dr,Suite 1308, Atlanta, GA 30332 USA.	manu.platt@bme.gatech.edu	Platt, Manu/ABY-6057-2022	Platt, Manu/0000-0001-6390-4320	National Institutes of Health New Innovator Grant [1DP2OD007433-01]; Office of the Director, National Institutes of Health [DP2OD007433]; Georgia Cancer Coalition, Georgia Institute of Technology startup funds; National Science Foundation through Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS) [CBET-0939511]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007433] Funding Source: NIH RePORTER	National Institutes of Health New Innovator Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition, Georgia Institute of Technology startup funds; National Science Foundation through Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health New Innovator Grant 1DP2OD007433-01 and by Award DP2OD007433 from the Office of the Director, National Institutes of Health. This work was also supported by the Georgia Cancer Coalition, Georgia Institute of Technology startup funds, and the National Science Foundation through Science and Technology Center Emergent Behaviors of Integrated Cellular Systems (EBICS) Grant CBET-0939511.	Bromme D, 2009, EXPERT OPIN INV DRUG, V18, P585, DOI [10.1517/13543780902832661 , 10.1517/13543780902832661]; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Godat E, 2008, BIOL CHEM, V389, P1123, DOI 10.1515/BC.2008.109; Hou WS, 2002, ARTHRITIS RHEUM, V46, P663, DOI 10.1002/art.10114; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; KIRSCHKE H, 1989, BIOCHEM J, V264, P467, DOI 10.1042/bj2640467; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; MACIEWICZ RA, 1988, BIOCHEM J, V256, P433, DOI 10.1042/bj2560433; Nissler K, 1999, EUR J BIOCHEM, V263, P717, DOI 10.1046/j.1432-1327.1999.00547.x; Novinec M, 2007, J BIOL CHEM, V282, P7893, DOI 10.1074/jbc.M610107200; Novinec M, 2010, BIOCHEM J, V429, P379, DOI 10.1042/BJ20100337; Platt MO, 2007, AM J PHYSIOL-HEART C, V292, pH1479, DOI 10.1152/ajpheart.00954.2006; Platt MO, 2006, ARTERIOSCL THROM VAS, V26, P1784, DOI 10.1161/01.ATV.0000227470.72109.2b; Selinger CI, 2005, J CELL BIOCHEM, V96, P996, DOI 10.1002/jcb.20575; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Wilder CL, 2011, ARCH BIOCHEM BIOPHYS, V516, P52, DOI 10.1016/j.abb.2011.09.009	26	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27723	27730		10.1074/jbc.M111.332684	http://dx.doi.org/10.1074/jbc.M111.332684			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730330	Green Published, hybrid			2022-12-25	WOS:000307840700046
J	Katsushima, K; Shinjo, K; Natsume, A; Ohka, F; Fujii, M; Osada, H; Sekido, Y; Kondo, Y				Katsushima, Keisuke; Shinjo, Keiko; Natsume, Atsushi; Ohka, Fumiharu; Fujii, Makiko; Osada, Hirotaka; Sekido, Yoshitaka; Kondo, Yutaka			Contribution of MicroRNA-1275 to Claudin 11 Protein Suppression via a Polycomb-mediated Silencing Mechanism in Human Glioma Stem-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; DNA METHYLATION; INITIATING CELLS; GLIOBLASTOMA; DISEASE; BRAIN; DIFFERENTIATION; IDENTIFICATION; INVASIVENESS; TRANSITIONS	Glioblastomas show heterogeneous histological features, and tumor cells show distinct phenotypic states that confer different functional attributes and an aggressive character. However, the molecular mechanisms underlying the heterogeneity in this disease are poorly understood. Glioma stem-like cells (GSCs) are considered able to aberrantly differentiate into diverse cell types and may contribute to the establishment of tumor heterogeneity. Using a GSC model, we investigated differentially expressed microRNAs (miRNAs) and associated epigenetic mechanisms that regulate the differentiation of GSCs. miRNA profiling using microarray technology showed that 13 and 34 miRNAs were commonly up-regulated and down-regulated in two independent GSC lines during differentiation, respectively. Among this set of miRNAs, quantitative PCR analysis showed that miRNA-1275 (miR-1275) was consistently down-regulated during GSC differentiation, along with the up-regulation of its target, CLDN11, an important protein during oligodendroglial lineage differentiation. Inhibition of miR-1275 with a specific antisense oligonucleotide (anti-miR-1275) in GSCs increased the expression of CLDN11, together with significant growth suppression. Epigenetic analysis revealed that gain of histone H3 lysine 27 trimethylation (H3K27me3) in the primary microRNA-1275 promoter was closely associated with miR-1275 expression. Treatment with 3-deazaneplanocin A, an inhibitor of H3K27 methyltransferase, attenuated CLDN11 induction by serum stimulation in parallel with sustained miR-1275 expression. Our results have illuminated the epigenetic regulatory pathways of miR-1275 that are closely associated with oligodendroglial differentiation, which may contribute to the tissue heterogeneity seen in the formation of glioblastomas. Given that inhibition of miR-1275 induces expression of oligodendroglial lineage proteins and suppresses tumor cell proliferation, this may be a potential therapeutic target for glioblastomas.	[Kondo, Yutaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Shinjo, Keiko; Osada, Hirotaka; Sekido, Yoshitaka] Nagoya Grad Sch Med, Dept Canc Genet, Nagoya, Aichi 4668560, Japan; [Natsume, Atsushi] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 4648560, Japan; [Kondo, Yutaka] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo 1020076, Japan	Aichi Cancer Center; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Kondo, Y (corresponding author), Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ykondo@aichi-cc.jp	Sekido, Yoshitaka/P-9756-2015; Natsume, Atsushi/I-7364-2014; katsushima, keisuke/AAV-5204-2020; Ohka, Fumiharu/A-3420-2016	Natsume, Atsushi/0000-0002-9113-0470; katsushima, keisuke/0000-0001-7770-432X; Ohka, Fumiharu/0000-0002-5569-5626; Sekido, Yoshitaka/0000-0002-2428-3848	PRESTO of JST; Japan Society for the Promotion of Science	PRESTO of JST; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from PRESTO of JST (to Y. K.) and a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to Y. K.).	ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Agarwal R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008002; Awsare NS, 2011, ONCOL REP, V25, P1503, DOI 10.3892/or.2011.1244; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Farah MH, 2000, DEVELOPMENT, V127, P693; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soini Y, 2010, HISTOPATHOLOGY, V56, P821, DOI 10.1111/j.1365-2559.2010.03538.x; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu A, 2008, STEM CELLS DEV, V17, P173, DOI 10.1089/scd.2007.0133; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yuki K, 2009, CANCER LETT, V284, P71, DOI 10.1016/j.canlet.2009.04.020	49	40	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27396	27406		10.1074/jbc.M112.359109	http://dx.doi.org/10.1074/jbc.M112.359109			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22736761	Green Published, hybrid			2022-12-25	WOS:000307840700011
J	Peng, HY; Guerau-de-Arellano, M; Mehta, VB; Yang, YH; Huss, DJ; Papenfuss, TL; Lovett-Racke, AE; Racke, MK				Peng, Haiyan; Guerau-de-Arellano, Mireia; Mehta, Veela B.; Yang, Yuhong; Huss, David J.; Papenfuss, Tracey L.; Lovett-Racke, Amy E.; Racke, Michael K.			Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor kappa B (NF-kappa B) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; TRANSCRIPTIONAL ACTIVATION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; INNATE IMMUNITY; T-BET; PHOSPHORYLATION; INDUCTION; P65; PATHWAY	Dimethyl fumarate (DMF) is an effective novel treatment for multiple sclerosis in clinical trials. A reduction of IFN-gamma-producing CD4(+) T cells is observed in DMF-treated patients and may contribute to its clinical efficacy. However, the cellular and molecular mechanisms behind this clinical observation are unclear. In this study, we investigated the effects of DMF on dendritic cell (DC) maturation and subsequent DC-mediated T cell responses. We show that DMF inhibits DC maturation by reducing inflammatory cytokine production (IL-12 and IL-6) and the expression of MHC class II, CD80, and CD86. Importantly, this immature DC phenotype generated fewer activated T cells that were characterized by decreased IFN-gamma and IL-17 production. Further molecular studies demonstrated that DMF impaired nuclear factor kappa B (NF-kappa B) signaling via reduced p65 nuclear translocalization and phosphorylation. NF-kappa B signaling was further decreased by DMF-mediated suppression of extracellular signal-regulated kinase 1 and 2 (ERK1/2) and its downstream kinase mitogen stress-activated kinase 1 (MSK1). MSK1 suppression resulted in decreased p65 phosphorylation at serine 276 and reduced histone phosphorylation at serine 10. As a consequence, DMF appears to reduce p65 transcriptional activity both directly and indirectly by promoting a silent chromatin environment. Finally, treatment of DCs with the MSK1 inhibitor H89 partially mimicked the effects of DMF on the DC signaling pathway and impaired DC maturation. Taken together, these studies indicate that by suppression of both NF-kappa B and ERK1/2-MSK1 signaling, DMF inhibits maturation of DCs and subsequently Th1 and Th17 cell differentiation.	[Peng, Haiyan; Lovett-Racke, Amy E.; Racke, Michael K.] Ohio State Univ, Neurosci Grad Studies Program, Columbus, OH 43210 USA; [Racke, Michael K.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Peng, Haiyan; Guerau-de-Arellano, Mireia; Mehta, Veela B.; Yang, Yuhong; Racke, Michael K.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Lovett-Racke, Amy E.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Huss, David J.; Lovett-Racke, Amy E.] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Papenfuss, Tracey L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Racke, MK (corresponding author), Ohio State Univ, Neurosci Grad Studies Program, Columbus, OH 43210 USA.	Michael.Racke@osumc.edu	Peng, Haiyan/A-1258-2015; Yang, Yuhong/A-6033-2013; Lovett-Racke, Amy/E-3545-2011; Papenfuss, Tracey/E-3814-2011	Peng, Haiyan/0000-0003-2703-6081; 	National Institutes of Health [RO1 NS067441-01, RO1 NS037513-10]; National Multiple Sclerosis Society [NMSS 4358-A-13]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR022198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067441, R01NS037513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS067441-01 to A. E. L. R.) and RO1 NS037513-10 (to M. K. R.). This work was also supported by National Multiple Sclerosis Society Grant NMSS 4358-A-13 (to M.K.R.).	[Anonymous], 2011, NAT REV DRUG DISCOV, V10, P404; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Arun P, 2009, CLIN CANCER RES, V15, P5974, DOI 10.1158/1078-0432.CCR-09-1352; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Fuseler JW, 2006, MICROSC MICROANAL, V12, P269, DOI 10.1017/S1431927606060260; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Gesser B, 2007, J INVEST DERMATOL, V127, P2129, DOI 10.1038/sj.jid.5700859; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Handley ME, 2005, FREE RADICAL BIO MED, V38, P1637, DOI 10.1016/j.freeradbiomed.2005.02.022; Hansen BS, 2006, J NEUROIMMUNOL, V172, P94, DOI 10.1016/j.jneuroim.2005.11.006; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Huss DJ, 2011, EUR J IMMUNOL, V41, P2987, DOI 10.1002/eji.201141666; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Joo JH, 2008, J BIOL CHEM, V283, P16391, DOI 10.1074/jbc.M800945200; Kappos L, 2008, LANCET, V372, P1463, DOI 10.1016/S0140-6736(08)61619-0; Karni A, 2006, J IMMUNOL, V177, P4196, DOI 10.4049/jimmunol.177.6.4196; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Mou HB, 2011, TRANSPL P, V43, P2049, DOI 10.1016/j.transproceed.2011.02.054; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; O'Mahony AM, 2004, J BIOL CHEM, V279, P18137, DOI 10.1074/jbc.M401397200; Papenfuss TL, 2011, J IMMUNOL, V186, P3346, DOI 10.4049/jimmunol.1001322; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schimrigk S, 2006, EUR J NEUROL, V13, P604, DOI 10.1111/j.1468-1331.2006.01292.x; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Svajger U, 2011, J LEUKOCYTE BIOL, V89, P893, DOI 10.1189/jlb.0810463; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584	47	138	148	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28017	28026		10.1074/jbc.M112.383380	http://dx.doi.org/10.1074/jbc.M112.383380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733812	Green Published, hybrid			2022-12-25	WOS:000307840700075
J	Steringer, JP; Bleicken, S; Andreas, H; Zacherl, S; Laussmann, M; Temmerman, K; Contreras, FX; Bharat, TAM; Lechner, J; Muller, HM; Briggs, JAG; Garcia-Saez, AJ; Nickel, W				Steringer, Julia P.; Bleicken, Stephanie; Andreas, Helena; Zacherl, Sonja; Laussmann, Mareike; Temmerman, Koen; Contreras, F. Xabier; Bharat, Tanmay A. M.; Lechner, Johannes; Mueller, Hans-Michael; Briggs, John A. G.; Garcia-Saez, Ana J.; Nickel, Walter			Phosphatidylinositol 4,5-Bisphosphate (PI(4,5)P-2)-dependent Oligomerization of Fibroblast Growth Factor 2 (FGF2) Triggers the Formation of a Lipidic Membrane Pore Implicated in Unconventional Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; PROTEIN SECRETION; CELL-SURFACE; IL-1-BETA SECRETION; MAMMALIAN-CELLS; PLASMA-MEMBRANE; TRANSLOCATION; EXPORT; BAX; MACHINERY	Fibroblast growth factor 2 (FGF2) is a critical mitogen with a central role in specific steps of tumor-induced angiogenesis. It is known to be secreted by unconventional means bypassing the endoplasmic reticulum/Golgi-dependent secretory pathway. However, the mechanism of FGF2 membrane translocation into the extracellular space has remained elusive. Here, we show that phosphatidylinositol 4,5-bisphosphate-dependent membrane recruitment causes FGF2 to oligomerize, which in turn triggers the formation of a lipidic membrane pore with a putative toroidal structure. This process is strongly up-regulated by tyrosine phosphorylation of FGF2. Our findings explain key requirements of FGF2 secretion from living cells and suggest a novel self-sustained mechanism of protein translocation across membranes with a lipidic membrane pore being a transient translocation intermediate.	[Steringer, Julia P.; Andreas, Helena; Zacherl, Sonja; Laussmann, Mareike; Temmerman, Koen; Contreras, F. Xabier; Lechner, Johannes; Mueller, Hans-Michael; Nickel, Walter] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Bharat, Tanmay A. M.; Briggs, John A. G.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)	Nickel, W (corresponding author), Univ Heidelberg, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de	Saez, Ana J. Garcia/U-1611-2019; Contreras, Xabier/AAA-8885-2019; Briggs, John/J-3096-2012	Bleicken, Stephanie/0000-0002-4789-0974; Muller, Hans-Michael/0000-0002-2384-7285; Briggs, John/0000-0003-3990-6910; Contreras, Xabier/0000-0003-0875-634X; Bharat, Tanmay/0000-0002-0168-0277	German Research Foundation [SFB 638, GRK 1188]; EuroMembrane Program of the European Science Foundation; AID-NET Program of the Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks	German Research Foundation(German Research Foundation (DFG)); EuroMembrane Program of the European Science Foundation; AID-NET Program of the Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks	This work was supported by German Research Foundation Grants SFB 638 and GRK 1188, the EuroMembrane Program of the European Science Foundation, the AID-NET Program of the Federal Ministry for Education and Research of Germany, and the Deutsche Forschungsgemeinschaft cluster of excellence CellNetworks.	Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Apellaniz B, 2010, BIOPHYS J, V99, P3619, DOI 10.1016/j.bpj.2010.09.027; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Bleicken S, 2011, CURR PROTEIN PEPT SC, V12, P691, DOI 10.2174/138920311798841744; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Cabral M, 2010, EUKARYOT CELL, V9, P1009, DOI 10.1128/EC.00337-09; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Kastrup JS, 1997, ACTA CRYSTALLOGR D, V53, P160, DOI 10.1107/S0907444996012711; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Muller P, 2000, CHEM PHYS LIPIDS, V106, P89, DOI 10.1016/S0009-3084(00)00134-1; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Prudovsky I, 2002, J CELL BIOL, V158, P201, DOI 10.1083/jcb.200203084; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Ries J, 2008, PHYS CHEM CHEM PHYS, V10, P3487, DOI 10.1039/b718132a; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xie JM, 2007, ACS CHEM BIOL, V2, P474, DOI 10.1021/cb700083w; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	52	74	74	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27659	27669		10.1074/jbc.M112.381939	http://dx.doi.org/10.1074/jbc.M112.381939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730382	Green Published, hybrid			2022-12-25	WOS:000307840700040
J	Yadav, V; Zhang, XY; Liu, JG; Estrem, S; Li, SY; Gong, XQ; Buchanan, S; Henry, JR; Starling, JJ; Peng, SB				Yadav, Vipin; Zhang, Xiaoyi; Liu, Jiangang; Estrem, Shawn; Li, Shuyu; Gong, Xue-Qian; Buchanan, Sean; Henry, James R.; Starling, James J.; Peng, Sheng-Bin			Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE INHIBITOR; ACQUIRED-RESISTANCE; BRAF INHIBITION; MUTATIONS; GROWTH; POTENT; MECHANISM; GENE; EXPRESSION; RESPONSES	Oncogenic B-RAF V600E mutation is found in 50% of melanomas and drives MEK/ERK pathway and cancer progression. Recently, a selective B-RAF inhibitor, vemurafenib (PLX4032), received clinical approval for treatment of melanoma with B-RAF V600E mutation. However, patients on vemurafenib eventually develop resistance to the drug and demonstrate tumor progression within an average of 7 months. Recent reports indicated that multiple complex and context-dependent mechanisms may confer resistance to B-RAF inhibition. In the study described herein, we generated B-RAF V600E melanoma cell lines of acquired-resistance to vemurafenib, and investigated the underlying mechanism(s) of resistance. Biochemical analysis revealed that MEK/ERK reactivation through Ras is the key resistance mechanism in these cells. Further analysis of total gene expression by microarray confirmed a significant increase of Ras and RTK gene signatures in the vemurafenib-resistant cells. Mechanistically, we found that the enhanced activation of fibroblast growth factor receptor 3 (FGFR3) is linked to Ras and MAPK activation, therefore conferring vemurafenib resistance. Pharmacological or genetic inhibition of the FGFR3/Ras axis restored the sensitivity of vemurafenib-resistant cells to vemurafenib. Additionally, activation of FGFR3 sufficiently reactivated Ras/MAPK signaling and conferred resistance to vemurafenib in the parental B-RAF V600E melanoma cells. Finally, we demonstrated that vemurafenib-resistant cells maintain their addiction to the MAPK pathway, and inhibition of MEK or pan-RAF activities is an effective therapeutic strategy to overcome acquired-resistance to vemurafenib. Together, we describe a novel FGFR3/Ras mediated mechanism for acquired-resistance to B-RAF inhibition. Our results have implications for the development of new therapeutic strategies to improve the outcome of patients with B-RAF V600E melanoma.	[Yadav, Vipin; Zhang, Xiaoyi; Starling, James J.; Peng, Sheng-Bin] Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA; [Liu, Jiangang; Estrem, Shawn; Li, Shuyu; Gong, Xue-Qian; Buchanan, Sean] Eli Lilly & Co, Lilly Res Labs, Translat Sci, Indianapolis, IN 46285 USA; [Henry, James R.] Eli Lilly & Co, Lilly Res Labs, Discovery Chem, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Peng, SB (corresponding author), Eli Lilly & Co, Lilly Res Labs, Oncol Discovery Res, Indianapolis, IN 46285 USA.	sbpeng@lilly.com	gong, xue/GYQ-8649-2022		Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This work was supported by Eli Lilly and Company.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Azuma K, 2011, BIOCHEM BIOPH RES CO, V407, P219, DOI 10.1016/j.bbrc.2011.03.002; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Easty DJ, 2011, PIGM CELL MELANOMA R, V24, P446, DOI 10.1111/j.1755-148X.2011.00836.x; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jang JH, 2001, CANCER RES, V61, P3541; Jeffers Michael, 2002, Expert Opin Ther Targets, V6, P469, DOI 10.1517/14728222.6.4.469; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Khazak V, 2007, EXPERT OPIN THER TAR, V11, P1587, DOI 10.1517/14728222.11.12.1587; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Yadav V, 2011, MOL CARCINOGEN, V50, P346, DOI 10.1002/mc.20716; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Zhao GS, 2011, MOL CANCER THER, V10, P2200, DOI 10.1158/1535-7163.MCT-11-0306	37	136	141	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					28087	28098		10.1074/jbc.M112.377218	http://dx.doi.org/10.1074/jbc.M112.377218			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730329	hybrid, Green Published			2022-12-25	WOS:000307840700082
J	Abrams, MB; Nilsson, I; Lewandowski, SA; Kjell, J; Codeluppi, S; Olson, L; Eriksson, U				Abrams, Mathew B.; Nilsson, Ingrid; Lewandowski, Sebastian A.; Kjell, Jacob; Codeluppi, Simone; Olson, Lars; Eriksson, Ulf			Imatinib Enhances Functional Outcome after Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; CELLULAR INFLAMMATORY RESPONSE; ENDOTHELIAL-CELLS; PROGENITOR-CELL; VASCULAR WALL; ACUTE-PHASE; PDGF-CC; RECOVERY; MACROPHAGES	We investigated whether imatinib (Gleevec (R), Novartis), a tyrosine kinase inhibitor, could improve functional outcome in experimental spinal cord injury. Rats subjected to contusion spinal cord injury were treated orally with imatinib for 5 days beginning 30 minutes after injury. We found that imatinib significantly enhanced blood-spinal cord-barrier integrity, hindlimb locomotor function, sensorimotor integration, and bladder function, as well as attenuated astrogliosis and deposition of chondroitin sulfate proteoglycans, and increased tissue preservation. These improvements were associated with enhanced vascular integrity and reduced inflammation. Our results show that imatinib improves recovery in spinal cord injury by preserving axons and other spinal cord tissue components. The rapid time course of these beneficial effects suggests that the effects of imatinib are neuroprotective rather than neurorestorative. The positive effects on experimental spinal cord injury, obtained by oral delivery of a clinically used drug, makes imatinib an interesting candidate drug for clinical trials in spinal cord injury.	[Abrams, Mathew B.; Kjell, Jacob; Codeluppi, Simone; Olson, Lars] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Nilsson, Ingrid; Lewandowski, Sebastian A.; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Abrams, MB (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	mathew.abrams@ki.se	Kjell, Jacob/HDN-4979-2022; codeluppi, simone/I-4143-2012; Lewandowski, Sebastian A./K-2492-2019	codeluppi, simone/0000-0002-7053-0520; Lewandowski, Sebastian A./0000-0002-5935-0211; Kjell, Jacob/0000-0002-8335-0780	Swedish Agency for Innovations (VINNOVA); Hallsten's Foundation; Swedish Brain Foundation; Wings for Life; Swedish Research Council; Anna-Stina och John Mattsons Minnesstiftelse for sonen Johan; AFA Insurance Company; Torsten och Ragnar Soderbergs stiftelser; United States Public Health Service grant; Swedish Stroke Foundation; Karolinska Institute; LeDucq Foundation	Swedish Agency for Innovations (VINNOVA); Hallsten's Foundation; Swedish Brain Foundation; Wings for Life; Swedish Research Council(Swedish Research CouncilEuropean Commission); Anna-Stina och John Mattsons Minnesstiftelse for sonen Johan; AFA Insurance Company; Torsten och Ragnar Soderbergs stiftelser; United States Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); Swedish Stroke Foundation; Karolinska Institute(Karolinska Institutet); LeDucq Foundation(Leducq Foundation)	This research was conducted with support from the following foundations: the Swedish Agency for Innovations (VINNOVA), Hallsten's Foundation, the Swedish Brain Foundation, Wings for Life, the Swedish Research Council, Anna-Stina och John Mattsons Minnesstiftelse for sonen Johan, AFA Insurance Company, Torsten och Ragnar Soderbergs stiftelser, a United States Public Health Service grant, the Swedish Stroke Foundation (to IN), and the Karolinska Institute, and the LeDucq Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bao F, 2012, J NEUROTRAUMA; Barbas D, 2005, J COMP NEUROL, V490, P295, DOI 10.1002/cne.20666; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Carroll WM, 1998, BRAIN, V121, P293, DOI 10.1093/brain/121.2.293; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Flanders AE, 1996, RADIOLOGY, V201, P649, DOI 10.1148/radiology.201.3.8939210; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hugenholtz H, 2003, CAN MED ASSOC J, V168, P1145; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; Lassila M, 2004, ARTERIOSCL THROM VAS, V24, P935, DOI 10.1161/01.ATV.0000124105.39900.db; Leder C, 2007, EXP HEMATOL, V35, P1266, DOI 10.1016/j.exphem.2007.04.016; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; MERRILL JE, 1991, GLIA, V4, P327, DOI 10.1002/glia.440040311; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Morelli PI, 2006, ATHEROSCLEROSIS, V184, P39, DOI 10.1016/j.atherosclerosis.2005.03.026; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Neumann H, 1998, J NEUROPATH EXP NEUR, V57, P1, DOI 10.1097/00005072-199801000-00001; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Potas JR, 2006, J NEUROTRAUM, V23, P660, DOI 10.1089/neu.2006.23.660; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; SCHAEFER DM, 1992, J NEUROSURG, V76, P218, DOI 10.3171/jns.1992.76.2.0218; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009	49	42	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38760	10.1371/journal.pone.0038760	http://dx.doi.org/10.1371/journal.pone.0038760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723886	Green Published, Green Submitted, gold			2022-12-25	WOS:000305652700029
J	Wu, TF; Xie, C; Han, J; Ye, YJ; Weiel, J; Li, Q; Blanco, I; Ahn, C; Olsen, N; Putterman, C; Saxena, R; Mohan, C				Wu, Tianfu; Xie, Chun; Han, Jie; Ye, Yujin; Weiel, Jim; Li, Quan; Blanco, Irene; Ahn, Chul; Olsen, Nancy; Putterman, Chaim; Saxena, Ramesh; Mohan, Chandra			Metabolic Disturbances Associated with Systemic Lupus Erythematosus	PLOS ONE			English	Article							DISEASE-ACTIVITY; FATTY-ACIDS; PROFILES; ATHEROSCLEROSIS; ANTIOXIDANTS	The metabolic disturbances that underlie systemic lupus erythematosus are currently unknown. A metabolomic study was executed, comparing the sera of 20 SLE patients against that of healthy controls, using LC/MS and GC/MS platforms. Validation of key differences was performed using an independent cohort of 38 SLE patients and orthogonal assays. SLE sera showed evidence of profoundly dampened glycolysis, Krebs cycle, fatty acid beta oxidation and amino acid metabolism, alluding to reduced energy biogenesis from all sources. Whereas long-chain fatty acids, including the n3 and n6 essential fatty acids, were significantly reduced, medium chain fatty acids and serum free fatty acids were elevated. The SLE metabolome exhibited profound lipid peroxidation, reflective of oxidative damage. Deficiencies were noted in the cellular anti-oxidant, glutathione, and all methyl group donors, including cysteine, methionine, and choline, as well as phosphocholines. The best discriminators of SLE included elevated lipid peroxidation products, MDA, gamma-glutamyl peptides, GGT, leukotriene B4 and 5-HETE. Importantly, similar elevations were not observed in another chronic inflammatory autoimmune disease, rheumatoid arthritis. To sum, comprehensive profiling of the SLE metabolome reveals evidence of heightened oxidative stress, inflammation, reduced energy generation, altered lipid profiles and a prothrombotic state. Resetting the SLE metabolome, either by targeting selected molecules or by supplementing the diet with essential fatty acids, vitamins and methyl group donors offers novel opportunities for disease modulation in this disabling systemic autoimmune ailment.	[Wu, Tianfu; Xie, Chun; Han, Jie; Ye, Yujin; Li, Quan; Ahn, Chul; Olsen, Nancy; Saxena, Ramesh; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Weiel, Jim] Metabolon Inc, Res Triangle Pk, NC USA; [Putterman, Chaim] Albert Einstein Coll Med, New York, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Metabolon; Yeshiva University	Wu, TF (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.	Chandra.mohan@utsouthwestern.edu	Putterman, Chaim/AFR-0429-2022; Wu, Tianfu/G-6672-2019; Wu, Tianfu/F-7071-2012; Mohan, Chandra/GPX-8233-2022	Wu, Tianfu/0000-0003-4406-1449; Wu, Tianfu/0000-0001-8235-5929	National Institutes of Health [R01 DK 081872]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01 DK 081872. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SC, 2002, RHEUMATOL INT, V22, P238, DOI 10.1007/s00296-002-0241-8; Balada E, 2007, ANN NY ACAD SCI, V1108, P127, DOI 10.1196/annals.1422.015; Boffa JJ, 2009, NEPHROL THER, V5, P595, DOI 10.1016/j.nephro.2009.06.009; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534; Deckelbaum RJ, 2010, ARTERIOSCL THROM VAS, V30, P2325, DOI 10.1161/ATVBAHA.110.214353; Fernandez D, 2009, AUTOIMMUN REV, V8, P184, DOI 10.1016/j.autrev.2008.07.041; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gladman DD, 2002, J RHEUMATOL, V29, P288; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008; Lutz NW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000595; McMahon M, 2007, CURR OPIN IMMUNOL, V19, P633, DOI 10.1016/j.coi.2007.11.001; Nuttall SL, 2003, RHEUMATOLOGY, V42, P758, DOI 10.1093/rheumatology/keg212; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Suwannaroj S, 2001, LUPUS, V10, P258, DOI 10.1191/096120301680416940; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wan JB, 2010, ARTERIOSCL THROM VAS, V30, P2487, DOI 10.1161/ATVBAHA.110.210054; Wright SA, 2008, ANN RHEUM DIS, V67, P841, DOI 10.1136/ard.2007.077156	20	120	125	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e37210	10.1371/journal.pone.0037210	http://dx.doi.org/10.1371/journal.pone.0037210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723834	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700003
J	Korenromp, EL; Glaziou, P; Fitzpatrick, C; Floyd, K; Hosseini, M; Raviglione, M; Atun, R; Williams, B				Korenromp, Eline L.; Glaziou, Philippe; Fitzpatrick, Christopher; Floyd, Katherine; Hosseini, Mehran; Raviglione, Mario; Atun, Rifat; Williams, Brian			Implementing the Global Plan to Stop TB, 2011-2015-Optimizing Allocations and the Global Fund's Contribution: A Scenario Projections Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; COMMUNITY-BASED CARE; COST-EFFECTIVENESS; RUSSIAN-FEDERATION; HIV; COHORT; FEASIBILITY; PREVALENCE; STRATEGIES; RESOURCES	Background: The Global Plan to Stop TB estimates funding required in low- and middle-income countries to achieve TB control targets set by the Stop TB Partnership within the context of the Millennium Development Goals. We estimate the contribution and impact of Global Fund investments under various scenarios of allocations across interventions and regions. Methodology/Principal Findings: Using Global Plan assumptions on expected cases and mortality, we estimate treatment costs and mortality impact for diagnosis and treatment for drug-sensitive and multidrug-resistant TB (MDR-TB), including antiretroviral treatment (ART) during DOTS for HIV-co-infected patients, for four country groups, overall and for the Global Fund investments. In 2015, China and India account for 24% of funding need, Eastern Europe and Central Asia (EECA) for 33%, sub-Saharan Africa (SSA) for 20%, and other low-and middle-income countries for 24%. Scale-up of MDR-TB treatment, especially in EECA, drives an increasing global TB funding need - an essential investment to contain the mortality burden associated with MDR-TB and future disease costs. Funding needs rise fastest in SSA, reflecting increasing coverage need of improved TB/HIV management, which saves most lives per dollar spent in the short term. The Global Fund is expected to finance 8-12% of Global Plan implementation costs annually. Lives saved through Global Fund TB support within the available funding envelope could increase 37% if allocations shifted from current regional demand patterns to a prioritized scale-up of improved TB/HIV treatment and secondly DOTS, both mainly in Africa - with EECA region, which has disproportionately high per-patient costs, funded from alternative resources. Conclusions/Significance: These findings, alongside country funding gaps, domestic funding and implementation capacity and equity considerations, should inform strategies and policies for international donors, national governments and disease control programs to implement a more optimal investment approach focusing on highest-impact populations and interventions.	[Korenromp, Eline L.; Hosseini, Mehran] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline L.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Glaziou, Philippe; Fitzpatrick, Christopher; Floyd, Katherine; Raviglione, Mario] WHO, CH-1211 Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England; [Williams, Brian] SACEMA, Stellenbosch, South Africa	Erasmus University Rotterdam; Erasmus MC; World Health Organization; Imperial College London	Korenromp, EL (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	eline.korenromp@theglobalfund.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Williams, Brian/0000-0002-3174-4876; Glaziou, Philippe/0000-0002-0649-1272; RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], 2011, GLOB TUB CONTR 2011; Atun RA, 2006, HEALTH POLICY PLANN, V21, P353, DOI 10.1093/heapol/czl023; Balabanova Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-44; Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Cohen Ted, 2009, Expert Rev Respir Med, V3, P67, DOI 10.1586/17476348.3.1.67; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Dye C, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000346; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P43, DOI 10.2471/BLT.04.018705; Floyd K, 2008, B WORLD HEALTH ORGAN, V86, P568, DOI 10.2471/BLT.07.049767; Floyd K, 2007, B WORLD HEALTH ORGAN, V85, P334, DOI 10.2471/BLT.06.034942; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P437, DOI 10.2471/BLT.05.024109; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; International Monetary Fund (IMF), 2022, WORLD EC OUTLOOK DAT; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Kazatchkine MD, 2010, LANCET, V376, P1439, DOI 10.1016/S0140-6736(10)61970-8; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Lal SS, 2011, TROP MED INT HEALTH, V16, P685, DOI 10.1111/j.1365-3156.2011.02749.x; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14; Okello D, 2003, INT J TUBERC LUNG D, V7, pS72; Pitter C, 2007, JAIDS-J ACQ IMM DEF, V44, P336, DOI 10.1097/QAI.0b013e31802f12b5; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; The Global Fund to Fight AIDS, 2011, GLOB FUND STRAT 2012; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, REPL 2011 2013 RES S; The Global Fund to fight AIDS Tuberculosis and Malaria, 2011, GFB2313GFB2313; The Global Fund to fight AIDS Tuberculosis and Malaria, 2011, GLOB FUNDS PROGR SEE; The Global Fund to fight AIDS Tuberculosis and Malaria, 2012, TRANS FUND MECH; The Global Fund to fight AIDS Tuberculosis and Malaria, 2012, APPR GRANT AM DISB D; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2011, POL EL CRIT COUNT FI; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2011, GLOB FUND RES REP 20; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; WHO, 2010, ANT THER HIV INF AD; *WHO, 2011, GLOB PLAN STOP TB 20; WHO, 2010, GLOB TUB CONTR 2010; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; [World Health Organization Stop TB Partnership], 2010, GLOB PLAN STOP TB 20; World Health Organization, 2006, TB PLANN BUDG TOOL; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	49	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38816	10.1371/journal.pone.0038816	http://dx.doi.org/10.1371/journal.pone.0038816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719954	gold, Green Published			2022-12-25	WOS:000305583300053
J	Li, YH; Wang, XX; Pan, YF; Lee, DH; Chowdhury, D; Kimmelman, AC				Li, Ying-Hua; Wang, Xiaoxu; Pan, Yunfeng; Lee, Dong-Hyun; Chowdhury, Dipanjan; Kimmelman, Alec C.			Inhibition of Non-Homologous End Joining Repair Impairs Pancreatic Cancer Growth and Enhances Radiation Response	PLOS ONE			English	Article							UP-REGULATION; BREAK REPAIR; DNA-PKCS; RECRUITMENT	Pancreatic ductal adenocarcinoma (PDAC) is amongst the deadliest of human cancers, due to its late diagnosis as well as its intense resistance to currently available therapeutics. To identify mechanisms as to why PDAC are refractory to DNA damaging cytoxic chemotherapy and radiation, we performed a global interrogation of the DNA damage response of PDAC. We find that PDAC cells generally harbor high levels of spontaneous DNA damage. Inhibition of Non-Homologous End Joining (NHEJ) repair either pharmacologically or by RNAi resulted in a further accumulation of DNA damage, inhibition of growth, and ultimately apoptosis even in the absence of exogenous DNA damaging agents. In response to radiation, PDAC cells rely on the NHEJ pathway to rapidly repair DNA double strand breaks. Mechanistically, when NHEJ is inhibited there is a compensatory increase in Homologous Recombination (HR). Despite this upregulation of HR, DNA damage persists and cells are significantly more sensitive to radiation. Together, these findings support the incorporation of NHEJ inhibition into PDAC therapeutic approaches, either alone, or in combination with DNA damaging therapies such as radiation.	[Li, Ying-Hua; Wang, Xiaoxu; Pan, Yunfeng; Lee, Dong-Hyun; Chowdhury, Dipanjan; Kimmelman, Alec C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Li, YH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	Alec_Kimmelman@DFCI.HARVARD.EDU			National Cancer Institute Grant [R01CA157490]; Kimmel Scholar Award; AACR-PanCAN Career Development Award; Karyopharm therapeutics; NATIONAL CANCER INSTITUTE [R01CA157490, R01CA142698] Funding Source: NIH RePORTER	National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kimmel Scholar Award; AACR-PanCAN Career Development Award; Karyopharm therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ACK is supported by the National Cancer Institute Grant R01CA157490, Kimmel Scholar Award, and AACR-PanCAN Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; ACK is a Consultant for Forma Therapeutics and for Dainippon Pharma. He has received research funding from Karyopharm therapeutics for an unrelated project and has received a speaking honorarium from Pfizer. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen C, 2003, MOL CANCER RES, V1, P913; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Ben-Josef E, 2008, INT J CLIN ONCOL, V13, P121, DOI 10.1007/s10147-007-0763-x; Beskow C, 2009, BRIT J CANCER, V101, P816, DOI 10.1038/sj.bjc.6605201; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hollick JJ, 2003, BIOORG MED CHEM LETT, V13, P3083, DOI 10.1016/S0960-894X(03)00652-8; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hosoi Y, 2004, INT J ONCOL, V25, P461; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Lee JM, 2011, MOL CELL, V4, P797; Lee SH, 2002, MOL CELLS, V13, P159; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; Shintani S, 2003, CANCER SCI, V94, P894, DOI 10.1111/j.1349-7006.2003.tb01372.x; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; van Veelen LR, 2005, MUTAT RES-FUND MOL M, V574, P22, DOI 10.1016/j.mrfmmm.2005.01.019; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200	35	49	50	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39588	10.1371/journal.pone.0039588	http://dx.doi.org/10.1371/journal.pone.0039588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724027	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300144
J	Vasilev, F; Chun, JT; Gragnaniello, G; Garante, E; Santella, L				Vasilev, Filip; Chun, Jong T.; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia			Effects of Ionomycin on Egg Activation and Early Development in Starfish	PLOS ONE			English	Article							SEA-URCHIN EGGS; CORTICAL GRANULE TRANSLOCATION; MEIOTIC MATURATION; NEUROENDOCRINE CELLS; INTRACELLULAR CA2+; OOCYTES REQUIRES; HIGH-AFFINITY; CALCIUM; ACTIN; RELEASE	Ionomycin is a Ca2+-selective ionophore that is widely used to increase intracellular Ca2+ levels in cell biology laboratories. It is also occasionally used to activate eggs in the clinics practicing in vitro fertilization. However, neither the precise molecular action of ionomycin nor its secondary effects on the eggs' structure and function is well known. In this communication we have studied the effects of ionomycin on starfish oocytes and zygotes. By use of confocal microscopy, calcium imaging, as well as light and transmission electron microscopy, we have demonstrated that immature oocytes exposed to ionomycin instantly increase intracellular Ca2+ levels and undergo structural changes in the cortex. Surprisingly, when microinjected into the cells, ionomycin produced no Ca2+ increase. The ionomycin-induced Ca2+ rise was followed by fast alteration of the actin cytoskeleton displaying conspicuous depolymerization at the oocyte surface and in microvilli with concomitant polymerization in the cytoplasm. In addition, cortical granules were disrupted or fused with white vesicles few minutes after the addition of ionomycin. These structural changes prevented cortical maturation of the eggs despite the normal progression of nuclear envelope breakdown. At fertilization, the ionomycin-pretreated eggs displayed reduced Ca2+ response, no elevation of the fertilization envelope, and the lack of orderly centripetal translocation of actin fibers. These alterations led to difficulties in cell cleavage in the monospermic zygotes and eventually to a higher rate of abnormal development. In conclusion, ionomycin has various deleterious impacts on egg activation and the subsequent embryonic development in starfish. Although direct comparison is difficult to make between our findings and the use of the ionophore in the in vitro fertilization clinics, our results call for more defining investigations on the issue of a potential risk in artificial egg activation.	[Vasilev, Filip; Chun, Jong T.; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia] Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Vasilev, F (corresponding author), Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, Naples, Italy.	santella@szn.it	Santella, Luigia/AAM-3524-2020; Chun, Jong Tai/AAM-3394-2020	Santella, Luigia/0000-0001-7159-0499; Chun, Jong Tai/0000-0002-6070-4953	Stazione Zoologica Napoli institutional funds	Stazione Zoologica Napoli institutional funds	This work has been supported by Stazione Zoologica Napoli institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; Chun JT, 2009, ACTA PHYSIOL, V195, P61, DOI 10.1111/j.1748-1716.2008.01921.x; Chun JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014100; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Ciapa B, 2011, INT J DEV BIOL, V55, P143, DOI 10.1387/ijdb.103122bc; DALE B, 1981, DEV BIOL, V83, P232, DOI 10.1016/0012-1606(81)90469-3; Darbellay B, 2011, J CELL BIOL, V194, P335, DOI 10.1083/jcb.201012157; EPEL D, 1990, CELL DIFFER DEV, V29, P1, DOI 10.1016/0922-3371(90)90019-S; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; GERSHMAN LC, 1986, BIOCHEM BIOPH RES CO, V135, P607, DOI 10.1016/0006-291X(86)90036-7; GILLOT I, 1991, DEV BIOL, V146, P396, DOI 10.1016/0012-1606(91)90241-T; Heytens E, 2010, REPROD BIOMED ONLINE, V21, P742, DOI 10.1016/j.rbmo.2010.07.006; Hirohashi N, 2008, DEV BIOL, V318, P194, DOI 10.1016/j.ydbio.2008.03.029; Jaffe LF, 2002, CELL CALCIUM, V32, P217, DOI 10.1016/S0143416002001574; KASAI M, 1969, BIOCHIM BIOPHYS ACTA, V172, P300, DOI 10.1016/0005-2728(69)90072-3; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KAUFFMAN RF, 1980, J BIOL CHEM, V255, P2735; Lange K, 2006, J CELL PHYSIOL, V209, P270, DOI 10.1002/jcp.20717; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; LIU CM, 1978, J BIOL CHEM, V253, P5892; LIU WC, 1978, J ANTIBIOT, V31, P815, DOI 10.7164/antibiotics.31.815; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Mason MJ, 1993, BIOCHEM J, V296, P22; MCPHERSON SM, 1992, J CELL BIOL, V116, P1111, DOI 10.1083/jcb.116.5.1111; MIYAZAKI S, 1991, CELL CALCIUM, V12, P205, DOI 10.1016/0143-4160(91)90021-6; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; MOREAU M, 1978, NATURE, V272, P251, DOI 10.1038/272251a0; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Morgan AJ, 2011, CELL CALCIUM, V50, P147, DOI 10.1016/j.ceca.2010.12.007; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nasr-Esfahani MH, 2008, FERTIL STERIL, V90, P2231, DOI 10.1016/j.fertnstert.2007.10.047; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; OBERDORF JA, 1986, J CELL BIOL, V102, P2205, DOI 10.1083/jcb.102.6.2205; Puppo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003588; Ramos IB, 2010, BIOCHEM J, V429, P485, DOI 10.1042/BJ20091956; Reunov AA, 2010, ZOOLOGY, V113, P295, DOI 10.1016/j.zool.2010.07.001; RIDGWAY EB, 1977, P NATL ACAD SCI USA, V74, P623, DOI 10.1073/pnas.74.2.623; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Santella L, 1999, EXP CELL RES, V248, P567, DOI 10.1006/excr.1999.4425; SANTELLA L, 1994, BIOCHEM BIOPH RES CO, V203, P674, DOI 10.1006/bbrc.1994.2235; Santella L, 2011, SCI CHINA LIFE SCI, V54, P733, DOI 10.1007/s11427-011-4202-x; SCHUETZ AW, 1975, J CELL BIOL, V66, P86, DOI 10.1083/jcb.66.1.86; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; STEINHAR.RA, 1974, P NATL ACAD SCI USA, V71, P1915, DOI 10.1073/pnas.71.5.1915; STEINHAR.RA, 1974, NATURE, V252, P41, DOI 10.1038/252041a0; Terada Y, 2009, FERTIL STERIL, V91, DOI 10.1016/j.fertnstert.2008.09.043; Terasaki M, 1996, CELL MOTIL CYTOSKEL, V34, P48, DOI 10.1002/(SICI)1097-0169(1996)34:1<48::AID-CM5>3.0.CO;2-E; Terasaki M, 2010, EXP CELL RES, V316, P2654, DOI 10.1016/j.yexcr.2010.05.031; TRIMMER JS, 1986, ANNU REV CELL BIOL, V2, P1; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Wessel GM, 2002, DEVELOPMENT, V129, P4315; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; YOSHIDA S, 1992, J PHYSIOL-LONDON, V458, P307, DOI 10.1113/jphysiol.1992.sp019419; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	64	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39231	10.1371/journal.pone.0039231	http://dx.doi.org/10.1371/journal.pone.0039231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723970	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300119
J	Brock, O; Keller, M; Douhard, Q; Bakker, J				Brock, Olivier; Keller, Matthieu; Douhard, Quentin; Bakker, Julie			Female Mice Deficient in Alpha-Fetoprotein Show Female-Typical Neural Responses to Conspecific-Derived Pheromones	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FOREBRAIN FOS RESPONSES; SEXUAL-DIFFERENTIATION; VOMERONASAL ORGAN; ANDROGEN RECEPTOR; RAPID ACTIVATION; OLFACTORY SYSTEM; MATE RECOGNITION; KNOCKOUT MICE; MALE-RAT	The neural mechanisms controlling sexual behavior are sexually differentiated by the perinatal actions of sex steroid hormones. We recently observed using female mice deficient in alpha-fetoprotein (AFP-KO) and which lack the protective actions of AFP against maternal estradiol, that exposure to prenatal estradiol completely defeminized the potential to show lordosis behavior in adulthood. Furthermore, AFP-KO females failed to show any male-directed mate preferences following treatment with estradiol and progesterone, indicating a reduced sexual motivation to seek out the male. In the present study, we asked whether neural responses to male-and female-derived odors are also affected in AFP-KO female mice. Therefore, we compared patterns of Fos, the protein product of the immediate early gene, c-fos, commonly used as a marker of neuronal activation, between wild-type (WT) and AFP-KO female mice following exposure to male or estrous female urine. We also tested WT males to confirm the previously observed sex differences in neural responses to male urinary odors. Interestingly, AFP-KO females showed normal, female-like Fos responses, i.e. exposure to urinary odors from male but not estrous female mice induced equivalent levels of Fos protein in the accessory olfactory pathways (e.g. the medial part of the preoptic nucleus, the bed nucleus of the stria terminalis, the amygdala, and the lateral part of the ventromedial hypothalamic nucleus) as well as in the main olfactory pathways (e.g. the piriform cortex and the anterior cortical amygdaloid nucleus), as WT females. By contrast, WT males did not show any significant induction of Fos protein in these brain areas upon exposure to either male or estrous female urinary odors. These results thus suggest that prenatal estradiol is not involved in the sexual differentiation of neural Fos responses to male-derived odors.	[Brock, Olivier; Bakker, Julie] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Keller, Matthieu] Univ Tours, CNRS, INRA, Behav & Reprod Physiol, Nouzilly, France; [Douhard, Quentin; Bakker, Julie] Univ Liege, GIGA Neurosci, Liege, Belgium; [Bakker, Julie] Vrije Univ, Med Ctr, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours; University of Liege; Vrije Universiteit Amsterdam	Brock, O (corresponding author), Netherlands Inst Neurosci, Amsterdam, Netherlands.	o.brock@nin.knaw.nl	Keller, Matthieu/Q-1431-2019	Keller, Matthieu/0000-0002-5445-7431; Brock, Olivier/0000-0003-1965-7531	Fonds National de la Recherche Scientifique (FNRS) (Mandat d'Impulsion Scientifique) [F.4502.07]; National Institutes of Child Health and Human Development (NICHD) [HD044897]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044897] Funding Source: NIH RePORTER	Fonds National de la Recherche Scientifique (FNRS) (Mandat d'Impulsion Scientifique)(Fonds de la Recherche Scientifique - FNRS); National Institutes of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the following grants: Fonds National de la Recherche Scientifique (FNRS) (Mandat d'Impulsion Scientifique F.4502.07) and the National Institutes of Child Health and Human Development (NICHD - HD044897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aste N, 2003, BRAIN RES BULL, V60, P191, DOI 10.1016/S0361-9230(03)00035-2; Bakker J, 2007, J NEUROENDOCRINOL, V19, P329, DOI 10.1111/j.1365-2826.2007.01540.x; Bakker J, 2006, NAT NEUROSCI, V9, P220, DOI 10.1038/nn1624; Bakker J, 2003, J NEUROENDOCRINOL, V15, P615, DOI 10.1046/j.1365-2826.2003.01036.x; Bakker J, 1996, NEUROSCIENCE, V74, P251, DOI 10.1016/0306-4522(96)00096-6; Bakker J, 1996, PHYSIOL BEHAV, V60, P489, DOI 10.1016/S0031-9384(96)80023-0; Bakker J, 2010, HORM BEHAV, V57, P390, DOI 10.1016/j.yhbeh.2009.11.005; Bodo C, 2008, ENDOCRINOLOGY, V149, P4142, DOI 10.1210/en.2008-0183; Bodo C, 2007, EUR J NEUROSCI, V25, P2182, DOI 10.1111/j.1460-9568.2007.05484.x; Bressler SC, 1996, NEUROSCIENCE, V71, P1063, DOI 10.1016/0306-4522(95)00493-9; Brock O, 2011, HORM BEHAV, V59, P83, DOI 10.1016/j.yhbeh.2010.10.012; Brown R.E., 1979, Advances in the Study of Behavior, V10, P103, DOI 10.1016/S0065-3454(08)60094-7; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; De Mees C, 2006, MOL CELL BIOL, V26, P2012, DOI 10.1128/MCB.26.5.2012-2018.2006; Dudley CA, 2001, BRAIN RES, V915, P32, DOI 10.1016/S0006-8993(01)02820-7; EDWARDS DA, 1973, PHYSIOL BEHAV, V11, P867, DOI 10.1016/0031-9384(73)90282-5; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gabant P, 2002, P NATL ACAD SCI USA, V99, P12865, DOI 10.1073/pnas.202215399; Gonzalez-Martinez D, 2008, ENDOCRINOLOGY, V149, P2333, DOI 10.1210/en.2007-1422; Guillamon A, 1997, BRAIN RES BULL, V44, P377, DOI 10.1016/S0361-9230(97)00217-7; Halem HA, 1999, J NEUROBIOL, V39, P249, DOI 10.1002/(SICI)1097-4695(199905)39:2<249::AID-NEU9>3.3.CO;2-I; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Hosokawa N, 2005, BRAIN RES, V1066, P101, DOI 10.1016/j.brainres.2005.10.036; Kang ND, 2006, NEUROSCI LETT, V398, P59, DOI 10.1016/j.neulet.2005.12.062; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Keller M, 2006, CHEM SENSES, V31, P315, DOI 10.1093/chemse/bjj035; Keller M, 2006, EUR J NEUROSCI, V23, P521, DOI 10.1111/j.1460-9568.2005.04589.x; Keller M, 2010, HORM BEHAV, V57, P434, DOI 10.1016/j.yhbeh.2010.01.013; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Pankevich DE, 2006, PHYSIOL BEHAV, V87, P781, DOI 10.1016/j.physbeh.2006.01.020; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PFAFF DW, 1969, BRAIN RES, V15, P137, DOI 10.1016/0006-8993(69)90315-1; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; RAYNAUD JP, 1973, MOL PHARMACOL, V9, P520; Reyes R, 2004, BRAIN RES BULL, V63, P301, DOI 10.1016/j.brainresbull.2004.03.006; Robarts DW, 2007, HORM BEHAV, V51, P104, DOI 10.1016/j.yhbeh.2006.08.009; Swaney WT, 2008, BEHAV NEUROSCI, V122, P963, DOI 10.1037/a0012706; Taziaux M, 2011, NEUROREPORT, V22, P294, DOI 10.1097/WNR.0b013e3283460f35; THOMPSON ML, 1972, PHYSIOL BEHAV, V8, P1141, DOI 10.1016/0031-9384(72)90210-7; Wersinger SR, 2000, J NEUROENDOCRINOL, V12, P103, DOI 10.1046/j.1365-2826.2000.00418.x	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39204	10.1371/journal.pone.0039204	http://dx.doi.org/10.1371/journal.pone.0039204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720075	Green Published, gold			2022-12-25	WOS:000305350000049
J	Chang, CS; Chang, YF; Liu, PY; Chen, CY; Tsai, YS; Wu, CH				Chang, Chin-Sung; Chang, Yin-Fan; Liu, Ping-Yen; Chen, Chuan-Yu; Tsai, Yau-Sheng; Wu, Chih-Hsing			Smoking, Habitual Tea Drinking and Metabolic Syndrome in Elderly Men Living in Rural Community: The Tianliao Old People (TOP) Study 02	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GREEN TEA; CIGARETTE-SMOKING; RISK-FACTORS; CARDIOVASCULAR RISK; CONSUMPTION; ASSOCIATION; PREVALENCE; ALCOHOL	The literature shows an inconsistent relationship between lifestyle behaviors and metabolic syndrome (MetS), especially in the elderly. We designed this study to investigate the interrelationships among cigarette smoking, tea drinking and MetS, and to verify the factors associated with MetS in elderly males dwelling in rural community. In July 2010, with a whole community sampling method, 414 male subjects aged over 65 dwelling in Tianliao township were randomly sampled. The response rate was 60.8%. Each subject completed the structured questionnaires including sociodemographic characteristics, habitual behaviors (including cigarette smoking and tea drinking habits) and medical history. After an overnight fast, the laboratory and anthropometric data were obtained. MetS was confirmed according to the criteria defined by the modified NCEP ATP III for the male Chinese population. Subjects were split into either non-MetS or MetS groups for further analysis. Of the 361 subjects with complete data, 132 (36.6%) elderly men were classified as having MetS. Using binary logistic regression, body mass index, serum uric acid, high sensitivity C-reactive protein, HOMA index, current smokers (OR = 2.72, 95%CI: 1.03 similar to 7.19), total smoking amount > = 30 (OR = 2.78, 95%CI: 1.31 similar to 5.90) and more than 20 cigarettes daily (OR = 2.54, 95%CI: 1.24 similar to 5.18) were positively associated with MetS. Current un- or partial fermented tea drinker (OR = 0.42, 95%CI: 0.22 similar to 0.84), tea drinking habit for 1-9 years (OR = 0.36, 95% CI: 0.15 similar to 0.90) and more than 240cc daily (OR = 0.35, 95%CI: 0.17 similar to 0.72) were negatively associated with MetS. In conclusion, this study suggests that smoking habit was positively associated with MetS, but tea drinking habit was negatively associated with MetS in elderly men dwelling in rural community.	[Chang, Chin-Sung; Chang, Yin-Fan; Wu, Chih-Hsing] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Liu, Ping-Yen] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Chen, Chuan-Yu] Tianliao Dist Publ Hlth Ctr, Kaohsiung, Taiwan; [Tsai, Yau-Sheng] Natl Cheng Kung Univ, Coll Med, Grad Inst Clin Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, CS (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.	paulo@mail.ncku.edu.tw			National Cheng Kung University Medical College	National Cheng Kung University Medical College	This work was supported by the grant received from National Cheng Kung University Medical College for the students' summer study program, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bianchi G, 2008, QJM-INT J MED, V101, P713, DOI 10.1093/qjmed/hcn084; Cao H, 2007, J AGR FOOD CHEM, V55, P6372, DOI 10.1021/jf070695o; Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x; Chang CH, 2009, ARCH GERONTOL GERIAT, V49, pS46, DOI 10.1016/S0167-4943(09)70013-5; Chen AR, 2010, CLIN INVEST MED, V33, pE290, DOI 10.25011/cim.v33i5.14354; Chen CC, 2008, METABOLISM, V57, P544, DOI 10.1016/j.metabol.2007.11.018; Chen H., 2011, TAIWAN GERIATR GERON, V6, P116; Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003; Cheriyath P, 2010, EUR J CARDIOV PREV R, V17, P309, DOI 10.1097/HJR.0b013e32833189b8; Chiang PH, 2009, WORLD J GASTROENTERO, V15, P5334, DOI 10.3748/wjg.15.5334; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Chiou WK, 2010, J EPIDEMIOL, V20, P219, DOI 10.2188/jea.JE20090078; Dalacorte RR, 2008, J AM GERIATR SOC, V56, P1372, DOI 10.1111/j.1532-5415.2008.01750.x; DECODA Study Grp, 2007, DIABETES RES CLIN PR, V76, P57, DOI 10.1016/j.diabres.2006.07.020; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Falkner KL, 1999, AM J EPIDEMIOL, V150, P195; Ferrannini E, 1997, DIABETES METAB REV, V13, P81; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Hahn V, 2009, DIABETES CARE, V32, P511, DOI 10.2337/dc08-1285; Hanyu O, 2009, J ATHEROSCLER THROMB, V16, P560, DOI 10.5551/jat.869; He Y, 2009, J AM COLL CARDIOL, V53, P363, DOI 10.1016/j.jacc.2008.08.073; Hosoda K, 2003, DIABETES CARE, V26, P1714, DOI 10.2337/diacare.26.6.1714; Hotta Y, 2008, DIABETES RES CLIN PR, V81, P358, DOI 10.1016/j.diabres.2008.05.005; Indraratna PL, 2009, J RHEUMATOL, V36, P2842, DOI 10.3899/jrheum.090500; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Katano S, 2010, J ATHEROSCLER THROMB, V17, P644, DOI 10.5551/jat.3699; Kawada Tomoyuki, 2006, J Cardiometab Syndr, V1, P313, DOI 10.1111/j.1524-6175.2006.05951.x; Kim BJ, 2009, DIABETES CARE, V32, P1314, DOI 10.2337/dc09-0060; Kim MH, 2007, ANN NUTR METAB, V51, P533, DOI 10.1159/000112977; Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Liu PY, 2007, J AM COLL CARDIOL, V49, P1619, DOI 10.1016/j.jacc.2006.12.043; Lu FH, 2000, J GERONTOL A-BIOL, V55, pM463, DOI 10.1093/gerona/55.8.M463; Manu P, 2010, EUR J INTERN MED, V21, P409, DOI 10.1016/j.ejim.2010.05.015; Minich DM, 2008, NUTR REV, V66, P429, DOI 10.1111/j.1753-4887.2008.00075.x; Mitu F, 2009, Rev Med Chir Soc Med Nat Iasi, V113, P1001; Moon HS, 2007, CHEM-BIOL INTERACT, V167, P85, DOI 10.1016/j.cbi.2007.02.008; Nakashita Y, 2010, J EPIDEMIOL, V20, P391, DOI 10.2188/jea.JE20100043; Panagiotakos DB, 2007, ASIA-PAC J PUBLIC HE, V19, P22, DOI 10.1177/101053950701900305; Puig JG, 2008, CURR OPIN RHEUMATOL, V20, P187, DOI 10.1097/BOR.0b013e3282f4b1ed; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; Takeuchi T, 2009, NICOTINE TOB RES, V11, P1093, DOI 10.1093/ntr/ntp106; Tamba S, 2008, INTERNAL MED, V47, P1175, DOI 10.2169/internalmedicine.47.0603; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang F, 2009, NUTR METAB CARDIOVAS, V19, P542, DOI 10.1016/j.numecd.2008.11.006; Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006; Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102; Wolfram S, 2007, J AM COLL NUTR, V26, p373S, DOI 10.1080/07315724.2007.10719626; Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534; Zhu YX, 2011, BIOMED ENVIRON SCI, V24, P475, DOI 10.3967/0895-3988.2011.05.004	54	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38874	10.1371/journal.pone.0038874	http://dx.doi.org/10.1371/journal.pone.0038874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WG	22719971	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347800024
J	Gruenwald, K; Holland, JT; Stromberg, V; Ahmad, A; Watcharakichkorn, D; Okumoto, S				Gruenwald, Katrin; Holland, John Todd; Stromberg, Verlyn; Ahmad, Altaf; Watcharakichkorn, Daisy; Okumoto, Sakiko			Visualization of Glutamine Transporter Activities in Living Cells Using Genetically Encoded Glutamine Sensors	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; FLUORESCENT PROTEIN; BINDING-PROTEIN; FUNCTIONAL-CHARACTERIZATION; EPILEPTIFORM ACTIVITY; ESCHERICHIA-COLI; HEPATOMA-CELLS; RAT-LIVER; SYNTHETASE; METABOLISM	Glutamine plays a central role in the metabolism of critical biological molecules such as amino acids, proteins, neurotransmitters, and glutathione. Since glutamine metabolism is regulated through multiple enzymes and transporters, the cellular glutamine concentration is expected to be temporally dynamic. Moreover, differentiation in glutamine metabolism between cell types in the same tissue (e.g. neuronal and glial cells) is often crucial for the proper function of the tissue as a whole, yet assessing cell-type specific activities of transporters and enzymes in such heterogenic tissue by physical fractionation is extremely challenging. Therefore, a method of reporting glutamine dynamics at the cellular level is highly desirable. Genetically encoded sensors can be targeted to a specific cell type, hence addressing this knowledge gap. Here we report the development of Foster Resonance Energy Transfer (FRET) glutamine sensors based on improved cyan and yellow fluorescent proteins, monomeric Teal Fluorescent Protein (mTFP) 1 and venus. These sensors were found to be specific to glutamine, and stable to pH-changes within a physiological range. Using cos7 cells expressing the human glutamine transporter ASCT2 as a model, we demonstrate that the properties of the glutamine transporter can easily be analyzed with these sensors. The range of glutamine concentration change in a given cell can also be estimated using sensors with different affinities. Moreover, the mTFP1-venus FRET pair can be duplexed with another FRET pair, mAmetrine and tdTomato, opening up the possibility for real-time imaging of another molecule. These novel glutamine sensors will be useful tools to analyze specificities of glutamine metabolism at the single-cell level.	[Gruenwald, Katrin; Holland, John Todd; Stromberg, Verlyn; Watcharakichkorn, Daisy; Okumoto, Sakiko] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Ahmad, Altaf] Hamdard Univ, Fac Sci, Dept Bot, New Delhi, India	Virginia Polytechnic Institute & State University; Jamia Hamdard University	Gruenwald, K (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	sokumoto@vt.edu	AHMAD, ALTAF/AAE-9371-2020	AHMAD, ALTAF/0000-0003-4099-7338	National Institutes of Health [1R21NS064412]; National Science Foundation (NSF) [1052048]; Jeffress Memorial Trust [J-908]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Jeffress Memorial Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant 1R21NS064412, National Science Foundation (NSF) grant 1052048 and Jeffress Memorial Trust grant J-908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Albrecht J, 2011, NEURON GLIA BIOL, P1; Bacci A, 2002, J NEUROPHYSIOL, V88, P2302, DOI 10.1152/jn.00665.2001; Barnett NL, 2000, GLIA, V30, P64, DOI 10.1002/(SICI)1098-1136(200003)30:1<64::AID-GLIA7>3.0.CO;2-I; Bode BP, 1998, SURGERY, V124, P260, DOI 10.1016/S0039-6060(98)70129-1; Bode BP, 2002, AM J PHYSIOL-GASTR L, V283, pG1062, DOI 10.1152/ajpgi.00031.2002; Boza JJ, 2000, EUR J NUTR, V39, P38, DOI 10.1007/s003940050074; BRIGHT GR, 1987, J CELL BIOL, V104, P1019, DOI 10.1083/jcb.104.4.1019; Broer A, 1999, J NEUROCHEM, V73, P2184; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Corless M, 2006, J ENDOCRINOL, V190, P719, DOI 10.1677/joe.1.06892; Curi R, 1999, BRAZ J MED BIOL RES, V32, P15, DOI 10.1590/S0100-879X1999000100002; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; DENMAN RB, 1984, ARCH BIOCHEM BIOPHYS, V232, P427, DOI 10.1016/0003-9861(84)90559-9; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dun Y, 2007, EXP EYE RES, V84, P191, DOI 10.1016/j.exer.2006.09.015; FAFOURNOUX P, 1983, BIOCHEM J, V216, P401, DOI 10.1042/bj2160401; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; FONNUM F, 1993, PROG BIOPHYS MOL BIO, V60, P47, DOI 10.1016/0079-6107(93)90012-9; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fuchs BC, 2004, AM J PHYSIOL-GASTR L, V286, pG467, DOI 10.1152/ajpgi.00344.2003; Gebhardt R, 2007, PROG HISTOCHEM CYTO, V41, P201, DOI 10.1016/j.proghi.2006.12.001; GHOSH S, 1960, J BIOL CHEM, V235, P1265; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; Gu SM, 2005, J BIOL CHEM, V280, P26055, DOI 10.1074/jbc.M504401200; HAUSSINGER D, 1986, ADV ENZYME REGUL, V25, P159, DOI 10.1016/0065-2571(86)90013-0; HAUSSINGER D, 1985, EUR J BIOCHEM, V152, P597, DOI 10.1111/j.1432-1033.1985.tb09237.x; Haussinger D, 1987, Beitr Infusionther Klin Ernahr, V17, P144; Hayashi M, 2001, J BIOL CHEM, V276, P43400, DOI 10.1074/jbc.M106244200; HIGASHIGUCHI T, 1993, JPEN-PARENTER ENTER, V17, P307, DOI 10.1177/0148607193017004307; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Kung HN, PLOS GENET, V7; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAPING NJ, 1994, ENDOCRINOLOGY, V135, P1928, DOI 10.1210/en.135.5.1928; Lavoinne A, 1998, BIOCHIMIE, V80, P807, DOI 10.1016/S0300-9084(00)88875-6; Lim J, 2006, EXP EYE RES, V83, P447, DOI 10.1016/j.exer.2006.01.028; Mizoguchi K, 2001, KIDNEY INT, V59, P1821, DOI 10.1046/j.1523-1755.2001.0590051821.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakanishi T, 2011, J PHARM SCI-US, V100, P3731, DOI 10.1002/jps.22576; Okumoto S, 2005, P NATL ACAD SCI USA, V102, P8740, DOI 10.1073/pnas.0503274102; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Palmada M, 2005, BIOCHEM BIOPH RES CO, V331, P272, DOI 10.1016/j.bbrc.2005.03.159; Paquette JC, 2005, J CELL PHYSIOL, V202, P912, DOI 10.1002/jcp.20194; Pawlik TM, 2000, J SURG RES, V90, P149, DOI 10.1006/jsre.2000.5872; Petroff OAC, 2002, EPILEPSIA, V43, P703, DOI 10.1046/j.1528-1157.2002.38901.x; POW DV, 1994, NEUROSCIENCE, V60, P355, DOI 10.1016/0306-4522(94)90249-6; Roth E, 2002, NUTRITION, V18, P217, DOI 10.1016/S0899-9007(01)00797-3; ROTHSTEIN JD, 1984, J NEUROCHEM, V43, P1438, DOI 10.1111/j.1471-4159.1984.tb05406.x; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Tani H, 2007, NEUROBIOL DIS, V25, P230, DOI 10.1016/j.nbd.2006.08.025; TATE SS, 1971, P NATL ACAD SCI USA, V68, P781, DOI 10.1073/pnas.68.4.781; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; VARDIMON L, 1993, DEV DYNAM, V196, P276, DOI 10.1002/aja.1001960410; Watford M, 2002, NUTRITION, V18, P301, DOI 10.1016/S0899-9007(02)00739-6; WEINER JH, 1971, ARCH BIOCHEM BIOPHYS, V142, P715, DOI 10.1016/0003-9861(71)90538-8; Wiren M, 1998, INT J BIOCHEM CELL B, V30, P1331, DOI 10.1016/S1357-2725(98)00104-6; Yang HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008917	66	45	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38591	10.1371/journal.pone.0038591	http://dx.doi.org/10.1371/journal.pone.0038591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22723868	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347800010
J	Shen, XX; Liang, D; Zhang, P				Shen, Xing-Xing; Liang, Dan; Zhang, Peng			The Development of Three Long Universal Nuclear Protein-Coding Locus Markers and Their Application to Osteichthyan Phylogenetics with Nested PCR	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; SISTER GROUP; TREE; DIVERSIFICATION; POSITION; TURTLES; INFORMATIVENESS; RECONSTRUCTION; HYPOTHESES	Background: Universal nuclear protein-coding locus (NPCL) markers that are applicable across diverse taxa and show good phylogenetic discrimination have broad applications in molecular phylogenetic studies. For example, RAG1, a representative NPCL marker, has been successfully used to make phylogenetic inferences within all major osteichthyan groups. However, such markers with broad working range and high phylogenetic performance are still scarce. It is necessary to develop more universal NPCL markers comparable to RAG1 for osteichthyan phylogenetics. Methodology/Principal Findings: We developed three long universal NPCL markers (>1.6 kb each) based on single-copy nuclear genes (KIAA1239, SACS and TTN) that possess large exons and exhibit the appropriate evolutionary rates. We then compared their phylogenetic utilities with that of the reference marker RAG1 in 47 jawed vertebrate species. In comparison with RAG1, each of the three long universal markers yielded similar topologies and branch supports, all in congruence with the currently accepted osteichthyan phylogeny. To compare their phylogenetic performance visually, we also estimated the phylogenetic informativeness (PI) profile for each of the four long universal NPCL markers. The PI curves indicated that SACS performed best over the whole timescale, while RAG1, KIAA1239 and TTN exhibited similar phylogenetic performances. In addition, we compared the success of nested PCR and standard PCR when amplifying NPCL marker fragments. The amplification success rate and efficiency of the nested PCR were overwhelmingly higher than those of standard PCR. Conclusions/Significance: Our work clearly demonstrates the superiority of nested PCR over the conventional PCR in phylogenetic studies and develops three long universal NPCL markers (KIAA1239, SACS and TTN) with the nested PCR strategy. The three markers exhibit high phylogenetic utilities in osteichthyan phylogenetics and can be widely used as pilot genes for phylogenetic questions of osteichthyans at different taxonomic levels.	[Shen, Xing-Xing; Liang, Dan; Zhang, Peng] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Shen, XX (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	alarzhang@gmail.com	Shen, Xing-Xing/V-4610-2019; Zhang, Peng/F-9664-2013	Shen, Xing-Xing/0000-0001-5765-1419; 	National Natural Science Foundation of China [30900136]; Natural Science Foundation of Guangdong Province [9151027501000084]; Grant of Excellent PhD thesis of Guangdong Province [sybzzxm201012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Grant of Excellent PhD thesis of Guangdong Province	This work was supported by National Natural Science Foundation of China (No. 30900136), Natural Science Foundation of Guangdong Province (9151027501000084), and Grant of Excellent PhD thesis of Guangdong Province (sybzzxm201012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; Benton Michael J., 2009, P35; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Cao Y, 2000, GENE, V259, P139, DOI 10.1016/S0378-1119(00)00425-X; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Groth JG, 1999, MOL PHYLOGENET EVOL, V12, P115, DOI 10.1006/mpev.1998.0603; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Karanth KP, 2008, MOL PHYLOGENET EVOL, V46, P683, DOI 10.1016/j.ympev.2007.11.026; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krenz JG, 2005, MOL PHYLOGENET EVOL, V37, P178, DOI 10.1016/j.ympev.2005.04.027; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nylander JAA, 2004, MRMODELTEST V2 0; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rasmussen MD, 2007, GENOME RES, V17, P1932, DOI 10.1101/gr.7105007; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saint KM, 1998, MOL PHYLOGENET EVOL, V10, P259, DOI 10.1006/mpev.1998.0515; San Mauro D, 2004, MOL PHYLOGENET EVOL, V33, P413, DOI 10.1016/j.ympev.2004.05.014; San Mauro D, 2010, MOL PHYLOGENET EVOL, V56, P554, DOI 10.1016/j.ympev.2010.04.019; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson RC, 2008, MOL PHYLOGENET EVOL, V49, P514, DOI 10.1016/j.ympev.2008.08.006; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; Zardoya R, 1998, P NATL ACAD SCI USA, V95, P14226, DOI 10.1073/pnas.95.24.14226; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zhang P, 2005, SYST BIOL, V54, P391, DOI 10.1080/10635150590945278; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010	55	65	65	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39256	10.1371/journal.pone.0039256	http://dx.doi.org/10.1371/journal.pone.0039256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720083	gold, Green Published, Green Submitted			2022-12-25	WOS:000305347800060
J	Wong, IOL; Cowling, BJ; Leung, GM; Schooling, CM				Wong, Irene O. L.; Cowling, Benjamin J.; Leung, Gabriel M.; Schooling, C. Mary			Trends in Mortality from Septicaemia and Pneumonia with Economic Development: An Age-Period-Cohort Analysis	PLOS ONE			English	Article							CANCER INCIDENCE; GROWTH; UNDERNUTRITION; BACTEREMIA; SEPSIS; GENDER; IMPACT	Background: Hong Kong population has experienced drastic changes in its economic development in the 1940s. Taking advantage of Hong Kong's unique demographic and socioeconomic history, characterized by massive, punctuated migration waves from Southern China, and recent, rapid transition from a pre-industrialized society to the first ethnic Chinese community reaching "first world" status over the last 60 years (i.e., in two or three generations), we examined the longitudinal trends in infection related mortality including septicemia compared to trends in non-bacterial pneumonia to generate hypotheses for further testing in other recently transitioned economies and to provide generalized aetiological insights on how economic transition affects infection-related mortality. Methods: We used deaths from septicemia and pneumonia not specified as bacterial, and population figures in Hong Kong from 1976-2005. We fitted age-period-cohort models to decompose septicemia and non-bacterial pneumonia mortality rates into age, period and cohort effects. Results: Septicaemia-related deaths increased exponentially with age, with a downturn by period. The birth cohort curves had downward inflections in both sexes in the 1940s, with a steeper deceleration for women. Non-bacterial pneumonia-related deaths also increased exponentially with age, but the birth cohort patterns showed no downturns for those born in the 1940s. Conclusion: The observed changes appeared to suggest that better early life conditions may enable better development of adaptive immunity, thus enhancing immunity against bacterial infections, with greater benefits for women than men. Given the interaction between the immune system and the gonadotropic axis, these observations are compatible with the hypothesis that upregulation of the gonadotropic axis underlies some of the changes in disease patterns with economic development.	[Wong, Irene O. L.; Cowling, Benjamin J.; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Lifestyle & Life Course Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY, Sch Publ Hlth, Hunter Coll, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System; Hunter College (CUNY)	Wong, IOL (corresponding author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Lifestyle & Life Course Epidemiol Grp, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Cowling, Benjamin John/C-4263-2009; Wong, Oi Ling/C-4538-2009	Cowling, Benjamin John/0000-0002-6297-7154; Schooling, Mary/0000-0001-9933-5887; Leung, Gabriel/0000-0002-2503-6283	Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; MedImmune Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; MedImmune Inc.(AstraZenecaMedimmune); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BJC was supported by the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BJC received research funding from MedImmune Inc., and consults for Crucell MV. BJC is an Academic Editor of the journal PLoS ONE. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have declared that no competing interest exist.	Adam CL, 1997, J REPROD FERTIL, V111, P121, DOI 10.1530/jrf.0.1110121; Bray I, 2002, J ROY STAT SOC C-APP, V51, P151, DOI 10.1111/1467-9876.00260; Campbell BC, 2004, ANN HUM BIOL, V31, P213, DOI 10.1080/03014460310001656604; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Choudhry Mashkoor A., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P127; Dorgan JF, 2003, J NATL CANCER I, V95, P132, DOI 10.1093/jnci/95.2.132; Falsey AR, 2006, CLIN INFECT DIS, V42, P518, DOI 10.1086/499955; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Hall AJ, 2002, INT J EPIDEMIOL, V31, P300, DOI 10.1093/ije/31.2.300; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Hollander GA, 2010, CURR OPIN PHARMACOL, V10, P443, DOI 10.1016/j.coph.2010.04.008; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Johnston SL, 2006, P ROY SOC B-BIOL SCI, V273, P1369, DOI 10.1098/rspb.2005.3456; Loucks EB, 2010, SOC SCI MED, V71, P187, DOI 10.1016/j.socscimed.2010.03.012; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Madsen KM, 1999, APMIS, V107, P346, DOI 10.1111/j.1699-0463.1999.tb01563.x; Martins VJB, 2011, INT J ENV RES PUB HE, V8, P1817, DOI 10.3390/ijerph8061817; McDade TW, 2005, AM J HUM BIOL, V17, P81, DOI 10.1002/ajhb.20095; McDade TW, 2001, J NUTR, V131, P1225, DOI 10.1093/jn/131.4.1225; Moore SE, 2006, P NUTR SOC, V65, P311, DOI 10.1079/PNS2006503; Nazmi A, 2010, SOC SCI MED, V70, P1229, DOI 10.1016/j.socscimed.2009.12.014; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Rosenberg PS, 2010, STAT MED, V29, P1228, DOI 10.1002/sim.3865; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Schooling CM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-345; Schooling CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019675; Schooling CM, 2011, ANN EPIDEMIOL, V21, P56, DOI 10.1016/j.annepidem.2010.05.005; Schooling CM, 2011, INT J EPIDEMIOLOGY; Shames RS, 2002, J ADOLESCENT HEALTH, V30, P59, DOI 10.1016/S1054-139X(01)00382-2; SLOB AK, 1979, BRIT J NUTR, V41, P231, DOI 10.1079/BJN19790032; Sogaard M, 2011, EPIDEMIOL INFECT, V139, P772, DOI 10.1017/S095026881000169X; Speigelhalter DJ, 2002, J ROYAL STAT SOC B, P583; Steinberg JP, 1996, CLIN INFECT DIS, V23, P255, DOI 10.1093/clinids/23.2.255; Tsang S., 2004, MODERN HIST HONG KON; Van Bodegom D, 2007, ANN NY ACAD SCI, V1100, P84, DOI 10.1196/annals.1395.007; Wong IOL, 2007, INT J CANCER, V121, P1556, DOI 10.1002/ijc.22731; Wong IOL, 2010, J EPIDEMIOL COMMUN H, V64, P596, DOI 10.1136/jech.2008.080788; Wu P, 2008, THORAX, V63, P312, DOI 10.1136/thx.2007.082354	40	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38988	10.1371/journal.pone.0038988	http://dx.doi.org/10.1371/journal.pone.0038988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WG	22720008	Green Published, gold			2022-12-25	WOS:000305347800033
J	Shanmugasundaram, K; Block, K; Nayak, BK; Livi, CB; Venkatachalam, MA; Sudarshan, S				Shanmugasundaram, K.; Block, K.; Nayak, B. K.; Livi, C. B.; Venkatachalam, M. A.; Sudarshan, S.			PI3K regulation of the SKP-2/p27 axis through mTORC2	ONCOGENE			English	Article						p27; SKP-2; mTOR; RICTOR	RENAL-CELL CARCINOMA; RAPAMYCIN COMPLEX 2; PROTEIN-KINASE B; TISSUE MICROARRAY; SUBCELLULAR-LOCALIZATION; CYTOPLASMIC LOCALIZATION; AKT PHOSPHORYLATION; MAMMALIAN TARGET; UBIQUITIN LIGASE; SKP2	The cyclin-dependent kinase inhibitor p27 is a key regulator of cell-cycle progression. Its expression and localization are altered in several types of malignancies, which has prognostic significance in cancers such as renal cell carcinoma (RCC). S-phase kinase-associated protein 2 (SKP-2) is an F-box protein that is part of the SKP-1/Cul1/F-box ubiquitin ligase complex that targets nuclear p27 among many other cell-cycle proteins for proteosomal degradation. Its overexpression has been observed in several tumor types. Signaling by phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) has previously been shown to regulate the SKP-2/p27 axis. Recent evidence suggests that PI3K signaling may activate mammalian target of rapamycin complex 2 (mTORC2) activity. As PI3K signaling is known to regulate SKP-2 and p27, we sought to determine whether these effects were mediated by mTORC2. Here we provide additional genetic evidence that PI3K signaling activates mTORC2 kinase activity. We also demonstrate a novel role for mTORC2 in the modulation of nuclear p27 levels. In particular, mTORC2 signaling promotes the reduction of nuclear p27 protein levels through the increased protein expression of SKP-2. These are the first data to demonstrate a role for mTOR in the regulation of SKP-2. In concordance with these findings, mTORC2 activity promotes cell proliferation of RCC cells at the G1-S interphase of the cell cycle. Collectively, these data implicate mTORC2 signaling in the regulation of the SKP-2/p27 axis, a signaling node commonly altered in cancer. Oncogene (2013) 32, 2027-2036; doi:10.1038/onc.2012.226; published online 25 June 2012	[Shanmugasundaram, K.; Sudarshan, S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Block, K.; Nayak, B. K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Livi, C. B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Venkatachalam, M. A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Block, K.] Audie L Murphy Mem Hosp Div, South Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Sudarshan, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, 7703 Floyd Curl Dr,MC 7845, San Antonio, TX 78229 USA.	sudarshan@uthscsa.edu		Livi, Carolina/0000-0001-8389-2830	Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center [NIH P30 CA054174-17]; NIH [K08 CA138774, R01 NCI CA131272]; Voelcker Fund Young Investigator Award; AUA Foundation/Astellas Rising Star Award; Veterans Administration Career Development Award [CDA-2]; NATIONAL CANCER INSTITUTE [P30CA054174, K08CA138774, R01CA131272] Funding Source: NIH RePORTER	Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund Young Investigator Award; AUA Foundation/Astellas Rising Star Award; Veterans Administration Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center (NIH P30 CA054174-17). SS is supported by NIH K08 CA138774, Voelcker Fund Young Investigator Award, AUA Foundation/Astellas Rising Star Award and a special gift from Mr Charles Butt and the employees of HEB. KB is supported by Veterans Administration Career Development Award (CDA-2) and NIH R01 NCI CA131272. We thank Z David Sharp for critical review of the manuscript. We thank William Friedrichs and Korri Weldon for technical assistance.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anastasiadis AG, 2003, ANTICANCER RES, V23, P217; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Haitel A, 2001, UROLOGY, V58, P477, DOI 10.1016/S0090-4295(01)01188-8; Hedberg Y, 2003, BRIT J CANCER, V88, P1417, DOI 10.1038/sj.bjc.6600922; Hedberg Y, 2002, INT J CANCER, V102, P601, DOI 10.1002/ijc.10763; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kim J, 2009, CLIN CANCER RES, V15, P81, DOI 10.1158/1078-0432.CCR-08-0170; Langner C, 2004, VIRCHOWS ARCH, V445, P631, DOI 10.1007/s00428-004-1121-2; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu Z, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-51; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Migita T, 2002, CANCER-AM CANCER SOC, V94, P973, DOI 10.1002/cncr.10338.abs; Nogueira V, 2012, EMBO J, V31, P1134, DOI 10.1038/emboj.2011.478; Saito K, 2001, J BIOL CHEM, V276, P16201, DOI 10.1074/jbc.M100873200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sgambato A, 2010, CANCER SCI, V101, P2080, DOI 10.1111/j.1349-7006.2010.01644.x; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wang HB, 2010, CELL CYCLE, V9, P1021, DOI 10.4161/cc.9.5.10916; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	43	24	26	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 18	2013	32	16					2027	2036		10.1038/onc.2012.226	http://dx.doi.org/10.1038/onc.2012.226			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	130LY	22733130	Green Accepted			2022-12-25	WOS:000317919900004
J	Petroi, D; Popova, B; Taheri-Talesh, N; Irniger, S; Shahpasandzadeh, H; Zweckstetter, M; Outeiro, TF; Braus, GH				Petroi, Doris; Popova, Blagovesta; Taheri-Talesh, Naimeh; Irniger, Stefan; Shahpasandzadeh, Hedieh; Zweckstetter, Markus; Outeiro, Tiago F.; Braus, Gerhard H.			Aggregate Clearance of alpha-Synuclein in Saccharomyces cerevisiae Depends More on Autophagosome and Vacuole Function Than on the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; DEGRADATION; INHIBITION; MEMBRANE; MACROAUTOPHAGY; NEUROTOXICITY; MUTANTS; NEURONS; DNA	Parkinson disease is the second most common neurodegenerative disease. The molecular hallmark is the accumulation of proteinaceous inclusions termed Lewy bodies containing misfolded and aggregated alpha-synuclein. The molecular mechanism of clearance of alpha-synuclein aggregates was addressed using the bakers' yeast Saccharomyces cerevisiae as the model. Overexpression of wild type alpha-synuclein or the genetic variant A53T integrated into one genomic locus resulted in a gene copy-dependent manner in cytoplasmic proteinaceous inclusions reminiscent of the pathogenesis of the disease. In contrast, overexpression of the genetic variant A30P resulted only in transient aggregation, whereas the designer mutant A30P/A36P/A76P neither caused aggregation nor impaired yeast growth. The alpha-synuclein accumulation can be cleared after promoter shutoff by a combination of autophagy and vacuolar protein degradation. Whereas the proteasomal inhibitor MG-132 did not significantly inhibit aggregate clearance, treatment with phenylmethylsulfonyl fluoride, an inhibitor of vacuolar proteases, resulted in significant reduction in clearance. Consistently, a cim3-1 yeast mutant restricted in the 19 S proteasome regulatory subunit was unaffected in clearance, whereas an Delta atg1 yeast mutant deficient in autophagy showed a delayed aggregate clearance response. A cim3-1 Delta atg1 double mutant was still able to clear aggregates, suggesting additional cellular mechanisms for alpha-synuclein clearance. Our data provide insight into the mechanisms yeast cells use for clearing different species of alpha-synuclein and demonstrate a higher contribution of the autophagy/vacuole than the proteasome system. This contributes to the understanding of how cells can cope with toxic and/or aggregated proteins and may ultimately enable the development of novel strategies for therapeutic intervention.	[Petroi, Doris; Popova, Blagovesta; Taheri-Talesh, Naimeh; Irniger, Stefan; Shahpasandzadeh, Hedieh; Braus, Gerhard H.] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Outeiro, Tiago F.] Univ Med Gottingen, Dept Neurodegenerat & Restorat Res, D-37077 Gottingen, Germany; [Petroi, Doris; Popova, Blagovesta; Taheri-Talesh, Naimeh; Irniger, Stefan; Shahpasandzadeh, Hedieh; Zweckstetter, Markus; Outeiro, Tiago F.; Braus, Gerhard H.] Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37077 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Braus, GH (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37077 Gottingen, Germany.	gbraus@gwdg.de	Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago F/C-1067-2008; Braus, Gerhard/ABC-6293-2021; Braus, Gerhard H/G-3999-2012	Outeiro, Tiago/0000-0003-1679-1727; Outeiro, Tiago F/0000-0003-1679-1727; Braus, Gerhard/0000-0002-3117-5626; Braus, Gerhard H/0000-0002-3117-5626; Zweckstetter, Markus/0000-0002-2536-6581; Popova, Blagovesta/0000-0001-6323-374X	Deutsche Forschungsgemeinschaft; Center for Molecular Physiology of the Brain, Bundesministerium fur Bildung und Forschung [NGFN-Plus 01GS08190]; European Union [NEURA-SYNC PITNGA-2009-238316]; Volkswagen-Stiftung; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Molecular Physiology of the Brain, Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Volkswagen-Stiftung(Volkswagen); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, the Center for Molecular Physiology of the Brain, Bundesministerium fur Bildung und Forschung (NGFN-Plus 01GS08190), European Union (NEURA-SYNC PITNGA-2009-238316), and the Volkswagen-Stiftung, and the Fonds der Chemischen Industrie.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P603; Balija MBG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024701; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; Dyllick-Brenzinger M, 2010, NEUROTOX RES, V17, P215, DOI 10.1007/s12640-009-9094-1; Flower TR, 2007, J CELL BIOL, V177, P1091, DOI 10.1083/jcb.200610071; Forno LS, 1996, ADV NEUROL, V69, P217; Fortun J, 2003, J NEUROSCI, V23, P10672; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Kahle PJ, 2000, ANN NY ACAD SCI, V920, P33; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; LAMPHIER MS, 1992, P NATL ACAD SCI USA, V89, P5922, DOI 10.1073/pnas.89.13.5922; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Riedel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008753; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soper JH, 2011, J MOL NEUROSCI, V43, P391, DOI 10.1007/s12031-010-9455-5; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Taschenberger G, 2012, ACTA NEUROPATHOL, V123, P671, DOI 10.1007/s00401-011-0926-8; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong GK, 1998, J ANTIBIOT, V51, P487, DOI 10.7164/antibiotics.51.487; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515	75	59	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27567	27579		10.1074/jbc.M112.361865	http://dx.doi.org/10.1074/jbc.M112.361865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722939	Green Published, hybrid			2022-12-25	WOS:000307840700032
J	Aldrich, MC; Kumar, R; Colangelo, LA; Williams, LK; Sen, S; Kritchevsky, SB; Meibohm, B; Galanter, J; Hu, DL; Gignoux, CR; Liu, YM; Harris, TB; Ziv, E; Zmuda, J; Garcia, M; Leak, TS; Foreman, MG; Smith, LJ; Fornage, M; Liu, K; Burchard, EG				Aldrich, Melinda C.; Kumar, Rajesh; Colangelo, Laura A.; Williams, L. Keoki; Sen, Saunak; Kritchevsky, Stephen B.; Meibohm, Bernd; Galanter, Joshua; Hu, Donglei; Gignoux, Christopher R.; Liu, Yongmei; Harris, Tamara B.; Ziv, Elad; Zmuda, Joseph; Garcia, Melissa; Leak, Tennille S.; Foreman, Marilyn G.; Smith, Lewis J.; Fornage, Myriam; Liu, Kiang; Burchard, Esteban G.		Hlth ABC CARDIA Studies	Genetic Ancestry-Smoking Interactions and Lung Function in African Americans: A Cohort Study	PLOS ONE			English	Article							FORCED EXPIRATORY VOLUME; PULMONARY-FUNCTION; CARDIOVASCULAR-DISEASE; LONGITUDINAL CHANGE; GENDER-DIFFERENCES; POPULATION; SCAN; RISK; HERITABILITY; LIMITATION	Background: Smoking tobacco reduces lung function. African Americans have both lower lung function and decreased metabolism of tobacco smoke compared to European Americans. African ancestry is also associated with lower pulmonary function in African Americans. We aimed to determine whether African ancestry modifies the association between smoking and lung function and its rate of decline in African Americans. Methodology/Principal Findings: We evaluated a prospective ongoing cohort of 1,281 African Americans participating in the Health, Aging, and Body Composition (Health ABC) Study initiated in 1997. We also examined an ongoing prospective cohort initiated in 1985 of 1,223 African Americans in the Coronary Artery Disease in Young Adults (CARDIA) Study. Pulmonary function and tobacco smoking exposure were measured at baseline and repeatedly over the follow-up period. Individual genetic ancestry proportions were estimated using ancestry informative markers selected to distinguish European and West African ancestry. African Americans with a high proportion of African ancestry had lower baseline forced expiratory volume in one second (FEV1) per pack-year of smoking (-5.7 ml FEV1/smoking pack-year) compared with smokers with lower African ancestry (-4.6 ml in FEV1/smoking pack-year) (interaction P value = 0.17). Longitudinal analyses revealed a suggestive interaction between smoking, and African ancestry on the rate of FEV1 decline in Health ABC and independently replicated in CARDIA. Conclusions/Significance: African American individuals with a high proportion of African ancestry are at greater risk for losing lung function while smoking.	[Aldrich, Melinda C.] Vanderbilt Univ, Div Epidemiol, Dept Thorac Surg, Nashville, TN USA; [Aldrich, Melinda C.; Galanter, Joshua; Hu, Donglei; Gignoux, Christopher R.; Ziv, Elad; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med Sci, San Francisco, CA 94143 USA; [Aldrich, Melinda C.; Galanter, Joshua; Hu, Donglei; Gignoux, Christopher R.; Ziv, Elad; Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Kumar, Rajesh] Northwestern Univ, Childrens Mem Hosp, Dept Pediat, Feinberg Sch Med, Chicago, IL 60614 USA; [Colangelo, Laura A.; Liu, Kiang] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Sticht Ctr Aging, Winston Salem, NC USA; [Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Memphis, TN 38163 USA; [Liu, Yongmei] Wake Forest Univ, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Harris, Tamara B.; Garcia, Melissa] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Zmuda, Joseph; Leak, Tennille S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Foreman, Marilyn G.] Morehouse Sch Med, Div Pulm & Crit Care Med, Atlanta, GA 30310 USA; [Smith, Lewis J.] Northwestern Univ, Dept Med, Div Pulm & Crit Care, Feinberg Sch Med, Chicago, IL 60611 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Div Epidemiol, Houston, TX USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Inst Mol Med, Houston, TX USA	Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California San Francisco; Wake Forest University; Wake Forest Baptist Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Morehouse School of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Aldrich, MC (corresponding author), Vanderbilt Univ, Div Epidemiol, Dept Thorac Surg, Nashville, TN USA.	melinda.aldrich@vanderbilt.edu	Ziv, Elad/L-5396-2014	Kritchevsky, Stephen/0000-0003-3336-6781; Meibohm, Bernd/0000-0003-3923-3648; Smith, Lewis J/0000-0002-4728-1562; Galanter, Joshua/0000-0002-2561-6384; Foreman, Marilyn/0000-0002-9405-7475; Kumar, Rajesh/0000-0002-1962-7108	National Institutes of Health [HL078885, AI077439, HL088133, R01 HL74104, AI079139, AI061774, HL079055, DK064695, K23HL093023, HL092601, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, N01-HC-48047, 48050, N01-HC-95095]; Vanderbilt Clinical and Translational Research Scholars Program; Flight Attendant Medical Research Institute (FAMRI); American Asthma Foundation; Sandler Foundation; National Heart, Lung, and Blood Institute (NHLBI); Karmel-Sonix; Merck Co; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048049, N01HC048047, N01HC095095, N01HC048050, N01HC048048] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088133, R01HL074104, K01HL092601, K23HL093023, R01HL079055, R01HL078885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079139, U19AI077439, R01AI061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, N01AG062101, N01AG062106, ZIAAG007390, ZIAAG006000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Clinical and Translational Research Scholars Program; Flight Attendant Medical Research Institute (FAMRI); American Asthma Foundation; Sandler Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Karmel-Sonix; Merck Co(Merck & Company); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the National Institutes of Health (HL078885, AI077439, HL088133, R01 HL74104, AI079139, AI061774, HL079055, DK064695, K23HL093023, HL092601, contracts N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, N01-HC-48047 through 48050, and N01-HC-95095), the Vanderbilt Clinical and Translational Research Scholars Program, the Flight Attendant Medical Research Institute (FAMRI), the American Asthma Foundation and the Sandler Foundation. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The NIA had final responsibility for the decision to submit for publication for Health ABC. The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham, University of Minnesota, Northwestern University, and Kaiser Foundation Research Institute. This manuscript has been reviewed by CARDIA for scientific content and consistency of data interpretation with previous CARDIA publications.; The authors have read the journal's policy and have the following conflicts: Dr. Aldrich has served as a Guest Editor for PLoS ONE. Christopher R. Gignoux holds stock with 23andMe, Inc. Dr. Smith received consultancy funds from Karmel-Sonix. Dr. Williams has received funding from Merck & Co for speaking engagements and travel. No other disclosures were reported. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; BEATY TH, 1984, AM REV RESPIR DIS, V129, P660, DOI 10.1164/arrd.1984.129.5.660; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry OF, 2008, CHEST, V134, P1231, DOI 10.1378/chest.08-0257; Centers For Disease Control (Usa), 1998, Morbidity and Mortality Weekly Report, V47, P1; Chanock SJ, 2011, NAT GENET, V43, P178, DOI 10.1038/ng0311-178; Chatila WM, 2004, CHEST, V125, P15, DOI 10.1378/chest.125.1.15; Cutter G R, 1991, Control Clin Trials, V12, p1S, DOI 10.1016/0197-2456(91)90002-4; Dransfield MT, 2006, RESP MED, V100, P1110, DOI 10.1016/j.rmed.2005.09.019; Foreman MG, 2011, AM J RESP CRIT CARE; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GIBSON KF, 1995, CHEST, V108, P1380; Gottlieb DJ, 2001, AM J RESP CRIT CARE, V164, P1655, DOI 10.1164/ajrccm.164.9.2010122; Gravel S, 2011, P NATL ACAD SCI; Griffith KA, 2001, AM J RESP CRIT CARE, V163, P61, DOI 10.1164/ajrccm.163.1.9906089; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harik-Khan RI, 2004, AM J EPIDEMIOL, V160, P893, DOI 10.1093/aje/kwh297; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Joost O, 2002, AM J RESP CRIT CARE, V165, P795, DOI 10.1164/ajrccm.165.6.2102057; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Kwan ML, 2004, AM J EPIDEMIOL, V160, P1098, DOI 10.1093/aje/kwh317; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Pritchard JK, 2000, GENETICS, V155, P945; REDLINE S, 1987, AM REV RESPIR DIS, V135, P217; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reiner AP, 2007, HUM GENET, V121, P565, DOI 10.1007/s00439-007-0350-2; RYBICKI BA, 1990, J CLIN EPIDEMIOL, V43, P667, DOI 10.1016/0895-4356(90)90037-P; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Selvin S., 1996, STAT ANAL EPIDEMIOLO; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trinidad DR, 2009, NICOTINE TOB RES, V11, P203, DOI 10.1093/ntr/ntn018; US Surgeon General, 1998, MMWR RECOMM REP, V47, pv; Vollmer WM, 2000, CHEST, V117, P764, DOI 10.1378/chest.117.3.764; Waterer GW, 2001, J AM GERIATR SOC, V49, P1032, DOI 10.1046/j.1532-5415.2001.49205.x; Whitfield KE, 2004, ETHNIC DIS, V14, P206; Wilk JB, 2003, AM J RESP CRIT CARE, V167, P1528, DOI 10.1164/rccm.200207-755OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Winkler CA, 2010, ANNU REV GENOM HUM G, V11, P65, DOI 10.1146/annurev-genom-082509-141523; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707	46	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39541	10.1371/journal.pone.0039541	http://dx.doi.org/10.1371/journal.pone.0039541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737244	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000305695100043
J	Tisato, V; Zauli, G; Voltan, R; Gianesini, S; di Iasio, MG; Volpi, I; Fiorentini, G; Zamboni, P; Secchiero, P				Tisato, Veronica; Zauli, Giorgio; Voltan, Rebecca; Gianesini, Sergio; di Iasio, Maria Grazia; Volpi, Ilaria; Fiorentini, Guido; Zamboni, Paolo; Secchiero, Paola			Endothelial Cells Obtained from Patients Affected by Chronic Venous Disease Exhibit a Pro-Inflammatory Phenotype	PLOS ONE			English	Article							RISK-FACTORS; OSTEOPROTEGERIN; ADHESION; ASSOCIATION; DIFFERENCE; PREDICTOR; MORTALITY; LEUKOCYTE; NUTLIN-3; PROTEIN	Background: The inflammatory properties of vein endothelium in relation to chronic venous disease (CVD) have been poorly investigated. Therefore, new insights on the characteristics of large vein endothelium would increase our knowledge of large vessel physiopathology. Methodology/Principal Findings: Surgical specimens of veins were obtained from the tertiary venous network (R3) and/or saphenous vein (SF) of patients affected by CVD and from control individuals. Highly purified venous endothelial cell (VEC) cultures obtained from CVD patients were characterized for morphological, phenotypic and functional properties compared to control VEC. An increase of CD31/PECAM-1, CD146 and ICAM-1 surface levels was documented at flow cytometry in pathological VEC with respect to normal controls. Of note, the strongest expression of these pro-inflammatory markers was observed in VEC obtained from patients with more advanced disease. Similarly, spontaneous cell proliferation and resistance to starvation was higher in pathological than in normal VEC, while the migratory response of VEC showed an opposite trend, being significantly lower in VEC obtained from pathological specimens. In addition, in keeping with a higher baseline transcriptional activity of NF-kB, the release of the pro-inflammatory cytokines osteoprotegerin (OPG) and vascular endothelial growth factor (VEGF) was higher in pathological VEC cultures with respect to control VEC. Interestingly, there was a systemic correlation to these in vitro data, as demonstrated by higher serum OPG and VEGF levels in CVD patients with respect to normal healthy controls. Conclusion/Significance: Taken together, these data indicate that large vein endothelial cells obtained from CVD patients exhibit a pro-inflammatory phenotype, which might significantly contribute to systemic inflammation in CVD patients.	[Tisato, Veronica; Voltan, Rebecca; di Iasio, Maria Grazia; Volpi, Ilaria; Secchiero, Paola] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Tisato, Veronica; Voltan, Rebecca; di Iasio, Maria Grazia; Volpi, Ilaria; Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Zauli, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Gianesini, Sergio; Fiorentini, Guido; Zamboni, Paolo] Univ Ferrara, Vasc Dis Ctr, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; IRCCS Burlo Garofolo; University of Ferrara	Tisato, V (corresponding author), Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.	paola.secchiero@unife.it	secchiero, paola/G-9689-2015; Tisato, Veronica/K-4525-2016; Zauli, Giorgio/ABE-8001-2020; GIANESINI, SERGIO/K-9992-2016	secchiero, paola/0000-0003-4101-7987; Zauli, Giorgio/0000-0002-3750-8698; Fiorentini, Guido/0000-0002-1186-1979; Tisato, Veronica/0000-0001-8448-066X	FoRST-Fondazione per la Ricerca Scientifica Termale	FoRST-Fondazione per la Ricerca Scientifica Termale	This work was supported by a grant from FoRST-Fondazione per la Ricerca Scientifica Termale (to GZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide P, 2012, J IMMUNOL, V188, P1421, DOI 10.4049/jimmunol.1101647; Auzky O, 2011, INT ANGIOL, V30, P335; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; Beidler SK, 2009, J VASC SURG, V49, P1013, DOI 10.1016/j.jvs.2008.11.049; CAMPIONI D, 1995, AIDS RES HUM RETROV, V11, P1039, DOI 10.1089/aid.1995.11.1039; Carrasco OF, 2009, ANGIOLOGY, V60, P763, DOI 10.1177/0003319709332108; Eberhardt RT, 2005, CIRCULATION, V111, P2398, DOI 10.1161/01.CIR.0000164199.72440.08; Eriksson EE, 2005, ARTERIOSCL THROM VAS, V25, P723, DOI 10.1161/01.ATV.0000157578.51417.6f; Eriksson Einar E., 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P309, DOI 10.2174/1568006033481357; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Glen K, 2012, J CELL PHYSIOL, V227, P2710, DOI 10.1002/jcp.23015; Harhouri K, 2010, BLOOD, V115, P3843, DOI 10.1182/blood-2009-06-229591; Hong C, 2005, ATHEROSCLEROSIS, V183, P169, DOI 10.1016/j.atherosclerosis.2005.03.047; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Leychenko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029055; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; Mogelvang R, 2012, AM J CARDIOL, V109, P515, DOI 10.1016/j.amjcard.2011.09.043; Naskret D, 2010, MICROVASC RES, V80, P440, DOI 10.1016/j.mvr.2010.07.009; Parkington HC, 2004, PHARMACOL RES, V49, P509, DOI 10.1016/j.phrs.2003.11.012; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Schmid-Schonbein GW, 2001, ANGIOLOGY, V52, pS27, DOI 10.1177/0003319701052001S04; Secchiero P, 2007, CURR DRUG METAB, V8, P395, DOI 10.2174/138920007780655432; Secchiero P, 2010, ATHEROSCLEROSIS, V210, P274, DOI 10.1016/j.atherosclerosis.2009.11.005; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; Ulbrich H, 2003, TRENDS PHARMACOL SCI, V24, P640, DOI 10.1016/j.tips.2003.10.004; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Vik A, 2011, J THROMB HAEMOST, V9, P638, DOI 10.1111/j.1538-7836.2011.04222.x; Voltan R, 2011, CLIN CANCER RES, V17, P5649, DOI 10.1158/1078-0432.CCR-11-1064; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakefield T W, 1997, Cardiovasc Surg, V5, P6, DOI 10.1016/S0967-2109(96)00083-X; Westra J, 2011, RHEUMATOLOGY, V50, P665, DOI 10.1093/rheumatology/keq378; Zauli G, 2009, CELL MOL LIFE SCI, V66, P841, DOI 10.1007/s00018-008-8536-x; Zauli G, 2007, BLOOD, V110, P536, DOI 10.1182/blood-2007-01-068395	38	38	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39543	10.1371/journal.pone.0039543	http://dx.doi.org/10.1371/journal.pone.0039543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737245	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100044
J	Cohen, TS; DiPaolo, BC; Lawrence, GG; Margulies, SS				Cohen, Taylor S.; DiPaolo, Brian C.; Lawrence, Gladys Gray; Margulies, Susan S.			Sepsis Enhances Epithelial Permeability with Stretch in an Actin Dependent Manner	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; LIGHT-CHAIN KINASE; TIGHT-JUNCTION PROTEINS; TIDAL VOLUME VENTILATION; BARRIER FUNCTION; ALVEOLAR EPITHELIA; IN-VITRO; ACTIVATION; CELLS	Ventilation of septic patients often leads to the development of edema and impaired gas exchange. We hypothesized that septic alveolar epithelial monolayers would experience stretch-induced barrier dysfunction at a lower magnitude of stretch than healthy alveolar epithelial monolayers. Alveolar epithelial cells were isolated from rats 24 hours after cecal ligation and double puncture (2CLP) or sham surgery. Following a 5-day culture period, monolayers were cyclically stretched for 0, 10, or 60 minutes to a magnitude of 12% or 25% change in surface area (Delta SA). Barrier function, MAPk and myosin light chain (MLC) phosphorylation, tight junction (TJ) protein expression and actin cytoskeletal organization were examined after stretch. Significant increases in epithelial permeability were observed only in 2CLP monolayers at the 12% Delta SA stretch level, and in both 2CLP and sham monolayers at the 25% Delta SA stretch level. Increased permeability in 2CLP monolayers was not associated with MAPk signaling or alterations in expression of TJ proteins. 2CLP monolayers had fewer actin stress fibers before stretch, a more robust stretch-induced actin redistribution, and reduced phosphorylated MLCK than sham monolayers. Jasplakinolide stabilization of the actin cytoskeleton in 2CLP monolayers prevented significant increases in permeability following 60 minutes of stretch to 12% Delta SA. We concluded that septic alveolar epithelial monolayers are more susceptible to stretch-induced barrier dysfunction than healthy monolayers due to actin reorganization.	[Cohen, Taylor S.; DiPaolo, Brian C.; Lawrence, Gladys Gray; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Cohen, TS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	National Institutes of Health [RO1-HL057204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by National Institutes of Health RO1-HL057204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azghani AO, 2002, INFLAMM RES, V51, P506, DOI 10.1007/PL00012420; Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cavanaugh KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1179, DOI 10.1152/ajpcell.00355.2004; Cavanaugh KJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1801, DOI 10.1152/ajpcell.00341.2002; Cavanaugh KJ, 2001, AM J RESP CELL MOL, V25, P584, DOI 10.1165/ajrcmb.25.5.4486; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Cohen TS, 2008, EUR RESPIR J, V32, P854, DOI 10.1183/09031936.00141007; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011322; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Desai LP, 2009, AM J PHYSIOL-LUNG C, V297, pL520, DOI 10.1152/ajplung.00076.2009; DiPaolo BC, 2012, AM J PHYSIOL-LUNG C, V302, pL992, DOI 10.1152/ajplung.00175.2011; DiPaolo BC, 2010, AM J PHYSIOL-CELL PH, V299, pC345, DOI 10.1152/ajpcell.00379.2009; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1; Groppera MA, 2008, CURR OPIN CRIT CARE, V14, P11, DOI 10.1097/MCC.0b013e3282f417a0; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Ikenouchi J, 2008, MOL BIOL CELL, V19, P4687, DOI 10.1091/mbc.E08-05-0530; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Levine GK, 2006, CRIT CARE MED, V34, P1746, DOI 10.1097/01.CCM.0000218813.77367.E2; Li KZ, 2007, CHINESE MED J-PEKING, V120, P1451, DOI 10.1097/00029330-200708020-00014; LUBMAN RL, 1997, LUNG SCI FDN, P585; MADARA JL, 1987, AM J PHYSIOL, V253, pC171, DOI 10.1152/ajpcell.1987.253.1.C171; Martin Thomas R, 2008, Proc Am Thorac Soc, V5, P291, DOI 10.1513/pats.200801-005DR; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Nagumo Y, 2008, BIOCHEM BIOPH RES CO, V377, P921, DOI 10.1016/j.bbrc.2008.10.071; Nin N, 2009, SHOCK, V31, P429, DOI 10.1097/SHK.0b013e318188b720; O'Mahony DS, 2006, CRIT CARE, V10, DOI 10.1186/cc5050; Raina H, 2009, J PHYSIOL-LONDON, V587, P2599, DOI 10.1113/jphysiol.2008.165258; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shen LH, 2009, SHOCK, V31, P500, DOI 10.1097/SHK.0b013e318189017a; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Upadhyay D, 2003, AM J PHYSIOL-LUNG C, V284, pL350, DOI 10.1152/ajplung.00161.2002; Van Lierop JE, 2002, J BIOL CHEM, V277, P6550, DOI 10.1074/jbc.M111404200; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	48	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38748	10.1371/journal.pone.0038748	http://dx.doi.org/10.1371/journal.pone.0038748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723883	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700026
J	Hagedorn, M; McCarthy, M; Carter, VL; Meyers, SA				Hagedorn, Mary; McCarthy, Megan; Carter, Virginia L.; Meyers, Stuart A.			Oxidative Stress in Zebrafish (Danio rerio) Sperm	PLOS ONE			English	Article							SPONTANEOUS LIPID-PEROXIDATION; OXYGEN SPECIES GENERATION; HUMAN-SPERMATOZOA; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; DNA-DAMAGE; GLUTATHIONE-PEROXIDASE; EQUINE SPERMATOZOA; MOUSE SPERMATOZOA; HIGH-THROUGHPUT	Laboratories around the world have produced tens of thousands of mutant and transgenic zebrafish lines. As with mice, maintaining all of these valuable zebrafish genotypes is expensive, risky, and beyond the capacity of even the largest stock centers. Because reducing oxidative stress has become an important aspect of reducing the variability in mouse sperm cryopreservation, we examined whether antioxidants might improve cryopreservation of zebrafish sperm. Four experiments were conducted in this study. First, we used the xanthine-xanthine oxidase (X-XO) system to generate reactive oxygen species (ROS). The X-XO system was capable of producing a stress reaction in zebrafish sperm reducing its sperm motility in a concentration dependent manner (P<0.05). Second, we examined X-XO and the impact of antioxidants on sperm viability, ROS and motility. Catalase (CAT) mitigated stress and maintained viability and sperm motility (P>0.05), whereas superoxide dismutase (SOD) and vitamin E did not (P<0.05). Third, we evaluated ROS in zebrafish spermatozoa during cryopreservation and its effect on viability and motility. Methanol (8%) reduced viability and sperm motility (P<0.05), but the addition of CAT mitigated these effects (P>0.05), producing a mean 2.0 to 2.9-fold increase in post-thaw motility. Fourth, we examined the effect of additional cryoprotectants and CAT on fresh sperm motility. Cryoprotectants, 8% methanol and 10% dimethylacetamide (DMA), reduced the motility over the control value (P<0.5), whereas 10% dimethylformamide (DMF) with or without CAT did not (P>0.05). Zebrafish sperm protocols should be modified to improve the reliability of the cryopreservation process, perhaps using a different cryoprotectant. Regardless, the simple addition of CAT to present-day procedures will significantly improve this process, assuring increased and less variable fertilization success and allowing resource managers to dependably plan how many straws are needed to safely cryopreserve a genetic line.	[Hagedorn, Mary; Carter, Virginia L.] Smithsonian Conservat Biol Inst, Dept Reprod Sci, Washington, DE USA; [Hagedorn, Mary; Carter, Virginia L.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [McCarthy, Megan; Meyers, Stuart A.] Univ Calif Davis, Dept Anat, Sch Vet Med, Davis, CA 95616 USA	University of Hawaii System; University of California System; University of California Davis	Hagedorn, M (corresponding author), Smithsonian Conservat Biol Inst, Dept Reprod Sci, Washington, DE USA.	hagedornm@si.edu			National Institutes of Health (NIH) [R24 RR016581, RO1 2RR016581]; Zebrafish International Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR016581] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zebrafish International Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant to MM from National Institutes of Health (NIH) # R24 RR016581 and SM from NIH # RO1 2RR016581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Bruce Draper for his kind assistance during the preliminary studies for this work and the Zebrafish International Research Center for their support and comments on this manuscript. In addition, we would like to thank the three anonymous reviewers whose comments greatly improved this paper. This manuscript has been approved for publication by the Hawaii Institute of Marine Biology as contribution #1490.	Aitken RJ, 2007, MOL HUM REPROD, V13, P203, DOI 10.1093/molehr/gal119; AITKEN RJ, 1993, J REPROD FERTIL, V97, P441; AITKEN RJ, 1989, J ANDROL, V10, P214; AITKEN RJ, 1988, J ANDROL, V9, P367; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Aitken RJ, 1994, MOL REPROD DEV, V39, P268; ALVAREZ JG, 1989, GAMETE RES, V23, P77, DOI 10.1002/mrd.1120230108; ALVAREZ JG, 1987, J ANDROL, V8, P338; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Baiardi G, 1997, CAN J PHYSIOL PHARM, V75, P173, DOI 10.1139/cjpp-75-3-173; Ball BA, 2001, J ANDROL, V22, P1061; Baumber J, 2000, J ANDROL, V21, P895; Baumber J, 2003, J ANDROL, V24, P621; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; BLOCK ER, 1991, J CELL PHYSIOL, V146, P362, DOI 10.1002/jcp.1041460305; Blondin P, 1997, J ANDROL, V18, P454; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; DELAMIRANDE E, 1992, J ANDROL, V13, P379; DELAMIRANDE E, 1992, J ANDROL, V13, P368; Donnelly ET, 2000, MUTAGENESIS, V15, P61, DOI 10.1093/mutage/15.1.61; Donnelly ET, 1999, MUTAGENESIS, V14, P505, DOI 10.1093/mutage/14.5.505; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Gadea J, 2004, THERIOGENOLOGY, V62, P690, DOI 10.1016/j.theriogenology.2003.11.013; GRIVEAU JF, 1995, J REPROD FERTIL, V103, P17; Griveau JF, 1997, INT J ANDROL, V20, P195, DOI 10.1046/j.1365-2605.1997.00049.x; Hagedorn M, 2009, CRYOBIOLOGY, V58, P12, DOI 10.1016/j.cryobiol.2008.09.013; Hagedorn M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021059; Halliwell B, 1996, PATHOL BIOL, V44, P6; HALLIWELL B, 1991, AM J MED S3C, V91, P14, DOI DOI 10.1016/0002-9343(91)90279-7; HARVEY B, 1982, CAN J ZOOL, V60, P1867, DOI 10.1139/z82-242; IWASAKI A, 1992, FERTIL STERIL, V57, P409, DOI 10.1016/s0015-0282(16)54855-9; JONES R, 1979, AM J ANAT, V156, P373, DOI 10.1002/aja.1001560307; Katkov II, 1998, CRYOBIOLOGY, V37, P325, DOI 10.1006/cryo.1998.2128; Knight J, 2002, NATURE, V417, P785, DOI 10.1038/417785a; Koshimoto C, 2002, CRYOBIOLOGY, V45, P80, DOI 10.1016/S0011-2240(02)00108-6; LASSO JL, 1994, J ANDROL, V15, P255; Lewis SE, 1996, MOL HUM REPROD, V2, P873, DOI 10.1093/molehr/2.11.873; McCarthy MJ, 2011, THERIOGENOLOGY, V76, P168, DOI 10.1016/j.theriogenology.2011.01.029; McCarthy MJ, 2010, BIOL REPROD, V82, P644, DOI 10.1095/biolreprod.109.080507; Morris JP, 2003, BIOTECHNIQUES, V35, P956; MORRIS SM, 1981, CELL TISSUE RES, V220, P739; OHYASHIKI T, 1988, BIOCHIM BIOPHYS ACTA, V939, P383, DOI 10.1016/0005-2736(88)90084-3; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; RAO B, 1989, GAMETE RES, V24, P127, DOI 10.1002/mrd.1120240202; Rocha Maria Joao, 2003, BMC Biochem, V4, P2, DOI 10.1186/1471-2091-4-2; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Storey BT, 1997, MOL HUM REPROD, V3, P203, DOI 10.1093/molehr/3.3.203; Storey BT, 1998, CRYOBIOLOGY, V37, P46, DOI 10.1006/cryo.1998.2097; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Takagi Y, 2004, BIOCHEM BIOPH RES CO, V320, P62, DOI 10.1016/j.bbrc.2004.05.131; Twigg J, 1998, HUM REPROD, V13, P1429, DOI 10.1093/humrep/13.6.1429; Van der Schans GP, 2000, J ANDROL, V21, P250; VANLOON AAWM, 1991, EXP CELL RES, V193, P303, DOI 10.1016/0014-4827(91)90101-Y; Vernet P, 2004, MOL CELL ENDOCRINOL, V216, P31, DOI 10.1016/j.mce.2003.10.069; Wang AW, 1997, UROLOGY, V49, P921, DOI 10.1016/S0090-4295(97)00070-8; Westerfield M., 2005, ZEBRAFISH BOOK GUIDE; Williams J., 2000, MANUAL FISHERIES SUR, VII; Yang HP, 2007, THERIOGENOLOGY, V68, P128, DOI 10.1016/j.theriogenology.2007.02.015; Zhou BS, 2006, AQUAT TOXICOL, V77, P136, DOI 10.1016/j.aquatox.2005.11.006	59	66	68	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39397	10.1371/journal.pone.0039397	http://dx.doi.org/10.1371/journal.pone.0039397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22724013	Green Submitted, gold, Green Published			2022-12-25	WOS:000305652700078
J	Riccio, AM; Saverino, D; Pesce, G; Rogkakou, A; Severino, M; Bonadonna, P; Ridolo, E; Mauro, M; Canonica, GW; Bagnasco, M; Passalacqua, G				Riccio, Anna Maria; Saverino, Daniele; Pesce, Giampaola; Rogkakou, Anthi; Severino, Maurizio; Bonadonna, Patrizia; Ridolo, Erminia; Mauro, Marina; Canonica, Giorgio Walter; Bagnasco, Marcello; Passalacqua, Giovanni			Effects of Different Up-Dosing Regimens for Hymenoptera Venom Immunotherapy on Serum CTLA-4 and IL-10	PLOS ONE			English	Article							SOLUBLE CTLA-4; CELL; CD28; MECHANISMS; PLASMA; CD86	Background: Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) is involved in the activation pathways of T lymphocytes. It has been shown that the circulating form of CTLA-4 is elevated in patients with hymenoptera allergy and can be down regulated by immunotherapy. Objective: to assess the effects on CTLA-4 of venom immunotherapy, given with different induction protocols: conventional (6 weeks), rush (3 days) or ultra rush (1 day). Methods: Sera from patients with hymenoptera allergy were collected at baseline and at the end of the induction phase. CTLA-4 and IL-10 were assayed in the same samples. A subset of patients were assayed also after 12 months of VIT maintenance. Results: Ninety-four patients were studied. Of them, 50 underwent the conventional induction, 20 the rush and 24 the ultra-rush. Soluble CTLA-4 was detectable in all patients at baseline, and significantly decreased at the end of the induction, irrespective of its duration. Of note, a significant decrease of sCTLA-4 could be seen already at 24 hours. In parallel, IL-10 significantly increased at the end of the induction. At 12 months, sCTLA-4 remained low, whereas IL-10 returned to the baseline values. Conclusions: Serum CTLA4 is an early marker of the immunological effects of venom immunotherapy, and its changes persist after one year of maintenance treatment.	[Riccio, Anna Maria; Pesce, Giampaola; Rogkakou, Anthi; Canonica, Giorgio Walter; Bagnasco, Marcello; Passalacqua, Giovanni] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Saverino, Daniele] Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy; [Severino, Maurizio] Osped San Giovanni di Dio, Allergy Unit, Florence, Italy; [Bonadonna, Patrizia] Verona Gen Hosp, Allergy Serv, Verona, Italy; [Ridolo, Erminia] Univ Parma, I-43100 Parma, Italy; [Mauro, Marina] St Anna Hosp, Allergy Unit, Como, Italy	University of Genoa; University of Genoa; University of Parma; University of Ferrara; Arcispedale Sant'Anna	Riccio, AM (corresponding author), Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy.	passalacqua@unige.it	canonica, giorgio walter/ABF-2037-2020; Saverino, Daniele/I-4741-2014	canonica, giorgio walter/0000-0001-8467-2557; RICCIO, ANNA MARIA/0000-0001-8392-533X; Pesce, Giampaola/0000-0002-6294-9110				Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Burr JS, 2001, AM J RESP CELL MOL, V24, P563, DOI 10.1165/ajrcmb.24.5.4375; Bussmann C, 2010, ALLERGY, V65, P1558, DOI 10.1111/j.1398-9995.2010.02430.x; Dreschler K, 2011, J ALLERGY CLIN IMMUN, V127, P487, DOI 10.1016/j.jaci.2010.12.003; Ip WK, 2006, PEDIATR PULM, V41, P674, DOI 10.1002/ppul.20432; Jasek M, 2006, INT ARCH ALLERGY IMM, V141, P223, DOI 10.1159/000095292; Kawayama T, 2008, RESPIROLOGY, V13, P1000, DOI 10.1111/j.1440-1843.2008.01381.x; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Rueff F, 2005, ALLERGY, V60, P1339; Saverino D, 2009, J ALLERGY CLIN IMMUN, V123, P258, DOI 10.1016/j.jaci.2008.09.023; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wong CK, 2005, CLIN EXP IMMUNOL, V141, P122, DOI 10.1111/j.1365-2249.2005.02815.x	19	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e37980	10.1371/journal.pone.0037980	http://dx.doi.org/10.1371/journal.pone.0037980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723841	Green Submitted, Green Published, gold			2022-12-25	WOS:000305652700007
J	Du, LQ; Subauste, MC; DeSevo, C; Zhao, ZZ; Baker, M; Borkowski, R; Schageman, JJ; Greer, R; Yang, CR; Suraokar, M; Wistuba, II; Gazdar, AF; Minna, JD; Pertsemlidis, A				Du, Liqin; Subauste, Maria C.; DeSevo, Christopher; Zhao, Zhenze; Baker, Michael; Borkowski, Robert; Schageman, Jeoffrey J.; Greer, Rachel; Yang, Chin-Rang; Suraokar, Milind; Wistuba, Ignacio I.; Gazdar, Adi F.; Minna, John D.; Pertsemlidis, Alexander			miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers	PLOS ONE			English	Article							MESSENGER-RNA; SIGNAL TRANSDUCER; MICRORNA TARGETS; MAP KINASE; PHASE-II; EXPRESSION; PROTEIN; RESISTANCE; PACLITAXEL; TAXOL	NSCLC (non-small cell lung cancer) often exhibits resistance to paclitaxel treatment. Identifying the elements regulating paclitaxel response will advance efforts to overcome such resistance in NSCLC therapy. Using in vitro approaches, we demonstrated that over-expression of the microRNA miR-337-3p sensitizes NCI-H1155 cells to paclitaxel, and that miR-337-3p mimic has a general effect on paclitaxel response in NSCLC cell lines, which may provide a novel adjuvant strategy to paclitaxel in the treatment of lung cancer. By combining in vitro and in silico approaches, we identified STAT3 and RAP1A as direct targets that mediate the effect of miR-337-3p on paclitaxel sensitivity. Further investigation showed that miR-337-3p mimic also sensitizes cells to docetaxel, another member of the taxane family, and that STAT3 levels are significantly correlated with taxane resistance in lung cancer cell lines, suggesting that endogenous STAT3 expression is a determinant of intrinsic taxane resistance in lung cancer. The identification of a miR-337-3p as a modulator of cellular response to taxanes, and STAT3 and RAP1A as regulatory targets which mediate that response, defines a novel regulatory pathway modulating paclitaxel sensitivity in lung cancer cells, which may provide novel adjuvant strategies along with paclitaxel in the treatment of lung cancer and may also provide biomarkers for predicting paclitaxel response in NSCLC.	[Du, Liqin; Zhao, Zhenze; Pertsemlidis, Alexander] UT Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX USA; [Du, Liqin; Pertsemlidis, Alexander] UT Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX USA; [Pertsemlidis, Alexander] UT Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX USA; [DeSevo, Christopher; Baker, Michael; Borkowski, Robert; Greer, Rachel] UT SW Med Ctr, SW Grad Sch Biomed Sci, Div Basic Sci, Dallas, TX USA; [Subauste, Maria C.; Schageman, Jeoffrey J.] UT SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Yang, Chin-Rang; Gazdar, Adi F.; Minna, John D.] UT SW Med Ctr, Simmons Comprehens Canc Ctr, Dallas, TX USA; [Gazdar, Adi F.; Minna, John D.] UT SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; [Minna, John D.] UT SW Med Ctr, Dept Pharmacol, Dallas, TX USA; [Minna, John D.] UT SW Med Ctr, Dept Internal Med, Dallas, TX USA; [Gazdar, Adi F.; Minna, John D.] UT SW Med Ctr, Dept Pathol, Dallas, TX USA; [Suraokar, Milind; Wistuba, Ignacio I.] UT MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA; [Wistuba, Ignacio I.] UT MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Du, LQ (corresponding author), UT Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX USA.	pertsemlidis@uthscsa.edu	Pertsemlidis, Alexander/Q-7899-2017; Zhao, Zhenze/AAW-5870-2020	Pertsemlidis, Alexander/0000-0003-1624-9372; 	Lung Cancer SPORE [P50 CA70907, R01 CA129632]; National Cancer Institute, and Academic Excellence [EDUD-7824-021007-US]; Sun Microsystems; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA129632] Funding Source: NIH RePORTER	Lung Cancer SPORE; National Cancer Institute, and Academic Excellence; Sun Microsystems; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by Lung Cancer SPORE P50 CA70907 (J. D. Minna), R01 CA129632 (A. Pertsemlidis) from the National Cancer Institute, and Academic Excellence Grant EDUD-7824-021007-US (A. Pertsemlidis) from Sun Microsystems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Caesar GJ, COMMENTARII BELLO GA, V6, P31; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; CHANG AY, 1993, J NATL CANCER I, V85, P388, DOI 10.1093/jnci/85.5.388; d'Amato TA, 2007, J THORAC CARDIOV SUR, V133, P352, DOI 10.1016/j.jtcvs.2006.10.019; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hari M, 2006, MOL CANCER THER, V5, P270, DOI 10.1158/1535-7163.MCT-05-0190; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hawthorne VS, 2009, MOL CANCER RES, V7, P592, DOI 10.1158/1541-7786.MCR-08-0316; Holmfeldt P, 2002, CURR BIOL, V12, P1034, DOI 10.1016/S0960-9822(02)00897-7; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; HOSHI M, 1992, EUR J BIOCHEM, V203, P43, DOI 10.1111/j.1432-1033.1992.tb19825.x; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Miller ML, 2001, CHEM REC, V1, P195, DOI 10.1002/tcr.1008; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; MURPHY WK, 1993, J NATL CANCER I, V85, P384, DOI 10.1093/jnci/85.5.384; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Oie HK, 1996, J CELL BIOCHEM, P24; Pensa S, 2009, JAK STAT PATHWAY DIS; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Phelps RM, 1996, J CELL BIOCHEM, P32; Pizon V, 2000, ONCOGENE, V19, P6074, DOI 10.1038/sj.onc.1203984; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Sangrajrang S, 2000, CHEMOTHERAPY, V46, P327, DOI 10.1159/000007306; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Walker SR, 2010, MOL PHARM; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	52	80	85	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39167	10.1371/journal.pone.0039167	http://dx.doi.org/10.1371/journal.pone.0039167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723956	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300110
J	Lu, R; Bian, F; Lin, J; Su, ZT; Qu, YLW; Pflugfelder, SC; Li, DQ				Lu, Rong; Bian, Fang; Lin, Jing; Su, Zhitao; Qu, Yangluowa; Pflugfelder, Stephen C.; Li, De-Quan			Identification of Human Fibroblast Cell Lines as a Feeder Layer for Human Corneal Epithelial Regeneration	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN OCULAR SURFACE; IN-VITRO; MESENCHYMAL INTERACTIONS; MICROARRAY DATA; CULTURE; TRANSPLANTATION; GROWTH; DIFFERENTIATION; EXPRESSION	There is a great interest in using epithelium generated in vitro for tissue bioengineering. Mouse 3T3 fibroblasts have been used as a feeder layer to cultivate human epithelia including corneal epithelial cells for more than 3 decades. To avoid the use of xeno-components, we evaluated human fibroblasts as an alternative feeder supporting human corneal epithelial regeneration. Five human fibroblast cell lines were used for evaluation with mouse 3T3 fibroblasts as a control. Human epithelial cells isolated from fresh corneal limbal tissue were seeded on these feeders. Colony forming efficiency (CFE) and cell growth capacity were evaluated on days 5-14. The phenotype of the regenerated epithelia was evaluated by morphology and immunostaining with epithelial markers. cDNA microarray was used to analyze the gene expression profile of the supportive human fibroblasts. Among 5 strains of human fibroblasts evaluated, two newborn foreskin fibroblast cell lines, Hs68 and CCD1112Sk, were identified to strongly support human corneal epithelial growth. Tested for 10 passages, these fibroblasts continually showed a comparative efficiency to the 3T3 feeder layer for CFE and growth capacity of human corneal epithelial cells. Limbal epithelial cells seeded at 1 x 10(4) in a 35-mm dish (9.6 cm(2)) grew to confluence (about 1.87-2.41 x 10(6) 6 cells) in 12-14 days, representing 187-241 fold expansion with over 7-8 doublings on these human feeders. The regenerated epithelia expressed K3, K12, connexin 43, p63, EGFR and integrin beta 1, resembling the phenotype of human corneal epithelium. DNA microarray revealed 3 up-regulated and 10 down-regulated genes, which may be involved in the functions of human fibroblast feeders. These findings demonstrate that commercial human fibroblast cell lines support human corneal epithelial regeneration, and have potential use in tissue bioengineering for corneal reconstruction.	[Lu, Rong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Rong; Bian, Fang; Lin, Jing; Su, Zhitao; Qu, Yangluowa; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Bian, Fang] Huazhong Sci & Technol Univ, Dept Ophthalmol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Lin, Jing] Qingdao Univ, Coll Med, Dept Ophthalmol, Qingdao 266071, Peoples R China	Sun Yat Sen University; Baylor College of Medicine; Huazhong University of Science & Technology; Qingdao University	Lu, R (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	dequanl@bcm.tmc.edu			Department of Defense CDMRP PRMRP [FY06 PR064719]; Lions Foundation for Sight; Fundamental Research Funds of State Key Laboratory of Ophthalmology (China); Research to Prevent Blindness, Oshman Foundation; William Stamps Farish Fund	Department of Defense CDMRP PRMRP; Lions Foundation for Sight; Fundamental Research Funds of State Key Laboratory of Ophthalmology (China); Research to Prevent Blindness, Oshman Foundation(Research to Prevent Blindness (RPB)); William Stamps Farish Fund	This study was supported by Department of Defense CDMRP PRMRP FY06 PR064719 (DQL), Lions Foundation for Sight, Fundamental Research Funds of State Key Laboratory of Ophthalmology (China), Research to Prevent Blindness, Oshman Foundation, and William Stamps Farish Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1985, EXP LUNG RES, V8, P261, DOI 10.3109/01902148509087808; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; Choo ABH, 2004, BIOTECHNOL BIOENG, V88, P321, DOI 10.1002/bit.20247; CUNHA GR, 1985, CELL DIFFER DEV, V17, P137, DOI 10.1016/0045-6039(85)90481-6; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093; DELUCA M, 1992, BURNS, V18, pS5, DOI 10.1016/0305-4179(92)90103-2; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dua H S, 2000, Indian J Ophthalmol, V48, P83; Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; HOWLETT AR, 1986, DEV BIOL, V118, P403, DOI 10.1016/0012-1606(86)90011-4; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kinoshita S, 2004, EXP EYE RES, V78, P483, DOI 10.1016/j.exer.2003.09.004; Koizumi N, 2002, INVEST OPHTH VIS SCI, V43, P2114; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; LINDBERG K, 1993, INVEST OPHTH VIS SCI, V34, P2672; Liu JY, 2005, DERMATOLOGY, V210, P45, DOI 10.1159/000081483; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003; SHARPE PM, 1988, J CELL SCI, P195; SLAVKIN HC, 1984, J CELL BIOCHEM, V26, P117, DOI 10.1002/jcb.240260207; SUN TT, 1977, NATURE, V269, P489, DOI 10.1038/269489a0; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tseng SCG, 1996, CORNEA, V15, P168, DOI 10.1097/00003226-199603000-00010; Tseng SCG, 1996, CURR EYE RES, V15, P973, DOI 10.3109/02713689609017643; van Rossum MM, 2002, J IMMUNOL METHODS, V267, P109, DOI 10.1016/S0022-1759(02)00151-5; WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814; Zipori D, 2004, BLOOD CELL MOL DIS, V33, P211, DOI 10.1016/j.bcmd.2004.08.019	37	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38825	10.1371/journal.pone.0038825	http://dx.doi.org/10.1371/journal.pone.0038825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723892	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300056
J	Adesida, AB; Mulet-Sierra, A; Laouar, L; Jomha, NM				Adesida, Adetola B.; Mulet-Sierra, Aillette; Laouar, Leila; Jomha, Nadr M.			Oxygen Tension Is a Determinant of the Matrix-Forming Phenotype of Cultured Human Meniscal Fibrochondrocytes	PLOS ONE			English	Article							TISSUE ENGINEERED MENISCUS; ARTICULAR-CARTILAGE; GROWTH-FACTORS; CELLS; DIFFERENTIATION; EXPRESSION; COLLAGEN; MICROVASCULATURE; TRANSPLANTATION; PROLIFERATION	Background: Meniscal cartilage displays a poor repair capacity, especially when injury is located in the avascular region of the tissue. Cell-based tissue engineering strategies to generate functional meniscus substitutes is a promising approach to treat meniscus injuries. Meniscus fibrochondrocytes (MFC) can be used in this approach. However, MFC are unable to retain their phenotype when expanded in culture. In this study, we explored the effect of oxygen tension on MFC expansion and on their matrix-forming phenotype. Methodology/Principal Findings: MFC were isolated from human menisci followed by basic fibroblast growth factor (FGF-2) mediated cell expansion in monolayer culture under normoxia (21%O-2) or hypoxia (3%O-2). Normoxia and hypoxia expanded MFC were seeded on to a collagen scaffold. The MFC seeded scaffolds (constructs) were cultured in a serum free chondrogenic medium for 3 weeks under normoxia and hypoxia. Constructs containing normoxia-expanded MFC were subsequently cultured under normoxia while those formed from hypoxia-expanded MFC were subsequently cultured under hypoxia. After 3 weeks of in vitro culture, the constructs were assessed biochemically, histologically and for gene expression via real-time reverse transcription-PCR assays. The results showed that constructs under normoxia produced a matrix with enhanced mRNA ratio (3.5-fold higher; p<0.001) of collagen type II to I. This was confirmed by enhanced deposition of collagen II using immuno-histochemistry. Furthermore, the constructs under hypoxia produced a matrix with higher mRNA ratio of aggrecan to versican (3.5-fold, p<0.05). However, both constructs had the same capacity to produce a glycosaminoglycan (GAG) -specific extracellular matrix. Conclusions: Our data provide evidence that oxygen tension is a key player in determining the matrix phenotype of cultured MFC. These findings suggest that the use of normal and low oxygen tension during MFC expansion and subsequent neo-tissue formation cultures may be important in engineering different regions of the meniscus.	[Adesida, Adetola B.; Mulet-Sierra, Aillette; Laouar, Leila; Jomha, Nadr M.] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta	Adesida, AB (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	adesida@ualberta.ca	Adesida, Adetola B/H-3549-2011	Adesida, Adetola B/0000-0003-1798-6251	Edmonton Orthopaedic Research Committee, University of Alberta Hospital Foundation; Department of Surgery, University of Alberta	Edmonton Orthopaedic Research Committee, University of Alberta Hospital Foundation; Department of Surgery, University of Alberta(University of Alberta)	Financial support was provided in part by Edmonton Orthopaedic Research Committee, University of Alberta Hospital Foundation to ABA and new investigator startup fund by Department of Surgery, University of Alberta to ABA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard H, 1999, SCAND J MED SCI SPOR, V9, P134; Adams M.E., 1992, KNEE MENISCUS BASIC, P15; Adams Samuel B Jr, 2005, J Knee Surg, V18, P25; Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Adesida AB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2267; Ahmed A.M., 1992, KNEE MENISCUS BASIC, P59; Aigner T, 2003, MATRIX BIOL, V22, P363, DOI 10.1016/S0945-053X(03)00049-0; Arnoczky S., 1992, KNEE MENISCUS BASIC, P1; ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205; Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS293; ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305; Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; Brew CJ, 2010, ANN RHEUM DIS, V69, P234, DOI 10.1136/ard.2008.097139; FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664, DOI 10.1302/0301-620X.30B4.664; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Gebhard PM, 2003, J ORTHOPAED RES, V21, P96, DOI 10.1016/S0736-0266(02)00094-3; Gruber HE, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-54; Ibarra C, 1997, TRANSPL P, V29, P986, DOI 10.1016/S0041-1345(96)00337-5; Ibarra C, 2000, ORTHOP CLIN N AM, V31, P411, DOI 10.1016/S0030-5898(05)70160-7; Kang SW, 2006, J BIOMED MATER RES A, V77A, P659, DOI 10.1002/jbm.a.30579; Le Graverand MPH, 2001, J ANAT, V198, P525, DOI 10.1046/j.1469-7580.2000.19850525.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009; Marsano A, 2006, BIOMATERIALS, V27, P5927, DOI 10.1016/j.biomaterials.2006.08.020; Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Martinek V, 2006, ARCH ORTHOP TRAUM SU, V126, P228, DOI 10.1007/s00402-005-0025-1; Mauck RL, 2007, ANAT REC, V290, P48, DOI 10.1002/ar.20419; McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140; MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8; McDevitt CA, 2002, CURR OPIN ORTHOP, V13, P345, DOI DOI 10.1097/00001433-200210000-00004; McDevitt CA, 1992, KNEE MENISCUS BASIC, P29; Melrose J, 2005, HISTOCHEM CELL BIOL, V124, P225, DOI 10.1007/s00418-005-0005-0; Messner K, 1998, J ANAT, V193, P161, DOI 10.1046/j.1469-7580.1998.19320161.x; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Nakata K, 2001, CLIN ORTHOP RELAT R, pS208; Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023; Pangborn CA, 2005, TISSUE ENG, V11, P1141, DOI 10.1089/ten.2005.11.1141; Pangborn CA, 2005, J ORTHOP RES, V23, P1184, DOI 10.1016/j.orthres.2005.01.019; Pradel W, 2008, J PHYSIOL PHARMACOL, V59, P47; Rodkey WG, 2010, MENISCUS, P367, DOI 10.1007/978-3-642-02450-4_11.1; Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281, DOI 10.1097/00003086-199910001-00027; Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656; Setton LA, 1999, CLIN ORTHOP RELAT R, pS254, DOI 10.1097/00003086-199910001-00025; Stone KR, 2010, J BONE JOINT SURG BR, V92B, P941, DOI 10.1302/0301-620X.92B7.23182; Tanaka T, 1999, KNEE SURG SPORT TR A, V7, P75, DOI 10.1007/s001670050125; VERDONK R, 1994, ORTHOPADE, V23, P153	49	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39339	10.1371/journal.pone.0039339	http://dx.doi.org/10.1371/journal.pone.0039339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720095	Green Published, gold, Green Submitted			2022-12-25	WOS:000305350000060
J	Clark, TD; Donaldson, MR; Pieperhoff, S; Drenner, SM; Lotto, A; Cooke, SJ; Hinch, SG; Patterson, DA; Farrell, AP				Clark, Timothy D.; Donaldson, Michael R.; Pieperhoff, Sebastian; Drenner, S. Matthew; Lotto, Andrew; Cooke, Steven J.; Hinch, Scott G.; Patterson, David A.; Farrell, Anthony P.			Physiological Benefits of Being Small in a Changing World: Responses of Coho Salmon (Oncorhynchus kisutch) to an Acute Thermal Challenge and a Simulated Capture Event	PLOS ONE			English	Article							CLIMATE-CHANGE; PACIFIC SALMON; MARINE FISHES; EXHAUSTIVE EXERCISE; OXYGEN-CONSUMPTION; NORTH PACIFIC; FRASER-RIVER; BODY-MASS; ION LOSS; TEMPERATURE	Evidence is building to suggest that both chronic and acute warm temperature exposure, as well as other anthropogenic perturbations, may select for small adult fish within a species. To shed light on this phenomenon, we investigated physiological and anatomical attributes associated with size-specific responses to an acute thermal challenge and a fisheries capture simulation (exercise+air exposure) in maturing male coho salmon (Oncorhynchus kisutch). Full-size females were included for a sex-specific comparison. A size-specific response in haematology to an acute thermal challenge (from 7 to 20 degrees C at 3 degrees C h(-1)) was apparent only for plasma potassium, whereby full-size males exhibited a significant increase in comparison with smaller males ('jacks'). Full-size females exhibited an elevated blood stress response in comparison with full-size males. Metabolic recovery following exhaustive exercise at 7 degrees C was size-specific, with jacks regaining resting levels of metabolism at 9.3+/-0.5 h post-exercise in comparison with 12.3+/-0.4 h for full-size fish of both sexes. Excess post-exercise oxygen consumption scaled with body mass in male fish with an exponent of b = 1.20+/-0.08. Jacks appeared to regain osmoregulatory homeostasis faster than full-size males, and they had higher ventilation rates at 1 h post-exercise. Peak metabolic rate during post-exercise recovery scaled with body mass with an exponent of b similar to 1, suggesting that the slower metabolic recovery in large fish was not due to limitations in diffusive or convective oxygen transport, but that large fish simply accumulated a greater 'oxygen debt' that took longer to pay back at the size-independent peak metabolic rate of similar to 6 mg min(-1) kg(-1). Post-exercise recovery of plasma testosterone was faster in jacks compared with full-size males, suggesting less impairment of the maturation trajectory of smaller fish. Supporting previous studies, these findings suggest that environmental change and non-lethal fisheries interactions have the potential to select for small individuals within fish populations over time.	[Clark, Timothy D.; Donaldson, Michael R.; Drenner, S. Matthew; Lotto, Andrew; Hinch, Scott G.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Pieperhoff, Sebastian] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Cooke, Steven J.] Carleton Univ, Fish Ecol & Conservat Physiol Lab, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Cooke, Steven J.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada; [Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Cooperat Resource Management Inst, Fisheries & Oceans Canada, Burnaby, BC V5A 1S6, Canada; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia; University of Edinburgh; Carleton University; Carleton University; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia	Clark, TD (corresponding author), Australian Inst Marine Sci, Townsville MC, PMB 3, Townsville, Qld 4810, Australia.	timothy.clark.mail@gmail.com	Clark, Timothy Darren/K-7129-2012; Cooke, Steven J/F-4193-2010	Clark, Timothy Darren/0000-0001-8738-3347; Cooke, Steven J/0000-0002-5407-0659; Donaldson, Michael/0000-0002-1178-5988	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Research funding was provided by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Baker MR, 2011, EVOL APPL, V4, P429, DOI 10.1111/j.1752-4571.2010.00154.x; Bigler BS, 1996, CAN J FISH AQUAT SCI, V53, P455, DOI 10.1139/cjfas-53-2-455; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Clark TD, 2011, J FISH BIOL, V79, P1322, DOI 10.1111/j.1095-8649.2011.03118.x; Clark TD, 2008, AM J PHYSIOL-REG I, V295, pR1631, DOI 10.1152/ajpregu.90461.2008; Clark TD, 2011, J EXP BIOL, V214, P3074, DOI 10.1242/jeb.060517; Clark TD, 2011, J EXP BIOL, V214, P887, DOI 10.1242/jeb.051607; Clark TD, 2010, J COMP PHYSIOL B, V180, P673, DOI 10.1007/s00360-009-0442-5; Clark TD, 2009, J COMP PHYSIOL B, V179, P663, DOI 10.1007/s00360-009-0349-1; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Cooke SJ, 2006, ECOLOGY, V87, P1575, DOI 10.1890/0012-9658(2006)87[1575:MBOIMI]2.0.CO;2; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DFO, 2006, CONS STRAT COH SALM; Donaldson MR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P973, DOI 10.1086/656336; Farrell AP, 2001, CAN J FISH AQUAT SCI, V58, P1932, DOI 10.1139/cjfas-58-10-1932; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Gallaugher PE, 2001, J EXP BIOL, V204, P2861; GONZALEZ RJ, 1994, J EXP BIOL, V190, P95; GONZALEZ RJ, 1992, J EXP BIOL, V163, P317; IWAMOTO RN, 1984, AQUACULTURE, V43, P105, DOI 10.1016/0044-8486(84)90015-2; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Jeffries KM, 2012, PHYSIOL BIOCHEM ZOOL, V85, P62, DOI 10.1086/663770; Kendall NW, 2009, EVOL APPL, V2, P523, DOI 10.1111/j.1752-4571.2009.00086.x; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Martins EG, 2011, CANADIAN J IN PRESS; Morita K, 2010, OIKOS, V119, P1265, DOI 10.1111/j.1600-0706.2009.18125.x; Morrison J, 2002, J HYDROL, V263, P230, DOI 10.1016/S0022-1694(02)00065-3; OIKAWA S, 1985, J EXP BIOL, V117, P1; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; PAULY D, 1981, MEERESFORSCHUNG, V28, P251; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; REIDY SP, 1995, J FISH BIOL, V47, P377, DOI 10.1111/j.1095-8649.1995.tb01907.x; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Ricker WE, 1981, CANADIAN J FISHERIES, V38, P1656; Sandblom E, 2009, AM J PHYSIOL-REG I, V297, pR1136, DOI 10.1152/ajpregu.00363.2009; SCARABELLO M, 1991, RESP PHYSIOL, V84, P245, DOI 10.1016/0034-5687(91)90121-X; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; SILVERSTEIN JT, 1992, J HERED, V83, P282, DOI 10.1093/oxfordjournals.jhered.a111214; SLATER CH, 1994, COMP BIOCHEM PHYS A, V109, P167, DOI 10.1016/0300-9629(94)90323-9; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Walker RV, 2000, FISH OCEANOGR, V9, P171, DOI 10.1046/j.1365-2419.2000.00131.x; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x; WOOD CM, 1991, J EXP BIOL, V160, P285	49	65	66	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39079	10.1371/journal.pone.0039079	http://dx.doi.org/10.1371/journal.pone.0039079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720035	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900080
J	Liu, Y; Li, YJ; Luo, EP; Lu, HB; Yin, H				Liu, Yang; Li, Yi-Jun; Luo, Er-Ping; Lu, Hong-Bing; Yin, Hong			Cortical Thinning in Patients with Recent Onset Post-Traumatic Stress Disorder after a Single Prolonged Trauma Exposure	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; HIPPOCAMPAL VOLUME; CEREBRAL-CORTEX; BRAIN; THICKNESS; MEMORY; CINGULATE; SURVIVORS; FMRI	Most of magnetic resonance imaging (MRI) studies about post-traumatic stress disorder (PTSD) focused primarily on measuring of small brain structure volume or regional brain volume changes. There were rare reports investigating cortical thickness alterations in recent onset PTSD. Recent advances in computational analysis made it possible to measure cortical thickness in a fully automatic way, along with voxel-based morphometry (VBM) that enables an exploration of global structural changes throughout the brain by applying statistical parametric mapping (SPM) to high-resolution MRI. In this paper, Laplacian method was utilized to estimate cortical thickness after automatic segmentation of gray matter from MR images under SPM. Then thickness maps were analyzed by SPM8. Comparison between 10 survivors from a mining disaster with recent onset PTSD and 10 survivors without PTSD from the same trauma indicates cortical thinning in the left parietal lobe, right inferior frontal gyrus, and right parahippocampal gyrus. The regional cortical thickness of the right inferior frontal gyrus showed a significant negative correlation with the CAPS score in the patients with PTSD. Our study suggests that shape-related cortical thickness analysis may be more sensitive than volumetric analysis to subtle alteration at early stage of PTSD.	[Liu, Yang; Li, Yi-Jun; Luo, Er-Ping; Lu, Hong-Bing] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Shaanxi, Peoples R China; [Yin, Hong] Xijing Hosp, Dept Radiol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, Y (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Shaanxi, Peoples R China.	luhb@fmmu.edu.cn; yinhong@fmmu.edu.cn	Yin, Hong/AAC-5784-2020; Yin, Hong/G-3877-2014	Yin, Hong/0000-0002-5215-1455	National Natural Science Foundation of China [81071220, 81171278]; National Science & Technology Pillar Program [2011BAI12B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program	This work was partially supported by the National Natural Science Foundation of China under Grant No. 81071220 and 81171278, and the National Science & Technology Pillar Program under Grant No. 2011BAI12B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Chen Z, 2011, EUR J RADIOL    0503; Corbo V, 2005, BIOL PSYCHIAT, V58, P119, DOI 10.1016/j.biopsych.2005.02.032; De Bellis MD, 2006, BIOL PSYCHIAT, V60, P697, DOI 10.1016/j.biopsych.2006.04.035; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Diep TM, 2007, I S BIOMED IMAGING, P592, DOI 10.1109/ISBI.2007.356921; Molina ME, 2010, WORLD J BIOL PSYCHIA, V11, P493, DOI 10.3109/15622970701472094; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Geuze E, 2007, PROG BRAIN RES, V167, P293, DOI 10.1016/S0079-6123(07)67026-5; GRIFFIN LD, 1994, J THEOR BIOL, V166, P261, DOI 10.1006/jtbi.1994.1024; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; Haidar H, 2006, J NEUROIMAGING, V16, P146, DOI 10.1111/j.1552-6569.2006.00036.x; HAIDAR H, 2005, J MATH MODELLING ALG, V4, P83, DOI DOI 10.1007/S10852-004-3524-0; Hou CL, 2007, BRAIN RES, V1144, P165, DOI 10.1016/j.brainres.2007.01.089; Hutton C, 2008, NEUROIMAGE, V40, P1701, DOI 10.1016/j.neuroimage.2008.01.027; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Karama S, 2011, NEUROIMAGE, V55, P1443, DOI 10.1016/j.neuroimage.2011.01.016; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Landre L, 2010, PSYCHIAT RES-NEUROIM, V183, P181, DOI 10.1016/j.pscychresns.2010.01.015; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Liberzon I, 1996, Depress Anxiety, V4, P146; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Lyons DM, 2007, BIOL PSYCHIAT, V62, P1171, DOI 10.1016/j.biopsych.2007.03.012; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Moores KA, 2008, PSYCHIAT RES-NEUROIM, V163, P156, DOI 10.1016/j.pscychresns.2007.08.011; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Narr KL, 2005, BIOL PSYCHIAT, V58, P32, DOI 10.1016/j.biopsych.2005.03.043; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; Peres JFP, 2007, PSYCHOL MED, V37, P1481, DOI 10.1017/S003329170700997X; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Spitzer B, 1996, STRUCT CLIN INT DSMI; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Taylor JG, 2000, NEURAL NETWORKS, V13, P923, DOI 10.1016/S0893-6080(00)00054-X; Thomaes K, 2009, PSYCHIAT RES-NEUROIM, V171, P44, DOI 10.1016/j.pscychresns.2008.03.003; Thompson PM, 2005, J NEUROSCI, V25, P4146, DOI 10.1523/JNEUROSCI.0165-05.2005; Wager TD, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P19, DOI 10.1017/CBO9780511546396.002; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Woodward SH, 2006, AM J PSYCHIAT, V163, P674, DOI 10.1176/appi.ajp.163.4.674; Woodward SH, 2009, ARCH GEN PSYCHIAT, V66, P1373, DOI 10.1001/archgenpsychiatry.2009.160; Wu K.K., 2004, HONG KONG J PSYCHIAT, V14, P2, DOI DOI 10.1007/S00127-003-0611-X; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016; Yehuda R, 2007, J PSYCHIATR RES, V41, P435, DOI 10.1016/j.jpsychires.2005.12.002; Yezzi AJ, 2003, IEEE T MED IMAGING, V22, P1332, DOI 10.1109/TMI.2003.817775; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	63	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39025	10.1371/journal.pone.0039025	http://dx.doi.org/10.1371/journal.pone.0039025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720021	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900075
J	Longoni, N; Kunderfranco, P; Pellini, S; Albino, D; Mello-Grand, M; Pinton, S; D'Ambrosio, G; Sarti, M; Sessa, F; Chiorino, G; Catapano, CV; Carbone, GM				Longoni, N.; Kunderfranco, P.; Pellini, S.; Albino, D.; Mello-Grand, M.; Pinton, S.; D'Ambrosio, G.; Sarti, M.; Sessa, F.; Chiorino, G.; Catapano, C. V.; Carbone, G. M.			Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression	ONCOGENE			English	Article						prostate cancer; DCDC2; doublecortin domain containing 2 protein; ESE3/EHF; ETS; cell migration; taxol resistance	MICROTUBULE-ASSOCIATED PROTEIN; PACLITAXEL SENSITIVITY; TRANSCRIPTION FACTORS; DOUBLECORTIN GENE; DCX SUPERFAMILY; MARKER; DISEASE; FAMILY; AGENTS; ROLES	By integrating gene profiling and immunohistochemical data with functional experiments in cell lines in this study we show for the first time that doublecortin (DCX) domain containing 2 (DCDC2), a protein belonging to the DCX family and involved in neuronal cell migration, is aberrantly expressed in prostate tumors whereas absent in normal prostate. Furthermore, in patients treated with radical prostatectomy, high levels of DCDC2 RNA were significantly associated with increased biochemical relapse (LogRank Mantel-Cox 0.012). Mechanistically, we found that the ETS transcription factor ESE3/EHF, which is expressed in normal prostate and frequently lost in prostate tumors, maintained DCDC2 repressed by binding to a novel identified ETS binding site in the gene promoter. Consistently, in prostate tumors and in cellular models of gain and loss of ESE3/EHF, the expression of DCDC2 and ESE3/EHF were inversely correlated. In prostate cancer cells, DCDC2 colocalized with microtubules and promoted cell migration and resistance to the microtubule-targeting drug taxol. Collectively, this study establishes DCDC2 as a novel ESE3/EHF oncogenic target in prostate cancer. These findings may be relevant for the clinical management of prostate cancer as DCDC2 may signal tumors more prone to relapse and resistant to taxol treatment.	[Longoni, N.; Kunderfranco, P.; Pellini, S.; Albino, D.; Pinton, S.; Sarti, M.; Catapano, C. V.; Carbone, G. M.] IOR, Bellinzona, Switzerland; [Longoni, N.; Kunderfranco, P.; Pellini, S.; Albino, D.; Pinton, S.; Sarti, M.; Catapano, C. V.; Carbone, G. M.] Oncol Inst Sourthern Switzerland IOSI, CH-6500 Bellinzona, Switzerland; [Mello-Grand, M.; Chiorino, G.] Fdn Edo & Elvo Tempia Valenta, Lab Canc Genom, Biella, Italy; [Sessa, F.] IRCCS Multimed, Milan, Italy; [Sessa, F.] Univ Insubria, Dept Pathol, Varese, Italy	Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Institute of Oncology Research (IOR); IRCCS Multimedica; University of Insubria	Carbone, GM (corresponding author), Oncol Inst Sourthern Switzerland IOSI, IOR, Via Vela 6, CH-6500 Bellinzona, Switzerland.	pina.carbone@ior.iosi.ch	Kunderfranco, Paolo/J-7636-2016; Kunderfranco, Paolo/GUQ-8968-2022; Chiorino, Giovanna/K-5037-2016; Kunderfranco, Paolo/ABH-9294-2020	Kunderfranco, Paolo/0000-0003-3636-3391; Kunderfranco, Paolo/0000-0001-7477-8710; Chiorino, Giovanna/0000-0002-9502-6400; Kunderfranco, Paolo/0000-0001-7477-8710; Catapano, Carlo V./0000-0002-7079-557X	Oncosuisse [KFS-01913-08, KFS-02573-02-2010]; Swiss National Science Foundation [FNS-31003A-118113]; Ticino Foundation for Cancer Research; Compagnia di San Paolo, Torino, Italy	Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ticino Foundation for Cancer Research; Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo)	This work was supported by grants from Oncosuisse (KFS-01913-08 and KFS-02573-02-2010), Swiss National Science Foundation (FNS-31003A-118113) and Ticino Foundation for Cancer Research to GMC. MMG and GC were supported by Compagnia di San Paolo, Torino, Italy.	Albertini V, 2006, NUCLEIC ACIDS RES, V34, P1721, DOI 10.1093/nar/gkl063; Bowen C, 2000, CANCER RES, V60, P6111; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Daou MC, 2005, ACTA NEUROPATHOL, V110, P472, DOI 10.1007/s00401-005-1070-0; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Dijkmans Thomas Frederik, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P32; Dobyns WB, 1999, NEUROLOGY, V53, P270, DOI 10.1212/WNL.53.2.270; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Massinen S, PLOS ONE, V6; Meng HY, 2011, BEHAV GENET, V41, P58, DOI 10.1007/s10519-010-9408-3; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Oltra S, 2005, DIAGN MOL PATHOL, V14, P53, DOI 10.1097/01.pas.0000149876.32376.c0; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Soltani MH, 2005, AM J PATHOL, V166, P1841, DOI 10.1016/S0002-9440(10)62493-5; Tint I, 2009, J NEUROSCI, V29, P10995, DOI 10.1523/JNEUROSCI.3399-09.2009; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Viprey VF, 2008, J PATHOL, V216, P245, DOI 10.1002/path.2406; Wagner P, 2005, CELL CYCLE, V4, P1149, DOI 10.4161/cc.4.9.2038; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	35	16	17	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2013	32	18					2315	2324		10.1038/onc.2012.245	http://dx.doi.org/10.1038/onc.2012.245			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	140VF	22733135				2022-12-25	WOS:000318683600008
J	Haque, MM; Fadlalla, MA; Aulak, KS; Ghosh, A; Durra, D; Stuehr, DJ				Haque, Mohammad Mahfuzul; Fadlalla, Mohammed A.; Aulak, Kulwant S.; Ghosh, Arnab; Durra, Deborah; Stuehr, Dennis J.			Control of Electron Transfer and Catalysis in Neuronal Nitric-oxide Synthase (nNOS) by a Hinge Connecting Its FMN and FAD-NADPH Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NO COMPLEX-FORMATION; REDUCTASE DOMAIN; CONFORMATIONAL EQUILIBRIUM; CYTOCHROME-P450 REDUCTASE; FLAVOPROTEIN DOMAIN; SURFACE-CHARGE; HEME REDUCTION; CALMODULIN; FLAVIN; MECHANISM	In nitric-oxide synthases (NOSs), two flexible hinges connect the FMN domain to the rest of the enzyme and may guide its interactions with partner domains for electron transfer and catalysis. We investigated the role of the FMN-FAD/NADPH hinge in rat neuronalNOS(nNOS) by constructing mutants that either shortened or lengthened this hinge by 2, 4, and 6 residues. Shortening the hinge progressively inhibited electron flux through the calmodulin (CaM)-free and CaM-bound nNOS to cytochrome c, whereas hinge lengthening relieved repression of electron flux in CaM-free nNOS and had no impact or slowed electron flux through CaM-bound nNOS to cytochrome c. How hinge length influenced heme reduction depended on whether enzyme flavins were pre-reduced with NADPH prior to triggering heme reduction. Without pre-reduction, changing the hinge length was deleterious; with pre-reduction, the hinge shortening was deleterious, and hinge lengthening increased heme reduction rates beyond wild type. Flavin fluorescence and stopped-flow kinetic studies on CaM-bound enzymes suggested hinge lengthening slowed the domain-domain interaction needed for FMN reduction. All hinge length changes lowered NO synthesis activity and increased uncoupled NADPH consumption. We conclude that several aspects of catalysis are sensitive to FMN-FAD/NADPH hinge length and that the native hinge allows a best compromise among the FMN domain interactions and associated electron transfer events to maximize NO synthesis and minimize uncoupled NADPH consumption.	[Haque, Mohammad Mahfuzul; Fadlalla, Mohammed A.; Aulak, Kulwant S.; Ghosh, Arnab; Durra, Deborah; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol NC 22, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org		HAQUE, MOHAMMAD/0000-0003-0852-6368; GHOSH, ARNAB/0000-0002-7498-1994	National Institutes of Health [GM51491, CA53914, HL58883]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM51491, CA53914, and HL58883 (to D. J. S.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Astashkin AV, 2010, J AM CHEM SOC, V132, P12059, DOI 10.1021/ja104461p; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2001, BIOCHEM SOC T, V29, P147, DOI 10.1042/0300-5127:0290147; Feng CJ, 2009, J BIOL INORG CHEM, V14, P133, DOI 10.1007/s00775-008-0431-2; Finn RD, 2003, EUR J BIOCHEM, V270, P1164, DOI 10.1046/j.1432-1033.2003.03474.x; Forstermann U, 1998, FASEB J, V12, P773; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2006, J BIOL CHEM, V281, P14173, DOI 10.1074/jbc.M509937200; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Grunau A, 2007, BIOCHEMISTRY-US, V46, P8244, DOI 10.1021/bi700596s; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2011, FEBS J, V278, P4055, DOI 10.1111/j.1742-4658.2011.08310.x; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; KLATT P, 1992, J BIOL CHEM, V267, P11374; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Laursen T, 2011, BBA-PROTEINS PROTEOM, V1814, P132, DOI 10.1016/j.bbapap.2010.07.003; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Panda K, 2004, J BIOL CHEM, V279, P18323, DOI 10.1074/jbc.M310391200; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tejero J, 2011, BIOCHEM J, V433, P163, DOI 10.1042/BJ20101353; Tejero J, 2010, J BIOL CHEM, V285, P27232, DOI 10.1074/jbc.M110.138842; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Welland A, 2010, FEBS J, V277, P3833, DOI 10.1111/j.1742-4658.2010.07787.x; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532	57	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30105	30116		10.1074/jbc.M112.339697	http://dx.doi.org/10.1074/jbc.M112.339697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22722929	hybrid, Green Published			2022-12-25	WOS:000308579800006
J	Murakami, R; Mutoh, R; Iwase, R; Furukawa, Y; Imada, K; Onai, K; Morishita, M; Yasui, S; Ishii, K; Swain, JOV; Uzumaki, T; Namba, K; Ishiura, M				Murakami, Reiko; Mutoh, Risa; Iwase, Ryo; Furukawa, Yukio; Imada, Katsumi; Onai, Kiyoshi; Morishita, Megumi; Yasui, So; Ishii, Kentaro; Swain, Jonathan Orville Valencia; Uzumaki, Tatsuya; Namba, Keiichi; Ishiura, Masahiro			The Roles of the Dimeric and Tetrameric Structures of the Clock Protein KaiB in the Generation of Circadian Oscillations in Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; SYNECHOCOCCUS-ELONGATUS; CRYSTAL-STRUCTURE; HISTIDINE KINASE; ATPASE ACTIVITY; REAL-TIME; IN-VITRO; PHOSPHORYLATION; COMPLEX; SYSTEM	The molecular machinery of the cyanobacterial circadian clock consists of three proteins, KaiA, KaiB, and KaiC. The three Kai proteins interact with each other and generate circadian oscillations in vitro in the presence of ATP (an in vitro KaiABC clock system). KaiB consists of four subunits organized as a dimer of dimers, and its overall shape is that of an elongated hexagonal plate with a positively charged cleft flanked by two negatively charged ridges. We found that a mutant KaiB with a C- terminal deletion ( KaiB(1-94)), which lacks the negatively charged ridges, was a dimer. Despite its dimeric structure, KaiB(1-94) interacted with KaiC and generated normal circadian oscillations in the in vitro KaiABC clock system. KaiB(1-94) also generated circadian oscillations in cyanobacterial cells, but they were weak, indicating that the C- terminal region and tetrameric structure of KaiB are necessary for the generation of normal gene expression rhythms in vivo. KaiB(1-94) showed the highest affinity for KaiC among the KaiC-binding proteins we examined and inhibited KaiC from forming a complex with SasA, which is involved in the main output pathway from the KaiABC clock oscillator in transcription regulation. This defect explains the mechanism underlying the lack of normal gene expression rhythms in cells expressing KaiB(1-94.)	[Mutoh, Risa; Iwase, Ryo; Yasui, So; Swain, Jonathan Orville Valencia; Uzumaki, Tatsuya; Ishiura, Masahiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Murakami, Reiko; Mutoh, Risa; Iwase, Ryo; Onai, Kiyoshi; Morishita, Megumi; Yasui, So; Ishii, Kentaro; Swain, Jonathan Orville Valencia; Ishiura, Masahiro] Nagoya Univ, Grad Sch Sci, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Furukawa, Yukio; Imada, Katsumi; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Nagoya University; Nagoya University; Osaka University	Ishiura, M (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	ishiura@gene.nagoya-u.ac.jp	Mutoh, Risa/L-6494-2017; Namba, Keiichi/A-9406-2016	Mutoh, Risa/0000-0003-0069-8931; Ishii, Kentaro/0000-0003-1722-2673; Onai, Kiyoshi/0000-0001-9062-2548; Imada, Katsumi/0000-0003-1342-8885	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Leavanest; MBL (Tokyo, Japan); Global Center of Excellence grant from Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists; SENTAN, JST	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Leavanest; MBL (Tokyo, Japan); Global Center of Excellence grant from Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SENTAN, JST(Japan Science & Technology Agency (JST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. I. and K. O.).; Supported by a grant from Leavanest and MBL (Tokyo, Japan).; Research assistants supported by a Global Center of Excellence grant from Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Supported by grants from Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. Present address: Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan.; We thank Satoko Ogawa and Kumiko Tanaka for technical support and Miriam Bloom (SciWrite Biomedical Writing and Editing Services) for professional editing. Development of the automated bioluminescence monitoring apparatus CL96-4 and the plate conveyor robot CI-08L were supported by SENTAN, JST. The apparatuses CL96-4 and CI- 08Lare commercially available through Churitsu Electric Corp. (Nagoya, Japan).	Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Aoki Setsuyuki, 2009, P259, DOI 10.1007/978-3-540-88431-6_15; Bunning E., 1973, PHYSL CLOCK CIRCADIA; Chang YG, 2011, P NATL ACAD SCI USA, V108, P14431, DOI 10.1073/pnas.1104221108; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Hayashi F, 2004, J BIOL CHEM, V279, P52331, DOI 10.1074/jbc.M406604200; Hayashi F, 2004, BIOCHEM BIOPH RES CO, V316, P195, DOI 10.1016/j.bbrc.2004.02.034; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Mutoh R, 2011, APPL MAGN RESON, V40, P525, DOI 10.1007/s00723-011-0228-2; Mutoh R, 2010, GENES CELLS, V15, P269, DOI 10.1111/j.1365-2443.2009.01377.x; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Okamoto K, 2005, PLANT CELL ENVIRON, V28, P1305, DOI 10.1111/j.1365-3040.2005.01377.x; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Onai M, 2004, J BACTERIOL, V186, P4972, DOI 10.1128/JB.186.15.4972-4977.2004; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023697; SWEENEY BM, 1989, J PHYCOL, V25, P183, DOI 10.1111/j.0022-3646.1989.00183.x; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uzumaki T, 2004, NAT STRUCT MOL BIOL, V11, P623, DOI 10.1038/nsmb781; Vakonakis I, 2004, J MOL BIOL, V342, P9, DOI 10.1016/j.jmb.2004.07.010; Valencia J, 2012, GENES CELLS, V17, P398, DOI 10.1111/j.1365-2443.2012.01597.x; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; YAMAOKA T, 1978, PLANT CELL PHYSIOL, V19, P943, DOI 10.1093/oxfordjournals.pcp.a075684	42	33	34	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2012	287	35					29506	29515		10.1074/jbc.M112.349092	http://dx.doi.org/10.1074/jbc.M112.349092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	999CO	22722936	hybrid, Green Published			2022-12-25	WOS:000308286900027
J	Cash, JG; Kuhel, DG; Basford, JE; Jaeschke, A; Chatterjee, TK; Weintraub, NL; Hui, DY				Cash, James G.; Kuhel, David G.; Basford, Joshua E.; Jaeschke, Anja; Chatterjee, Tapan K.; Weintraub, Neal L.; Hui, David Y.			Apolipoprotein E4 Impairs Macrophage Efferocytosis and Potentiates Apoptosis by Accelerating Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE STRUCTURE CORRECTORS; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHASE; AMYLOID-BETA PEPTIDE; DIET-INDUCED OBESITY; DOMAIN INTERACTION; LDL RECEPTOR; MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE	Apolipoprotein (apo) E4 is a major genetic risk factor for a wide spectrum of inflammatory metabolic diseases, including atherosclerosis, diabetes, and Alzheimer disease. This study compared diet-induced adipose tissue inflammation as well as functional properties of macrophages isolated from human APOE3 and APOE4 mice to identify the mechanism responsible for the association between apoE4 and inflammatory metabolic diseases. The initial study confirmed previous reports that APOE4 gene replacement mice were less sensitive than APOE3 mice to diet-induced body weight gain but exhibited hyperinsulinemia, and their adipose tissues were similarly inflamed as those in APOE3 mice. Peritoneal macrophages isolated from APOE4 mice were defective in efferocytosis compared with APOE3 macrophages. Increased cell death was also observed in APOE4 macrophages when stimulated with LPS or oxidized LDL. Western blot analysis of cell lysates revealed that APOE4 macrophages displayed elevated JNK phosphorylation indicative of cell stress even under basal culturing conditions. Significantly higher cell stress due mainly to potentiation of endoplasmic reticulum (ER) stress signaling was also observed in APOE4 macrophages after LPS and oxidized LDL activation. The defect in efferocytosis and elevated apoptosis sensitivity of APOE4 macrophages was ameliorated by treatment with the ER chaperone tauroursodeoxycholic acid. Taken together, these results showed that apoE4 expression causes macrophage dysfunction and promotes apoptosis via ER stress induction. The reduction of ER stress in macrophages may be a viable option to reduce inflammation and inflammation-related metabolic disorders associated with the apoE4 polymorphism.	[Cash, James G.; Kuhel, David G.; Basford, Joshua E.; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Chatterjee, Tapan K.; Weintraub, Neal L.] Univ Cincinnati, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Dept Pathol ML 0507, Metab Dis Inst, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu		Weintraub, Neal/0000-0002-5138-3705	National Institutes of Health [DK74932]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112640, R01HL076684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK74932 (to D. Y. H.).	Altenburg M, 2007, J BIOL CHEM, V282, P7817, DOI 10.1074/jbc.M610712200; Anthopoulos PG, 2010, MOL GENET METAB, V100, P283, DOI 10.1016/j.ymgme.2010.03.008; Arbones-Mainar JM, 2008, INT J OBESITY, V32, P1595, DOI 10.1038/ijo.2008.143; Arbones-Mainar JM, 2010, FASEB J, V24, P3809, DOI 10.1096/fj.10-159517; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cash JG, 2011, INT J OBESITY, V35, P877, DOI 10.1038/ijo.2010.215; Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Eberle D, 2012, ARTERIOSCL THROM VAS, V32, P1116, DOI 10.1161/ATVBAHA.112.246389; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Johnson LA, 2011, DIABETES, V60, P2285, DOI 10.2337/db11-0466; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kodvawala A, 2005, J BIOL CHEM, V280, P38592, DOI 10.1074/jbc.M502266200; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1989, METABOLIC BASIS INHE, V1, P1195; Marques MA, 2003, J MOL NEUROSCI, V20, P327, DOI 10.1385/JMN:20:3:327; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Moore ZWQ, 2005, J LIPID RES, V46, P2083, DOI 10.1194/jlr.M500177-JLR200; Moore ZWQ, 2004, AM J PATHOL, V164, P2109, DOI 10.1016/S0002-9440(10)63769-8; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Sacre SM, 2003, FEBS LETT, V540, P181, DOI 10.1016/S0014-5793(03)00261-8; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sima A, 2007, CLIN CHEM LAB MED, V45, P1149, DOI 10.1515/CCLM.2007.258; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Vaisi-Raygani A, 2007, CLIN BIOCHEM, V40, P1150, DOI 10.1016/j.clinbiochem.2007.06.010; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Volcik KA, 2006, AM J EPIDEMIOL, V164, P342, DOI 10.1093/aje/kwj202; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Xaus J, 2000, BLOOD, V95, P3823; Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464; Zhu YJ, 2010, BIOCHEM J, V428, P47, DOI 10.1042/BJ20100016	58	61	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27876	27884		10.1074/jbc.M112.377549	http://dx.doi.org/10.1074/jbc.M112.377549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730380	Green Published, hybrid			2022-12-25	WOS:000307840700061
J	Ebner-Bennatan, S; Patrich, E; Peretz, A; Kornilov, P; Tiran, Z; Elson, A; Attali, B				Ebner-Bennatan, Sharon; Patrich, Eti; Peretz, Asher; Kornilov, Polina; Tiran, Zohar; Elson, Ari; Attali, Bernard			Multifaceted Modulation of K+ Channels by Protein-tyrosine Phosphatase epsilon Tunes Neuronal Excitability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA1 PYRAMIDAL CELLS; LONG-TERM POTENTIATION; ACTIVATED POTASSIUM CHANNELS; LARGE-CONDUCTANCE; DEPENDENT REGULATION; HIPPOCAMPAL-NEURONS; SCHWANN-CELLS; SPIKE AFTERDEPOLARIZATION; ACETYLCHOLINE-RECEPTOR; BURST GENERATION	Non-receptor-tyrosine kinases (protein-tyrosine kinases) and non-receptor tyrosine phosphatases (PTPs) have been implicated in the regulation of ion channels, neuronal excitability, and synaptic plasticity. We previously showed that protein-tyrosine kinases such as Src kinase and PTPs such as PTP alpha and PTP epsilon modulate the activity of delayed-rectifier K+ channels (IK). Here we show cultured cortical neurons from PTP epsilon knockout (EKO) mice to exhibit increased excitability when compared with wild type (WT) mice, with larger spike discharge frequency, enhanced fast after-hyperpolarization, increased after-depolarization, and reduced spike width. A decrease in IK and a rise in large-conductance Ca2+-activated K+ currents (mBK) were observed in EKO cortical neurons compared with WT. Parallel studies in transfected CHO cells indicate that Kv1.1, Kv1.2, Kv7.2/7.3, and mBK are plausible molecular correlates of this multifaceted modulation of K+ channels by PTP epsilon. In CHO cells, Kv1.1, Kv1.2, and Kv7.2/7.3 K+ currents were up-regulated by PTP epsilon, whereas mBK channel activity was reduced. The levels of tyrosine phosphorylation of Kv1.1, Kv1.2, Kv7.3, and mBK potassium channels were increased in the brain cortices of neonatal and adult EKO mice compared with WT, suggesting that PTP epsilon in the brain modulates these channel proteins. Our data indicate that in EKO mice, the lack of PTP epsilon-mediated dephosphorylation of Kv1.1, Kv1.2, and Kv7.3 leads to decreased IK density and enhanced after-depolarization. In addition, the deficient PTP epsilon-mediated dephosphorylation of mBK channels likely contributes to enhanced mBK and fast after-hyperpolarization, spike shortening, and consequent increase in neuronal excitability observed in cortical neurons from EKO mice.	[Ebner-Bennatan, Sharon; Patrich, Eti; Peretz, Asher; Kornilov, Polina; Attali, Bernard] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Tiran, Zohar; Elson, Ari] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Attali, B (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	battali@post.tau.ac.il		Elson, Ari/0000-0001-9808-9135	Deutsch-Israelische Projektkooperation DIP fund	Deutsch-Israelische Projektkooperation DIP fund	This work was supported by the Deutsch-Israelische Projektkooperation DIP fund to B.A.	ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; Ahn M, 2007, J NEUROSCI, V27, P11533, DOI 10.1523/JNEUROSCI.5005-06.2007; Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Chen SM, 2005, J PHYSIOL-LONDON, V567, P79, DOI 10.1113/jphysiol.2005.084590; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fadool DA, 1997, J NEUROPHYSIOL, V78, P1563, DOI 10.1152/jn.1997.78.3.1563; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Gamper N, 2003, J NEUROSCI, V23, P84; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Golomb D, 2006, J NEUROPHYSIOL, V96, P1912, DOI 10.1152/jn.00205.2006; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; Imbrici P, 2000, PFLUG ARCH EUR J PHY, V441, P257, DOI 10.1007/s004240000406; Jaffe DB, 2011, NEUROSCIENCE, V192, P205, DOI 10.1016/j.neuroscience.2011.06.028; Jia QZ, 2007, J NEUROSCI, V27, P2503, DOI 10.1523/JNEUROSCI.2911-06.2007; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; Li Y, 2004, J BIOL CHEM, V279, P45399, DOI 10.1074/jbc.M408410200; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; Metz AE, 2007, J PHYSIOL-LONDON, V581, P175, DOI 10.1113/jphysiol.2006.127068; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nitabach MN, 2002, J NEUROSCI, V22, P7913; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Peretz A, 1999, J PHYSIOL-LONDON, V519, P373, DOI 10.1111/j.1469-7793.1999.0373m.x; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; REINHART PH, 1991, J NEUROSCI, V11, P1627; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Sobko A, 1998, EMBO J, V17, P4723, DOI 10.1093/emboj/17.16.4723; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; Szabo I, 1996, J BIOL CHEM, V271, P20465, DOI 10.1074/jbc.271.34.20465; Tian L, 2008, J BIOL CHEM, V283, P3067, DOI 10.1074/jbc.M706826200; Tiran Z, 2003, J BIOL CHEM, V278, P17509, DOI 10.1074/jbc.M212766200; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Zhou R, 2005, CARDIOVASC RES, V68, P327, DOI 10.1016/j.cardiores.2005.06.005	68	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27614	27628		10.1074/jbc.M112.342519	http://dx.doi.org/10.1074/jbc.M112.342519			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722941	Green Published, hybrid			2022-12-25	WOS:000307840700036
J	Andreote, FD; Jimenez, DJ; Chaves, D; Dias, ACF; Luvizotto, DM; Dini-Andreote, F; Fasanella, CC; Lopez, MV; Baena, S; Taketani, RG; de Melo, IS				Andreote, Fernando Dini; Javier Jimenez, Diego; Chaves, Diego; Franco Dias, Armando Cavalcante; Luvizotto, Danice Mazzer; Dini-Andreote, Francisco; Fasanella, Cristiane Cipola; Lopez, Maryeimy Varon; Baena, Sandra; Taketani, Rodrigo Gouvea; de Melo, Itamar Soares			The Microbiome of Brazilian Mangrove Sediments as Revealed by Metagenomics	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; ARCHAEAL COMMUNITIES; DIVERSITY; PRODUCTIVITY; GENERATION; REDUCTION; RESOURCE; GENOMICS; ECOLOGY; SERVER	Here we embark in a deep metagenomic survey that revealed the taxonomic and potential metabolic pathways aspects of mangrove sediment microbiology. The extraction of DNA from sediment samples and the direct application of pyrosequencing resulted in approximately 215 Mb of data from four distinct mangrove areas (BrMgv01 to 04) in Brazil. The taxonomic approaches applied revealed the dominance of Deltaproteobacteria and Gammaproteobacteria in the samples. Paired statistical analysis showed higher proportions of specific taxonomic groups in each dataset. The metabolic reconstruction indicated the possible occurrence of processes modulated by the prevailing conditions found in mangrove sediments. In terms of carbon cycling, the sequences indicated the prevalence of genes involved in the metabolism of methane, formaldehyde, and carbon dioxide. With respect to the nitrogen cycle, evidence for sequences associated with dissimilatory reduction of nitrate, nitrogen immobilization, and denitrification was detected. Sequences related to the production of adenylsulfate, sulfite, and H2S were relevant to the sulphur cycle. These data indicate that the microbial core involved in methane, nitrogen, and sulphur metabolism consists mainly of Burkholderiaceae, Planctomycetaceae, Rhodobacteraceae, and Desulfobacteraceae. Comparison of our data to datasets from soil and sea samples resulted in the allotment of the mangrove sediments between those samples. The results of this study add valuable data about the composition of microbial communities in mangroves and also shed light on possible transformations promoted by microbial organisms in mangrove sediments.	[Andreote, Fernando Dini; Franco Dias, Armando Cavalcante; Luvizotto, Danice Mazzer; Dini-Andreote, Francisco; Fasanella, Cristiane Cipola; Lopez, Maryeimy Varon] Univ Sao Paulo, Dept Soil Sci, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil; [Javier Jimenez, Diego; Baena, Sandra] Pontificia Univ Javeriana, Dept Biol, Bogota, Distrito Capita, Colombia; [Javier Jimenez, Diego] Colombian Corp Agr Res CORPO, Ctr Biotechnol & Bioind, Bogota, Distrito Capita, Colombia; [Javier Jimenez, Diego; Chaves, Diego; Baena, Sandra] Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, Distrito Capita, Colombia; [Taketani, Rodrigo Gouvea; de Melo, Itamar Soares] EMBRAPA Environm, Lab Environm Microbiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Pontificia Universidad Javeriana; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Andreote, FD (corresponding author), Univ Sao Paulo, Dept Soil Sci, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil.	fdandreo@gmail.com	Dias, Armando Cavalcante Franco/O-1477-2019; Taketani, Rodrigo Gouvêa/D-1145-2011; Dini-Andreote, Francisco/M-6176-2017; Jimenez, Diego/GNW-3973-2022; Dias, Armando Cavalcante Franco/F-5878-2012; Baena, Sandra/AAF-8165-2019; Andreote, Fernando Dini/B-8499-2012; Melo, Itamar S/I-8516-2012	Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Taketani, Rodrigo Gouvêa/0000-0002-5999-8704; Dini-Andreote, Francisco/0000-0002-6654-0769; Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Andreote, Fernando Dini/0000-0002-9883-9968; Baena, Sandra/0000-0001-5377-9079; Jimenez Avella, Diego Javier/0000-0002-9339-6520	Sao Paulo Research Foundation (FAPESP) [2004/13910-6]; FAPESP [Proc. 2008/54013-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported financially by the Sao Paulo Research Foundation (FAPESP, proc. number 2004/13910-6), and A.C.F. Dias received a graduate fellowship from FAPESP (Proc. 2008/54013-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONGI DM, 1988, MICROBIAL ECOL, V15, P59, DOI 10.1007/BF02012952; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Andreote FD, 2009, BRAZ J MICROBIOL, V40, P417, DOI 10.1590/S1517-83822009000300001; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2011, ISME J, V5, P1038, DOI 10.1038/ismej.2010.199; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Clark MW, 1998, CHEM GEOL, V149, P147, DOI 10.1016/S0009-2541(98)00034-5; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dar SA, 2008, APPL MICROBIOL BIOT, V78, P1045, DOI 10.1007/s00253-008-1391-8; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dias ACF, 2010, ANTON LEEUW INT J G, V98, P541, DOI 10.1007/s10482-010-9471-z; Dias ACF, 2009, WORLD J MICROB BIOT, V25, P1305, DOI 10.1007/s11274-009-0013-7; dos Santos HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016943; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Ferreira TO, 2010, J SOIL SEDIMENT, V10, P995, DOI 10.1007/s11368-010-0224-4; Flores-Mireles AL, 2007, APPL ENVIRON MICROB, V73, P7308, DOI 10.1128/AEM.01892-06; Dias ACF, 2011, J SOIL SEDIMENT, V11, P1466, DOI 10.1007/s11368-011-0423-7; Gerlach W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-430; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Ghosh Abhrajyoti, 2010, Saline Syst, V6, P1, DOI 10.1186/1746-1448-6-1; Gilbert JA, 2011, ISME J, V5, P777, DOI 10.1038/ismej.2010.178; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Gomes NCM, 2010, FEMS MICROBIOL ECOL, V74, P276, DOI 10.1111/j.1574-6941.2010.00962.x; Gomes NCM, 2008, FEMS MICROBIOL ECOL, V66, P96, DOI 10.1111/j.1574-6941.2008.00519.x; Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319; Huang Y, 2009, HDB MOL MICROBIAL EC, P784; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Li M, 2011, APPL MICROBIOL BIOT, V89, P1243, DOI 10.1007/s00253-010-2929-0; Lyimo TJ, 2002, AMBIO, V31, P614, DOI 10.1639/0044-7447(2002)031[0614:SRAMIS]2.0.CO;2; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; OREMLAND RS, 1982, NATURE, V296, P143, DOI 10.1038/296143a0; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Sahoo K, 2009, INDIAN J MAR SCI, V38, P249; Saunders DL, 2001, WATER RES, V35, P1897, DOI 10.1016/S0043-1354(00)00479-6; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; Sousa OV, 2006, MAR POLLUT BULL, V52, P1725, DOI 10.1016/j.marpolbul.2006.07.006; Steele HL, 2005, FEMS MICROBIOL LETT, V247, P105, DOI 10.1016/j.femsle.2005.05.011; Taketani RG, 2010, ANTON LEEUW INT J G, V97, P401, DOI 10.1007/s10482-010-9422-8; Taketani RG, 2010, J MICROBIOL, V48, P7, DOI 10.1007/s12275-009-0147-1; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tian Y, 2008, MAR POLLUT BULL, V57, P707, DOI 10.1016/j.marpolbul.2008.03.011; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yan B, 2006, J MICROBIOL, V44, P566	59	150	166	5	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e38600	10.1371/journal.pone.0038600	http://dx.doi.org/10.1371/journal.pone.0038600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737213	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100010
J	Nanni, P; Nicoletti, G; Palladini, A; Croci, S; Murgo, A; Ianzano, ML; Grosso, V; Stivani, V; Antognoli, A; Lamolinara, A; Landuzzi, L; di Tomaso, E; Iezzi, M; De Giovanni, C; Lollini, PL				Nanni, Patrizia; Nicoletti, Giordano; Palladini, Arianna; Croci, Stefania; Murgo, Annalisa; Ianzano, Marianna L.; Grosso, Valentina; Stivani, Valeria; Antognoli, Agnese; Lamolinara, Alessia; Landuzzi, Lorena; di Tomaso, Emmanuelle; Iezzi, Manuela; De Giovanni, Carla; Lollini, Pier-Luigi			Multiorgan Metastasis of Human HER-2(+) Breast Cancer in Rag2(-/-);Il2rg(-/-) Mice and Treatment with PI3K Inhibitor	PLOS ONE			English	Article							BRAIN METASTASES; CELL-LINES; MOUSE MODELS; TRASTUZUMAB; CARCINOMA; TUMORS	In vivo studies of the metastatic process are severely hampered by the fact that most human tumor cell lines derived from highly metastatic tumors fail to consistently metastasize in immunodeficient mice like nude mice. We describe a model system based on a highly immunodeficient double knockout mouse, Rag2(-/-);Il2rg(-/-), which lacks T, B and NK cell activity. In this model human metastatic HER-2(+) breast cancer cells displayed their full multiorgan metastatic potential, without the need for selections or additional manipulations of the system. Human HER-2(+) breast cancer cell lines MDA-MB-453 and BT-474 injected into Rag2(-/-);Il2rg(-/-) mice faithfully reproduced human cancer dissemination, with multiple metastatic sites that included lungs, bones, brain, liver, ovaries, and others. Multiorgan metastatic spread was obtained both from local tumors, growing orthotopically or subcutaneously, and from cells injected intravenously. The problem of brain recurrencies is acutely felt in HER-2(+) breast cancer, because monoclonal antibodies against HER-2 penetrate poorly the blood-brain barrier. We studied whether a novel oral small molecule inhibitor of downstream PI3K, selected for its penetration of the blood-brain barrier, could affect multiorgan metastatic spread in Rag2(-/-);Il2rg(-/-) mice. NVP-BKM120 effectively controlled metastatic growth in multiple organs, and resulted in a significant proportion of mice free from brain and bone metastases. Human HER-2(+) human breast cancer cells in Rag2(-/-);Il2rg(-/-) mice faithfully reproduced the multiorgan metastatic pattern observed in patients, thus allowing the investigation of metastatic mechanisms and the preclinical study of novel antimetastatic agents.	[Nanni, Patrizia; Palladini, Arianna; Croci, Stefania; Murgo, Annalisa; Ianzano, Marianna L.; Grosso, Valentina; Stivani, Valeria; Antognoli, Agnese; De Giovanni, Carla] Univ Bologna, Dept Expt Pathol, Sect Canc Res, I-40126 Bologna, Italy; [Nicoletti, Giordano; Landuzzi, Lorena] Rizzoli Orthoped Inst, Bologna, Italy; [Lamolinara, Alessia; Iezzi, Manuela] Univ G DAnnunzio, Aging Res Ctr, Chieti, Italy; [di Tomaso, Emmanuelle] Novartis Inst BioMed Res Inc, Cambridge, MA USA; [Lollini, Pier-Luigi] Univ Bologna, Dept Hematol & Oncol Sci, Bologna, Italy	University of Bologna; IRCCS Istituto Ortopedico Rizzoli; G d'Annunzio University of Chieti-Pescara; Novartis; University of Bologna	Nanni, P (corresponding author), Univ Bologna, Dept Expt Pathol, Sect Canc Res, I-40126 Bologna, Italy.	carla.degiovanni@unibo.it	Palladini, Arianna/A-8994-2013; Landuzzi, Lorena/J-6511-2016; Iezzi, Manuela/AAB-7939-2019; Lollini, Pier Luigi/A-7644-2008; lamolinara, alessia/AAB-8833-2019; Croci, Stefania/K-2899-2016	Iezzi, Manuela/0000-0002-6296-6498; Lollini, Pier Luigi/0000-0003-1702-4108; lamolinara, alessia/0000-0002-7421-4509; Croci, Stefania/0000-0002-8622-0439; Nanni, Patrizia/0000-0001-5319-0803; Landuzzi, Lorena/0000-0001-9879-8118	Italian Association for Cancer Research (AIRC), Milan, Italy [10353]; Department of Experimental Pathology, University of Bologna; Italian Ministry for University and Research; Italian Ministry of Health	Italian Association for Cancer Research (AIRC), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Department of Experimental Pathology, University of Bologna; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Association for Cancer Research (AIRC), Milan, Italy (project n. 10353); the Department of Experimental Pathology, University of Bologna (Pallotti funds); the Italian Ministry for University and Research (PRIN 2008); and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxevanis CN, 2010, IMMUNOTHERAPY-UK, V2, P213, DOI 10.2217/IMT.09.89; Becker M, 2002, BRIT J CANCER, V87, P1328, DOI 10.1038/sj.bjc.6600573; Bos PD, 2010, CURR OPIN PHARMACOL, V10, P571, DOI 10.1016/j.coph.2010.06.003; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bria E, 2008, BREAST CANCER RES TR, V109, P231, DOI 10.1007/s10549-007-9663-z; Cavallo F, 2011, CANCER IMMUNOL IMMUN, V60, P319, DOI 10.1007/s00262-010-0968-0; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Clinchy B, 2000, BREAST CANCER RES TR, V61, P217, DOI 10.1023/A:1006494001861; Cruz-Munoz W, 2011, SEMIN CANCER BIOL, V21, P123, DOI 10.1016/j.semcancer.2010.12.001; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; GAROFALO A, 1993, INVAS METAST, V13, P82; HANNA N, 1981, J IMMUNOL, V127, P1754; Jonkers J, 2007, J MAMMARY GLAND BIOL, V12, P191, DOI 10.1007/s10911-007-9050-8; Kim IS, 2010, BIOCHEM BIOPH RES CO, V394, P443, DOI 10.1016/j.bbrc.2010.03.070; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Le Devedec SE, 2009, CLIN EXP METASTAS, V26, P673, DOI 10.1007/s10585-009-9267-6; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Lollini PL, 2006, NAT REV CANCER, V6, P204, DOI 10.1038/nrc1815; Lorger M, 2011, J NEUROONCOL; Lucci MA, 2010, CELL ONCOL, V32, P361, DOI 10.3233/CLO-2010-0520; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Nanni P, 2010, EUR J CANCER, V46, P659, DOI 10.1016/j.ejca.2009.11.018; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ocana A, 2011, NAT REV CLIN ONCOL, V8, P200, DOI 10.1038/nrclinonc.2010.194; Palmieri D, 2007, CLIN CANCER RES, V13, P1656, DOI 10.1158/1078-0432.CCR-06-2659; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Sanchez CG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2833; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Welch D. R., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P30; ZHANG RD, 1991, INVAS METAST, V11, P204	38	66	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39626	10.1371/journal.pone.0039626	http://dx.doi.org/10.1371/journal.pone.0039626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737248	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100047
J	Huang, LL; Yang, X; Sun, P; Tong, W; Hu, SQ				Huang Lulin; Yang Xiao; Sun Pei; Tong Wen; Hu Shangqin			The First Illumina-Based De Novo Transcriptome Sequencing and Analysis of Safflower Flowers	PLOS ONE			English	Article							CARTHAMUS-TINCTORIUS L.; HYDROXYSAFFLOR-YELLOW-A; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; ENDOTHELIAL-CELLS; LINOLEIC-ACID; RNA-SEQ; GENE; OIL; FLAVONOIDS	Background: The safflower, Carthamus tinctorius L., is a worldwide oil crop, and its flowers, which have a high flavonoid content, are an important medicinal resource against cardiovascular disease in traditional medicine. Because the safflower has a large and complex genome, the development of its genomic resources has been delayed. Second-generation Illumina sequencing is now an efficient route for generating an enormous volume of sequences that can represent a large number of genes and their expression levels. Methodology/Principal Findings: To investigate the genes and pathways that might control flavonoids and other secondary metabolites in the safflower, we used Illumina sequencing to perform a de novo assembly of the safflower tubular flower tissue transcriptome. We obtained a total of 4.69 Gb in clean nucleotides comprising 52,119,104 clean sequencing reads, 195,320 contigs, and 120,778 unigenes. Based on similarity searches with known proteins, we annotated 70,342 of the unigenes (about 58% of the identified unigenes) with cut-off E-values of 10(-5). In total, 21,943 of the safflower unigenes were found to have COG classifications, and BLAST2GO assigned 26,332 of the unigenes to 1,754 GO term annotations. In addition, we assigned 30,203 of the unigenes to 121 KEGG pathways. When we focused on genes identified as contributing to flavonoid biosynthesis and the biosynthesis of unsaturated fatty acids, which are important pathways that control flower and seed quality, respectively, we found that these genes were fairly well conserved in the safflower genome compared to those of other plants. Conclusions/Significance: Our study provides abundant genomic data for Carthamus tinctorius L. and offers comprehensive sequence resources for studying the safflower. We believe that these transcriptome datasets will serve as an important public information platform to accelerate studies of the safflower genome, and may help us define the mechanisms of flower tissue-specific and secondary metabolism in this non-model plant.	[Huang Lulin; Yang Xiao; Sun Pei; Tong Wen; Hu Shangqin] Sichuan Acad Agr Sci, Ind Crop Inst, Dept Tradit Chinese Med Study, Jianyang, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS)	Huang, LL (corresponding author), Sichuan Acad Agr Sci, Ind Crop Inst, Dept Tradit Chinese Med Study, Jianyang, Sichuan, Peoples R China.	jysqhu@163.com			foundations of Genetic Engineering of Special Funds by Sichuan province [2011LWJJ-001, 2011JYGC02-006]; Youth Foundation of Sichuan Academy of Agricultural Sciences [2009QNJJ-005]	foundations of Genetic Engineering of Special Funds by Sichuan province; Youth Foundation of Sichuan Academy of Agricultural Sciences	This work was supported by the foundations of Genetic Engineering of Special Funds by Sichuan province (No. 2011LWJJ-001 and No. 2011JYGC02-006) and Youth Foundation of Sichuan Academy of Agricultural Sciences (2009QNJJ-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Chapman MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-60; Chapman MA, 2010, AM J BOT, V97, P831, DOI 10.3732/ajb.0900137; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; De Franco M, 2010, CANCER LETT, V294, P187, DOI 10.1016/j.canlet.2010.01.038; Fan L, 2009, J CHROMATOGR A, V1216, P2063, DOI 10.1016/j.chroma.2008.03.046; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Gecgel U, 2007, J AM OIL CHEM SOC, V84, P47, DOI 10.1007/s11746-006-1007-3; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Higa R, 2010, MOL HUM REPROD, V16, P286, DOI 10.1093/molehr/gap109; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iwashina T, 2007, J HERED, V98, P250, DOI 10.1093/jhered/esm012; Ji DB, 2008, J CARDIOVASC PHARM, V52, P191, DOI 10.1097/FJC.0b013e318181fb02; Ji DB, 2009, VASC PHARMACOL, V50, P137, DOI 10.1016/j.vph.2008.11.009; Jiang TF, 2005, J SEP SCI, V28, P1244, DOI 10.1002/jssc.200500001; Jin Y, 2000, Zhongguo Zhong Xi Yi Jie He Za Zhi, V20, P430; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KNUTZON DS, 1992, P NATL ACAD SCI USA, V89, P2624, DOI 10.1073/pnas.89.7.2624; Koyama N, 2009, BRIT J NUTR, V101, P568, DOI 10.1017/S0007114508025786; Li HY, 2011, PLANTA, V233, P611, DOI 10.1007/s00425-010-1327-2; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li Yanmei, 1998, Yaoxue Xuebao, V33, P626; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; MELANCON SB, 1982, CAN J NEUROL SCI, V9, P155, DOI 10.1017/S0317167100043870; MESELHY MR, 1993, CHEM PHARM BULL, V41, P1796, DOI 10.1248/cpb.41.1796; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nakao, 1999, Genome Inform Ser Workshop Genome Inform, V10, P94; Natale DA, 2000, GENOME BIOL, V1; Norris LE, 2009, AM J CLIN NUTR, V90, P468, DOI 10.3945/ajcn.2008.27371; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Pahlavani MH, 2004, J HERED, V95, P265, DOI 10.1093/jhered/esh030; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Shi Ning-ning, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1322; Srinivas CVS, 1999, PLANT FOOD HUM NUTR, V54, P89, DOI 10.1023/A:1008107521247; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Sun CY, 2010, PHYTOTHER RES, V24, P1788, DOI 10.1002/ptr.3166; TABRETT DG, 1982, ANAESTH INTENS CARE, V10, P258, DOI 10.1177/0310057X8201000316; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tian Jing-wei, 2004, Yaoxue Xuebao, V39, P774; Wong MML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-342; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Qiong, 2005, Chin J Integr Med, V11, P222; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015; Zhu HB, 2003, PLANTA MED, V69, P429, DOI 10.1055/s-2003-39714	51	86	109	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38653	10.1371/journal.pone.0038653	http://dx.doi.org/10.1371/journal.pone.0038653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723874	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700019
J	Santos-Valle, P; Guijarro-Munoz, I; Cuesta, AM; Alonso-Camino, V; Villate, M; Alvarez-Cienfuegos, A; Blanco, FJ; Sanz, L; Alvarez-Vallina, L				Santos-Valle, Patricia; Guijarro-Munoz, Irene; Cuesta, Angel M.; Alonso-Camino, Vanesa; Villate, Maider; Alvarez-Cienfuegos, Ana; Blanco, Francisco J.; Sanz, Laura; Alvarez-Vallina, Luis			The Heterotrimeric Laminin Coiled-Coil Domain Exerts Anti-Adhesive Effects and Induces a Pro-Invasive Phenotype	PLOS ONE			English	Article							HUMAN BREAST-CANCER; LARGE GENE LISTS; EXTRACELLULAR-MATRIX; CELL-MIGRATION; MULTIDOMAIN PROTEIN; BINDING SITE; CHAIN; EXPRESSION; CLEAVAGE; ARRAY	Laminins are large heterotrimeric cross-shaped extracellular matrix glycoproteins with terminal globular domains and a coiled-coil region through which the three chains are assembled and covalently linked. Laminins are key components of basement membranes, and they serve as attachment sites for cell adhesion, migration and proliferation. In this work, we produced a recombinant fragment comprising the entire laminin coiled-coil of the alpha 1-, beta 1-, and gamma 1-chains that assemble into a stable heterotrimeric coiled-coil structure independently of the rest of the molecule. This domain was biologically active and not only failed to serve as a substrate for cell attachment, spreading and focal adhesion formation but also inhibited cell adhesion to laminin when added to cells in a soluble form at the time of seeding. Furthermore, gene array expression profiling in cells cultured in the presence of the laminin coiled-coil domain revealed up-regulation of genes involved in cell motility and invasion. These findings were confirmed by real-time quantitative PCR and zymography assays. In conclusion, this study shows for the first time that the laminin coiled-coil domain displays anti-adhesive functions and has potential implications for cell migration during matrix remodeling.	[Santos-Valle, Patricia; Guijarro-Munoz, Irene; Cuesta, Angel M.; Alonso-Camino, Vanesa; Alvarez-Cienfuegos, Ana; Sanz, Laura; Alvarez-Vallina, Luis] Hosp Univ Puerta Hierro, Mol Immunol Unit, Madrid, Spain; [Villate, Maider; Blanco, Francisco J.] CIC BioGUNE, Struct Biol Unit, Derio, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Hospital Puerta de Hierro-Majadahonda; CIC bioGUNE; Basque Foundation for Science	Santos-Valle, P (corresponding author), Hosp Univ Puerta Hierro, Mol Immunol Unit, Madrid, Spain.	lsanz.hpth@salud.madrid.org; lalvarezv.hpth@salud.madrid.org	Alvarez-Vallina, Luis/A-2033-2010; Sanz, Laura/F-8542-2010; AM, Cuesta/AAA-9356-2020; cancer, biogune/H-7276-2012; Blanco, Francisco J/D-4401-2009; Cuesta, Angel/F-1668-2011; Alvarez-Vallina, Luis/ABD-2431-2020	Sanz, Laura/0000-0002-3119-3218; AM, Cuesta/0000-0002-6596-9600; Blanco, Francisco J/0000-0003-2545-4319; Cuesta, Angel/0000-0002-6596-9600; Alvarez-Vallina, Luis/0000-0003-3053-6757	Ministerio de Ciencia e Innovacion [BIO2008-03233]; Comunidad Autonoma de Madrid [S-BIO-0236-2006]; European Union [SUDOE-FEDER] [IMMUNONET-SOE1/P1/E014]; Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III [PI08/90856, PS09/00227]; Fundacion Investigacion Biomedica-Hospital Universitario Puerta de Hierro;  [CTQ2011-28680]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); European Union [SUDOE-FEDER]; Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fundacion Investigacion Biomedica-Hospital Universitario Puerta de Hierro; 	This study was supported by grants from the Ministerio de Ciencia e Innovacion (BIO2008-03233), the Comunidad Autonoma de Madrid (S-BIO-0236-2006) and the European Union [SUDOE-FEDER (IMMUNONET-SOE1/P1/E014)] to LA-V; from the Fondo de Investigacion Sanitaria/Instituto de Salud Carlos III (PI08/90856 and PS09/00227) and the Fundacion Investigacion Biomedica-Hospital Universitario Puerta de Hierro to LS; and CTQ2011-28680 to FJB and PS-V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; CHIQUETEHRISMANN R, 1995, CURR OPIN CELL BIOL, V7, P715, DOI 10.1016/0955-0674(95)80114-6; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Doucet A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003533; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao YH, 2005, BIOCHEM BIOPH RES CO, V335, P343, DOI 10.1016/j.bbrc.2005.07.087; Garamszegi N, 2009, MOL CANCER RES, V7, P319, DOI 10.1158/1541-7786.MCR-08-0227; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Koshikawa N, 2003, FASEB J, V17, P364, DOI 10.1096/fj.03-0584fje; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Mole DJ, 2011, BRIT J CANCER, V104, P1007, DOI 10.1038/bjc.2011.33; Morrison C, 2011, J BIOL CHEM, V286, P34271, DOI 10.1074/jbc.M111.222513; Nomizu M, 1996, BIOCHEMISTRY-US, V35, P2885, DOI 10.1021/bi951555n; NOMIZU M, 1994, J BIOL CHEM, V269, P30386; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; Patani N, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-29; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Ramesh R, 2004, MOL THER, V9, P510, DOI 10.1016/j.ymthe.2004.01.019; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Sanchez-Martin D, 2011, J BIOL CHEM, V286, P5197, DOI 10.1074/jbc.M110.161927; Sanz L, 2003, TRENDS MOL MED, V9, P256, DOI 10.1016/S1471-4914(03)00070-4; Sanz L, 2003, EMBO J, V22, P1508, DOI 10.1093/emboj/cdg150; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STEADMAN R, 1993, J LEUKOCYTE BIOL, V53, P354, DOI 10.1002/jlb.53.4.354; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Zhang B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-83; Zimmerman T, 2007, J BIOMOL STRUCT DYN, V24, P413, DOI 10.1080/07391102.2007.10507129	45	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39097	10.1371/journal.pone.0039097	http://dx.doi.org/10.1371/journal.pone.0039097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723936	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700048
J	Clotault, J; Peltier, D; Soufflet-Freslon, V; Briard, M; Geoffriau, E				Clotault, Jeremy; Peltier, Didier; Soufflet-Freslon, Vanessa; Briard, Mathilde; Geoffriau, Emmanuel			Differential Selection on Carotenoid Biosynthesis Genes as a Function of Gene Position in the Metabolic Pathway: A Study on the Carrot and Dicots	PLOS ONE			English	Article							EVOLUTIONARY RATE VARIATION; MOLECULAR EVOLUTION; NUCLEOTIDE DIVERSITY; DAUCUS-CAROTA; DNA-SEQUENCE; ARABIDOPSIS; PATTERNS; SITES; L.; LIKELIHOOD	Background: Selection of genes involved in metabolic pathways could target them differently depending on the position of genes in the pathway and on their role in controlling metabolic fluxes. This hypothesis was tested in the carotenoid biosynthesis pathway using population genetics and phylogenetics. Methodology/Principal Findings: Evolutionary rates of seven genes distributed along the carotenoid biosynthesis pathway, IPI, PDS, CRTISO, LCYB, LCYE, CHXE and ZEP, were compared in seven dicot taxa. A survey of deviations from neutrality expectations at these genes was also undertaken in cultivated carrot (Daucus carota subsp. sativus), a species that has been intensely bred for carotenoid pattern diversification in its root during its cultivation history. Parts of sequences of these genes were obtained from 46 individuals representing a wide diversity of cultivated carrots. Downstream genes exhibited higher deviations from neutral expectations than upstream genes. Comparisons of synonymous and nonsynonymous substitution rates between genes among dicots revealed greater constraints on upstream genes than on downstream genes. An excess of intermediate frequency polymorphisms, high nucleotide diversity and/or high differentiation of CRTISO, LCYB1 and LCYE in cultivated carrot suggest that balancing selection may have targeted genes acting centrally in the pathway. Conclusions/Significance: Our results are consistent with relaxed constraints on downstream genes and selection targeting the central enzymes of the carotenoid biosynthesis pathway during carrot breeding history.	[Clotault, Jeremy; Peltier, Didier; Soufflet-Freslon, Vanessa; Briard, Mathilde; Geoffriau, Emmanuel] Univ Angers, PRES LUNAM, Inst Rech Hort & Semences, UMR1345, Angers, France; [Clotault, Jeremy; Peltier, Didier; Soufflet-Freslon, Vanessa; Briard, Mathilde; Geoffriau, Emmanuel] Inst Rech Hort & Semences, Agrocampus Ouest, UMR1345, Angers, France; [Clotault, Jeremy; Peltier, Didier; Soufflet-Freslon, Vanessa; Briard, Mathilde; Geoffriau, Emmanuel] Inst Rech Hort & Semences, UMR1345, INRA, Beaucouze, France	Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; INRAE	Clotault, J (corresponding author), Univ Angers, PRES LUNAM, Inst Rech Hort & Semences, UMR1345, Angers, France.	jeremy.clotault@univ-angers.fr	martel, celine/O-6651-2016	martel, celine/0000-0002-1800-4558; Clotault, Jeremy/0000-0002-7678-1929	Pays de la Loire region; French Ministry of Research	Pays de la Loire region(Region Pays de la Loire); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by grants from the Pays de la Loire region. Jeremy Clotault was a PhD student funded by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANGA O., 1957, EUPHYTICA, V6, P54; Banga O., 1963, MAIN TYPES W CAROTEN; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; BARTLEY GE, 1995, PLANT CELL, V7, P1027, DOI 10.1105/tpc.7.7.1027; Baudry E, 2003, GENETICS, V165, P1619; Beaumont MA, 2002, GENETICS, V162, P2025; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; CHAKRABORTY R, 1993, EXS, V67, P153; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Clotault J, 2012, MOL BIOL EVOL, V29, P1199, DOI 10.1093/molbev/msr287; Clotault J, 2010, THEOR APPL GENET, V121, P659, DOI 10.1007/s00122-010-1338-1; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; De Mita S, 2007, GENETICS, V177, P2123, DOI 10.1534/genetics.107.076943; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Flowers JM, 2007, MOL BIOL EVOL, V24, P1347, DOI 10.1093/molbev/msm057; Fu ZY, 2010, THEOR APPL GENET, V120, P709, DOI 10.1007/s00122-009-1188-x; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1992, GENETICS, V132, P583; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Just BJ, 2009, THEOR APPL GENET, V119, P1155, DOI 10.1007/s00122-009-1117-z; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Kronholm I, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-33; Laufer B, 1919, SINO IRANICA CHINESE, V15, P451; LI WH, 1985, MOL BIOL EVOL, V2, P150; Livingstone K, 2009, J HERED, V100, P754, DOI 10.1093/jhered/esp026; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; MACKEVIC VI, 1929, B APPL BOT GENET PL, V20, P517; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicolle C, 2004, J AM SOC HORTIC SCI, V129, P523, DOI 10.21273/JASHS.129.4.0523; Nordborg M, 2003, GENETICS, V163, P1201; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; Pavlidis P, 2010, MOL ECOL RESOUR, V10, P723, DOI 10.1111/j.1755-0998.2010.02832.x; R Development Core Team, 2009, R FDN STAT COMP; Ramos-Onsins SE, 2008, MOL ECOL, V17, P1211, DOI 10.1111/j.1365-294X.2007.03633.x; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2008, J MOL EVOL, V67, P137, DOI 10.1007/s00239-008-9105-5; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shinohara S, 1984, VEGETABLE SEED PRODU, P273; Surles RL, 2004, J AGR FOOD CHEM, V52, P3417, DOI 10.1021/jf035472m; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright KM, 2010, GENETICS, V184, P483, DOI 10.1534/genetics.109.110411; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Yang YH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-206; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu GQ, 2011, MOL BIOL EVOL, V28, P659, DOI 10.1093/molbev/msq243; Yu HS, 2011, MOL BIOL EVOL, V28, P1785, DOI 10.1093/molbev/msr002; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432	65	36	37	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38724	10.1371/journal.pone.0038724	http://dx.doi.org/10.1371/journal.pone.0038724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22737218	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300042
J	Koo, JE; Hong, HJ; Dearth, A; Kobayashi, KS; Koh, YS				Koo, Jung-Eun; Hong, Hye-Jin; Dearth, Andrea; Kobayashi, Koichi S.; Koh, Young-Sang			Intracellular Invasion of Orientia tsutsugamushi Activates Inflammasome in ASC-Dependent Manner	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; RICKETTSIA-TSUTSUGAMUSHI; SCRUB TYPHUS; CELL-DEATH; AIM2 INFLAMMASOME; HOST-DEFENSE; MICE; RECEPTORS; MACROPHAGES; APOPTOSIS	Orientia tsutsugamushi, a causative agent of scrub typhus, is an obligate intracellular bacterium, which escapes from the endo/phagosome and replicates in the host cytoplasm. O. tsutsugamushi infection induces production of pro-inflammatory mediators including interleukin-1 beta (IL-1 beta), which is secreted mainly from macrophages upon cytosolic stimuli by activating cysteine protease caspase-1 within a complex called the inflammasome, and is a key player in initiating and maintaining the inflammatory response. However, the mechanism for IL-1 beta maturation upon O. tsutsugamushi infection has not been identified. In this study, we show that IL-1 receptor signaling is required for efficient host protection from O. tsutsugamushi infection. Live Orientia, but not heat-or UV-inactivated Orientia, activates the inflammasome through active bacterial uptake and endo/phagosomal maturation. Furthermore, Orientia-stimulated secretion of IL-1 beta and activation of caspase-1 are ASC- and caspase-1- dependent since IL-1 beta production was impaired in Asc- and caspase-1-deficient macrophages but not in Nlrp3-, Nlrc4- and Aim2-deficient macrophages. Therefore, live O. tsutsugamushi triggers ASC inflammasome activation leading to IL-1 beta production, which is a critical innate immune response for effective host defense.	[Koo, Jung-Eun; Hong, Hye-Jin; Koh, Young-Sang] Jeju Natl Univ, Sch Med, Dept Microbiol & Immunol, Brain Korea Program 21, Cheju, Jeju Do, South Korea; [Koo, Jung-Eun; Hong, Hye-Jin; Koh, Young-Sang] Jeju Natl Univ, Inst Med Sci, Cheju, Jeju Do, South Korea; [Dearth, Andrea; Kobayashi, Koichi S.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Jeju National University; Jeju National University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Koo, JE (corresponding author), Jeju Natl Univ, Sch Med, Dept Microbiol & Immunol, Brain Korea Program 21, Cheju, Jeju Do, South Korea.	Koichi_Kobayashi@dfci.harvard.edu; yskoh7@jejunu.ac.kr		Kobayashi, Koichi/0000-0003-2930-0114	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0023645]; NIH [R01DK074738]; Cancer Research Institute; Claudia Adams Barr Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Claudia Adams Barr Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0023645) to YSK and a grant from the NIH (R01DK074738) to KSK. KSK is a recipient of the Investigator Award from the Cancer Research Institute and the Claudia Adams Barr Award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chi WC, 1997, SCAND J INFECT DIS, V29, P634, DOI 10.3109/00365549709035911; Cho BA, 2010, INFECT IMMUN, V78, P1915, DOI 10.1128/IAI.01316-09; Chu H, 2006, INFECT IMMUN, V74, P4246, DOI 10.1128/IAI.01620-05; Chung DR, 2008, J INFECTION, V56, P44, DOI 10.1016/j.jinf.2007.09.009; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim MK, 2002, INFECT IMMUN, V70, P4692, DOI 10.1128/IAI.70.8.4692-4696.2002; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Koh YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011758; Koo JE, 2010, WORLD J MICROB BIOT, V26, P753, DOI 10.1007/s11274-009-0215-z; Koo JE, 2009, MICROBIOL IMMUNOL, V53, P123, DOI 10.1111/j.1348-0421.2008.00098.x; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Moron CG, 2001, MODERN PATHOL, V14, P752, DOI 10.1038/modpathol.3880385; MURATA M, 1985, JPN J EXP MED, V55, P193; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; NG FKP, 1985, JPN J MED SCI BIOL, V38, P125, DOI 10.7883/yoken1952.38.125; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; RIKIHISA Y, 1979, J EXP MED, V150, P703, DOI 10.1084/jem.150.3.703; Roy CR, 2006, NAT IMMUNOL, V7, P549, DOI 10.1038/ni0606-549; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Singhsilarak T, 2005, AM J TROP MED HYG, V72, P640, DOI 10.4269/ajtmh.2005.72.640; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Walsh DS, 2001, AM J TROP MED HYG, V65, P899, DOI 10.4269/ajtmh.2001.65.899; WATT G, 1994, CLIN INFECT DIS, V18, P624, DOI 10.1093/clinids/18.4.624; Whitfield NN, 2010, INFECT IMMUN, V78, P423, DOI 10.1128/IAI.00070-09; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	53	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39042	10.1371/journal.pone.0039042	http://dx.doi.org/10.1371/journal.pone.0039042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723924	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300082
J	Lawson, L; Zhang, J; Gomgnimbou, MK; Abdurrahman, ST; Le Moullec, S; Mohamed, F; Uzoewulu, GN; Sogaolu, OM; Goh, KS; Emenyonu, N; Refregier, G; Cuevas, LE; Sola, C				Lawson, Lovett; Zhang, Jian; Gomgnimbou, Michel K.; Abdurrahman, Saddiq T.; Le Moullec, Stephanie; Mohamed, Fatima; Uzoewulu, Gertrude N.; Sogaolu, Olumide M.; Goh, Khye Seng; Emenyonu, Nnamdi; Refregier, Guislaine; Cuevas, Luis E.; Sola, Christophe			A Molecular Epidemiological and Genetic Diversity Study of Tuberculosis in Ibadan, Nnewi and Abuja, Nigeria	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; COMPLEX STRAINS; BURKINA-FASO; BACTERIA; CLASSIFICATION; HYBRIDIZATION; THROUGHPUT; RESISTANCE; CAMEROON; CLUSTER	Background: Nigeria has the tenth highest burden of tuberculosis (TB) among the 22 TB high-burden countries in the world. This study describes the biodiversity and epidemiology of drug-susceptible and drug-resistant TB in Ibadan, Nnewi and Abuja, using 409 DNAs extracted from culture positive TB isolates. Methodology/Principal Findings: DNAs extracted from clinical isolates of Mycobacterium tuberculosis complex were studied by spoligotyping and 24 VNTR typing. The Cameroon clade (CAM) was predominant followed by the M. africanum (West African 1) and T (mainly T2) clades. By using a smooth definition of clusters, 32 likely epi-linked clusters related to the Cameroon genotype family and 15 likely epi-linked clusters related to other "modern'' genotypes were detected. Eight clusters concerned M. africanum West African 1. The recent transmission rate of TB was 38%. This large study shows that the recent transmission of TB in Nigeria is high, without major regional differences, with MDR-TB clusters. Improvement in the TB control programme is imperative to address the TB control problem in Nigeria.	[Lawson, Lovett; Emenyonu, Nnamdi] Zankli Med Ctr, Abuja, Nigeria; [Zhang, Jian; Gomgnimbou, Michel K.; Le Moullec, Stephanie; Mohamed, Fatima; Refregier, Guislaine; Sola, Christophe] Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR8621, F-91405 Orsay, France; [Abdurrahman, Saddiq T.] Natl TB & Leprosy Control Programme, Abuja, Nigeria; [Uzoewulu, Gertrude N.] Nnamdi Azikiwe Teaching Hosp, Nnewi, Nigeria; [Sogaolu, Olumide M.] Univ Coll Hosp, Ibadan, Nigeria; [Emenyonu, Nnamdi; Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Ibadan; University College Hospital, Ibadan; Liverpool School of Tropical Medicine; University of Liverpool	Lawson, L (corresponding author), Zankli Med Ctr, Abuja, Nigeria.	christophe.sola@u-psud.fr	Cuevas, Luis E/I-3697-2015; Sola, Christophe/A-7992-2016; Refregier, Guislaine/AAU-8777-2021	Cuevas, Luis E/0000-0002-6581-0587; Sola, Christophe/0000-0003-4672-2140; Refregier, Guislaine/0000-0003-3749-7981; Lawson, Lovett/0000-0001-9019-7537	CNRS; Fondation Merieux, (Lyon, France); Luminex Corp. Austin, TX	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation Merieux, (Lyon, France); Luminex Corp. Austin, TX	M. Francois Topin, Luminex BV, The Netherlands, is acknowledged for technical support. M.K.G is a PhD fellow of the IGEPE Team supported by the CNRS and the Fondation Merieux, (Lyon, France).; All authors, except CS, declare to have no competing interests. CS is an Academic Editor of PLoS ONE. CS also acknowledges receiving travel grants for speaking or participation at Luminex meetings. He does not have stocks or shares, is not paid, employed or consultant, does not belong to the Board membership, does not hold Patent applications (pending or actual) or benefitted from Research grants from Luminex Corp. Austin, TX. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Akhtar P, 2009, J MED MICROBIOL, V58, P798, DOI 10.1099/jmm.0.002550-0; Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Jong BC, 2009, J CLIN MICROBIOL; Demay C, 2012, INFECT GENET EV 0217, V17; Diguimbaye C, 2006, J CLIN MICROBIOL, V44, P1575, DOI 10.1128/JCM.44.4.1575-1577.2006; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Dos Vultos T, 2009, FEMS MICROBIOL REV, V33, P471, DOI 10.1111/j.1574-6976.2009.00170.x; Fabre L, 2012, PLOS ONE IN PRESS; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Godreuil S, 2007, AIDS, V21, P248, DOI 10.1097/QAD.0b013e328011ec64; Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275; Jenkins AO, 2011, VET MICROBIOL, V151, P139, DOI 10.1016/j.vetmic.2011.02.037; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Lawson L, 2011, TROP MED INT HLTH; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Muller B, 2009, J BACTERIOL, V191, P1951, DOI 10.1128/JB.01590-08; Murray M, 2002, P NATL ACAD SCI USA, V99, P1538, DOI 10.1073/pnas.022618299; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Streicher EM, 2011, INFECT GENET EVOL; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tafaj S, 2009, J CLIN MICROBIOL, V47, P1581, DOI 10.1128/JCM.02284-08; Thumamo BP, 2011, INFECT GENET EVOL; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Zhang J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-42; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	41	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38409	10.1371/journal.pone.0038409	http://dx.doi.org/10.1371/journal.pone.0038409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723859	Green Published, Green Accepted, gold			2022-12-25	WOS:000305583300027
J	Liu, Y; Wu, BQ; Zhong, HH; Tian, XX; Fang, WG				Liu, Yan; Wu, Bing-quan; Zhong, Hao-hao; Tian, Xin-xia; Fang, Wei-gang			Quantification of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase and Correlations with Telomerase Activity in Lung Cancer	PLOS ONE			English	Article							REPEAT AMPLIFICATION PROTOCOL; MESSENGER-RNA; QUANTITATIVE-ANALYSIS; HTERT EXPRESSION; DELETION VARIANT; ASSAY; GENE; CARCINOMA; CELLS; DIFFERENTIATION	Telomerase plays important roles in the development and progression of malignant tumors, and its activity is primarily determined by transcriptional regulation of human telomerase reverse transcriptase (hTERT). Several mRNA alternative splicing variants (ASVs) for hTERT have been identified, but it remains unclear whether telomerase activity is directly associated with hTERT splicing transcripts. In this study, we developed novel real-time PCR protocols using molecular beacons and applied to lung carcinoma cell lines and cancerous tissues for quantification of telomerase activity and three essential hTERT deletion transcripts respectively. The results showed that lung carcinoma cell lines consistently demonstrated telomerase activity (14.22-31.43 TPG units per 100 cells) and various hTERT alternative splicing transcripts. For 165 lung cancer cases, telomerase activity showed significant correlation with tumor differentiation (poorly-> moderately-> well-differentiated, P < 0.01) and with histotypes (combined small cell and squamous cell carcinoma > squamous cell carcinoma > adenosquamous carcinoma > adenocarcinoma, P < 0.05). Although the overall hTERT transcripts were detected in all the samples, they were not associated with telomerase activity (r = 0.092, P = 0.24). Telomerase activity was significantly correlated with the transcriptional constituent ratio of alpha-deletion (r = -0.267, P = 0.026), beta-deletion (r = -0.693, P = 0.0001) and gamma-deletion (r = -0.614, P = 0.001). The positive rate and average constituent ratio of beta-deletion transcripts (92.12%, 0.23) were higher than those of alpha-deletion (41.82%, 0.12) or gamma-deletion (16.36%, 0.18) transcripts. The combined small-cell and squamous cell carcinomas expressed less deletion transcripts, especially beta-deletion, than other histotypes, which might explain their higher telomerase activity. In conclusion, the molecular beacon-based real-time PCR protocols are rapid, sensitive and specific methods to quantify telomerase activity and hTERT ASVs. Telomerase activity may serve as a reliable and effective molecular marker to assist the evaluation of histological subtype and differentiation of lung carcinomas. Further studies on hTERT deletion splicing transcripts, rather than the overall hTERT transcripts, may improve our understanding of telomerase regulation.	[Liu, Yan; Wu, Bing-quan; Zhong, Hao-hao; Tian, Xin-xia; Fang, Wei-gang] Peking Univ, Key Lab Carcinogenesis & Translat Res, Sch Basic Med Sci, Minist Educ,Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University	Liu, Y (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Sch Basic Med Sci, Minist Educ,Hlth Sci Ctr, Beijing 100871, Peoples R China.	tianxinxia@yahoo.com; wgfang@bjmu.edu.cn			Ministry of Science and Technology of China [2010CB529402]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants to WG Fang from the 973 Program (2010CB529402) from The Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchler P, 2001, PANCREAS, V22, P331, DOI 10.1097/00006676-200105000-00001; Colgin LM, 2000, NEOPLASIA, V2, P426, DOI 10.1038/sj.neo.7900112; Elmore LW, 2002, DIAGN MOL PATHOL, V11, P177, DOI 10.1097/00019606-200209000-00009; Fujiwara M, 2000, MODERN PATHOL, V13, P723, DOI 10.1038/modpathol.3880125; Hara T, 2001, UROL RES, V29, P1, DOI 10.1007/s002400000156; Hartmann U, 2005, HAEMATOLOGICA, V90, P307; Hisatomi H, 2003, NEOPLASIA, V5, P193, DOI 10.1016/S1476-5586(03)80051-9; Hou M, 2001, CLIN CHEM, V47, P519; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lantuejoul S, 2004, BRIT J CANCER, V90, P1222, DOI 10.1038/sj.bjc.6601643; Lincz LF, 2008, NEOPLASIA, V10, P1131, DOI 10.1593/neo.08644; Liu Y, 2010, PATHOL INT, V60, P386, DOI 10.1111/j.1440-1827.2010.02529.x; Maniwa Y, 2001, CHEST, V120, P589, DOI 10.1378/chest.120.2.589; Marchetti A, 2002, LAB INVEST, V82, P729, DOI 10.1097/01.LAB.0000017165.26718.60; Mavrogiannou E, 2007, CLIN CHEM, V53, P53, DOI 10.1373/clinchem.2006.073015; McGruder BM, 2006, CANCER LETT, V244, P91, DOI 10.1016/j.canlet.2005.12.012; Ohmura Y, 2000, CLIN CANCER RES, V6, P2980; Piotrowska K, 2005, LAB INVEST, V85, P1565, DOI 10.1038/labinvest.3700352; Rha SY, 2009, ONCOL RES, V18, P213, DOI 10.3727/096504009X12596189659123; Saeboe-Larssen S, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-26; Taveau M, 2002, ANAL BIOCHEM, V305, P227, DOI 10.1006/abio.2002.5664; Ulaner GA, 2001, INT J CANCER, V91, P644, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.0.CO;2-V; Wang J, 2000, CHINESE MED J-PEKING, V113, P985; Wang L, 2002, CLIN CANCER RES, V8, P2883; Wang YC, 2008, THYROID, V18, P1055, DOI 10.1089/thy.2008.0101; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Wu TC, 2003, LUNG CANCER-J IASLC, V41, P163, DOI 10.1016/S0169-5002(03)00195-8; Xu JH, 2009, PATHOBIOLOGY, V76, P23, DOI 10.1159/000178152; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818	30	22	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38868	10.1371/journal.pone.0038868	http://dx.doi.org/10.1371/journal.pone.0038868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723897	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300062
J	Podlesakova, K; Zalabak, D; Cudejkova, M; Plihal, O; Szucova, L; Dolezal, K; Spichal, L; Strnad, M; Galuszka, P				Podlesakova, Katerina; Zalabak, David; Cudejkova, Maria; Plihal, Ondrej; Szuecova, Lucie; Dolezal, Karel; Spichal, Lukas; Strnad, Miroslav; Galuszka, Petr			Novel Cytokinin Derivatives Do Not Show Negative Effects on Root Growth and Proliferation in Submicromolar Range	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; BIOLOGICAL-ACTIVITY; SOMACLONAL VARIATION; MERISTEM ACTIVITY; HISTIDINE KINASE; LEAF SENESCENCE; PLANT-TISSUES; METABOLISM; RECEPTOR; SPECIFICITY	Background: When applied to a nutrition solution or agar media, the non-substituted aromatic cytokinins caused thickening and shortening of the primary root, had an inhibitory effect on lateral root branching, and even showed some negative effects on development of the aerial part at as low as a 10 nanomolar concentration. Novel analogues of aromatic cytokinins ranking among topolins substituted on N9-atom of adenine by tetrahydropyranyl or 4-chlorobutyl group have been prepared and tested in standardized cytokinin bioassays [1]. Those showing comparable activities with N-6 benzylaminopurine were further tested in planta. Methodology/Principal Findings: The main aim of the study was to explain molecular mechanism of function of novel cytokinin derivatives on plant development. Precise quantification of cytokinin content and profiling of genes involved in cytokinin metabolism and perception in treated plants revealed several aspects of different action of m-methoxytopolin base and its substituted derivative on plant development. In contrast to standard cytokinins, N9- tetrahydropyranyl derivative of m-topolin and its methoxy-counterpart showed the negative effects on root development only at three orders of magnitude higher concentrations. Moreover, the methoxy-derivative demonstrates a positive effect on lateral root branching and leaf emerging in a nanomolar range of concentrations, in comparison with untreated plants. Conclusions/Significance: Tetrahydropyranyl substitution at N9-position of cytokinin purine ring significantly enhances acropetal transport of a given cytokinins. Together with the methoxy-substitution, impedes accumulation of non-active cytokinin glucoside forms in roots, allows gradual release of the active base, and has a significant effect on the distribution and amount of endogenous isoprenoid cytokinins in different plant tissues. The utilization of novel aromatic cytokinin derivatives can distinctively improve expected hormonal effects in plant propagation techniques in the future.	[Podlesakova, Katerina; Galuszka, Petr] Palacky Univ, Fac Sci, Dept Biochem, CR-77147 Olomouc, Czech Republic; [Zalabak, David; Cudejkova, Maria; Plihal, Ondrej; Szuecova, Lucie; Dolezal, Karel; Spichal, Lukas; Strnad, Miroslav; Galuszka, Petr] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc	Podlesakova, K (corresponding author), Palacky Univ, Fac Sci, Dept Biochem, CR-77147 Olomouc, Czech Republic.	petr.galuszka@upol.cz	Spichal, Lukas/H-6873-2014; Plíhalová, Lucie/F-6118-2014; Doležal, Karel/H-2436-2014; PLÍHAL, Ondřej/AAC-9319-2021; Strnad, Miroslav/H-1858-2014	Doležal, Karel/0000-0003-4938-0350; PLÍHAL, Ondřej/0000-0003-0645-2019; Strnad, Miroslav/0000-0002-2806-794X; Zalabak, David/0000-0002-4825-8321; Spichal, Lukas/0000-0001-6483-8628	Czech Ministry of Education Youth and Sports [OP RDI ED0007/01/01]; National Science Foundation, Czech Republic [522/08/0920, P501/10/1141]	Czech Ministry of Education Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); National Science Foundation, Czech Republic(Czech Republic Government)	This work was supported by the Czech Ministry of Education Youth and Sports (grant number OP RD&I ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research) and the National Science Foundation, Czech Republic (grant numbers 522/08/0920 and P501/10/1141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer CA, 1996, J PLANT GROWTH REGUL, V15, P201, DOI 10.1007/BF00190585; Bairu MW, 2008, PLANT CELL TISS ORG, V95, P373, DOI 10.1007/s11240-008-9451-4; Bairu MW, 2006, SCI HORTIC-AMSTERDAM, V108, P347, DOI 10.1016/j.scienta.2006.01.039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTELL G, 1992, PHYSIOL PLANTARUM, V84, P255, DOI 10.1111/j.1399-3054.1992.tb04662.x; BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; CORSE J, 1989, J PLANT GROWTH REGUL, V8, P211, DOI 10.1007/BF02308090; Debnath SC, 2008, PLANT CELL TISS ORG, V93, P231, DOI 10.1007/s11240-008-9366-0; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Filipi T, 2012, PHYTOCHEMISTRY, V74, P40, DOI 10.1016/j.phytochem.2011.10.008; FOX JE, 1971, PLANT PHYSIOL, V47, P275, DOI 10.1104/pp.47.2.275; Gallie DR, 2004, MOL GENET GENOMICS, V271, P267, DOI 10.1007/s00438-004-0977-9; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Holub J, 1998, PLANT GROWTH REGUL, V26, P109, DOI 10.1023/A:1006192619432; Hothorn M, 2011, NAT CHEM BIOL, V7, P766, DOI 10.1038/nchembio.667; Kopecny D, 2010, BIOCHIMIE, V92, P1052, DOI 10.1016/j.biochi.2010.05.006; Kudo T, 2010, J INTEGR PLANT BIOL, V52, P53, DOI 10.1111/j.1744-7909.2010.00898.x; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; LETHAM DS, 1978, PHYTOCHEMISTRY, V17, P2053, DOI 10.1016/S0031-9422(00)89279-1; MCGAW BA, 1984, PHYTOCHEMISTRY, V23, P1373, DOI 10.1016/S0031-9422(00)80468-9; MCGAW BA, 1985, PHYTOCHEMISTRY, V24, P9, DOI 10.1016/S0031-9422(00)80797-9; Mik V, 2011, PHYTOCHEMISTRY, V72, P821, DOI 10.1016/j.phytochem.2011.02.002; Mok MC, 2005, PLANT PHYSIOL, V137, P1057, DOI 10.1104/pp.104.057174; Nisler J, 2010, PHYTOCHEMISTRY, V71, P823, DOI 10.1016/j.phytochem.2010.01.018; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; PIETRAFACE WJ, 1981, PHYSIOL PLANTARUM, V53, P249, DOI 10.1111/j.1399-3054.1981.tb04495.x; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Ruzicka K, 2009, P NATL ACAD SCI USA, V106, P4284, DOI 10.1073/pnas.0900060106; Saleem M, 2010, PLANT PHYSIOL, V152, P4, DOI 10.1104/pp.109.150425; Spichal L, 2004, PLANT CELL PHYSIOL, V45, P1299, DOI 10.1093/pcp/pch132; Spichal L, 2009, FEBS J, V276, P244, DOI 10.1111/j.1742-4658.2008.06777.x; SUL IW, 1994, IN VITRO CELL DEV-PL, V30P, P131; Suttle JC, 2005, J PLANT PHYSIOL, V162, P1189, DOI 10.1016/j.jplph.2005.03.012; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Szucova L, 2009, BIOORGAN MED CHEM, V17, P1938, DOI 10.1016/j.bmc.2009.01.041; Tarkowska D, 2003, PHYSIOL PLANTARUM, V117, P579, DOI 10.1034/j.1399-3054.2003.00071.x; Valero-Aracama C, 2010, PLANT GROWTH REGUL, V60, P43, DOI 10.1007/s10725-009-9417-5; Vyroubalova S, 2009, PLANT PHYSIOL, V151, P433, DOI 10.1104/pp.109.142489; WEAVER RJ, 1965, NATURE, V206, P952, DOI 10.1038/206952b0; WERBROUCK SPO, 1995, PLANT CELL REP, V14, P662, DOI 10.1007/BF00232734; Werbrouck SPO, 1996, PHYSIOL PLANTARUM, V98, P291, DOI 10.1034/j.1399-3054.1996.980210.x; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; West T.P., 2004, ACTA HORTIC, V630, P293; WINKLER R, 1992, J AGR FOOD CHEM, V40, P2008, DOI 10.1021/jf00022a054; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Yonekura-Sakakibara K, 2004, PLANT PHYSIOL, V134, P1654, DOI 10.1104/pp.103.037176; ZHANG R, 1989, J PLANT GROWTH REGUL, V8, P181, DOI 10.1007/BF02308087	54	43	44	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39293	10.1371/journal.pone.0039293	http://dx.doi.org/10.1371/journal.pone.0039293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723989	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300130
J	Drury, PP; Bennet, L; Booth, LC; Davidson, JO; Wassink, G; Gunn, AJ				Drury, Paul P.; Bennet, Laura; Booth, Lindsea C.; Davidson, Joanne O.; Wassink, Guido; Gunn, Alistair J.			Maturation of the Mitochondrial Redox Response to Profound Asphyxia in Fetal Sheep	PLOS ONE			English	Article							UMBILICAL-CORD OCCLUSION; CEREBRAL-BLOOD-FLOW; NEAR-INFRARED SPECTROSCOPY; MAGNETIC-RESONANCE-SPECTROSCOPY; CYTOCHROME-OXIDASE; ISCHEMIC BRAIN; RAT-BRAIN; ELECTROCORTICAL ACTIVITY; EPILEPTIFORM ACTIVITY; ENERGY-METABOLISM	Fetal susceptibility to hypoxic brain injury increases over the last third of gestation. This study examined the hypothesis that this is associated with impaired mitochondrial adaptation, as measured by more rapid oxidation of cytochrome oxidase (CytOx) during profound asphyxia. Methods: Chronically instrumented fetal sheep at 0.6, 0.7, and 0.85 gestation were subjected to either 30 min (0.6 gestational age (ga), n = 6), 25 min (0.7 ga, n = 27) or 15 min (0.85 ga, n = 17) of complete umbilical cord occlusion. Fetal EEG, cerebral impedance (to measure brain swelling) and near-infrared spectroscopy-derived intra-cerebral oxygenation (Delta Hb = HbO(2) - Hb), total hemoglobin (THb) and CytOx redox state were monitored continuously. Occlusion was associated with profound, rapid fall in DHb in all groups to a plateau from 6 min, greatest at 0.85 ga compared to 0.6 and 0.7 ga (p<0.05). THb initially increased at all ages, with the greatest rise at 0.85 ga (p<0.05), followed by a progressive fall from 7 min in all groups. CytOx initially increased in all groups with the greatest rise at 0.85 ga (p<0.05), followed by a further, delayed increase in preterm fetuses, but a striking fall in the 0.85 group after 6 min of occlusion. Cerebral impedance (a measure of cytotoxic edema) increased earlier and more rapidly with greater gestation. In conclusion, the more rapid rise in CytOx and cortical impedance during profound asphyxia with greater maturation is consistent with increasing dependence on oxidative metabolism leading to earlier onset of neural energy failure before the onset of systemic hypotension.	[Drury, Paul P.; Bennet, Laura; Booth, Lindsea C.; Davidson, Joanne O.; Wassink, Guido; Gunn, Alistair J.] Univ Auckland, Dept Physiol, Fetal Physiol & Neurosci Grp, Auckland 1, New Zealand; [Booth, Lindsea C.] Univ Melbourne, Howard Florey Inst, Melbourne, Vic, Australia; [Gunn, Alistair J.] Starship Childrens Hosp, Auckland, New Zealand	University of Auckland; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Starship Children's Hospital	Drury, PP (corresponding author), Univ Auckland, Dept Physiol, Fetal Physiol & Neurosci Grp, Auckland 1, New Zealand.	aj.gunn@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021	Bennet, Laura/0000-0002-4336-7596; Gunn, Alistair/0000-0003-0656-7035; Davidson, Joanne/0000-0002-6781-4258; Booth, Lindsea/0000-0003-3093-5766	Health Research Council of New Zealand; Auckland Medical Research Foundation; National Institutes of Health [R21 NS063141-01A1]; New Zealand Neurological Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063141] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Neurological Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Health Research Council of New Zealand, the Auckland Medical Research Foundation and National Institutes of Health grant R21 NS063141-01A1. P Drury is supported by the New Zealand Neurological Foundation W&B Miller Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; AZZOPARDI D, 1989, PEDIATR RES, V25, P440, DOI 10.1203/00006450-198905000-00003; BALL RH, 1994, AM J OBSTET GYNECOL, V171, P1549, DOI 10.1016/0002-9378(94)90400-6; Barcroft J., 1946, RESEARCHES PRENATAL; Barfield CP, 1999, PEDIATR RES, V46, P50, DOI 10.1203/00006450-199907000-00009; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; BARTELDS B, 1993, PEDIATR RES, V34, P51, DOI 10.1203/00006450-199307000-00013; Bennet L, 2006, J PHYSIOL-LONDON, V572, P141, DOI 10.1113/jphysiol.2006.105197; Bennet L, 1999, J PHYSIOL-LONDON, V517, P247, DOI 10.1111/j.1469-7793.1999.0247z.x; Bennet L, 2007, AM J PHYSIOL-REG I, V292, pR1569, DOI 10.1152/ajpregu.00743.2006; BERGER R, 1991, J DEV PHYSIOL, V16, P317; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Boushel R, 2000, ACTA PHYSIOL SCAND, V168, P615, DOI 10.1046/j.1365-201x.2000.00713.x; Brown GC, 1997, MOL CELL BIOCHEM, V174, P189, DOI 10.1023/A:1006800322719; Brun NC, 1997, AM J PHYSIOL-HEART C, V273, pH682, DOI 10.1152/ajpheart.1997.273.2.H682; DAWES GS, 1959, J PHYSIOL-LONDON, V146, P516, DOI 10.1113/jphysiol.1959.sp006208; Dean JM, 2008, NEUROPHARMACOLOGY, V55, P166, DOI 10.1016/j.neuropharm.2008.05.009; Dieni S, 2003, J NEUROBIOL, V55, P41, DOI 10.1002/neu.10194; Downen M, 1999, J NEUROPATH EXP NEUR, V58, P12, DOI 10.1097/00005072-199901000-00002; DUFFY TE, 1975, J NEUROCHEM, V24, P271, DOI 10.1111/j.1471-4159.1975.tb11875.x; DUNNIHOO DR, 1973, AM J OBSTET GYNECOL, V116, P648, DOI 10.1016/S0002-9378(15)33129-X; DUPLESSIS AJ, 1995, ANN NEUROL, V37, P488; Fraser M, 2005, DEV BRAIN RES, V154, P45, DOI 10.1016/j.devbrainres.2004.10.002; Gagnon RE, 2005, COMP BIOCHEM PHYS A, V141, P264, DOI 10.1016/j.cbpb.2005.04.003; George S, 2004, AM J PHYSIOL-REG I, V287, pR925, DOI 10.1152/ajpregu.00263.2004; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; GLEASON CA, 1989, AM J PHYSIOL, V256, pR1264, DOI 10.1152/ajpregu.1989.256.6.R1264; GLEASON CA, 1990, AM J PHYSIOL, V258, pH1064, DOI 10.1152/ajpheart.1990.258.4.H1064; Gonzalez H, 2005, J CEREBR BLOOD F MET, V25, P911, DOI 10.1038/sj.jcbfm.9600087; GOPLERUD JM, 1989, J APPL PHYSIOL, V66, P2827, DOI 10.1152/jappl.1989.66.6.2827; Gunn AJ, 2001, DEV NEUROSCI-BASEL, V23, P175, DOI 10.1159/000046139; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Ilie A, 2006, J NEUROPHYSIOL, V96, P2809, DOI 10.1152/jn.00466.2006; ITSKOVITZ J, 1982, AM J PHYSIOL, V242, pH916, DOI 10.1152/ajpheart.1982.242.5.H916; JENSEN A, 1987, J DEV PHYSIOL, V9, P543; JENSEN A, 1991, J DEV PHYSIOL, V16, P181; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; JOHNSON GN, 1979, AM J OBSTET GYNECOL, V135, P48; Kaneko M, 2003, AM J OBSTET GYNECOL, V188, P961, DOI 10.1067/mob.2003.219; Keunen H, 1997, AM J OBSTET GYNECOL, V176, P515, DOI 10.1016/S0002-9378(97)70539-8; LAWLER FH, 1982, AM J PHYSIOL, V243, pR433, DOI 10.1152/ajpregu.1982.243.3.R433; Ley D, 2004, PEDIATR RES, V55, P568, DOI 10.1203/01.PDR.0000113785.66455.E7; LOU HC, 1985, EUR J PEDIATR, V144, P225, DOI 10.1007/BF00451945; MALLARD EC, 1994, AM J OBSTET GYNECOL, V170, P206; MALLARD EC, 1992, AM J OBSTET GYNECOL, V167, P1423, DOI 10.1016/S0002-9378(11)91728-1; Marks KA, 1996, PEDIATR RES, V39, P48, DOI 10.1203/00006450-199601000-00007; Matsumoto H, 1996, ANESTH ANALG, V83, P513, DOI 10.1097/00000539-199609000-00012; Matsunaga A, 1998, AM J PHYSIOL-CELL PH, V275, pC1022, DOI 10.1152/ajpcell.1998.275.4.C1022; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Moroz T, 2012, J ROYAL SOC INTERFAC; Mortola JP, 2004, RESP PHYSIOL NEUROBI, V141, P345, DOI 10.1016/j.resp.2004.01.011; Newman JP, 2000, J APPL PHYSIOL, V88, P82, DOI 10.1152/jappl.2000.88.1.82; Nilsson GE, 2004, J CEREBR BLOOD F MET, V24, P475, DOI 10.1097/00004647-200405000-00001; Nishidate I, 2010, APPL OPTICS, V49, P6617, DOI 10.1364/AO.49.006617; PAPILE LA, 1985, PEDIATR RES, V19, P159, DOI 10.1203/00006450-198502000-00001; Reddy K, 1998, PEDIATR RES, V43, P674, DOI 10.1203/00006450-199805000-00017; REYNOLDS EOR, 1988, BRIT MED BULL, V44, P1052, DOI 10.1093/oxfordjournals.bmb.a072289; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Shadid M, 1999, EARLY HUM DEV, V55, P169, DOI 10.1016/S0378-3782(99)00024-9; Springett RJ, 2003, ADV EXP MED BIOL, V530, P555; SYLVIA AL, 1989, J DEV PHYSIOL, V12, P287; Tan WKM, 1996, PEDIATR RES, V39, P791, DOI 10.1203/00006450-199605000-00008; TWEED A, 1986, PEDIATR RES, V20, P516, DOI 10.1203/00006450-198606000-00007; VANBEL F, 1994, PEDIATR RES, V35, P329; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Wassink G, 2007, J APPL PHYSIOL, V103, P1311, DOI 10.1152/japplphysiol.00396.2007; Wibbens B, 2005, AM J OBSTET GYNECOL, V193, P803, DOI 10.1016/j.ajog.2005.01.058; WILLIAMS CE, 1991, STROKE, V22, P516, DOI 10.1161/01.STR.22.4.516; WILLIAMS CE, 1992, ANN NEUROL, V31, P14, DOI 10.1002/ana.410310104; Wood CE, 2005, AM J PHYSIOL-REG I, V289, pR613, DOI 10.1152/ajpregu.00722.2004; WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086; Yager JY, 1996, BRAIN RES, V712, P230, DOI 10.1016/0006-8993(95)01423-3; Yawno T, 2007, NEUROSCIENCE, V146, P1726, DOI 10.1016/j.neuroscience.2007.03.023	75	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39273	10.1371/journal.pone.0039273	http://dx.doi.org/10.1371/journal.pone.0039273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720088	Green Published, gold			2022-12-25	WOS:000305350000056
J	Pons, V; Ustunel, C; Rolland, C; Torti, E; Parton, RG; Gruenberg, J				Pons, Veronique; Ustunel, Cansel; Rolland, Corinne; Torti, Eleonora; Parton, Robert G.; Gruenberg, Jean			SNX12 Role in Endosome Membrane Transport	PLOS ONE			English	Article							SORTING NEXIN; PROTEIN; ENDOCYTOSIS; VESICLES; BIOGENESIS; RETRIEVAL; COMPONENT; RETROMER; PATHWAYS; DOMAIN	In this paper, we investigated the role of sorting nexin 12 (SNX12) in the endocytic pathway. SNX12 is a member of the PX domain-containing sorting nexin family and shares high homology with SNX3, which plays a central role in the formation of intralumenal vesicles within multivesicular endosomes. We found that SNX12 is expressed at very low levels compared to SNX3. SNX12 is primarily associated with early endosomes and this endosomal localization depends on the binding to 3-phosphoinositides. We find that overexpression of SNX12 prevents the detachment (or maturation) of multivesicular endosomes from early endosomes. This in turn inhibits the degradative pathway from early to late endosomes/lysosomes, much like SNX3 overexpression, without affecting endocytosis, recycling and retrograde transport. In addition, while previous studies showed that Hrs knockdown prevents EGF receptor sorting into multivesicular endosomes, we find that overexpression of SNX12 restores the sorting process in an Hrs knockdown background. Altogether, our data show that despite lower expression level, SNX12 shares redundant functions with SNX3 in the biogenesis of multivesicular endosomes.	[Pons, Veronique; Ustunel, Cansel; Torti, Eleonora; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Pons, Veronique] Univ Toulouse III, Inst Malad Metab & Cardiovasc, INSERM, UMR 1048, Toulouse, France; [Rolland, Corinne] CPTP, UPS, INSERM, U1043, Toulouse, France; [Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Queensland; University of Queensland	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	jean.gruenberg@unige.ch	Parton, Robert G/C-5673-2009	Parton, Robert G/0000-0002-7494-5248; PONS, Veronique/0000-0001-5821-8481	Swiss National Science Foundation [31003A_124776]; EU; Swiss SystemsX initiative in Systems Biology; L'Association pour la Recherche contre le Cancer (ARC); Roche Foundation; EMBO	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Swiss SystemsX initiative in Systems Biology; L'Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Roche Foundation; EMBO(European Molecular Biology Organization (EMBO))	Support was from the Swiss National Science Foundation (grant number: 31003A_124776), PRISM from the EU Sixth Framework Programme, LipidX from the Swiss SystemsX initiative in Systems Biology, evaluated by the Swiss National Science Foundation and the National Center for Competence in Research (NCCR) in Chemical Biology (to J.G.), and the Human Frontier Science Program Organization (R.G.P.). V.P. was supported by L'Association pour la Recherche contre le Cancer (ARC), the Roche Foundation, and EMBO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr VA, 2000, TRAFFIC, V1, P904, DOI 10.1034/j.1600-0854.2000.011109.x; Bissig C, 2012, METHOD CELL BIOL, V108, P19, DOI 10.1016/B978-0-12-386487-1.00002-X; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Brankatschk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021771; Braun V, 2010, CELL MICROBIOL, V12, P1352, DOI 10.1111/j.1462-5822.2010.01476.x; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Choi JH, 2004, J CELL SCI, V117, P4209, DOI 10.1242/jcs.01233; GRUENBERG J, 1985, EUR J CELL BIOL, V38, P312; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hao X, 2011, CELL SIGNAL; Harterink M, 2011, NAT CELL BIOL; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Luyet PP, 2008, TRAFFIC, V9, P2279, DOI 10.1111/j.1600-0854.2008.00820.x; Malaval C, 2009, CELL SIGNAL, V21, P120, DOI 10.1016/j.cellsig.2008.09.016; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pons V, 2008, PLOS BIOL, V6, P1942, DOI 10.1371/journal.pbio.0060214; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; Voos W, 1998, J CELL BIOL, V140, P577, DOI 10.1083/jcb.140.3.577; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhang J, 2009, J BIOL CHEM, V284, P21659, DOI 10.1074/jbc.M109.007278; Zheng B, 2006, P NATL ACAD SCI USA, V103, P16776, DOI 10.1073/pnas.0607974103	41	17	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e38949	10.1371/journal.pone.0038949	http://dx.doi.org/10.1371/journal.pone.0038949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22719997	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000030
J	Ata, H; Shrestha, D; Oka, M; Ochi, R; Jong, CJ; Gebb, S; Benjamin, J; Schaffer, S; Hobart, HH; Downey, J; McMurtry, I; Gupte, R				Ata, Hirotaka; Shrestha, Deepa; Oka, Masahiko; Ochi, Rikuo; Jong, Chian Ju; Gebb, Sarah; Benjamin, John; Schaffer, Stephen; Hobart, Holly H.; Downey, James; McMurtry, Ivan; Gupte, Rakhee			Down-Regulation of Replication Factor C-40 (RFC40) Causes Chromosomal Missegregation in Neonatal and Hypertrophic Adult Rat Cardiac Myocytes	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CELL NUCLEAR ANTIGEN; VENTRICULAR MYOCYTES; ALZHEIMERS-DISEASE; DNA-SYNTHESIS; HEART-FAILURE; CARDIOMYOCYTE PROLIFERATION; MYOCARDIAL-INFARCTION; POLYMERASE-ALPHA; MITOTIC DIVISION	Background: Adult mammalian cardiac myocytes are generally assumed to be terminally differentiated; nonetheless, a small fraction of cardiac myocytes have been shown to replicate during ventricular remodeling. However, the expression of Replication Factor C (RFC; RFC140/40/38/37/36) and DNA polymerase delta (Pol delta) proteins, which are required for DNA synthesis and cell proliferation, in the adult normal and hypertrophied hearts has been rarely studied. Methods: We performed qRT-PCR and Western blot analysis to determine the levels of RFC and Pol delta message and proteins in the adult normal cardiac myocytes and cardiac fibroblasts, as well as in adult normal and pulmonary arterial hypertension induced right ventricular hypertrophied hearts. Immunohistochemical analyses were performed to determine the localization of the re-expressed DNA replication and cell cycle proteins in adult normal (control) and hypertrophied right ventricle. We determined right ventricular cardiac myocyte polyploidy and chromosomal missegregation/aneuploidy using Fluorescent in situ hybridization (FISH) for rat chromosome 12. Results: RFC40-mRNA and protein was undetectable, whereas Pol delta message was detectable in the cardiac myocytes isolated from control adult hearts. Although RFC40 and Pol delta message and protein significantly increased in hypertrophied hearts as compared to the control hearts; however, this increase was marginal as compared to the fetal hearts. Immunohistochemical analyses revealed that in addition to RFC40, proliferative and mitotic markers such as cyclin A, phospho-Aurora A/B/C kinase and phospho-histone 3 were also re-expressed/up-regulated simultaneously in the cardiac myocytes. Interestingly, FISH analyses demonstrated cardiac myocytes polyploidy and chromosomal missegregation/aneuploidy in these hearts. Knock-down of endogenous RFC40 caused chromosomal missegregation/aneuploidy and decrease in the rat neonatal cardiac myocyte numbers. Conclusion: Our novel findings suggest that transcription of RFC40 is suppressed in the normal adult cardiac myocytes and its insufficient re-expression may be responsible for causing chromosomal missegregation/aneuploidy and in cardiac myocytes during right ventricular hypertrophy.	[Ata, Hirotaka; Oka, Masahiko; Jong, Chian Ju; Schaffer, Stephen] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA	University of South Alabama	Ata, H (corresponding author), Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA.	rakheegupte@usouthal.edu	Jong, Chian Ju/AAL-4026-2020	Jong, Chian Ju/0000-0003-0505-5185; Ata, Hirotaka/0000-0003-0027-205X	University of South Alabama, College of Medicine Funds	University of South Alabama, College of Medicine Funds	This work was supported by University of South Alabama, College of Medicine Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Ahuja P, 2007, EXP CELL RES, V313, P1270, DOI 10.1016/j.yexcr.2007.01.009; Anversa P, 1997, CURR OPIN NEPHROL HY, V6, P169, DOI 10.1097/00041552-199703000-00011; Arendt T, 2010, AM J PATHOL, V177, P15, DOI 10.2353/ajpath.2010.090955; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; Chim SS, 2000, J CELL BIOCHEM, V78, P533, DOI 10.1002/1097-4644(20000915)78:4<533::AID-JCB2>3.0.CO;2-7; Engel FB, 2005, CELL CYCLE, V4, P1360, DOI 10.4161/cc.4.10.2081; Geller LN, 1999, NEUROBIOL DIS, V6, P167, DOI 10.1006/nbdi.1999.0236; GERDES AM, 1994, CARDIOSCIENCE, V5, P203; Granata R, 2009, CARDIOVASC RES, V83, P303, DOI 10.1093/cvr/cvp090; Gupte RS, 2005, CELL CYCLE, V4, P323; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; KELLERMAN S, 1992, J MOL CELL CARDIOL, V24, P497, DOI 10.1016/0022-2828(92)91839-W; King RW, 2008, BBA-REV CANCER, V1786, P4, DOI 10.1016/j.bbcan.2008.07.007; Koudssi F, 1998, J BIOL CHEM, V273, P25796, DOI 10.1074/jbc.273.40.25796; Kozlovskis PL, 1996, CIRC RES, V78, P289, DOI 10.1161/01.RES.78.2.289; Krause SA, 2001, MOL CELL BIOL, V21, P5156, DOI 10.1128/MCB.21.15.5156-5168.2001; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Leeuwenburgh BPJ, 2008, J ANAT, V212, P286, DOI 10.1111/j.1469-7580.2008.00853.x; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Marino TA, 1996, ANAT RECORD, V245, P677, DOI 10.1002/(SICI)1097-0185(199608)245:4<677::AID-AR8>3.0.CO;2-L; Matouskova E, 2005, ANTICANCER RES, V25, P1051; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Meckert PC, 2005, CARDIOVASC RES, V67, P116, DOI 10.1016/j.cardiores.2005.02.017; Minegishi S, 2011, INT HEART J, V52, P56, DOI 10.1536/ihj.52.56; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; QUAINI F, 1994, CIRC RES, V75, P1050, DOI 10.1161/01.RES.75.6.1050; Sarkar S, 2004, J BIOL CHEM, V279, P52630, DOI 10.1074/jbc.M402037200; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; Setoguchi M, 1999, LAB INVEST, V79, P1545; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Tasara T, 2003, NUCLEIC ACIDS RES, V31, P2636, DOI 10.1093/nar/gkg371; Tsujikawa H, 2008, AM J PHYSIOL-HEART C, V294, pH285, DOI 10.1152/ajpheart.00824.2007; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; Vliegen H W, 1995, Am J Cardiovasc Pathol, V5, P27; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wohlschlaeger J, 2010, CIRCULATION, V121, P989, DOI 10.1161/CIRCULATIONAHA.108.808071; Yang AH, 2003, J NEUROSCI, V23, P10454; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; ZHANG SJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P24, DOI 10.1016/0003-9861(87)90004-X	54	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39009	10.1371/journal.pone.0039009	http://dx.doi.org/10.1371/journal.pone.0039009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720015	Green Published, gold			2022-12-25	WOS:000305347800036
J	Brand, IL; Civciristov, S; Taylor, NL; Talbo, GH; Pantaki-Eimany, D; Levina, V; Clem, RJ; Perugini, MA; Kvansakul, M; Hawkins, CJ				Brand, Ingo L.; Civciristov, Srgjan; Taylor, Nicole L.; Talbo, Gert H.; Pantaki-Eimany, Delara; Levina, Vita; Clem, Rollie J.; Perugini, Matthew A.; Kvansakul, Marc; Hawkins, Christine J.			Caspase Inhibitors of the P35 Family Are More Active When Purified from Yeast than Bacteria	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; SIZE-DISTRIBUTION ANALYSIS; REACTIVE-SITE LOOP; BACULOVIRUS P35; CRYSTAL-STRUCTURE; IN-VIVO; METHIONINE AMINOPEPTIDASES; SACCHAROMYCES-CEREVISIAE; EFFECTOR CASPASE	Many insect viruses express caspase inhibitors of the P35 superfamily, which prevent defensive host apoptosis to enable viral propagation. The prototypical P35 family member, AcP35 from Autographa californica M nucleopolyhedrovirus, has been extensively studied. Bacterially purified AcP35 has been previously shown to inhibit caspases from insect, mammalian and nematode species. This inhibition occurs via a pseudosubstrate mechanism involving caspase-mediated cleavage of a "reactive site loop'' within the P35 protein, which ultimately leaves cleaved P35 covalently bound to the caspase's active site. We observed that AcP35 purifed from Saccharomyces cerevisae inhibited caspase activity more efficiently than AcP35 purified from Escherichia coli. This differential potency was more dramatic for another P35 family member, MaviP35, which inhibited human caspase 3 almost 300-fold more potently when purified from yeast than bacteria. Biophysical assays revealed that MaviP35 proteins produced in bacteria and yeast had similar primary and secondary structures. However, bacterially produced MaviP35 possessed greater thermal stability and propensity to form higher order oligomers than its counterpart purified from yeast. Caspase 3 could process yeast-purified MaviP35, but failed to detectably cleave bacterially purified MaviP35. These data suggest that bacterially produced P35 proteins adopt subtly different conformations from their yeast-expressed counterparts, which hinder caspase access to the reactive site loop to reduce the potency of caspase inhibition, and promote aggregation. These data highlight the differential caspase inhibition by recombinant P35 proteins purified from different sources, and caution that analyses of bacterially produced P35 family members ( and perhaps other types of proteins) may underestimate their activity.	[Brand, Ingo L.; Civciristov, Srgjan; Taylor, Nicole L.; Talbo, Gert H.; Pantaki-Eimany, Delara; Levina, Vita; Perugini, Matthew A.; Kvansakul, Marc; Hawkins, Christine J.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia; [Taylor, Nicole L.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Clem, Rollie J.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Hawkins, Christine J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	La Trobe University; University of Melbourne; Kansas State University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Brand, IL (corresponding author), La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia.	c.hawkins@latrobe.edu.au	Hawkins, Christine/B-8769-2011; Kvansakul, Marc/AAF-2453-2019	Hawkins, Christine/0000-0001-8120-1071; Kvansakul, Marc/0000-0003-2639-2498; Civciristov, Srgjan/0000-0002-9320-9668; Clem, Rollie/0000-0002-2368-720X; Perugini, Matthew/0000-0001-8052-5584	National Health and Medical Research Council project grant [602525, 637372]; Australian Research Council Future Fellowships [FT0991464, FT0991245]; La Trobe University; Cooperative Research Centre for Biomarker Translation	National Health and Medical Research Council project grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowships(Australian Research Council); La Trobe University; Cooperative Research Centre for Biomarker Translation(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by a National Health and Medical Research Council project grant to CJH and RJC (#602525) and a fellowship to MK (#637372), Australian Research Council Future Fellowships to CJH (#FT0991464) and MAP (#FT0991245), and scholarships to ILB from La Trobe University and the Cooperative Research Centre for Biomarker Translation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1997, J BIOL CHEM, V272, P1421, DOI 10.1074/jbc.272.3.1421; Bertin J, 1996, J VIROL, V70, P6251, DOI 10.1128/JVI.70.9.6251-6259.1996; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Brand IL, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.127; Brondyk WH, 2009, METHOD ENZYMOL, V463, P131, DOI 10.1016/S0076-6879(09)63011-1; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Chen SP, 2002, ARCH BIOCHEM BIOPHYS, V398, P87, DOI 10.1006/abbi.2001.2675; Chen YR, 2008, J GEN VIROL, V89, P2315, DOI 10.1099/vir.0.2008/001412-0; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; dela Cruz WP, 2001, J BIOL CHEM, V276, P32933, DOI 10.1074/jbc.M103930200; Du QS, 1999, J VIROL, V73, P1278, DOI 10.1128/JVI.73.2.1278-1285.1999; Eddins MJ, 2002, ACTA CRYSTALLOGR D, V58, P299, DOI 10.1107/S0907444901018753; Fisher AJ, 1999, EMBO J, V18, P2031, DOI 10.1093/emboj/18.8.2031; Gasser B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-11; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guy MP, 2008, J VIROL, V82, P7504, DOI 10.1128/JVI.00231-08; Hawkins CJ, 2000, METHOD ENZYMOL, V322, P162; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Jabbour AM, 2004, CELL DEATH DIFFER, V11, P1309, DOI 10.1038/sj.cdd.4401501; Jabbour AM, 2004, CURR GENOMICS, V5, P215, DOI 10.2174/1389202043349417; Jabbour AM, 2002, CELL DEATH DIFFER, V9, P1311, DOI 10.1038/sj.cdd.4401135; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; LaCount DJ, 2000, J BIOL CHEM, V275, P15657, DOI 10.1074/jbc.M000791200; Lannan E, 2007, J VIROL, V81, P9319, DOI 10.1128/JVI.00247-07; Laue TM, 1992, COMPUTER AIDED INTER, P90; McDonald JF, 2003, BIOCHEMISTRY-US, V42, P10001, DOI 10.1021/bi0341408; Means JC, 2007, VIROLOGY, V358, P436, DOI 10.1016/j.virol.2006.08.043; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Pei Z, 2002, J BIOL CHEM; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Riedl SJ, 2001, BIOCHEMISTRY-US, V40, P13274, DOI 10.1021/bi010574w; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Snipas SJ, 2001, BIOCHEM J, V357, P575, DOI 10.1042/0264-6021:3570575; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vier J, 2000, BIOCHEM BIOPH RES CO, V276, P855, DOI 10.1006/bbrc.2000.3560; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Xu GZ, 2003, J BIOL CHEM, V278, P5455, DOI 10.1074/jbc.M211607200; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Yu M, 2005, VIRUS GENES, V31, P145, DOI 10.1007/s11262-005-1786-x; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w; Zhou Q, 2000, METHOD ENZYMOL, V322, P143; Zoog SJ, 1999, J BIOL CHEM, V274, P25995, DOI 10.1074/jbc.274.37.25995; Zoog SJ, 2002, EMBO J, V21, P5130	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39248	10.1371/journal.pone.0039248	http://dx.doi.org/10.1371/journal.pone.0039248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720082	Green Published, gold			2022-12-25	WOS:000305347800059
J	Fruchart-Gaillard, C; Mourier, G; Blanchet, G; Vera, L; Gilles, N; Menez, R; Marcon, E; Stura, EA; Servent, D				Fruchart-Gaillard, Carole; Mourier, Gilles; Blanchet, Guillaume; Vera, Laura; Gilles, Nicolas; Menez, Renee; Marcon, Elodie; Stura, Enrico A.; Servent, Denis			Engineering of Three-Finger Fold Toxins Creates Ligands with Original Pharmacological Profiles for Muscarinic and Adrenergic Receptors	PLOS ONE			English	Article							MAMBA DENDROASPIS-ANGUSTICEPS; SITE-DIRECTED MUTAGENESIS; GREEN MAMBA; ACETYLCHOLINE-RECEPTOR; FUNCTIONAL-PROPERTIES; ANIMAL TOXINS; SNAKE TOXINS; M-1 RECEPTOR; VENOM; IDENTIFICATION	Protein engineering approaches are often a combination of rational design and directed evolution using display technologies. Here, we test "loop grafting," a rational design method, on three-finger fold proteins. These small reticulated proteins have exceptional affinity and specificity for their diverse molecular targets, display protease-resistance, and are highly stable and poorly immunogenic. The wealth of structural knowledge makes them good candidates for protein engineering of new functionality. Our goal is to enhance the efficacy of these mini-proteins by modifying their pharmacological properties in order to extend their use in imaging, diagnostics and therapeutic applications. Using the interaction of three-finger fold toxins with muscarinic and adrenergic receptors as a model, chimeric toxins have been engineered by substituting loops on toxin MT7 by those from toxin MT1. The pharmacological impact of these grafts was examined using binding experiments on muscarinic receptors M1 and M4 and on the alpha(1A)-adrenoceptor. Some of the designed chimeric proteins have impressive gain of function on certain receptor subtypes achieving an original selectivity profile with high affinity for muscarinic receptor M1 and alpha(1A)-adrenoceptor. Structure-function analysis supported by crystallographic data for MT1 and two chimeras permits a molecular based interpretation of these gains and details the merits of this protein engineering technique. The results obtained shed light on how loop permutation can be used to design new three-finger proteins with original pharmacological profiles.	[Fruchart-Gaillard, Carole; Mourier, Gilles; Blanchet, Guillaume; Vera, Laura; Gilles, Nicolas; Menez, Renee; Marcon, Elodie; Stura, Enrico A.; Servent, Denis] CEA, IBiTecS, Serv Ingn Mol Prot, Lab Toxinol Mol & Biotechnol, Gif Sur Yvette, France; [Blanchet, Guillaume] Univ Paris 06, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Fruchart-Gaillard, C (corresponding author), CEA, IBiTecS, Serv Ingn Mol Prot, Lab Toxinol Mol & Biotechnol, Gif Sur Yvette, France.	denis.servent@cea.fr	Stura, Enrico A./A-2793-2010; Fruchart Gaillard, Carole/GWV-2801-2022	Stura, Enrico A./0000-0001-6718-2118; Fruchart Gaillard, Carole/0000-0002-3149-4774; Servent, Denis/0000-0002-0774-1691				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADEM A, 1988, BIOCHIM BIOPHYS ACTA, V968, P340, DOI 10.1016/0167-4889(88)90025-0; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Doley R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-146; Doley R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-196; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fruchart-Gaillard C, 2006, MOL PHARMACOL, V69, P1641, DOI 10.1124/mol.105.020883; Fruchart-Gaillard C, 2008, MOL PHARMACOL, V74, P1554, DOI 10.1124/mol.108.050773; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Gilquin B, 2003, PROTEIN SCI, V12, P266, DOI 10.1110/ps.0227703; Harvey AL, 2002, NEUROCHEM RES, V27, P1543, DOI 10.1023/A:1021660708187; JOLKKONEN M, 1994, FEBS LETT, V352, P91, DOI 10.1016/0014-5793(94)00933-3; KARLSSON E, 1994, ANN NY ACAD SCI, V710, P153, DOI 10.1111/j.1749-6632.1994.tb26623.x; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Koivula K, 2010, TOXICON, V56, P440, DOI 10.1016/j.toxicon.2010.05.001; Krajewski JL, 2001, MOL PHARMACOL, V60, P725; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Le Du MH, 2000, J MOL BIOL, V296, P1017; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Marchot P, 1997, J BIOL CHEM, V272, P3502, DOI 10.1074/jbc.272.6.3502; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; MAX SI, 1993, J NEUROSCI, V13, P4293; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Mourier G, 2000, PROTEIN ENG, V13, P217, DOI 10.1093/protein/13.3.217; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUTTER M, 1995, PEPTIDE RES, V8, P145; Naimuddin M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-2; Nareoja K, 2011, BRIT J PHARMACOL, V164, P538, DOI 10.1111/j.1476-5381.2011.01468.x; Olianas MC, 2000, BRIT J PHARMACOL, V131, P447, DOI 10.1038/sj.bjp.0703606; PILLET L, 1993, J BIOL CHEM, V268, P909; Quinton L, 2010, BRIT J PHARMACOL, V159, P316, DOI 10.1111/j.1476-5381.2009.00532.x; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; Ricciardi A, 2000, J BIOL CHEM, V275, P18302, DOI 10.1074/jbc.275.24.18302; Rouget C, 2010, BRIT J PHARMACOL, V161, P1361, DOI 10.1111/j.1476-5381.2010.00966.x; Servent D, 2011, TOXICON, V58, P455, DOI 10.1016/j.toxicon.2011.08.004; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589	46	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39166	10.1371/journal.pone.0039166	http://dx.doi.org/10.1371/journal.pone.0039166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720062	Green Submitted, Green Published, gold			2022-12-25	WOS:000305347800050
J	Urbina, H; Blackwell, M				Urbina, Hector; Blackwell, Meredith			Multilocus Phylogenetic Study of the Scheffersomyces Yeast Clade and Characterization of the N-Terminal Region of Xylose Reductase Gene	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE STRAIN; PICHIA-STIPITIS; CANDIDA-SHEHATAE; ETHANOL-PRODUCTION; FERMENTING YEAST; SP-NOV; RPB1 SEQUENCES; RIBOSOMAL DNA; CORN STOVER; FERMENTATION	Many of the known xylose-fermenting (X-F) yeasts are placed in the Scheffersomyces clade, a group of ascomycete yeasts that have been isolated from plant tissues and in association with lignicolous insects. We formally recognize fourteen species in this clade based on a maximum likelihood (ML) phylogenetic analysis using a multilocus dataset. This clade is divided into three subclades, each of which exhibits the biochemical ability to ferment cellobiose or xylose. New combinations are made for seven species of Candida in the clade, and three X-F taxa associated with rotted hardwood are described: Scheffersomyces illinoinensis (type strain NRRL Y-48827(T) = CBS 12624), Scheffersomyces quercinus (type strain NRRL Y-48825(T) = CBS 12625), and Scheffersomyces virginianus (type strain NRRL Y-48822(T) = CBS 12626). The new X-F species are distinctive based on their position in the multilocus phylogenetic analysis and biochemical and morphological characters. The molecular characterization of xylose reductase (XR) indicates that the regions surrounding the conserved domain contain mutations that may enhance the performance of the enzyme in X-F yeasts. The phylogenetic reconstruction using XYL1 or RPB1 was identical to the multilocus analysis, and these loci have potential for rapid identification of cryptic species in this clade.	[Urbina, Hector; Blackwell, Meredith] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Urbina, H (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mblackwell@lsu.edu		Urbina, Hector/0000-0002-5570-4537	National Science Foundation (NSF) [DEB-0417180, 0732671]; Department of Energy [DE-AC52-07NA27344]; LSU Boyd Professor Research Fund	National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); LSU Boyd Professor Research Fund	This work was supported by the National Science Foundation grants (NSF DEB-0417180 and 0732671), Department of Energy contract to Lawrence Livermore National Laboratory (DE-AC52-07NA27344), and the LSU Boyd Professor Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Agbogbo FK, 2008, APPL BIOCHEM BIOTECH, V145, P53, DOI 10.1007/s12010-007-8056-4; Agbogbo FK, 2007, J IND MICROBIOL BIOT, V34, P723, DOI 10.1007/s10295-007-0247-z; Agbogbo FK, 2006, BIOTECHNOL LETT, V28, P2065, DOI 10.1007/s10529-006-9192-6; ALEXANDER MA, 1988, APPL MICROBIOL BIOT, V28, P478, DOI 10.1007/BF00268219; ALEXANDER MA, 1987, BIOTECHNOL BIOENG, V30, P685, DOI 10.1002/bit.260300515; Bajwa PK, 2011, BIORESOURCE TECHNOL, V102, P9965, DOI 10.1016/j.biortech.2011.08.027; BARNETT JA, 2000, YEASTS CHARACTERISTI; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Cadete RM, 2011, INT J SYST IN PRESS; Cadez N, 2006, INT J SYST EVOL MICR, V56, P1157, DOI 10.1099/ijs.0.64052-0; Chang CF, 2011, INT J SYST EVOL MICR, V61, P690, DOI 10.1099/ijs.0.020511-0; Chu BCH, 2006, CURR MICROBIOL, V53, P118, DOI 10.1007/s00284-005-0325-2; DELGENES JP, 1986, BIOTECHNOL LETT, V8, P897, DOI 10.1007/BF01078656; DELGENES JP, 1989, BIOTECHNOL BIOENG, V34, P398, DOI 10.1002/bit.260340314; DUPREEZ JC, 1986, ENZYME MICROB TECH, V8, P360, DOI 10.1016/0141-0229(86)90136-5; Fadda ME, 2010, INT J FOOD MICROBIOL, V136, P376, DOI 10.1016/j.ijfoodmicro.2009.10.007; Fadda ME, 2004, INT J FOOD MICROBIOL, V95, P51, DOI 10.1016/j.ijfoodmicro.2004.02.001; Fromanger R, 2010, J IND MICROBIOL BIOT, V37, P437, DOI 10.1007/s10295-009-0688-7; Fuentefria AM, 2008, MYCOL RES, V112, P93, DOI 10.1016/j.mycres.2007.05.001; Ganter PF, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P303, DOI 10.1007/3-540-30985-3_14; Grunwald S, 2010, SYST APPL MICROBIOL, V33, P25, DOI 10.1016/j.syapm.2009.10.002; Hahn-Hagerdal B, 2007, ADV BIOCHEM ENG BIOT, V108, P147, DOI 10.1007/10_2007_062; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Han JH, 2011, ARCH MICROBIOL, V193, P335, DOI 10.1007/s00203-011-0678-9; Hector RE, 2008, APPL MICROBIOL BIOT, V80, P675, DOI 10.1007/s00253-008-1583-2; Hibbett DS, 1996, MOL BIOL EVOL, V13, P903, DOI 10.1093/oxfordjournals.molbev.a025658; HO NWY, 1990, ENZYME MICROB TECH, V12, P33, DOI 10.1016/0141-0229(90)90177-R; Houseknecht JL, 2011, INT J SYST EVOL MICR, V61, P1751, DOI 10.1099/ijs.0.026427-0; Hughes SR, 2012, J IND MICROBIOL BIOT, V39, P163, DOI 10.1007/s10295-011-1012-x; Hughes SR, 2009, PLASMID, V61, P22, DOI 10.1016/j.plasmid.2008.09.001; Jeffries T W, 1999, Adv Biochem Eng Biotechnol, V65, P117; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Jeffries TW, 2009, FEMS YEAST RES, V9, P793, DOI 10.1111/j.1567-1364.2009.00525.x; JEFFRIES TW, 1986, ABSTR PAP AM CHEM S, V192, P51; JEFFRIES TW, 1994, ENZYME MICROB TECH, V16, P922, DOI 10.1016/0141-0229(94)90001-9; Jeppsson M, 2006, BIOTECHNOL BIOENG, V93, P665, DOI 10.1002/bit.20737; Jin YS, 2003, APPL ENVIRON MICROB, V69, P495, DOI 10.1128/AEM.69.1.495-503.2003; Karhumaa K, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-5; Karhumaa K, 2007, APPL MICROBIOL BIOT, V73, P1039, DOI 10.1007/s00253-006-0575-3; Khattab SMR, 2011, BIOCHEM BIOPH RES CO, V404, P634, DOI 10.1016/j.bbrc.2010.12.028; Knapp S, 2011, TAXON, V60, P1498, DOI 10.1002/tax.605031; Kreger-van Rij NJW, 1970, YEASTS TAXONOMIC STU, P455; Kumar S, 2011, APPL MICROBIOL BIOT, V89, P1405, DOI 10.1007/s00253-010-2997-1; Kurtzman CP, 2007, FEMS YEAST RES, V7, P141, DOI 10.1111/j.1567-1364.2006.00157.x; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, pXIII, DOI 10.1016/B978-0-444-52149-1.00180-4; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; KURTZMAN CP, 1990, ANTON LEEUW INT J G, V57, P215, DOI 10.1007/BF00400153; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2010, ANTON LEEUW INT J G, V97, P155, DOI 10.1007/s10482-009-9399-3; Lee JW, 2011, APPL BIOCHEM BIOTECH, V165, P814, DOI 10.1007/s12010-011-9299-7; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Maddison WP, 2005, EVOLUTION, V62, P1103; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Milan EP, 2001, MYCOSES, V44, P273, DOI 10.1111/j.1439-0507.2001.00652.x; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Nardi JB, 2006, ARTHROPOD STRUCT DEV, V35, P57, DOI 10.1016/j.asd.2005.06.003; Nguyen NH, 2006, MYCOL RES, V110, P1232, DOI 10.1016/j.mycres.2006.07.002; OHAMA T, 1993, NUCLEIC ACIDS RES, V21, P4039, DOI 10.1093/nar/21.17.4039; PALNITKAR S, 1992, CAN J MICROBIOL, V38, P258, DOI 10.1139/m92-043; PALNITKAR SS, 1990, APPL BIOCHEM BIOTECH, V26, P151, DOI 10.1007/BF02921531; PAREKH S, 1986, BIOTECHNOL LETT, V8, P597, DOI 10.1007/BF01028092; PAREKH SR, 1986, APPL MICROBIOL BIOT, V25, P300, DOI 10.1007/BF00253667; PASSOTH V, 1992, CURR GENET, V22, P429, DOI 10.1007/BF00352445; PRIOR BA, 1988, BIOTECHNOL LETT, V10, P37, DOI 10.1007/BF01030021; Robbertse B, 2006, FUNGAL GENET BIOL, V43, P715, DOI 10.1016/j.fgb.2006.05.001; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ryabova EB, 2003, FEMS YEAST RES, V4, P157, DOI 10.1016/S1567-1356(03)00146-6; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Shi NQ, 2002, YEAST, V19, P1203, DOI 10.1002/yea.915; Shi NQ, 1999, YEAST, V15, P1021, DOI 10.1002/(SICI)1097-0061(199908)15:11<1021::AID-YEA429>3.0.CO;2-V; SREENATH HK, 1986, APPL MICROBIOL BIOT, V24, P294, DOI 10.1007/BF00257052; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suh SO, 2004, INT J SYST EVOL MICR, V54, P2409, DOI 10.1099/ijs.0.63246-0; Suh SO, 2004, MYCOLOGIA, V96, P756, DOI 10.2307/3762109; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; Suh SO, 2006, MYCOLOGIA, V98, P1006, DOI 10.3852/mycologia.98.6.1006; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Tanahashi M, 2010, NATURWISSENSCHAFTEN, V97, P311, DOI 10.1007/s00114-009-0643-5; TOIVOLA A, 1984, APPL ENVIRON MICROB, V47, P1221, DOI 10.1128/AEM.47.6.1221-1223.1984; Van Vleet JH, 2008, METAB ENG, V10, P360, DOI 10.1016/j.ymben.2007.12.002; Vaughan-Martini A., 1984, ANN FAC AGRAR U PERU, V66, P331; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9; Zhang J, 2010, Prikl Biokhim Mikrobiol, V46, P456; Zhang N, 2003, J INVERTEBR PATHOL, V84, P226, DOI 10.1016/j.jip.2003.10.002; Zhang QS, 2010, PLANT PHYSIOL, V153, P555, DOI 10.1104/pp.110.157644	93	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39128	10.1371/journal.pone.0039128	http://dx.doi.org/10.1371/journal.pone.0039128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720049	Green Published, gold, Green Submitted			2022-12-25	WOS:000305347800046
J	Laubenthal, J; Zlobinskaya, O; Poterlowicz, K; Baumgartner, A; Gdula, MR; Fthenou, E; Keramarou, M; Hepworth, SJ; Kleinjans, JCS; van Schooten, FJ; Brunborg, G; Godschalk, RW; Schmid, TE; Anderson, D				Laubenthal, Julian; Zlobinskaya, Olga; Poterlowicz, Krzysztof; Baumgartner, Adolf; Gdula, Michal R.; Fthenou, Eleni; Keramarou, Maria; Hepworth, Sarah J.; Kleinjans, Jos C. S.; van Schooten, Frederik-Jan; Brunborg, Gunnar; Godschalk, Roger W.; Schmid, Thomas E.; Anderson, Diana			Cigarette smoke-induced transgenerational alterations in genome stability in cord blood of human F1 offspring	FASEB JOURNAL			English	Article						toxicants; DNA damage; male germline; transmission; germ cell mutagen	TOBACCO-SMOKE; DNA-DAMAGE; CRITICAL WINDOWS; GENE-EXPRESSION; EXPOSURE; PREGNANCY; MOTHERS; LINE; SUSCEPTIBILITY; RNA	The relevance of preconceptional and prenatal toxicant exposures for genomic stability in offspring is difficult to analyze in human populations, because gestational exposures usually cannot be separated from preconceptional exposures. To analyze the roles of exposures during gestation and conception on genomic stability in the offspring, stability was assessed via the Comet assay and highly sensitive, semiautomated confocal laser scans of gamma H2AX foci in cord, maternal, and paternal blood as well as spermatozoa from 39 families in Crete, Greece, and the United Kingdom. With use of multivariate linear regression analysis with backward selection, preconceptional paternal smoking (% tail DNA: P>0.032; gamma H2AX foci: P>0.018) and gestational maternal (% tail DNA: P>0.033) smoking were found to statistically significantly predict DNA damage in the cord blood of F1 offspring. Maternal passive smoke exposure was not identified as a predictor of DNA damage in cord blood, indicating that the effect of paternal smoking may be transmitted via the spermatozoal genome. Taken together, these studies reveal a role for cigarette smoke in the induction of DNA alterations in human F1 offspring via exposures of the fetus in utero or the paternal germline. Moreover, the identification of transgenerational DNA alterations in the unexposed F1 offspring of smoking-exposed fathers supports the claim that cigarette smoke is a human germ cell mutagen.-Laubenthal, J., Zlobinskaya, O., Poterlowicz, K., Baumgartner, A., Gdula, M. R., Fthenou, E., Keramarou, M., Hepworth, S. J., Kleinjans, J. C. S., van Schooten, F.-J., Brunborg, G., Godschalk, R. W., Schmid, T. E., Anderson, D. Cigarette smoke-induced transgenerational alterations in genome stability in cord blood of human F1 offspring. FASEB J. 26, 3946-3956 (2012). www.fasebj.org	[Laubenthal, Julian; Baumgartner, Adolf; Anderson, Diana] Univ Bradford, Sch Life Sci, Div Biomed Sci, Bradford BD7 1DP, W Yorkshire, England; [Poterlowicz, Krzysztof] Univ Bradford, Sch Life Sci, Ctr Skin Sci, Bradford BD7 1DP, W Yorkshire, England; [Zlobinskaya, Olga; Schmid, Thomas E.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Therapy, D-8000 Munich, Germany; [Baumgartner, Adolf] Univ Leipzig, Cardiac Ctr, Dept Paediat Cardiol, Leipzig, Germany; [Gdula, Michal R.] Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA; [Fthenou, Eleni; Keramarou, Maria] Univ Crete, Sch Med, Dept Social Med, Iraklion, Greece; [Hepworth, Sarah J.] Univ Leeds, Div Epidemiol, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [van Schooten, Frederik-Jan; Godschalk, Roger W.] Univ Maastricht, Dept Toxicol, Maastricht, Netherlands; [Kleinjans, Jos C. S.] Univ Maastricht, Dept Toxicogen, Maastricht, Netherlands; [Brunborg, Gunnar] Norwegian Inst Publ Hlth, Div Environm Med, Dept Chem Toxicol, Oslo, Norway	University of Bradford; University of Bradford; Technical University of Munich; Leipzig University; Boston University; University of Crete; University of Leeds; Maastricht University; Maastricht University; Norwegian Institute of Public Health (NIPH)	Anderson, D (corresponding author), Univ Bradford, Sch Life Sci, Div Biomed Sci, Richmond Rd, Bradford BD7 1DP, W Yorkshire, England.	d.anderson1@bradford.ac.uk	Anderson, Diana/J-6472-2015; Laubenthal, Julian/GPK-1372-2022; Poterlowicz, Krzysztof/AAS-2395-2020; Gdula, Michal/AAX-2755-2020; Kleinjans, Jos C.S./E-7241-2015	Anderson, Diana/0000-0001-9673-0398; Poterlowicz, Krzysztof/0000-0001-6173-5674; Gdula, Michal/0000-0002-8667-7359; Schmid, Thomas/0000-0002-8894-8087; Fthenou, Eleni/0000-0002-1178-6841; Laubenthal, Julian/0000-0001-9214-5538; Fleming, Sarah/0000-0002-7655-4806	European Union Integrated Project NewGeneris, 6th Framework Programme, Priority 5: Food Quality and Safety [FOOD-CT-2005-016320]	European Union Integrated Project NewGeneris, 6th Framework Programme, Priority 5: Food Quality and Safety	The authors thank M. Kogevinas (Centre for Research in Environmental Epidemiology, Barcelona, Spain) for enabling samples to be provided from the NewGeneris subcohort in Crete, Greece; Leda Chatzi for her considerable contribution to the cotinine data (University of Crete, Heraklion, Greece); G. Chalkiadaki and T. Roumeliwtaki (University of Crete) as well as M. Kurzawa-Zegota and E. Cemeli (Food Standards Agency, London, UK) for support with sample collection and preparation; V. A. Botchkarev (University of Boston, Boston, MA, USA) for support with LSCM; Constantine Vardavas (Harvard University, Boston, MA, USA) for discussion on cotinine analysis; and M. Kogevinas and I. F. Merlo (Istituto Di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliera Universitaria San Martino-IST-National Cancer Research Institute, Genoa, Italy) for critical review of the article. This work was financed by the European Union Integrated Project NewGeneris, 6th Framework Programme, Priority 5: Food Quality and Safety, contract FOOD-CT-2005-016320 (http://www.newgeneris.org).	Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS254, DOI 10.1016/j.fertnstert.2008.08.035; Anderson Diana, 2005, Toxicol Appl Pharmacol, V207, P506, DOI 10.1016/j.taap.2005.01.022; Anderson LM, 2000, ENVIRON HEALTH PERSP, V108, P573, DOI 10.2307/3454549; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barber RC, 2006, ONCOGENE, V25, P7336, DOI 10.1038/sj.onc.1209723; Bennett LM, 2010, MUTAT RES-GEN TOX EN, V696, P81, DOI 10.1016/j.mrgentox.2009.12.015; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Brevik A., 2012, INT J CELL BIOL, V2012, P407; Brevik A, 2011, REPROD TOXICOL, V32, P463, DOI 10.1016/j.reprotox.2011.09.005; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Chatzi L, 2009, AM J EPIDEMIOL, V170, P829, DOI 10.1093/aje/kwp211; de la Chica RA, 2005, JAMA-J AM MED ASSOC, V293, P1212, DOI 10.1001/jama.293.10.1212; DeMarini DM, 2012, ENVIRON MOL MUTAGEN, V53, P166, DOI 10.1002/em.21685; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; DeMarini DM, 2005, JAMA-J AM MED ASSOC, V293, P1264, DOI 10.1001/jama.293.10.1264; Dubrova YE, 2000, NATURE, V405, P37, DOI 10.1038/35011135; Dubrova YE, 2003, ONCOGENE, V22, P7087, DOI 10.1038/sj.onc.1206993; Glen CD, 2008, CANCER RES, V68, P3630, DOI 10.1158/0008-5472.CAN-08-0484; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Hammadeh ME, 2010, HUM REPROD, V25, P2708, DOI 10.1093/humrep/deq226; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hecht SS, 1999, CANCER RES, V59, P590; Hecht SS, 2006, CANCER EPIDEM BIOMAR, V15, P988, DOI 10.1158/1055-9965.EPI-05-0596; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Keohavong P, 2005, MUTAT RES-FUND MOL M, V572, P156, DOI 10.1016/j.mrfmmm.2005.01.014; Leonardi-Bee J, 2011, PEDIATRICS, V127, P734, DOI 10.1542/peds.2010-3041; Linschooten JO, 2011, REPROD TOXICOL, V32, P106, DOI 10.1016/j.reprotox.2011.05.004; Linschooten JO, 2009, MUTAT RES-FUND MOL M, V667, P70, DOI 10.1016/j.mrfmmm.2008.12.014; Marchetti F, 2011, P NATL ACAD SCI USA, V108, P12811, DOI 10.1073/pnas.1106896108; Merlo DF, 2009, CANCER EPIDEM BIOMAR, V18, P5, DOI 10.1158/1055-9965.EPI-08-0876; Ng HK, 2010, PLACENTA, V31, P259, DOI 10.1016/j.placenta.2010.01.009; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Olsen AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011349; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Scares SR, 2008, CURR OPIN OBSTET GYN, V20, P281, DOI 10.1097/GCO.0b013e3282fc9c1e; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P451, DOI 10.2307/3454536; Shutin D, 2010, COMPUT METH PROG BIO, V97, P114, DOI 10.1016/j.cmpb.2009.05.009; Singer TM, 2010, ENVIRON MOL MUTAGEN, V51, P919, DOI 10.1002/em.20613; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sipinen V, 2010, MUTAGENESIS, V25, P417, DOI 10.1093/mutage/geq024; Vande Loock K, 2011, ENVIRON HEALTH PERSP, V119, P1460, DOI 10.1289/ehp.1003246; Vardavas CI, 2013, TOB CONTROL, V22, P194, DOI 10.1136/tobaccocontrol-2011-050144; Venners SA, 2004, AM J EPIDEMIOL, V159, P993, DOI 10.1093/aje/kwh128; Verhofstad N, 2011, TOXICOL SCI, V119, P218, DOI 10.1093/toxsci/kfq325; Verhofstad N, 2010, ENVIRON MOL MUTAGEN, V51, P123, DOI 10.1002/em.20516; Waters DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1906, DOI 10.1158/1055-9965.EPI-07-0034; Wild CP, 2003, CANCER EPIDEM BIOMAR, V12, P1389; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Wyatt NP, 2007, MUTAGENESIS, V22, P123, DOI 10.1093/mutage/gel062; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125; Zlobinskaya O, 2012, RADIAT ENVIRON BIOPH, V51, P23, DOI 10.1007/s00411-011-0398-1	59	54	55	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2012	26	10					3946	3956		10.1096/fj.11-201194	http://dx.doi.org/10.1096/fj.11-201194			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	018YM	22730438				2022-12-25	WOS:000309704000003
J	Balzarini, J; Gago, F; Kulik, W; van Kuilenburg, ABP; Karlsson, A; Peterson, MA; Robins, MJ				Balzarini, Jan; Gago, Federico; Kulik, Wim; van Kuilenburg, Andre B. P.; Karlsson, Anna; Peterson, Matt A.; Robins, Morris J.			Introduction of a Fluorine Atom at C3 of 3-Deazauridine Shifts Its Antimetabolic Activity from Inhibition of CTP Synthetase to Inhibition of Orotidylate Decarboxylase, an Early Event in the de Novo Pyrimidine Nucleotide Biosynthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROOROTATE DEHYDROGENASE; COLON-CARCINOMA; BINDING; PURINE; ACID; PHOSPHORYLATION; 5-FLUOROURACIL; PYRAZOFURIN; CATALYSIS; TOXICITY	The antimetabolite prodrug 3-deazauridine (3DUrd) inhibits CTP synthetase upon intracellular conversion to its triphosphate, which selectively depletes the intracellular CTP pools. Introduction of a fluorine atom at C3 of 3DUrd shifts its anti-metabolic action to inhibition of the orotidylate decarboxylase (ODC) activity of the UMP synthase enzyme complex that catalyzes an early event in pyrimidine nucleotide biosynthesis. This results in concomitant depletion of the intracellular UTP and CTP pools. The new prodrug (designated 3F-3DUrd) exerts its inhibitory activity because its monophosphate is not further converted intracellularly to its triphosphate derivative to a detectable extent. Combinations with hypoxanthine and adenine markedly potentiate the cytostatic activity of 3F-3DUrd. This is likely because of depletion of 5-phosphoribosyl-1-pyrophosphate (consumed in the hypoxanthine phosphoribosyl transferase/adenine phosphoribosyl transferase reaction) and subsequent slowing of the 5-phosphoribosyl-1-pyrophosphate-dependent orotate phosphoribosyl transferase reaction, which depletes orotidylate, the substrate for ODC. Further efficient anabolism by nucleotide kinases is compromised apparently because of the decrease in pK(a) brought about by the fluorine atom, which affects the ionization state of the new prodrug. The 3F-3DUrd monophosphate exhibits new inhibitory properties against a different enzyme of the pyrimidine nucleotide metabolism, namely the ODC activity of UMP synthase.	[Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Gago, Federico] Univ Alcala de Henares, Dept Farmacol, E-28871 Alcala De Henares, Madrid, Spain; [Kulik, Wim; van Kuilenburg, Andre B. P.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Karlsson, Anna] Karolinska Inst, S-14186 Stockholm, Sweden; [Peterson, Matt A.; Robins, Morris J.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	KU Leuven; Universidad de Alcala; University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; Brigham Young University	Balzarini, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	jan.balzarini@rega.kuleuven.be	Gago, Federico/AAS-3992-2020; Gago, Federico/H-1004-2015	Gago, Federico/0000-0002-3071-4878; Gago, Federico/0000-0002-3071-4878; van Kuilenburg, Andre/0000-0002-7989-4910; Karlsson, Anna/0000-0001-6843-6685	Katholieke Universiteit Leuven [GOA 10/14]	Katholieke Universiteit Leuven(KU Leuven)	The work was supported by Katholieke Universiteit Leuven Grant GOA 10/14.	AHMED NK, 1984, CANCER, V54, P1370, DOI 10.1002/1097-0142(19841001)54:7<1370::AID-CNCR2820540723>3.0.CO;2-5; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; DAHLIGHARLEY E, 1984, CANCER RES, V44, P161; DECLERCQ E, 1987, NUCLEOS NUCLEOT NUCL, V6, P197, DOI 10.1080/07328318708056192; DIX DE, 1979, CANCER RES, V39, P4485; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; GASSEN HG, 1972, BIOCHIM BIOPHYS ACTA, V272, P560, DOI 10.1016/0005-2787(72)90511-4; GLAZER RI, 1985, BIOCHEM PHARMACOL, V34, P2535, DOI 10.1016/0006-2952(85)90539-8; GREENE S, 1995, BIOCHEM PHARMACOL, V50, P861, DOI 10.1016/0006-2952(95)00255-X; GUPTA RS, 1982, J CELL PHYSIOL, V111, P291, DOI 10.1002/jcp.1041110310; HANDSCHUMACHER RE, 1960, J BIOL CHEM, V235, P2917; Heinrich D, 2009, CHEM-EUR J, V15, P6619, DOI 10.1002/chem.200900397; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; MCPARTLAND RP, 1974, CANCER RES, V34, P3107; NESNOW S, 1973, J MED CHEM, V16, P524, DOI 10.1021/jm00263a026; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; ROBINS MJ, 1968, CHEM COMMUN, P1547; ROBINS MJ, 1975, J MED CHEM, V18, P1070, DOI 10.1021/jm00245a005; Robins MJ, 2009, J MED CHEM, V52, P3018, DOI 10.1021/jm900203h; Sakamoto E, 2007, BIOCHEM BIOPH RES CO, V363, P216, DOI 10.1016/j.bbrc.2007.08.164; SCHWALBE CH, 1972, NATURE-NEW BIOL, V238, P171, DOI 10.1038/newbio238171a0; SHIRASAKA T, 1993, CANCER RES, V53, P4004; TSUBOI KK, 1978, CANCER RES, V38, P3745; Van Kuilenburg ABP, 2004, CLIN CHEM, V50, P2117, DOI 10.1373/clinchem.2004.038869; Van Rompay AR, 2001, MOL PHARMACOL, V59, P1181, DOI 10.1124/mol.59.5.1181; Van Rompay AR, 1999, MOL PHARMACOL, V56, P562, DOI 10.1124/mol.56.3.562; Vyas VK, 2011, MINI-REV MED CHEM, V11, P1039; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Wu N, 2002, J BIOL CHEM, V277, P28080, DOI 10.1074/jbc.M202362200	30	7	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30444	30454		10.1074/jbc.M112.378091	http://dx.doi.org/10.1074/jbc.M112.378091			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22730407	Green Published, hybrid			2022-12-25	WOS:000308579800037
J	Shomura, Y; Higuchi, Y				Shomura, Yasuhito; Higuchi, Yoshiki			Structural Basis for the Reaction Mechanism of S-Carbamoylation of HypE by HypF in the Maturation of [NiFe]-Hydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; ESCHERICHIA-COLI; O-CARBAMOYLTRANSFERASE; PROTEINS HYPC; ACYLPHOSPHATASE; CYANIDE; MODEL; BIOSYNTHESIS; HYDROGENASES	As a remarkable structural feature of hydrogenase active sites, [NiFe]-hydrogenases harbor one carbonyl and two cyano ligands, where HypE and HypF are involved in the biosynthesis of the nitrile group as a precursor of the cyano groups. HypF catalyzes S-carbamoylation of the C-terminal cysteine of HypE via three steps using carbamoylphosphate and ATP, producing two unstable intermediates: carbamate and carbamoyladenylate. Although the crystal structures of intact HypE homodimers and partial HypF have been reported, it remains unclear how the consecutive reactions occur without the loss of unstable intermediates during the proposed reaction scheme. Here we report the crystal structures of full-length HypF both alone and in complex with HypE at resolutions of 2.0 and 2.6 angstrom, respectively. Three catalytic sites of the structures of the HypF nucleotideand phosphate-bound forms have been identified, with each site connected via channels inside the protein. This finding suggests that the first two consecutive reactions occur without the release of carbamate or carbamoyladenylate from the enzyme. The structure of HypF in complex with HypE revealed that HypF can associate with HypE without disturbing its homodimeric interaction and that the binding manner allows the C-terminal Cys-351 of HypE to access the S-carbamoylation active site in HypF, suggesting that the third step can also proceed without the release of carbamoyladenylate. A comparison of the structure of HypF with the recently reported structures of O-carbamoyltransferase revealed different reaction mechanisms for carbam-oyladenylate synthesis and a similar reaction mechanism for carbamoyltransfer to produce the carbamoyl-HypE molecule.	[Shomura, Yasuhito; Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Shomura, Yasuhito; Higuchi, Yoshiki] RIKEN SPring 8 Ctr, Biomet Sci Lab, Mikazuki, Hyogo 6795148, Japan	University of Hyogo; RIKEN	Shomura, Y (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	shomura@sci.u-hyogo.ac.jp; hig@sci.u-hyogo.ac.jp		Higuchi, Yoshiki/0000-0001-8284-5709	MEXT [18054029, 20051022, 22770111, 18GS0207]; JSPS [24657077, 22370061, 22657031]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research from MEXT [18054029 (to Y. S.), 20051022 (to Y. S.), 22770111 (to Y. S.), and 18GS0207 (to Y. H.)] and from JSPS [24657077(to Y. H.), 22370061 (to Y. H.), and 22657031 (to Y. H.)].	Agari Y, 2008, PROTEINS, V70, P1108, DOI 10.1002/prot.21794; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT EL, 1984, J BACTERIOL, V158, P972, DOI 10.1128/JB.158.3.972-977.1984; Blokesch M, 2004, EUR J BIOCHEM, V271, P3428, DOI 10.1111/j.1432-1033.2004.04280.x; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Blokesch M, 2006, FEBS LETT, V580, P4065, DOI 10.1016/j.febslet.2006.06.045; Burstel I, 2011, J BIOL CHEM, V286, P44937, DOI 10.1074/jbc.M111.309351; Cheung YY, 2005, BIOCHEMISTRY-US, V44, P4601, DOI 10.1021/bi047832k; CHRISTENSEN HEM, 1994, EUR J BIOCHEM, V224, P97, DOI 10.1111/j.1432-1033.1994.tb19999.x; COQUE JJR, 1995, GENE, V162, P21, DOI 10.1016/0378-1119(95)00308-S; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hecker A, 2008, EMBO J, V27, P2340, DOI 10.1038/emboj.2008.157; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Jia J, 2002, PROTEINS, V49, P139, DOI 10.1002/prot.10178; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2012, ANGEW CHEM INT EDIT, V51, P4046, DOI 10.1002/anie.201108896; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; RAGSDALE SW, 1984, J BACTERIOL, V157, P1; Rangarajan ES, 2008, J BACTERIOL, V190, P1447, DOI 10.1128/JB.01610-07; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Rosano C, 2002, J MOL BIOL, V321, P785, DOI 10.1016/S0022-2836(02)00713-1; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Shomura Y, 2007, J MOL BIOL, V372, P1045, DOI 10.1016/j.jmb.2007.07.023; TADDEI N, 1994, BBA-PROTEIN STRUCT M, V1208, P75, DOI 10.1016/0167-4838(94)90161-9; Teplova M, 2000, PROTEIN SCI, V9, P2557, DOI 10.1110/ps.9.12.2557; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Thunnissen MMGM, 1997, STRUCTURE, V5, P69, DOI 10.1016/S0969-2126(97)00167-6; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WANG TT, 1972, J BIOL CHEM, V247, P4437; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	48	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28409	28419		10.1074/jbc.M112.387134	http://dx.doi.org/10.1074/jbc.M112.387134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22740694	hybrid, Green Published			2022-12-25	WOS:000308074600017
J	Bartoszewska, M; Williams, C; Kikhney, A; Opalinski, L; van Roermund, CWT; de Boer, R; Veenhuis, M; van der Klei, IJ				Bartoszewska, Magdalena; Williams, Chris; Kikhney, Alexey; Opalinski, Lukasz; van Roermund, Carlo W. T.; de Boer, Rinse; Veenhuis, Marten; van der Klei, Ida J.			Peroxisomal Proteostasis Involves a Lon Family Protein That Functions as Protease and Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; PENICILLIUM-CHRYSOGENUM; HANSENULA-POLYMORPHA; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; CITRATE SYNTHASE; HIGH-RESOLUTION; MATRIX PROTEIN; IN-VITRO	Proteins are subject to continuous quality control for optimal proteostasis. The knowledge of peroxisome quality control systems is still in its infancy. Here we show that peroxisomes contain a member of the Lon family of proteases (Pln). We show that Pln is a heptameric protein and acts as an ATP-fueled protease and chaperone. Hence, Pln is the first chaperone identified in fungal peroxisomes. In cells of a PLN deletion strain peroxisomes contain protein aggregates, a major component of which is catalase-peroxidase. We show that this enzyme is sensitive to oxidative damage. The oxidatively damaged, but not the native protein, is a substrate of the Pln protease. Cells of the pln strain contain enhanced levels of catalase-peroxidase protein but reduced catalase-peroxidase enzyme activities. Together with the observation that Pln has chaperone activity in vitro, our data suggest that catalase-peroxidase aggregates accumulate in peroxisomes of pln cells due to the combined absence of Pln protease and chaperone activities.	[Bartoszewska, Magdalena; Opalinski, Lukasz; de Boer, Rinse; Veenhuis, Marten; van der Klei, Ida J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Kluyver Ctr Genom Ind Fermentat, NL-9700 CC Groningen, Netherlands; [Williams, Chris; Kikhney, Alexey] DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany; [van Roermund, Carlo W. T.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Amsterdam; Academic Medical Center Amsterdam	van der Klei, IJ (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Kluyver Ctr Genom Ind Fermentat, POB 11103, NL-9700 CC Groningen, Netherlands.	I.J.van.der.klei@rug.nl	Williams, Chris/C-4216-2012; van der Klei, Ida J/D-1919-2012	Williams, Chris/0000-0003-1757-6156; Van der Klei, Ida J./0000-0001-7165-9679; Opalinski, Lukasz/0000-0001-9656-8714; Opalinska, Magdalena/0000-0003-1449-4243	Netherlands Organization for Scientific Research [825.08.023]; Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Organization for Scientific Research via the IBOS (Integration of Biosynthesis and Organic Synthesis) Programme of Advanced Chemical Technologies for Sustainability (ACTS) [IBOS 053.63.011]; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Organization for Scientific Research via the IBOS (Integration of Biosynthesis and Organic Synthesis) Programme of Advanced Chemical Technologies for Sustainability (ACTS); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported in part by a Rubicon Fellowship (825.08.023) from the Netherlands Organization for Scientific Research (to C. W.).; Supported by the Research Program of the Kluyver Centre for Genomics of Industrial Fermentation, which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.; Supported by the Netherlands Organization for Scientific Research via the IBOS (Integration of Biosynthesis and Organic Synthesis) Programme of Advanced Chemical Technologies for Sustainability (ACTS) (project IBOS 053.63.011).	Aksam EB, 2007, AUTOPHAGY, V3, P96, DOI 10.4161/auto.3534; Antonenkov VD, 2010, ANTIOXID REDOX SIGN, V13, P525, DOI 10.1089/ars.2009.2996; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartoszewska M, 2011, APPL ENVIRON MICROB, V77, P1413, DOI 10.1128/AEM.01531-10; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Fraaije MW, 1996, EUR J BIOCHEM, V235, P192, DOI 10.1111/j.1432-1033.1996.00192.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GOLDBERG AL, 1994, METHOD ENZYMOL, V244, P350; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HILLENGA DJ, 1994, EUR J BIOCHEM, V224, P581, DOI 10.1111/j.1432-1033.1994.t01-1-00581.x; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jaenicke R, 1998, BIOL CHEM, V379, P237; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Kiel JAKW, 2000, APPL MICROBIOL BIOT, V54, P238, DOI 10.1007/s002530000378; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee AYL, 2004, J BIOL CHEM, V279, P34903, DOI 10.1074/jbc.M403562200; Lingard MJ, 2009, PLANT PHYSIOL, V151, P1354, DOI 10.1104/pp.109.142505; Liu FF, 2011, DEV CELL, V21, P457, DOI 10.1016/j.devcel.2011.08.004; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Nijland JG, 2008, FUNGAL GENET BIOL, V45, P1415, DOI 10.1016/j.fgb.2008.07.008; Okumoto K, 2011, J BIOL CHEM, V286, P44367, DOI 10.1074/jbc.M111.285197; Omi S, 2008, J BIOCHEM, V143, P649, DOI 10.1093/jb/mvn020; Opalinski L, 2010, FEBS J, V277, P3203, DOI 10.1111/j.1742-4658.2010.07726.x; Paraszkiewicz K, 2010, ARCH MICROBIOL, V192, P135, DOI 10.1007/s00203-009-0542-3; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Petoukhov MV, 2002, BIOPHYS J, V83, P3113, DOI 10.1016/S0006-3495(02)75315-0; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Roudiak SG, 1998, BIOCHEMISTRY-US, V37, P377, DOI 10.1021/bi971732f; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Stahlberg H, 1999, P NATL ACAD SCI USA, V96, P6787, DOI 10.1073/pnas.96.12.6787; Steinberg S. J., 1993, PEROXISOME BIOGENESI; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; VANDIJKEN JP, 1976, ARCH MICROBIOL, V111, P137; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737; WEST SM, 1990, BIOCHIM BIOPHYS ACTA, V1037, P332, DOI 10.1016/0167-4838(90)90034-D	59	45	45	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27380	27395		10.1074/jbc.M112.381566	http://dx.doi.org/10.1074/jbc.M112.381566			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22733816	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000307840700010
J	Rives, ML; Rossillo, M; Liu-Chen, LY; Javitch, JA				Rives, Marie-Laure; Rossillo, Mary; Liu-Chen, Lee-Yuan; Javitch, Jonathan A.			6 '-Guanidinonaltrindole (6 '-GNTI) Is a G Protein-biased kappa-Opioid Receptor Agonist That Inhibits Arrestin Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL SENSORY NEURONS; FUNCTIONAL SELECTIVITY; IN-VIVO; ACTIVATION; TRAFFICKING; TOLERANCE; EFFICACY; STRESS; KINASE; DELTA	kappa-Opioid receptor (KOR) agonists do not activate the reward pathway stimulated by morphine-like mu-opioid receptor (MOR) agonists and thus have been considered to be promising nonaddictive analgesics. However, KOR agonists produce other adverse effects, including dysphoria, diuresis, and constipation. The therapeutic promise of KOR agonists has nonetheless recently been revived by studies showing that their dysphoric effects require arrestin recruitment, whereas their analgesic effects do not. Moreover, KOR agonist-induced antinociceptive tolerance observed in vivo has also been proposed to be correlated to the ability to induce arrestin-dependent phosphorylation, desensitization, and internalization of the receptor. The discovery of functionally selective drugs that are therapeutically effective without the adverse effects triggered by the arrestin pathway is thus an important goal. We have identified such an extreme G protein-biased KOR compound, 6'-guanidinonal-trindole (6'-GNTI), a potent partial agonist at the KOR receptor for the G protein activation pathway that does not recruit arrestin. Indeed, 6'-GNTI functions as an antagonist to block the arrestin recruitment and KOR internalization induced by other nonbiased agonists. As an extremely G protein-biased KOR agonist, 6'-GNTI represents a promising lead compound in the search for nonaddictive opioid analgesic as its signaling profile suggests that it will be without the dysphoria and other adverse effects promoted by arrestin recruitment and its downstream signaling.	[Rives, Marie-Laure; Rossillo, Mary; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10032 USA; [Rives, Marie-Laure; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA	Columbia University; Columbia University; New York State Psychiatry Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Javitch, JA (corresponding author), Columbia Univ, Dept Psychiat, Coll Phys & Surg, P&S 11-401,630 W 168th St,Box 7, New York, NY 10032 USA.	jaj2@columbia.edu		Rives, Marie-Laure/0000-0003-3324-2412; Rossillo, Mary/0000-0002-5103-0985; Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health [DA022413, MH054137]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R01DA017302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA022413 and MH054137 (to J. A. J.).	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Ansonoff MA, 2010, PSYCHOPHARMACOLOGY, V210, P161, DOI 10.1007/s00213-010-1826-7; BASBAUM AI, 2000, PRINCIPLES NEURAL SC, P472; Beguin C, 2012, BIOORG MED CHEM LETT, V22, P1023, DOI 10.1016/j.bmcl.2011.11.128; Berg KA, 2012, MOL PHARMACOL, V81, P264, DOI 10.1124/mol.111.072702; Berg KA, 2011, J PHARMACOL EXP THER, V338, P92, DOI 10.1124/jpet.110.177493; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; Chavkin C, 2011, NEUROPSYCHOPHARMACOL, V36, P369, DOI 10.1038/npp.2010.137; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; HENRY DJ, 1995, MOL PHARMACOL, V47, P551; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Liu-Chen LY, 2004, LIFE SCI, V75, P511, DOI 10.1016/j.lfs.2003.10.041; McLaughlin JP, 2004, J BIOL CHEM, V279, P1810, DOI 10.1074/jbc.M305796200; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; SCHOFFELMEER ANM, 1988, EUR J PHARMACOL, V154, P169, DOI 10.1016/0014-2999(88)90094-5; Sharma SK, 2001, J MED CHEM, V44, P2073, DOI 10.1021/jm010095v; TALLENT M, 1994, NEUROSCIENCE, V63, P1033, DOI 10.1016/0306-4522(94)90570-3; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vanderah TW, 2010, CLIN J PAIN, V26, pS10, DOI 10.1097/AJP.0b013e3181c49e3a; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Wang YH, 2010, ACTA PHARMACOL SIN, V31, P1065, DOI 10.1038/aps.2010.138; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007	38	79	81	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2012	287	32					27050	27054		10.1074/jbc.C112.387332	http://dx.doi.org/10.1074/jbc.C112.387332			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	986ZK	22736766	Green Published, hybrid			2022-12-25	WOS:000307386000057
J	Huang, JH; Lu, L; Zhang, JB; Hu, XY; Zhang, YG; Liang, W; Wu, SY; Luo, ZJ				Huang, Jinghui; Lu, Lei; Zhang, Jianbin; Hu, Xueyu; Zhang, Yongguang; Liang, Wei; Wu, Siyu; Luo, Zhuojing			Electrical Stimulation to Conductive Scaffold Promotes Axonal Regeneration and Remyelination in a Rat Model of Large Nerve Defect	PLOS ONE			English	Article							POOR FUNCTIONAL RECOVERY; SCHWANN-CELLS; NEURITE OUTGROWTH; CONTRIBUTING FACTORS; CEREBRAL-ISCHEMIA; REPAIR; POLYMER; GROWTH; GUIDANCE; FIELDS	Background: Electrical stimulation (ES) has been shown to promote nerve regeneration when it was applied to the proximal nerve stump. However, the possible beneficial effect of establishing a local electrical environment between a large nerve defect on nerve regeneration has not been reported in previous studies. The present study attempted to establish a local electrical environment between a large nerve defect, and examined its effect on nerve regeneration and functional recovery. Methodology/Findings: In the present study, a conductive scaffold was constructed and used to bridge a 15 mm sciatic nerve defect in rats, and intermittent ES (3 V, 20 Hz) was applied to the conductive scaffold to establish an electrical environment at the site of nerve defect. Nerve regeneration and functional recovery were examined after nerve injury repair and ES. We found that axonal regeneration and remyelination of the regenerated axons were significantly enhanced by ES which was applied to conductive scaffold. In addition, both motor and sensory functional recovery was significantly improved and muscle atrophy was partially reversed by ES localized at the conductive scaffold. Further investigations showed that the expression of S-100, BDNF (brain-derived neurotrophic factor), P0 and Par-3 was significantly up-regulated by ES at the conductive scaffold. Conclusions/Significance: Establishing an electrical environment with ES localized at the conductive scaffold is capable of accelerating nerve regeneration and promoting functional recovery in a 15 mm nerve defect in rats. The findings provide new directions for exploring regenerative approaches to achieve better functional recovery in the treatment of large nerve defect.	[Huang, Jinghui; Hu, Xueyu; Zhang, Yongguang; Liang, Wei; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China; [Lu, Lei] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Anat & Physiol, Xian 710032, Peoples R China; [Zhang, Jianbin] Fourth Mil Med Univ, Sch Publ Hlth, Key Lab Hazard Assessment & Control Special Opera, Minist Educ, Xian 710032, Peoples R China; [Zhang, Jianbin] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Peoples R China; [Zhang, Yongguang] Fuzhou Gen Hosp, Fuzhou, Peoples R China; [Wu, Siyu] Third Mil Med Univ, Daping Hosp, Dept Orthopaed, Chongqing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Army Medical University	Huang, JH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China.	zjluo@fmmu.edu.cn		Huang, Jinghui/0000-0002-0991-0591	National Natural Science Foundation of China [30770571, 30973052]; National Hi-Tech Research and Development Program of China (863 Program) [2002AA216101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30770571 and No. 30973052) and the National Hi-Tech Research and Development Program of China (863 Program) (No. 2002AA216101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn P, 2007, EXP NEUROL, V208, P137, DOI 10.1016/j.expneurol.2007.08.005; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Bloch J, 2001, EXP NEUROL, V172, P425, DOI 10.1006/exnr.2001.7778; Brushart TM, 2002, J NEUROSCI, V22, P6631; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748; HARE GMT, 1992, PLAST RECONSTR SURG, V89, P251, DOI 10.1097/00006534-199202000-00009; Hendriks WTJ, 2004, PROG BRAIN RES, V146, P451; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI [10.1089/ten.tea.2009.0017, 10.1089/ten.TEA.2009.0017]; Huang JH, 2010, NEUROREHAB NEURAL RE, V24, P736, DOI 10.1177/1545968310368686; Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511; Huang JH, 2010, GLIA, V58, P622, DOI 10.1002/glia.20951; Huang JH, 2009, J NEUROTRAUM, V26, P1805, DOI 10.1089/neu.2008-0732; Komotar RJ, 2007, NAT PROTOC, V2, P2345, DOI 10.1038/nprot.2007.359; Li BC, 2010, J BIOMED MATER RES A, V94A, P769, DOI 10.1002/jbm.a.32727; Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; Martini R, 2008, GLIA, V56, P1566, DOI 10.1002/glia.20766; McKasson MJ, 2008, EXP NEUROL, V211, P585, DOI 10.1016/j.expneurol.2008.02.015; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Moroder P, 2011, ACTA BIOMATER, V7, P944, DOI 10.1016/j.actbio.2010.10.013; PATEL N, 1982, J NEUROSCI, V2, P483; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Sughrue ME, 2006, J NEUROSCI METH, V151, P83, DOI 10.1016/j.jneumeth.2005.04.023; Tseng CY, 2003, J RECONSTR MICROSURG, V19, P331; Wood M, 2006, BIOELECTROMAGNETICS, V27, P328, DOI 10.1002/bem.20214; Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x	32	79	87	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39526	10.1371/journal.pone.0039526	http://dx.doi.org/10.1371/journal.pone.0039526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737243	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100042
J	Loong, CKP; Zhou, HX; Chase, PB				Loong, Campion K. P.; Zhou, Huan-Xiang; Chase, P. Bryant			Persistence Length of Human Cardiac alpha-Tropomyosin Measured by Single Molecule Direct Probe Microscopy	PLOS ONE			English	Article							REGULATORY UNIT INTERACTIONS; MECHANICAL-PROPERTIES; THERMAL FLUCTUATIONS; FLEXURAL RIGIDITY; FORCE MICROSCOPY; BINDING-SITES; MUSCLE; ACTIN; FLEXIBILITY; ACTOMYOSIN	alpha-Tropomyosin (alpha Tm) is the predominant tropomyosin isoform in adult human heart and constitutes a major component in Ca2+-regulated systolic contraction of cardiac muscle. We present here the first direct probe images of WT human cardiac alpha Tm by atomic force microscopy, and quantify its mechanical flexibility with three independent analysis methods. Single molecules of bacterially-expressed human cardiac alpha Tm were imaged on poly-lysine coated mica and their contours were analyzed. Analysis of tangent-angle (theta(s)) correlation along molecular contours, second moment of tangent angles (<theta(2)(s)>), and end-to-end length (Le-e) distributions respectively yielded values of persistence length (L-p) of 41-46 nm, 40-45 nm, and 42-52 nm, corresponding to 1-1.3 molecular contour lengths (L-c). We also demonstrate that a sufficiently large population, with at least 100 molecules, is required for a reliable L-p measurement of alpha Tm in single molecule studies. Our estimate that L-p for alpha Tm is only slightly longer than L-c is consistent with a previous study showing there is little spread of cooperative activation into near-neighbor regulatory units of cardiac thin filaments. The L-p determined here for human cardiac alpha Tm perhaps represents an evolutionarily tuned optimum between Ca2+ sensitivity and cooperativity in cardiac thin filaments and likely constitutes an essential parameter for normal function in the human heart.	[Loong, Campion K. P.; Chase, P. Bryant] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Loong, Campion K. P.; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Loong, CKP (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	campion.loong@gmail.com; chase@bio.fsu.edu	zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016; Chase, P. Bryant/M-6322-2019	Zhou, Huan-Xiang/0000-0001-9020-0302; Chase, P. Bryant/0000-0001-9701-561X	United States National Institutes of Health [GM88187]; American Heart Association Predoctoral Fellowship [0815127E]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088187] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Huan-Xiang Zhou was supported in part by United States National Institutes of Health Grant GM88187. Campion K. P. Loong was supported in part by American Heart Association Predoctoral Fellowship 0815127E. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels JA, 2005, BIOPHYS J, V88, P2737, DOI 10.1529/biophysj.104.052811; Albet-Torres N, 2007, LANGMUIR, V23, P11147, DOI 10.1021/la7008682; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228; Brangwynne CP, 2007, BIOPHYS J, V93, P346, DOI 10.1529/biophysj.106.096966; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Brunet NM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/657523; Byun KE, 2007, LANGMUIR, V23, P9535, DOI 10.1021/la7019318; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Chase PB, 2004, ANN BIOMED ENG, V32, P1559, DOI 10.1114/B:ABME.0000049039.89173.08; Cheng Y, 2011, BIOSENS BIOELECTRON, V26, P4538, DOI 10.1016/j.bios.2011.05.019; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Daniel TL, 1998, BIOPHYS J, V74, P1611, DOI 10.1016/S0006-3495(98)77875-0; FRONTALI C, 1979, BIOPOLYMERS, V18, P1353, DOI 10.1002/bip.1979.360180604; Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Harris DC, 1998, J CHEM EDUC, V75, P119, DOI 10.1021/ed075p119; Howard J, 1996, Proc Natl Acad Sci U S A, V93, P4462; Howard J., 2001, MECH MOTOR PROTEINS; Howe N, 2007, BETTER SKELETONIZATI; HVIDT S, 1982, BIOCHEMISTRY-US, V21, P4064, DOI 10.1021/bi00260a024; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jaber JA, 2003, NANO LETT, V3, P1505, DOI 10.1021/nl034539h; Kataoka A, 2007, J BIOMECH, V40, P2044, DOI 10.1016/j.jbiomech.2006.09.026; LANG D, 1968, J MOL BIOL, V36, P137, DOI 10.1016/0022-2836(68)90225-8; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Loong CKP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00080; Manandhar P, 2005, LANGMUIR, V21, P3213, DOI 10.1021/la047227i; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Martyn DA, 2002, BIOPHYS J, V83, P3425, DOI 10.1016/S0006-3495(02)75342-3; Mathur MC, 2011, BIOCHEM BIOPH RES CO, V406, P74, DOI 10.1016/j.bbrc.2011.01.112; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Mucke N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007756; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; OTT A, 1993, PHYS REV E, V48, pR1642, DOI 10.1103/PhysRevE.48.R1642; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Phillips GN, 1996, BIOPOLYMERS, V38, P89, DOI 10.1002/(SICI)1097-0282(199601)38:1<89::AID-BIP7>3.3.CO;2-X; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Regnier M, 2002, J PHYSIOL-LONDON, V540, P485, DOI 10.1113/jphysiol.2001.013179; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Schoffstall B, 2011, DNA CELL BIOL, V30, P653, DOI 10.1089/dna.2010.1163; Schoffstall B, 2006, J PHYSIOL-LONDON, V577, P935, DOI 10.1113/jphysiol.2006.120105; Smillie L, 1996, BIOCH SMOOTH MUSCLE, P63; Sousa D, 2010, BIOPHYS J, V99, P862, DOI 10.1016/j.bpj.2010.05.004; STEWART M, 1975, FEBS LETT, V53, P5, DOI 10.1016/0014-5793(75)80668-5; TRIFONOV EN, 1985, CRC CR REV BIOCH MOL, V19, P89, DOI 10.3109/10409238509082540; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Wang F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/435271; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581	55	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39676	10.1371/journal.pone.0039676	http://dx.doi.org/10.1371/journal.pone.0039676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737252	Green Published, gold, Green Submitted			2022-12-25	WOS:000305695100051
J	Cubeddu, L; Joseph, S; Richard, DJ; Matthews, JM				Cubeddu, Liza; Joseph, Soumya; Richard, Derek J.; Matthews, Jacqueline M.			Contribution of DEAF1 Structural Domains to the Interaction with the Breast Cancer Oncogene LMO4	PLOS ONE			English	Article							NUCLEAR-EXPORT SIGNALS; MAMMARY EPITHELIAL-CELLS; COILED-COIL; SUBCELLULAR-LOCALIZATION; PROTEIN LMO4; CYCLE ENTRY; LIM; EXPRESSION; IDENTIFICATION; SUPPRESSOR	The proteins LMO4 and DEAF1 contribute to the proliferation of mammary epithelial cells. During breast cancer LMO4 is upregulated, affecting its interaction with other protein partners. This may set cells on a path to tumour formation. LMO4 and DEAF1 interact, but it is unknown how they cooperate to regulate cell proliferation. In this study, we identify a specific LMO4-binding domain in DEAF1. This domain contains an unstructured region that directly contacts LMO4, and a coiled coil that contains the DEAF1 nuclear export signal (NES). The coiled coil region can form tetramers and has the typical properties of a coiled coil domain. Using a simple cell-based assay, we show that LMO4 modulates the activity of the DEAF NES, causing nuclear accumulation of a construct containing the LMO4-interaction region of DEAF1.	[Cubeddu, Liza; Joseph, Soumya; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Richard, Derek J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	University of Sydney; Queensland University of Technology (QUT)	Cubeddu, L (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia.	liza.cubeddu@sydney.edu.au; jacqueline.matthews@sydney.edu.au	Richard, Derek/J-1338-2012; Matthews, Jacqueline/A-7322-2013	Richard, Derek/0000-0002-4839-8471; Joseph, Soumya/0000-0002-0487-1378; Matthews, Jacqueline/0000-0001-8518-3472	Australian Research Council; Association for International Cancer Research	Australian Research Council(Australian Research Council); Association for International Cancer Research	This work was supported by grants from the Australian Research Council and the Association for International Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker HE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-94; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; Dixon AS, 2010, BIOTECHNIQUES, V49, P519, DOI 10.2144/000113452; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Dubin MJ, 2004, J BIOL CHEM, V279, P26932, DOI 10.1074/jbc.M313974200; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gadd MS, 2011, J BIOL CHEM, V286, P42971, DOI 10.1074/jbc.M111.248559; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hermanson O, 1999, CELL MOL BIOL, V45, P677; Jensik PJ, 2004, J BIOL CHEM, V279, P32692, DOI 10.1074/jbc.M400946200; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Kenny DA, 1998, P NATL ACAD SCI USA, V95, P11257, DOI 10.1073/pnas.95.19.11257; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LeBoeuf RD, 1998, J BIOL CHEM, V273, P361, DOI 10.1074/jbc.273.1.361; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lu Z, 2006, ONCOGENE, V25, P2920, DOI 10.1038/sj.onc.1209318; Manne U, 2001, CLIN CANCER RES, V7, P3495; Matthews JM, 2009, CURR PHARM DESIGN, V15, P3681, DOI 10.2174/138161209789271861; Michelson RJ, 1999, J BIOL CHEM, V274, P30510, DOI 10.1074/jbc.274.43.30510; Mizuno T, 1996, J CELL SCI, V109, P2627; Montanez-Wiscovich ME, 2010, J PATHOL, V222, P271, DOI 10.1002/path.2762; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pasion SG, 1999, MOL BIOL CELL, V10, P4043, DOI 10.1091/mbc.10.12.4043; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Spinola-Amilibia M, 2011, J MOL BIOL, V411, P1114, DOI 10.1016/j.jmb.2011.07.006; Stokes PH, 2007, BIOCHEM BIOPH RES CO, V354, P197, DOI 10.1016/j.bbrc.2006.12.178; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Tickenbrock L, 2002, J BIOL CHEM, V277, P32332, DOI 10.1074/jbc.M203990200; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Wang N, 2004, ONCOGENE, V23, P1507, DOI 10.1038/sj.onc.1207288; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150	45	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39218	10.1371/journal.pone.0039218	http://dx.doi.org/10.1371/journal.pone.0039218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723967	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700055
J	Lyngdoh, T; Vuistiner, P; Marques-Vidal, P; Rousson, V; Waeber, G; Vollenweider, P; Bochud, M				Lyngdoh, Tanica; Vuistiner, Philippe; Marques-Vidal, Pedro; Rousson, Valentin; Waeber, Gerard; Vollenweider, Peter; Bochud, Murielle			Serum Uric Acid and Adiposity: Deciphering Causality Using a Bidirectional Mendelian Randomization Approach	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-FAT DISTRIBUTION; FTO GENE; URATE EXCRETION; BLOOD-PRESSURE; WEIGHT-LOSS; ASSOCIATION; HYPERURICEMIA; OBESITY; HYPERTENSION	Background: Although the relationship between serum uric acid (SUA) and adiposity is well established, the direction of the causality is still unclear in the presence of conflicting evidences. We used a bidirectional Mendelian randomization approach to explore the nature and direction of causality between SUA and adiposity in a population-based study of Caucasians aged 35 to 75 years. Methods and Findings: We used, as instrumental variables, rs6855911 within the SUA gene SLC2A9 in one direction, and combinations of SNPs within the adiposity genes FTO, MC4R and TMEM18 in the other direction. Adiposity markers included weight, body mass index, waist circumference and fat mass. We applied a two-stage least squares regression: a regression of SUA/adiposity markers on our instruments in the first stage and a regression of the response of interest on the fitted values from the first stage regression in the second stage. SUA explained by the SLC2A9 instrument was not associated to fat mass (regression coefficient [95% confidence interval]: 0.05 [-0.10, 0.19] for fat mass) contrasting with the ordinary least square estimate (0.37 [0.34, 0.40]). By contrast, fat mass explained by genetic variants of the FTO, MC4R and TMEM18 genes was positively and significantly associated to SUA (0.31 [0.01, 0.62]), similar to the ordinary least square estimate (0.27 [0.25, 0.29]). Results were similar for the other adiposity markers. Conclusions: Using a bidirectional Mendelian randomization approach in adult Caucasians, our findings suggest that elevated SUA is a consequence rather than a cause of adiposity.	[Lyngdoh, Tanica; Vuistiner, Philippe; Marques-Vidal, Pedro; Rousson, Valentin; Bochud, Murielle] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lyngdoh, T (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	murielle.bochud@chuv.ch	Marques-Vidal, Pedro M/C-9449-2009; Bochud, Murielle/A-3981-2010; Vuistiner, Philippe/AAD-5010-2020; Colaus, PsyColaus/K-6607-2013	Marques-Vidal, Pedro M/0000-0002-4548-8500; Bochud, Murielle/0000-0002-5727-0218; Rousson, Valentin/0000-0001-8092-4446; Waeber, Gerard/0000-0003-4193-788X; Vuistiner, Philippe/0000-0002-2661-4970	Swiss National Science Foundation [33CSCO-122661, PRODOC PDFMP3_127393/1]; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	The CoLaus study was supported by research grants from the Swiss National Science Foundation (grant no: 33CSCO-122661), GlaxoSmithKline and the Faculty of Biology and Medicine of Lausanne, Switzerland. Tanica Lyngdoh is supported by a grant from the Swiss National Science Foundation (PRODOC PDFMP3_127393/1). Murielle Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Bochud M, 2010, INT J ENV RES PUB HE, V7, P711, DOI 10.3390/ijerph7030711; Bochud M, 2009, J CLIN ENDOCR METAB, V94, P3969, DOI 10.1210/jc.2008-2428; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; Burgess S, 2011, STAT MED, V30, P1312, DOI 10.1002/sim.4197; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Carnethon MR, 2003, AM J EPIDEMIOL, V158, P1058, DOI 10.1093/aje/kwg260; Chang CH, 2009, ARCH GERONTOL GERIAT, V49, pS46, DOI 10.1016/S0167-4943(09)70013-5; Chauhan G, 2011, J HUM GENET, V56, P720, DOI 10.1038/jhg.2011.87; Chen JH, 2012, CLIN RHEUMATOL, V31, P239, DOI 10.1007/s10067-011-1802-6; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; CIGOLINI M, 1995, INT J OBESITY, V19, P92; Costa A, 2002, METABOLISM, V51, P372, DOI 10.1053/meta.2002.30523; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; GILLUM RF, 1987, J CHRON DIS, V40, P413, DOI 10.1016/0021-9681(87)90174-3; GLYNN RJ, 1983, ARTHRITIS RHEUM-US, V26, P87, DOI 10.1002/art.1780260115; Goncalves JP, 2012, ENDOCRINE; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Hikita M, 2007, INTERNAL MED, V46, P1353, DOI 10.2169/internalmedicine.46.0045; Ishizaka N, 2010, J RHEUMATOL, V37, P410, DOI 10.3899/jrheum.090736; KLEIN R, 1973, ARCH INTERN MED, V132, P401, DOI 10.1001/archinte.132.3.401; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Lei MT, 2008, NEPHROL DIAL TRANSPL, V23, P2746, DOI 10.1093/ndt/gfn349; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Malis C, 2005, OBES RES, V13, P2139, DOI 10.1038/oby.2005.265; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nakanishi N, 2001, METABOLISM, V50, P621, DOI 10.1053/meta.2001.24196; NICHOLLS A, 1972, LANCET, V2, P1223; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Palmer T.M., 2011, STAT METHODS MED RES; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; RAMYA K, 2011, DIABETES TECHNOL THE, V13, P33, DOI DOI 10.1089/dia.2010.0071; Rattarasarn C, 2003, DIABETES RES CLIN PR, V60, P87, DOI 10.1016/S0168-8227(03)00017-2; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schmidt MI, 1996, METABOLISM, V45, P699, DOI 10.1016/S0026-0495(96)90134-1; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Viazzi F, 2011, DIABETES CARE, V34, P126, DOI 10.2337/dc10-0918; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Welsh P, 2010, J CLIN ENDOCR METAB, V95, P93, DOI 10.1210/jc.2009-1064; WEXLER BC, 1977, METABOLISM, V26, P1309, DOI 10.1016/0026-0495(77)90027-0; YAMASHITA S, 1986, INT J OBESITY, V10, P255; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zhu YY, 2010, RHEUMATOLOGY, V49, P2391, DOI 10.1093/rheumatology/keq256	59	88	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39321	10.1371/journal.pone.0039321	http://dx.doi.org/10.1371/journal.pone.0039321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723994	gold, Green Published, Green Submitted			2022-12-25	WOS:000305652700067
J	Zamora-Vilchis, I; Williams, SE; Johnson, CN				Zamora-Vilchis, Itzel; Williams, Stephen E.; Johnson, Christopher N.			Environmental Temperature Affects Prevalence of Blood Parasites of Birds on an Elevation Gradient: Implications for Disease in a Warming Climate	PLOS ONE			English	Article							RAIN-FOREST BIRDS; AUSTRALIAN WET TROPICS; ASSEMBLAGE STRUCTURE; SPECIES RICHNESS; POPULATION; ABUNDANCE; MALARIA; HAEMOPROTEUS; HEMATOZOA; PATTERNS	Background: The rising global temperature is predicted to expand the distribution of vector-borne diseases both in latitude and altitude. Many host communities could be affected by increased prevalence of disease, heightening the risk of extinction for many already threatened species. To understand how host communities could be affected by changing parasite distributions, we need information on the distribution of parasites in relation to variables like temperature and rainfall that are predicted to be affected by climate change. Methodology/Principal Findings: We determined relations between prevalence of blood parasites, temperature, and seasonal rainfall in a bird community of the Australian Wet Tropics along an elevation gradient. We used PCR screening to investigate the prevalence and lineage diversity of four genera of blood parasites (Plasmodium, Haemoproteus, Leucocytozoon and Trypanosoma) in 403 birds. The overall prevalence of the four genera of blood parasites was 32.3%, with Haemoproteus the predominant genus. A total of 48 unique lineages were detected. Independent of elevation, parasite prevalence was positively and strongly associated with annual temperature. Parasite prevalence was elevated during the dry season. Conclusions/Significance: Low temperatures of the higher elevations can help to reduce both the development of avian haematozoa and the abundance of parasite vectors, and hence parasite prevalence. In contrast, high temperatures of the lowland areas provide an excellent environment for the development and transmission of haematozoa. We showed that rising temperatures are likely to lead to increased prevalence of parasites in birds, and may force shifts of bird distribution to higher elevations. We found that upland tropical areas are currently a low-disease habitat and their conservation should be given high priority in management plans under climate change.	[Zamora-Vilchis, Itzel; Williams, Stephen E.; Johnson, Christopher N.] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia	James Cook University	Zamora-Vilchis, I (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.	Itzel.ZamoraVilchis@my.jcu.edu.au	Johnson, Chris N/A-7275-2008; Johnson, Christopher/J-7894-2014; Williams, Stephen E/A-7250-2008	Johnson, Christopher/0000-0002-9719-3771; Williams, Stephen E/0000-0002-2510-7408	Stuart Leslie Bird Research Award of Birds Australia; Joyce W. Vickery Scientific Research Fund of The Linnean Society of New South Wales; Earthwatch Institute; James Cook University Research Advancement Program; Mexican Science Council (CONACYT)	Stuart Leslie Bird Research Award of Birds Australia; Joyce W. Vickery Scientific Research Fund of The Linnean Society of New South Wales; Earthwatch Institute; James Cook University Research Advancement Program; Mexican Science Council (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by Stuart Leslie Bird Research Award of Birds Australia (http://www.birdsaustralia.com.au/), Joyce W. Vickery Scientific Research Fund of The Linnean Society of New South Wales (http://linneansocietynsw.org.au/), Earthwatch Institute (http://www.earthwatch.org/australia/) and James Cook University Research Advancement Program. IZV benefited from a doctoral grant from the Mexican Science Council (CONACYT; http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniazzi LR, 2011, J ZOOL, V283, P126, DOI 10.1111/j.1469-7998.2010.00753.x; Arriero E, 2008, J EVOLUTION BIOL, V21, P1504, DOI 10.1111/j.1420-9101.2008.01613.x; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Atkinson CT, 2009, HAEMOPROTEUS PARASIT, P11; Atkinson CT, 2008, PARASITIC DIS WILD B; Bartlett CM, 2009, FILARIOID NEMATODES, P439; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Cubasch U, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P525; Cumming GS, 2006, GLOBAL ECOL BIOGEOGR, V15, P486, DOI 10.1111/j.1466-822x.2006.00241.x; Dawson RD, 2005, ENVIRON ENTOMOL, V34, P563, DOI 10.1603/0046-225X-34.3.563; Donovan TA, 2008, J VET DIAGN INVEST, V20, P304, DOI 10.1177/104063870802000307; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Folland CK, 2001, GEOPHYS RES LETT, V28, P2621, DOI 10.1029/2001GL012877; Foufopoulos J, 2011, AM NAT, V177, P119, DOI 10.1086/657624; Garvin MC, 1997, AUK, V114, P179, DOI 10.2307/4089159; Gasner MR, 2010, BIOL CONSERV, V143, P1250, DOI 10.1016/j.biocon.2010.02.034; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; HIGGINS PJ, 2002, HDB AUSTR NZ ANTARTI, V6; HOUGHTON JT, 2001, IPCC 3 ASSESSMENT RE; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; LaPointe Dennis, 2005, P317; Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087; MacDonald GT, 2000, SECURING WET TROPICS; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Meik JM, 2008, J ARID ENVIRON, V72, P1193, DOI 10.1016/j.jaridenv.2008.01.003; Norte AC, 2009, IBIS, V151, P677, DOI 10.1111/j.1474-919X.2009.00960.x; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Patz JA, 2001, TRENDS IMMUNOL, V22, P171, DOI 10.1016/S1471-4906(01)01867-1; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Rohan DW, 2007, BIODIVERS CONSERV, V16, P3163, DOI 10.1007/s10531-007-9170-x; Sehgal RNM, 2001, MOL ECOL, V10, P2319, DOI 10.1046/j.1365-294X.2001.01339.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shoo LP, 2005, GLOBAL CHANGE BIOL, V11, P1469, DOI 10.1111/j.1365-2486.2005.00995.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Tella JL, 1999, P NATL ACAD SCI USA, V96, P1785, DOI 10.1073/pnas.96.4.1785; Tracey JG, 1982, VEGETATION HUMID TRO; Tryjanowski P, 2005, DIVERS DISTRIB, V11, P219, DOI 10.1111/j.1366-9516.2005.00140.x; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Walsh KJE, 2000, J CLIMATE, V13, P3029, DOI 10.1175/1520-0442(2000)013<3029:TCIINA>2.0.CO;2; Webb LJ, 1981, ECOLOGICAL BIOGEOGRA, P605, DOI DOI 10.1007/978-94-009-8629-9_22; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; Williams SE, 2010, AUSTRAL ECOL, V35, P650, DOI 10.1111/j.1442-9993.2009.02073.x	45	121	123	4	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e39208	10.1371/journal.pone.0039208	http://dx.doi.org/10.1371/journal.pone.0039208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723966	gold, Green Accepted, Green Published			2022-12-25	WOS:000305652700054
J	Chen, K; Ahmed, S; Adeyi, O; Dick, JE; Ghanekar, A				Chen, Kui; Ahmed, Sharif; Adeyi, Oyedele; Dick, John E.; Ghanekar, Anand			Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus	PLOS ONE			English	Article							CANCER XENOGRAFTS; CELLS; IDENTIFICATION; ESTABLISHMENT	Xenografting primary human solid tumor tissue into immunodeficient mice is a widely used tool in studies of human cancer biology; however, care must be taken to prove that the tumors obtained recapitulate parent tissue. We xenografted primary human hepatocellular carcinoma (HCC) tumor fragments or bulk tumor cell suspensions into immunodeficient mice. We unexpectedly observed that 11 of 21 xenografts generated from 16 independent patient samples resembled lymphoid neoplasms rather than HCC. Immunohistochemistry and flow cytometry analyses revealed that the lymphoid neoplasms were comprised of cells expressing human CD45 and CD19/20, consistent with human B lymphocytes. In situ hybridization was strongly positive for Epstein-Barr virus (EBV) encoded RNA. Genomic analysis revealed unique monoclonal or oligoclonal immunoglobulin heavy chain gene rearrangements in each B-cell neoplasm. These data demonstrate that the lymphoid neoplasms were EBV-associated human B-cell lymphomas. Analogous to EBV-associated lymphoproliferative disorders in immunocompromised humans, the human lymphomas in these HCC xenografts likely developed from reactivation of latent EBV in intratumoral passenger B lymphocytes following their xenotransplantation into immunodeficient recipient mice. Given the high prevalence of latent EBV infection in humans and the universal presence of B lymphocytes in solid tumors, this potentially confounding process represents an important pitfall of human solid tumor xenografting. This phenomenon can be recognized and avoided by routine phenotyping of primary tumors and xenografts with human leukocyte markers, and provides a compelling biological rationale for exclusion of these cells from human solid tumor xenotransplantation assays.	[Chen, Kui; Ahmed, Sharif; Dick, John E.; Ghanekar, Anand] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Adeyi, Oyedele] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Dick, John E.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M4X 1K9, Canada; [Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ghanekar, Anand] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Chen, K (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	anand.ghanekar@uhn.ca		Dick, John/0000-0002-9527-8317; Adeyi, Oyedele/0000-0003-4272-1095	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported in part by a Canadian Institutes of Health Research (www.cihr.ca) Phase 1 Clinician-Scientist Award (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allen U, 2009, AM J TRANSPLANT, V9, pS87, DOI 10.1111/j.1600-6143.2009.02898.x; BIRX DL, 1986, NEW ENGL J MED, V314, P874, DOI 10.1056/NEJM198604033141403; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Dainiak MB, 2007, ADV BIOCHEM ENG BIOT, V106, P1, DOI 10.1007/10_2007_069; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; MOSIER DE, 1992, CANCER RES, V52, pS5552; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Petrova M, 2010, WORLD J GASTROENTERO, V16, P4130, DOI 10.3748/wjg.v16.i33.4130; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sausville E.A., 2006, CANCER RES, V66; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Utsunomiya T, 2009, SURG TODAY, V39, P1010, DOI 10.1007/s00595-009-3966-0; Vereide D, 2010, ADV CANCER RES, V108, P1, DOI 10.1016/S0065.230X(10)08004.8; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	27	64	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39294	10.1371/journal.pone.0039294	http://dx.doi.org/10.1371/journal.pone.0039294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723990	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300131
J	Kuipers, I; Bracke, KR; Brusselle, GG; Aesif, SW; Krijgsman, R; Arts, IC; Wouters, EFM; Reynaert, NL				Kuipers, Ine; Bracke, Ken R.; Brusselle, Guy G.; Aesif, Scott W.; Krijgsman, Renske; Arts, Ilja C.; Wouters, Emiel F. M.; Reynaert, Niki L.			Altered Cigarette Smoke-Induced Lung Inflammation Due to Ablation of Grx1	PLOS ONE			English	Article							S-GLUTATHIONYLATION; KAPPA-B; EPITHELIAL-CELLS; GLUTAREDOXIN 1; REDOX CONTROL; ACTIVATION; MICE; MODULATION; MECHANISMS	Glutaredoxins (Grx) are redox enzymes that remove glutathione bound to protein thiols, know as S-glutathionylation (PSSG). PSSG is a reservoir of GSH and can affect the function of proteins. It inhibits the NF-kappa B pathway and LPS aspiration in Grx1 KO mice with decreased inflammatory cytokine levels. In this study we investigated whether absence of Grx1 similarly repressed cigarette smoke-induced inflammation in an exposure model in mice. Cigarette smoke exposure for four weeks decreased lung PSSG levels, but increased PSSG in lavaged cells and lavage fluid (BALF). Grx1 KO mice had increased levels of PSSG in lung tissue, BALF and BAL cells in response to smoke compared to wt mice. Importantly, levels of multiple inflammatory mediators in the BALF were decreased in Grx1 KO animals following cigarette smoke exposure compared to wt mice, as were levels of neutrophils, dendritic cells and lymphocytes. On the other hand, macrophage numbers were higher in Grx1 KO mice in response to smoke. Although cigarette smoke in vivo caused inverse effects in inflammatory and resident cells with respect to PSSG, primary macrophages and epithelial cells cultured from Grx1 KO mice both produced less KC compared to cells isolated from WT mice after smoke extract exposure. In this manuscript, we provide evidence that Grx1 has an important role in regulating cigarette smoke-induced lung inflammation which seems to diverge from its effects on total PSSG. Secondly, these data expose the differential effect of cigarette smoke on PSSG in inflammatory versus resident lung cells.	[Kuipers, Ine; Krijgsman, Renske; Wouters, Emiel F. M.; Reynaert, Niki L.] Maastricht Univ, Med Ctr, Dept Resp Med, Nutrim Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Bracke, Ken R.; Brusselle, Guy G.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Aesif, Scott W.] George Washington Univ Hosp, Dept Pathol, Washington, DC USA; [Arts, Ilja C.] Maastricht Univ, Med Ctr, Dept Epidemiol, Nutrim Sch Nutr Toxicol & Metab, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Ghent University; Ghent University Hospital; George Washington University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kuipers, I (corresponding author), Maastricht Univ, Med Ctr, Dept Resp Med, Nutrim Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	n.reynaert@maastrichtuniversity.nl	Wouters, Emiel/ABD-6200-2021; Bracke, Ken R/GSN-7630-2022; Arts, Ilja CW/C-6946-2008; Reynaert, Niki L/C-5491-2014	Bracke, Ken R/0000-0001-5906-4605; Arts, Ilja CW/0000-0001-6462-6692; Aesif, Scott/0000-0002-4798-7290; Reynaert, Niki/0000-0002-8577-8094; Brusselle, Guy/0000-0001-7021-8505	School for Nutrition, Toxicology and Metabolism of Maastricht University (NUTRIM); Fund for Scientific Research in Flanders (FWO Vlaanderen) [G.0011.03]; Ghent University [BOF/GOA 01G01009]; Interuniversity Attraction Poles (Belgian State, Belgian Science Policy) [P6/35]; NWO/ZonMW [016.086.090]	School for Nutrition, Toxicology and Metabolism of Maastricht University (NUTRIM); Fund for Scientific Research in Flanders (FWO Vlaanderen)(FWO); Ghent University(Ghent University); Interuniversity Attraction Poles (Belgian State, Belgian Science Policy); NWO/ZonMW(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work was supported by School for Nutrition, Toxicology and Metabolism of Maastricht University (NUTRIM), the Fund for Scientific Research in Flanders (FWO Vlaanderen, Research Project G.0011.03), the Concerted Research Action of the Ghent University (BOF/GOA 01G01009) and the Interuniversity Attraction Poles (Belgian State, Belgian Science Policy, Project P6/35). NLR is a recipient of a VENI grant from NWO/ZonMW (016.086.090) and KRB is a post-doctoral researcher of the Fund for Scientific Research in Flanders (FWO Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aesif SW, 2011, AM J RESP CELL MOL, V44, P491, DOI 10.1165/rcmb.2009-0136OC; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; Demoor T, 2011, J IMMUNOL, V186, P5457, DOI 10.4049/jimmunol.1003862; Huang Z, 2008, BIOCHEM PHARMACOL, V75, P2234, DOI 10.1016/j.bcp.2008.02.026; Janssen-Heininger Yvonne M W, 2009, Proc Am Thorac Soc, V6, P249, DOI 10.1513/pats.200806-054RM; Kuipers I, 2012, FREE RADICAL RES, V46, P164, DOI 10.3109/10715762.2011.647011; Kuipers I, 2011, AM J RESP CELL MOL, V45, P931, DOI 10.1165/rcmb.2010-0249OC; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; Peltoniemi MJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-133; Rahman I, 2005, MUTAT RES-FUND MOL M, V579, P58, DOI 10.1016/j.mrfmmm.2005.02.025; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Reynaert NL, 2006, AM J RESP CELL MOL B; REYNAERT NL, 2006, BIOCHIM BIOPHYS ACTA, V1760, P180; van der Toorn M, 2009, AM J PHYSIOL-LUNG C, V297, pL109, DOI 10.1152/ajplung.90461.2008; WU R, 1982, IN VITRO CELL DEV B, V18, P800; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504	21	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38984	10.1371/journal.pone.0038984	http://dx.doi.org/10.1371/journal.pone.0038984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723915	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300077
J	Mader, A; Kunert, R				Mader, Alexander; Kunert, Renate			Evaluation of the Potency of the Anti-Idiotypic Antibody Ab2/3H6 Mimicking gp41 as an HIV-1 Vaccine in a Rabbit Prime/Boost Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; PROXIMAL EXTERNAL REGION; T-CELL EPITOPES; NEUTRALIZING ANTIBODIES; IN-VITRO; IMMUNE-RESPONSES; CHO-CELLS; 2F5; MEMBRANE	The HIV-1 envelope protein harbors several conserved epitopes that are recognized by broadly neutralizing antibodies. One of these neutralizing sites, the MPER region of gp41, is targeted by one of the most potent and broadly neutralizing monoclonal antibody, 2F5. Different vaccination strategies and a lot of efforts have been undertaken to induce MPER neutralizing antibodies but little success has been achieved so far. We tried to consider the alternative anti-idiotypic vaccination approach for induction of 2F5-like antibodies. The previously developed and characterized anti-idiotypic antibody Ab2/3H6 was expressed as antibody fragment fusion protein with C-terminally attached immune-modulators and used for immunization of rabbits to induce antibodies specific for HIV-1. Only those rabbits immunized with immunogens fused with the immune-modulators developed HIV-1 specific antibodies. Anti-anti-idiotypic antibodies were affinity purified using a two-step affinity purification protocol which revealed that only little amount of the total rabbit IgG fraction contained HIV-1 specific antibodies. The characterization of the induced anti-anti-idiotypic antibodies showed specificity for the linear epitope of 2F5 GGGELDKWASL and the HIV-1 envelope protein gp140. Despite specificity for the linear epitope and the truncated HIV-1 envelope protein these antibodies were not able to exhibit virus neutralization activities. These results suggest that Ab2/3H6 alone might not be suitable as a vaccine.	[Mader, Alexander; Kunert, Renate] Univ Nat Resources & Life Sci Vienna, BOKU, VIBT, Dept Biotechnol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Mader, A (corresponding author), Univ Nat Resources & Life Sci Vienna, BOKU, VIBT, Dept Biotechnol, Vienna, Austria.	renate.kunert@boku.ac.at	Kunert, Renate E/B-9185-2018	Kunert, Renate E/0000-0002-3397-3621	Austrian Science Fund (FWF) [P20603-B13]; Austrian Science Fund (FWF) [P 20603] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF; www.fwf.ac.at), project number P20603-B13. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Amanna IJ, 2009, ANTIVIR RES, V84, P119, DOI 10.1016/j.antiviral.2009.08.008; Benferhat R, 2009, MOL IMMUNOL, V46, P705, DOI 10.1016/j.molimm.2008.10.001; Bryson S, 2008, J MOL BIOL, V382, P910, DOI 10.1016/j.jmb.2008.07.057; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; de Cerio ALD, 2007, ONCOGENE, V26, P3594, DOI 10.1038/sj.onc.1210371; Gach JS, 2008, MOL IMMUNOL, V45, P1027, DOI 10.1016/j.molimm.2007.07.030; Gach JS, 2007, AIDS RES HUM RETROV, V23, P1405, DOI 10.1089/aid.2007.0089; Gach JS, 2007, J BIOTECHNOL, V128, P735, DOI 10.1016/j.jbiotec.2006.12.020; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; HIV/AIDS UJPo, 2010, GLOB REP UNAIDS REP; Ho J, 2002, VACCINE, V20, P1169, DOI 10.1016/S0264-410X(01)00441-8; HO PC, 1990, EUR J IMMUNOL, V20, P477, DOI 10.1002/eji.1830200304; Hu SL, 2007, CURR HIV RES, V5, P507, DOI 10.2174/157016207782418542; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kaumaya Pravin T. P., 1993, Journal of Molecular Recognition, V6, P81, DOI 10.1002/jmr.300060206; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Kunert R, 2000, BIOTECHNOL BIOENG, V67, P97, DOI 10.1002/(SICI)1097-0290(20000105)67:1<97::AID-BIT11>3.0.CO;2-2; Kunert RE, 2002, AIDS, V16, P667, DOI 10.1097/00002030-200203080-00020; Ladjemi MZ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2826; Lee G, 2010, CANCER IMMUNOL IMMUN, V59, P1347, DOI 10.1007/s00262-010-0864-7; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lorizate M, 2006, J BIOL CHEM, V281, P39598, DOI 10.1074/jbc.M605998200; Mader A, 2010, PROTEIN ENG DES SEL, V23, P947, DOI 10.1093/protein/gzq092; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Menendez A, 2004, J MOL BIOL, V338, P311, DOI 10.1016/j.jmb.2004.02.051; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Nishiyama Y, 2009, J BIOL CHEM, V284, P30627, DOI 10.1074/jbc.M109.032185; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Opalka D, 2004, J IMMUNOL METHODS, V287, P49, DOI 10.1016/j.jim.2004.01.016; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Perera LP, 2007, J VIROL, V81, P8774, DOI 10.1128/JVI.00538-07; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Ramos AS, 2011, CANCER SCI, V102, P64, DOI 10.1111/j.1349-7006.2010.01771.x; Rodrigues L, 2009, EXPERT REV VACCINES, V8, P167, DOI 10.1586/14760584.8.2.167; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Stoiber H, 1997, MOL IMMUNOL, V34, P855, DOI 10.1016/S0161-5890(97)00108-9; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang JJ, 2010, INT IMMUNOPHARMACOL, V10, P707, DOI 10.1016/j.intimp.2010.04.001; Wang ZG, 2005, MICROBIOL IMMUNOL, V49, P703, DOI 10.1111/j.1348-0421.2005.tb03657.x; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	61	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39063	10.1371/journal.pone.0039063	http://dx.doi.org/10.1371/journal.pone.0039063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720027	Green Published, Green Submitted, gold			2022-12-25	WOS:000305350000035
J	Bauer, U; Di Giusto, B; Skepper, J; Grafe, TU; Federle, W				Bauer, Ulrike; Di Giusto, Bruno; Skepper, Jeremy; Grafe, T. Ulmar; Federle, Walter			With a Flick of the Lid: A Novel Trapping Mechanism in Nepenthes gracilis Pitcher Plants	PLOS ONE			English	Article							INSECT ATTACHMENT; STRATEGIES; SLIPPERY; BORNEO; SIZE; RAFFLESIANA; ROUGHNESS; PATTERNS; CAPTURE; SURFACE	Carnivorous pitcher plants capture prey with modified leaves (pitchers), using diverse mechanisms such as 'insect aquaplaning' on the wet pitcher rim, slippery wax crystals on the inner pitcher wall, and viscoelastic retentive fluids. Here we describe a new trapping mechanism for Nepenthes gracilis which has evolved a unique, semi-slippery wax crystal surface on the underside of the pitcher lid and utilises the impact of rain drops to 'flick' insects into the trap. Depending on the experimental conditions (simulated 'rain', wet after 'rain', or dry), insects were captured mainly by the lid, the peristome, or the inner pitcher wall, respectively. The application of an anti-slip coating to the lower lid surface reduced prey capture in the field. Compared to sympatric N. rafflesiana, N. gracilis pitchers secreted more nectar under the lid and less on the peristome, thereby directing prey mainly towards the lid. The direct contribution to prey capture represents a novel function of the pitcher lid.	[Bauer, Ulrike] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Bauer, Ulrike; Grafe, T. Ulmar] Univ Brunei Darussalam, Dept Biol, Gadong, Brunei; [Di Giusto, Bruno] Ming Chuan Univ, English Language Ctr, Taipei, Taiwan; [Skepper, Jeremy] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge; University Brunei Darussalam; Ming Chuan University; University of Cambridge; University of Cambridge	Bauer, U (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	ub213@cam.ac.uk	Di Giusto, Bruno/AAL-2166-2020; Federle, Walter/K-8263-2014	Di Giusto, Bruno/0000-0002-1037-276X; Federle, Walter/0000-0002-6375-3005; Bauer, Ulrike/0000-0002-4701-793X	Henslow Research Fellowship of the Cambridge Philosophical Society; Charles Slater Fund, Cambridge; BBSRC [BB/I008667/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008667/1] Funding Source: researchfish	Henslow Research Fellowship of the Cambridge Philosophical Society; Charles Slater Fund, Cambridge; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Henslow Research Fellowship of the Cambridge Philosophical Society and a field work grant by the Charles Slater Fund, Cambridge, to UB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer U, 2012, J EVOLUTION BIOL, V25, P90, DOI 10.1111/j.1420-9101.2011.02406.x; Bauer U, 2008, P ROY SOC B-BIOL SCI, V275, P259, DOI 10.1098/rspb.2007.1402; Bauer U, 2011, J EXP BOT, V62, P3683, DOI 10.1093/jxb/err082; Bauer U, 2009, ANN BOT-LONDON, V103, P1219, DOI 10.1093/aob/mcp065; Bidin K, 2006, HYDROL PROCESS, V20, P3835, DOI 10.1002/hyp.6160; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Bonhomme V, 2011, NEW PHYTOL, V191, P545, DOI 10.1111/j.1469-8137.2011.03696.x; BRANDT CJ, 1989, CATENA, V16, P507, DOI 10.1016/0341-8162(89)90032-5; Chin LJ, 2010, NEW PHYTOL, V186, P461, DOI 10.1111/j.1469-8137.2009.03166.x; Clarke C., 1997, NEPENTHES OF BORNEO; Cranbrook GG-H, 1994, BELALONG TROPICAL RA; Dai ZD, 2002, J EXP BIOL, V205, P2479; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Gaume L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001185; Gorb E, 2005, J EXP BIOL, V208, P4651, DOI 10.1242/jeb.01939; Grafe TU, 2011, BIOL LETTERS, V7, P436, DOI 10.1098/rsbl.2010.1141; GUNN R, 1949, J METEOROL, V6, P243, DOI 10.1175/1520-0469(1949)006<0243:TTVOFF>2.0.CO;2; Juniper B.E., 1989, CARNIVOROUS PLANTS; Juniper BE., 1962, NEW SCI, V13, P75; Kimble P.D., 1996, THESIS W KENTUCKY U; KNOLL F, 1914, JB WISS BOT, V54, P448; Merbach MA, 2001, FLORA, V196, P153, DOI 10.1016/S0367-2530(17)30030-0; Moran JA, 2010, J EXP BOT, V61, P1365, DOI 10.1093/jxb/erq004; Scholz I, 2010, J EXP BIOL, V213, P1115, DOI 10.1242/jeb.035618; Ulbrich CW, 2007, J APPL METEOROL CLIM, V46, P1777, DOI 10.1175/2007JAMC1649.1	25	27	27	1	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38951	10.1371/journal.pone.0038951	http://dx.doi.org/10.1371/journal.pone.0038951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719998	Green Published, Green Submitted, gold			2022-12-25	WOS:000305341900067
J	Evans, DW; Orr, PT; Lazar, SM; Breton, D; Gerard, J; Ledbetter, DH; Janosco, K; Dotts, J; Batchelder, H				Evans, David W.; Orr, Patrick T.; Lazar, Steven M.; Breton, Daniel; Gerard, Jennifer; Ledbetter, David H.; Janosco, Kathleen; Dotts, Jessica; Batchelder, Holly			Human Preferences for Symmetry: Subjective Experience, Cognitive Conflict and Cortical Brain Activity	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; EVENT-RELATED POTENTIALS; FACIAL ATTRACTIVENESS; DISGUST SENSITIVITY; BEHAVIOR; ASYMMETRY; SYMPTOMS; AUTISM; MODEL; TASK	This study examines the links between human perceptions, cognitive biases and neural processing of symmetrical stimuli. While preferences for symmetry have largely been examined in the context of disorders such as obsessive-compulsive disorder and autism spectrum disorders, we examine various these phenomena in non-clinical subjects and suggest that such preferences are distributed throughout the typical population as part of our cognitive and neural architecture. In Experiment 1, 82 young adults reported on the frequency of their obsessive-compulsive spectrum behaviors. Subjects also performed an emotional Stroop or variant of an Implicit Association Task (the OC-CIT) developed to assess cognitive biases for symmetry. Data not only reveal that subjects evidence a cognitive conflict when asked to match images of positive affect with asymmetrical stimuli, and disgust with symmetry, but also that their slowed reaction times when asked to do so were predicted by reports of OC behavior, particularly checking behavior. In Experiment 2, 26 participants were administered an oddball Event-Related Potential task specifically designed to assess sensitivity to symmetry as well as the OC-CIT. These data revealed that reaction times on the OC-CIT were strongly predicted by frontal electrode sites indicating faster processing of an asymmetrical stimulus (unparallel lines) relative to a symmetrical stimulus (parallel lines). The results point to an overall cognitive bias linking disgust with asymmetry and suggest that such cognitive biases are reflected in neural responses to symmetrical/asymmetrical stimuli.	[Evans, David W.; Orr, Patrick T.; Lazar, Steven M.; Breton, Daniel; Gerard, Jennifer; Ledbetter, David H.; Janosco, Kathleen; Dotts, Jessica; Batchelder, Holly] Bucknell Univ, Program Neurosci, Lewisburg, PA 17837 USA; [Evans, David W.; Orr, Patrick T.; Ledbetter, David H.] Geisinger Hlth Syst, Danville, PA USA	Bucknell University; Geisinger Health System	Evans, DW (corresponding author), Bucknell Univ, Program Neurosci, Lewisburg, PA 17837 USA.	dwevans@bucknell.edu	Lazar, Steven M./AAN-4462-2020	Lazar, Steven M./0000-0002-2815-6045	National Institutes of Health [2R01 MH074090-06]; Bucknell University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bucknell University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by National Institutes of Health Grant 2R01 MH074090-06 and Bucknell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; BAXTER LR, 1990, J CLIN PSYCHIAT, V51, P70; BAXTER LR, 1990, J CLIN PSYCHIAT, V51, P61; BORNSTEIN MH, 1981, DEV PSYCHOL, V17, P82, DOI 10.1037/0012-1649.17.1.82; Boyer P, 2008, CURR DIR PSYCHOL SCI, V17, P291, DOI 10.1111/j.1467-8721.2008.00592.x; Burriss RP, 2011, PERS SOC PSYCHOL B, V37, P601, DOI 10.1177/0146167211399584; Cavedini P, 2010, BIOL PSYCHIAT, V67, P1178, DOI 10.1016/j.biopsych.2010.02.012; Ciesielski KT, 2011, CLIN NEUROPHYSIOL, V122, P107, DOI 10.1016/j.clinph.2010.05.027; CIESIELSKI KT, 1990, ELECTROEN CLIN NEURO, V75, P207, DOI 10.1016/0013-4694(90)90174-I; COURCHESNE E, 1985, J AUTISM DEV DISORD, V15, P55, DOI 10.1007/BF01837899; COURCHESNE E, 1989, J AUTISM DEV DISORD, V19, P1, DOI 10.1007/BF02212714; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; Evans DW, 2011, BEHAV BRAIN RES, V224, P174, DOI 10.1016/j.bbr.2011.05.025; Evans DW, 1997, CHILD DEV, V68, P58, DOI 10.2307/1131925; Evans DW, 2004, BRAIN COGNITION, V55, P220, DOI 10.1016/s0278-2626(03)00274-4; Evans DW, 2006, DEV PSYCHOPATHOL, P404; Foa EB, 1998, PSYCHOL ASSESSMENT, V10, P206, DOI 10.1037/1040-3590.10.3.206; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; FREESTON MH, 1991, BEHAV RES THER, V29, P585, DOI 10.1016/0005-7967(91)90008-Q; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Hartston HJ, 1999, NEUROPSYCHOLOGY, V13, P447, DOI 10.1037/0894-4105.13.3.447; Jeste SS, 2009, J AUTISM DEV DISORD, V39, P495, DOI 10.1007/s10803-008-0652-9; Judge PG, 2011, BEHAV BRAIN RES, V222, P57, DOI 10.1016/j.bbr.2011.03.016; Kemner C, 1998, J AUTISM DEV DISORD, V28, P61, DOI 10.1023/A:1026015120128; Kivircik BB, 2003, PROG NEURO-PSYCHOPH, V27, P601, DOI 10.1016/S0278-5846(03)00047-2; Leckman JF, 2008, AM J PSYCHIAT, V165, P1229, DOI 10.1176/appi.ajp.2008.08060891; Leckman JF, 1999, CHILD ADOL PSYCH CL, V8, P635; Leckman JF, 1999, ACTA PSYCHIAT SCAND, V100, P1, DOI 10.1111/j.1600-0447.1999.tb10951.x; Little AC, 2007, P ROY SOC B-BIOL SCI, V274, P3113, DOI 10.1098/rspb.2007.0895; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Mataix-Cols D, 2008, J AM ACAD CHILD PSY, V47, P773, DOI 10.1097/CHI.0b013e31816b73c0; Mavrogiorgou P, 2002, J PSYCHIATR RES, V36, P399, DOI 10.1016/S0022-3956(02)00055-9; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Perreault A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019519; RACHMAN S, 1978, BEHAV RES THER, V16, P233, DOI 10.1016/0005-7967(78)90022-0; Rao NP, 2010, PSYCHIAT RES, V180, P99, DOI 10.1016/j.psychres.2009.10.017; SALKOVSKIS PM, 1984, BEHAV RES THER, V22, P549, DOI 10.1016/0005-7967(84)90057-3; Schienle A, 2003, J NERV MENT DIS, V191, P831, DOI 10.1097/01.nmd.0000100928.99910.2d; Schultz RT, 1999, CHILD ADOL PSYCH CL, V8, P513; Schultz RT, 1999, CHILD ADOL PSYCH CL, V8, pviii; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SWADDLE JP, 1995, P ROY SOC B-BIOL SCI, V261, P111, DOI 10.1098/rspb.1995.0124; Tolin DF, 2006, J BEHAV THER EXP PSY, V37, P30, DOI 10.1016/j.jbtep.2005.09.003; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; WATSON PJ, 1994, TRENDS ECOL EVOL, V9, P21, DOI 10.1016/0169-5347(94)90227-5; Wignall AE, 2006, ETHOLOGY, V112, P510, DOI 10.1111/j.1439-0310.2006.01199.x	47	11	11	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38966	10.1371/journal.pone.0038966	http://dx.doi.org/10.1371/journal.pone.0038966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UV	22720004	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900069
J	Hebner, CM; Han, B; Brendza, KM; Nash, M; Sulfab, M; Tian, Y; Hung, M; Fung, WC; Vivian, RW; Trenkle, J; Taylor, J; Bjornson, K; Bondy, S; Liu, XH; Link, J; Neyts, J; Sakowicz, R; Zhong, WD; Tang, HL; Schmitz, U				Hebner, Christy M.; Han, Bin; Brendza, Katherine M.; Nash, Michelle; Sulfab, Maisoun; Tian, Yang; Hung, Magdeleine; Fung, Wanchi; Vivian, Randall W.; Trenkle, James; Taylor, James; Bjornson, Kyla; Bondy, Steven; Liu, Xiaohong; Link, John; Neyts, Johan; Sakowicz, Roman; Zhong, Weidong; Tang, Hengli; Schmitz, Uli			The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; PLUS RIBAVIRIN; PROTEASE INHIBITOR; VIRUS; REPLICATION; BOCEPREVIR; MUTATIONS; THERAPY	Tegobuvir (TGV) is a novel non-nucleoside inhibitor (NNI) of HCV RNA replication with demonstrated antiviral activity in patients with genotype 1 chronic HCV infection. The mechanism of action of TGV has not been clearly defined despite the identification of resistance mutations mapping to the NS5B polymerase region. TGV does not inhibit NS5B enzymatic activity in biochemical assays in vitro, suggesting a more complex antiviral mechanism with cellular components. Here, we demonstrate that TGV exerts anti-HCV activity utilizing a unique chemical activation and subsequent direct interaction with the NS5B protein. Treatment of HCV subgenomic replicon cells with TGV results in a modified form of NS5B with a distinctly altered mobility on a SDS-PAGE gel. Further analysis reveals that the aberrantly migrating NS5B species contains the inhibitor molecule. Formation of this complex does not require the presence of any other HCV proteins. The intensity of the aberrantly migrating NS5B species is strongly dependent on cellular glutathione levels as well as CYP 1A activity. Furthermore analysis of NS5B protein purified from a heterologous expression system treated with TGV by mass spectrometry suggests that TGV undergoes a CYP-mediated intracellular activation step and the resulting metabolite, after forming a glutathione conjugate, directly and specifically interacts with NS5B. Taken together, these data demonstrate that upon metabolic activation TGV is a specific, covalent inhibitor of the HCV NS5B polymerase and is mechanistically distinct from other classes of the non-nucleoside inhibitors (NNI) of the viral polymerase.	[Hebner, Christy M.; Han, Bin; Brendza, Katherine M.; Nash, Michelle; Sulfab, Maisoun; Tian, Yang; Hung, Magdeleine; Fung, Wanchi; Vivian, Randall W.; Trenkle, James; Taylor, James; Bjornson, Kyla; Bondy, Steven; Liu, Xiaohong; Link, John; Sakowicz, Roman; Schmitz, Uli] Gilead Sci Inc, Foster City, CA 94404 USA; [Neyts, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Rega Inst, Louvain, Belgium; [Zhong, Weidong] Novartis, Emeryville, CA USA; [Tang, Hengli] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	Gilead Sciences; KU Leuven; Novartis; State University System of Florida; Florida State University	Hebner, CM (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	uli.schmitz@gilead.com	Neyts, Johan/U-8267-2017; Tang, Hengli/F-2085-2014	Neyts, Johan/0000-0002-0033-7514; 	Gilead Sciences	Gilead Sciences(Gilead Sciences)	All authors with the exception of JN and HT were employees of Gilead Sciences. JN and HT receive funds and/or compounds from Gilead Sciences. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bondy S, 2008, WORLD INTELLECTUAL P; Chen KX, 2012, J MED CHEM; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Foster G, 2010, J HEPATOL, V54, ps172; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hebner C, 2011, J HEPATOL, V54, pS478, DOI 10.1016/S0168-8278(11)61213-0; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lok A, 2011, J HEPATOL, V54, pS536, DOI 10.1016/S0168-8278(11)61358-5; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mo H, 2011, J HEPATOL, V54, pS484, DOI 10.1016/S0168-8278(11)61227-0; Paeshuyse J, 2006, J VIROL, V80, P149, DOI 10.1128/JVI.80.1.149-160.2006; Park BK, 2001, ANNU REV PHARMACOL, V41, P443, DOI 10.1146/annurev.pharmtox.41.1.443; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Powers JP, 2006, J MED CHEM, V49, P1034, DOI 10.1021/jm050859x; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Shih IH, 2011, ANTIMICROB AGENTS CH, V55, P4196, DOI 10.1128/AAC.00307-11; Vrancken R, 2008, ANTIVIR RES, V77, P114, DOI 10.1016/j.antiviral.2007.09.006; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Yan SQ, 2007, BIOORG MED CHEM LETT, V17, P28, DOI 10.1016/j.bmcl.2006.10.002; Yang H, 2006, J CLIN VIROL, V36, pS109, DOI 10.1016/S1386-6532(06)80339-2; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	25	37	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39163	10.1371/journal.pone.0039163	http://dx.doi.org/10.1371/journal.pone.0039163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720059	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341900088
J	Cramer, EP; Glenthoj, A; Hager, M; Juncker-Jensen, A; Engelholm, LH; Santoni-Rugiu, E; Lund, LR; Laerum, OD; Cowland, JB; Borregaard, N				Cramer, Elisabeth P.; Glenthoj, Andreas; Hager, Mattias; Juncker-Jensen, Anna; Engelholm, Lars H.; Santoni-Rugiu, Eric; Lund, Leif R.; Laerum, Ole D.; Cowland, Jack B.; Borregaard, Niels			No Effect of NGAL/lipocalin-2 on Aggressiveness of Cancer in the MMTV-PyMT/FVB/N Mouse Model for Breast Cancer	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE RENAL INJURY; NEUTROPHIL-GELATINASE; CATHEPSIN-B; SUBCELLULAR-LOCALIZATION; EPITHELIAL-CELLS; LUNG METASTASIS; NGAL; IDENTIFICATION; EXPRESSION	NGAL/lipocalin-2 is a siderophore-binding protein that is highly expressed in several cancers. It is suggested to confer a proliferative advantage to cancer cells. Its expression has been correlated with aggressiveness of breast cancer as determined both in patients and in mouse breast cancer models. This was recently confirmed in two mouse models of spontaneous breast cancer in wild-type and lipocalin-2-deficient mice. We used a similar strategy using a different mouse strain. Lipocalin-2-deficient mice and mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) mice were crossed into the same FVB/N background. All mice developed tumors by week 8. The mice were sacrificed on week 13 and tissue was processed for biochemical and histological analysis. The total tumor volume and number of metastases were quantitated in 26 lipocalin-2-deficient mice and 34 wild-type controls. Lipocalin-2 expression in tumors of MMTV-PyMT-positive and wild-type mice was assessed by quantitative real-time PCR and by immunohistochemistry. The expression of the lipocalin-2 receptors 24p3R and megalin and of Mmp-9, transferrin receptor, and Bdh2 (a producer of a mammalian siderophore) were quantitated by real-time PCR. No significant difference was observed between wild-type and lipocalin-2-deficient mice. Lipocalin-2 was highly expressed in tumors from wild-type mice, but the expression did not correlate with tumor size. No effect of lipocalin-2 was observed with respect to time to tumor appearance, total tumor volume, or to the number of metastases. Histology and gelatinolytic activity of the mammary tumors did not differ between wild-type and lipocalin-2-deficient mice. We conclude that NGAL/lipocalin-2 does not invariably affect the aggressiveness of breast cancers as assessed in mouse models, thus questioning the role of lipocalin-2 in cancer development.	[Cramer, Elisabeth P.; Glenthoj, Andreas; Hager, Mattias; Cowland, Jack B.; Borregaard, Niels] Copenhagen Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark; [Juncker-Jensen, Anna; Engelholm, Lars H.; Laerum, Ole D.] Univ Copenhagen, Rigshosp, Natl Univ Hosp, Finsen Lab, DK-1168 Copenhagen, Denmark; [Santoni-Rugiu, Eric] Univ Copenhagen, Rigshosp, Natl Univ Hosp, Dept Pathol, DK-1168 Copenhagen, Denmark; [Lund, Leif R.] Univ Copenhagen, Dept Cellular & Mol Med, DK-1168 Copenhagen, Denmark; [Laerum, Ole D.] Univ Bergen, Gade Inst, Sect Pathol, N-5020 Bergen, Norway	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Bergen	Cramer, EP (corresponding author), Copenhagen Univ Hosp, Dept Hematol, Granulocyte Res Lab, Copenhagen, Denmark.	jcowland@rh.dk; borregaard@rh.dk	Santoni-Rugiu, Eric/AAH-3368-2020; Glenthøj, Andreas/ABD-5948-2021; Santoni-Rugiu, Eric/H-4913-2019	Santoni-Rugiu, Eric/0000-0002-2283-3535; Glenthøj, Andreas/0000-0003-2082-0738; Cowland, Jack Bernard/0000-0002-7429-5388; Engelholm, Lars/0000-0002-6616-1232	Lundbeck Foundation [139/05]; Danish Cancer Research Foundation [13-07]; Novo Nordisk Foundation [4292-80]; Danish Medical Research Council [22-04-0399, 09-061617]	Lundbeck Foundation(Lundbeckfonden); Danish Cancer Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Lundbeck Foundation (http://www.lundbeckfonden.dk, 139/05), the Danish Cancer Research Foundation (http://www.dansk-kraeftforsknings-fond.dk, 13-07), The Novo Nordisk Foundation (http://www.novonordiskfonden.dk, 4292-80), and the Danish Medical Research Council (http://www.fi.dk/raad-og-udvalg/det-frie-forskningsraad, 22-04-0399 and 09-061617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Almholt K, 2008, MOL CANCER THER, V7, P2758, DOI 10.1158/1535-7163.MCT-08-0251; Almholt K, 2007, J MAMMARY GLAND BIOL, V12, P83, DOI 10.1007/s10911-007-9040-x; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Cancedda FD, 1996, J BIOL CHEM, V271, P20163, DOI 10.1074/jbc.271.33.20163; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FLOWER DR, 1991, BIOCHEM BIOPH RES CO, V180, P69, DOI 10.1016/S0006-291X(05)81256-2; Friedl A, 1999, HISTOCHEM J, V31, P433, DOI 10.1023/A:1003708808934; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Johnson EE, 2010, FEMS IMMUNOL MED MIC, V58, P138, DOI 10.1111/j.1574-695X.2009.00622.x; Juncker-Jensen A, 2009, MOL CARCINOGEN, V48, P618, DOI 10.1002/mc.20503; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; KJELDSEN L, 1992, BIOCHEM J, V287, P603, DOI 10.1042/bj2870603; Kjeldsen L, 1996, J IMMUNOL METHODS, V198, P155, DOI 10.1016/S0022-1759(96)00153-6; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KJELDSEN L, 1994, BLOOD, V83, P799; Klausen P, 2005, EUR J HAEMATOL, V75, P332, DOI 10.1111/j.1600-0609.2005.00511.x; Kubben FJGM, 2007, EUR J CANCER, V43, P1869, DOI 10.1016/j.ejca.2007.05.013; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Mallbris L, 2002, EXP DERMATOL, V11, P584, DOI 10.1034/j.1600-0625.2002.110611.x; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; Mazzoni A, 2007, J DENT RES, V86, P436, DOI 10.1177/154405910708600509; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Sevenich L, 2011, ONCOGENE, V30, P54, DOI 10.1038/onc.2010.387; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Stoesz SP, 1995, ONCOGENE, V11, P2233; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Wu H, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-96; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106	57	22	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39646	10.1371/journal.pone.0039646	http://dx.doi.org/10.1371/journal.pone.0039646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737251	gold, Green Published, Green Submitted			2022-12-25	WOS:000305695100050
J	Ibrahim, GM; Akiyama, T; Ochi, A; Otsubo, H; Smith, ML; Taylor, MJ; Donner, E; Rutka, JT; Snead, OC; Doesburg, SM				Ibrahim, George M.; Akiyama, Tomoyuki; Ochi, Ayako; Otsubo, Hiroshi; Smith, Mary Lou; Taylor, Margot J.; Donner, Elizabeth; Rutka, James T.; Snead, O. Carter, III; Doesburg, Sam M.			Disruption of Rolandic Gamma-Band Functional Connectivity by Seizures is Associated with Motor Impairments in Children with Epilepsy	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; TEMPORAL-LOBE EPILEPSY; EPILEPTOGENIC NETWORKS; MEMORY FORMATION; EEG ACTIVITY; BRAIN; SYNCHRONIZATION; COHERENCE; RESPONSES; RESECTION	Although children with epilepsy exhibit numerous neurological and cognitive deficits, the mechanisms underlying these impairments remain unclear. Synchronization of oscillatory neural activity in the gamma frequency range (>30 Hz) is purported to be a mechanism mediating functional integration within neuronal networks supporting cognition, perception and action. Here, we tested the hypothesis that seizure-induced alterations in gamma synchronization are associated with functional deficits. By calculating synchrony among electrodes and performing graph theoretical analysis, we assessed functional connectivity and local network structure of the hand motor area of children with focal epilepsy from intracranial electroencephalographic recordings. A local decrease in inter-electrode phase synchrony in the gamma bands during ictal periods, relative to interictal periods, within the motor cortex was strongly associated with clinical motor weakness. Gamma-band ictal desychronization was a stronger predictor of deficits than the presence of the seizure-onset zone or lesion within the motor cortex. There was a positive correlation between the magnitude of ictal desychronization and impairment of motor dexterity in the contralateral, but not ipsilateral hand. There was no association between ictal desynchronization within the hand motor area and non-motor deficits. This study uniquely demonstrates that seizure-induced disturbances in cortical functional connectivity are associated with network-specific neurological deficits.	[Ibrahim, George M.; Rutka, James T.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Akiyama, Tomoyuki; Ochi, Ayako; Otsubo, Hiroshi; Smith, Mary Lou; Donner, Elizabeth; Snead, O. Carter, III] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Ibrahim, George M.; Taylor, Margot J.; Snead, O. Carter, III] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Taylor, Margot J.; Doesburg, Sam M.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Taylor, Margot J.; Snead, O. Carter, III; Doesburg, Sam M.] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Smith, Mary Lou] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Taylor, Margot J.; Doesburg, Sam M.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ibrahim, GM (corresponding author), Hosp Sick Children, Div Neurosurg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sam.doesburg@sickkids.ca	Donner, Elizabeth/AAW-4773-2021		Hospital for Sick Children, Foundation Student Scholarship Program; Hospital for Sick Children Centre for Brain and Behavior; Ontario Brain Institute; Wiley Family and Jack Beqaj Funds for epilepsy surgery research; University of Toronto; Royal College of Physicians and Surgeons of Canada	Hospital for Sick Children, Foundation Student Scholarship Program; Hospital for Sick Children Centre for Brain and Behavior; Ontario Brain Institute; Wiley Family and Jack Beqaj Funds for epilepsy surgery research; University of Toronto(University of Toronto); Royal College of Physicians and Surgeons of Canada	This work was supported by the Hospital for Sick Children, Foundation Student Scholarship Program, the Hospital for Sick Children Centre for Brain and Behavior, the Ontario Brain Institute, the Wiley Family and Jack Beqaj Funds for epilepsy surgery research, the University of Toronto Surgeon-Scientist Program, and the Royal College of Physicians and Surgeons of Canada Clinician-Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2011, EPILEPSIA, V52, P1802, DOI 10.1111/j.1528-1167.2011.03199.x; Bartolomei F, 2005, CLIN NEUROPHYSIOL, V116, P2473, DOI 10.1016/j.clinph.2005.05.013; Benasich AA, 2008, BEHAV BRAIN RES, V195, P215, DOI 10.1016/j.bbr.2008.08.049; Benifla M, 2009, J NEUROSURG-PEDIATR, V4, P199, DOI 10.3171/2009.3.PEDS08459; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fell J, 2006, NEUROSCI LETT, V407, P37, DOI 10.1016/j.neulet.2006.07.074; Fisher RA, 1935, DESIGN EXPT; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Jonas R, 2004, NEUROLOGY, V62, P1712, DOI 10.1212/01.WNL.0000127109.14569.C3; Kemp B, 2003, CLIN NEUROPHYSIOL, V114, P1755, DOI 10.1016/S1388-2457(03)00123-8; Kulandaivel K, 2011, EPILEPSY BEHAV, V20, P700, DOI 10.1016/j.yebeh.2011.02.021; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Masquelier T, 2009, J NEUROSCI, V29, P13484, DOI 10.1523/JNEUROSCI.2207-09.2009; Matthew C.G., 1964, GROOVED PEGBOARD INS; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Meador KJ, 2002, NEUROLOGY, V58, pS21, DOI 10.1212/WNL.58.8_suppl_5.S21; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Nariai H, 2011, EPILEPSIA, V52, P63, DOI 10.1111/j.1528-1167.2010.02786.x; Newman M.E.J., 2010, NETWORKS INTRO; Ochi A, 2007, EPILEPSIA, V48, P286, DOI 10.1111/j.1528-1167.2007.00923.x; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Reitan RM., 1969, MANUAL ADM NEUROPSYC; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rose M, 2006, CEREB CORTEX, V16, P1522, DOI 10.1093/cercor/bhj089; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; van Wingerden M, 2010, J NEUROSCI, V30, P10025, DOI 10.1523/JNEUROSCI.0222-10.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang Y, 2011, J NEUROSCI, V31, P13204, DOI 10.1523/JNEUROSCI.6227-10.2011; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; Weschler D, 2003, WISC 4 ADM MANUAL MA; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	51	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39326	10.1371/journal.pone.0039326	http://dx.doi.org/10.1371/journal.pone.0039326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737233	Green Submitted, Green Published, gold			2022-12-25	WOS:000305695100031
J	Nassiri, I; Masoudi-Nejad, A; Jalili, M; Moeini, A				Nassiri, Isar; Masoudi-Nejad, Ali; Jalili, Mahdi; Moeini, Ali			Nonparametric Simulation of Signal Transduction Networks with Semi-Synchronized Update	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; MODEL; CONSEQUENCES; PATHWAYS; TOPOLOGY; DYNAMICS	Simulating signal transduction in cellular signaling networks provides predictions of network dynamics by quantifying the changes in concentration and activity-level of the individual proteins. Since numerical values of kinetic parameters might be difficult to obtain, it is imperative to develop non-parametric approaches that combine the connectivity of a network with the response of individual proteins to signals which travel through the network. The activity levels of signaling proteins computed through existing non-parametric modeling tools do not show significant correlations with the observed values in experimental results. In this work we developed a non-parametric computational framework to describe the profile of the evolving process and the time course of the proportion of active form of molecules in the signal transduction networks. The model is also capable of incorporating perturbations. The model was validated on four signaling networks showing that it can effectively uncover the activity levels and trends of response during signal transduction process.	[Nassiri, Isar; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Jalili, Mahdi] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran; [Moeini, Ali] Univ Tehran, Coll Engn, Dept Algorithms & Computat, Tehran, Iran	University of Tehran; Sharif University of Technology; University of Tehran	Nassiri, I (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.	amasoudin@ibb.ut.ac.ir	Masoudi-Nejad, Ali/E-7922-2010; Masoudi-Nejad, Ali/ABH-2078-2021	Masoudi-Nejad, Ali/0000-0003-0659-5183; Jalili, Mahdi/0000-0002-0517-9420				Abhishek Garg KM, 2008, BIOINFORMATICS, V25, P101; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Albert R, 2009, METHOD ENZYMOL, V467, P281, DOI 10.1016/S0076-6879(09)67011-7; Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; Apgar JF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040030; Assmann SM, 2009, METHODS MOL BIOL, V553, P207, DOI 10.1007/978-1-60327-563-7_10; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Breitling R, 2005, FEBS LETT, V579, P6289, DOI 10.1016/j.febslet.2005.10.034; Brun C, 2004, GENOME BIOL, V5; Cevikbas F, 2012, J INVEST DERMATOL, V132, P1326, DOI 10.1038/jid.2012.66; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Chen L, 2009, BIOMOLECULAR NETWORK; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P602, DOI 10.1109/TCSI.2002.1001949; Cope AP, 2004, ARTHRITIS RES THER, V6, P112, DOI 10.1186/ar1185; Cosgrove BD, 2009, TOXICOL APPL PHARM, V237, P317, DOI 10.1016/j.taap.2009.04.002; Costa LD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-16; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Doherty DG, 1999, J IMMUNOL, V163, P2314; Fu C, 2009, MOL BIOSYST, V5, P1809, DOI [10.1039/b905382d, 10.1039/B905382D]; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Jack J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-109; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Jenkins DJ, 2010, J MOL EVOL, V70, P215, DOI 10.1007/s00239-010-9323-5; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kampen V, 1992, STOCHASTIC PROCESSES, V1; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Klann MT, 2009, BIOPHYS J, V96, P5122, DOI 10.1016/j.bpj.2009.03.049; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Leydesdorff L, 2006, J AM SOC INF SCI TEC, V57, P1616, DOI 10.1002/asi.20335; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Melas IN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-107; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Muller M, 2008, FASEB J, V22, P1393, DOI 10.1096/fj.07-9100com; Nees J, 2009, SCIENTOMETRICS, V5, P14; Nisbach F, 2007, EUR PHYS J B, V58, P185, DOI 10.1140/epjb/e2007-00214-4; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Pritchard JR, 2009, MOL CANCER THER, V8, P2183, DOI 10.1158/1535-7163.MCT-08-1203; Ruths D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000005; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Saez-Rodriguez J, 2008, BIOINFORMATICS, V24, P840, DOI 10.1093/bioinformatics/btn018; Saez-Rodriguez J, 2011, CANCER RES, V71, P5400, DOI 10.1158/0008-5472.CAN-10-4453; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Van Den Berg HA, 2001, J THEOR BIOL, V209, P465, DOI 10.1006/jtbi.2001.2281; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; vSun J, 2007, J CHEM PHYS, V127; Wallner B, 2005, PROTEIN SCI, V14, P1315, DOI 10.1110/ps.041253405; Wang RS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-44; Wedagedara J, 2011, J NATL SCI FOUND SRI, V39, P03; White FM, 2008, CURR OPIN BIOTECH, V19, P404, DOI 10.1016/j.copbio.2008.06.006; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang RR, 2008, P NATL ACAD SCI USA, V105, P16308, DOI 10.1073/pnas.0806447105; Zielinski R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-88	65	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39643	10.1371/journal.pone.0039643	http://dx.doi.org/10.1371/journal.pone.0039643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737250	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100049
J	Villalobos-Comparan, M; Villamil-Ramirez, H; Villarreal-Molina, T; Larrieta-Carrasco, E; Leon-Mimila, P; Romero-Hidalgo, S; Jacobo-Albavera, L; Liceaga-Fuentes, AE; Campos-Perez, FJ; Lopez-Contreras, BE; Tusie-Luna, T; del Rio-Navarro, BE; Aguilar-Salinas, CA; Canizales-Quinteros, S				Villalobos-Comparan, Marisela; Villamil-Ramirez, Hugo; Villarreal-Molina, Teresa; Larrieta-Carrasco, Elena; Leon-Mimila, Paola; Romero-Hidalgo, Sandra; Jacobo-Albavera, Leonor; Liceaga-Fuentes, Adriana E.; Campos-Perez, Francisco J.; Lopez-Contreras, Blanca E.; Tusie-Luna, Teresa; del Rio-Navarro, Blanca E.; Aguilar-Salinas, Carlos A.; Canizales-Quinteros, Samuel			PCSK1 rs6232 Is Associated with Childhood and Adult Class III Obesity in the Mexican Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; VARIANTS; MUTATIONS; RISK; GENE	Background: Common variants rs6232 and rs6235 in the PCSK1 gene have been associated with obesity in European populations. We aimed to evaluate the contribution of these variants to obesity and related traits in Mexican children and adults. Methodology/Principal Findings: Rs6232 and rs6235 were genotyped in 2382 individuals, 1206 children and 1176 adults. Minor allele frequencies were 0.78% for rs6232 and 19.99% for rs6235. Rs6232 was significantly associated with childhood obesity and adult class III obesity (OR = 3.01 95% CI 1.64-5.53; P = 4 x 10(-4) in the combined analysis). In addition, this SNP was significantly associated with lower fasting glucose levels (P = 0.01) and with increased insulin levels and HOMA-B (P = 0.05 and 0.01, respectively) only in non-obese children. In contrast, rs6235 showed no significant association with obesity or with glucose homeostasis parameters in any group. Conclusion/Significance: Although rs6232 is rare in the Mexican population, it should be considered as an important risk factor for extreme forms of obesity.	[Villalobos-Comparan, Marisela; Villamil-Ramirez, Hugo; Leon-Mimila, Paola; Jacobo-Albavera, Leonor; Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico; [Villalobos-Comparan, Marisela; Villamil-Ramirez, Hugo; Larrieta-Carrasco, Elena; Leon-Mimila, Paola; Jacobo-Albavera, Leonor; Lopez-Contreras, Blanca E.; Tusie-Luna, Teresa; Canizales-Quinteros, Samuel] INCMNSZ, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa; Romero-Hidalgo, Sandra; Lopez-Contreras, Blanca E.] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Liceaga-Fuentes, Adriana E.; Campos-Perez, Francisco J.] Hosp Ruben Lenero, Clin Obesidad, Mexico City, DF, Mexico; [Tusie-Luna, Teresa] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [del Rio-Navarro, Blanca E.] Hosp Infantil Mexico Dr Federico Gomez, Dept Alergia & Inmunol Clin, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos A.] INCMNSZ, Dept Endocrinol & Metab, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico Federico Gomez	Villalobos-Comparan, M (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico.	cani@servidor.unam.mx	Salinas, Carlos A Aguilar/AAL-4491-2020; Leon-Mimila, Paola/U-2375-2019	Romero-Hidalgo, Sandra/0000-0003-3077-7825; Jacobo-Albavera, Leonor/0000-0001-5129-8108; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690; Leon, Paola/0000-0001-6334-1492	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [113861, 210322, 244112, 234714, 195399]; Ciencias Biomedicas at Universidad Nacional Autonoma de Mexico (UNAM)	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ciencias Biomedicas at Universidad Nacional Autonoma de Mexico (UNAM)	This research was supported by grant 113861 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT, http://www.conacyt.mx/Paginas/default.aspx). MVC is in the PhD program from Ciencias Biomedicas at Universidad Nacional Autonoma de Mexico (UNAM). MVC, HVR, PLM and LJA are recipients of the CONACyT scholarship number 210322, 244112, 234714 and 195399, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Canizales-Quinteros S, 2007, HUM BIOL, V79, P111, DOI 10.1353/hub.2007.0022; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gjesing AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023907; Heni M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-86; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Qi QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010590; Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Sandholt CH, 2010, DIABETES, V59, P1667, DOI 10.2337/db09-1042; Secretaria de Salud Instituto Nacional de Salud Publica, 2006, ENC NAC SAL NUTR ENS; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Villarreal-Molina MT, 2007, DIABETES, V56, P1881, DOI 10.2337/db06-0905; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087	27	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39037	10.1371/journal.pone.0039037	http://dx.doi.org/10.1371/journal.pone.0039037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737226	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100025
J	Furlan, S; Comparini, D; Ciszak, M; Beccai, L; Mancuso, S; Mazzolai, B				Furlan, Silvano; Comparini, Diego; Ciszak, Marzena; Beccai, Lucia; Mancuso, Stefano; Mazzolai, Barbara			Origin of Polar Order in Dense Suspensions of Phototactic Micro-Swimmers	PLOS ONE			English	Article							FLUID-DYNAMICS; RANDOM-WALK; CHLAMYDOMONAS; LOCOMOTION; MOTION; LIGHT	A main question for the study of collective motion in living organisms is the origin of orientational polar order, i.e., how organisms align and what are the benefits of such collective behaviour. In the case of micro-organisms swimming at a low Reynolds number, steric repulsion and long-range hydrodynamic interactions are not sufficient to explain a homogeneous polar order state in which the direction of motion is aligned. An external symmetry-breaking guiding field such as a mechanism of taxis appears necessary to understand this phonemonon. We have investigated the onset of polar order in the velocity field induced by phototaxis in a suspension of a motile micro-organism, the algae Chlamydomonas reinhardtii, for density values above the limit provided by the hydrodynamic approximation of a force dipole model. We show that polar order originates from a combination of both the external guiding field intensity and the population density. In particular, we show evidence for a linear dependence of a phototactic guiding field on cell density to determine the polar order for dense suspensions and demonstrate the existence of a density threshold for the origin of polar order. This threshold represents the density value below which cells undergoing phototaxis are not able to maintain a homogeneous polar order state and marks the transition to ordered collective motion. Such a transition is driven by a noise dominated phototactic reorientation where the noise is modelled as a normal distribution with a variance that is inversely proportional to the guiding field strength. Finally, we discuss the role of density in dense suspensions of phototactic micro-swimmers.	[Furlan, Silvano; Beccai, Lucia; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Furlan, Silvano] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy; [Comparini, Diego; Ciszak, Marzena; Mancuso, Stefano] Univ Florence, Dept Plant Soil & Environm Sci, Lab Int Neurobiol Vegetale, Florence, Italy; [Ciszak, Marzena] CNR, Ist Nazl Ott, Florence, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR)	Furlan, S (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy.	silvano.furlan@iit.it	Mazzolai, Barbara/I-8876-2016; Mancuso, Stefano/G-6515-2012	Mazzolai, Barbara/0000-0003-0722-8350; Mancuso, Stefano/0000-0003-1752-3986; Beccai, Lucia/0000-0002-8754-5155				Baskaran A, 2009, P NATL ACAD SCI USA, V106, P15567, DOI 10.1073/pnas.0906586106; Baskaran A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011920; Baskaran A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.268101; Bastiaans RJM, 2000, 99W001 EUT TU EINDH; Bayly PV, 2011, BIOPHYS J, V100, P2716, DOI 10.1016/j.bpj.2011.05.001; Bertin E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.022101; Cavagna A, 2010, P NATL ACAD SCI US; Cisneros LH, 2007, EXP FLUIDS, V43, P737, DOI 10.1007/s00348-007-0387-y; Cisneros LH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061907; Czirok A, 1997, J PHYS A-MATH GEN, V30, P1375, DOI 10.1088/0305-4470/30/5/009; de Gennes P. G., 1995, PHYS LIQUID CRYSTALS; Drescher K, 2011, P NATL ACAD SCI USA, V108, P10940, DOI 10.1073/pnas.1019079108; Drescher K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168101; Dusenbery DB, 1997, P NATL ACAD SCI USA, V94, P10949, DOI 10.1073/pnas.94.20.10949; Ebbens SJ, 2010, SOFT MATTER, V6, P726, DOI 10.1039/b918598d; Elfring GJ, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3532954; Evans AA, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3660268; FOSTER KW, 1980, MICROBIOL REV, V44, P572, DOI 10.1128/MMBR.44.4.572-630.1980; Fujiu K, 2011, NAT CELL BIOL, V13, P630, DOI 10.1038/ncb2214; Goldstein RE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.148103; Goldstein RE, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.168103; Guasto JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168102; Haeder D, 2001, COMPREHENSIVE SERIES, V1; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; Hill NA, 2005, FLUID DYN RES, V37, P1, DOI 10.1016/j.fluiddyn.2005.03.002; HYAMS JS, 1978, J CELL SCI, V33, P235; Jaffe LF, 2007, BIOL CELL, V99, P175, DOI 10.1042/BC20060031; Kotar J, 2010, P NATL ACAD SCI USA, V107, P7669, DOI 10.1073/pnas.0912455107; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Mardia K. V., 2000, DIRECTIONAL STAT; MORELLAURENS N, 1987, PHOTOCHEM PHOTOBIOL, V45, P119, DOI 10.1111/j.1751-1097.1987.tb08412.x; Mori N, 2003, INTRO MPIV MATLAB; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; Pooley CM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228103; Rao JS., 2001, TOPICS CIRCULAR STAT; Saintillan D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058102; Schaller K, 1997, BIOPHYS J, V73, P1562, DOI 10.1016/S0006-3495(97)78188-8; SCHIENBEIN M, 1994, PHYS REV E, V49, P5462, DOI 10.1103/PhysRevE.49.5462; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vilfan A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058102; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	47	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38895	10.1371/journal.pone.0038895	http://dx.doi.org/10.1371/journal.pone.0038895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723904	Green Submitted, Green Published, gold			2022-12-25	WOS:000305652700038
J	Dittmar, MS; Petermichl, W; Schlachetzki, F; Graf, BM; Gruber, M				Dittmar, Michael S.; Petermichl, Walter; Schlachetzki, Felix; Graf, Bernhard M.; Gruber, Michael			Isoflurane Induces Endothelial Apoptosis of the Post-Hypoxic Blood-Brain Barrier in a Transdifferentiated Human Umbilical Vein Edothelial Cell Model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEUROVASCULAR UNIT; ARTERY OCCLUSION; NITRIC-OXIDE; RATS; INJURY; STROKE; PERMEABILITY; INHIBITION; ANESTHESIA	Isoflurane is a popular volatile anesthetic agent used in humans as well as in experimental animal research. In previous animal studies of the blood-brain barrier (BBB), observations towards an increased permeability after exposure to isoflurane are reported. In this study we investigated the effect of a 2-hour isoflurane exposure on apoptosis of the cerebral endothelium following 24 hours of hypoxia in an in vitro BBB model using astrocyte-conditioned human umbilical vein endothelial cells (AC-HUVECs). Apoptosis of AC-HUVECs was investigated using light microscopy of the native culture for morphological changes, Western blot (WB) analysis of Bax and Bcl-2, and a TUNEL assay. Treatment of AC-HUVECs with isoflurane resulted in severe cellular morphological changes and a significant dose-dependent increase in DNA fragmentation, which was observed during the TUNEL assay analysis. WB analysis confirmed increases in pro-apoptotic Bax levels at 4 hours and 24 hours and decreases in anti-apoptotic Bcl-2 in a dose-dependent manner compared with the control group. These negative effects of isoflurane on the BBB after a hypoxic challenge need to be taken into account not only in experimental stroke research, but possibly also in clinical practice.	[Dittmar, Michael S.; Petermichl, Walter; Graf, Bernhard M.; Gruber, Michael] Univ Regensburg, Dept Anesthesiol, Med Ctr, Regensburg, Germany; [Schlachetzki, Felix] Univ Regensburg, Dept Neurol, Bezirksklinikum Regensburg, Regensburg, Germany	University of Regensburg; University of Regensburg	Dittmar, MS (corresponding author), Univ Regensburg, Dept Anesthesiol, Med Ctr, Regensburg, Germany.	michael.dittmar@ukr.de	Gruber, Michael/A-5342-2012	Gruber, Michael/0000-0002-5509-9760; Dittmar, Michael S./0000-0002-8687-5830	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The project was financed by institutional funds. Cost of publication was covered by financial means from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Chi OZ, 2010, ANESTH ANALG, V110, P1412, DOI 10.1213/ANE.0b013e3181d6c0ae; del Zoppo GJ, 2006, NEW ENGL J MED, V354, P553, DOI 10.1056/NEJMp058312; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DRUMMOND JC, 1995, NEUROSURGERY, V37, P742, DOI 10.1227/00006123-199510000-00019; DRUMMOND JC, 1995, NEUROSURGERY, V37, P748; Eisert Wolfgang G, 2009, Handb Clin Neurol, V92, P197, DOI 10.1016/S0072-9752(08)01910-6; Engelhard K, 1999, BRIT J ANAESTH, V83, P415, DOI 10.1093/bja/83.3.415; FLYNN NM, 1992, ANESTHESIOLOGY, V76, P461, DOI 10.1097/00000542-199203000-00021; Gwak MS, 2011, ENVIRON TOXICOL PHAR, V31, P262, DOI 10.1016/j.etap.2010.10.009; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Inoue S, 2004, ANESTHESIOLOGY, V101, P75, DOI 10.1097/00000542-200407000-00013; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JENSEN NF, 1992, ANESTHESIOLOGY, V76, P624, DOI 10.1097/00000542-199204000-00021; Kawaguchi M, 2004, ANESTH ANALG, V98, P798; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; KOENIG HM, 1994, ANESTH ANALG, V79, P886; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lo EH, 2004, STROKE, V35, P354, DOI 10.1161/01.STR.0000115164.80010.8A; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; MILDE LN, 1988, ANESTHESIOLOGY, V69, P905, DOI 10.1097/00000542-198812000-00017; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; Okamoto H, 1997, ANESTHESIOLOGY, V86, P875, DOI 10.1097/00000542-199704000-00018; OLSSON Y, 1971, ACTA NEUROPATHOL, V18, P89, DOI 10.1007/BF00687597; Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; PRESTON E, 1993, NEUROSCI LETT, V149, P75, DOI 10.1016/0304-3940(93)90351-K; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sood RR, 2008, J CEREBR BLOOD F MET, V28, P431, DOI 10.1038/sj.jcbfm.9600534; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; YAMAGISHI S, 1993, BIOCHEM BIOPH RES CO, V190, P418, DOI 10.1006/bbrc.1993.1064; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	42	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38260	10.1371/journal.pone.0038260	http://dx.doi.org/10.1371/journal.pone.0038260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723852	gold, Green Published, Green Submitted			2022-12-25	WOS:000305583300023
J	Kukita, A; Ichigi, Y; Takigawa, I; Watanabe, T; Kukita, T; Miyamoto, H				Kukita, Akiko; Ichigi, Yuka; Takigawa, Ippei; Watanabe, Toshiyuki; Kukita, Toshio; Miyamoto, Hiroshi			Infection of RANKL-Primed RAW-D Macrophages with Porphyromonas gingivalis Promotes Osteoclastogenesis in a TNF-alpha-Independent Manner	PLOS ONE			English	Article							KAPPA-B LIGAND; CYTOKINE PRODUCTION; BONE LOSS; DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR; DIRECT STIMULATION; GENE-EXPRESSION; IN-VIVO; C-FOS; LIPOPOLYSACCHARIDE	Infection of macrophages with bacteria induces the production of pro-inflammatory cytokines including TNF-alpha. TNF-alpha directly stimulates osteoclast differentiation from bone marrow macrophages in vitro as well as indirectly via osteoblasts. Recently, it was reported that bacterial components such as LPS inhibited RANKL-induced osteoclastogenesis in early stages, but promoted osteoclast differentiation in late stages. However, the contribution to osteoclast differentiation of TNF-alpha produced by infected macrophages remains unclear. We show here that Porphyromonas gingivalis, one of the major pathogens in periodontitis, directly promotes osteoclastogenesis from RANKL-primed RAW-D (subclone of RAW264) mouse macrophages, and we show that TNF-alpha is not involved in the stimulatory effect on osteoclastogenesis. P. gingivalis infection of RANKL-primed RAW-D macrophages markedly stimulated osteoclastogenesis in a RANKL-independent manner. In the presence of the TLR4 inhibitor, polymyxin B, infection of RANKL-primed RAW-D cells with P. gingivalis also induced osteoclastogenesis, indicating that TLR4 is not involved. Infection of RAW-D cells with P. gingivalis stimulated the production of TNF-alpha, whereas the production of TNF-alpha by similarly infected RANKL-primed RAW-D cells was markedly down-regulated. In addition, infection of RANKL-primed macrophages with P. gingivalis induced osteoclastogenesis in the presence of neutralizing antibody against TNF-alpha. Inhibitors of NFATc1 and p38MAPK, but not of NF-kappa B signaling, significantly suppressed P. gingivalis-induced osteoclastogenesis from RANKL-primed macrophages. Moreover, re-treatment of RANKL-primed macrophages with RANKL stimulated osteoclastogenesis in the presence or absence of P. gingivalis infection, whereas re-treatment of RANKL-primed macrophages with TNF-alpha did not enhance osteoclastogenesis in the presence of live P. gingivalis. Thus, P. gingivalis infection of RANKL-primed macrophages promoted osteoclastogenesis in a TNF-a independent manner, and RANKL but not TNF-alpha was effective in inducing osteoclastogenesis from RANKL-primed RAW-D cells in the presence of P. gingivalis.	[Kukita, Akiko; Ichigi, Yuka; Takigawa, Ippei; Miyamoto, Hiroshi] Saga Univ, Dept Microbiol, Fac Med, Saga 840, Japan; [Watanabe, Toshiyuki; Kukita, Toshio] Kyushu Univ, Fac Dent Sci, Fukuoka 812, Japan	Saga University; Kyushu University	Kukita, A (corresponding author), Saga Univ, Dept Microbiol, Fac Med, Saga 840, Japan.	kukita@cc.saga-u.ac.jp			 [21592366]		Financial support for this study was provided by Grant-in-Aid for Scientific Research (C) of Japan, grant number 21592366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Aoki Y, 2010, BIOCHEM BIOPH RES CO, V398, P86, DOI 10.1016/j.bbrc.2010.06.040; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688; Jin QM, 2007, J PERIODONTOL, V78, P1300, DOI 10.1902/jop.2007.070073; Kajiya M., 2010, J ORAL MICROBIOL, V2; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Mabilleau G, 2011, J BIOL CHEM, V286, P3242, DOI 10.1074/jbc.M110.150300; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Sakuma Y, 2000, INFECT IMMUN, V68, P6819, DOI 10.1128/IAI.68.12.6819-6825.2000; Sato N, 2004, J EXP MED, V200, P601, DOI 10.1084/jem.20040689; Schwartz Z, 1997, PERIODONTOL 2000, V14, P158, DOI 10.1111/j.1600-0757.1997.tb00196.x; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Ukai T, 2008, INFECT IMMUN, V76, P812, DOI 10.1128/IAI.01241-07; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Yang J, 2009, J LEUKOCYTE BIOL, V86, P823, DOI 10.1189/jlb.0309206; Yang SH, 2005, J IMMUNOL, V175, P1956, DOI 10.4049/jimmunol.175.3.1956; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yuan HP, 2011, J CLIN PERIODONTOL, V38, P1029, DOI 10.1111/j.1600-051X.2011.01780.x; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	43	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38500	10.1371/journal.pone.0038500	http://dx.doi.org/10.1371/journal.pone.0038500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723864	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300030
J	Lu, CH; Lin, YF; Lin, JJ; Yu, CS				Lu, Chih-Hao; Lin, Yu-Feng; Lin, Jau-Ji; Yu, Chin-Sheng			Prediction of Metal Ion-Binding Sites in Proteins Using the Fragment Transformation Method	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ZINC-BINDING; ESCHERICHIA-COLI; NEURAL-NETWORKS; IDENTIFICATION; SEQUENCE; CLASSIFICATION; TEMPLATES; EVOLUTION; REDUCTASE	The structure of a protein determines its function and its interactions with other factors. Regions of proteins that interact with ligands, substrates, and/or other proteins, tend to be conserved both in sequence and structure, and the residues involved are usually in close spatial proximity. More than 70,000 protein structures are currently found in the Protein Data Bank, and approximately one-third contain metal ions essential for function. Identifying and characterizing metal ion-binding sites experimentally is time-consuming and costly. Many computational methods have been developed to identify metal ion-binding sites, and most use only sequence information. For the work reported herein, we developed a method that uses sequence and structural information to predict the residues in metal ion-binding sites. Six types of metal ion-binding templates-those involving Ca2+, Cu2+, Fe3+, Mg2+, Mn2+, and Zn2+-were constructed using the residues within 3.5 angstrom of the center of the metal ion. Using the fragment transformation method, we then compared known metal ion-binding sites with the templates to assess the accuracy of our method. Our method achieved an overall 94.6 % accuracy with a true positive rate of 60.5 % at a 5 % false positive rate and therefore constitutes a significant improvement in metal-binding site prediction.	[Lu, Chih-Hao; Lin, Yu-Feng] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Lin, Yu-Feng; Lin, Jau-Ji] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Lin, Jau-Ji] Acad Sinica, Bioinformat Program, Taiwan Int Grad Program, Inst Informat Sci, Taipei 115, Taiwan; [Lin, Jau-Ji] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Yu, Chin-Sheng] Feng Chia Univ, Dept Informat Engn & Comp Sci, Taichung 40724, Taiwan; [Yu, Chin-Sheng] Feng Chia Univ, Masters Program Biomed Informat & Biomed Engn, Taichung 40724, Taiwan	China Medical University Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Feng Chia University; Feng Chia University	Lu, CH (corresponding author), China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan.	chlu@mail.cmu.edu.tw			National Science Council [NSC 99-2113-M-039-002-MY2]; China Medical University Taiwan [CMU98-N2-19]; National Science Council Taiwan [NSC 98-2627-B-035-001-]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University Taiwan(China Medical University); National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council(NSC 99-2113-M-039-002-MY2) and China Medical University(CMU98-N2-19), Taiwan to CHL and the National Science Council(NSC 98-2627-B-035-001-), Taiwan to CSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahvazi B, 2003, J BIOL CHEM, V278, P23834, DOI 10.1074/jbc.M301162200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ana V, 1997, J BIOL INORG CHEM, V2, P10; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Binet MRB, 2003, ANAL BIOCHEM, V318, P30, DOI 10.1016/S0003-2697(03)00190-8; Bond CS, 1999, ACTA CRYSTALLOGR D, V55, P414, DOI 10.1107/S0907444998012074; Dautant A, 1998, ACTA CRYSTALLOGR D, V54, P16, DOI 10.1107/S0907444997006811; Degtyarenko K, 2000, BIOINFORMATICS, V16, P851, DOI 10.1093/bioinformatics/16.10.851; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Golovin A, 2005, PROTEINS, V58, P190, DOI 10.1002/prot.20288; Govindarajan S, 1997, PROTEINS, V29, P461, DOI 10.1002/(SICI)1097-0134(199712)29:4<461::AID-PROT6>3.0.CO;2-B; Gower JC, 1969, J ROY STAT SOC, V18, P11; Goyal K, 2008, PROTEINS, V70, P1206, DOI 10.1002/prot.21601; Guntinas MBDC, 2002, ANAL BIOANAL CHEM, V374, P369, DOI 10.1007/s00216-002-1508-3; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Herald VL, 2003, FEBS LETT, V537, P96, DOI 10.1016/S0014-5793(03)00101-7; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Jensen MR, 2005, BIOCHEMISTRY-US, V44, P11014, DOI 10.1021/bi0508136; Levy R, 2009, PROTEINS, V76, P365, DOI 10.1002/prot.22352; Lin CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116; Lin HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S13; Lu CH, 2006, PROTEINS, V63, P636, DOI 10.1002/prot.20904; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Parisi G, 2001, MOL BIOL EVOL, V18, P750, DOI 10.1093/oxfordjournals.molbev.a003857; Passerini A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-39; Passerini A, 2006, PROTEINS, V65, P305, DOI 10.1002/prot.21135; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Reed GH, 2000, MET IONS BIOL SYST, V37, P183; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Sandier A, 1997, J CHROMATOGR A, V776, P93, DOI 10.1016/S0021-9673(97)00450-0; Schrodinger L., 2020, PYMOL; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Sieker LC, 1999, NAT STRUCT BIOL, V6, P308; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; TAINER JA, 1991, CURR OPIN BIOTECH, V2, P582, DOI 10.1016/0958-1669(91)90084-I; Tseng YY, 2009, PROTEINS, V76, P959, DOI 10.1002/prot.22402; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; Yeh AP, 2000, BIOCHEMISTRY-US, V39, P2499, DOI 10.1021/bi992428k; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P9	44	53	53	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39252	10.1371/journal.pone.0039252	http://dx.doi.org/10.1371/journal.pone.0039252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723976	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300122
J	Mitchell, GB; Sigurdson, CJ; O'Rourke, KI; Algire, J; Harrington, NP; Walther, I; Spraker, TR; Balachandran, A				Mitchell, Gordon B.; Sigurdson, Christina J.; O'Rourke, Katherine I.; Algire, James; Harrington, Noel P.; Walther, Ines; Spraker, Terry R.; Balachandran, Aru			Experimental Oral Transmission of Chronic Wasting Disease to Reindeer (Rangifer tarandus tarandus)	PLOS ONE			English	Article							DEER ODOCOILEUS-HEMIONUS; WHITE-TAILED DEER; RESISTANT PRION PROTEIN; CERVUS-ELAPHUS-NELSONI; CAPTIVE MULE DEER; SPONGIFORM ENCEPHALOPATHY; STRAIN MUTATION; TRANSGENIC MICE; FALLOW DEER; ELK	Chronic wasting disease (CWD), a transmissible spongiform encephalopathy of cervids, remains prevalent in North American elk, white-tailed deer and mule deer. A natural case of CWD in reindeer (Rangifer tarandus tarandus) has not been reported despite potential habitat overlap with CWD-infected deer or elk herds. This study investigates the experimental transmission of CWD from elk or white-tailed deer to reindeer by the oral route of inoculation. Ante-mortem testing of the three reindeer exposed to CWD from white-tailed deer identified the accumulation of pathological PrP (PrPCWD) in the recto-anal mucosa associated lymphoid tissue (RAMALT) of two reindeer at 13.4 months post-inoculation. Terminal CWD occurred in the two RAMALT-positive reindeer at 18.5 and 20 months post-inoculation while one other reindeer in the white-tailed deer CWD inoculum group and none of the 3 reindeer exposed to elk CWD developed disease. Tissue distribution analysis of PrPCWD in CWD-affected reindeer revealed widespread deposition in central and peripheral nervous systems, lymphoreticular tissues, the gastrointestinal tract, neuroendocrine tissues and cardiac muscle. Analysis of prion protein gene (PRNP) sequences in the 6 reindeer identified polymorphisms at residues 2 (V/M), 129 (G/S), 138 (S/N) and 169 (V/M). These findings demonstrate that (i) a sub-population of reindeer are susceptible to CWD by oral inoculation implicating the potential for transmission to other Rangifer species, and (ii) certain reindeer PRNP polymorphisms may be protective against CWD infection.	[Mitchell, Gordon B.; Algire, James; Harrington, Noel P.; Walther, Ines; Balachandran, Aru] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Natl & OIE Reference Lab Scrapie & CWD, Ottawa, ON, Canada; [Sigurdson, Christina J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Sigurdson, Christina J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sigurdson, Christina J.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [O'Rourke, Katherine I.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Spraker, Terry R.] Colorado State Univ, Vet Diagnost Lab, Ft Collins, CO 80523 USA	Canadian Food Inspection Agency; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; United States Department of Agriculture (USDA); Colorado State University	Mitchell, GB (corresponding author), Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Natl & OIE Reference Lab Scrapie & CWD, Ottawa, ON, Canada.	Aru.Balachandran@inspection.gc.ca			Canadian Food Inspection Agency; Agriculture and Agri-Food Canada [C00233]; United States Department of Agriculture Agricultural Research Service [CRIS 5348-32000-026-00-D]; United States National Institutes of Health [NS069566, U54AI0359]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069566, R01NS076896] Funding Source: NIH RePORTER	Canadian Food Inspection Agency; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Canadian Food Inspection Agency and Agriculture and Agri-Food Canada under C00233, the United States Department of Agriculture Agricultural Research Service under CRIS 5348-32000-026-00-D and the United States National Institutes of Health under NS069566 and U54AI0359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2007, ARCH NEUROL-CHICAGO, V64, P439, DOI 10.1001/archneur.64.3.439; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; Balachandran A, 2010, CAN VET J, V51, P169; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Brayton KA, 2004, GENE, V326, P167, DOI 10.1016/j.gene.2003.10.022; Collinge J, 2010, SCIENCE, V328, P1111, DOI 10.1126/science.1190815; Cronin MA, 2003, ANIM GENET, V34, P33, DOI 10.1046/j.1365-2052.2003.00927.x; Cronin MRA, 2005, J MAMMAL, V86, P495, DOI 10.1644/1545-1542(2005)86[495:VIMDAM]2.0.CO;2; Daus ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018345; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Hamir AN, 2011, CAN J VET RES, V75, P152; Hamir AN, 2004, VET PATHOL, V41, P78, DOI 10.1354/vp.41-1-78; Happ GM, 2007, J WILDLIFE DIS, V43, P224, DOI 10.7589/0090-3558-43.2.224; Heaton MP, 2003, MAMM GENOME, V14, P765, DOI 10.1007/s00335-003-2283-y; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Kim TY, 2005, J VET MED SCI, V67, P753, DOI 10.1292/jvms.67.753; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Lapointe JM, 2002, CAN VET J, V43, P886; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; MaWhinney S, 2006, EMERG INFECT DIS, V12, P1527, DOI 10.3201/eid1210.060019; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Pushie MJ, 2011, J TOXICOL ENV HEAL A, V74, P1476, DOI 10.1080/15287394.2011.618977; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Rhyan JC, 2011, J WILDLIFE DIS, V47, P739, DOI 10.7589/0090-3558-47.3.739; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Spraker TR, 2002, VET PATHOL, V39, P110, DOI 10.1354/vp.39-1-110; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264	48	60	62	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39055	10.1371/journal.pone.0039055	http://dx.doi.org/10.1371/journal.pone.0039055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723928	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300086
J	Wu, JCC; Chen, KY; Yu, YW; Huang, SW; Shih, HM; Chiu, WT; Chiang, YH; Shiau, CY				Wu, John Chung-Che; Chen, Kai-Yun; Yu, Yu-Wen; Huang, Song-Wei; Shih, Hsiu-Ming; Chiu, Wen-Ta; Chiang, Yung-Hsiao; Shiau, Chia-Yang			Location and Level of Etk Expression in Neurons Are Associated with Varied Severity of Traumatic Brain Injury	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MEDIATED CYTOSKELETAL DEGRADATION; CALPAIN INHIBITOR MDL-28170; CORTICAL IMPACT INJURY; OXIDATIVE DAMAGE; SERUM MARKERS; PROTEIN; ENOLASE; PEROXYNITRITE; BIOMARKER	Background: Much recent research effort in traumatic brain injury (TBI) has been devoted to the discovery of a reliable biomarker correlating with severity of injury. Currently, no consensus has been reached regarding a representative marker for traumatic brain injury. In this study, we explored the potential of epithelial/endothelial tyrosine kinase (Etk) as a novel marker for TBI. Methodology/Principal Findings: TBI was induced in Sprague Dawley (SD) rats by controlled cortical impact. Brain tissue samples were analyzed by Western blot, Q-PCR, and immunofluorescence staining using various markers including glial fibrillary acidic protein, and epithelial/endothelial tyrosine kinase (Etk). Results show increased Etk expression with increased number and severity of impacts. Expression increased 2.36 to 7-fold relative to trauma severity. Significant upregulation of Etk appeared at 1 hour after injury. The expression level of Etk was inversely correlated with distance from injury site. Etk and trauma/inflammation related markers increased post-TBI, while other tyrosine kinases did not. Conclusion/Significance: The observed correlation between Etk level and the number of impacts, the severity of impact, and the time course after impact, as well as its inverse correlation with distance away from injury site, support the potential of Etk as a possible indicator of trauma severity.	[Wu, John Chung-Che; Shiau, Chia-Yang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wu, John Chung-Che] Taitung Christian Hosp, Taitung, Taiwan; [Wu, John Chung-Che; Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chen, Kai-Yun; Yu, Yu-Wen; Chiang, Yung-Hsiao] Coll Med Sci & Technol, Neural Regenerat Program, Taipei, Taiwan; [Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Chen, Kai-Yun; Yu, Yu-Wen; Huang, Song-Wei; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chiu, Wen-Ta] Minist Hlth, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Academia Sinica - Taiwan	Wu, JCC (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	ychiang@tmu.edu.tw; cys@ndmctsgh.edu.tw	Shih, Hsiu-Ming/S-7023-2018	YU, YU-WEN/0000-0002-7279-2532	Taipei Medical University-Shuang Ho Hospital [100TMU-SHH-12]; National Taipei University of Technology-Taipei Medical University [NTUT-TMU-100-08]; Center of Excellence for Clinical Trial and Research in Neurology Neurosurgery [DOH99-TD-B-111-003]; National Science Council [NSC98-2314-B038-011-MY3]; Cheng-Hsin Research [100-23]	Taipei Medical University-Shuang Ho Hospital; National Taipei University of Technology-Taipei Medical University; Center of Excellence for Clinical Trial and Research in Neurology Neurosurgery; National Science Council(Ministry of Science and Technology, Taiwan); Cheng-Hsin Research	Funding provided by Taipei Medical University-Shuang Ho Hospital 100TMU-SHH-12, National Taipei University of Technology-Taipei Medical University NTUT-TMU-100-08, Center of Excellence for Clinical Trial and Research in Neurology & Neurosurgery DOH99-TD-B-111-003, and National Science Council Grant NSC98-2314-B038-011-MY3, Cheng-Hsin Research Grant 100-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Cekic M, 2012, RESTORATIVE NEUROLOG; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen KY, 2011, CELL TRANSPLANTATION; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Das A, 2008, J PINEAL RES, V45, P117, DOI 10.1111/j.1600-079X.2008.00582.x; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gyorgy AB, 2011, J NEUROTRAUMA; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Jasielska M, 2010, INVEST OPHTH VIS SCI, V51, P3874, DOI 10.1167/iovs.09-5003; Kasahara Y, 2010, BRAIN RES, V1340, P70, DOI 10.1016/j.brainres.2010.03.101; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI 10.1089/neu.2008-0753; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Samantaray S, 2008, J PINEAL RES, V44, P348, DOI 10.1111/j.1600-079X.2007.00534.x; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Sribnick EA, 2006, J NEUROSCI RES, V84, P1064, DOI 10.1002/jnr.21016; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Wang Y, 1997, J NEUROSCI, V17, P4341; Woertgen C, 2002, ACT NEUR S, V81, P205; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Yu CG, 2008, J NEUROTRAUM, V25, P833, DOI 10.1089/neu.2007.0490; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39226	10.1371/journal.pone.0039226	http://dx.doi.org/10.1371/journal.pone.0039226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723969	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300118
J	Bhasin, M; Huang, Z; Pradhan-Nabzdyk, L; Malek, JY; LoGerfo, PJ; Contreras, M; Guthrie, P; Csizmadia, E; Andersen, N; Kocher, O; Ferran, C; LoGerfo, FW				Bhasin, Manoj; Huang, Zhen; Pradhan-Nabzdyk, Leena; Malek, Junaid Y.; LoGerfo, Philip J.; Contreras, Mauricio; Guthrie, Patrick; Csizmadia, Eva; Andersen, Nicholas; Kocher, Olivier; Ferran, Christiane; LoGerfo, Frank W.			Temporal Network Based Analysis of Cell Specific Vein Graft Transcriptome Defines Key Pathways and Hub Genes in Implantation Injury	PLOS ONE			English	Article							NF-KAPPA-B; ASPIRIN PLUS DIPYRIDAMOLE; INTIMAL HYPERPLASIA; COLLAGEN-SYNTHESIS; ENDOTHELIAL-CELLS; EXPRESSION; ACTIVATION; INTERLEUKIN-8; INCREASES; ARTERIES	Vein graft failure occurs between 1 and 6 months after implantation due to obstructive intimal hyperplasia, related in part to implantation injury. The cell-specific and temporal response of the transcriptome to vein graft implantation injury was determined by transcriptional profiling of laser capture microdissected endothelial cells (EC) and medial smooth muscle cells (SMC) from canine vein grafts, 2 hours (H) to 30 days (D) following surgery. Our results demonstrate a robust genomic response beginning at 2 H, peaking at 12-24 H, declining by 7 D, and resolving by 30 D. Gene ontology and pathway analyses of differentially expressed genes indicated that implantation injury affects inflammatory and immune responses, apoptosis, mitosis, and extracellular matrix reorganization in both cell types. Through backpropagation an integrated network was built, starting with genes differentially expressed at 30 D, followed by adding upstream interactive genes from each prior time-point. This identified significant enrichment of IL-6, IL-8, NF-kappa B, dendritic cell maturation, glucocorticoid receptor, and Triggering Receptor Expressed on Myeloid Cells (TREM-1) signaling, as well as PPAR alpha activation pathways in graft EC and SMC. Interactive network-based analyses identified IL-6, IL-8, IL-1 alpha, and Insulin Receptor (INSR) as focus hub genes within these pathways. Real-time PCR was used for the validation of two of these genes: IL-6 and IL-8, in addition to Collagen 11A1 (COL11A1), a cornerstone of the backpropagation. In conclusion, these results establish causality relationships clarifying the pathogenesis of vein graft implantation injury, and identifying novel targets for its prevention.	[Bhasin, Manoj; LoGerfo, Philip J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Genom & Prote Ctr,Div Interdisciplinary Med & Bio, Boston, MA 02215 USA; [Huang, Zhen; Pradhan-Nabzdyk, Leena; Malek, Junaid Y.; Contreras, Mauricio; Guthrie, Patrick; Andersen, Nicholas; Ferran, Christiane; LoGerfo, Frank W.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Div Vasc & Endovasc Surg, Boston, MA 02215 USA; [Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Csizmadia, Eva; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Nephrol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Bhasin, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Genom & Prote Ctr,Div Interdisciplinary Med & Bio, Boston, MA 02215 USA.	cferran@bidmc.harvard.edu; flogerfo@bidmc.harvard.edu		Bhasin, Manoj/0000-0001-5172-420X; Andersen, Nicholas/0000-0002-0905-1694	NIH [1R01HL086741, 5T32HL007734, R01HL080130, DK063275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080130, R01HL086741, T32HL007734, R01HL021796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK063275, R01DK063275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is funded by NIH 1R01HL086741 and 5T32HL007734 to FWL and NIH R01HL080130 and DK063275 to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ND, 2007, J AM COLL SURGEONS, V204, P399, DOI 10.1016/j.jamcollsurg.2006.12.029; Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Belkin M, 2000, VASCULAR SURG; Chung SW, 2010, BIOCHEM BIOPH RES CO, V396, P748, DOI 10.1016/j.bbrc.2010.05.009; Colotti C, 2009, CYTOKINE, V46, P228, DOI 10.1016/j.cyto.2009.02.002; Conte MS, 2007, J VASC SURG, V45, p74A, DOI 10.1016/j.jvs.2007.02.031; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; Cooper JAD, 2000, BIOCHEM PHARMACOL, V59, P605, DOI 10.1016/S0006-2952(99)00375-5; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; COX JL, 1991, PROG CARDIOVASC DIS, V34, P45, DOI 10.1016/0033-0620(91)90019-I; DAVIES MG, 1995, EUR J VASC ENDOVASC, V9, P7, DOI 10.1016/S1078-5884(05)80218-7; DHHS, 2010, STAT HOSP BAS CAR US; El-Hamamsy I, 2005, J HEART LUNG TRANSPL, V24, P251, DOI 10.1016/j.healun.2003.12.012; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hall MJ, 2007, NATL HLTH STAT REP; Hamdan AD, 1997, J VASC SURG, V26, P79, DOI 10.1016/S0741-5214(97)70150-2; He XP, 2008, TRANSPL P, V40, P1722, DOI 10.1016/j.transproceed.2008.01.063; Higashi N, 2004, GENES CELLS, V9, P233, DOI 10.1111/j.1356-9597.2004.00715.x; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Kalish JA, 2004, J VASC SURG, V39, P645, DOI 10.1016/j.jvs.2003.10.049; Kang SH, 2008, KOREAN J PHYSIOL PHA, V12, P171, DOI 10.4196/kjpp.2008.12.4.171; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kitagaki M, 2012, J ATHEROSCLER THROMB, V19, P36, DOI 10.5551/jat.9746; Kohler T, 2005, VASCULAR SURG BASIC; KOHLER TR, 1984, SURGERY, V96, P462; KUROKI Y, 1992, BIOCHEM BIOPH RES CO, V182, P1389, DOI 10.1016/0006-291X(92)91887-V; Kwon HM, 1998, J AM COLL CARDIOL, V32, P2072, DOI 10.1016/S0735-1097(98)00482-3; Lazar HL, 2004, ANN THORAC SURG, V78, P730, DOI 10.1016/j.athoracsur.2003.12.041; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; LoGerfo F, 2006, J VASC SURG, V43, P750; LOGERFO FW, 1981, SURGERY, V90, P1015; Mako V, 2011, CYTOM PART A, V77, P962; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; MAYER JE, 1981, ANN THORAC SURG, V31, P204, DOI 10.1016/S0003-4975(10)60927-7; MORISHITA R, 1994, J CLIN INVEST, V93, P1458, DOI 10.1172/JCI117123; MORTON LF, 1982, ATHEROSCLEROSIS, V42, P41, DOI 10.1016/0021-9150(82)90124-1; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Mukundan L, 2004, CELL SIGNAL, V16, P375, DOI 10.1016/j.cellsig.2003.08.008; Murayama R, 2011, J PERIODONTAL RES, V46, P568, DOI 10.1111/j.1600-0765.2011.01374.x; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Nagler A, 1997, ARTERIOSCL THROM VAS, V17, P194, DOI 10.1161/01.ATV.17.1.194; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Nowygrod R, 2006, J VASC SURG, V43, P205, DOI 10.1016/j.jvs.2005.11.002; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Perrault LP, 2005, CAN J CARDIOL, V21, P1077; PFISTERER M, 1989, LANCET, V2, P1; QUIST WC, 1992, J THORAC CARDIOV SUR, V103, P671; R Development Core Team, 2009, R FDN STAT COMP; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; Schoneveld AH, 2005, CARDIOVASC RES, V66, P162, DOI 10.1016/j.cardiores.2004.12.016; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; Takeuchi K, 2007, SURG TODAY, V37, P575, DOI 10.1007/s00595-007-3469-9; VANDERMEER J, 1994, J AM COLL CARDIOL, V24, P1181, DOI 10.1016/0735-1097(94)90096-5; Wang Chengxiong, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P736; Wang Z, 2010, J SURG RES; Westerband A, 2000, J AM COLL SURGEONS, V191, P264, DOI 10.1016/S1072-7515(00)00320-3; Wolff RA, 2006, J VASC SURG, V43, P1028, DOI 10.1016/j.jvs.2006.01.016; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zimmerman MA, 2002, AM J PHYSIOL-HEART C, V283, pH175, DOI 10.1152/ajpheart.00987.2001	66	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39123	10.1371/journal.pone.0039123	http://dx.doi.org/10.1371/journal.pone.0039123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720046	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350000042
J	Marotta, M; Piontkivska, H; Tanaka, H				Marotta, Michael; Piontkivska, Helen; Tanaka, Hisashi			Molecular Trajectories Leading to the Alternative Fates of Duplicate Genes	PLOS ONE			English	Article							COPY NUMBER VARIATION; CLASS GLUTATHIONE TRANSFERASE; RECENT SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; S-TRANSFERASE; EVOLUTION; GENOME; IDENTIFICATION; REVEALS; PALINDROMES	Gene duplication generates extra gene copies in which mutations can accumulate without risking the function of preexisting genes. Such mutations modify duplicates and contribute to evolutionary novelties. However, the vast majority of duplicates appear to be short-lived and experience duplicate silencing within a few million years. Little is known about the molecular mechanisms leading to these alternative fates. Here we delineate differing molecular trajectories of a relatively recent duplication event between humans and chimpanzees by investigating molecular properties of a single duplicate: DNA sequences, gene expression and promoter activities. The inverted duplication of the Glutathione S-transferase Theta 2 (GSTT2) gene had occurred at least 7 million years ago in the common ancestor of African great apes and is preserved in chimpanzees (Pan troglodytes), whereas a deletion polymorphism is prevalent in humans. The alternative fates are associated with expression divergence between these species, and reduced expression in humans is regulated by silencing mutations that have been propagated between duplicates by gene conversion. In contrast, selective constraint preserved duplicate divergence in chimpanzees. The difference in evolutionary processes left a unique DNA footprint in which dying duplicates are significantly more similar to each other (99.4%) than preserved ones. Such molecular trajectories could provide insights for the mechanisms underlying duplicate life and death in extant genomes.	[Marotta, Michael; Tanaka, Hisashi] Cleveland Clin Fdn, Dept Mol Genet, Cleveland, OH 44195 USA; [Piontkivska, Helen] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Marotta, M (corresponding author), Cleveland Clin Fdn, Dept Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	tanakah@ccf.org	Tanaka, Hisashi/ABE-7637-2020	Tanaka, Hisashi/0000-0001-9223-4186	Cleveland Clinic Foundation; NIH (National Institutes of Health) [CA149385, GM86782-01A1]; NATIONAL CANCER INSTITUTE [R01CA149385] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM086782] Funding Source: NIH RePORTER	Cleveland Clinic Foundation; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the funding from Cleveland Clinic Foundation, NIH (National Institutes of Health) CA149385 to Hisashi Tanaka, and GM86782-01A1 to Helen Piontkivska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bischof JM, 2006, HUM MUTAT, V27, P545, DOI 10.1002/humu.20335; Blekhman R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000271; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Casola C, 2011, GENOME RES; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Coggan M, 1998, BIOCHEM J, V334, P617, DOI 10.1042/bj3340617; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Farlow A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000819; Force A, 1999, GENETICS, V151, P1531; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gazave E, 2011, GENOME RES, V21, P1626, DOI 10.1101/gr.117242.110; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; Goidts V, 2006, HUM GENET, V119, P185, DOI 10.1007/s00439-005-0130-9; Gokcumen O, 2009, METHODS, V49, P18, DOI 10.1016/j.ymeth.2009.06.001; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Katju V, 2003, GENETICS, V165, P1793; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; KOCH AL, 1972, GENETICS, V72, P297; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M., 2007, ORIGINS GENOME ARCHI, pxvi; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Marques-Bonet T, 2009, TRENDS GENET, V25, P443, DOI 10.1016/j.tig.2009.08.002; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; MARSHALL CR, 1994, P NATL ACAD SCI USA, V91, P12283, DOI 10.1073/pnas.91.25.12283; Matejcic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029366; McClintock JM, 2002, DEVELOPMENT, V129, P2339; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; OHNO S., 1970, Evolution by gene duplication.; Parl FF, 2005, CANCER LETT, V221, P123, DOI 10.1016/j.canlet.2004.06.016; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shiu SH, 2006, P NATL ACAD SCI USA, V103, P2232, DOI 10.1073/pnas.0510388103; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamura K, 2011, MOL BIOL EVOL; Tan KL, 1996, BIOCHEM J, V315, P727, DOI 10.1042/bj3150727; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Tayebi N, 2003, AM J HUM GENET, V72, P519, DOI 10.1086/367850; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WALSH JB, 1987, GENETICS, V117, P543; WALSH JB, 1995, GENETICS, V139, P421; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhao YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000472	72	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e38958	10.1371/journal.pone.0038958	http://dx.doi.org/10.1371/journal.pone.0038958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720000	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800031
J	Garma, L; Mukherjee, S; Mitra, P; Zhang, Y				Garma, Leonardo; Mukherjee, Srayanta; Mitra, Pralay; Zhang, Yang			How Many Protein-Protein Interactions Types Exist in Nature?	PLOS ONE			English	Article							STRUCTURE PREDICTION; MOLECULAR BIOLOGIST; FAMILIES; FOLDS; NUMBER; DOMAIN; CLASSIFICATION; INTERFACES; COMPLEXES; SEQUENCE	"Protein quaternary structure universe" refers to the ensemble of all protein-protein complexes across all organisms in nature. The number of quaternary folds thus corresponds to the number of ways proteins physically interact with other proteins. This study focuses on answering two basic questions: Whether the number of protein-protein interactions is limited and, if yes, how many different quaternary folds exist in nature. By all-to-all sequence and structure comparisons, we grouped the protein complexes in the protein data bank (PDB) into 3,629 families and 1,761 folds. A statistical model was introduced to obtain the quantitative relation between the numbers of quaternary families and quaternary folds in nature. The total number of possible protein-protein interactions was estimated around 4,000, which indicates that the current protein repository contains only 42% of quaternary folds in nature and a full coverage needs approximately a quarter century of experimental effort. The results have important implications to the protein complex structural modeling and the structure genomics of protein-protein interactions.	[Garma, Leonardo; Mukherjee, Srayanta; Mitra, Pralay; Zhang, Yang] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Garma, Leonardo] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Garma, Leonardo] Univ Oulu, Dept Biochem, Oulu, Finland	University of Michigan System; University of Michigan; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Garma, L (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	zhng@umich.edu	Mitra, Pralay/P-4207-2019; Mitra, Pralay/C-7221-2012	Mitra, Pralay/0000-0003-4119-3788; Garma, Leonardo Daniel/0000-0003-1220-8397	NSF (National Science Foundation) Career Award [DBI 1027394]; National Institute of General Medical Sciences [GM083107, GM084222]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084222, R01GM083107] Funding Source: NIH RePORTER	NSF (National Science Foundation) Career Award; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project is supported in part by the NSF (National Science Foundation) Career Award (DBI 1027394), and the National Institute of General Medical Sciences (GM083107, GM084222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Aloy P, 2005, CURR OPIN STRUC BIOL, V15, P15, DOI 10.1016/j.sbi.2005.01.012; Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Burley SK, 2008, STRUCTURE, V16, P5, DOI 10.1016/j.str.2007.12.002; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cramer H., 1946, MATH METHODS STAT; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Douguet D, 2006, BIOINFORMATICS, V22, P2612, DOI 10.1093/bioinformatics/btl447; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Kihara D, 2003, J MOL BIOL, V334, P793, DOI 10.1016/j.jmb.2003.10.027; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; Mitra P, 2011, STRUCTURE, V19, P304, DOI 10.1016/j.str.2011.01.009; Mukherjee S, 2009, NUCLEIC ACIDS RES, P1, DOI [10.1093/nar/gkp1318, DOI 10.1093/NAR/GKP1318]; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Sammut SJ, 2008, BRIEF BIOINFORM, V9, P210, DOI 10.1093/bib/bbn010; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Szilagyi A, 2005, PHYS BIOL, V2, pS1, DOI 10.1088/1478-3975/2/2/S01; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Vakser IA, 2008, STRUCTURE, V16, P1, DOI 10.1016/j.str.2007.12.005; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wolf YI, 2000, J MOL BIOL, V299, P897, DOI 10.1006/jmbi.2000.3786; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang CO, 1998, J MOL BIOL, V284, P1301, DOI 10.1006/jmbi.1998.2282; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	48	23	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38913	10.1371/journal.pone.0038913	http://dx.doi.org/10.1371/journal.pone.0038913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719985	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341900064
J	Yehezkel, G; Cohen, L; Kliger, A; Manor, E; Khalaila, I				Yehezkel, Galit; Cohen, Liz; Kliger, Adi; Manor, Esther; Khalaila, Isam			O-Linked beta-N-Acetylglucosaminylation (O-GlcNAcylation) in Primary and Metastatic Colorectal Cancer Clones and Effect of N-Acetyl-beta-D-glucosaminidase Silencing on Cell Phenotype and Transcriptome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; C-MYC; GLCNAC; GLYCOSYLATION; PROGRESSION; P53; CYTOKINESIS; METABOLISM; STABILITY; PATHWAYS	O-Linked beta-N-acetylglucosamine (O-GlcNAc) glycosylation is a regulatory post-translational modification occurring on the serine or threonine residues of nucleocytoplasmic proteins. O-GlcNAcylation is dynamically regulated by O-GlcNAc transferase and O-GlcNAcase (OGA), which are responsible for O-GlcNAc addition and removal, respectively. Although O-GlcNAcylation was found to play a significant role in several pathologies such as type II diabetes and neurodegenerative diseases, the role of O-GlcNAcylation in the etiology and progression of cancer remains vague. Here, we followed O-GlcNAcylation and its catalytic machinery in metastatic clones of human colorectal cancer and the effect of OGA knockdown on cellular phenotype and on the transcriptome. The colorectal cancer SW620 metastatic clone exhibited increased O-GlcNAcylation and decreased OGA expression compared with its primary clone, SW480. O-GlcNAcylation elevation in SW620 cells, through RNA interference of OGA, resulted in phenotypic alterations that included acquisition of a fibroblast-like morphology, which coincides with epithelial metastatic progression and growth retardation. Microarray analysis revealed that OGA silencing altered the expression of about 1300 genes, mostly involved in cell movement and growth, and specifically affected metabolic pathways of lipids and carbohydrates. These findings support the involvement of O-GlcNAcylation in various aspects of tumor cell physiology and suggest that this modification may serve as a link between metabolic changes and cancer.	[Yehezkel, Galit; Cohen, Liz; Kliger, Adi; Khalaila, Isam] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Fac Engn Sci, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Manor, Esther] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Inst Human Genet, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Khalaila, I (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Fac Engn Sci, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-84105 Beer Sheva, Israel.	isam@bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778	Israel Cancer Association; Israel Science Foundation [1287/08]; Kahanoff Foundation	Israel Cancer Association; Israel Science Foundation(Israel Science Foundation); Kahanoff Foundation	This work was supported by grants from the Israel Cancer Association and Israel Science Foundation Grant 1287/08.; Recipient of Ma'of Fellowship from the Kahanoff Foundation. To whom correspondence should be addressed. Tel.: 972-8-6461903; Fax: 972-8-6479074; E-mail: isam@bgu.ac.il.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Duranton B, 2003, AMINO ACIDS, V24, P63, DOI 10.1007/s00726-002-0333-5; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Gu YY, 2011, ARCH BIOCHEM BIOPHYS, V505, P98, DOI 10.1016/j.abb.2010.09.024; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hewitt RE, 2000, J PATHOL, V192, P446; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katayama M, 2006, SURG TODAY, V36, P1085, DOI 10.1007/s00595-006-3301-y; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Mandahl N, 1992, HUMAN CYTOGENETICS P, VII, P155; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Potter JD, 1999, JNCI-J NATL CANCER I, V91, P916, DOI 10.1093/jnci/91.11.916; Provenzani A, 2006, CARCINOGENESIS, V27, P1323, DOI 10.1093/carcin/bgi377; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Stichelen SOV, 2012, AM J PHYSIOL-ENDOC M, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wai PY, 2008, ONCOL REV, V2, P9, DOI 10.1007/s12156-008-0051-7; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; WICE BM, 1985, J BIOL CHEM, V260, P139; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999; ZIRVI KA, 1991, CANCER LETT, V60, P85, DOI 10.1016/0304-3835(91)90052-J	44	65	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					28755	28769		10.1074/jbc.M112.345546	http://dx.doi.org/10.1074/jbc.M112.345546			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22730328	Green Published, hybrid			2022-12-25	WOS:000308074600049
J	Hou, SW; Suresh, PS; Qi, XM; Lepp, A; Mirza, SP; Chen, G				Hou, Songwang; Suresh, Padmanaban S.; Qi, Xiaomei; Lepp, Adrienne; Mirza, Shama P.; Chen, Guan			p38 gamma Mitogen-activated Protein Kinase Signals through Phosphorylating Its Phosphatase PTPH1 in Regulating Ras Protein Oncogenesis and Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MAP KINASE; ESTROGEN-RECEPTOR; DIFFERENTIAL REGULATION; P38; PATHWAY; TRANSFORMATION; SUBSTRATE; P38-ALPHA; FEEDBACK	Phosphatase plays a crucial role in determining cellular fate by inactivating its substrate kinase, but it is not known whether a kinase can vice versa phosphorylate its phosphatase to execute this function. Protein-tyrosine phosphatase H1 (PTPH1) is a specific phosphatase of p38 gamma mitogen-activated protein kinase (MAPK) through PDZ binding, and here, we show that p38 gamma is also a PTPH1 kinase through which it executes its oncogenic activity and regulates stress response. PTPH1 was identified as a substrate of p38 gamma by unbiased proteomic analysis, and its resultant phosphorylation at Ser-459 occurs in vitro and in vivo through their complex formation. Genetic and pharmacological analyses showed further that Ser-459 phosphorylation is directly regulated by Ras signaling and is important for Ras, p38 gamma, and PTPH1 oncogenic activity. Moreover, experiments with physiological stimuli revealed a novel stress pathway from p38 gamma to PTPH1/Ser-459 phosphorylation in regulating cell growth and cell death by a mechanism dependent on cellular environments but independent of canonical MAPK activities. These results thus reveal a new mechanism by which a MAPK regulates Ras oncogenesis and stress response through directly phosphorylating its phosphatase.	[Hou, Songwang; Suresh, Padmanaban S.; Qi, Xiaomei; Lepp, Adrienne; Chen, Guan] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Mirza, Shama P.] Med Coll Wisconsin, Dept Biochem & Biotechnol, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Mirza, Shama P.] Med Coll Wisconsin, Ctr Bioengn, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Chen, Guan] Med Coll Wisconsin, Res Serv, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Zablocki Vet Affairs Med Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	gchen@mcw.edu	P.S, Suresh/AAX-9666-2020		National Institutes of Health [2R01 CA91576]; Department of Veterans Affairs Merit Review; Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House); NATIONAL CANCER INSTITUTE [R01CA091576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grant 2R01 CA91576. This work was also supported by a Department of Veterans Affairs Merit Review and the Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House)	Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Barr AJ, 2006, TRENDS PHARMACOL SCI, V27, P525, DOI 10.1016/j.tips.2006.08.005; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Hou S., 2010, UCSD NAT MOL PAGES, DOI 1038/mp.a001720.01; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Kalmes A, 1999, FEBS LETT, V444, P71, DOI 10.1016/S0014-5793(99)00034-4; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Lassar AB, 2009, J CELL BIOL, V187, P941, DOI 10.1083/jcb.200911123; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Lin YW, 2003, J BIOL CHEM, V278, P21534, DOI 10.1074/jbc.M301854200; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Meng FY, 2011, NEOPLASIA, V13, P472, DOI 10.1593/neo.101748; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Ozes O, 2008, United States Patent-US, P1, Patent No. [7,407,973, 7407973, US7407973B2]; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2012, J BIOL CHEM, V287, P14681, DOI 10.1074/jbc.M112.349357; Qi XM, 2011, J BIOL CHEM, V286, P35883, DOI 10.1074/jbc.M111.229260; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Sabio G, 2004, BIOCHEM J, V380, P19, DOI 10.1042/BJ20031628; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wu CC, 2010, PROTEIN CELL, V1, P573, DOI 10.1007/s13238-010-0075-1; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786; Zhi HY, 2011, ONCOGENE, V30, P1706, DOI 10.1038/onc.2010.543	52	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27895	27905		10.1074/jbc.M111.335794	http://dx.doi.org/10.1074/jbc.M111.335794			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22730326	hybrid, Green Published			2022-12-25	WOS:000307840700063
J	Stolovich-Rain, M; Hija, A; Grimsby, J; Glaser, B; Dor, Y				Stolovich-Rain, Miri; Hija, Ayat; Grimsby, Joseph; Glaser, Benjamin; Dor, Yuval			Pancreatic Beta Cells in Very Old Mice Retain Capacity for Compensatory Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT-MOUSE PANCREAS; PRIMARY MECHANISM; IN-VIVO; REGENERATION; AGE; REPLICATION; PROGENITORS; MASS; EXPRESSION; ENDOCRINE	Recent studies suggested that in old mice, beta cells lose their regenerative potential and cannot respond to mitogenic triggers. These studies examined beta cell replication in aged mice under basal conditions and in response to specific stimuli including treatment with the glucagon-like peptide-1 analog exenatide, streptozotocin injection, partial pancreatectomy, and high fat diet. However, it remains possible that the ability to mount a compensatory response of beta cells is retained in old age, but depends on the specific stimulus. Here, we asked whether partial ablation of beta cells in transgenic mice, using doxycycline-inducible expression of diphtheria toxin, triggers a significant compensatory proliferative response in 1-2-year-old animals. Consistent with previous reports, the basal rate of beta cell replication declines dramatically with age, averaging 0.1% in 2-year-old mice. Transient expression of diphtheria toxin in beta cells of old mice resulted in impaired glucose homeostasis and disruption of islet architecture (ratio of beta to alpha cells). Strikingly, the replication rate of surviving beta cells increased 3-fold over basal rate, similarly to the -fold increase in replication rate of beta cells in young transgenic mice. Islet architecture and glucose tolerance slowly normalized, indicating functional significance of compensatory beta cell replication in this setting. Finally, administration of a small molecule glucokinase activator to old mice doubled the frequency of beta cell replication, further showing that old beta cells can respond to the mitogenic trigger of enhanced glycolysis. We conclude that the potential for functionally significant compensatory proliferation of beta cells is retained in old mice, despite a decline in basal replication rate.	[Stolovich-Rain, Miri; Hija, Ayat; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada IMRIC, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Grimsby, Joseph] Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Serv Endocrinol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Roche Holding; Hebrew University of Jerusalem; Hadassah University Medical Center	Dor, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada IMRIC, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel.	yuvald@ekmd.huji.ac.il	Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000	National Institutes of Health Beta Cell Biology Consortium; Juvenile Diabetes Research Foundation; Helmsley Foundation; Dutch friends of Hebrew University; European Union [241883]; European Research Council; DON Foundation; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41.11]	National Institutes of Health Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Helmsley Foundation; Dutch friends of Hebrew University; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); DON Foundation; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This work was supported, in whole or in part, by the National Institutes of Health Beta Cell Biology Consortium. This work was also supported by grants from Juvenile Diabetes Research Foundation, the Helmsley Foundation, and the Dutch friends of Hebrew University, the European Union Seventh Framework Programme Grant 241883 and European Research Council, the DON Foundation, the I-CORE Program of the Planning and Budgeting Committee, and The Israel Science Foundation Grant 41.11 (to Y. D.).	Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen XJ, 2009, TRANSPLANTATION, V88, P496, DOI 10.1097/TP.0b013e3181b0d2ee; DECLERCQ L, 1988, MECH AGEING DEV, V43, P11, DOI 10.1016/0047-6374(88)90094-2; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Levitt HE, 2011, DIABETOLOGIA, V54, P572, DOI 10.1007/s00125-010-1919-1; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Wong ESM, 2009, DEV CELL, V17, P142, DOI 10.1016/j.devcel.2009.05.009; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	28	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27407	27414		10.1074/jbc.M112.350736	http://dx.doi.org/10.1074/jbc.M112.350736			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22740691	Green Published, hybrid			2022-12-25	WOS:000307840700012
J	Lazard, DS; Marozeau, J; McDermott, HJ				Lazard, Diane S.; Marozeau, Jeremy; McDermott, Hugh J.			The Sound Sensation of Apical Electric Stimulation in Cochlear Implant Recipients with Contralateral Residual Hearing	PLOS ONE			English	Article							PITCH COMPARISONS; ACOUSTIC MODELS; PERCEPTION; MUSIC	Background: Studies using vocoders as acoustic simulators of cochlear implants have generally focused on simulation of speech understanding, gender recognition, or music appreciation. The aim of the present experiment was to study the auditory sensation perceived by cochlear implant (CI) recipients with steady electrical stimulation on the most-apical electrode. Methodology/Principal Findings: Five unilateral CI users with contralateral residual hearing were asked to vary the parameters of an acoustic signal played to the non-implanted ear, in order to match its sensation to that of the electric stimulus. They also provided a rating of similarity between each acoustic sound they selected and the electric stimulus. On average across subjects, the sound rated as most similar was a complex signal with a concentration of energy around 523 Hz. This sound was inharmonic in 3 out of 5 subjects with a moderate, progressive increase in the spacing between the frequency components. Conclusions/Significance: For these subjects, the sound sensation created by steady electric stimulation on the most-apical electrode was neither a white noise nor a pure tone, but a complex signal with a progressive increase in the spacing between the frequency components in 3 out of 5 subjects. Knowing whether the inharmonic nature of the sound was related to the fact that the non-implanted ear was impaired has to be explored in single-sided deafened patients with a contralateral CI. These results may be used in the future to better understand peripheral and central auditory processing in relation to cochlear implants.	[Lazard, Diane S.; Marozeau, Jeremy; McDermott, Hugh J.] Bion Inst, Melbourne, Vic, Australia; [McDermott, Hugh J.] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia	Bionics Institute; University of Melbourne	Lazard, DS (corresponding author), Bion Inst, Melbourne, Vic, Australia.	dianelazard@yahoo.fr	Marozeau, Jeremy/AAA-1880-2021; Marozeau, Jeremy/E-9329-2017; Marozeau, Jeremy/L-2915-2019	Marozeau, Jeremy/0000-0002-4505-135X; Lazard, Diane/0000-0001-8329-1381	Fondation Bettencourt-Schueller; Cochlear(R) France; NHMRC [100882]; Victorian Lions Foundation; Cochlear France; Victorian Government	Fondation Bettencourt-Schueller; Cochlear(R) France; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Lions Foundation; Cochlear France; Victorian Government	Funding came from Fondation Bettencourt-Schueller, Cochlear (R) France, NHMRC Project Grant (No. 100882), and the Victorian Lions Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following conflicts: Cochlear France funded Diane Lazard's plane ticket to Australia. Cochlear France did not fund any other part of the research project, and did not participate in any stage of the project. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The authors acknowledge Bev Sheridan for her help in recruiting patients, and the subjects for their generous participation.	Blamey PJ, 1996, HEARING RES, V99, P139, DOI 10.1016/S0378-5955(96)00095-0; BLAMEY PJ, 1984, J ACOUST SOC AM, V76, P97, DOI 10.1121/1.391012; Boex C, 2006, JARO-J ASSOC RES OTO, V7, P110, DOI 10.1007/s10162-005-0027-2; BYRNE D, 1986, EAR HEARING, V7, P257, DOI 10.1097/00003446-198608000-00007; Carlyon RP, 2010, JARO-J ASSOC RES OTO, V11, P625, DOI 10.1007/s10162-010-0222-7; Deeks JM, 2004, J ACOUST SOC AM, V115, P1736, DOI 10.1121/1.1675814; Dorman MF, 1997, AM J OTOL, V18, pS113; Dorman MF, 2007, JARO-J ASSOC RES OTO, V8, P234, DOI 10.1007/s10162-007-0071-1; Eddington D K, 1978, Ann Otol Rhinol Laryngol, V87, P1; Fu QJ, 2005, J ACOUST SOC AM, V118, P1711, DOI 10.1121/1.1985024; Gfeller K, 2000, J Am Acad Audiol, V11, P390; Green T, 2011, INT J AUDIOL; Kovacic D, 2009, J ACOUST SOC AM, V126, P762, DOI 10.1121/1.3158855; Laneau J, 2006, J ACOUST SOC AM, V119, P491, DOI 10.1121/1.2133391; Leal MC, 2003, ACTA OTO-LARYNGOL, V123, P826, DOI 10.1080/00016480310000386; Loizou Philipos C, 2006, Adv Otorhinolaryngol, V64, P109, DOI 10.1159/000094648; Massida Z, 2011, HEARING RES, V275, P120, DOI 10.1016/j.heares.2010.12.010; McDermott H, 2009, AUDIOL NEURO-OTOL, V14, P2, DOI 10.1159/000206489; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; McKay CM, 1999, J ACOUST SOC AM, V105, P347, DOI 10.1121/1.424553; Moore BC., 1995, PERCEPTUAL CONSEQUEN, DOI 10.1093/acprof:oso/9780198523307.001.0001; Pressnitzer D, 2005, ANN NY ACAD SCI, V1060, P343, DOI 10.1196/annals.1360.050; Reiss LAJ, 2007, JARO-J ASSOC RES OTO, V8, P241, DOI 10.1007/s10162-007-0077-8; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Strydom T, 2011, J ACOUST SOC AM, V129, P920, DOI 10.1121/1.3518760	25	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38687	10.1371/journal.pone.0038687	http://dx.doi.org/10.1371/journal.pone.0038687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723876	Green Published, gold			2022-12-25	WOS:000305652700021
J	Gladwin, TE; Derks, EM; Rietschel, M; Mattheisen, M; Breuer, R; Schulze, TG; Nothen, MM; Levinson, D; Shi, JX; Gejman, PV; Cichon, S; Ophoff, RA				Gladwin, Thomas E.; Derks, Eske M.; Rietschel, Marcella; Mattheisen, Manuel; Breuer, Rene; Schulze, Thomas G.; Noethen, Markus M.; Levinson, Douglas; Shi, Jianxin; Gejman, Pablo V.; Cichon, Sven; Ophoff, Roel A.		Genetic Risk & Outcome Psychosis G	Segment-Wise Genome-Wide Association Analysis Identifies a Candidate Region Associated with Schizophrenia in Three Independent Samples	PLOS ONE			English	Article							COMMON VARIANTS	Recent studies suggest that variation in complex disorders (e.g., schizophrenia) is explained by a large number of genetic variants with small effect size (Odds Ratio similar to 1.05-1.1). The statistical power to detect these genetic variants in Genome Wide Association (GWA) studies with large numbers of cases and controls (similar to 15,000) is still low. As it will be difficult to further increase sample size, we decided to explore an alternative method for analyzing GWA data in a study of schizophrenia, dramatically reducing the number of statistical tests. The underlying hypothesis was that at least some of the genetic variants related to a common outcome are collocated in segments of chromosomes at a wider scale than single genes. Our approach was therefore to study the association between relatively large segments of DNA and disease status. An association test was performed for each SNP and the number of nominally significant tests in a segment was counted. We then performed a permutation-based binomial test to determine whether this region contained significantly more nominally significant SNPs than expected under the null hypothesis of no association, taking linkage into account. Genome Wide Association data of three independent schizophrenia case/control cohorts with European ancestry (Dutch, German, and US) using segments of DNA with variable length (2 to 32 Mbp) was analyzed. Using this approach we identified a region at chromosome 5q23.3-q31.3 (128-160 Mbp) that was significantly enriched with nominally associated SNPs in three independent case-control samples. We conclude that considering relatively wide segments of chromosomes may reveal reliable relationships between the genome and schizophrenia, suggesting novel methodological possibilities as well as raising theoretical questions.	[Gladwin, Thomas E.; Derks, Eske M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Rietschel, Marcella; Breuer, Rene; Schulze, Thomas G.] Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, Mannheim, Germany; [Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Mattheisen, Manuel] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Schulze, Thomas G.] Univ Gottingen, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-3400 Gottingen, Germany; [Levinson, Douglas] Stanford Univ, Dept Psychiat, Sch Med, Palo Alto, CA USA; [Shi, Jianxin] NCI, Bethesda, MD 20892 USA; [Gejman, Pablo V.] Northshore Univ Hlth Syst, Dept Psychiat & Behav Sci, Evanston, IL USA; [Gejman, Pablo V.] Univ Chicago, Evanston, IL USA; [Ophoff, Roel A.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA USA; [Gladwin, Thomas E.] Univ Amsterdam, Dept Dev Psychol, ADAPT Lab, Amsterdam, Netherlands; [Derks, Eske M.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Central Institute of Mental Health; University of Bonn; University of Bonn; University of Bonn; University of Gottingen; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NorthShore University Health System; University of Chicago; University of California System; University of California Los Angeles; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Gladwin, TE (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	e.m.derks@amc.uva.nl	Mattheisen, Manuel/B-4949-2012; Schulze, Thomas G/H-2157-2013; Gladwin, Thomas E./F-6685-2010; Myin-Germeys, Inez/L-5106-2014; Mattheisen, Manuel/S-3725-2019; van Os, Jim/C-2113-2014; Derks, Eske M/A-1652-2017; Cichon, Sven/H-8803-2013	Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Derks, Eske M/0000-0002-6292-6883; Cichon, Sven/0000-0002-9475-086X; Myin-Germeys, Inez/0000-0002-3731-4930; Nothen, Markus/0000-0002-8770-2464; Gladwin, Thomas/0000-0001-9538-6425; Bruggeman, Richard/0000-0002-3238-8471	NIMH [RO1 MHO78075]; Foundation for the National Institutes of Health; Dutch Health Research Council(ZON-MW) [10-000-1002]; EU; German Federal Ministry of Education and Research (BMBF); National Genome Research Network plus (NGFNplus); MooDS-Net [01GS08144, 01GS08147]; Alfried Krupp von Bohlen und Halbach-Stiftung; Netherlands Scientific Organization (NWO) [451-080-010, 480-05-003]; Academic Psychiatric Centre AMC, Amsterdam; Ingeest, Amsterdam; Arkin, Amsterdam; Dijk enDuin, Amsterdam; Rivierduinen, Amsterdam; ErasmusMC, Amsterdam; GGZ Noord HollandNoord, Amsterdam; University Medical Centre Utrecht, Utrecht; Altrecht, Utrecht; Symfora, Utrecht; Meerkanten, Utrecht; Riagg Amersfoort, Utrecht; Delta, Utrecht; University Medical CenterGroningen, Groningen; Lentis, Groningen; GGZ Friesland, Groningen; GGZ Drenthe, Groningen; Adhesie, Groningen; Mediant, Groningen; GGZ De Grote Rivieren, Groningen; Parnassia psycho-medical centre, Groningen; MaastrichtUniversity Medical Center, Maastricht; GGZ Eindhoven, Maastricht; GGZMidden-Brabant, Maastricht; GGZ Oost-Brabant, Maastricht; GGZ Noord-Midden Limburg, Maastricht; Mondriaan Zorggroep, Maastricht; Prins Claus-centrum Sittard, Maastricht; RIAGG Roermond, Maastricht; Universitair Centrum Sint-Jozef Kortenberg, Maastricht; CAPRI University ofAntwerp, Maastricht; PC Ziekeren Sint-Truiden, Maastricht; PZ Sancta MariaSint-Truiden, Maastricht; GGZ Overpelt, Maastricht; OPZ Rekem, Maastricht	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Health Research Council(ZON-MW)(Netherlands Organization for Health Research and Development); EU(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); MooDS-Net; Alfried Krupp von Bohlen und Halbach-Stiftung; Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Academic Psychiatric Centre AMC, Amsterdam; Ingeest, Amsterdam; Arkin, Amsterdam; Dijk enDuin, Amsterdam; Rivierduinen, Amsterdam; ErasmusMC, Amsterdam; GGZ Noord HollandNoord, Amsterdam; University Medical Centre Utrecht, Utrecht; Altrecht, Utrecht; Symfora, Utrecht; Meerkanten, Utrecht; Riagg Amersfoort, Utrecht; Delta, Utrecht; University Medical CenterGroningen, Groningen; Lentis, Groningen; GGZ Friesland, Groningen; GGZ Drenthe, Groningen; Adhesie, Groningen; Mediant, Groningen; GGZ De Grote Rivieren, Groningen; Parnassia psycho-medical centre, Groningen; MaastrichtUniversity Medical Center, Maastricht; GGZ Eindhoven, Maastricht; GGZMidden-Brabant, Maastricht; GGZ Oost-Brabant, Maastricht; GGZ Noord-Midden Limburg, Maastricht; Mondriaan Zorggroep, Maastricht; Prins Claus-centrum Sittard, Maastricht; RIAGG Roermond, Maastricht; Universitair Centrum Sint-Jozef Kortenberg, Maastricht; CAPRI University ofAntwerp, Maastricht; PC Ziekeren Sint-Truiden, Maastricht; PZ Sancta MariaSint-Truiden, Maastricht; GGZ Overpelt, Maastricht; OPZ Rekem, Maastricht	Genotyping of the Dutch samples was sponsored by NIMH funding, RO1 MHO78075 (to R.A.O.). Funding support for Linking Genome-Wide Association Study of Schizophrenia was provided by Foundation for the National Institutes of Health and the genotyping of samples was provided through the Genetic Association Information Network (GAIN). The dataset used for the analyses described in this manuscript was obtained from the GAIN Database found at http://view.ncbi.nlm.nih.gov/dbgap-controlled through dbGaP accession number phs000021. The GROUP study was supported by the Geestkrachtprogramme of the Dutch Health Research Council(ZON-MW, grant number 10-000-1002); the EU Seventh Framework Programme (consortium name: EU-GEI)and matching funds from participating universities andmental health care organizations (Site Amsterdam: Academic Psychiatric Centre AMC, Ingeest, Arkin, Dijk enDuin, Rivierduinen, ErasmusMC, GGZ Noord HollandNoord; Site Utrecht: University Medical Centre Utrecht, Altrecht, Symfora, Meerkanten, Riagg Amersfoort, Delta; Site Groningen: University Medical CenterGroningen, Lentis, GGZ Friesland, GGZ Drenthe, Adhesie, Mediant, GGZ De Grote Rivieren and Parnassia psycho-medical centre; Site Maastricht: MaastrichtUniversity Medical Center, GGZ Eindhoven, GGZMidden-Brabant, GGZ Oost-Brabant, GGZ Noord-Midden Limburg, Mondriaan Zorggroep, Prins Claus-centrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University ofAntwerp, PC Ziekeren Sint-Truiden, PZ Sancta MariaSint-Truiden, GGZ Overpelt, OPZ Rekem). The German genome-wide association study of schizophrenia was supported by the German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network plus (NGFNplus), and the MooDS-Net (grant 01GS08144 to S.C. and M.M.N., grant 01GS08147 to M.R.). M.M.N. also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. German control genotypes were derived from community-based cohorts collected in the framework of the PopGen (Dr. Stefan Schreiber. Kiel), KORA (Dr. H.-Erich Wichmann, Munich), and Heinz-Nixdorf-Recall (Dr. Susanne Moebus, Essen) studies. PopGen and KORA controls were made available to participants of NGFNplus for use as universal controls in genetic studies of the funded disease phenotypes. Dr. E.M. Derks is supported by the Netherlands Scientific Organization (NWO; project number 451-080-010). Statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org) which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Chen YH, 2009, SCHIZOPHR RES, V108, P191, DOI 10.1016/j.schres.2008.12.021; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fernandez-Egea E, 2008, SCHIZOPHR RES, V103, P110, DOI 10.1016/j.schres.2008.04.017; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Woo YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012158	19	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38828	10.1371/journal.pone.0038828	http://dx.doi.org/10.1371/journal.pone.0038828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723893	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300057
J	Palmer, CNA; Maglio, C; Pirazzi, C; Burza, MA; Adiels, M; Burch, L; Donnelly, LA; Colhoun, H; Doney, AS; Dillon, JF; Pearson, ER; McCarthy, M; Hattersley, AT; Frayling, T; Morris, AD; Peltonen, M; Svensson, PA; Jacobson, P; Boren, J; Sjostrom, L; Carlsson, LMS; Romeo, S				Palmer, Colin N. A.; Maglio, Cristina; Pirazzi, Carlo; Burza, Maria Antonella; Adiels, Martin; Burch, Lindsay; Donnelly, Louise A.; Colhoun, Helen; Doney, Alexander S.; Dillon, John F.; Pearson, Ewan R.; McCarthy, Mark; Hattersley, Andrew T.; Frayling, Tim; Morris, Andrew D.; Peltonen, Markku; Svensson, Per-Arne; Jacobson, Peter; Boren, Jan; Sjostrom, Lars; Carlsson, Lena M. S.; Romeo, Stefano			Paradoxical Lower Serum Triglyceride Levels and Higher Type 2 Diabetes Mellitus Susceptibility in Obese Individuals with the PNPLA3 148M Variant	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DOMAIN-CONTAINING 3; INSULIN-RESISTANCE; FASTING GLUCOSE; I148M; RISK; ASSOCIATION; ADIPONUTRIN; LOCI; GENE	Background: Obesity is highly associated with elevated serum triglycerides, hepatic steatosis and type 2 diabetes (T2D). The I148M (rs738409) genetic variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is known to modulate hepatic triglyceride accumulation, leading to steatosis. No association between PNPLA3 I148M genotype and T2D in Europeans has been reported. Aim of this study is to examine the relationship between PNPLA3 I148M genotypes and serum triglycerides, insulin resistance and T2D susceptibility by testing a gene-environment interaction model with severe obesity. Methods and Findings: PNPLA3 I148M was genotyped in a large obese cohort, the SOS study (n = 3,473) and in the Go-DARTS (n = 15,448), a T2D case-control study. Metabolic parameters were examined across the PNPLA3 I148M genotypes in participants of the SOS study at baseline and at 2- and 10-year follow up after bariatric surgery or conventional therapy. The associations with metabolic parameters were validated in the Go-DARTS study. Serum triglycerides were found to be lower in the PNPLA3 148M carriers from the SOS study at baseline and from the Go-DARTS T2D cohort. An increased risk for T2D conferred by the 148M allele was found in the SOS study (O.R. 1.09, 95% C.I. 1.01-1.39, P = 0.040) and in severely obese individuals in the Go-DARTS study (O. R. 1.37, 95% C.I. 1.13-1.66, P = 0.001). The 148M allele was no longer associated with insulin resistance or T2D after bariatric surgery in the SOS study and no association with the 148M allele was observed in the less obese (BMI<35) individuals in the Go-DARTS study (P for interaction = 0.002). This provides evidence for the obesity interaction with 148M allele and T2D risk in a large-scale cross-sectional and a prospective interventional study. Conclusions: Severely obese individuals carrying the PNPLA3 148M allele have lower serum triglyceride levels, are more insulin resistant and more susceptible to T2D. This study supports the hypothesis that obesity-driven hepatic lipid accumulation may contribute to T2D susceptibility.	[Palmer, Colin N. A.; Burch, Lindsay; Donnelly, Louise A.; Colhoun, Helen; Doney, Alexander S.; Dillon, John F.; Pearson, Ewan R.; Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Maglio, Cristina; Pirazzi, Carlo; Burza, Maria Antonella; Adiels, Martin; Svensson, Per-Arne; Jacobson, Peter; Boren, Jan; Sjostrom, Lars; Carlsson, Lena M. S.; Romeo, Stefano] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Maglio, Cristina; Pirazzi, Carlo; Burza, Maria Antonella; Adiels, Martin; Svensson, Per-Arne; Jacobson, Peter; Boren, Jan; Sjostrom, Lars; Carlsson, Lena M. S.; Romeo, Stefano] Univ Gothenburg, Sahlgrenska Acad, Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [McCarthy, Mark] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Hattersley, Andrew T.; Frayling, Tim] Univ Exeter, Peninsula Coll Med & Dent, Peninsula NIHR Clin Res Facil, Exeter, Devon, England; [Peltonen, Markku] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Romeo, Stefano] Univ Catanzaro, Dept Clin & Expt Med, Catanzaro, Italy	University of Dundee; University of Gothenburg; University of Gothenburg; University of Oxford; University of Exeter; University of Plymouth; Finland National Institute for Health & Welfare; Magna Graecia University of Catanzaro	Palmer, CNA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland.	stefano.romeo@wlab.gu.se	Peltonen, Markku/F-3037-2015; Maglio, Cristina/AAN-6004-2021; Romeo, Stefano/L-6861-2015; Svensson, Per-Arne/R-4626-2019; Study, GoDARTS/K-9448-2016; Doney, Alexander SF/P-7437-2017; Palmer, Colin NA/C-7053-2008; Carlsson, Lena/F-7570-2018; McCarthy, Mark/M-3763-2015	Peltonen, Markku/0000-0002-3767-4223; Romeo, Stefano/0000-0001-9168-4898; Doney, Alexander SF/0000-0002-6210-5620; Palmer, Colin NA/0000-0002-6415-6560; Carlsson, Lena/0000-0003-4145-6242; Jacobson, Peter/0000-0002-1769-1827; Dillon, John/0000-0002-2164-4476; Maglio, Cristina/0000-0002-3786-5767; Colhoun, Helen/0000-0002-8345-3288; Pearson, Ewan/0000-0001-9237-8585; McCarthy, Mark/0000-0002-4393-0510; Hattersley, Andrew/0000-0001-5620-473X; Svensson, Per-Arne/0000-0002-6731-806X	Swedish Research Council [K2010-55X-11285-13, K2008-65X-20753-01-04]; Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research; Swedish federal government under the LUA/ALF agreement; Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (Go-DARTS); Scottish Health Informatics Programme; Chief Scientist Office of Scotland; UK Medical Research Council [G0601261]; Medical Research Council [G0601261] Funding Source: researchfish; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish; MRC [G0601261] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research(Swedish Foundation for Strategic Research); Swedish federal government under the LUA/ALF agreement; Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (Go-DARTS); Scottish Health Informatics Programme; Chief Scientist Office of Scotland; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the Swedish Research Council (K2010-55X-11285-13, K2008-65X-20753-01-04), the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research and the Swedish federal government under the LUA/ALF agreement. The strategic initiative for foreigner researchers from the Institute of Medicine at the University of Gothenburg supported Cristina Maglio and Carlo Pirazzi. The Wellcome Trust provides support for Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (Go-DARTS) and the Scottish Health Informatics Programme. Further informatics support is provided by the Chief Scientist Office of Scotland. This work was also supported by the UK Medical Research Council (G0601261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2007, DIABETOLOGIA, V50, P2356, DOI 10.1007/s00125-007-0790-1; Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Browning JD, 2010, HEPATOLOGY, V52, P1189, DOI 10.1002/hep.23946; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; del Giudice EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027933; Doney ASF, 2005, CIRCULATION, V111, P2927, DOI 10.1161/CIRCULATIONAHA.104.509224; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Goran MI, 2010, DIABETES, V59, P3127, DOI 10.2337/db10-0554; GOTTO AM, 1986, METHOD ENZYMOL, V128, P3; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Kollerits B, 2009, HUM MOL GENET, V18, P4669, DOI 10.1093/hmg/ddp424; Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Krawczyk M, 2011, J PHYSIOL PHARMACOL, V62, P369; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Palmer CNA, 2010, DIABETES, V59, P2945, DOI 10.2337/db09-1690; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang CW, 2011, LIVER INT, V31, P1326, DOI 10.1111/j.1478-3231.2011.02526.x; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	36	72	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39362	10.1371/journal.pone.0039362	http://dx.doi.org/10.1371/journal.pone.0039362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22724004	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300138
J	Park, SO; Kumar, M; Gupta, S				Park, Sun O.; Kumar, Mukesh; Gupta, Sanjeev			TGF-beta and Iron Differently Alter HBV Replication in Human Hepatocytes through TGF-beta/BMP Signaling and Cellular MicroRNA Expression	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CONSERVED RNA SEQUENCE; TRANSGENIC MICE; SURFACE-ANTIGEN; VIRAL-DNA; CELLS; INHIBITION; HEPCIDIN; PARTICLES; PATHWAYS	The nature of host-virus interactions in hepatitis B virus infection is incompletely understood. Since soluble factors, e.g., cytokines and metals, may exacerbate liver injury in chronic hepatitis, we considered that defining the effects of receptor-mediated signaling upon viral replication will be significant. Consequently, we studied effects of iron or TGF-beta-induced TGF-beta/BMP signaling in the HepG2 2.2.15 cell model of hepatitis B virus replication. We found iron and TGF-beta increased hepcidin mRNA expression or TGF-beta receptor kinase activity, respectively, which indicated that 2.2.15 cells responded appropriately to these substances. However, iron increased but TGF-beta decreased hepatitis B virus mRNA and DNA expression. TGF-beta-induced expression at the mRNA level of multiple TGF-beta/BMP pathway genes. This change was not observed in iron-treated cells. On the other hand, presence of SMAD proteins in iron or TGF-beta-treated cells, including of SMAD4, did confirm convergence of TGF-beta/BMP signaling pathways under these conditions. Since transcription factors in TGF-beta/BMP signaling pathways could not have directly targeted hepatitis B virus itself, we studied whether iron or TGF-beta exerted their effects through alternative mechanisms, such as by involvement of antiviral cellular microRNAs. We discovered cellular microRNA expression profiles were significantly different in iron or TGF-beta-treated cells compared with untreated control cells. In many cases, exposure to iron or TGF-beta changed microRNA expression in opposite directions. Introduction in cells of sequences representing such differentially expressed microRNAs, e.g., hsa-miR-125a-5p and -151-5p, even reproduced effects on virus replication of iron- or TGF-beta. We surmised that TGF-beta/BMP pathway members, i.e., SMADs, likely governed iron or TGF-beta-induced microRNA expression. Iron may have mediated Drosha/DGCR8/heme-mediated processing of microRNAs. In turn, cellular microRNAs regulated replication of hepatitis B virus in iron or TGF-beta-treated cells. This knowledge should advance studies of mechanisms in viral-host interactions, hepatic injury, and therapeutic developments for hepatitis B.	[Park, Sun O.; Kumar, Mukesh; Gupta, Sanjeev] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Gupta, Sanjeev] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Gupta, Sanjeev] Ruth L & David S Gottesman Inst Stem Cell & Regen, Diabet Res Ctr, Ctr Canc, Marion Bessin Liver Res Ctr, Bronx, NY USA; [Gupta, Sanjeev] Inst Clin & Translat Res, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Park, SO (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	sanjeev.gupta@einstein.yu.edu			National Institutes of Health [R01 DK071111, R01 DK088561, P30 DK41296, P30 CA13330, T32 DK007218-35]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007218, P30DK041296, R01DK071111, R01DK088561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These investigators were supported in part by National Institutes of Health grants R01 DK071111, R01 DK088561, P30 DK41296, P30 CA13330, and T32 DK007218-35. The funding provided partial salary support and core services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no other external funding sources for this study.	Barr I, 2012, P NATL ACAD SCI USA, V109, P1919, DOI 10.1073/pnas.1114514109; Bartolomei G, 2011, J GEN VIROL, V92, P2072, DOI 10.1099/vir.0.032706-0; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Cavanaugh VJ, 1997, J VIROL, V71, P3236, DOI 10.1128/JVI.71.4.3236-3243.1997; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Chou YC, 2007, HEPATOLOGY, V46, P672, DOI 10.1002/hep.21726; Chouteau P, 2001, J HEPATOL, V34, P108, DOI 10.1016/S0168-8278(00)00012-X; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis-Dusenbery BN, 2011, RNA BIOL, V8, P71, DOI 10.4161/rna.8.1.14299; DUBOIS MF, 1980, P NATL ACAD SCI-BIOL, V77, P4549, DOI 10.1073/pnas.77.8.4549; Fein E, 2007, PEPTIDES, V28, P951, DOI 10.1016/j.peptides.2007.01.016; FELTON C, 1979, P NATL ACAD SCI USA, V76, P2438, DOI 10.1073/pnas.76.5.2438; Goodnough JB, 2012, HEPATOLOGY, DOI [10.1002/hep.25615, DOI 10.1002/HEP.25615.]; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kimura K, 2002, J VIROL, V76, P10702, DOI 10.1128/JVI.76.21.10702-10707.2002; Kumar M, 2012, ANTIVIR THER, V17, P519, DOI 10.3851/IMP2014; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Liu AM, 2011, OMICS, V15, P187, DOI 10.1089/omi.2010.0098; Masihi KN, 2011, INFECT DIS CLIN N AM, V25, P723, DOI 10.1016/j.idc.2011.07.002; Murakami M, 2009, GENES CELLS, V14, P469, DOI 10.1111/j.1365-2443.2009.01283.x; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Park IH, 2011, MOL CELLS, V32, P167, DOI 10.1007/s10059-011-1059-6; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Robek MD, 2004, P NATL ACAD SCI USA, V101, P1743, DOI 10.1073/pnas.0308340100; Sebastiani G, 2012, J VIRAL HEPATITIS, V19, pE170, DOI 10.1111/j.1365-2893.2011.01508.x; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008	30	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39276	10.1371/journal.pone.0039276	http://dx.doi.org/10.1371/journal.pone.0039276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723983	Green Published, Green Submitted, gold			2022-12-25	WOS:000305583300124
J	Pan, CY; Chen, H; Wang, LH; Yang, SS; Fu, HL; Zheng, YX; Miao, MY; Jiao, BH				Pan, Chuanyong; Chen, Huan; Wang, Lianghua; Yang, Shengsheng; Fu, Hailong; Zheng, Yongxia; Miao, Mingyong; Jiao, Binghua			Down-Regulation of MiR-127 Facilitates Hepatocyte Proliferation during Rat Liver Regeneration	PLOS ONE			English	Article							CENTER B-CELLS; PARTIAL-HEPATECTOMY; GENE-EXPRESSION; HISTONE METHYLTRANSFERASE; MICRORNA EXPRESSION; S-PHASE; P53; METHYLATION; BCL6; MICE	Liver regeneration (LR) after partial hepatectomy (PH) involves the proliferation and apoptosis of hepatocytes, and microRNAs have been shown to post-transcriptionally regulate genes involved in the regulation of these processes. To explore the role of miR-127 during LR, the expression patterns of miR-127 and its related proteins were investigated. MiR-127 was introduced into a rat liver cell line to examine its effects on the potential target genes Bcl6 and Setd8, and functional studies were undertaken. We discovered that miR-127 was down-regulated and inversely correlated with the expression of Bcl6 and Setd8 at 24 hours after PH, a time at which hypermethylation of the promoter region of the miR-127 gene was detected. Furthermore, in BRL-3A rat liver cells, we observed that overexpression of miR-127 significantly suppressed cell growth and directly inhibited the expression of Bcl6 and Setd8. The results suggest that down-regulation of miR-127 may be due to the rapid methylation of its promoter during the first 24 h after PH, and this event facilitates hepatocyte proliferation by releasing Bcl6 and Setd8. These findings support a miRNA-mediated negative regulation pattern in LR and implicate an anti-proliferative role for miR-127 in liver cells.	[Pan, Chuanyong; Chen, Huan; Wang, Lianghua; Yang, Shengsheng; Zheng, Yongxia; Miao, Mingyong; Jiao, Binghua] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China; [Fu, Hailong] Second Mil Med Univ, Changzheng Hosp, Dept Anaesthesiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Pan, CY (corresponding author), Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China.	miaomy@163.com; jiaobh@live.cn		Chen, Huan/0000-0001-8648-1631	Basic Research Program of Science and Technology Commission Foundation of Shanghai [10JC1417400]; National Natural Science Foundation of China [30800553]	Basic Research Program of Science and Technology Commission Foundation of Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Basic Research Program of Science and Technology Commission Foundation of Shanghai (No. 10JC1417400) to M.Y.M. and the National Natural Science Foundation of China (No. 30800553) to H.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Chen XL, 2011, TRANSPLANTATION, V91, P293, DOI 10.1097/TP.0b013e318204756c; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Eipel C, 2005, J HEPATOL, V43, P829, DOI 10.1016/j.jhep.2005.04.018; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; KOCH KS, 1979, CELL, V18, P153, DOI 10.1016/0092-8674(79)90364-7; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li TT, 2010, MOL GENET GENOMICS, V283, P485, DOI 10.1007/s00438-010-0530-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Margalit O, 2006, BLOOD, V107, P1599, DOI 10.1182/blood-2005-04-1629; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Pager CT, 2009, PROG MOL BIOL TRANSL, V90, P187, DOI 10.1016/S1877-1173(09)90005-9; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Port JD, 2010, J CARDIOVASC PHARM, V56, P444, DOI 10.1097/FJC.0b013e3181f605b6; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shu JM, 2011, HEPATOLOGY, V54, P609, DOI 10.1002/hep.24421; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; THOMPSON NL, 1986, CANCER RES, V46, P3111; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Zimmermann A, 2004, NEPHROL DIAL TRANSPL, V19, P6, DOI 10.1093/ndt/gfh1034	40	52	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39151	10.1371/journal.pone.0039151	http://dx.doi.org/10.1371/journal.pone.0039151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720056	Green Submitted, gold, Green Published			2022-12-25	WOS:000305350000043
J	Liu, T; Xu, YY; Sun, DP; Xie, LX				Liu, Ting; Xu, Yuanyuan; Sun, Dapeng; Xie, Lixin			Histological Evaluation of Corneal Scar Formation in Pseudophakic Bullous Keratopathy	PLOS ONE			English	Article							LAMELLAR ENDOTHELIAL KERATOPLASTY; LASER CONFOCAL MICROSCOPY; TISSUE GROWTH-FACTOR; PENETRATING KERATOPLASTY; EXTRACELLULAR-MATRIX; EXPRESSION; COLLAGEN; CTGF	Purpose: To evaluate histological changes in the corneal stroma in pseudophakic bullous keratopathy. Methods: Twenty-eight patients (28 eyes) with pseudophakic bullous keratopathy underwent therapeutic penetrating keratoplasty at Shandong Eye Institute between January 2006 and November 2011. The patients were divided into two groups according to the duration of bullous keratopathy (<1.0 year group or >1.0 year group), and three buttons from enucleated eyes with choroidal melanoma served as a control. In vivo confocal microscopy examination, hematoxylin-eosin, Masson's trichrome stain and Van Gieson staining were used for microscopic examination. The histological evaluation and scoring of the buttons for morphological changes, including the degree of stromal scars, neovascularization and inflammatory cells within the corneal buttons, were compared. To study the underlying mechanism, connective tissue growth factor (CTGF) and TGF-beta immunohistochemistry were performed. Results: Confocal microscopy examination and histological evaluation and scoring of the buttons showed that compared with the <1.0 year group, stromal scars, neovascularization and inflammatory cells were more severe in the >1.0 year group (P < 0.05). There was an increase in CTGF-and TGF-beta 1-positive stromal cells in the >1.0 year group. Conclusions: During the progression of pseudophakic bullous keratopathy, stromal scars occurred more often in the patients that had a longer duration of disease. Cytokines such as CTGF and TGF-beta 1 may play a role in this pathological process and deserve further investigation.	[Liu, Ting; Xu, Yuanyuan; Sun, Dapeng; Xie, Lixin] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Liu, T (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China.	lixin_xie@yahoo.com	Xie, li/HGE-6052-2022		Research Fund for the Doctoral Program of Higher Education of China [20113706110004]; National Natural Science Foundation of China [30901636]; Foundation of Province of state key laboratory cultivation base construction [SDYK-KF-2010-6]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Province of state key laboratory cultivation base construction	Research was supported by the Research Fund for the Doctoral Program of Higher Education of China (No. 20113706110004), National Natural Science Foundation of China (No. 30901636) and the Foundation of Province of state key laboratory cultivation base construction (No. SDYK-KF-2010-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Basak SK, 2008, INDIAN J OPHTHALMOL, V56, P291, DOI 10.4103/0301-4738.41412; Blalock TD, 2003, INVEST OPHTH VIS SCI, V44, P1879, DOI 10.1167/iovs.02-0860; Chiou AGY, 1998, CORNEA, V17, P669, DOI 10.1097/00003226-199811000-00016; Garrett Q, 2004, INVEST OPHTH VIS SCI, V45, P1109, DOI 10.1167/iovs.03-0660; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Glasgow BJ, 2009, INVEST OPHTH VIS SCI, V50, P4060, DOI 10.1167/iovs.08-3361; Heidemann DG, 2008, CORNEA, V27, P161, DOI 10.1097/ICO.0b013e31815b8304; Hillenaar T, 2010, OPHTHALMOLOGY, V117, P2255, DOI 10.1016/j.ophtha.2010.03.047; KENNEY MC, 1990, CORNEA, V9, P115; Khor WB, 2011, AM J OPHTHALMOL, V151, P223, DOI 10.1016/j.ajo.2010.08.027; Kobayashi A, 2008, AM J OPHTHALMOL, V145, P977, DOI 10.1016/j.ajo.2008.02.009; Kobayashi A, 2009, OPHTHALMOLOGY, V116, P1306, DOI 10.1016/j.ophtha.2009.01.053; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; LIU GJ, 1993, JPN J OPHTHALMOL, V37, P414; Ljubimov AV, 1996, INVEST OPHTH VIS SCI, V37, P997; Mashor RS, 2010, OPHTHALMOLOGY, V117, P680, DOI 10.1016/j.ophtha.2009.12.039; Price MO, 2007, CURR OPIN OPHTHALMOL, V18, P290, DOI 10.1097/ICU.0b013e3281a4775b; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Rose L, 2009, CAN J OPHTHALMOL, V44, P401, DOI 10.3129/i09-090; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Strzalka-Mrozik B, 2010, MOL VIS, V16, P161; Tall EG, 2010, INVEST OPHTH VIS SCI, V51, P5002, DOI 10.1167/iovs.09-5110; Wunderlich K, 2000, OPHTHALMOLOGICA, V214, P341, DOI 10.1159/000027517; Xie LX, 2007, CORNEA, V26, P158, DOI 10.1097/01.ico.0000248381.24519.0d; Yang M, 2010, CORNEA, V29, P108, DOI 10.1097/ICO.0b013e3181a3c516	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39201	10.1371/journal.pone.0039201	http://dx.doi.org/10.1371/journal.pone.0039201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720074	Green Published, Green Submitted, gold			2022-12-25	WOS:000305347800056
J	Wu, ST; Li, CJ; Huang, W; Li, WZ; Li, RW				Wu, Sitao; Li, Congjun; Huang, Wen; Li, Weizhong; Li, Robert W.			Alternative Splicing Regulated by Butyrate in Bovine Epithelial Cells	PLOS ONE			English	Article							HISTONE DEACETYLASES; GENE FUSION; PROHIBITIN; TRANSCRIPTION; INHIBITORS; VARIANTS; SIRTUINS; TARGET	As a signaling molecule and an inhibitor of histone deacetylases (HDACs), butyrate exerts its impact on a broad range of biological processes, such as apoptosis and cell proliferation, in addition to its critical role in energy metabolism in ruminants. This study examined the effect of butyrate on alternative splicing in bovine epithelial cells using RNA-seq technology. Junction reads account for 11.28 and 12.32% of total mapped reads between the butyrate-treated (BT) and control (CT) groups. 201,326 potential splicing junctions detected were supported by >= 3 junction reads. Approximately 94% of these junctions conformed to the consensus sequence (GT/AG) while similar to 3% were GC/AG junctions. No AT/AC junctions were observed. A total of 2,834 exon skipping events, supported by a minimum of 3 junction reads, were detected. At least 7 genes, their mRNA expression significantly affected by butyrate, also had exon skipping events differentially regulated by butyrate. Furthermore, COL5A3, which was induced 310-fold by butyrate (FDR <0.001) at the gene level, had a significantly higher number of junction reads mapped to Exon#8 (Donor) and Exon#11 (Acceptor) in BT. This event had the potential to result in the formation of a COL5A3 mRNA isoform with 2 of the 69 exons missing. In addition, 216 differentially expressed transcript isoforms regulated by butyrate were detected. For example, Isoform 1 of ORC1 was strongly repressed by butyrate while Isoform 2 remained unchanged. Butyrate physically binds to and inhibits all zinc-dependent HDACs except HDAC6 and HDAC10. Our results provided evidence that butyrate also regulated deacetylase activities of classical HDACs via its transcriptional control. Moreover, thirteen gene fusion events differentially affected by butyrate were identified. Our results provided a snapshot into complex transcriptome dynamics regulated by butyrate, which will facilitate our understanding of the biological effects of butyrate and other HDAC inhibitors.	[Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA; [Li, Congjun; Li, Robert W.] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Huang, Wen] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of California System; University of California San Diego; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University	Wu, ST (corresponding author), Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA.	robert.li@ars.usda.gov	Huang, Wen/B-5005-2011; Li, Weizhong/A-9735-2008; Li, Cong-jun/J-8572-2014	Li, Weizhong/0000-0003-1804-9403; Li, Cong-jun/0000-0003-1389-9820; Huang, Wen/0000-0001-6788-8364	National Human Genome Research Institute (NHGRI) [R01HG005978]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was partly supported by Award R01HG005978 to WL from the National Human Genome Research Institute (NHGRI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Baldwin RLV, 2012, QUANTIFICATION UNPUB; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Carafa V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00004; Churbanov A, 2008, BIOL DIRECT, V3, P1, DOI 10.1186/1745-6150-3-30; Ciura J, 2010, MOL BIOL REP, V37, P3729, DOI 10.1007/s11033-010-0026-1; Corbi Graziamaria, 2012, Front Biosci (Elite Ed), V4, P768; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Daly K, 2006, DNA CELL BIOL, V25, P49, DOI 10.1089/dna.2006.25.49; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Hnilicova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016727; Jupe ER, 1996, EXP CELL RES, V224, P128, DOI 10.1006/excr.1996.0120; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kinsella M, 2011, BIOINFORMATICS, V27, P1068, DOI 10.1093/bioinformatics/btr085; KRUPITZA G, 1995, CARCINOGENESIS, V16, P1199; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Lee H, 2010, INT J BIOL MACROMOL, V47, P685, DOI 10.1016/j.ijbiomac.2010.08.018; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li CJ, 2008, GENE REGUL SYST BIO, V2, P113; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-114; Li RW, 2011, FUNCTIONAL INTEGRATI; Murray JI, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r97; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Nissim-Rafinia M, 2004, EMBO REP, V5, P1071, DOI 10.1038/sj.embor.7400273; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Puppin C, 2011, ONCOL REP, V25, P393, DOI 10.3892/or.2010.1075; Ranganna K, 2003, MOL CELL BIOCHEM, V254, P21, DOI 10.1023/A:1027383710582; Schemies J, 2010, MED RES REV, V30, P861, DOI 10.1002/med.20178; Shin JH, 2012, FUNCT INTEGR GENOMIC, V12, P119, DOI 10.1007/s10142-012-0263-6; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Tazi J, 2010, FEBS J, V277, P867, DOI 10.1111/j.1742-4658.2009.07522.x; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Will C. L., 2011, COLD SPRING HARBOR P, V3, ppii; Wu S, 2012, TRANSCRIPTOME UNPUB; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	45	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2012	7	6							e39182	10.1371/journal.pone.0039182	http://dx.doi.org/10.1371/journal.pone.0039182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WG	22720068	Green Submitted, gold, Green Published			2022-12-25	WOS:000305347800053
J	Iwamori, N; Iwamori, T; Matzuk, MM				Iwamori, Naoki; Iwamori, Tokuko; Matzuk, Martin M.			Characterization of Spermatogonial Stem Cells Lacking Intercellular Bridges and Genetic Replacement of a Mutation in Spermatogonial Stem Cells	PLOS ONE			English	Article							MALE GERM-CELLS; SELF-RENEWAL; UNDIFFERENTIATED SPERMATOGONIA; NUCLEAR TRANSPLANTATION; SEMINIFEROUS TUBULES; MOUSE TESTES; MICE; SPERMATOGENESIS; EXPRESSION; PROTEIN	Stem cells have a potential of gene therapy for regenerative medicine. Among various stem cells, spermatogonial stem cells have a unique characteristic in which neighboring cells can be connected by intercellular bridges. However, the roles of intercellular bridges for stem cell self-renewal, differentiation, and proliferation remain to be elucidated. Here, we show not only the characteristics of testis-expressed gene 14 (TEX14) null spermatogonial stem cells lacking intercellular bridges but also a trial application of genetic correction of a mutation in spermatogonial stem cells as a model for future gene therapy. In TEX14 null testes, some genes important for undifferentiated spermatogonia as well as some differentiation-related genes were activated. TEX14 null spermatogonial stem cells, surprisingly, could form chain-like structures even though they do not form stable intercellular bridges. TEX14 null spermatogonial stem cells in culture possessed both characteristics of undifferentiated and differentiated spermatogonia. Long-term culture of TEX14 null spermatogonial stem cells could not be established likely secondary to up-regulation of CDK4 inhibitors and down-regulation of cyclin E. These results suggest that intercellular bridges are essential for both maintenance of spermatogonial stem cells and their proliferation. Lastly, a mutation in Tex14(+/-) spermatogonial stem cells was successfully replaced by homologous recombination in vitro. Our study provides a therapeutic potential of spermatogonial stem cells for reproductive medicine if they can be cultured long-term.	[Iwamori, Naoki; Iwamori, Tokuko; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Iwamori, Naoki; Matzuk, Martin M.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Iwamori, N (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	iwamori@bcm.tmc.edu; mmatzuk@bcm.tmc.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD057880]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057880] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	These studies were supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD057880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Greenbaum MP, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005850; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2004, HEMATOL J, V5, pS114, DOI 10.1038/sj.thj.6200435; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; HUCKINS C, 1978, ANAT REC, V192, P519, DOI 10.1002/ar.1091920406; Iwamori T, 2010, MOL CELL BIOL, V30, P2280, DOI 10.1128/MCB.01392-09; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Kanatsu-Shinohara M, 2011, BIOL REPROD, V85, P208, DOI 10.1095/biolreprod.111.090837; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Wu MH, 2003, GENE EXPR PATTERNS, V3, P231, DOI 10.1016/S1567-133X(03)00036-X; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zhou Q., 2008, REGULATION SPERMATOG; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	39	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38914	10.1371/journal.pone.0038914	http://dx.doi.org/10.1371/journal.pone.0038914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719986	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341900065
J	Garrido, MD; Penna, ML; Perez-Porcuna, TM; de Souza, AB; Marreiro, LD; Albuquerque, BC; Martinez-Espinosa, FE; Buhrer-Sekula, S				Garrido, Marlucia da Silva; Penna, Maria Lucia; Perez-Porcuna, Tomas M.; de Souza, Alexandra Brito; Marreiro, Leni da Silva; Albuquerque, Bernardino Claudio; Martinez-Espinosa, Flor Ernestina; Buehrer-Sekula, Samira			Factors Associated with Tuberculosis Treatment Default in an Endemic Area of the Brazilian Amazon: A Case Control-Study	PLOS ONE			English	Article							PULMONARY TB PATIENTS; RISK-FACTORS; CARE; NONADHERENCE; RETREATMENT; PREDICTORS; KENYA; ABUSE; CITY	Setting: Treatment default is a serious problem in tuberculosis control because it implies persistence of infection source, increased mortality, increased relapse rates and facilitates the development of resistant strains. Objective: This study analyzed tuberculosis treatment default determinants in the Amazonas State to contribute in planning appropriate control interventions. Design: Observational study with a retrospective cohort using Brazilian Disease Notification System data from 2005 to 2010. A nested case control study design was used. Patients defaulting from treatment were considered as 'cases' and those completing treatment as 'controls'. In the analysis, 11,312 tuberculosis patients were included, 1,584 cases and 9,728 controls. Results: Treatment default was observed to be associated to previous default (aOR 3.20; p<0.001), HIV positivity (aOR 1.62; p<0.001), alcoholism (aOR 1.51; p<0.001), low education level (aOR 1.35; p<0.001) and other co-morbidities (aOR 1.31; p = 0.05). Older patients (aOR 0.98; p = 0.001) and DOT (aOR 0,72; p<0.01) were considered as protective factor for default. Conclusions: Associated factors should be considered in addressing care and policy actions to tuberculosis control. Information on disease and treatment should be intensified and appropriate to the level of education of the population, in order to promote adherence to treatment and counter the spread of multidrug resistance to anti-TB drugs.	[Garrido, Marlucia da Silva; Perez-Porcuna, Tomas M.; Martinez-Espinosa, Flor Ernestina; Buehrer-Sekula, Samira] Amazonas State Univ, Trop Med Postgrad Program, Dr Heitor Vieira Dourado Trop Med Fdn, Manaus, Amazonas, Brazil; [Garrido, Marlucia da Silva; Albuquerque, Bernardino Claudio] Hlth Surveillance Fdn Amazonas State, Epidemiol Surveillance Dept, Manaus, Amazonas, Brazil; [Garrido, Marlucia da Silva; Marreiro, Leni da Silva] Municipal Hlth Secretary Manaus, Epidemiol Surveillance Dept, Manaus, Amazonas, Brazil; [Penna, Maria Lucia] Univ Fed Fluminense, Epidemiol & Biostat Dept, Rio De Janeiro, Brazil; [Perez-Porcuna, Tomas M.] Univ Barcelona, Sch Med, Dept Publ Hlth, Barcelona, Catalonia, Spain; [Perez-Porcuna, Tomas M.] Univ Barcelona, Dept Pediat CAP Valdoreix, Univ Hosp MutuaTerrassa, MutuaTerrassa Res Fdn, Catalonia, Spain; [de Souza, Alexandra Brito; Marreiro, Leni da Silva] Dr Heitor Vieira Dourado Trop Med Fdn, Epidemiol & Publ Hlth Dept, Manaus, Amazonas, Brazil; [Martinez-Espinosa, Flor Ernestina] Fundacao Oswaldo Cruz, Leonidas & Maria Deane Inst, Manaus, Amazonas, Brazil; [Buehrer-Sekula, Samira] Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Goiania, Go, Brazil	Universidade do Estado do Amazonas; Universidade Federal Fluminense; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona; Fundacao Oswaldo Cruz; Universidade Federal de Goias	Garrido, MD (corresponding author), Amazonas State Univ, Trop Med Postgrad Program, Dr Heitor Vieira Dourado Trop Med Fdn, Manaus, Amazonas, Brazil.	marlucia.garrido@gmail.com	Garrido, Marlucia/AAK-1001-2020; Bührer-Sékula, Samira/H-5115-2012	Bührer-Sékula, Samira/0000-0002-5984-7770; Perez-Porcuna, Tomas Maria/0000-0002-9951-7768				[Anonymous], 2010, MAN REC CONTR TUB BR; [Anonymous], 2011, GLOB TUB CONTR; Ayisi JG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-515; Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003; Comolet TM, 1998, INT J TUBERC LUNG D, V2, P891; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Ferreira V, 2011, REV SAUDE PUBL, V45, P40, DOI 10.1590/S0034-89102010005000055; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; IBGE, 2011, CENS 2010; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P353; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Marreiro LD, 2009, EPIDEMIOL SERV SAUDE, V18, P237; Mesfin MM, 2009, HEALTH POLICY PLANN, V24, P457, DOI 10.1093/heapol/czp030; Ministerio da Saude PNCT, 2011, SER HIST TAX INC TUB; Mittal Chhaya, 2011, Indian J Community Med, V36, P27, DOI 10.4103/0970-0218.80789; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Natal S, 1999, B PNEUMOL SANIT, P7; Oeltmann JE, 2009, ARCH INTERN MED, V169, P189, DOI 10.1001/archinternmed.2008.535; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Penna G, 2009, EMERG INFECT DIS, V15, P626, DOI 10.3201/eid1504.081329; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stata Corp, 2005, STAT STAT SOFTW REL; van Altena R, 2007, Ned Tijdschr Geneeskd, V151, P2652; Vijay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010043; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; World Health Organization, 2006, STOP TB STRAT BUILD	30	55	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e39134	10.1371/journal.pone.0039134	http://dx.doi.org/10.1371/journal.pone.0039134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22720052	gold, Green Published, Green Submitted			2022-12-25	WOS:000305340000067
J	Marijnissen, RJ; Koenders, MI; van de Veerdonk, FL; Dulos, J; Netea, MG; Boots, AMH; Joosten, LAB; van den Berg, WB				Marijnissen, Renoud J.; Koenders, Marije I.; van de Veerdonk, Frank L.; Dulos, John; Netea, Mihai G.; Boots, Annemieke M. H.; Joosten, Leo A. B.; van den Berg, Wim B.			Exposure to Candida albicans Polarizes a T-Cell Driven Arthritis Model towards Th17 Responses, Resulting in a More Destructive Arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; COLLAGEN-INDUCED ARTHRITIS; AUTOIMMUNE ARTHRITIS; CARTILAGE DESTRUCTION; JOINT INFLAMMATION; DIFFERENTIATION; INTERLEUKIN-1; EXPRESSION; INDUCTION; GLUCAN	Background: Fungal components have been shown very effective in generating Th17 responses. We investigated whether exposure to a minute amount of C. albicans in the arthritic joint altered the local cytokine environment, leading to enhanced Th17 expansion and resulting in a more destructive arthritis. Methodology: Chronic SCW arthritis was induced by repeated injection with Streptococcus pyogenes (SCW) cell wall fragments into the knee joint of C57Bl/6 mice, alone or in combination with the yeast of C. albicans or Zymosan A. During the chronic phase of the arthritis, the cytokine levels, mRNA expression and histopathological analysis of the joints were performed. To investigate the phenotype of the IL-17 producing T-cells, synovial cells were isolated and analyzed by flowcytometry. Principal Findings: Intra-articular injection of either Zymosan A or C. albicans on top of the SCW injection both resulted in enhanced joint swelling and inflammation compared to the normal SCW group. However, only the addition of C. albicans during SCW arthritis resulted in severe chondrocyte death and enhanced destruction of cartilage and bone. Additionally, exposure to C. albicans led to increased IL-17 in the arthritic joint, which was accompanied by an increased synovial mRNA expression of T-bet and ROR gamma T. Moreover, the C. albicans-injected mice had significantly more Th17 cells in the synovium, of which a large population also produced IFN-gamma. Conclusion: This study clearly shows that minute amounts of fungal components, like C. albicans, are very potent in interfering with the local cytokine environment in an arthritic joint, thereby polarizing arthritis towards a more destructive phenotype.	[Marijnissen, Renoud J.; Koenders, Marije I.; van den Berg, Wim B.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun N4I, NL-6525 ED Nijmegen, Netherlands; [Dulos, John] Crucell, Dept I&DL, Pharmacol Sect, Leiden, Netherlands; [Boots, Annemieke M. H.] Univ Groningen, Dept Rheumatol & Clin Immunol, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Johnson & Johnson; University of Groningen	Marijnissen, RJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands.	rjmarijnissen@reuma.umcn.nl	van den Berg, W.B./H-8010-2014; van de Veerdonk, Frank L/C-7256-2008; Koenders, Marije I/A-1341-2012; Boots, Annemieke M/D-7266-2011; Joosten, Leo AB/H-3138-2015; Netea, Mihai/N-5155-2014; Marijnissen, Renoud/M-5541-2013	van de Veerdonk, Frank L/0000-0002-1121-4894; Koenders, Marije I/0000-0001-5845-8362; Joosten, Leo AB/0000-0001-6166-9830; Marijnissen, Renoud/0000-0002-6836-675X				Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Abdollahi-Roodsaz S, 2008, ARTHRITIS RHEUM, V58, P3753, DOI 10.1002/art.24127; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Cao DJ, 2004, ARTHRITIS RES THER, V6, pR335, DOI 10.1186/ar1192; Conrad K, 2010, AUTOIMMUN REV, V9, P431, DOI 10.1016/j.autrev.2009.11.017; Cosmi L., 2011, ARTHRITIS RHEUM; Doodes PD, 2010, J IMMUNOL, V184, P1552, DOI 10.4049/jimmunol.0902907; Egan PJ, 2008, ARTHRITIS RHEUM-US, V58, P3720, DOI 10.1002/art.24075; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gullick NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012516; Hauknes HA, 2002, J INFECT DIS, V185, P915, DOI 10.1086/339407; Hida S, 2005, J AUTOIMMUN, V25, P93, DOI 10.1016/j.jaut.2005.06.002; Hida S, 2007, BIOL PHARM BULL, V30, P1589, DOI 10.1248/bpb.30.1589; Hida S, 2006, MICROBIOL IMMUNOL, V50, P453, DOI 10.1111/j.1348-0421.2006.tb03814.x; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Israeli E, 2009, LUPUS, V18, P1217, DOI 10.1177/0961203309345724; JOOSTEN LAB, 1994, CLIN EXP IMMUNOL, V97, P204; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Joosten LAB, 2008, ARTHRITIS RHEUM-US, V58, P98, DOI 10.1002/art.23152; Katz Y, 2001, ARTHRITIS RHEUM-US, V44, P2176, DOI 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Koenders MI, 2011, ARTHRITIS RHEUM; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Santegoets KC, 2011, FEBS LETT; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Sonoyama K, 2011, MED MYCOL, V49, P237, DOI 10.3109/13693786.2010.511284; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; van de Veerdonk FL, 2011, ARTHRITIS RHEUM-US, V63, P1507, DOI 10.1002/art.30314; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van den Berg WB, 1999, ANN RHEUM DIS, V58, P40; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; VANDELOO FAJ, 1995, ARTHRITIS RHEUM, V38, P164; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2012	7	6							e38889	10.1371/journal.pone.0038889	http://dx.doi.org/10.1371/journal.pone.0038889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UJ	22719976	Green Published, gold, Green Submitted			2022-12-25	WOS:000305340000051
J	Zhao, XM; Mohan, R; Ozcan, S; Tang, XQ				Zhao, Xiaomin; Mohan, Ramkumar; Oezcan, Sabire; Tang, Xiaoqing			MicroRNA-30d Induces Insulin Transcription Factor MafA and Insulin Production by Targeting Mitogen-activated Protein 4 Kinase 4 (MAP4K4) in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; KEY REGULATOR; EXPRESSION; ALPHA; MECHANISMS; CONTRIBUTE; MIRNAS	MicroRNAs (miRNAs) represent small noncoding RNAs that play a role in many diseases, including diabetes. miRNAs target genes important for pancreas development, beta-cell proliferation, insulin secretion, and exocytosis. Previously, we documented that microRNA-30d (miR-30d), one of miRNAs up-regulated by glucose, induces insulin gene expression in pancreatic beta-cells. Here, we found that the induction of insulin production by overexpression of miR-30d is associated with increased expression of MafA, a beta-cell-specific transcription factor. Of interest, overexpression of miR-30d prevented the reduction in both MafA and insulin receptor substrate 2 (IRS2) with TNF-alpha exposure. Moreover, we identified that mitogen-activated protein 4 kinase 4 (MAP4K4), a TNF-alpha-activated kinase, is a direct target of miR-30d. Overexpression of miR-30d protected beta-cells against TNF-alpha suppression on both insulin transcription and insulin secretion through the down-regulation of MAP4K4 by the miR-30d. Adecrease of miR-30d expression was observed in the islets of diabetic db/db mice, in which MAP4K4 expression level was elevated. Our data support the notion that miR-30d plays multiple roles in activating insulin transcription and protecting beta-cell functions from impaired by proinflammatory cytokines and underscore the concept that miR-30d may represent a novel pharmacological target for diabetes intervention.	[Oezcan, Sabire] Univ Kentucky, Dept Mol & Cellular Biochem, BBSRB, Lexington, KY 40536 USA; [Zhao, Xiaomin] NW A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Zhao, Xiaomin; Mohan, Ramkumar; Tang, Xiaoqing] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	University of Kentucky; Northwest A&F University - China; Michigan Technological University	Ozcan, S (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, BBSRB, 741 S Limestone St,B155, Lexington, KY 40536 USA.	sozcan@uky.edu; xtang2@mtu.edu	Mohan, Ramkumar/J-9037-2019	Mohan, Ramkumar/0000-0002-1308-1642; Zhao, Xiaomin/0000-0002-1814-8586	National Institutes of Health [K01 DK078648, R03 DK084166, R01 DK067581]; American Diabetes Association [1-05-CD-15]; China Scholarship Council Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078648, R03DK084166, R01DK067581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); China Scholarship Council Fellowship(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK078648 and R03 DK084166 (to X. T.). This work was also supported in part by National Institutes of Health Grant R01 DK067581 and American Diabetes Association Grant 1-05-CD-15 (to S. O.).; Partially supported by a China Scholarship Council Fellowship.	Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Babu DA, 2008, J BIOL CHEM, V283, P8164, DOI 10.1074/jbc.M800336200; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Chin-Chance CVT, 2006, J INVEST MED, V54, P132, DOI 10.2310/6650.2006.05035; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Tang XQ, 2008, BBA-GENE REGUL MECH, V1779, P697, DOI 10.1016/j.bbagrm.2008.06.010; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Vanderford NL, 2008, ARCH BIOCHEM BIOPHYS, V480, P138, DOI 10.1016/j.abb.2008.10.001; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	39	95	102	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2012	287	37					31155	31164		10.1074/jbc.M112.362632	http://dx.doi.org/10.1074/jbc.M112.362632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	006AK	22733810	Green Published, hybrid			2022-12-25	WOS:000308791300028
J	Zhang, L; Zhou, FF; Li, YH; Drabsch, Y; Zhang, J; van Dam, H; ten Dijke, P				Zhang, Long; Zhou, Fangfang; Li, Yihao; Drabsch, Yvette; Zhang, Juan; van Dam, Hans; ten Dijke, Peter			Fas-associated Factor 1 Is a Scaffold Protein That Promotes beta-Transducin Repeat-containing Protein (beta-TrCP)-mediated beta-Catenin Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INTRACELLULAR DOMAIN AICD; WNT SIGNALING PATHWAY; BREAST-CANCER; KAPPA-B; MAMMARY DEVELOPMENT; DUCTAL CARCINOMA; FAF1; ACTIVATION; EXPRESSION	FAS-associated factor 1 (FAF1) antagonizes Wnt signaling by stimulating beta-catenin degradation. However, the molecular mechanism underlying this effect is unknown. Here, we demonstrate that the E3 ubiquitin ligase beta-transducin repeat-containing protein (beta-TrCP) is required for FAF1 to suppress Wnt signaling and that FAF1 specifically associates with the SCF (Skp1-Cul1-F-box protein)-beta-TrCP complex. Depletion of beta-TrCP reduced FAF1-mediated beta-catenin polyubiquitination and impaired FAF1 in antagonizing Wnt/beta-catenin signaling. FAF1 was shown to act as a scaffold for beta-catenin and beta-TrCP and thereby to potentiate beta-TrCP-mediated beta-catenin ubiquitination and degradation. Data mining revealed that FAF1 expression is statistically down-regulated in human breast carcinoma compared with normal breast tissue. Consistent with this, FAF1 expression is higher in epithelial-like MCF7 than mesenchymal-like MDA-MB-231 human breast cancer cells. Depletion of FAF1 in MCF7 cells resulted in increased beta-catenin accumulation and signaling. Importantly, FAF1 knockdown promoted a decrease in epithelial E-cadherin and an increase in mesenchymal vimentin expression, indicative for an epithelial to mesenchymal transition. Moreover, ectopic FAF1 expression reduces breast cancer cell migration in vitro and invasion/metastasis in vivo. Thus, our studies strengthen a tumor-suppressive function for FAF1.	[Zhou, Fangfang] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zhou, FF (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Bldg 2,Rm S-02-05,Postzone S-1-P,POB 9600, NL-2300 RC Leiden, Netherlands.	f.zhou@lumc.nl; p.ten_dijke@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Zhang, Long/AAT-6571-2021	Dijke, Peter ten/0000-0002-7234-342X; Zhang, Long/0000-0001-8139-0474; Li, Yihao/0000-0003-1900-8099; van Dam, Hans/0000-0002-8307-4325	Netherlands Organization for Scientific Research [NWO 918.66.066]; Centre for Biomedical Genetics	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biomedical Genetics	This work was supported by the Netherlands Organization for Scientific Research Grant NWO 918.66.066 and by the Centre for Biomedical Genetics.	Adham IM, 2008, MOL HUM REPROD, V14, P207, DOI 10.1093/molehr/gan009; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Frohlich T, 1998, J CELL SCI, V111, P2353; Gebeshuber CA, 2007, CELLS TISSUES ORGANS, V185, P51, DOI 10.1159/000101303; Gilles C, 2003, CANCER RES, V63, P2658; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; He S., 2012, J PATHOL IN PRESS; Hidalgo A, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-77; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu JX, 2012, CHEM COMMUN, V48, P398, DOI 10.1039/c1cc15341b; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marini P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-5; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Prasad CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-325; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rowlands TM, 2003, P NATL ACAD SCI USA, V100, P11400, DOI 10.1073/pnas.1534601100; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang L, 2012, MOL CELL, V46, P650, DOI 10.1016/j.molcel.2012.04.003; Zhang L, 2012, BIOCHEM BIOPH RES CO, V419, P83, DOI 10.1016/j.bbrc.2012.01.132; Zhang L, 2011, MOL BIOL CELL, V22, P1617, DOI 10.1091/mbc.E10-12-0985; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200; Zhou FF, 2008, BIOCHEM BIOPH RES CO, V365, P149, DOI 10.1016/j.bbrc.2007.10.138; Zhou FF, 2012, BBA-MOL CELL RES, V1823, P1233, DOI 10.1016/j.bbamcr.2012.05.011; Zhou FF, 2012, PROTEIN CELL, V3, P311, DOI 10.1007/s13238-012-2027-4; Zhou FF, 2012, J BIOL CHEM, V287, P11002, DOI 10.1074/jbc.M111.328187; Zhou FF, 2011, BIOCHEM BIOPH RES CO, V412, P68, DOI 10.1016/j.bbrc.2011.07.040; Zhou FF, 2011, PROTEIN CELL, V2, P377, DOI 10.1007/s13238-011-1047-9	60	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2012	287	36					30701	30710		10.1074/jbc.M112.353524	http://dx.doi.org/10.1074/jbc.M112.353524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	003AF	22730322	Green Published, hybrid			2022-12-25	WOS:000308579800059
J	Dean, JL; McClendon, AK; Knudsen, ES				Dean, Jeffry L.; McClendon, A. Kathleen; Knudsen, Erik S.			Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITUMOR-ACTIVITY; CYCLIN D; RECOMBINATION; REPAIR; PHOSPHORYLATION; SUPPRESSION; RB; ASSOCIATION; DEFICIENCY; ACTIVATION	The RB/E2F axis represents a critical node of cell signaling that integrates a diverse array of signaling pathways. Recent evidence has suggested a role for E2F-mediated gene transcription in DNA damage response and repair, as well as apoptosis signaling. Herein, we investigated how repression of E2F activity via CDK4/6 inhibition and RB activation impacts the response of triple negative breast cancer (TNBC) to frequently used therapeutic agents. In combination with taxanes and anthracyclines CDK4/6 inhibition and consequent cell cycle arrest prevented the induction of DNA damage and associated cell death in an RB-dependent manner; thereby demonstrating antagonism between the cytostatic influence of the CDK-inhibitor and cytotoxic agents. As many of these effects were secondary to cell cycle arrest, gamma-irradiation (IR) was utilized to examine effects of CDK4/6 inhibition on direct DNA damage. Although E2F controls a number of genes involved in DNA repair (e. g. Rad51), CDK4/6 inhibition did not alter the overall rate of DNA repair, rather it significantly shifted the burden of this repair from homologous recombination (HR) to non-homologous end joining (NHEJ). Together, these data indicate that CDK4/6 inhibition can antagonize cytotoxic therapeutic strategies and increases utilization of error-prone DNA repair mechanisms that could contribute to disease progression.	[Dean, Jeffry L.; McClendon, A. Kathleen; Knudsen, Erik S.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Center, Philadelphia, PA 19107 USA	Jefferson University	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Center, 233 S 10th St BLSB-650, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org			NATIONAL CANCER INSTITUTE [R01CA129134] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129134] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn JY, 2000, CANCER RES, V60, P5934; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fry DW, 2004, MOL CANCER THER, V3, P1427; Fry DW, 2001, J BIOL CHEM, V276, P16617, DOI 10.1074/jbc.M008867200; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McClendon AK, 2011, GASTROENTEROLOGY, V141, P1439, DOI 10.1053/j.gastro.2011.06.046; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Schild D, 2010, NUCLEIC ACIDS RES, V38, P1061, DOI 10.1093/nar/gkp1063; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Thangavel C, 2011, ENDOCR-RELAT CANCER, V18, P333, DOI 10.1530/ERC-10-0262; Trere D, 2009, ANN ONCOL, V20, P1818, DOI 10.1093/annonc/mdp209; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753	36	108	110	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2012	287	34					29075	29087		10.1074/jbc.M112.365494	http://dx.doi.org/10.1074/jbc.M112.365494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	996HD	22733811	Green Published, hybrid			2022-12-25	WOS:000308074600074
J	Zhang, XH; He, X; Baker, J; Tama, F; Chang, G; Wright, SH				Zhang, Xiaohong; He, Xiao; Baker, Joseph; Tama, Florence; Chang, Geoffrey; Wright, Stephen H.			Twelve Transmembrane Helices Form the Functional Core of Mammalian MATE1 (Multidrug and Toxin Extruder 1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC CATION TRANSPORTERS; BORDER MEMBRANE-VESICLES; MOLECULAR-DYNAMICS SIMULATIONS; MAJOR FACILITATOR SUPERFAMILY; FINAL EXCRETION STEP; RAT PROXIMAL TUBULE; H+ EXCHANGER; TETRAETHYLAMMONIUM TRANSPORT; SUBSTRATE RECOGNITION; PK(A) VALUES	The x-ray structure of the prototypic MATE family member, NorM from Vibrio cholerae, reveals a protein fold composed of 12 transmembrane helices (TMHs), confirming hydropathy analyses of the majority of (prokaryotic and plant) MATE transporters. However, the mammalian MATEs are generally predicted to have a 13th TMH and an extracellular C terminus. Here we affirm this prediction, showing that the C termini of epitope-tagged, full-length human, rabbit, and mouse MATE1 were accessible to antibodies from the extracellular face of the membrane. Truncation of these proteins at or near the predicted junction between the 13th TMH and the long cytoplasmic loop that precedes it resulted in proteins that (i) trafficked to the membrane and (ii) interacted with antibodies only after permeabilization of the plasma membrane. CHO cells expressing rbMate1 truncated at residue Gly-545 supported levels of pH-sensitive transport similar to that of cells expressing the full-length protein. Although the high transport rate of the Gly-545 truncation mutant was associated with higher levels of membrane expression (than full-length MATE1), suggesting the 13th TMH may influence substrate translocation, the selectivity profile of the mutant indicated that TMH13 has little impact on ligand binding. We conclude that the functional core of MATE1 consists of 12 (not 13) TMHs. Therefore, we used the x-ray structure of NorM to develop a homology model of the first 12 TMHs of MATE1. The model proved to be stable in molecular dynamic simulations and agreed with topology evident from preliminary cysteine scanning of intracellular versus extracellular loops.	[Wright, Stephen H.] Univ Arizona, Dept Physiol, Coll Med, Tucson, AZ 85724 USA; [Baker, Joseph; Tama, Florence; Wright, Stephen H.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85724 USA; [Baker, Joseph; Chang, Geoffrey] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Arizona; University of Arizona; Scripps Research Institute	Wright, SH (corresponding author), Univ Arizona, Dept Physiol, Coll Med, Tucson, AZ 85724 USA.	shwright@u.arziona.edu	tama, florence/S-2733-2019; Tama, Florence/A-7077-2016	tama, florence/0000-0003-2021-5618; Tama, Florence/0000-0003-2021-5618; Baker, Joseph/0000-0003-1286-6605	National Institutes of Health [1R01DK080801, 1U54GM094610, 5P30ES006694]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK080801, 1U54GM094610, and 5P30ES006694. This work was also supported by the Skaggs Institute for Chemical Biology.	Asaka J, 2007, MOL PHARMACOL, V71, P1487, DOI 10.1124/mol.106.032938; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen Y, 2007, J PHARMACOL EXP THER, V322, P695, DOI 10.1124/jpet.107.123554; Dangprapai Y, 2011, AM J PHYSIOL-RENAL, V301, pF520, DOI 10.1152/ajprenal.00075.2011; DANTZLER WH, 1991, AM J PHYSIOL, V261, pF386, DOI 10.1152/ajprenal.1991.261.3.F386; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVID C, 1995, PFLUG ARCH EUR J PHY, V430, P477, DOI 10.1007/BF00373884; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hiasa M, 2006, AM J PHYSIOL-CELL PH, V291, pC678, DOI 10.1152/ajpcell.00090.2006; Holyoake J, 2006, BIOPHYS J, V91, pL84, DOI 10.1529/biophysj.106.093971; HORI R, 1989, J BIOL CHEM, V264, P12232; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Kobara A, 2008, ARCH BIOCHEM BIOPHYS, V469, P195, DOI 10.1016/j.abb.2007.10.010; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Komatsu T, 2011, INT J BIOCHEM CELL B, V43, P913, DOI 10.1016/j.biocel.2011.03.005; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law RJ, 2005, J MOL GRAPH MODEL, V24, P157, DOI 10.1016/j.jmgm.2005.05.006; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MALO C, 1991, J MEMBRANE BIOL, V122, P127, DOI 10.1007/BF01872636; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205; Matsumoto T, 2008, AM J PHYSIOL-CELL PH, V294, pC1074, DOI 10.1152/ajpcell.00504.2007; MEIJER DKF, 1990, J PHARMACOKINET BIOP, V18, P35, DOI 10.1007/BF01063621; MONTROSERAFIZADEH C, 1987, BIOCHIM BIOPHYS ACTA, V904, P175, DOI 10.1016/0005-2736(87)90102-7; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Pelis RM, 2006, AM J PHYSIOL-RENAL, V290, pF1118, DOI 10.1152/ajprenal.00462.2005; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; SCHALI C, 1983, AM J PHYSIOL, V245, pF238, DOI 10.1152/ajprenal.1983.245.2.F238; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Tandon SK, 1996, FUND APPL TOXICOL, V31, P141, DOI 10.1006/faat.1996.0085; Tanihara Y, 2007, BIOCHEM PHARMACOL, V74, P359, DOI 10.1016/j.bcp.2007.04.010; Tsuda M, 2009, MOL PHARMACOL, V75, P1280, DOI 10.1124/mol.109.056242; Ullrich KJ, 1996, PFLUG ARCH EUR J PHY, V432, P471, DOI 10.1007/s004240050159; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Watanabe S, 2010, J PHARMACOL EXP THER, V334, P651, DOI 10.1124/jpet.110.169433; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; WRIGHT SH, 1995, PFLUG ARCH EUR J PHY, V429, P313, DOI 10.1007/BF00374145; WRIGHT SH, 1988, J BIOL CHEM, V263, P19494; Wright SH, 1999, PFLUG ARCH EUR J PHY, V437, P603, DOI 10.1007/s004240050823; Zhang XH, 2007, AM J PHYSIOL-RENAL, V293, pF360, DOI 10.1152/ajprenal.00102.2007; Zhang XH, 2009, AM J PHYSIOL-RENAL, V297, pF263, DOI 10.1152/ajprenal.00123.2009; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	57	32	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2012	287	33					27971	27982		10.1074/jbc.M112.386979	http://dx.doi.org/10.1074/jbc.M112.386979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	993FF	22722930	Green Published, hybrid			2022-12-25	WOS:000307840700071
J	Jarosz, M; Robbez-Masson, L; Chioni, AM; Cross, B; Rosewell, I; Grose, R				Jarosz, Monika; Robbez-Masson, Luisa; Chioni, Athina-Myrto; Cross, Barbara; Rosewell, Ian; Grose, Richard			Fibroblast Growth Factor 22 Is Not Essential for Skin Development and Repair but Plays a Role in Tumorigenesis	PLOS ONE			English	Article							GENE-EXPRESSION; RECEPTOR SPECIFICITY; DIFFERENTIATION; KERATINOCYTES; FGF10; LIMB; MORPHOGENESIS; INDUCTION	Fibroblast Growth Factors play critical roles during development, tissue homeostasis and repair by controlling cell proliferation, survival, migration and differentiation. Of the 22 mammalian FGFs, FGF22, a member of the FGF7/10/22 subfamily, has been shown to have a clear role in synaptogenesis, but its roles in other tissues have not been studied. We have investigated the in vivo functions of FGF22 in mice. Fgf22 null animals were viable, fertile and did not display any obvious abnormalities. Despite the known expression profile of FGF22 in the skin, no differences in either skin or pelage were observed, demonstrating that FGF22 is dispensable during embryogenesis and in unchallenged adult skin. Mice lacking FGF22 were able to heal acute wounds just as efficiently as wild type mice. However, classical two-step skin carcinogenesis challenge revealed that FGF22 null mice developed fewer papillomas than wild type controls, suggesting a potential pro-oncogenic role for FGF22 in the skin.	[Jarosz, Monika; Robbez-Masson, Luisa; Chioni, Athina-Myrto; Grose, Richard] Queen Mary Univ London, Ctr Tumour Biol, Barts Canc Inst, London, England; [Cross, Barbara; Rosewell, Ian] Canc Res UK London Res Inst, Clare Hall Labs, Biol Serv, S Mimms, Herts, England	University of London; Queen Mary University London; Cancer Research UK	Jarosz, M (corresponding author), Queen Mary Univ London, Ctr Tumour Biol, Barts Canc Inst, London, England.	r.p.grose@qmul.ac.uk		Grose, Richard/0000-0002-4738-0173; Robbez-Masson, Luisa/0000-0002-6060-8080	Cancer Research UK; Wellcome Trust [076678/Z/05/Z]; Trustees of St Barts; London Charitable Foundation	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Trustees of St Barts; London Charitable Foundation	This research was funded by Cancer Research UK, The Wellcome Trust (076678/Z/05/Z) and the Trustees of St Barts and The London Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer TA, 2003, EXP CELL RES, V287, P228, DOI 10.1016/S0014-4827(03)00139-3; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Braun S, 2004, PHILOS T R SOC B, V359, P753, DOI 10.1098/rstb.2004.1464; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Chioni AM, 2009, EUR J CELL BIOL, V88, P371, DOI 10.1016/j.ejcb.2009.01.004; DANILENKO DM, 1995, AM J PATHOL, V147, P145; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Grose R, 2007, EMBO J, V26, P1268, DOI 10.1038/sj.emboj.7601583; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; Hamada K, 1999, Exp Dermatol, V8, P347; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; Itoh N., 2010, J BIOCH; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Komi-Kuramochi A, 2005, J ENDOCRINOL, V186, P273, DOI 10.1677/joe.1.06055; Kumin A, 2006, AM J PATHOL, V169, P1194, DOI 10.2353/ajpath.2006.060119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Nakatake Y, 2001, BBA-GENE STRUCT EXPR, V1517, P460, DOI 10.1016/S0167-4781(00)00302-X; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Schlake T, 2005, DEVELOPMENT, V132, P2981, DOI 10.1242/dev.01873; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Sundberg JP., 1994, HDB MOUSE MUTATIONS, P57; Tagashira S, 1997, GENE, V197, P399, DOI 10.1016/S0378-1119(97)00187-X; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Zhang HB, 2004, EUR J CELL BIOL, V83, P3, DOI 10.1078/0171-9335-00355; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	36	24	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39436	10.1371/journal.pone.0039436	http://dx.doi.org/10.1371/journal.pone.0039436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737238	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000305695100037
J	Zhang, XJ; Kendrick, KM; Zhou, HF; Zhan, Y; Feng, JF				Zhang, Xuejuan; Kendrick, Keith M.; Zhou, Haifu; Zhan, Yang; Feng, Jianfeng			A Computational Study on Altered Theta-Gamma Coupling during Learning and Phase Coding	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; NEURONAL SYNCHRONIZATION; SPIKING NEURONS; WORKING-MEMORY; SYNAPTIC BASIS; OSCILLATIONS; NETWORKS; DYNAMICS; RHYTHM; HIPPOCAMPUS	There is considerable interest in the role of coupling between theta and gamma oscillations in the brain in the context of learning and memory. Here we have used a neural network model which is capable of producing coupling of theta phase to gamma amplitude firstly to explore its ability to reproduce reported learning changes and secondly to memory-span and phase coding effects. The spiking neural network incorporates two kinetically different GABAA receptor-mediated currents to generate both theta and gamma rhythms and we have found that by selective alteration of both NMDA receptors and GABAA, slow receptors it can reproduce learning-related changes in the strength of coupling between theta and gamma either with or without coincident changes in theta amplitude. When the model was used to explore the relationship between theta and gamma oscillations, working memory capacity and phase coding it showed that the potential storage capacity of short term memories, in terms of nested gamma-subcycles, coincides with the maximal theta power. Increasing theta power is also related to the precision of theta phase which functions as a potential timing clock for neuronal firing in the cortex or hippocampus.	[Zhang, Xuejuan; Zhou, Haifu; Feng, Jianfeng] Zhejiang Normal Univ, Dept Math, Jinhua, Peoples R China; [Kendrick, Keith M.] Univ Elect Sci & Technol China, Key Lab Neuroinformat, Social Cognit & Affect Neurosci Grp, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhan, Yang] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Zhan, Yang] EMBL EBI, Cambridge, England; [Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	Zhejiang Normal University; University of Electronic Science & Technology of China; European Molecular Biology Laboratory (EMBL); Fudan University; European Molecular Biology Laboratory (EMBL); University of Warwick	Zhang, XJ (corresponding author), Zhejiang Normal Univ, Dept Math, Jinhua, Peoples R China.	jianfeng.feng@warwick.ac.uk		Kendrick, Keith/0000-0002-0371-5904; Zhan, Yang/0000-0002-1150-6344; feng, jianfeng/0000-0002-9328-5732	CARMEN e-science project; EPSRC [EP/E002331/1]; EU; Natural Science Foundation of China (NSFC) [10971196]; Royal Society; Zhejiang Innovation Project [T200905]; FANEDD in China	CARMEN e-science project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Royal Society(Royal Society of London); Zhejiang Innovation Project; FANEDD in China	JF is a Royal Society Wolfson Research Award Holder and was partially supported by CARMEN e-science project (www.carmen.org.uk) funded by the EPSRC (EP/E002331/1) and an EU grant BION. XZ was partially supported by the Natural Science Foundation of China (NSFC) (Nos. 10971196), Zhejiang Innovation Project (Grant No. T200905), and the FANEDD in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amit DJ, 1997, NETWORK-COMP NEURAL, V8, P373, DOI 10.1088/0954-898X/8/4/003; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Banks MI, 1998, J NEUROSCI, V18, P1305; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; Broadbent DE, 1975, MAGIC NUMBER 7 15; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Hyman JM, 2003, J NEUROSCI, V23, P11725; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kaminski J, 2011, NEUROBIOL LEARN MEM, V95, P19, DOI 10.1016/j.nlm.2010.10.001; Kendrick KM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-55; Kopell N, 2010, SPR S COMPUTAT NEURO, P423; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Sceniak MP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-8; Smerieri A, 2010, J NEUROSCI, V30, P14173, DOI 10.1523/JNEUROSCI.0945-10.2010; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; Ursino M, 2006, J THEOR BIOL, V242, P171, DOI 10.1016/j.jtbi.2006.02.012; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Wang XJ, 1999, J NEUROSCI, V19, P9587; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; Zou CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-122	39	4	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e36472	10.1371/journal.pone.0036472	http://dx.doi.org/10.1371/journal.pone.0036472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737207	Green Published, Green Submitted, gold			2022-12-25	WOS:000305695100002
J	Greth, A; Lampkin, S; Mayura-Guru, P; Rodda, F; Drysdale, K; Roberts-Thomson, M; McMorran, BJ; Foote, SJ; Burgio, G				Greth, Andreas; Lampkin, Shelley; Mayura-Guru, Preethi; Rodda, Fleur; Drysdale, Karen; Roberts-Thomson, Meredith; McMorran, Brendan J.; Foote, Simon J.; Burgio, Gaetan			A Novel ENU-Mutation in Ankyrin-1 Disrupts Malaria Parasite Maturation in Red Blood Cells of Mice	PLOS ONE			English	Article							HEMATOLOGICALLY IMPORTANT MUTATIONS; PLASMODIUM-FALCIPARUM; CYSTEINE PROTEASE; GENETIC-CONTROL; NATURAL-SELECTION; RESISTANCE LOCUS; GENOME-WIDE; SUSCEPTIBILITY; INFECTION; PROTEINS	The blood stage of the plasmodium parasite life cycle is responsible for the clinical symptoms of malaria. Epidemiological studies have identified coincidental malarial endemicity and multiple red blood cell (RBC) disorders. Many RBC disorders result from mutations in genes encoding cytoskeletal proteins and these are associated with increased protection against malarial infections. However the mechanisms underpinning these genetic, host responses remain obscure. We have performed an N-ethyl-N-nitrosourea (ENU) mutagenesis screen and have identified a novel dominant (haploinsufficient) mutation in the Ank-1 gene (Ank1(MRI23420)) of mice displaying hereditary spherocytosis (HS). Female mice, heterozygous for the Ank-1 mutation showed increased survival to infection by Plasmodium chabaudi adami DS with a concomitant 30% decrease in parasitemia compared to wild-type, isogenic mice (wt). A comparative in vivo red cell invasion and parasite growth assay showed a RBC-autonomous effect characterised by decreased proportion of infected heterozygous RBCs. Within approximately 6-8 hours post-invasion, TUNEL staining of intraerythrocytic parasites, showed a significant increase in dead parasites in heterozygotes. This was especially notable at the ring and trophozoite stages in the blood of infected heterozygous mutant mice compared to wt (p<0.05). We conclude that increased malaria resistance due to ankyrin-1 deficiency is caused by the intraerythrocytic death of P. chabaudi parasites.	[Greth, Andreas; Lampkin, Shelley; Mayura-Guru, Preethi; Rodda, Fleur; Drysdale, Karen; Roberts-Thomson, Meredith; McMorran, Brendan J.; Foote, Simon J.; Burgio, Gaetan] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Greth, Andreas; Lampkin, Shelley; McMorran, Brendan J.; Foote, Simon J.; Burgio, Gaetan] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia	University of Tasmania; Macquarie University	Greth, A (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	grburgio@utas.edu.au	Burgio, Gaetan/B-6722-2015; Foote, Simon J/F-2802-2013	Burgio, Gaetan/0000-0002-7434-926X; Foote, Simon/0000-0002-9142-2107; McMorran, Brendan/0000-0003-1845-8872	National Health and Medical Research Council [605524, 490037]; Bill and Melinda Gates Foundation [OPP10070544]; Howard Hughes Medical Institute [55005505]; Department of Innovation, Industry, Science and Research; Tasmania Graduate Research scholarship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Innovation, Industry, Science and Research; Tasmania Graduate Research scholarship	This study was supported by grants from the following institutions; National Health and Medical Research Council Project Grant 605524; Program Grant 490037 (http://www.nhmrc.gov.au/), Bill and Melinda Gates Foundation OPP10070544 (http://www.gatesfoundation.org), Howard Hughes Medical Institute No. 55005505 (www.hhmi.org/), and National Collaborative Research Infrastructure Strategy grant from the Department of Innovation, Industry, Science and Research. (http://ncris.innovation.gov.au). AG is a recipient of a Tasmania Graduate Research scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2008, AM J PHYSIOL-ENDOC M, V294, pE232, DOI 10.1152/ajpendo.00592.2007; Berghout J, 2010, GENES IMMUN, V11, P310, DOI 10.1038/gene.2009.79; Birkenmeier Connie S, 2003, Hematol J, V4, P445, DOI 10.1038/sj.thj.6200307; Burt RA, 2002, INFECT IMMUN, V70, P4750, DOI 10.1128/IAI.70.8.4750-4753.2002; Carvalho LJM, 2010, TRENDS PARASITOL, V26, P271, DOI 10.1016/j.pt.2010.03.001; Chimanuka B, 1999, BIOL RHYTHM RES, V30, P54, DOI 10.1076/brhm.30.1.54.3062; Chishti AH, 1996, BLOOD, V87, P3462, DOI 10.1182/blood.V87.8.3462.bloodjournal8783462; Cooke BM, 2004, SEMIN HEMATOL, V41, P173, DOI 10.1053/j.seminhematol.2004.01.004; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Dhawan S, 2003, J BIOL CHEM, V278, P30180, DOI 10.1074/jbc.M305132200; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Gallagher PG, 1998, BLOOD CELL MOL DIS, V24, P539, DOI 10.1006/bcmd.1998.0217; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; Hanspal M, 2002, BLOOD, V100, P1048, DOI 10.1182/blood-2002-01-0101; Hanspal M, 2000, BBA-GENE STRUCT EXPR, V1493, P242, DOI 10.1016/S0167-4781(00)00159-7; Hernandez-Valladares M, 2005, TRENDS PARASITOL, V21, P352, DOI 10.1016/j.pt.2005.06.010; Hoebe K, 2008, ADV DRUG DELIVER REV, V60, P824, DOI 10.1016/j.addr.2008.02.002; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; Koechl Silvano, 2005, V297, P13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin E, 2006, INFECT IMMUN, V74, P5814, DOI 10.1128/IAI.01690-05; Longley R, 2011, MAMM GENOME, V22, P32, DOI 10.1007/s00335-010-9302-6; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Millholland MG, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010678-1, 10.1074/mcp.M111.010678]; Modiano D, 2001, T ROY SOC TROP MED H, V95, P149, DOI 10.1016/S0035-9203(01)90141-5; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Ohno T, 2001, IMMUNOGENETICS, V53, P736, DOI 10.1007/s00251-001-0390-z; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Randon J, 1997, BRIT J HAEMATOL, V96, P500, DOI 10.1046/j.1365-2141.1997.d01-2074.x; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; Raphael P, 2000, MOL BIOCHEM PARASIT, V110, P259, DOI 10.1016/S0166-6851(00)00283-8; Richer E, 2010, J IMMUNOL, V185, P3593, DOI 10.4049/jimmunol.1000890; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; SCHULMAN S, 1990, P NATL ACAD SCI USA, V87, P7339, DOI 10.1073/pnas.87.18.7339; SHEAR HL, 1991, BRIT J HAEMATOL, V78, P555, DOI 10.1111/j.1365-2141.1991.tb04488.x; SHEAR HL, 1993, EXPERIENTIA, V49, P37, DOI 10.1007/BF01928786; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; STEVENSON MM, 1990, MICROB PATHOGENESIS, V9, P303, DOI 10.1016/0882-4010(90)90065-X; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x; WERTHEIMER SP, 1989, EXP PARASITOL, V69, P340, DOI 10.1016/0014-4894(89)90083-0; YAP GS, 1992, EXP PARASITOL, V75, P340, DOI 10.1016/0014-4894(92)90219-Z; Yates L, 2009, BIOCHEM SOC T, V37, P838, DOI 10.1042/BST0370838; Zimmerman PA, 2003, TRENDS PARASITOL, V19, P250, DOI 10.1016/S1471-4922(03)00112-0	55	23	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38999	10.1371/journal.pone.0038999	http://dx.doi.org/10.1371/journal.pone.0038999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22723917	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700042
J	Anderson, I; Abt, B; Lykidis, A; Klenk, HP; Kyrpides, N; Ivanova, N				Anderson, Iain; Abt, Birte; Lykidis, Athanasios; Klenk, Hans-Peter; Kyrpides, Nikos; Ivanova, Natalia			Genomics of Aerobic Cellulose Utilization Systems in Actinobacteria	PLOS ONE			English	Article							BINDING PROTEIN; SP-NOV.; SEQUENCE; THERMOMONOSPORA; ACTINOMYCETE; BETA-1,4-ENDOGLUCANASE; PURIFICATION; CLONING	Cellulose degrading enzymes have important functions in the biotechnology industry, including the production of biofuels from lignocellulosic biomass. Anaerobes including Clostridium species organize cellulases and other glycosyl hydrolases into large complexes known as cellulosomes. In contrast, aerobic actinobacteria utilize systems comprised of independently acting enzymes, often with carbohydrate binding domains. Numerous actinobacterial genomes have become available through the Genomic Encyclopedia of Bacteria and Archaea (GEBA) project. We identified putative cellulose-degrading enzymes belonging to families GH5, GH6, GH8, GH9, GH12, GH48, and GH51 in the genomes of eleven members of the actinobacteria. The eleven organisms were tested in several assays for cellulose degradation, and eight of the organisms showed evidence of cellulase activity. The three with the highest cellulase activity were Actinosynnema mirum, Cellulomonas flavigena, and Xylanimonas cellulosilytica. Cellobiose is known to induce cellulolytic enzymes in the model organism Thermobifida fusca, but only Nocardiopsis dassonvillei showed higher cellulolytic activity in the presence of cellobiose. In T. fusca, cellulases and a putative cellobiose ABC transporter are regulated by the transcriptional regulator CelR. Nine organisms appear to use the CelR site or a closely related binding site to regulate an ABC transporter. In some, CelR also regulates cellulases, while cellulases are controlled by different regulatory sites in three organisms. Mining of genome data for cellulose degradative enzymes followed by experimental verification successfully identified several actinobacteria species which were not previously known to degrade cellulose as cellulolytic organisms.	[Anderson, Iain; Lykidis, Athanasios; Kyrpides, Nikos; Ivanova, Natalia] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Abt, Birte; Klenk, Hans-Peter] Leibniz Inst DSMZ, German Collect Microorganisms & Cell Cultures, Braunschweig, Germany	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Anderson, I (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	IJAnderson@lbl.gov	Kyrpides, Nikos C./A-6305-2014	Kyrpides, Nikos C./0000-0002-6131-0462; Ivanova, Natalia/0000-0002-5802-9485	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt B, 2010, STAND GENOMIC SCI, V3, P15, DOI 10.4056/sigs.1012662; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Busti E, 2006, INT J SYST EVOL MICR, V56, P1741, DOI 10.1099/ijs.0.63858-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chertkov O, 2011, STAND GENOMIC SCI, V4, P13, DOI 10.4056/sigs.1453580; Copeland A, 2009, STAND GENOMIC SCI, V1, P119, DOI [10.4056/sigs.17259, 10.4056/sigs.29547]; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Foster B, 2010, STAND GENOMIC SCI, V2, P1, DOI 10.4056/sigs.571102; Gilad R, 2003, J BACTERIOL, V185, P391, DOI 10.1128/JB.185.2.391-398.2003; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Land M, 2009, STAND GENOMIC SCI, V1, P46, DOI 10.4056/sigs.21137; LIN SB, 1995, J APPL BACTERIOL, V79, P447, DOI 10.1111/j.1365-2672.1995.tb03160.x; Liolios K, 2010, STAND GENOMIC SCI, V2, P318, DOI 10.4056/sigs.962171; Lykidis A, 2007, J BACTERIOL, V189, P2477, DOI 10.1128/JB.01899-06; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Marushima K, 2009, J BACTERIOL, V191, P5930, DOI 10.1128/JB.00703-09; MCCARTHY AJ, 1984, J GEN MICROBIOL, V130, P5; Mejia-Castillo T, 2008, BIOTECHNOL LETT, V30, P681, DOI 10.1007/s10529-007-9589-x; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Munk C, 2009, STAND GENOMIC SCI, V1, P292, DOI 10.4056/sigs.47643; Nolan M, 2010, STAND GENOMIC SCI, V2, P29, DOI 10.4056/sigs.631049; Pukall R, 2009, STAND GENOMIC SCI, V1, P262, DOI 10.4056/sigs.41646; Rivas R, 2003, INT J SYST EVOL MICR, V53, P99, DOI 10.1099/ijs.0.02207-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlosser A, 1999, APPL ENVIRON MICROB, V65, P2636; Spiridonov NA, 1999, J BIOL CHEM, V274, P13127, DOI 10.1074/jbc.274.19.13127; Spiridonov NA, 2001, CURR MICROBIOL, V42, P295, DOI 10.1007/s002840010220; Stackebrandt E., 1986, BERGEYS MANUAL SYSTE, P1325; Stackebrandt E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P983, DOI 10.1007/0-387-30743-5_40; STUTZENBERGER FJ, 1971, APPL MICROBIOL, V22, P147, DOI 10.1128/AEM.22.2.147-152.1971; Sun H, 2010, STAND GENOMIC SCI, V3, P325, DOI 10.4056/sigs.1363462; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALDRON CR, 1986, APPL MICROBIOL BIOT, V24, P477; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	40	64	65	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39331	10.1371/journal.pone.0039331	http://dx.doi.org/10.1371/journal.pone.0039331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723998	gold, Green Submitted, Green Published			2022-12-25	WOS:000305583300134
J	Palmer, ME; Feldman, MW				Palmer, Michael E.; Feldman, Marcus W.			Survivability Is More Fundamental Than Evolvability	PLOS ONE			English	Article							SPECIES SELECTION; CHANGING ENVIRONMENT; ESCHERICHIA-COLI; EVOLUTION; MUTATION; ADAPTATION; MACROEVOLUTION; INDIVIDUALITY; VARIABILITY; FITNESS	For a lineage to survive over long time periods, it must sometimes change. This has given rise to the term evolvability, meaning the tendency to produce adaptive variation. One lineage may be superior to another in terms of its current standing variation, or it may tend to produce more adaptive variation. However, evolutionary outcomes depend on more than standing variation and produced adaptive variation: deleterious variation also matters. Evolvability, as most commonly interpreted, is not predictive of evolutionary outcomes. Here, we define a predictive measure of the evolutionary success of a lineage that we call the k-survivability, defined as the probability that the lineage avoids extinction for k generations. We estimate the k-survivability using multiple experimental replicates. Because we measure evolutionary outcomes, the initial standing variation, the full spectrum of generated variation, and the heritability of that variation are all incorporated. Survivability also accounts for the decreased joint likelihood of extinction of sub-lineages when they 1) disperse in space, or 2) diversify in lifestyle. We illustrate measurement of survivability with in silico models, and suggest that it may also be measured in vivo using multiple longitudinal replicates. The k-survivability is a metric that enables the quantitative study of, for example, the evolution of 1) mutation rates, 2) dispersal mechanisms, 3) the genotype-phenotype map, and 4) sexual reproduction, in temporally and spatially fluctuating environments. Although these disparate phenomena evolve by well-understood microevolutionary rules, they are also subject to the macroevolutionary constraint of long-term survivability.	[Palmer, Michael E.; Feldman, Marcus W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Palmer, ME (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mep@charles.stanford.edu			National Institutes of Health (NIH) [GM28016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) (http://www.nih.gov/) grant GM28016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKAU BJ, 1973, GENETICS, V74, P171; COOPER WS, 1984, J THEOR BIOL, V107, P603, DOI 10.1016/S0022-5193(84)80135-6; Draghi J, 2009, J EVOLUTION BIOL, V22, P599, DOI 10.1111/j.1420-9101.2008.01663.x; Draghi J, 2008, EVOLUTION, V62, P301, DOI 10.1111/j.1558-5646.2007.00303.x; FELDMAN MW, 1986, P NATL ACAD SCI USA, V83, P4824, DOI 10.1073/pnas.83.13.4824; Gould S. J., 1989, WONDERFUL LIFE BURGE; Gould SJ, 1999, P NATL ACAD SCI USA, V96, P11904, DOI 10.1073/pnas.96.21.11904; GRANTHAM TA, 1995, ANNU REV ECOL SYST, V26, P301; Gregory TR, 2004, PALEOBIOLOGY, V30, P179, DOI 10.1666/0094-8373(2004)030<0179:MHTATC>2.0.CO;2; Griswold CK, 2006, EVOL DEV, V8, P81, DOI 10.1111/j.1525-142X.2006.05077.x; HOULE D, 1992, GENETICS, V130, P195; HULL DL, 1980, ANNU REV ECOL SYST, V11, P311, DOI 10.1146/annurev.es.11.110180.001523; ISHII K, 1989, GENETICS, V121, P163; Jones AG, 2007, EVOLUTION, V61, P727, DOI 10.1111/j.1558-5646.2007.00071.x; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; LEIGH EG, 1970, AM NAT, V104, P301, DOI 10.1086/282663; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Liberman U, 2011, GENETICS, V187, P837, DOI 10.1534/genetics.110.123620; LLOYD EA, 1993, P NATL ACAD SCI USA, V90, P595, DOI 10.1073/pnas.90.2.595; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Palmer ME, 2006, GENETICS, V173, P461, DOI 10.1534/genetics.105.049445; Palmer ME, 2011, EVOLUTION, V65, P2345, DOI 10.1111/j.1558-5646.2011.01283.x; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Salathe M, 2009, GENETICS, V182, P1159, DOI 10.1534/genetics.109.103333; SLOBODKIN LB, 1974, Q REV BIOL, V49, P181, DOI 10.1086/408082; Sterelny K., 2001, CYCLES CONTINGENCY D, P331; THODAY JM, 1953, SYM SOC EXP BIOL, V7, P96; VRBA ES, 1984, SYST ZOOL, V33, P318, DOI 10.2307/2413077; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Waxman D, 1999, GENETICS, V153, P1041; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	31	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38025	10.1371/journal.pone.0038025	http://dx.doi.org/10.1371/journal.pone.0038025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723844	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300018
J	Prchal-Murphy, M; Semper, C; Lassnig, C; Wallner, B; Gausterer, C; Teppner-Klymiuk, I; Kobolak, J; Muller, S; Kolbe, T; Karaghiosoff, M; Dinnyes, A; Rulicke, T; Leitner, NR; Strobl, B; Muller, M				Prchal-Murphy, Michaela; Semper, Christian; Lassnig, Caroline; Wallner, Barbara; Gausterer, Christian; Teppner-Klymiuk, Ingeborg; Kobolak, Julianna; Mueller, Simone; Kolbe, Thomas; Karaghiosoff, Marina; Dinnyes, Andras; Ruelicke, Thomas; Leitner, Nicole R.; Strobl, Birgit; Mueller, Mathias			TYK2 Kinase Activity Is Required for Functional Type I Interferon Responses In Vivo	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; GAMMA-INDUCIBLE GENE; DISTINCT DOMAINS; ALPHA RECEPTOR; EXPRESSION; ACTIVATION; JAK1; PHOSPHORYLATION; INHIBITORS; MICE	Tyrosine kinase 2 (TYK2) is a member of the Janus kinase (JAK) family and is involved in cytokine signalling. In vitro analyses suggest that TYK2 also has kinase-independent, i.e., non-canonical, functions. We have generated gene-targeted mice harbouring a mutation in the ATP-binding pocket of the kinase domain. The Tyk2 kinase-inactive (Tyk2(K923E)) mice are viable and show no gross abnormalities. We show that kinase-active TYK2 is required for full-fledged type I interferon- (IFN) induced activation of the transcription factors STAT1-4 and for the in vivo antiviral defence against viruses primarily controlled through type I IFN actions. In addition, TYK2 kinase activity was found to be required for the protein's stability. An inhibitory function was only observed upon over-expression of TYK2(K923E) in vitro. Tyk2(K923E) mice represent the first model for studying the kinase-independent function of a JAK in vivo and for assessing the consequences of side effects of JAK inhibitors.	[Prchal-Murphy, Michaela; Semper, Christian; Lassnig, Caroline; Wallner, Barbara; Gausterer, Christian; Teppner-Klymiuk, Ingeborg; Mueller, Simone; Karaghiosoff, Marina; Leitner, Nicole R.; Strobl, Birgit; Mueller, Mathias] Univ Vet Med, Inst Genet & Anim Breeding, Vienna, Austria; [Lassnig, Caroline; Kolbe, Thomas; Ruelicke, Thomas; Mueller, Mathias] Univ Vet Med, Biomodels Austria, Vienna, Austria; [Kobolak, Julianna; Dinnyes, Andras] Agr Biotechnol Ctr, Genet Reprogramming Grp, H-2101 Godollo, Hungary; [Kolbe, Thomas] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Vienna, Austria; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci, Vienna, Austria; [Dinnyes, Andras] Szent Istvan Univ, Mol Anim Biotechnol Lab, Godollo, Hungary; [Dinnyes, Andras] BioTalentum Ltd, Godollo, Hungary	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; Hungarian University of Agriculture & Life Sciences; BioTalentum Ltd	Prchal-Murphy, M (corresponding author), Univ Vet Med, Inst Genet & Anim Breeding, Vienna, Austria.	mathias.mueller@vetmeduni.ac.at	; Dinnyes, Andras/D-5131-2013	LASSNIG, Caroline/0000-0001-7905-3620; Dinnyes, Andras/0000-0003-3791-2583; Kobolak, Julianna/0000-0002-0986-9517; Strobl, Birgit/0000-0001-5716-3212; Gausterer, Christian/0000-0002-4875-5459; Muller, Mathias/0000-0002-7879-3552	Austrian Science Fund (FWF, SFB F28); Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse''); EU FP6 "Clonet'' [MRTN-CT-2006-035468]; MedRat [LSHG-CT-2006-518240]; Austrian Science Fund (FWF) [F 2808] Funding Source: researchfish	Austrian Science Fund (FWF, SFB F28)(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse''); EU FP6 "Clonet''; MedRat; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF, SFB F28), the Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III "Austromouse''), EU FP6 "Clonet'' (MRTN-CT-2006-035468) and "MedRat'' (LSHG-CT-2006-518240). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frenzel K, 2006, EXP CELL RES, V312, P2735, DOI 10.1016/j.yexcr.2006.05.004; Gakovic M, 2008, J BIOL CHEM, V283, P18522, DOI 10.1074/jbc.M801427200; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Haan C, 2010, J CELL MOL MED, V14, P504, DOI 10.1111/j.1582-4934.2010.01018.x; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Krishnan K, 1997, EUR J BIOCHEM, V247, P298, DOI 10.1111/j.1432-1033.1997.00298.x; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Mamo S, 2011, WORLD J STEM CELLS, V26, P127; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Potla R, 2006, MOL CELL BIOL, V26, P8562, DOI 10.1128/MCB.00497-06; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Rani MRS, 2007, J INTERF CYTOK RES, V27, P767, DOI 10.1089/jir.2007.0005; Rani MRS, 1999, J BIOL CHEM, V274, P32507, DOI 10.1074/jbc.274.45.32507; Rani MRS, 1999, J BIOL CHEM, V274, P1891, DOI 10.1074/jbc.274.4.1891; Ren JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024496; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Schwarz EM, 1998, J VIROL, V72, P5654, DOI 10.1128/JVI.72.7.5654-5660.1998; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shaw MH, 2003, P NATL ACAD SCI USA, V100, P11594, DOI 10.1073/pnas.1930781100; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Strobl B, 2005, J IMMUNOL, V175, P4000, DOI 10.4049/jimmunol.175.6.4000; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Teppner I, 2004, LAB ANIM-UK, V38, P406, DOI 10.1258/0023677041958882; Tsui V, 2011, PROTEINS, V79, P393, DOI 10.1002/prot.22889; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; Vogl C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-199; Wilks AF, 2008, SEMIN CELL DEV BIOL, V19, P319, DOI 10.1016/j.semcdb.2008.07.020; Wu WT, 2004, BIOCHEM J, V379, P587, DOI 10.1042/BJ20031579; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yeh TC, 2000, P NATL ACAD SCI USA, V97, P8991, DOI 10.1073/pnas.160130297; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	62	48	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39141	10.1371/journal.pone.0039141	http://dx.doi.org/10.1371/journal.pone.0039141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723949	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300102
J	Yang, XD; Liu, XY; Lv, WH; Li, L; Shi, QQ; Yang, JH; Zhang, MF				Yang, Xiaodong; Liu, Xunyan; Lv, Wenhui; Li, Lu; Shi, Qianqian; Yang, Jinghua; Zhang, Mingfang			Reduced Expression of BjRCE1 Gene Modulated by Nuclear-Cytoplasmic Incompatibility Alters Auxin Response in Cytoplasmic Male-Sterile Brassica juncea	PLOS ONE			English	Article							MITOCHONDRIAL RETROGRADE REGULATION; ALTERNATIVE OXIDASE; ARABIDOPSIS-THALIANA; BIOTIC STRESS; PROTEIN RUB1; TUNING FORK; PLANTS; UBIQUITIN; COMMUNICATION; SPECIFICITY	The signal from organelle to nucleus, namely retrograde regulation of nuclear gene expression, was largely unknown. Due to the nuclear-cytoplasmic incompatibility in cytoplasmic male-sterile (CMS) plants, we employed CMS Brassica juncea to investigate the retrograde regulation of nuclear gene expression in this study. We studied how reduced BjRCE1 gene expression caused by the nuclear-cytoplasmic incompatibility altered the auxin response in CMS of B. juncea. We isolated the BjRCE1 gene that was located in the nucleus from B. juncea. Over-expression of BjRCE1 enhanced auxin response in transgenic Arabidopsis. The expression of BjRCE1 was significantly reduced in CMS compared with its maintainer fertile (MF) line of B. juncea. There were fewer lateral roots in CMS than MF under normal and treatment of indole-3-acetic acid (IAA) conditions. Expression patterns of several auxin-related genes together with their phenotypes indicated a reduced auxin response in CMS compared to MF. The phenotypes of auxin response and auxin-related gene expression pattern could be mimicked by inhibiting mitochondrial function in MF. Taken together, we proposed reduced expression of BjRCE1 gene modulated by nuclear-cytoplasmic incompatibility alters auxin response in CMS B. juncea. This may be an important mechanism of retrograde regulation of nuclear gene expression in plants.	[Yang, Xiaodong; Lv, Wenhui; Li, Lu; Shi, Qianqian; Yang, Jinghua; Zhang, Mingfang] Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Xiaodong; Lv, Wenhui; Li, Lu; Shi, Qianqian; Yang, Jinghua; Zhang, Mingfang] Minist Agr, Key Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Liu, Xunyan] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Hangzhou Normal University	Yang, XD (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Germplasm Innovat & Mol Breeding, Hangzhou 310003, Zhejiang, Peoples R China.	yangjinghua@zju.edu.cn	Yang, Jinghua/G-9164-2016		National Natural Science Foundation of China; Zhejiang Province; Ph.D. Programs Foundation of Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China and Zhejiang Province and the Ph.D. Programs Foundation of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Amirsadeghi S, 2007, PHYSIOL PLANTARUM, V129, P253, DOI 10.1111/j.1399-3054.2006.00775.x; Arimura S, 2002, P NATL ACAD SCI USA, V99, P5727, DOI 10.1073/pnas.082663299; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Carlsson J, 2007, PLANT J, V49, P452, DOI 10.1111/j.1365-313X.2006.02975.x; Chen ZhuJun, 1995, Acta Horticulturae Sinica, V22, P40; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Djajanegara I, 2002, PLANT MOL BIOL, V50, P735, DOI 10.1023/A:1019942720636; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Fujii S, 2008, PLANT CELL PHYSIOL, V49, P1484, DOI 10.1093/pcp/pcn102; Fujii S, 2007, PLANT MOL BIOL, V63, P405, DOI 10.1007/s11103-006-9097-8; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Gray GR, 2004, PLANT CELL REP, V23, P497, DOI 10.1007/s00299-004-0848-1; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Ito J, 2006, J PROTEOME RES, V5, P3459, DOI 10.1021/pr060403j; Karpova OV, 2002, PLANT CELL, V14, P3271, DOI 10.1105/tpc.005603; Kaul, 1988, MALE STERILITY HIGHE; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kuzmin EV, 2004, J BIOL CHEM, V279, P20672, DOI 10.1074/jbc.M400640200; LASER KD, 1972, BOT REV, V38, P425, DOI 10.1007/BF02860010; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Liu XY, 2012, PHYSIOL PLANTARUM, V145, P332, DOI 10.1111/j.1399-3054.2012.01588.x; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Rhoads DM, 2005, PHYSIOL PLANTARUM, V123, P435, DOI 10.1111/j.1399-3054.2005.00473.x; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Saisho D, 2001, J PLANT PHYSIOL, V158, P241, DOI 10.1078/0176-1617-00193; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Weijers D, 2004, CURR OPIN PLANT BIOL, V7, P687, DOI 10.1016/j.pbi.2004.09.006; Woo DK, 2009, BBA-GENE REGUL MECH, V1789, P135, DOI 10.1016/j.bbagrm.2008.09.008; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yang JH, 2008, PHYSIOL PLANTARUM, V133, P426, DOI 10.1111/j.1399-3054.2008.01064.x; Yang JH, 2009, MOL BIOL REP, V36, P273, DOI 10.1007/s11033-007-9176-1; Yang JH, 2008, J GENET GENOMICS, V35, P65, DOI 10.1016/S1673-8527(08)60010-7; Yang JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-231; Yu JP, 2001, PLANT PHYSIOL BIOCH, V39, P345, DOI 10.1016/S0981-9428(01)01254-2; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zubko MK, 2004, TRENDS PLANT SCI, V9, P61, DOI 10.1016/j.tplants.2003.12.001	45	5	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e38821	10.1371/journal.pone.0038821	http://dx.doi.org/10.1371/journal.pone.0038821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22719957	Green Submitted, Green Published, gold			2022-12-25	WOS:000305583300055
J	Hause, BM; Collin, EA; Ran, ZG; Zhu, LH; Webby, RJ; Simonson, RR; Li, F				Hause, Ben M.; Collin, Emily A.; Ran, Zhiguang; Zhu, Laihua; Webby, Richard J.; Simonson, Randy R.; Li, Feng			In Vitro Reassortment between Endemic H1N2 and 2009 H1N1 Pandemic Swine Influenza Viruses Generates Attenuated Viruses	PLOS ONE			English	Article							GENETIC COMPATIBILITY; A VIRUSES; PIGS; ADAPTATION; VIRULENCE; PROTEIN; M1	The pandemic H1N1 (pH1N1) influenza virus was first reported in humans in the spring of 2009 and soon thereafter was identified in numerous species, including swine. Reassortant viruses, presumably arising from the co-infection of pH1N1 and endemic swine influenza virus (SIV), were subsequently identified from diagnostic samples collected from swine. In this study, co-infection of swine testicle (ST) cells with swine-derived endemic H1N2 (MN745) and pH1N1 (MN432) yielded two reassortant H1N2 viruses (R1 and R2), both possessing a matrix gene derived from pH1N1. In ST cells, the reassortant viruses had growth kinetics similar to the parental H1N2 virus and reached titers approximately 2 log(10) TCID50/mL higher than the pH1N1 virus, while in A549 cells these viruses had similar growth kinetics. Intranasal challenge of pigs with H1N2, pH1N1, R1 or R2 found that all viruses were capable of infecting and transmitting between direct contact pigs as measured by real time reverse transcription PCR of nasal swabs. Lung samples were also PCR-positive for all challenge groups and influenza-associated microscopic lesions were detected by histology. Interestingly, infectious virus was detected in lung samples for pigs challenged with the parental H1N2 and pH1N1 at levels significantly higher than either reassortant virus despite similar levels of viral RNA. Results of our experiment suggested that the reassortant viruses generated through in vitro cell culture system were attenuated without gaining any selective growth advantage in pigs over the parental lineages. Thus, reassortant influenza viruses described in this study may provide a good system to study genetic basis of the attenuation and its mechanism.	[Hause, Ben M.; Collin, Emily A.; Simonson, Randy R.] Newport Labs, Worthington, MN USA; [Ran, Zhiguang; Zhu, Laihua; Li, Feng] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Hause, Ben M.; Ran, Zhiguang; Zhu, Laihua; Li, Feng] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Webby, Richard J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA	South Dakota State University; South Dakota State University; St Jude Children's Research Hospital	Hause, BM (corresponding author), Newport Labs, Worthington, MN USA.	bhause@newportlabs.com; feng.li@sdstate.edu	Webby, Richard J/N-5657-2018	Li, Feng/0000-0002-8904-2893	Newport Laboratories	Newport Laboratories	This work was funded by Newport Laboratories who, in consultation with the collaborating authors, contributed to the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; GREGORIADES A, 1984, J VIROL, V49, P229, DOI 10.1128/JVI.49.1.229-235.1984; Harmon K, 2010, INFLUENZA OTHER RESP, V4, P405, DOI 10.1111/j.1750-2659.2010.00153.x; Howard WA, 2011, EMERG INFECT DIS, V17, P1049, DOI [10.3201/eid1706.101886, 10.3201/eid/1706.101886]; Howden KJ, 2009, CAN VET J, V50, P1153; Ilyushina NA, 2010, MBIO, V1, DOI 10.1128/mBio.00249-10; Lohr CV, 2010, VET PATHOL, V47, P378, DOI 10.1177/0300985810368393; Ma WJ, 2012, J GEN VIROL, V93, P1261, DOI 10.1099/vir.0.040535-0; McCullers JA, 2005, VIROLOGY, V336, P318, DOI 10.1016/j.virol.2005.03.028; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077; Nfon CK, 2011, J VIROL, V85, P8667, DOI 10.1128/JVI.00801-11; Octaviani CP, 2011, VIRUS RES, V156, P147, DOI 10.1016/j.virusres.2010.12.014; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Song MS, 2011, J VIROL, V85, P6275, DOI 10.1128/JVI.02125-10; Starick E, 2011, J GEN VIROL, V92, P1184, DOI 10.1099/vir.0.028662-0; Swenson SL, 2010, J VET DIAGN INVEST, V22, P784, DOI 10.1177/104063871002200525; Tremblay D, 2011, J CLIN MICROBIOL, V49, P4386, DOI 10.1128/JCM.05676-11; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; Zhu HC, 2011, J VIROL, V85, P10432, DOI 10.1128/JVI.05352-11	25	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e39177	10.1371/journal.pone.0039177	http://dx.doi.org/10.1371/journal.pone.0039177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22720066	gold, Green Published			2022-12-25	WOS:000305341900090
J	Sun, L; Yu, Y; Huang, T; An, P; Yu, DX; Yu, ZJ; Li, HX; Sheng, HG; Cai, L; Xue, J; Jing, M; Li, YX; Lin, X; Wang, FD				Sun, Liang; Yu, Yu; Huang, Tao; An, Peng; Yu, Danxia; Yu, Zhijie; Li, Huaixing; Sheng, Hongguang; Cai, Lu; Xue, Jun; Jing, Miao; Li, Yixue; Lin, Xu; Wang, Fudi			Associations between Ionomic Profile and Metabolic Abnormalities in Human Population	PLOS ONE			English	Article							OXIDATIVE STRESS; MUTUAL INFORMATION; INSULIN-RESISTANCE; BIOLOGICAL SAMPLES; DIABETES-MELLITUS; FEATURE-SELECTION; IRON STORES; VITAMIN-D; TYPE-2; SERUM	Background: Few studies assessed effects of individual and multiple ions simultaneously on metabolic outcomes, due to methodological limitation. Methodology/Principal Findings: By combining advanced ionomics and mutual information, a quantifying measurement for mutual dependence between two random variables, we investigated associations of ion modules/networks with overweight/obesity, metabolic syndrome (MetS) and type 2 diabetes (T2DM) in 976 middle-aged Chinese men and women. Fasting plasma ions were measured by inductively coupled plasma mass spectroscopy. Significant ion modules were selected by mutual information to construct disease related ion networks. Plasma copper and phosphorus always ranked the first two among three specific ion networks associated with overweight/obesity, MetS and T2DM. Comparing the ranking of ion individually and in networks, three patterns were observed (1) "Individual ion," such as potassium and chrome, which tends to work alone; (2) "Module ion," such as iron in T2DM, which tends to act in modules/network; and (3) "odule-individual ion," such as copper in overweight/obesity, which seems to work equivalently in either way. Conclusions: In conclusion, by using the novel approach of the ionomics strategy and the information theory, we observed potential associations of ions individually or as modules/networks with metabolic disorders. Certainly, these findings need to be confirmed in future biological studies.	[Sun, Liang; Yu, Yu; An, Peng; Yu, Danxia; Yu, Zhijie; Li, Huaixing; Lin, Xu; Wang, Fudi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Sun, Liang; Yu, Yu; Huang, Tao; An, Peng; Yu, Danxia; Yu, Zhijie; Li, Huaixing; Li, Yixue; Lin, Xu; Wang, Fudi] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Huang, Tao; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Sheng, Hongguang] Shanghai Xuhui Dist Cent Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Cai, Lu] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA; [Xue, Jun] Nanjing Med Univ, Nanjing People Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China; [Jing, Miao] Agilent Technol Co Ltd, Life Sci & Chem Anal Grp, Shanghai, Peoples R China; [Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Louisville; Nanjing Medical University; Agilent Technologies; Chinese Academy of Sciences	Sun, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	yxli@sibs.ac.cn; xlin@sibs.ac.cn; wangfd@sibs.ac.cn	An, Peng/GWZ-9176-2022; Wang, Fudi/L-7888-2018; Cai, Lu/AAG-9920-2019	Wang, Fudi/0000-0001-8730-0003; Yu, Yu/0000-0003-2291-0606; An, Peng/0000-0002-0421-0035; Yu, Danxia/0000-0002-1710-9382	Ministry of Science and Technology of China (973 Program) [2009CB941400, 2011CB966200, 2011CB504002, 2008DFA31960, 2011CB910200]; National High Technology Research and Development Program (863 Program) [2009AA022704]; National Natural Science Foundation of China [10979071, 30970665, 31030039, 30930081, 81021002, 90913009, 30901193]; Knowledge Innovation Program Project of the Chinese Academy of Sciences [KSCX2-EW-R-10, KSCX2-EW-R-04]; Chinese Academy of Sciences Hundred Talents Program [KSCX2-YW-R-141]; Science & Technology Commission of Shanghai Municipality grant [10JC1416800]; Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2008006]; Clinical Center of Shanghai Xuhui District Central Hospital grant [CRC2010012]; CAS/SAFEA International Partnership Program for Creative Research Teams; China Postdoctoral Science Foundation [20110490751, 2012M510902]; SIBS-CAS Outstanding Youth fellowship [2010KIP309]	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences Hundred Talents Program(Chinese Academy of Sciences); Science & Technology Commission of Shanghai Municipality grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Clinical Center of Shanghai Xuhui District Central Hospital grant; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); SIBS-CAS Outstanding Youth fellowship	This work was supported by research grants from the Ministry of Science and Technology of China (973 Program) (2009CB941400, 2011CB966200 to F. W., 2011CB504002 and 2008DFA31960 to X. L., and 2011CB910200 to Y.L.); the National High Technology Research and Development Program (863 Program) (2009AA022704 to X. L.); the National Natural Science Foundation of China (10979071, 30970665, 31030039 to F. W., 30930081, 81021002 to X. L., 90913009 to Y.L.; 30901193 to Y.Y.); the Knowledge Innovation Program Project of the Chinese Academy of Sciences (KSCX2-EW-R-10 to X. L. and KSCX2-EW-R-04 to Y.L.); Chinese Academy of Sciences Hundred Talents Program (KSCX2-YW-R-141 to F. W.); Science & Technology Commission of Shanghai Municipality grant (10JC1416800 to F. W.); Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006 to X. L.) and Clinical Center of Shanghai Xuhui District Central Hospital grant (CRC2010012 to F. W.), the CAS/SAFEA International Partnership Program for Creative Research Teams and the China Postdoctoral Science Foundation (20110490751 to L. S.; 2012M510902 to Y.Y.) and SIBS-CAS Outstanding Youth fellowship (2010KIP309 to Y.Y.). F. W. is a scholar of the Hundred Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2009, ARCH GYNECOL OBSTET, V280, P415, DOI 10.1007/s00404-009-0955-x; Aguilar V, 2007, ANN NUTR METAB, V51, P402, DOI 10.1159/000108108; Al-Saleh E, 2007, ACTA DIABETOL, V44, P106, DOI 10.1007/s00592-007-0250-x; Alvarez HM, 2010, SCIENCE, V327, P331, DOI 10.1126/science.1179907; CHAITIN GJ, 1975, J ACM, V22, P329, DOI 10.1145/321892.321894; Chonchol M, 2009, AM J MED, V122, P380, DOI 10.1016/j.amjmed.2008.09.039; Collins JF, 2010, NUTR REV, V68, P133, DOI 10.1111/j.1753-4887.2010.00271.x; DEMARTINES P, 1993, LECT NOTES COMPUTER, V686, P328; Deng ZP, 2009, BIOMETALS, V22, P803, DOI 10.1007/s10534-009-9227-2; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; Gan W, 2012, AM J CLIN NUTR, V95, P626, DOI 10.3945/ajcn.111.025684; Gozdasoglu S, 2003, BIOL TRACE ELEM RES, V91, P191, DOI 10.1385/BTER:91:2:191; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guerrero-Romero F, 2002, ACTA DIABETOL, V39, P209, DOI 10.1007/s005920200036; Guo CH, 2011, CLIN BIOCHEM, V44, P275, DOI 10.1016/j.clinbiochem.2010.12.017; Hopping BN, 2010, J NUTR, V140, P68, DOI 10.3945/jn.109.112441; Huang Tao, 2011, International Journal of Computational Biology and Drug Design, V4, P5, DOI 10.1504/IJCBDD.2011.038654; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Jumaan Raba'a M, 2008, Sultan Qaboos Univ Med J, V8, P291; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; Kumar PTK, 2011, COMPUT BIOL MED, V41, P357, DOI 10.1016/j.compbiomed.2011.03.013; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Larsson TE, 2010, ARTERIOSCL THROM VAS, V30, P333, DOI 10.1161/ATVBAHA.109.196675; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Liu ZP, 2011, MOL BIOSYST, V7, P1441, DOI 10.1039/c0mb00325e; Malavolta M, 2010, BIOGERONTOLOGY, V11, P309, DOI 10.1007/s10522-009-9251-1; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Marreiro DD, 2006, BIOL TRACE ELEM RES, V112, P109, DOI 10.1385/BTER:112:2:109; Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9; Naziroglu M, 2009, NEUROCHEM RES, V34, P2181, DOI 10.1007/s11064-009-0015-8; Ogra Y, 1999, J INORG BIOCHEM, V75, P199, DOI 10.1016/S0162-0134(99)00057-4; Onufrak SJ, 2008, ATHEROSCLEROSIS, V199, P424, DOI 10.1016/j.atherosclerosis.2007.11.004; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ozata M, 2002, CLIN BIOCHEM, V35, P627, DOI 10.1016/S0009-9120(02)00363-6; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Persichini T, 2006, ANTIOXID REDOX SIGN, V8, P1897, DOI 10.1089/ars.2006.8.1897; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Rea PA, 2003, NAT BIOTECHNOL, V21, P1149, DOI 10.1038/nbt1003-1149; Flores CR, 2011, DIABETES RES CLIN PR, V91, P333, DOI 10.1016/j.diabres.2010.12.014; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Salt DE, 2004, PLANT PHYSIOL, V136, P2451, DOI 10.1104/pp.104.047753; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Skalnaya MG, 2007, J TRACE ELEM MED BIO, V21, P59, DOI 10.1016/j.jtemb.2007.09.019; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Szpunar J, 2004, ANAL BIOANAL CHEM, V378, P54, DOI 10.1007/s00216-003-2333-z; Szymczak Silke, 2007, BMC Proc, V1 Suppl 1, pS9; Tanaka A, 2009, ENDOCR J, V56, P699, DOI 10.1507/endocrj.K09E-051; Tourassi GD, 2001, MED PHYS, V28, P2394, DOI 10.1118/1.1418724; Viktorinova A, 2009, METABOLISM, V58, P1477, DOI 10.1016/j.metabol.2009.04.035; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; Zhao T, 2009, ANAL CHEM, V81, P3683, DOI 10.1021/ac900311q	61	61	66	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2012	7	6							e38845	10.1371/journal.pone.0038845	http://dx.doi.org/10.1371/journal.pone.0038845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UV	22719963	Green Submitted, gold, Green Published			2022-12-25	WOS:000305341900054
J	Chen, MJ; Lin, CY; Wu, YT; Wu, PC; Lung, SC; Su, HJ				Chen, Mu-Jean; Lin, Chuan-Yao; Wu, Yi-Ting; Wu, Pei-Chih; Lung, Shih-Chun; Su, Huey-Jen			Effects of Extreme Precipitation to the Distribution of Infectious Diseases in Taiwan, 1994-2008	PLOS ONE			English	Article							CLIMATE-CHANGE; BACILLARY DYSENTERY; POTENTIAL IMPACTS; UNITED-STATES; RAINFALL; MELIOIDOSIS; VARIABILITY; OUTBREAK; HEALTH; LEPTOSPIROSIS	The incidence of extreme precipitation has increased with the exacerbation of worldwide climate disruption. We hypothesize an association between precipitation and the distribution patterns that would affect the endemic burden of 8 infectious diseases in Taiwan, including water- and vector-borne infectious diseases. A database integrating daily precipitation and temperature, along with the infectious disease case registry for all 352 townships in the main island of Taiwan was analysed for the period from 1994 to 2008. Four precipitation levels, <130 mm, 130-200 mm, 200-350 mm and >350 mm, were categorized to represent quantitative differences, and their associations with each specific disease was investigated using the Generalized Additive Mixed Model and afterwards mapped on to the Geographical Information System. Daily precipitation levels were significantly correlated with all 8 mandatory-notified infectious diseases in Taiwan. For water-borne infections, extreme torrential precipitation (>350 mm/day) was found to result in the highest relative risk for bacillary dysentery and enterovirus infections when compared to ordinary rain (<130 mm/day). Yet, for vector-borne diseases, the relative risk of dengue fever and Japanese encephalitis increased with greater precipitation only up to 350 mm. Differential lag effects following precipitation were statistically associated with increased risk for contracting individual infectious diseases. This study's findings can help health resource sector management better allocate medical resources and be better prepared to deal with infectious disease outbreaks following future extreme precipitation events.	[Chen, Mu-Jean; Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Lin, Chuan-Yao; Lung, Shih-Chun] Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan; [Wu, Yi-Ting] Fdn Taiwan Ind Serv, Dept Occupat Safety, Taipei, Taiwan; [Wu, Pei-Chih] Chang Jung Christian Univ, Dept Occupat Safety & Hlth, Tainan, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; Chang Jung Christian University	Chen, MJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw	Lung, Shih-Chun Candice/ABA-1011-2020; Lung, Shih-Chun Candice/GYD-5623-2022; Lin, CY/K-6503-2014; lin, chuan/HHD-2571-2022	Lung, Shih-Chun Candice/0000-0002-4227-0469; Lung, Shih-Chun Candice/0000-0002-4227-0469; Lin, CY/0000-0002-0005-7088; Su, Huey-Jen/0000-0003-3589-9987	Taiwan National Science Council [NSC95-2625-Z-006-018, NSC96-2625-Z-006-016, NSC97-2625-Z-006-016, NSC99-2621-M-006-008]; Taiwan's Centers for Diseases Control [DOH98-DC-1002]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taiwan's Centers for Diseases Control	This supplement received financial support from the Taiwan National Science Council [http://web1.nsc.gov.tw/] (NSC95-2625-Z-006-018, NSC96-2625-Z-006-016, NSC97-2625-Z-006-016, NSC99-2621-M-006-008) and Taiwan's Centers for Diseases Control [http://www.cdc.gov.tw/mp.asp?mp=1] (DOH98-DC-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar R, 1996, LANCET, V348, P1457, DOI 10.1016/S0140-6736(04)70109-9; Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Benitez MA, 2009, LANCET, V373, P1070, DOI 10.1016/S0140-6736(09)60634-6; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; Bi P, 2003, VECTOR-BORNE ZOONOT, V3, P111, DOI 10.1089/153036603768395807; Brockmann S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-91; Centers for Disease Control (CDC) Taiwan, TAIW SURV SYST; Chen VYJ, 2010, SCI TOTAL ENVIRON, V408, P2042, DOI 10.1016/j.scitotenv.2009.11.044; Chou DW, 2007, J FORMOS MED ASSOC, V106, P1013, DOI 10.1016/S0929-6646(08)60077-7; Corkeron ML, 2010, EPIDEMIOL INFECT, V138, P1346, DOI 10.1017/S0950268809991634; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Davis J.C., 1986, STAT DATA ANAL GEOLO; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Dura G, 2010, J WATER HEALTH, V8, P513, DOI 10.2166/wh.2010.099; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; ECHEVERRIA P, 1983, DIAGN MICR INFEC DIS, V1, P193, DOI 10.1016/0732-8893(83)90018-4; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Ge XY, 2010, ATMOS SCI LETT, V11, P46, DOI 10.1002/asl.255; Greenough G, 2001, ENVIRON HEALTH PERSP, V109, P191, DOI 10.2307/3435009; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Hong CC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042761; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; Hung MN, 2009, TAIWAN EPIDEMIOL B, V25, P625; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; Islam MS, 2009, T ROY SOC TROP MED H, V103, P1165, DOI 10.1016/j.trstmh.2009.04.016; Jean JS, 2006, J APPL MICROBIOL, V101, P1224, DOI 10.1111/j.1365-2672.2006.03025.x; Lai SK, 2010, TAIWAN EPIDEMIOL B, V26, P178; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Liu SC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040218; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Majani BS, 2007, ANAL EXTERNAL DRIFT; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2008, LANCET, V371, P1895, DOI 10.1016/S0140-6736(08)60811-9; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Pappachan MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1054, DOI 10.1136/jech.2003.018556; Patz JA, 2008, AM J PREV MED, V35, P451, DOI 10.1016/j.amepre.2008.08.026; Qin Juan, 2009, Wei Sheng Yan Jiu, V38, P762; Robertson J, 2010, AM J TROP MED HYG, V82, P88, DOI 10.4269/ajtmh.2010.09-0226; Sam IC, 2007, J INFECTION, V54, P519, DOI 10.1016/j.jinf.2006.07.007; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Shiu CJ, 2009, J CLIMATE, V22, P5635, DOI 10.1175/2009JCLI2514.1; Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931; Slack AT, 2006, EPIDEMIOL INFECT, V134, P1217, DOI 10.1017/S0950268806006352; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Su HP, 2007, EMERG INFECT DIS, V13, P1795, DOI 10.3201/eid1311.061461; SUPUTTAMONGKOL Y, 1994, INT J EPIDEMIOL, V23, P1082, DOI 10.1093/ije/23.5.1082; The Taiwan Central Weather Bureau, PREC CLASS; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; van der Linden P.J, 2007, CLIMATE CHANGE 2007, P391; Vecchi GA, 2007, NATURE, V450, P1066, DOI 10.1038/nature06423; WENIGER BG, 1983, AM J PUBLIC HEALTH, V73, P868, DOI 10.2105/AJPH.73.8.868; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wu PC, 2011, OCCUP ENVIRON MED, V68, P525, DOI 10.1136/oem.2010.056168; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002	60	185	204	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e34651	10.1371/journal.pone.0034651	http://dx.doi.org/10.1371/journal.pone.0034651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737206	Green Submitted, gold, Green Published			2022-12-25	WOS:000305695100001
J	Zhang, JX; Han, BC; Wei, XN; Tan, CY; Chen, YZ; Jiang, YY				Zhang, Jingxian; Han, Bucong; Wei, Xiaona; Tan, Chunyan; Chen, Yuzong; Jiang, Yuyang			A Two-Step Target Binding and Selectivity Support Vector Machines Approach for Virtual Screening of Dopamine Receptor Subtype-Selective Ligands	PLOS ONE			English	Article							LARGE COMPOUND LIBRARIES; D-3 RECEPTOR; PARKINSONS-DISEASE; CURRENT PERSPECTIVES; MEDICINAL CHEMISTRY; RECENT PROGRESS; DRUG-DISCOVERY; FINGERPRINTS; QSAR; CLASSIFICATION	Target selective drugs, such as dopamine receptor (DR) subtype selective ligands, are developed for enhanced therapeutics and reduced side effects. In silico methods have been explored for searching DR selective ligands, but encountered difficulties associated with high subtype similarity and ligand structural diversity. Machine learning methods have shown promising potential in searching target selective compounds. Their target selective capability can be further enhanced. In this work, we introduced a new two-step support vector machines target-binding and selectivity screening method for searching DR subtype-selective ligands, which was tested together with three previously-used machine learning methods for searching D1, D2, D3 and D4 selective ligands. It correctly identified 50.6%-88.0% of the 21-408 subtype selective and 71.7%-81.0% of the 39-147 multi-subtype ligands. Its subtype selective ligand identification rates are significantly better than, and its multi-subtype ligand identification rates are comparable to the best rates of the previously used methods. Our method produced low false-hit rates in screening 13.56 M PubChem, 168,016 MDDR and 657,736 ChEMBLdb compounds. Molecular features important for subtype selectivity were extracted by using the recursive feature elimination feature selection method. These features are consistent with literature-reported features. Our method showed similar performance in searching estrogen receptor subtype selective ligands. Our study demonstrated the usefulness of the two-step target binding and selectivity screening method in searching subtype selective ligands from large compound libraries.	[Zhang, Jingxian; Tan, Chunyan; Chen, Yuzong; Jiang, Yuyang] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China; [Zhang, Jingxian; Han, Bucong; Wei, Xiaona; Chen, Yuzong] Natl Univ Singapore, Ctr Computat Sci & Engn, Dept Pharm, Bioinformat & Drug Design Grp, Singapore 117548, Singapore; [Han, Bucong; Wei, Xiaona] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Zhang, JX (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China.	phacyz@nus.edu.sg; jiangyy@sz.tsinghua.edu.cn	Zhang, Jing/GWZ-7332-2022; jiang, yu/HGU-0029-2022; Tan, Chunyan/F-2785-2012	Tan, Chunyan/0000-0002-4263-2175; Chen, Yu Zong/0000-0002-5473-8022; Sarkar, Indra Neil/0000-0003-2054-7356	Academic Research Funds Singapore [R-148-000-081-112]; Ministry of Science and Technology; 863 Hi-Tech Program China [2007AA02Z160]; Key Special Project [009ZX09501-004]; Ministry of Science and Technology, China	Academic Research Funds Singapore(Ministry of Education, Singapore); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 863 Hi-Tech Program China(National High Technology Research and Development Program of China); Key Special Project; Ministry of Science and Technology, China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea)	The authors acknowledge the support from Academic Research Funds Singapore (R-148-000-081-112), Ministry of Science and Technology, 863 Hi-Tech Program China (2007AA02Z160), Key Special Project Grant 009ZX09501-004. Y.Z. Chen is supported by Academic Research Funds Singapore. Y.Y. Jiang is supported by the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersen M, 2010, EXPERT OPIN EMERG DR, V15, P467, DOI 10.1517/14728214.2010.480973; Aloisi G, 2011, NEUROPHARMACOLOGY, V60, P439, DOI 10.1016/j.neuropharm.2010.10.018; Audouze K, 2004, J MED CHEM, V47, P3089, DOI 10.1021/jm031111m; Bellis LJ, 2011, BIOCHEM SOC T, V39, P1365, DOI 10.1042/BST0391365; Bender A, 2006, J CHEM INF MODEL, V46, P2445, DOI 10.1021/ci600197y; Boeckler F, 2006, PHARMACOL THERAPEUT, V112, P281, DOI 10.1016/j.pharmthera.2006.04.007; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Carro L, 2009, BIOORG MED CHEM LETT, V19, P6059, DOI 10.1016/j.bmcl.2009.09.041; Cha MY, 2003, BIOORGAN MED CHEM, V11, P1293, DOI 10.1016/S0968-0896(02)00617-X; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cho DI, 2010, ARCH PHARM RES, V33, P1521, DOI 10.1007/s12272-010-1005-8; Clark RD, 2009, J COMPUT AID MOL DES, V23, P765, DOI 10.1007/s10822-008-9227-2; Czerminski R, 2001, QUANT STRUCT-ACT REL, V20, P227, DOI 10.1002/1521-3838(200110)20:3<227::AID-QSAR227>3.0.CO;2-Y; Durrant JD, 2010, CURR OPIN PHARMACOL, V10, P770, DOI 10.1016/j.coph.2010.09.001; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Enguehard-Gueiffier C, 2006, CURR MED CHEM, V13, P2981, DOI 10.2174/092986706778521841; Erhan D, 2006, J CHEM INF MODEL, V46, P626, DOI 10.1021/ci050367t; Givehchi A, 2006, J CHEM INF MODEL, V46, P1078, DOI 10.1021/ci0500233; Han LY, 2008, J MOL GRAPH MODEL, V26, P1276, DOI 10.1016/j.jmgm.2007.12.002; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Herm L, 2009, BIOORGAN MED CHEM, V17, P4756, DOI 10.1016/j.bmc.2009.04.047; Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huber D, 2009, J MED CHEM, V52, P6860, DOI 10.1021/jm901120h; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Johnson R, 1982, APPL MULTIVARIATE ST; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Li H, 2007, J PHARM SCI-US, V96, P2838, DOI 10.1002/jps.20985; Li ZR, 2007, BIOTECHNOL BIOENG, V97, P389, DOI 10.1002/bit.21214; Liu XH, 2009, J CHEM INF MODEL, V49, P2101, DOI 10.1021/ci900135u; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Lober S, 2009, CHEMMEDCHEM, V4, P325, DOI 10.1002/cmdc.200800395; Lopez L, 2010, CHEMMEDCHEM, V5, P1300, DOI 10.1002/cmdc.201000101; Ma XH, 2010, MOL PHARMACEUT, V7, P1545, DOI 10.1021/mp100179t; Ma XH, 2009, COMB CHEM HIGH T SCR, V12, P344, DOI 10.2174/138620709788167944; Mahe P, 2009, COMB CHEM HIGH T SCR, V12, P409, DOI 10.2174/138620709788167926; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McCall RB, 2005, J PHARMACOL EXP THER, V314, P1248, DOI 10.1124/jpet.105.084202; Micheli F, 2011, CHEMMEDCHEM, V6, P1152, DOI 10.1002/cmdc.201000538; Michielan L, 2009, J CHEM INF MODEL, V49, P2588, DOI 10.1021/ci900299a; Mishra Nitish K., 2010, BMC Pharmacology, V10, P8, DOI 10.1186/1471-2210-10-8; Monge A, 2006, MOL DIVERS, V10, P389, DOI 10.1007/s11030-006-9033-5; Overington John, 2009, J Comput Aided Mol Des, V23, P195, DOI 10.1007/s10822-009-9260-9; Pilla M, 1999, NATURE, V400, P371, DOI 10.1038/43944; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Renner S, 2008, J CHEM INF MODEL, V48, P319, DOI 10.1021/ci7003626; Salama I, 2007, J MED CHEM, V50, P489, DOI 10.1021/jm0611152; Sato T, 2010, J CHEM INF MODEL, V50, P170, DOI 10.1021/ci900382e; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Shi Z, 2012, J MOL GRAPH MODEL, V32, P49, DOI 10.1016/j.jmgm.2011.09.002; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; Singer C, 2007, MOVEMENT DISORD, V22, P476, DOI 10.1002/mds.21361; Sprous DG, 2010, CURR TOP MED CHEM, V10, P619, DOI 10.2174/156802610791111506; Sun HM, 2008, CURR MED CHEM, V15, P1018, DOI 10.2174/092986708784049630; Talevi A, 2009, CURR COMPUT-AID DRUG, V5, P23, DOI 10.2174/157340909787580854; Trotter MWB, 2001, MEAS CONTROL-UK, V34, P235, DOI 10.1177/002029400103400803; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Tsoumakas G, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P667, DOI 10.1007/978-0-387-09823-4_34; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Verheij HJ, 2006, MOL DIVERS, V10, P377, DOI 10.1007/s11030-006-9040-6; Wang Q, 2010, J CHEM INF MODEL, V50, P1970, DOI 10.1021/ci1002747; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wester MJ, 2008, J CHEM INF MODEL, V48, P1311, DOI 10.1021/ci700342h; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Willett P, 2011, METHODS MOL BIOL, V672, P133, DOI 10.1007/978-1-60761-839-3_5; Xue Y, 2004, J CHEM INF COMP SCI, V44, P1630, DOI 10.1021/ci049869h; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zeng CY, 2011, HYPERTENSION, V57, P11, DOI 10.1161/HYPERTENSIONAHA.110.157727; Zhang A, 2007, CHEM REV, V107, P274, DOI 10.1021/cr050263h; Zhang J, 2009, MED RES REV, V29, P272, DOI 10.1002/med.20130; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019	74	246	265	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39076	10.1371/journal.pone.0039076	http://dx.doi.org/10.1371/journal.pone.0039076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720033	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350000037
J	Zhou, X; Marian, C; Makambi, KH; Kosti, O; Kallakury, BVS; Loffredo, CA; Zheng, YL				Zhou, Xin; Marian, Catalin; Makambi, Kepher H.; Kosti, Ourania; Kallakury, Bhaskar V. S.; Loffredo, Christopher A.; Zheng, Yun-Ling			MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status	PLOS ONE			English	Article							CONSERVING THERAPY; EXPRESSION PROFILES; EPIGENETIC REGULATION; RISK-FACTORS; CELL; CARCINOMAS; MASTECTOMY; SURVIVAL; SURGERY; RADIOTHERAPY	MicroRNAs (miRs) are small, non-protein coding transcripts involved in many cellular functions. Many miRs have emerged as important cancer biomarkers. In the present study, we investigated whether miR levels in breast tumors are predictive of breast cancer local recurrence (LR). Sixty-eight women who were diagnosed with breast cancer at the Lombardi Comprehensive Cancer Center were included in this study. Breast cancer patients with LR and those without LR were matched on year of surgery, age at diagnosis, and type of surgery. Candidate miRs were identified by screening the expression levels of 754 human miRs using miR arrays in 16 breast tumor samples from 8 cases with LR and 8 cases without LR. Eight candidate miRs that showed significant differences between tumors with and without LR were further verified in 52 tumor samples using real-time PCR. Higher expression of miR-9 was significantly associated with breast cancer LR in all cases as well as the subset of estrogen receptor (ER) positive cases (p = 0.02). The AUCs (Area Under Curve) of receiver operating characteristic (ROC) curves of miR-9 for all tumors and ER positive tumors are 0.68 (p = 0.02) and 0.69 (p = 0.02), respectively. In ER positive cases, Kaplan-Meier analysis showed that patients with lower miR-9 levels had significantly better 10-year LR-free survival (67.9% vs 30.8%, p = 0.02). Expression levels of miR-9 and another miR candidate, miR-375, were also strongly associated with ER status (p<0.001 for both). The potential of miR-9 as a biomarker for LR warrants further investigation with larger sample size.	[Zhou, Xin; Marian, Catalin; Makambi, Kepher H.; Kosti, Ourania; Loffredo, Christopher A.; Zheng, Yun-Ling] Georgetown Univ, Canc Prevent & Control Program, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Kallakury, Bhaskar V. S.] Georgetown Univ, Dept Pathol, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University; Georgetown University	Zhou, X (corresponding author), Georgetown Univ, Canc Prevent & Control Program, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	yz37@georgetown.edu	Marian, Catalin/P-2885-2019; Marian, Catalin/B-1750-2012	Marian, Catalin/0000-0002-7749-1384; Marian, Viorica/0000-0002-8335-1433	Susan G Komen for the Cure [BCTR0707157]; CMESR (Clinical and Molecular Epidemiology Shared Resource); HTSR (Histopathology and Tissue Shared Resource); GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health] [P30 CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); CMESR (Clinical and Molecular Epidemiology Shared Resource); HTSR (Histopathology and Tissue Shared Resource); GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health]; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from Susan G Komen for the Cure [BCTR0707157 to YZ, ww5.komen.org/] and by the CMESR (Clinical and Molecular Epidemiology Shared Resource), HTSR (Histopathology and Tissue Shared Resource) and GESR (Genomics & Epigenomics Shared Resource) of the Lombardi Comprehensive Cancer Center [National Institutes of Health grant P30 CA51008, www.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Basu Aruna, 2011, Genes Cancer, V2, P108, DOI 10.1177/1947601911409212; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; BORGER J, 1994, J CLIN ONCOL, V12, P653, DOI 10.1200/JCO.1994.12.4.653; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Elkhuizen PHM, 1998, INT J RADIAT ONCOL, V40, P859, DOI 10.1016/S0360-3016(97)00917-6; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Iorio MV, 2008, EUR J CANCER, V44, P2753, DOI 10.1016/j.ejca.2008.09.037; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Kim N, 2011, HEPATOL RES, V41, P170, DOI 10.1111/j.1872-034X.2010.00752.x; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Kong KL, 2011, GUT; Kreike B, 2006, CLIN CANCER RES, V12, P5705, DOI 10.1158/1078-0432.CCR-06-0805; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li XL, 2011, DIGEST DIS SCI, V56, P2849, DOI 10.1007/s10620-011-1711-1; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Magee B, 1996, RADIOTHER ONCOL, V39, P223, DOI 10.1016/0167-8140(96)01747-1; Mazar J, 2011, FEBS LETT, V585, P2467, DOI 10.1016/j.febslet.2011.06.025; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Nuyten DSA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1614; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Shigehara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023584; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tan HX, 2010, MED ONCOL, V27, P654, DOI 10.1007/s12032-009-9264-2; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Voogd AC, 1999, EUR J CANCER, V35, P1828, DOI 10.1016/S0959-8049(99)00220-8; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Yu L, 2010, INT J CANC; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758; Zhu L, 2011, MED ONCOL	54	116	121	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39011	10.1371/journal.pone.0039011	http://dx.doi.org/10.1371/journal.pone.0039011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22916227	Green Published, gold, Green Submitted			2022-12-25	WOS:000305583300080
J	Zhang, JB; Hanner, R				Zhang, Junbin; Hanner, Robert			Molecular Approach to the Identification of Fish in the South China Sea	PLOS ONE			English	Article							GENETIC-DIVERGENCE; MITOCHONDRIAL PSEUDOGENES; DNA BARCODES; REEF; POPULATIONS; EVOLUTION; DASCYLLUS; SYSTEM	Background: DNA barcoding is one means of establishing a rapid, accurate, and cost-effective system for the identification of species. It involves the use of short, standard gene targets to create sequence profiles of known species against sequences of unknowns that can be matched and subsequently identified. The Fish Barcode of Life (FISH-BOL) campaign has the primary goal of gathering DNA barcode records for all the world's fish species. As a contribution to FISH-BOL, we examined the degree to which DNA barcoding can discriminate marine fishes from the South China Sea. Methodology/Principal Findings: DNA barcodes of cytochrome oxidase subunit I (COI) were characterized using 1336 specimens that belong to 242 species fishes from the South China Sea. All specimen provenance data (including digital specimen images and geospatial coordinates of collection localities) and collateral sequence information were assembled using Barcode of Life Data System (BOLD; www.barcodinglife.org). Small intraspecific and large interspecific differences create distinct genetic boundaries among most species. In addition, the efficiency of two mitochondrial genes, 16S rRNA (16S) and cytochrome b (cytb), and one nuclear ribosomal gene, 18S rRNA (18S), was also evaluated for a few select groups of species. Conclusions/Significance: The present study provides evidence for the effectiveness of DNA barcoding as a tool for monitoring marine biodiversity. Open access data of fishes from the South China Sea can benefit relative applications in ecology and taxonomy.	[Zhang, Junbin] Shanghai Ocean Univ, Dept Aquaculture & Life Sci, Shanghai, Peoples R China; [Zhang, Junbin; Hanner, Robert] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Shanghai Ocean University; University of Guelph	Zhang, JB (corresponding author), Shanghai Ocean Univ, Dept Aquaculture & Life Sci, Shanghai, Peoples R China.	jb-zhang@shou.edu.cn	Zhang, Jing/GWZ-7332-2022; jiang, yu/HGU-0029-2022; Tan, Chunyan/F-2785-2012	Tan, Chunyan/0000-0002-4263-2175; Chen, Yu Zong/0000-0002-5473-8022; Sarkar, Indra Neil/0000-0003-2054-7356	Genome Canada (through the Ontario Genomics Institute); Chinese National Funding awards [40776089, U0633007]	Genome Canada (through the Ontario Genomics Institute)(Genome Canada); Chinese National Funding awards	This research was supported through funding to the Canadian Barcode of Life Network from Genome Canada (through the Ontario Genomics Institute) and by Chinese National Funding awards 40776089 and U0633007, which supported specimen collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernardi G, 2002, P ROY SOC B-BIOL SCI, V269, P599, DOI 10.1098/rspb.2001.1922; Bernardi G, 2001, MAR BIOL, V138, P457, DOI 10.1007/s002270000484; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Chakrabarty Prosanta, 2010, Marine Biodiversity, V40, P107, DOI 10.1007/s12526-010-0037-0; Chen JTF, 1986, SYNOPSIS VERTEBRATES; Chenoweth SF, 1997, J FISH BIOL, V50, P721, DOI 10.1006/jfbi.1996.0336; Comi G, 2005, FOOD CONTROL, V16, P37, DOI 10.1016/j.foodcont.2003.11.003; Cui ZX, 2010, ICHTHYOL RES, V57, P32, DOI 10.1007/s10228-009-0119-9; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Doyle JJ, 2000, PLANT MOL BIOL, V42, P1, DOI 10.1023/A:1006349518932; Dudgeon CL, 2000, MAR BIOL, V137, P1059, DOI 10.1007/s002270000403; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Greenstone MH, 2005, MOL ECOL, V14, P3247, DOI 10.1111/j.1365-294X.2005.02628.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HANNER R, 2005, PROPOSED STANDARDS B; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellberg ME, 2002, B MAR SCI, V70, P273; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Liu Jing, 2002, Studia Marina Sinica, V44, P240; Lucy K, 2010, UNDERGRADUATE RES J; NEI M, 2000, MOL EVOLUTION PHYLOG; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Parin NV, 2004, J ICHTHYOLOGY S1, V44, P33; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Piganeau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016342; Planes S, 2001, EVOLUTION, V55, P2263; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Ruedas LA, 2000, MOL PHYLOGENET EVOL, V17, P129, DOI 10.1006/mpev.2000.0737; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P204, DOI 10.1603/0013-8746(2006)099[0204:DBATIL]2.0.CO;2; Shen SC, COASTAL FISHES TAIWA, P180; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sparks JS, 2005, CLADISTICS, V21, P305, DOI 10.1111/j.1096-0031.2005.00067.x; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Swartz ER, 2008, S AFR J SCI, V104, P293; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Tuckey JW, 1977, EXPLORATORY DATA ANA, P688; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Victor BC, 2009, ZOOTAXA, P24; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xiao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015067; Zhang JB, 2004, J EXP MAR BIOL ECOL, V298, P3, DOI 10.1016/S0022-0981(03)00341-1; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	62	246	265	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30621	10.1371/journal.pone.0030621	http://dx.doi.org/10.1371/journal.pone.0030621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22720033	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600041
J	Liao, MZ; Nie, XJ; Pan, RJ; Wang, CX; Ruan, SM; Zhang, CQ; Kang, DM; Fu, JH; Qian, YS; Tao, XR; Zhao, JK				Liao, Meizhen; Nie, Xijuan; Pan, Rongjian; Wang, Chuangxin; Ruan, Shiman; Zhang, Changqing; Kang, Dianming; Fu, Jihua; Qian, Yuesheng; Tao, Xiaorun; Zhao, Jinkou			Consistently Low Prevalence of Syphilis among Female Sex Workers in Jinan, China: Findings from Two Consecutive Respondent Driven Sampling Surveys	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; METHAMPHETAMINE USE; HIV PREVALENCE; RISK; MEN; INFECTION; PROVINCE; TRIAL	Background: Routine surveillance using convenient sampling found low prevalence of HIV and syphilis among female sex workers in China. Two consecutive surveys using respondent driven sampling were conducted in 2008 and 2009 to examine the prevalence of HIV and syphilis among female sex workers in Jinan, China. Methods: A face-to-face interview was conducted to collect demographic, behavioral and service utilization information using a structured questionnaire. Blood samples were drawn for serological tests of HIV-1 antibody and syphilis antibody. Respondent Driven Sampling Analysis Tool was used to generate population level estimates. Results: In 2008 and in 2009, 363 and 432 subjects were recruited and surveyed respectively. Prevalence of syphilis was 2.8% in 2008 and 2.2% in 2009, while no HIV case was found in both years. Results are comparable to those from routine sentinel surveillance system in the city. Only 60.8% subjects in 2008 and 48.3% in 2009 reported a consistent condom use with clients during the past month. Over 50% subjects had not been covered by any HIV-related services in the past year, with only 15.6% subjects in 2008 and 13.1% in 2009 ever tested for HIV. Conclusions: Despite the low prevalence of syphilis and HIV, risk behaviors are common. Targeted interventions to promote the safe sex and utilization of existing intervention services are still needed to keep the epidemic from growing.	[Liao, Meizhen; Kang, Dianming; Fu, Jihua; Qian, Yuesheng; Tao, Xiaorun] Shandong Prov Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Nie, Xijuan; Pan, Rongjian; Wang, Chuangxin] Licheng Dist Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Ruan, Shiman; Zhang, Changqing] Jinan Municipal Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Monitoring & Evaluat Unit, Geneva, Switzerland		Liao, MZ (corresponding author), Shandong Prov Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Jinan, Shandong Provin, Peoples R China.	jinkou.zhao@theglobalfund.org	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138; Zhao, Jinkou/0000-0001-9184-3385	China-US cooperation on HIV prevention and care	China-US cooperation on HIV prevention and care	This work was supported by the China-US cooperation on HIV prevention and care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 2011 EST HIV AIDS EP; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Chapman J, 2008, SEX HEALTH, V5, P291, DOI 10.1071/SH07057; China CDC, 2011, NAT BEH BIOL SURV RE; China-CDC, 2009, NAT GUID DET HIV AID; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Cohen J, 2004, SCIENCE, V304, P1934, DOI 10.1126/science.304.5679.1934; Colfax G, 2006, CLIN INFECT DIS, V42, P1463, DOI 10.1086/503259; Fu JH, 2009, CHIN J PUBLIC HLTH, V25, P1004; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; Heimer R, 2005, AIDS BEHAV, V9, P403, DOI 10.1007/s10461-005-9030-1; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kang DM, 2011, AIDS CARE, V23, P26, DOI 10.1080/09540121.2011.560930; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Liao MZ, 2011, SEX TRANSM DIS, V38, P57, DOI 10.1097/OLQ.0b013e3181ebb475; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Ma X, 2007, J ACQ IMMUN DEF SYND, V45, P581; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Pascom AR, 2010, BRAZ J INFECT DIS, V14, P385, DOI 10.1590/S1413-86702010000400014; Potula R, 2008, AM J PATHOL, V172, P1467, DOI 10.2353/ajpath.2008.080130; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Scorgie F, 2011, AIDS BEHAV IN PRESS; Shandong Provincial CDC, 2010, COMPR REP HIV AIDS S; Shandong Provincial CDC, 2011, COMPR REP HIV AIDS S; Stormer A, 2006, J URBAN HEALTH, V83, pI73, DOI 10.1007/s11524-006-9105-y; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; UNODC, 2008, 2008 WORLD DRUG REP; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang Lan, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1009; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; World Health Organization, 2000, 2 GEN SURV HIV NEXT; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang XS, 2006, AIDS EDUC PREV, V18, P333, DOI 10.1521/aeap.2006.18.4.333	37	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2012	7	4							e34085	10.1371/journal.pone.0034085	http://dx.doi.org/10.1371/journal.pone.0034085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UP	22737230	Green Published, gold, Green Submitted			2022-12-25	WOS:000305341000007
J	Liao, M; Huang, XH; Gao, Y; Tan, AH; Lu, Z; Wu, CL; Zhang, YJ; Yang, XB; Zhang, HY; Qin, X; Mo, ZN				Liao, Ming; Huang, Xianghua; Gao, Yong; Tan, Aihua; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Mo, Zengnan			Testosterone Is Associated with Erectile Dysfunction: A Cross-Sectional Study in Chinese Men	PLOS ONE			English	Article							AGE-RELATED DECLINE; SEX-HORMONE LEVELS; AREA MALE HEALTH; RISK-FACTORS; INTERNATIONAL INDEX; ANDROGEN DEFICIENCY; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; PREVALENCE; SYMPTOMS	Background: Testosterone is essential for the regulation of erectile physiology, but the relationship between low testosterone and erectile dysfunction (ED) has not been firmly established. Purpose: To examine the association between serum total, free and bio-available testosterone and ED in a population-based sample. Methods: A consecutive series of 1776 men aged 20-77 participated in the routine physical examination from September 2009 to December 2009 in Guangxi, China. ED was assessed using the five-item International Index of Erectile Function (IIEF-5) questionnaire. Total testosterone (TT), sex hormone binding globulin (SHBG) and other biochemical profiles were measured. Free testosterone (FT) and bio-available testosterone (BT) were calculated based on Vermeulen's formula. Data were collected with regard to smoking, alcoholic drinking, physical activity and metabolic syndrome. Results: The prevalence of ED (IIEF-5<22) was 47.6%. Men with ED were significantly older, and more prone to smoke cigarettes (>= 20 cigarettes/day) or drink alcohol (>= 3 drinks/week), and more likely to have elevated blood pressure (P = 0.036) or hyperglycemia (P < 0.001) compared with those without ED. The significant increase in SHBG with age was parallel to its increase with increasing severity of ED (P < 0.001). The obscure increase in TT across the ED status was detected without significance (P = 0.418), but TT was positively associated with ED after adjustment for age [odds ratio (OR) = 1.02, 95% CI (confidence internal): 1.00-1.04]. FT and BT were inversely associated with ED (OR = 0.14, 95% CI: 0.06-0.33; OR = 0.92 (95% CI: 0.89-0.96, respectively) in the univariate analysis, and this inverse association appeared to be independent of smoking status, alcoholic drinking, physical activity, hyper-triglyceridemia and hyperglycemia. Conclusions: FT and BT are inversely related to worsening ED, whereas the positive association between TT and ED is most likely due to the increase in SHBG.	[Liao, Ming; Gao, Yong; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Liao, Ming; Huang, Xianghua; Gao, Yong; Tan, Aihua; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Yang, Xiaobo; Zhang, Haiying; Qin, Xue; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Tan, Aihua] Guangxi Med Univ, Affiliated Hosp 1, Ctr Metab Dis & Diabet, Nanning, Guangxi Zhuang, Peoples R China; [Yang, Xiaobo; Zhang, Haiying] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Gao, Yong] Fudan Univ, Sch Life Sci, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Huang, Xianghua] Guigang Peoples Hosp, Dept Urol, Guigang, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University	Liao, M (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138; Zhao, Jinkou/0000-0001-9184-3385	National Natural Science Foundation of China [30945204]; Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China [2009GJCJ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China	The work described in this article is supported by grants from the National Natural Science Foundation of China (Grant No. 30945204) and the Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China (Grant No. 2009GJCJ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2002, BJU INT, V89, P526, DOI 10.1046/j.1464-410X.2002.02650.x; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Armagan A, 2006, J ANDROL, V27, P517, DOI 10.2164/jandrol.05157; Bai Q, 2004, ASIAN J ANDROL, V6, P343; Basar MM, 2005, UROLOGY, V66, P597, DOI 10.1016/j.urology.2005.03.060; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Christensen BS, 2011, J SEX MED, V8, P1903, DOI 10.1111/j.1743-6109.2011.02291.x; Chughtai B, 2011, CURR OPIN UROL, V21, P514, DOI 10.1097/MOU.0b013e32834b8681; Corona G, 2004, INT J IMPOT RES, V16, P395, DOI 10.1038/sj.ijir.3901225; Corona G, 2009, INT J ANDROL, V32, P720, DOI 10.1111/j.1365-2605.2009.00952.x; Corona G, 2010, J SEX MED, V7, P1362, DOI 10.1111/j.1743-6109.2009.01601.x; Corona G, 2010, J SEX MED, V7, P182, DOI 10.1111/j.1743-6109.2009.01497.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DAMASSA DA, 1977, HORM BEHAV, V8, P275, DOI 10.1016/0018-506X(77)90002-2; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fisher AD, 2009, J SEX MED, V6, P866, DOI 10.1111/j.1743-6109.2008.01140.x; Gades NM, 2008, J SEX MED, V5, P2209, DOI 10.1111/j.1743-6109.2008.00924.x; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Gooren LJG, 1996, BRIT J UROL, V78, P763, DOI 10.1046/j.1464-410X.1996.05918.x; Grover SA, 2006, ARCH INTERN MED, V166, P213, DOI 10.1001/archinte.166.2.213; Hao ZY, 2011, J ANDROL, V32, P496, DOI 10.2164/jandrol.110.012138; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Kocoglu H, 2011, AGING MALE, V14, P207, DOI 10.3109/13685538.2011.617798; Kupelian V, 2007, EUR UROL, V52, P416, DOI 10.1016/j.eururo.2007.03.015; Kupelian V, 2010, PREV MED, V50, P19, DOI 10.1016/j.ypmed.2009.11.006; Lee ACK, 2010, INT J IMPOT RES, V22, P272, DOI 10.1038/ijir.2010.15; Lee JC, 2011, BJU INT, V107, P956, DOI 10.1111/j.1464-410X.2010.09691.x; Lu Z, 2012, PROSTATE, V72, P193, DOI 10.1002/pros.21421; Ly LP, 2010, CLIN ENDOCRINOL, V73, P382, DOI 10.1111/j.1365-2265.2010.03804.x; Muezzinoglu T, 2007, YONSEI MED J, V48, P1015, DOI 10.3349/ymj.2007.48.6.1015; O'Connor DB, 2011, J CLIN ENDOCR METAB, V96, pE1577, DOI 10.1210/jc.2010-2216; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Rhoden EL, 2002, INT J IMPOT RES, V14, P167, DOI 10.1038/sj.ijir.3900852; Rhoden EL, 2002, J UROLOGY, V167, P1745, DOI 10.1016/S0022-5347(05)65191-9; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Traish AM, 2007, EUR UROL, V52, P54, DOI 10.1016/j.eururo.2007.02.034; Traish AM, 2006, J SEX MED, V3, P382, DOI 10.1111/j.1743-6109.2006.00245.x; Tsujimura A, 2003, J UROLOGY, V170, P2345, DOI 10.1097/01.ju.0000089768.17091.c0; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; VERMEULEN A, 1993, ANN MED, V25, P531; Wu CL, 2011, J ANDROL, V33, P59, DOI 10.2164/jandrol.110.012542; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101	46	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2012	7	6							e39234	10.1371/journal.pone.0039234	http://dx.doi.org/10.1371/journal.pone.0039234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KY	22737230	Green Published, gold, Green Submitted			2022-12-25	WOS:000305695100028
J	Chen, MN; Li, X; Yang, QL; Chi, XY; Pan, LJ; Chen, N; Yang, Z; Wang, T; Wang, MA; Yu, SL				Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin			Soil Eukaryotic Microorganism Succession as Affected by Continuous Cropping of Peanut - Pathogenic and Beneficial Fungi were Selected	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; SOILBORNE DISEASES; MYCORRHIZAL FUNGI; ENZYME-ACTIVITIES; PLANT-PATHOGENS; YIELD DECLINE; BIOCONTROL; DIVERSITY; TRICHODERMA; POPULATIONS	Peanut is an important oil crop worldwide and shows considerable adaptability but growth and yield are negatively affected by continuous cropping. Soil micro-organisms are efficient bio-indicators of soil quality and plant health and are critical to the sustainability of soil-based ecosystem function and to successful plant growth. In this study, 18S rRNA gene clone library analyses were employed to study the succession progress of soil eukaryotic micro-organisms under continuous peanut cultivation. Eight libraries were constructed for peanut over three continuous cropping cycles and its representative growth stages. Cluster analyses indicated that soil micro-eukaryotic assemblages obtained from the same peanut cropping cycle were similar, regardless of growth period. Six eukaryotic groups were found and fungi predominated in all libraries. The fungal populations showed significant dynamic change and overall diversity increased over time under continuous peanut cropping. The abundance and/or diversity of clones affiliated with Eurotiales, Hypocreales, Glomerales, Orbiliales, Mucorales and Tremellales showed an increasing trend with continuous cropping but clones affiliated with Agaricales, Cantharellales, Pezizales and Pyxidiophorales decreased in abundance and/or diversity over time. The current data, along with data from previous studies, demonstrated that the soil microbial community was affected by continuous cropping, in particular, the pathogenic and beneficial fungi that were positively selected over time, which is commonplace in agro-ecosystems. The trend towards an increase in fungal pathogens and simplification of the beneficial fungal community could be important factors contributing to the decline in peanut growth and yield over many years of continuous cropping.	[Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Peoples R China		Chen, MN (corresponding author), Shandong Peanut Res Inst, Qingdao, Peoples R China.	yshanlin1956@163.com	Lung, Shih-Chun Candice/ABA-1011-2020; Lung, Shih-Chun Candice/GYD-5623-2022; Lin, CY/K-6503-2014; lin, chuan/HHD-2571-2022	Lung, Shih-Chun Candice/0000-0002-4227-0469; Lung, Shih-Chun Candice/0000-0002-4227-0469; Lin, CY/0000-0002-0005-7088; Su, Huey-Jen/0000-0003-3589-9987	China Agriculture Research System [CARS-14]; National Natural Science Foundation of China [31000728, 31100205]; Natural Science Fund of Shangdong Province [ZR2009DQ004, ZR2011CQ036]; Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province [BS2010NY023]; Qingdao Municipal Science and Technology Plan Project [11-2-4-9-(3)-jch, 11-2-3-26-nsh]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shangdong Province; Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from China Agriculture Research System (CARS-14), the National Natural Science Foundation of China (31000728; 31100205), the Natural Science Fund of Shangdong Province (ZR2009DQ004; ZR2011CQ036), the Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province (BS2010NY023), Qingdao Municipal Science and Technology Plan Project (11-2-4-9-(3)-jch; 11-2-3-26-nsh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2008, CROP PROT, V27, P410, DOI 10.1016/j.cropro.2007.07.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anaissie EJ, 2002, CLIN INFECT DIS, V34, P780, DOI 10.1086/338958; Avidano L, 2005, APPL SOIL ECOL, V30, P21, DOI 10.1016/j.apsoil.2005.01.003; Benhamou N, 2004, PHYTOPATHOLOGY, V94, P693, DOI 10.1094/PHYTO.2004.94.7.693; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; Blakney AJC, 2011, FEMS MICROBIOL ECOL, V77, P546, DOI 10.1111/j.1574-6941.2011.01136.x; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Bruehl GW., 1987, SOILBORNE PLANT PATH; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Budi SW, 1999, APPL ENVIRON MICROB, V65, P5148; Caesar-TonThat T, 2010, EUR J SOIL BIOL, V46, P119, DOI 10.1016/j.ejsobi.2009.12.004; Cizkova D, 2005, FOLIA MICROBIOL, V50, P59, DOI 10.1007/BF02931294; Cotxarrera L, 2002, SOIL BIOL BIOCHEM, V34, P467, DOI 10.1016/S0038-0717(01)00205-X; CURL EA, 1988, CRIT REV PLANT SCI, V7, P175, DOI 10.1080/07352688809382263; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; DELEIJ FAAM, 1995, APPL ENVIRON MICROB, V61, P3443, DOI 10.1128/AEM.61.9.3443-3453.1995; Dobermann A, 2000, AGRON J, V92, P633, DOI 10.2134/agronj2000.924633x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031806; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Heydari A., 2010, Journal of Biological Sciences, V10, P273; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3378, DOI 10.1128/AEM.02715-09; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; JOHNSON NC, 1992, AGRON J, V84, P387, DOI 10.2134/agronj1992.00021962008400030007x; Kandeler E, 2006, SOIL BIOL BIOCHEM, V38, P2448, DOI 10.1016/j.soilbio.2006.02.021; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; Kubicek C. P., 2001, Journal of Plant Pathology, V83, P11; Larkin RP, 2008, SOIL BIOL BIOCHEM, V40, P1341, DOI 10.1016/j.soilbio.2007.03.005; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; Lithourgidis AS, 2006, EUR J AGRON, V25, P208, DOI 10.1016/j.eja.2006.05.003; Lutz MP, 2003, APPL ENVIRON MICROB, V69, P3077, DOI 10.1128/AEM.69.6.3077-3084.2003; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; Morace Giulia, 2012, Int J Microbiol, V2012, P349278, DOI 10.1155/2012/349278; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Nayyar A, 2009, APPL SOIL ECOL, V43, P115, DOI 10.1016/j.apsoil.2009.06.008; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pankhurst CE, 1996, BIODIVERS CONSERV, V5, P197, DOI 10.1007/BF00055830; Pliego C, 2011, PLANT SOIL, V340, P505, DOI 10.1007/s11104-010-0615-8; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Reichardt W, 1997, APPL ENVIRON MICROB, V63, P233, DOI 10.1128/AEM.63.1.233-238.1997; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sharma KK, 2006, METH MOL B, V343, P347; Sikes BA, 2009, J ECOL, V97, P1274, DOI 10.1111/j.1365-2745.2009.01557.x; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Sudini H, 2011, PHYTOPATHOLOGY, V101, P819, DOI 10.1094/PHYTO-11-10-0310; Tedersoo L, 2006, NEW PHYTOL, V170, P581, DOI 10.1111/j.1469-8137.2006.01678.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Elsas JD., 2006, MODERN SOIL MICROBIO, DOI [10.1201/9781420015201, DOI 10.1201/9781420015201]; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027381; Wehner J, 2010, PEDOBIOLOGIA, V53, P197, DOI 10.1016/j.pedobi.2009.10.002; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2; Ying SH, 2004, J APPL MICROBIOL, V97, P323, DOI 10.1111/j.1365-2672.2004.02311.x	64	185	204	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40659	10.1371/journal.pone.0040659	http://dx.doi.org/10.1371/journal.pone.0040659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22737206	Green Published, Green Submitted, gold			2022-12-25	WOS:000306355500068
J	Lee, BR; Huseby, S; Koprivova, A; Chetelat, A; Wirtz, M; Mugford, ST; Navid, E; Brearley, C; Saha, S; Mithen, R; Hell, R; Farmer, EE; Kopriva, S				Lee, Bok-Rye; Huseby, Stine; Koprivova, Anna; Chetelat, Aurore; Wirtz, Markus; Mugford, Sam T.; Navid, Emily; Brearley, Charles; Saha, Shikha; Mithen, Richard; Hell, Ruediger; Farmer, Edward E.; Kopriva, Stanislav			Effects of fou8/fry1 Mutation on Sulfur Metabolism: Is Decreased Internal Sulfate the Trigger of Sulfate Starvation Response?	PLOS ONE			English	Article							ADENOSINE 5'-PHOSPHOSULFATE REDUCTASE; INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; OF-FUNCTION ALLELE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; 5-PHOSPHOSULFATE REDUCTASE; TRANSCRIPTOME ANALYSIS; GLUTATHIONE-DEFICIENT; NEGATIVE REGULATOR; SALT TOLERANCE	The fou8 loss of function allele of adenosine bisphosphate phosphatase FIERY1 results in numerous phenotypes including the increased enzymatic oxygenation of fatty acids and increased jasmonate synthesis. Here we show that the mutation causes also profound alterations of sulfur metabolism. The fou8 mutants possess lower levels of sulfated secondary compounds, glucosinolates, and accumulate the desulfo-precursors similar to previously described mutants in adenosine 5'phosphosulfate kinase. Transcript levels of genes involved in sulfate assimilation differ in fou8 compared to wild type Col-0 plants and are similar to plants subjected to sulfate deficiency. Indeed, independent microarray analyses of various alleles of mutants in FIERY1 showed similar patterns of gene expression as in sulfate deficient plants. This was not caused by alterations in signalling, as the fou8 mutants contained significantly lower levels of sulfate and glutathione and, consequently, of total elemental sulfur. Analysis of mutants with altered levels of sulfate and glutathione confirmed the correlation of sulfate deficiency-like gene expression pattern with low internal sulfate but not low glutathione. The changes in sulfur metabolism in fou8 correlated with massive increases in 3'-phosphoadenosine 5'-phosphate levels. The analysis of fou8 thus revealed that sulfate starvation response is triggered by a decrease in internal sulfate as opposed to external sulfate availability and that the presence of desulfo-glucosinolates does not induce the glucosinolate synthesis network. However, as well as resolving these important questions on the regulation of sulfate assimilation in plants, fou8 has also opened an array of new questions on the links between jasmonate synthesis and sulfur metabolism.	[Lee, Bok-Rye; Huseby, Stine; Koprivova, Anna; Mugford, Sam T.; Kopriva, Stanislav] Norwich Res Pk, John Innes Ctr, Norwich, Norfolk, England; [Huseby, Stine] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Chetelat, Aurore; Navid, Emily; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Wirtz, Markus; Hell, Ruediger] Heidelberg Inst Plant Sci HIP, Heidelberg, Germany; [Brearley, Charles] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Saha, Shikha; Mithen, Richard] Norwich Res Pk, Inst Food Res, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Norwegian University of Life Sciences; University of Lausanne; Ruprecht Karls University Heidelberg; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Lee, BR (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	stanislav.kopriva@jic.ac.uk	Hell, Ruediger/E-5436-2014; Wirtz, Markus/G-5917-2010; Kopriva, Stanislav/C-7401-2013; Farmer, Edward E/H-1635-2011	Wirtz, Markus/0000-0001-7790-4022; Kopriva, Stanislav/0000-0002-7416-6551; Brearley, Charles/0000-0001-6179-9109; Hell, Ruediger/0000-0002-6238-4818; Mugford, Sam/0000-0002-8537-5578; Mithen, Richard/0000-0001-7307-4324; Ryu, Choong-Min/0000-0002-7276-1189; Saha, Shikha/0000-0002-5010-5105	British Biotechnology and Biological Sciences Research Council (BBSRC); Swiss National Science Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044431] Funding Source: researchfish; BBSRC [BBS/E/F/00044431] Funding Source: UKRI	British Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SK's research is supported by British Biotechnology and Biological Sciences Research Council (BBSRC). EEF is supported by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball L, 2004, PLANT CELL, V16, P2448, DOI 10.1105/tpc.104.022608; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bonaventure G, 2007, PLANT CELL PHYSIOL, V48, P1775, DOI 10.1093/pcp/pcm151; Bonaventure G, 2007, PLANT J, V49, P889, DOI 10.1111/j.1365-313X.2006.03002.x; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Burstenbinder K, 2007, PLANT J, V49, P238, DOI 10.1111/j.1365-313X.2006.02942.x; Caldelari D, 1998, PHYTOCHEMISTRY, V47, P599, DOI 10.1016/S0031-9422(97)00443-3; Carland F, 2009, PLANT J, V59, P895, DOI 10.1111/j.1365-313X.2009.03920.x; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Chen H, 2010, PLANT CELL ENVIRON, V33, P2180, DOI 10.1111/j.1365-3040.2010.02218.x; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Cobbett CS, 1998, PLANT J, V16, P73, DOI 10.1046/j.1365-313x.1998.00262.x; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harada E, 2000, J PLANT PHYSIOL, V156, P272, DOI 10.1016/S0176-1617(00)80317-X; Hartmann T, 2004, J EXP BOT, V55, P837, DOI 10.1093/jxb/erh094; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Hirsch J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016724; Jost R, 2005, PHOTOSYNTH RES, V86, P491, DOI 10.1007/s11120-005-7386-8; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Klein M, 2006, FEBS J, V273, P122, DOI 10.1111/j.1742-4658.2005.05048.x; Kopriva S, 1999, PLANT J, V20, P37, DOI 10.1046/j.1365-313X.1999.00573.x; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Koprivova A, 2010, PLANT CELL REP, V29, P1157, DOI 10.1007/s00299-010-0902-0; Lee BR, 2011, PLANT J, V67, P1042, DOI 10.1111/j.1365-313X.2011.04656.x; Malitsky S, 2008, PLANT PHYSIOL, V148, P2021, DOI 10.1104/pp.108.124784; Maruyama-Nakashita A, 2003, PLANT PHYSIOL, V132, P597, DOI 10.1104/pp.102.019802; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mugford SG, 2011, PLANT J, V65, P96, DOI 10.1111/j.1365-313X.2010.04410.x; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Nikiforova V, 2003, PLANT J, V33, P633, DOI 10.1046/j.1365-313X.2003.01657.x; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Piotrowski M, 2004, J BIOL CHEM, V279, P50717, DOI 10.1074/jbc.M407681200; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; Scheerer U, 2010, J EXP BOT, V61, P609, DOI 10.1093/jxb/erp327; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Troufflard S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-172; Underhill E. W., 1973, BIOCH SOC S, V38, P303; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Wirtz M, 2003, AMINO ACIDS, V24, P195, DOI 10.1007/s00726-002-0313-9; Xiong LM, 2004, PLANT J, V40, P536, DOI 10.1111/j.1365-313X.2004.02225.x; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x	58	148	155	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39425	10.1371/journal.pone.0039425	http://dx.doi.org/10.1371/journal.pone.0039425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	23209558	gold, Green Submitted, Green Published			2022-12-25	WOS:000305583300140
J	Chen, QY; Wang, H; Liu, Y; Song, YJ; Lai, LH; Han, Q; Cao, XT; Wang, QQ				Chen, Qingyun; Wang, Hui; Liu, Yang; Song, Yinjing; Lai, Lihua; Han, Quan; Cao, Xuetao; Wang, Qingqing			Inducible MicroRNA-223 Down-Regulation Promotes TLR-Triggered IL-6 and IL-1 beta Production in Macrophages by Targeting STAT3	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL TRANSDUCER; IN-VIVO; TRANSCRIPTION; EXPRESSION; INTERLEUKIN-6; INFLAMMATION; ALPHA; LIPOPOLYSACCHARIDE; DIFFERENTIATION	MicroRNAs are small non-coding RNA molecules that regulate gene expression by either translational inhibition or mRNA degradation. MicroRNAs play pivotal roles in the regulation of both innate and adaptive immune responses, including TLR-triggered inflammatory response. Here we reported that the expression of microRNA-223 (miR-223) was significantly decreased in murine macrophages during activation by lipopolysaccharide (LPS) or poly (I:C) stimulation. The inducible miR-223 down-regulation resulted in the activation of signal transducer and activator of transcription 3 (STAT3), which is directly targeted by miR-223, thus promoting the production of pro-inflammatory cytokines IL-6 and IL-1 beta, but not TNF-alpha. Interestingly, IL-6 was found to be a main factor in inducing the decrease in miR-223 expression after LPS stimulation, which formed a positive feedback loop to regulate IL-6 and IL-1 beta. Herein, our findings provide a new explanation characterizing the molecular mechanism responsible for the regulation of IL-6 production after TLR-triggered macrophage activation.	[Chen, Qingyun; Liu, Yang; Song, Yinjing; Lai, Lihua; Han, Quan; Cao, Xuetao; Wang, Qingqing] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hui] Chinese Peoples Armed Police Force, Coll Med, Tianjin, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University	Chen, QY (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	wqq@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		National Natural Science Foundation of China [81072405]; Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China [NCET-08-0486]; Zhejiang Provincial Natural Science Foundation of China [R2100528]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	This work was supported by grants from the National Natural Science Foundation of China (81072405), Program for New Century Excellent Talents in University from Ministry of Education of People's Republic of China (NCET-08-0486), grant from Zhejiang Provincial Natural Science Foundation of China (R2100528) and also sponsored by Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; HACK CE, 1989, BLOOD, V74, P1704; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lee C, 2006, MOL PHARMACOL, V69, P1041, DOI 10.1124/mol.105.018481; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; O'Connell RM., 2011, ANN REV IMMUNOL; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Prele CM, 2007, CLIN EXP IMMUNOL, V147, P564, DOI 10.1111/j.1365-2249.2006.03291.x; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547	35	231	245	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e42971	10.1371/journal.pone.0042971	http://dx.doi.org/10.1371/journal.pone.0042971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22723833	Green Published, gold, Green Submitted			2022-12-25	WOS:000308225500025
J	Chen, QY; Park, HC; Goligorsky, MS; Chander, P; Fischer, SM; Gross, SS				Chen, Qiuying; Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen; Fischer, Steven M.; Gross, Steven S.			Untargeted Plasma Metabolite Profiling Reveals the Broad Systemic Consequences of Xanthine Oxidoreductase Inactivation in Mice	PLOS ONE			English	Article							KYNURENINE PATHWAY ENZYMES; CHRONIC KIDNEY-DISEASE; REPERFUSION INJURY; METABOLOMICS; ALLOPURINOL; OXIDASE; IDENTIFICATION; CHROMATOGRAPHY; DEHYDROGENASE; ERYTHROCYTE	A major challenge in systems biology is integration of molecular findings for individual enzyme activities into a cohesive high-level understanding of cellular metabolism and physiology/pathophysiology. However, meaningful prediction for how a perturbed enzyme activity will globally impact metabolism in a cell, tissue or intact organisms is precluded by multiple unknowns, including in vivo enzymatic rates, subcellular distribution and pathway interactions. To address this challenge, metabolomics offers the potential to simultaneously survey changes in thousands of structurally diverse metabolites within complex biological matrices. The present study assessed the capability of untargeted plasma metabolite profiling to discover systemic changes arising from inactivation of xanthine oxidoreductase (XOR), an enzyme that catalyzes the final steps in purine degradation. Using LC-MS coupled with a multivariate statistical data analysis platform, we confidently surveyed >3,700 plasma metabolites (50-1,000 Da) for differential expression in XOR wildtype vs. mice with inactivated XOR, arising from gene deletion or pharmacological inhibition. Results confirmed the predicted derangements in purine metabolism, but also revealed unanticipated perturbations in metabolism of pyrimidines, nicotinamides, tryptophan, phospholipids, Krebs and urea cycles, and revealed kidney dysfunction biomarkers. Histochemical studies confirmed and characterized kidney failure in xor-nullizygous mice. These findings provide new insight into XOR functions and demonstrate the power of untargeted metabolite profiling for systemic discovery of direct and indirect consequences of gene mutations and drug treatments.	[Chen, Qiuying; Gross, Steven S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Med, Renal Res Inst, Valhalla, NY 10595 USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Pathol, Renal Res Inst, Valhalla, NY 10595 USA; [Park, Hyeong-Cheon; Goligorsky, Michael S.; Chander, Praveen] New York Med Coll, Dept Pharmacol, Renal Res Inst, Valhalla, NY 10595 USA; [Fischer, Steven M.] Agilent Technol, Metab Lab, Santa Clara, CA USA	Cornell University; New York Medical College; Renal Research Institute; New York Medical College; Renal Research Institute; New York Medical College; Renal Research Institute; Agilent Technologies	Chen, QY (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA.	ssgross@med.cornell.edu	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022		NIH (National Institute of Health) [HL87062, HD067244, K45462, tDK84394]	NIH (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by NIH (National Institute of Health) grants HL87062 (SSG), HD067244 (SSG), K45462 (MSG) and tDK84394 (MSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Barbas C, 2011, J PHARMACEUT BIOMED, V55, P823, DOI 10.1016/j.jpba.2011.02.001; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Battelli MG, 2011, J BIOL REG HOMEOS AG, V25, P77; Biasioli S, 1987, Nephrol Dial Transplant, V2, P313; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Chohan S, 2009, CURR OPIN RHEUMATOL, V21, P143, DOI 10.1097/BOR.0b013e328325bd94; Cubbon S, 2010, MASS SPECTROM REV, V29, P671, DOI 10.1002/mas.20252; Dawson J, 2009, BRIT J CLIN PHARMACO, V68, P662, DOI 10.1111/j.1365-2125.2009.03497.x; Dewan AK, 2010, PEDIATR DERMATOL, V27, P270, DOI 10.1111/j.1525-1470.2009.00983.x; Drexler DM, 2011, ANAL BIOANAL CHEM, V399, P2645, DOI 10.1007/s00216-010-4370-8; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiehn O, 2009, QUALITY CONTROL META; Fini MA, 2011, MOL CANCER RES, V9, P1242, DOI 10.1158/1541-7786.MCR-11-0176; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; George Jacob, 2009, Ther Clin Risk Manag, V5, P799; Gibbings S, 2011, J BIOL CHEM, V286, P961, DOI 10.1074/jbc.M110.150847; Gierasch LM, 2009, NAT CHEM BIOL, V5, P774, DOI 10.1038/nchembio.241; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Govani SM, 2010, J CROHNS COLITIS, V4, P444, DOI 10.1016/j.crohns.2010.02.009; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Huang LY, 2010, NITRIC OXIDE-BIOL CH, V22, P191, DOI 10.1016/j.niox.2010.01.004; Igarashi K, 2006, AMINO ACIDS, V31, P477, DOI 10.1007/s00726-006-0264-7; Issaq HJ, 2009, J SEP SCI, V32, P2183, DOI 10.1002/jssc.200900152; Joel D.KoppleSGM, 2004, UREMIC TOXICITY ITS, P682; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kim AW, 2011, LUNG CANCER, V71, P186, DOI 10.1016/j.lungcan.2010.05.006; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Linder N, 2011, GYNECOL ONCOL; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Martelin E, 2002, AM J PHYSIOL-CELL PH, V283, pC1722, DOI 10.1152/ajpcell.00280.2002; McManaman JL, 2002, J BIOL CHEM, V277, P21261, DOI 10.1074/jbc.M200828200; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Michopoulos F, 2009, J PROTEOME RES, V8, P2114, DOI 10.1021/pr801045q; Nagrath D, 2011, BBA-BIOENERGETICS, V1807, P650, DOI 10.1016/j.bbabio.2011.03.006; Nishino T, 2002, J BIOCHEM, V132, P597, DOI 10.1093/oxfordjournals.jbchem.a003262; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; Ohtsubo T, 2009, HYPERTENSION, V54, P868, DOI 10.1161/HYPERTENSIONAHA.109.135152; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pesek JJ, 2009, J SEP SCI, V32, P2200, DOI 10.1002/jssc.200900270; Reaves ML, 2011, CURR OPIN BIOTECH, V22, P17, DOI 10.1016/j.copbio.2010.10.001; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Sanders SA, 1999, ANTIOXID REDOX SIGN, V1, P371, DOI 10.1089/ars.1999.1.3-371; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; SPECTOR T, 1986, BIOCHEM PHARMACOL, V35, P3109, DOI 10.1016/0006-2952(86)90394-1; Stamp LK, 2010, ARTHRITIS RHEUM; SWENDSEID ME, 1978, AM J CLIN NUTR, V31, P1581, DOI 10.1093/ajcn/31.9.1581; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Tankiewicz A, 2003, ADV EXP MED BIOL, V527, P409; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Wei XL, 2011, ANAL CHEM, V83, P7668, DOI 10.1021/ac2017025; Weisenberg SA, 2009, J SEP SCI, V32, P2262, DOI 10.1002/jssc.200900256; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P66, DOI 10.1016/S0891-5849(97)00165-2; Zhang Z, 1998, FREE RADICAL RES, V28, P151, DOI 10.3109/10715769809065801	60	231	245	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e37149	10.1371/journal.pone.0037149	http://dx.doi.org/10.1371/journal.pone.0037149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	22723833	Green Submitted, gold, Green Published			2022-12-25	WOS:000305583300005
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	23029330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	23029330	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	23029330	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400093
